Resistance O O
to O O
IL-10 O O
inhibition O O
of O O
interferon O O
gamma O O
production O O
and O O
expression O O
of O O
suppressor O O
of O O
cytokine O O
signaling O O
1 O O
in O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O

Abstract O O

IL-10 O O
has O O
been O O
shown O O
to O O
block O O
the O O
antigen-specific O O
T-cell O O
cytokine O O
response O O
by B-conn Purpose.Enablement
inhibiting O O
the O O
CD28 O O
signaling O O
pathway O O
. O O

We O O
found O O
that O O
peripheral O O
blood O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
active O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
were O O
able O O
to O O
produce O O
greater O O
amounts O O
of O O
interferon O O
gamma O O
after B-conn Temporal.Succession
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
the O O
presence O O
of O O
1 O O
ng/ml O O
IL-10 O O
than O O
were O O
normal O O
control O O
CD4+ O O
T O O
cells O O
, O O
although B-conn Concession.Expectation
their O O
surface O O
expression O O
of O O
the O O
type O O
1 O O
IL-10 O O
receptor O O
was O O
increased O O
. O O

The O O
phosphorylation O O
of O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
3 O O
was O O
sustained O O
in O O
both O O
blood O O
and O O
synovial O O
tissue O O
CD4+ O O
T O O
cells O O
of O O
RA O O
, O O
but B-conn Contrast
it O O
was O O
not O O
augmented O O
by O O
the O O
presence O O
of O O
1 O O
ng/ml O O
IL-10 O O
. O O

Sera O O
from O O
RA O O
patients O O
induced O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
3 O O
phosphorylation O O
in O O
normal O O
CD4+ O O
T O O
cells O O
, O O
which O O
was O O
mostly O O
abolished O O
by B-conn Purpose.Enablement
neutralizing O O
anti-IL-6 O O
antibody O O
. O O

Preincubation O O
of O O
normal O O
CD4+ O O
T O O
cells O O
with O O
IL-6 O O
reduced O O
IL-10-mediated O O
inhibition O O
of O O
interferon O O
gamma O O
production O O
. O O

Blood O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
contained O O
higher O O
levels O O
of O O
suppressor O O
of O O
cytokine O O
signaling O O
1 O O
but O O
lower O O
levels O O
of O O
suppressor O O
of O O
cytokine O O
signaling O O
3 O O
mRNA O O
compared O O
with O O
control O O
CD4+ O O
T O O
cells O O
, O O
as O O
determined O O
by O O
real-time O O
PCR O O
. O O

These O O
results O O
indicate O O
that O O
RA O O
CD4+ O O
T O O
cells O O
become O O
resistant O O
to O O
the O O
immunosuppressive O O
effect O O
of O O
IL-10 O O
before B-conn Temporal.Precedence
migration O O
into O O
synovial O O
tissue O O
, O O
and B-conn Conjunction
this O O
impaired O O
IL-10 O O
signaling O O
may O O
be O O
associated O O
with O O
sustained O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
3 O O
activation O O
and O O
suppressor O O
of O O
cytokine O O
signaling O O
1 O O
induction O O
. O O

Introduction O O

IL-10 O O
is O O
a O O
key O O
cytokine O O
in O O
regulating O O
inflammatory O O
responses O O
, O O
mainly B-conn Purpose.Enablement
by I-conn Purpose.Enablement
inhibiting O O
the O O
production O O
and O O
function O O
of O O
proinflammatory O O
cytokines O O
. O O

IL-10 O O
binds O O
to O O
the O O
IL-10 O O
receptor O O
-LRB- O O
IL-10R O O
-RRB- O O
complex O O
that O O
is O O
composed O O
of O O
two O O
subunits O O
, O O
the O O
primary O O
ligand-binding O O
component O O
type O O
1 O O
IL-10R O O
-LRB- O O
IL-10R1 O O
-RRB- O O
and O O
the O O
accessory O O
component O O
type O O
2 O O
IL-10R O O
-LSB-1 O O
-RSB- O O
. O O

The O O
interaction O O
of O O
IL-10 O O
and O O
IL-10R O O
engages O O
the O O
Janus O O
kinase O O
-LRB- O O
JAK O O
-RRB- O O
family O O
tyrosine O O
kinases O O
Jak1 O O
and O O
Tyk2 O O
, O O
which O O
are O O
constitutively O O
associated O O
with O O
IL-10R1 O O
and O O
type O O
2 O O
IL-10R O O
, O O
respectively O O
-LSB-2 O O
-RSB- O O
. O O

IL-10 O O
induces O O
tyrosine O O
phosphorylation O O
and O O
activation O O
of O O
the O O
latent O O
transcriptional O O
factors O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
-LRB- O O
STAT O O
-RRB- O O
3 O O
and O O
STAT1 O O
-LSB-3 O O
-RSB- O O
. O O

Upon O O
phosphorylation O O
, O O
STAT1 O O
and O O
STAT3 O O
proteins O O
form O O
homodimers O O
or O O
heterodimers O O
, O O
rapidly O O
translocate O O
into O O
the O O
nucleus O O
, O O
and O O
modulate O O
gene O O
transcription O O
. O O

Intriguingly O O
, O O
STAT3 O O
is O O
indispensable O O
for O O
both O O
IL-10-derived O O
anti-inflammatory O O
and O O
IL-6-derived O O
proinflammatory O O
responses O O
-LSB-4 O O
-RSB- O O
. O O

Studies O O
of O O
cell-type-specific O O
STAT3-deficient O O
mice O O
have O O
shown O O
that O O
STAT3 O O
activation O O
is O O
essential O O
for O O
IL-10-mediated O O
anti-inflammatory O O
reactions O O
in O O
macrophages O O
and O O
neutrophils O O
-LSB-5 O O
-RSB- O O
, O O
but O O
is O O
responsible O O
for O O
IL-6-mediated O O
prevention O O
of O O
apoptosis O O
in O O
T O O
cells O O
-LSB-6 O O
-RSB- O O
. O O

The O O
suppressor O O
of O O
cytokine O O
signaling O O
-LRB- O O
SOCS O O
-RRB- O O
proteins O O
have O O
been O O
identified O O
as O O
a O O
family O O
of O O
endogenous O O
JAK O O
kinase O O
inhibitors O O
that O O
can O O
act O O
in O O
classic O O
feedback O O
inhibition O O
loops O O
, O O
but B-conn Concession.Contra-expectation
their O O
roles O O
as O O
the O O
mediators O O
of O O
crosstalk O O
inhibition O O
by O O
opposing O O
cytokine O O
signaling O O
pathways O O
have O O
been O O
clarified O O
-LSB-7 O O
-RSB- O O
. O O

Recent O O
studies O O
indicate O O
that O O
SOCS3 O O
plays O O
a O O
key O O
role O O
in O O
regulating O O
the O O
divergent O O
action O O
of O O
IL-10 O O
and O O
IL-6 O O
, O O
by B-conn Purpose.Enablement
specifically B-conn Restatement.Specification
blocking O O
STAT3 O O
activation O O
induced O O
by O O
IL-6 O O
but O O
not O O
that O O
induced O O
by O O
IL-10 O O
-LSB-8,9 O O
-RSB- O O
. O O

The O O
synovial O O
membrane O O
of O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
is O O
characterized O O
by O O
an O O
infiltrate O O
of O O
a O O
variety O O
of O O
inflammatory O O
cells O O
, O O
such O O
as O O
lymphocytes O O
, O O
macrophages O O
, O O
and O O
dendritic O O
cells O O
, O O
together O O
with O O
proliferation O O
of O O
synovial O O
fibroblast-like O O
cells O O
. O O

Numerous O O
cytokines O O
are O O
overproduced O O
in O O
the O O
inflamed O O
joint O O
, O O
and B-conn Continuation
macrophages O O
and O O
synovial O O
fibroblasts O O
are O O
an O O
important O O
source O O
of O O
proinflammatory O O
cytokines O O
. O O

Tumor O O
necrosis O O
factor O O
alpha O O
-LRB- O O
TNF-α O O
-RRB- O O
and O O
IL-1 O O
, O O
two O O
major O O
macrophage O O
products O O
, O O
are O O
crucial O O
in O O
the O O
process O O
of O O
chronic O O
inflammation O O
and O O
joint O O
destruction O O
, O O
and B-conn Continuation
they O O
give O O
rise O O
to O O
effector O O
components O O
, O O
including O O
other O O
inflammatory O O
cytokines O O
, O O
chemokines O O
, O O
growth O O
factors O O
, O O
matrix O O
proteases O O
, O O
nitric O O
oxide O O
, O O
and O O
reactive O O
oxygen O O
species O O
-LSB-10 O O
-RSB- O O
. O O

IL-6 O O
is O O
a O O
pleiotropic O O
cytokine O O
produced O O
substantially O O
by O O
activated O O
fibroblasts O O
, O O
and B-conn Continuation
its O O
proinflammatory O O
actions O O
include O O
simulating O O
the O O
acute-phase O O
response O O
, O O
B-cell O O
maturation O O
into O O
plasma O O
cells O O
, O O
T-cell O O
functions O O
, O O
and O O
hematopoietic O O
precursor O O
cell O O
differentiation O O
-LSB-11 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
anti-inflammatory O O
cytokines O O
and O O
cytokine O O
inhibitors O O
are O O
also O O
present O O
in O O
large O O
quantities O O
in O O
RA O O
joints O O
. O O

IL-10 O O
, O O
produced O O
by O O
macrophages O O
and O O
partly O O
by O O
T O O
cells O O
in O O
the O O
synovial O O
tissue O O
-LRB- O O
ST O O
-RRB- O O
, O O
is O O
best O O
known O O
as O O
a O O
negative O O
regulator O O
for O O
macrophage O O
and O O
Th1 O O
cells O O
, O O
but B-conn Concession.Contra-expectation
the O O
expression O O
level O O
is O O
insufficient O O
to O O
counterbalance O O
the O O
cascade O O
of O O
proinflammatory O O
events O O
-LSB-12 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
anti-inflammatory O O
action O O
of O O
IL-10 O O
appears O O
to O O
be O O
modulated O O
at O O
the O O
level O O
of O O
signal O O
transduction O O
during O O
chronic O O
inflammation O O
. O O

IL-10 O O
signaling O O
is O O
impaired O O
in O O
macrophages O O
upon O O
chronic O O
exposure O O
to O O
proinflammatory O O
cytokines O O
such O O
as O O
TNF-α O O
and O O
IL-1 O O
and O O
immune O O
complexes O O
-LSB-13,14 O O
-RSB- O O
. O O

Cell O O
surface O O
expression O O
of O O
IL-10R1 O O
is O O
decreased O O
in O O
synovial O O
fluid O O
dendritic O O
cells O O
due O O
to O O
the O O
presence O O
of O O
TNF-α O O
, O O
IL-1 O O
, O O
and O O
granulocyte–macrophage O O
colony-stimulating O O
factor O O
-LSB-15 O O
-RSB- O O
. O O

CD4+ O O
T O O
cells O O
may O O
be O O
activated O O
by O O
arthritogenic O O
antigens O O
, O O
in O O
conjunction O O
with O O
CD28-mediated O O
costimulatory O O
signaling O O
, O O
in O O
RA O O
. O O

The O O
significance O O
of O O
this O O
autoimmune O O
process O O
has O O
been O O
supported O O
by O O
the O O
linkage O O
of O O
the O O
MHC O O
class O O
II O O
antigens O O
HLA-DRB1 O O
* O O
0404 O O
and O O
HLA-DRB1 O O
* O O
0401 O O
with O O
disease O O
susceptibility O O
and O O
severity O O
-LSB-16,17 O O
-RSB- O O
, O O
and O O
by O O
the O O
high-level O O
expression O O
of O O
MHC O O
class O O
II O O
molecules O O
and O O
both O O
CD28 O O
ligands O O
, O O
CD80 O O
and O O
CD86 O O
, O O
in O O
the O O
inflamed O O
ST O O
-LSB-18-20 O O
-RSB- O O
. O O

The O O
continuing O O
emergence O O
of O O
activated O O
CD4+ O O
T O O
cells O O
, O O
even O O
though O O
few O O
in O O
number O O
, O O
may O O
be O O
crucial O O
in O O
sustaining O O
the O O
activation O O
of O O
macrophages O O
and O O
synovial O O
fibroblasts O O
through O O
cell O O
surface O O
signaling O O
by O O
means O O
of O O
cell O O
surface O O
CD69 O O
and O O
CD11 O O
, O O
as O O
well O O
as O O
the O O
release O O
of O O
proinflammatory O O
Th1 O O
cytokines O O
such O O
as O O
interferon O O
gamma O O
-LRB- O O
IFN O O
-RRB- O O
-γ O O
and O O
IL-17 O O
-LSB-21,22 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
CD4+ O O
T O O
cells O O
could O O
stimulate O O
B-cell O O
production O O
of O O
autoantibodies O O
such O O
as O O
rheumatoid O O
factor O O
and O O
osteoclast-mediated O O
bone O O
destruction O O
. O O

Their O O
obligatory O O
role O O
in O O
RA O O
synovitis O O
was O O
recently O O
proved O O
by O O
successful O O
treatment O O
of O O
active O O
disease O O
by B-conn Purpose.Enablement
selective O O
inhibition O O
of O O
T-cell O O
activation O O
with O O
fusion O O
protein O O
of O O
cytotoxic O O
T-cell-associated O O
antigen O O
4 O O
-LRB- O O
CD152 O O
-RRB- O O
-IgG O O
, O O
which O O
can O O
block O O
the O O
engagement O O
of O O
CD28 O O
on O O
T O O
cells O O
by B-conn Purpose.Enablement
binding O O
to O O
CD80 O O
and O O
CD86 O O
with O O
high O O
avidity O O
-LSB-23 O O
-RSB- O O
. O O

IL-10 O O
efficiently O O
blocks O O
the O O
antigen-specific O O
T-cell O O
cytokine O O
response O O
by B-conn Purpose.Enablement
inhibiting O O
the O O
CD28 O O
signaling O O
pathway O O
-LSB-24 O O
-RSB- O O
, O O
as O O
well O O
as O O
indirectly O O
by B-conn Purpose.Enablement
downregulating O O
the O O
function O O
of O O
antigen-presenting O O
cells O O
. O O

To B-conn Purpose.Goal
elucidate O O
the O O
resistance O O
of O O
CD4+ O O
T O O
cells O O
to O O
this O O
direct O O
inhibition O O
in O O
RA O O
, O O
we O O
investigated O O
the O O
production O O
of O O
IFN-γ O O
after B-conn Temporal.Succession
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
the O O
presence O O
of O O
IL-10 O O
, O O
the O O
induction O O
of O O
STAT1 O O
and O O
STAT3 O O
phosphorylation O O
by O O
IL-10 O O
, O O
and O O
the O O
expression O O
of O O
SOCS1 O O
and O O
SOCS3 O O
mRNA O O
in O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
. O O

Materials O O
and O O
methods O O

The O O
total O O
patient O O
population O O
consisted O O
of O O
32 O O
patients O O
with O O
RA O O
-LRB- O O
25 O O
women O O
and O O
seven O O
men O O
; O O
mean O O
± O O
standard O O
deviation O O
age O O
, O O
52.8 O O
± O O
12.4 O O
years O O
-RRB- O O
diagnosed O O
according O O
to O O
the O O
revised O O
1987 O O
criteria O O
of O O
the O O
American O O
College O O
of O O
Rheumatology O O
-LRB- O O
formally O O
, O O
the O O
American O O
Rheumatism O O
Association O O
-RRB- O O
-LSB-25 O O
-RSB- O O
. O O

All O O
patients O O
were O O
receiving O O
prednisolone O O
-LRB- O O
≤ O O
7.5 O O
mg/day O O
-RRB- O O
and O O
disease-modifying O O
antirheumatic O O
drugs O O
. O O

Clinical O O
parameters O O
in O O
the O O
study O O
patients O O
were O O
as O O
follows O O
-LRB- O O
mean O O
± O O
standard O O
deviation O O
-RRB- O O
: O O
erythrocyte O O
sedimentation O O
rate O O
, O O
55.9 O O
± O O
35.4 O O
mm/hour O O
; O O
serum O O
C-reactive O O
protein O O
-LRB- O O
CRP O O
-RRB- O O
level O O
, O O
32.0 O O
± O O
32.0 O O
mg/l O O
; O O
and O O
IgM O O
class O O
rheumatoid O O
factor O O
titer O O
, O O
142 O O
± O O
158 O O
U/ml O O
. O O

Patients O O
were O O
divided O O
into O O
two O O
groups O O
: O O
24 O O
patients O O
with O O
active O O
disease O O
, O O
who O O
had O O
multiple O O
tender O O
and/or O O
swollen O O
joints O O
and O O
elevated O O
serum O O
CRP O O
level O O
-LRB- O O
≥ O O
10 O O
mg/l O O
-RRB- O O
; O O
and O O
eight O O
patients O O
with O O
inactive O O
disease O O
, O O
who O O
satisfied O O
the O O
American O O
College O O
of O O
Rheumatology O O
preliminary O O
criteria O O
for O O
clinical O O
remission O O
-LSB-26 O O
-RSB- O O
. O O

Sixteen O O
healthy O O
volunteers O O
-LRB- O O
11 O O
women O O
and O O
five O O
men O O
; O O
age O O
, O O
45.8 O O
± O O
11.2 O O
years O O
-RRB- O O
served O O
as O O
controls O O
. O O

ST O O
samples O O
were O O
obtained O O
from O O
three O O
RA O O
patients O O
undergoing O O
total O O
knee O O
replacement O O
. O O

All O O
patients O O
gave O O
informed O O
consent O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
were O O
prepared O O
from O O
heparinized O O
blood O O
samples O O
by B-conn Purpose.Enablement
centrifugation O O
over O O
Ficoll-Hypaque O O
density O O
gradients O O
-LRB- O O
Pharmacia O O
, O O
Uppsala O O
, O O
Sweden O O
-RRB- O O
. O O

CD4+ O O
T O O
cells O O
were O O
purified O O
from O O
PBMC O O
by B-conn Purpose.Enablement
positive O O
selection O O
using O O
anti-CD4 O O
mAb-coated O O
magnetic O O
beads O O
-LRB- O O
Miltenyi O O
Biotec O O
, O O
Gladbach O O
, O O
Germany O O
-RRB- O O
, O O
according O O
to O O
the O O
manufacturer O O
's O O
instructions O O
. O O

CD4+ O O
T O O
cells O O
were O O
isolated O O
from O O
ST O O
samples O O
, O O
as O O
previously O O
described O O
-LSB-27 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
fresh O O
ST O O
samples O O
were O O
fragmented O O
and O O
digested O O
with O O
collagenase O O
and O O
DNase O O
for O O
1 O O
hour O O
at O O
37°C O O
. O O

After B-conn Temporal.Succession
removing O O
tissue O O
debris O O
, O O
ST O O
cell O O
suspensions O O
in O O
culture O O
medium O O
-LRB- O O
RPMI O O
1640 O O
medium O O
; O O
Life O O
Technologies O O
, O O
Gaithersburg O O
, O O
MD O O
, O O
USA O O
-RRB- O O
supplemented O O
with O O
25 O O
mM O O
HEPES O O
-LRB- O O
2 O O
mM O O
L-glutamine O O
, O O
2 O O
% O O
nonessential O O
amino O O
acids O O
, O O
100 O O
IU/ml O O
penicillin O O
, O O
and O O
100 O O
mg/ml O O
streptomycin O O
; O O
Life O O
Technologies O O
-RRB- O O
with O O
10 O O
% O O
heat-inactivated O O
FCS O O
-LRB- O O
Life O O
Technologies O O
-RRB- O O
were O O
incubated O O
at O O
37°C O O
in O O
six-well O O
plates O O
-LRB- O O
Coster O O
, O O
Cambridge O O
, O O
MA O O
, O O
USA O O
-RRB- O O
for O O
45 O O
min O O
. O O

Non-adherent O O
cells O O
were O O
harvested O O
and B-conn Temporal.Precedence
CD4+ O O
T O O
cells O O
were O O
purified O O
by B-conn Purpose.Enablement
positive O O
selection O O
as O O
already O O
described O O
. O O

PB O O
CD4+ O O
T-cell O O
populations O O
were O O
resuspended O O
at O O
a O O
density O O
of O O
1 O O
× O O
106 O O
cells/ml O O
in O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
, O O
and B-conn Conjunction
0.5 O O
ml O O
cell O O
suspensions O O
were O O
dispensed O O
into O O
the O O
wells O O
of O O
24-well O O
microtiter O O
plates O O
-LRB- O O
Coster O O
-RRB- O O
coated O O
with O O
1 O O
μg/ml O O
anti-CD3 O O
mAb O O
-LRB- O O
Immunotech O O
, O O
Marseille O O
, O O
France O O
-RRB- O O
. O O

The O O
cells O O
were O O
incubated O O
with O O
1 O O
μg/ml O O
anti-CD28 O O
mAb O O
-LRB- O O
Immunotech O O
-RRB- O O
in O O
the O O
presence O O
or O O
absence O O
of O O
the O O
indicated O O
concentrations O O
of O O
IL-10 O O
-LRB- O O
Becton O O
Dickinson O O
, O O
San O O
Jose O O
, O O
CA O O
, O O
USA O O
-RRB- O O
at O O
37°C O O
in O O
a O O
humidified O O
atmosphere O O
containing O O
5 O O
% O O
CO2 O O
-LSB-28 O O
-RSB- O O
. O O

Culture O O
supernatants O O
were O O
collected O O
36 O O
hours O O
later O O
and B-conn Conjunction
cell-free O O
samples O O
were O O
stored O O
at O O
-30°C O O
until B-conn Temporal.Precedence
cytokine O O
assay O O
. O O

To B-conn Purpose.Goal
examine O O
the O O
effect O O
of O O
IL-6 O O
on O O
T-cell O O
responsiveness O O
to O O
IL-10 O O
, O O
CD4+ O O
T O O
cells O O
from O O
healthy O O
controls O O
were O O
incubated O O
in O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
in O O
the O O
presence O O
or O O
absence O O
of O O
10 O O
ng/ml O O
IL-6 O O
-LRB- O O
Becton O O
Dickinson O O
-RRB- O O
for O O
36 O O
hours O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
stimulated O O
for O O
36 O O
hours O O
with O O
anti-CD3 O O
mAb O O
and O O
anti-CD28 O O
mAb O O
in O O
the O O
presence O O
or O O
absence O O
of O O
1 O O
ng/ml O O
IL-10 O O
. O O

Culture O O
supernatants O O
were O O
measured O O
for O O
IFN-γ O O
concentrations O O
. O O

A O O
sample O O
of O O
5 O O
× O O
105 O O
cells O O
of O O
PBMC O O
was O O
resuspended O O
in O O
PBS O O
with O O
1 O O
% O O
FCS O O
. O O

PBMC O O
were O O
incubated O O
with O O
saturating O O
concentrations O O
of O O
anti-IL-10R1 O O
mAb O O
-LRB- O O
IgG1 O O
; O O
R&D O O
systems O O
, O O
Minneapolis O O
, O O
MN O O
, O O
USA O O
-RRB- O O
or O O
with O O
isotype-matched O O
control O O
mAb O O
-LRB- O O
Immunotech O O
-RRB- O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
incubation O O
with O O
FITC-conjugated O O
goat O O
anti-mouse O O
IgG1 O O
polyclonal O O
antibody O O
-LRB- O O
Santa O O
Cruz O O
Biotechnologies O O
, O O
Santa O O
Cruz O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
incubated O O
with O O
phycoerythrin-conjugated O O
anti-CD4 O O
mAb O O
-LRB- O O
Becton O O
Dickinson O O
-RRB- O O
. O O

Cells O O
were O O
washed O O
well O O
with O O
1 O O
% O O
FCS/PBS O O
between O O
incubations O O
. O O

Analysis O O
was O O
performed O O
on O O
a O O
FACScan O O
flow O O
cytometer O O
-LRB- O O
Becton O O
Dickinson O O
-RRB- O O
. O O

Concentrations O O
of O O
IFN-γ O O
and O O
IL-2 O O
in O O
culture O O
supernatants O O
of O O
CD4+ O O
T O O
cells O O
were O O
measured O O
in O O
duplicate O O
by O O
the O O
quantitative O O
sandwich O O
ELISA O O
using O O
cytokine-specific O O
capture O O
with O O
biotinylated O O
detection O O
mAb O O
and O O
recombinant O O
cytokine O O
proteins O O
-LRB- O O
all O O
from O O
Becton O O
Dickinson O O
-RRB- O O
, O O
according O O
to O O
the O O
manufacturer O O
's O O
protocol O O
. O O

The O O
detection O O
limits O O
for O O
IFN-γ O O
and O O
IL-2 O O
were O O
15 O O
pg/ml O O
. O O

Total O O
cellular O O
RNA O O
was O O
extracted O O
from O O
PB O O
CD4+ O O
T O O
cells O O
using O O
an O O
RNA O O
isolation O O
kit O O
-LRB- O O
RNeasy O O
Mini O O
kit O O
; O O
Qiagen O O
, O O
Valencia O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
according O O
to O O
the O O
manufacturer O O
's O O
instructions O O
. O O

cDNA O O
was O O
synthesized O O
from O O
total O O
RNA O O
with O O
Molony O O
murine O O
leukemia O O
virus O O
reverse O O
transcriptase O O
-LRB- O O
US O O
Biochemical O O
, O O
Cleveland O O
, O O
OH O O
, O O
USA O O
-RRB- O O
and O O
oligo- O O
-LRB- O O
dT O O
-RRB- O O
15 O O
primers O O
-LRB- O O
Promega O O
, O O
Madison O O
, O O
WI O O
, O O
USA O O
-RRB- O O
. O O

Real-time O O
PCR O O
was O O
performed O O
with O O
the O O
LightCycler O O
Instrument O O
-LRB- O O
Roche O O
Diagnostics O O
, O O
Penzberg O O
, O O
Germany O O
-RRB- O O
in O O
glass O O
capillaries O O
. O O

The O O
reaction O O
mix O O
containing O O
Taq O O
DNA O O
polymerase O O
and O O
DNA O O
double-strand-specific O O
SYBR O O
Green O O
I O O
dye O O
-LRB- O O
Lightcycler O O
FastStart O O
DNA O O
Master O O
SYBR O O
Green O O
I O O
; O O
Roche O O
Diagnostics O O
-RRB- O O
and O O
specific O O
primers O O
were O O
added O O
to O O
cDNA O O
dilutions O O
. O O

The O O
cDNA O O
samples O O
were O O
denatured O O
at O O
95° O O
C O O
for O O
10 O O
min O O
, O O
and O O
were O O
then B-conn Temporal.Precedence
amplified O O
for O O
40–50 O O
cycles O O
: O O
at O O
95° O O
C O O
-LRB- O O
10 O O
s O O
-RRB- O O
, O O
at O O
65° O O
C O O
-LRB- O O
15 O O
s O O
-RRB- O O
, O O
and O O
72° O O
C O O
-LRB- O O
22 O O
s O O
-RRB- O O
for O O
β-actin O O
; O O
at O O
95° O O
C O O
-LRB- O O
10 O O
s O O
-RRB- O O
, O O
at O O
62° O O
C O O
-LRB- O O
15 O O
s O O
-RRB- O O
, O O
and O O
at O O
72° O O
C O O
-LRB- O O
10 O O
s O O
-RRB- O O
for O O
SOCS1 O O
; O O
and O O
at O O
96° O O
C O O
-LRB- O O
10 O O
s O O
-RRB- O O
, O O
at O O
68° O O
C O O
-LRB- O O
15 O O
s O O
-RRB- O O
, O O
and O O
at O O
72° O O
C O O
-LRB- O O
15 O O
s O O
-RRB- O O
for O O
SOCS3 O O
. O O

Amplification O O
curves O O
of O O
the O O
fluorescence O O
values O O
versus O O
cycle O O
number O O
were O O
obtained O O
, O O
and B-conn Conjunction
a O O
melting O O
curve O O
analysis O O
was O O
then B-conn Temporal.Precedence
performed O O
. O O

The O O
levels O O
of O O
SOCS1 O O
and O O
SOCS3 O O
expression O O
were O O
determined O O
by B-conn Purpose.Enablement
normalizing O O
relative O O
to O O
β-actin O O
expression O O
. O O

The O O
forward O O
and O O
reverse O O
primers O O
were O O
as O O
follows O O
: O O
for O O
β-actin O O
, O O
5'-GTGGGGCGCCCCAGGCACCA-3 O O
' O O
and O O
5'-CTCCTTAATGTCACGCACGATTTC-3 O O
' O O
; O O
for O O
SOCS1 O O
, O O
5'-AGACCCCTTCTCACCTCTTG-3 O O
' O O
and O O
5'-GCACAGCAGAAAAATAAAGC-3 O O
' O O
; O O
and O O
for O O
SOCS3 O O
, O O
5'-CCCGCCGGCACCTTTCTG-3 O O
' O O
and O O
5'-AGGGGCCGGCTCAACACC-3 O O
' O O
. O O

CD4+ O O
T O O
cells O O
were O O
stimulated O O
for O O
20 O O
min O O
by O O
the O O
indicated O O
concentrations O O
of O O
IL-10 O O
and O O
IL-6 O O
at O O
a O O
density O O
of O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
. O O

To B-conn Purpose.Goal
examine O O
the O O
effect O O
of O O
serum O O
IL-6 O O
on O O
STAT O O
phosphorylation O O
, O O
normal O O
CD4+ O O
T O O
cells O O
were O O
stimulated O O
for O O
20 O O
min O O
with O O
30 O O
% O O
active O O
RA O O
serum O O
in O O
culture O O
medium O O
with O O
40 O O
μg/ml O O
neutralizing O O
goat O O
anti-IL-6 O O
polyclonal O O
antibody O O
-LRB- O O
IgG O O
; O O
Techne O O
, O O
Princeton O O
, O O
NJ O O
, O O
USA O O
-RRB- O O
or O O
control O O
goat O O
IgG O O
-LRB- O O
Techne O O
-RRB- O O
. O O

Whole O O
cell O O
lysates O O
were O O
prepared O O
by B-conn Purpose.Enablement
placing O O
cells O O
in O O
100 O O
μl O O
SDS O O
lysing O O
buffer O O
-LRB- O O
62.5 O O
mM O O
Tris–HCl O O
-LSB-pH O O
6.8 O O
-RSB- O O
, O O
2 O O
% O O
SDS O O
, O O
10 O O
% O O
glycerol O O
, O O
50 O O
mM O O
dithiothreitol O O
, O O
0.1 O O
% O O
bromphenol O O
blue O O
-RRB- O O
. O O

Then B-conn Temporal.Precedence
20 O O
μl O O
protein O O
samples O O
were O O
fractionated O O
on O O
10 O O
% O O
SDS-polyacrylamide O O
gels O O
and O O
were O O
transferred O O
to O O
nitrocellulose O O
membranes O O
-LRB- O O
Amersham O O
, O O
Buckinghamshire O O
, O O
UK O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
membrane O O
was O O
blocked O O
with O O
5 O O
% O O
skim O O
milk O O
in O O
Tris-buffered O O
saline O O
with O O
0.1 O O
% O O
Tween O O
20 O O
. O O

Tyrosine O O
phosphorylation O O
of O O
STAT1 O O
and O O
STAT3 O O
was O O
detected O O
using O O
commercial O O
available O O
kits O O
-LRB- O O
Cell O O
Signaling O O
Technology O O
, O O
Beverly O O
, O O
MA O O
, O O
USA O O
-RRB- O O
according O O
to O O
the O O
manufacturer O O
's O O
instructions O O
. O O

Briefly B-conn Restatement.Specification
, O O
the O O
membrane O O
was O O
incubated O O
with O O
the O O
antibodies O O
-LRB- O O
rabbit O O
IgG O O
-RRB- O O
anti-STAT1 O O
antibody O O
, O O
anti-phosphorylated O O
tyrosine O O
701 O O
of O O
STAT1 O O
antibody O O
, O O
anti-STAT3 O O
antibody O O
, O O
and O O
anti-phosphorylated O O
tyrosine O O
705 O O
of O O
STAT3 O O
antibody O O
, O O
diluted O O
as O O
recommended O O
at O O
1/2000 O O
with O O
Tris-buffered O O
saline O O
with O O
0.1 O O
% O O
Tween O O
20 O O
with O O
5 O O
% O O
BSA O O
. O O

Antibody O O
binding O O
was O O
detected O O
by O O
horseradish O O
peroxidase-conjugated O O
anti-rabbit O O
IgG O O
antibody O O
diluted O O
at O O
1/4000 O O
with O O
Tris-buffered O O
saline O O
with O O
0.1 O O
% O O
Tween O O
20 O O
with O O
5 O O
% O O
BSA O O
, O O
and O O
was O O
revealed O O
using O O
the O O
chemiluminescence O O
system O O
. O O

Protein O O
bands O O
were O O
quantified O O
by O O
densitometry O O
using O O
NIH-Image O O
analysis O O
, O O
and B-conn Conjunction
STAT O O
phosphorylation O O
was O O
compared O O
with O O
the O O
total O O
amount O O
of O O
STAT O O
protein O O
. O O

IFN-γ-stimulated O O
Hela O O
cells O O
were O O
used O O
as O O
a O O
positive O O
control O O
for O O
STAT1 O O
phosophorylation O O
. O O

Data O O
are O O
expressed O O
as O O
the O O
mean O O
value O O
± O O
standard O O
error O O
of O O
the O O
mean O O
or O O
box O O
plots O O
. O O

The O O
statistical O O
significance O O
of O O
differences O O
between O O
two O O
groups O O
was O O
determined O O
by O O
the O O
Mann–Whitney O O
U O O
test O O
or O O
the O O
Wilcoxon O O
signed O O
rank O O
test O O
. O O

P O O
< O O
0.05 O O
was O O
considered O O
significant O O
. O O

Results O O

The O O
CD28 O O
costimulatory O O
pathway O O
is O O
crucial O O
for O O
effective O O
antigen-specific O O
T-cell O O
cytokine O O
production O O
, O O
and B-conn Continuation
IL-10 O O
can O O
directly O O
suppress O O
this O O
response O O
by B-conn Purpose.Enablement
inhibiting O O
CD28 O O
tyrosine O O
phosphorylation O O
and O O
binding O O
of O O
phosphatidylinositol O O
3-kinase O O
-LSB-24 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
evaluate O O
the O O
responsiveness O O
of O O
RA O O
CD4+ O O
T O O
cells O O
to O O
IL-10 O O
, O O
purified O O
PB O O
CD4+ O O
T O O
cells O O
from O O
three O O
patients O O
with O O
active O O
RA O O
and O O
from O O
three O O
healthy O O
controls O O
were O O
stimulated O O
by O O
immobilized O O
anti-CD3 O O
antibody O O
and O O
anti-CD28 O O
antibody O O
with O O
or O O
without O O
diluted O O
concentrations O O
of O O
IL-10 O O
for O O
36 O O
hours O O
, O O
and B-conn Conjunction
IFN-γ O O
production O O
was O O
measured O O
by O O
ELISA O O
. O O

As O O
shown O O
in O O
Fig. O O
1 O O
, O O
IFN-γ O O
production O O
by O O
activated O O
normal O O
CD4+ O O
T O O
cells O O
was O O
mostly O O
inhibited O O
at O O
concentrations O O
as O O
low O O
as O O
1 O O
ng/ml O O
IL-10 O O
. O O

However B-conn Contrast
, O O
RA O O
CD4+ O O
T O O
cells O O
were O O
able O O
to O O
produce O O
significant O O
amounts O O
of O O
IFN-γ O O
in O O
the O O
presence O O
of O O
1 O O
ng/ml O O
IL-10 O O
, O O
and B-conn Conjunction
the O O
maximal O O
but O O
not O O
complete O O
inhibition O O
by O O
IL-10 O O
was O O
obtained O O
at O O
10–100 O O
ng/ml O O
. O O

We O O
thus B-conn Cause.Result
compared O O
the O O
levels O O
of O O
IFN-γ O O
production O O
by O O
CD4+ O O
T O O
cells O O
after B-conn Temporal.Succession
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
the O O
presence O O
of O O
1 O O
ng/ml O O
IL-10 O O
in O O
RA O O
patients O O
with O O
active O O
disease O O
-LRB- O O
multiple O O
inflammatory O O
joints O O
, O O
CRP O O
level O O
≥ O O
10 O O
mg/l O O
-RRB- O O
and O O
inactive O O
disease O O
-LRB- O O
in O O
remission O O
, O O
CRP O O
level O O
< O O
10 O O
mg/l O O
-RRB- O O
-LSB-26 O O
-RSB- O O
and O O
in O O
healthy O O
controls O O
. O O

There O O
were O O
no O O
statistically O O
significant O O
differences O O
in O O
IFN-γ O O
production O O
without O O
IL-10 O O
among O O
these O O
three O O
groups O O
-LRB- O O
Fig. O O
2a O O
-RRB- O O
, O O
but B-conn Concession.Contra-expectation
the O O
inhibitory O O
effect O O
of O O
IL-10 O O
on O O
IFN-γ O O
production O O
was O O
significantly O O
limited O O
in O O
the O O
active O O
RA O O
group O O
as O O
compared O O
with O O
the O O
inactive O O
RA O O
group O O
and O O
healthy O O
controls O O
-LRB- O O
percentage O O
decrease O O
: O O
active O O
RA O O
, O O
2.9 O O
± O O
14.4 O O
% O O
; O O
inactive O O
RA O O
, O O
45.6 O O
± O O
14.4 O O
% O O
; O O
controls O O
, O O
65.8 O O
± O O
7.9 O O
% O O
-RRB- O O
-LRB- O O
Fig. O O
2b O O
-RRB- O O
. O O

As B-conn Cause.Result
a I-conn Cause.Result
consequence I-conn Cause.Result
, O O
CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
patients O O
produced O O
higher O O
levels O O
of O O
IFN-γ O O
in O O
the O O
presence O O
of O O
1 O O
ng/ml O O
IL-10 O O
than O O
did O O
normal O O
CD4+ O O
T O O
cells O O
-LRB- O O
Fig. O O
2a O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
we O O
compared O O
IL-2 O O
production O O
by O O
CD4+ O O
T O O
cells O O
after O O
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
the O O
presence O O
of O O
IL-10 O O
in O O
active O O
RA O O
patients O O
and O O
in O O
healthy O O
controls O O
. O O

Similarly O O
, O O
IL-2 O O
production O O
was O O
not O O
affected O O
by O O
1 O O
ng/ml O O
IL-10 O O
in O O
RA O O
patients O O
-LRB- O O
percentage O O
decrease O O
, O O
-2.1 O O
± O O
13.8 O O
% O O
-RRB- O O
, O O
while B-conn Contrast
it O O
was O O
significantly O O
reduced O O
in O O
healthy O O
controls O O
-LRB- O O
61.1 O O
± O O
13.7 O O
% O O
; O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

Taken O O
together O O
, O O
these O O
results O O
indicate O O
that O O
RA O O
CD4+ O O
T O O
cells O O
become O O
less O O
susceptible O O
to O O
the O O
immunoregulatory O O
effect O O
of O O
IL-10 O O
during O O
the O O
active O O
phase O O
. O O

The O O
functional O O
receptor O O
complex O O
of O O
IL-10 O O
consists O O
of O O
two O O
subunits O O
, O O
the O O
primary O O
ligand-binding O O
component O O
IL-10R1 O O
and O O
the O O
accessory O O
component O O
type O O
2 O O
IL-10R O O
-LSB-1 O O
-RSB- O O
. O O

IL-10R1 O O
expression O O
plays O O
a O O
critical O O
role O O
in O O
cellular O O
responses O O
to O O
IL-10 O O
-LSB-29 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
examine O O
whether O O
the O O
resistance O O
to O O
IL-10 O O
inhibition O O
in O O
RA O O
CD4+ O O
T O O
cells O O
was O O
due B-conn Cause.Reason
to I-conn Cause.Reason
limited O O
receptor O O
expression O O
, O O
the O O
cell O O
surface O O
expression O O
of O O
IL-10R1 O O
on O O
PB O O
CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
patients O O
and O O
from O O
healthy O O
controls O O
was O O
determined O O
by O O
flow O O
cytometric O O
analysis O O
. O O

As O O
shown O O
in O O
Fig. O O
3a,3b O O
, O O
the O O
intensity O O
of O O
IL-10R1 O O
expression O O
on O O
CD4+ O O
T O O
cells O O
was O O
significantly O O
increased O O
in O O
RA O O
patients O O
compared O O
with O O
in O O
healthy O O
controls O O
. O O

These O O
results O O
suggest O O
that O O
the O O
intracellular O O
signal O O
transduction O O
pathway O O
of O O
IL-10 O O
may O O
be O O
impaired O O
in O O
CD4+ O O
T O O
cells O O
of O O
active O O
RA O O
. O O

The O O
interaction O O
of O O
IL-10R O O
with O O
IL-10 O O
induces O O
tyrosine O O
phosphorylation O O
and O O
activation O O
of O O
the O O
latent O O
transcription O O
factors O O
STAT1 O O
and O O
STAT3 O O
-LSB-3 O O
-RSB- O O
. O O

Macrophage-specific O O
STAT3-deficient O O
mice O O
demonstrated O O
that O O
STAT3 O O
plays O O
a O O
dominant O O
role O O
in O O
IL-10-mediated O O
anti-inflammatory O O
responses O O
-LSB-5 O O
-RSB- O O
, O O
which O O
has O O
recently O O
been O O
confirmed O O
in O O
human O O
macrophages O O
by O O
studies O O
of O O
dominant-negative O O
STAT3 O O
overexpression O O
-LSB-30 O O
-RSB- O O
. O O

The O O
induction O O
of O O
STAT1 O O
and O O
STAT3 O O
phosphorylation O O
by O O
IL-10 O O
in O O
PB O O
CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
patients O O
and O O
from O O
healthy O O
controls O O
was O O
examined O O
using O O
western O O
blotting O O
. O O

STAT3 O O
phosphorylation O O
was O O
dose-dependently O O
induced O O
after B-conn Temporal.Succession
IL-10 O O
activation O O
for O O
20 O O
min O O
in O O
normal O O
CD4+ O O
T O O
cells O O
-LRB- O O
Fig. O O
4a,4b O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
STAT3 O O
was O O
phosphorylated O O
in O O
freshly O O
isolated O O
PB O O
CD4+ O O
cells O O
from O O
RA O O
patients O O
and B-conn Conjunction
this O O
STAT3 O O
phosphorylation O O
was O O
detectable O O
for O O
up O O
to O O
6 O O
hours O O
. O O

STAT3 O O
phosphorylation O O
was O O
augmented O O
only B-conn Temporal.Succession
when I-conn Temporal.Succession
activated O O
by O O
as O O
much O O
as O O
10 O O
ng/ml O O
IL-10 O O
. O O

Both O O
sustained O O
STAT3 O O
phosphorylation O O
and O O
defective O O
IL-10-induced O O
STAT3 O O
phosphorylation O O
were O O
found O O
in O O
RA O O
ST O O
CD4+ O O
T O O
cells O O
-LRB- O O
Fig. O O
4c O O
-RRB- O O
. O O

On B-conn Contrast
the I-conn Contrast
other I-conn Contrast
hand I-conn Contrast
, O O
IL-10-induced O O
STAT1 O O
phosphorylation O O
was O O
not O O
detected O O
in O O
either O O
RA O O
CD4+ O O
T O O
cells O O
or O O
normal O O
CD4+ O O
T O O
cells O O
-LRB- O O
Fig. O O
4a O O
-RRB- O O
. O O

These O O
results O O
indicate O O
that O O
STAT3 O O
is O O
the O O
major O O
IL-10-activated O O
STAT O O
in O O
CD4+ O O
T O O
cells O O
, O O
and B-conn Conjunction
IL-10-induced O O
STAT3 O O
activation O O
may O O
be O O
diminished O O
in O O
active O O
RA O O
, O O
in O O
association O O
with O O
sustained O O
STAT3 O O
phosphorylation O O
. O O

STAT3 O O
is O O
activated O O
by O O
many O O
cytokines O O
and O O
growth O O
factors O O
such O O
as O O
the O O
IL-6 O O
family O O
of O O
cytokines O O
-LRB- O O
IL-6 O O
, O O
IL-11 O O
, O O
leukemia O O
inhibitory O O
factor O O
, O O
and O O
oncostatin O O
M O O
-RRB- O O
, O O
platelet-derived O O
growth O O
factor O O
, O O
and O O
epidermal O O
growth O O
factor O O
, O O
in O O
addition O O
to O O
IL-10 O O
-LSB-4 O O
-RSB- O O
, O O
but B-conn Concession.Contra-expectation
previous O O
studies O O
have O O
demonstrated O O
that O O
IL-6 O O
is O O
the O O
major O O
factor O O
in O O
RA O O
synovial O O
fluid O O
that O O
induces O O
constitutive O O
activation O O
of O O
STAT3 O O
in O O
mononuclear O O
cells O O
-LSB-31 O O
-RSB- O O
. O O

Since B-conn Cause.Reason
IL-6 O O
is O O
also O O
abundant O O
in O O
sera O O
of O O
active O O
RA O O
patients O O
, O O
frequently O O
detected O O
at O O
> O O
1 O O
ng/ml O O
-LSB-27 O O
-RSB- O O
, O O
we O O
examined O O
whether O O
persistent O O
exposure O O
of O O
CD4+ O O
T O O
cells O O
to O O
high O O
concentrations O O
of O O
IL-6 O O
in O O
the O O
blood O O
circulation O O
was O O
responsible O O
for O O
their O O
sustained O O
STAT3 O O
activation O O
and O O
resistance O O
to O O
IL-10 O O
inhibition O O
in O O
active O O
RA O O
. O O

Both O O
STAT1 O O
and O O
STAT3 O O
phosphorylation O O
was O O
activated O O
by O O
IL-6 O O
in O O
normal O O
CD4+ O O
T O O
cells O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
in O O
agreement O O
with O O
previous O O
observations O O
-LSB-4 O O
-RSB- O O
. O O

Normal O O
CD4+ O O
T O O
cells O O
were O O
thus B-conn Cause.Result
incubated O O
for O O
20 O O
min O O
with O O
culture O O
medium O O
containing O O
30 O O
% O O
serum O O
from O O
active O O
RA O O
patients O O
and O O
neutralizing O O
anti-IL-6 O O
antibody O O
or O O
control O O
antibody O O
, O O
and B-conn Conjunction
STAT O O
phosphorylation O O
was O O
examined O O
by O O
western O O
blot O O
analysis O O
. O O

RA O O
serum O O
was O O
able O O
to O O
induce O O
tyrosine O O
phosphorylation O O
of O O
STAT3 O O
but O O
not O O
STAT1 O O
, O O
and B-conn Conjunction
this O O
STAT3 O O
activation O O
was O O
mostly O O
abolished O O
by B-conn Purpose.Enablement
neutralization O O
of O O
IL-6 O O
activity O O
-LRB- O O
Fig. O O
5a O O
-RRB- O O
. O O

These O O
results O O
indicate O O
that O O
IL-6 O O
is O O
the O O
dominant O O
STAT3-activating O O
factor O O
contained O O
in O O
sera O O
of O O
active O O
RA O O
patients O O
. O O

The O O
lack O O
of O O
STAT1 O O
activation O O
by O O
RA O O
serum O O
suggests O O
that O O
much O O
higher O O
concentrations O O
of O O
IL-6 O O
may O O
be O O
required O O
for O O
STAT1 O O
activation O O
as O O
compared O O
with O O
STAT3 O O
activation O O
, O O
or B-conn Alternative.Disjunctive
that O O
inhibitors O O
of O O
STAT1 O O
signaling O O
may O O
be O O
present O O
in O O
RA O O
serum O O
. O O

We O O
next B-conn Temporal.Precedence
examined O O
whether O O
IL-6 O O
could O O
suppress O O
the O O
effect O O
of O O
IL-10 O O
to O O
inhibit O O
IFN-γ O O
production O O
by O O
CD4+ O O
T O O
cells O O
. O O

After B-conn Temporal.Succession
preincubation O O
with O O
or O O
without O O
10 O O
ng/ml O O
IL-6 O O
for O O
36 O O
hours O O
, O O
normal O O
CD4+ O O
T O O
cells O O
were O O
stimulated O O
by B-conn Purpose.Enablement
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
the O O
presence O O
or O O
absence O O
of O O
1 O O
ng/ml O O
IL-10 O O
for O O
36 O O
hours O O
, O O
and B-conn Conjunction
the O O
IFN-γ O O
production O O
was O O
measured O O
by O O
ELISA O O
. O O

IL-6 O O
pretreatment O O
of O O
normal O O
cells O O
reduced O O
IL-10-mediated O O
inhibition O O
of O O
IFN-γ O O
production O O
-LRB- O O
Fig. O O
5b O O
-RRB- O O
, O O
indicating O O
that O O
high O O
concentrations O O
of O O
IL-6 O O
could O O
modulate O O
T-cell O O
responsiveness O O
to O O
IL-10 O O
. O O

Taken O O
together O O
, O O
these O O
findings O O
suggest O O
that O O
persistent O O
exposure O O
to O O
serum O O
IL-6 O O
may O O
have O O
a O O
role O O
in O O
both O O
the O O
induction O O
of O O
STAT3 O O
activation O O
and O O
the O O
resistance O O
to O O
the O O
inhibitory O O
effect O O
of O O
IL-10 O O
in O O
RA O O
CD4+ O O
T O O
cells O O
. O O

IL-6 O O
induces O O
two O O
potent O O
inhibitors O O
of O O
JAKs O O
-LRB- O O
SOCS1 O O
and O O
SOCS3 O O
proteins O O
-RRB- O O
that O O
not B-conn Conjunction
only I-conn Conjunction
act O O
as O O
mediators O O
of O O
negative O O
feedback O O
inhibition O O
, O O
but B-conn Conjunction
also I-conn Conjunction
play O O
a O O
major O O
role O O
in O O
crosstalk O O
inhibition O O
by B-conn Purpose.Enablement
opposing O O
other O O
cytokine-signaling O O
pathways O O
-LSB-7 O O
-RSB- O O
. O O

SOCS3 O O
has O O
recently O O
been O O
shown O O
to O O
specifically O O
inhibit O O
STAT3 O O
activation O O
induced O O
by O O
IL-6 O O
but O O
not O O
by O O
IL-10 O O
, O O
thereby B-conn Cause.Result
regulating O O
the O O
divergent O O
action O O
of O O
IL-6 O O
and O O
IL-10 O O
-LSB-8,9 O O
-RSB- O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
SOCS1 O O
is O O
able O O
to O O
partially O O
inhibit O O
IL-10-mediated O O
STAT3 O O
activation O O
and O O
cellular O O
responses O O
, O O
as O O
well O O
as O O
IFN-γ-mediated O O
STAT1 O O
activation O O
-LSB-32 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
determine O O
whether O O
SOCSs O O
were O O
involved O O
in O O
the O O
defective O O
IL-10-induced O O
STAT3 O O
activation O O
of O O
RA O O
CD4+ O O
T O O
cells O O
, O O
the O O
levels O O
of O O
SOCS1 O O
and O O
SOCS3 O O
mRNA O O
expression O O
in O O
PB O O
CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
patients O O
and O O
from O O
healthy O O
controls O O
were O O
compared O O
by O O
semiquantitative O O
real-time O O
PCR O O
. O O

The O O
RA O O
CD4+ O O
T O O
cells O O
contained O O
higher O O
levels O O
of O O
SOCS1 O O
but O O
lower O O
levels O O
of O O
SOCS3 O O
transcripts O O
than O O
did O O
control O O
CD4+ O O
T O O
cells O O
-LRB- O O
Fig. O O
6a O O
-RRB- O O
. O O

Constitutive O O
expression O O
of O O
SOCS1 O O
mRNA O O
in O O
RA O O
CD4+ O O
T O O
cells O O
was O O
comparable O O
with O O
the O O
expression O O
in O O
normal O O
CD4+ O O
T O O
cells O O
stimulated O O
by O O
10 O O
ng/ml O O
IL-6 O O
-LRB- O O
Fig. O O
6b O O
-RRB- O O
, O O
supporting O O
its O O
functional O O
significance O O
. O O

Defective O O
IL-10-induced O O
STAT3 O O
activation O O
therefore B-conn Cause.Claim
appears B-conn Cause.Reason
to I-conn Cause.Reason
be I-conn Cause.Reason
due I-conn Cause.Reason
at I-conn Cause.Reason
least I-conn Cause.Reason
in I-conn Cause.Reason
part I-conn Cause.Reason
to I-conn Cause.Reason
an O O
abundance O O
of O O
SOCS1 O O
in O O
RA O O
CD4+ O O
T O O
cells O O
. O O

Discussion O O

CD4+ O O
T O O
cells O O
orchestrate O O
the O O
Th1-type O O
cell-mediated O O
immune O O
response O O
in O O
RA O O
-LSB-22 O O
-RSB- O O
. O O

Activated O O
CD4+ O O
T O O
cells O O
stimulate O O
macrophages O O
, O O
synovial O O
fibroblasts O O
, O O
B O O
cells O O
, O O
and O O
osteoclasts O O
through B-conn Purpose.Enablement
the O O
expression O O
of O O
cell O O
surface O O
molecules O O
and O O
Th1 O O
cytokines O O
, O O
thereby B-conn Cause.Result
contributing O O
to O O
both O O
the O O
chronic O O
inflammation O O
and O O
the O O
joint O O
destruction O O
. O O

CD4+ O O
T O O
cells O O
require O O
two O O
signals O O
to O O
be O O
activated O O
; O O
antigen O O
receptor O O
occupancy O O
and O O
CD28-mediated O O
costimulation O O
. O O

In O O
the O O
ST O O
lesion O O
, O O
the O O
CD28 O O
ligands O O
, O O
both O O
CD80 O O
and O O
CD86 O O
, O O
together O O
with O O
MHC O O
class O O
II O O
antigens O O
, O O
are O O
substantially O O
expressed O O
by O O
antigen-presenting O O
cells O O
such O O
as O O
macrophages O O
and O O
dendritic O O
cells O O
-LSB-18-20 O O
-RSB- O O
. O O

The O O
significance O O
of O O
CD28 O O
engagement O O
in O O
the O O
T-cell-mediated O O
disease O O
process O O
has O O
recently O O
been O O
proven O O
by O O
the O O
clinical O O
efficacy O O
of O O
its O O
blocker O O
cytotoxic O O
T-cell-associated O O
antigen O O
4 O O
-LRB- O O
CD152 O O
-RRB- O O
-IgG O O
in O O
RA O O
patients O O
-LSB-23 O O
-RSB- O O
. O O

IL-10 O O
plays O O
a O O
predominant O O
role O O
in O O
limiting O O
immune O O
and O O
inflammatory O O
responses O O
by B-conn Purpose.Enablement
regulating O O
the O O
function O O
of O O
both O O
macrophages O O
and O O
Th1 O O
cells O O
-LSB-1 O O
-RSB- O O
. O O

IL-10 O O
inhibits O O
the O O
tyrosine O O
phosphorylation O O
of O O
the O O
CD28 O O
molecule O O
and O O
the O O
subsequent O O
phosphatidylinositol O O
3-kinase O O
binding O O
in O O
T O O
cells O O
, O O
and O O
thereby B-conn Cause.Result
directly O O
acts O O
on O O
T O O
cells O O
-LSB-24 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
found O O
that O O
PB O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
active O O
RA O O
, O O
in O O
the O O
presence O O
of O O
IL-10 O O
, O O
are O O
able O O
to O O
produce O O
higher O O
levels O O
of O O
IFN-γ O O
after B-conn Temporal.Succession
CD3 O O
and O O
CD28 O O
costimulation O O
than O O
normal O O
CD4+ O O
T O O
cells O O
. O O

Despite B-conn Concession.Expectation
high-level O O
IL-10R1 O O
expression O O
and O O
constitutive O O
STAT3 O O
activation O O
, O O
IL-10-induced O O
tyrosine O O
phosphorylation O O
of O O
STAT3 O O
is O O
suppressed O O
in O O
RA O O
CD4+ O O
T O O
cells O O
, O O
in O O
contrast O O
to O O
normal O O
CD4+ O O
T O O
cells O O
, O O
where O O
STAT3 O O
phosphorylation O O
is O O
dose-dependently O O
inducible O O
by O O
IL-10 O O
. O O

Serum O O
IL-6 O O
from O O
RA O O
patients O O
induces O O
STAT3 O O
but O O
not O O
STAT1 O O
phosphorylation O O
in O O
normal O O
CD4+ O O
T O O
cells O O
, O O
and B-conn Conjunction
exogenous O O
IL-6 O O
induces O O
the O O
resistance O O
to O O
IL-10 O O
inhibition O O
of O O
IFN-γ O O
production O O
. O O

RA O O
CD4+ O O
T O O
cells O O
contain O O
higher O O
levels O O
of O O
SOCS1 O O
but O O
contain O O
lower O O
levels O O
of O O
SOCS3 O O
transcripts O O
in O O
comparison O O
with O O
normal O O
CD4+ O O
T O O
cells O O
. O O

These O O
findings O O
indicate O O
that O O
CD4+ O O
T O O
cells O O
become O O
resistant O O
to O O
the O O
inhibitory O O
effect O O
of O O
IL-10 O O
before B-conn Temporal.Precedence
migration O O
into O O
the O O
inflamed O O
ST O O
, O O
and O O
suggest O O
that O O
this O O
resistance O O
may O O
be O O
attributable O O
to O O
impaired O O
IL-10-dependent O O
STAT3 O O
activation O O
, O O
in O O
association O O
with O O
sustained O O
STAT3 O O
phosphorylation O O
and O O
SOCS1 O O
induction O O
. O O

IL-10-mediated O O
inhibition O O
of O O
CD4+ O O
T-cell O O
cytokine O O
production O O
is O O
principally O O
dependent O O
on O O
its O O
inhibition O O
of O O
macrophage O O
antigen-presenting O O
cell O O
function O O
-LSB-1 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
this O O
indirect O O
inhibitory O O
effect O O
is O O
thought O O
to O O
be O O
restricted O O
at O O
the O O
site O O
of O O
T-cell O O
activation O O
in O O
RA O O
, O O
because B-conn Cause.Justification
macrophages O O
in O O
the O O
ST O O
express O O
high O O
levels O O
of O O
cytokines O O
, O O
CD80 O O
and O O
CD86 O O
molecules O O
, O O
and O O
MHC O O
class O O
II O O
antigens O O
-LSB-10,18-20 O O
-RSB- O O
. O O

More O O
recently O O
, O O
IL-10 O O
has O O
been O O
shown O O
to O O
induce O O
the O O
antigen-specific O O
T-cell O O
unresponsiveness O O
by B-conn Purpose.Enablement
inhibiting O O
CD28 O O
tyrosine O O
phosphorylation O O
-LSB-33 O O
-RSB- O O
. O O

This O O
direct O O
effect O O
also O O
may O O
be O O
limited O O
in O O
active O O
RA O O
patients O O
, O O
because B-conn Cause.Justification
their O O
PB O O
CD4+ O O
T O O
cells O O
showed O O
a O O
defective O O
IL-10 O O
inhibition O O
of O O
CD28-costimulated O O
production O O
of O O
both O O
IFN-γ O O
and O O
IL-2 O O
. O O

Numerous O O
cytokines O O
, O O
both O O
proinflammatory O O
and O O
anti-inflammatory O O
, O O
have O O
been O O
detected O O
in O O
the O O
ST O O
of O O
RA O O
, O O
and B-conn Continuation
the O O
balance O O
between O O
these O O
opposing O O
cytokine O O
activities O O
regulates O O
disease O O
severity O O
-LSB-10 O O
-RSB- O O
. O O

Endogenous O O
IL-10 O O
, O O
produced O O
mainly O O
by O O
macrophages O O
and O O
T O O
cells O O
, O O
inhibits O O
proinflammatory O O
cytokine O O
production O O
by O O
ST O O
cells O O
-LSB-12 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
this O O
regulatory O O
activity O O
seems O O
to O O
be O O
restricted O O
during O O
chronic O O
inflammation O O
. O O

The O O
activation O O
of O O
both O O
the O O
extracellular O O
stimulus-regulated O O
kinase O O
and O O
p38 O O
kinase O O
pathways O O
, O O
induced O O
by O O
TNF-α O O
and O O
IL-1 O O
, O O
inhibits O O
the O O
Jak1–STAT3 O O
signaling O O
pathway O O
shared O O
by O O
IL-10 O O
and O O
IL-6 O O
in O O
adhered O O
macrophages O O
-LSB-13 O O
-RSB- O O
. O O

More O O
importantly O O
, O O
IL-10-mediated O O
STAT3 O O
activation O O
is O O
mostly O O
undetectable O O
in O O
RA O O
synovial O O
macrophages O O
. O O

This O O
impaired O O
IL-10 O O
signaling O O
is O O
probably O O
induced O O
by B-conn Purpose.Enablement
chronic O O
exposure O O
to O O
immune O O
complexes O O
in O O
vivo O O
, O O
because B-conn Cause.Justification
both O O
cell O O
surface O O
IL-10R1 O O
expression O O
and O O
IL-10-induced O O
Jak1 O O
activation O O
are O O
suppressed O O
in O O
IFN-γ-primed O O
macrophages O O
by O O
a O O
protein O O
kinase O O
C-dependent O O
pathway O O
following B-conn Temporal.Succession
ligation O O
of O O
the O O
IgG O O
Fc O O
gamma O O
receptor O O
-LSB-14 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
dendritic O O
cells O O
from O O
RA O O
synovial O O
fluids O O
are O O
resistant O O
to O O
the O O
immunoregulatory O O
effect O O
of O O
IL-10 O O
due B-conn Cause.Reason
to I-conn Cause.Reason
decreased O O
transport O O
of O O
intracellular O O
IL-10R1 O O
in O O
the O O
presence O O
of O O
proinflammatory O O
cytokine O O
stimuli O O
such O O
as O O
TNF-α O O
, O O
IL-1 O O
, O O
and O O
granulocyte–macrophage O O
colony-stimulating O O
factor O O
-LSB-15 O O
-RSB- O O
. O O

We O O
have O O
demonstrated O O
that O O
the O O
resistance O O
of O O
RA O O
CD4+ O O
T O O
cells O O
to O O
IL-10 O O
may O O
be O O
associated O O
with O O
defective O O
IL-10-dependent O O
STAT3 O O
activation O O
, O O
but O O
not O O
with O O
IL-10R1 O O
expression O O
. O O

Inhibitory O O
effects O O
of O O
IL-10 O O
on O O
these O O
inflammatory O O
cell O O
types O O
are O O
therefore B-conn Cause.Claim
differentially O O
modulated O O
at O O
the O O
signal O O
transduction O O
level O O
under O O
the O O
inflammatory O O
environment O O
in O O
RA O O
. O O

In O O
association O O
with O O
impaired O O
IL-10-mediated O O
STAT3 O O
activation O O
, O O
STAT3 O O
was O O
found O O
to O O
be O O
tyrosine O O
phosphorylated O O
persistently O O
-LRB- O O
up O O
to O O
6 O O
hours O O
-RRB- O O
in O O
freshly O O
isolated O O
PB O O
and O O
ST O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
. O O

STAT3 O O
is O O
activated O O
by O O
a O O
variety O O
of O O
cytokines O O
, O O
notably O O
the O O
IL-6 O O
family O O
of O O
cytokines O O
-LRB- O O
e.g. O O

IL-6 O O
, O O
IL-11 O O
, O O
leukemia O O
inhibitory O O
factor O O
, O O
and O O
oncostatin O O
M O O
-RRB- O O
and O O
growth O O
factors O O
, O O
in O O
addition O O
to O O
IL-10 O O
-LSB-4 O O
-RSB- O O
. O O

Of O O
these O O
cytokines O O
, O O
IL-6 O O
plays O O
a O O
predominant O O
role O O
in O O
eliciting O O
a O O
systemic O O
reaction O O
such O O
as O O
the O O
acute O O
phase O O
response O O
in O O
active O O
RA O O
, O O
due B-conn Cause.Reason
mainly I-conn Cause.Reason
to I-conn Cause.Reason
its O O
abundance O O
in O O
the O O
blood O O
circulation O O
-LSB-27 O O
-RSB- O O
. O O

Consistent O O
with O O
this O O
notion O O
, O O
IL-6 O O
was O O
the O O
major O O
STAT3-activating O O
factor O O
contained O O
in O O
the O O
serum O O
of O O
active O O
RA O O
patients O O
, O O
and B-conn Conjunction
the O O
responsiveness O O
to O O
IL-10 O O
was O O
suppressed O O
in O O
normal O O
CD4+ O O
T O O
cells O O
after O O
36 O O
hours O O
of O O
incubation O O
with O O
IL-6 O O
. O O

These O O
results O O
suggest O O
that O O
both O O
the O O
sustained O O
STAT3 O O
activation O O
and O O
the O O
resistance O O
to O O
IL-10 O O
inhibition O O
found O O
in O O
RA O O
CD4+ O O
T O O
cells O O
may O O
be O O
induced O O
after B-conn Temporal.Succession
chronic O O
exposure O O
in O O
vivo O O
to O O
high O O
concentrations O O
of O O
serum O O
IL-6 O O
. O O

However B-conn Concession.Contra-expectation
, O O
it O O
is O O
also O O
possible O O
that O O
STAT3 O O
activity O O
could O O
be O O
constitutively O O
induced O O
in O O
CD4+ O O
T O O
cells O O
by O O
their O O
own O O
IL-10 O O
secretion O O
, O O
leading O O
to O O
the O O
loss O O
of O O
sensitivity O O
to O O
exogenous O O
IL-10 O O
, O O
because B-conn Cause.Justification
RA O O
CD4+ O O
T O O
cells O O
in O O
the O O
ST O O
are O O
capable O O
of O O
producing O O
significant O O
levels O O
of O O
IL-10 O O
-LSB-34 O O
-RSB- O O
. O O

CD4+ O O
T O O
cells O O
isolated O O
from O O
the O O
ST O O
of O O
RA O O
also B-conn Conjunction
showed O O
a O O
defect O O
in O O
the O O
IL-10-induced O O
STAT3 O O
signaling O O
pathway O O
. O O

It O O
is O O
most O O
probable O O
that O O
the O O
resistance O O
of O O
CD4+ O O
T O O
cells O O
to O O
IL-10 O O
can O O
be O O
even O O
augmented O O
after B-conn Temporal.Succession
migration O O
into O O
the O O
inflamed O O
ST O O
, O O
because B-conn Cause.Justification
IL-6 O O
is O O
highly O O
concentrated O O
compared O O
with O O
the O O
blood O O
level O O
-LSB-27 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
involvement O O
of O O
other O O
essential O O
proinflammatory O O
cytokines O O
in O O
this O O
process O O
was O O
suggested O O
by O O
our O O
preliminary O O
experiments O O
demonstrating O O
that O O
IL-10-mediated O O
IFN-γ O O
inhibition O O
in O O
CD4+ O O
T O O
cells O O
was O O
reduced O O
by B-conn Purpose.Enablement
pretreatment O O
with O O
IL-1β O O
and O O
TNF-α O O
, O O
although B-conn Concession.Expectation
less O O
effectively O O
than O O
by O O
IL-6 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
IFN-γ O O
and O O
IL-10 O O
produced O O
by O O
CD4+ O O
T O O
cells O O
themselves O O
could O O
be O O
responsible O O
for O O
impaired O O
IL-10 O O
signaling O O
in O O
the O O
ST O O
, O O
because B-conn Cause.Justification
T-cell O O
infiltrates O O
produce O O
both O O
cytokines O O
-LSB-34,35 O O
-RSB- O O
. O O

In O O
an O O
autocrine O O
fashion O O
, O O
IL-10 O O
may O O
persistently O O
stimulate O O
STAT3 O O
activation O O
and B-conn Conjunction
IFN-γ O O
can O O
induce O O
SOCS1 O O
protein O O
as O O
a O O
crosstalk O O
inhibitor O O
of O O
IL-10 O O
signaling O O
-LSB-32 O O
-RSB- O O
. O O

The O O
T-cell-inhibitory O O
effect O O
of O O
IL-10 O O
may O O
therefore B-conn Cause.Result
be O O
modulated O O
complicatedly O O
upon B-conn Temporal.Synchronous
exposure O O
to O O
an O O
inflammatory O O
environment O O
in O O
RA O O
joints O O
, O O
where O O
many O O
cytokines O O
are O O
present O O
substantially O O
-LSB-10 O O
-RSB- O O
. O O

STAT3 O O
activation O O
has O O
been O O
implicated O O
in O O
the O O
pathogenesis O O
of O O
RA O O
. O O

Active O O
STAT3 O O
is O O
constitutively O O
expressed O O
in O O
synovial O O
fluid O O
mononuclear O O
cells O O
from O O
RA O O
patients O O
-LSB-36 O O
-RSB- O O
. O O

IL-6 O O
is O O
the O O
major O O
STAT3-activating O O
factor O O
present O O
in O O
synovial O O
fluid O O
, O O
which O O
has O O
a O O
crucial O O
role O O
in O O
the O O
activation O O
of O O
monocyte O O
functions O O
such O O
as O O
gene O O
expression O O
of O O
the O O
Fc O O
gamma O O
receptor O O
type O O
I O O
and O O
type O O
III O O
and O O
of O O
HLA-DR O O
-LSB-31 O O
-RSB- O O
. O O

More O O
recently O O
, O O
high O O
levels O O
of O O
activated O O
STAT3 O O
, O O
thought O O
to O O
be O O
induced O O
mainly O O
by O O
IL-6 O O
, O O
have O O
been O O
detected O O
in O O
the O O
ST O O
, O O
and B-conn Conjunction
STAT3 O O
activation O O
has O O
been O O
shown O O
to O O
be O O
involved O O
in O O
synovial O O
fibroblast O O
proliferation O O
and O O
IL-6 O O
production O O
-LSB-37 O O
-RSB- O O
. O O

In O O
this O O
regard O O
, O O
STAT3 O O
is O O
critical O O
in O O
the O O
survival O O
and O O
expansion O O
of O O
growth O O
factor-dependent O O
synovial O O
fibroblasts O O
-LSB-38 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
the O O
significance O O
of O O
persistent O O
STAT3 O O
signaling O O
in O O
Th1-cell-dominated O O
autoimmune O O
arthritis O O
has O O
been O O
suggested O O
by O O
studies O O
of O O
the O O
gp130F759/F759 O O
mice O O
, O O
in O O
which O O
the O O
Src O O
homology O O
phosphatase-2 O O
binding O O
site O O
of O O
gp130 O O
-LRB- O O
the O O
transmembrane O O
glycoprotein O O
β O O
subunit O O
of O O
the O O
IL-6 O O
family O O
cytokine O O
receptor O O
-RRB- O O
, O O
tyrosine O O
759 O O
, O O
was O O
mutated O O
to O O
phenylalanine O O
-LSB-39 O O
-RSB- O O
. O O

In O O
the O O
gp130F759/F759 O O
mice O O
, O O
T O O
cells O O
, O O
particularly O O
the O O
CD4+ O O
T-cell O O
subset O O
, O O
are O O
chronically O O
activated O O
and O O
resistant O O
to O O
activation-induced O O
cell O O
death O O
through B-conn Purpose.Enablement
gp130-mediated O O
STAT3 O O
activation O O
. O O

The O O
longevity O O
of O O
cytokine O O
signals O O
transduced O O
by O O
the O O
JAK–STAT O O
pathway O O
is O O
regulated O O
by O O
the O O
SOCS O O
family O O
proteins O O
-LSB-7 O O
-RSB- O O
. O O

We O O
found O O
that O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
active O O
RA O O
expressed O O
higher O O
levels O O
of O O
SOCS1 O O
, O O
but O O
lower O O
levels O O
of O O
SOCS3 O O
, O O
compared O O
with O O
normal O O
CD4+ O O
T O O
cells O O
. O O

SOCS1 O O
prevents O O
activation O O
of O O
JAK O O
by B-conn Purpose.Enablement
directly O O
binding O O
to O O
JAK O O
, O O
and B-conn Conjunction
SOCS3 O O
inhibits O O
the O O
action O O
of O O
JAK O O
by B-conn Purpose.Enablement
binding O O
to O O
the O O
Src O O
homology O O
phosphatase-2-binding O O
domain O O
of O O
receptors O O
such O O
as O O
gp130 O O
-LSB-40 O O
-RSB- O O
. O O

SOCS1 O O
and O O
SOCS3 O O
are O O
induced O O
by O O
various O O
cytokines O O
, O O
including O O
IL-6 O O
and O O
IL-10 O O
, O O
as O O
mediators O O
of O O
negative O O
feedback O O
and O O
crosstalk O O
inhibition O O
-LSB-7 O O
-RSB- O O
. O O

Recent O O
studies O O
with O O
mice O O
lacking O O
SOCS3 O O
or O O
SOCS1 O O
revealed O O
that O O
SOCS3 O O
is O O
a O O
negative O O
regulator O O
of O O
IL-6 O O
signaling O O
but O O
not O O
of O O
IL-10 O O
signaling O O
. O O

Studies O O
of O O
conditional O O
SOCS3-deficient O O
mice O O
have O O
shown O O
that O O
SOCS3 O O
deficiency O O
, O O
but O O
not O O
SOCS1 O O
deficiency O O
, O O
results O O
in O O
sustained O O
activation O O
of O O
STAT3 O O
in O O
response O O
to O O
IL-6 O O
-LSB-8,41 O O
-RSB- O O
. O O

The O O
analysis O O
of O O
SOCS3-deficient O O
macrophages O O
has O O
indicated O O
that O O
SOCS3 O O
is O O
a O O
crucial O O
inhibitor O O
of O O
the O O
IL-6-induced O O
transcriptional O O
response O O
-LSB-42 O O
-RSB- O O
. O O

However B-conn Contrast
, O O
SOCS3 O O
is O O
dispensable O O
for O O
both O O
the O O
negative O O
feedback O O
inhibition O O
and O O
the O O
immunoregulatory O O
action O O
of O O
IL-10 O O
in O O
macrophages O O
-LSB-41 O O
-RSB- O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
SOCS1 O O
was O O
found O O
to O O
directly O O
inhibit O O
IL-10-mediated O O
signaling O O
-LSB-43 O O
-RSB- O O
. O O

Increased O O
SOCS1 O O
expression O O
in O O
RA O O
CD4+ O O
T O O
cells O O
may O O
therefore B-conn Cause.Claim
be O O
associated O O
with O O
both O O
the O O
impaired O O
responsiveness O O
to O O
IL-10 O O
and O O
to O O
IL-10-mediated O O
STAT3 O O
activation O O
, O O
and B-conn Conjunction
defective O O
SOCS3 O O
expression O O
may O O
be O O
responsible O O
for O O
persistent O O
STAT3 O O
activation O O
in O O
response O O
to O O
serum O O
IL-6 O O
. O O

There O O
is O O
a O O
possibility O O
that O O
SOCS1 O O
induction O O
may O O
be O O
associated O O
with O O
the O O
ability O O
of O O
CD4+ O O
T O O
cells O O
to O O
produce O O
IFN-γ O O
, O O
because B-conn Cause.Justification
CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
could O O
produce O O
high O O
levels O O
of O O
IFN-γ O O
in O O
the O O
presence O O
of O O
IL-10 O O
, O O
and B-conn Conjunction
because O O
IFN-γ O O
has O O
been O O
known O O
as O O
a O O
potent O O
inducer O O
of O O
SOCS1 O O
-LSB-32 O O
-RSB- O O
. O O

It O O
is O O
of O O
interest O O
in O O
this O O
regard O O
to O O
indicate O O
that O O
polarized O O
Th1 O O
and O O
Th2 O O
cells O O
express O O
high O O
levels O O
of O O
SOCS1 O O
and O O
SOCS3 O O
mRNA O O
, O O
respectively O O
-LSB-44 O O
-RSB- O O
. O O

IL-12-induced O O
STAT4 O O
activation O O
is O O
inhibited O O
by B-conn Purpose.Enablement
SOCS3 O O
induction O O
in O O
Th2 O O
cells O O
, O O
whereas B-conn Contrast
IL-4-induced O O
STAT6 O O
signaling O O
is O O
diminished O O
by B-conn Purpose.Enablement
SOCS1 O O
induction O O
in O O
Th1 O O
cells O O
. O O

SOCS1 O O
and O O
SOCS3 O O
may O O
thus B-conn Cause.Claim
have O O
important O O
roles O O
as O O
Th1-specific O O
and O O
Th2-specific O O
, O O
mutually O O
exclusive O O
, O O
cross-talk O O
repressors O O
of O O
the O O
IL-4–STAT6 O O
and O O
the O O
IL-12–STAT4 O O
signaling O O
pathways O O
, O O
respectively O O
. O O

Consistent O O
with O O
this O O
notion O O
, O O
PB O O
T O O
cells O O
from O O
patients O O
with O O
allergic O O
diseases O O
significantly O O
express O O
high O O
levels O O
of O O
SOCS3 O O
transcripts O O
, O O
and B-conn Conjunction
the O O
SOCS3 O O
expression O O
correlates O O
well O O
with O O
serum O O
IgE O O
levels O O
and O O
disease O O
pathology O O
-LSB-45 O O
-RSB- O O
. O O

Higher O O
SOCS1 O O
expression O O
with O O
lower O O
SOCS3 O O
expression O O
in O O
PB O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
, O O
compared O O
with O O
healthy O O
controls O O
, O O
is O O
therefore B-conn Cause.Claim
probably O O
consistent O O
with O O
their O O
systemic O O
bias O O
towards O O
a O O
Th1 O O
phenotype O O
, O O
as O O
has O O
previously O O
been O O
demonstrated O O
-LSB-46-49 O O
-RSB- O O
. O O

Conclusion O O

CD4+ O O
T O O
cells O O
from O O
active O O
RA O O
patients O O
are O O
characterized O O
by O O
their O O
resistance O O
to O O
IL-10 O O
inhibition O O
of O O
IFN-γ O O
production O O
, O O
due B-conn Cause.Reason
to I-conn Cause.Reason
constitutive O O
STAT3 O O
phosphorylation O O
and O O
impaired O O
IL-10-mediated O O
STAT3 O O
activation O O
. O O

The O O
defective O O
STAT3 O O
signaling O O
is O O
possibly O O
associated O O
with O O
SOCS1 O O
predominance O O
over O O
SOCS3 O O
. O O

These O O
abnormalities O O
in O O
active O O
RA O O
are O O
thought O O
to O O
be O O
induced O O
mainly O O
after B-conn Temporal.Succession
chronic O O
exposure O O
to O O
high O O
concentrations O O
of O O
IL-6 O O
. O O

The O O
limited O O
efficacy O O
of O O
IL-10 O O
treatment O O
of O O
RA O O
patients O O
-LSB-50 O O
-RSB- O O
may O O
be O O
explained O O
in O O
part O O
by O O
the O O
unresponsiveness O O
to O O
IL-10 O O
of O O
inflammatory O O
cells O O
, O O
including O O
T O O
cells O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
the O O
therapeutic O O
efficacy O O
of O O
anti-IL-6 O O
receptor O O
antibody O O
has O O
been O O
reported O O
in O O
RA O O
patients O O
-LSB-51 O O
-RSB- O O
, O O
and B-conn Continuation
one O O
of O O
the O O
effects O O
of O O
this O O
therapy O O
may O O
be O O
to O O
normalize O O
T O O
cells O O
through B-conn Purpose.Enablement
the O O
inhibition O O
of O O
IL-6-dependent O O
STAT3 O O
activation O O
. O O

More O O
specific O O
therapy O O
targeting O O
STAT3 O O
activation O O
will O O
be O O
awaited O O
; O O
for B-conn Instantiation
example I-conn Instantiation
, O O
the O O
induction O O
of O O
the O O
SOCS3 O O
gene O O
, O O
the O O
efficacy O O
of O O
which O O
has O O
been O O
demonstrated O O
in O O
animal O O
models O O
-LSB-37 O O
-RSB- O O
. O O

Abbreviations O O

BSA O O
= O O
bovine O O
serum O O
albumin O O
; O O
CRP O O
= O O
C-reactive O O
protein O O
; O O
ELISA O O
= O O
enzyme-linked O O
immunosorbent O O
assay O O
; O O
Fc O O
= O O
crystallazibe O O
fragment O O
; O O
FCS O O
= O O
fetal O O
calf O O
serum O O
; O O
FITC O O
= O O
fluorescein O O
isothiocyanate O O
; O O
IFN-γ O O
= O O
interferon O O
gamma O O
; O O
IL O O
= O O
interleukin O O
; O O
IL-10R O O
= O O
interleukin-10 O O
receptor O O
; O O
IL-10R1 O O
= O O
type O O
1 O O
interleukin-10 O O
receptor O O
; O O
JAK O O
= O O
Janus O O
kinase O O
; O O
mAb O O
= O O
monoclonal O O
antibody O O
; O O
MHC O O
= O O
major O O
histocompatibility O O
complex O O
; O O
PB O O
= O O
peripheral O O
blood O O
; O O
PBMC O O
= O O
peripheral O O
blood O O
mononuclear O O
cells O O
; O O
PBS O O
= O O
phosphate-buffered O O
saline O O
; O O
PCR O O
= O O
polymerase O O
chain O O
reaction O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
SOXS O O
= O O
suppressor O O
of O O
cytokine O O
signaling O O
; O O
ST O O
= O O
synovial O O
tissue O O
; O O
STAT O O
= O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
; O O
Th O O
= O O
T O O
helper O O
cells O O
; O O
TNF-α O O
= O O
tumor O O
necrosis O O
factor O O
alpha O O
. O O

Competing O O
interests O O

The O O
author O O
-LRB- O O
s O O
-RRB- O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Authors O O
' O O
contributions O O

Jiro O O
Yamana O O
was O O
responsible O O
for O O
the O O
experiments O O
and O O
data O O
analysis O O
and O O
wrote O O
the O O
report O O
. O O

Masahiro O O
Yamamura O O
was O O
responsible O O
for O O
the O O
planning O O
of O O
the O O
research O O
and O O
wrote O O
up O O
the O O
manuscript O O
. O O

Akira O O
Okamoto O O
, O O
Tetsushi O O
Aita O O
, O O
Mitsuhiro O O
Iwahashi O O
, O O
and O O
Katsue O O
Sunahori O O
assisted O O
the O O
experiments O O
. O O

Hirofumi O O
Makino O O
critically O O
read O O
the O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Dose O O
response O O
of O O
IL-10 O O
inhibition O O
of O O
interferon O O
gamma O O
-LRB- O O
IFN-γ O O
-RRB- O O
production O O
by O O
CD4+ O O
T O O
cells O O
after O O
CD3 O O
and O O
CD28 O O
costimulation O O
in O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
and O O
in O O
healthy O O
controls O O
-LRB- O O
HC O O
-RRB- O O
. O O

CD4+ O O
T O O
cells O O
were O O
purified O O
from O O
peripheral O O
blood O O
mononuclear O O
cells O O
of O O
three O O
RA O O
patients O O
and O O
three O O
HC O O
by O O
positive O O
selection O O
with O O
anti-CD4 O O
antibody O O
. O O

CD4+ O O
T O O
cells O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
-RRB- O O
were O O
stimulated O O
by O O
immobilized O O
anti-CD3 O O
antibody O O
and O O
anti-CD28 O O
antibody O O
in O O
the O O
presence O O
or O O
absence O O
of O O
diluted O O
IL-10 O O
concentrations O O
for O O
36 O O
hours O O
. O O

Culture O O
supernatants O O
were O O
measured O O
for O O
concentrations O O
of O O
IFN-γ O O
by O O
ELISA O O
. O O

IFN-γ O O
production O O
with O O
IL-10 O O
expressed O O
as O O
% O O
IFN-γ O O
production O O
without O O
IL-10 O O
. O O

Values O O
are O O
the O O
mean O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

Figure O O
2 O O
: O O
-LRB- O O
a O O
-RRB- O O
Interferon O O
gamma O O
-LRB- O O
IFN-γ O O
-RRB- O O
production O O
by O O
CD3 O O
and O O
CD28 O O
costimulated O O
CD4+ O O
T O O
cells O O
in O O
the O O
presence O O
of O O
IL-10 O O
in O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
and O O
in O O
healthy O O
controls O O
-LRB- O O
HC O O
-RRB- O O
. O O

CD4+ O O
T O O
cells O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
-RRB- O O
were O O
stimulated O O
by O O
anti-CD3 O O
antibody O O
and O O
anti-CD28 O O
antibody O O
with O O
or O O
without O O
1 O O
ng/ml O O
IL-10 O O
. O O

Concentrations O O
of O O
IFN-γ O O
in O O
culture O O
supernatants O O
were O O
measured O O
in O O
duplicate O O
by O O
ELISA O O
. O O

RA O O
patients O O
were O O
divided O O
into O O
those O O
with O O
active O O
disease O O
-LRB- O O
multiple O O
inflammatory O O
joints O O
and O O
CRP O O
level O O
≥ O O
10 O O
mg/l O O
-RRB- O O
and O O
inactive O O
disease O O
-LRB- O O
in O O
remission O O
and O O
CRP O O
level O O
≤ O O
4 O O
mg/l O O
-RRB- O O
. O O

The O O
results O O
are O O
represented O O
as O O
a O O
box O O
plot O O
; O O
upper O O
and O O
lower O O
bars O O
, O O
90th O O
and O O
10th O O
percentiles O O
, O O
respectively O O
; O O
upper O O
, O O
center O O
and O O
lower O O
lines O O
of O O
box O O
, O O
75th O O
, O O
50th O O
, O O
and O O
25th O O
percentiles O O
, O O
respectively O O
. O O

-LRB- O O
b O O
-RRB- O O
Percentage O O
of O O
IFN-γ O O
production O O
. O O

IFN-γ O O
production O O
with O O
IL-10 O O
expressed O O
as O O
% O O
IFN-γ O O
production O O
without O O
IL-10 O O
. O O

Values O O
are O O
the O O
mean O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

n O O
, O O
number O O
of O O
samples O O
tested O O
. O O

Figure O O
3 O O
: O O
-LRB- O O
a O O
-RRB- O O
Cell O O
surface O O
expression O O
of O O
type O O
1 O O
interleukin-10 O O
receptor O O
-LRB- O O
IL-10R1 O O
-RRB- O O
on O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
and O O
from O O
healthy O O
controls O O
-LRB- O O
HC O O
-RRB- O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
were O O
stained O O
with O O
anti-IL-10R1 O O
antibody O O
or O O
with O O
isotype-matched O O
control O O
antibody O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
incubation O O
with O O
FITC-conjugated O O
goat O O
anti-mouse O O
IgG1 O O
polyclonal O O
antibody O O
, O O
and O O
were O O
then B-conn Temporal.Precedence
stained O O
with O O
phycoerythrin-conjugated O O
anti-CD4 O O
mAb O O
. O O

The O O
expression O O
of O O
CD4 O O
and O O
IL-10R1 O O
was O O
determined O O
by O O
flow O O
cytometric O O
analysis O O
. O O

Representative O O
histographic O O
patterns O O
of O O
IL-10R1 O O
expression O O
on O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
and O O
HC O O
are O O
shown O O
. O O

-LRB- O O
b O O
-RRB- O O
The O O
intensity O O
of O O
IL-10R1 O O
on O O
CD4+ O O
T O O
cells O O
was O O
expressed O O
as O O
the O O
ratio O O
of O O
the O O
mean O O
fluorescence O O
intensity O O
-LRB- O O
MFI O O
-RRB- O O
of O O
staining O O
with O O
anti-IL-10R1 O O
to O O
control O O
antibody O O
. O O

Values O O
are O O
the O O
mean O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

n O O
, O O
number O O
of O O
samples O O
tested O O
. O O

Figure O O
4 O O
: O O
-LRB- O O
a O O
-RRB- O O
IL-10-mediated O O
phosphorylation O O
of O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
-LRB- O O
STAT O O
-RRB- O O
1 O O
and O O
STAT3 O O
in O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
and O O
from O O
healthy O O
controls O O
-LRB- O O
HC O O
-RRB- O O
. O O

CD4+ O O
T O O
cells O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
-RRB- O O
were O O
incubated O O
with O O
or O O
without O O
IL-10 O O
-LRB- O O
1 O O
and O O
10 O O
ng/ml O O
-RRB- O O
and B-conn Conjunction
cells O O
were O O
harvested O O
20 B-conn Temporal.Precedence
min I-conn Temporal.Precedence
later I-conn Temporal.Precedence
. O O

Whole O O
cell O O
extracts O O
were O O
prepared O O
by B-conn Purpose.Enablement
placing O O
cells O O
in O O
SDS O O
buffer O O
, O O
and B-conn Conjunction
tyrosine O O
phosophorylation O O
-LRB- O O
p-Tyr O O
-RRB- O O
of O O
STAT1 O O
and O O
STAT3 O O
was O O
detected O O
by O O
western O O
blot O O
analysis O O
. O O

IFN-γ-stimulated O O
Hela O O
cells O O
were O O
used O O
as O O
a O O
positive O O
control O O
for O O
STAT1 O O
phosphorylation O O
. O O

-LRB- O O
b O O
-RRB- O O
Percentage O O
of O O
IL-10-activated O O
STAT3 O O
phosphorylation O O
in O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
and O O
from O O
HC O O
. O O

Protein O O
bands O O
were O O
quantified O O
by O O
densitometry O O
using O O
NIH-Image O O
analysis O O
, O O
and B-conn Continuation
STAT3 O O
phosphorylation O O
was O O
expressed O O
as O O
% O O
total O O
STAT3 O O
protein O O
. O O

-LRB- O O
c O O
-RRB- O O
STAT3 O O
phosphorylation O O
in O O
ST O O
CD4+ O O
T O O
cells O O
from O O
RA O O
patients O O
. O O

Representative O O
results O O
of O O
STAT3 O O
phosphorylation O O
in O O
CD4+ O O
T O O
cells O O
from O O
three O O
synovial O O
tissue O O
samples O O
of O O
RA O O
patients O O
and O O
three O O
peripheral O O
blood O O
samples O O
of O O
HC O O
are O O
shown O O
. O O

Values O O
are O O
the O O
mean O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

n O O
, O O
number O O
of O O
samples O O
tested O O
. O O

Figure O O
5 O O
: O O
-LRB- O O
a O O
-RRB- O O
Activation O O
of O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
-LRB- O O
STAT O O
-RRB- O O
3 O O
in O O
normal O O
CD4+ O O
T O O
cells O O
by O O
serum O O
IL-6 O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
. O O

CD4+ O O
T O O
cells O O
from O O
healthy O O
controls O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
-RRB- O O
were O O
stimulated O O
by O O
30 O O
% O O
RA O O
serum O O
in O O
the O O
presence O O
of O O
neutralizing O O
anti-IL-6 O O
antibody O O
-LRB- O O
Ab O O
-RRB- O O
-LRB- O O
40 O O
μg/ml O O
-RRB- O O
or O O
of O O
control O O
antibody O O
-LRB- O O
40 O O
μg/ml O O
-RRB- O O
for O O
20 O O
min O O
. O O

Phosophorylation O O
of O O
STAT1 O O
and O O
STAT3 O O
was O O
detected O O
by O O
western O O
blot O O
analysis. O O
-LRB- O O
b O O
-RRB- O O

Effect O O
of O O
IL-6 O O
pretreatment O O
on O O
IL-10 O O
inhibition O O
of O O
IFN-γ O O
production O O
by O O
CD4+ O O
T O O
cells O O
. O O

CD4+ O O
T O O
cells O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
-RRB- O O
were O O
incubated O O
with O O
or O O
without O O
IL-6 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
for O O
36 O O
hours O O
, O O
and O O
were O O
then B-conn Temporal.Precedence
stimulated O O
by O O
anti-CD3 O O
antibody O O
and O O
anti-CD28 O O
antibody O O
in O O
the O O
presence O O
or O O
absence O O
of O O
IL-10 O O
-LRB- O O
1 O O
ng/ml O O
-RRB- O O
for O O
36 O O
hours O O
. O O

Concentrations O O
of O O
IFN-γ O O
in O O
culture O O
supernatants O O
were O O
measured O O
in O O
duplicate O O
by O O
ELISA O O
. O O

IFN-γ O O
production O O
with O O
IL-10 O O
was O O
expressed O O
as O O
% O O
IFN-γ O O
production O O
without O O
IL-10 O O
. O O

Values O O
are O O
the O O
mean O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

n O O
, O O
number O O
of O O
samples O O
tested O O
. O O

P-Tyr O O
, O O
tyrosine O O
phosophorylation O O
. O O

Figure O O
6 O O
: O O
-LRB- O O
a O O
-RRB- O O
The O O
mRNA O O
expression O O
of O O
SOCS1 O O
and O O
SOCS3 O O
in O O
CD4+ O O
T O O
cells O O
from O O
patients O O
with O O
RA O O
and O O
healthy O O
controls O O
-LRB- O O
HC O O
-RRB- O O
. O O

Total O O
cellular O O
RNA O O
was O O
extracted O O
from O O
freshly O O
isolated O O
CD4+ O O
T O O
cells O O
and O O
mRNA O O
expression O O
of O O
SOCS1 O O
and O O
SOCS3 O O
was O O
analyzed O O
by O O
real O O
time-PCR O O
as O O
described O O
in O O
Patients O O
and O O
Methods O O
. O O

Levels O O
of O O
SOCS1 O O
and O O
SOCS3 O O
mRNAs O O
were O O
normalized O O
relative O O
to O O
β-actin O O
expression O O
. O O

Values O O
are O O
the O O
mean O O
± O O
SEM. O O
n O O
= O O
number O O
of O O
samples O O
tested O O
. O O

-LRB- O O
b O O
-RRB- O O
Kinetics O O
of O O
IL-6-induced O O
SOCS1 O O
mRNA O O
expression O O
in O O
normal O O
CD4+ O O
T O O
cells O O
. O O

CD4+ O O
T O O
cells O O
from O O
HC O O
-LRB- O O
5 O O
× O O
105 O O
cells O O
in O O
0.5 O O
ml O O
of O O
culture O O
medium O O
with O O
10 O O
% O O
FCS O O
-RRB- O O
were O O
stimulated O O
with O O
IL-6 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
and B-conn Conjunction
SOCS1 O O
mRNA O O
expression O O
was O O
determined O O
at O O
the O O
indicated O O
time O O
after O O
stimulation O O
. O O

Increased O O
interleukin-17 O O
production O O
via O O
a O O
phosphoinositide O O
3-kinase/Akt O O
and O O
nuclear O O
factor O O
κB-dependent O O
pathway O O
in O O
patients O O
with O O
rheumatoid O O
arthritis O O

Abstract O O

Inflammatory O O
mediators O O
have O O
been O O
recognized O O
as O O
being O O
important O O
in O O
the O O
pathogenesis O O
of O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
. O O

Interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
is O O
an O O
important O O
regulator O O
of O O
immune O O
and O O
inflammatory O O
responses O O
, O O
including O O
the O O
induction O O
of O O
proinflammatory O O
cytokines O O
and O O
osteoclastic O O
bone O O
resorption O O
. O O

Evidence O O
for O O
the O O
expression O O
and O O
proinflammatory O O
activity O O
of O O
IL-17 O O
has O O
been O O
demonstrated O O
in O O
RA O O
synovium O O
and O O
in O O
animal O O
models O O
of O O
RA O O
. O O

Although B-conn Concession.Contra-expectation
some O O
cytokines O O
-LRB- O O
IL-15 O O
and O O
IL-23 O O
-RRB- O O
have O O
been O O
reported O O
to O O
regulate O O
IL-17 O O
production O O
, O O
the O O
intracellular O O
signaling O O
pathways O O
that O O
regulate O O
IL-17 O O
production O O
remain O O
unknown O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
investigated O O
the O O
role O O
of O O
the O O
phosphoinositide O O
3-kinase O O
-LRB- O O
PI3K O O
-RRB- O O
/Akt O O
pathway O O
in O O
the O O
regulation O O
of O O
IL-17 O O
production O O
in O O
RA O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
from O O
patients O O
with O O
RA O O
-LRB- O O
n O O
= O O
24 O O
-RRB- O O
were O O
separated O O
, O O
then B-conn Temporal.Precedence
stimulated O O
with O O
various O O
agents O O
including O O
anti-CD3 O O
, O O
anti-CD28 O O
, O O
phytohemagglutinin O O
-LRB- O O
PHA O O
-RRB- O O
and O O
several O O
inflammatory O O
cytokines O O
and O O
chemokines O O
. O O

IL-17 O O
levels O O
were O O
determined O O
by O O
sandwich O O
enzyme-linked O O
immunosorbent O O
assay O O
and O O
reverse O O
transcription–polymerase O O
chain O O
reaction O O
. O O

The O O
production O O
of O O
IL-17 O O
was O O
significantly O O
increased O O
in O O
cells O O
treated O O
with O O
anti-CD3 O O
antibody O O
with O O
or O O
without O O
anti-CD28 O O
and O O
PHA O O
-LRB- O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

Among O O
tested O O
cytokines O O
and O O
chemokines O O
, O O
IL-15 O O
, O O
monocyte O O
chemoattractant O O
protein-1 O O
and O O
IL-6 O O
upregulated O O
IL-17 O O
production O O
-LRB- O O
P O O
< O O
0.05 O O
-RRB- O O
, O O
whereas B-conn Contrast
tumor O O
necrosis O O
factor-α O O
, O O
IL-1β O O
, O O
IL-18 O O
or O O
transforming O O
growth O O
factor-β O O
did O O
not O O
. O O

IL-17 O O
was O O
also B-conn Conjunction
detected O O
in O O
the O O
PBMC O O
of O O
patients O O
with O O
osteoarthritis O O
, O O
but B-conn Concession.Contra-expectation
their O O
expression O O
levels O O
were O O
much O O
lower O O
than O O
those O O
of O O
RA O O
PBMC O O
. O O

Anti-CD3 O O
antibody O O
activated O O
the O O
PI3K/Akt O O
pathway O O
; O O
activation O O
of O O
this O O
pathway O O
resulted O O
in O O
a O O
pronounced O O
augmentation O O
of O O
nuclear O O
factor O O
κB O O
-LRB- O O
NF-κB O O
-RRB- O O
DNA-binding O O
activity O O
. O O

IL-17 O O
production O O
by O O
activated O O
RA O O
PBMC O O
is O O
completely O O
or O O
partly O O
blocked O O
in O O
the O O
presence O O
of O O
the O O
NF-κB O O
inhibitor O O
pyrrolidine O O
dithiocarbamate O O
and O O
the O O
PI3K/Akt O O
inhibitor O O
wortmannin O O
and O O
LY294002 O O
, O O
respectively O O
. O O

However B-conn Contrast
, O O
inhibition O O
of O O
activator O O
protein-1 O O
and O O
extracellular O O
signal-regulated O O
kinase O O
1/2 O O
did O O
not O O
affect O O
IL-17 O O
production O O
. O O

These O O
results O O
suggest O O
that O O
signal O O
transduction O O
pathways O O
dependent O O
on O O
PI3K/Akt O O
and O O
NF-κB O O
are O O
involved O O
in O O
the O O
overproduction O O
of O O
the O O
key O O
inflammatory O O
cytokine O O
IL-17 O O
in O O
RA O O
. O O

Introduction O O

Rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
is O O
characterized O O
by O O
infiltrations O O
of O O
macrophages O O
and O O
T O O
cells O O
into O O
the O O
joint O O
, O O
and O O
synovial O O
hyperplasia O O
. O O

Proinflammatory O O
cytokines O O
released O O
from O O
these O O
cells O O
are O O
known O O
to O O
be O O
important O O
in O O
the O O
destruction O O
of O O
joints O O
in O O
RA O O
-LSB-1 O O
-RSB- O O
. O O

The O O
favorable O O
clinical O O
benefits O O
obtained O O
with O O
inhibitors O O
of O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
-RRB- O O
and O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-1 O O
suggest O O
that O O
the O O
blockade O O
of O O
key O O
inflammatory O O
cytokines O O
has O O
been O O
the O O
important O O
issue O O
in O O
the O O
development O O
of O O
new O O
therapeutic O O
applications O O
-LSB-2 O O
-RSB- O O
. O O

A O O
little O O
over O O
a O O
decade O O
ago O O
, O O
the O O
primacy O O
of O O
T O O
cells O O
in O O
the O O
pathogenesis O O
of O O
autoimmune O O
disease O O
such O O
as O O
RA O O
was O O
undisputed O O
because B-conn Cause.Reason
they O O
are O O
the O O
largest O O
cell O O
population O O
infiltrating O O
the O O
synovium O O
. O O

However B-conn Contrast
, O O
a O O
series O O
of O O
studies O O
demonstrated O O
paucity O O
of O O
T O O
cell-derived O O
cytokines O O
such O O
as O O
IL-2 O O
and O O
interferon-γ O O
in O O
the O O
joints O O
of O O
RA O O
, O O
whereas B-conn Contrast
macrophage O O
and O O
fibroblast O O
cytokines O O
including O O
IL-1 O O
, O O
IL-6 O O
, O O
IL-15 O O
, O O
IL-18 O O
and O O
TNF-α O O
were O O
abundant O O
in O O
rheumatoid O O
synovium O O
. O O

This O O
paradox O O
has O O
questioned O O
the O O
role O O
of O O
T O O
cells O O
in O O
the O O
pathogenesis O O
of O O
RA O O
-LSB-3 O O
-RSB- O O
. O O

Because B-conn Cause.Reason
we O O
have O O
already O O
demonstrated O O
the O O
enhanced O O
proliferation O O
of O O
antigen O O
specific O O
T O O
cells O O
, O O
especially O O
to O O
type O O
II O O
collagen O O
, O O
and O O
the O O
skewing O O
of O O
T O O
helper O O
type O O
1 O O
-LRB- O O
Th1 O O
-RRB- O O
cytokines O O
in O O
RA O O
-LSB-4 O O
-RSB- O O
, O O
the O O
role O O
of O O
T O O
cells O O
needs O O
to O O
be O O
elucidated O O
in O O
different O O
aspects O O
. O O

IL-17 O O
is O O
one O O
of O O
the O O
inflammatory O O
cytokines O O
secreted O O
mainly O O
by O O
activated O O
T O O
cells O O
, O O
which O O
can O O
induce O O
IL-6 O O
and O O
IL-8 O O
by O O
fibroblasts O O
-LSB-5 O O
-RSB- O O
. O O

This O O
cytokine O O
is O O
of O O
interest O O
for O O
two O O
major O O
reasons O O
: O O
first O O
, O O
similarly O O
to O O
TNF-α O O
and O O
IL-1 O O
, O O
IL-17 O O
has O O
proinflammatory O O
properties O O
; O O
second B-conn Conjunction
, O O
it O O
is O O
produced O O
by O O
T O O
cells O O
-LSB-6 O O
-RSB- O O
. O O

Recent O O
observations O O
demonstrated O O
that O O
IL-17 O O
can O O
also B-conn Conjunction
activate O O
osteoclastic O O
bone O O
resorption O O
by B-conn Purpose.Enablement
the O O
induction O O
of O O
RANKL O O
-LRB- O O
receptor O O
activator O O
of O O
nuclear O O
factor O O
κB O O
-LSB-NF-κB O O
-RSB- O O
ligand O O
-RRB- O O
, O O
which O O
is O O
involved O O
in O O
bony O O
erosion O O
in O O
RA O O
-LSB-7 O O
-RSB- O O
. O O

It O O
also B-conn Conjunction
stimulates O O
the O O
production O O
of O O
IL-6 O O
and O O
leukemia O O
inhibitory O O
factor O O
by O O
synoviocytes O O
, O O
and O O
of O O
prostaglandin O O
E2 O O
and O O
nitric O O
oxide O O
by O O
chondrocytes O O
, O O
and O O
has O O
the O O
ability O O
to O O
differentiate O O
and O O
activate O O
the O O
dendritic O O
cells O O
-LSB-8-10 O O
-RSB- O O
. O O

Levels O O
of O O
IL-17 O O
in O O
synovial O O
fluids O O
were O O
significantly O O
higher O O
in O O
patients O O
with O O
RA O O
than O O
in O O
patients O O
with O O
osteoarthritis O O
-LRB- O O
OA O O
-RRB- O O
, O O
and B-conn Conjunction
it O O
was O O
produced O O
by O O
CD4+ O O
T O O
cells O O
in O O
the O O
synovium O O
-LSB-11,12 O O
-RSB- O O
. O O

IL-15 O O
, O O
secreted O O
from O O
activated O O
macrophages O O
, O O
has O O
been O O
reported O O
to O O
be O O
an O O
important O O
trigger O O
of O O
IL-17 O O
production O O
in O O
RA O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
by O O
cyclosporine O O
and O O
steroid O O
sensitive O O
pathways O O
-LSB-13 O O
-RSB- O O
. O O

Recently O O
, O O
Happel O O
and O O
colleagues O O
also B-conn Conjunction
showed O O
that O O
IL-23 O O
could O O
be O O
an O O
efficient O O
trigger O O
of O O
IL-17 O O
production O O
from O O
both O O
CD4+ O O
and O O
CD8+ O O
T O O
cells O O
-LSB-14 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
the O O
contribution O O
of O O
IL-17 O O
in O O
joint O O
inflammation O O
in O O
RA O O
has O O
been O O
documented O O
in O O
earlier O O
studies O O
-LSB-12,15,16 O O
-RSB- O O
, O O
the O O
intracellular O O
signal O O
transduction O O
pathway O O
for O O
IL-17 O O
production O O
remains O O
uncertain O O
. O O

In O O
the O O
present O O
study O O
we O O
used O O
various O O
stimuli O O
to O O
investigate O O
IL-17 O O
production O O
in O O
PBMC O O
of O O
patients O O
with O O
RA O O
and O O
its O O
signaling O O
transduction O O
pathway O O
. O O

We O O
found O O
that O O
the O O
intracellular O O
signaling O O
pathway O O
involving O O
phosphoinositide O O
3-kinase O O
-LRB- O O
PI3K O O
-RRB- O O
/Akt O O
and O O
NF-κB O O
might O O
be O O
involved O O
in O O
the O O
overproduction O O
of O O
the O O
key O O
inflammatory O O
cytokine O O
IL-17 O O
in O O
RA O O
. O O

These O O
results O O
might O O
provide O O
new O O
insights O O
into O O
the O O
pathogenesis O O
of O O
RA O O
and O O
future O O
directions O O
for O O
new O O
therapeutic O O
strategies O O
in O O
RA O O
. O O

Materials O O
and O O
methods O O

Informed O O
consent O O
was O O
obtained O O
from O O
24 O O
patients O O
-LRB- O O
5 O O
men O O
and O O
19 O O
women O O
-RRB- O O
with O O
RA O O
who O O
fulfilled O O
the O O
1987 O O
revised O O
criteria O O
of O O
the O O
American O O
College O O
of O O
Rheumatology O O
-LRB- O O
formerly O O
the O O
American O O
Rheumatism O O
Association O O
-RRB- O O
-LSB-17 O O
-RSB- O O
. O O

The O O
age O O
of O O
the O O
patients O O
with O O
RA O O
was O O
50 O O
± O O
8 O O
-LRB- O O
mean O O
± O O
SEM O O
-RRB- O O
years O O
-LRB- O O
range O O
23–71 O O
years O O
-RRB- O O
. O O

All O O
medications O O
were O O
stopped O O
48 O O
hours O O
before O O
entry O O
to O O
the O O
study O O
. O O

Comparisons O O
were O O
made O O
with O O
14 O O
patients O O
with O O
OA O O
-LRB- O O
3 O O
men O O
and O O
11 O O
women O O
-RRB- O O
and O O
with O O
14 O O
healthy O O
controls O O
-LRB- O O
3 O O
men O O
and O O
11 O O
women O O
-RRB- O O
who O O
had O O
no O O
rheumatic O O
diseases O O
. O O

The O O
mean O O
ages O O
of O O
the O O
patients O O
with O O
OA O O
and O O
the O O
healthy O O
controls O O
were O O
50 O O
± O O
8 O O
years O O
-LRB- O O
range O O
34–68 O O
years O O
-RRB- O O
and O O
30 O O
± O O
6 O O
years O O
-LRB- O O
range O O
24–57 O O
years O O
-RRB- O O
. O O

Informed O O
consent O O
was O O
obtained O O
, O O
and O O
the O O
protocol O O
was O O
approved O O
by O O
the O O
Catholic O O
University O O
of O O
Korea O O
Human O O
Research O O
Ethics O O
Committee O O
. O O

Recombinant O O
IL-17 O O
, O O
IL-18 O O
, O O
IL-15 O O
, O O
monocyte O O
chemoattractant O O
protein-1 O O
-LRB- O O
MCP-1 O O
-RRB- O O
, O O
macrophage O O
inflammatory O O
protein O O
-LRB- O O
MIP O O
-RRB- O O
-1α O O
, O O
MIP-1β O O
, O O
IL-6 O O
and O O
IL-8 O O
were O O
purchased O O
from O O
R O O
& O O
D O O
systems O O
-LRB- O O
Minneapolis O O
, O O
MN O O
, O O
USA O O
-RRB- O O
. O O

Recombinant O O
transforming O O
growth O O
factor O O
-LRB- O O
TGF O O
-RRB- O O
-β O O
was O O
purchased O O
from O O
Peprotech O O
-LRB- O O
London O O
, O O
UK O O
-RRB- O O
. O O

Recombinant O O
TNF-α O O
and O O
IL-1 O O
were O O
purchased O O
from O O
Endogen O O
Inc. O O
-LRB- O O
Cambridge O O
, O O
MA O O
, O O
USA O O
-RRB- O O
. O O

Cyclosporin O O
A O O
was O O
provided O O
by O O
Sandos O O
Ltd. O O
-LRB- O O
Basel O O
, O O
Switzerland O O
-RRB- O O
. O O

Phytohemagglutinin O O
-LRB- O O
PHA O O
-RRB- O O
, O O
pyrrolidine O O
dithiocarbamate O O
-LRB- O O
PDTC O O
-RRB- O O
, O O
rapamycin O O
, O O
dexamethasone O O
and O O
curcumin O O
were O O
all O O
obtained O O
from O O
the O O
Sigma O O
Chemical O O
Co. O O
. O O

-LRB- O O
St O O
Louis O O
, O O
MA O O
, O O
USA O O
-RRB- O O
. O O

Anti-CD3 O O
monoclonal O O
antibody O O
and O O
anti-CD28 O O
monoclonal O O
antibody O O
were O O
obtained O O
from O O
BD O O
Biosciences O O
-LRB- O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

LY294002 O O
, O O
SB203580 O O
, O O
FK506 O O
, O O
wortmannin O O
and O O
PD98059 O O
were O O
obtained O O
from O O
Calbiochem O O
-LRB- O O
Schwalbach O O
, O O
Germany O O
-RRB- O O
. O O

PBMC O O
were O O
prepared O O
from O O
heparinized O O
blood O O
by O O
Ficoll-Hypaque O O
-LRB- O O
SG1077 O O
-RRB- O O
density-gradient O O
centrifugation O O
. O O

Cell O O
cultures O O
were O O
performed O O
as O O
described O O
previously O O
-LSB-18 O O
-RSB- O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
the O O
cell O O
suspensions O O
were O O
adjusted O O
to O O
a O O
concentration O O
of O O
106/ml O O
in O O
RPMI O O
1640 O O
medium O O
supplemented O O
with O O
10 O O
% O O
fetal O O
calf O O
serum O O
, O O
100 O O
U/ml O O
penicillin O O
, O O
100 O O
mg/ml O O
streptomycin O O
and O O
2 O O
mM O O
L-glutamine O O
. O O

Cell O O
suspension O O
-LRB- O O
1 O O
ml O O
-RRB- O O
was O O
dispensed O O
into O O
24-well O O
multi-well O O
plates O O
-LRB- O O
Nunc O O
, O O
Roskilde O O
, O O
Denmark O O
-RRB- O O
, O O
and O O
incubated O O
for O O
24 O O
hours O O
at O O
37°C O O
in O O
5 O O
% O O
CO2 O O
. O O

Subsequently B-conn Temporal.Precedence
, O O
various O O
concentrations O O
of O O
cyclosporin O O
A O O
-LRB- O O
10–500 O O
ng/ml O O
-RRB- O O
were O O
added O O
to O O
the O O
medium O O
and B-conn Conjunction
cells O O
were O O
incubated O O
for O O
24 O O
hours O O
. O O

To O O
each O O
well O O
was O O
added O O
FK506 O O
, O O
rapamycin O O
, O O
curcumin O O
, O O
PDTC O O
, O O
LY294002 O O
, O O
SB203580 O O
, O O
PD98059 O O
, O O
dexamethasone O O
or O O
wortmannin O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
24 O O
hours O O
-LRB- O O
unless O O
otherwise O O
stated O O
-RRB- O O
, O O
cell-free O O
media O O
were O O
collected O O
and O O
stored O O
at O O
-20°C O O
until B-conn Temporal.Precedence
assayed O O
. O O

All O O
cultures O O
were O O
set O O
up O O
in O O
triplicate O O
, O O
and B-conn Conjunction
results O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
. O O

Anti-CD4 O O
microbeads O O
were O O
used O O
essentially O O
as O O
recommended O O
by O O
the O O
manufacturer O O
-LRB- O O
Miltenyi O O
-RRB- O O
-LSB-19 O O
-RSB- O O
. O O

PBMC O O
were O O
resuspended O O
in O O
80 O O
μl O O
of O O
FBS O O
staining O O
buffer O O
. O O

Anti-CD4 O O
microbeads O O
-LRB- O O
20 O O
μl O O
-RRB- O O
were O O
added O O
and O O
incubated O O
for O O
15 O O
min O O
at O O
6–12°C O O
. O O

Saturating O O
amounts O O
of O O
fluorochrome-conjugated O O
antibodies O O
were O O
added O O
for O O
a O O
further O O
10 O O
min O O
. O O

Cells O O
were O O
diluted O O
in O O
2.5 O O
ml O O
of O O
FBS O O
staining O O
buffer O O
, O O
pelleted O O
, O O
resuspended O O
in O O
500 O O
μl O O
and O O
magnetically O O
separated O O
, O O
usually O O
on O O
an O O
AutoMACS O O
magnet O O
fitted O O
with O O
a O O
MACS O O
MS O O
column O O
. O O

Flow-through O O
and O O
two O O
1 O O
ml O O
washes O O
were O O
collected O O
as O O
the O O
negative O O
fraction O O
. O O

Enriched O O
cells O O
were O O
collected O O
in O O
two O O
0.5 O O
ml O O
aliquots O O
from O O
the O O
column O O
after B-conn Temporal.Succession
removal O O
from O O
the O O
magnet O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
cells O O
stained O O
with O O
anti-CD4–phycoerythrin O O
were O O
washed O O
, O O
magnetically O O
labeled O O
with O O
anti-phycoerythrin O O
microbeads O O
-LRB- O O
20 O O
μl O O
added O O
to O O
80 O O
μl O O
of O O
cell O O
suspension O O
; O O
15 O O
min O O
, O O
6–12°C O O
-RRB- O O
, O O
and O O
magnetically O O
separated O O
as O O
described O O
above O O
. O O

The O O
purity O O
of O O
cells O O
was O O
assessed O O
by O O
flow O O
cytometric O O
analysis O O
of O O
stained O O
cells O O
on O O
a O O
FACS O O
Vantage O O
sorter O O
. O O

Most O O
-LRB- O O
more O O
than O O
97 O O
% O O
-RRB- O O
of O O
the O O
isolated O O
cells O O
had O O
the O O
CD4 O O
T O O
cell O O
marker O O
. O O

IL-17 O O
in O O
culture O O
supernatants O O
was O O
measured O O
by O O
sandwich O O
enzyme-linked O O
immunosorbent O O
assay O O
as O O
described O O
previously O O
-LSB-20 O O
-RSB- O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
a O O
96-well O O
plate O O
-LRB- O O
Nunc O O
-RRB- O O
was O O
coated O O
with O O
4 O O
μg/ml O O
monoclonal O O
antibodies O O
against O O
IL-17 O O
-LRB- O O
R O O
& O O
D O O
Systems O O
-RRB- O O
at O O
4°C O O
overnight O O
. O O

After B-conn Temporal.Succession
blocking O O
with O O
phosphate-buffered O O
saline/1 O O
% O O
bovine O O
serum O O
albumin O O
-LRB- O O
BSA O O
-RRB- O O
/0.05 O O
% O O

Tween O O
20 O O
for O O
2 O O
hours O O
at O O
room O O
temperature O O
-LRB- O O
22–25°C O O
-RRB- O O
, O O
test O O
samples O O
and O O
the O O
standard O O
recombinant O O
IL-17 O O
-LRB- O O
R O O
& O O
D O O
Systems O O
-RRB- O O
were O O
added O O
to O O
the O O
96-well O O
plate O O
and O O
incubated O O
at O O
room O O
temperature O O
for O O
2 O O
hours O O
. O O

Plates O O
were O O
washed O O
four O O
times O O
with O O
phosphate-buffered O O
saline/Tween O O
20 O O
, O O
and O O
then B-conn Temporal.Precedence
incubated O O
with O O
500 O O
ng/ml O O
biotinylated O O
mouse O O
monoclonal O O
antibodies O O
against O O
IL-17 O O
-LRB- O O
R O O
& O O
D O O
Systems O O
-RRB- O O
for O O
2 O O
hours O O
at O O
room O O
temperature O O
. O O

After O O
washing O O
, O O
streptavidin–alkaline O O
phosphate–horseradish O O
peroxidase O O
conjugate O O
-LRB- O O
Sigma O O
-RRB- O O
was O O
incubated O O
for O O
2 O O
hours O O
, O O
then B-conn Temporal.Precedence
washed O O
again O O
and O O
incubated O O
with O O
1 O O
mg/ml O O
p-nitrophenyl O O
phosphate O O
-LRB- O O
Sigma O O
-RRB- O O
dissolved O O
in O O
diethanolamine O O
-LRB- O O
Sigma O O
-RRB- O O
to B-conn Purpose.Goal
develop O O
the O O
color O O
reaction O O
. O O

The O O
reaction O O
was O O
stopped O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
1 O O
M O O
NaOH O O
and B-conn Conjunction
the O O
optical O O
density O O
of O O
each O O
well O O
was O O
read O O
at O O
405 O O
nm O O
. O O

The O O
lower O O
limit O O
of O O
IL-17 O O
detection O O
was O O
10 O O
pg/ml O O
. O O

Recombinant O O
human O O
IL-17 O O
diluted O O
in O O
culture O O
medium O O
was O O
used O O
as O O
a O O
calibration O O
standard O O
, O O
ranging O O
from O O
10 O O
to O O
2000 O O
pg/ml O O
. O O

A O O
standard O O
curve O O
was O O
drawn O O
by B-conn Purpose.Enablement
plotting O O
optical O O
density O O
against O O
the O O
log O O
of O O
the O O
concentration O O
of O O
recombinant O O
cytokines O O
, O O
and O O
used O O
for O O
determination O O
of O O
IL-17 O O
in O O
test O O
samples O O
. O O

PBMC O O
were O O
incubated O O
with O O
various O O
concentrations O O
of O O
anti-CD3 O O
in O O
the O O
presence O O
or O O
absence O O
of O O
inhibitors O O
-LRB- O O
LY294002 O O
, O O
PDTC O O
-RRB- O O
. O O

After O O
16 O O
hours O O
of O O
incubation O O
, O O
mRNA O O
was O O
extracted O O
with O O
RNAzol O O
B O O
-LRB- O O
Biotex O O
Laboratories O O
, O O
Houston O O
, O O
TX O O
, O O
USA O O
-RRB- O O
in O O
accordance O O
with O O
the O O
manufacturer O O
's O O
instructions O O
. O O

Reverse O O
transcription O O
of O O
2 O O
μg O O
of O O
total O O
mRNA O O
was O O
performed O O
at O O
42°C O O
using O O
the O O
Superscript™ O O
reverse O O
transcription O O
system O O
-LRB- O O
Takara O O
, O O
Shiga O O
, O O
Japan O O
-RRB- O O
. O O

PCR O O
amplification O O
of O O
cDNA O O
aliquots O O
was O O
performed O O
by B-conn Purpose.Enablement
adding O O
2.5 O O
mM O O
dNTPs O O
, O O
2.5 O O
U O O
of O O
Taq O O
DNA O O
polymerase O O
-LRB- O O
Takara O O
-RRB- O O
and O O
0.25 O O
μM O O
of O O
sense O O
and O O
antisense O O
primers O O
. O O

The O O
reaction O O
was O O
performed O O
in O O
PCR O O
buffer O O
-LRB- O O
1.5 O O
mM O O
MgCl2 O O
, O O
50 O O
mM O O
KCl O O
, O O
10 O O
mM O O
Tris-HCl O O
, O O
pH O O
8.3 O O
-RRB- O O
in O O
a O O
total O O
volume O O
of O O
25 O O
μl O O
. O O

The O O
following O O
sense O O
and O O
antisense O O
primers O O
for O O
each O O
molecules O O
were O O
used O O
: O O
IL-17 O O
sense O O
, O O
5'-ATG O O
ACT O O
CCT O O
GGG O O
AAG O O
ACC O O
TCA O O
TTG-3 O O
' O O
; O O
IL-17 O O
antisense O O
, O O
5'-TTA O O
GGC O O
CAC O O
ATG O O
GTG O O
GAC O O
AAT O O
CGG-3 O O
' O O
; O O
glyceraldehyde-3-phosphate O O
dehydrogenase O O
-LRB- O O
GAPDH O O
-RRB- O O
sense O O
, O O
5'-CGA O O
TGC O O
TGG O O
GCG O O
TGA O O
GTA O O
C-3 O O
' O O
; O O
GAPDH O O
antisense O O
, O O
5'-CGT O O
TCA O O
GCT O O
CAG O O
GGA O O
TGA O O
CC-3 O O
' O O
. O O

Reactions O O
were O O
processed O O
in O O
a O O
DNA O O
thermal O O
cycler O O
-LRB- O O
Perkin-Elmer O O
Cetus O O
, O O
Norwalk O O
, O O
CT O O
, O O
USA O O
-RRB- O O
through O O
cycles O O
for O O
30 O O
s O O
of O O
denaturation O O
at O O
94°C O O
, O O
1 O O
min O O
of O O
annealing O O
at O O
56°C O O
for O O
GAPDH O O
and O O
IL-17 O O
, O O
followed O O
by O O
1 O O
min O O
of O O
elongation O O
at O O
72°C O O
. O O

PCR O O
rounds O O
were O O
repeated O O
for O O
25 O O
cycles O O
each O O
for O O
both O O
GAPDH O O
and O O
IL-17 O O
; O O
this O O
was O O
determined O O
as O O
falling O O
within O O
the O O
exponential O O
phase O O
of O O
amplification O O
for O O
each O O
molecule O O
. O O

The O O
level O O
of O O
mRNA O O
expression O O
was O O
presented O O
as O O
a O O
ratio O O
of O O
IL-17 O O
PCR O O
product O O
over O O
GAPDH O O
product O O
. O O

PBMC O O
were O O
incubated O O
with O O
anti-CD3 O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
in O O
the O O
presence O O
or O O
absence O O
of O O
LY294002 O O
-LRB- O O
20 O O
μM O O
-RRB- O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
1 O O
hour O O
, O O
whole O O
cell O O
lysates O O
were O O
prepared O O
from O O
about O O
107 O O
cells O O
by O O
homogenization O O
in O O
the O O
lysis O O
buffer O O
, O O
and O O
centrifuged O O
at O O
14,000 O O
r.p.m. O O
-LRB- O O
19,000 O O
g O O
-RRB- O O
for O O
15 O O
min O O
. O O

Protein O O
concentrations O O
in O O
the O O
supernatants O O
were O O
determined O O
with O O
the O O
Bradford O O
method O O
-LRB- O O
Bio-Rad O O
, O O
Hercules O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Protein O O
samples O O
were O O
separated O O
by O O
10 O O
% O O
SDS–PAGE O O
and O O
transferred O O
to O O
a O O
nitrocellulose O O
membrane O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
, O O
Uppsala O O
, O O
Sweden O O
-RRB- O O
. O O

For B-conn Purpose.Goal
western O O
hybridization O O
, O O
membrane O O
was O O
preincubated O O
with O O
0.1 O O
% O O
skimmed O O
milk O O
in O O
TBS-T O O
buffer O O
-LRB- O O
0.1 O O
% O O
Tween O O
20 O O
in O O
Tris-buffered O O
saline O O
-RRB- O O
at O O
room O O
temperature O O
for O O
2 O O
hours O O
, O O
then B-conn Temporal.Precedence
primary O O
antibodies O O
against O O
Akt O O
, O O
phosphorylated O O
Akt O O
and O O
IκB-α O O
-LRB- O O
Cell O O
Signaling O O
Technology O O
Inc. O O
, O O
Beverly O O
, O O
MA O O
, O O
USA O O
-RRB- O O
, O O
diluted O O
1:1000 O O
in O O
5 O O
% O O
BSA/TBS-T O O
, O O
were O O
added O O
and O O
incubated O O
overnight O O
at O O
4°C O O
. O O

After B-conn Temporal.Succession
washing O O
four O O
times O O
with O O
TBS-T O O
, O O
horseradish O O
peroxidase-conjugated O O
secondary O O
antibodies O O
were O O
added O O
and O O
allowed O O
to O O
incubate O O
for O O
1 O O
hour O O
at O O
room O O
temperature O O
. O O

After O O
TBS-T O O
washing O O
, O O
hybridized O O
bands O O
were O O
detected O O
with O O
the O O
enhanced O O
chemiluminescence O O
-LRB- O O
ECL O O
-RRB- O O
detection O O
kit O O
and O O
Hyperfilm-ECL O O
reagents O O
-LRB- O O
Amersham O O
Pharmacia O O
-RRB- O O
. O O

Nuclear O O
proteins O O
were O O
extracted O O
from O O
about O O
5 O O
× O O
106 O O
PBMC O O
. O O

Oligonucleotide O O
probes O O
encompassing O O
the O O
NF-κB O O
binding O O
site O O
of O O
the O O
human O O
IL-17 O O
promoter O O
-LRB- O O
5'-ATG O O
ACC O O
TGG O O
AAA O O
TAC O O
CCA O O
AAA O O
TTC-3 O O
' O O
-RRB- O O
were O O
generated O O
by B-conn Purpose.Enablement
5'-end O O
labeling O O
of O O
the O O
sense O O
strand O O
with O O
-LSB-γ-32P O O
-RSB- O O
dATP O O
-LRB- O O
Amersham O O
Pharmacia O O
-RRB- O O
and O O
T4 O O
polynucleotide O O
kinase O O
-LRB- O O
TaKaRa O O
-RRB- O O
. O O

Unincorporated O O
nucleotides O O
were O O
removed O O
by O O
NucTrap O O
probe O O
purification O O
columns O O
-LRB- O O
Stratagene O O
, O O
La O O
Jolla O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Nuclear O O
extracts O O
-LRB- O O
2 O O
μg O O
of O O
protein O O
-RRB- O O
were O O
incubated O O
with O O
radiolabeled O O
DNA O O
probes O O
-LRB- O O
10 O O
ng O O
; O O
100,000 O O
c.p.m. O O
-RRB- O O
for O O
30 O O
min O O
at O O
room O O
temperature O O
in O O
20 O O
μl O O
of O O
binding O O
buffer O O
consisting O O
of O O
20 O O
mM O O
Tris-HCl O O
, O O
pH O O
7.9 O O
, O O
50 O O
mM O O
KCl O O
, O O
1 O O
mM O O
dithiothreitol O O
, O O
0.5 O O
mM O O
EDTA O O
, O O
5 O O
% O O
glycerol O O
, O O
1 O O
mg/ml O O
BSA O O
, O O
0.2 O O
% O O
Nonidet O O
P40 O O
and O O
50 O O
ng/μl O O
poly O O
-LRB- O O
dI-dC O O
-RRB- O O
. O O

Samples O O
were O O
subjected O O
to O O
electrophoresis O O
on O O
nondenaturing O O
5 O O
% O O
polyacrylamide O O
gels O O
in O O
0.5 O O
× O O
Tris-borate-EDTA O O
buffer O O
-LRB- O O
pH O O
8.0 O O
-RRB- O O
at O O
100 O O
V. O O
Gels O O
were O O
dried O O
under O O
vacuum O O
and O O
exposed O O
to O O
Kodak O O
X-OMAT O O
film O O
at O O
-70°C O O
with O O
intensifying O O
screens O O
. O O

Rabbit O O
polyclonal O O
antibodies O O
against O O
NF-κB O O
subunits O O
p50 O O
, O O
p65 O O
and O O
c-Rel O O
were O O
from O O
Santa O O
Cruz O O
Biotechnology O O
-LRB- O O
Santa O O
Cruz O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

For B-conn Purpose.Goal
cell O O
viability O O
assays O O
, O O
the O O
trypan O O
blue O O
dye O O
exclusion O O
method O O
was O O
used O O
to O O
evaluate O O
the O O
potential O O
of O O
direct O O
cytotoxic O O
effect O O
of O O
inhibitors O O
on O O
cells O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
24 O O
hours O O
, O O
the O O
cells O O
were O O
harvested O O
and B-conn Conjunction
the O O
percentage O O
cell O O
viability O O
was O O
calculated O O
with O O
the O O
formula O O
100 O O
× O O
-LRB- O O
number O O
of O O
viable O O
cells/number O O
of O O
both O O
viable O O
and O O
dead O O
cells O O
-RRB- O O
-LSB-21 O O
-RSB- O O
. O O

Data O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
. O O

Statistical O O
analysis O O
was O O
performed O O
with O O
Student O O
's O O
t-test O O
for O O
matched O O
pairs O O
. O O

P O O
values O O
less O O
than O O
0.05 O O
were O O
considered O O
significant O O
. O O

Results O O

PBMC O O
were O O
separated O O
and O O
cultured O O
with O O
PHA O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
from O O
patients O O
with O O
RA O O
, O O
patients O O
with O O
OA O O
, O O
and O O
age-matched O O
normal O O
controls O O
; O O
IL-17 O O
levels O O
were O O
then B-conn Temporal.Precedence
determined O O
in O O
the O O
culture O O
supernatants O O
-LRB- O O
Fig. O O
1 O O
-RRB- O O
. O O

Although B-conn Contrast
the O O
amounts O O
of O O
basal O O
IL-17 O O
secretion O O
were O O
not O O
different O O
between O O
RA O O
, O O
OA O O
and O O
normal O O
controls O O
-LRB- O O
62 O O
± O O
31 O O
, O O
43 O O
± O O
19 O O
and O O
43 O O
± O O
10 O O
pg/ml O O
, O O
respectively O O
-RRB- O O
, O O
the O O
IL-17 O O
production O O
stimulated O O
by O O
PHA O O
was O O
significantly O O
higher O O
in O O
RA O O
PBMC O O
than O O
in O O
those O O
from O O
OA O O
and O O
controls O O
-LRB- O O
768 O O
± O O
295 O O
versus O O
463 O O
± O O
211 O O
pg/ml O O
-LSB-P O O
< O O
0.05 O O
-RSB- O O
and O O
241 O O
± O O
29 O O
pg/ml O O
-LSB-P O O
< O O
0.001 O O
-RSB- O O
-RRB- O O
. O O

Because B-conn Cause.Reason
IL-17 O O
was O O
already O O
known O O
from O O
earlier O O
reports O O
to O O
be O O
produced O O
mainly O O
by O O
activated O O
T O O
cells O O
, O O
we O O
investigated O O
the O O
effect O O
of O O
different O O
concentrations O O
of O O
anti-CD3 O O
-LRB- O O
1 O O
, O O
5 O O
and O O
10 O O
μg/ml O O
-RRB- O O
as O O
a O O
T O O
cell O O
activation O O
, O O
which O O
showed O O
a O O
dose-dependent O O
increase O O
in O O
IL-17 O O
levels O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

On O O
the O O
basis O O
of O O
this O O
, O O
we O O
chose O O
10 O O
μg/ml O O
as O O
a O O
stimulation O O
concentration O O
for O O
anti-CD3 O O
. O O

As O O
shown O O
in O O
Table O O
1 O O
, O O
anti-CD3 O O
significantly O O
upregulated O O
IL-17 O O
production O O
up O O
to O O
3.7-fold O O
, O O
and B-conn Conjunction
the O O
combination O O
of O O
anti-CD28 O O
and O O
anti-CD3 O O
produced O O
more O O
IL-17 O O
-LRB- O O
approximately O O
1.3-1.5-fold O O
-RRB- O O

than O O
anti-CD3 O O
alone O O
. O O

Furthermore B-conn Conjunction
, O O
when B-conn Temporal.Synchronous
incubated O O
with O O
T O O
cell O O
mitogens O O
such O O
as O O
PHA O O
, O O
increased O O
IL-17 O O
production O O
was O O
more O O
pronounced O O
than O O
with O O
anti-CD3 O O
and O O
anti-CD28 O O
-LRB- O O
588 O O
± O O
85 O O
versus O O
211 O O
± O O
1 O O
pg/ml O O
; O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

Because B-conn Cause.Reason
RA O O
PBMC O O
include O O
several O O
cell O O
types O O
in O O
addition O O
to O O
T O O
cells O O
, O O
some O O
inflammatory O O
cytokines O O
released O O
from O O
macrophages O O
and O O
other O O
lymphocytes O O
might O O
have O O
affected O O
the O O
production O O
of O O
IL-17 O O
from O O
T O O
cells O O
. O O

To B-conn Purpose.Goal
evaluate O O
the O O
effects O O
of O O
inflammatory O O
cytokines O O
released O O
by O O
activated O O
PBMC O O
, O O
we O O
tested O O
the O O
effects O O
of O O
several O O
cytokines O O
and O O
chemokines O O
on O O
IL-17 O O
production O O
. O O

We O O
detected O O
an O O
increase O O
in O O
IL-17 O O
level O O
after B-conn Temporal.Succession
stimulation O O
with O O
IL-15 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
whereas B-conn Contrast
with O O
IL-1β O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
TNF-α O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
IL-18 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
or O O
TGF-β O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
the O O
levels O O
in O O
IL-17 O O
were O O
unchanged O O
-LRB- O O
Fig. O O
2a O O
-RRB- O O
. O O

When B-conn Temporal.Succession
treated O O
with O O
MCP-1 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
or O O
IL-6 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
significant O O
upregulations O O
of O O
IL-17 O O
proteins O O
were O O
observed O O
-LRB- O O
62 O O
± O O
42 O O
and O O
50 O O
± O O
10 O O
versus O O
31 O O
± O O
11 O O
pg/ml O O
, O O
respectively O O
; O O
P O O
< O O
0.05 O O
-RRB- O O
, O O
whereas B-conn Contrast
none O O
was O O
observed O O
with O O
IL-8 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
MIP-1α O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
or O O
MIP-1β O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
-LRB- O O
Fig. O O
2b O O
-RRB- O O
. O O

Having O O
observed O O
the O O
increased O O
IL-17 O O
production O O
in O O
RA O O
PBMC O O
, O O
it O O
was O O
important O O
to O O
know O O
which O O
signal O O
transduction O O
pathways O O
were O O
involved O O
. O O

As O O
illustrated O O
in O O
Fig. O O
3 O O
, O O
an O O
significant O O
decrease O O
in O O
anti-CD3-induced O O
IL-17 O O
production O O
was O O
observed O O
when B-conn Temporal.Succession
co-incubated O O
with O O
NF-κB O O
inhibitor O O
, O O
PDTC O O
and O O
dexamethasone O O
in O O
comparison O O
with O O
anti-CD3 O O
alone O O
-LRB- O O
38 O O
± O O
5 O O
and O O
54 O O
± O O
11 O O
versus O O
98 O O
± O O
19 O O
pg/ml O O
, O O
respectively O O
; O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

LY294002 O O
and O O
wortmannin O O
, O O
as O O
an O O
inhibitor O O
of O O
PI3K O O
, O O
also B-conn Conjunction
markedly O O
inhibited O O
the O O
anti-CD3-induced O O
IL-17 O O
production O O
in O O
RA O O
PBMC O O
-LRB- O O
98 O O
± O O
19 O O
versus O O
38 O O
± O O
10 O O
pg/ml O O
-LSB-P O O
< O O
0.005 O O
-RSB- O O
and O O
48 O O
± O O
4 O O
pg/ml O O
-LSB-P O O
< O O
0.05 O O
-RSB- O O
, O O
respectively O O
-RRB- O O
. O O

The O O
calcineurin O O
inhibitors O O
cyclosporin O O
A O O
and O O
FK506 O O
also B-conn Conjunction
downregulated O O
the O O
IL-17 O O
secretion O O
as O O
well O O
as O O
the O O
mitogen-activated O O
protein O O
kinase O O
-LRB- O O
MAPK O O
-RRB- O O
p38 O O
inhibitor O O
SB203580 O O
did O O
, O O
whereas B-conn Contrast
rapamycin O O
and O O
PD98059 O O
had O O
no O O
effect O O
on O O
IL-17 O O
levels O O
-LRB- O O
Fig. O O
3 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
evaluate O O
the O O
possibility O O
of O O
non-specific O O
inhibition O O
by O O
the O O
drug O O
at O O
high O O
concentrations O O
, O O
we O O
observed O O
the O O
dose O O
response O O
of O O
PDTC O O
and O O
LY294002 O O
for O O
the O O
inhibition O O
of O O
IL-17 O O
production O O
in O O
PBMC O O
. O O

There O O
were O O
dose-dependent O O
inhibitions O O
of O O
IL-17 O O
production O O
with O O
chemical O O
inhibitors O O
-LRB- O O
Fig. O O
4a O O
-RRB- O O
. O O

The O O
other O O
inhibitors O O
in O O
addition O O
to O O
PDTC O O
and O O
LY294002 O O
showed O O
the O O
same O O
pattern O O
of O O
inhibition O O
. O O

Cytotoxic O O
effects O O
on O O
PBMC O O
by O O
the O O
chemical O O
inhibitors O O
at O O
experimental O O
concentrations O O
were O O
not O O
observed O O
-LRB- O O
Fig. O O
4b O O
-RRB- O O
. O O

To B-conn Purpose.Goal
see O O
whether O O
enhanced O O
IL-17 O O
production O O
could O O
be O O
regulated O O
at O O
a O O
transcriptional O O
level O O
, O O
semi-quantatitive O O
reverse O O
transcription–polymerase O O
chain O O
reaction O O
was O O
performed O O
. O O

We O O
observed O O
a O O
dose-dependent O O
increase O O
in O O
IL-17 O O
mRNA O O
transcripts O O
after B-conn Temporal.Succession
stimulation O O
with O O
anti-CD3 O O
; O O
this O O
was O O
inhibited O O
by O O
the O O
PI3K O O
inhibitor O O
LY294002 O O
and O O
by O O
the O O
NF-κB O O
inhibitor O O
PDTC O O
-LRB- O O
Fig. O O
5 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
determine O O
downstream O O
effector O O
molecules O O
of O O
the O O
PI3K O O
pathway O O
, O O
we O O
evaluated O O
the O O
activation O O
of O O
Akt O O
by O O
western O O
blotting O O
. O O

As O O
shown O O
in O O
Fig. O O
6 O O
, O O
at O O
10 O O
min O O
of O O
incubation O O
with O O
anti-CD3 O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
or O O
LY294002 O O
-LRB- O O
20 O O
μM O O
-RRB- O O
, O O
no O O
difference O O
in O O
the O O
amounts O O
of O O
phosphorylated O O
Akt O O
was O O
observed O O
. O O

However B-conn Contrast
, O O
after O O
30 O O
min O O
of O O
incubation O O
, O O
phosphorylated O O
Akt O O
increased O O
-LRB- O O
lane O O
2 O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
effect O O
of O O
inhibition O O
by O O
LY294002 O O
-LRB- O O
lane O O
3 O O
-RRB- O O
reached O O
a O O
peak O O
at O O
60 O O
min O O
, O O
lasting O O
to O O
120–240 O O
min O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
non-phosphorylated O O
Akt O O
and O O
β-actin O O
remained O O
unchanged O O
regardless O O
of O O
incubation O O
time O O
. O O

PHA O O
, O O
concanavalin O O
A O O
and O O
IL-15 O O
also B-conn Conjunction
demonstrated O O
the O O
same O O
effect O O
on O O
phosphorylated O O
Akt O O
as O O
shown O O
with O O
anti-CD3 O O
, O O
which O O
was O O
an O O
inhibition O O
by O O
wortmannin O O
and O O
PDTC O O
as O O
well O O
as O O
by O O
LY294002 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

To B-conn Purpose.Goal
investigate O O
further O O
the O O
intracellular O O
signaling O O
pathway O O
activated O O
by O O
anti-CD3 O O
plus O O
anti-CD28 O O
, O O
concanavalin O O
A O O
, O O
PHA O O
and O O
IL-15 O O
, O O
and O O
responsible O O
for O O
inducing O O
IL-17 O O
expression O O
, O O
we O O
performed O O
an O O
electrophoretic O O
mobility-shift O O
assay O O
-LRB- O O
EMSA O O
-RRB- O O
of O O
NF-κB O O
recognition O O
sites O O
in O O
the O O
promoters O O
of O O
IL-17 O O
. O O

As O O
shown O O
in O O
Fig. O O
7a O O
, O O
nuclear O O
extracts O O
from O O
RA O O
PBMC O O
stimulated O O
with O O
anti-CD3 O O
plus O O
anti-CD28 O O
-LRB- O O
lane O O
2 O O
-RRB- O O
demonstrated O O
increased O O
binding O O
of O O
NF-κB O O
to O O
IL-17 O O
promoters O O
in O O
comparison O O
with O O
that O O
of O O
controls O O
-LRB- O O
lane O O
1 O O
-RRB- O O
. O O

A O O
supershift O O
assay O O
demonstrated O O
shifted O O
bands O O
in O O
p65 O O
and O O
p50 O O
-LRB- O O
lanes O O
3 O O
and O O
4 O O
-RRB- O O
not O O
in O O
c-Rel O O
-LRB- O O
lane O O
5 O O
-RRB- O O
. O O

In O O
normal O O
PBMC O O
the O O
same O O
pattern O O
was O O
observed O O
, O O
but B-conn Concession.Contra-expectation
the O O
degree O O
of O O
NF-κB O O
activation O O
by O O
anti-CD3 O O
plus O O
anti-CD28 O O
was O O
less O O
intense O O
than O O
that O O
in O O
RA O O
PBMC O O
-LRB- O O
Fig. O O
7b O O
-RRB- O O
. O O

To B-conn Purpose.Goal
confirm O O
the O O
link O O
between O O
PI3K O O
activity O O
and O O
NF-κB O O
, O O
we O O
performed O O
EMSA O O
to O O
determine O O
the O O
NF-κB O O
binding O O
activity O O
after B-conn Temporal.Succession
treatment O O
with O O
both O O
LY294002 O O
and O O
PDTC O O
. O O

Both O O
agents O O
block O O
NF-κB O O
DNA-binding O O
activity O O
in O O
the O O
IL-17 O O
promoter O O
-LRB- O O
Fig. O O
7c O O
-RRB- O O
. O O

Western O O
blotting O O
for O O
IκB-α O O
showed O O
inhibition O O
of O O
degradation O O
of O O
IκB-α O O
by O O
LY294002 O O
and O O
PDTC O O
at O O
the O O
same O O
time O O
-LRB- O O
Fig. O O
7c O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
AP-1 O O
pathway O O
was O O
not O O
activated O O
by O O
stimulation O O
with O O
anti-CD3 O O
plus O O
anti-CD28 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
demonstrating O O
that O O
NF-κB O O
is O O
the O O
main O O
intracellular O O
signaling O O
pathway O O
in O O
IL-17 O O
production O O
by O O
activated O O
PBMC O O
from O O
patients O O
with O O
RA O O
. O O

Discussion O O

IL-17 O O
was O O
first O O
described O O
as O O
a O O
T O O
cell O O
product O O
with O O
proinflammatory O O
properties O O
-LSB-5,22 O O
-RSB- O O
. O O

RA O O
is O O
characterized O O
by O O
hyperplasia O O
of O O
synovial O O
lining O O
cells O O
and O O
an O O
intense O O
infiltration O O
by O O
mononuclear O O
cells O O
-LSB-23 O O
-RSB- O O
. O O

Proinflammatory O O
cytokines O O
such O O
as O O
IL-1 O O
and O O
TNF-α O O
are O O
abundant O O
in O O
rheumatoid O O
synovium O O
, O O
whereas B-conn Contrast
the O O
T O O
cell-derived O O
cytokines O O
, O O
especially O O
IL-4 O O
and O O
interferon-γ O O
, O O
have O O
often O O
proved O O
difficult O O
to O O
detect O O
in O O
RA O O
synovium O O
-LSB-24 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
T O O
cells O O
may O O
have O O
a O O
role O O
in O O
the O O
augmentation O O
of O O
rheumatoid O O
synovial O O
inflammation O O
, O O
the O O
lack O O
of O O
T O O
cell-derived O O
cytokines O O
has O O
limited O O
its O O
importance O O
. O O

In O O
this O O
respect O O
, O O
IL-17 O O
is O O
appealing O O
because B-conn Cause.Reason
it O O
has O O
been O O
described O O
as O O
a O O
T O O
cell-derived O O
cytokine O O
with O O
proinflammatory O O
properties O O
. O O

In O O
our O O
studies O O
, O O
we O O
tried O O
to O O
evaluate O O
how O O
IL-17 O O
production O O
is O O
regulated O O
in O O
RA O O
PBMC O O
, O O
and B-conn Conjunction
which O O
signaling O O
pathway O O
it O O
used O O
. O O

Levels O O
of O O
IL-17 O O
were O O
found O O
to O O
be O O
higher O O
in O O
RA O O
synovial O O
fluid O O
than O O
in O O
OA O O
synovial O O
fluid O O
-LSB-15 O O
-RSB- O O
. O O

However B-conn Contrast
, O O
there O O
are O O
few O O
data O O
available O O
on O O
the O O
agents O O
that O O
stimulate O O
IL-17 O O
production O O
in O O
RA O O
, O O
although B-conn Concession.Contra-expectation
the O O
highest O O
level O O
of O O
IL-17 O O
production O O
can O O
be O O
achieved O O
by B-conn Purpose.Enablement
anti-CD3/anti-CD28 O O
stimulation O O
in O O
healthy O O
individuals O O
-LSB-25 O O
-RSB- O O
. O O

In O O
our O O
experiments O O
, O O
PHA O O
as O O
mitogens O O
, O O
as O O
well O O
as O O
anti-CD3/anti-CD28 O O
for O O
signaling O O
through O O
the O O
T O O
cell O O
receptor O O
, O O
increased O O
IL-17 O O
production O O
from O O
RA O O
PBMC O O
in O O
a O O
dose-dependent O O
manner O O
. O O

We O O
found O O
, O O
by O O
a O O
cell O O
proliferation O O
assay O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
that O O
this O O
upregulation O O
of O O
IL-17 O O
might O O
be O O
due B-conn Cause.Reason
to I-conn Cause.Reason
increased O O
cellular O O
activity O O
rather O O
than O O
to O O
cellular O O
proliferation O O
. O O

IL-17 O O
is O O
produced O O
mainly O O
by O O
activated O O
CD4+ O O
T O O
cells O O
, O O
especially O O
for O O
Th1/Th0 O O
cells O O
, O O
not O O
the O O
Th2 O O
phenotype O O
-LSB-26 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
it O O
can O O
also O O
be O O
produced O O
by O O
CD8+ O O
T O O
cells O O
via B-conn Purpose.Enablement
an O O
IL-23 O O
triggering O O
mechanism O O
in O O
Gram-negative O O
pulmonary O O
infection O O
-LSB-14 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
IL-17 O O
production O O
was O O
significantly O O
augmented O O
by O O
T O O
cells O O
recognizing O O
type O O
II O O
collagen O O
in O O
a O O
collagen-induced O O
arthritis O O
model O O
-LSB-27 O O
-RSB- O O
. O O

A O O
complex O O
interaction O O
between O O
cells O O
in O O
inflamed O O
RA O O
joints O O
might O O
produce O O
a O O
variety O O
of O O
proinflammatory O O
cytokines O O
and O O
chemokines O O
, O O
which O O
also O O
activate O O
other O O
cells O O
in O O
the O O
joints O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
IL-17 O O
stimulates O O
rheumatoid O O
synoviocytes O O
to O O
secrete O O
several O O
cytokines O O
such O O
as O O
IL-6 O O
, O O
IL-8 O O
and O O
tumor O O
necrosis O O
factor-stimulated O O
gene O O
6 O O
as O O
well O O
as O O
prostaglandin O O
E2 O O
in O O
vitro O O
-LSB-12,28,29 O O
-RSB- O O
. O O

There O O
are O O
as O O
yet O O
few O O
data O O
available O O
on O O
the O O
agents O O
that O O
stimulate O O
IL-17 O O
production O O
in O O
RA O O
, O O
although B-conn Concession.Contra-expectation
some O O
cytokines O O
-LRB- O O
IL-15 O O
and O O
IL-23 O O
-RRB- O O
have O O
been O O
known O O
to O O
regulate O O
IL-17 O O
production O O
-LSB-13,14 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
investigated O O
the O O
in O O
vitro O O
production O O
of O O
IL-17 O O
in O O
RA O O
PBMC O O
responding O O
to O O
a O O
variety O O
of O O
cytokines/chemokines O O
and O O
mitogens O O
as O O
well O O
as O O
T O O
cell O O
receptor O O
-LRB- O O
TCR O O
-RRB- O O
ligation O O
using O O
anti-CD3/anti-CD28 O O
. O O

Our O O
studies O O
demonstrated O O
that O O
IL-15 O O
and O O
MCP-1 O O
as O O
well O O
as O O
TCR O O
ligation O O
significantly O O
increased O O
the O O
production O O
of O O
IL-17 O O
in O O
RA O O
PBMC O O
. O O

Adding O O
IL-15 O O
or O O
MCP-1 O O
to O O
TCR O O
ligation O O
augmented O O
IL-17 O O
production O O
more O O
markedly O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
IL-1 O O
and O O
TNF-α O O
, O O
which O O
are O O
known O O
to O O
have O O
proinflammatory O O
properties O O
and O O
to O O
be O O
increased O O
in O O
RA O O
joints O O
, O O
did O O
not O O
affect O O
IL-17 O O
production O O
. O O

Our O O
data O O
were O O
consistent O O
with O O
a O O
recent O O
report O O
that O O
IL-15 O O
triggered O O
in O O
vitro O O
IL-17 O O
production O O
in O O
PBMC O O
, O O
but B-conn Contrast
TNF-α O O
did O O
not O O
do O O
so O O
-LSB-13 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
there O O
were O O
no O O
data O O
that O O
MCP-1 O O
directly O O
induces O O
T O O
cell O O
activation O O
, O O
it O O
might O O
exert O O
effects O O
indirectly O O
on O O
T O O
cells O O
through O O
the O O
activation O O
of O O
monocytes/macrophages O O
in O O
PBMC O O
cultures O O
. O O

As O O
reported O O
for O O
normal O O
individuals O O
-LSB-25 O O
-RSB- O O
, O O
T O O
cell O O
activation O O
through O O
anti-CD3/anti-CD28 O O
also O O
increases O O
IL-17 O O
induction O O
in O O
RA O O
PBMC O O
. O O

Although B-conn Concession.Expectation
the O O
signaling O O
pathway O O
for O O
the O O
induction O O
of O O
cytokines/chemokines O O
by O O
IL-17 O O
has O O
been O O
documented O O
widely O O
-LSB-8,30,31 O O
-RSB- O O
, O O
no O O
data O O
have O O
been O O
available O O
on O O
how O O
IL-17 O O
production O O
can O O
be O O
regulated O O
by O O
certain O O
signaling O O
pathways O O
. O O

By B-conn Purpose.Enablement
using O O
signal O O
transduction O O
inhibitors O O
, O O
we O O
therefore B-conn Cause.Result
examined O O
which O O
signaling O O
pathway O O
was O O
mainly O O
involved O O
in O O
the O O
induction O O
of O O
IL-17 O O
in O O
RA O O
PBMC O O
. O O

We O O
identified O O
that O O
anti-CD3-induced O O
IL-17 O O
production O O
in O O
RA O O
PBMC O O
was O O
significantly O O
hampered O O
by O O
the O O
PI3K O O
inhibitor O O
LY294002 O O
and O O
the O O
NF-κB O O
inhibitor O O
PDTC O O
to O O
comparable O O
levels O O
of O O
basal O O
production O O
without O O
stimulation O O
. O O

We O O
also B-conn Conjunction
found O O
that O O
anti-CD3-induced O O
IL-17 O O
production O O
was O O
downregulated O O
by B-conn Cause.Reason
the O O
addition O O
of O O
SB203580 O O
, O O
a O O
p38 O O
MAPK O O
inhibitor O O
. O O

It O O
is O O
interesting O O
that O O
a O O
series O O
of O O
evidence O O
supports O O
crosstalk O O
between O O
NF-κB O O
and O O
p38 O O
. O O

In O O
myocytes O O
, O O
IκB O O
kinase-β O O
is O O
activated O O
by O O
p38 O O
-LSB-32 O O
-RSB- O O
, O O
and B-conn Conjunction
the O O
activated O O
p38 O O
can O O
stimulate O O
NF-κB O O
by B-conn Cause.Reason
a O O
mechanism O O
involving O O
histone O O
acetylase O O
p300/CREB-binding O O
protein O O
-LSB-33 O O
-RSB- O O
. O O

Our O O
results O O
revealed O O
that O O
p38 O O
MAPK O O
activation O O
was O O
not O O
affected O O
by O O
LY294002 O O
, O O
whereas B-conn Contrast
NF-κB O O
binding O O
activity O O
was O O
decreased O O
by O O
LY294002 O O
, O O
which O O
provided O O
the O O
evidence O O
for O O
a O O
p38 O O
MAPK O O
pathway O O
independent O O
of O O
PI3K O O
activation O O
. O O

The O O
direct O O
relationship O O
between O O
p38 O O
and O O
NF-κB O O
for O O
IL-17 O O
production O O
needs O O
to O O
be O O
studied O O
in O O
future O O
experiments O O
. O O

The O O
search O O
for O O
a O O
downstream O O
pathway O O
of O O
PI3K O O
seemed O O
to O O
have O O
a O O
maximal O O
response O O
of O O
Akt O O
activation O O
at O O
1 O O
hour O O
and O O
a O O
gradual O O
loss O O
of O O
activity O O
at O O
2 O O
hours O O
. O O

The O O
fact O O
that O O
Akt O O
is O O
phosphorylated O O
upon B-conn Temporal.Succession
anti-CD3 O O
stimulation O O
suggests O O
the O O
possible O O
involvement O O
of O O
PI3K O O
in O O
the O O
induction O O
of O O
IL-17 O O
in O O
RA O O
. O O

In B-conn Cause.Justification
view I-conn Cause.Justification
of I-conn Cause.Justification
the I-conn Cause.Justification
fact I-conn Cause.Justification
that I-conn Cause.Justification
NF-κB O O
was O O
also O O
activated O O
by O O
anti-CD3/anti-CD28 O O
, O O
IL-15 O O
or O O
mitogens O O
in O O
our O O
experiments O O
, O O
it O O
is O O
most O O
likely O O
that O O
the O O
NF-κB O O
pathway O O
is O O
also O O
actively O O
involved O O
in O O
the O O
induction O O
of O O
IL-17 O O
in O O
RA O O
PBMC O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
AP-1 O O
signal O O
transduction O O
pathway O O
, O O
another O O
important O O
signaling O O
pathway O O
for O O
cytokines/chemokines O O
, O O
was O O
not O O
activated O O
in O O
our O O
experiments O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
PI3K O O
and O O
its O O
downstream O O
kinase O O
Akt O O
in O O
association O O
with O O
NF-κB O O
have O O
been O O
reported O O
to O O
deliver O O
activating O O
signals O O
in O O
many O O
cell O O
types O O
, O O
the O O
data O O
on O O
the O O
signal O O
inducing O O
IL-17 O O
are O O
lacking O O
. O O

Our O O
data O O
clearly O O
demonstrated O O
that O O
PI3K/Akt O O
and O O
resultant O O
NF-κB O O
activation O O
could O O
be O O
an O O
important O O
arbitrator O O
of O O
the O O
upregulation O O
of O O
IL-17 O O
in O O
RA O O
, O O
on B-conn Cause.Justification
the I-conn Cause.Justification
basis I-conn Cause.Justification
of I-conn Cause.Justification
our O O
experiments O O
showing O O
simultaneous O O
blocking O O
of O O
NF-κB O O
binding O O
activity O O
in O O
the O O
IL-17 O O
promoter O O
by O O
PDTC O O
and O O
LY294002 O O
. O O

Considering O O
its O O
proinflammatory O O
activities O O
and O O
successful O O
induction O O
of O O
anti-IL-17 O O
for O O
ameliorating O O
arthritis O O
in O O
animal O O
models O O
-LSB-2,6,34-36 O O
-RSB- O O
, O O
understanding O O
the O O
IL-17 O O
signaling O O
pathway O O
is O O
an O O
important O O
element O O
of O O
developing O O
new O O
targeted O O
therapies O O
in O O
RA O O
. O O

Conclusions O O

We O O
have O O
detected O O
a O O
more O O
pronounced O O
production O O
of O O
IL-17 O O
from O O
RA O O
PBMC O O
in O O
response O O
to O O
IL-15 O O
and O O
MCP-1 O O
as O O
well O O
as O O
stimulation O O
by O O
anti-CD3/anti-CD28 O O
. O O

We O O
have O O
also B-conn Conjunction
shown O O
that O O
upregulation O O
of O O
IL-17 O O
by O O
activated O O
T O O
cells O O
in O O
patients O O
with O O
RA O O
could O O
be O O
the O O
result O O
of O O
activation O O
via O O
the O O
PI3K/Akt O O
pathway O O
with O O
resultant O O
NF-κB O O
activation O O
. O O

Our O O
data O O
provide O O
insights O O
into O O
cellular O O
mechanisms O O
of O O
the O O
regulation O O
of O O
IL-17 O O
production O O
in O O
RA O O
, O O
and O O
highlight O O
the O O
role O O
of O O
T O O
cells O O
, O O
which O O
has O O
hitherto O O
been O O
neglected O O
in O O
RA O O
pathogenesis O O
. O O

Together O O
with O O
recent O O
data O O
on O O
the O O
successful O O
introduction O O
of O O
anti-IL-17 O O
in O O
RA O O
, O O
our O O
results O O
have O O
added O O
information O O
for O O
the O O
future O O
molecular O O
targeting O O
of O O
new O O
therapeutic O O
applications O O
in O O
RA O O
. O O

Abbreviations O O

AP-1 O O
, O O
activator O O
protein-1 O O
; O O
BSA O O
= O O
bovine O O
serum O O
albumin O O
; O O
EMSA O O
= O O
electrophoretic O O
mobility-shift O O
assay O O
; O O
GAPDH O O
= O O
glyceraldehyde-3-phosphate O O
dehydrogenase O O
; O O
IL O O
= O O
interleukin O O
; O O
MAPK O O
= O O
mitogen-activated O O
protein O O
kinase O O
; O O
MCP-1 O O
= O O
monocyte O O
chemoattractant O O
protein-1 O O
; O O
MIP O O
= O O
macrophage O O
inflammatory O O
protein O O
; O O
NF-κB O O
= O O
nuclear O O
factor O O
κB O O
; O O
OA O O
= O O
osteoarthritis O O
; O O
PBMC O O
= O O
peripheral O O
blood O O
mononuclear O O
cells O O
; O O
PDTC O O
= O O
pyrrolidine O O
dithiocarbamate O O
; O O
PHA O O
= O O
phytohemagglutinin O O
; O O
PI3K O O
= O O
phosphoinositide O O
3-kinase O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
TGF O O
= O O
transforming O O
growth O O
factor O O
; O O
Th O O
= O O
T O O
helper O O
; O O
TNF O O
= O O
tumor O O
necrosis O O
factor O O
. O O

Competing O O
interests O O

The O O
author O O
-LRB- O O
s O O
-RRB- O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Authors O O
' O O
contributions O O

KWK O O
performed O O
the O O
cellular O O
immune O O
response O O
studies O O
and O O
participated O O
in O O
the O O
immunoassays O O
. O O

MLC O O
participated O O
in O O
the O O
design O O
of O O
the O O
study O O
and O O
performed O O
the O O
statistical O O
analysis O O
. O O

MKP O O
participated O O
in O O
the O O
isolation O O
of O O
the O O
cells O O
. O O

CHY O O
drafted O O
the O O
manuscript O O
. O O

SHP O O
participated O O
in O O
the O O
molecular O O
biology O O
and O O
in O O
the O O
PCR O O
. O O

SHL O O
conceived O O
the O O
study O O
, O O
participated O O
in O O
its O O
design O O
and O O
coordination O O
and O O
helped O O
to O O
draft O O
the O O
manuscript O O
. O O

HYK O O
helped O O
to O O
draft O O
the O O
manuscript O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Levels O O
of O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
production O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
; O O
n O O
= O O
24 O O
-RRB- O O
, O O
patients O O
with O O
osteoarthritis O O
-LRB- O O
OA O O
-RRB- O O
-LRB- O O
n O O
= O O
14 O O
-RRB- O O
and O O
normal O O
individuals O O
-LRB- O O
n O O
= O O
14 O O
-RRB- O O
. O O

Each O O
peripheral O O
blood O O
mononuclear O O
cell O O
was O O
stimulated O O
for O O
24 O O
hours O O
with O O
or O O
without O O
phytohemagglutinin O O
-LRB- O O
PHA O O
; O O
5 O O
μg/ml O O
-RRB- O O
. O O

IL-17 O O
was O O
measured O O
in O O
culture O O
supernatants O O
by O O
sandwich O O
enzyme-linked O O
immunosorbent O O
assay O O
. O O

Data O O
are O O
expressed O O
as O O
means O O
and O O
SEM O O
. O O

One O O
representative O O
result O O
of O O
five O O
independent O O
experiments O O
is O O
shown O O
. O O

Student O O
's O O
t-test O O
was O O
used O O
to O O
compare O O
each O O
group O O
. O O

* O O
, O O
P O O
< O O
0.05 O O
; O O
** O O
, O O
P O O
< O O
0.001 O O
. O O

Figure O O
2 O O
: O O
Production O O
of O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
by O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
. O O

-LRB- O O
a O O
-RRB- O O
Production O O
of O O
IL-17 O O
by O O
cytokine O O
induction O O
. O O

PBMC O O
from O O
patients O O
with O O
RA O O
were O O
stimulated O O
for O O
24 O O
hours O O
with O O
IL-15 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
IL-1β O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
tumor O O
necrosis O O
factor-α O O
-LRB- O O
TNF-α O O
; O O
10 O O
ng/ml O O
-RRB- O O
, O O
IL-18 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
and O O
transforming O O
growth O O
factor-β O O
-LRB- O O
TGF-β O O
; O O
10 O O
ng/ml O O
-RRB- O O
. O O

Levels O O
of O O
IL-17 O O
were O O
measured O O
in O O
culture O O
supernatants O O
by O O
enzyme-linked O O
immunosorbent O O
assay O O
. O O

Each O O
value O O
represents O O
the O O
mean O O
and O O
SEM O O
of O O
three O O
independent O O
experiments O O
. O O

-LRB- O O
b O O
-RRB- O O
Production O O
of O O
IL-17 O O
by O O
chemokine O O
induction O O
. O O

PBMC O O
were O O
cultured O O
in O O
the O O
presence O O
of O O
monocyte O O
chemoattractant O O
protein-1 O O
-LRB- O O
MCP-1 O O
; O O
10 O O
ng/ml O O
-RRB- O O
, O O
macrophage O O
inflammatory O O
protein-1α O O
-LRB- O O
MIP-1α O O
; O O
10 O O
ng/ml O O
-RRB- O O
, O O
MIP-1β O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
IL-6 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
and O O
IL-8 O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
. O O

* O O
, O O
P O O
< O O
0.05 O O
. O O

Figure O O
3 O O
: O O
Effects O O
of O O
protein O O
kinase O O
inhibitors O O
and O O
anti-rheumatic O O
drug O O
on O O
anti-CD3 O O
triggered O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
production O O
by O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
. O O

PBMC O O
pretreated O O
for O O
1 O O
hour O O
with O O
pyrrolidine O O
dithiocarbamate O O
-LRB- O O
PDTC O O
; O O
300 O O
μM O O
-RRB- O O
, O O
curcumin O O
-LRB- O O
10 O O
μM O O
-RRB- O O
, O O
LY294002 O O
-LRB- O O
20 O O
μM O O
-RRB- O O
, O O
wortmannin O O
-LRB- O O
200 O O
nM O O
-RRB- O O
, O O
Cyclosporin O O
A O O
-LRB- O O
500 O O
ng/ml O O
-RRB- O O
, O O
dexamethasone O O
-LRB- O O
DEX O O
; O O
100 O O
nM O O
-RRB- O O
, O O
FK506 O O
-LRB- O O
100 O O
ng/ml O O
-RRB- O O
, O O
rapamycin O O
-LRB- O O
10 O O
ng/ml O O
-RRB- O O
, O O
SB203580 O O
-LRB- O O
10 O O
nM O O
-RRB- O O
or O O
PD98059 O O
-LRB- O O
20 O O
μM O O
-RRB- O O
in O O
combination O O
with O O
anti-CD3 O O
antibody O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
. O O

Culture O O
supernatant O O
was O O
assayed O O
for O O
IL-17 O O
as O O
described O O
in O O
the O O
Materials O O
and O O
methods O O
section O O
. O O

Each O O
value O O
represents O O
the O O
mean O O
and O O
SEM O O
of O O
three O O
independent O O
experiments O O
. O O

* O O
, O O
P O O
< O O
0.05 O O
; O O
** O O
, O O
P O O
< O O
0.005 O O
. O O

Figure O O
4 O O
: O O
Dose-dependent O O
effects O O
of O O
LY294002 O O
or O O
pyrrolidine O O
dithiocarbamate O O
-LRB- O O
PDTC O O
-RRB- O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
. O O

-LRB- O O
a O O
-RRB- O O
Effect O O
of O O
inhibitors O O
on O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
release O O
by O O
anti-CD3-stimulated O O
PBMC O O
from O O
patients O O
with O O
RA O O
. O O

-LRB- O O
b O O
-RRB- O O
Effects O O
of O O
LY294002 O O
or O O
PDTC O O
on O O
PBMC O O
viability O O
. O O

PBMC O O
were O O
cultured O O
at O O
a O O
concentration O O
of O O
2 O O
× O O
105 O O
cells O O
per O O
well O O
with O O
medium O O
, O O
anti-CD3 O O
, O O
anti-CD3 O O
and O O
LY294002 O O
or O O
PDTC O O
under O O
the O O
conditions O O
described O O
in O O
the O O
Materials O O
and O O
methods O O
section O O
. O O

After O O
24 O O
hours O O
of O O
treatment O O
, O O
cell O O
viability O O
was O O
assessed O O
by O O
the O O
trypan O O
blue O O
dye O O
exclusion O O
method O O
and O O
expressed O O
as O O
a O O
percentage O O
with O O
the O O
formula O O
100 O O
× O O
-LRB- O O
number O O
of O O
viable O O
cells/number O O
of O O
both O O
viable O O
and O O
dead O O
cells O O
-RRB- O O
. O O

Figure O O
5 O O
: O O
Effects O O
of O O
LY294002 O O
or O O
pyrrolidine O O
dithiocarbamate O O
-LRB- O O
PDTC O O
-RRB- O O
on O O
anti-CD3 O O
antibody-triggered O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
mRNA O O
expression O O
by O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O
. O O

PBMC O O
were O O
cultured O O
with O O
medium O O
only O O
-LRB- O O
lane O O
1 O O
-RRB- O O
, O O
anti-CD3 O O
antibody O O
-LRB- O O
1 O O
μg/ml O O
; O O
lane O O
2 O O
-RRB- O O
, O O
anti-CD3 O O
antibody O O
-LRB- O O
10 O O
μg/ml O O
; O O
lane O O
3 O O
-RRB- O O
, O O
anti-CD3 O O
antibody O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
plus O O
LY294002 O O
-LRB- O O
20 O O
μM O O
; O O
lane O O
4 O O
-RRB- O O
or O O
anti-CD3 O O
antibody O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
plus O O
PDTC O O
-LRB- O O
300 O O
μM O O
; O O
lane O O
5 O O
-RRB- O O
for O O
12 O O
hours O O
; O O
lane O O
6 O O
shows O O
a O O
negative O O
control O O
. O O

Total O O
RNA O O
-LRB- O O
2 O O
μg O O
-RRB- O O
was O O
used O O
for O O
cDNA O O
synthesis O O
in O O
a O O
volume O O
of O O
20 O O
μl O O
; O O
1 O O
μl O O
of O O
the O O
synthesized O O
cDNA O O
was O O
used O O
for O O
reverse O O
transcription–polymerase O O
chain O O
reaction O O
as O O
described O O
. O O

PCR O O
reaction O O
product O O
-LRB- O O
25 O O
μl O O
-RRB- O O
was O O
separated O O
on O O
an O O
agarose O O
gel O O
containing O O
ethidium O O
bromide O O
. O O

The O O
relative O O
intensities O O
of O O
the O O
bands O O
were O O
revealed O O
under O O
UV O O
radiation O O
. O O

Figure O O
6 O O
: O O
Activation O O
of O O
phosphorylated O O
Akt O O
after O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-17 O O
induction O O
by O O
anti-CD3 O O
antibody O O
, O O
and O O
its O O
inhibition O O
by O O
LY294002 O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
were O O
cultured O O
with O O
medium O O
only O O
-LRB- O O
lane O O
1 O O
-RRB- O O
, O O
anti-CD3 O O
antibody O O
-LRB- O O
10 O O
μg/ml O O
; O O
lane O O
2 O O
-RRB- O O
or O O
anti-CD3 O O
antibody O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
plus O O
LY294002 O O
-LRB- O O
20 O O
μM O O
; O O
lane O O
3 O O
-RRB- O O
for O O
10–120 O O
min O O
. O O

Cell O O
lysates O O
were O O
analyzed O O
for O O
Akt O O
activation O O
by O O
western O O
blot O O
analysis O O
of O O
total O O
and O O
Ser473-phosphorylated O O
Akt O O
-LRB- O O
P-Akt O O
-RRB- O O
using O O
specific O O
antibodies O O
. O O

Levels O O
of O O
phosphorylated O O
Akt O O
were O O
compared O O
at O O
each O O
time O O
point O O
, O O
after B-conn Temporal.Succession
normalization O O
to O O
Akt O O
and O O
β-actin O O
in O O
the O O
same O O
sample O O
. O O

A O O
representative O O
example O O
of O O
three O O
separate O O
experiments O O
is O O
shown O O
. O O

Figure O O
7 O O
: O O
Effects O O
of O O
anti-CD3 O O
plus O O
anti-CD28 O O
on O O
NF-κB O O
complex O O
in O O
nuclear O O
extracts O O
of O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
and O O
normal O O
PBMC O O
. O O

-LRB- O O
a O O
-RRB- O O
NF-κB O O
activity O O
in O O
the O O
absence O O
-LRB- O O
lane O O
1 O O
-RRB- O O
or O O
presence O O
-LRB- O O
lane O O
2 O O
-RRB- O O
of O O
anti-CD3 O O
plus O O
anti-CD28 O O
antibody O O
; O O
supershift O O
assay O O
of O O
NF-κB O O
site O O
with O O
antibodies O O
against O O
p65 O O
-LRB- O O
lane O O
3 O O
-RRB- O O
, O O
p50 O O
-LRB- O O
lane O O
4 O O
-RRB- O O
and O O
c-Rel O O
-LRB- O O
lane O O
5 O O
-RRB- O O
. O O

PBMC O O
from O O
patients O O
with O O
RA O O
were O O
stimulated O O
with O O
anti-CD3 O O
plus O O
anti-CD28 O O
and O O
were O O
used O O
for O O
the O O
supershift O O
assay O O
. O O

-LRB- O O
b O O
-RRB- O O
NF-κB O O
activity O O
in O O
the O O
absence O O
-LRB- O O
lane O O
1 O O
-RRB- O O
or O O
presence O O
-LRB- O O
lane O O
2 O O
-RRB- O O
of O O
anti-CD3 O O
antibody O O
plus O O
anti-CD28 O O
in O O
normal O O
PBMC O O
. O O

-LRB- O O
c O O
-RRB- O O
NF-κB O O
activity O O
in O O
the O O
absence O O
-LRB- O O
lane O O
1 O O
-RRB- O O
or O O
presence O O
-LRB- O O
lane O O
2 O O
-RRB- O O
of O O
anti-CD3 O O
, O O
anti-CD3 O O
plus O O
LY294002 O O
-LRB- O O
lane O O
3 O O
-RRB- O O
or O O
anti-CD3 O O
plus O O
pyrrolidine O O
dithiocarbamate O O
-LRB- O O
PDTC O O
; O O
lane O O
4 O O
-RRB- O O
. O O

Arrows O O
denote O O
a O O
labeled O O
oligonucleotide O O
band O O
shifted O O
after B-conn Temporal.Succession
NF-κB O O
binding O O
. O O

The O O
lower O O
panel O O
shows O O
an O O
immunoblot O O
for O O
IκB-α O O
and O O
actin O O
at O O
the O O
same O O
time O O
. O O

Table O O
1 O O
: O O
Production O O
of O O
interleukin-17 O O
in O O
response O O
to O O
anti-CD3 O O
and O O
mitogens O O
by O O
peripheral O O
blood O O
mononuclear O O
cells O O
and O O
T O O
cells O O
from O O
patients O O
with O O
rheumatoid O O
arthritis O O

Rheumatoid O O
arthritis O O
synovium O O
contains O O
plasmacytoid O O
dendritic O O
cells O O

Abstract O O

We O O
have O O
previously O O
described O O
enrichment O O
of O O
antigen-presenting O O
HLA-DR+ O O
nuclear O O
RelB+ O O
dendritic O O
cells O O
-LRB- O O
DCs O O
-RRB- O O
in O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
synovium O O
. O O

CD123+HLA-DR+ O O
plasmacytoid O O
DCs O O
-LRB- O O
pDCs O O
-RRB- O O
and O O
their O O
precursors O O
have O O
been O O
identified O O
in O O
human O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
, O O
lymphoid O O
tissue O O
, O O
and O O
some O O
inflamed O O
tissues O O
. O O

We O O
hypothesized O O
recruitment O O
of O O
pDCs O O
into O O
the O O
inflamed O O
RA O O
synovial O O
environment O O
and O O
their O O
contribution O O
as O O
antigen-presenting O O
cells O O
-LRB- O O
APCs O O
-RRB- O O
and O O
inflammatory O O
cells O O
in O O
RA O O
. O O

CD11c+ O O
myeloid O O
DCs O O
and O O
CD123+ O O
pDCs O O
were O O
compared O O
in O O
normal O O
and O O
RA O O
PB O O
, O O
synovial O O
fluid O O
-LRB- O O
SF O O
-RRB- O O
, O O
and O O
synovial O O
tissue O O
by O O
flow O O
cytometry O O
, O O
immunohistochemistry O O
, O O
and O O
electron O O
microscopy O O
and O O
were O O
sorted O O
for O O
functional O O
studies O O
. O O

Nuclear O O
RelB-CD123+ O O
DCs O O
were O O
located O O
in O O
perivascular O O
regions O O
of O O
RA O O
, O O
in O O
a O O
similar O O
frequency O O
to O O
nuclear O O
RelB+CD123- O O
DCs O O
, O O
but O O
not O O
normal O O
synovial O O
tissue O O
sublining O O
. O O

Apart O O
from O O
higher O O
expression O O
of O O
HLA-DR O O
, O O
the O O
numbers O O
and O O
phenotypes O O
of O O
SF O O
pDCs O O
were O O
similar O O
to O O
those O O
of O O
normal O O
PB O O
pDCs O O
. O O

While B-conn Contrast
the O O
APC O O
function O O
of O O
PB O O
pDCs O O
was O O
less O O
efficient O O
than O O
that O O
of O O
PB O O
myeloid O O
DCs O O
, O O
RA O O
SF O O
pDCs O O
efficiently O O
activated O O
resting O O
allogeneic O O
PB O O
T O O
cells O O
, O O
and B-conn Conjunction
high O O
levels O O
of O O
IFN-γ O O
, O O
IL-10 O O
, O O
and O O
tumor O O
necrosis O O
factor O O
α O O
were O O
produced O O
in B-conn Circumstance.Forward Circumstance
response I-conn Circumstance.Forward Circumstance
to I-conn Circumstance.Forward Circumstance
incubation O O
of O O
allogeneic O O
T O O
cells O O
with O O
either O O
type O O
of O O
SF O O
DCs O O
. O O

Thus B-conn Restatement.Generalization
, O O
pDCs O O
are O O
recruited O O
to O O
RA O O
synovial O O
tissue O O
and O O
comprise O O
an O O
APC O O
population O O
distinct O O
from O O
the O O
previously O O
described O O
nuclear O O
RelB+ O O
synovial O O
DCs O O
. O O

pDCs O O
may O O
contribute O O
significantly O O
to O O
the O O
local O O
inflammatory O O
environment O O
. O O

Introduction O O

Plasmacytoid O O
dendritic O O
cells O O
-LRB- O O
pDCs O O
-RRB- O O
are O O
a O O
distinct O O
population O O
of O O
antigen-presenting O O
cells O O
-LRB- O O
APCs O O
-RRB- O O
with O O
the O O
capacity O O
for O O
potent O O
antigen-presenting O O
function O O
and O O
production O O
of O O
large O O
amounts O O
of O O
cytokines O O
, O O
including O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
and O O
IFN-α O O
. O O

Human O O
pDCs O O
can O O
be O O
identified O O
by B-conn Purpose.Enablement
cell-surface O O
expression O O
of O O
MHC O O
molecules O O
, O O
the O O
α-chain O O
of O O
the O O
IL-3 O O
receptor O O
-LRB- O O
CD123 O O
-RRB- O O
, O O
and O O
the O O
presence O O
of O O
blood O O
dendritic-cell O O
-LRB- O O
DC O O
-RRB- O O
antigens O O
known O O
as O O
BDCA2 O O
and O O
BDCA4 O O
in O O
a O O
proportion O O
of O O
cells O O
-LSB-1 O O
-RSB- O O
. O O

In B-conn Contrast
comparison I-conn Contrast
with I-conn Contrast
CD11c+ O O
myeloid O O
DCs O O
, O O
pDCs O O
display O O
a O O
distinct O O
set O O
of O O
chemokine O O
and O O
Toll-like O O
receptors O O
-LSB-2-4 O O
-RSB- O O
. O O

In O O
response O O
to O O
viruses O O
and O O
CpG O O
DNA O O
, O O
pDCs O O
become O O
activated O O
to O O
produce O O
IFN-α O O
and B-conn Conjunction
their O O
APC O O
function O O
is O O
enhanced O O
-LSB-5-8 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
pDCs O O
were O O
first O O
demonstrated O O
in O O
the O O
T-cell O O
areas O O
of O O
lymph O O
nodes O O
-LSB-5,9 O O
-RSB- O O
, O O
precursors O O
of O O
this O O
DC O O
population O O
have O O
been O O
isolated O O
from O O
several O O
sources O O
, O O
including O O
normal O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
, O O
thymus O O
, O O
fetal O O
liver O O
, O O
and O O
bone O O
marrow O O
-LSB-10 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
they O O
do O O
not O O
reside O O
in O O
normal O O
peripheral O O
tissues O O
, O O
pDCs O O
have O O
been O O
shown O O
to O O
infiltrate O O
certain O O
inflamed O O
tissues O O
and O O
tumor O O
sites O O
, O O
including O O
the O O
skin O O
in O O
psoriasis O O
and O O
lupus O O
, O O
the O O
cerebrospinal O O
fluid O O
in O O
multiple O O
sclerosis O O
, O O
and O O
melanoma O O
and O O
ovarian O O
carcinoma O O
-LSB-11-15 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
pDCs O O
play O O
an O O
important O O
effector O O
role O O
in O O
viral O O
disease O O
, O O
being O O
the O O
major O O
producers O O
of O O
IFN-α O O
and O O
having O O
a O O
primary O O
role O O
in O O
innate O O
immunity O O
, O O
there O O
is O O
also O O
evidence O O
that O O
they O O
may O O
play O O
an O O
immunoregulatory O O
role O O
, O O
through B-conn Purpose.Enablement
the O O
induction O O
of O O
Th2 O O
-LRB- O O
T O O
helper O O
2 O O
-RRB- O O
-type O O
cytokines O O
-LSB-9,16-18 O O
-RSB- O O
. O O

The O O
synovial O O
autoimmune O O
reaction O O
of O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
is O O
characterized O O
by O O
lymphocyte O O
, O O
macrophage O O
, O O
and O O
DC O O
infiltration O O
that O O
can O O
progress O O
to O O
the O O
development O O
of O O
lymphoid O O
tissue O O
in O O
established O O
disease O O
-LSB-19-21 O O
-RSB- O O
. O O

DCs O O
are O O
likely O O
to O O
contribute O O
to O O
the O O
formation O O
and O O
maintenance O O
of O O
such O O
organized O O
lymphoid O O
tissue O O
and O O
antigen O O
presentation O O
in O O
RA O O
and O O
other O O
autoimmune O O
lesions O O
-LSB-22-24 O O
-RSB- O O
. O O

We O O
have O O
previously O O
shown O O
that O O
the O O
effector O O
site O O
in O O
RA O O
synovial O O
tissue O O
is O O
enriched O O
in O O
differentiated O O
myeloid O O
DCs O O
, O O
which O O
express O O
CD33 O O
, O O
CD11c O O
, O O
MHC O O
and O O
costimulatory O O
molecules O O
, O O
and O O
nuclear O O
RelB O O
-LSB-21,25 O O
-RSB- O O
. O O

Translocation O O
of O O
RelB O O
to O O
the O O
nucleus O O
of O O
myeloid O O
DCs O O
is O O
associated O O
with O O
APC O O
function O O
, O O
particularly B-conn Purpose.Enablement
through I-conn Purpose.Enablement
increased O O
expression O O
of O O
MHC O O
molecules O O
CD86 O O
and O O
CD40 O O
-LSB-26 O O
-RSB- O O
. O O

The O O
proinflammatory O O
cytokines O O
TNF-α O O
and O O
IL-1β O O
are O O
key O O
contributors O O
to O O
the O O
inflammatory O O
cytokine O O
cascade O O
in O O
RA O O
-LSB-27,28 O O
-RSB- O O
. O O

This O O
relates O O
to O O
a O O
number O O
of O O
actions O O
, O O
but B-conn Concession.Contra-expectation
activation O O
of O O
the O O
endothelium O O
by O O
TNF-α O O
is O O
particularly O O
important O O
in O O
cellular O O
recruitment O O
to O O
the O O
synovium O O
-LSB-29-31 O O
-RSB- O O
. O O

Since B-conn Cause.Reason
RA O O
is O O
characterized O O
by O O
endothelial O O
activation O O
, O O
leukocyte O O
recruitment O O
, O O
and O O
the O O
development O O
of O O
high O O
endothelial O O
venules O O
, O O
we O O
hypothesized O O
that O O
pDCs O O
would O O
be O O
enriched O O
in O O
inflamed O O
but O O
not O O
normal O O
synovium O O
. O O

Since B-conn Cause.Reason
the O O
functional O O
role O O
of O O
pDCs O O
in O O
disease O O
pathogenesis O O
is O O
only O O
partly O O
understood O O
, O O
we O O
also B-conn Conjunction
wished O O
to O O
address O O
whether O O
these O O
cells O O
represent O O
a O O
population O O
distinct O O
from O O
the O O
described O O
nuclear O O
RelB+ O O
synovial O O
DCs O O
, O O
and B-conn Conjunction
whether O O
they O O
may O O
contribute O O
as O O
APCs O O
or O O
inflammatory O O
cells O O
in O O
RA O O
-LSB-21 O O
-RSB- O O
. O O

Materials O O
and O O
methods O O

Thirty O O
patients O O
who O O
fulfilled O O
the O O
American O O
College O O
of O O
Rheumatology O O
criteria O O
for O O
RA O O
were O O
included O O
-LSB-32 O O
-RSB- O O
. O O

Of O O
these O O
, O O
10 O O
provided O O
synovial O O
fluid O O
-LRB- O O
SF O O
-RRB- O O
samples O O
and O O
27 O O
provided O O
PB O O
samples O O
. O O

Of O O
the O O
30 O O
patients O O
, O O
80 O O
% O O
were O O
seropositive O O
, O O
62 O O
% O O
were O O
female O O
, O O
and O O
73 O O
% O O
were O O
taking O O
at O O
least O O
one O O
disease-modifying O O
antirheumatic O O
drug O O
or O O
low-dose O O
prednisone O O
or O O
both O O
. O O

Synovial O O
tissue O O
was O O
obtained O O
at O O
arthroscopy O O
from O O
seven O O
patients O O
with O O
RA O O
, O O
of O O
whom O O
three O O
were O O
untreated O O
and O O
four O O
were O O
taking O O
at O O
least O O
one O O
disease-modifying O O
antirheumatic O O
drug O O
and O O
low-dose O O
prednisone O O
. O O

The O O
duration O O
of O O
disease O O
ranged O O
from O O
0.5 O O
to O O
18 O O
years O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
we O O
studied O O
synovial O O
tissue O O
from O O
four O O
healthy O O
individuals O O
with O O
nonspecific O O
knee O O
pain O O
undergoing O O
arthroscopy O O
, O O
one O O
patient O O
who O O
had O O
had O O
psoriatic O O
arthritis O O
for O O
8 O O
years O O
, O O
and O O
one O O
patient O O
who O O
had O O
had O O
ankylosing O O
spondylitis O O
for O O
30 O O
years O O
. O O

Each O O
patient O O
with O O
spondyloarthropathy O O
was O O
taking O O
sulfasalazine O O
. O O

No O O
patient O O
in O O
the O O
study O O
was O O
taking O O
biologics O O
. O O

Synovial O O
tissue O O
was O O
provided O O
by O O
Dr O O
Malcolm O O
Smith O O
-LRB- O O
Repatriation O O
Hospital O O
, O O
Adelaide O O
, O O
Australia O O
-RRB- O O
. O O

PB O O
buffy O O
coats O O
prepared O O
from O O
30 O O
healthy O O
donors O O
were O O
obtained O O
from O O
the O O
Red O O
Cross O O
Blood O O
Transfusion O O
Service O O
-LRB- O O
Brisbane O O
, O O
QLD O O
, O O
Australia O O
-RRB- O O
. O O

The O O
study O O
was O O
approved O O
by O O
the O O
Research O O
Ethics O O
Committee O O
of O O
the O O
Princess O O
Alexandra O O
Hospital O O
. O O

All O O
cells O O
were O O
cultured O O
in O O
RPMI O O
1640 O O
-LRB- O O
Gibco O O
, O O
Life O O
Technologies O O
, O O
Mulgrave O O
, O O
VIC O O
, O O
Australia O O
-RRB- O O
supplemented O O
with O O
10 O O
% O O
FCS O O
-LRB- O O
CSL O O
Ltd O O
, O O
Parkville O O
, O O
VIC O O
, O O
Australia O O
-RRB- O O
, O O
0.3 O O
mg/ml O O
L-glutamine O O
-LRB- O O
Trace O O
Biosciences O O
, O O
Castle O O
Hill O O
, O O
NSW O O
, O O
Australia O O
-RRB- O O
, O O
0.12 O O
mg/ml O O
benzylpenicillin O O
-LRB- O O
CSL O O
-RRB- O O
, O O
and O O
10 O O
μg/ml O O
gentamicin O O
-LRB- O O
Delta O O
West O O
, O O
Pharmacia O O
and O O
Upjohn O O
, O O
Spring O O
Hill O O
, O O
QLD O O
, O O
Australia O O
-RRB- O O
. O O

The O O
monoclonal O O
antibodies O O
used O O
in O O
this O O
study O O
include O O
FITC O O
, O O
phycoerythrin O O
-LRB- O O
PE O O
-RRB- O O
, O O
and O O
purified O O
anti-CD11c O O
, O O
CD14-PerCP O O
, O O
PE O O
, O O
biotinylated O O
and O O
purified O O
anti-CD123 O O
, O O
CD86-FITC O O
-LRB- O O
all O O
from O O
BD O O
Pharmingen O O
, O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
BDCA2-FITC O O
-LRB- O O
Miltenyi O O
Biotech O O
, O O
San O O
Francisco O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
HLA-DR-biotin O O
-LRB- O O
Coulter O O
Immunotech O O
, O O
Fullerton O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
CD40-FITC O O
-LRB- O O
Biolegend O O
, O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
CD80-FITC O O
-LRB- O O
Cymbus O O
Biotech O O
, O O
Chandlers O O
Ford O O
, O O
Hants O O
, O O
UK O O
-RRB- O O
, O O
CD68 O O
-LRB- O O
Kp-1 O O
, O O
DAKO O O
, O O
Carpinteria O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
RelB O O
-LRB- O O
C-19 O O
, O O
Santa O O
Cruz O O
Biotech O O
, O O
Santa O O
Cruz O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
and O O
biotinylated O O
Ulex O O
europaeus O O
agglutinin O O
I O O
-LRB- O O
Vector O O
Laboratories O O
, O O
Burlingame O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Mononuclear O O
cells O O
were O O
prepared O O
from O O
normal O O
or O O
RA O O
PB O O
or O O
RA O O
SF O O
by O O
density O O
gradient O O
centrifugation O O
over O O
Ficoll-Paque O O
-LRB- O O
Pharmacia O O
Biotech O O
, O O
Uppsala O O
, O O
Sweden O O
-RRB- O O
as O O
described O O
elsewhere O O
-LSB-33 O O
-RSB- O O
. O O

T O O
cells O O
were O O
purified O O
from O O
PB O O
mononuclear O O
cells O O
by B-conn Purpose.Enablement
passing O O
the O O
cells O O
over O O
a O O
nylon O O
wool O O
column O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
immunomagnetic O O
depletion O O
of O O
remaining O O
monocytes O O
, O O
DCs O O
, O O
B O O
cells O O
, O O
and O O
NK O O
-LRB- O O
natural O O
killer O O
-RRB- O O
cells O O
using O O
monoclonal O O
antibodies O O
against O O
CD14 O O
, O O
CD16 O O
, O O
CD19 O O
, O O
CD56 O O
, O O
and O O
HLA-DR O O
-LRB- O O
all O O
from O O
BD O O
Pharmingen O O
-RRB- O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
goat O O
antimouse O O
immunoglobulin O O
magnetic O O
beads O O
, O O
then B-conn Temporal.Precedence
passage O O
through O O
a O O
strong O O
magnetic O O
field O O
-LRB- O O
MACS O O
, O O
Miltenyi O O
Biotech O O
-RRB- O O
, O O
and O O
collection O O
of O O
the O O
unbound O O
fraction O O
. O O

On O O
analysis O O
by O O
flow O O
cytometry O O
, O O
the O O
unbound O O
fraction O O
routinely O O
contained O O
95–98 O O
% O O
CD3+ O O
T O O
cells O O
. O O

DC-enriched O O
non-T O O
cells O O
were O O
produced O O
by B-conn Purpose.Enablement
immunomagnetic O O
depletion O O
of O O
T O O
, O O
B O O
, O O
and O O
NK O O
cells O O
from O O
non-T O O
cells O O
, O O
by B-conn Purpose.Enablement
incubation O O
with O O
monoclonal O O
antibodies O O
against O O
CD19 O O
, O O
CD16 O O
, O O
CD56 O O
, O O
and O O
CD3 O O
. O O

To B-conn Purpose.Goal
enumerate O O
CD123+ O O
and O O
CD11c+ O O
subsets O O
of O O
DCs O O
, O O
mononuclear O O
cells O O
from O O
normal O O
PB O O
or O O
RA O O
SF O O
were O O
stained O O
for O O
four-colour O O
flow O O
cytometry O O
as O O
described O O
elsewhere O O
-LSB-33 O O
-RSB- O O
, O O
using O O
monoclonal O O
antibodies O O
against O O
CD14-PECy5 O O
, O O
CD11c-FITC O O
, O O
CD123-PE O O
, O O
and O O
HLA-DR-APC O O
. O O

Live O O
CD14-HLA-DR+ O O
mononuclear O O
cells O O
were O O
gated O O
for O O
analysis O O
. O O

Subset O O
percentages O O
are O O
expressed O O
as O O
percentage O O
of O O
total O O
mononuclear O O
cells O O
. O O

Listmode O O
data O O
were O O
analyzed O O
using O O
Winlist O O
2.0 O O
software O O
-LRB- O O
Verity O O
Software O O
House O O
, O O
Topsham O O
, O O
ME O O
, O O
USA O O
-RRB- O O
. O O

For B-conn Purpose.Goal
sorting O O
, O O
PB O O
or O O
SF O O
DC-enriched O O
non-T O O
cells O O
stained O O
with O O
the O O
same O O
four O O
markers O O
were O O
sorted O O
using O O
the O O
Moflo O O
flow O O
cytometer O O
-LRB- O O
DAKO O O
-RRB- O O
, O O
gating O O
on O O
CD14-HLA-DR+ O O
and O O
either O O
CD123+CD11c- O O
or O O
CD11c+CD123- O O
cells O O
, O O
respectively O O
. O O

For B-conn Purpose.Goal
phenotypic O O
analysis O O
, O O
mononuclear O O
cells O O
from O O
PB O O
or O O
SF O O
were O O
stained O O
with O O
CD14-PECy5 O O
, O O
CD123-PE O O
or O O
CD11c-PE O O
, O O
HLA-DR-APC O O
, O O
and O O
either O O
a O O
fourth O O
monoclonal O O
antibody O O
or O O
isotype O O
control O O
monoclonal O O
antibody O O
conjugated O O
with O O
FITC O O
. O O

DCs O O
were O O
gated O O
as O O
described O O
above O O
. O O

Electron O O
microscopy O O
of O O
freshly O O
sorted O O
cells O O
was O O
carried O O
out O O
as O O
described O O
elsewhere O O
-LSB-5 O O
-RSB- O O
. O O

After B-conn Temporal.Succession
fixation O O
in O O
2.5 O O
% O O
glutaraldehyde O O
in O O
phosphate-buffered O O
saline O O
, O O
the O O
cells O O
were O O
post-fixed O O
with O O
an O O
aqueous O O
solution O O
of O O
1 O O
% O O
OsO4 O O
containing O O
1.5 O O
% O O
K4Fe O O
-LRB- O O
CN O O
-RRB- O O
6 O O
. O O

Subsequently B-conn Temporal.Precedence
, O O
the O O
specimens O O
were O O
dehydrated O O
in O O
an O O
alcohol O O
series O O
and O O
embedded O O
into O O
epon O O
. O O

Ultrathin O O
sections O O
-LRB- O O
50 O O
nm O O
-RRB- O O
were O O
contrasted O O
with O O
lead O O
citrate O O
and O O
uranyl O O
acetate O O
and O O
studied O O
with O O
a O O
CM100 O O
electron O O
microscope O O
-LRB- O O
Philips O O
, O O
Eindhoven O O
, O O
The O O
Netherlands O O
-RRB- O O
. O O

Various O O
numbers O O
of O O
sorted O O
PB O O
or O O
RA O O
SF O O
DCs O O
were O O
incubated O O
with O O
105 O O
allogeneic O O
PB O O
T O O
cells O O
in O O
triplicate O O
wells O O
for O O
5 O O
days O O
, O O
as O O
described O O
elsewhere O O
-LSB-33 O O
-RSB- O O
. O O

Supernatants O O
were O O
removed O O
from O O
some O O
cultures O O
and O O
-LSB-3H O O
-RSB- O O
thymidine O O
-LRB- O O
1 O O
μCi/well O O
, O O
ICN O O
Biochemicals O O
-RRB- O O
was O O
added O O
to O O
the O O
remainder O O
for O O
the O O
final O O
18 O O
h O O
. O O

Cells O O
were O O
harvested O O
onto O O
glass-fiber O O
filter O O
mats O O
and B-conn Conjunction
the O O
incorporation O O
of O O
-LSB-3H O O
-RSB- O O
thymidine O O
was O O
determined O O
by O O
liquid O O
scintillation O O
spectroscopy O O
-LRB- O O
Packard O O
Topcount O O
, O O
Packard O O
Instrument O O
Co O O
, O O
Meriden O O
, O O
CT O O
, O O
USA O O
-RRB- O O
. O O

IFN-γ O O
, O O
IL-10 O O
, O O
and O O
TNF-α O O
were O O
measured O O
in O O
supernatants O O
by O O
ELISA O O
using O O
OptEIA O O
ELISA O O
kits O O
-LRB- O O
BD O O
Pharmingen O O
-RRB- O O
. O O

Frozen O O
or O O
paraffin-embedded O O
sections O O
of O O
synovial O O
tissue O O
from O O
patients O O
with O O
untreated O O
active O O
RA O O
were O O
obtained O O
by O O
arthroscopic O O
biopsy O O
and O O
supplied O O
by O O
Malcolm O O
Smith O O
-LRB- O O
Repatriation O O
Hospital O O
, O O
Adelaide O O
, O O
Australia O O
-RRB- O O
. O O

Normal O O
synovial O O
tissue O O
was O O
obtained O O
at O O
arthroscopy O O
from O O
patients O O
undergoing O O
arthroscopy O O
for O O
nonspecific O O
knee O O
pain O O
and O O
in O O
whom O O
no O O
abnormality O O
was O O
found O O
. O O

After B-conn Temporal.Succession
fixation O O
with O O
acetone O O
, O O
sections O O
were O O
stained O O
with O O
anti-CD11c O O
or O O
anti-CD123 O O
using O O
an O O
immunoperoxidase O O
technique O O
, O O
and O O
revealed O O
with O O
diaminobenzidine O O
-LRB- O O
brown O O
-RRB- O O
. O O

Frozen O O
sections O O
were O O
double-stained O O
with O O
U. O O
europaeus O O
agglutinin O O
I O O
-LRB- O O
Ulex O O
-RRB- O O
, O O
a O O
lectin O O
that O O
specifically O O
binds O O
endothelial O O
cells O O
-LRB- O O
fast O O
red O O
-RRB- O O
, O O
and O O
anti-CD123 O O
-LRB- O O
brown O O
-RRB- O O
, O O
using O O
a O O
double O O
, O O
immunoperoxidase–immunoalkaline O O
phosphatase O O
technique O O
as O O
described O O
elsewhere O O
-LSB-34 O O
-RSB- O O
. O O

Formalin-fixed O O
paraffin-embedded O O
sections O O
were O O
antigen-retrieved O O
in O O
10 O O
mM O O
citrate O O
buffer O O
at O O
pH6 O O
in O O
an O O
autoclave O O
, O O
then B-conn Temporal.Precedence
stained O O
with O O
anti-CD123 O O
-LRB- O O
diaminobenzidine O O
, O O
brown O O
-RRB- O O
alone O O
, O O
or O O
in O O
combination O O
with O O
anti-RelB O O
-LRB- O O
BCIP O O
, O O
DAKO O O
, O O
purple O O
-RRB- O O
. O O

Sections O O
were O O
counterstained O O
with O O
hematoxylin O O
except B-conn Exception
when O O
they O O
had O O
been O O
double-stained O O
for O O
CD123 O O
and O O
RelB O O
and O O
were O O
photographed O O
using O O
a O O
transmitted-light O O
microscope O O
-LRB- O O
Leitz O O
Diaplan O O
, O O
Leica O O
, O O
Germany O O
-RRB- O O
. O O

To B-conn Purpose.Goal
quantitate O O
infiltration O O
by O O
CD123+ O O
DCs O O
, O O
the O O
number O O
of O O
CD123+Ulex- O O
cells O O
was O O
counted O O
in O O
sections O O
double-stained O O
with O O
CD123 O O
and O O
Ulex O O
. O O

Cells O O
were O O
counted O O
in O O
each O O
of O O
the O O
entire O O
sections O O
from O O
three O O
patients O O
and O O
three O O
normal O O
controls O O
at O O
high O O
power O O
, O O
and B-conn Conjunction
for O O
each O O
biopsy O O
this O O
number O O
was O O
corrected O O
for O O
the O O
area O O
of O O
the O O
section O O
to B-conn Purpose.Goal
obtain O O
the O O
number O O
per O O
mm2 O O
. O O

To B-conn Purpose.Goal
quantitate O O
infiltration O O
by O O
CD11c+ O O
cells O O
, O O
the O O
number O O
of O O
these O O
cells O O
was O O
counted O O
in O O
three O O
high-power O O
fields O O
of O O
the O O
synovial O O
sublining O O
in O O
sections O O
from O O
three O O
patients O O
and O O
three O O
normal O O
controls O O
. O O

Differences O O
were O O
analyzed O O
using O O
unpaired O O
Student O O
's O O
t-tests O O
. O O

Results O O

We O O
have O O
previously O O
shown O O
that O O
synovial O O
tissue O O
in O O
RA O O
and O O
spondyloarthropathy O O
is O O
enriched O O
in O O
differentiated O O
myeloid O O
DCs O O
that O O
express O O
CD33 O O
, O O
CD11c O O
, O O
MHC O O
class O O
II O O
, O O
costimulatory O O
molecules O O
, O O
and O O
nuclear O O
RelB O O
-LSB-21,25 O O
-RSB- O O
. O O

Translocation O O
of O O
RelB O O
to O O
the O O
nucleus O O
is O O
associated O O
with O O
maturation O O
and O O
APC O O
function O O
of O O
myeloid O O
DCs O O
-LSB-26 O O
-RSB- O O
. O O

These O O
nuclear O O
RelB+ O O
DCs O O
are O O
absent O O
in O O
normal O O
synovial O O
tissue O O
and O O
are O O
rare O O
in O O
RA O O
SF O O
-LSB-21,23 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
determine O O
whether O O
RA O O
synovial O O
tissue O O
was O O
infiltrated O O
by O O
CD123+ O O
pDCs O O
in O O
addition O O
to O O
CD11c+ O O
myeloid O O
cells O O
, O O
frozen O O
synovial O O
tissue O O
sections O O
, O O
either O O
normal O O
or O O
from O O
patients O O
with O O
RA O O
or O O
spondyloarthropathy O O
, O O
were O O
stained O O
with O O
CD11c O O
or O O
CD123 O O
. O O

CD11c+ O O
cells O O
were O O
found O O
both O O
in O O
the O O
lining O O
layer O O
and O O
adjacent O O
to O O
vessels O O
in O O
the O O
sublining O O
of O O
normal O O
synovial O O
tissue O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
CD123 O O
only O O
stained O O
endothelial O O
cells O O
in O O
the O O
normal O O
tissue O O
-LRB- O O
Fig. O O
1a,1b O O
-RRB- O O
. O O

In O O
RA O O
synovial O O
tissue O O
, O O
CD11c O O
again O O
stained O O
cells O O
adjacent O O
to O O
vessels O O
, O O
now O O
within O O
lymphoid O O
aggregates O O
in O O
the O O
sublining O O
. O O

A O O
population O O
of O O
CD123+ O O
cells O O
with O O
dendritic O O
appearance O O
was O O
also B-conn Conjunction
stained O O
adjacent O O
to O O
CD123+ O O
blood O O
vessels O O
in O O
RA O O
-LRB- O O
Fig. O O
1c,1d O O
, O O
-RRB- O O
. O O

Cells O O
expressing O O
TNF-α O O
in O O
RA O O
synovial O O
tissue O O
were O O
found O O
in O O
a O O
similar O O
location O O
in O O
serial O O
sections O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
as O O
demonstrated O O
previously O O
-LSB-35 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
confirm O O
the O O
perivascular O O
CD123+ O O
cells O O
in O O
synovial O O
tissue O O
, O O
normal O O
and O O
RA O O
synovial O O
tissue O O
were O O
double-stained O O
with O O
the O O
endothelial O O
cell O O
marker O O
Ulex O O
agglutinin O O
-LRB- O O
red O O
-RRB- O O
and O O
with O O
CD123 O O
-LRB- O O
brown O O
-RRB- O O
. O O

Whereas B-conn Contrast
all O O
CD123+ O O
structures O O
in O O
normal O O
synovial O O
tissue O O
colocalized O O
with O O
Ulex O O
agglutinin O O
-LRB- O O
orange O O
-RRB- O O
, O O
single-stained O O
CD123+ O O
cells O O
-LRB- O O
brown O O
-RRB- O O
were O O
located O O
in O O
perivascular O O
lymphoid O O
aggregates O O
and O O
within O O
the O O
lumen O O
of O O
occasional O O
blood O O
vessels O O
in O O
RA O O
synovial O O
tissue O O
-LRB- O O
Fig. O O
1e,1f O O
-RRB- O O
. O O

These O O
CD123+ O O
cells O O
are O O
similar O O
in O O
appearance O O
to O O
those O O
previously O O
demonstrated O O
as O O
CD123+ O O
pDCs O O
in O O
human O O
tonsil O O
, O O
in B-conn Restatement.Specification
that I-conn Restatement.Specification
they O O
are O O
smaller O O
than O O
CD11c+ O O
myeloid O O
DCs O O
, O O
with O O
shorter O O
dendritic O O
processes O O
, O O
and B-conn Conjunction
cell O O
clusters O O
gave O O
the O O
appearance O O
of O O
locally O O
proliferating O O
cells O O
-LRB- O O
Fig. O O
1g O O
-RRB- O O
-LSB-5,36 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
some O O
macrophages O O
can O O
express O O
CD123 O O
, O O
there O O
was O O
no O O
colocalization O O
in O O
synovial O O
tissue O O
of O O
CD123 O O
and O O
CD68 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
aside O O
from O O
the O O
dendritic O O
morphology O O
, O O
we O O
cannot O O
exclude O O
that O O
some O O
of O O
the O O
CD123+ O O
cells O O
stained O O
are O O
mast O O
cells O O
-LSB-37 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
determine O O
whether O O
CD123+ O O
cells O O
in O O
synovial O O
tissue O O
were O O
also O O
nuclear O O
RelB+ O O
, O O
formalin-fixed O O
tissue O O
was O O
double-stained O O
for O O
RelB O O
and O O
CD123 O O
without O O
hematoxylin O O
counterstaining O O
. O O

No O O
CD123+ O O
cells O O
had O O
translocated O O
RelB O O
to O O
the O O
nucleus O O
, O O
although B-conn Concession.Contra-expectation
some O O
expressed O O
cytoplasmic O O
RelB O O
-LRB- O O
Fig. O O
1h,1i O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
nuclear O O
staining O O
of O O
RelB O O
was O O
evident O O
in O O
adjacent O O
CD123- O O
cells O O
-LRB- O O
Fig. O O
1h O O
, O O
arrows O O
-RRB- O O
. O O

All O O
patients O O
with O O
RA O O
showed O O
similar O O
infiltration O O
by O O
pDCs O O
and B-conn Conjunction
no O O
differences O O
in O O
the O O
cell O O
numbers O O
or O O
location O O
were O O
noted O O
between O O
patients O O
with O O
RA O O
or O O
spondyloarthropathy O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

We O O
quantitated O O
pDCs O O
in O O
normal O O
or O O
RA O O
synovial O O
tissue O O
by B-conn Purpose.Enablement
counting O O
CD123+Ulex- O O
cells O O
in O O
synovial O O
tissue O O
sections O O
from O O
patients O O
with O O
RA O O
or O O
normal O O
controls O O
stained O O
with O O
CD123 O O
and O O
Ulex O O
as O O
shown O O
in O O
Fig. O O
1 O O
. O O

Whereas B-conn Contrast
no O O
pDCs O O
infiltrated O O
the O O
normal O O
tissue O O
, O O
approximately O O
22 O O
pDCs O O
per O O
mm2 O O
were O O
identified O O
within O O
the O O
RA O O
tissue O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

This O O
number O O
is O O
similar O O
to O O
the O O
number O O
of O O
nuclear O O
RelB+ O O
differentiated O O
DCs O O
identified O O
previously O O
in O O
RA O O
synovial O O
tissue O O
-LSB-38 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
CD11c+ O O
cells O O
infiltrated O O
both O O
normal O O
and O O
RA O O
synovial O O
tissue O O
, O O
with O O
significantly O O
larger O O
numbers O O
in O O
RA O O
-LRB- O O
P O O
< O O
0.05 O O
-RRB- O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

We O O
conclude O O
that O O
the O O
CD123+ O O
cell O O
population O O
is O O
most O O
likely O O
a O O
pDC O O
population O O
that O O
infiltrates O O
RA O O
and O O
spondyloarthropathy O O
but O O
not O O
normal O O
synovial O O
tissue O O
and B-conn Conjunction
that O O
it O O
is O O
distinct O O
from O O
the O O
described O O
nuclear O O
RelB+ O O
DCs O O
-LSB-21,36,39 O O
-RSB- O O
. O O

CD11c+ O O
cells O O
comprise O O
immature O O
and O O
differentiated O O
myeloid O O
DCs O O
as O O
well O O
as O O
monocytes O O
-LSB-1,34 O O
-RSB- O O
. O O

Differentiated O O
nuclear O O
RelB+ O O
DCs O O
are O O
found O O
within O O
the O O
CD11c+ O O
DC O O
population O O
in O O
RA O O
and O O
other O O
inflammatory O O
arthritides O O
but O O
not O O
in O O
normal O O
synovial O O
tissue O O
-LSB-21 O O
-RSB- O O
. O O

Workers O O
in O O
our O O
laboratory O O
have O O
previously O O
shown O O
that O O
RA O O
SF O O
is O O
enriched O O
in O O
CD11c+CD33brightCD14- O O
myeloid O O
DCs O O
with O O
efficient O O
APC O O
function O O
-LSB-25,40 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
when B-conn Circumstance.Forward Circumstance
freshly O O
isolated O O
, O O
only O O
a O O
small O O
proportion O O
of O O
SF O O
CD33brightCD14- O O
DCs O O
have O O
translocated O O
RelB O O
to O O
the O O
nucleus O O
. O O

RA O O
and O O
normal O O
PB O O
mononuclear O O
cells O O
contain O O
similar O O
proportions O O
of O O
CD33brightCD14- O O
DCs O O
-LSB-25 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
examine O O
plasmacytoid O O
and O O
myeloid O O
DCs O O
in O O
parallel O O
, O O
we O O
compared O O
RA O O
SF O O
with O O
RA O O
and O O
healthy O O
, O O
control O O
PB O O
for O O
the O O
proportion O O
of O O
CD123+ O O
and O O
CD11c+ O O
HLA-DR+CD14- O O
DCs O O
. O O

After B-conn Temporal.Succession
purification O O
of O O
mononuclear O O
cells O O
from O O
either O O
normal O O
or O O
RA O O
PB O O
or O O
RA O O
SF O O
by O O
gradient O O
centrifugation O O
, O O
cells O O
were O O
stained O O
with O O
CD123-PE O O
, O O
CD11c-FITC O O
, O O
CD14-PECy5 O O
, O O
and O O
HLA-DR-APC O O
. O O

Polymorphonuclear O O
cells O O
were O O
excluded O O
on O O
the O O
basis O O
of O O
forward O O
and O O
side O O
light-scatter O O
. O O

Since B-conn Cause.Reason
basophils O O
and O O
monocytes O O
can O O
also O O
express O O
CD123 O O
, O O
potential O O
CD123+ O O
non-DCs O O
were O O
excluded O O
by B-conn Purpose.Enablement
gating O O
CD14-HLA-DR+ O O
cells O O
-LSB-10 O O
-RSB- O O
. O O

By O O
four-color O O
analysis O O
, O O
CD14-HLA-DR+CD123+ O O
and O O
CD11c+ O O
DC O O
populations O O
could O O
be O O
distinguished O O
-LRB- O O
Fig. O O
3 O O
-RRB- O O
. O O

The O O
percentages O O
of O O
CD123+CD11c- O O
pDCs O O
in O O
RA O O
PB O O
and O O
normal O O
PB O O
were O O
low O O
and O O
did O O
not O O
differ O O
from O O
each O O
other O O
. O O

This O O
observation O O
contrasts O O
with O O
the O O
reduction O O
in O O
pDCs O O
observed O O
in O O
blood O O
from O O
patients O O
with O O
systemic O O
lupus O O
erythematosus O O
-LSB-41 O O
-RSB- O O
. O O

CD11c+CD123- O O
myeloid O O
DCs O O
were O O
more O O
common O O
than O O
CD123+ O O
DCs O O
in O O
patient O O
and O O
control O O
blood O O
-LRB- O O
P O O
< O O
0.005 O O
-RRB- O O
, O O
in O O
keeping O O
with O O
previous O O
studies O O
of O O
normal O O
PB O O
-LSB-1 O O
-RSB- O O
. O O

RA O O
SF O O
contained O O
a O O
significantly O O
greater O O
percentage O O
of O O
CD11c+ O O
DCs O O
than O O
normal O O
or O O
RA O O
PB O O
-LRB- O O
P O O
< O O
0.005 O O
-RRB- O O
– O O
in O O
accord O O
with O O
previous O O
studies O O
using O O
the O O
markers O O
CD33 O O
and O O
CD14 O O
-LSB-40 O O
-RSB- O O
. O O

The O O
proportion O O
of O O
CD11c+ O O
DCs O O
in O O
RA O O
SF O O
was O O
higher O O
than O O
that O O
of O O
RA O O
SF O O
CD123+ O O
DCs O O
-LRB- O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
the O O
difference O O
was O O
small O O
, O O
the O O
percentage O O
of O O
CD123+ O O
DCs O O
in O O
RA O O
SF O O
was O O
higher O O
than O O
in O O
RA O O
or O O
control O O
PB O O
-LRB- O O
P O O
< O O
0.05 O O
-RRB- O O
. O O

The O O
data O O
show O O
that O O
CD123+ O O
DCs O O
are O O
present O O
in O O
RA O O
SF O O
, O O
and B-conn Conjunction
that O O
the O O
ratio O O
of O O
CD11c+ O O
to O O
CD123+ O O
DCs O O
is O O
similar O O
in O O
RA O O
SF O O
to O O
that O O
in O O
normal O O
or O O
RA O O
PB O O
-LRB- O O
approximately O O
10:1 O O
-RRB- O O
. O O

In O O
RA O O
synovial O O
tissue O O
, O O
mature O O
myeloid O O
nuclear O O
RelB+ O O
and O O
CD123+ O O
DCs O O
have O O
infiltrated O O
perivascular O O
lymphoid O O
aggregates O O
in O O
similar O O
numbers O O
. O O

Previously O O
, O O
similar O O
numbers O O
of O O
immature O O
and O O
mature O O
myeloid O O
DCs O O
were O O
identified O O
in O O
RA O O
synovial O O
tissue O O
-LSB-42 O O
-RSB- O O
. O O

Thus B-conn Cause.Claim
pDCs O O
make O O
up O O
about O O
30 O O
% O O
of O O
DCs O O
within O O
RA O O
synovial O O
tissue O O
. O O

The O O
present O O
and O O
previously O O
published O O
data O O
, O O
taken O O
together O O
, O O
show O O
that O O
both O O
pDCs O O
and O O
myeloid O O
DCs O O
are O O
recruited O O
to O O
RA O O
synovium O O
, O O
with O O
an O O
enrichment O O
of O O
pDCs O O
in O O
synovial O O
tissue O O
relative O O
to O O
blood O O
or O O
SF O O
. O O

In O O
normal O O
PB O O
, O O
pDCs O O
circulate O O
as O O
precursors O O
with O O
the O O
potential O O
for O O
recruitment O O
into O O
tissues O O
in O O
response O O
to O O
chemokines O O
-LSB-2,43 O O
-RSB- O O
. O O

These O O
precursors O O
exhibit O O
a O O
characteristic O O
plasmacytoid O O
morphology O O
on O O
electron O O
microscopy O O
, O O
a O O
cell-surface O O
phenotype O O
characterized O O
by O O
expression O O
of O O
the O O
BDCA2 O O
antigen O O
, O O
by O O
low O O
levels O O
of O O
costimulatory O O
molecule O O
expression O O
, O O
and O O
by O O
the O O
potential O O
for O O
IFN-α O O
production O O
in O O
response O O
to O O
viral O O
or O O
immunostimulatory O O
CpG O O
DNA O O
motifs O O
-LSB-1 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
analyzed O O
the O O
characteristics O O
of O O
sorted O O
RA O O
SF O O
CD123+ O O
DCs O O
and O O
compared O O
them O O
with O O
control O O
PB O O
CD123+ O O
DCs O O
. O O

On B-conn Temporal.Synchronous
electron O O
microscopic O O
examination O O
, O O
freshly O O
sorted O O
PB O O
and O O
SF O O
CD123+ O O
DCs O O
appeared O O
similar O O
, O O
with O O
a O O
smooth O O
surface O O
and O O
abundant O O
rough O O
endoplasmic O O
reticulum O O
in O O
the O O
cytoplasm O O
. O O

The O O
nucleus O O
was O O
nonlobulated O O
and O O
abundant O O
in O O
euchromatin O O
and O O
contained O O
a O O
distinct O O
nucleolus O O
-LRB- O O
Fig. O O
4 O O
-RRB- O O
. O O

CD11c+ O O
PB O O
DCs O O
were O O
morphologically O O
distinct O O
from O O
the O O
CD123+ O O
pDCs O O
, O O
with O O
a O O
lobulated O O
nucleus O O
and O O
some O O
phagocytic O O
vesicles O O
. O O

CD11c+ O O
DCs O O
from O O
SF O O
showed O O
more O O
membrane O O
ruffling O O
and O O
phagocytic O O
activity O O
than O O
those O O
from O O
PB O O
-LRB- O O
Fig. O O
4 O O
-RRB- O O
. O O

Thus B-conn Restatement.Generalization
SF O O
CD123+ O O
DCs O O
morphologically O O
resemble O O
CD123+ O O
DCs O O
in O O
PB O O
, O O
whereas B-conn Contrast
CD11c+ O O
SF O O
DCs O O
display O O
a O O
greater O O
level O O
of O O
ruffling O O
and O O
phagocytic O O
activity O O
, O O
consistent O O
with O O
their O O
enhanced O O
level O O
of O O
activation O O
, O O
than O O
CD11c+ O O
circulating O O
precursors O O
-LSB-21 O O
-RSB- O O
. O O

On B-conn Temporal.Synchronous
four-color O O
flow O O
cytometric O O
analysis O O
, O O
gated O O
RA O O
SF O O
CD14-HLA-DR+CD123+ O O
DCs O O
expressed O O
low O O
levels O O
of O O
CD40 O O
, O O
CD80 O O
, O O
and O O
CD86 O O
. O O

All O O
or O O
the O O
majority O O
of O O
SF O O
CD123+ O O
DCs O O
expressed O O
the O O
BDCA2 O O
marker O O
of O O
immature O O
pDC O O
precursors O O
-LSB-1 O O
-RSB- O O
. O O

This O O
cell-surface O O
phenotype O O
closely O O
resembles O O
that O O
of O O
control O O
PB O O
CD123+ O O
DC O O
precursors O O
, O O
although B-conn Concession.Expectation
BDCA2 O O
was O O
consistently O O
expressed O O
at O O
high O O
levels O O
only O O
by O O
a O O
subset O O
of O O
CD123+ O O
HLA-DR+ O O
cells O O
in O O
PB O O
-LRB- O O
Fig. O O
4b O O
-RRB- O O
. O O

No O O
PB O O
or O O
SF O O
cells O O
expressed O O
the O O
DC O O
differentiation O O
marker O O
CD83 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

However B-conn Contrast
, O O
SF O O
CD123+ O O
and O O
CD11c+ O O
DCs O O
expressed O O
higher O O
levels O O
of O O
cell-surface O O
HLA-DR O O
than O O
the O O
corresponding O O
cells O O
in O O
PB O O
, O O
suggesting O O
some O O
cellular O O
activation O O
within O O
the O O
SF O O
environment O O
-LSB-5,10,44 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
CD123+ O O
pDCs O O
comprise O O
a O O
small O O
proportion O O
of O O
RA O O
SF O O
mononuclear O O
cells O O
, O O
which O O
are O O
predominantly O O
immature O O
but O O
show O O
some O O
evidence O O
of O O
activation O O
in O O
situ O O
. O O

These O O
observations O O
regarding O O
phenotype O O
and O O
PB O O
and O O
SF O O
numbers O O
are O O
consistent O O
with O O
findings O O
in O O
two O O
recent O O
studies O O
-LSB-39,45 O O
-RSB- O O
. O O

We O O
have O O
previously O O
shown O O
that O O
freshly O O
isolated O O
CD33brightCD14-CD11c+ O O
SF O O
DCs O O
efficiently O O
stimulate O O
resting O O
T O O
cells O O
in O O
allogeneic O O
mixed O O
lymphocyte O O
reactions O O
-LSB-21 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
whereas B-conn Contrast
freshly O O
isolated O O
CD11c+ O O
PB O O
DCs O O
are O O
efficient O O
APCs O O
in O O
mixed O O
lymphocyte O O
reactions O O
, O O
CD123+ O O
PB O O
DCs O O
usually O O
require O O
prior O O
activation O O
in O O
the O O
presence O O
of O O
IL-3 O O
and O O
CD154 O O
for O O
acquisition O O
of O O
APC O O
function O O
in O O
this O O
assay O O
. O O

To B-conn Purpose.Goal
analyse O O
the O O
functional O O
capability O O
of O O
RA O O
SF O O
DCs O O
, O O
CD11c+ O O
and O O
CD123+ O O
DCs O O
were O O
sorted O O
from O O
either O O
normal O O
PB O O
or O O
RA O O
SF O O
and O O
incubated O O
with O O
freshly O O
isolated O O
normal O O
allogeneic O O
PB O O
T O O
cells O O
. O O

Freshly O O
isolated O O
PB O O
CD11c+ O O
but O O
not O O
CD123+ O O
DCs O O
efficiently O O
stimulated O O
allogeneic O O
T-cell O O
proliferation O O
and O O
IFN-γ O O
and O O
IL-10 O O
production O O
in O O
mixed O O
lymphocyte O O
reactions O O
. O O

Addition O O
of O O
IL-3 O O
made O O
no O O
difference O O
to O O
the O O
T-cell O O
proliferation O O
in O O
response O O
to O O
CD123+ O O
DCs O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
suggesting O O
that O O
death O O
of O O
the O O
APCs O O
was O O
not O O
responsible O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
both O O
freshly O O
isolated O O
CD11c+ O O
and O O
CD123+ O O
SF O O
DCs O O
efficiently O O
stimulated O O
proliferation O O
and O O
IFN-γ O O
and O O
IL-10 O O
production O O
by O O
resting O O
normal O O
allogeneic O O
T O O
cells O O
-LRB- O O
Fig. O O
5 O O
-RRB- O O
. O O

A O O
recent O O
study O O
demonstrated O O
the O O
capacity O O
of O O
RA O O
SF O O
to O O
inhibit O O
pDC O O
differentiation O O
in O O
vitro O O
-LSB-39 O O
-RSB- O O
. O O

The O O
current O O
studies O O
are O O
consistent O O
, O O
in B-conn Restatement.Specification
that I-conn Restatement.Specification
SF O O
pDCs O O
showed O O
only O O
some O O
evidence O O
of O O
activation O O
in O O
situ O O
, O O
but B-conn Concession.Contra-expectation
once B-conn Circumstance.Forward Circumstance
incubated O O
in O O
mixed O O
lymphocyte O O
reactions O O
in O O
the O O
absence O O
of O O
SF O O
they O O
displayed O O
enhanced O O
APC O O
function O O
relative O O
to O O
that O O
of O O
PB O O
pDCs O O
. O O

Whereas B-conn Contrast
stimulation O O
of O O
mixed O O
lymphocyte O O
reactions O O
either O O
by O O
CD11c+ O O
or O O
by O O
CD123+ O O
PB O O
DCs O O
resulted O O
in O O
little O O
TNF-α O O
production O O
, O O
stimulation O O
by O O
either O O
of O O
these O O
DCs O O
from O O
RA O O
SF O O
resulted O O
in O O
high O O
levels O O
of O O
TNF-α O O
secretion O O
-LRB- O O
Fig. O O
5 O O
-RRB- O O
. O O

The O O
data O O
indicate O O
that O O
pDCs O O
have O O
the O O
capacity O O
for O O
enhanced O O
APC O O
function O O
relative O O
to O O
PB O O
pDCs O O
once B-conn Circumstance.Forward Circumstance
removed O O
from O O
the O O
RA O O
SF O O
environment O O
. O O

Furthermore B-conn Conjunction
, O O
at O O
the O O
time O O
of O O
antigen O O
presentation O O
by O O
SF O O
DCs O O
to O O
T O O
cells O O
, O O
production O O
of O O
a O O
number O O
of O O
cytokines O O
by O O
either O O
T O O
cells O O
or O O
DCs O O
may O O
be O O
stimulated O O
, O O
including O O
TNF-α O O
, O O
and B-conn Conjunction
this O O
appears O O
to O O
be O O
a O O
characteristic O O
of O O
RA O O
synovial O O
DCs O O
rather O O
than O O
the O O
subtype O O
of O O
stimulating O O
DCs O O
. O O

Discussion O O

Ongoing O O
inflammation O O
in O O
RA O O
involves O O
positive O O
feedback O O
loops O O
between O O
activated O O
T O O
cells O O
, O O
B O O
cells O O
, O O
DCs O O
, O O
macrophages O O
, O O
and O O
their O O
products O O
, O O
with O O
destructive O O
consequences O O
for O O
parenchymal O O
cells O O
. O O

Clinical O O
and O O
animal O O
data O O
indicate O O
that O O
effector-site O O
DCs O O
play O O
an O O
important O O
proinflammatory O O
role O O
in O O
the O O
perpetuation O O
of O O
autoimmune O O
disease O O
and O O
contribute O O
to O O
the O O
lymph-node-like O O
organization O O
of O O
that O O
tissue O O
-LSB-22,46 O O
-RSB- O O
. O O

This O O
role O O
may O O
be O O
effected O O
by O O
local O O
antigen O O
presentation O O
to O O
CD4+ O O
and O O
CD8+ O O
effector O O
cells O O
, O O
but B-conn Concession.Contra-expectation
DC O O
cytokine O O
and O O
chemokine O O
secretion O O
are O O
also O O
important O O
-LSB-47,48 O O
-RSB- O O
. O O

TNF-α O O
and O O
IL-1β O O
are O O
important O O
downstream O O
proinflammatory O O
and O O
destructive O O
cytokines O O
in O O
RA O O
for O O
somatic O O
cells O O
, O O
whose O O
release O O
is O O
promoted O O
by O O
activation O O
of O O
macrophages O O
. O O

IL-10 O O
is O O
highly O O
expressed O O
in O O
RA O O
, O O
and B-conn Conjunction
IFN-γ O O
is O O
an O O
important O O
T-cell O O
effector O O
cytokine O O
-LSB-49,50 O O
-RSB- O O
. O O

In O O
the O O
current O O
studies O O
, O O
we O O
show O O
that O O
, O O
in O O
addition O O
to O O
the O O
previously O O
described O O
population O O
of O O
nuclear O O
RelB+ O O
DCs O O
, O O
a O O
further O O
population O O
of O O
nuclear O O
RelB-CD123+ O O
pDCs O O
is O O
located O O
in O O
perivascular O O
regions O O
of O O
RA O O
but O O
not O O
normal O O
synovial O O
tissue O O
sublining O O
. O O

Moreover B-conn Conjunction
, O O
pDCs O O
were O O
located O O
within O O
blood O O
vessels O O
, O O
and B-conn Conjunction
both O O
DC O O
populations O O
were O O
observed O O
in O O
perivascular O O
areas O O
in O O
which O O
cells O O
producing O O
TNF-α O O
were O O
colocated O O
-LSB-35 O O
-RSB- O O
. O O

Adherence O O
of O O
CD123+ O O
and O O
CD11c+ O O
DCs O O
to O O
TNF-α-activated O O
endothelium O O
was O O
higher O O
than O O
to O O
resting O O
endothelium O O
in O O
vitro O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

TNF-α O O
plays O O
an O O
important O O
role O O
in O O
the O O
recruitment O O
of O O
other O O
leukocytes O O
to O O
RA O O
synovial O O
tissue O O
-LSB-29 O O
-RSB- O O
, O O
and B-conn Conjunction
this O O
most O O
likely O O
pertains O O
to O O
the O O
recruitment O O
of O O
pDCs O O
to O O
RA O O
but O O
not O O
normal O O
synovial O O
tissue O O
through B-conn Purpose.Enablement
expression O O
of O O
adhesion O O
molecules O O
such O O
as O O
intercellular O O
adhesion O O
molecule O O
-LRB- O O
ICAM O O
-RRB- O O
-1 O O
, O O
CD62-E O O
, O O
and O O
CD62-P O O
and O O
interaction O O
with O O
their O O
ligands O O
on O O
pDCs O O
-LSB-9,11,51-54 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
TNF-α O O
up-regulates O O
synthesis O O
of O O
chemokines O O
by O O
endothelial O O
cells O O
-LSB-55 O O
-RSB- O O
. O O

During B-conn Temporal.Synchronous
experimentally O O
elicited O O
allergic O O
rhinitis O O
, O O
CD123+HLA-DR+ O O
pDCs O O
have O O
been O O
shown O O
to O O
be O O
recruited O O
to O O
human O O
nasal O O
mucosa O O
-LSB-11 O O
-RSB- O O
. O O

The O O
gene O O
for O O
MxA O O
is O O
specifically O O
induced O O
by O O
IFN-α O O
and O O
therefore B-conn Cause.Result
identifies O O
a O O
population O O
of O O
activated O O
pDCs O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
BDCA2 O O
is O O
a O O
marker O O
of O O
immature O O
pDCs O O
. O O

MxA+ O O
pDCs O O
have O O
previously O O
been O O
demonstrated O O
in O O
involved O O
lupus O O
skin O O
and O O
inflamed O O
tonsil O O
-LSB-13 O O
-RSB- O O
. O O

In O O
RA O O
synovial O O
tissue O O
, O O
BDCA2 O O
was O O
shown O O
to O O
stain O O
fewer O O
cells O O
than O O
CD123 O O
or O O
MxA O O
, O O
suggesting O O
differentiation O O
in O O
situ O O
of O O
a O O
large O O
proportion O O
of O O
pDCs O O
into O O
cells O O
with O O
a O O
capacity O O
for O O
production O O
of O O
IFN-α O O
and O O
other O O
cytokines O O
. O O

Together O O
, O O
the O O
current O O
and O O
previous O O
studies O O
demonstrate O O
recruitment O O
of O O
pDCs O O
to O O
normal O O
lymphoid O O
organs O O
as O O
well O O
as O O
inflammatory O O
sites O O
, O O
with O O
local O O
differentiation O O
, O O
but O O
no O O
recruitment O O
to O O
normal O O
peripheral O O
tissues O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
CD11c+ O O
myeloid O O
precursors O O
populate O O
normal O O
resting O O
tissues O O
, O O
as O O
shown O O
here O O
, O O
but B-conn Concession.Contra-expectation
additional O O
CD11c+ O O
myeloid O O
cellular O O
recruitment O O
takes O O
place O O
at O O
inflammatory O O
sites O O
, O O
where O O
RelB O O
nuclear O O
translocation O O
takes O O
place O O
-LSB-21,56 O O
-RSB- O O
. O O

We O O
have O O
previously O O
shown O O
that O O
, O O
like O O
synovial O O
pDCs O O
, O O
CD123+ O O
DCs O O
in O O
the O O
T-cell O O
area O O
of O O
human O O
tonsil O O
are O O
also O O
nuclear O O
RelB- O O
-LSB-23 O O
-RSB- O O
. O O

The O O
data O O
suggest O O
either B-conn Alternative.Disjunctive
that O O
activation O O
of O O
pDCs O O
is O O
not O O
associated O O
with O O
nuclear O O
translocation O O
and O O
transcriptional O O
activity O O
of O O
RelB O O
or B-conn Alternative.Disjunctive
that O O
conditions O O
in O O
tonsil O O
and O O
synovium O O
do O O
not O O
induce O O
sufficient O O
RelB O O
translocation O O
for O O
detection O O
by O O
immunohistochemistry O O
-LSB-26,57 O O
-RSB- O O
. O O

As B-conn Cause.Justification
preliminary O O
studies O O
in O O
vitro O O
demonstrate O O
induction O O
of O O
RelB O O
in O O
PB O O
pDCs O O
after B-conn Temporal.Succession
stimulation O O
with O O
lipopolysaccharide O O
and O O
CpG O O
, O O
and O O
reduced O O
production O O
of O O
IFN-α O O
by O O
pDCs O O
in O O
RelB-deficient O O
mice O O
, O O
it O O
is O O
likely O O
that O O
RelB O O
activation O O
does O O
accompany O O
pDC O O
activation O O
. O O

However B-conn Concession.Contra-expectation
, O O
RelB O O
translocation O O
might O O
be O O
quantitatively O O
reduced O O
or B-conn Alternative.Disjunctive
RelB O O
might O O
be O O
more O O
rapidly O O
degraded O O
in O O
the O O
nucleus O O
of O O
pDCs O O
than O O
of O O
myeloid O O
DCs O O
in O O
inflamed O O
tissues O O
-LSB-58 O O
-RSB- O O
. O O

Of O O
relevance O O
to O O
the O O
RA O O
inflammatory O O
lesion O O
, O O
stimulation O O
of O O
blood O O
pDC O O
precursors O O
with O O
signals O O
including O O
CD154 O O
, O O
influenza O O
virus O O
, O O
or O O
CpG O O
oligonucleotides O O
induces O O
production O O
of O O
large O O
amounts O O
of O O
cytokines O O
, O O
including O O
IFN-α O O
, O O
IFN-β O O
, O O
and O O
TNF-α O O
; O O
induction O O
of O O
DC O O
differentiation O O
; O O
and O O
stimulation O O
of O O
APC O O
function O O
-LSB-3,39,44,59 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
inhibitory O O
effects O O
of O O
SF O O
on O O
DC O O
function O O
, O O
and O O
thus B-conn Cause.Result
on O O
T-cell O O
proliferation O O
and O O
cytokine O O
production O O
, O O
are O O
confirmed O O
here O O
-LSB-21,39,60 O O
-RSB- O O
, O O
factors O O
in O O
the O O
RA O O
SF O O
environment O O
, O O
such O O
as O O
IL-3 O O
and O O
CD154 O O
, O O
may O O
be O O
sufficient O O
to O O
precondition O O
the O O
SF O O
pDCs O O
for O O
efficient O O
APC O O
function O O
ex O O
vivo O O
-LSB-36,44 O O
-RSB- O O
. O O

IFN-γ O O
, O O
IL-10 O O
, O O
and O O
TNF-α O O
were O O
produced O O
in O O
mixed O O
lymphocyte O O
reactions O O
stimulated O O
by O O
myeloid O O
or O O
pDCs O O
derived O O
from O O
SF O O
but O O
not O O
PB O O
, O O
potentially O O
by O O
DCs O O
or O O
by O O
T O O
cells O O
or O O
both O O
. O O

In O O
the O O
tissue O O
, O O
as B-conn Cause.Reason
a I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
antigen O O
presentation O O
by O O
myeloid O O
DCs O O
or O O
pDCs O O
, O O
key O O
effector O O
cytokines O O
may O O
be O O
produced O O
in O O
perivascular O O
areas O O
in O O
RA O O
, O O
located O O
strategically O O
close O O
to O O
endothelial O O
cells O O
, O O
as O O
well O O
as O O
incoming O O
leukocytes O O
. O O

It O O
is O O
not O O
known O O
whether O O
pDCs O O
are O O
capable O O
, O O
like O O
myeloid O O
DCs O O
, O O
of O O
migration O O
from O O
synovial O O
tissue O O
to O O
draining O O
lymph O O
nodes O O
. O O

However B-conn Concession.Contra-expectation
, O O
it O O
seems O O
probable O O
that O O
pDCs O O
conditioned O O
by O O
local O O
IL-3 O O
and O O
CD154 O O
, O O
or O O
even O O
viral O O
or O O
bacterial O O
products O O
transported O O
to O O
the O O
synovium O O
, O O
predominantly O O
play O O
local O O
proinflammatory O O
and O O
antigen-presenting O O
roles O O
, O O
through B-conn Purpose.Enablement
secretion O O
of O O
cytokines O O
such O O
as O O
IFN-α O O
and O O
possibly O O
TNF-α O O
-LSB-61,62 O O
-RSB- O O
. O O

Conclusion O O

pDCs O O
are O O
recruited O O
to O O
RA O O
synovial O O
tissue O O
and O O
comprise O O
an O O
APC O O
population O O
distinct O O
from O O
the O O
previously O O
described O O
nuclear O O
RelB+ O O
synovial O O
DCs O O
. O O

The O O
APC O O
function O O
of O O
pDCs O O
is O O
greater O O
in O O
SF O O
than O O
in O O
PB O O
. O O

Activated O O
pDCs O O
and O O
interacting O O
T O O
cells O O
may O O
contribute O O
significantly O O
to O O
the O O
inflammatory O O
environment O O
in O O
RA O O
. O O

Abbreviations O O

APC O O
= O O
antigen-presenting O O
cell O O
; O O
DC O O
= O O
dendritic O O
cell O O
; O O
ELISA O O
= O O
enzyme-linked O O
immunosorbent O O
assay O O
; O O
FCS O O
= O O
fetal O O
calf O O
serum O O
; O O
FITC O O
= O O
fluorescein O O
isothiocyanate O O
; O O
IFN O O
= O O
interferon O O
; O O
IL O O
= O O
interleukin O O
; O O
NK O O
= O O
natural O O
killer O O
; O O
PB O O
= O O
peripheral O O
blood O O
; O O
pDC O O
= O O
plasmacytoid O O
DC O O
; O O
PE O O
= O O
phycoerythrin O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
SF O O
= O O
synovial O O
fluid O O
; O O
TNF O O
= O O
tumor O O
necrosis O O
factor O O
. O O

Competing O O
interests O O

The O O
author O O
-LRB- O O
s O O
-RRB- O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Authors O O
' O O
contributions O O

LC O O
, O O
RT O O
, O O
LF O O
, O O
and O O
PP O O
conceived O O
the O O
experiments O O
and B-conn Conjunction
LC O O
, O O
AB O O
, O O
LS O O
, O O
JP O O
, O O
and O O
LF O O
carried O O
them O O
out O O
. O O

LC O O
, O O
RT O O
, O O
and O O
LF O O
wrote O O
the O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Nuclear O O
RelB-CD123+ O O
plasmacytoid O O
dendritic O O
cells O O
-LRB- O O
pDCs O O
-RRB- O O
are O O
located O O
in O O
close O O
association O O
with O O
cells O O
expressing O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
in O O
lymphoid O O
aggregates O O
of O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
synovial O O
tissue O O
. O O

Sections O O
of O O
frozen O O
normal O O
human O O
synovial O O
tissue O O
-LRB- O O
a O O
, O O
b O O
, O O
e O O
-RRB- O O
or O O
synovial O O
tissue O O
from O O
a O O
patient O O
with O O
untreated O O
active O O
RA O O
-LRB- O O
c O O
, O O
f O O
, O O
g O O
-RRB- O O
or O O
formalin-fixed O O
sections O O
from O O
a O O
patient O O
with O O
active O O
RA O O
-LRB- O O
d O O
, O O
h O O
, O O
i O O
-RRB- O O
were O O
stained O O
with O O
anti-CD11c O O
-LRB- O O
brown O O
, O O
a O O
, O O
c O O
-RRB- O O
, O O
anti-CD123 O O
-LRB- O O
brown O O
, O O
b O O
, O O
d O O
-RRB- O O
, O O
or O O
anti-TNF-α O O
-LRB- O O
brown O O
, O O
g O O
-RRB- O O
using O O
an O O
immunoperoxidase O O
technique O O
. O O

For B-conn Purpose.Goal
double O O
staining O O
, O O
sections O O
were O O
stained O O
with O O
Ulex O O
-LRB- O O
red O O
-RRB- O O
and O O
anti-CD123 O O
-LRB- O O
brown O O
, O O
e O O
, O O
f O O
, O O
g O O
-RRB- O O
or O O
with O O
RelB O O
-LRB- O O
purple O O
-RRB- O O
and O O
CD123 O O
-LRB- O O
brown O O
, O O
h O O
, O O
i O O
-RRB- O O
using O O
a O O
double O O
, O O
immunoperoxidase–immunoalkaline O O
phosphatase O O
technique O O
. O O

All O O
sections O O
were O O
counterstained O O
with O O
hematoxylin O O
-LRB- O O
blue O O
-RRB- O O
except O O
h O O
and O O
i O O
, O O
in O O
which O O
the O O
nucleus O O
of O O
CD123+ O O
cells O O
appears O O
as O O
a O O
hole O O
. O O

The O O
thick O O
arrow O O
in O O
d O O
identifies O O
a O O
blood O O
vessel O O
. O O

Thin O O
arrows O O
denote O O
representative O O
CD123+ O O
perivascular O O
DCs O O
-LRB- O O
d O O
-RRB- O O
, O O
representative O O
double-stained O O
vessels O O
-LRB- O O
e O O
-RRB- O O
, O O
a O O
CD123+ O O
cell O O
within O O
a O O
blood O O
vessel O O
-LRB- O O
f O O
-RRB- O O
, O O
and O O
nuclei O O
stained O O
by O O
RelB O O
-LRB- O O
h O O
-RRB- O O
. O O

Data O O
are O O
representative O O
of O O
at O O
least O O
three O O
separate O O
RA O O
donors O O
in O O
individual O O
experiments O O
. O O

Scale O O
bars O O
represent O O
20 O O
μm O O
. O O

Figure O O
2 O O
: O O
CD123+ O O
dendritic O O
cells O O
-LRB- O O
DCs O O
-RRB- O O
and O O
CD11c+ O O
cells O O
are O O
enriched O O
in O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
synovial O O
tissue O O
-LRB- O O
ST O O
-RRB- O O
. O O

CD123+ O O
DCs O O
were O O
quantitated O O
by B-conn Purpose.Enablement
counting O O
the O O
number O O
of O O
CD123+Ulex- O O
cells O O
in O O
sections O O
double-stained O O
with O O
CD123 O O
and O O
Ulex O O
. O O

Cells O O
were O O
counted O O
in O O
each O O
of O O
the O O
entire O O
sections O O
from O O
three O O
patients O O
and O O
three O O
normal O O
controls O O
at O O
high O O
power O O
, O O
and B-conn Conjunction
for O O
each O O
biopsy O O
this O O
number O O
was O O
corrected O O
for O O
the O O
area O O
of O O
the O O
section O O
to O O
obtain O O
the O O
number/mm2 O O
. O O

To B-conn Purpose.Goal
quantitate O O
CD11c+ O O
cellular O O
infiltration O O
, O O
the O O
number O O
of O O
CD11c+ O O
cells O O
was O O
counted O O
in O O
three O O
high-power O O
fields O O
of O O
the O O
synovial O O
sublining O O
in O O
sections O O
from O O
three O O
patients O O
and O O
three O O
normal O O
controls O O
. O O

Data O O
represent O O
means O O
± O O
standard O O
error O O
of O O
the O O
mean O O
. O O

Figure O O
3 O O
: O O
CD11c+ O O
dendritic O O
cells O O
-LRB- O O
DCs O O
-RRB- O O
and O O
CD123+ O O
DCs O O
are O O
present O O
in O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
synovial O O
fluid O O
-LRB- O O
SF O O
-RRB- O O
. O O

After B-conn Temporal.Succession
purification O O
of O O
mononuclear O O
cells O O
from O O
either O O
normal O O
or O O
RA O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
or O O
RA O O
SF O O
, O O
cells O O
were O O
stained O O
with O O
CD123-PE O O
, O O
CD11c O O
FITC O O
, O O
CD14-PECy5 O O
, O O
and O O
HLA-DR-APC O O
. O O

Live O O
HLA-DR+CD14- O O
mononuclear O O
cells O O
were O O
gated O O
; O O
polymorphonuclear O O
cells O O
were O O
excluded O O
on O O
the O O
basis O O
of O O
forward O O
and O O
side O O
light-scatter O O
. O O

Scatter O O
plots O O
depict O O
percentage O O
of O O
total O O
PB O O
or O O
SF O O
cells O O
expressing O O
the O O
indicated O O
markers O O
for O O
all O O
donors O O
. O O

APC O O
, O O
antigen-presenting O O
cell O O
; O O
PBMC O O
, O O
peripheral O O
blood O O
mononuclear O O
cells O O
; O O
PE O O
, O O
phycoerythrin O O
; O O
SFMC O O
, O O
synovial O O
fluid O O
mononuclear O O
cells O O
. O O

Figure O O
4 O O
: O O
Morphology O O
and O O
cell-surface O O
phenotype O O
of O O
dendritic O O
cell O O
-LRB- O O
DC O O
-RRB- O O
subpopulations O O
. O O

-LRB- O O
a O O
-RRB- O O
Freshly O O
isolated O O
CD11c+CD123- O O
DCs O O
and O O
CD123+CD11c- O O
DCs O O
were O O
sorted O O
from O O
either O O
normal O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
or O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
synovial O O
fluid O O
-LRB- O O
SF O O
-RRB- O O
according O O
to O O
the O O
gating O O
strategy O O
outlined O O
in O O
the O O
legend O O
to O O
Fig. O O
3 O O
and O O
were O O
then B-conn Temporal.Precedence
prepared O O
for O O
transmission O O
electron O O
microscopy O O
. O O

Micrographs O O
are O O
representative O O
of O O
three O O
separate O O
donors O O
. O O

Scale O O
bars O O
represent O O
20 O O
μm O O
. O O

-LRB- O O
b O O
-RRB- O O
Normal O O
PB O O
or O O
RA O O
SF O O
mononuclear O O
cells O O
were O O
stained O O
with O O
CD123-PE O O
, O O
CD14-PECy5 O O
, O O
HLA-DR-APC O O
, O O
and B-conn Conjunction
either O O
isotype O O
control O O
or O O
the O O
depicted O O
marker O O
labelled O O
with O O
FITC O O
. O O

Live O O
HLA-DR+CD14-CD123+ O O
cells O O
or O O
HLA-DR+CD14-CD11c+ O O
cells O O
were O O
gated O O
; O O
polymorphonuclear O O
cells O O
were O O
excluded O O
on O O
the O O
basis O O
of O O
forward O O
and O O
side O O
light-scatter O O
. O O

The O O
expression O O
of O O
isotype O O
control O O
-LRB- O O
dotted O O
lines O O
-RRB- O O
and O O
indicated O O
markers O O
-LRB- O O
continuous O O
lines O O
-RRB- O O
by O O
the O O
gated O O
cells O O
are O O
depicted O O
. O O

Data O O
are O O
from O O
three O O
donors O O
of O O
normal O O
PB O O
or O O
RA O O
SF O O
. O O

APC O O
, O O
antigen-presenting O O
cell O O
; O O
PE O O
, O O
phycoerythrin O O
. O O

Figure O O
5 O O
: O O
CD123+ O O
and O O
CD11c+ O O
synovial O O
fluid O O
-LRB- O O
SF O O
-RRB- O O
dendritic O O
cells O O
-LRB- O O
DCs O O
-RRB- O O
are O O
efficient O O
antigen-presenting O O
cells O O
-LRB- O O
APCs O O
-RRB- O O
and O O
induce O O
secretion O O
of O O
tumor O O
necrosis O O
factor O O
α. O O
Freshly O O
sorted O O
CD123+CD11c- O O
or O O
CD11c+CD123- O O
DCs O O
from O O
either O O
normal O O
peripheral O O
blood O O
-LRB- O O
PB O O
-RRB- O O
-LRB- O O
a–d O O
-RRB- O O
or O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
SF O O
-LRB- O O
e–h O O
-RRB- O O
were O O
incubated O O
with O O
105 O O
purified O O
normal O O
allogeneic O O
T O O
cells O O
. O O

T-cell O O
proliferation O O
was O O
measured O O
by O O
-LSB-3H O O
-RSB- O O
thymidine O O
incorporation O O
of O O
triplicate O O
wells O O
after O O
60 O O
hours O O
-LRB- O O
a O O
, O O
e O O
-RRB- O O
. O O

Unstimulated O O
T-cell O O
proliferation O O
was O O
routinely O O
<500 O O
cpm O O
. O O

Data O O
represent O O
means O O
± O O
standard O O
error O O
of O O
the O O
mean O O
of O O
triplicate O O
wells O O
and O O
are O O
from O O
three O O
individual O O
PB O O
and O O
SF O O
donors O O
. O O

The O O
concentrations O O
of O O
IFNγ O O
, O O
IL-10 O O
, O O
and O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
were O O
measured O O
in O O
supernatants O O
of O O
allogeneic O O
mixed O O
lymphocyte O O
reactions O O
stimulated O O
by O O
sorted O O
PB O O
-LRB- O O
b–d O O
-RRB- O O
or O O
SF O O
DCs O O
-LRB- O O
f–h O O
-RRB- O O
. O O

Data O O
are O O
means O O
of O O
duplicate O O
samples O O
and O O
are O O
from O O
two O O
separate O O
SF O O
donors O O
. O O

Transforming O O
growth O O
factor-β-induced O O
regulatory O O
T O O
cells O O
referee O O
inflammatory O O
and O O
autoimmune O O
diseases O O

Abstract O O

Naturally O O
occurring O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
mediate O O
immune O O
suppression O O
to B-conn Purpose.Goal
limit O O
immunopathogenesis O O
associated O O
with O O
chronic O O
inflammation O O
, O O
persistent O O
infections O O
and O O
autoimmune O O
diseases O O
. O O

Their O O
mode O O
of O O
suppression O O
is O O
contact-dependent O O
, O O
antigen-nonspecific O O
and O O
involves O O
a O O
nonredundant O O
contribution O O
from O O
the O O
cytokine O O
transforming O O
growth O O
factor O O
-LRB- O O
TGF O O
-RRB- O O
-β O O
. O O

Not B-conn Conjunction
only I-conn Conjunction
can O O
TGF-β O O
mediate O O
cell–cell O O
suppression O O
between O O
the O O
regulatory O O
T O O
cells O O
and O O
CD4+CD25- O O
or O O
CD8+ O O
T O O
cells O O
, O O
but B-conn Conjunction
new O O
evidence O O
also B-conn Conjunction
reveals O O
its O O
role O O
in O O
the O O
conversion O O
of O O
CD4+CD25- O O
T O O
cells O O
, O O
together O O
with O O
TCR O O
antigen O O
stimulation O O
, O O
into O O
the O O
regulatory O O
phenotype O O
. O O

Elemental O O
to O O
this O O
conversion O O
process O O
is O O
induction O O
of O O
expression O O
of O O
the O O
forkhead O O
transcription O O
factor O O
, O O
Foxp3 O O
. O O

This O O
context-dependent O O
coercion O O
of O O
naive O O
CD4+ O O
T O O
cells O O
into O O
a O O
powerful O O
subset O O
of O O
regulatory O O
cells O O
provides O O
a O O
window O O
into O O
potential O O
manipulation O O
of O O
these O O
cells O O
to B-conn Purpose.Goal
orchestrate O O
therapeutic O O
intervention O O
in O O
diseases O O
characterized O O
by O O
inadequate O O
suppression O O
, O O
as O O
well O O
as O O
a O O
promising O O
means O O
of O O
controlling O O
pathologic O O
situations O O
in O O
which O O
excessive O O
suppression O O
dominates O O
. O O

Introduction O O

Autoimmune O O
diseases O O
are O O
characterized O O
by O O
a O O
loss O O
of O O
regulation O O
of O O
T O O
cell O O
growth O O
and O O
activation O O
, O O
with O O
resultant O O
overexuberant O O
inflammation O O
and O O
tissue O O
destruction O O
. O O

Although B-conn Contrast
T O O
cell O O
responses O O
to O O
foreign O O
antigens O O
are O O
essential O O
to O O
our O O
protection O O
from O O
a O O
plethora O O
of O O
potentially O O
pathogenic O O
agents O O
and O O
microbes O O
, O O
T O O
cell O O
responses O O
to O O
self O O
antigens O O
can O O
be O O
overtly O O
deleterious O O
. O O

As B-conn Temporal.Synchronous
the O O
signaling O O
pathways O O
associated O O
with O O
T O O
cell O O
activation O O
continue O O
to O O
be O O
illuminated O O
, O O
there O O
is O O
also B-conn Conjunction
an O O
emerging O O
excitement O O
about O O
naturally O O
occurring O O
opposing O O
forces O O
that O O
can O O
exert O O
control O O
over O O
antigen-activated O O
T O O
cells O O
to B-conn Purpose.Goal
prevent O O
reactivity O O
to O O
self O O
. O O

Suppressor O O
T O O
cells O O
, O O
implicated O O
in O O
this O O
regulatory O O
process O O
decades O O
ago O O
, O O
fell O O
into O O
ill O O
repute O O
but O O
have O O
recently O O
re-emerged O O
not O O
only O O
as O O
a O O
real O O
population O O
but O O
as O O
a O O
population O O
crucial O O
to O O
immune O O
homeostasis O O
, O O
maintenance O O
of O O
tolerance O O
, O O
and O O
prevention O O
of O O
the O O
onset O O
of O O
autoimmune O O
disease O O
. O O

Their O O
existence O O
is O O
no O O
longer O O
in O O
question O O
, O O
but B-conn Concession.Contra-expectation
true O O
to O O
their O O
history O O
these O O
cells O O
, O O
their O O
origin O O
, O O
generation O O
, O O
and O O
mechanisms O O
of O O
action O O
have O O
generated O O
considerable O O
controversy O O
. O O

Recognition O O
of O O
the O O
potential O O
impact O O
of O O
these O O
cells O O
in O O
clinical O O
cellular O O
therapy O O
has O O
driven O O
a O O
rapid O O
expansion O O
of O O
the O O
field O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
understand O O
and O O
manipulate O O
the O O
regulatory O O
T O O
cell O O
population O O
to B-conn Purpose.Goal
devise O O
strategies O O
to O O
control O O
autoimmunity O O
, O O
transplantation O O
tolerance O O
, O O
tumor O O
immunity O O
, O O
allergy O O
and O O
infectious O O
diseases O O
, O O
particularly O O
HIV O O
. O O

One O O
of O O
the O O
most O O
intensely O O
studied O O
of O O
the O O
heterogeneous O O
family O O
of O O
regulatory O O
T O O
cells O O
is O O
a O O
population O O
of O O
CD4+ O O
T O O
cells O O
constitutively O O
expressing O O
CD25 O O
-LRB- O O
IL-2Rα O O
-RRB- O O
, O O
found O O
in O O
thymus O O
and O O
in O O
peripheral O O
lymphoid O O
organs O O
, O O
and O O
comprising O O
5 O O
to O O
10 O O
% O O
of O O
the O O
total O O
CD4+ O O
T O O
cells O O
in O O
mice O O
and O O
humans O O
-LSB-1-5 O O
-RSB- O O
. O O

On O O
the O O
basis O O
of O O
their O O
unique O O
functional O O
properties O O
, O O
this O O
small O O
but O O
powerful O O
population O O
of O O
T O O
cells O O
has O O
been O O
dubbed O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
-LRB- O O
Treg O O
-RRB- O O
. O O

In O O
contrast O O
to O O
CD4+CD25- O O
T O O
cells O O
, O O
freshly O O
isolated O O
CD4+CD25+ O O
Treg O O
are O O
anergic O O
to O O
TCR O O
stimulation O O
in O O
vitro O O
. O O

However B-conn Concession.Contra-expectation
, O O
once B-conn Temporal.Synchronous
activated O O
, O O
these O O
Treg O O
are O O
robust O O
suppressors O O
and O O
can O O
mediate O O
the O O
inhibition O O
of O O
CD4+CD25- O O
responder O O
T O O
cells O O
by B-conn Purpose.Enablement
means I-conn Purpose.Enablement
of I-conn Purpose.Enablement
a O O
cell-contact-dependent O O
mechanism O O
involving O O
transforming O O
growth O O
factor O O
-LRB- O O
TGF O O
-RRB- O O
-β O O
-LSB-6-9 O O
-RSB- O O
-LRB- O O
Fig. O O
1 O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
the O O
role O O
of O O
TGF-β O O
has O O
not O O
yet O O
been O O
universally O O
accepted O O
-LSB-10,11 O O
-RSB- O O
, O O
the O O
preponderance O O
of O O
evidence O O
has O O
solidified O O
a O O
contribution O O
from O O
TGF-β O O
in O O
the O O
regulatory O O
process O O
-LSB-6-8,12-15 O O
-RSB- O O
. O O

The O O
essentiality O O
of O O
this O O
endogenous O O
population O O
in O O
protecting O O
the O O
host O O
from O O
disproportionate O O
T O O
cell O O
activation O O
and O O
autoreactive O O
effector O O
cells O O
is O O
underscored O O
both O O
in O O
experimental O O
models O O
and O O
in O O
humans O O
in O O
which O O
the O O
numbers O O
and/or O O
function O O
of O O
Treg O O
are O O
compromised O O
-LSB-6,10,16-20 O O
-RSB- O O
. O O

In O O
mice O O
, O O
depletion O O
of O O
CD4+CD25+ O O
T O O
cells O O
by O O
neonatal O O
-LRB- O O
day O O
3 O O
-RRB- O O
thymectomy O O
leads O O
to O O
spontaneous O O
development O O
of O O
organ-specific O O
autoimmune O O
diseases O O
, O O
including O O
autoimmune O O
thyroiditis O O
, O O
gastritis O O
, O O
and O O
wasting O O
-LSB-19 O O
-RSB- O O
, O O
which O O
can O O
be O O
reversed O O
by B-conn Purpose.Enablement
adoptive O O
transfer O O
of O O
Treg O O
-LSB-21 O O
-RSB- O O
. O O

Treg O O
are O O
pivotal O O
in O O
the O O
protection O O
of O O
lymphopenic O O
mice O O
from O O
induced O O
inflammatory O O
bowel O O
disease O O
, O O
experimental O O
autoimmune O O
encephalomyelitis O O
, O O
diabetes O O
, O O
and O O
allergy O O
-LSB-16,18,22 O O
-RSB- O O
. O O

In O O
infectious O O
models O O
, O O
Treg O O
also B-conn Conjunction
influence O O
the O O
effector O O
immune O O
response O O
, O O
as O O
is O O
evident O O
in O O
Leishmania O O
major O O
infection O O
-LSB-20 O O
-RSB- O O
. O O

Both O O
innate O O
and O O
adaptive O O
immune O O
responses O O
are O O
subject O O
to O O
Treg O O
control O O
. O O

Triggering O O
of O O
dendritic O O
cells O O
by O O
Toll-like O O
receptor O O
ligands O O
expressed O O
by O O
invading O O
pathogens O O
leads O O
to O O
the O O
production O O
of O O
soluble O O
factors O O
, O O
including O O
IL-6 O O
, O O
that O O
may O O
render O O
effector O O
cells O O
refractory O O
to O O
regulatory O O
activity O O
-LSB-23 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
activated O O
dendritic O O
cells O O
produce O O
TGF-β O O
, O O
which O O
may O O
further O O
influence O O
the O O
development O O
of O O
Treg O O
-LSB-24 O O
-RSB- O O
. O O

By O O
such O O
intersecting O O
pathways O O
, O O
the O O
innate O O
and O O
regulatory O O
arms O O
of O O
the O O
immune O O
system O O
have O O
the O O
capacity O O
to O O
exert O O
sufficient O O
control O O
over O O
each O O
other O O
to B-conn Purpose.Goal
enable O O
effector O O
cells O O
to O O
mount O O
efficient O O
immune O O
responses O O
with O O
minimal O O
pathology O O
. O O

In O O
human O O
infectious O O
, O O
neoplastic O O
, O O
and O O
autoimmune O O
diseases O O
, O O
Treg O O
activities O O
often O O
mirror O O
those O O
in O O
murine O O
systems O O
. O O

Numbers O O
of O O
Treg O O
are O O
reportedly O O
reduced O O
in O O
human O O
autoimmune O O
diseases O O
-LSB-17,25 O O
-RSB- O O
, O O
although B-conn Concession.Contra-expectation
their O O
significance O O
in O O
the O O
evolution O O
of O O
immunopathogenesis O O
remains O O
an O O
area O O
of O O
continued O O
exploration O O
. O O

Moreover B-conn Conjunction
, O O
increased O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
have O O
been O O
reported O O
in O O
HIV-1 O O
immunodeficiency O O
-LSB-26 O O
-RSB- O O
, O O
and B-conn Conjunction
in O O
lung O O
cancer O O
patients O O
the O O
increased O O
numbers O O
of O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
directly O O
inhibit O O
autologous O O
T O O
cell O O
proliferation O O
-LSB-27 O O
-RSB- O O
. O O

Thus B-conn Cause.Claim
, O O
this O O
unique O O
and O O
persuasive O O
population O O
of O O
regulatory O O
T O O
cells O O
has O O
a O O
crucial O O
role O O
in O O
the O O
maintenance O O
of O O
tolerance O O
and O O
immune O O
homeostasis O O
through O O
immune O O
suppression O O
. O O

Mechanism O O
of O O
Treg O O
suppression O O

Treg O O
are O O
both O O
anergic O O
, O O
at O O
least O O
in O O
vitro O O
, O O
and O O
immunosuppressive O O
. O O

The O O
absence O O
of O O
Treg O O
results O O
in O O
the O O
breakdown O O
of O O
tolerance O O
and O O
the O O
development O O
of O O
autoimmune O O
diseases O O
-LSB-28 O O
-RSB- O O
. O O

Our O O
understanding O O
of O O
the O O
functional O O
domain O O
of O O
these O O
cells O O
has O O
rapidly O O
advanced O O
through O O
cell O O
culture O O
experiments O O
. O O

In O O
vitro O O
, O O
the O O
ability O O
of O O
CD4+CD25+ O O
Treg O O
to O O
suppress O O
responder O O
T O O
cell O O
proliferation O O
and O O
cytokine O O
production O O
requires O O
their O O
activation O O
, O O
is O O
dependent O O
on O O
cell O O
contact O O
, O O
and O O
is O O
antigen O O
nonspecific O O
-LSB-1,6,10 O O
-RSB- O O
. O O

After B-conn Temporal.Succession
years O O
of O O
searching O O
for O O
the O O
elusive O O
mediator O O
-LRB- O O
s O O
-RRB- O O
of O O
suppression O O
consistent O O
with O O
the O O
accepted O O
cell-contact-dependent O O
mechanism O O
, O O
membrane-associated O O
TGF-β O O
was O O
identified O O
as O O
a O O
pivotal O O
perpetrator O O
-LSB-6,7,14 O O
-RSB- O O
. O O

In O O
this O O
regard O O
, O O
latent O O
TGF-β O O
was O O
first O O
reported O O
to O O
be O O
constitutively O O
present O O
on O O
the O O
surface O O
of O O
Treg O O
-LSB-6,7 O O
-RSB- O O
; O O
subsequently B-conn Temporal.Precedence
, O O
active O O
TGF-β O O
was O O
identified O O
-LSB-6,8,14 O O
-RSB- O O
. O O

In O O
vitro O O
stimulation O O
with O O
anti-CD3 O O
and O O
antigen-presenting O O
cells O O
-LRB- O O
APCs O O
-RRB- O O
enhances O O
membrane-bound O O
active O O
TGF-β O O
, O O
which O O
is O O
consistent O O
with O O
the O O
requirement O O
that O O
Treg O O
activation O O
promotes O O
their O O
suppressive O O
potential O O
-LSB-6,13 O O
-RSB- O O
-LRB- O O
W O O
Chen O O
, O O
unpublished O O
data O O
-RRB- O O
. O O

Blockade O O
of O O
cell-surface O O
TGF-β O O
with O O
neutralizing O O
antibodies O O
, O O
with O O
soluble O O
TGF-β O O
receptor O O
, O O
or O O
with O O
recombinant O O
latency-associated O O
peptide O O
disrupts O O
the O O
ability O O
of O O
these O O
cells O O
to O O
block O O
responder O O
T O O
cell O O
proliferation O O
, O O
confirming O O
TGF-β O O
as O O
an O O
instrument O O
of O O
suppression O O
-LSB-6-8,12,13,15,29 O O
-RSB- O O
. O O

Still O O
missing O O
was O O
the O O
connecting O O
link O O
by O O
which O O
membrane-bound O O
TGF-β O O
could O O
interact O O
with O O
the O O
CD4+CD25- O O
responder O O
cells O O
. O O

Recently O O
, O O
TGF-β O O
receptor O O
type O O
II O O
-LRB- O O
TβRII O O
-RRB- O O
was O O
detected O O
at O O
elevated O O
levels O O
on O O
responder O O
T O O
cells O O
once B-conn Temporal.Synchronous
they O O
were O O
activated O O
through O O
their O O
TCR O O
, O O
thereby B-conn Cause.Result
providing O O
the O O
molecular O O
bridge O O
by O O
which O O
TGF-β O O
on O O
the O O
Treg O O
orchestrates O O
suppression O O
of O O
the O O
responder O O
cells O O
-LSB-6,8,12 O O
-RSB- O O
. O O

TGF-β O O
signaling O O
and O O
regulation O O

TGF-β O O
is O O
a O O
potent O O
cytokine O O
and O O
growth O O
factor O O
whose O O
biological O O
activity O O
is O O
primarily O O
regulated O O
post-translationally O O
-LSB-30 O O
-RSB- O O
, O O
because B-conn Cause.Reason
it O O
is O O
transcribed O O
and O O
translated O O
as O O
a O O
small O O
latent O O
complex O O
composed O O
not O O
only O O
of O O
active O O
TGF-β O O
, O O
but O O
also O O
of O O
a O O
latency-associated O O
peptide O O
-LRB- O O
LAP O O
-RRB- O O
to O O
which O O
it O O
is O O
noncovalently O O
bound O O
and B-conn Conjunction
which O O
prevents O O
its O O
interaction O O
with O O
its O O
specific O O
receptors O O
on O O
the O O
target O O
cell O O
surface O O
. O O

This O O
small O O
latent O O
complex O O
can O O
be O O
associated O O
with O O
the O O
latent O O
TGF-β1-binding O O
protein O O
, O O
forming O O
a O O
large O O
latent O O
complex O O
thought O O
to O O
serve O O
as O O
a O O
tether O O
for O O
binding O O
proteins O O
and O O
matrix O O
molecules O O
-LSB-31 O O
-RSB- O O
. O O

In O O
this O O
configuration O O
, O O
TGF-β O O
is O O
not O O
active O O
but O O
requires O O
cleavage O O
or O O
dissociation O O
from O O
LAP O O
to B-conn Purpose.Goal
enable O O
its O O
interaction O O
with O O
its O O
cognate O O
receptor O O
complex O O
, O O
TβRII O O
and O O
TβRI O O
-LSB-32 O O
-RSB- O O
. O O

Activation O O
of O O
TGF-β O O
can O O
occur O O
by B-conn Purpose.Enablement
any O O
of O O
a O O
number O O
of O O
mechanisms O O
including O O
cleavage O O
with O O
plasmin O O
-LSB-33 O O
-RSB- O O
, O O
interaction O O
with O O
αvβ6 O O
-LSB-34 O O
-RSB- O O
, O O
or O O
through O O
an O O
ill-defined O O
interaction O O
of O O
LAP O O
with O O
thrombospondin O O
I O O
-LRB- O O
TSP-I O O
-RRB- O O
, O O
a O O
ligand O O
for O O
the O O
CD36 O O
receptor O O
-LSB-35 O O
-RSB- O O
. O O

Adding O O
credence O O
to O O
a O O
role O O
for O O
TSP-1 O O
, O O
the O O
TSP-1-null O O
mice O O
exhibit O O
persistent O O
inflammation O O
, O O
particularly O O
in O O
the O O
pancreas O O
and O O
lung O O
, O O
and O O
display O O
a O O
phenotype O O
with O O
similarities O O
to O O
TGF-β-null O O
mice O O
-LSB-36,37 O O
-RSB- O O
, O O
although B-conn Concession.Contra-expectation
to O O
a O O
lesser O O
extent O O
because B-conn Cause.Reason
alternative O O
mechanisms O O
of O O
TGF-β O O
activation O O
compensate O O
. O O

Nonetheless B-conn Concession.Contra-expectation
, O O
TSP-1 O O
is O O
a O O
major O O
activator O O
of O O
TGF-β1 O O
in O O
vivo O O
-LSB-36 O O
-RSB- O O
, O O
and B-conn Conjunction
a O O
TSP O O
peptide O O
that O O
activates O O
TGF-β O O
reverses O O
the O O
TSP-1-null O O
phenotype O O
by B-conn Purpose.Enablement
dampening O O
the O O
tissue O O
inflammation O O
. O O

In O O
a O O
feedback O O
loop O O
, O O
TGF-β O O
augments O O
TSP O O
secretion O O
by O O
dendritic O O
cells O O
and O O
macrophages O O
, O O
and B-conn Conjunction
TGF-β-treated O O
APCs O O
facilitate O O
the O O
generation O O
of O O
regulatory O O
T O O
cells O O
-LSB-38 O O
-RSB- O O
, O O
creating O O
an O O
environment O O
favorable O O
for O O
the O O
induction O O
of O O
suppression O O
and/or O O
tolerance O O
to B-conn Purpose.Goal
ensure O O
the O O
blunting O O
of O O
any O O
inflammatory O O
reaction O O
. O O

Often O O
seeming O O
paradoxical O O
, O O
activated O O
TGF-β O O
has O O
both O O
stimulatory O O
and O O
inhibitory O O
influences O O
on O O
T O O
cell O O
function O O
-LSB-6,8 O O
-RSB- O O
. O O

These O O
apparently O O
disparate O O
effects O O
are O O
dependent O O
on O O
context O O
, O O
including O O
state O O
of O O
differentiation O O
, O O
presence O O
of O O
other O O
growth O O
factors O O
or O O
cytokines O O
, O O
matrix O O
molecules O O
, O O
additional O O
proximal O O
cell O O
populations O O
, O O
and O O
membrane O O
receptor O O
levels O O
. O O

Beyond O O
its O O
involvement O O
in O O
contact-dependent O O
suppression O O
, O O
soluble O O
TGF-β O O
can O O
directly O O
inhibit O O
T O O
cell O O
proliferation O O
, O O
suppress O O
macrophage O O
activation O O
and O O
modulate O O
dendritic O O
cell O O
function O O
in O O
its O O
role O O
as O O
an O O
immunoregulatory O O
cytokine O O
. O O

Deletion O O
of O O
this O O
cytokine O O
is O O
associated O O
with O O
lethal O O
immune O O
dysregulation O O
and O O
multi-organ O O
inflammatory O O
disease O O
-LSB-39,40 O O
-RSB- O O
. O O

In O O
mediating O O
its O O
suppressive O O
effects O O
, O O
TGF-β O O
signals O O
through O O
the O O
type O O
I O O
and O O
type O O
II O O
TGF-β O O
serine–threonine O O
kinase O O
receptors O O
, O O
TβRI O O
and O O
TβRII O O
. O O

Interaction O O
of O O
the O O
TGF-β O O
ligand O O
with O O
these O O
receptors O O
on O O
target O O
cells O O
engages O O
a O O
signaling O O
cascade O O
precipitated O O
by O O
the O O
phosphorylation O O
of O O
cytosolic O O
proteins O O
identified O O
as O O
Smads O O
-LSB-41,42 O O
-RSB- O O
. O O

When B-conn Temporal.Synchronous
CD4+CD25+ O O
Treg O O
are O O
co-cultured O O
with O O
TCR-activated O O
CD4+CD25- O O
responder O O
T O O
cells O O
, O O
there O O
is O O
a O O
rapid O O
engagement O O
of O O
this O O
intracellular O O
signaling O O
pathway O O
that O O
is O O
consistent O O
with O O
TGF-β O O
as O O
the O O
link O O
between O O
these O O
two O O
cells O O
and O O
the O O
impending O O
functional O O
inhibition O O
manifested O O
in O O
the O O
responder O O
cell O O
population O O
-LSB-6,12,15 O O
-RSB- O O
. O O

In O O
this O O
regard O O
, O O
phosphorylation O O
of O O
Smads O O
, O O
initially O O
detected O O
with O O
antibodies O O
that O O
recognize O O
both O O
Smad2 O O
and O O
Smad3 O O
-LSB-6 O O
-RSB- O O
-LRB- O O
W O O
Chen O O
, O O
unpublished O O
data O O
-RRB- O O
, O O
and O O
more O O
recently O O
with O O
Smad2-specific O O
antibodies O O
-LSB-15 O O
-RSB- O O
, O O
occurred O O
within O O
minutes O O
after O O
exposure O O
of O O
responder O O
T O O
cells O O
to O O
Treg O O
. O O

Smad2 O O
and O O
Smad3 O O
serve O O
as O O
receptor-activated O O
Smad O O
signaling O O
intermediates O O
, O O
whereas B-conn Contrast
Smad4 O O
is O O
a O O
common O O
Smad O O
that O O
complexes O O
with O O
Smad2/3 O O
to B-conn Purpose.Goal
enable O O
translocation O O
to O O
the O O
nucleus O O
. O O

Once O O
within O O
the O O
nucleus O O
, O O
the O O
Smad O O
complex O O
may O O
interact O O
with O O
specific O O
DNA O O
sequences O O
and O O
with O O
multiple O O
specific O O
transcription O O
factors O O
, O O
in O O
addition O O
to O O
transcriptional O O
coactivators O O
and/or O O
co-repressors O O
, O O
culminating O O
in O O
the O O
transcription O O
of O O
target O O
genes O O
and O O
the O O
transduction O O
of O O
a O O
variety O O
of O O
signals O O
dependent O O
on O O
the O O
target O O
cell O O
-LSB-41 O O
-RSB- O O
. O O

Smad2/3 O O
are O O
anchored O O
to O O
the O O
plasma O O
membrane O O
through O O
the O O
Smad O O
anchor O O
for O O
receptor O O
activation O O
-LRB- O O
SARA O O
-RRB- O O
, O O
which O O
probably O O
increases O O
the O O
efficiency O O
of O O
activation O O
by O O
the O O
TGF-β-receptor O O
complexes O O
-LSB-43 O O
-RSB- O O
. O O

Smad2 O O
, O O
rather O O
than O O
Smad3 O O
, O O
may O O
be O O
the O O
critical O O
connector O O
in O O
the O O
intracellular O O
signaling O O
pathway O O
engaged O O
in O O
the O O
responder O O
cells O O
by O O
Treg O O
surface-bound O O
TGF-β O O
, O O
because B-conn Cause.Justification
mice O O
deficient O O
in O O
Smad3 O O
respond O O
to O O
Treg O O
suppression O O
and O O
also O O
to O O
exogenous O O
TGF-β O O
-LSB-6 O O
-RSB- O O
-LRB- O O
W O O
Chen O O
, O O
unpublished O O
data O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
to I-conn Conjunction
that O O
mediated O O
by O O
Smad2 O O
, O O
TGF-β O O
signaling O O
is O O
regulated O O
by O O
complex O O
mechanisms O O
in O O
the O O
cytoplasm O O
and O O
nucleus O O
. O O

Beyond O O
engaging O O
Smad O O
activity O O
, O O
TGF-β O O
triggers O O
the O O
extracellular O O
signal-related O O
kinase O O
and O O
p38 O O
mitogen-activated O O
kinase O O
pathways O O
-LSB-44 O O
-RSB- O O
to B-conn Purpose.Goal
link O O
additional O O
signaling O O
cascades O O
involved O O
in O O
modulating O O
cell O O
function O O
. O O

Perturbations O O
in O O
this O O
immunoregulatory O O
circuit O O
can O O
occur O O
through B-conn Purpose.Enablement
dysregulation O O
of O O
the O O
inhibitory O O
Smad O O
, O O
Smad7 O O
, O O
which O O
typically O O
represses O O
TGF-β O O
signaling O O
by B-conn Purpose.Enablement
interacting O O
with O O
activated O O
TGF-β O O
receptors O O
to B-conn Purpose.Goal
prevent O O
the O O
activation O O
of O O
Smad2/3 O O
and/or B-conn Alternative.Conjunctive
by O O
interfering O O
with O O
complex O O
formation O O
between O O
Smad2/3 O O
and O O
Smad4 O O
-LSB-45 O O
-RSB- O O
. O O

Facilitating O O
the O O
inhibitory O O
Smad O O
signals O O
are O O
the O O
Smad O O
ubiquitin O O
regulatory O O
factors O O
-LRB- O O
Smurfs O O
-RRB- O O
, O O
E3 O O
ubiquitin O O
ligases O O
, O O
capable O O
of O O
inducing O O
polyubiquitination O O
and O O
degradation O O
of O O
TβRI O O
-LSB-46,47 O O
-RSB- O O
. O O

Smad7 O O
is O O
inducible O O
by O O
TGF-β O O
itself O O
as O O
part O O
of O O
a O O
feedback O O
loop O O
, O O
as O O
well O O
as O O
by O O
the O O
IFN-γ O O
and O O
NF-κB O O
pathways O O
-LSB-41 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
the O O
transcriptional O O
co-repressors O O
c-Ski O O
and O O
SnoN O O
, O O
by B-conn Purpose.Enablement
means I-conn Purpose.Enablement
of I-conn Purpose.Enablement
their O O
interactions O O
with O O
Smad2/3/4 O O
, O O
repress O O
TGF-β-induced O O
transcription O O
and O O
are O O
upregulated O O
by O O
TGF-β O O
as O O
another O O
negative O O
feedback O O
loop O O
to B-conn Purpose.Goal
maintain O O
control O O
of O O
this O O
incredibly O O
powerful O O
molecule O O
-LSB-41 O O
-RSB- O O
. O O

Dissection O O
of O O
these O O
circuits O O
will O O
probably O O
reveal O O
pathways O O
by O O
which O O
suppression O O
can O O
be O O
manipulated O O
to B-conn Purpose.Goal
orchestrate O O
changes O O
in O O
aberrant O O
immunity O O
. O O

Although B-conn Concession.Expectation
the O O
preponderance O O
of O O
evidence O O
supports O O
a O O
major O O
role O O
for O O
TGF-β O O
in O O
the O O
mediation O O
of O O
Treg O O
suppressive O O
activity O O
, O O
there O O
are O O
likely O O
to O O
be O O
additional O O
factors O O
and/or O O
cofactors O O
that O O
secondarily O O
contribute O O
to O O
their O O
function O O
and B-conn Conjunction
that O O
may O O
become O O
prevalent O O
in O O
the O O
absence O O
of O O
TGF-β O O
and/or B-conn Alternative.Conjunctive
if O O
TGF-β O O
is O O
dysregulated O O
. O O

The O O
identification O O
and O O
intersection O O
points O O
of O O
such O O
pathways O O
await O O
further O O
study O O
. O O

Among O O
the O O
factors O O
that O O
contribute O O
to O O
the O O
regulation O O
of O O
TGF-β O O
in O O
CD4+CD25+ O O
Treg O O
are O O
CD28 O O
, O O
cytotoxic O O
T O O
lymphocyte O O
antigen-4 O O
, O O
glucocorticoid-induced O O
TNF O O
receptor O O
and O O
forkhead/winged O O
helix O O
or O O
forkhead O O
box O O
P3 O O
encoded O O
by O O
Foxp3 O O
-LSB-48-51 O O
-RSB- O O
. O O

Generation O O
of O O
Treg O O

Although B-conn Concession.Expectation
Treg O O
were O O
originally O O
considered O O
to O O
derive O O
only O O
from O O
thymic O O
precursors O O
-LSB-1 O O
-RSB- O O
, O O
to O O
be O O
exported O O
to O O
the O O
periphery O O
, O O
and O O
to O O
represent O O
less O O
than O O
10 O O
% O O
of O O
CD4+ O O
T O O
cells O O
-LSB-52 O O
-RSB- O O
, O O
thereby B-conn Cause.Result
limiting O O
their O O
potential O O
for O O
manipulation O O
for O O
therapeutic O O
considerations O O
, O O
important O O
new O O
evidence O O
documents O O
that O O
Treg O O
can O O
be O O
expanded O O
and/or O O
induced O O
de O O
novo O O
from O O
CD4+CD25- O O
precursor O O
T O O
cells O O
. O O

How O O
, O O
where O O
, O O
and O O
if O O
the O O
size O O
and O O
function O O
of O O
this O O
population O O
can O O
be O O
intentionally O O
controlled O O
is O O
of O O
the O O
utmost O O
importance O O
. O O

The O O
thymic O O
derivation O O
of O O
Treg O O
is O O
genetically O O
as O O
well O O
as O O
developmentally O O
regulated O O
, O O
but B-conn Concession.Contra-expectation
it O O
seems O O
to O O
be O O
constitutive O O
and O O
relatively O O
stable O O
. O O

Recruitment O O
to O O
a O O
site O O
of O O
autoimmune O O
reactivity O O
may O O
increase O O
their O O
numbers O O
locally O O
, O O
but B-conn Concession.Contra-expectation
in O O
a O O
limited O O
fashion O O
. O O

The O O
ability O O
to O O
coerce O O
expansion O O
of O O
functional O O
Treg O O
opens O O
up O O
possibilities O O
for O O
the O O
manipulation O O
of O O
inflammation O O
and O O
immunity O O
. O O

CD4+CD25+ O O
Treg O O
undergo O O
proliferation O O
with O O
TCR O O
stimulation O O
in O O
the O O
presence O O
of O O
high O O
doses O O
of O O
exogenous O O
IL-2 O O
-LRB- O O
more O O
than O O
100 O O
U/ml O O
-RRB- O O
in O O
vitro O O
-LSB-10 O O
-RSB- O O
. O O

Importantly O O
, O O
these O O
expanded O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
preserve O O
their O O
anergic O O
features O O
and O O
immunosuppressive O O
ability O O
once B-conn Temporal.Succession
IL-2 O O
is O O
removed O O
. O O

This O O
unique O O
aspect O O
of O O
CD4+CD25+ O O
Treg O O
has O O
definite O O
potential O O
application O O
in O O
designing O O
future O O
clinical O O
therapy O O
for O O
autoimmune O O
diseases O O
, O O
inflammation O O
and O O
transplantation O O
. O O

Nonetheless B-conn Concession.Contra-expectation
, O O
the O O
insufficiency O O
of O O
naturally O O
derived O O
CD4+CD25+ O O
Treg O O
in O O
autoimmunity O O
and O O
other O O
immune O O
diseases O O
has O O
driven O O
the O O
search O O
for O O
approaches O O
to O O
convert O O
normal O O
naive O O
CD4+CD25-T O O
cells O O
into O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
. O O

The O O
generation O O
of O O
functionally O O
uncompromised O O
CD4+CD25+ O O
Treg O O
involves O O
the O O
unique O O
induction O O
of O O
forkhead/winged O O
helix O O
transcription O O
factor O O
Foxp3 O O
-LRB- O O
Scurfin O O
-RRB- O O
in O O
Foxp3-negative O O
CD4+CD25- O O
precursors O O
. O O

Foxp3 O O
is O O
highly O O
conserved O O
, O O
and B-conn Conjunction
in O O
both O O
mice O O
and O O
humans O O
genetically O O
defective O O
Foxp3 O O
is O O
associated O O
with O O
autoimmune O O
and O O
inflammatory O O
disease O O
-LSB-48,53-57 O O
-RSB- O O
. O O

In O O
Foxp3 O O
null O O
mice O O
, O O
the O O
deficiency O O
of O O
CD4+CD25+ O O
Treg O O
results O O
in O O
a O O
lethal O O
autoimmune O O
syndrome O O
-LSB-53,55,57 O O
-RSB- O O
. O O

In O O
vitro O O
, O O
gene O O
transfer O O
of O O
Foxp3 O O
converts O O
naive O O
CD4+CD25- O O
T O O
cells O O
into O O
phenotypic O O
and O O
functional O O
Treg O O
-LSB-48,53,55,56 O O
-RSB- O O
, O O
which O O
is O O
consistent O O
with O O
the O O
ability O O
to O O
rescue O O
Foxp3-null O O
mice O O
with O O
adoptive O O
transfer O O
of O O
Treg O O
-LSB-55 O O
-RSB- O O
. O O

These O O
data O O
support O O
the O O
pivotal O O
and O O
nonredundant O O
role O O
of O O
this O O
transcription O O
factor O O
in O O
Treg O O
development O O
and O O
function O O
. O O

Conversely B-conn Conjunction
, O O
the O O
overexpression O O
of O O
Foxp3 O O
in O O
a O O
transgenic O O
mouse O O
model O O
results O O
in O O
enhanced O O
numbers O O
of O O
CD4+CD25+ O O
Treg O O
and B-conn Continuation
, O O
furthermore B-conn Conjunction
, O O
Foxp3-expressing O O
CD4+CD25- O O
, O O
as O O
well O O
as O O
CD4-CD8+ O O
, O O
T O O
cells O O
in O O
these O O
transgenic O O
mice O O
constitutively O O
exhibit O O
suppressive O O
functions O O
-LSB-57 O O
-RSB- O O
. O O

Despite B-conn Concession.Expectation
the O O
success O O
of O O
the O O
artificial O O
gene O O
transfer O O
of O O
Foxp3 O O
into O O
CD4+CD25- O O
naive O O
T O O
cells O O
to B-conn Purpose.Goal
coerce O O
them O O
into O O
a O O
CD4+CD25+ O O
regulatory O O
T O O
cell O O
phenotype O O
, O O
the O O
existence O O
of O O
a O O
physiologic O O
inducer O O
of O O
Foxp3 O O
was O O
unknown O O
. O O

The O O
recent O O
elucidation O O
of O O
a O O
signaling O O
pathway O O
leading O O
to O O
the O O
conversion O O
of O O
CD4+CD25- O O
precursors O O
into O O
Treg O O
revealed O O
a O O
pivotal O O
role O O
for O O
TGF-β O O
-LSB-8,12,14 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
the O O
genetic O O
deletion O O
of O O
Foxp3 O O
results O O
in O O
an O O
overlapping O O
phenotype O O
with O O
the O O
TGF-β1-null O O
mice O O
-LSB-40 O O
-RSB- O O
, O O
implicating O O
a O O
connection O O
and/or O O
shared O O
mechanism O O
of O O
action O O
. O O

The O O
induction O O
of O O
gene O O
expression O O
of O O
Foxp3 O O
, O O
a O O
transcription O O
factor O O
unique O O
to O O
Treg O O
-LSB-48,53-57 O O
-RSB- O O
is O O
, O O
in B-conn Reinforcement
fact I-conn Reinforcement
, O O
TGF-β O O
dependent O O
-LSB-12 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
TGF-β O O
cannot O O
act O O
independently O O
on O O
precursor O O
cells O O
to O O
generate O O
Treg O O
but O O
requires O O
co-stimulation O O
through O O
TCR O O
and O O
IL-2R O O
-LSB-12,58 O O
-RSB- O O
. O O

Naive O O
splenic O O
CD4+CD25- O O
T O O
cells O O
cultured O O
for O O
7 O O
to O O
9 O O
days O O
with O O
TCR O O
stimulation O O
and O O
TGF-β O O
in O O
the O O
presence O O
of O O
APCs O O
emerge O O
as O O
CD4+CD25+ O O
Treg O O
with O O
the O O
ability O O
to O O
suppress O O
CD4+ O O
responder O O
T O O
cell O O
proliferation O O
. O O

A O O
similar O O
conversion O O
pattern O O
occurs O O
in O O
TCR O O
transgenic O O
mice O O
if B-conn Condition.Hypothetical
the O O
CD4+CD25- O O
naive O O
T O O
cells O O
are O O
stimulated O O
with O O
specific O O
antigen O O
and O O
APCs O O
with O O
TGF-β O O
added O O
-LSB-12 O O
-RSB- O O
. O O

This O O
engagement O O
of O O
the O O
TCR O O
and O O
co-stimulator O O
molecules O O
-LRB- O O
such O O
as O O
CD28 O O
-RRB- O O
-LSB-49,50,59,60 O O
-RSB- O O
in O O
concert O O
with O O
TβRII O O
ligation O O
triggers O O
signaling O O
pathways O O
that O O
culminate O O
in O O
Foxp3 O O
transcription O O
, O O
which O O
is O O
essential O O
to O O
generation O O
of O O
Treg O O
. O O

In O O
this O O
fashion O O
, O O
TGF-β O O
is O O
not O O
only O O
expressed O O
by O O
Treg O O
but O O
also B-conn Conjunction
programs O O
their O O
development O O
and O O
function O O
. O O

TGF-β-converted O O
Treg O O
control O O
immune O O
responses O O
in O O
vivo O O

On B-conn Cause.Reason
the I-conn Cause.Reason
basis I-conn Cause.Reason
of I-conn Cause.Reason
this O O
understanding O O
of O O
the O O
novel O O
mechanism O O
underlying O O
conversion O O
of O O
CD4+CD25- O O
T O O
cells O O
into O O
phenotypic O O
and O O
functional O O
CD4+CD25+ O O
Treg O O
, O O
the O O
expansion O O
of O O
Treg O O
for O O
therapeutic O O
consideration O O
becomes O O
an O O
achievable O O
goal O O
. O O

Provided B-conn Condition.Hypothetical
that I-conn Condition.Hypothetical
the O O
regulatory O O
conditions O O
are O O
met O O
, O O
the O O
converted O O
CD4+CD25+ O O
Treg O O
function O O
like O O
conventional O O
Treg O O
, O O
at O O
least O O
in O O
vitro O O
. O O

Although B-conn Concession.Expectation
it O O
has O O
previously O O
been O O
shown O O
that O O
naturally O O
occurring O O
CD4+CD25+ O O
Treg O O
are O O
potent O O
inhibitors O O
of O O
innate/adaptive O O
immunity O O
-LSB-61-63 O O
-RSB- O O
, O O
induction O O
of O O
a O O
population O O
of O O
Treg O O
and O O
documentation O O
of O O
their O O
in O O
vivo O O
potential O O
was O O
an O O
important O O
next O O
step O O
. O O

In O O
pursuit O O
of O O
this O O
goal O O
, O O
recent O O
studies O O
demonstrated O O
for O O
the O O
first O O
time O O
that O O
the O O
transfer O O
of O O
in O O
vitro O O
generated O O
Treg O O
into O O
disease O O
models O O
does O O
in B-conn Reinforcement
fact I-conn Reinforcement
ameliorate O O
pathogenesis O O
-LSB-12 O O
-RSB- O O
. O O

Initially O O
, O O
it O O
was O O
shown O O
that O O
adoptive O O
transfer O O
of O O
in O O
vitro O O
TGF-β-converted O O
Treg O O
together O O
with O O
ovalbumin-specific O O
TCR O O
transgenic O O
T O O
cells O O
resulted O O
in O O
a O O
profound O O
inhibition O O
of O O
antigen-specific O O
expansion O O
of O O
naive O O
CD4+ O O
transgenic O O
T O O
cells O O
in O O
vivo O O
. O O

Although B-conn Concession.Expectation
the O O
TGF-β-converted O O
CD25+ O O
suppressor O O
population O O
-LRB- O O
DO11.10 O O

TCR O O
transgenic O O
, O O
KJ1-26+ O O
-RRB- O O
proliferated O O
in O O
vivo O O
on O O
immunization O O
with O O
ovalbumin O O
peptide O O
, O O
the O O
recovered O O
KJ1-26+ O O
CD4+ O O
T O O
cells O O
from O O
draining O O
lymph O O
nodes O O
remained O O
unresponsive O O
to O O
re-challenge O O
with O O
ovalbumin O O
peptide O O
in O O
vitro O O
, O O
produced O O
no O O
antigen-specific O O
IL-4 O O
and O O
IFN-γ O O
, O O
and O O
expressed O O
high O O
levels O O
of O O
CD25 O O
-LSB-12 O O
-RSB- O O
, O O
all O O
consistent O O
with O O
professional O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
-LSB-64,65 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
in O O
a O O
dramatic O O
turnaround O O
of O O
allergen-induced O O
asthmatic O O
lung O O
disease O O
, O O
TGF-β-converted/induced O O
Treg O O
, O O
when B-conn Temporal.Synchronous
transferred O O
to O O
an O O
asthmatic O O
mouse O O
, O O
suppressed O O
allergen-induced O O
inflammation O O
and O O
pathogenesis O O
-LSB-12 O O
-RSB- O O
. O O

In O O
this O O
model O O
, O O
mice O O
are O O
immunized O O
with O O
house O O
dust O O
mite O O
and O O
then B-conn Temporal.Precedence
challenged O O
intratracheally O O
with O O
house O O
dust O O
mite O O
to B-conn Purpose.Goal
induce O O
airway O O
hyperreactivity O O
, O O
mucus O O
accumulation O O
, O O
eosinophilia O O
and O O
IgE O O
production O O
. O O

Delivery O O
of O O
Treg O O
to O O
these O O
asthmatic O O
mice O O
on O O
day O O
0 O O
and O O
14 O O
was O O
able O O
to O O
prevent O O
the O O
immunopathogenic O O
response O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
, O O
confirming O O
the O O
functional O O
prowess O O
of O O
these O O
newly O O
converted O O
cells O O
in O O
the O O
suppression O O
of O O
inflammatory O O
and O O
immune O O
responses O O
in O O
vivo O O
. O O

Treg O O
in O O
autoimmune O O
diseases O O

Human O O
systemic O O
lupus O O
erythematosus O O
-LRB- O O
SLE O O
-RRB- O O
patients O O
and O O
murine O O
models O O
of O O
SLE O O
manifest O O
a O O
wide O O
range O O
of O O
immunological O O
abnormalities O O
. O O

The O O
most O O
pervasive O O
of O O
these O O
include O O
the O O
generation O O
of O O
pathogenic O O
autoantibodies O O
. O O

In O O
this O O
regard O O
, O O
98 O O
% O O
of O O
human O O
SLE O O
patients O O
possess O O
antinuclear O O
antibodies O O
and B-conn Conjunction
50 O O
to O O
80 O O
% O O
of O O
these O O
have O O
anti-double-stranded O O
DNA O O
antibodies O O
, O O
the O O
result O O
of O O
unchecked O O
B O O
lymphocyte O O
activation O O
and O O
antibody O O
production O O
, O O
probably B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
uncontrolled O O
T O O
cell O O
hyper-responsiveness O O
. O O

Both O O
Th1 O O
and O O
Th2 O O
responses O O
are O O
elevated O O
, O O
as O O
demonstrated O O
by O O
the O O
upregulation O O
of O O
proinflammatory O O
cytokines O O
, O O
notably O O
IFN-γ O O
, O O
IL-6 O O
, O O
IL-12 O O
, O O
and O O
IL-10 O O
, O O
as O O
well O O
as O O
T O O
cell-dependent O O
autoantibody O O
production O O
. O O

Interestingly O O
, O O
these O O
T O O
and O O
B O O
lymphocyte O O
abnormalities O O
have O O
been O O
attributed O O
, O O
at O O
least O O
partly O O
, O O
to O O
defective O O
production O O
and O O
function O O
of O O
TGF-β O O
-LSB-12,66 O O
-RSB- O O
. O O

In O O
contrast O O
to O O
strong O O
suspicions O O
, O O
few O O
data O O
yet O O
exist O O
as O O
to O O
whether O O
the O O
uncontrolled O O
T O O
and O O
B O O
cell O O
activation O O
and O O
pathogenesis O O
in O O
SLE O O
can O O
be O O
attributed O O
to O O
a O O
deficiency O O
in O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
. O O

In O O
this O O
regard O O
, O O
one O O
study O O
indicated O O
that O O
CD4+CD25+ O O
T O O
cells O O
were O O
significantly O O
decreased O O
in O O
patients O O
with O O
active O O
SLE O O
in O O
comparison O O
with O O
normal O O
subjects O O
and O O
patients O O
with O O
an O O
inactive O O
stage O O
of O O
the O O
disease O O
-LSB-67 O O
-RSB- O O
, O O
and B-conn Conjunction
in O O
another O O
recent O O
study O O
-LSB-68 O O
-RSB- O O
Treg O O
were O O
reported O O
to O O
be O O
abnormal O O
in O O
number O O
, O O
phenotype O O
, O O
and O O
function O O
in O O
patients O O
with O O
active O O
SLE O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
exact O O
role O O
of O O
the O O
decreased O O
CD4+CD25+ O O
Treg O O
levels O O
in O O
the O O
pathogenesis O O
of O O
SLE O O
awaits O O
demonstration O O
of O O
a O O
significant O O
correlation O O
between O O
the O O
levels O O
of O O
CD4+CD25+ O O
Treg O O
and O O
inactive O O
disease O O
or O O
flare O O
activity O O
-LSB-69 O O
-RSB- O O
. O O

In O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
, O O
the O O
relationship O O
between O O
CD4+CD25+ O O
Treg O O
and O O
Th1-dependent O O
pathogenesis O O
of O O
the O O
disease O O
also O O
remains O O
under O O
study O O
. O O

It O O
was O O
recently O O
suggested O O
-LSB-70 O O
-RSB- O O
that O O
no O O
significant O O
difference O O
in O O
suppressive O O
activity O O
was O O
found O O
between O O
CD4+CD25+ O O
T O O
cells O O
from O O
peripheral O O
blood O O
of O O
RA O O
patients O O
and O O
healthy O O
control O O
subjects O O
, O O
although B-conn Concession.Expectation
the O O
numbers O O
may O O
be O O
less O O
-LSB-25 O O
-RSB- O O
. O O

Nonetheless B-conn Concession.Contra-expectation
, O O
CD4+CD25+ O O
T O O
cells O O
from O O
synovial O O
fluid O O
reportedly O O
had O O
a O O
significantly O O
higher O O
suppressive O O
activity O O
than O O
those O O
in O O
peripheral O O
blood O O
of O O
RA O O
patients O O
. O O

Notably O O
, O O
despite B-conn Concession.Expectation
the O O
presence O O
of O O
these O O
highly O O
functional O O
Treg O O
in O O
synovial O O
fluid O O
, O O
there O O
was O O
still O O
ongoing O O
inflammation O O
in O O
the O O
joints O O
, O O
indicating O O
the O O
complex O O
picture O O
of O O
RA O O
pathogenesis O O
, O O
which O O
might O O
reflect O O
a O O
prominent O O
imbalance O O
between O O
regulatory O O
and O O
inflammatory O O
checkpoints O O
. O O

In O O
an O O
encouraging O O
experimental O O
therapy O O
study O O
, O O
patients O O
with O O
RA O O
who O O
were O O
treated O O
for O O
6 O O
months O O
with O O
oral O O
dnaJP1 O O
, O O
a O O
peptide O O
that O O
induces O O
proinflammatory O O
T O O
cell O O
responses O O
in O O
naive O O
RA O O
patients O O
, O O
manifested O O
increased O O
Foxp3+CD4+CD25+ O O
T O O
cells O O
, O O
suggesting O O
that O O
the O O
treatment O O
induced O O
the O O
emergence O O
-LRB- O O
enhancement O O
-RRB- O O
of O O
T O O
cells O O
with O O
the O O
regulatory O O
phenotype O O
-LSB-71 O O
-RSB- O O
. O O

In B-conn Cause.Claim
short I-conn Cause.Claim
, O O
despite B-conn Concession.Expectation
the O O
complex O O
picture O O
of O O
Treg O O
in O O
autoimmunity O O
, O O
it O O
can O O
be O O
envisioned O O
that O O
it O O
will O O
become O O
feasible O O
to O O
manipulate O O
regulatory O O
T O O
cells O O
for O O
therapeutic O O
benefit O O
. O O

With O O
continued O O
efforts O O
, O O
a O O
better O O
understanding O O
and O O
more O O
advanced O O
techniques O O
will O O
emerge O O
for O O
the O O
induction O O
and/or O O
expansion O O
of O O
Treg O O
to B-conn Purpose.Goal
enhance O O
their O O
role O O
in O O
autoimmunity O O
, O O
allergy O O
, O O
and O O
graft O O
rejection O O
. O O

Conclusion O O

Innate O O
and O O
adaptive O O
immune O O
responses O O
are O O
essential O O
to O O
protect O O
the O O
host O O
from O O
a O O
plethora O O
of O O
potentially O O
pathogenic O O
microorganisms O O
, O O
but B-conn Concession.Contra-expectation
countermeasures O O
to O O
prevent O O
reactivity O O
of O O
self O O
are O O
equally O O
essential O O
. O O

Although B-conn Concession.Expectation
protection O O
against O O
self-recognition-induced O O
autoimmunity O O
is O O
accomplished O O
in B-conn Purpose.Enablement
large I-conn Purpose.Enablement
part I-conn Purpose.Enablement
by I-conn Purpose.Enablement
the O O
central O O
deletion O O
of O O
autoreactive O O
T O O
cells O O
during O O
intrathymic O O
development O O
, O O
this O O
process O O
is O O
not O O
perfect O O
and B-conn Conjunction
self-reactive O O
escapees O O
can O O
wreak O O
havoc O O
on O O
the O O
immune O O
system O O
. O O

However B-conn Concession.Contra-expectation
, O O
among O O
the O O
backup O O
pathways O O
in O O
the O O
periphery O O
to O O
protect O O
us O O
from O O
self-destruction O O
are O O
deletion O O
, O O
anergy O O
, O O
ignorance O O
, O O
and O O
active O O
suppression O O
. O O

Among O O
these O O
, O O
current O O
interest O O
has O O
zeroed O O
in O O
on O O
CD4+CD25+ O O
regulatory O O
T O O
cells O O
, O O
which O O
can O O
profoundly O O
suppress O O
responder O O
T O O
cell O O
proliferation O O
and O O
cytokines O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

Originally O O
considered O O
an O O
exclusive O O
product O O
of O O
the O O
thymus O O
, O O
important O O
new O O
data O O
indicate O O
that O O
these O O
cells O O
can O O
be O O
generated O O
from O O
peripheral O O
CD4+ O O
T O O
cells O O
and O O
expanded O O
for O O
delivery O O
as O O
a O O
cellular O O
therapeutic O O
strategy O O
. O O

Opportunities O O
to O O
use O O
suppressor O O
T O O
cell O O
populations O O
in O O
the O O
treatment O O
of O O
debilitating O O
autoimmune O O
diseases O O
, O O
allergy O O
, O O
chronic O O
infectious O O
diseases O O
, O O
and O O
transplant O O
rejection O O
are O O
no O O
longer O O
a O O
dream O O
of O O
the O O
future O O
but O O
are O O
an O O
emerging O O
reality O O
. O O

Moreover B-conn Conjunction
, O O
as B-conn Temporal.Synchronous
we O O
illuminate O O
the O O
mechanisms O O
of O O
regulation O O
of O O
these O O
Treg O O
, O O
it O O
might O O
also B-conn Conjunction
become O O
feasible O O
to O O
diminish O O
, O O
rather O O
than O O
augment O O
, O O
their O O
numbers/activity O O
to B-conn Purpose.Goal
promote O O
tumor O O
rejection O O
and O O
vaccine O O
responses O O
and/or B-conn Alternative.Conjunctive
to O O
reverse O O
immunodeficiency O O
diseases O O
. O O

Abbreviations O O

APCs O O
= O O
antigen-presenting O O
cells O O
; O O
IFN O O
= O O
interferon O O
; O O
IL O O
= O O
interleukin O O
; O O
LAP O O
= O O
latency-associated O O
peptide O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
SLE O O
= O O
systemic O O
lupus O O
erythematosus O O
; O O
TβR O O
= O O
TGF-β O O
receptor O O
; O O
TCR O O
= O O
T-cell O O
receptor O O
; O O
TGF O O
= O O
transforming O O
growth O O
factor O O
; O O
Th O O
= O O
T O O
helper O O
cell O O
; O O
Treg O O
= O O
regulatory O O
T O O
cell O O
-LRB- O O
s O O
-RRB- O O
; O O
TSP O O
= O O
thrombospondin O O
. O O

Competing O O
interests O O

The O O
author O O
-LRB- O O
s O O
-RRB- O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Regulatory O O
T O O
cells O O
mediate O O
inflammatory O O
and O O
immune O O
reactions O O
. O O

CD4+CD25+ O O
Treg O O
can O O
suppress O O
CD4+CD25- O O
T O O
cell O O
responses O O
to O O
antigens O O
through O O
a O O
contact-dependent O O
, O O
antigen-nonspecific O O
mechanism O O
involving O O
TGF-β O O
. O O

Treg O O
suppress O O
CD4+CD25- O O
responder O O
T O O
cell O O
proliferation O O
and O O
cytokine O O
production O O
, O O
reining O O
in O O
Th1 O O
and/or O O
Th2 O O
immunity O O
. O O

Without O O
adequate O O
intercession O O
by O O
Treg O O
, O O
Th1- O O
or O O
Th2-dominated O O
responses O O
may O O
become O O
pathogenic O O
. O O

Figure O O
2 O O
: O O
Treg O O
expanded O O
in O O
vitro O O
suppress O O
allergen-induced O O
asthma O O
in O O
vivo O O
. O O

Mice O O
sensitized O O
to O O
house O O
dust O O
mite O O
-LRB- O O
HDM O O
-RRB- O O
by O O
intraperitoneal O O
-LRB- O O
ip O O
-RRB- O O
injection O O
with O O
HDM O O
on O O
days O O
0 O O
and O O
7 O O
and O O
then B-conn Temporal.Precedence
challenged O O
by O O
intratracheal O O
-LRB- O O
it O O
-RRB- O O
injection O O
on O O
days O O
14 O O
and O O
21 O O
were O O
injected O O
intraperitoneally O O
on O O
days O O
0 O O
and O O
14 O O
with O O
Treg O O
. O O

Three B-conn Temporal.Succession
days I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
second O O
intratracheal O O
challenge O O
with O O
HDM O O
, O O
the O O
lungs O O
were O O
assessed O O
for O O
histopathology O O
by O O
periodic O O
acid O O
Schiff O O
staining O O
for O O
mucopolysaccharides O O
-LRB- O O
red O O
-RRB- O O
. O O

Inflammatory O O
pathology O O
and O O
mucin O O
obstruction O O
of O O
the O O
airways O O
were O O
strikingly O O
reduced O O
in O O
mice O O
receiving O O
Treg O O
-LSB-12 O O
-RSB- O O
. O O

Analysis O O
of O O
the O O
CCR3 O O
promoter O O
reveals O O
a O O
regulatory O O
region O O
in O O
exon O O
1 O O
that O O
binds O O
GATA-1 O O

Abstract O O

Background O O
: O O
CC O O
Chemokine O O
Receptor O O
3 O O
-LRB- O O
CCR3 O O
-RRB- O O
, O O
the O O
major O O
chemokine O O
receptor O O
expressed O O
on O O
eosinophils O O
, O O
binds O O
promiscuously O O
to O O
several O O
ligands O O
including O O
eotaxins O O
1 O O
, O O
2 O O
, O O
and O O
3 O O
. O O

Even B-conn Concession.Expectation
though I-conn Concession.Expectation
the O O
only O O
cells O O
that O O
consistently O O
accumulate O O
following B-conn Temporal.Succession
eotaxin O O
administration O O
in O O
vivo O O
are O O
myeloid O O
cells O O
-LRB- O O
primarily O O
eosinophils O O
-RRB- O O
, O O
other O O
cell O O
types O O
have O O
recently O O
been O O
shown O O
to O O
express O O
CCR3 O O
. O O

It O O
is O O
therefore B-conn Cause.Result
important O O
to O O
elucidate O O
the O O
molecular O O
mechanisms O O
regulating O O
receptor O O
expression O O
. O O

Results O O
: O O
In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
define O O
regions O O
responsible O O
for O O
CCR3 O O
transcription O O
, O O
a O O
DNAse O O
hypersensitive O O
site O O
was O O
identified O O
in O O
the O O
vicinity O O
of O O
exon O O
1. O O
Coupled O O
with O O
our O O
previous O O
data O O
implicating O O
exon O O
1 O O
in O O
CCR3 O O
transcription O O
, O O
we O O
hypothesized O O
that O O
transcription O O
factors O O
bind O O
to O O
exon-1 O O
. O O

Electrophoretic O O
mobility O O
shift O O
analysis O O
revealed O O
that O O
nuclear O O
proteins O O
in O O
eosinophilic O O
cells O O
bound O O
to O O
exon O O
1 O O
. O O

Furthermore B-conn Conjunction
, O O
antibody O O
interference O O
and O O
mutation O O
studies O O
demonstrated O O
GATA-1 O O
binding O O
to O O
exon O O
1 O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
test O O
the O O
1.6-kb O O

CCR3 O O
promoter O O
element O O
-LRB- O O
that O O
includes O O
exon O O
1 O O
-RRB- O O
for O O
in O O
vivo O O
function O O
, O O
this O O
region O O
was O O
used O O
to O O
generate O O
transgenic O O
mice O O
that O O
expressed O O
a O O
reporter O O
protein O O
. O O

Strong O O
transgene O O
expression O O
was O O
achieved O O
, O O
with O O
the O O
pattern O O
of O O
expression O O
suggesting O O
a O O
broad O O
acting O O
promoter O O
. O O

Conclusion O O
: O O
The O O
transcription O O
factor O O
GATA-1 O O
binds O O
to O O
CCR3 O O
exon O O
1 O O
. O O

The O O
1.6-kb O O

CCR3 O O
promoter O O
element O O
, O O
that O O
includes O O
exon O O
1 O O
, O O
is O O
a O O
strong O O
promoter O O
in O O
vivo O O
. O O

Background O O

CCR3 O O
, O O
the O O
eotaxin O O
receptor O O
, O O
is O O
the O O
major O O
chemokine O O
receptor O O
expressed O O
on O O
eosinophils O O
, O O
basophils O O
and O O
a O O
subpopulation O O
of O O
Th2 O O
lymphocytes O O
-LSB-1-10 O O
-RSB- O O
. O O

Recently O O
, O O
CCR3 O O
has O O
been O O
shown O O
to O O
be O O
upregulated O O
on O O
neutrophils O O
and O O
monocytoid O O
U937 O O
cells O O
by O O
interferons O O
in O O
vitro O O
and O O
to O O
be O O
expressed O O
by O O
endothelial O O
cells O O
, O O
epithelial O O
cells O O
and O O
mast O O
cells O O
-LSB-11-16 O O
-RSB- O O
. O O

The O O
relevance O O
of O O
these O O
findings O O
and O O
the O O
function O O
of O O
CCR3 O O
on O O
non-leukocytes O O
remain O O
to O O
be O O
elucidated O O
since B-conn Cause.Justification
the O O
only O O
cells O O
that O O
consistently O O
accumulate O O
following B-conn Temporal.Succession
eotaxin O O
administration O O
in O O
vivo O O
are O O
myeloid O O
cells O O
-LRB- O O
primarily O O
eosinophils O O
-RRB- O O
-LSB-17-20 O O
-RSB- O O
. O O

To O O
date O O
, O O
the O O
complete O O
mRNA O O
and O O
genomic O O
organization O O
of O O
only O O
a O O
limited O O
number O O
of O O
chemokine O O
receptors O O
has O O
been O O
described O O
-LSB-21-26 O O
-RSB- O O
. O O

These O O
studies O O
have O O
shown O O
that O O
the O O
5 O O
' O O
untranslated O O
region O O
-LRB- O O
5 O O
' O O
UTR O O
-RRB- O O
can O O
be O O
complex O O
and O O
contain O O
up O O
to O O
11 O O
exons O O
as O O
in O O
the O O
CXCR2 O O
gene O O
. O O

As B-conn Cause.Result
a I-conn Cause.Result
result I-conn Cause.Result
, O O
alternative O O
splicing O O
and O O
transcription O O
directed O O
by O O
multiple O O
promoters O O
can O O
give O O
rise O O
to O O
variable O O
mRNA O O
isoforms O O
. O O

The O O
function O O
of O O
these O O
5 O O
' O O
untranslated O O
exons O O
has O O
not O O
been O O
examined O O
except B-conn Exception
for I-conn Exception
a O O
single O O
study O O
focused O O
on O O
CCR2 O O
, O O
demonstrating O O
a O O
transcriptional O O
role O O
for O O
exon O O
1 O O
-LSB-24 O O
-RSB- O O
. O O

We O O
have O O
previously O O
characterized O O
the O O
genomic O O
structure O O
and O O
promoter O O
function O O
of O O
the O O
human O O
CCR3 O O
gene O O
-LSB-27 O O
-RSB- O O
. O O

The O O
CCR3 O O
gene O O
contains O O
at O O
least O O
4 O O
exons O O
that O O
give O O
rise O O
to O O
multiple O O
mRNA O O
species O O
by B-conn Purpose.Enablement
alternative O O
splicing O O
. O O

The O O
first O O
1.6 O O
kb O O
of O O
the O O
5 O O
' O O
flanking O O
region O O
of O O
exon O O
1 O O
had O O
strong O O
promoter O O
activity O O
in O O
eosinophilic O O
, O O
lymphoid O O
and O O
respiratory O O
epithelial O O
cell O O
lines O O
. O O

Deletion O O
analysis O O
revealed O O
differential O O
regulation O O
of O O
the O O
CCR3 O O
promoter O O
in O O
eosinophilic O O
and O O
epithelial O O
cell O O
lines O O
suggesting O O
the O O
presence O O
of O O
lineage-specific O O
elements O O
. O O

Interestingly O O
, O O
exon O O
1 O O
enhanced O O
the O O
activity O O
of O O
the O O
promoter O O
. O O

Since B-conn Temporal.Succession
our O O
initial O O
characterization O O
, O O
two O O
other O O
groups O O
have O O
studied O O
the O O
CCR3 O O
promoter O O
-LSB-28,29 O O
-RSB- O O
; O O
however B-conn Contrast
, O O
their O O
studies O O
focused O O
on O O
lymphocytic O O
and O O
monocytic O O
cell O O
lines O O
, O O
respectively O O
, O O
rather O O
than O O
eosinophils O O
. O O

Scotet O O
et O O
al. O O
-LSB-29 O O
-RSB- O O
demonstrated O O
that O O
the O O
human O O
CCR3 O O
promoter O O
is O O
active O O
in O O
vitro O O
in O O
lymphocytic O O
cell O O
lines O O
. O O

They O O
also B-conn Conjunction
demonstrate O O
a O O
role O O
for O O
chromatin O O
remodeling O O
in O O
the O O
regulation O O
of O O
CCR3 O O
expression O O
in O O
Th2 O O
cells O O
. O O

Vijh O O
et O O
al. O O
-LSB-28 O O
-RSB- O O
demonstrated O O
that O O
the O O
human O O
CCR3 O O
promoter O O
is O O
active O O
in O O
monocytic O O
cell O O
lines O O
and O O
defined O O
the O O
minimal O O
promoter O O
that O O
consists O O
of O O
a O O
downstream O O
promoter O O
element O O
-LRB- O O
DPE O O
-RRB- O O
, O O
a O O
common O O
element O O
in O O
Drosophila O O
genes O O
, O O
but O O
rare O O
in O O
human O O
genes O O
. O O

This O O
element O O
is O O
upstream O O
-LRB- O O
50 O O
bp O O
-RRB- O O
of O O
the O O
exon O O
1 O O
sequence O O
studied O O
in O O
the O O
current O O
report O O
. O O

It O O
has O O
been O O
reported O O
that O O
5 O O
' O O
untranslated O O
exons O O
, O O
and O O
sometimes O O
introns O O
, O O
can O O
regulate O O
the O O
expression O O
of O O
genes O O
in O O
two O O
different O O
ways O O
. O O

An O O
untranslated O O
sequence O O
can O O
act O O
as O O
a O O
tissue-specific O O
translational O O
regulator O O
. O O

A O O
striking O O
example O O
is O O
the O O
gonadotropin O O
releasing O O
hormone O O
gene O O
which O O
is O O
transcribed O O
in O O
multiple O O
tissue O O
, O O
but O O
cannot O O
be O O
translated O O
due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
lack O O
of O O
specific O O
intron O O
removal O O
-LSB-30 O O
-RSB- O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
untranslated O O
regions O O
-LRB- O O
UTR O O
-RRB- O O
can O O
facilitate O O
transcription O O
of O O
a O O
gene O O
. O O

Examples O O
include O O
a O O
GATA-1 O O
site O O
in O O
the O O
5'-UTR O O
of O O
the O O
γ-globin O O
gene O O
, O O
an O O
HNF-1 O O
site O O
in O O
the O O
plasminogen O O
gene O O
and O O
a O O
C/EBP O O
site O O
in O O
the O O
CCR2 O O
gene O O
-LSB-24,31,32 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
the O O
mechanism O O
of O O
action O O
is O O
not O O
completely O O
clear O O
, O O
it O O
is O O
thought O O
that O O
transcription O O
factors O O
binding O O
to O O
untranslated O O
regions O O
affect O O
transcription O O
of O O
the O O
gene O O
through B-conn Purpose.Enablement
interactions O O
with O O
the O O
RNA O O
transcription O O
complex O O
. O O

The O O
role O O
of O O
untranslated O O
exons O O
in O O
the O O
CCR3 O O
gene O O
has O O
not O O
been O O
studied O O
. O O

In O O
this O O
report O O
, O O
DNase O O
I O O
hypersensitivity O O
identified O O
a O O
major O O
hypersensitive O O
site O O
located O O
in O O
the O O
vicinity O O
of O O
untranslated O O
exon O O
1 O O
. O O

Furthermore B-conn Conjunction
, O O
the O O
transcription O O
factor O O
GATA-1 O O
is O O
shown O O
to O O
bind O O
to O O
untranslated O O
exon O O
1 O O
, O O
suggesting O O
a O O
potential O O
mechanism O O
for O O
the O O
regulation O O
of O O
CCR3 O O
transcription O O
by O O
this O O
exon O O
. O O

Finally B-conn Temporal.Precedence
, O O
using O O
a O O
transgenic O O
approach O O
, O O
we O O
demonstrate O O
that O O
the O O
1.6 O O
kb O O
5 O O
' O O
flanking O O
region O O
of O O
CCR3 O O
-LRB- O O
including O O
exon O O
1 O O
-RRB- O O
has O O
promoter O O
activity O O
in O O
vivo O O
. O O

Results O O

We O O
aimed O O
to O O
define O O
regulatory O O
regions O O
in O O
the O O
CCR3 O O
gene O O
by B-conn Purpose.Enablement
a O O
gene-wide O O
search O O
. O O

Thus B-conn Cause.Result
, O O
we O O
performed O O
DNase O O
I O O
hypersensitivity O O
of O O
CCR3 O O
in O O
primary O O
human O O
eosinophils O O
. O O

The O O
entire O O
24 O O
kb O O
of O O
the O O
CCR3 O O
gene O O
were O O
screened O O
for O O
DNase O O
I O O
hypersensitivity O O
using O O
probes O O
specific O O
for O O
Eco O O
RI O O
and O O
Hind O O
III O O
fragments O O
-LRB- O O
Figure O O
1A O O
and O O
data O O
not O O
shown O O
-RRB- O O
. O O

Only O O
one O O
hypersensitive O O
site O O
was O O
noted O O
; O O
this O O
was O O
in O O
the O O
area O O
of O O
exon O O
1 O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
. O O

Similar O O
results O O
were O O
obtained O O
with O O
nuclei O O
from O O
the O O
eosinophilic O O
AML14.3D10 O O

cell O O
line O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

This O O
cell O O
line O O
does O O
not O O
express O O
CCR3 O O
unless B-conn Alternative.Disjunctive
induced O O
with O O
butyric O O
acid O O
and O O
IL-5 O O
; O O
suggesting O O
that O O
chromatin O O
remodeling O O
in O O
the O O
HS1 O O
site O O
precedes O O
CCR3 O O
transcription O O
. O O

Thus B-conn Cause.Claim
, O O
our O O
analysis O O
revealed O O
areas O O
of O O
active O O
chromatin O O
remodeling O O
in O O
the O O
vicinity O O
of O O
exon O O
1 O O
suggesting O O
that O O
this O O
area O O
may O O
be O O
important O O
for O O
CCR3 O O
transcription O O
. O O

DNase O O
I O O
hypersensitivity O O
indicated O O
that O O
a O O
region O O
consistent O O
with O O
exon O O
1 O O
is O O
active O O
in O O
CCR3 O O
transcription O O
. O O

Together O O
with O O
our O O
previous O O
data O O
showing O O
that O O
untranslated O O
exon O O
1 O O
has O O
an O O
important O O
role O O
in O O
CCR3 O O
transcription O O
-LSB-27 O O
-RSB- O O
, O O
we O O
hypothesized O O
that O O
nuclear O O
proteins O O
bind O O
to O O
exon O O
1 O O
, O O
and O O
in B-conn Temporal.Precedence
turn I-conn Temporal.Precedence
regulate O O
the O O
transcription O O
of O O
CCR3 O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
test O O
this O O
hypothesis O O
, O O
a O O
double-stranded O O
oligonucleotide O O
probe O O
that O O
corresponds O O
to O O
bp O O
+10 O O
to O O
+60 O O
of O O
the O O
CCR3 O O
gene O O
was O O
prepared O O
, O O
referred O O
to O O
as O O
E1-FL O O
-LRB- O O
exon O O
1- O O
full O O
length O O
, O O
Figure O O
2A O O
-RRB- O O
. O O

This O O
is O O
the O O
exact O O
sequence O O
that O O
was O O
deleted O O
in O O
the O O
CCR3 O O
-LRB- O O
-exon1 O O
-RRB- O O
.pGL3 O O

plasmid O O
that O O
demonstrated O O
decreased O O
activity O O
compared O O
to O O
the O O
full O O
length O O
1.6 O O
kb O O
construct O O
-LSB-27 O O
-RSB- O O
. O O

Nuclear O O
extracts O O
from O O
AML14.3D10 O O
cells O O
were O O
incubated O O
with O O
the O O
probe O O
and O O
resolved O O
on O O
a O O
polyacrylamide O O
gel O O
. O O

Two O O
bands O O
were O O
visible O O
-LRB- O O
Figure O O
2B O O
-RRB- O O
. O O

The O O
upper O O
band O O
was O O
eliminated O O
when B-conn Temporal.Synchronous
150x O O
molar O O
excess O O
of O O
the O O
unlabelled O O
probe O O
was O O
used O O
-LRB- O O
CC O O
: O O
E1-FL O O
in O O
Figure O O
2B O O
-RRB- O O
, O O
indicating O O
that O O
this O O
is O O
the O O
specific O O
band O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
precisely O O
localize O O
the O O
region O O
responsible O O
for O O
factor O O
binding O O
, O O
overlapping O O
cold O O
competitors O O
were O O
used O O
: O O
E1-A O O
spanning O O
from O O
+10 O O
to O O
+31 O O
, O O
E1-B O O
spanning O O
from O O
+25 O O
to O O
+46 O O
and O O
E1-C O O
spanning O O
from O O
+40 O O
to O O
+60 O O
. O O

The O O
specific O O
band O O
was O O
eliminated O O
with O O
E1-B O O
and O O
E1-C O O
cold O O
competitors O O
indicating O O
that O O
the O O
factor O O
binds O O
in O O
the O O
region O O
between O O
+25 O O
and O O
+60 O O
-LRB- O O
Figure O O
2B O O
-RRB- O O
. O O

In B-conn Restatement.Generalization
summary I-conn Restatement.Generalization
, O O
these O O
data O O
indicate O O
the O O
presence O O
of O O
proteins O O
in O O
the O O
nuclei O O
of O O
AML14.3D10 O O
cells O O
that O O
bind O O
to O O
CCR3 O O
exon O O
1 O O
between O O
bp O O
25 O O
and O O
60 O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
define O O
the O O
proteins O O
capable O O
of O O
binding O O
to O O
CCR3 O O
exon O O
1 O O
, O O
the O O
exon O O
1 O O
sequence O O
was O O
analyzed O O
using O O
the O O
publicly O O
available O O
TFSEARCH O O
engine O O
. O O

This O O
analysis O O
indicated O O
the O O
presence O O
of O O
consensus O O
DNA-binding O O
sites O O
in O O
the O O
exon O O
1 O O
region O O
for O O
several O O
transcription O O
factors O O
-LRB- O O
i.e. O O

GATA O O
, O O
AML1 O O
, O O
SRY O O
, O O
S8 O O
etc O O
. O O
-RRB- O O
. O O

Proteins O O
of O O
the O O
GATA O O
family O O
have O O
been O O
detected O O
in O O
eosinophils O O
-LRB- O O
specifically O O
GATA-1 O O
, O O
GATA-2 O O
and O O
low O O
levels O O
of O O
GATA-3 O O
-RRB- O O
-LSB-33 O O
-RSB- O O
. O O

Additionally B-conn Conjunction
, O O
GATA-1 O O
transactivates O O
the O O
EOS47 O O
promoter O O
, O O
an O O
eosinophil-specific O O
promoter O O
, O O
through O O
a O O
site O O
in O O
the O O
5 O O
' O O
UTR O O
-LSB-34 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
we O O
hypothesized O O
that O O
proteins O O
of O O
the O O
GATA O O
family O O
bind O O
to O O
sites O O
in O O
exon O O
1 O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
address O O
the O O
binding O O
of O O
GATA O O
proteins O O
to O O
CCR3 O O
exon O O
1 O O
, O O
we O O
prepared O O
oligonucleotides O O
corresponding O O
to O O
probe O O
E1-B O O
and O O
-C O O
with O O
the O O
GATA O O
site O O
mutated O O
. O O

As O O
demonstrated O O
in O O
Figure O O
3A O O
, O O
when B-conn Temporal.Synchronous
used O O
as O O
cold O O
competitor O O
, O O
the O O
GATA O O
mutant O O
oligonucleotide O O
was O O
not O O
capable O O
of O O
interfering O O
with O O
the O O
binding O O
of O O
nuclear O O
factors O O
to O O
either O O
CCR3 O O
exon O O
1 O O
probe O O
E1-B O O
or O O
probe O O
E1-C O O
. O O

Additionally B-conn Conjunction
, O O
we O O
used O O
a O O
GATA O O
consensus O O
oligonucleotide O O
with O O
binding O O
sites O O
for O O
GATA O O
proteins O O
. O O

This O O
oligonucleotide O O
completely O O
abolished O O
binding O O
of O O
nuclear O O
factors O O
to O O
both O O
CCR3 O O
exon O O
1 O O
probes O O
E1-B O O
and O O
E1-C O O
-LRB- O O
Figure O O
3A O O
-RRB- O O
. O O

Together O O
, O O
these O O
data O O
indicate O O
that O O
GATA O O
proteins O O
, O O
present O O
in O O
nuclear O O
extracts O O
of O O
AML14.3D10 O O

cells O O
, O O
are O O
capable O O
of O O
binding O O
to O O
CCR3 O O
exon O O
1 O O
sequence O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
delineate O O
which O O
GATA O O
factors O O
are O O
binding O O
to O O
exon O O
1 O O
, O O
nuclear O O
extracts O O
from O O
AML14.3D10 O O
cells O O
were O O
incubated O O
with O O
the O O
radiolabelled O O
full-length O O
CCR3 O O
exon O O
1 O O
probe O O
in O O
the O O
presence O O
or O O
absence O O
of O O
anti-GATA-1 O O
antibody O O
. O O

As O O
seen O O
in O O
Figure O O
3B O O
, O O
the O O
GATA-1 O O
antibody O O
was O O
able O O
to O O
interfere O O
with O O
the O O
binding O O
of O O
the O O
protein O O
factor O O
from O O
the O O
nuclear O O
extracts O O
to O O
the O O
radiolabelled O O
probe O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
more O O
precisely O O
localize O O
to O O
which O O
part O O
of O O
exon O O
1 O O
GATA-1 O O
is O O
capable O O
of O O
binding O O
, O O
overlapping O O
oligonucleotide O O
probes O O
were O O
radiolabelled O O
and O O
incubated O O
with O O
nuclear O O
extracts O O
from O O
AML14.3D10 O O
cells O O
in O O
the O O
presence O O
and O O
absence O O
of O O
the O O
GATA-1 O O
antibody O O
. O O

This O O
treatment O O
efficiently O O
inhibited O O
the O O
binding O O
of O O
probes O O
E1-B O O
and O O
-C O O
to O O
the O O
nuclear O O
factor O O
-LRB- O O
Figure O O
3C O O
-RRB- O O
. O O

These O O
data O O
indicate O O
that O O
GATA-1 O O
, O O
present O O
in O O
nuclear O O
extracts O O
of O O
AML14.3D10 O O

cells O O
, O O
is O O
at O O
least O O
one O O
of O O
the O O
factors O O
capable O O
of O O
binding O O
the O O
CCR3 O O
exon O O
1 O O
between O O
bp O O
25 O O
and O O
60 O O
. O O

We O O
have O O
previously O O
characterized O O
the O O
human O O
CCR3 O O
promoter O O
in O O
vitro O O
-LSB-27 O O
-RSB- O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
determine O O
if O O
this O O
region O O
had O O
promoter O O
activity O O
in O O
vivo O O
and O O
to O O
assess O O
cell-specificity O O
, O O
we O O
generated O O
transgenic O O
mice O O
expressing O O
the O O
reporter O O
gene O O
EGFP O O
under O O
the O O
control O O
of O O
the O O
CCR3 O O
promoter O O
-LRB- O O
Figure O O
4A O O
-RRB- O O
. O O

1.6 O O
kb O O
of O O
the O O
promoter O O
and O O
60 O O
base O O
pairs O O
of O O
exon O O
1 O O
were O O
cloned O O
upstream O O
of O O
the O O
EGFP O O
gene O O
. O O

Seven O O
transgenic O O
founder O O
lines O O
were O O
identified O O
. O O

Two O O
of O O
the O O
founder O O
lines O O
did O O
not O O
transmit O O
the O O
transgene O O
to O O
their O O
offspring O O
and B-conn Conjunction
one O O
line O O
did O O
not O O
show O O
transgene O O
expression O O
as O O
determined O O
by O O
Northern O O
blotting O O
and O O
RT-PCR O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
four O O
of O O
the O O
lines O O
the O O
level O O
and O O
pattern O O
of O O
transgene O O
expression O O
varied O O
suggesting O O
integration O O
site O O
effects O O
. O O

Two O O
of O O
the O O
lines O O
-LRB- O O
4.1 O O
and O O
4.2 O O
-RRB- O O
displayed O O
minimal O O
mRNA O O
expression O O
and O O
were O O
not O O
further O O
analyzed O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
other O O
two O O
lines O O
-LRB- O O
3.1 O O
and O O
3.2 O O
-RRB- O O
showed O O
high O O
expression O O
of O O
the O O
transgene O O
in O O
multiple O O
tissues O O
. O O

Line O O
3.1 O O
displayed O O
varying O O
levels O O
of O O
mRNA O O
expression O O
in O O
all O O
organs O O
tested O O
: O O
lungs O O
, O O
kidneys O O
, O O
jejunum O O
, O O
thymus O O
, O O
bone O O
marrow O O
, O O
and O O
spleen O O
, O O
with O O
highest O O
expression O O
in O O
the O O
thymus O O
-LRB- O O
by O O
Northern O O
blot O O
analysis O O
, O O
Figure O O
4B O O
and O O
RT-PCR O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

While B-conn Concession.Expectation
we O O
expected O O
the O O
transcript O O
to O O
be O O
about O O
1 O O
kb O O
in O O
size O O
-LRB- O O
Figure O O
4A O O
-RRB- O O
, O O
two O O
bands O O
~4 O O
and O O
5 O O
kb O O
were O O
apparent O O
. O O

Since B-conn Cause.Justification
this O O
was O O
not O O
the O O
case O O
with O O
other O O
lines O O
, O O
we O O
suspect O O
it O O
is O O
integration-site O O
specific O O
and B-conn Conjunction
another O O
gene O O
may O O
have O O
been O O
transcribed O O
together O O
with O O
GFP O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
size O O
of O O
the O O
RT-PCR O O
amplified O O
fragment O O
was O O
of O O
the O O
expected O O
size O O
and B-conn Conjunction
the O O
protein O O
was O O
detectable O O
by O O
immunohistochemistry O O
-LRB- O O
see O O
below O O
-RRB- O O
thus B-conn Cause.Claim
implying O O
that O O
this O O
did O O
not O O
affect O O
the O O
translation O O
of O O
the O O
protein O O
and O O
integrity O O
of O O
the O O
epitope O O
for O O
the O O
antibody O O
. O O

Expression O O
in O O
the O O
lungs O O
, O O
jejunum O O
, O O
thymus O O
and O O
kidney O O
was O O
confirmed O O
by O O
anti-GFP O O
immunohistochemistry O O
-LRB- O O
Figure O O
4C O O
and O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
the O O
jejunum O O
, O O
staining O O
was O O
present O O
predominantly O O
in O O
stromal O O
cells O O
-LRB- O O
Figure O O
4C O O
-RRB- O O
. O O

Of O O
note O O
, O O
eosinophils O O
normally O O
reside O O
in O O
the O O
gastrointestinal O O
tract O O
and O O
are O O
located O O
in O O
the O O
stroma O O
of O O
the O O
jejunum O O
. O O

However B-conn Contrast
, O O
in O O
the O O
lungs O O
, O O
which O O
are O O
normally O O
devoid O O
of O O
eosinophils O O
at O O
baseline O O
, O O
there O O
was O O
GFP O O
expression O O
that O O
was O O
confined O O
to O O
the O O
alveolar O O
lining O O
consistent O O
with O O
predominant O O
expression O O
in O O
type O O
I O O
pneumocytes O O
-LRB- O O
Figure O O
4C O O
-RRB- O O
. O O

In O O
the O O
thymus O O
, O O
compared O O
to O O
staining O O
without O O
primary O O
antibody O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
all O O
thymocytes O O
stained O O
positive O O
for O O
GFP O O
. O O

Additionally B-conn Conjunction
, O O
in O O
the O O
kidney O O
all O O
cells O O
were O O
positive O O
, O O
both O O
in O O
the O O
medulla O O
and O O
cortex O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Line O O
3.2 O O
displayed O O
a O O
different O O
pattern O O
of O O
transgene O O
expression O O
. O O

Northern O O
blot O O
analysis O O
revealed O O
expression O O
in O O
multiple O O
organs O O
with O O
the O O
lungs O O
and O O
kidneys O O
expressing O O
the O O
highest O O
levels O O
-LRB- O O
Figure O O
4B O O
-RRB- O O
. O O

Consistent O O
with O O
this O O
, O O
protein O O
was O O
detected O O
by O O
immunohistochemistry O O
at O O
high O O
levels O O
in O O
lungs O O
and O O
kidneys O O
and O O
only O O
marginally O O
in O O
the O O
jejunum O O
-LRB- O O
Figure O O
4C O O
and O O
data O O
not O O
shown O O
-RRB- O O
. O O

While B-conn Contrast
staining O O
in O O
the O O
lungs O O
was O O
comparable O O
to O O
line O O
3.1 O O
, O O
only O O
a O O
minority O O
of O O
stromal O O
cells O O
and O O
no O O
epithelial O O
cells O O
were O O
stained O O
in O O
the O O
jejunum O O
. O O

In O O
the O O
kidney O O
, O O
almost O O
all O O
cells O O
expressed O O
the O O
transgene O O
in O O
the O O
medulla O O
, O O
while B-conn Contrast
in O O
the O O
cortex O O
staining O O
was O O
prominent O O
in O O
the O O
glomeruli O O
. O O

There O O
was O O
no O O
anti-GFP O O
staining O O
observed O O
in O O
wild O O
type O O
mice O O
-LRB- O O
Figure O O
4C O O
-RRB- O O
. O O

No O O
changes O O
in O O
expression O O
were O O
found O O
when O O
the O O
transgene O O
was O O
crossed O O
with O O
CD2.IL-5 O O
transgenic O O
mice O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

In B-conn Restatement.Generalization
summary I-conn Restatement.Generalization
, O O
the O O
1.6 O O
kb O O
of O O
the O O
5 O O
' O O
flanking O O
region O O
of O O
the O O
CCR3 O O
gene O O
has O O
strong O O
promoter O O
activity O O
in O O
vivo O O
. O O

However B-conn Concession.Contra-expectation
, O O
both O O
the O O
level O O
and O O
pattern O O
of O O
expression O O
vary O O
between O O
founder O O
lines O O
and O O
lack O O
cell O O
specificity O O
. O O

Thus B-conn Cause.Claim
, O O
the O O
identified O O
region O O
of O O
the O O
CCR3 O O
promoter O O
contains O O
a O O
broadly O O
active O O
promoter O O
with O O
hematopoietic O O
and O O
non-hematopoietic O O
activity O O
. O O

Discussion O O

In O O
this O O
report O O
, O O
DNase O O
I O O
hypersensitivity O O
implicated O O
untranslated O O
exon O O
1 O O
in O O
regulating O O
CCR3 O O
transcription O O
. O O

Furthermore B-conn Conjunction
, O O
nuclear O O
proteins O O
derived O O
from O O
eosinophilic O O
cells O O
were O O
shown O O
to O O
bind O O
CCR3 O O
exon O O
between O O
nucleotides O O
+25 O O
to O O
+60 O O
. O O

Using O O
unlabelled O O
competitors O O
and O O
antibodies O O
, O O
proteins O O
of O O
the O O
GATA O O
family O O
, O O
specifically O O
GATA-1 O O
, O O
were O O
shown O O
to O O
bind O O
to O O
this O O
region O O
. O O

Taken O O
together O O
, O O
these O O
data O O
suggest O O
that O O
untranslated O O
exon O O
1 O O
, O O
via O O
GATA-1 O O
, O O
has O O
a O O
regulatory O O
role O O
in O O
CCR3 O O
transcription O O
. O O

Finally B-conn Temporal.Precedence
, O O
we O O
demonstrate O O
that O O
the O O
1.6-kb O O

CCR3 O O
promoter O O
element O O
, O O
that O O
includes O O
exon O O
1 O O
, O O
is O O
broadly O O
active O O
in O O
vivo O O
. O O

The O O
HS1 O O
site O O
was O O
located O O
in O O
the O O
vicinity O O
of O O
exon O O
1 O O
. O O

Combined O O
with O O
our O O
previous O O
results O O
demonstrating O O
diminished O O
promoter O O
activity O O
when O O
exon O O
1 O O
is O O
deleted O O
from O O
the O O
promoter O O
construct O O
, O O
these O O
data O O
suggested O O
that O O
5 O O
' O O
untranslated O O
exon O O
1 O O
may O O
have O O
a O O
regulatory O O
function O O
. O O

It O O
has O O
been O O
reported O O
that O O
the O O
5 O O
' O O
untranslated O O
exons O O
may O O
contain O O
sequences O O
that O O
facilitate O O
transcription O O
of O O
the O O
gene O O
. O O

Examples O O
include O O
a O O
GATA-1 O O
site O O
in O O
the O O
5'-UTR O O
of O O
the O O
γ-globin O O
gene O O
, O O
an O O
HNF-1 O O
site O O
in O O
the O O
plasminogen O O
gene O O
, O O
a O O
PU.1 O O
site O O
in O O
the O O
PU.1 O O
gene O O
and O O
a O O
C/EBP O O
site O O
in O O
the O O
CCR2 O O
gene O O
-LSB-24,31,32,35 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
, O O
we O O
hypothesized O O
that O O
nuclear O O
proteins O O
bind O O
to O O
exon O O
1 O O
. O O

Our O O
EMSA O O
analysis O O
, O O
coupled O O
with O O
cold O O
competitors O O
and O O
specific O O
antibodies O O
, O O
indicates O O
that O O
proteins O O
of O O
the O O
GATA O O
family O O
, O O
specifically O O
GATA-1 O O
bind O O
to O O
the O O
CCR3 O O
exon O O
1 O O
. O O

Thus B-conn Cause.Claim
, O O
GATA-1 O O
binding O O
to O O
exon O O
1 O O
may O O
regulate O O
CCR3 O O
transcription O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
GATA-1 O O
binding O O
to O O
exon O O
1 O O
may O O
affect O O
transcription O O
start O O
site O O
function O O
, O O
RNA O O
stability O O
or O O
translation O O
. O O

These O O
possibilities O O
will O O
be O O
addressed O O
in O O
future O O
studies O O
. O O

It O O
is O O
important O O
that O O
this O O
data O O
be O O
viewed O O
with O O
what O O
is O O
known O O
about O O
other O O
myeloid-specific O O
promoters O O
, O O
that O O
have O O
often O O
proven O O
to O O
be O O
difficult O O
to O O
function O O
independently O O
in O O
vivo O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
constructs O O
using O O
the O O
5 O O
' O O
flanking O O
region O O
of O O
myeloid-specific O O
genes O O
have O O
not O O
been O O
useful O O
for O O
transgenic O O
work O O
-LRB- O O
such O O
as O O
the O O
CD14 O O
promoter O O
-LSB-36 O O
-RSB- O O
, O O
the O O
c-kit O O
promoter O O
-LSB-37 O O
-RSB- O O
, O O
or O O
the O O
1.7 O O
kb O O
CD11b O O
promoter O O
-LSB-38 O O
-RSB- O O
-RRB- O O
. O O

Better O O
success O O
was O O
obtained O O
when B-conn Temporal.Synchronous
the O O
entire O O
gene O O
, O O
including O O
the O O
open O O
reading O O
frame O O
, O O
was O O
used O O
-LRB- O O
e.g. O O
the O O
human O O
cathepsin O O
G O O
, O O
chicken O O
lysozyme O O
and O O
c-fps/fes O O
transgenic O O
constructs O O
-LSB-39-41 O O
-RSB- O O
-RRB- O O
. O O

These O O
constructs O O
were O O
at O O
least O O
6 O O
kb O O
in O O
size O O
and O O
contained O O
all O O
exons O O
and O O
introns O O
and O O
several O O
kb O O
of O O
5 O O
' O O
and O O
3 O O
' O O
flanking O O
sequence O O
. O O

Presumably O O
, O O
these O O
larger O O
constructs O O
contained O O
the O O
locus O O
control O O
region O O
-LRB- O O
LCR O O
-RRB- O O
- O O
sequences O O
that O O
have O O
the O O
ability O O
to O O
dominantly O O
control O O
gene O O
expression O O
in O O
any O O
chromosomal O O
region O O
. O O

This O O
in B-conn Cause.Result
turn I-conn Cause.Result
allows O O
for O O
a O O
high O O
degree O O
of O O
consistency O O
among O O
independent O O
mouse O O
lines O O
with O O
regard O O
to O O
cell O O
specificity O O
, O O
level O O
of O O
expression O O
and O O
proportionality O O
to O O
gene O O
copy O O
number O O
. O O

These O O
regions O O
may O O
be O O
located O O
at O O
several O O
different O O
sites O O
in O O
the O O
gene O O
, O O
including O O
introns O O
and O O
coding O O
exons O O
; O O
thus B-conn Cause.Result
, O O
screening O O
with O O
DNase O O
I O O
hypersensitivity O O
is O O
usually O O
the O O
first O O
method O O
employed O O
to O O
identify O O
these O O
regions O O
. O O

Transgenic O O
mice O O
expressing O O
the O O
EGFP O O
reporter O O
gene O O
under O O
the O O
control O O
of O O
the O O
CCR3 O O
promoter O O
demonstrate O O
that O O
the O O
1.6 O O
kb O O
promoter O O
and O O
60 O O
bp O O
of O O
exon O O
1 O O
of O O
the O O
CCR3 O O
gene O O
confer O O
strong O O
promoter O O
activity O O
in O O
vivo O O
. O O

However B-conn Concession.Contra-expectation
, O O
these O O
sequences O O
do O O
not O O
contain O O
the O O
entire O O
LCR O O
, O O
since B-conn Cause.Reason
expression O O
of O O
the O O
reporter O O
gene O O
was O O
variable O O
among O O
multiple O O
founder O O
lines O O
. O O

DNase O O
I O O
hypersensitivity O O
studies O O
discovered O O
one O O
hypersensitive O O
site O O
in O O
the O O
CCR3 O O
locus O O
. O O

The O O
HS1 O O
site O O
was O O
apparently O O
not O O
sufficient O O
for O O
integration-site O O
independent O O
effects O O
, O O
since B-conn Cause.Reason
it O O
is O O
contained O O
in O O
the O O
promoter O O
construct O O
used O O
. O O

Thus B-conn Cause.Result
, O O
future O O
studies O O
will O O
need O O
to O O
broaden O O
the O O
search O O
for O O
the O O
CCR3 O O
LCR O O
. O O

It O O
is O O
important O O
to O O
note O O
that O O
the O O
true O O
cellular O O
specificity O O
of O O
CCR3 O O
has O O
not O O
been O O
established O O
. O O

While B-conn Concession.Expectation
this O O
gene O O
product O O
is O O
often O O
considered O O
to O O
be O O
specific O O
for O O
inflammatory O O
cells O O
involved O O
in O O
allergic O O
inflammation O O
-LRB- O O
eosinophils O O
, O O
mast O O
cells O O
, O O
and O O
possibly O O
Th2 O O
cells O O
-RRB- O O
, O O
several O O
reports O O
have O O
documented O O
expression O O
by O O
other O O
cell O O
types O O
including O O
additional O O
leukocytes O O
-LRB- O O
e.g. O O

dendritic O O
cells O O
-RRB- O O
, O O
as O O
well O O
as O O
tissue O O
cells O O
-LRB- O O
epithelial O O
and O O
endothelial O O
cells O O
-RRB- O O
-LSB-11-16,42 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
, O O
it O O
remains O O
to O O
be O O
determined O O
if O O
our O O
observation O O
that O O
the O O
CCR3 O O
promoter O O
has O O
broad O O
activity O O
in O O
vivo O O
represents O O
the O O
true O O
endogenous O O
activity O O
. O O

Since B-conn Cause.Reason
CCR3 O O
is O O
expressed O O
strongly O O
on O O
eosinophils O O
, O O
analysis O O
of O O
the O O
signals O O
that O O
induce O O
its O O
expression O O
may O O
give O O
insight O O
into O O
the O O
molecular O O
mechanisms O O
for O O
the O O
commitment O O
of O O
myeloid O O
progenitors O O
to O O
the O O
eosinophil O O
lineage O O
. O O

It O O
is O O
generally O O
believed O O
that O O
transcription O O
factors O O
are O O
the O O
final O O
common O O
pathway O O
driving O O
differentiation O O
and B-conn Conjunction
that O O
hematopoietic O O
commitment O O
to O O
different O O
lineages O O
is O O
driven O O
by O O
alternative O O
expression O O
of O O
specific O O
combinations O O
of O O
transcription O O
factors O O
-LSB-43,44 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
no O O
eosinophil-specific O O
transcription O O
factors O O
have O O
been O O
reported O O
, O O
eosinophil O O
commitment O O
appears O O
to O O
be O O
regulated O O
by O O
GATA-1 O O
, O O
PU-1 O O
and O O
C/EBP O O
proteins O O
-LSB-34,45-48 O O
-RSB- O O
. O O

Consistent O O
with O O
this O O
, O O
DNA O O
binding O O
sites O O
for O O
these O O
transcription O O
factors O O
are O O
found O O
in O O
several O O
eosinophil-selective O O
promoters O O
, O O
such O O
as O O
the O O
promoter O O
for O O
major O O
basic O O
protein O O
-LRB- O O
MBP O O
-RRB- O O
, O O
IL-5 O O
receptor O O
alpha O O
-LRB- O O
IL-5Rα O O
-RRB- O O
chain O O
and O O
Charcot-Leyden O O
crystal O O
-LRB- O O
CLC O O
-RRB- O O
protein O O
. O O

Specifically B-conn Restatement.Specification
, O O
ectopic O O
overexpression O O
of O O
GATA-1 O O
in O O
chicken O O
myeloblasts O O
leads O O
to O O
transdifferentiation O O
into O O
eosinophils O O
or O O
thromboblasts O O
depending O O
on O O
the O O
dose O O
used O O
-LSB-47 O O
-RSB- O O
. O O

GATA-1 O O
transactivates O O
several O O
eosinophil-selective O O
promoters O O
-LSB-48 O O
-RSB- O O
including O O
the O O
avian O O
EOS47 O O
promoter O O
in O O
which O O
the O O
GATA-1 O O
site O O
is O O
located O O
downstream O O
of O O
the O O
transcription O O
start O O
site O O
-LSB-34 O O
-RSB- O O
. O O

Conclusion O O

In O O
summary O O
, O O
in O O
this O O
report O O
we O O
have O O
demonstrated O O
that O O
: O O
1 O O
-RRB- O O
DNase O O
I O O
hypersensitivity O O
studies O O
implicate O O
untranslated O O
exon O O
1 O O
in O O
CCR3 O O
transcription O O
; O O
2 O O
-RRB- O O
proteins O O
of O O
the O O
GATA O O
family O O
, O O
specifically O O
GATA-1 O O
, O O
bind O O
to O O
untranslated O O
exon O O
1 O O
in O O
the O O
CCR3 O O
gene O O
; O O
and B-conn Conjunction
3 O O
-RRB- O O
the O O
1.6 O O
kb O O
5 O O
' O O
flanking O O
region O O
of O O
the O O
CCR3 O O
gene O O
is O O
broadly O O
active O O
as O O
a O O
promoter O O
in O O
vivo O O
. O O

Methods O O

The O O
AML14.3D10 O O
cell O O
line O O
-LRB- O O
kindly O O
provided O O
by O O
C.C. O O
Paul O O
, O O
Dayton O O
VA O O
Medical O O
Center O O
, O O
Dayton O O
, O O
OH O O
-RRB- O O
-LSB-49,50 O O
-RSB- O O
was O O
grown O O
in O O
RPMI O O
1640 O O
-LRB- O O
Gibco O O
BRL O O
, O O
Gaithersburg O O
, O O
MD O O
-RRB- O O
containing O O
10 O O
% O O
fetal O O
calf O O
serum O O
-LRB- O O
FCS O O
, O O
Gibco O O
BRL O O
-RRB- O O
, O O
50 O O
μM O O
2-mercaptoethanol O O
-LRB- O O
Sigma O O
, O O
St. O O
Louis O O
, O O
MO O O
-RRB- O O
, O O
0.1 O O
mM O O
nonessential O O
amino O O
acids O O
-LRB- O O
Gibco O O
BRL O O
-RRB- O O
, O O
1 O O
mM O O
sodium O O
pyruvate O O
-LRB- O O
Sigma O O
-RRB- O O
, O O
and O O
penicillin-streptomycin O O
-LRB- O O
Gibco O O
BRL O O
-RRB- O O
. O O

Eosinophils O O
were O O
isolated O O
by O O
anti-CD16 O O
negative O O
selection O O
from O O
granulocyte O O
preparations O O
of O O
healthy O O
or O O
atopic O O
volunteers O O
as O O
described O O
previously O O
-LSB-51 O O
-RSB- O O
. O O

Nuclei O O
were O O
derived O O
from O O
cell O O
lines O O
and O O
primary O O
cells O O
using O O
a O O
polyamine O O
buffer O O
containing O O
0.34 O O
M O O
sucrose O O
, O O
13.3 O O
mM O O
Tris O O
-LRB- O O
pH7.5 O O
-RRB- O O
, O O

53.2 O O
mM O O
KCl O O
, O O
13.3 O O
mM O O
NaCl O O
, O O
2 O O
mM O O
EDTA O O
, O O
0.5 O O
mM O O
EGTA O O
, O O
0.133 O O
mM O O
spermine O O
, O O
0.5 O O
mM O O
spermidine O O
, O O
0.1 O O
% O O
TritonX-100 O O
, O O
2 O O
mM O O
MgCl2 O O
and O O
freshly O O
prepared O O
2-mercaptoethanol O O
and O O
phenylmethylsulfonyl O O
fluoride O O
-LRB- O O
PMSF O O
-RRB- O O
. O O

Nuclei O O
were O O
then B-conn Temporal.Precedence
centrifuged O O
at O O
2300 O O
g O O
for O O
30 O O
min O O
over O O
a O O
cushion O O
of O O
1.2 O O
M O O
sucrose O O
and O O
washed O O
twice O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
resuspension O O
in O O
DNase O O
I O O
digestion O O
buffer O O
-LRB- O O
60 O O
mM O O
KCl O O
, O O
5 O O
mM O O
MgCl2 O O
, O O
15 O O
mM O O
Tris O O
-LRB- O O
pH7.5 O O
-RRB- O O
, O O

0.1 O O
mM O O
EGTA O O
, O O
0.5 O O
mM O O
DTT O O
and O O
5 O O
% O O
glycerol O O
-RRB- O O
. O O

Nuclei O O
were O O
resuspended O O
at O O
a O O
concentration O O
of O O
2–4 O O
× O O
106 O O
nuclei/ml O O
and B-conn Conjunction
gentle O O
DNase O O
I O O
digestion O O
was O O
carried O O
out O O
in O O
a O O
volume O O
of O O
0.2 O O
ml O O
with O O
0 O O
to O O
100 O O
units O O
of O O
DNase O O
I O O
-LRB- O O
Roche O O
-RRB- O O
for O O
5 O O
minutes O O
at O O
30°C O O
. O O

Following O O
DNase O O
I O O
treatment O O
, O O
nuclei O O
were O O
lysed O O
and O O
DNA O O
purified O O
by O O
phenol/chloroform O O
extraction O O
and O O
ethanol O O
precipitation O O
. O O

DNA O O
was O O
digested O O
with O O
appropriate O O
restriction O O
enzymes O O
-LRB- O O
Eco O O
RI O O
and O O
Hind O O
III O O
-RRB- O O
and O O
electrophoresed O O
on O O
a O O
0.8 O O
% O O
agarose O O
gel O O
. O O

Following B-conn Temporal.Succession
transfer O O
to O O
nylon O O
membranes O O
, O O
hybridization O O
was O O
performed O O
using O O
standard O O
procedures O O
. O O

Probe O O
fragments O O
were O O
made O O
by O O
PCR O O
from O O
genomic O O
DNA. O O
Figure O O
1 O O
depicts O O
the O O
CCR3 O O
gene O O
structure O O
and O O
restriction O O
fragments O O
and O O
their O O
corresponding O O
probes O O
that O O
were O O
used O O
to O O
span O O
the O O
entire O O
gene O O
. O O

Cultured O O
cells O O
were O O
washed O O
twice O O
with O O
ice O O
cold O O
phosphate O O
buffered O O
saline O O
-LRB- O O
PBS O O
, O O
Gibco O O
BRL O O
-RRB- O O
. O O

2.5 O O
× O O
106 O O
cells O O
were O O
lysed O O
in O O
lysis O O
buffer O O
-LSB-100 O O
mM O O
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic O O
acid O O
-LRB- O O
HEPES O O
-RRB- O O
, O O
pH O O
7.9 O O
, O O
10 O O
mM O O
KCl O O
, O O
0.1 O O
mM O O
EDTA O O
, O O
1.5 O O
mM O O
MgCl2 O O
, O O
0.2 O O
% O O
Nonidet O O
P-40 O O
, O O
1 O O
mM O O
dithiothreitol O O
-LRB- O O
DTT O O
-RRB- O O
, O O
and O O
0.5 O O
mM O O
PMSF O O
-RSB- O O
, O O
briefly O O
vortexed O O
at O O
a O O
moderate O O
speed O O
, O O
then B-conn Temporal.Precedence
incubated O O
on O O
ice O O
for O O
5 O O
minutes O O
. O O

Sample O O
was O O
centrifuged O O
and B-conn Conjunction
the O O
pellet O O
was O O
next B-conn Temporal.Precedence
resuspended O O
in O O
20 O O
μl O O
of O O
extraction O O
buffer O O
-LRB- O O
20 O O
mM O O
HEPES O O
, O O
pH O O
7.9 O O
, O O
420 O O
mM O O
NaCl O O
, O O
0.1 O O
mM O O
EDTA O O
, O O
1.5 O O
mM O O
MgCl2 O O
, O O
25 O O
% O O
glycerol O O
, O O
1 O O
mM O O
DTT O O
, O O
and O O
0.5 O O
mM O O
PMSF O O
-RRB- O O
, O O
mildly O O
vortexed O O
, O O
and O O
incubated O O
on O O
ice O O
for O O
15 O O
minutes O O
. O O

Samples O O
were O O
centrifuged O O
to B-conn Purpose.Goal
pellet O O
the O O
nuclear O O
debris O O
. O O

Supernatants O O
were O O
placed O O
in O O
silicon O O
coated O O
microcentrifuge O O
tubes O O
and O O
stored O O
at O O
-80°C O O
until B-conn Temporal.Precedence
further O O
use O O
. O O

Single-stranded O O
oligonucleotides O O
based O O
on O O
the O O
sequence O O
of O O
untranslated O O
exon O O
1 O O
of O O
the O O
CCR3 O O
promoter O O
were O O
synthesized O O
by O O
Integrated O O
DNA O O
Technologies O O
, O O
Inc. O O
-LRB- O O
Coralville O O
, O O
IA O O
-RRB- O O
. O O

One O O
full O O
length O O
51 O O
base O O
pair O O
-LRB- O O
+10 O O
to O O
+60 O O
-RRB- O O
oligonucleotide O O
-LRB- O O
GGTACCACTGGTCTTCTTGTGCTTATCCGGGCAAGAACTTATCGAAATACA O O
-RRB- O O
and O O
three O O
overlapping O O
oligonucleotides O O
-LRB- O O
+10 O O
to O O
+31 O O
, O O
+25 O O
to O O
+46 O O
, O O
and O O
+40 O O
to O O
+60 O O
-RRB- O O
and O O
their O O
reverse O O
complements O O
were O O
produced O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

Two O O
of O O
the O O
overlapping O O
fragments O O
contained O O
putative O O
GATA O O
binding O O
sites O O
-LRB- O O
underlined O O
-RRB- O O
. O O

Two O O
mutants O O
and O O
their O O
complements O O
were O O
also B-conn Conjunction
made O O
which O O
changed O O
the O O
GATA O O
sequence O O
TATC O O
to O O
TTGA O O
. O O

This O O
mutation O O
does O O
not O O
change O O
the O O
GC O O
content O O
of O O
the O O
oligonucleotides O O
, O O
nor B-conn Alternative.Disjunctive
does O O
it O O
create O O
a O O
new O O
transcription O O
factor O O
site O O
for O O
any O O
of O O
the O O
transcription O O
factors O O
represented O O
in O O
the O O
publicly O O
available O O
TFSEARCH O O
engine O O
. O O

Each O O
oligonucleotide O O
was O O
resuspended O O
to O O
a O O
concentration O O
of O O
50 O O
μM O O
in O O
TE O O
buffer O O
-LRB- O O
10 O O
mM O O
Tris-Cl O O
, O O
pH O O
7.4 O O
, O O
and O O
0.1 O O
mM O O
EDTA O O
, O O
Sigma O O
-RRB- O O
. O O

Complimentary O O
single-stranded O O
oligonucleotides O O
were O O
annealed O O
at O O
a O O
concentration O O
of O O
10 O O
mM O O
in O O
restriction O O
enzyme O O
buffer O O
M O O
-LRB- O O
10 O O
mM O O
Tris-Cl O O
, O O
10 O O
mM O O
MgCl2 O O
, O O
50 O O
mM O O
NaCl O O
, O O
and O O
1 O O
mM O O
dithioerythritol O O
, O O
Roche O O
Molecular O O
Biochemicals O O
, O O
Indianapolis O O
, O O
IN O O
-RRB- O O
. O O

Samples O O
were O O
placed O O
in O O
a O O
95°C O O
dry O O
heat O O
block O O
for O O
5 O O
minutes O O
and O O
then B-conn Temporal.Precedence
the O O
block O O
was O O
removed O O
from O O
the O O
unit O O
and O O
allowed O O
to O O
cool O O
slowly O O
to O O
room O O
temperature O O
. O O

The O O
double-stranded O O
oligomers O O
were O O
diluted O O
to O O
1 O O
μM O O
with O O
TE O O
buffer O O
and B-conn Conjunction
30 O O
ng O O
were O O
end-labelled O O
using O O
-LSB-γ-32P O O
-RSB- O O
ATP O O
-LRB- O O
NEN O O
Life O O
Science O O
, O O
Boston O O
, O O
MA O O
-RRB- O O
and O O
T4 O O
polynucleotide O O
kinase O O
-LRB- O O
Gibco O O
BRL O O
-RRB- O O
. O O

Probe O O
was O O
purified O O
over O O
Quick O O
Spin O O
G-25 O O
Sephadex O O
columns O O
-LRB- O O
Roche O O
-RRB- O O
and O O
recovered O O
in O O
a O O
volume O O
of O O
50 O O
μl O O
. O O

Protein O O
content O O
of O O
the O O
nuclear O O
extracts O O
were O O
determined O O
by O O
Bradford O O
-LRB- O O
Coomassie O O
-RRB- O O
assay O O
-LRB- O O
Pierce O O
, O O
Rockford O O
, O O
IL O O
-RRB- O O
. O O

Total O O
protein O O
-LRB- O O
5 O O
μg O O
-RRB- O O
was O O
incubated O O
on O O
ice O O
for O O
10 O O
minutes O O
with O O
2X O O
EMSA O O
buffer O O
-LRB- O O
24 O O
% O O
glycerol O O
, O O
0.08 O O
μg/ml O O
poly O O
dI-dC O O
, O O
24 O O
mM O O
HEPES O O
, O O
pH O O
7.9 O O
, O O
8 O O
mM O O
Tris-Cl O O
, O O
pH O O
7.9 O O
, O O
2 O O
mM O O
EDTA O O
, O O
2 O O
mM O O
DTT O O
, O O
50 O O
mM O O
KCl O O
, O O
and O O
10 O O
mM O O
MgCl2 O O
, O O
-RRB- O O
, O O
and O O
when B-conn Temporal.Synchronous
indicated O O
, O O
with O O
150 O O
fold O O
excess O O
of O O
cold O O
competitor O O
oligonucleotide O O
. O O

Radiolabelled O O
oligo O O
probe O O
was O O
added O O
to O O
each O O
sample O O
and B-conn Conjunction
incubation O O
continued O O
for O O
an O O
additional O O
10 O O
minutes O O
on O O
ice O O
. O O

For O O
antibody O O
supershift O O
assays O O
, O O
anti-GATA-1 O O
antibody O O
-LRB- O O
clone O O
C20 O O
, O O
Santa O O
Cruz O O
Biotechnology O O
, O O
Santa O O
Cruz O O
, O O
CA O O
-RRB- O O
was O O
added O O
following B-conn Temporal.Succession
the O O
addition O O
of O O
the O O
probe O O
and B-conn Conjunction
samples O O
incubated O O
on O O
ice O O
for O O
one O O
hour O O
. O O

In O O
control O O
experiments O O
, O O
isotype-control O O
antibodies O O
did O O
not O O
have O O
a O O
significant O O
effect O O
. O O

The O O
DNA-protein O O
complexes O O
were O O
then B-conn Temporal.Precedence
resolved O O
on O O
a O O
non-denaturing O O
5 O O
% O O
acrylamide O O
gel O O
-LSB-29:1 O O
acrylamide/bis-acrylamide O O
, O O
0.5X O O
TBE O O
buffer O O
-LRB- O O
44.5 O O
mM O O
Tris O O
, O O
44.5 O O
mM O O
borate O O
, O O
and O O
1 O O
mM O O
EDTA O O
-RRB- O O
, O O
and O O
25 O O
% O O
glycerol O O
-RSB- O O
at O O
constant O O
current O O
of O O
30 O O
mA O O
for O O
approximately O O
60 O O
minutes O O
. O O

Gels O O
were O O
dried O O
on O O
blotting O O
paper O O
and O O
exposed O O
to O O
x-ray O O
film O O
. O O

1.6 O O
kb O O
of O O
the O O
CCR3 O O
promoter O O
, O O
including O O
60 O O
bp O O
of O O
untranslated O O
exon O O
1 O O
, O O
was O O
subcloned O O
into O O
the O O
pEGFP O O
vector O O
-LRB- O O
Clontech O O
, O O
Palo O O
Alto O O
, O O
CA O O
-RRB- O O
. O O

The O O
transgenic O O
construct O O
containing O O
the O O
promoter O O
, O O
reporter O O
gene O O
enhanced O O
green O O
fluorescent O O
probe O O
-LRB- O O
EGFP O O
-RRB- O O
and O O
the O O
SV40 O O
polyadenylation O O
signal O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
were O O
liberated O O
by O O
Afl O O
II O O
and O O
Hind O O
III O O
digestion O O
and O O
injected O O
into O O
the O O
pronucleus O O
of O O
fertilized O O
eggs O O
from O O
FVB/N O O
mice O O
by O O
the O O
Transgenic O O
Core O O
Facility O O
at O O
Cincinnati O O
Children O O
's O O
Hospital O O
Medical O O
Center O O
. O O

Transgenic O O
mice O O
were O O
identified O O
by O O
Southern O O
blot O O
analysis O O
after B-conn Temporal.Succession
digestion O O
with O O
BamHI O O
, O O
using O O
the O O
SV40 O O
poly O O
A O O
fragment O O
as O O
a O O
probe O O
. O O

Lines O O
were O O
tested O O
for O O
expression O O
of O O
the O O
transgene O O
in O O
multiple O O
organs O O
by O O
Northern O O
blotting O O
and O O
RT-PCT O O
. O O

The O O
SV40 O O
poly O O
A O O
fragment O O
was O O
used O O
as O O
a O O
probe O O
for O O
Northern O O
blotting O O
. O O

PCR O O
primers O O
for O O
EGFP O O
were O O
as O O
follows O O
: O O
5 O O
' O O
ATGGTGAGCCAAGGGCGAG3 O O
' O O
and O O
5 O O
' O O
CTTGTACAGCTCGTCCATG3 O O
' O O
. O O
RNA O O
integrity O O
and O O
RT O O
efficiency O O
was O O
verified O O
by B-conn Purpose.Enablement
performing O O
PCR O O
for O O
β-actin O O
on O O
the O O
same O O
cDNA O O
samples O O
. O O

Primers O O
used O O
were O O
as O O
follows O O
: O O
5 O O
' O O
GGAATCCTGTGGCATCCATGAAACT3 O O
' O O
and O O
5 O O
' O O
TAAAACGCAGCTCAGTAACAGTCCG3 O O
' O O
. O O

Immunohistochemistry O O
was O O
performed O O
on O O
frozen O O
sections O O
essentially O O
as O O
described O O
-LSB-52 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
following B-conn Temporal.Succession
endogenous O O
peroxidase O O
quenching O O
, O O
slides O O
were O O
blocked O O
and O O
stained O O
with O O
a O O
rabbit-anti-GFP O O
antibody O O
-LRB- O O
AB3080 O O
at O O
1:400 O O
dilution O O
, O O
Chemicon O O
International O O
, O O
Temecula O O
, O O
CA O O
-RRB- O O
. O O

The O O
slides O O
were O O
washed O O
and O O
incubated O O
with O O
biotinylated O O
goat O O
anti-rabbit O O
antibody O O
and O O
avidin-peroxidase O O
complex O O
-LRB- O O
Vectastain O O
ABC O O
Peroxidase O O
Elite O O
kit O O
, O O
Vector O O
Laboratories O O
-RRB- O O
. O O

The O O
slides O O
were O O
then B-conn Temporal.Precedence
developed O O
by O O
nickel O O
diaminobenzidine O O
, O O
enhanced O O
nickel O O
cobalt O O
chloride O O
to O O
form O O
a O O
black O O
precipitate O O
and O O
counterstained O O
with O O
nuclear O O
fast O O
red O O
. O O

Authors O O
' O O
contributions O O

JLC O O
carried O O
out O O
the O O
EMSA O O
analysis O O
. O O

LEK O O
performed O O
the O O
DNAse O O
hypersensitivity O O
studies O O
. O O

NZ O O
carried O O
out O O
the O O
generation O O
and O O
analysis O O
of O O
transgenic O O
mice O O
, O O
participated O O
in O O
the O O
design O O
and O O
coordination O O
of O O
the O O
overall O O
study O O
and O O
drafted O O
the O O
manuscript O O
. O O

MER O O
participated O O
in O O
the O O
design O O
and O O
coordination O O
of O O
the O O
overall O O
study O O
and O O
helped O O
to O O
draft O O
the O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
DNase O O
I O O
hypersensitivity O O
studies O O
. O O

In O O
-LRB- O O
A O O
-RRB- O O
, O O
a O O
schematic O O
representation O O
of O O
the O O
CCR3 O O
gene O O
is O O
shown O O
. O O

Exons O O
1 O O
through O O
4 O O
-LRB- O O
E1 O O
– O O
E4 O O
-RRB- O O
are O O
depicted O O
as O O
boxes O O
; O O
open O O
box O O
represents O O
the O O
open O O
reading O O
frame O O
, O O
while B-conn Contrast
the O O
closed O O
box O O
represents O O
the O O
untranslated O O
region O O
. O O

The O O
position O O
of O O
Hind O O
III O O
-LRB- O O
H O O
-RRB- O O
and O O
Eco O O
RI O O
-LRB- O O
RI O O
-RRB- O O
restriction O O
sites O O
is O O
depicted O O
with O O
arrows O O
and B-conn Conjunction
probes O O
used O O
for O O
DNase O O
I O O
hypersensitivity O O
are O O
depicted O O
as O O
lines O O
above O O
the O O
genomic O O
fragment O O
. O O

The O O
position O O
of O O
hypersensitive O O
site O O
is O O
depicted O O
as O O
HS1 O O
. O O

In O O
-LRB- O O
B O O
-RRB- O O
, O O
Southern O O
blot O O
analysis O O
for O O
the O O
HS O O
site O O
is O O
shown O O
. O O

Nuclei O O
from O O
the O O
primary O O
human O O
eosinophils O O
were O O
digested O O
with O O
indicated O O
doses O O
of O O
DNase O O
I O O
for O O
5 O O
minutes O O
at O O
30°C O O
. O O

Following B-conn Temporal.Succession
DNA O O
purification O O
and O O
digestion O O
with O O
restriction O O
enzymes O O
-LRB- O O
shown O O
in O O
figure O O
is O O
Eco O O
RI O O
-RRB- O O
, O O
DNA O O
was O O
electrophoresed O O
on O O
an O O
agarose O O
gel O O
and O O
transferred O O
to O O
nylon O O
membranes O O
. O O

Following B-conn Temporal.Succession
hybridization O O
with O O
genomic O O
probes O O
, O O
membranes O O
were O O
exposed O O
to O O
film O O
. O O

Size O O
markers O O
are O O
shown O O
on O O
the O O
right O O
. O O

Ethidium O O
bromide O O
staining O O
of O O
the O O
gel O O
is O O
also O O
shown O O
. O O

Figure O O
2 O O
: O O
Binding O O
of O O
transcription O O
factors O O
to O O
CCR3 O O
exon O O
1 O O
. O O

In O O
-LRB- O O
A O O
-RRB- O O
, O O
a O O
schematic O O
representation O O
of O O
the O O
CCR3 O O
exon O O
region O O
used O O
for O O
electrophoretic O O
mobility O O
shift O O
assays O O
is O O
shown O O
. O O

E1-FL O O
is O O
the O O
exon O O
1 O O
full-length O O
probe O O
. O O

Overlapping O O
short O O
probes O O
are O O
called O O
E1-A O O
, O O
E1-B O O
and O O
E1-C O O
, O O
respectively O O
. O O

The O O
DNA O O
sequence O O
is O O
shown O O
with O O
GATA O O
sites O O
boxed O O
. O O

In O O
-LRB- O O
B O O
-RRB- O O
, O O
EMSA O O
assay O O
with O O
the O O
full-length O O
probe O O
and O O
extracts O O
from O O
eosinophilic O O
AML14.3D10 O O
cells O O
is O O
shown O O
. O O

As O O
cold O O
competitors O O
-LRB- O O
CC O O
-RRB- O O
, O O
the O O
full-length O O
probe O O
and O O
short O O
probes O O
E1-A O O
through O O
C O O
were O O
used O O
. O O

The O O
arrow O O
depicts O O
the O O
specific O O
band O O
. O O

A O O
representative O O
experiment O O
, O O
of O O
three O O
similar O O
experiments O O
, O O
is O O
shown O O
. O O

Figure O O
3 O O
: O O
Binding O O
of O O
GATA O O
factors O O
to O O
CCR3 O O
exon O O
1 O O
. O O

In O O
-LRB- O O
A O O
-RRB- O O
, O O
EMSA O O
assay O O
with O O
probes O O
E1-B O O
-LRB- O O
left O O
panel O O
-RRB- O O
and O O
E1-C O O
-LRB- O O
right O O
panel O O
-RRB- O O
and O O
nuclear O O
extracts O O
from O O
AML14.3D10 O O
cells O O
is O O
shown O O
. O O

Three O O
cold O O
competitors O O
were O O
used O O
in O O
each O O
case O O
: O O
the O O
probe O O
itself O O
-LRB- O O
E1-B-WT O O
and O O
E1-C-WT O O
, O O
respectively O O
-RRB- O O
, O O
the O O
probe O O
with O O
the O O
GATA O O
site O O
mutated O O
-LRB- O O
E1-B-mut O O
and O O
E1-C-mut O O
, O O
respectively O O
-RRB- O O
and O O
the O O
GATA O O
consensus O O
oligonucleotide O O
-LRB- O O
GATA O O
cons O O
-RRB- O O
. O O

A O O
representative O O
experiment O O
, O O
of O O
three O O
similar O O
experiments O O
, O O
is O O
shown O O
. O O

In O O
-LRB- O O
B O O
-RRB- O O
, O O
EMSA O O
assay O O
with O O
the O O
full-length O O
probe O O
-LRB- O O
E1-FL O O
-RRB- O O
and O O
extracts O O
from O O
eosinophilic O O
AML14.3D10 O O
cells O O
in O O
the O O
presence O O
or O O
absence O O
of O O
antibodies O O
against O O
GATA-1 O O
is O O
shown O O
. O O

The O O
arrow O O
depicts O O
the O O
specific O O
band O O
. O O

In O O
-LRB- O O
C O O
-RRB- O O
, O O
EMSA O O
assay O O
with O O
probes O O
E1-B O O
-LRB- O O
left O O
panel O O
-RRB- O O
and O O
E1-C O O
-LRB- O O
right O O
panel O O
-RRB- O O
and O O
nuclear O O
extracts O O
from O O
AML14.3D10 O O
cells O O
and O O
cold O O
competitor O O
probe O O
itself O O
-LRB- O O
CC O O
: O O
E1-B O O
and O O
CC O O
: O O
E1-C O O
, O O
respectively O O
-RRB- O O
or O O
anti-GATA-1 O O
antibody O O
-LRB- O O
GATA-1 O O
atb O O
-RRB- O O
is O O
shown O O
. O O

Figure O O
4 O O
: O O
The O O
CCR3/EGFP O O
transgenic O O
mice O O
. O O

In O O
-LRB- O O
A O O
-RRB- O O
, O O
a O O
schematic O O
representation O O
of O O
the O O
transgenic O O
construct O O
is O O
shown O O
. O O

The O O
genomic O O
fragment O O
encoding O O
1.6 O O
kb O O
of O O
the O O
CCR3 O O
promoter O O
including O O
60 O O
bp O O
of O O
exon O O
1 O O
-LRB- O O
E1 O O
-RRB- O O
, O O
was O O
cloned O O
into O O
the O O
Hind O O
III O O
and O O
Bam O O
HI O O
sites O O
upstream O O
from O O
the O O
EGFP O O
gene O O
in O O
the O O
pEGFP1 O O
vector O O
. O O

The O O
positions O O
of O O
restriction O O
sites O O
are O O
indicated O O
. O O

In O O
-LRB- O O
B O O
-RRB- O O
, O O
Northern O O
blot O O
analysis O O
of O O
multiple O O
tissues O O
from O O
transgenic O O
mice O O
is O O
shown O O
. O O

RNA O O
was O O
isolated O O
from O O
the O O
spleen O O
, O O
lung O O
, O O
thymus O O
, O O
kidney O O
and O O
jejunum O O
of O O
CCR3/EGFP O O
transgenic O O
mice O O
-LRB- O O
lines O O
3.1 O O
and O O
3.2 O O
-RRB- O O
. O O
10 O O
μg O O
total O O
RNA O O
was O O
electrophoresed O O
on O O
an O O
agarose O O
gel O O
, O O
transferred O O
to O O
nylon O O
membranes O O
and O O
probed O O
with O O
the O O
SV40 O O
polyA O O
probe O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
detect O O
expression O O
of O O
the O O
transgene O O
. O O

Position O O
of O O
28S O O
and O O
18S O O
is O O
depicted O O
with O O
arrows O O
. O O

Ethidium O O
bromide O O
staining O O
of O O
the O O
gel O O
is O O
also O O
shown O O
. O O

In O O
-LRB- O O
C O O
-RRB- O O
, O O
immunohistochemistry O O
using O O
an O O
anti-GFP O O
antibody O O
is O O
shown O O
. O O

Organs O O
were O O
collected O O
, O O
frozen O O
sections O O
obtained O O
and O O
anti-GFP O O
immunohistochemistry O O
performed O O
. O O

Positive O O
staining O O
is O O
represented O O
as O O
black O O
precipitate O O
. O O

Accumulation O O
of O O
marginal O O
zone O O
B O O
cells O O
and O O
accelerated O O
loss O O
of O O
follicular O O
dendritic O O
cells O O
in O O
NF-κB O O
p50-deficient O O
mice O O

Abstract O O

Background O O
: O O
Marginal O O
zone O O
-LRB- O O
MZ O O
-RRB- O O
B O O
cells O O
play O O
important O O
roles O O
in O O
the O O
early O O
phases O O
of O O
humoral O O
immune O O
responses O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
to I-conn Conjunction
possessing O O
an O O
inherent O O
capacity O O
to O O
rapidly O O
differentiate O O
into O O
antibody O O
secreting O O
cells O O
, O O
MZ O O
B O O
cells O O
also O O
help O O
to O O
regulate O O
the O O
fate O O
of O O
both O O
T-independent O O
and O O
T-dependent O O
blood-borne O O
antigens O O
in O O
the O O
spleen O O
. O O

For O O
T-dependent O O
antigens O O
, O O
MZ O O
B O O
cells O O
bind O O
IgM-antigen O O
complexes O O
in O O
a O O
complement-dependent O O
manner O O
. O O

Once O O
MZ O O
B O O
cells O O
bind O O
IgM-containing O O
immune O O
complexes O O
-LRB- O O
IgM-IC O O
-RRB- O O
, O O
they O O
transport O O
them O O
into O O
B O O
cell O O
follicles O O
for B-conn Purpose.Goal
deposition O O
onto O O
follicular O O
dendritic O O
cells O O
-LRB- O O
FDCs O O
-RRB- O O
, O O
an O O
important O O
component O O
of O O
secreted O O
IgM O O
's O O
ability O O
to O O
enhance O O
adaptive O O
immune O O
responses O O
. O O

To B-conn Purpose.Goal
further O O
define O O
the O O
requirement O O
for O O
MZ O O
B O O
cells O O
in O O
IgM-IC O O
deposition O O
, O O
mice O O
deficient O O
in O O
the O O
NF-κB O O
protein O O
p50 O O
, O O
which O O
have O O
been O O
reported O O
to O O
lack O O
MZ O O
B O O
cells O O
, O O
were O O
analyzed O O
for O O
their O O
ability O O
to O O
trap O O
IgM-IC O O
onto O O
FDCs O O
. O O

Results O O
: O O
Mice O O
-LRB- O O
2 O O
months O O
of O O
age O O
-RRB- O O
deficient O O
in O O
p50 O O
-LRB- O O
p50-/- O O
-RRB- O O
had O O
small O O
numbers O O
of O O
MZ O O
B O O
cells O O
, O O
as O O
determined O O
by O O
cell O O
surface O O
phenotype O O
and O O
localization O O
in O O
the O O
splenic O O
MZ O O
. O O

These O O
cells O O
bound O O
high O O
levels O O
of O O
IgM-IC O O
both O O
in O O
vivo O O
and O O
in O O
vitro O O
. O O

Subsequent O O
to O O
the O O
binding O O
of O O
IgM-IC O O
by O O
the O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
, O O
small O O
amounts O O
of O O
IgM-IC O O
were O O
found O O
localized O O
on O O
FDCs O O
, O O
suggesting O O
that O O
the O O
MZ O O
B O O
cells O O
retained O O
their O O
ability O O
to O O
transport O O
these O O
complexes O O
into O O
splenic O O
follicles O O
. O O

Strikingly O O
, O O
MZ O O
B O O
cells O O
accumulated O O
with O O
age O O
in O O
p50-/- O O
mice O O
. O O

By O O
6 O O
months O O
of O O
age O O
, O O
p50-/- O O
mice O O
contained O O
normal O O
numbers O O
of O O
these O O
cells O O
as O O
defined O O
by O O
CD21/CD23 O O
profile O O
and O O
high O O
level O O
expression O O
of O O
CD1d O O
, O O
CD9 O O
, O O
and O O
IgM O O
, O O
and O O
by O O
their O O
positioning O O
around O O
the O O
marginal O O
sinus O O
. O O

However B-conn Concession.Contra-expectation
, O O
FDCs O O
from O O
these O O
older O O
p50-/- O O
mice O O
exhibited O O
a O O
reduced O O
capacity O O
to O O
trap O O
IgM-IC O O
and O O
retain O O
complement O O
components O O
. O O

Conclusion O O
: O O
These O O
results O O
demonstrate O O
that O O
while B-conn Concession.Expectation
the O O
p50 O O
component O O
of O O
the O O
NF-κB O O
transcription O O
complex O O
plays O O
an O O
important O O
role O O
in O O
the O O
early O O
development O O
of O O
MZ O O
B O O
cells O O
, O O
MZ O O
B O O
cells O O
can O O
develop O O
and O O
accumulate O O
in O O
mice O O
lacking O O
this O O
protein O O
. O O

These O O
results O O
highlight O O
the O O
interface O O
between O O
genetic O O
deficiencies O O
and O O
age O O
, O O
and O O
suggest O O
that O O
different O O
transcription O O
factors O O
may O O
play O O
distinct O O
roles O O
in O O
the O O
development O O
and O O
maintenance O O
of O O
cell O O
populations O O
at O O
different O O
ages O O
. O O

Background O O

Secreted O O
IgM O O
antibodies O O
play O O
important O O
roles O O
in O O
the O O
initial O O
phases O O
of O O
humoral O O
immune O O
responses O O
. O O

Unlike O O
other O O
antibody O O
isotypes O O
, O O
secreted O O
IgM O O
uniquely O O
functions O O
as O O
an O O
adjuvant O O
, O O
promoting O O
primary O O
antibody O O
responses O O
to O O
sub-immunogenic O O
doses O O
of O O
T-dependent O O
antigens O O
-LSB-1-7 O O
-RSB- O O
. O O

The O O
adjuvanticity O O
of O O
IgM O O
is O O
completely O O
dependent O O
on O O
an O O
intact O O
complement O O
system O O
-LSB-7-9 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
mice O O
deficient O O
in O O
secreted O O
IgM O O
make O O
protective O O
antibody O O
responses O O
to O O
pathogens O O
, O O
these O O
responses O O
are O O
delayed O O
compared O O
to O O
the O O
immune O O
response O O
of O O
IgM O O
sufficient O O
mice O O
-LSB-10-13 O O
-RSB- O O
Interestingly O O
, O O
pathogens O O
more O O
readily O O
disseminate O O
into O O
vital O O
organs O O
in O O
secreted O O
IgM-deficient O O
mice O O
, O O
rather O O
than O O
concentrate O O
them O O
into O O
secondary O O
lymphoid O O
organs O O
-LSB-14 O O
-RSB- O O
. O O

This O O
suggests O O
that O O
an O O
important O O
role O O
for O O
IgM O O
is O O
to O O
serve O O
as O O
an O O
arbiter O O
of O O
antigen O O
localization O O
, O O
which O O
may O O
contribute O O
to O O
its O O
adjuvant O O
function O O
-LRB- O O
s O O
-RRB- O O
. O O

To B-conn Purpose.Goal
investigate O O
how O O
IgM O O
affects O O
the O O
localization O O
of O O
foreign O O
antigen O O
, O O
a O O
system O O
was O O
developed O O
to O O
follow O O
the O O
fate O O
of O O
IgM-containing O O
immune O O
complexes O O
-LRB- O O
IgM-IC O O
-RRB- O O
following B-conn Temporal.Succession
their O O
intravenous O O
-LRB- O O
i.v. O O
-RRB- O O
administration O O
-LSB-7,15 O O
-RSB- O O
IgM-IC O O
first O O
localize O O
to O O
the O O
splenic O O
marginal O O
zone O O
-LRB- O O
MZ O O
-RRB- O O
, O O
where O O
they O O
are O O
phagocytized O O
by O O
MZ O O
macrophages O O
and O O
are O O
also B-conn Conjunction
bound O O
to O O
MZ O O
B O O
cells O O
. O O

Binding O O
of O O
IgM-IC O O
to O O
MZ O O
B O O
cells O O
is O O
strictly O O
complement O O
dependent O O
. O O

The O O
MZ O O
B O O
cells O O
subsequently B-conn Temporal.Precedence
transport O O
the O O
IgM-IC O O
into O O
the O O
B O O
cell O O
follicles O O
where O O
they O O
are O O
deposited O O
onto O O
follicular O O
dendritic O O
cells O O
-LRB- O O
FDCs O O
-RRB- O O
-LSB-15 O O
-RSB- O O
. O O

The O O
important O O
role O O
of O O
MZ O O
B O O
cells O O
in O O
this O O
process O O
was O O
established O O
by B-conn Purpose.Enablement
monitoring O O
IgM-IC O O
deposition O O
onto O O
FDCs O O
in O O
mice O O
that O O
lacked O O
MZ O O
B O O
cells O O
, O O
either B-conn Alternative.Disjunctive
as B-conn Cause.Reason
a I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
a O O
genetic O O
lesion O O
-LRB- O O
CD19-deficient O O
mice O O
-RRB- O O
that O O
inhibited O O
MZ O O
B O O
cell O O
survival O O
, O O
or B-conn Alternative.Disjunctive
by O O
their O O
depletion O O
using O O
pertussis O O
toxin O O
. O O

In O O
these O O
mice O O
, O O
little O O
if O O
any O O
IgM-IC O O
was O O
deposited O O
onto O O
FDCs O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
adoptive O O
transfer O O
of O O
B O O
cells O O
with O O
bound O O
IgM-IC O O
into O O
mice O O
led O O
to O O
IgM-IC O O
deposition O O
onto O O
FDCs O O
. O O

In O O
these O O
mice O O
, O O
transferred O O
MZ O O
B O O
cells O O
in O O
close O O
proximity O O
to O O
FDCs O O
were O O
found O O
to O O
have O O
IgM-IC O O
capped O O
and O O
directed O O
toward O O
the O O
FDC O O
dendrites O O
, O O
strongly O O
suggesting O O
IgM-IC O O
was O O
being O O
transferred O O
to O O
FDCs O O
by O O
MZ O O
B O O
cells O O
-LSB-15 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
further O O
investigate O O
the O O
role O O
of O O
MZ O O
B O O
cells O O
in O O
IgM-IC O O
transport O O
, O O
we O O
used O O
mice O O
deficient O O
in O O
p50 O O
, O O
a O O
member O O
of O O
the O O
NF-κB O O
family O O
of O O
transcription O O
factors O O
-LSB-16 O O
-RSB- O O
. O O

These O O
mice O O
have O O
been O O
reported O O
to O O
lack O O
MZ O O
B O O
cells O O
, O O
suggesting O O
an O O
unambiguous O O
role O O
for O O
this O O
component O O
of O O
the O O
NF-κB O O
transcription O O
factor O O
complex O O
in O O
the O O
development O O
of O O
this O O
subset O O
of O O
B O O
cells O O
-LSB-17 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
we O O
found O O
that O O
small O O
numbers O O
of O O
MZ O O
B O O
cells O O
are O O
present O O
in O O
young O O
p50-/- O O
mice O O
, O O
and B-conn Conjunction
these O O
cells O O
are O O
capable O O
of O O
binding O O
high O O
levels O O
of O O
IgM-IC O O
in O O
vivo O O
and O O
in O O
vitro O O
. O O

Interestingly O O
, O O
MZ O O
B O O
cells O O
were O O
found O O
to O O
accumulate O O
with O O
age O O
in O O
p50-/- O O
mice O O
such O O
that O O
by O O
6 O O
months O O
a O O
normal O O
sized O O
MZ O O
B O O
cell O O
compartment O O
was O O
present O O
. O O

We O O
also B-conn Conjunction
found O O
that O O
p50-/- O O
mice O O
exhibited O O
an O O
accelerated O O
loss O O
of O O
FDC O O
networks O O
, O O
as O O
assessed O O
by O O
intense O O
CD21 O O
staining O O
. O O

These O O
data O O
indicate O O
that O O
MZ O O
B O O
cells O O
can O O
develop O O
in O O
the O O
complete O O
absence O O
of O O
p50 O O
, O O
and O O
suggest O O
that O O
the O O
transcriptional O O
requirements O O
for O O
the O O
development O O
and/or O O
survival O O
of O O
MZ O O
B O O
cells O O
might O O
differ O O
in O O
young O O
and O O
old O O
mice O O
. O O

Results O O

Two O O
month O O
old O O
p50-/- O O
or O O
control O O
C57BL/6 O O
-LRB- O O
B6 O O
-RRB- O O
mice O O
were O O
injected O O
with O O
IgM-IC O O
and B-conn Conjunction
the O O
spleens O O
removed O O
16 O O
h O O
later O O
. O O

Based B-conn Cause.Reason
on I-conn Cause.Reason
the O O
reported O O
lack O O
of O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
-LSB-17 O O
-RSB- O O
and B-conn Conjunction
the O O
requirement O O
for O O
MZ O O
B O O
cells O O
in O O
the O O
transport O O
and O O
deposition O O
of O O
IgM-IC O O
onto O O
FDCs O O
-LSB-15 O O
-RSB- O O
, O O
we O O
expected O O
that O O
IgM-IC O O
would O O
not O O
be O O
found O O
localized O O
on O O
FDCs O O
in O O
the O O
splenic O O
follicles O O
of O O
these O O
mice O O
. O O

However B-conn Concession.Contra-expectation
, O O
immunohistochemistry O O
-LRB- O O
IH O O
-RRB- O O
revealed O O
the O O
presence O O
of O O
IgM-IC O O
on O O
FDCs O O
in O O
p50-/- O O
mice O O
-LRB- O O
Figure O O
1 O O
-RRB- O O
. O O

The O O
amount O O
of O O
IgM-IC O O
localized O O
in O O
the O O
spleen O O
follicles O O
of O O
p50-/- O O
mice O O
was O O
substantially O O
less O O
than O O
in O O
control O O
B6 O O
mice O O
, O O
but O O
none-the-less B-conn Concession.Contra-expectation
readily O O
detectable O O
. O O

These O O
results O O
could O O
indicate O O
either B-conn Alternative.Disjunctive
that O O
IgM-IC O O
can O O
traffic O O
to O O
FDCs O O
by B-conn Cause.Reason
a O O
previously O O
unanticipated O O
mechanism O O
independent O O
of O O
MZ O O
B O O
cells O O
, O O
or B-conn Alternative.Disjunctive
p50-/- O O
mice O O
may O O
possess O O
small O O
numbers O O
of O O
MZ O O
B O O
cells O O
that O O
are O O
still O O
functional O O
for O O
transporting O O
IgM-IC O O
into O O
follicles O O
. O O

To B-conn Purpose.Goal
help O O
discriminate O O
between O O
these O O
alternatives O O
, O O
splenic O O
B O O
cells O O
from O O
p50-/- O O
mice O O
were O O
analyzed O O
for O O
the O O
presence O O
of O O
MZ O O
B O O
cells O O
by O O
FACS O O
. O O

MZ O O
B O O
cells O O
can O O
be O O
phenotypically O O
distinguished O O
from O O
other O O
B O O
cell O O
subsets O O
in O O
the O O
spleen O O
based O O
on O O
CD21/23 O O
-LSB-18,19 O O
-RSB- O O
and O O
B220/CD1d O O
-LSB-20,21 O O
-RSB- O O
. O O

profiles O O
. O O

As O O
shown O O
in O O
Figure O O
2 O O
, O O
MZ O O
B O O
cells O O
were O O
, O O
as O O
expected O O
-LSB-17 O O
-RSB- O O
, O O
severely O O
reduced O O
in O O
p50-/- O O
mice O O
. O O

However B-conn Concession.Contra-expectation
, O O
small O O
numbers O O
of O O
B O O
cells O O
fell O O
within O O
the O O
CD21hi/CD23lo O O
and O O
B220+/CD1dhi O O
gates O O
, O O
at O O
~10 O O
% O O
of O O
the O O
frequency O O
found O O
in O O
the O O
B O O
cell O O
compartment O O
of O O
control O O
B6 O O
mice O O
. O O

To B-conn Purpose.Goal
determine O O
if O O
these O O
MZ O O
B O O
cells O O
could O O
bind O O
high O O
levels O O
of O O
IgM-IC O O
, O O
spleen O O
cells O O
from O O
mice O O
that O O
had O O
been O O
injected O O
1 O O
h O O
earlier O O
were O O
isolated O O
and B-conn Conjunction
the O O
presence O O
of O O
IgM-IC O O
on O O
B O O
cell O O
subsets O O
was O O
determined O O
by O O
FACS O O
. O O

When B-conn Temporal.Synchronous
IgM-IC O O
were O O
injected O O
into O O
B6 O O
mice O O
, O O
the O O
complexes O O
were O O
found O O
associated O O
with O O
MZ O O
B O O
cells O O
at O O
high O O
levels O O
-LRB- O O
Figure O O
2A O O
-RRB- O O
, O O
as O O
expected O O
from O O
their O O
high O O
level O O
expression O O
of O O
the O O
complement O O
receptor O O
CR2 O O
-LRB- O O
CD21 O O
-RRB- O O
and O O
localization O O
at O O
the O O
marginal O O
sinus O O
, O O
which O O
facilitates O O
exposure O O
to O O
blood-borne O O
IgM-IC O O
-LSB-15 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
little O O
if O O
any O O
of O O
the O O
IgM-IC O O
were O O
present O O
on O O
follicular O O
-LRB- O O
FO O O
-RRB- O O
B O O
cells O O
. O O

In O O
p50-/- O O
mice O O
, O O
there O O
was O O
discernable O O
binding O O
of O O
IgM-IC O O
to O O
MZ O O
B O O
cells O O
-LRB- O O
as O O
defined O O
by O O
a O O
shift O O
in O O
the O O
FACS O O
profile O O
-RRB- O O
while B-conn Contrast
, O O
as O O
seen O O
in O O
B6 O O
mice O O
, O O
IgM-IC O O
did O O
not O O
bind O O
to O O
FO O O
B O O
cells O O
-LRB- O O
Figure O O
2A O O
-RRB- O O
. O O

This O O
suggests O O
that O O
the O O
cells O O
in O O
the O O
CD21hi O O
gate O O
in O O
p50-/- O O
mice O O
were O O
authentic O O
MZ O O
B O O
cells O O
. O O

To B-conn Purpose.Goal
confirm O O
this O O
, O O
the O O
capacity O O
of O O
these O O
cells O O
to O O
bind O O
IgM-IC O O
was O O
determined O O
using O O
in O O
vitro O O
binding O O
assays O O
-LRB- O O
Figure O O
2B O O
-RRB- O O
. O O

When O O
p50-/- O O
B O O
cells O O
were O O
incubated O O
with O O
IgM-IC O O
in O O
vitro O O
, O O
MZ O O
B O O
cells O O
bound O O
higher O O
levels O O
of O O
IgM-IC O O
than O O
did O O
FO O O
B O O
cells O O
-LRB- O O
3 O O
to O O
5 O O
times O O
as O O
assessed O O
by O O
mean O O
fluorescence O O
intensity O O
-RRB- O O
, O O
similar O O
to O O
results O O
using O O
B O O
cells O O
from O O
B6 O O
mice O O
. O O

Note O O
that O O
the O O
spleens O O
of O O
p50-/- O O
mice O O
contain O O
an O O
increased O O
number O O
of O O
CD21loCD23lo O O
B O O
cells O O
-LRB- O O
Fig. O O
2A O O
; O O
see O O
also O O
Fig. O O
3A O O
-RRB- O O
. O O

While B-conn Concession.Expectation
we O O
have O O
not O O
explored O O
the O O
identity O O
of O O
these O O
cells O O
in O O
detail O O
. O O

they O O
are O O
likely O O
to O O
reflect O O
increased O O
numbers O O
of O O
immature O O
`` O O
transitional O O
'' O O
B O O
cell O O
subsets O O
, O O
since B-conn Cause.Justification
the O O
number O O
of O O
AA4.1+ O O
B O O
cells O O
-LSB-22 O O
-RSB- O O
in O O
the O O
spleens O O
of O O
these O O
mice O O
are O O
increased O O
-LRB- O O
up O O
to O O
2-fold O O
-RRB- O O
over O O
those O O
in O O
age-matched O O
control O O
B6 O O
mice O O
. O O

As O O
expected O O
from O O
their O O
low O O
levels O O
of O O
CD21 O O
, O O
however B-conn Concession.Contra-expectation
, O O
this O O
population O O
of O O
cells O O
does O O
not O O
bind O O
IgM-IC O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

MZ O O
B O O
cells O O
can O O
be O O
distinguished O O
as O O
IgMhi O O
B O O
cells O O
positioned O O
outside O O
of O O
the O O
marginal O O
sinus O O
. O O

To B-conn Purpose.Goal
determine O O
whether O O
the O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
were O O
positioned O O
correctly O O
around O O
the O O
marginal O O
sinus O O
of O O
the O O
spleen O O
, O O
immunofluorescence O O
-LRB- O O
IF O O
-RRB- O O
was O O
performed O O
on O O
spleen O O
sections O O
using O O
anti-IgM O O
and O O
anti-MOMA-1 O O
, O O
which O O
stains O O
marginal O O
metallophilic O O
macrophages O O
and O O
delineates O O
the O O
MZ O O
-LSB-23 O O
-RSB- O O
. O O

In O O
control O O
B6 O O
mice O O
, O O
IgMhi O O
cells O O
-LRB- O O
in O O
red O O
-RRB- O O
were O O
present O O
in O O
the O O
MZ O O
, O O
outside O O
of O O
the O O
MOMA-1+ O O
cells O O
-LRB- O O
Figure O O
2C O O
-RRB- O O
. O O

IgMhi O O
MZ O O
B O O
cells O O
were O O
also B-conn Conjunction
found O O
outside O O
of O O
the O O
MOMA-1 O O
ring O O
in O O
p50-/- O O
mice O O
, O O
but B-conn Concession.Contra-expectation
in O O
reduced O O
numbers O O
, O O
as O O
expected O O
from O O
the O O
drastic O O
reductions O O
in O O
MZ O O
B O O
cells O O
in O O
these O O
mice O O
-LRB- O O
Figure O O
2A O O
-RRB- O O
. O O

Taken O O
together O O
, O O
these O O
data O O
indicate O O
that O O
p50-/- O O
mice O O
contain O O
small O O
numbers O O
of O O
MZ O O
B O O
cells O O
that O O
are O O
correctly O O
positioned O O
around O O
the O O
marginal O O
sinus O O
, O O
where O O
they O O
can O O
encounter O O
blood-borne O O
IgM-IC O O
and O O
transport O O
them O O
into O O
splenic O O
follicles O O
for B-conn Purpose.Goal
deposition O O
onto O O
FDCs O O
. O O

When B-conn Temporal.Synchronous
older O O
p50-/- O O
mice O O
were O O
analyzed O O
for O O
the O O
presence O O
of O O
MZ O O
B O O
cells O O
, O O
increased O O
frequencies O O
of O O
MZ O O
B O O
cells O O
were O O
detected O O
. O O

At O O
4 O O
months O O
of O O
age O O
, O O
some O O
p50-/- O O
mice O O
contained O O
increased O O
numbers O O
of O O
MZ O O
B O O
cells O O
, O O
whereas B-conn Contrast
others O O
did O O
not O O
, O O
suggesting O O
that O O
these O O
cells O O
might O O
be O O
emerging O O
around O O
this O O
time O O
period O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

By O O
6 O O
months O O
of O O
age O O
, O O
a O O
phenotypically O O
distinct O O
MZ O O
B O O
cell O O
population O O
was O O
detected O O
in O O
all O O
of O O
the O O
more O O
than O O
10 O O
mice O O
analyzed O O
, O O
as O O
determined O O
by O O
the O O
CD21/23 O O
profile O O
. O O

In O O
these O O
mice O O
, O O
MZ O O
B O O
cells O O
were O O
present O O
at O O
frequencies O O
comparable O O
to O O
those O O
found O O
in O O
B6 O O
mice O O
-LRB- O O
Figure O O
3A O O
, O O
left O O
panels O O
-RRB- O O
, O O
although B-conn Concession.Contra-expectation
the O O
total O O
number O O
of O O
splenic O O
B O O
cells O O
did O O
not O O
appear O O
to O O
change O O
. O O

At O O
all O O
ages O O
tested O O
, O O
p50-/- O O
and O O
B6 O O
mice O O
had O O
similar O O
frequencies O O
of O O
T O O
and O O
B O O
cells O O
in O O
their O O
spleens O O
, O O
and B-conn Conjunction
their O O
spleen O O
sizes O O
were O O
also O O
similar O O
-LRB- O O
unpublished O O
results O O
-RRB- O O
, O O
and O O
the O O
cellularity O O
of O O
the O O
spleens O O
-LRB- O O
as O O
determined O O
by O O
IH O O
; O O
see O O
for O O
example O O
Fig. O O
5B O O
-RRB- O O
were O O
also O O
similar O O
, O O
indicating O O
that O O
the O O
increased O O
number O O
of O O
MZ O O
B O O
cells O O
was O O
selective O O
for O O
this O O
subset O O
of O O
cells O O
. O O

To B-conn Purpose.Goal
confirm O O
the O O
phenotypic O O
identity O O
of O O
the O O
CD21hi/CD23lo O O
B O O
cells O O
as O O
MZ O O
B O O
cells O O
, O O
the O O
expression O O
of O O
other O O
markers O O
of O O
MZ O O
B O O
cells O O
, O O
including O O
CD1d O O
-LSB-20 O O
-RSB- O O
and O O
CD9 O O
-LSB-24 O O
-RSB- O O
, O O
was O O
assessed O O
. O O

As O O
shown O O
in O O
Figure O O
4A O O
, O O
populations O O
of O O
B220+ O O
B O O
cells O O
with O O
CD1dhi O O
and O O
CD9hi O O
phenotypes O O
were O O
present O O
in O O
p50-/- O O
mice O O
, O O
consistent O O
with O O
the O O
presence O O
of O O
MZ O O
B O O
cells O O
. O O

The O O
frequencies O O
of O O
these O O
cells O O
were O O
similar O O
to O O
those O O
in O O
aged-matched O O
control O O
B6 O O
mice O O
. O O

We O O
also B-conn Conjunction
assessed O O
the O O
levels O O
of O O
IgM O O
on O O
the O O
CD21hiCD23lo O O
cells O O
, O O
since B-conn Cause.Reason
MZ O O
B O O
cells O O
express O O
higher O O
levels O O
of O O
IgM O O
compared O O
with O O
FO O O
B O O
cells O O
-LSB-25 O O
-RSB- O O
. O O

MZ O O
B O O
cells O O
from O O
p50-/- O O
mice O O
clearly O O
expressed O O
higher O O
levels O O
of O O
IgM O O
than O O
on O O
FO O O
B O O
cells O O
from O O
these O O
same O O
mice O O
, O O
and O O
at O O
levels O O
similar O O
to O O
those O O
in O O
control O O
mice O O
-LRB- O O
Figure O O
4B O O
-RRB- O O
. O O

These O O
B O O
cells O O
were O O
also B-conn Conjunction
positioned O O
within O O
the O O
MZ O O
in O O
p50-/- O O
mice O O
-LRB- O O
Figure O O
4C O O
-RRB- O O
, O O
as O O
indicated O O
by O O
the O O
presence O O
of O O
IgM+ O O
cells O O
outside O O
of O O
the O O
marginal O O
sinus O O
as O O
revealed O O
by O O
laminin O O
staining O O
-LSB-26 O O
-RSB- O O
. O O

As B-conn Purpose.Goal
further O O
evidence O O
that O O
the O O
accumulating O O
cells O O
were O O
functional O O
MZ O O
B O O
cells O O
, O O
cells O O
were O O
tested O O
for O O
their O O
capacity O O
to O O
bind O O
IgM-IC O O
in O O
vivo O O
and O O
in O O
vitro O O
. O O

MZ O O
B O O
cells O O
from O O
2 O O
and O O
6 O O
month O O
old O O
B6 O O
mice O O
or O O
from O O
6 O O
month O O
old O O
p50-/- O O
mice O O
had O O
high O O
levels O O
of O O
IgM-IC O O
bound O O
following B-conn Temporal.Succession
i.v. O O
. O O

injection O O
, O O
whereas B-conn Contrast
FO O O
B O O
cells O O
bound O O
little O O
or O O
no O O
IgM-IC O O
-LRB- O O
Figure O O
3A O O
-RRB- O O
. O O

An O O
in O O
vitro O O
binding O O
assay O O
also B-conn Conjunction
demonstrated O O
the O O
capacity O O
of O O
the O O
MZ O O
B O O
cells O O
from O O
p50-/- O O
mice O O
to O O
bind O O
high O O
levels O O
of O O
IgM-IC O O
compared O O
to O O
FO O O
B O O
cells O O
-LRB- O O
Figure O O
3B O O
-RRB- O O
. O O

Taken O O
together O O
, O O
the O O
data O O
demonstrate O O
that O O
while B-conn Concession.Expectation
few O O
MZ O O
B O O
cells O O
are O O
present O O
in O O
young O O
p50-/- O O
mice O O
, O O
they O O
do O O
develop O O
and O O
accumulate O O
with O O
age O O
, O O
such B-conn Cause.Result
that I-conn Cause.Result
by O O
6 O O
months O O
they O O
have O O
reached O O
normal O O
levels O O
and O O
can O O
functionally O O
bind O O
IgM-IC O O
at O O
high O O
levels O O
, O O
as O O
would O O
be O O
expected O O
from O O
their O O
increased O O
expression O O
of O O
CR1/2 O O
-LRB- O O
CD21/35 O O
-RRB- O O
. O O

In B-conn Purpose.Goal
an I-conn Purpose.Goal
effort I-conn Purpose.Goal
to I-conn Purpose.Goal
determine O O
whether O O
the O O
repopulation O O
of O O
older O O
p50-/- O O
mice O O
with O O
MZ O O
B O O
cells O O
enabled O O
efficient O O
IgM-IC O O
trapping O O
, O O
mice O O
were O O
injected O O
with O O
IgM-IC O O
and O O
analyzed O O
for O O
FDC O O
deposition O O
. O O

Despite B-conn Concession.Expectation
the O O
normal O O
levels O O
and O O
positioning O O
of O O
MZ O O
B O O
cells O O
, O O
no O O
IgM-IC O O
deposition O O
was O O
observed O O
in O O
the O O
spleens O O
of O O
6 O O
month O O
old O O
p50-/- O O
mice O O
-LRB- O O
Figure O O
5A O O
-RRB- O O
. O O

The O O
failure O O
of O O
the O O
IgM-IC O O
to O O
localize O O
in O O
the O O
follicles O O
of O O
these O O
mice O O
could O O
be O O
due O O
to O O
the O O
absence O O
of O O
FDCs O O
. O O

However B-conn Concession.Contra-expectation
, O O
as O O
shown O O
in O O
Figure O O
5B O O
, O O
FDCs O O
were O O
present O O
in O O
these O O
mice O O
, O O
as O O
assessed O O
by O O
CD21 O O
staining O O
. O O

However B-conn Concession.Contra-expectation
, O O
they O O
appeared O O
to O O
be O O
much O O
smaller O O
and O O
the O O
dendrites O O
less O O
pronounced O O
than O O
in O O
age-matched O O
B6 O O
mice O O
, O O
as O O
evident O O
from O O
the O O
diminished O O
area O O
of O O
intense O O
CD21 O O
staining O O
-LRB- O O
Figure O O
5B O O
, O O
right O O
panels O O
; O O
see O O
arrows O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
number O O
of O O
follicles O O
with O O
intense O O
CD21 O O
staining O O
was O O
reduced O O
in O O
the O O
6 O O
month O O
old O O
p50-/- O O
mice O O
compared O O
with O O
age O O
matched O O
B6 O O
mice O O
-LRB- O O
Figure O O
5B O O
, O O
4× O O
view O O
in O O
left O O
panels O O
-RRB- O O
. O O

This O O
suggests O O
that O O
the O O
ability O O
of O O
FDCs O O
from O O
p50-/- O O
mice O O
to O O
retain O O
complement O O
fragments O O
might O O
be O O
diminished O O
at O O
6 O O
months O O
of O O
age O O
. O O

Interestingly O O
, O O
6 O O
month O O
old O O
B6 O O
mice O O
also B-conn Conjunction
exhibited O O
some O O
reduced O O
capacity O O
to O O
trap O O
IgM-IC O O
-LRB- O O
Figure O O
5A O O
-RRB- O O
and O O
slightly O O
reduced O O
CD21 O O
staining O O
compared O O
with O O
younger O O
mice O O
-LRB- O O
Figure O O
5B O O
-RRB- O O
, O O
suggesting O O
a O O
loss O O
of O O
FDC O O
function O O
may O O
also O O
be O O
occurring O O
naturally O O
with O O
age O O
, O O
as O O
previously O O
observed O O
-LSB-27 O O
-RSB- O O
. O O

Consistent O O
with O O
this O O
, O O
FDCs O O
in O O
6 O O
month O O
old O O
p50-/- O O
and O O
B6 O O
mice O O
could O O
not O O
be O O
detected O O
by O O
FDC-M2 O O
staining O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
in O O
contrast O O
with O O
younger O O
mice O O
-LRB- O O
Figure O O
1 O O
-RRB- O O
. O O

FDC-M2 O O
is O O
a O O
FDC O O
specific O O
antibody O O
-LSB-28 O O
-RSB- O O
that O O
detects O O
the O O
complement O O
component O O
C4 O O
on O O
FDCs O O
-LSB-29 O O
-RSB- O O
. O O

The O O
data O O
indicate O O
the O O
loss O O
of O O
FDC O O
function O O
may O O
be O O
accelerated O O
in O O
mice O O
lacking O O
p50 O O
. O O

Together O O
, O O
the O O
data O O
imply O O
that O O
the O O
lack O O
of O O
FDC O O
localization O O
of O O
IgM-IC O O
in O O
6 O O
month O O
old O O
p50-deficient O O
mice O O
is O O
not B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
functional O O
inactivity O O
of O O
the O O
MZ O O
B O O
cells O O
that O O
have O O
accumulated O O
in O O
these O O
mice O O
, O O
but O O
reflects O O
a O O
loss O O
of O O
FDCs O O
and/or O O
FDC O O
function O O
by O O
this O O
age O O
. O O

Discussion O O

Our O O
data O O
demonstrate O O
that O O
while B-conn Concession.Expectation
NF-κB O O
p50-/- O O
mice O O
are O O
clearly O O
deficient O O
in O O
MZ O O
B O O
cells O O
for O O
the O O
first O O
2 O O
months O O
of O O
life O O
, O O
MZ O O
B O O
cells O O
appear O O
with O O
age O O
, O O
such B-conn Cause.Result
that I-conn Cause.Result
by O O
6 O O
months O O
a O O
normal O O
splenic O O
MZ O O
B O O
cell O O
compartment O O
has O O
been O O
reconstituted O O
. O O

There O O
are O O
at O O
least O O
four O O
distinct O O
but O O
not O O
mutually O O
exclusive O O
mechanisms O O
that O O
could O O
account O O
for O O
the O O
late O O
appearance O O
of O O
cells O O
within O O
the O O
MZ O O
of O O
p50-/- O O
mice O O
. O O

First O O
, O O
these O O
B O O
cells O O
could O O
be O O
memory O O
B O O
cells O O
, O O
which O O
have O O
been O O
reported O O
to O O
accumulate O O
in O O
the O O
MZ O O
-LSB-30 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
we O O
cannot O O
formally O O
rule O O
out O O
this O O
possibility O O
, O O
B O O
cells O O
from O O
p50-/- O O
mice O O
respond O O
poorly O O
to O O
antigenic O O
challenge O O
, O O
especially O O
T-dependent O O
antigens O O
-LSB-16 O O
-RSB- O O
. O O

Consequently B-conn Cause.Result
, O O
it O O
is O O
unlikely O O
that O O
memory O O
B O O
cells O O
would O O
be O O
generated O O
in O O
these O O
mice O O
, O O
irrespective O O
of O O
their O O
age O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
the O O
emergence O O
of O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
could O O
represent O O
the O O
accumulation O O
of O O
these O O
cells O O
through B-conn Purpose.Enablement
homeostatic O O
proliferation O O
, O O
in O O
which O O
cells O O
proliferate O O
to O O
fill O O
niches O O
in B-conn Cause.Reason
response I-conn Cause.Reason
to I-conn Cause.Reason
deficits O O
in O O
specific O O
subsets O O
of O O
cells O O
-LSB-31 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
splenic O O
B O O
cells O O
from O O
p50-/- O O
mice O O
will O O
undergo O O
homeostatic O O
proliferation O O
as B-conn Cause.Reason
a I-conn Cause.Reason
consequence I-conn Cause.Reason
of I-conn Cause.Reason
their O O
transfer O O
into O O
SCID O O
recipients O O
-LSB-32 O O
-RSB- O O
, O O
the O O
ability O O
of O O
the O O
few O O
MZ O O
B O O
cells O O
in O O
the O O
p50-/- O O
donor O O
spleen O O
to O O
expand O O
following B-conn Temporal.Succession
transfer O O
was O O
not O O
examined O O
-LSB-32 O O
-RSB- O O
. O O

Nevertheless B-conn Concession.Contra-expectation
, O O
we O O
view O O
it O O
as O O
unlikely O O
that O O
homeostatic O O
proliferation O O
accounts O O
for O O
the O O
accumulation O O
of O O
MZ O O
B O O
cells O O
in O O
the O O
spleens O O
of O O
older O O
p50-/- O O
mice O O
, O O
since B-conn Cause.Reason
the O O
accumulation O O
of O O
cells O O
brought O O
on O O
by O O
homeostatic O O
proliferation O O
is O O
generally O O
observed O O
over O O
a O O
much O O
shorter O O
period O O
of O O
time O O
, O O
days O O
to O O
a O O
couple O O
of O O
weeks O O
, O O
rather O O
than O O
the O O
months O O
required O O
to O O
reconstitute O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
. O O

A O O
third O O
possibility O O
is O O
that O O
a O O
NF-κB O O
p50-dependent O O
signal O O
transduction O O
pathway O O
that O O
activates O O
a O O
developmentally O O
required O O
transcription O O
program O O
in O O
MZ O O
B O O
cells O O
or O O
their O O
precursors O O
is O O
overcome O O
by O O
compensatory O O
mechanisms O O
with O O
aging O O
. O O

NF-κB O O
p50 O O
is O O
involved O O
in O O
a O O
number O O
of O O
pathways O O
crucial O O
for O O
B O O
cell O O
development O O
and O O
maturation O O
, O O
including O O
B O O
cell O O
receptor O O
-LRB- O O
BCR O O
-RRB- O O
signalling O O
and O O
responses O O
to O O
members O O
of O O
the O O
TNF O O
family O O
-LSB-33-35 O O
-RSB- O O
Signal O O
strength O O
through O O
the O O
BCR O O
has O O
been O O
proposed O O
to O O
be O O
an O O
important O O
determinant O O
of O O
B O O
cell O O
lineage O O
fate O O
decisions O O
, O O
including O O
the O O
MZ O O
B O O
cell O O
pool O O
-LSB-36,37 O O
-RSB- O O
BAFF O O
signalling O O
is O O
also B-conn Conjunction
important O O
for O O
the O O
selection O O
of O O
B O O
cells O O
into O O
the O O
MZ O O
B O O
cell O O
pool O O
-LSB-38 O O
-RSB- O O
, O O
while B-conn Conjunction
an O O
intact O O
LT-β O O
R O O
signalling O O
pathway O O
is O O
required O O
for O O
the O O
proper O O
positioning O O
of O O
these O O
cells O O
-LSB-39 O O
-RSB- O O
. O O

The O O
accumulation O O
of O O
MZ O O
B O O
cells O O
in O O
older O O
p50-/- O O
mice O O
could O O
reflect O O
compensatory O O
mechanisms O O
in O O
one O O
or O O
more O O
of O O
these O O
signal O O
transduction O O
pathways O O
important O O
for O O
the O O
emergence O O
or O O
maintenance O O
of O O
MZ O O
B O O
cells O O
. O O

A O O
fourth O O
possibility O O
is O O
that O O
the O O
small O O
numbers O O
of O O
MZ O O
B O O
cells O O
that O O
successfully O O
emerge O O
in O O
p50-/- O O
mice O O
survive O O
for O O
extended O O
periods O O
of O O
time O O
, O O
resulting O O
in O O
the O O
slow O O
accumulation O O
of O O
this O O
subset O O
of O O
cells O O
with O O
age O O
. O O

Hao O O
and O O
Rajewsky O O
-LSB-40 O O
-RSB- O O
have O O
demonstrated O O
that O O
the O O
half-life O O
of O O
MZ O O
B O O
cells O O
is O O
greater O O
than O O
that O O
of O O
FO O O
B O O
cells O O
. O O

Thus B-conn Cause.Claim
, O O
a O O
simple O O
explanation O O
for O O
the O O
accumulation O O
of O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
with O O
age O O
is O O
that O O
these O O
cells O O
preferentially O O
survive O O
, O O
and B-conn Continuation
thus B-conn Cause.Result
their O O
frequency O O
relative O O
to O O
the O O
FO O O
B O O
cell O O
pool O O
and O O
other O O
B O O
cells O O
in O O
the O O
spleen O O
increases O O
slowly O O
with O O
age O O
. O O

B O O
cells O O
from O O
p50-/- O O
mice O O
are O O
compromised O O
in O O
their O O
ability O O
to O O
respond O O
to O O
specific O O
antigen O O
challenge O O
, O O
and O O
are O O
completely O O
unresponsive O O
to O O
mitogenic O O
substances O O
such O O
as O O
LPS O O
-LSB-16 O O
-RSB- O O
. O O

However B-conn Contrast
, O O
our O O
data O O
suggests O O
that O O
MZ O O
B O O
cells O O
from O O
p50-/- O O
mice O O
display O O
some O O
functionality O O
, O O
including O O
the O O
binding O O
, O O
transport O O
and O O
deposition O O
of O O
IgM-IC O O
onto O O
FDCs O O
, O O
a O O
function O O
unique O O
to O O
MZ O O
B O O
cells O O
-LSB-15 O O
-RSB- O O
. O O

Like O O
IgM-containing O O
T-dependent O O
immune O O
complexes O O
, O O
MZ O O
B O O
cells O O
also B-conn Conjunction
bind O O
T-independent O O
type O O
2 O O
-LRB- O O
TI-2 O O
-RRB- O O
antigens O O
in O O
a O O
complement O O
and O O
CR1/2-dependent O O
manner O O
-LSB-41 O O
-RSB- O O
. O O

Despite B-conn Concession.Expectation
the I-conn Concession.Expectation
fact I-conn Concession.Expectation
that I-conn Concession.Expectation
p50-/- O O
mice O O
are O O
widely O O
considered O O
to O O
be O O
devoid O O
of O O
MZ O O
B O O
cells O O
, O O
the O O
presence O O
of O O
small O O
numbers O O
of O O
these O O
B O O
cells O O
in O O
p50-/- O O
mice O O
were O O
in B-conn Reinforcement
fact I-conn Reinforcement
noted O O
in O O
the O O
initial O O
studies O O
of O O
Pillai O O
and O O
colleagues O O
, O O
and B-conn Conjunction
these O O
appeared O O
to O O
bind O O
low O O
levels O O
of O O
TI-2 O O
antigens O O
-LSB-17 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
further O O
analysis O O
of O O
the O O
consequences O O
of O O
this O O
binding O O
, O O
such O O
as O O
the O O
transfer O O
of O O
immune O O
complexes O O
to O O
FDCs O O
, O O
was O O
not O O
evaluated O O
. O O

The O O
results O O
of O O
the O O
current O O
study O O
not O O
only O O
extend O O
these O O
previous O O
studies O O
, O O
but O O
demonstrate O O
that O O
one O O
consequence O O
of O O
the O O
small O O
amount O O
of O O
IgM-IC O O
binding O O
manifests O O
itself O O
by O O
the O O
limited O O
, O O
but O O
none-the-less O O
detectable O O
, O O
deposition O O
of O O
these O O
complexes O O
onto O O
FDCs O O
. O O

This O O
suggests O O
that O O
this O O
function O O
of O O
MZ O O
B O O
cells O O
is O O
completely O O
independent O O
of O O
the O O
activation O O
of O O
NF-κB O O
, O O
at O O
least O O
those O O
complexes O O
containing O O
p50 O O
. O O

These O O
results O O
extend O O
other O O
evidence O O
suggesting O O
that O O
the O O
activation O O
of O O
MZ O O
B O O
cells O O
through O O
engagement O O
of O O
the O O
BCR O O
may O O
not O O
be O O
required O O
for O O
transport O O
and O O
deposition O O
of O O
IgM-IC O O
, O O
since B-conn Cause.Reason
MZ O O
B O O
cells O O
from O O
CD19-deficient O O
mice O O
, O O
which O O
also O O
have O O
deficits O O
in O O
MZ O O
B O O
cells O O
, O O
are O O
also O O
functional O O
in O O
this O O
assay O O
-LSB-15 O O
-RSB- O O
. O O

Together O O
, O O
these O O
results O O
raise O O
the O O
question O O
of O O
whether O O
MZ O O
B O O
cells O O
require O O
activating O O
signals O O
to O O
migrate O O
into O O
B O O
cell O O
follicles O O
following B-conn Temporal.Succession
IgM-IC O O
binding O O
to O O
CR1/2 O O
. O O

MZ O O
B O O
cell O O
migration O O
can O O
be O O
detected O O
in O O
1 O O
h O O
or O O
less O O
after B-conn Temporal.Succession
the O O
binding O O
of O O
IgM-IC O O
-LSB-15 O O
-RSB- O O
. O O

The O O
binding O O
of O O
IgM-IC O O
to O O
these O O
cells O O
may O O
interfere O O
with O O
one O O
or O O
more O O
of O O
the O O
mechanisms O O
proposed O O
to O O
play O O
a O O
role O O
in O O
MZ O O
B O O
cell O O
positioning O O
, O O
including O O
retention O O
by O O
macrophages O O
within O O
the O O
MZ O O
-LSB-42 O O
-RSB- O O
, O O
integrin-mediated O O
retention O O
-LSB-39 O O
-RSB- O O
, O O
or O O
responsiveness O O
to O O
lysophospholipids O O
in O O
the O O
blood O O
-LSB-43 O O
-RSB- O O
. O O

Once B-conn Temporal.Succession
released O O
, O O
the O O
MZ O O
B O O
cells O O
would O O
be O O
expected O O
to O O
migrate O O
into O O
follicles O O
in O O
response O O
to O O
chemoattractants O O
such O O
as O O
BLC O O
-LSB-44 O O
-RSB- O O
. O O

These O O
considerations O O
suggest O O
that O O
follicular O O
migration O O
of O O
MZ O O
B O O
cells O O
may O O
be O O
the O O
`` O O
default O O
'' O O
pathway O O
, O O
whereas B-conn Contrast
BCR O O
engagement O O
, O O
which O O
is O O
known O O
to O O
direct O O
MZ O O
B O O
cells O O
not O O
into O O
the O O
follicles O O
but O O
to O O
the O O
T-B O O
interface O O
-LSB-45-47 O O
-RSB- O O
, O O
actively O O
alters O O
the O O
fate O O
of O O
antigen O O
specific O O
MZ O O
cells O O
away O O
from O O
follicular O O
migration O O
. O O

Despite B-conn Concession.Expectation
the O O
increase O O
in O O
frequency O O
-LRB- O O
and O O
numbers O O
-RRB- O O
of O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
, O O
the O O
deposition O O
of O O
IgM-IC O O
within O O
the O O
follicles O O
does O O
not O O
improve O O
with O O
age O O
, O O
but O O
declines O O
severely O O
. O O

This O O
appears O O
to O O
be O O
due O O
to O O
a O O
decrease O O
in O O
function O O
of O O
FDCs O O
, O O
which O O
are O O
fewer O O
in O O
number O O
and O O
are O O
less O O
pronounced O O
, O O
as O O
evidenced O O
by O O
CD21 O O
staining O O
-LRB- O O
Figure O O
5 O O
-RRB- O O
. O O

Thus B-conn Cause.Claim
, O O
the O O
decreased O O
ability O O
of O O
FDCs O O
to O O
retain O O
complement O O
containing O O
immune O O
complexes O O
observed O O
in O O
old O O
mice O O
-LSB-27 O O
-RSB- O O
, O O
appear O O
to O O
emerge O O
with O O
accelerated O O
kinetics O O
in O O
p50-/- O O
mice O O
. O O

NF-κB O O
p50 O O
is O O
only O O
one O O
of O O
a O O
growing O O
number O O
of O O
genes O O
, O O
including O O
a O O
number O O
of O O
transcription O O
factors O O
, O O
whose O O
expression O O
influences O O
the O O
development O O
of O O
MZ O O
B O O
cells O O
-LRB- O O
reviewed O O
in O O
-LSB-48 O O
-RSB- O O
-RRB- O O
, O O
highlighting O O
the O O
complex O O
interactions O O
that O O
must O O
converge O O
to O O
generate O O
this O O
B O O
cell O O
compartment O O
. O O

The O O
fact O O
that O O
the O O
requirements O O
for O O
individual O O
proteins O O
, O O
such O O
as O O
p50 O O
, O O
could O O
change O O
with O O
age O O
suggests O O
that O O
compensatory O O
mechanisms O O
exist O O
which O O
can O O
overcome O O
cellular O O
defects O O
, O O
and/or B-conn Alternative.Conjunctive
that O O
more O O
than O O
one O O
pathway O O
to O O
generate O O
these O O
cells O O
may O O
exist O O
. O O

Conclusion O O

These O O
experiments O O
demonstrate O O
the O O
profound O O
influence O O
age O O
can O O
exert O O
on O O
cellular O O
populations O O
in O O
genetically O O
modified O O
mice O O
. O O

The O O
appearance O O
of O O
large O O
numbers O O
of O O
MZ O O
B O O
cells O O
in O O
6 O O
month O O
old O O
p50-/- O O
mice O O
suggests O O
that O O
compensatory O O
mechanisms O O
overcome O O
the O O
deficits O O
caused O O
by O O
p50-deficiency O O
. O O

Both O O
in O O
young O O
and O O
old O O
p50-/- O O
mice O O
, O O
these O O
MZ O O
B O O
cells O O
appear O O
to O O
retain O O
some O O
functionality O O
, O O
as O O
assessed O O
by O O
their O O
ability O O
to O O
bind O O
, O O
transport O O
and O O
deposit O O
IgM-IC O O
onto O O
FDCs O O
. O O

On B-conn Contrast
the I-conn Contrast
other I-conn Contrast
hand I-conn Contrast
, O O
FDCs O O
are O O
unable O O
to O O
maintain O O
their O O
functional O O
capacity O O
to O O
trap O O
IgM-IC O O
in O O
aged O O
p50-/- O O
mice O O
indicating O O
that O O
, O O
while B-conn Concession.Expectation
MZ O O
B O O
cells O O
recover O O
with O O
age O O
, O O
other O O
immune O O
defects O O
become O O
more O O
pronounced O O
as B-conn Cause.Reason
a I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
deficiency O O
in O O
this O O
member O O
of O O
the O O
NF-κB O O
family O O
of O O
transcription O O
factors O O
. O O

Methods O O

C57BL/6J O O
and O O
NF-κB O O
p50 O O
deficient O O
-LRB- O O
B6 O O
; O O
129P2-Nfkb1tm1Bal O O
-RRB- O O
-LSB-16 O O
-RSB- O O
mice O O
were O O
purchased O O
from O O
Jackson O O
Laboratories O O
-LRB- O O
Bar O O
Harbor O O
, O O
ME O O
-RRB- O O
. O O

Mice O O
were O O
maintained O O
in O O
the O O
Laboratory O O
Animal O O
Sciences O O
Center O O
, O O
Boston O O
University O O
Medical O O
Center O O
. O O

All O O
studies O O
were O O
reviewed O O
by O O
an O O
Institutional O O
Animal O O
Care O O
and O O
Use O O
Committee O O
and O O
carried O O
out O O
in O O
accordance O O
with O O
established O O
guidelines O O
according O O
to O O
National O O
Institutes O O
of O O
Health O O
. O O

Mice O O
of O O
both O O
sexes O O
were O O
used O O
at O O
2 O O
to O O
6 O O
months O O
of O O
age O O
as O O
described O O
. O O

Mice O O
were O O
injected O O
i.v. O O
with O O
a O O
mixture O O
of O O
15 O O
to O O
20 O O
μg O O
each O O
of O O
NP12-BSA-biotin O O
-LRB- O O
Biosearch O O
Technologies O O
, O O
Novato O O
, O O
CA O O
-RRB- O O
and O O
affinity O O
purified O O
pentameric O O
IgM O O
anti-NP O O
monoclonal O O
antibody O O
-LRB- O O
B1-8 O O
-RRB- O O
exactly O O
as O O
previously O O
described O O
-LSB-7,15 O O
-RSB- O O
. O O

In O O
vitro O O
assays O O
to O O
assess O O
the O O
binding O O
of O O
IgM-IC O O
to O O
MZ O O
B O O
cells O O
were O O
performed O O
as O O
previously O O
described O O
-LSB-15 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
IgM-IC O O
were O O
formed O O
by B-conn Purpose.Enablement
mixing O O
1 O O
μg O O
each O O
of O O
NP-BSA-biotin O O
and O O
B1-8 O O
IgM O O
in O O
RPMI O O
in O O
the O O
presence O O
of O O
10 O O
% O O
fresh O O
mouse O O
serum O O
as O O
a O O
source O O
of O O
complement O O
and O O
incubated O O
for O O
30 O O
minutes O O
at O O
37°C O O
. O O

Splenocytes O O
-LRB- O O
107 O O
-RRB- O O
were O O
resuspended O O
in O O
the O O
IgM-IC O O
and O O
incubated O O
at O O
37°C O O
for O O
an O O
additional O O
30 O O
minutes O O
. O O

Cells O O
were O O
washed O O
and O O
analyzed O O
by O O
flow O O
cytometry O O
. O O

Staining O O
of O O
spleen O O
sections O O
was O O
performed O O
exactly O O
as O O
previously O O
described O O
-LSB-7,15 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
spleens O O
were O O
removed O O
and O O
snap O O
frozen O O
in O O
O.C.T. O O
Compound O O
-LRB- O O
Tissue O O
Tek O O
, O O
Torrance O O
, O O
CA O O
-RRB- O O
and O O
stored O O
at O O
-80°C O O
. O O

6 O O
μm O O
sections O O
were O O
cut O O
-LRB- O O
IEC O O
Microtome O O
, O O
Needham O O
, O O
MA O O
-RRB- O O
and O O
fixed O O
in O O
acetone O O
at O O
-20°C O O
for O O
10 O O
min O O
. O O

Sections O O
were O O
incubated O O
with O O
0.3 O O
% O O
H2O2/PBS O O
for O O
5 O O
min O O
and O O
blocked O O
with O O
3 O O
% O O
normal O O
rabbit O O
or O O
rat O O
serum O O
. O O

All O O
antibodies O O
were O O
diluted O O
in O O
5 O O
% O O
BSA O O
in O O
PBS O O
. O O

Primary O O
antibodies O O
used O O
included O O
: O O
anti-CD3-FITC O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-CD3-biotin O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-CD21/35-FITC O O
-LRB- O O
1/100 O O
-RRB- O O
, O O
-LRB- O O
all O O
from O O
BD O O
Biosciences O O
, O O
San O O
Diego O O
-RRB- O O
, O O
ER-TR9 O O
-LRB- O O
1/200 O O
; O O
BMA O O
Biomedical O O
, O O
Augst O O
, O O
Switzerland O O
-RRB- O O
, O O
and O O
anti-FDC-M2 O O
-LRB- O O
1/200 O O
; O O
Immunokontact O O
, O O
Frankfurt O O
, O O
Germany O O
-RRB- O O
. O O

Secondary O O
antibodies O O
included O O
anti-FITC-HRP O O
-LRB- O O
1/100 O O
; O O
Roche O O
Molecular O O
Biochemicals O O
, O O
Indianapolis O O
, O O
IN O O
-RRB- O O
, O O
goat O O
anti-rat O O
IgG-HRP O O
-LRB- O O
1/500 O O
; O O
Jackson O O
Immunoresearch O O
, O O
West O O
Grove O O
, O O
PA O O
-RRB- O O
, O O
and O O
goat O O
anti-rat O O
IgM O O
-LRB- O O
Fab O O
' O O
-RRB- O O
2-HRP O O
-LRB- O O
1/1000 O O
; O O
Jackson O O
Immunoresearch O O
-RRB- O O
. O O

NP12-BSA-biotin O O
and O O
anti-CD3-biotin O O
was O O
visualized O O
by O O
alkaline O O
phosphatase O O
-LRB- O O
AP O O
-RRB- O O
-streptavidin O O
-LRB- O O
1/400 O O
; O O
Molecular O O
Probes O O
, O O
Eugene O O
, O O
OR O O
-RRB- O O
and O O
developed O O
with O O
napthol O O
AS-MX O O
phosphate/Fast O O
blue O O
BB O O
base O O
-LRB- O O
Sigma O O
, O O
St. O O
Louis O O
, O O
MO O O
-RRB- O O
. O O

Visualization O O
of O O
antibody O O
stains O O
was O O
accomplished O O
using O O
horse O O
radish O O
peroxidase O O
-LRB- O O
HRP O O
-RRB- O O
conjugated O O
secondary O O
antibodies O O
developed O O
with O O
3-amino-9-ethylcarbazole O O
-LRB- O O
Sigma O O
-RRB- O O
and O O
H202 O O
. O O

After O O
staining O O
, O O
sections O O
were O O
covered O O
with O O
crystal O O
mount O O
-LRB- O O
Biomedia O O
, O O
Foster O O
City O O
, O O
CA O O
-RRB- O O
before B-conn Temporal.Precedence
examining O O
by O O
digital O O
microscopy O O
-LRB- O O
Zeiss O O
, O O
Axiovert O O
200 O O
M O O
, O O
Oberkochen O O
, O O
Germany O O
-RRB- O O
. O O

Unless B-conn Alternative.Disjunctive
otherwise O O
noted O O
, O O
all O O
images O O
were O O
obtained O O
using O O
a O O
10× O O
objective O O
-LRB- O O
initial O O
magnification O O
of O O
100× O O
-RRB- O O
unless O O
otherwise O O
noted O O
-LRB- O O
see O O
Fig. O O
4 O O
-RRB- O O
. O O

Sections O O
were O O
initially O O
treated O O
as O O
for O O
IH O O
. O O

Antibodies O O
utilized O O
included O O
anti-MOMA-1 O O
-LRB- O O
1/25 O O
; O O
Serotec O O
, O O
Raleigh O O
NC O O
-RRB- O O
visualized O O
with O O
a O O
goat O O
anti-rat O O
IgG-AMCA O O
-LRB- O O
1/100 O O
; O O
Jackson O O
Immunoresearch O O
-RRB- O O
, O O
anti-IgM-Texas O O
Red O O
-LRB- O O
1/100 O O
; O O
BD O O
Biosciences O O
-RRB- O O
, O O
and O O
anti-laminin O O
-LRB- O O
1/500 O O
; O O
Sigma O O
-RRB- O O
visualized O O
with O O
an O O
anti-rabbit O O
IgG-FITC O O
-LRB- O O
1/100 O O
; O O
Jackson O O
Immunoresearch O O
-RRB- O O
. O O

All O O
sections O O
were O O
covered O O
with O O
Fluoromount O O
G O O
-LRB- O O
Jackson O O
Immunoresearch O O
-RRB- O O
and O O
a O O
cover O O
slip O O
before B-conn Temporal.Precedence
examining O O
by O O
digital O O
microscopy O O
-LRB- O O
Zeiss O O
, O O
Axiovert O O
200 O O
M O O
, O O
Oberkochen O O
, O O
Germany O O
-RRB- O O
. O O

Splenocytes O O
were O O
isolated O O
at O O
the O O
indicated O O
times O O
and O O
stained O O
as O O
follows O O
. O O

The O O
lymphocyte O O
gate O O
was O O
utilized O O
for O O
all O O
analysis O O
. O O

Cells O O
were O O
analyzed O O
using O O
a O O
FACScan O O
-LRB- O O
Becton O O
Dickinson O O
, O O
Franklin O O
Lakes O O
, O O
NJ O O
-RRB- O O
and O O
FlowJo O O
software O O
-LRB- O O
Tree O O
Star O O
, O O
Ashland O O
, O O
OR O O
-RRB- O O
. O O

Antibodies O O
utilized O O
were O O
anti-B220-FITC O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-B220-biotin O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-B220-PE O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-CD21/35-FITC O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
anti-CD23-PE O O
-LRB- O O
1/200 O O
-RRB- O O
, O O
and O O
anti-CD1d-FITC O O
or O O
PE O O
-LRB- O O
1/100 O O
-RRB- O O
-LRB- O O
BD O O
Biosciences O O
-RRB- O O
. O O

Streptavidin-Cy5 O O
-LRB- O O
1/200 O O
; O O
BD O O
Biosciences O O
-RRB- O O
was O O
used O O
to B-conn Purpose.Goal
identify O O
the O O
NP O O
antigen O O
-LRB- O O
NP12-BSA-biotin O O
-RRB- O O
associated O O
with O O
lymphocytes O O
, O O
as O O
well O O
as O O
to O O
visualize O O
biotin-labelled O O
antibodies O O
. O O

Authors O O
' O O
contributions O O

A.R.F. O O
. O O

performed O O
the O O
experiments O O
reported O O
in O O
this O O
manuscript O O
and O O
participated O O
in O O
the O O
data O O
interpretation O O
and O O
analysis O O
. O O

R.B.C. O O
originally O O
conceived O O
of O O
the O O
study O O
, O O
participated O O
in O O
data O O
interpretation O O
and O O
analysis O O
, O O
and O O
takes O O
overall O O
responsibility O O
for O O
the O O
conduct O O
of O O
the O O
studies O O
. O O

Both O O
authors O O
have O O
read O O
and O O
approve O O
of O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
p50-/- O O
mice O O
trap O O
IgM-IC O O
less O O
efficiently O O
on O O
FDCs O O
. O O

Localization O O
of O O
IgM-IC O O
in O O
B6 O O
or O O
p50-/- O O
mice O O
was O O
determined O O
by O O
IH O O
16 O O
h O O
after O O
injection O O
. O O

ER-TR9 O O
identifies O O
marginal O O
zone O O
macrophages O O
-LRB- O O
MZM O O
-RRB- O O
and O O
FDC-M2 O O
identifies O O
FDCs O O
. O O

IgM-IC O O
-LRB- O O
which O O
appear O O
blue O O
in O O
this O O
and O O
all O O
subsequent O O
figures O O
and O O
are O O
identified O O
by O O
arrows O O
-RRB- O O
are O O
localized O O
to O O
FDCs O O
in O O
spleens O O
from O O
both O O
groups O O
of O O
mice O O
, O O
but B-conn Contrast
FDCs O O
from O O
B6 O O
mice O O
show O O
more O O
intense O O
staining O O
, O O
indicating O O
that O O
more O O
IgM-IC O O
are O O
trapped O O
in O O
these O O
mice O O
. O O

All O O
IH O O
stains O O
were O O
performed O O
on O O
serial O O
sections O O
and O O
were O O
developed O O
side-by-side O O
for O O
identical O O
periods O O
of O O
time O O
. O O

Figure O O
2 O O
: O O
p50-/- O O
mice O O
contain O O
reduced O O
numbers O O
of O O
MZ O O
B O O
cells O O
that O O
bind O O
high O O
levels O O
of O O
IgM-IC O O
A. O O
B O O
cell O O
subsets O O
and O O
IgM-IC O O
binding O O
. O O

Splenocytes O O
from O O
B6 O O
or O O
p50-/- O O
mice O O
were O O
analyzed O O
for O O
B O O
cell O O
subsets O O
by O O
FACS O O
using O O
CD21/CD23 O O
or O O
B220/CD1d O O
expression O O
. O O

Histograms O O
on O O
the O O
right O O
show O O
binding O O
of O O
IgM-IC O O
to O O
MZ O O
and O O
FO O O
B O O
cells O O
1 O O
h O O
after O O
i.v. O O
. O O

injection O O
-LRB- O O
shaded O O
region O O
-RRB- O O
; O O
clear O O
profiles O O
represent O O
uninjected O O
control O O
mice O O
. O O

Although B-conn Concession.Expectation
spleen O O
cells O O
from O O
p50-/- O O
mice O O
contained O O
reduced O O
numbers O O
of O O
MZ O O
B O O
cells O O
, O O
the O O
cells O O
present O O
in O O
the O O
MZ O O
B O O
cell O O
gate O O
bind O O
IgM-IC O O
at O O
high O O
levels O O
over O O
background O O
, O O
similar O O
to O O
levels O O
of O O
binding O O
of O O
IgM-IC O O
to O O
B6 O O
MZ O O
B O O
cells O O
. O O

B. O O
In O O
vitro O O
binding O O
assay O O
showing O O
binding O O
of O O
IgM-IC O O
to O O
MZ O O
B O O
cells O O
-LRB- O O
shaded O O
region O O
-RRB- O O
compared O O
with O O
FO O O
B O O
cells O O
-LRB- O O
clear O O
region O O
-RRB- O O
. O O

MZ O O
B O O
cells O O
from O O
both O O
B6 O O
and O O
p50-/- O O
mice O O
bind O O
high O O
levels O O
of O O
IgM-IC O O
compared O O
to O O
FO O O
B O O
cells O O
. O O

C. O O
Immunofluorescence O O
shows O O
the O O
presence O O
of O O
IgMhi O O
cells O O
-LRB- O O
red O O
-RRB- O O
in O O
the O O
MZ O O
as O O
demarcated O O
by O O
MOMA-1 O O
-LRB- O O
marginal O O
metallophilic O O
macrophages O O
, O O
blue O O
-RRB- O O
staining O O
. O O

p50-/- O O
mice O O
possess O O
some O O
IgM+ O O
cells O O
in O O
the O O
MZ O O
outside O O
of O O
the O O
MOMA-1 O O
ring O O
, O O
consistent O O
with O O
the O O
presence O O
of O O
appropriately O O
positioned O O
MZ O O
B O O
cells O O
in O O
these O O
mice O O
. O O

Figure O O
3 O O
: O O
p50-/- O O
mice O O
accumulate O O
MZ O O
B O O
cells O O
with O O
age O O
that O O
have O O
the O O
capacity O O
to O O
bind O O
high O O
levels O O
of O O
IgM-IC O O
A. O O
FACS O O
profile O O
of O O
splenocytes O O
from O O
2 O O
and O O
6 O O
month O O
old O O
B6 O O
and O O
6 O O
month O O
p50-/- O O
mice O O
reveal O O
the O O
presence O O
of O O
normal O O
numbers O O
of O O
MZ O O
B O O
cells O O
in O O
spleens O O
of O O
the O O
p50-/- O O
mice O O
. O O

Histograms O O
illustrate O O
binding O O
of O O
IgM-IC O O
to O O
p50-/- O O
MZ O O
B O O
cells O O
as O O
described O O
in O O
Figure O O
2A O O
. O O

B. O O
In O O
vitro O O
IgM-IC O O
binding O O
assay O O
. O O

Binding O O
to O O
MZ O O
B O O
cells O O
-LRB- O O
shaded O O
profiles O O
-RRB- O O
; O O
binding O O
to O O
FO O O
B O O
cells O O
-LRB- O O
clear O O
profiles O O
-RRB- O O
. O O

Figure O O
4 O O
: O O
Phenotypic O O
and O O
histological O O
analysis O O
of O O
MZ O O
B O O
cells O O
in O O
p50-/- O O
mice O O
A. O O
FACS O O
profile O O
of O O
splenocytes O O
from O O
2 O O
and O O
6 O O
month O O
old O O
B6 O O
and O O
6 O O
month O O
old O O
p50-/- O O
mice O O
revealed O O
by O O
B220/CD1d O O
and O O
B220/CD9 O O
profiles O O
. O O

B. O O
FACS O O
histograms O O
showing O O
IgM O O
levels O O
on O O
MZ O O
and O O
FO O O
B O O
cells O O
-LRB- O O
shaded O O
and O O
clear O O
regions O O
, O O
respectively O O
-RRB- O O
as O O
determined O O
by O O
CD21/23 O O
profiles O O
. O O

Cells O O
present O O
in O O
the O O
MZ O O
B O O
cell O O
gate O O
in O O
p50-/- O O
mice O O
express O O
higher O O
levels O O
of O O
IgM O O
compared O O
with O O
FO O O
B O O
cells O O
, O O
similar O O
to O O
B6 O O
mice O O
. O O

C. O O
IF O O
reveals O O
well O O
demarcated O O
IgMhi O O
cells O O
-LRB- O O
in O O
red O O
-RRB- O O
in O O
the O O
MZ O O
outside O O
of O O
the O O
laminin O O
staining O O
-LRB- O O
which O O
identifies O O
the O O
marginal O O
sinus O O
; O O
in O O
green O O
-RRB- O O
in O O
6 O O
month O O
p50-/- O O
mice O O
. O O

Figure O O
5 O O
: O O
Deteriorated O O
FDCs O O
in O O
aged O O
p50-/- O O
mice O O
correlates O O
with O O
reduced O O
IgM-IC O O
localization O O
A. O O
2 O O
month O O
and O O
6 O O
month O O
old O O
B6 O O
mice O O
and O O
6 O O
month O O
old O O
p50-/- O O
mice O O
were O O
injected O O
with O O
IgM-IC O O
and O O
analyzed O O
by O O
IH O O
for O O
IgM-IC O O
localization O O
16 O O
h O O
later O O
. O O

IgM-IC O O
were O O
present O O
on O O
FDCs O O
in O O
2 O O
and O O
6 O O
month O O
B6 O O
mice O O
-LRB- O O
see O O
arrows O O
-RRB- O O
, O O
but O O
were O O
not O O
deposited O O
onto O O
FDCs O O
in O O
p50-/- O O
mice O O
. O O

B. O O
Intense O O
CD21 O O
staining O O
-LRB- O O
designated O O
by O O
arrows O O
-RRB- O O
was O O
less O O
visible O O
in O O
the O O
spleens O O
of O O
p50-/- O O
mice O O
, O O
indicating O O
that O O
FDC O O
networks O O
were O O
poorly O O
developed O O
in O O
these O O
mice O O
. O O

This O O
suggests O O
that O O
reduced O O
IgM-IC O O
localization O O
may O O
be O O
attributed O O
to O O
the O O
loss O O
of O O
functional O O
FDC O O
networks O O
in O O
p50-/- O O
mice O O
. O O

The O O
magnifications O O
noted O O
refer O O
to O O
the O O
objective O O
used O O
, O O
not O O
the O O
absolute O O
magnification O O
. O O

Differential O O
clinical O O
efficacy O O
of O O
anti-CD4 O O
monoclonal O O
antibodies O O
in O O
rat O O
adjuvant O O
arthritis O O
is O O
paralleled O O
by O O
differential O O
influence O O
on O O
NF-κB O O
binding O O
activity O O
and O O
TNF-α O O
secretion O O
of O O
T O O
cells O O

Abstract O O

The O O
aim O O
of O O
this O O
study O O
was O O
to O O
analyze O O
the O O
differential O O
effects O O
of O O
three O O
anti-CD4 O O
monoclonal O O
antibodies O O
-LRB- O O
mAbs O O
-RRB- O O
-LRB- O O
with O O
distinct O O
epitope O O
specifities O O
-RRB- O O
in O O
the O O
treatment O O
of O O
rat O O
adjuvant O O
arthritis O O
-LRB- O O
AA O O
-RRB- O O
and O O
on O O
T-cell O O
function O O
and O O
signal O O
transduction O O
. O O

Rat O O
AA O O
was O O
preventively O O
treated O O
by B-conn Purpose.Enablement
intraperitoneal O O
injection O O
of O O
the O O
anti-CD4 O O
mAbs O O
W3/25 O O
, O O
OX35 O O
, O O
and O O
RIB5/2 O O
-LRB- O O
on O O
days O O
-1 O O
, O O
0 O O
, O O
3 O O
, O O
and O O
6 O O
, O O
i.e. O O
1 O O
day O O
before O O
AA O O
induction O O
, O O
on O O
the O O
day O O
of O O
induction O O
-LSB-day O O
0 O O
-RSB- O O
, O O
and O O
thereafter O O
-RRB- O O
. O O

The O O
effects O O
on O O
T-cell O O
reactivity O O
in O O
vivo O O
-LRB- O O
delayed-type O O
hypersensitivity O O
-RRB- O O
, O O
ex O O
vivo O O
-LRB- O O
ConA-induced O O
proliferation O O
-RRB- O O
, O O
and O O
in O O
vitro O O
-LRB- O O
mixed O O
lymphocyte O O
culture O O
-RRB- O O
were O O
assessed O O
. O O

The O O
in O O
vitro O O
effects O O
of O O
anti-CD4 O O
preincubation O O
on O O
T-cell O O
receptor O O
-LRB- O O
TCR O O
-RRB- O O
/CD3-induced O O
cytokine O O
production O O
and O O
signal O O
transduction O O
were O O
also B-conn Conjunction
analyzed O O
. O O

While B-conn Contrast
preventive O O
treatment O O
with O O
OX35 O O
and O O
W3/25 O O
significantly O O
ameliorated O O
AA O O
from O O
the O O
onset O O
, O O
treatment O O
with O O
RIB5/2 O O
even O O
accelerated O O
the O O
onset O O
of O O
AA O O
by O O
approximately O O
2 O O
days O O
-LRB- O O
day O O
10 O O
-RRB- O O
, O O
and O O
ameliorated O O
the O O
arthritis O O
only O O
in O O
the O O
late O O
phase O O
-LRB- O O
day O O
27 O O
-RRB- O O
. O O

Differential O O
clinical O O
effects O O
at O O
the O O
onset O O
of O O
AA O O
were O O
paralleled O O
by O O
a O O
differential O O
influence O O
of O O
the O O
mAbs O O
on O O
T-cell O O
functions O O
, O O
i.e. B-conn Restatement.Specification
in O O
comparison O O
with O O
OX35 O O
and O O
W3/25 O O
, O O
the O O
' O O
accelerating O O
' O O
mAb O O
RIB5/2 O O
failed O O
to O O
increase O O
the O O
delayed-type O O
hypersentivity O O
-LRB- O O
DTH O O
-RRB- O O
to O O
Mycobacterium O O
tuberculosis O O
, O O
increased O O
the O O
in O O
vitro O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
secretion O O
, O O
and O O
more O O
strongly O O
induced O O
NF-κB O O
binding O O
activity O O
after B-conn Temporal.Succession
anti-CD4 O O
preincubation O O
and O O
subsequent O O
TCR/CD3-stimulation. O O
Depending O O
on O O
their O O
epitope O O
specificity O O
, O O
different O O
anti-CD4 O O
mAbs O O
differentially O O
influence O O
individual O O
proinflammatory O O
functions O O
of O O
T O O
cells O O
. O O

This O O
fine O O
regulation O O
may O O
explain O O
the O O
differential O O
efficacy O O
in O O
the O O
treatment O O
of O O
AA O O
and O O
may O O
contribute O O
to O O
the O O
understanding O O
of O O
such O O
treatments O O
in O O
other O O
immunopathologies O O
. O O

Introduction O O

CD4+ O O
T O O
cells O O
and O O
their O O
cytokine O O
products O O
play O O
an O O
important O O
role O O
in O O
rheumatoid O O
arthritis O O
and O O
experimental O O
models O O
of O O
arthritis O O
, O O
therefore B-conn Cause.Result
representing O O
potential O O
therapeutic O O
targets O O
-LSB-1 O O
-RSB- O O
. O O

A O O
specific O O
therapeutic O O
approach O O
is O O
the O O
direct O O
targeting O O
of O O
CD4+ O O
T O O
cells O O
by B-conn Purpose.Enablement
use O O
of O O
monoclonal O O
antibodies O O
-LRB- O O
mAbs O O
-RRB- O O
against O O
the O O
CD4 O O
coreceptor O O
. O O

Anti-CD4 O O
mAbs O O
induce O O
either O O
cell O O
depletion O O
-LSB-2 O O
-RSB- O O
or O O
functional O O
inactivation O O
of O O
T O O
cells O O
-LSB-3,4 O O
-RSB- O O
, O O
although B-conn Contrast
activation O O
of O O
T-cell O O
functions O O
has O O
also O O
been O O
reported O O
-LSB-5 O O
-RSB- O O
. O O

These O O
contrasting O O
effects O O
may O O
explain O O
the O O
variability O O
in O O
the O O
clinical O O
efficacy O O
of O O
different O O
anti-CD4 O O
mAbs O O
in O O
the O O
treatment O O
of O O
rheumatoid O O
arthritis O O
, O O
i.e. B-conn Restatement.Specification
promising O O
initial O O
efficacy O O
in O O
open O O
anti-CD4 O O
trials O O
-LSB-6,7 O O
-RSB- O O
, O O
subsequent O O
disappointing O O
double-blind O O
clinical O O
trials O O
-LRB- O O
reviewed O O
in O O
-LSB-8 O O
-RSB- O O
-RRB- O O
, O O
and O O
, O O
finally O O
, O O
a O O
revival O O
of O O
the O O
anti-CD4 O O
treatment O O
principle O O
with O O
new O O
, O O
humanized O O
anti-CD4 O O
mAbs O O
-LSB-9,10 O O
-RSB- O O
. O O

The O O
focus O O
of O O
the O O
present O O
study O O
was O O
to O O
analyze O O
the O O
effects O O
of O O
the O O
anti-CD4 O O
mAbs O O
W3/25 O O
, O O
OX35 O O
, O O
and O O
RIB5/2 O O
in O O
rat O O
adjuvant O O
arthritis O O
-LRB- O O
AA O O
-RRB- O O
, O O
a O O
well-known O O
, O O
clearly O O
CD4+ O O
T-cell-dependent O O
experimental O O
arthritis O O
model O O
-LSB-11-13 O O
-RSB- O O
. O O

These O O
mAbs O O
target O O
different O O
epitopes O O
of O O
the O O
CD4 O O
molecule O O
and O O
do O O
not O O
compete O O
for O O
CD4 O O
binding O O
-LSB-14 O O
-RSB- O O
. O O

They O O
are O O
equally O O
effective O O
in O O
suppressing O O
AA O O
upon B-conn Circumstance.Forward Circumstance
treatment O O
of O O
established O O
disease O O
-LSB-11,12 O O
-RSB- O O
-LRB- O O
and O O
authors O O
own O O
unpublished O O
observations O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
preventive O O
treatment O O
with O O
the O O
anti-CD4 O O
mAbs O O
W3/25 O O
, O O
OX35 O O
, O O
and O O
RIB5/2 O O
-LRB- O O
on O O
days O O
-1 O O
, O O
0 O O
, O O
3 O O
, O O
and O O
6 O O
, O O
i.e. O O
1 O O
day O O
before O O
AA O O
induction O O
, O O
on O O
the O O
day O O
of O O
induction O O
-LSB-day O O
0 O O
-RSB- O O
, O O
and O O
thereafter O O
-RRB- O O
had O O
opposite O O
effects O O
in O O
the O O
induction O O
phase O O
of O O
AA O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
explain O O
this O O
differential O O
efficacy O O
, O O
several O O
parameters O O
were O O
analyzed O O
. O O

Methods O O

For O O
animals O O
, O O
arthritis O O
model O O
, O O
antibodies O O
, O O
and O O
affinity O O
determination O O
-LRB- O O
surface O O
plasmon O O
resonance O O
-RRB- O O
, O O
see O O
Supplementary O O
material O O
. O O

T-cell O O
reactivity O O
was O O
measured O O
in O O
vivo O O
by O O
delayed-type O O
hypersensitivity O O
-LRB- O O
DTH O O
-RRB- O O
and O O
in O O
vitro O O
by O O
proliferation O O
assay O O
or O O
mixed O O
lymphocyte O O
culture O O
, O O
and B-conn Conjunction
cytokines O O
were O O
measured O O
by O O
bioassay O O
or O O
ELISA O O
-LRB- O O
see O O
Supplementary O O
material O O
; O O
for O O
tumor O O
necrosis O O
factor O O
-LRB- O O
TNF O O
-RRB- O O
-α O O
-LSB-15 O O
-RSB- O O
-RRB- O O
. O O

Cells O O
were O O
stimulated O O
by B-conn Purpose.Enablement
preincubation O O
with O O
anti-CD4 O O
mAbs O O
and O O
subsequent O O
stimulation O O
of O O
T-cell O O
receptors O O
. O O

Electrophoretic O O
mobility O O
shift O O
assay O O
-LRB- O O
EMSA O O
-RRB- O O
was O O
as O O
described O O
in O O
the O O
Supplementary O O
material O O
. O O

For O O
statistical O O
analysis O O
, O O
we O O
used O O
the O O
Mann–Whitney O O
-LRB- O O
U O O
-RRB- O O
test/Spearman O O
rank O O
correlation O O
-LRB- O O
P O O
≤ O O
0.05 O O
; O O
see O O
Supplementary O O
material O O
-RRB- O O
. O O

Results O O

Preventive O O
treatment O O
with O O
the O O
anti-CD4 O O
mAbs O O
W3/25 O O
and O O
OX35 O O
led O O
to O O
a O O
marked O O
, O O
significant O O
suppression O O
of O O
the O O
arthritis O O
score O O
from O O
day O O
13 O O
to O O
30 O O
in O O
comparison O O
with O O
PBS-treated O O
animals O O
-LRB- O O
P O O
≤ O O
0.05 O O
; O O
Fig. O O
1 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
anti-CD4 O O
mAb O O
RIB5/2 O O
significantly O O
accelerated O O
the O O
onset O O
of O O
the O O
arthritis O O
by O O
approximately O O
2 O O
days O O
-LRB- O O
P O O
≤ O O
0.01 O O
; O O
days O O
11 O O
, O O
12 O O
; O O
see O O
Fig. O O
1 O O
-RRB- O O
, O O
resulting O O
in O O
an O O
aggravated O O
clinical O O
score O O
on O O
these O O
days O O
, O O
and O O
ameliorated O O
clinical O O
signs O O
only O O
from O O
day O O
27 O O
-LRB- O O
P O O
≤ O O
0.05 O O
; O O
see O O
Fig. O O
1 O O
-RRB- O O
. O O

The O O
accelerating O O
effect O O
of O O
the O O
mAb O O
RIB5/2 O O
was O O
reproduced O O
in O O
two O O
additional O O
treatment O O
experiments O O
, O O
and B-conn Conjunction
this O O
effect O O
was O O
observed O O
despite B-conn Concession.Expectation
a O O
variable O O
onset O O
of O O
AA O O
in O O
the O O
PBS-treated O O
animals O O
-LRB- O O
day O O
9 O O
to O O
11 O O
-RRB- O O
; O O
i.e. B-conn Restatement.Specification
in O O
all O O
experiments O O
, O O
the O O
onset O O
of O O
AA O O
occurred O O
2 O O
days O O
earlier O O
than O O
in O O
the O O
controls O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
identify O O
potential O O
mechanisms O O
for O O
these O O
differential O O
effects O O
, O O
the O O
molecular O O
properties O O
of O O
the O O
mAbs O O
and O O
their O O
influence O O
on O O
T-cell O O
effector O O
functions O O
in O O
vivo O O
and O O
in O O
vitro O O
were O O
investigated O O
. O O

For O O
the O O
sake O O
of O O
simplicity O O
, O O
we O O
refer O O
to O O
the O O
mAb O O
RIB5/2 O O
as O O
' O O
accelerating O O
' O O
-LRB- O O
although B-conn Concession.Contra-expectation
this O O
term O O
is O O
applicable O O
only O O
to O O
the O O
onset O O
of O O
AA O O
-RRB- O O
and B-conn Conjunction
the O O
mAbs O O
W3/25 O O
and O O
OX35 O O
as O O
' O O
ameliorating O O
' O O
. O O

Calculation O O
of O O
the O O
affinity O O
constant O O
-LRB- O O
KA O O
-RRB- O O
resulted O O
in O O
comparable O O
values O O
for O O
OX35 O O
and O O
RIB5/2 O O
-LRB- O O
see O O
Supplementary O O
Table O O
1 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
affinity O O
of O O
W3/25 O O
was O O
50-fold O O
that O O
for O O
the O O
two O O
other O O
mAbs O O
. O O

While B-conn Contrast
the O O
association O O
rate O O
constants O O
-LRB- O O
kass O O
-RRB- O O
for O O
all O O
three O O
mAbs O O
were O O
within O O
the O O
same O O
order O O
of O O
magnitude O O
, O O
striking O O
differences O O
-LRB- O O
up O O
to O O
40-fold O O
-RRB- O O
were O O
observed O O
for O O
the O O
dissociation O O
rate O O
constants O O
-LRB- O O
kdiss O O
-RRB- O O
. O O

Thus B-conn Restatement.Generalization
, O O
although B-conn Concession.Expectation
differences O O
in O O
overall O O
affinity O O
did O O
not O O
match O O
differential O O
clinical O O
efficacy O O
, O O
the O O
accelerating O O
mAb O O
RIB5/2 O O
displayed O O
the O O
highest O O
kdiss O O
. O O

T-cell O O
reactivity O O
was O O
investigated O O
on O O
day O O
13 O O
of O O
AA O O
, O O
i.e. O O
when O O
the O O
clinical O O
differences O O
between O O
the O O
accelerating O O
and O O
ameliorating O O
anti-CD4 O O
mAbs O O
were O O
maximal O O
. O O

Compared O O
to O O
the O O
PBS-treated O O
control O O
group O O
, O O
the O O
ameliorating O O
mAb O O
OX35 O O
induced O O
a O O
significant O O
increase O O
of O O
the O O
DTH O O
in O O
response O O
to O O
the O O
arthritogen O O
Mycobacterium O O
tuberculosis O O
-LRB- O O
Supplementary O O
Fig. O O
1 O O
-RRB- O O
. O O

The O O
other O O
ameliorating O O
anti-CD4 O O
mAb O O
, O O
W3/25 O O
, O O
also O O
induced O O
an O O
increase O O
, O O
but B-conn Concession.Contra-expectation
statistical O O
significance O O
was O O
not O O
reached O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
treatment O O
with O O
the O O
accelerating O O
anti-CD4 O O
mAb O O
, O O
RIB5/2 O O
, O O
had O O
virtually O O
no O O
influence O O
on O O
the O O
DTH O O
. O O

Upon B-conn Circumstance.Forward Circumstance
stimulation O O
with O O
concanavalin O O
A O O
-LRB- O O
ConA O O
-RRB- O O
, O O
total O O
T O O
cells O O
from O O
RIB5/2-treated O O
animals O O
showed O O
lower O O
proliferation O O
rates O O
than O O
those O O
from O O
W3/25- O O
or O O
OX35-treated O O
rats O O
-LRB- O O
Supplementary O O
Fig. O O
2 O O
-RRB- O O
. O O

In O O
the O O
mixed O O
lymphocyte O O
culture O O
, O O
RIB5/2 O O
was O O
also O O
the O O
most O O
potent O O
inhibitor O O
of O O
T-cell O O
activation O O
in O O
the O O
case O O
of O O
total O O
T O O
cells O O
; O O
however B-conn Concession.Contra-expectation
, O O
this O O
was O O
not O O
observed O O
in O O
purified O O
CD4+ O O
T O O
cells O O
-LRB- O O
Supplementary O O
Fig. O O
4 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
simulate O O
the O O
preventive O O
therapeutic O O
application O O
in O O
AA O O
, O O
i.e. B-conn Restatement.Specification
the O O
activation O O
of O O
CD4+ O O
T O O
cells O O
in O O
the O O
presence O O
of O O
anti-CD4 O O
mAbs O O
, O O
purified O O
spleen O O
CD4+ O O
T O O
cells O O
were O O
incubated O O
with O O
anti-CD4 O O
mAb O O
and O O
, O O
after B-conn Temporal.Succession
cross-linking O O
, O O
stimulated O O
with O O
plate-bound O O
anti-T-cell-receptor O O
-LRB- O O
TCR O O
-RRB- O O
α/β O O
mAb O O
-LRB- O O
so O O
called O O
anti-CD4 O O
preincubation O O
-RRB- O O
. O O

Interestingly O O
, O O
anti-CD4 O O
preincubation O O
with O O
the O O
accelerating O O
anti-CD4 O O
mAb O O
RIB5/2 O O
led O O
to O O
a O O
significantly O O
higher O O
TNF-α O O
secretion O O
, O O
in O O
comparison O O
both O O
with O O
the O O
isotype O O
control O O
and O O
with O O
the O O
two O O
other O O
anti-CD4 O O
mAbs O O
, O O
W3/25 O O
and O O
OX35 O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

Differential O O
induction O O
of O O
TNF-α O O
by O O
RIB5/2 O O
was O O
also O O
seen O O
after B-conn Temporal.Succession
CD4-cross-linking O O
on O O
the O O
CD4+ O O
T-cell O O
clone O O
A2b O O
or O O
on O O
TCR-stimulated O O
CD4+ O O
T-cell O O
blasts O O
-LRB- O O
both O O
data O O
sets O O
not O O
shown O O
-RRB- O O
. O O

For O O
IFN-γ O O
, O O
IL-10 O O
, O O
and O O
IL-4 O O
, O O
see O O
Supplementary O O
material O O
. O O

Because B-conn Cause.Reason
the O O
three O O
anti-CD4 O O
mAbs O O
recognize O O
distinct O O
epitopes O O
of O O
the O O
CD4 O O
molecule O O
, O O
which O O
is O O
involved O O
in O O
signaling O O
cascades O O
, O O
the O O
influence O O
of O O
these O O
mAbs O O
on O O
early O O
signaling O O
events O O
was O O
also B-conn Conjunction
investigated O O
. O O

No O O
influence O O
at O O
all O O
of O O
the O O
anti-CD4 O O
mAbs O O
was O O
found O O
for O O
calcium O O
influx O O
-LRB- O O
primary O O
CD4+ O O
spleen O O
T O O
cells O O
-RRB- O O
, O O
phosphorylation O O
of O O
src-homology-domain-containing O O
protein O O
-LRB- O O
Shc O O
-RRB- O O
, O O
or O O
the O O
translocation O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
-LRB- O O
NF-AT O O
-RRB- O O
-LRB- O O
both O O
primary O O
CD4+ O O
T O O
cells O O
and O O
clone O O
A2b O O
-RRB- O O
, O O
and O O
the O O
activity O O
of O O
p59fyn O O
-LRB- O O
A2b O O
-RRB- O O
. O O

The O O
activity O O
of O O
the O O
CD4-associated O O
p56lck O O
after B-conn Temporal.Succession
CD4 O O
cross-linking O O
-LRB- O O
A2b O O
-RRB- O O
was O O
comparably O O
increased O O
by O O
all O O
three O O
anti-CD4 O O
mAbs O O
-LRB- O O
all O O
the O O
data O O
not O O
shown O O
-RRB- O O
. O O

The O O
binding O O
activities O O
of O O
the O O
transcription O O
factors O O
activator O O
protein-1 O O
-LRB- O O
AP-1 O O
-RRB- O O
and O O
NF-κB O O
were O O
determined O O
in O O
nuclear O O
extracts O O
of O O
spleen O O
CD4+ O O
T O O
cells O O
preincubated O O
with O O
anti-CD4 O O
mAbs O O
. O O

The O O
activity O O
of O O
AP-1 O O
was O O
slightly O O
but O O
significantly O O
decreased O O
by B-conn Temporal.Succession
pretreatment O O
with O O
all O O
three O O
anti-CD4 O O
mAbs O O
, O O
to O O
a O O
similar O O
degree O O
-LRB- O O
Fig. O O
3 O O
-RRB- O O
. O O

Interestingly O O
, O O
preincubation O O
with O O
the O O
accelerating O O
anti-CD4 O O
mAb O O
, O O
RIB5/2 O O
, O O
induced O O
a O O
significantly O O
higher O O
binding O O
activity O O
of O O
NF-κB O O
than O O
did O O
preincubation O O
with O O
the O O
ameliorating O O
W3/25 O O
and O O
OX35 O O
, O O
which O O
only O O
moderately O O
increased O O
the O O
NF-κB O O
binding O O
activity O O
-LRB- O O
see O O
Fig. O O
3 O O
-RRB- O O
. O O

Discussion O O

The O O
present O O
study O O
shows O O
differential O O
clinical O O
efficacy O O
of O O
three O O
anti-CD4 O O
mAbs O O
in O O
the O O
preventive O O
treatment O O
of O O
AA O O
. O O

The O O
lack O O
of O O
differential O O
clinical O O
efficacy O O
of O O
the O O
same O O
mAbs O O
in O O
established O O
AA O O
may O O
be O O
explained O O
by O O
a O O
completely O O
divergent O O
immunological O O
constellation O O
in O O
connection O O
with O O
the O O
known O O
differential O O
effects O O
of O O
anti-CD4 O O
mAbs O O
on O O
naive O O
and O O
memory O O
T O O
cells O O
. O O

Although B-conn Concession.Expectation
successful O O
treatment O O
with O O
anti-CD4 O O
mAbs O O
has O O
been O O
achieved O O
in O O
various O O
arthritis O O
models O O
-LSB-12,16-18 O O
-RSB- O O
, O O
there O O
is O O
no O O
evidence O O
for O O
a O O
differential O O
efficacy O O
of O O
anti-CD4 O O
mAbs O O
in O O
arthritis O O
models O O
to O O
date O O
. O O

Thus B-conn Cause.Claim
, O O
this O O
finding O O
may O O
represent O O
the O O
experimental O O
counterpart O O
of O O
the O O
conflicting O O
results O O
observed O O
thus O O
far O O
in O O
studies O O
of O O
human O O
rheumatoid O O
arthritis O O
-LSB-6,8,10 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
a O O
reported O O
study O O
of O O
experimental O O
allergic O O
encephalomyelitis O O
-LSB-19 O O
-RSB- O O
, O O
the O O
present O O
study O O
did O O
not O O
confirm O O
a O O
role O O
for O O
the O O
mAb O O
isotype O O
in O O
AA O O
, O O
as B-conn Cause.Reason
the O O
isotypes O O
of O O
the O O
three O O
anti-CD4 O O
mAbs O O
did O O
not O O
match O O
their O O
differential O O
preventive O O
effects O O
in O O
AA O O
. O O

The O O
ameliorating O O
mAb O O
W3/25 O O
had O O
a O O
very O O
high O O
affinity O O
, O O
as O O
previously O O
reported O O
-LSB-20 O O
-RSB- O O
, O O
whereas B-conn Contrast
the O O
affinity O O
of O O
the O O
other O O
ameliorating O O
mAb O O
, O O
OX35 O O
, O O
was O O
comparable O O
to O O
that O O
of O O
the O O
accelerating O O
mAb O O
, O O
RIB5/2 O O
. O O

On B-conn Concession.Contra-expectation
the I-conn Concession.Contra-expectation
other I-conn Concession.Contra-expectation
hand I-conn Concession.Contra-expectation
, O O
a O O
contribution O O
of O O
the O O
strikingly O O
higher O O
kdiss O O
of O O
the O O
mAb O O
RIB5/2 O O
to O O
its O O
differential O O
clinical O O
effects O O
cannot O O
be O O
excluded O O
, O O
in O O
analogy O O
to O O
high O O
and O O
low O O
kdiss O O
for O O
agonistic O O
and O O
antagonistic O O
TCR-peptides O O
, O O
respectively O O
-LSB-21 O O
-RSB- O O
. O O

In O O
spite O O
of O O
these O O
considerations O O
, O O
recognition O O
of O O
different O O
epitopes O O
by O O
the O O
mAbs O O
-LSB-14 O O
-RSB- O O
, O O
with O O
distinct O O
functional O O
consequences O O
for O O
the O O
target O O
cells O O
, O O
remains O O
the O O
most O O
likely O O
explanation O O
for O O
their O O
differential O O
clinical O O
efficacy O O
-LSB-22 O O
-RSB- O O
. O O

While B-conn Contrast
the O O
binding O O
sites O O
of O O
W3/25 O O
and O O
OX35 O O
are O O
situated O O
in O O
the O O
C´–C´´ O O
region O O
of O O
domain O O
D1 O O
and O O
the O O
B–C O O
region O O
of O O
domain O O
D2 O O
of O O
the O O
CD4 O O
molecule O O
, O O
respectively O O
-LSB-23 O O
-RSB- O O
, O O
we O O
could O O
roughly O O
localize O O
the O O
epitope O O
of O O
RIB5/2 O O
in O O
the O O
F–G O O
region O O
of O O
domain O O
D1 O O
, O O
as O O
demonstrated O O
by O O
effective O O
competition O O
with O O
the O O
mAb O O
OX65 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
known O O
to O O
bind O O
this O O
region O O
of O O
the O O
CD4 O O
molecule O O
-LSB-23 O O
-RSB- O O
. O O

Binding O O
of O O
anti-CD4 O O
mAbs O O
to O O
separate O O
epitopes O O
of O O
the O O
CD4 O O
molecule O O
could O O
result O O
in O O
differential O O
effects O O
on O O
T-cell O O
functions O O
by B-conn Purpose.Enablement
inducing O O
distinct O O
conformational O O
changes O O
of O O
the O O
extracellular O O
and O O
the O O
intracellular O O
parts O O
of O O
the O O
CD4 O O
, O O
resulting O O
in O O
modified O O
interaction O O
with O O
other O O
signaling O O
molecules O O
, O O
as O O
has O O
been O O
discussed O O
recently O O
with O O
regard O O
to O O
the O O
aspartate O O
receptor O O
-LSB-24 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
, O O
the O O
ameliorating O O
anti-CD4 O O
mAbs O O
W3/25 O O
and O O
OX35 O O
-LRB- O O
but O O
not O O
the O O
accelerating O O
mAb O O
, O O
RIB5/2 O O
-RRB- O O
numerically/significantly O O
increased O O
the O O
DTH O O
to O O
the O O
arthritogen O O
M. O O
tuberculosis O O
. O O

In O O
the O O
total O O
T-cell O O
population O O
, O O
two O O
of O O
the O O
three O O
anti-CD4 O O
mAbs O O
-LRB- O O
and O O
in O O
purified O O
CD4+ O O
T O O
cells O O
, O O
all O O
three O O
anti-CD4 O O
mAbs O O
-RRB- O O
increased O O
the O O
in O O
vitro O O
reactivity O O
to O O
ConA O O
. O O

In O O
the O O
case O O
of O O
CD4+ O O
T O O
cells O O
, O O
this O O
increased O O
reactivity O O
was O O
negatively O O
correlated O O
with O O
the O O
clinical O O
score O O
of O O
individual O O
animals O O
. O O

The O O
successful O O
mode O O
of O O
action O O
of O O
anti-CD4 O O
mAbs O O
in O O
arthritides O O
may O O
therefore B-conn Cause.Claim
be O O
based O O
on O O
increasing O O
the O O
reactivity O O
of O O
a O O
subpopulation O O
of O O
regulatory O O
T O O
cells O O
, O O
an O O
interpretation O O
that O O
is O O
supported O O
by O O
i O O
-RRB- O O
the O O
increase O O
of O O
T-cell O O
reactivity O O
in O O
some O O
patients O O
successfully O O
treated O O
with O O
anti-CD4 O O
mAbs O O
-LSB-6 O O
-RSB- O O
, O O
ii O O
-RRB- O O
an O O
increased O O
DTH O O
to O O
antigens O O
like O O
tetanus O O
toxoid O O
in O O
less O O
active O O
versus O O
active O O
rheumatoid O O
arthritis O O
-LSB-25 O O
-RSB- O O
, O O
iii O O
-RRB- O O
the O O
reduced O O
responsiveness O O
to O O
poly-specific O O
stimulation O O
of O O
spleen O O
cells O O
from O O
rats O O
with O O
acute O O
AA O O
in O O
comparison O O
with O O
healthy O O
animals O O
-LSB-26 O O
-RSB- O O
, O O
and O O
iv O O
-RRB- O O
the O O
almost O O
complete O O
restoration O O
of O O
T-cell O O
responsiveness O O
upon B-conn Circumstance.Forward Circumstance
disease O O
resolution/transition O O
into O O
the O O
chronic O O
phase O O
-LSB-27 O O
-RSB- O O
. O O

The O O
accelerating O O
mAb O O
RIB5/2 O O
significantly O O
increased O O
the O O
secretion O O
of O O
TNF-α O O
, O O
as O O
observed O O
in O O
primary O O
CD4+ O O
T O O
cells O O
both B-conn Circumstance.Forward Circumstance
upon I-conn Circumstance.Forward Circumstance
anti-CD4 O O
preincubation O O
and B-conn Conjunction
upon O O
CD4 O O
cross-linking O O
after B-conn Temporal.Succession
stimulation O O
with O O
TCR O O
-LRB- O O
see O O
Fig. O O
2 O O
-RRB- O O
. O O

In O O
view O O
of O O
the O O
known O O
local O O
and O O
systemic O O
importance O O
of O O
TNF-α O O
in O O
experimental O O
AA O O
-LSB-28-30 O O
-RSB- O O
and O O
human O O
rheumatoid O O
arthritis O O
-LSB-31 O O
-RSB- O O
, O O
this O O
effect O O
may O O
contribute O O
to O O
the O O
acceleration O O
of O O
the O O
onset O O
of O O
AA O O
after B-conn Temporal.Succession
pretreatment O O
with O O
the O O
mAb O O
RIB5/2 O O
. O O

This O O
finding O O
may O O
be O O
important O O
for O O
the O O
understanding O O
of O O
pathogenesis O O
in O O
arthritis O O
despite B-conn Concession.Expectation
predominant O O
production O O
of O O
TNF-α O O
by O O
macrophages/monocytes O O
-LRB- O O
reviewed O O
in O O
-LSB-32 O O
-RSB- O O
-RRB- O O
, O O
since B-conn Cause.Justification
TNF-α O O
production O O
by O O
T O O
cells O O
has O O
been O O
demonstrated O O
both O O
in O O
the O O
synovial O O
membrane O O
-LSB-33 O O
-RSB- O O
and O O
in O O
lymphoid O O
organs O O
-LRB- O O
authors O O
own O O
unpublished O O
observations O O
-RRB- O O
. O O

Since B-conn Cause.Justification
TNF-α O O
production O O
is O O
known O O
to O O
be O O
regulated O O
predominantly O O
by O O
NF-κB O O
-LSB-34 O O
-RSB- O O
, O O
it O O
was O O
revealing O O
that O O
the O O
accelerating O O
mAb O O
, O O
RIB5/2 O O
, O O
besides O O
inducing O O
TNF-α O O
secretion O O
, O O
also O O
strongly O O
upregulated O O
NF-κB O O
binding O O
activity O O
. O O

This O O
was O O
especially O O
striking O O
because O O
binding O O
of O O
another O O
major O O
transcription O O
factor O O
involved O O
in O O
T-cell O O
activation O O
, O O
AP-1 O O
-LSB-35 O O
-RSB- O O
, O O
was O O
even O O
slightly O O
downregulated O O
by O O
the O O
anti-CD4 O O
mAbs O O
, O O
in O O
line O O
with O O
recently O O
published O O
data O O
in O O
murine O O
cells O O
-LSB-36 O O
-RSB- O O
. O O

These O O
findings O O
in O O
our O O
study O O
support O O
, O O
again O O
, O O
the O O
notion O O
that O O
NF-κB-mediated O O
upregulation O O
of O O
TNF-α O O
secretion O O
-LRB- O O
or O O
vice O O
versa O O
-RRB- O O
may O O
contribute O O
to O O
the O O
acceleration O O
of O O
disease O O
onset O O
in O O
AA O O
upon B-conn Temporal.Succession
preventive O O
treatment O O
with O O
RIB5/2 O O
. O O

The O O
differential O O
clinical O O
efficacy O O
of O O
anti-CD4 O O
mAbs O O
is O O
not O O
restricted O O
to O O
arthritis O O
but O O
is O O
also O O
observed O O
in O O
transplantation O O
models O O
-LSB-37 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
while B-conn Contrast
preventive O O
treatment O O
with O O
the O O
anti-CD4 O O
mAb O O
RIB5/2 O O
leads O O
to O O
an O O
acceleration O O
of O O
AA O O
, O O
it O O
is O O
a O O
very O O
effective O O
anti-CD4 O O
mAb O O
for O O
the O O
induction O O
of O O
tolerance O O
in O O
transplantation O O
models O O
-LSB-14,37 O O
-RSB- O O
. O O

This O O
indicates O O
that O O
clinical O O
efficacy O O
-LRB- O O
and O O
its O O
time O O
course O O
-RRB- O O
may O O
depend O O
on O O
the O O
actual O O
immunological O O
constellation O O
and B-conn Conjunction
that O O
a O O
given O O
anti-CD4 O O
mAb O O
may O O
have O O
beneficial O O
effects O O
only O O
in O O
particular O O
pathologies O O
and/or O O
stages O O
of O O
disease O O
. O O

From O O
the O O
results O O
of O O
the O O
present O O
study O O
, O O
it O O
is O O
evident O O
that O O
the O O
individual O O
features O O
and O O
effects O O
of O O
a O O
particular O O
anti-CD4 O O
mAb O O
have O O
to O O
be O O
assessed O O
before B-conn Temporal.Precedence
treatment O O
trials O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
predict O O
its O O
clinical O O
efficacy O O
in O O
vivo O O
. O O

This O O
may O O
require O O
several O O
in O O
vivo O O
, O O
ex O O
vivo O O
, O O
or O O
in O O
vitro O O
assays O O
of O O
T-cell O O
function O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
reveal O O
subtle O O
differences O O
between O O
anti-CD4 O O
mAbs O O
. O O

Experimental O O
models O O
such O O
as O O
transgenic O O
mice O O
expressing O O
human O O
but O O
not O O
mouse O O
CD4 O O
may O O
make O O
it O O
possible O O
to O O
address O O
such O O
questions O O
in O O
the O O
future O O
-LSB-38 O O
-RSB- O O
. O O

Recently O O
, O O
preclinical O O
testing O O
has O O
been O O
exploited O O
in O O
murine O O
CD4-knockout/human O O
CD4-transgenic O O
-LRB- O O
huCD4-transgenic O O
-RRB- O O
systems O O
to B-conn Purpose.Goal
assess O O
the O O
immunological O O
effects O O
of O O
a O O
particular O O
anti-human-CD4 O O
mAb O O
in O O
various O O
disease O O
models O O
-LSB-39,40 O O
-RSB- O O
. O O

Analogous O O
preclinical O O
testing O O
may O O
prove O O
useful O O
also O O
for O O
the O O
comparison O O
of O O
anti-human-CD4 O O
mAbs O O
targeting O O
distinct O O
epitopes O O
. O O

Supplementary O O
material O O

Female O O
Lewis O O
rats O O
-LRB- O O
8–16 O O
weeks O O
old O O
; O O
body O O
weight O O
150–220 O O
g O O
-RRB- O O
were O O
obtained O O
from O O
Charles O O
River O O
-LRB- O O
Sulzfeld O O
, O O
Germany O O
-RRB- O O
or O O
from O O
the O O
Medical O O
Experimental O O
Center O O
of O O
the O O
University O O
of O O
Leipzig O O
. O O

Female O O
inbred O O
Wistar–Prob O O
rats O O
-LRB- O O
12–16 O O
weeks O O
old O O
-RRB- O O
were O O
bred O O
in O O
the O O
Medical O O
Experimental O O
Center O O
. O O

The O O
animals O O
were O O
kept O O
under O O
standard O O
conditions O O
, O O
two O O
per O O
cage O O
, O O
with O O
food O O
and O O
water O O
ad O O
libitum O O
and O O
a O O
12 O O
h/12 O O
h O O
light/dark O O
cycle O O
. O O

The O O
mouse O O
anti-rat-CD4 O O
mAbs O O
W3/25 O O
, O O
OX35 O O
, O O
and O O
RIB5/2 O O
-LRB- O O
IgG1 O O
, O O
IgG2a O O
, O O
and O O
IgG2a O O
, O O
respectively O O
-RRB- O O
were O O
used O O
as O O
ascites O O
fluid O O
for O O
in O O
vivo O O
treatment O O
or O O
purified O O
on O O
Protein O O
A–sepharose O O
-LRB- O O
for O O
OX35 O O
and O O
RIB5/2 O O
-RRB- O O
or O O
Protein O O
G–sepharose O O
-LRB- O O
for O O
W3/25 O O
-RRB- O O
columns O O
-LRB- O O
Pharmacia O O
, O O
Freiburg O O
, O O
Germany O O
-RRB- O O
for O O
all O O
in O O
vitro O O
experiments O O
. O O

The O O
maximal O O
endo-toxin O O
content O O
of O O
the O O
ascites O O
was O O
58 O O
IU/ml O O
-LRB- O O
W3/25 O O
-RRB- O O
, O O
17 O O
IU/ml O O
-LRB- O O
RIB5/2 O O
-RRB- O O
, O O
and O O
5 O O
IU/ml O O
-LRB- O O
OX35 O O
-RRB- O O
; O O
the O O
final O O
endotoxin O O
concentrations O O
for O O
in O O
vitro O O
experiments O O
were O O
less O O
than O O
1 O O
IU/ml O O
. O O

For O O
flow O O
cytometry O O
, O O
directly O O
FITC-labeled O O
W3/25 O O
and O O
OX35 O O
-LRB- O O
gifts O O
from O O
P O O
Kühnlein O O
, O O
Institute O O
of O O
Virology O O
, O O
University O O
of O O
Würzburg O O
-RRB- O O
, O O
and O O
the O O
mAbs O O
G4.18 O O
-LRB- O O
anti-CD3 O O
, O O
Pharmingen O O
, O O
Hamburg O O
, O O
Germany O O
-RRB- O O
, O O
OX8 O O
-LRB- O O
anti-CD8 O O
, O O
Serotec O O
, O O
Oxford O O
; O O
UK O O
-RRB- O O
, O O
OX81 O O
-LRB- O O
anti-IL4 O O
, O O
Pharmingen O O
-RRB- O O
, O O
A5-4 O O
-LRB- O O
anti-IL-10 O O
, O O
Pharmingen O O
-RRB- O O
, O O
and O O
DB-1 O O
-LRB- O O
anti-IFN-γ O O
, O O
Serotec O O
-RRB- O O
were O O
used O O
. O O

MAbs O O
MOPC21 O O
-LRB- O O
IgG1 O O
-RRB- O O
, O O
UPC10 O O
-LRB- O O
IgG2a O O
, O O
both O O
from O O
Sigma O O
, O O
Deisenhofen O O
, O O
Germany O O
-RRB- O O
and O O
mouse O O
anti-glucose-oxidase O O
FITC/phycoerythrin O O
-LRB- O O
PE O O
-RRB- O O
-LRB- O O
IgG1 O O
, O O
IgG2a O O
, O O
Dako O O
, O O
Hamburg O O
Germany O O
-RRB- O O
served O O
as O O
isotype-matched O O
control O O
antibodies O O
. O O

The O O
anti-TCRα/β O O
mAb O O
R73 O O
was O O
a O O
kind O O
gift O O
of O O
T O O
Hünig O O
-LRB- O O
Institute O O
of O O
Virology O O
, O O
University O O
of O O
Würzburg O O
-RRB- O O
. O O

For O O
sandwich O O
ELISA O O
analysis O O
of O O
cytokine O O
concentrations O O
, O O
the O O
following O O
antibodies O O
were O O
used O O
: O O
DB-1 O O
-LRB- O O
anti-IFN-γ O O
-RRB- O O
, O O
biotinylated O O
rabbit O O
anti-rat O O
IFN-γ O O
-LRB- O O
both O O
Biosource O O
, O O
Ratingen O O
, O O
Germany O O
-RRB- O O
; O O
rabbit O O
anti-rat O O
IL-2 O O
, O O
biotinylated O O
A38-3 O O
-LRB- O O
anti-IL-2 O O
, O O
both O O
Pharmingen O O
-RRB- O O
, O O
A5-7 O O
, O O
biotinylated O O
A5-6 O O
-LRB- O O
both O O
anti-IL-10 O O
, O O
Pharmingen O O
-RRB- O O
; O O
OX81 O O
-LRB- O O
anti-IL-4 O O
-RRB- O O
, O O
biotinylated O O
rabbit O O
anti-rat O O
IL-4 O O
-LRB- O O
Biosource O O
-RRB- O O
. O O

The O O
mAbs O O
were O O
bound O O
to O O
a O O
BIAcore O O
surface O O
via O O
goat O O
anti-mouse O O
Ig-Fc O O
and O O
incubated O O
with O O
various O O
concentrations O O
of O O
soluble O O
rat O O
CD4 O O
-LRB- O O
a O O
gift O O
of O O
N O O
Barclay O O
, O O
Oxford O O
, O O
UK O O
-RRB- O O
. O O

The O O
data O O
were O O
analyzed O O
in O O
accordance O O
with O O
the O O
method O O
of O O
Karlsson O O
et O O
al.-LSB-S1 O O
-RSB- O O
, O O
and B-conn Conjunction
the O O
association O O
rate O O
constant O O
kass O O
, O O
the O O
dissociation O O
rate O O
constant O O
kdiss O O
, O O
and O O
the O O
affinity O O
constant O O
KA O O
-LRB- O O
kass/kdiss O O
-RRB- O O
were O O
calculated O O
. O O

Lewis O O
rats O O
-LRB- O O
8–12 O O
weeks O O
old O O
-RRB- O O
were O O
given O O
0.5 O O
mg O O
heat-inactivated O O
M. O O
tuberculosis O O
-LRB- O O
Difco O O
, O O
Detroit O O
, O O
MI O O
, O O
USA O O
-RRB- O O
in O O
100 O O
μl O O
paraffin O O
oil O O
-LRB- O O
Riedel O O
de O O
Haën O O
, O O
Seelze O O
, O O
Germany O O
-RRB- O O
, O O
which O O
was O O
injected O O
intradermally O O
into O O
the O O
base O O
of O O
the O O
tail O O
. O O

For B-conn Purpose.Goal
preventive O O
treatment O O
, O O
the O O
rats O O
-LRB- O O
n O O
= O O
6 O O
in O O
each O O
group O O
-RRB- O O
received O O
3 O O
mg O O
of O O
RIB5/2 O O
, O O
3 O O
mg O O
of O O
W3/25 O O
, O O
or O O
2 O O
mg O O
of O O
OX35 O O
intraperitoneally O O
-LRB- O O
corresponding O O
to O O
17.1 O O
and O O
11.4 O O
mg/kg O O
, O O
respectively O O
, O O
on O O
the O O
basis O O
of O O
a O O
mean O O
body O O
weight O O
of O O
175 O O
g O O
-RRB- O O
on O O
days O O
-1 O O
, O O
0 O O
, O O
3 O O
, O O
and O O
6 O O
, O O
i.e. O O
1 O O
day O O
before O O
AA O O
induction O O
, O O
on O O
the O O
day O O
of O O
induction O O
-LRB- O O
day O O
0 O O
-RRB- O O
, O O
and O O
thereafter O O
. O O

The O O
lower O O
dose O O
of O O
OX35 O O
-LRB- O O
2 O O
mg O O
-RRB- O O
was O O
chosen O O
on O O
the O O
basis O O
of O O
previous O O
experiments O O
demonstrating O O
its O O
high O O
clinical O O
efficacy O O
in O O
AA O O
-LSB-S2 O O
-RSB- O O
. O O

The O O
control O O
group O O
received O O
PBS O O
-LSB-S3 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
preventive O O
treatment O O
with O O
an O O
isotype-matched O O
mAb O O
from O O
birth O O
had O O
shown O O
no O O
effect O O
on O O
rat O O
AA O O
in O O
a O O
previous O O
study O O
-LSB-S3 O O
-RSB- O O
. O O

For B-conn Purpose.Goal
determination O O
of O O
the O O
arthritis O O
score O O
, O O
each O O
paw O O
was O O
graded O O
according O O
to O O
the O O
extent O O
of O O
erythema O O
and O O
edema O O
of O O
the O O
periarticular O O
tissue O O
, O O
on O O
a O O
scale O O
of O O
0–4 O O
, O O
where O O
0=no O O
inflammation O O
, O O
1=unequivocal O O
inflammation O O
of O O
one O O
paw O O
joint O O
, O O
2=unequivocal O O
inflammation O O
of O O
at O O
least O O
two O O
paw O O
joints O O
or O O
moderate O O
inflammation O O
of O O
one O O
paw O O
joint O O
, O O
3=severe O O
inflammation O O
of O O
one O O
or O O
more O O
paw O O
joints O O
, O O
and O O
4=maximum O O
inflammation O O
of O O
one O O
or O O
more O O
paw O O
joints O O
-LSB-S4 O O
, O O
S5 O O
-RSB- O O
. O O

The O O
scores O O
were O O
then B-conn Temporal.Precedence
added O O
to O O
obtain O O
the O O
total O O
score O O
-LRB- O O
maximal O O
possible O O
score O O
of O O
16 O O
for O O
each O O
animal O O
-RRB- O O
. O O

For B-conn Purpose.Goal
determination O O
of O O
cell O O
depletion O O
and O O
modulation O O
of O O
surface O O
molecules O O
, O O
blood O O
samples O O
-LRB- O O
100 O O
μl O O
-RRB- O O
were O O
taken O O
via O O
retro-orbital O O
puncture O O
on O O
day O O
8 O O
or O O
day O O
13 O O
after O O
induction O O
of O O
AA O O
. O O

Whole-blood O O
cells O O
were O O
stained O O
with O O
saturating O O
amounts O O
of O O
directly O O
FITC-labeled O O
W3/25 O O
, O O
OX35 O O
, O O
G4.18 O O
, O O
OX8 O O
, O O
or O O
respective O O
isotype O O
, O O
followed O O
by O O
erythrocyte O O
lysis O O
. O O

Ten O O
thousand O O
events O O
were O O
analyzed O O
using O O
an O O
Epics O O
XL O O
flow O O
cytometer O O
-LRB- O O
Coulter O O
, O O
Krefeld O O
, O O
Germany O O
-RRB- O O
and B-conn Conjunction
the O O
results O O
displayed O O
as O O
histograms O O
. O O

To B-conn Purpose.Goal
assess O O
the O O
DTH O O
, O O
either O O
10 O O
μg O O
of O O
the O O
arthritogen O O
M. O O
tuberculosis O O
in O O
50 O O
μl O O
PBS O O
, O O
or O O
50 O O
μl O O
PBS O O
only O O
, O O
were O O
injected O O
intradermally O O
into O O
the O O
pinna O O
of O O
the O O
left O O
or O O
the O O
right O O
ear O O
, O O
respectively O O
, O O
on O O
day O O
13 O O
after O O
induction O O
of O O
AA O O
. O O

One B-conn Temporal.Succession
day I-conn Temporal.Succession
after I-conn Temporal.Succession
injection O O
, O O
the O O
swelling O O
of O O
the O O
ears O O
was O O
determined O O
with O O
a O O
gauge O O
-LRB- O O
Hahn O O
& O O
Kolb O O
, O O
Stuttgart O O
, O O
Germany O O
-RRB- O O
. O O

Swelling O O
was O O
expressed O O
as O O
the O O
difference O O
-LRB- O O
mm O O
-RRB- O O
between O O
the O O
thickness O O
of O O
the O O
left O O
and O O
the O O
right O O
ear O O
. O O

T O O
cells O O
were O O
purified O O
from O O
spleens O O
as O O
described O O
elsewhere O O
-LSB-S6 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
the O O
spleens O O
were O O
passed O O
through O O
a O O
stainless O O
steel O O
sieve O O
and B-conn Conjunction
the O O
resulting O O
suspension O O
was O O
centrifuged O O
through O O
Lymphoprep O O
-LRB- O O
Pharmacia O O
-RRB- O O
. O O

Cells O O
contained O O
in O O
the O O
interphase O O
were O O
then B-conn Temporal.Precedence
washed O O
twice O O
and O O
loaded O O
onto O O
a O O
10-ml O O
syringe O O
with O O
1.2 O O
g O O
nylon O O
wool O O
-LRB- O O
Polyscience O O
, O O
Eppelheim O O
, O O
Germany O O
-RRB- O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
1 O O
hour O O
at O O
37°C O O
, O O
5 O O
% O O
CO2 O O
, O O
the O O
cells O O
were O O
eluted O O
with O O
RPMI O O
1640/GlutaMaxI O O
con- O O
taining O O
10 O O
% O O
FCS O O
, O O
15 O O
mM O O
HEPES O O
, O O
100 O O
U/ml O O
penicillin O O
, O O
and O O
100 O O
μg/ml O O
streptomycin O O
-LRB- O O
thereafter O O
called O O
R10F O O
, O O
all O O
from O O
GIBCO-BRL O O
, O O
Eggenstein O O
, O O
Germany O O
-RRB- O O
. O O

The O O
resulting O O
total O O
T-cell O O
suspension O O
was O O
≥ O O
95 O O
% O O
CD3+ O O
, O O
as O O
evaluated O O
by O O
flow O O
cytometry O O
. O O

Either B-conn Alternative.Disjunctive
purified O O
total O O
T O O
cells O O
were O O
directly O O
used O O
for O O
proliferation O O
assays O O
, O O
or B-conn Alternative.Disjunctive
CD4+ O O
T O O
cells O O
were O O
first O O
negatively O O
purified O O
by B-conn Purpose.Enablement
adding O O
5 O O
μg/1×107 O O
cells O O
OX8 O O
mAb O O
for O O
30 O O
min O O
on O O
ice O O
and B-conn Conjunction
, O O
after B-conn Temporal.Succession
washing O O
, O O
75 O O
μl O O
Dynabeads-M450 O O
coupled O O
to O O
goat O O
anti-mouse O O
IgG O O
-LRB- O O
Dynal O O
, O O
Hamburg O O
, O O
Germany O O
-RRB- O O
. O O

The O O
suspension O O
was O O
again O O
incubated O O
for O O
30 O O
min O O
on O O
ice O O
and O O
then B-conn Temporal.Precedence
separated O O
by O O
a O O
magnetic O O
particle O O
concentrator O O
-LRB- O O
MPC® O O
, O O
Dynal O O
-RRB- O O
. O O

The O O
purity O O
of O O
CD4+ O O
T-cell O O
populations O O
was O O
always O O
≥ O O
95 O O
% O O
, O O
as O O
assessed O O
by O O
flow O O
cytometry O O
. O O

For B-conn Purpose.Goal
enrichment O O
of O O
dendritic O O
cells O O
-LRB- O O
DC O O
-RRB- O O
, O O
suspensions O O
of O O
spleen O O
cells O O
from O O
healthy O O
rats O O
were O O
subjected O O
to O O
an O O
overnight O O
adhesion O O
step O O
on O O
Petri O O
dishes O O
-LRB- O O
Falcon® O O
, O O
Becton O O
Dickinson O O
, O O
Heidelberg O O
, O O
Germany O O
-RRB- O O
and O O
then B-conn Temporal.Precedence
centrifuged O O
through O O
2 O O
ml O O
of O O
a O O
14.5 O O
% O O
metrizamide O O
solution O O
-LRB- O O
Sigma O O
-RRB- O O
in O O
R10F O O
. O O

DC O O
were O O
then B-conn Temporal.Precedence
irradiated O O
with O O
15 O O
Gy O O
to B-conn Purpose.Goal
prevent O O
their O O
proliferation O O
in O O
subsequent O O
assays O O
. O O

For O O
proliferation O O
assays O O
, O O
1 O O
× O O
105 O O
purified O O
total O O
or O O
CD4+ O O
spleen O O
T O O
cells O O
per O O
well O O
of O O
96-well O O
round-bottom O O
plates O O
were O O
incubated O O
with O O
1 O O
× O O
104 O O
DC O O
per O O
well O O
and O O
1 O O
μg/ml O O
ConA O O
-LRB- O O
Sigma O O
-RRB- O O
for O O
72 O O
hours O O
. O O

Then B-conn Temporal.Precedence
1 O O
μCi/well O O
3H-thymidine O O
-LRB- O O
Amersham-Buchler O O
, O O
Braunschweig O O
, O O
Germany O O
-RRB- O O
was O O
added O O
. O O

After B-conn Temporal.Succession
an O O
additional O O
incubation O O
for O O
16 O O
hours O O
, O O
cells O O
were O O
harvested O O
onto O O
fiber O O
filters O O
and B-conn Conjunction
cell-bound O O
radioactivity O O
was O O
measured O O
by O O
β-scintillation O O
counting O O
-LRB- O O
Matrix96® O O
, O O
Canberra O O
Packard O O
, O O
Dreieich O O
, O O
Germany O O
-RRB- O O
. O O

Total O O
T O O
cells O O
or O O
purified O O
CD4+ O O
T O O
cells O O
from O O
spleens O O
of O O
healthy O O
Lewis O O
rats O O
, O O
and O O
allogeneic O O
DC O O
from O O
spleens O O
of O O
Wistar–Prob O O
rats O O
, O O
were O O
prepared O O
as O O
described O O
above O O
. O O

Total O O
or O O
CD4+ O O
T O O
cells O O
were O O
seeded O O
at O O
4 O O
× O O
105 O O
cells O O
per O O
well O O
in O O
96-well O O
flat-bottom O O
plates O O
, O O
together O O
with O O
1 O O
, O O
2 O O
, O O
or O O
4 O O
× O O
104 O O
DC O O
per O O
well O O
and O O
1 O O
, O O
5 O O
, O O
or O O
10 O O
μg/ml O O
of O O
the O O
respective O O
purified O O
anti-CD4 O O
mAb O O
-LRB- O O
or O O
isotype O O
control O O
mAbs O O
-RRB- O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
72 O O
hours O O
-LRB- O O
37°C O O
, O O
5 O O
% O O
CO2 O O
-RRB- O O
, O O
bromodeoxyuridine O O
-LRB- O O
BrdU O O
-RRB- O O
was O O
added O O
and B-conn Conjunction
incubation O O
was O O
continued O O
for O O
an O O
additional O O
16 O O
hours O O
. O O

The O O
proliferation O O
was O O
determined O O
by O O
a O O
BrdU O O
cell-proliferation O O
ELISA O O
-LRB- O O
Boehringer O O
Mannheim O O
, O O
Mannheim O O
, O O
Germany O O
-RRB- O O
in O O
accordance O O
with O O
the O O
supplier O O
's O O
recommendations O O
. O O

For B-conn Purpose.Goal
anti-CD4 O O
preincubation O O
, O O
spleen O O
CD4+ O O
T O O
cells O O
were O O
incubated O O
with O O
the O O
anti-CD4 O O
mAbs O O
or O O
isotype O O
control O O
mAbs O O
-LRB- O O
10 O O
μg O O
per O O
1 O O
× O O
107 O O
cells O O
-RRB- O O
for O O
30 O O
min O O
at O O
4°C O O
and O O
washed O O
once O O
. O O

The O O
bound O O
mAbs O O
were O O
then B-conn Temporal.Precedence
cross-linked O O
with O O
goat O O
anti-mouse O O
IgG O O
-LRB- O O
Jackson O O
Lab O O
, O O
20 O O
μg/1 O O
× O O
107 O O
cells O O
-RRB- O O
for O O
1 O O
hour O O
at O O
37°C O O
. O O

After B-conn Temporal.Succession
washing O O
, O O
the O O
cells O O
-LRB- O O
1 O O
× O O
106 O O
per O O
ml O O
and O O
per O O
well O O
-RRB- O O
were O O
seeded O O
in O O
24-well O O
plates O O
previously O O
coated O O
with O O
R73 O O
and O O
harvested O O
after O O
24 O O
and O O
48 O O
hours O O
. O O

Anti-CD4-preincubated O O
cells O O
were O O
washed O O
, O O
fixed O O
with O O
4 O O
% O O
paraformaldehyde O O
in O O
PBS O O
, O O
permeabilized O O
-LRB- O O
0.5 O O
% O O
saponin O O
in O O
PBS O O
, O O
1 O O
% O O
FCS O O
, O O
0.01 O O
% O O
NaN3 O O
; O O
for O O
this O O
step O O
, O O
supplemented O O
with O O
10 O O
% O O
rat O O
serum O O
-RRB- O O
, O O
and O O
incubated O O
with O O
1 O O
μg O O
anti-IFN-γ O O
FITC O O
, O O
anti-IL-4 O O
PE O O
, O O
anti-IL-10 O O
PE O O
, O O
or O O
directly O O
labeled O O
isotype-control O O
mAbs O O
for O O
30 O O
min O O
at O O
4°C O O
. O O

FACS O O
analysis O O
was O O
performed O O
using O O
a O O
FACScan® O O
flow O O
cytometer O O
-LRB- O O
Becton O O
Dickinson O O
-RRB- O O
. O O

Detection O O
of O O
TNF-α O O
was O O
performed O O
using O O
a O O
bioassay O O
based O O
on O O
the O O
lysis O O
of O O
the O O
WEHI164/13 O O
cell O O
line O O
after B-conn Temporal.Succession
exposure O O
to O O
TNF-α O O
. O O

Assay O O
specificity O O
was O O
ensured O O
by B-conn Purpose.Enablement
adding O O
a O O
neutralizing O O
mAb O O
to O O
rat O O
TNF-α O O
-LRB- O O
100 O O
μg/ml O O
; O O
clone O O
45418.111 O O
; O O

R&D O O
Systems O O
, O O
Wiesbaden O O
, O O
Germany O O
-RRB- O O
. O O

Culture O O
supernatants O O
were O O
analyzed O O
for O O
IFN-γ O O
, O O
IL-2 O O
, O O
IL-4 O O
, O O
and O O
IL-10 O O
by O O
sandwich O O
ELISA O O
with O O
the O O
above-mentioned O O
capture O O
and O O
detection O O
antibodies O O
. O O

Recombinant O O
cytokine O O
standards O O
were O O
as O O
follows O O
: O O
IFN-γ O O
-LRB- O O
Laboserv O O
-RRB- O O
, O O
IL-2 O O
, O O
IL-10 O O
, O O
and O O
IL-4 O O
-LRB- O O
Pharmingen O O
-RRB- O O
; O O
range O O
for O O
IFN-γ O O
, O O
IL-2 O O
, O O
and O O
IL-10 O O
was O O
39–5000 O O
pg/ml O O
; O O
range O O
for O O
IL-4 O O
was O O
9.85–1250 O O
pg/ml O O
. O O

Cytokine O O
concentrations O O
in O O
the O O
culture O O
supernatants O O
were O O
calculated O O
from O O
a O O
standard O O
curve O O
using O O
the O O
software O O
EasyFit O O
-LRB- O O
SLT O O
, O O
Crailsheim O O
, O O
Germany O O
-RRB- O O
. O O

Purified O O
spleen O O
CD4+ O O
T O O
cells O O
were O O
preincubated O O
with O O
the O O
anti-CD4 O O
mAbs O O
as O O
above O O
and O O
then B-conn Temporal.Precedence
either O O
stimulated O O
on O O
anti-CD3 O O
mAb-precoated O O
6-well O O
plates O O
-LRB- O O
1 O O
× O O
107 O O
cells O O
per O O
well O O
-RRB- O O
or O O
with O O
a O O
combination O O
of O O
phorbol O O
myristoyl O O
acetate O O
-LRB- O O
PMA O O
; O O
10 O O
ng/ml O O
-RRB- O O
and O O
ionomycin O O
-LRB- O O
250 O O
ng/ml O O
-RRB- O O
for O O
4 O O
hours O O
at O O
37°C O O
. O O

After B-conn Temporal.Succession
stimulation O O
, O O
the O O
cells O O
were O O
washed O O
once O O
with O O
PBS O O
and O O
microcentrifuged O O
-LRB- O O
10,000 O O
× O O
g O O
-RRB- O O
at O O
4°C O O
for O O
1 O O
min O O
. O O

The O O
pellet O O
was O O
resuspended O O
in O O
400 O O
μl O O
ice-cold O O
buffer O O
A O O
-LRB- O O
10 O O
mM O O
HEPES O O
, O O
10 O O
mM O O
KCl O O
, O O
0.1 O O
mM O O
EDTA O O
, O O
0.1 O O
mM O O
EGTA O O
, O O
0.5 O O
mM O O
PMSF O O
, O O
1 O O
mM O O
dithiothreitol O O
, O O
and O O
1 O O
mM O O
Na3VO4 O O
-RRB- O O
and O O
placed O O
on O O
ice O O
for O O
15 O O
min O O
. O O

Subsequently B-conn Temporal.Precedence
, O O
25 O O
μl O O
of O O
a O O
10 O O
% O O
Nonidet O O
P-40 O O
solution O O
-LRB- O O
Boehringer O O
Mannheim O O
-RRB- O O
were O O
added O O
to O O
the O O
sample O O
and B-conn Conjunction
the O O
cells O O
were O O
homogenized O O
by B-conn Purpose.Enablement
vortexing O O
for O O
30 O O
s O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
microcentrifugation O O
for O O
1 O O
min O O
. O O

The O O
nuclear O O
pellets O O
were O O
resuspended O O
in O O
50 O O
μl O O
of O O
buffer O O
B O O
-LRB- O O
20 O O
mM O O
HEPES O O
, O O
400 O O
mM O O
NaCl O O
, O O
0.1 O O
mM O O
EDTA O O
, O O
0.1 O O
mM O O
EGTA O O
, O O
2 O O
mM O O
PMSF O O
, O O
1 O O
mM O O
dithiothreitol O O
, O O
and O O
1 O O
mM O O
Na3VO4 O O
-RRB- O O
and O O
shaken O O
for O O
15 O O
min O O
at O O
4°C O O
. O O

After B-conn Temporal.Succession
microcentrifugation O O
for O O
5 O O
min O O
at O O
4°C O O
, O O
the O O
supernatants O O
were O O
aliquoted O O
and O O
stored O O
at O O
-70°C O O
until B-conn Temporal.Precedence
further O O
use O O
. O O

The O O
nuclear O O
extracts O O
-LRB- O O
10 O O
μg O O
total O O
protein O O
-RRB- O O
were O O
than O O
incubated O O
with O O
2 O O
× O O
108 O O
cpm O O
of O O
32P-labeled O O
, O O
double-stranded O O
oligonucleotide O O
probe O O
-LRB- O O
sense O O
strand O O
only O O
; O O
AP-1 O O
: O O
5'-CGC O O
TTG O O
ATG O O
AGT O O
CAG O O
CCG O O
GAA-3 O O
' O O
; O O
NF-κB O O
: O O
5'-AGT O O
TGA O O
GGG O O
GAC O O
TTT O O
CCC O O
AGG O O
C-3 O O
' O O
; O O
both O O
from O O
Promega O O
, O O
Mannheim O O
, O O
Germany O O
; O O
NF-AT O O
: O O
5'-CGC O O
CCA O O
AAG O O
AGG O O
AAA O O
ATT O O
TGT O O
TTC O O
ATA-3 O O
' O O
; O O
Santa O O
Cruz O O
, O O
Heidelberg O O
, O O
Germany O O
-RRB- O O
in O O
25 O O
μl O O
binding O O
buffer O O
-LRB- O O
1 O O
M O O
Tris O O
, O O
1 O O
M O O
boric O O
acid O O
, O O
0.02 O O
M O O
EDTA O O
, O O
5 O O
% O O
glycerol O O
-RRB- O O
supplemented O O
with O O
poly O O
-LSB-dI-dC O O
-RSB- O O
-LRB- O O
0.16 O O
mg/ml O O
Pharmacia O O
-RRB- O O
and O O
2 O O
mM O O
dithiothreitol O O
. O O

The O O
samples O O
were O O
separated O O
on O O
a O O
4 O O
% O O
polyacrylamide O O
gel O O
at O O
200 O O
V O O
. O O

After B-conn Temporal.Succession
scanning O O
in O O
a O O
phosphor O O
imager O O
-LRB- O O
BAS-1000 O O
, O O
Fuij O O
Photo O O
Film O O
Co. O O
Ltd O O
, O O
Japan O O
-RRB- O O
, O O
the O O
bands O O
were O O
quantified O O
using O O
the O O
PCBAS O O
2.09g O O
software O O
-LRB- O O
Fuij O O
Photo O O
Film O O
Co. O O
Ltd O O
-RRB- O O
. O O

Differences O O
between O O
experimental O O
groups O O
were O O
evaluated O O
with O O
the O O
two-tailed O O
nonparametric O O
Mann–Whitney O O
-LRB- O O
U O O
-RRB- O O
test O O
. O O

The O O
Spearman O O
rank O O
correlation O O
test O O
was O O
used O O
to O O
verify O O
whether O O
the O O
ex O O
vivo  3H-thymidine O O
uptake O O
of O O
CD4+ O O
T O O
cells O O
correlated O O
with O O
the O O
arthritis O O
score O O
of O O
individual O O
rats O O
. O O

Statistical O O
significance O O
was O O
accepted O O
at O O
P O O
≤ O O
0.05 O O
. O O

Total O O
T O O
cells O O
and O O
CD4+ O O
T O O
cells O O
from O O
spleens O O
of O O
individual O O
rats O O
-LRB- O O
day O O
13 O O
of O O
AA O O
-RRB- O O
were O O
stimulated O O
in O O
vitro O O
with O O
ConA O O
. O O

The O O
in O O
vitro O O
proliferation O O
rates O O
of O O
total O O
T O O
cells O O
from O O
OX35- O O
and O O
W3/25-treated O O
animals O O
in B-conn Circumstance.Forward Circumstance
response I-conn Circumstance.Forward Circumstance
to I-conn Circumstance.Forward Circumstance
polyspecific O O
stimulation O O
with O O
ConA O O
were O O
higher O O
than O O
those O O
of O O
PBS-treated O O
rats O O
, O O
while B-conn Contrast
T O O
cells O O
of O O
the O O
RIB5/2-treated O O
rats O O
showed O O
proliferation O O
rates O O
similar O O
to O O
those O O
of O O
T O O
cells O O
from O O
PBS-treated O O
animals O O
-LRB- O O
Supplementary O O
Fig. O O
2 O O
-RRB- O O
. O O

ConA O O
stimulation O O
of O O
CD4+ O O
T O O
cells O O
resulted O O
in O O
generally O O
lower O O
proliferation O O
rates O O
than O O
those O O
of O O
total O O
T O O
cells O O
in O O
PBS-treated O O
rats O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
values O O
of O O
CD4+ O O
T O O
cells O O
from O O
individual O O
, O O
anti-CD4-treated O O
animals O O
were O O
always O O
higher O O
than O O
those O O
of O O
the O O
PBS-treated O O
control O O
group O O
-LRB- O O
Supplementary O O
Fig. O O
3a O O
-RRB- O O
. O O

There O O
was O O
a O O
highly O O
significant O O
negative O O
correlation O O
between O O
the O O
degree O O
of O O
the O O
ConA-induced O O
proliferation O O
of O O
CD4+ O O
spleen O O
T O O
cells O O
and O O
the O O
severity O O
of O O
the O O
arthritis O O
score O O
, O O
i.e. B-conn Restatement.Specification
the O O
lower O O
the O O
arthritis O O
score O O
, O O
the O O
higher O O
the O O
proliferation O O
rate O O
-LRB- O O
Supplementary O O
Fig. O O
3b O O
-RRB- O O
. O O

In O O
these O O
experiments O O
, O O
the O O
inhibitory O O
potency O O
of O O
the O O
anti-CD4 O O
mAbs O O
on O O
the O O
mixed O O
lymphocyte O O
culture O O
, O O
an O O
equivalent O O
of O O
a O O
transplant O O
rejection O O
, O O
was O O
investigated O O
as O O
a O O
model O O
for O O
MHC-dependent O O
T-cell O O
activation O O
. O O

The O O
anti-CD4 O O
mAbs O O
moderately O O
inhibited O O
the O O
proliferation O O
of O O
total O O
spleen O O
T O O
cells O O
, O O
depending O O
on O O
the O O
stimulator O O
cell O O
concentration O O
-LRB- O O
Supplementary O O
Fig. O O
4a O O
-RRB- O O
. O O

The O O
accelerating O O
mAb O O
RIB5/2 O O
led O O
to O O
significant O O
inhibition O O
at O O
all O O
concentrations O O
of O O
mAb O O
-LRB- O O
1 O O
, O O
5 O O
, O O
and O O
10 O O
μg/ml O O
; O O
only O O
1 O O
μg/ml O O
is O O
shown O O
in O O
Supplementary O O
Fig. O O
4a O O
-RRB- O O
and O O
DC O O
, O O
whereas B-conn Contrast
the O O
other O O
two O O
anti-CD4 O O
mAbs O O
significantly O O
inhibited O O
the O O
proliferation O O
only O O
in O O
some O O
cases O O
. O O

Furthermore B-conn Conjunction
, O O
RIB5/2 O O
inhibited O O
the O O
proliferation O O
to O O
a O O
statistically O O
significant O O
degree O O
at O O
1 O O
μg/ml O O
and O O
2 O O
× O O
104 O O
DC/well O O
more O O
strongly O O
than O O
both O O
W3/25 O O
and O O
OX35 O O
. O O

Thus B-conn Cause.Claim
, O O
these O O
differential O O
results O O
-LRB- O O
inversely O O
-RRB- O O
match O O
the O O
differential O O
clinical O O
efficacy O O
seen O O
with O O
the O O
three O O
mAbs O O
. O O

The O O
possibility O O
that O O
CD8+ O O
T O O
cells O O
would O O
mask O O
the O O
inhibitory O O
potency O O
of O O
the O O
anti-CD4 O O
mAbs O O
on O O
the O O
proliferation O O
of O O
CD4+ O O
T O O
cells O O
in O O
a O O
total O O
T-cell O O
population O O
was O O
excluded O O
by B-conn Purpose.Enablement
using O O
purified O O
CD4+ O O
T O O
cells O O
. O O

They O O
showed O O
a O O
clearer O O
inhibition O O
of O O
their O O
proliferation O O
rates O O
-LRB- O O
50 O O
to O O
80 O O
% O O
in O O
comparison O O
with O O
the O O
isotype O O
-RRB- O O
when B-conn Circumstance.Forward Circumstance
used O O
as O O
responder O O
cells O O
. O O

However B-conn Concession.Contra-expectation
, O O
in O O
contrast O O
to O O
the O O
total O O
T-cell O O
population O O
, O O
there O O
was O O
no O O
significant O O
difference O O
in O O
the O O
inhibitory O O
potency O O
among O O
the O O
three O O
anti-CD4 O O
mAbs O O
-LRB- O O
Supplementary O O
Fig. O O
4b O O
-RRB- O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
characterize O O
the O O
depleting O O
and O O
modulating O O
capacity O O
of O O
the O O
three O O
mAbs O O
, O O
FACS O O
of O O
peripheral O O
blood O O
mononu-clear O O
cells O O
was O O
performed O O
on O O
days O O
8 O O
and O O
13 O O
of O O
AA O O
-LRB- O O
Supplementary O O
Table O O
2A O O
, O O
B O O
-RRB- O O
. O O

Two O O
different O O
anti-CD4 O O
mAbs O O
-LRB- O O
W3/25 O O
and O O
OX35 O O
, O O
which O O
do O O
not O O
compete O O
for O O
CD4 O O
binding O O
-RRB- O O
were O O
employed O O
to B-conn Purpose.Goal
differentiate O O
coating O O
with O O
therapeutic O O
mAb O O
from O O
depletion O O
of O O
CD4+ O O
T O O
cells/CD4-modulation O O
. O O

After B-conn Temporal.Succession
treatment O O
with O O
W3/25 O O
, O O
the O O
percentage O O
and/or O O
MFI O O
-LRB- O O
mean O O
fluorescence O O
intensity O O
-RRB- O O
of O O
CD3+ O O
cells O O
in O O
the O O
peripheral O O
blood O O
on O O
days O O
8 O O
and O O
13 O O
was O O
numerically O O
lower O O
than O O
in O O
the O O
PBS-treated O O
control O O
group O O
, O O
resulting O O
in O O
a O O
significantly O O
lower O O
MFI O O
on O O
day O O
13 O O
-LRB- O O
note O O
: O O
the O O
fact O O
that O O
on O O
day O O
8 O O
only O O
two O O
animals O O
of O O
the O O
W3/25-treated O O
group O O
were O O
investigated O O
likely O O
prevented O O
statistical O O
significance O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
a O O
decrease O O
of O O
CD4+ O O
cells O O
was O O
observed O O
when B-conn Circumstance.Forward Circumstance
the O O
cells O O
were O O
stained O O
with O O
OX35 O O
-LRB- O O
more O O
prominent O O
on O O
day O O
13 O O
; O O
see O O
Supplementary O O
Table O O
2B O O
-RRB- O O
. O O

After B-conn Temporal.Succession
ex O O
vivo O O
staining O O
with O O
W3/25 O O
– O O
the O O
mAb O O
also O O
used O O
for O O
treatment O O
– O O
only O O
7 O O
% O O
-LRB- O O
day O O
8 O O
-RRB- O O
and O O
28 O O
% O O
-LRB- O O
day O O
13 O O
-RRB- O O
of O O
the O O
peripheral O O
blood O O
mononuclear O O
cells O O
were O O
CD4+ O O
. O O

This O O
fact O O
, O O
and O O
the O O
positive O O
staining O O
with O O
an O O
anti-mouse O O
IgG O O
on O O
days O O
8 O O
and O O
13 O O
-LRB- O O
18 O O
% O O
and O O
9 O O
% O O
, O O
respectively O O
-RRB- O O
, O O
showed O O
that O O
the O O
therapeutic O O
anti-CD4 O O
mAb O O
was O O
present O O
on O O
the O O
cells O O
as O O
long O O
as O O
7 O O
days O O
after O O
the O O
last O O
injection O O
of O O
the O O
mAb O O
. O O

After B-conn Temporal.Succession
treatment O O
with O O
W3/25 O O
, O O
the O O
percentage O O
of O O
CD8+ O O
cells O O
did O O
not O O
show O O
any O O
significant O O
changes O O
on O O
days O O
8 O O
or O O
13 O O
; O O
however B-conn Contrast
, O O
the O O
MFI O O
for O O
CD8 O O
on O O
day O O
13 O O
was O O
significantly O O
decreased O O
-LRB- O O
see O O
Supplementary O O
Table O O
2B O O
-RRB- O O
. O O

Therefore B-conn Restatement.Generalization
, O O
the O O
anti-CD4 O O
mAb O O
W3/25 O O
induced O O
only O O
weak O O
depletion O O
of O O
CD4+ O O
cells O O
, O O
as O O
indicated O O
by O O
unchanged O O
percentages O O
of O O
CD8+ O O
cells O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
there O O
was O O
modulation O O
of O O
the O O
CD4 O O
and O O
co-modulation O O
of O O
the O O
CD3 O O
surface O O
molecules O O
and O O
indirect O O
modulation O O
of O O
the O O
CD8 O O
molecule O O
-LRB- O O
see O O
Supplementary O O
Table O O
2B O O
-RRB- O O
. O O

The O O
anti-CD4 O O
mAb O O
W3/25 O O
therefore B-conn Cause.Claim
represented O O
a O O
weakly O O
depleting O O
, O O
but O O
modulating O O
antibody O O
. O O

In O O
the O O
peripheral O O
blood O O
of O O
OX35-treated O O
rats O O
, O O
the O O
percentage O O
of O O
CD3+ O O
cells O O
was O O
significantly O O
lower O O
than O O
in O O
PBS-treated O O
animals O O
-LRB- O O
see O O
Supplementary O O
Table O O
2A O O
, O O
B O O
-RRB- O O
. O O

The O O
percentage O O
of O O
CD4+ O O
cells O O
in O O
the O O
OX35-treated O O
group O O
was O O
also O O
significantly O O
lower O O
than O O
that O O
of O O
the O O
PBS O O
control O O
, O O
both B-conn Temporal.Succession
upon I-conn Temporal.Succession
staining O O
with O O
W3/25 O O
and O O
OX35 O O
-LRB- O O
see O O
Supplementary O O
Table O O
2A O O
, O O
B O O
-RRB- O O
. O O

The O O
therapeutically O O
applied O O
OX35 O O
was O O
no O O
longer O O
present O O
on O O
the O O
cells O O
at O O
this O O
stage O O
, O O
as O O
demonstrated O O
by O O
negative O O
staining O O
for O O
mouse O O
IgG O O
. O O

The O O
percentage O O
of O O
CD8+ O O
cells O O
of O O
OX35-treated O O
rats O O
was O O
either O O
significantly O O
or O O
numerically O O
increased O O
compared O O
to O O
the O O
PBS-treated O O
control O O
on O O
day O O
8 O O
or O O
13 O O
, O O
respectively O O
, O O
whereas B-conn Contrast
the O O
MFI O O
of O O
the O O
CD8 O O
molecule O O
was O O
significantly O O
decreased O O
on O O
both O O
days O O
. O O

In O O
comparison O O
with O O
W3/25 O O
, O O
the O O
mAb O O
OX35 O O
induced O O
a O O
clearer O O
depletion O O
of O O
CD4+ O O
cells O O
of O O
the O O
peripheral O O
blood O O
, O O
as O O
indicated O O
by O O
a O O
significant O O
increase O O
in O O
the O O
percentage O O
of O O
CD8+ O O
cells O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
mAb O O
OX35 O O
induced O O
CD4-modulation O O
and O O
CD3-co-modulation O O
, O O
as O O
shown O O
by O O
a O O
profound O O
decrease O O
of O O
CD4+ O O
cells O O
and O O
a O O
decrease O O
of O O
the O O
MFI O O
for O O
CD4 O O
. O O

Thus B-conn Cause.Claim
, O O
OX35 O O
represented O O
a O O
depleting O O
and O O
modulating O O
antibody O O
. O O

RIB5/2 O O
also O O
induced O O
a O O
significant O O
reduction O O
of O O
CD3+ O O
cells O O
in O O
comparison O O
with O O
the O O
PBS O O
group O O
-LRB- O O
see O O
Supplementary O O
Table O O
2A O O
, O O
B O O
-RRB- O O
. O O

The O O
percentage O O
of O O
CD4+ O O
cells O O
was O O
also O O
significantly O O
decreased O O
on O O
days O O
8 O O
and O O
13 O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
there O O
was O O
a O O
significant O O
increase O O
of O O
CD8+ O O
cells O O
in O O
the O O
periphery O O
of O O
RIB5/2-treated O O
rats O O
in O O
comparison O O
with O O
the O O
PBS-treated O O
control O O
-LRB- O O
see O O
Supplementary O O
Table O O
2A O O
, O O
B O O
-RRB- O O
. O O

Similarly O O
to O O
the O O
findings O O
for O O
mAb O O
OX35 O O
, O O
mAb O O
RIB5/2 O O
induced O O
T-cell O O
depletion O O
and O O
CD4 O O
modulation O O
; O O
however B-conn Concession.Contra-expectation
, O O
the O O
degree O O
of O O
peripheral O O
T-cell O O
depletion O O
was O O
stronger O O
than O O
in O O
the O O
case O O
of O O
OX35 O O
. O O

Thus B-conn Cause.Claim
, O O
since B-conn Cause.Justification
both O O
ameliorating O O
and O O
accelerating O O
mAbs O O
-LRB- O O
OX35 O O
and O O
RIB5/2 O O
-RRB- O O
depleted O O
CD4+ O O
T O O
cells O O
from O O
peripheral O O
blood O O
, O O
and B-conn Conjunction
since O O
all O O
three O O
mAbs O O
were O O
modulating O O
, O O
there O O
was O O
no O O
apparent O O
match O O
of O O
these O O
parameters O O
with O O
the O O
clinical O O
efficacy O O
. O O

Intracellular O O
staining O O
of O O
cells O O
preincubated O O
with O O
anti-CD4 O O
mAbs O O
or O O
isotype O O
controls O O
showed O O
a O O
uniformly O O
high O O
expression O O
for O O
IFN-γ O O
-LRB- O O
Supplementary O O
Fig. O O
5a O O
, O O
b O O
; O O
between O O
80 O O
% O O
and O O
100 O O
% O O
positive O O
cells O O
; O O
MFI O O
approximately O O
30 O O
-RRB- O O
. O O

There O O
were O O
no O O
differences O O
between O O
the O O
anti-CD4 O O
mAb-treated O O
or O O
isotype-treated O O
cultures O O
for O O
the O O
concentration O O
of O O
IFN-γ O O
in O O
the O O
supernatant O O
-LRB- O O
Supplementary O O
Fig. O O
5c O O
-RRB- O O
. O O

The O O
anti-CD4 O O
mAb O O
W3/25 O O
induced O O
a O O
significantly O O
higher O O
percentage O O
of O O
IL-4-positive O O
cells O O
at O O
24 O O
and O O
48 O O
hours O O
than O O
did O O
the O O
isotype O O
control O O
-LRB- O O
Supplementary O O
Fig. O O
5d O O
-RRB- O O
; O O
the O O
MFI O O
was O O
also O O
significantly O O
higher O O
in O O
comparison O O
with O O
OX35 O O
and O O
RIB5/2 O O
-LRB- O O
Supplementary O O
Fig. O O
5e O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
there O O
were O O
no O O
significant O O
differences O O
of O O
the O O
IL-4 O O
concentration O O
in O O
the O O
supernatant O O
of O O
the O O
cultures O O
-LRB- O O
Supplementary O O
Fig. O O
5f O O
-RRB- O O
. O O

This O O
observation O O
may O O
be O O
attributable O O
to O O
a O O
delayed O O
secretion O O
of O O
IL-4 O O
or O O
consumption O O
of O O
the O O
cytokine O O
during O O
culture O O
. O O

At O O
24 O O
h O O
, O O
a O O
numerical O O
increase O O
of O O
the O O
percentage O O
of O O
IL-10-positive O O
cells O O
could O O
be O O
detected O O
after B-conn Temporal.Succession
preincubation O O
with O O
the O O
ameliorating O O
mAb O O
W3/25 O O
and O O
the O O
accelerating O O
mAb O O
RIB5/2 O O
, O O
whereas B-conn Contrast
the O O
other O O
ameliorating O O
mAb O O
, O O
OX35 O O
, O O
induced O O
a O O
significant O O
increase O O
-LRB- O O
Supplementary O O
Fig. O O
5g O O
-RRB- O O
. O O

This O O
increase O O
was O O
no O O
longer O O
observed O O
at O O
48 O O
h O O
-LRB- O O
Supplementary O O
Fig. O O
5g O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
MFI O O
for O O
IL-10 O O
was O O
increased O O
both O O
24 O O
h O O
and O O
48 O O
h O O
after B-conn Temporal.Succession
pretreatment O O
with O O
anti-CD4 O O
mAbs O O
. O O

At O O
24 O O
h O O
, O O
only O O
the O O
increase O O
induced O O
by O O
the O O
mAb O O
OX35 O O
was O O
significant O O
, O O
but B-conn Contrast
at O O
48 O O
h O O
all O O
three O O
mAbs O O
induced O O
a O O
significant O O
increase O O
of O O
the O O
MFI O O
-LRB- O O
Supplementary O O
Fig. O O
5h O O
-RRB- O O
. O O

Preincubation O O
with O O
all O O
anti-CD4 O O
mAbs O O
induced O O
a O O
significantly O O
higher O O
secretion O O
of O O
IL-10 O O
than O O
did O O
the O O
isotype O O
control O O
, O O
not O O
only O O
after O O
24 O O
h O O
, O O
but O O
also O O
after O O
48 O O
hours O O
-LRB- O O
the O O
latter O O
increase O O
did O O
not O O
reach O O
statistical O O
significance O O
in O O
the O O
case O O
of O O
OX35 O O
-RRB- O O
. O O

None O O
of O O
the O O
parameters O O
, O O
however B-conn Concession.Contra-expectation
, O O
showed O O
significant O O
differences O O
among O O
the O O
three O O
different O O
anti-CD4 O O
mAbs O O
-LRB- O O
Supplementary O O
Fig. O O
5i O O
-RRB- O O
. O O

The O O
use O O
of O O
nondepleting O O
anti-CD4 O O
mAbs O O
for O O
treatment O O
of O O
human O O
rheumatoid O O
arthritis O O
is O O
being O O
discussed O O
at O O
present O O
; O O
such O O
treatment O O
would O O
be O O
intended O O
to O O
influence O O
the O O
reactivity O O
of O O
CD4+ O O
T O O
cells O O
, O O
rather O O
than O O
remove O O
them O O
completely O O
-LRB- O O
particularly B-conn Cause.Reason
since I-conn Cause.Reason
depletion O O
may O O
induce O O
transient O O
immunodeficiency O O
-RRB- O O
. O O

In O O
vivo O O
, O O
the O O
depleting O O
and O O
modulating O O
capacities O O
of O O
the O O
three O O
anti-CD4 O O
mAbs O O
were O O
different O O
. O O

Whereas B-conn Contrast
W3/25 O O
was O O
a O O
weakly O O
depleting O O
, O O
but O O
clearly O O
modulating O O
, O O
mAb O O
, O O
RIB5/2 O O
and O O
OX35 O O
were O O
moderately O O
or O O
strongly O O
depleting O O
and O O
modulating O O
mAbs O O
, O O
respectively O O
; O O
this O O
pattern O O
did O O
not O O
match O O
the O O
treatment O O
effects O O
of O O
the O O
three O O
mAbs O O
. O O

In O O
the O O
present O O
study O O
, O O
CD4+ O O
T-cell O O
depletion O O
was O O
assessed O O
only O O
in O O
the O O
peripheral O O
blood O O
, O O
the O O
compartment O O
most O O
easily O O
accessible O O
also O O
in O O
humans O O
. O O

Because B-conn Cause.Reason
depletion/modulation O O
in O O
peripheral O O
blood O O
may O O
differ O O
from O O
that O O
in O O
other O O
compartments O O
-LRB- O O
e.g. O O

lymphoid O O
organs O O
-RRB- O O
, O O
the O O
use O O
of O O
the O O
terms O O
' O O
depleting O O
' O O
or O O
' O O
nondepleting O O
' O O
has O O
to O O
be O O
restricted O O
to O O
the O O
blood O O
. O O

In O O
the O O
case O O
of O O
the O O
mAbs O O
W3/25 O O
and O O
OX35 O O
, O O
however B-conn Concession.Contra-expectation
, O O
studies O O
with O O
marked O O
, O O
antibody-coated O O
cells O O
indicate O O
a O O
redistribution O O
of O O
the O O
cells O O
from O O
lymphoid O O
organs O O
to O O
the O O
liver O O
, O O
possibly O O
including O O
phagocytosis O O
and O O
depletion O O
of O O
the O O
opsonized O O
' O O
cells O O
' O O
by O O
liver O O
macrophages O O
-LRB- O O
unpublished O O
observations O O
-RRB- O O
. O O

Contrasting O O
earlier O O
findings O O
concerning O O
the O O
depleting O O
capacity O O
of O O
the O O
mAb O O
RIB5/2 O O
-LSB-S7 O O
, O O
S8 O O
-RSB- O O
may O O
be O O
attributable O O
to O O
different O O
time O O
points O O
of O O
investigation O O
, O O
different O O
amounts O O
of O O
injected O O
mAb O O
or O O
number O O
of O O
therapeutic O O
injections O O
, O O
and O O
different O O
experimental O O
models O O
-LRB- O O
personal O O
communication O O
, O O
Dr O O
M O O
Lehmann O O
, O O
University O O
of O O
Rostock O O
-RRB- O O
. O O

Differential O O
effects O O
of O O
the O O
three O O
anti-CD4 O O
mAbs O O
on O O
the O O
mixed O O
lymphocyte O O
culture O O
were O O
noted O O
only O O
occasionally O O
, O O
especially O O
with O O
total O O
T O O
cells O O
as O O
responders O O
. O O

The O O
accelerating O O
mAb O O
RIB5/2 O O
was O O
again O O
more O O
effective O O
. O O

The O O
observation O O
of O O
differential O O
effects O O
only O O
with O O
total O O
T O O
cells O O
, O O
but O O
not O O
in O O
CD4+ O O
T O O
cells O O
, O O
indicates O O
a O O
differential O O
contribution O O
of O O
the O O
CD4+ O O
and O O
CD8+ O O
T-cell O O
subpopulation O O
and O O
suggests O O
that O O
interactions O O
between O O
CD4+ O O
and O O
CD8+ O O
T O O
cells O O
-LSB-S9 O O
-RSB- O O
are O O
critical O O
for O O
T-cell O O
activation O O
and O O
the O O
effects O O
of O O
anti-CD4 O O
mAbs O O
on O O
this O O
process O O
. O O

Whereas B-conn Contrast
IFN-γ O O
secretion O O
was O O
completely O O
unaffected O O
by O O
anti-CD4 O O
preincubation O O
and B-conn Conjunction
IL-4 O O
was O O
only O O
increased O O
by O O
the O O
mAb O O
W3/25 O O
-LRB- O O
as O O
previously O O
reported O O
; O O
-LSB-S10 O O
-RSB- O O
-RRB- O O
, O O
IL-10 O O
secretion O O
was O O
strikingly O O
induced O O
by O O
all O O
three O O
anti-CD4 O O
mAbs O O
. O O

At O O
least O O
in O O
the O O
case O O
of O O
the O O
ameliorating O O
mAbs O O
W3/25 O O
and O O
OX35 O O
, O O
this O O
effect O O
is O O
compatible O O
with O O
the O O
anti-inflammatory O O
role O O
of O O
IL-10 O O
in O O
arthritis O O
-LSB-S11 O O
, O O
S12 O O
-RSB- O O
and O O
has O O
been O O
reported O O
also O O
after B-conn Temporal.Succession
anti-CD4 O O
therapy O O
in O O
transplantation O O
-LSB-S13 O O
-RSB- O O
. O O

The O O
fact O O
that O O
the O O
total O O
number O O
of O O
IFN-γ-positive O O
and O O
IL-4-/IL-10-positive O O
T O O
cells O O
exceeds O O
100 O O
% O O
indicates O O
the O O
presence O O
of O O
TH0 O O
cells O O
in O O
this O O
particular O O
experimental O O
system O O
. O O

Abbreviations O O

AA O O
= O O
rat O O
adjuvant O O
arthritis O O
; O O
AP-1 O O
= O O
activator O O
protein-1 O O
; O O
ConA O O
= O O
concanavalin O O
A O O
; O O
DC O O
= O O
dendritic O O
cells O O
; O O
DTH O O
= O O
delayed-type O O
hypersensitivity O O
; O O
ELISA O O
= O O
enzyme-linked O O
immunosorbent O O
assay O O
; O O
FACS O O
= O O
flowcytometry O O
; O O
FCS O O
= O O
fetal O O
calf O O
serum O O
; O O
FITC O O
= O O
fluorescein O O
isothiocyanate O O
; O O
HEPES O O
= O O
N- O O
-LRB- O O
2-hydroxyethyl O O
-RRB- O O
piperazine-N'- O O
-LRB- O O
2-ethanesulfonic O O
acid O O
-RRB- O O
; O O
IFN O O
= O O
interferon O O
; O O
IL O O
= O O
interleukin O O
; O O
KA O O
= O O
affinity O O
constant O O
; O O
kass O O
= O O
association O O
rate O O
constant O O
; O O
kdiss O O
= O O
dissociation O O
rate O O
constant O O
; O O
mAb O O
= O O
monoclonal O O
antibody O O
; O O
MFI O O
= O O
mean O O
fluorescence O O
intensity O O
; O O
MHC O O
= O O
major O O
histocompatibility O O
complex O O
; O O
NF-AT O O
= O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
; O O
PBS O O
= O O
phosphate-buffered O O
saline O O
; O O
PE O O
= O O
phycoerythrin O O
; O O
PMA O O
= O O
phorbol O O
myristoyl O O
acetate O O
; O O
PMSF O O
= O O
phenylmethylsulfonyl O O
fluoride O O
; O O
RPMI O O
= O O
Roswell O O
Park O O
Memorial O O
Institute O O
-LSB-medium O O
-RSB- O O
; O O
SEM O O
= O O
standard O O
error O O
of O O
the O O
mean O O
; O O
Shc O O
= O O
src-homology-domain-containing-protein O O
; O O
TNF O O
= O O
tumor O O
necrosis O O
factor O O
; O O
TCR O O
= O O
T-cell O O
receptor O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Arthritis O O
score O O
after O O
preventive O O
treatment O O
of O O
rat O O
adjuvant O O
arthritis O O
-LRB- O O
AA O O
-RRB- O O
with O O
various O O
anti-CD4 O O
mAbs O O
or O O
PBS O O
-LRB- O O
controls O O
-RRB- O O
-LRB- O O
means O O
± O O
SEM O O
; O O
n O O
= O O
6 O O
for O O
all O O
groups O O
-RRB- O O
. O O

Arrows O O
show O O
the O O
days O O
of O O
treatment O O
-LRB- O O
days O O
-1 O O
, O O
0 O O
, O O
3 O O
, O O
6 O O
-RRB- O O
. O O

Treatment O O
with O O
W3/25 O O
and O O
OX35 O O
significantly O O
suppressed O O
AA O O
from O O
day O O
13 O O
until O O
day O O
30 O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
RIB5/2 O O
accelerated O O
the O O
onset O O
of O O
AA O O
by O O
2 O O
days O O
and O O
led O O
to O O
significant O O
improvement O O
only O O
in O O
the O O
late O O
phase O O
-LRB- O O
from O O
day O O
27 O O
-RRB- O O
. O O

** O O
P O O
≤ O O
0.01 O O
, O O
* O O
P O O
≤ O O
0.05 O O
, O O
in O O
comparison O O
with O O
PBS-treated O O
rats O O
. O O

One O O
representative O O
of O O
three O O
experiments O O
is O O
shown O O
. O O

Supplementary O O
Figure O O
1 O O
: O O
In O O
vivo O O
delayed-type O O
hypersensitivity O O
to O O
Mycobacterium O O
tuberculosis O O
on O O
day O O
13 O O
after O O
preventive O O
treatment O O
of O O
AA O O
, O O
i.e. O O
when O O
the O O
clinical O O
differences O O
between O O
the O O
accelerating O O
and O O
ameliorating O O
anti-CD4 O O
mAbs O O
were O O
maximal O O
. O O

The O O
data O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
-LRB- O O
n O O
= O O
6 O O
for O O
all O O
groups O O
, O O
one O O
representative O O
of O O
three O O
in O O
vivo O O
experiments O O
-RRB- O O
of O O
the O O
difference O O
between O O
the O O
swelling O O
of O O
the O O
left O O
-LRB- O O
mycobacterium-treated O O
-RRB- O O
and O O
the O O
right O O
-LRB- O O
PBS-treated O O
-RRB- O O
ears O O
. O O

* O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
PBS-treated O O
rats O O
. O O

Supplementary O O
Figure O O
2 O O
: O O
Concanavalin O O
A O O
-LRB- O O
ConA O O
-RRB- O O
reactivity O O
of O O
total O O
spleen O O
T O O
cells O O
-LRB- O O
day O O
13 O O
of O O
adjuvant O O
arthritis O O
-RRB- O O
from O O
rats O O
preventively O O
treated O O
with O O
anti-CD4 O O
mAbs O O
. O O

Proliferation O O
data O O
from O O
two O O
individual O O
animals O O
of O O
each O O
treatment O O
group O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
of O O
triplicate O O
cultures O O
from O O
one O O
in O O
vivo O O
experiment O O
. O O

The O O
corresponding O O
arthritis O O
score O O
for O O
the O O
animals O O
is O O
shown O O
below O O
the O O
graph O O
. O O

Supplementary O O
Figure O O
4 O O
: O O
Mixed O O
lymphocyte O O
culture O O
of O O
total O O
-LRB- O O
a O O
-RRB- O O
and O O
CD4+ O O
-LRB- O O
b O O
-RRB- O O
spleen O O
T O O
cells O O
from O O
normal O O
Lewis O O
rats O O
with O O
different O O
densities O O
of O O
allogeneic O O
-LRB- O O
Wistar–Prob O O
-RRB- O O
stimulator O O
cells O O
, O O
supplemented O O
with O O
isotype O O
controls O O
-LRB- O O
IgG1 O O
, O O
IgG2a O O
-RRB- O O
, O O
or O O
the O O
anti-CD4 O O
mAbs O O
W3/25 O O
, O O
OX35 O O
, O O
and O O
RIB5/2 O O
at O O
1 O O
μg/ml O O
. O O

Data O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
of O O
the O O
relative O O
absorbance O O
from O O
three O O
independent O O
experiments O O
-LRB- O O
triplicates O O
in O O
each O O
experiment O O
-RRB- O O
, O O
normalized O O
to O O
the O O
absorbance O O
of O O
PBS-treated O O
cultures O O
-LRB- O O
=100 O O
% O O
-RRB- O O
. O O

* O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
the O O
respective O O
isotype O O
control O O
, O O
# O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
W3/25 O O
, O O
§P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
OX35 O O
. O O

Figure O O
2 O O
: O O
Production O O
of O O
TNF-α O O
by O O
spleen O O
CD4+ O O
T O O
cells O O
after O O
anti-CD4 O O
preincubation O O
, O O
as O O
measured O O
by O O
bioassay O O
-LRB- O O
means O O
± O O
SEM O O
of O O
three O O
experiments O O
; O O
pooled O O
T O O
cells O O
from O O
three O O
normal O O
rats O O
each O O
-RRB- O O
. O O

The O O
accelerating O O
mAb O O
, O O
RIB5/2 O O
, O O
induced O O
a O O
significantly O O
stronger O O
increase O O
of O O
secreted O O
TNF-α O O
than O O
the O O
other O O
mAbs O O
. O O

Specificity O O
was O O
ensured O O
by B-conn Purpose.Enablement
adding O O
a O O
neutralizing O O
anti-TNF-α O O
mAb O O
to O O
supernatants O O
from O O
RIB5/2-treated O O
cultures O O
. O O

* O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
the O O
isotype O O
control O O
, O O
# O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
W3/25 O O
, O O
§P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
OX35 O O
. O O

Figure O O
3 O O
: O O
Electromobility O O
shift O O
assay O O
-LRB- O O
EMSA O O
-RRB- O O
of O O
nuclear O O
extracts O O
from O O
CD4+ O O
T O O
cells O O
-LRB- O O
preincubated O O
with O O
anti-CD4 O O
mAbs O O
or O O
stimulated O O
with O O
PMA/ionomycin O O
-RRB- O O
for O O
AP-1 O O
-LRB- O O
a O O
-RRB- O O
and O O
NF-κB O O
-LRB- O O
b O O
-RRB- O O
. O O

One O O
representative O O
phosphoimage O O
of O O
three O O
independent O O
experiments O O
is O O
shown O O
-LRB- O O
upper O O
panels O O
-RRB- O O
. O O

Quantification O O
of O O
the O O
bands O O
of O O
all O O
three O O
experiments O O
is O O
shown O O
below O O
-LRB- O O
means O O
± O O
SEM O O
-RRB- O O
. O O

All O O
three O O
anti-CD4 O O
mAbs O O
slightly O O
decreased O O
the O O
AP-1 O O
activity O O
, O O
and O O
RIB5/2 O O
induced O O
a O O
profound O O
, O O
significant O O
increase O O
of O O
NF-κB O O
activity O O
. O O

* O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
the O O
isotype O O
control O O
, O O
# O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
W3/25 O O
, O O
§P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
OX35 O O
, O O
&P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
RIB5/2 O O
. O O

Supplementary O O
Figure O O
3 O O
: O O
Concanavalin O O
A O O
-LRB- O O
ConA O O
-RRB- O O
reactivity O O
-LRB- O O
a O O
-RRB- O O
of O O
CD4+ O O
spleen O O
T O O
cells O O
-LRB- O O
day O O
13 O O
of O O
adjuvant O O
arthritis O O
-RRB- O O
from O O
preventively O O
treated O O
rats O O
with O O
anti-CD4 O O
mAbs O O
. O O

Proliferation O O
data O O
from O O
two O O
individual O O
animals O O
of O O
each O O
group O O
are O O
expressed O O
as O O
means O O
± O O
SEM O O
of O O
triplicate O O
cultures O O
. O O

The O O
corresponding O O
arthritis O O
score O O
for O O
the O O
animals O O
is O O
shown O O
in O O
the O O
middle O O
. O O

The O O
correlation O O
between O O
reactivity O O
to O O
ConA O O
and O O
the O O
severity O O
of O O
arthritis O O
is O O
shown O O
in O O
-LRB- O O
b O O
-RRB- O O
. O O

Normals O O
= O O
normal O O
, O O
untreated O O
rats O O
. O O

Supplementary O O
Figure O O
5 O O
: O O
Production O O
of O O
IFN-γ O O
-LRB- O O
a O O
, O O
b O O
, O O
c O O
-RRB- O O
, O O
IL-4 O O
-LRB- O O
d O O
, O O
e O O
, O O
f O O
-RRB- O O
, O O
and O O
IL-10 O O
-LRB- O O
g O O
, O O
h O O
, O O
i O O
-RRB- O O
by O O
spleen O O
CD4+ O O
T O O
cells O O
after O O
anti-CD4-preincubation O O
. O O

Percentage O O
of O O
cytokine-positive O O
cells O O
-LRB- O O
upper O O
panels O O
-RRB- O O
, O O
their O O
mean O O
fluorescence O O
intensity O O
-LRB- O O
MFI O O
-RRB- O O
after O O
intracellular O O
staining O O
-LRB- O O
middle O O
panels O O
-RRB- O O
, O O
and O O
secretion O O
of O O
the O O
cytokine O O
into O O
cell O O
culture O O
supernatant O O
as O O
measured O O
by O O
ELISA O O
-LRB- O O
lower O O
panels O O
-RRB- O O
, O O
shown O O
as O O
means O O
± O O
SEM O O
of O O
three O O
independent O O
experiments O O
-LRB- O O
triplicate O O
determinations O O
in O O
pooled O O
cells O O
from O O
three O O
normal O O
rats O O
in O O
each O O
experiment O O
-RRB- O O
. O O

* O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
isotype O O
control O O
, O O
# O O
P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
W3/25 O O
, O O
§P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
OX35 O O
, O O
&P O O
≤ O O
0.05 O O
in O O
comparison O O
with O O
RIB5/2 O O
. O O

For O O
key O O
to O O
bars O O
, O O
see O O
Supplementary O O
Figure O O
4 O O
. O O

Supplementary O O
Table O O
1 O O
: O O
Affinity O O
data O O
of O O
the O O
anti-CD4 O O
mAb O O

Supplementary O O
Table O O
2 O O
: O O
Cytofluorometric O O
analyses O O
of O O
peripheral O O
blood O O
mononuclear O O
cells O O
on O O
day O O
8 O O
-LRB- O O
A O O
-RRB- O O
and O O
day O O
13 O O
-LRB- O O
B O O
-RRB- O O
of O O
anti-CD4 O O
treatment O O
-LRB- O O
data O O
from O O
one O O
representative O O
of O O
three O O
in O O
vivo O O
experiments O O
-RRB- O O
. O O

Tissue O O
factor O O
as O O
a O O
proinflammatory O O
agent O O

Abstract O O

Tissue O O
factor O O
-LRB- O O
TF O O
-RRB- O O
is O O
a O O
transmembrane O O
glycoprotein O O
and O O
the O O
main O O
triggering O O
element O O
of O O
blood O O
coagulation O O
. O O

TF O O
expression O O
on O O
monocytes O O
and O O
endothelial O O
cells O O
is O O
induced O O
by O O
exposure O O
to O O
endotoxin O O
, O O
tumor O O
necrosis O O
factor O O
, O O
and O O
IL-1 O O
and O O
is O O
considered O O
to O O
appear O O
in B-conn Cause.Reason
consequence I-conn Cause.Reason
of I-conn Cause.Reason
inflammation O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
assess O O
the O O
proinflammatory O O
capacity O O
of O O
TF O O
itself O O
, O O
the O O
recombinant O O
extracellular O O
domain O O
of O O
TF O O
was O O
injected O O
intra-articularly O O
into O O
healthy O O
mice O O
. O O

To B-conn Purpose.Goal
characterize O O
the O O
role O O
of O O
immune O O
cells O O
in O O
the O O
TF-induced O O
arthritis O O
, O O
mice O O
deprived O O
of O O
lymphocytes O O
, O O
neutrophils O O
and O O
monocytes O O
were O O
used O O
. O O

Histomorphological O O
analysis O O
of O O
the O O
joints O O
with O O
respect O O
to O O
inflammatory O O
cell O O
infiltration O O
, O O
pannus O O
formation O O
and O O
erosion O O
formation O O
revealed O O
development O O
of O O
arthritis O O
in O O
80 O O
% O O
of O O
animals O O
injected O O
with O O
TF O O
. O O

In O O
most O O
of O O
the O O
cases O O
synovial O O
proliferation O O
was O O
accompanied O O
by O O
pannus O O
formation O O
and O O
cartilage O O
destruction O O
. O O

Inflammatory O O
cell O O
infiltrate O O
consisted O O
of O O
CD4-Mac1+ O O
macrophages O O
. O O

Depletion O O
of O O
monocytes O O
was O O
, O O
however B-conn Concession.Contra-expectation
, O O
not O O
enough O O
to O O
abolish O O
inflammation O O
. O O

Indeed B-conn Reinforcement
, O O
combined O O
deficiency O O
of O O
monocytes O O
and O O
lymphocytes O O
was O O
required O O
to B-conn Purpose.Goal
prevent O O
inflammation O O
following B-conn Temporal.Succession
the O O
injection O O
of O O
TF O O
. O O

We O O
observed O O
that O O
TF O O
induced O O
chemokine O O
production O O
-LRB- O O
MIP-1α O O
and O O
RANTES O O
-RRB- O O
, O O
but O O
did O O
not O O
induce O O
a O O
proliferative O O
response O O
nor O O
cytokine O O
release O O
by O O
mouse O O
spleen O O
cells O O
. O O

TF O O
has O O
strong O O
inflammatogenic O O
properties O O
mediated O O
predominantly O O
by O O
monocytes O O
and O O
their O O
release O O
of O O
chemokines O O
. O O

Our O O
study O O
shows O O
that O O
TF O O
can O O
simultaneously O O
trigger O O
the O O
immune O O
and O O
coagulation O O
systems O O
. O O

Introduction O O

Tissue O O
factor O O
-LRB- O O
TF O O
-RRB- O O
is O O
a O O
transmembrane O O
glycoprotein O O
and O O
the O O
major O O
cellular O O
trigger O O
of O O
blood O O
coagulation O O
. O O

Assembly O O
of O O
a O O
complex O O
between O O
TF O O
and O O
factor O O
VII O O
-LRB- O O
FVII O O
-RRB- O O
initiates O O
fibrin O O
formation O O
. O O

Besides O O
its O O
role O O
in O O
blood O O
coagulation O O
, O O
TF O O
is O O
also B-conn Conjunction
important O O
for O O
the O O
vascular O O
development O O
regulating O O
embryonic O O
angiogenesis O O
and O O
supporting O O
proliferative O O
and O O
invasive O O
capacities O O
of O O
cells O O
-LSB-1-4 O O
-RSB- O O
. O O

Expression O O
of O O
TF O O
on O O
the O O
cell O O
surface O O
and O O
its O O
appearance O O
as O O
a O O
soluble O O
molecule O O
are O O
characteristic O O
features O O
of O O
acute O O
and O O
chronic O O
inflammation O O
in O O
conditions O O
such O O
as O O
sepsis O O
, O O
atherosclerosis O O
, O O
Crohn O O
's O O
desease O O
, O O
systemic O O
lupus O O
erythematosus O O
, O O
and O O
rejection O O
reactions O O
-LSB-5-9 O O
-RSB- O O
. O O

The O O
role O O
of O O
TF O O
in O O
the O O
inflammatory O O
process O O
is O O
a O O
matter O O
of O O
discussion O O
. O O

A O O
variety O O
of O O
inflammatory O O
stimuli O O
, O O
including O O
mitogens O O
, O O
bacterial O O
cell O O
products O O
, O O
components O O
of O O
the O O
complement O O
system O O
and O O
cytokines O O
, O O
are O O
known O O
to O O
promote O O
the O O
expression O O
of O O
TF O O
on O O
the O O
surface O O
of O O
endothelial O O
cells O O
and O O
monocytes O O
-LSB-10 O O
-RSB- O O
. O O

T O O
cells O O
regulate O O
TF O O
expression O O
: O O
upregulation O O
is O O
achieved O O
by O O
Th1 O O
cytokines O O
, O O
while B-conn Contrast
Th2-derived O O
cytokines O O
are O O
mostly O O
inhibitory O O
-LSB-11 O O
-RSB- O O
. O O

TF O O
, O O
in B-conn Conjunction
turn I-conn Conjunction
, O O
may O O
participate O O
in O O
cellular O O
interactions O O
promoting O O
leukocyte O O
adhesion O O
and O O
transendothelial O O
migration O O
-LSB-12,13 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
we O O
investigated O O
the O O
capacity O O
of O O
TF O O
to O O
induce O O
inflammation O O
by B-conn Purpose.Enablement
injecting O O
human O O
recombinant O O
TF O O
-LRB- O O
rTF O O
-RRB- O O
into O O
joint O O
cavities O O
of O O
healthy O O
mice O O
. O O

Histomorphological O O
investigation O O
of O O
the O O
injected O O
joints O O
showed O O
a O O
remarkable O O
cellular O O
infiltration O O
of O O
synovia O O
and O O
occasionally O O
cartilage O O
destruction O O
, O O
indicating O O
that O O
TF O O
possesses O O
strong O O
proinflammatory O O
properties O O
. O O

Expression O O
of O O
TF O O
on O O
monocytes O O
and O O
synovial O O
cells O O
may O O
be O O
crucial O O
for O O
potentiating O O
the O O
initial O O
stages O O
of O O
inflammation O O
in O O
joints O O
. O O

Materials O O
and O O
methods O O

BALB/c O O
and O O
NMRI O O
mice O O
were O O
purchased O O
from O O
ALAB O O
-LRB- O O
Stockholm O O
, O O
Sweden O O
-RRB- O O
. O O

Severe O O
combined O O
immunodeficient O O
-LRB- O O
SCID O O
-RRB- O O
mice O O
and O O
their O O
congenic O O
strain O O
CB17 O O
were O O
purchased O O
from O O
M&B O O
-LRB- O O
Bomholtvej O O
, O O
Denmark O O
-RRB- O O
. O O

All O O
mice O O
were O O
housed O O
in O O
the O O
animal O O
facility O O
of O O
the O O
Department O O
of O O
Rheumatology O O
, O O
University O O
of O O
Göteborg O O
. O O

Female O O
mice O O
6–8 O O
weeks O O
of O O
age O O
were O O
used O O
in O O
all O O
the O O
experiments O O
. O O

This O O
version O O
of O O
rTF O O
contains O O
the O O
extracellular O O
domain O O
of O O
human O O
TF O O
, O O
amino O O
acid O O
residues O O
1–219 O O
-LSB-14 O O
-RSB- O O
, O O
which O O
retains O O
the O O
ability O O
to O O
bind O O
to O O
FVII O O
and O O
FVIIa O O
and O O
to O O
enhance O O
enzymatic O O
activity O O
of O O
FVIIa O O
. O O

rTF O O
preparation O O
was O O
dissolved O O
in O O
Hepes O O
buffered O O
saline O O
-LRB- O O
Hepes O O
30 O O
mM O O
, O O
NaCl O O
100 O O
mM O O
, O O
0.02 O O
% O O
Na-azide O O
; O O
pH7.5 O O
-RRB- O O
and O O
kept O O
in O O
aliquots O O
at O O
-70°C O O
until B-conn Temporal.Precedence
use O O
. O O

Two O O
preparations O O
of O O
TF O O
were O O
used O O
that O O
contained O O
3.7 O O
μg/ml O O
and O O
32 O O
ng/ml O O
of O O
lipopolysaccharide O O
-LRB- O O
LPS O O
-RRB- O O
, O O
respectively O O
. O O

No O O
significant O O
difference O O
in O O
the O O
results O O
obtained O O
with O O
these O O
two O O
preparations O O
was O O
observed O O
and B-conn Continuation
the O O
results O O
were O O
thus B-conn Cause.Result
pooled O O
. O O

NMRI O O
strain O O
mice O O
were O O
used O O
in O O
the O O
experiments O O
unless B-conn Alternative.Disjunctive
stated O O
otherwise O O
. O O

Induction O O
of O O
arthritis O O
was O O
performed O O
by B-conn Purpose.Enablement
injection O O
of O O
rTF O O
in O O
a O O
volume O O
of O O
20 O O
μl O O
intra-articularly O O
into O O
the O O
right O O
knee O O
joint O O
. O O

Control O O
experiments O O
were O O
performed O O
by B-conn Purpose.Enablement
injecting O O
an O O
equivalent O O
amount O O
of O O
LPS O O
preparation O O
in O O
Hepes O O
buffered O O
saline O O
into O O
the O O
contralateral O O
knee O O
joint O O
. O O

Neutrophil O O
depletion O O
was O O
performed O O
by B-conn Purpose.Enablement
intraperitoneal O O
injection O O
of O O
the O O
monoclonal O O
antibody O O
RB6-8C5 O O
-LRB- O O
hybridoma O O
was O O
kindly O O
provided O O
by O O
Dr O O
R O O
Coffman O O
, O O
DNAX O O
Research O O
Institute O O
, O O
Palo O O
Alto O O
, O O
CA O O
, O O
USA O O
-RRB- O O
two B-conn Temporal.Precedence
hours I-conn Temporal.Precedence
before I-conn Temporal.Precedence
the O O
rTF O O
injection O O
, O O
as O O
described O O
previously O O
-LSB-15 O O
-RSB- O O
. O O

The O O
IgG O O
rat O O
antiovalbumin O O
monoclonal O O
antibody O O
-LRB- O O
kindly O O
provided O O
by O O
Dr O O
E O O
Telemo O O
, O O
Department O O
of O O
Clinical O O
Immunology O O
, O O
University O O
of O O
Göteborg O O
, O O
Sweden O O
-RRB- O O
was O O
injected O O
into O O
the O O
control O O
group O O
. O O

Monocyte O O
depletion O O
was O O
induced O O
by B-conn Purpose.Enablement
subcutaneous O O
injection O O
of O O
etoposide O O
-LRB- O O
Bristol-Myers O O
Squibb O O
, O O
Bromma O O
, O O
Sweden O O
; O O
12.5 O O
mg/kg O O
body O O
weight O O
, O O
in O O
a O O
volume O O
of O O
100 O O
μl O O
-LSB-16 O O
-RSB- O O
-RRB- O O
on O O
three O O
consecutive O O
days O O
before O O
and O O
three O O
consecutive O O
days O O
after O O
injection O O
of O O
rTF O O
. O O

The O O
impact O O
of O O
lymphocytes O O
was O O
studied O O
by B-conn Purpose.Enablement
injecting O O
rTF O O
into O O
SCID O O
mice O O
lacking O O
B O O
and O O
T O O
lymphocytes O O
and O O
their O O
congenic O O
strain O O
, O O
CB17 O O
. O O

This O O
was O O
achieved O O
by B-conn Purpose.Enablement
using O O
mini-osmotic O O
pumps O O
-LRB- O O
model O O
2002 O O
, O O
Alza O O
Corp O O
, O O
Palo O O
Alto O O
, O O
CA O O
, O O
USA O O
-RRB- O O
filled O O
with O O
buffered O O
solution O O
containing O O
200 O O
U/ml O O
ancrod O O
-LRB- O O
Sigma O O
Chemical O O
, O O
St O O
Louis O O
, O O
MO O O
, O O
USA O O
-RRB- O O
implanted O O
subcutaneously O O
three B-conn Temporal.Precedence
days I-conn Temporal.Precedence
before I-conn Temporal.Precedence
the O O
injection O O
of O O
rTF O O
-LSB-17 O O
-RSB- O O
. O O

Histological O O
examination O O
of O O
joints O O
was O O
done O O
after B-conn Temporal.Succession
paraffin O O
embedding O O
, O O
cutting O O
, O O
and O O
staining O O
with O O
hematoxylin O O
and O O
eosin O O
. O O

All O O
the O O
slides O O
were O O
coded O O
and O O
evaluated O O
blindly O O
. O O

The O O
specimens O O
were O O
evaluated O O
with O O
respect O O
to O O
occurrence O O
of O O
synovial O O
hypertrophy O O
, O O
inflammatory O O
cells O O
in O O
synovial O O
sublining O O
compartment O O
, O O
pannus O O
formation O O
and O O
cartilage O O
and/or O O
subchondral O O
bone O O
destruction O O
. O O

Intensity O O
of O O
synovial O O
inflammation O O
-LRB- O O
arthritis O O
index O O
-RRB- O O
was O O
graded O O
arbitrarily O O
from O O
0 O O
to O O
3 O O
. O O

For O O
immunohistochemical O O
examination O O
, O O
the O O
knee O O
joints O O
were O O
removed O O
and O O
demineralized O O
as O O
described O O
-LSB-18 O O
-RSB- O O
. O O

Serial O O
cryosections O O
of O O
6 O O
μm O O
thickness O O
were O O
stained O O
with O O
rat O O
monoclonal O O
antibodies O O
directed O O
against O O
mouse O O
CD11b O O
-LRB- O O
Mac-1 O O
; O O
M O O
1/70 O O
-RRB- O O
or O O
CD4 O O
-LRB- O O
GK1.5 O O
-RRB- O O

-LRB- O O
both O O
antibodies O O
from O O
PharMingen O O
, O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
then B-conn Temporal.Precedence
incubated O O
with O O
biotinylated O O
secondary O O
antibodies O O
-LRB- O O
DAKO O O
A/S O O
, O O
Gosulp O O
, O O
Denmark O O
-RRB- O O
and O O
avidin-biotin-peroxidase O O
complexes O O
-LRB- O O
ABC O O
-RRB- O O
. O O

All O O
sections O O
were O O
counterstained O O
with O O
Mayer O O
's O O
hematoxylin O O
. O O

Murine O O
splenocyte O O
suspension O O
-LRB- O O
cell O O
density O O
2 O O
× O O
106/ml O O
-RRB- O O
in O O
Iscove O O
's O O
medium O O
supplemented O O
with O O
10 O O
% O O
fetal O O
calf O O
serum O O
-LRB- O O
FCS O O
-RRB- O O
, O O
2 O O
nM O O
L-glutamine O O
, O O
mercaptoethanol O O
and O O
50 O O
μg/ml O O
gentamicin O O
was O O
stimulated O O
with O O
rTF O O
at O O
a O O
final O O
concentration O O
of O O
0.1–10 O O
μg/ml O O
. O O

At O O
defined O O
time O O
points O O
, O O
supernatants O O
were O O
collected O O
for B-conn Purpose.Goal
determination O O
of O O
cytokine O O
and O O
chemokine O O
levels O O
. O O

Proliferation O O
was O O
determined O O
by B-conn Purpose.Enablement
the O O
incorporation O O
of O O
-LSB-3H O O
-RSB- O O
-thymidine O O
-LRB- O O
specific O O
activity O O
, O O
42 O O
Ci/mmol O O
; O O
Amersham O O
International O O
, O O
Buckinghamshire O O
, O O
UK O O
-RRB- O O
into O O
splenocyte O O
suspension O O
-LRB- O O
cell O O
density O O
4 O O
× O O
105/ml O O
-RRB- O O
, O O
stimulated O O
for O O
72 O O
hours O O
with O O
either O O
rTF O O
or O O
LPS O O
at O O
a O O
final O O
concentration O O
of O O
0.1–10 O O
μg/ml O O
. O O

The O O
results O O
were O O
expressed O O
as O O
a O O
stimulation O O
index O O
-LRB- O O
counts O O
per O O
minute O O
, O O
mean O O
± O O
standard O O
deviation O O
-RRB- O O
. O O

The O O
level O O
of O O
interleukin O O
-LRB- O O
IL O O
-RRB- O O
-6 O O
in O O
the O O
rTF-stimulated O O
supernatants O O
was O O
determined O O
by O O
a O O
bioassay O O
measuring O O
the O O
effect O O
of O O
test O O
samples O O
on O O
the O O
growth O O
of O O
the O O
IL-6-dependent O O
cell O O
line O O
B13.29 O O
-LSB-19 O O
-RSB- O O
. O O

The O O
results O O
were O O
analyzed O O
by B-conn Purpose.Enablement
incorporation O O
of O O
-LSB-3H O O
-RSB- O O
-thymidine O O
after B-conn Temporal.Succession
72 O O
hours O O
stimulation O O
and O O
compared O O
to O O
results O O
with O O
the O O
standard O O
dilutions O O
of O O
recombinant O O
mouse O O
IL-6 O O
-LRB- O O
Genzyme O O
, O O
Cambridge O O
, O O
MA O O
, O O
USA O O
-RRB- O O
. O O

The O O
levels O O
of O O
macrophage O O
inflammatory O O
protein O O
-LRB- O O
MIP O O
-RRB- O O
-1α O O
and O O
RANTES O O
-LRB- O O
regulated O O
on O O
activation O O
normal O O
T-cell O O
expressed O O
and O O
secreted O O
-RRB- O O
were O O
measured O O
by O O
an O O
enzyme-linked O O
immunosorbent O O
assay O O
using O O
Quantikine O O
M O O
kits O O
-LRB- O O
R&D O O
Systems O O
, O O
Minneapolis O O
, O O
MN O O
, O O
USA O O
-RRB- O O
and O O
expressed O O
in O O
pg/ml O O
. O O

The O O
differences O O
in O O
the O O
incidence O O
and O O
the O O
severity O O
of O O
arthritis O O
in O O
the O O
groups O O
were O O
analyzed O O
by O O
the O O
Fisher O O
's O O
test O O
and O O
Mann–Whitney O O
U O O
test O O
, O O
respectively O O
. O O

Results O O

The O O
ability O O
of O O
rTF O O
to O O
induce O O
arthritis O O
was O O
evaluated O O
by B-conn Purpose.Enablement
injection O O
of O O
rTF O O
in O O
the O O
doses O O
0.2 O O
, O O
2.0 O O
, O O
and O O
20 O O
μg O O
-LRB- O O
0.004 O O
, O O
0.04 O O
, O O
and O O
0.4 O O
nmol O O
-RRB- O O
into O O
the O O
knee O O
joint O O
of O O
NMRI O O
mice O O
. O O

Four B-conn Temporal.Succession
days I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
inoculation O O
, O O
morphological O O
signs O O
of O O
arthritis O O
-LRB- O O
synovial O O
tissue O O
hypertrophy O O
, O O
and O O
inflammatory O O
cell O O
infiltrates O O
-RRB- O O
were O O
found O O
in O O
33 O O
% O O
, O O
56 O O
% O O
and O O
83 O O
% O O
of O O
joints O O
, O O
respectively O O
. O O

Control O O
mice O O
injected O O
with O O
the O O
amount O O
of O O
LPS O O
equivalent O O
to O O
its O O
concentration O O
in O O
the O O
rTF O O
preparation O O
exhibited O O
arthritis O O
only O O
in O O
28 O O
% O O
of O O
cases O O
-LRB- O O
13/15 O O
versus O O
4/14 O O
; O O
P O O
< O O
0.01 O O
-RRB- O O
. O O

The O O
arthritis O O
index O O
of O O
the O O
rTF-induced O O
arthritis O O
was O O
significantly O O
higher O O
in O O
joints O O
injected O O
with O O
20 O O
μg O O
of O O
rTF O O
than O O
in O O
the O O
controls O O
-LRB- O O
1.73 O O
versus O O
0.23 O O
; O O
P O O
< O O
0.01 O O
-RRB- O O
. O O

Moreover B-conn Conjunction
, O O
6/13 O O
joints O O
injected O O
with O O
20 O O
μg O O
of O O
rTF O O
developed O O
extrasynovial O O
features O O
of O O
arthritis O O
-LRB- O O
pannus O O
formation O O
, O O
n O O
= O O
2 O O
; O O
cartilage O O
destruction O O
, O O
n O O
= O O
3 O O
and O O
periarticular O O
bone O O
destruction O O
, O O
n O O
= O O
1 O O
-RRB- O O
compared O O
to O O
only O O
one O O
in O O
the O O
control O O
group O O
. O O

In O O
all O O
further O O
experiments O O
the O O
dose O O
of O O
20 O O
μg O O
of O O
TF O O
per O O
knee O O
was O O
used O O
. O O

Dynamics O O
of O O
rTF-induced O O
arthritis O O
were O O
assessed O O
morphologically O O
on O O
days O O
4 O O
, O O
14 O O
and O O
60 O O
after O O
the O O
rTF O O
injection O O
. O O

The O O
highest O O
frequency O O
of O O
arthritis O O
and O O
severity O O
of O O
inflammation O O
was O O
observed O O
on O O
day O O
4 O O
after O O
injection O O
and B-conn Conjunction
it O O
diminished O O
significantly O O
by O O
days O O
14 O O
and O O
60 O O
-LRB- O O
13/15 O O
versus O O
2/8 O O
and O O
2/6 O O
, O O
P O O
< O O
0.05 O O
; O O
Fig. O O
1a O O
, O O
b O O
-RRB- O O
. O O

Notably O O
, O O
erosion O O
and/or O O
pannus O O
formation O O
were O O
always O O
found O O
in O O
cases O O
of O O
long O O
lasting O O
arthritis O O
but O O
in O O
none O O
of O O
the O O
controls O O
. O O

Sensitivity O O
to O O
rTF O O
varied O O
between O O
the O O
healthy O O
mouse O O
strains O O
. O O

Four B-conn Temporal.Succession
days I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
injection O O
of O O
rTF O O
-LRB- O O
20 O O
μg/knee O O
-RRB- O O
into O O
NMRI O O
-LRB- O O
n O O
= O O
15 O O
-RRB- O O
, O O
CB17 O O
-LRB- O O
n O O
= O O
8 O O
-RRB- O O
and O O
BALB/c O O
mice O O
-LRB- O O
n O O
= O O
8 O O
-RRB- O O
, O O
morphological O O
signs O O
of O O
arthritis O O
were O O
registered O O
in O O
80 O O
% O O
, O O
75 O O
% O O
and O O
50 O O
% O O
of O O
knee O O
joints O O
, O O
respectively O O
. O O

These O O
results O O
indicate O O
that O O
susceptibility O O
to O O
inflammatory O O
potential O O
of O O
rTF O O
is O O
dependent O O
on O O
genetic O O
background O O
of O O
the O O
host O O
. O O

Immunochemical O O
staining O O
of O O
joint O O
sections O O
revealed O O
dense O O
infiltrates O O
consisting O O
of O O
Mac-1+ O O
mononuclear O O
cells O O
in O O
the O O
synovial O O
tissue O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
all O O
the O O
sections O O
were O O
negative O O
for O O
staining O O
with O O
CD4-specific O O
antibodies O O
. O O

This O O
allowed O O
us O O
to O O
conclude O O
that O O
the O O
inflammatory O O
infiltrate O O
observed O O
after B-conn Temporal.Succession
the O O
injection O O
of O O
rTF O O
consisted O O
predominantly O O
of O O
macrophages O O
accompanied O O
by O O
few O O
if O O
any O O
neutrophils O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
evaluate O O
the O O
role O O
of O O
different O O
immune O O
cells O O
in O O
the O O
development O O
of O O
rTF-induced O O
inflammation O O
, O O
cell O O
depletion O O
procedures O O
were O O
performed O O
. O O

Mice O O
pretreated O O
with O O
lysing O O
antineutrophil O O
antibodies O O
showed O O
no O O
reduction O O
in O O
the O O
frequency O O
or O O
intensity O O
of O O
arthritis O O
compared O O
to O O
controls O O
that O O
received O O
antiovalbumin O O
antibodies O O
-LRB- O O
5/8 O O
versus O O
7/8 O O
, O O
respectively O O
-RRB- O O
. O O

Mice O O
injected O O
with O O
etoposide O O
, O O
and O O
thereby B-conn Cause.Result
deprived O O
of O O
monocyte/macrophage O O
cell O O
population O O
, O O
demonstrated O O
a O O
tendency O O
to O O
a O O
reduction O O
in O O
frequency O O
but O O
not O O
the O O
severity O O
of O O
arthritis O O
-LRB- O O
6/8 O O
versus O O
4/7 O O
; O O
not O O
significant O O
; O O
Fig. O O
3 O O
-RRB- O O
. O O

Intra-articular O O
injection O O
of O O
rTF O O
into O O
SCID O O
mice O O
deficient O O
for O O
T- O O
and O O
B-lymphocytes O O
revealed O O
no O O
difference O O
in O O
the O O
frequency O O
of O O
arthritis O O
compared O O
to O O
congenic O O
CB17 O O
mice O O
strain O O
-LRB- O O
11/15 O O
versus O O
12/15 O O
, O O
not O O
significant O O
-RRB- O O
. O O

The O O
results O O
of O O
experiments O O
indicated O O
that O O
isolated O O
depletion O O
of O O
neither O O
monocyte O O
nor O O
lymphocyte O O
cell O O
populations O O
was O O
enough O O
to O O
abolish O O
the O O
induction O O
of O O
rTF-induced O O
arthritis O O
. O O

To B-conn Purpose.Goal
test O O
if O O
a O O
combined O O
lymphocyte O O
and O O
monocyte O O
cell O O
depletion O O
was O O
efficient O O
in O O
prevention O O
of O O
rTF-induced O O
cell O O
infiltration O O
, O O
SCID O O
mice O O
treated O O
with O O
etoposide O O
were O O
intra-articularly O O
injected O O
with O O
rTF O O
. O O

Only O O
one O O
of O O
seven O O
mice O O
in O O
this O O
group O O
developed O O
arthritis O O
in B-conn Temporal.Succession
response I-conn Temporal.Succession
to I-conn Temporal.Succession
injection O O
of O O
rTF O O
, O O
demonstrating O O
that O O
interaction O O
between O O
macrophages O O
and O O
lymphocytes O O
is O O
essential O O
for O O
cellular O O
infiltration O O
of O O
synovium O O
following B-conn Temporal.Succession
rTF O O
injection O O
-LRB- O O
Fig. O O
3 O O
-RRB- O O
. O O

Systemic O O
depletion O O
of O O
fibrinogen O O
with O O
ancrod O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
rTF O O
injection O O
did O O
not O O
reduce O O
the O O
incidence O O
of O O
rTF-induced O O
arthritis O O
in O O
6/8 O O
NMRI O O
mice O O
. O O

Effects O O
of O O
rTF O O
on O O
lymphoid O O
cells O O
were O O
investigated O O
by B-conn Purpose.Enablement
incubating O O
mouse O O
splenocytes O O
with O O
rTF O O
-LRB- O O
0.1 O O
μg/ml O O
, O O
1 O O
μg/ml O O
, O O
5 O O
μg/ml O O
, O O
or O O
10 O O
μg/ml O O
-RRB- O O
. O O

Investigation O O
of O O
supernatants O O
after O O
48 O O
hours O O
of O O
stimulation O O
for O O
the O O
level O O
of O O
IL-6 O O
, O O
RANTES O O
, O O
and O O
MIP-1α O O
demonstrated O O
a O O
dose-dependent O O
increase O O
in O O
the O O
level O O
of O O
chemokines O O
. O O

The O O
increase O O
was O O
pronounced O O
for O O
MIP-1α O O
-LRB- O O
73 O O
± O O
33 O O
pg/ml O O
in O O
non-stimulated O O
cells O O
versus O O
139 O O
± O O
32 O O
pg/ml O O
after O O
stimulation O O
with O O
5 O O
μg/ml O O
of O O
rTF O O
; O O
n O O
= O O
3 O O
-RRB- O O
but O O
was O O
only O O
marginal O O
for O O
RANTES O O
-LRB- O O
256 O O
± O O
46 O O
pg/ml O O
versus O O
365 O O
± O O
32 O O
pg/ml O O
; O O
n O O
= O O
3 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
neither O O
change O O
in O O
the O O
level O O
of O O
IL-6 O O
nor O O
proliferation O O
of O O
lymphocytes O O
was O O
observed O O
. O O

Discussion O O

Inflammation O O
and O O
thrombosis O O
are O O
linked O O
in O O
many O O
clinical O O
conditions O O
. O O

It O O
is O O
presumed O O
that O O
proinflammatory O O
mediators O O
potentiate O O
activation O O
of O O
blood O O
coagulation O O
and O O
serine O O
proteases O O
of O O
the O O
coagulation O O
system O O
, O O
especially O O
the O O
terminal O O
enzyme O O
thrombin O O
, O O
known O O
for O O
proinflammatory O O
and O O
mitogenic/chemotactic O O
effects O O
both O O
in O O
circulation O O
and O O
locally O O
in O O
synovial O O
tissue O O
-LSB-20-22 O O
-RSB- O O
. O O

An O O
indication O O
of O O
the O O
importance O O
of O O
TF O O
in O O
the O O
inflammatory O O
process O O
was O O
obtained O O
in O O
the O O
animal O O
model O O
of O O
sepsis O O
, O O
in O O
which O O
TF-dependent O O
procoagulant O O
activity O O
correlated O O
with O O
the O O
level O O
of O O
tumor O O
necrosis O O
factor-α O O
-LSB-23 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
modulation O O
of O O
TF-dependent O O
coagulation O O
by B-conn Purpose.Enablement
administration O O
of O O
either O O
TF-pathway O O
inhibitor O O
or O O
anti-TF O O
antibodies O O
decreased O O
circulating O O
levels O O
of O O
IL-6 O O
and O O
IL-8 O O
-LSB-24,25 O O
-RSB- O O
, O O
and O O
diminished O O
proliferation O O
and O O
perivascular O O
cell O O
infiltration O O
-LSB-26,27 O O
-RSB- O O
. O O

This O O
study O O
shows O O
that O O
the O O
TF O O
molecule O O
possesses O O
strong O O
proinflammatory O O
properties O O
, O O
causing O O
arthritis O O
. O O

Histological O O
analysis O O
revealed O O
that O O
TF-induced O O
synovitis O O
could O O
be O O
attributed O O
mostly O O
to O O
infiltrating O O
macrophages O O
. O O

Mononuclear O O
cell O O
influx O O
into O O
synovia O O
is O O
an O O
early O O
finding O O
in O O
the O O
majority O O
of O O
asymptomatic O O
subjects O O
, O O
preceding O O
clinically O O
overt O O
arthritis O O
in O O
RA O O
-LSB-28,29 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
synovial O O
macrophage O O
infiltration O O
is O O
a O O
characteristic O O
feature O O
of O O
both O O
autoimmune O O
and O O
bacterial O O
arthritis O O
-LSB-30,31 O O
-RSB- O O
and O O
is O O
a O O
determinant O O
of O O
joint O O
erosions O O
-LSB-32,33 O O
-RSB- O O
. O O

Our O O
observation O O
, O O
in O O
combination O O
with O O
an O O
increased O O
TF-dependent O O
procoagulant O O
activity O O
in O O
blood O O
and O O
synovial O O
fluid O O
of O O
patients O O
with O O
RA O O
, O O
implies O O
participation O O
of O O
TF O O
in O O
triggering O O
the O O
initial O O
steps O O
of O O
inflammation O O
during O O
RA O O
and/or O O
in O O
rendering O O
the O O
inflammation O O
chronic O O
. O O

Composition O O
of O O
inflammatory O O
infiltrate O O
and O O
cell O O
depletion O O
studies O O
showed O O
that O O
TF O O
exerts O O
its O O
proinflammatory O O
properties O O
in O O
a O O
cell-specific O O
manner O O
targeting O O
the O O
macrophage/ O O
monocyte O O
population O O
. O O

This O O
is O O
not O O
surprising O O
taking O O
into O O
consideration O O
that O O
macrophages/monocytes O O
are O O
the O O
only O O
cells O O
in O O
the O O
blood O O
circulation O O
compartment O O
which O O
express O O
TF O O
on O O
their O O
surface O O
-LSB-8,34 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
we O O
demonstrated O O
that O O
an O O
interaction O O
between O O
monocytes O O
and O O
lymphocytes O O
was O O
a O O
prerequisite O O
of O O
the O O
TF-induced O O
arthritis O O
. O O

Activated O O
T O O
cells O O
were O O
able O O
to O O
induce O O
TF O O
production O O
by O O
stimulating O O
monocytes O O
through O O
CD40 O O
ligand O O
-LSB-35,36 O O
-RSB- O O
. O O

This O O
mechanism O O
may O O
contribute O O
to O O
a O O
positive O O
feedback O O
essential O O
for O O
maintenance O O
of O O
TF-induced O O
inflammation O O
. O O

Interestingly O O
, O O
neutrophils O O
, O O
other O O
principal O O
inflammatory O O
cells O O
, O O
were O O
not O O
sensitive O O
to O O
TF O O
stimulation O O
– O O
these O O
cells O O
were O O
neither O O
found O O
in O O
synovial O O
tissues O O
nor O O
affected O O
arthritis O O
frequency O O
in O O
the O O
depletion O O
experiments O O
. O O

Mononuclear O O
cells O O
composing O O
the O O
inflammatory O O
infiltrate O O
in O O
synovia O O
were O O
mostly O O
Mac-1+ O O
CD4- O O
cells O O
. O O

Abundant O O
expression O O
of O O
Mac-1 O O
molecule O O
on O O
the O O
monocyte O O
surface O O
indicates O O
a O O
principal O O
role O O
of O O
β2-integrins O O
in O O
cell O O
activation O O
following O O
exposure O O
to O O
TF O O
. O O

Two O O
methods O O
of O O
such O O
activation O O
may O O
be O O
considered O O
. O O

TF O O
may O O
attract O O
Mac-1+ O O
cells O O
indirectly O O
by B-conn Purpose.Enablement
increasing O O
formation O O
of O O
coagulation O O
proteins O O
known O O
as O O
Mac-1 O O
ligands O O
, O O
e.g. O O
. O O

Factor O O
X O O
and O O
fibrinogen O O
. O O

However B-conn Contrast
, O O
the O O
high O O
incidence O O
of O O
TF-induced O O
arthritis O O
in O O
defibrinated O O
mice O O
favors O O
a O O
direct O O
stimulatory O O
effect O O
of O O
TF O O
on O O
sensitive O O
cells O O
. O O

Treatment O O
of O O
macrophages O O
with O O
TF O O
in O O
vitro O O
has O O
been O O
shown O O
to O O
increase O O
the O O
expression O O
of O O
β2-chain-containing O O
adhesion O O
molecules O O
-LSB-37 O O
-RSB- O O
and O O
supports O O
the O O
idea O O
of O O
direct O O
TF-induced O O
Mac-1 O O
expression O O
. O O

Lack O O
of O O
CD4+ O O
cells O O
responsible O O
for O O
peptide O O
presentation O O
through O O
MHC O O
class O O
II O O
molecules O O
shows O O
that O O
this O O
mechanism O O
is O O
not O O
compulsory O O
for O O
TF-induced O O
synovial O O
infiltration O O
, O O
in O O
contrast O O
to O O
experimental O O
glomerulonephritis O O
where O O
simultaneous O O
expression O O
of O O
TF O O
and O O
MHC O O
class O O
II O O
molecules O O
was O O
observed O O
and O O
efficiently O O
blocked O O
by O O
anti-TF O O
antibodies O O
-LSB-38,39 O O
-RSB- O O
. O O

The O O
way O O
in O O
which O O
TF O O
interacts O O
with O O
macrophages O O
is O O
not O O
clear O O
. O O

Exposure O O
of O O
spleen O O
cell O O
cultures O O
to O O
TF O O
did O O
not O O
induce O O
the O O
release O O
of O O
proinflammatory O O
cytokines O O
. O O

These O O
results O O
favor O O
the O O
suggestion O O
that O O
TF O O
acts O O
directly O O
on O O
inflammatory O O
cells O O
and O O
not O O
by O O
a O O
cytokine-mediated O O
mechanism O O
. O O

TF-mediated O O
release O O
of O O
chemoattractant O O
molecules O O
, O O
which O O
recruit O O
inflammatory O O
cells O O
from O O
the O O
circulation O O
or O O
surrounding O O
tissues O O
, O O
is O O
an O O
alternative O O
possibility O O
. O O

We O O
found O O
that O O
in O O
vitro O O
splenocyte O O
stimulation O O
with O O
TF O O
was O O
associated O O
with O O
selective O O
release O O
of O O
the O O
monocyte O O
chemoattractant O O
molecule O O
MIP-1α O O
. O O

This O O
observation O O
may O O
explain O O
the O O
dominance O O
of O O
mononuclear O O
cells O O
in O O
the O O
synovial O O
inflammatory O O
infiltrates O O
of O O
the O O
joints O O
injected O O
with O O
TF O O
. O O

Altogether O O
our O O
observations O O
suggest O O
that O O
TF O O
may O O
play O O
an O O
active O O
role O O
during O O
arthritis O O
by B-conn Purpose.Enablement
direct O O
and/or O O
indirect O O
stimulation O O
of O O
influx O O
of O O
monocytes O O
into O O
the O O
synovial O O
tissue O O
. O O

Abbreviations O O

FCS O O
= O O
fetal O O
calf O O
serum O O
; O O
FVII O O
= O O
factor O O
VII O O
; O O
IL O O
= O O
interleukin O O
; O O
LPS O O
= O O
lipopolysaccharide O O
; O O
MIP O O
= O O
macrophage O O
inhibitory O O
protein O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
RANTES O O
= O O
regulated O O
on O O
activation O O
normal O O
T-cell O O
expressed O O
and O O
secreted O O
; O O
RTF O O
= O O
recombinant O O
TF O O
; O O
SCID O O
= O O
severe O O
combined O O
immunodeficient O O
; O O
TF O O
= O O
tissue O O
factor O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Measurements O O
of O O
arthritis O O
in O O
murine O O
knee O O
joints O O
. O O

-LRB- O O
a O O
-RRB- O O
Arthritis O O
index O O
and O O
-LRB- O O
b O O
-RRB- O O
incidence O O
of O O
arthritis O O
after O O
intra-articular O O
injection O O
of O O
TF O O
-LRB- O O
20 O O
μg/joint O O
-RRB- O O
as O O
evaluated O O
by O O
histological O O
examination O O
. O O

Arthritis O O
index O O
was O O
assessed O O
as O O
described O O
in O O
the O O
Materials O O
and O O
methods O O
section O O
. O O

Asterisks O O
indicate O O
significant O O
differences O O
of O O
the O O
means O O
between O O
the O O
mice O O
receiving O O
TF O O
and O O
the O O
controls O O
. O O

Figure O O
2 O O
: O O
Morphological O O
changes O O
in O O
the O O
joint O O
after O O
injection O O
of O O
TF O O
. O O
-LRB- O O
a O O
-RRB- O O
Histopathology O O
of O O
an O O
arthritic O O
knee O O
joint O O
four O O
days O O
after O O
injection O O
of O O
TF O O
-LRB- O O
20 O O
μg/joint O O
-RRB- O O
. O O

Infiltration O O
of O O
mononuclear O O
cells O O
in O O
synovial O O
tissue O O
is O O
apparent O O
. O O

Original O O
magnification O O
×20 O O
. O O

-LRB- O O
b O O
-RRB- O O
Immunohistochemical O O
staining O O
of O O
an O O
arthritic O O
knee O O
joint O O
, O O
showing O O
cells O O
expressing O O
Mac-1 O O
. O O

Original O O
magnification O O
×40 O O
. O O

JC O O
, O O
joint O O
cavity O O
; O O
C O O
, O O
cartilage O O
; O O
SH O O
, O O
synovial O O
hyperplasy O O
; O O
P O O
, O O
pannus O O
; O O
Er O O
, O O
bone O O
erosion O O
; O O
ST O O
, O O
synovial O O
tissue O O
. O O

Arrows O O
indicate O O
inflammatory O O
cells O O
in O O
synovia O O
, O O
pannus O O
formation O O
and O O
cartilage O O
destruction O O
. O O

Figure O O
3 O O
: O O
Lymphocytes O O
and O O
monocytes O O
are O O
mandatory O O
for O O
the O O
development O O
of O O
TF-induced O O
arthritis O O
. O O

Incidence O O
of O O
arthritis O O
was O O
assessed O O
in O O
mice O O
depleted O O
of O O
various O O
immune O O
cells O O
. O O

Significant O O
differences O O
of O O
incidence O O
of O O
arthritis O O
between O O
the O O
groups O O
are O O
indicated O O
. O O

Predictive O O
screening O O
for O O
regulators O O
of O O
conserved O O
functional O O
gene O O
modules O O
-LRB- O O
gene O O
batteries O O
-RRB- O O
in O O
mammals O O

Abstract O O

Background O O
: O O
The O O
expression O O
of O O
gene O O
batteries O O
, O O
genomic O O
units O O
of O O
functionally O O
linked O O
genes O O
which O O
are O O
activated O O
by O O
similar O O
sets O O
of O O
cis- O O
and O O
trans-acting O O
regulators O O
, O O
has O O
been O O
proposed O O
as O O
a O O
major O O
determinant O O
of O O
cell O O
specialization O O
in O O
metazoans O O
. O O

We O O
developed O O
a O O
predictive O O
procedure O O
to B-conn Purpose.Goal
screen O O
the O O
mouse O O
and O O
human O O
genomes O O
and O O
transcriptomes O O
for O O
cases O O
of O O
gene-battery-like O O
regulation O O
. O O

Results O O
: O O
In O O
a O O
screen O O
that O O
covered O O
~40 O O
per O O
cent O O
of O O
all O O
annotated O O
protein-coding O O
genes O O
, O O
we O O
identified O O
21 O O
co-expressed O O
gene O O
clusters O O
with O O
statistically O O
supported O O
sharing O O
of O O
cis-regulatory O O
sequence O O
elements O O
. O O

66 O O
predicted O O
cases O O
of O O
over-represented O O
transcription O O
factor O O
binding O O
motifs O O
were O O
validated O O
against O O
the O O
literature O O
and O O
fell O O
into O O
three O O
categories O O
: O O
-LRB- O O
i O O
-RRB- O O
previously O O
described O O
cases O O
of O O
gene O O
battery-like O O
regulation O O
, O O
-LRB- O O
ii O O
-RRB- O O
previously O O
unreported O O
cases O O
of O O
gene O O
battery-like O O
regulation O O
with O O
some O O
support O O
in O O
a O O
limited O O
number O O
of O O
genes O O
, O O
and O O
-LRB- O O
iii O O
-RRB- O O
predicted O O
cases O O
that O O
currently O O
lack O O
experimental O O
support O O
. O O

The O O
novel O O
predictions O O
include O O
for B-conn Instantiation
example I-conn Instantiation
Sox O O
17 O O
and O O
RFX O O
transcription O O
factor O O
binding O O
sites O O
that O O
were O O
detected O O
in O O
~10 O O
% O O
of O O
all O O
testis O O
specific O O
genes O O
, O O
and O O
HNF-1 O O
and O O
4 O O
binding O O
sites O O
that O O
were O O
detected O O
in O O
~30 O O
% O O
of O O
all O O
kidney O O
specific O O
genes O O
respectively O O
. O O

The O O
results O O
are O O
publicly O O
available O O
at O O
. O O

Conclusion O O
: O O
21 O O
co-expressed O O
gene O O
clusters O O
were O O
enriched O O
for O O
a O O
total O O
of O O
66 O O
shared O O
cis-regulatory O O
sequence O O
elements O O
. O O

A O O
majority O O
of O O
these O O
predictions O O
represent O O
novel O O
cases O O
of O O
potential O O
co-regulation O O
of O O
functionally O O
coupled O O
proteins O O
. O O

Critical O O
technical O O
parameters O O
were O O
evaluated O O
, O O
and B-conn Conjunction
the O O
results O O
and O O
the O O
methods O O
provide O O
a O O
valuable O O
resource O O
for O O
future O O
experimental O O
design O O
. O O

Background O O

To O O
understand O O
how O O
gene O O
expression O O
is O O
coordinated O O
to B-conn Purpose.Goal
produce O O
hundreds O O
of O O
cell O O
phenotypes O O
from O O
an O O
identical O O
complement O O
of O O
genes O O
is O O
a O O
principal O O
challenge O O
in O O
mammalian O O
genome O O
research O O
. O O

A O O
commonly O O
suggested O O
model O O
for O O
terminal O O
differentiation O O
in O O
metazoans O O
is O O
that O O
the O O
core O O
features O O
of O O
the O O
cellular O O
phenotype O O
are O O
mediated O O
by B-conn Purpose.Enablement
a O O
set O O
of O O
genes O O
that O O
is O O
regulated O O
as O O
a O O
gene O O
battery O O
, O O
i.e. B-conn Restatement.Specification
a O O
set O O
of O O
functionally O O
coupled O O
genes O O
that O O
are O O
activated O O
by O O
similar O O
cis- O O
and O O
trans-acting O O
regulators O O
-LSB-1-3 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
the O O
gene O O
battery O O
is O O
an O O
idealized O O
concept O O
, O O
concrete O O
examples O O
of O O
gene O O
battery-like O O
regulation O O
have O O
been O O
found O O
in O O
for B-conn Instantiation
example I-conn Instantiation
muscle O O
subtypes O O
-LSB-4-7 O O
-RSB- O O
, O O
megakaryocytes O O
-LSB-8 O O
-RSB- O O
, O O
the O O
epidermis O O
-LSB-9 O O
-RSB- O O
and O O
lymphocytes O O
-LSB-10,11 O O
-RSB- O O
. O O

A O O
key O O
step O O
in O O
the O O
elucidation O O
of O O
gene O O
battery-like O O
regulation O O
is O O
to O O
detect O O
and O O
functionally O O
test O O
the O O
cis O O
regulatory O O
elements O O
that O O
mediate O O
the O O
co-regulation O O
. O O

A O O
number O O
of O O
computation-based O O
methods O O
have O O
been O O
proposed O O
to B-conn Purpose.Goal
do O O
this O O
. O O

In O O
micro-organisms O O
, O O
computational O O
methods O O
have O O
proven O O
useful O O
to B-conn Purpose.Goal
detect O O
modules O O
of O O
co-regulated O O
genes O O
-LSB-12,13 O O
-RSB- O O
. O O

In O O
mammals O O
, O O
predictive O O
models O O
based O O
on O O
assumed O O
co-regulation O O
at O O
the O O
cis O O
level O O
have O O
been O O
constructed O O
for B-conn Purpose.Goal
liver- O O
and O O
skeletal O O
muscle-selective O O
gene O O
regulation O O
-LSB-14,15 O O
-RSB- O O
, O O
and B-conn Conjunction
general O O
tools O O
have O O
been O O
developed O O
for B-conn Purpose.Goal
the O O
regulatory O O
analysis O O
of O O
co-expressed O O
genes O O
-LSB-16-18 O O
-RSB- O O
. O O

The O O
aim O O
of O O
this O O
work O O
is O O
to O O
screen O O
the O O
mouse O O
and O O
human O O
genomes O O
and O O
transcriptomes O O
for O O
instances O O
where O O
sharing O O
of O O
cis-regulatory O O
sequences O O
is O O
statistically O O
coupled O O
to O O
conserved O O
co-expression O O
of O O
genes O O
, O O
i.e. B-conn Restatement.Specification
cases O O
that O O
fall O O
within O O
or O O
near O O
the O O
idealized O O
gene O O
battery O O
concept O O
. O O

Another O O
aim O O
is O O
to O O
critically O O
investigate O O
technical O O
parameters O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
maximize O O
the O O
sensitivity O O
by O O
which O O
co-regulation O O
of O O
co-expressed O O
genes O O
can O O
be O O
detected O O
. O O

In O O
a O O
screen O O
that O O
covered O O
~40 O O
per O O
cent O O
of O O
all O O
protein-coding O O
genes O O
according O O
to O O
the O O
latest O O
Ensembl O O
annotation O O
, O O
we O O
identified O O
21 O O
co-expressed O O
gene O O
clusters O O
with O O
66 O O
cases O O
of O O
statistically O O
supported O O
sharing O O
of O O
cis-regulatory O O
sequence O O
motifs O O
. O O

The O O
predictive O O
value O O
of O O
the O O
assignment O O
of O O
transcription O O
factor O O
binding O O
sites O O
was O O
experimentally O O
evaluated O O
on O O
EBF O O
binding O O
sites O O
in O O
a O O
set O O
of O O
B-cell O O
expressed O O
gene O O
clusters O O
. O O

The O O
predicted O O
cases O O
of O O
co-regulation O O
include O O
several O O
previously O O
known O O
prototype O O
examples O O
of O O
tissue O O
specific O O
regulation O O
, O O
but O O
also O O
novel O O
predictions O O
. O O

All O O
data O O
are O O
made O O
available O O
to O O
the O O
research O O
community O O
in O O
the O O
form O O
of O O
an O O
internet O O
resource O O
that O O
may O O
serve O O
as O O
a O O
starting O O
point O O
for O O
further O O
analysis O O
. O O

Results O O

The O O
analysis O O
was O O
based O O
on O O
the O O
assumption O O
that O O
homologous O O
genes O O
in O O
mouse O O
and O O
human O O
are O O
equivalent O O
in O O
most O O
aspects O O
of O O
regulation O O
and O O
function O O
. O O

In B-conn Restatement.Specification
particular I-conn Restatement.Specification
, O O
we O O
assumed O O
that O O
the O O
transcriptional O O
regulation O O
is O O
conserved O O
for O O
orthologous O O
genes O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
the O O
mouse O O
gene O O
Myh1 O O
and O O
the O O
human O O
gene O O
MYH1 O O
are O O
assumed O O
to O O
share O O
expression O O
pattern O O
and O O
to O O
share O O
important O O
cis-regulatory O O
sequences O O
. O O

Below O O
, O O
the O O
term O O
' O O
ortholog O O
pair O O
' O O
will O O
be O O
applied O O
as O O
a O O
two-species O O
equivalent O O
of O O
' O O
gene O O
' O O
, O O
for O O
which O O
expression O O
and O O
sequence O O
data O O
where O O
retrieved O O
for O O
both O O
mouse O O
and O O
human O O
. O O

Ensembl O O
gene O O
annotations O O
-LSB-19,20 O O
-RSB- O O
were O O
applied O O
thoughout O O
the O O
analysis O O
. O O

Previous O O
results O O
by O O
our O O
group O O
and O O
others O O
have O O
shown O O
that O O
statistical O O
analysis O O
of O O
gene O O
expression O O
profiles O O
in O O
a O O
large O O
compendium O O
of O O
expression O O
data O O
can O O
predict O O
targets O O
of O O
differentiation O O
processes O O
, O O
and O O
identify O O
functionally O O
coupled O O
genes O O
-LSB-12,21,22 O O
-RSB- O O
. O O

In O O
the O O
following O O
analysis O O
, O O
we O O
specifically B-conn Restatement.Specification
focused O O
on O O
a O O
compendium O O
derived O O
from O O
the O O
recently O O
completed O O
Novartis O O
expression O O
atlas O O
-LRB- O O
SymAtlas O O
-RRB- O O
-LSB-23 O O
-RSB- O O
. O O

These O O
data O O
contain O O
transcription O O
profiles O O
for O O
140 O O
mouse O O
and O O
human O O
tissues O O
generated O O
by B-conn Purpose.Enablement
hybridization O O
on O O
customized O O
Affymetrix O O
chips O O
, O O
and O O
cover O O
a O O
large O O
fraction O O
of O O
the O O
mouse O O
and O O
human O O
protein-coding O O
genes O O
. O O

Sequence O O
annotation O O
of O O
the O O
Novartis O O
probes O O
linked O O
the O O
mouse O O
and O O
human O O
data O O
to O O
approximately O O
17.000 O O
unique O O
Ensembl O O
gene O O
identities O O
in O O
each O O
species O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

Between O O
the O O
two O O
datasets O O
, O O
13282 O O
non-redundant O O
ortholog O O
pairs O O
could O O
be O O
identified O O
by B-conn Purpose.Enablement
linkage O O
of O O
reciprocal O O
Ensembl O O
homology O O
assignments O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

In O O
later O O
steps O O
, O O
we O O
excluded O O
genes O O
for O O
which O O
regulatory O O
sequence O O
could O O
not O O
be O O
extracted O O
-LRB- O O
Methods O O
-RRB- O O
, O O
leaving O O
9561 O O
ortholog O O
pairs O O
for O O
clustering O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

The O O
final O O
dataset O O
included O O
~40 O O
% O O
of O O
the O O
mouse O O
and O O
human O O
Ensembl O O
annotated O O
genes O O
. O O

We O O
clustered O O
the O O
mouse/human O O
ortholog O O
pairs O O
based O O
on O O
their O O
expression O O
profiles O O
across O O
the O O
140 O O
mouse O O
and O O
human O O
tissues O O
-LRB- O O
Methods O O
-RRB- O O
. O O

We O O
computed O O
clusters O O
at O O
cut-off O O
levels O O
ranging O O
from O O
Pearson O O
's O O
correlation O O
coefficient O O
-LRB- O O
hereafter O O
termed O O
PCC O O
-RRB- O O
0.61 O O
to O O
0.99 O O
. O O

At O O
the O O
lowest O O
applied O O
cut-off O O
, O O
57 O O
% O O
of O O
all O O
ortholog O O
pairs O O
in O O
the O O
data O O
were O O
members O O
of O O
a O O
cluster O O
. O O

The O O
cluster O O
sizes O O
were O O
distributed O O
in O O
a O O
skewed O O
manner O O
, O O
with O O
a O O
predominant O O
formation O O
of O O
small O O
clusters O O
-LRB- O O
Figure O O
1A O O
-RRB- O O
. O O

All O O
analyses O O
hereafter B-conn Temporal.Precedence
were O O
performed O O
at O O
a O O
PCC O O
= O O
0.75 O O
cut-off O O
, O O
which O O
generated O O
160 O O
clusters O O
with O O
2407 O O
ortholog O O
pairs O O
. O O

This O O
relatively O O
stringent O O
cut-off O O
was O O
chosen O O
to B-conn Purpose.Goal
reduce O O
the O O
number O O
of O O
non-relevant O O
genes O O
in O O
the O O
clusters O O
. O O

A O O
higher O O
cut-off O O
did O O
not O O
seem O O
reasonable O O
given O O
the O O
noise-level O O
of O O
the O O
microarray O O
experiments O O
-LRB- O O
as O O
judged O O
by O O
the O O
Pearson O O
correlation O O
between O O
replicated O O
samples O O
and O O
between O O
probes O O
that O O
are O O
annotated O O
for O O
the O O
same O O
gene O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

According O O
to O O
the O O
definition O O
, O O
a O O
gene O O
battery O O
should O O
encode O O
functionally O O
linked O O
proteins O O
. O O

We O O
used O O
Gene O O
Ontology O O
-LRB- O O
GO O O
-RRB- O O
terms O O
, O O
protein-protein O O
interactions O O
-LRB- O O
from O O
the O O
BIND O O
database O O
-LSB-24 O O
-RSB- O O
-RRB- O O
, O O
and O O
manual O O
curation O O
to B-conn Purpose.Goal
assess O O
functional O O
linkage O O
within O O
our O O
expression O O
clusters O O
. O O

First O O
, O O
we O O
investigated O O
the O O
relationship O O
between O O
expression O O
profile O O
similarity O O
of O O
two O O
ortholog O O
pairs O O
and O O
their O O
relative O O
probability O O
to O O
share O O
a O O
functional O O
annotation O O
term O O
or O O
to O O
encode O O
interacting O O
proteins O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
. O O

There O O
was O O
a O O
consistent O O
correlation O O
between O O
co-expression O O
and O O
the O O
relative O O
probability O O
for O O
two O O
genes O O
to O O
share O O
a O O
GO-term O O
or O O
to O O
encode O O
interacting O O
proteins O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
. O O

Second O O
, O O
we O O
studied O O
the O O
statistical O O
over-representation O O
of O O
GO O O
terms O O
and O O
interacting O O
proteins O O
inside O O
the O O
clusters O O
-LRB- O O
Methods O O
-RRB- O O
. O O

30/32 O O
clusters O O
with O O
ten O O
or O O
more O O
ortholog O O
pairs O O
contained O O
at O O
least O O
one O O
over-represented O O
GO O O
term O O
. O O

The O O
proportion O O
of O O
small O O
clusters O O
with O O
over-represented O O
GO O O
terms O O
was O O
lower O O
, O O
which O O
reflects O O
a O O
lack O O
of O O
statistical O O
power O O
in O O
small O O
clusters O O
. O O

Genes O O
encoding O O
interacting O O
protein O O
pairs O O
were O O
also B-conn Conjunction
over-represented O O
inside O O
clusters O O
. O O

35 O O
cases O O
of O O
protein-protein O O
interaction O O
between O O
two O O
genes O O
in O O
the O O
same O O
cluster O O
were O O
found O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
1000 O O
simulations O O
on O O
permuted O O
data O O
revealed O O
a O O
median O O
of O O
9 O O
interactions O O
-LRB- O O
observations O O
ranging O O
between O O
5 O O
and O O
21 O O
-RRB- O O
. O O

The O O
BIND O O
data O O
contained O O
only O O
600 O O
interactions O O
that O O
could O O
be O O
mapped O O
to O O
the O O
dataset O O
, O O
which O O
explains O O
the O O
seemingly O O
low O O
number O O
of O O
35 O O
interactions O O
. O O

Finally O O
, O O
the O O
clusters O O
were O O
annotated O O
by B-conn Purpose.Enablement
manual O O
curation O O
. O O

Six O O
examples O O
are O O
shown O O
in O O
Figures O O
2 O O
, O O
3 O O
, O O
4 O O
, O O
5 O O
, O O
6 O O
, O O
7 O O
, O O
and O O
clusters O O
with O O
predicted O O
regulators O O
are O O
listed O O
in O O
Table O O
2 O O
. O O

For O O
a O O
full O O
overview O O
, O O
see O O
the O O
web O O
supplement O O
. O O

Several O O
clusters O O
clearly O O
represent O O
gene O O
sets O O
that O O
mediate O O
specialized O O
features O O
of O O
different O O
cell O O
types O O
, O O
including O O
smooth O O
muscle O O
specific O O
genes O O
-LRB- O O
cluster O O
40 O O
, O O
Figure O O
2 O O
-RRB- O O
, O O
B O O
lymphocyte-specific O O
genes O O
-LRB- O O
cluster O O
16 O O
, O O
Figure O O
3 O O
-RRB- O O
, O O
and O O
genes O O
selectively O O
expressed O O
in O O
the O O
testis O O
-LRB- O O
cluster O O
5 O O
, O O
part O O
shown O O
in O O
Figure O O
4 O O
-RRB- O O
. O O

Further B-conn Conjunction
, O O
we O O
detected O O
clusters O O
that O O
were O O
related O O
to O O
cellular O O
processes O O
or O O
organelles O O
, O O
including O O
endoplasmatic O O
reticulum O O
-LRB- O O
cluster O O
13 O O
, O O
Figure O O
5 O O
-RRB- O O
, O O
protein O O
synthesis O O
-LRB- O O
cluster O O
1 O O
, O O
Figure O O
6 O O
-RRB- O O
, O O
and O O
modulators O O
of O O
transcriptional O O
regulation O O
-LRB- O O
cluster O O
65 O O
, O O
Figure O O
7 O O
-RRB- O O
. O O

A O O
grand O O
majority O O
of O O
the O O
clusters O O
were O O
defined O O
by B-conn Purpose.Enablement
peaks O O
at O O
different O O
amplitudes O O
in O O
several O O
tissues O O
. O O

As B-conn Instantiation
an I-conn Instantiation
example I-conn Instantiation
, O O
the O O
endoplasmatic O O
reticulum O O
cluster O O
-LRB- O O
Figure O O
5 O O
-RRB- O O
was O O
defined O O
by B-conn Purpose.Enablement
a O O
highly O O
variant O O
profile O O
with O O
strong O O
expression O O
in O O
, O O
for B-conn Instantiation
example I-conn Instantiation
, O O
exocrine O O
glands O O
. O O

Generally O O
, O O
the O O
cluster O O
profiles O O
were O O
conserved O O
between O O
species O O
, O O
in O O
the O O
sense O O
that O O
clusters O O
were O O
defined O O
by B-conn Purpose.Enablement
peaks O O
in O O
the O O
same O O
organs O O
. O O

This O O
effect O O
was O O
more O O
pronounced O O
for O O
clusters O O
with O O
expression O O
in O O
a O O
single O O
organ O O
, O O
such O O
as O O
the O O
testis O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
combination O O
, O O
the O O
GO O O
term O O
enrichment O O
, O O
the O O
protein-protein O O
interaction O O
, O O
and O O
the O O
manual O O
curation O O
convincingly O O
show O O
that O O
clustered O O
genes O O
are O O
functionally O O
linked O O
. O O

In O O
the O O
next O O
part O O
of O O
the O O
analysis O O
, O O
individual O O
ortholog O O
pairs O O
were O O
scored O O
for O O
transcription O O
factor O O
binding O O
sites O O
. O O

Binding O O
motifs O O
were O O
represented O O
in O O
the O O
form O O
of O O
Position O O
Frequency O O
Matrices O O
-LRB- O O
hereafter O O
denoted O O
PFMs O O
-RRB- O O
. O O

Based O O
on O O
a O O
fixed O O
amount O O
of O O
upstream O O
DNA O O
sequence O O
in O O
each O O
ortholog O O
pair O O
, O O
a O O
statistical O O
score O O
was O O
computed O O
to B-conn Purpose.Goal
predict O O
the O O
potential O O
for O O
a O O
site O O
in O O
the O O
sequence O O
to O O
bind O O
the O O
factor O O
corresponding O O
to O O
a O O
PFM O O
-LRB- O O
described O O
in O O
detail O O
in O O
Methods O O
-RRB- O O
. O O

We O O
extracted O O
upstream O O
+ O O
intronic O O
sequence O O
from O O
the O O
Ensembl O O
database O O
, O O
in O O
amounts O O
of O O
2 O O
, O O
6 O O
or O O
15 O O
kb O O
per O O
gene O O
-LRB- O O
see O O
Methods O O
for O O
details O O
on O O
boundaries O O
-RRB- O O
. O O

A O O
filter O O
was O O
applied O O
that O O
removed O O
ortholog O O
pairs O O
for O O
which O O
the O O
transcription O O
start O O
differed O O
between O O
the O O
two O O
species O O
-LRB- O O
>1000 O O
bp O O
difference O O
, O O
see O O
Methods O O
-RRB- O O
. O O

Filtering O O
was O O
successful O O
for O O
12239 O O
unique O O
ortholog O O
pairs O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

In O O
a O O
subsequent O O
filter O O
, O O
DNA O O
sequence O O
that O O
was O O
not O O
conserved O O
between O O
mouse O O
and O O
human O O
was O O
removed O O
, O O
so-called O O
phylogenetic O O
footprinting O O
. O O

Phylogenetic O O
footprinting O O
was O O
applied O O
at O O
different O O
stringency O O
, O O
to B-conn Purpose.Goal
allow O O
the O O
following O O
optimization O O
of O O
the O O
protocol O O
-LRB- O O
below O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
all O O
exon O O
sequence O O
was O O
removed O O
from O O
the O O
analysis O O
-LRB- O O
Methods O O
-RRB- O O
. O O

Finally B-conn Temporal.Precedence
, O O
the O O
sequences O O
were O O
matched O O
with O O
the O O
expression O O
data O O
based O O
on O O
annotation O O
, O O
the O O
overlap O O
being O O
9561 O O
ortholog O O
pairs O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

322 O O
vertebrate O O
PFMs O O
were O O
downloaded O O
from O O
the O O
TRANSFAC O O
and O O
JASPAR O O
databases O O
-LSB-25,26 O O
-RSB- O O
. O O

Since B-conn Cause.Reason
the O O
databases O O
appeared O O
to O O
contain O O
redundant O O
or O O
equivalent O O
entries O O
, O O
highly O O
similar O O
PFMs O O
were O O
grouped O O
and O O
merged O O
using O O
single O O
linkage O O
hierarchical O O
clustering O O
and O O
a O O
PFM O O
distance O O
measure O O
defined O O
in O O
-LSB-27 O O
-RSB- O O
, O O
which O O
reduced O O
the O O
number O O
of O O
PFMs O O
from O O
322 O O
to O O
266 O O
-LRB- O O
Methods O O
-RRB- O O
. O O

This O O
step O O
reduced O O
the O O
redundancy O O
, O O
but O O
did O O
not O O
merge O O
all O O
identically O O
annotated O O
PFMs O O
-LRB- O O
see O O
for O O
example O O
the O O
redundant O O
serum O O
response O O
factor O O
-LRB- O O
SRF O O
-RRB- O O
PFMs O O
in O O
Table O O
2 O O
, O O
cluster O O
40 O O
-RRB- O O
. O O

After B-conn Temporal.Succession
the O O
retrieval O O
and O O
preprocessing O O
of O O
both O O
sequences O O
and O O
PFMs O O
, O O
all O O
individual O O
sequences O O
were O O
tested O O
for O O
PFM O O
matches O O
using O O
the O O
MAST O O
software O O
-LSB-28 O O
-RSB- O O
, O O
a O O
software O O
for O O
identifying O O
single O O
or O O
multiple O O
motifs O O
in O O
sequences O O
. O O

MAST O O
was O O
set O O
to O O
compute O O
one O O
p-value O O
for O O
each O O
PFM O O
with O O
respect O O
to O O
each O O
sequence O O
-LRB- O O
Methods O O
-RRB- O O
. O O

Based O O
on O O
the O O
p-values O O
obtained O O
from O O
the O O
MAST O O
software O O
, O O
a O O
composite O O
score O O
was O O
defined O O
as O O
the O O
product O O
of O O
the O O
p-value O O
in O O
the O O
mouse O O
and O O
human O O
sequences O O
of O O
an O O
ortholog O O
pair O O
-LRB- O O
Methods O O
-RRB- O O
. O O

A O O
composite O O
score O O
close O O
to O O
0 O O
indicates O O
that O O
both O O
the O O
mouse O O
and O O
human O O
promoter O O
sequence O O
in O O
the O O
ortholog O O
pair O O
contains O O
sequence O O
elements O O
that O O
are O O
in O O
very O O
good O O
agreement O O
with O O
a O O
certain O O
PFM O O
. O O

To B-conn Purpose.Goal
address O O
the O O
biological O O
validity O O
of O O
the O O
MAST O O
composite O O
scores O O
within O O
the O O
context O O
of O O
a O O
set O O
of O O
co-expressed O O
genes O O
, O O
we O O
screened O O
48 O O
ortholog O O
pairs O O
present O O
in O O
B-cell O O
expressed O O
clusters O O
for O O
individual O O
EBF O O
sites O O
. O O

In O O
all O O
, O O
24 O O
individual O O
EBF O O
sites O O
in O O
15 O O
different O O
ortholog O O
pairs O O
were O O
detected O O
-LRB- O O
supplementary O O
data O O
, O O
additional O O
file O O
1 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
test O O
the O O
functionality O O
-LRB- O O
in O O
terms O O
of O O
EBF O O
binding O O
-RRB- O O
of O O
these O O
sites O O
, O O
we O O
examined O O
the O O
potential O O
of O O
22 O O
basepair O O
duplex O O
oligo-nucleotides O O
spanning O O
the O O
presumed O O
sites O O
to O O
compete O O
for O O
protein O O
binding O O
in O O
Electrophoretic O O
Mobility O O
Shift O O
Assays O O
-LRB- O O
EMSA O O
: O O
s O O
-RRB- O O
. O O

EBF O O
binding O O
capacity O O
was O O
assayed O O
using O O
nuclear O O
extracts O O
from O O
the O O
pre-B O O
cell O O
line O O
40-EI O O
, O O
a O O
labelled O O
mouse O O
mb-1 O O
promoter O O
high O O
affinity O O
EBF O O
site O O
-LSB-29 O O
-RSB- O O
, O O
and O O
competitor O O
oligo-nucleotides O O
covering O O
the O O
new O O
potential O O
binding O O
sites O O
. O O

In O O
the O O
absence O O
of O O
competitor O O
oligo-nucleotide O O
, O O
a O O
prominent O O
DNA/protein O O
complex O O
-LRB- O O
mb-1/EBF O O
-RRB- O O
could O O
be O O
detected O O
whereas B-conn Contrast
this O O
complex O O
was O O
undetectable O O
after O O
the O O
addition O O
of O O
a O O
300 O O
fold O O
molar O O
excess O O
of O O
the O O
unlabeled O O
binding O O
site O O
-LRB- O O
mb-1 O O
-RRB- O O
. O O

The O O
identity O O
of O O
the O O
protein O O
and O O
the O O
specificity O O
of O O
the O O
binding O O
were O O
verified O O
by B-conn Purpose.Enablement
competition O O
with O O
a O O
point O O
mutated O O
mb-1/EBF O O
site O O
and O O
by O O
the O O
inclusion O O
of O O
an O O
EBF O O
specific O O
antibody O O
into O O
the O O
reaction O O
mixture O O
-LRB- O O
Figure O O
8B O O
-RRB- O O
. O O

The O O
point O O
mutated O O
EBF O O
binding O O
site O O
was O O
unable O O
to O O
abolish O O
complex O O
formation O O
even O O
in O O
a O O
1000-fold O O
molar O O
excess O O
-LRB- O O
Figure O O
8B O O
-RRB- O O
, O O
indicating O O
that O O
we O O
detect O O
specific O O
protein O O
DNA O O
interactions O O
with O O
this O O
experimental O O
set O O
up. O O
18 O O
out O O
of O O
the O O
24 O O
new O O
binding O O
sites O O
competed O O
for O O
complex O O
formation O O
when O O
added O O
in O O
a O O
300- O O
or O O
1000-fold O O
molar O O
excess O O
, O O
and O O
thus B-conn Cause.Result
have O O
the O O
ability O O
to O O
bind O O
EBF O O
in O O
vitro O O
-LRB- O O
Figure O O
8A O O
-RRB- O O
. O O

We O O
conclude O O
that O O
the O O
large O O
majority O O
of O O
binding O O
sites O O
were O O
able O O
to O O
functionally O O
interact O O
with O O
the O O
predicted O O
protein O O
, O O
and O O
that O O
the O O
composite O O
score O O
in O O
principle O O
detected O O
factor O O
binding O O
. O O

It O O
should O O
however B-conn Concession.Contra-expectation
be O O
emphasized O O
that O O
the O O
quality O O
of O O
predictions O O
is O O
dependent O O
on O O
the O O
quality O O
of O O
the O O
binding O O
site O O
descriptions O O
, O O
and B-conn Conjunction
the O O
result O O
does O O
not O O
necessarily O O
imply O O
that O O
other O O
predicted O O
factors O O
bind O O
. O O

To B-conn Purpose.Goal
test O O
whether O O
the O O
identified O O
clusters O O
represent O O
potential O O
gene O O
batteries O O
, O O
i.e. B-conn Restatement.Specification
contain O O
shared O O
cis-regulatory O O
elements O O
, O O
we O O
designed O O
a O O
procedure O O
to B-conn Purpose.Goal
detect O O
significant O O
over-representation O O
of O O
orthologs O O
that O O
match O O
a O O
PFM O O
inside O O
a O O
cluster O O
. O O

The O O
procedure O O
is O O
based O O
on O O
a O O
modification O O
of O O
Fisher O O
's O O
exact O O
test O O
, O O
which O O
tests O O
for O O
dependency O O
between O O
two O O
events O O
-LRB- O O
in O O
this O O
case O O
cluster O O
membership O O
vs O O
detection O O
of O O
a O O
motif O O
-RRB- O O
-LSB-30 O O
-RSB- O O
. O O

We O O
introduced O O
a O O
procedure O O
to B-conn Purpose.Goal
optimize O O
the O O
composite O O
score O O
thresholds O O
for O O
individual O O
PFMs O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
we O O
selected O O
the O O
threshold O O
that O O
gave O O
the O O
lowest O O
Fisher O O
test O O
p-value O O
in O O
any O O
one O O
cluster O O
. O O

This O O
was O O
based O O
on O O
the O O
assumption O O
that O O
non-random O O
distribution O O
of O O
detections O O
over O O
clusters O O
reflects O O
biological O O
function O O
, O O
as O O
has O O
been O O
proposed O O
in O O
-LSB-31 O O
-RSB- O O
. O O

The O O
Fisher O O
test O O
p-values O O
with O O
the O O
optimized O O
thresholds O O
are O O
hereafter O O
termed O O
p-scores O O
. O O

The O O
tests O O
of O O
multiple O O
detection O O
thresholds O O
, O O
multiple O O
clusters O O
and O O
266 O O
PFMs O O
led O O
to O O
a O O
need O O
to O O
compensate O O
for O O
mass O O
testing O O
. O O

This O O
was O O
done O O
by B-conn Purpose.Enablement
estimating O O
false O O
discovery O O
rates O O
-LRB- O O
FDR O O
-RRB- O O
based O O
on O O
simulations O O
on O O
randomized O O
data O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
we O O
compared O O
the O O
outcome O O
when O O
using O O
permuted O O
and O O
when O O
using O O
observed O O
data O O
at O O
different O O
p-scores O O
, O O
and O O
defined O O
the O O
FDR O O
as O O
the O O
ratio O O
between O O
the O O
two O O
-LRB- O O
Figure O O
9A O O
-RRB- O O
. O O

This O O
procedure O O
allowed O O
us O O
to O O
choose O O
a O O
significance O O
threshold O O
with O O
a O O
controlled O O
expected O O
number O O
of O O
spurious O O
detections O O
. O O

Simulations O O
were O O
repeated O O
100 O O
times O O
. O O

Since B-conn Cause.Reason
optimization O O
of O O
detection O O
thresholds O O
were O O
repeated O O
in O O
each O O
simulation O O
round O O
, O O
no O O
bias O O
in O O
disfavour O O
of O O
the O O
control O O
case O O
was O O
introduced O O
. O O

Using O O
the O O
described O O
algorithm O O
, O O
we O O
analyzed O O
the O O
number O O
of O O
times O O
a O O
motif O O
was O O
over-represented O O
when O O
using O O
different O O
amounts O O
of O O
DNA O O
sequence O O
per O O
gene O O
-LRB- O O
2 O O
, O O
6 O O
or O O
15 O O
kb O O
-RRB- O O
and O O
different O O
stringency O O
in O O
the O O
phylogenetic O O
footprinting O O
-LRB- O O
>0 O O
% O O
-LRB- O O
keep O O
all O O
sequence O O
-RRB- O O
, O O
>60 O O
% O O
, O O
>70 O O
% O O
, O O
>80 O O
% O O
or O O
>90 O O
% O O
identity O O
-RRB- O O
. O O

The O O
analysis O O
was O O
performed O O
at O O
10 O O
% O O
false O O
discovery O O
rate O O
and O O
with O O
the O O
clustering O O
obtained O O
at O O
PCC O O
= O O
0.75 O O
clustering O O
cut-off O O
. O O

At O O
all O O
DNA O O
amounts O O
, O O
higher O O
stringency O O
phylogenetic O O
footprinting O O
appeared O O
to O O
be O O
beneficial O O
, O O
and O O
between O O
DNA O O
amounts O O
, O O
2 O O
kb O O
and O O
4 O O
kb O O
compared O O
favourably O O
over O O
15 O O
kb O O
-LRB- O O
Figure O O
9C O O
-RRB- O O
. O O

We O O
conclude O O
that O O
optimal O O
results O O
are O O
obtained O O
when O O
using O O
a O O
limited O O
amount O O
of O O
sequence O O
per O O
gene O O
-LRB- O O
see O O
Discussion O O
-RRB- O O
. O O

A O O
potential O O
confounding O O
factor O O
in O O
the O O
analysis O O
is O O
that O O
similarity O O
in O O
upstream O O
sequence O O
may O O
be O O
attributable O O
to O O
factors O O
other O O
than O O
shared O O
cis-regulatory O O
elements O O
. O O

The O O
most O O
important O O
such O O
factor O O
is O O
likely O O
to O O
be O O
gene O O
paralogy O O
, O O
since B-conn Cause.Reason
over-represented O O
motifs O O
might O O
simply O O
represent O O
matches O O
to O O
non-functional O O
-LRB- O O
not O O
yet O O
diverged O O
-RRB- O O
sequence O O
in O O
a O O
co-expressed O O
gene O O
family O O
. O O

In O O
total O O
, O O
22343 O O
cases O O
of O O
pairwise O O
paralogy O O
were O O
detected O O
in O O
the O O
dataset O O
of O O
9561 O O
ortholog O O
pairs O O
using O O
BLAST O O
. O O

All O O
genes O O
with O O
transcripts O O
matches O O
at O O
a O O
BLAST O O
E-value O O
less O O
than O O
1.0 O O
were O O
defined O O
as O O
potential O O
paralogs O O
. O O

Of O O
the O O
2407 O O
ortholog O O
pairs O O
that O O
clustered O O
, O O
219 O O
genes O O
had O O
a O O
paralog O O
inside O O
the O O
same O O
cluster O O
. O O

This O O
was O O
clearly O O
an O O
over-representation O O
since B-conn Cause.Reason
filling O O
clusters O O
with O O
random O O
genes O O
from O O
the O O
dataset O O
produced O O
an O O
average O O
of O O
122 O O
genes O O
with O O
a O O
paralog O O
inside O O
a O O
cluster O O
-LRB- O O
values O O
between O O
104 O O
to O O
131 O O
observed O O
in O O
10 O O
randomization O O
rounds O O
-RRB- O O
. O O

In O O
a O O
side-by-side O O
comparison O O
, O O
we O O
therefore B-conn Cause.Result
analyzed O O
the O O
effect O O
of O O
removing O O
paralogs O O
from O O
a O O
cluster O O
before B-conn Temporal.Precedence
testing O O
for O O
over-represented O O
motifs O O
-LRB- O O
see O O
Methods O O
-RRB- O O
, O O
as O O
opposed O O
to O O
not O O
removing O O
paralogs O O
but O O
the O O
same O O
number O O
of O O
randomly O O
selected O O
genes O O
. O O

The O O
results O O
showed O O
no O O
increase O O
in O O
the O O
number O O
of O O
over-represented O O
motifs O O
when O O
allowing O O
paralogs O O
in O O
the O O
same O O
cluster O O
-LRB- O O
Figure O O
9B O O
-RRB- O O
. O O

The O O
final O O
analysis O O
was O O
performed O O
with O O
2 O O
kb O O
sequence O O
and O O
80 O O
% O O
phylogenetic O O
footprinting O O
-LRB- O O
results O O
generated O O
with O O
variations O O
of O O
these O O
parameters O O
are O O
found O O
in O O
the O O
web O O
supplement O O
-RRB- O O
. O O

Again O O
, O O
the O O
clustering O O
generated O O
at O O
PCC O O
= O O
0.75 O O
was O O
chosen O O
for O O
analysis O O
. O O

The O O
over-representation O O
algorithm O O
was O O
run O O
in O O
the O O
above O O
cases O O
, O O
using O O
100 O O
simulations O O
to B-conn Purpose.Goal
estimate O O
false O O
discovery O O
rate O O
thresholds O O
. O O

Over-represented O O
motifs O O
with O O
FDR O O
: O O
s O O
less O O
than O O
2.5 O O
% O O
and O O
10 O O
% O O
were O O
recorded O O
. O O

Key O O
features O O
of O O
these O O
results O O
are O O
presented O O
in O O
Tables O O
2 O O
and O O
3 O O
, O O
and O O
the O O
complete O O
results O O
are O O
available O O
by O O
web O O
browser O O
. O O

A O O
predictive O O
screen O O
performed O O
with O O
these O O
settings O O
associated O O
66 O O
motifs O O
to O O
co-expression O O
in O O
a O O
total O O
of O O
21 O O
clusters O O
at O O
FDR O O
thresholds O O
2.5 O O
% O O
and O O
10 O O
% O O
-LRB- O O
Table O O
2 O O
-RRB- O O
. O O

There O O
was O O
a O O
clear O O
tendency O O
for O O
motifs O O
to O O
be O O
detected O O
in O O
most O O
large O O
clusters O O
, O O
and O O
for O O
smaller O O
clusters O O
to O O
lack O O
over-represented O O
motifs O O
. O O

This O O
can O O
be O O
directly O O
explained O O
by O O
the O O
fact O O
that O O
even O O
a O O
high O O
degree O O
of O O
motif O O
presence O O
in O O
a O O
small O O
cluster O O
can O O
be O O
attributed O O
to O O
spurious O O
detections O O
, O O
and O O
that O O
the O O
Fisher O O
test O O
accounts O O
for O O
that O O
. O O

The O O
over-represented O O
motifs O O
were O O
validated O O
against O O
the O O
literature O O
, O O
and O O
fell O O
into O O
three O O
main O O
categories O O
: O O
1 O O
-RRB- O O
previously O O
described O O
cases O O
of O O
gene-battery-like O O
regulation O O
, O O
2 O O
-RRB- O O
previously O O
unreported O O
cases O O
of O O
gene O O
battery-like O O
regulation O O
with O O
some O O
support O O
in O O
a O O
limited O O
number O O
of O O
genes O O
, O O
and O O
3 O O
-RRB- O O
hypothetical O O
cases O O
of O O
gene O O
battery O O
regulation O O
-LRB- O O
Table O O
3 O O
, O O
Discussion O O
-RRB- O O
. O O

In O O
the O O
typical O O
case O O
, O O
an O O
over-represented O O
motif O O
did O O
not O O
cover O O
all O O
cluster O O
members O O
but O O
rather B-conn Alternative.Chosen alternative
a O O
fraction O O
. O O

The O O
average O O
coverage O O
was O O
15 O O
% O O
, O O
with O O
observations O O
ranging O O
from O O
1 O O
% O O
to O O
100 O O
% O O
. O O

The O O
limited O O
coverage O O
can O O
be O O
exemplified O O
by B-conn Purpose.Enablement
the O O
relatively O O
large O O
-LRB- O O
104 O O
ortholog O O
pairs O O
-RRB- O O
cluster O O
of O O
liver-selective O O
genes O O
, O O
which O O
contained O O
8 O O
over-represented O O
motifs O O
at O O
FDR<10 O O
% O O
, O O
where O O
the O O
PFM O O
annotation O O
implied O O
HNF1 O O
, O O
HNF4 O O
, O O
ARP1 O O
, O O
PPAR-γ O O
, O O
and O O
COUP-TF O O
as O O
the O O
binding O O
factors O O
-LRB- O O
Table O O
2 O O
-RRB- O O
. O O

These O O
different O O
motifs O O
were O O
detected O O
in O O
between O O
8 O O
and O O
19 O O
ortholog O O
pairs O O
, O O
indicating O O
a O O
cluster O O
coverage O O
of O O
less O O
than O O
20 O O
% O O
. O O

An O O
example O O
of O O
very O O
high O O
coverage O O
was O O
observed O O
in O O
the O O
cluster O O
that O O
contained O O
smooth O O
muscle O O
differentiation O O
markers O O
, O O
in O O
which O O
6/7 O O
-LRB- O O
86 O O
% O O
-RRB- O O
ortholog O O
pairs O O
were O O
positive O O
for O O
a O O
Serum O O
Response O O
Factor O O
-LRB- O O
SRF O O
-RRB- O O
motif O O
. O O

We O O
compared O O
our O O
results O O
for O O
HNF-1 O O
to O O
a O O
whole-genome O O
experimental O O
screen O O
for O O
targets O O
of O O
this O O
factor O O
in O O
hepatocytes O O
-LSB-32 O O
-RSB- O O
. O O

28 O O
% O O
-LRB- O O
29/104 O O
-RRB- O O
of O O
the O O
ortholog O O
pairs O O
inside O O
the O O
liver O O
cluster O O
contained O O
experimentally O O
verified O O
HNF-1 O O
sites O O
, O O
which O O
indicates O O
a O O
high O O
but O O
not O O
complete O O
coverage O O
. O O

Cross-comparison O O
of O O
experimentally O O
and O O
computationally O O
identified O O
HNF-1 O O
targets O O
showed O O
a O O
69 O O
% O O
– O O
71 O O
% O O
agreement O O
-LRB- O O
results O O
for O O
the O O
two O O
different O O
HNF-1 O O
PFMs O O
at O O
2 O O
kb/gene O O
masked O O
for O O
90 O O
% O O
phylogenetic O O
conservation O O
-RRB- O O
. O O

As O O
a O O
complement O O
to O O
using O O
database O O
motifs O O
, O O
we O O
applied O O
de O O
novo O O
motif O O
elicitation O O
to B-conn Purpose.Goal
screen O O
the O O
regulatory O O
sequence O O
of O O
each O O
cluster O O
for O O
over-represented O O
DNA O O
motifs O O
that O O
were O O
not O O
present O O
in O O
databases O O
. O O

A O O
two-step O O
procedure O O
based O O
on O O
the O O
MEME O O
algorithm O O
-LSB-33 O O
-RSB- O O
was O O
developed O O
-LRB- O O
Methods O O
-RRB- O O
. O O

The O O
use O O
of O O
a O O
cluster O O
to B-conn Purpose.Goal
define O O
a O O
PFM O O
will O O
lead O O
to O O
a O O
bias O O
when O O
testing O O
for O O
over-representation O O
. O O

A O O
simulation O O
that O O
involved O O
motif O O
elicitation O O
from O O
randomized O O
clusters O O
was O O
used O O
to B-conn Purpose.Goal
account O O
for O O
this O O
bias O O
-LRB- O O
Methods O O
-RRB- O O
. O O

28 O O
de O O
novo O O
motifs O O
were O O
identified O O
as O O
over-represented O O
in O O
relation O O
to O O
the O O
null O O
simulation O O
-LRB- O O
Supplementary O O
data O O
, O O
additional O O
file O O
1 O O
-RRB- O O
. O O

Of O O
these O O
28 O O
motifs O O
, O O
13 O O
matched O O
a O O
described O O
database O O
motif O O
-LRB- O O
based O O
on O O
the O O
PFM O O
similarity O O
score O O
described O O
in O O
Methods O O
and O O
in O O
footnote O O
of O O
supplementary O O
table O O
-RRB- O O
. O O

9/13 O O
of O O
the O O
matching O O
motifs O O
corresponded O O
to O O
motifs O O
that O O
were O O
over-represented O O
in O O
Table O O
3 O O
. O O

The O O
remaining O O
15 O O
motifs O O
may O O
represent O O
novel O O
regulatory O O
elements O O
. O O

These O O
motifs O O
, O O
and O O
a O O
description O O
of O O
the O O
procedure O O
, O O
are O O
available O O
in O O
the O O
supplementary O O
information O O
. O O

Discussion O O

The O O
gene O O
battery O O
theory O O
predicts O O
that O O
the O O
core O O
features O O
of O O
differentiated O O
cells O O
are O O
encoded O O
by B-conn Purpose.Enablement
gene O O
batteries O O
, O O
i.e. B-conn Restatement.Specification
groups O O
of O O
functionally O O
coupled O O
, O O
co-expressed O O
genes O O
that O O
are O O
regulated O O
by B-conn Purpose.Enablement
similar O O
sets O O
of O O
cis-regulatory O O
elements O O
. O O

The O O
primary O O
aim O O
of O O
this O O
article O O
was O O
to O O
survey O O
the O O
mouse O O
and O O
human O O
genomes O O
for O O
cases O O
that O O
fall O O
within O O
or O O
close O O
to O O
the O O
idealized O O
gene O O
battery O O
concept O O
. O O

Hierarchical O O
clustering O O
of O O
an O O
extensive O O
compendium O O
of O O
micro-array O O
expression O O
data O O
in O O
mouse O O
and O O
human O O
identified O O
large O O
numbers O O
of O O
co-expressed O O
gene O O
groups O O
. O O

A O O
grand O O
majority O O
of O O
the O O
larger O O
clusters O O
were O O
significantly O O
enriched O O
for O O
genes O O
that O O
shared O O
one O O
or O O
several O O
GO-terms O O
, O O
indicating O O
that O O
co-expressed O O
genes O O
are O O
functionally O O
coupled O O
. O O

Moreover B-conn Conjunction
, O O
interactions O O
were O O
significantly O O
more O O
common O O
between O O
proteins O O
that O O
are O O
encoded O O
by B-conn Purpose.Enablement
clustered O O
pairs O O
compared O O
to O O
randomly O O
chosen O O
pairs O O
. O O

21 O O
clusters O O
, O O
finally B-conn Temporal.Precedence
, O O
were O O
significantly O O
enriched O O
for O O
genes O O
that O O
shared O O
potential O O
cis-regulatory O O
elements O O

The O O
predicted O O
over O O
represented O O
motifs O O
-LRB- O O
Table O O
2 O O
-RRB- O O
fell O O
into O O
three O O
principal O O
categories O O
: O O
-LRB- O O
i O O
-RRB- O O
predictions O O
in O O
agreement O O
with O O
described O O
gene O O
batteries O O
, O O
-LRB- O O
ii O O
-RRB- O O
predictions O O
supported O O
by O O
a O O
limited O O
number O O
of O O
observations O O
, O O
where O O
the O O
analysis O O
predicted O O
gene O O
battery-like O O
regulation O O
, O O
and O O
-LRB- O O
iii O O
-RRB- O O
novel O O
predictions O O
of O O
hypothetical O O
gene O O
batteries O O
. O O

The O O
findings O O
are O O
summarized O O
with O O
respect O O
to O O
these O O
categories O O
in O O
Table O O
3 O O
. O O

For O O
type O O
-LRB- O O
i O O
-RRB- O O
predictions O O
the O O
method O O
is O O
useful O O
for B-conn Purpose.Goal
proposing O O
new O O
target O O
genes O O
. O O

As B-conn Instantiation
an I-conn Instantiation
example I-conn Instantiation
, O O
the O O
smooth O O
muscle O O
cluster O O
contains O O
4 O O
validated O O
serum O O
response O O
factor O O
-LRB- O O
SRF O O
-RRB- O O
targets O O
-LRB- O O
Acta2 O O
, O O
Actg2 O O
, O O
Myl11 O O
, O O
Tagln O O
-RRB- O O
-LSB-5 O O
-RSB- O O
. O O

The O O
method O O
identifies O O
two O O
more O O
genes O O
in O O
this O O
cluster O O
, O O
Myl9 O O
and O O
Lpp O O
as O O
potential O O
SRF O O
targets O O
in O O
smooth O O
muscle O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

The O O
findings O O
in O O
two O O
clusters O O
that O O
are O O
relevant O O
for O O
lymphocytes O O
-LRB- O O
cluster O O
4 O O
in O O
the O O
web O O
supplement O O
-RRB- O O
and O O
B-lymphocytes O O
-LRB- O O
cluster O O
16 O O
, O O
Figure O O
3 O O
-RRB- O O
are O O
further B-conn Conjunction
examples O O
of O O
type O O
-LRB- O O
i O O
-RRB- O O
predictions O O
. O O

Cluster O O
4 O O
contains O O
genes O O
that O O
are O O
expressed O O
by B-conn Purpose.Enablement
various O O
lymphocyte O O
populations O O
. O O

Significantly O O
enriched O O
motifs O O
were O O
Irf1/Irf2 O O
, O O
NF-kappaB O O
, O O
and O O
ISRE O O
. O O

Irf1 O O
and O O
Ir2 O O
appear O O
to O O
bind O O
the O O
same O O
sites O O
-LSB-34 O O
-RSB- O O
. O O

Irf1 O O
knockout O O
mice O O
are O O
impaired O O
in O O
their O O
myelopoiesis O O
-LSB-35 O O
-RSB- O O
. O O

NFkappaB O O
is O O
a O O
well-known O O
regulator O O
of O O
inflammation O O
and O O
immune O O
functions O O
-LSB-36 O O
-RSB- O O
. O O

Cluster O O
16 O O
contains O O
genes O O
that O O
are O O
specifically O O
expressed O O
in O O
B-lymphocytes O O
. O O

SpiB O O
was O O
identified O O
as O O
the O O
most O O
over-represented O O
PFM O O
followed O O
by O O
AREB6 O O
and O O
Oct-1 O O
. O O

Knockout O O
of O O
SpiB O O
caused O O
specific O O
defects O O
in O O
B-cell O O
terminally O O
differentiated O O
functions O O
-LSB-37 O O
-RSB- O O
. O O

AREB6 O O
is O O
a O O
hematopoietic O O
transcriptional O O
repressor O O
-LSB-38 O O
-RSB- O O
. O O

Whereas B-conn Contrast
Oct-1 O O
seems O O
to O O
be O O
dispensable O O
for O O
B-cell O O
development O O
-LSB-39 O O
-RSB- O O
, O O
it O O
regulates O O
B O O
lymphocyte O O
genes O O
in O O
combination O O
with O O
specific O O
co-activators O O
-LSB-40 O O
-RSB- O O
. O O

In O O
type O O
-LRB- O O
ii O O
-RRB- O O
cases O O
, O O
a O O
regulator O O
with O O
some O O
degree O O
of O O
documentation O O
is O O
statistically O O
supported O O
to B-conn Purpose.Goal
play O O
a O O
role O O
in O O
gene O O
battery-like O O
regulation O O
. O O

As B-conn Instantiation
an I-conn Instantiation
example I-conn Instantiation
, O O
RFX O O
family O O
proteins O O
have O O
been O O
shown O O
to O O
regulate O O
a O O
limited O O
number O O
of O O
genes O O
in O O
spermatogenesis O O
, O O
and B-conn Conjunction
SOX17 O O
has O O
been O O
shown O O
to O O
be O O
expressed O O
in O O
the O O
testis O O
-LSB-41-43 O O
-RSB- O O
. O O

Here O O
, O O
we O O
demonstrate O O
that O O
motifs O O
corresponding O O
to O O
these O O
factors O O
are O O
present O O
in O O
8–11 O O
% O O
of O O
testis-selective O O
genes O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

29 O O
% O O
of O O
kidney-specific O O
genes O O
were O O
covered O O
by O O
HNF-1 O O
and O O
HNF-4 O O
sites O O
, O O
suggesting O O
that O O
these O O
genes O O
may O O
be O O
general O O
regulators O O
in O O
the O O
kidney O O
. O O

Finally O O
, O O
type O O
-LRB- O O
iii O O
-RRB- O O
cases O O
represent O O
novel O O
predictions O O
which O O
can O O
be O O
viewed O O
as O O
testable O O
hypotheses O O
of O O
regulatory O O
mechanisms O O
. O O

A O O
complete O O
list O O
of O O
PFMs O O
in O O
the O O
different O O
categories O O
with O O
references O O
to O O
the O O
literature O O
is O O
presented O O
in O O
Table O O
3. O O
Examples O O
include O O
a O O
potential O O
functional O O
role O O
for O O
an O O
Ikaros-like O O
motif O O
in O O
retina-selective O O
genes O O
-LRB- O O
cluster O O
44 O O
in O O
the O O
web O O
supplementary O O
-RRB- O O
, O O
and O O
a O O
Pax O O
family O O
factor O O
acting O O
on O O
extracellular O O
matrix O O
genes O O
with O O
strong O O
expression O O
in O O
arteries O O
-LRB- O O
cluster O O
8 O O
in O O
the O O
web O O
supplementary O O
-RRB- O O
. O O

Interestingly O O
, O O
a O O
combination O O
of O O
Ets O O
family O O
factor O O
motifs O O
, O O
Nuclear O O
respiratory O O
factor O O
motifs O O
, O O
and O O
E2F O O
motifs O O
was O O
detected O O
in O O
several O O
clusters O O
of O O
a O O
housekeeping O O
character O O
-LRB- O O
Table O O
3 O O
-RRB- O O
. O O

The O O
gene O O
battery O O
concept O O
predicts O O
that O O
upstream O O
transcription O O
factors O O
coordinate O O
the O O
expression O O
of O O
target O O
genes O O
through B-conn Purpose.Enablement
binding O O
to O O
similar O O
cis-regulatory O O
elements O O
in O O
the O O
target O O
genes O O
. O O

In O O
a O O
recent O O
report O O
, O O
Alloco O O
and O O
co-workers O O
-LSB-44 O O
-RSB- O O
studied O O
the O O
relationship O O
between O O
co-expression O O
in O O
yeast O O
-LRB- O O
as O O
determined O O
by O O
correlation O O
in O O
a O O
set O O
of O O
610 O O
arrays O O
-RRB- O O
and O O
the O O
probability O O
of O O
sharing O O
a O O
transcription O O
factor O O
-LRB- O O
as O O
determined O O
by O O
experiments O O
-RRB- O O
. O O

In O O
their O O
experiments O O
, O O
an O O
expression O O
profile O O
correlation O O
of O O
0.85 O O
implied O O
a O O
probability O O
of O O
transcription O O
factor O O
sharing O O
of O O
>0.5 O O
. O O

The O O
incomplete O O
coverage O O
in O O
our O O
analysis O O
may O O
similarly B-conn Similarity
indicate O O
that O O
other O O
mechanisms O O
than O O
co-regulation O O
contribute O O
to O O
the O O
coordinated O O
expression O O
. O O

Importantly O O
, O O
it O O
is O O
technically O O
difficult O O
to O O
accurately O O
quantify O O
the O O
fraction O O
of O O
genes O O
in O O
a O O
cluster O O
that O O
respond O O
to O O
a O O
factor O O
. O O

The O O
presence O O
of O O
false O O
positive O O
gene O O
cluster O O
members O O
reduces O O
the O O
coverage O O
. O O

Uncertainty O O
in O O
the O O
motif O O
assignment O O
to O O
ortholog O O
pairs O O
may O O
also B-conn Conjunction
reduce O O
the O O
coverage O O
. O O

In O O
one O O
case O O
study O O
, O O
we O O
could O O
use O O
data O O
from O O
an O O
independent O O
experimental O O
screen O O
to B-conn Purpose.Goal
confirm O O
that O O
the O O
liver-selective O O
cluster O O
had O O
a O O
limited O O
coverage O O
of O O
HNF-1 O O
responders O O
-LRB- O O
results O O
-RRB- O O
. O O

Further O O
experiments O O
are O O
required O O
to B-conn Purpose.Goal
resolve O O
to O O
what O O
extent O O
the O O
lack O O
of O O
coverage O O
reflects O O
alternative O O
regulatory O O
mechanisms O O
or O O
technical O O
limitations O O
. O O

The O O
tissues O O
in O O
the O O
dataset O O
represent O O
samples O O
of O O
limited O O
morphological O O
resolution O O
at O O
a O O
fixed O O
time O O
point O O
. O O

As B-conn Cause.Result
a I-conn Cause.Result
consequence I-conn Cause.Result
, O O
co-expressed O O
gene O O
groups O O
that O O
are O O
active O O
under O O
specific O O
developmental O O
phases O O
, O O
under O O
specific O O
environmental O O
stresses O O
, O O
or O O
in O O
small O O
and O O
localized O O
anatomical O O
structures O O
are O O
likely O O
to O O
escape O O
detection O O
. O O

Moreover B-conn Conjunction
, O O
co-expressed O O
gene O O
groups O O
with O O
a O O
peak O O
in O O
one O O
tissue O O
only O O
are O O
unresolved O O
for O O
single O O
cell O O
types O O
. O O

Low O O
coverage O O
of O O
motifs O O
in O O
such O O
clusters O O
may O O
reflect O O
contaminating O O
genes O O
that O O
derive O O
from O O
another O O
cell O O
type O O
. O O

The O O
Affymetrix O O
technology O O
that O O
were O O
used O O
to B-conn Purpose.Goal
generate O O
the O O
expression O O
measurements O O
has O O
been O O
validated O O
and O O
match O O
results O O
obtained O O
with O O
tag O O
sampling O O
for O O
sufficiently O O
abundant O O
genes O O
-LSB-45,46 O O
-RSB- O O
. O O

Low O O
intensity O O
signals O O
did O O
not O O
correlate O O
well O O
, O O
indicating O O
that O O
such O O
genes O O
are O O
less O O
likely O O
to O O
form O O
clusters O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Cross O O
hybridization O O
between O O
related O O
genes O O
may O O
, O O
in O O
theory O O
, O O
contribute O O
to O O
correlating O O
expression O O
levels O O
. O O

We O O
can O O
exclude O O
that O O
clusters O O
primarily O O
form O O
as O O
a O O
result O O
of O O
cross-hybridization O O
, O O
since B-conn Cause.Reason
-LRB- O O
1 O O
-RRB- O O
members O O
of O O
well-characterized O O
gene O O
families O O
appear O O
in O O
different O O
-LRB- O O
the O O
expected O O
-RRB- O O
clusters O O
-LRB- O O
eg O O
smooth O O
muscle O O
and O O
cardiac O O
actins O O
-RRB- O O
and B-conn Conjunction
since B-conn Cause.Reason
-LRB- O O
2 O O
-RRB- O O
co-expressed O O
genes O O
tended O O
to O O
share O O
GO O O
terms O O
or O O
to O O
encode O O
interacting O O
proteins O O
to O O
a O O
higher O O
degree O O
than O O
they O O
tended O O
to O O
be O O
paralogs O O
-LRB- O O
supplementary O O
data O O
, O O
additional O O
file O O
1 O O
-RRB- O O
. O O

We O O
cannot O O
however B-conn Contrast
exclude O O
subtle O O
effects O O
related O O
to O O
cross-hybridization O O
, O O
since B-conn Cause.Reason
results O O
with O O
cDNA O O
microarrays O O
indicate O O
this O O
possibility O O
-LSB-47 O O
-RSB- O O
. O O

Transcription O O
factors O O
in O O
the O O
same O O
family O O
often O O
have O O
similar O O
DNA O O
binding O O
properties O O
and O O
bind O O
to O O
the O O
same O O
sites O O
on O O
target O O
genes O O
. O O

This O O
leads O O
to O O
an O O
ambiguity O O
in O O
the O O
interpretation O O
of O O
PFM O O
annotations O O
. O O

The O O
MEF2 O O
motif O O
, O O
is O O
for B-conn Instantiation
example I-conn Instantiation
a O O
receptor O O
for O O
the O O
mammalian O O
MEF2A O O
, O O
MEF2B O O
, O O
MEFC O O
and O O
MEFD O O
transcription O O
factors O O
-LSB-48 O O
-RSB- O O
. O O

Similarly B-conn Similarity
, O O
the O O
E2F O O
motif O O
is O O
a O O
receptor O O
for O O
a O O
family O O
of O O
9 O O
E2F O O
family O O
proteins O O
that O O
form O O
heterodimers O O
with O O
another O O
family O O
of O O
proteins O O
, O O
the O O
DP O O
proteins O O
, O O
in O O
a O O
way O O
that O O
affects O O
the O O
binding O O
affinity O O
-LSB-49 O O
-RSB- O O
. O O

Different O O
E2F O O
proteins O O
act O O
at O O
different O O
stages O O
in O O
the O O
cell O O
cycle O O
-LSB-50 O O
-RSB- O O
, O O
and B-conn Conjunction
this O O
is O O
not O O
captured O O
by B-conn Purpose.Enablement
our O O
method O O
. O O

One O O
additional O O
data O O
limitation O O
is O O
that O O
a O O
fraction O O
of O O
Ensembl O O
transcripts O O
may O O
lack O O
sequence O O
in O O
their O O
5 O O
' O O
ends O O
. O O

The O O
accuracy O O
of O O
our O O
transcription O O
starts O O
is O O
therefore B-conn Cause.Result
dependent O O
on O O
the O O
quality O O
of O O
the O O
Ensembl O O
transcript O O
database O O
. O O

Our O O
approach O O
is O O
technically O O
related O O
to O O
the O O
Toucan O O
and O O
ConFac O O
tools O O
-LSB-17,51 O O
-RSB- O O
. O O

Important O O
differences O O
and O O
extensions O O
are O O
the O O
introduction O O
of O O
a O O
composite O O
scoring O O
system O O
, O O
a O O
procedure O O
to O O
optimize O O
PFM O O
thresholds O O
, O O
and O O
the O O
use O O
of O O
simulation O O
at O O
the O O
level O O
of O O
the O O
whole O O
clustering O O
to B-conn Purpose.Goal
measure O O
significances O O
. O O

The O O
performance O O
of O O
the O O
method O O
was O O
not O O
affected O O
by B-conn Purpose.Enablement
the O O
removal O O
of O O
paralogous O O
genes O O
from O O
the O O
clusters O O
-LRB- O O
Figure O O
9B O O
-RRB- O O
, O O
and B-conn Conjunction
clustering O O
of O O
such O O
genes O O
is O O
clearly O O
not O O
a O O
significant O O
source O O
of O O
false O O
positive O O
motif O O
prediction O O
. O O

Consequently B-conn Cause.Result
, O O
we O O
decided O O
to O O
include O O
the O O
paralogs O O
in O O
the O O
final O O
analysis O O
since B-conn Cause.Reason
we O O
believe O O
that O O
co-expression O O
of O O
such O O
genes O O
may O O
be O O
a O O
result O O
of O O
shared O O
cis-regulatory O O
elements O O
. O O

We O O
further O O
evaluated O O
the O O
effects O O
of O O
using O O
different O O
DNA O O
amounts O O
in O O
the O O
analysis O O
. O O

In O O
principal O O
, O O
it O O
is O O
motivated O O
to O O
include O O
a O O
substantial O O
amount O O
of O O
DNA O O
sequence O O
per O O
gene O O
, O O
since O O
mammalian O O
enhancers O O
are O O
frequently O O
located O O
far O O
upstream O O
in O O
relation O O
to O O
the O O
transcription O O
start O O
, O O
or O O
downstream O O
in O O
intronic O O
DNA O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
benefits O O
of O O
including O O
as O O
much O O
sequence O O
as O O
possible O O
must O O
be O O
balanced O O
against O O
the O O
risk O O
of O O
introducing O O
vast O O
amounts O O
of O O
non-informative O O
sequence O O
into O O
the O O
analysis O O
. O O

The O O
evaluation O O
clearly O O
favoured O O
using O O
limited O O
amounts O O
of O O
DNA O O
, O O
and O O
high O O
stringency O O
phylogenetic O O
footprinting O O
-LRB- O O
Figure O O
9C O O
-RRB- O O
. O O

The O O
optimal O O
future O O
alternative O O
may O O
be O O
to O O
assemble O O
a O O
small O O
amount O O
of O O
DNA O O
from O O
a O O
large O O
area O O
of O O
the O O
genome O O
using O O
algorithms O O
that O O
sort O O
out O O
regulatory O O
DNA O O
regions O O
more O O
efficient O O
than O O
phylogenetic O O
footprinting O O
. O O

The O O
approach O O
presented O O
here O O
needs O O
to O O
be O O
extended O O
to B-conn Purpose.Goal
generate O O
more O O
complete O O
models O O
of O O
gene O O
battery O O
regulation O O
. O O

Modelling O O
of O O
cis-regulatory O O
element O O
combinations O O
and O O
the O O
relative O O
position O O
and O O
spacing O O
of O O
elements O O
are O O
examples O O
of O O
such O O
extensions O O
. O O

The O O
use O O
of O O
PCC O O
as O O
a O O
measure O O
of O O
co-expression O O
may O O
need O O
to O O
be O O
reconsidered O O
if O O
extending O O
the O O
approach O O
to O O
very O O
large O O
datasets O O
, O O
since B-conn Cause.Reason
this O O
measure O O
may O O
be O O
sensitive O O
to O O
noninformative O O
signals O O
in O O
a O O
majority O O
of O O
samples O O
. O O

Further B-conn Conjunction
, O O
the O O
expression O O
levels O O
of O O
potential O O
trans-regulators O O
and O O
co-factors O O
-LRB- O O
based O O
on O O
protein O O
interaction O O
networks O O
-RRB- O O
can O O
be O O
introduced O O
. O O

Most O O
likely O O
, O O
the O O
method O O
will O O
benefit O O
from O O
a O O
more O O
accurate O O
identification O O
of O O
regulatory O O
regions O O
-LRB- O O
Crawford-04 O O
-RRB- O O

Conclusion O O

We O O
screened O O
the O O
mouse O O
and O O
human O O
genomes O O
and O O
transcriptomes O O
for O O
instances O O
of O O
gene O O
battery-like O O
regulation O O
. O O

Comparative O O
clustering O O
was O O
highly O O
predictive O O
of O O
gene O O
function O O
and O O
protein O O
interaction O O
, O O
which O O
indicates O O
that O O
potential O O
gene O O
batteries O O
could O O
be O O
identified O O
this O O
way O O
. O O

Based O O
on O O
a O O
statistical O O
composite O O
score O O
for O O
motifs O O
in O O
ortholog O O
pairs O O
, O O
and O O
a O O
simulation O O
approach O O
to O O
determine O O
significance O O
levels O O
, O O
we O O
found O O
21 O O
instances O O
of O O
statistically O O
supported O O
gene O O
battery-like O O
regulation O O
that O O
were O O
conserved O O
between O O
mouse O O
and O O
human O O
. O O

These O O
included O O
known O O
cases O O
of O O
gene O O
battery O O
regulation O O
in O O
tissues O O
such O O
as O O
muscle O O
, O O
lymphocytes O O
, O O
erythrocytes O O
, O O
and O O
liver O O
. O O

A O O
second O O
category O O
of O O
predictions O O
included O O
regulators O O
with O O
some O O
degree O O
of O O
documentation O O
, O O
e.g. B-conn Instantiation
in O O
testis O O
, O O
kidney O O
, O O
and O O
endoplasmatic O O
reticulum O O
. O O

Finally B-conn Temporal.Precedence
, O O
new O O
candidate O O
gene O O
batteries O O
with O O
statistically O O
enriched O O
cis-regulatory O O
motifs O O
were O O
listed O O
. O O

The O O
results O O
of O O
this O O
investigation O O
emphasizes O O
the O O
need O O
to O O
study O O
differentiation O O
in O O
terms O O
of O O
larger O O
transcriptional O O
units O O
, O O
and O O
extends O O
the O O
methodology O O
for O O
doing O O
this O O
. O O

Methods O O

Target O O
sequences O O
for O O
the O O
Novartis O O
Gene O O
Atlas O O
V2 O O
mouse O O
and O O
human O O
expression O O
datasets O O
-LSB-23 O O
-RSB- O O
were O O
matched O O
against O O
the O O
Ensembl O O
-LSB-20 O O
-RSB- O O
collection O O
of O O
mouse O O
and O O
human O O
transcripts O O
using O O
BLAST O O
-LSB-52 O O
-RSB- O O
. O O

In O O
cases O O
where O O
the O O
E-value O O
exceeded O O
10-20 O O
, O O
the O O
BLAST O O
search O O
was O O
re-done O O
against O O
Ensembl O O
gene O O
sequences O O
. O O

If O O
there O O
was O O
no O O
match O O
below O O
10-20 O O
, O O
the O O
probe O O
set O O
was O O
excluded O O
from O O
further O O
analysis O O
. O O

The O O
resulting O O
datasets O O
covered O O
17552 O O
mouse O O
and O O
16929 O O
human O O
unique O O
Ensembl O O
genes O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

Mouse/human O O
orthologous O O
gene O O
pairs O O
were O O
formed O O
using O O
Ensembl O O
homology O O
maps O O
. O O

Redundant O O
occurrences O O
of O O
the O O
same O O
gene O O
in O O
more O O
than O O
one O O
ortholog O O
pair O O
were O O
avoided O O
according O O
to O O
the O O
following O O
procedure O O
: O O
the O O
Ensembl O O
human O O
orthologs O O
for O O
each O O
Ensembl O O
mouse O O
gene O O
were O O
identified O O
. O O

When O O
more O O
than O O
one O O
ortholog O O
was O O
assigned O O
to O O
a O O
mouse O O
gene O O
, O O
the O O
one O O
with O O
the O O
lowest O O
positional O O
disagreement O O
d O O
-LRB- O O
defined O O
below O O
-RRB- O O
was O O
chosen O O
. O O

The O O
procedure O O
was O O
repeated O O
for O O
all O O
Ensembl O O
human O O
genes O O
. O O

Reciprocally O O
matching O O
ortholog O O
pairs O O
were O O
identified O O
, O O
and O O
others O O
were O O
excluded O O
from O O
further O O
analysis O O
. O O

The O O
mouse O O
and O O
human O O
expression O O
profiles O O
of O O
each O O
ortholog O O
pair O O
were O O
normalized O O
with O O
respect O O
to O O
mean O O
and O O
standard O O
deviation O O
and O O
combined O O
into O O
a O O
single O O
larger O O
profile O O
, O O
finally B-conn Temporal.Precedence
yielding O O
an O O
expression O O
dataset O O
with O O
13282 O O
non-redundant O O
ortholog O O
pairs O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

For O O
each O O
ortholog O O
pair O O
, O O
mouse O O
and O O
human O O
candidate O O
regulatory O O
sequence O O
was O O
extracted O O
from O O
Ensembl O O
. O O

The O O
sequence O O
extraction O O
algorithm O O
starts O O
with O O
an O O
ortholog O O
pair O O
, O O
localizes O O
the O O
5 O O
' O O
end O O
of O O
the O O
transcript O O
in O O
the O O
genome O O
in O O
each O O
species O O
, O O
and O O
computes O O
a O O
value O O
that O O
measures O O
the O O
positional O O
disagreement O O
between O O
the O O
transcript O O
5 O O
' O O
ends O O
in O O
the O O
two O O
species O O
. O O

If O O
the O O
disagreement O O
is O O
too O O
large O O
, O O
the O O
ortholog O O
pair O O
is O O
excluded O O
from O O
the O O
analysis O O
. O O

Of O O
the O O
12239 O O
ortholog O O
pairs O O
in O O
the O O
expression O O
dataset O O
, O O
9561 O O
satisfied O O
this O O
criterion O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

A O O
full O O
description O O
of O O
the O O
sequence O O
extraction O O
procedure O O
is O O
available O O
in O O
the O O
online O O
supplement O O
. O O

Three O O
different O O
lengths O O
of O O
DNA O O
were O O
extracted O O
: O O
2 O O
kb O O
, O O
6 O O
kb O O
and O O
15 O O
kb O O
. O O

The O O
2 O O
kb O O
dataset O O
contained O O
nucleotide O O
positions O O
ranging O O
from O O
-2000 O O
to O O
-1 O O
relative O O
to O O
the O O
transcription O O
start O O
, O O
the O O
6 O O
kb O O
dataset O O
contained O O
positions O O
-4000 O O
to O O
+2000 O O
and O O
the O O
15 O O
k O O
dataset O O
contained O O
positions O O
-10000 O O
to O O
+5000 O O
. O O

The O O
sequence O O
datasets O O
were O O
subjected O O
to O O
phylogenetic O O
footprinting O O
, O O
i.e. B-conn Restatement.Specification
removal O O
of O O
poorly O O
conserved O O
sequence O O
. O O

The O O
mouse O O
and O O
human O O
sequences O O
of O O
each O O
ortholog O O
pair O O
were O O
aligned O O
by B-conn Purpose.Enablement
use O O
of O O
the O O
LAGAN O O
software O O
-LSB-53 O O
-RSB- O O
-LRB- O O
standard O O
settings O O
-RRB- O O
. O O

Similarity O O
was O O
defined O O
as O O
the O O
number O O
of O O
identical O O
nucleotides O O
in O O
a O O
20 O O
bp O O
window O O
. O O

Nucleotides O O
in O O
windows O O
with O O
similarity O O
below O O
the O O
threshold O O
were O O
removed O O
. O O

In O O
all O O
, O O
five O O
different O O
similarity O O
threshold O O
were O O
applied O O
: O O
>0 O O
% O O
-LRB- O O
no O O
footprinting O O
– O O
use O O
all O O
sequence O O
-RRB- O O
, O O
>60 O O
% O O
, O O
>70 O O
% O O
, O O
>80 O O
% O O
and O O
>90 O O
% O O
identity O O
. O O

Each O O
candidate O O
regulatory O O
sequence O O
was O O
aligned O O
to O O
the O O
corresponding O O
transcripts O O
-LRB- O O
pairwise O O
BLAST O O
, O O
e-value O O
threshold O O
0.01 O O
-RRB- O O
. O O

Nucleotides O O
aligning O O
with O O
one O O
or O O
more O O
transcripts O O
were O O
removed O O
. O O

The O O
set O O
of O O
9561 O O
orthologs O O
pairs O O
, O O
for O O
which O O
both O O
regulatory O O
sequence O O
and O O
expression O O
data O O
could O O
be O O
assembled O O
, O O
were O O
clustered O O
with O O
respect O O
to O O
expression O O
pattern O O
using O O
hierarchical O O
clustering O O
-LSB-54 O O
-RSB- O O
with O O
average O O
group O O
linkage O O
and O O
Pearson O O
's O O
correlation O O
coefficient O O
as O O
distance O O
measure O O
. O O

In O O
the O O
average O O
group O O
linkage O O
algorithm O O
, O O
cluster O O
distances O O
are O O
defined O O
as O O
the O O
distances O O
between O O
cluster O O
means O O
. O O

We O O
defined O O
the O O
cluster O O
mean O O
as O O
the O O
arithmetic O O
mean O O
of O O
all O O
cluster O O
members O O
. O O

Correlation O O
thresholds O O
between O O
0.61 O O
and O O
0.99 O O
were O O
applied O O
in O O
steps O O
of O O
0.01 O O
. O O

Motifs O O
represented O O
as O O
position O O
frequency O O
matrices O O
-LRB- O O
PFMs O O
-RRB- O O
were O O
downloaded O O
from O O
the O O
TRANSFAC O O
-LSB-55 O O
-RSB- O O
and O O
JASPAR O O
-LSB-25 O O
-RSB- O O
databases O O
. O O

Non-vertebrate O O
matrices O O
were O O
filtered O O
out O O
. O O

Highly O O
similar O O
matrices O O
were O O
grouped O O
and O O
merged O O
using O O
single O O
linkage O O
hierarchical O O
clustering O O
, O O
reducing O O
the O O
number O O
of O O
PFMs O O
from O O
322 O O
to O O
266 O O
. O O

Distances O O
between O O
matrices O O
were O O
calculated O O
using O O
a O O
probabilistic O O
method O O
-LSB-56 O O
-RSB- O O
. O O

Individual O O
positions O O
between O O
matrices O O
were O O
compared O O
using O O
the O O
chi O O
square O O
test O O
, O O
and B-conn Conjunction
p-values O O
for O O
all O O
overlapping O O
positions O O
were O O
combined O O
using O O
the O O
geometric O O
mean O O
. O O

Sense O O
and O O
antisense O O
of O O
motifs O O
were O O
compared O O
for O O
all O O
possible O O
frameshifts O O
with O O
at O O
least O O
75 O O
% O O
overlap O O
. O O

Clustered O O
motifs O O
-LRB- O O
score O O
> O O
0.5 O O
-RRB- O O
were O O
added O O
together O O
in O O
overlapping O O
positions O O
, O O
and B-conn Conjunction
flanking O O
positions O O
were O O
discarded O O
. O O

PFMs O O
were O O
transformed O O
into O O
position O O
weight O O
matrices O O
-LRB- O O
PWM O O
: O O
s O O
-RRB- O O
to B-conn Purpose.Goal
make O O
them O O
compatible O O
with O O
the O O
MAST O O
software O O
-LRB- O O
see O O
below O O
-RRB- O O
. O O

The O O
value O O
of O O
each O O
matrix O O
element O O
was O O
calculated O O
according O O
to O O
the O O
following O O
formula O O
: O O

where O O
n O O
is O O
the O O
raw O O
count O O
from O O
the O O
corresponding O O
position O O
in O O
the O O
PFM O O
, O O
N O O
is O O
the O O
the O O
number O O
of O O
observations O O
-LRB- O O
sum O O
of O O
each O O
position/column O O
in O O
the O O
PFM O O
-RRB- O O
, O O
and O O
are O O
pseudocounts O O
and O O
p O O
-LRB- O O
b O O
-RRB- O O
is O O
the O O
background O O
frequency O O
of O O
the O O
corresponding O O
nucleotide O O
. O O

For O O
each O O
ortholog O O
pair O O
, O O
both O O
mouse O O
and O O
human O O
regulatory O O
sequences O O
were O O
scored O O
for O O
all O O
motif O O
PWM O O
's O O
using O O
the O O
MAST O O
software O O
-LSB-57 O O
-RSB- O O
. O O

MAST O O
was O O
set O O
to O O
compute O O
whole-sequence O O
p-values O O
-LRB- O O
-seqp O O
setting O O
-RRB- O O
, O O
using O O
a O O
first O O
order O O
Markov O O
chain O O
background O O
. O O

The O O
Markov O O
chain O O
background O O
data O O
where O O
computed O O
from O O
unmasked O O
genomic O O
sequence O O
-4000 O O
upstream O O
to O O
+2000 O O
downstream O O
in O O
all O O
ortholog O O
pairs O O
. O O

The O O
p-values O O
reported O O
by O O
MAST O O
for O O
the O O
mouse O O
and O O
human O O
sequences O O
of O O
an O O
ortholog O O
pair O O
were O O
multiplied O O
for O O
each O O
PWM O O
. O O

The O O
result O O
was O O
treated O O
as O O
a O O
composite O O
score O O
that O O
reflects O O
the O O
overall O O
`` O O
signal O O
'' O O
for O O
a O O
certain O O
binding O O
site O O
in O O
the O O
regulatory O O
sequences O O
of O O
an O O
ortholog O O
pair O O
. O O

The O O
composite O O
score O O
is O O
a O O
product O O
of O O
two O O
p-values O O
but O O
should O O
not O O
be O O
interpreted O O
as O O
a O O
p-value O O
, O O
since B-conn Cause.Reason
the O O
mouse O O
and O O
human O O
sequences O O
are O O
highly O O
dependent O O
. O O

Clusters O O
were O O
evaluated O O
for O O
over-representation O O
of O O
GO O O
terms O O
using O O
Fisher O O
's O O
exact O O
test O O
-LSB-30 O O
-RSB- O O
. O O

Due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
large O O
number O O
of O O
tests O O
-LRB- O O
the O O
number O O
of O O
clusters O O
times O O
the O O
number O O
of O O
GO O O
terms O O
-RRB- O O
, O O
the O O
resulting O O
p-values O O
were O O
corrected O O
using O O
the O O
Bonferroni O O
method O O
-LSB-30 O O
-RSB- O O
. O O

The O O
test O O
was O O
applied O O
to O O
the O O
9561 O O
ortholog O O
pairs O O
with O O
both O O
sequence O O
and O O
expression O O
data O O
. O O

These O O
constituted O O
the O O
population O O
. O O

For O O
each O O
PWM O O
, O O
genes O O
with O O
MAST O O
composite O O
scores O O
below O O
a O O
threshold O O
were O O
defined O O
as O O
labeled O O
and O O
the O O
others O O
as O O
unlabeled O O
. O O

Further B-conn Conjunction
, O O
each O O
cluster O O
was O O
considered O O
as O O
a O O
sample O O
from O O
the O O
population O O
. O O

The O O
algorithm O O
is O O
briefly O O
sketched O O
here O O
and O O
is O O
available O O
in O O
detail O O
in O O
the O O
online O O
supplement O O
: O O

First O O
, O O
ortholog O O
pairs O O
were O O
permuted O O
across O O
the O O
dataset O O
, O O
making O O
each O O
cluster O O
a O O
random O O
selection O O
of O O
genes O O
. O O

Second B-conn Temporal.Precedence
, O O
an O O
optimal O O
composite O O
score O O
threshold O O
was O O
found O O
for O O
each O O
PWM O O
. O O

This O O
was O O
done O O
by B-conn Purpose.Enablement
computing O O
the O O
Fischer O O
test O O
p-value O O
for O O
over-representation O O
of O O
labeled O O
ortholog O O
pairs O O
for O O
all O O
clusters O O
k O O
at O O
a O O
range O O
of O O
detection O O
thresholds O O
ranging O O
from O O
10-8 O O
to O O
10-3 O O
in O O
stepwise O O
increases O O
by O O
a O O
factor O O
of O O
100.5 O O
. O O

The O O
threshold O O
chosen O O
for O O
each O O
PWM O O
was O O
the O O
one O O
that O O
gave O O
the O O
best O O
p-value O O
for O O
that O O
PWM O O
in O O
any O O
cluster O O
. O O

P-values O O
for O O
over-representation O O
of O O
all O O
motifs O O
in O O
all O O
clusters O O
were O O
finally B-conn Temporal.Precedence
calculated O O
using O O
the O O
optimized O O
thresholds O O
. O O

We O O
refer O O
to O O
this O O
statistic O O
as O O
the O O
p-score O O
. O O

This O O
whole O O
procedure O O
was O O
repeated O O
for O O
100 O O
iterations O O
, O O
which O O
resulted O O
in O O
empirical O O
estimates O O
of O O
how O O
many O O
over-represented O O
motifs O O
we O O
could O O
expect O O
below O O
a O O
certain O O
p-score O O
under O O
the O O
null O O
hypothesis O O
. O O

This O O
step O O
was O O
identical O O
to O O
step O O
1 O O
but O O
without O O
permutations O O
and O O
repetitions O O
. O O

After B-conn Temporal.Succession
the O O
simulation O O
, O O
we O O
defined O O
the O O
false O O
discovery O O
rate O O
-LRB- O O
FDR O O
-RRB- O O
at O O
p-score O O
p O O
as O O
the O O
expected O O
number O O
of O O
over-represented O O
motifs O O
in O O
the O O
null O O
simulation O O
, O O
divided O O
by O O
the O O
corresponding O O
value O O
in O O
the O O
observed O O
data O O
. O O

40-EI O O
and O O
230–238 O O
cells O O
were O O
grown O O
in O O
RPMI O O
medium O O
supplemented O O
with O O
10 O O
% O O
FCS O O
, O O
10 O O
mM O O
HEPES O O
, O O
2 O O
mM O O
pyruvate O O
, O O
50 O O
μM O O
2-mercaptoethanol O O
and O O
50 O O
μg O O
gentamicin O O
per O O
ml O O
-LRB- O O
complete O O
RPMI O O
media O O
-RRB- O O
. O O

STAT O O
activation O O
in O O
230–238 O O
cells O O
was O O
achieved O O
by B-conn Purpose.Enablement
5 O O
hours O O
of O O
incubation O O
with O O
0.5 O O
ng/ml O O
recombinant O O
mouse O O
interferon O O
gamma O O
-LRB- O O
Immunokontact O O
, O O
Germany O O
-RRB- O O
. O O

Nuclear O O
extracts O O
were O O
prepared O O
according O O
to O O
Schreiber O O
et O O
al. O O
-LSB-58 O O
-RSB- O O
. O O

DNA O O
probes O O
were O O
labelled O O
with O O
γ-LSB-32P O O
-RSB- O O
ATP O O
-LRB- O O
Amersham O O
Biosciences O O
, O O
UK O O
-RRB- O O
by B-conn Purpose.Enablement
incubation O O
with O O
T4 O O
polynucleotide O O
kinase O O
-LRB- O O
Roche O O
Diagnostics O O
, O O
Mannheim O O
, O O
Germany O O
-RRB- O O
, O O
and O O
purified O O
on O O
a O O
mini O O
Quick O O
Spin O O
Oligo O O
Column O O
-LRB- O O
Roche O O
Diagnostics O O
, O O
Sweden O O
-RRB- O O
. O O

Nuclear O O
extracts O O
were O O
incubated O O
with O O
labelled O O
probe O O
-LRB- O O
20,000 O O
cpm O O
, O O
3 O O
fmol O O
-RRB- O O
for O O
30 O O
min O O
at O O
room O O
temperature O O
in O O
binding O O
buffer O O
-LRB- O O
10 O O
mM O O
HEPES O O
-LSB-pH O O
7.9 O O
-RSB- O O
, O O
70 O O
mM O O
KCl O O
, O O
1 O O
mM O O
dithiothreitol O O
, O O
1 O O
mM O O
EDTA O O
, O O
2.5 O O
mM O O
MgCl2 O O
, O O
4 O O
% O O
Glycerol O O
-RRB- O O
with O O
0.75 O O
μg O O
Poly O O
-LRB- O O
dI/dC O O
-RRB- O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
, O O
UK O O
-RRB- O O
. O O

When B-conn Temporal.Synchronous
EBF-binding O O
was O O
investigated O O
, O O
1 O O
mM O O
ZnCl2 O O
was O O
supplemented O O
to O O
the O O
mixture O O
. O O

The O O
samples O O
were O O
separated O O
on O O
a O O
6 O O
% O O
polyacrylamide O O
TBE O O
gel O O
, O O
which O O
was O O
dried O O
and O O
subjected O O
to O O
autoradiography O O
. O O

In O O
the O O
supershift O O
experiments O O
-LRB- O O
Figure O O
8B O O
-RRB- O O
, O O
DNA O O
competitors O O
or O O
antibodies O O
-LRB- O O
anti-EBF O O
SC-15333 O O
, O O
anti-Actin O O
SC-1616 O O
, O O
Santa O O
Cruz O O
Biotech O O
-RRB- O O
were O O
added O O
10 B-conn Temporal.Precedence
min I-conn Temporal.Precedence
before I-conn Temporal.Precedence
the O O
addition O O
of O O
the O O
DNA O O
probe O O
. O O

To B-conn Purpose.Goal
visualize O O
the O O
super-shifted O O
complex O O
, O O
the O O
unbound O O
probe O O
was O O
run O O
out O O
of O O
the O O
gel O O
. O O

The O O
following O O
Oligonucleotides O O
were O O
used O O
for O O
EMSA O O
: O O
mb-1 O O
sense O O
: O O
5'-AGCCACCTCTCAGGGGAATTGTGG-3 O O
' O O
; O O
mb-1 O O
antisense O O
: O O
5'-CCACAATTCCCCTGAGAGGTGGCT-3 O O
' O O
; O O
mutated O O
mb-1sense O O
: O O
5'-AGCCACCTCTCAGCCGTTTTGTGG-3 O O
' O O
; O O
mutated O O
mb-1 O O
antisense O O
: O O
5'-CCACAAAACGGCTGAGAGGTGGCT-3 O O
' O O
; O O

List O O
of O O
abbreviations O O

EBF O O
Early O O
B O O
cell O O
factor O O

EMSA O O
Electrophoretic O O
Mobility O O
Shift O O
Assay O O

GO O O
term O O
Gene O O
Ontology O O
term O O

PCC O O
Pearson O O
's O O
correlation O O
coefficient O O

PFM O O
Position O O
frequency O O
matrix O O

PWM O O
Position O O
weight O O
matrix O O

Authors O O
' O O
contributions O O

The O O
overall O O
computational O O
strategy O O
applied O O
was O O
conceived O O
by B-conn Purpose.Enablement
SN O O
, O O
EL O O
and O O
PM O O
together O O
with O O
EK O O
, O O
PL O O
, O O
and O O
ON O O
. O O

SN O O
and O O
EL O O
performed O O
the O O
bulk O O
of O O
the O O
analysis O O
and B-conn Conjunction
the O O
manuscript O O
was O O
drafted O O
by O O
SN O O
, O O
EL O O
and O O
PL O O
with O O
contributions O O
from O O
all O O
authors O O
. O O

The O O
experimental O O
validation O O
of O O
EBF O O
sites O O
was O O
conceived O O
and O O
performed O O
by O O
RM O O
and O O
MS O O
. O O

The O O
de O O
novo O O
detection O O
of O O
motifs O O
was O O
conceived O O
and O O
performed O O
by O O
EK O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Cluster O O
statistics O O
A O O
: O O
Histogram O O
showing O O
the O O
log O O
number O O
of O O
clusters O O
as O O
a O O
function O O
of O O
log O O
cluster O O
size O O
, O O
based O O
on O O
the O O
clustering O O
at O O
Pearson O O
correlation O O
coefficient O O
0.75 O O
cut-off O O
. O O

Numbers O O
on O O
the O O
x O O
axis O O
denote O O
cluster O O
size O O
intervals O O
-LRB- O O
2 O O
-RRB- O O
, O O
-LRB- O O
3–4 O O
-RRB- O O
, O O
-LRB- O O
5–8 O O
-RRB- O O
, O O
-LRB- O O
9–16 O O
-RRB- O O
, O O
.. O O
. O O
B O O
: O O
Co-expression O O
as O O
a O O
predictor O O
for O O
shared O O
function O O
, O O
protein O O
interaction O O
and O O
paralogy O O
. O O

We O O
identified O O
all O O
gene O O
pairs O O
that O O
correlated O O
above O O
or O O
below O O
a O O
threshold O O
T O O
-LRB- O O
X-axis O O
-RRB- O O
. O O

We O O
measured O O
the O O
fraction O O
of O O
such O O
pairs O O
for O O
which O O
there O O
was O O
-LRB- O O
i O O
-RRB- O O
a O O
BIND O O
database O O
protein-protein O O
interaction O O
recorded O O
in O O
human O O
, O O
-LRB- O O
ii O O
-RRB- O O
at O O
least O O
one O O
shared O O
gene O O
ontology O O
term O O
, O O
and O O
-LRB- O O
iii O O
-RRB- O O
evidence O O
of O O
paralogy O O
. O O

We O O
then B-conn Temporal.Precedence
computed O O
the O O
relative O O
probability O O
for O O
genes O O
above O O
T O O
with O O
this O O
feature O O
, O O
compared O O
to O O
gene O O
pairs O O
below O O
T. O O
At O O
expression O O
correlation O O
0.80 O O
, O O
co-expression O O
was O O
associated O O
with O O
a O O
100-fold O O
relative O O
probability O O
for O O
genes O O
to O O
encode O O
protein O O
interactors O O
, O O
a O O
10-fold O O
probability O O
for O O
genes O O
to O O
share O O
functional O O
annotation O O
, O O
but O O
only O O
a O O
3-fold O O
probability O O
for O O
genes O O
to O O
be O O
paralogs O O
. O O

C O O
: O O
Fraction O O
of O O
clusters O O
with O O
at O O
least O O
one O O
over-represented O O
GO O O
term O O
-LRB- O O
Y O O
axis O O
-RRB- O O
, O O
as O O
a O O
function O O
of O O
cluster O O
size O O
-LRB- O O
X O O
axis O O
-RRB- O O
. O O

GO O O
term O O
over-representations O O
were O O
computed O O
at O O
a O O
10 O O
% O O
false O O
discovery O O
rate O O
. O O

Figure O O
2 O O
: O O
A O O
smooth O O
muscle O O
differentiation O O
battery O O
: O O
The O O
bar O O
chart O O
-LRB- O O
left O O
-RRB- O O
illustrates O O
the O O
average O O
expression O O
level O O
of O O
cluster O O
members O O
-LRB- O O
Y O O
axis O O
-RRB- O O
across O O
arbitrarily O O
ordered O O
tissues O O
-LRB- O O
X O O
axis O O
-RRB- O O
in O O
two O O
species O O
-LRB- O O
red O O
= O O
mouse O O
and O O
blue O O
= O O
human O O
-RRB- O O
. O O

Three O O
tables O O
list O O
over-represented O O
functional O O
terms O O
-LRB- O O
upper O O
small O O
table O O
-RRB- O O
, O O
over O O
represented O O
motifs O O
-LRB- O O
PFMs O O
-RRB- O O
-LRB- O O
middle O O
table O O
-RRB- O O
, O O
and O O
cluster O O
members O O
-LRB- O O
lower O O
table O O
-RRB- O O
. O O

Figure O O
3 O O
: O O
B-lymphocyte O O
differentiation O O
battery O O
: O O
Tables O O
and O O
charts O O
are O O
organized O O
as O O
in O O
figure O O
2 O O
. O O

Figure O O
4 O O
: O O
Testis O O
selective O O
battery O O
: O O
Over O O
representation O O
of O O
RFX O O
and O O
SOX17 O O
motifs O O
indicates O O
new O O
roles O O
for O O
these O O
factors O O
as O O
coordinators O O
of O O
testis O O
selective O O
gene O O
expression O O
. O O

Tables O O
and O O
charts O O
are O O
organized O O
as O O
in O O
figure O O
2 O O
. O O

Figure O O
5 O O
: O O
Endoplasmatic O O
reticulum O O
associated O O
genes O O
: O O
Over O O
representation O O
of O O
XBP-1 O O
, O O
NRF O O
and O O
RTS O O
motifs O O
suggest O O
novel O O
functions O O
for O O
NRF O O
and O O
ETS O O
family O O
factors O O
in O O
the O O
regulation O O
of O O
ER-related O O
genes O O
. O O

Tables O O
and O O
charts O O
are O O
organized O O
as O O
in O O
figure O O
2 O O
. O O

Figure O O
6 O O
: O O
Ribosomal O O
genes O O
: O O
Tables O O
and O O
charts O O
are O O
organized O O
as O O
in O O
figure O O
2 O O
. O O

Figure O O
7 O O
: O O
NF-kappaB O O
pathway O O
: O O
Over O O
representation O O
of O O
REL O O
and O O
NFkappaB O O
motifs O O
indicates O O
feed O O
back O O
signalling O O
. O O

Tables O O
and O O
charts O O
are O O
organized O O
as O O
in O O
figure O O
2 O O
. O O

Figure O O
8 O O
: O O
EMSA O O
validation O O
of O O
EBF O O
binding O O
sites O O
: O O
A O O
: O O
The O O
figure O O
displays O O
EMSAs O O
in O O
which O O
binding O O
of O O
EBF O O
to O O
a O O
mb-1 O O
promoter O O
EBF O O
site O O
is O O
competed O O
for O O
by B-conn Purpose.Enablement
the O O
inclusion O O
of O O
300 O O
or O O
1000-fold O O
molar O O
excess O O
of O O
unlabelled O O
oligonucleotides O O
that O O
correspond O O
to O O
the O O
predicted O O
motifs O O
. O O

The O O
name O O
of O O
the O O
gene O O
and O O
the O O
position O O
of O O
the O O
motif O O
is O O
given O O
in O O
the O O
figure O O
. O O

-LRB- O O
m O O
-RRB- O O
indicates O O
mouse O O
and O O
-LRB- O O
h O O
-RRB- O O
human O O
. O O

`` O O
EBF O O
'' O O
shows O O
the O O
position O O
of O O
the O O
DNA/protein O O
complex O O
, O O
and O O
`` O O
Probe O O
'' O O
indicates O O
the O O
position O O
of O O
free O O
DNA O O
. O O

See O O
supplementary O O
information O O
for O O
a O O
detailed O O
description O O
of O O
the O O
sites O O
. O O

B O O
: O O
The O O
mb-1 O O
promoter O O
EBF O O
site O O
interacts O O
specifically O O
with O O
EBF O O
protein O O
in O O
a O O
pre-B O O
cell O O
nuclear O O
extract O O
. O O

The O O
figure O O
displays O O
an O O
autoradiogram O O
in O O
which O O
a O O
labelled O O
EBF O O
binding O O
site O O
from O O
the O O
mb-1 O O
promoter O O
has O O
been O O
incubated O O
with O O
nuclear O O
extracts O O
from O O
40EI O O
pre-B O O
cells O O
and O O
competitors O O
or O O
antibodies O O
as O O
indicated O O
. O O

EBF O O
denotes O O
the O O
bound O O
EBF O O
protein O O
and O O
EBF-SS O O
the O O
super-shifted O O
complex O O
obtained O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
the O O
EBF O O
reactive O O
antibody O O
to O O
the O O
reaction O O
mixture O O
. O O

Figure O O
9 O O
: O O
False O O
discovery O O
rate O O
estimation O O
. O O

A O O
: O O
Illustration O O
of O O
how O O
false O O
discovery O O
rates O O
-LRB- O O
FDRs O O
-RRB- O O
were O O
estimated O O
by B-conn Purpose.Enablement
use O O
of O O
simulations O O
. O O

Values O O
on O O
the O O
y O O
axis O O
represent O O
the O O
number O O
of O O
motifs O O
below O O
a O O
certain O O
p-score O O
-LRB- O O
x O O
axis O O
-RRB- O O
. O O

Triangles O O
show O O
results O O
for O O
observed O O
data O O
, O O
filled O O
circles O O
show O O
results O O
for O O
permuted O O
data O O
-LRB- O O
error O O
bars O O
show O O
the O O
90 O O
% O O
confidence O O
interval O O
from O O
100 O O
simulations O O
-RRB- O O
. O O

The O O
FDR O O
was O O
calculated O O
as O O
the O O
ratio O O
between O O
the O O
simulated O O
expectation O O
and O O
the O O
observation O O
. O O

Red O O
dotted O O
line O O
: O O
The O O
number O O
of O O
clusters O O
with O O
at O O
least O O
one O O
enriched O O
motif O O
. O O

Note O O
that O O
several O O
motifs O O
where O O
over-represented O O
in O O
the O O
same O O
cluster O O
. O O

B O O
: O O
Removal O O
of O O
paralogous O O
genes O O
from O O
each O O
cluster O O
did O O
not O O
affect O O
the O O
number O O
of O O
detected O O
motifs O O
. O O

Consequently B-conn Cause.Claim
, O O
co-expressed O O
paralogs O O
is O O
not O O
an O O
important O O
source O O
of O O
false O O
positives O O
. O O

C O O
: O O
The O O
amount O O
of O O
DNA O O
used O O
per O O
gene O O
, O O
and O O
the O O
phylogenetic O O
footprinting O O
stringency O O
has O O
a O O
strong O O
effect O O
on O O
the O O
number O O
of O O
detected O O
over-represented O O
motifs O O
. O O

The O O
sensitivity O O
is O O
higher O O
when B-conn Temporal.Synchronous
the O O
amount O O
of O O
DNA O O
is O O
reduced O O
. O O

Error O O
bars O O
in O O
B O O
and O O
C O O
were O O
obtained O O
by B-conn Purpose.Enablement
using O O
the O O
5th O O
and O O
95th O O
percentiles O O
in O O
the O O
simulation O O
to B-conn Purpose.Goal
define O O
the O O
FDR O O
. O O

Table O O
1 O O
: O O
Gene O O
coverage O O
of O O
the O O
analysis O O

Table O O
2 O O
: O O
over-represented O O
motifs O O
detected O O
at O O
<10 O O
% O O
false O O
discovery O O
rate O O

Table O O
3 O O
: O O
Interpretation O O
of O O
over-represented O O
motifs O O
with O O
respect O O
to O O
published O O
evidence O O
. O O

-LRB- O O
See O O
footnote O O
for B-conn Purpose.Goal
definition O O
of O O
the O O
categories O O
. O O
-RRB- O O

BMP-6 O O
inhibits O O
growth O O
of O O
mature O O
human O O
B O O
cells O O
; O O
induction O O
of O O
Smad O O
phosphorylation O O
and O O
upregulation O O
of O O
Id1 O O

Abstract O O

Background O O
: O O
Bone O O
morphogenetic O O
proteins O O
-LRB- O O
BMPs O O
-RRB- O O
belong O O
to O O
the O O
TGF-β O O
superfamily O O
and O O
are O O
secreted O O
proteins O O
with O O
pleiotropic O O
roles O O
in O O
many O O
different O O
cell O O
types O O
. O O

A O O
potential O O
role O O
of O O
BMP-6 O O
in O O
the O O
immune O O
system O O
has O O
been O O
implied O O
by O O
various O O
studies O O
of O O
malignant O O
and O O
rheumatoid O O
diseases O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
explored O O
the O O
role O O
of O O
BMP-6 O O
in O O
normal O O
human O O
peripheral O O
blood O O
B O O
cells O O
. O O

Results O O
: O O
The O O
B O O
cells O O
were O O
found O O
to O O
express O O
BMP O O
type O O
I O O
and O O
type O O
II O O
receptors O O
and B-conn Conjunction
BMP-6 O O
rapidly O O
induced O O
phosphorylation O O
of O O
Smad1/5/8 O O
. O O

Furthermore B-conn Conjunction
, O O
Smad-phosphorylation O O
was O O
followed O O
by O O
upregulation O O
of O O
Id1 O O
mRNA O O
and O O
Id1 O O
protein O O
, O O
whereas B-conn Contrast
Id2 O O
and O O
Id3 O O
expression O O
was O O
not O O
affected O O
. O O

Furthermore B-conn Conjunction
, O O
we O O
found O O
that O O
BMP-6 O O
had O O
an O O
antiproliferative O O
effect O O
both O O
in O O
naïve O O
-LRB- O O
CD19+CD27- O O
-RRB- O O
and O O
memory O O
B O O
cells O O
-LRB- O O
CD19+CD27+ O O
-RRB- O O
stimulated O O
with O O
anti-IgM O O
alone O O
or O O
the O O
combined O O
action O O
of O O
anti-IgM O O
and O O
CD40L O O
. O O

Additionally B-conn Conjunction
, O O
BMP-6 O O
induced O O
cell O O
death O O
in O O
activated O O
memory O O
B O O
cells O O
. O O

Importantly O O
, O O
the O O
antiproliferative O O
effect O O
of O O
BMP-6 O O
in O O
B-cells O O
was O O
completely O O
neutralized O O
by O O
the O O
natural O O
antagonist O O
, O O
noggin O O
. O O

Furthermore B-conn Conjunction
, O O
B O O
cells O O
were O O
demonstrated O O
to O O
upregulate O O
BMP-6 O O
mRNA O O
upon B-conn Temporal.Synchronous
stimulation O O
with O O
anti-IgM O O
. O O

Conclusion O O
: O O
In O O
mature O O
human O O
B O O
cells O O
, O O
BMP-6 O O
inhibited O O
cell O O
growth O O
, O O
and O O
rapidly O O
induced O O
phosphorylation O O
of O O
Smad1/5/8 O O
followed O O
by O O
an O O
upregulation O O
of O O
Id1 O O
. O O

Background O O

Members O O
of O O
the O O
transforming O O
growth O O
factor O O
β O O
-LRB- O O
TGF-β O O
-RRB- O O
superfamily O O
play O O
central O O
roles O O
in O O
controlling O O
cellular O O
proliferation O O
, O O
differentiation O O
, O O
migration O O
and O O
apoptosis O O
-LSB-1 O O
-RSB- O O
. O O

These O O
cytokines O O
can O O
be O O
divided O O
into O O
three O O
subgroups O O
: O O
TGF-β O O
, O O
the O O
activins/inhibins O O
, O O
and O O
the O O
bone O O
morphogenetic O O
proteins O O
-LRB- O O
BMPs O O
-RRB- O O
, O O
of O O
which O O
the O O
latter O O
constitute O O
the O O
largest O O
family O O
. O O

BMPs O O
are O O
30–38 O O
kDa O O
hetero- O O
or O O
homodimeric O O
proteins O O
originally O O
identified O O
by O O
their O O
ability O O
to O O
induce O O
ectopic O O
cartilage O O
and O O
bone O O
formation O O
-LSB-2,3 O O
-RSB- O O
. O O

Several O O
studies O O
have O O
demonstrated O O
an O O
essential O O
role O O
of O O
these O O
proteins O O
during O O
embryogenesis O O
, O O
and O O
more O O
recently O O
, O O
also O O
in O O
adult O O
tissues O O
-LSB-1 O O
-RSB- O O
. O O

TGF-β O O
has O O
been O O
intensively O O
studied O O
in O O
normal O O
and O O
malignant O O
haematopoietic O O
cells O O
and O O
is O O
one O O
of O O
the O O
most O O
potent O O
endogenous O O
negative O O
regulators O O
known O O
to O O
date O O
. O O

-LSB-4 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
effect O O
of O O
BMPs O O
in O O
the O O
immune O O
system O O
has O O
not O O
been O O
widely O O
investigated O O
. O O

In O O
that O O
respect O O
, O O
BMP- O O
2 O O
, O O
-4 O O
and O O
-7 O O
have O O
been O O
found O O
to O O
control O O
differentiation O O
of O O
hematopoietic O O
stem O O
cells O O
-LSB-5 O O
-RSB- O O
and O O
early O O
T O O
cell O O
development O O
-LSB-6,7 O O
-RSB- O O
. O O

BMP-6 O O
has O O
been O O
reported O O
to O O
reduce O O
the O O
number O O
of O O
cobblestone-area-forming O O
cells O O
of O O
normal O O
human O O
haematopoietic O O
cells O O
-LSB-8 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
BMP-2 O O
, O O
-4 O O
, O O
6 O O
and O O
-7 O O
had O O
an O O
antiproliferative O O
and O O
a O O
proapoptotic O O
effect O O
on O O
multiple O O
myeloma O O
cells O O
-LSB-9-11 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
by B-conn Purpose.Enablement
gene O O
expression O O
profiling O O
, O O
BMP-6 O O
significantly O O
increased O O
the O O
predictive O O
value O O
for O O
a O O
multi-gene O O
signature O O
test O O
and O O
was O O
associated O O
with O O
a O O
poor O O
outcome O O
in O O
diffuse O O
large O O
B O O
cell O O
lymphomas O O
-LRB- O O
DLBCL O O
-RRB- O O
-LSB-12 O O
-RSB- O O
. O O

BMP-6 O O
, O O
like O O
the O O
other O O
BMP O O
members O O
, O O
signals O O
through B-conn Purpose.Enablement
ligation O O
and O O
heterodimerzation O O
of O O
BMP O O
type O O
I O O
-LSB-activin-like-kinase O O
-LRB- O O
ALK O O
-RRB- O O
-RSB- O O
and O O
type O O
II O O
serine-threonine O O
kinase O O
receptors O O
, O O
which O O
subsequently B-conn Temporal.Precedence
propagates O O
the O O
signal O O
downstream O O
by B-conn Purpose.Enablement
phosphorylating O O
Smad O O
proteins O O
. O O

BMP-6 O O
can O O
signal O O
through B-conn Purpose.Enablement
the O O
ligation O O
of O O
the O O
type O O
I O O
receptors O O
Act-RIA O O
, O O
BMP-RIA O O
, O O
and O O
BMP-RIB O O
and O O
the O O
type O O
II O O
receptors O O
BMP-RII O O
, O O
Act-RIIA O O
and O O
Act-RIIB O O
, O O
which O O
lead O O
to O O
the O O
phosphorylation O O
of O O
the O O
receptor O O
Smads O O
-LRB- O O
Smad-1 O O
, O O
Smad-5 O O
, O O
and O O
Smad-8 O O
-RRB- O O
. O O

The O O
R- O O
Smads O O
then B-conn Temporal.Precedence
form O O
complexes O O
with O O
the O O
co-Smad O O
-LRB- O O
Smad4 O O
-RRB- O O
and O O
are O O
translocated O O
into O O
the O O
nucleus O O
where O O
they O O
exert O O
gene O O
regulation O O
-LSB-1,13 O O
-RSB- O O
. O O

Given B-conn Cause.Reason
the O O
reported O O
role O O
of O O
BMP-6 O O
in O O
B-cell O O
malignancies O O
and O O
haematopoietic O O
progenitor O O
cells O O
, O O
we O O
wanted O O
to O O
explore O O
its O O
potential O O
role O O
in O O
normal O O
human O O
B O O
cells O O
. O O

We O O
studied O O
the O O
effects O O
of O O
BMP-6 O O
on O O
proliferation O O
and O O
apoptosis O O
on O O
resting O O
and O O
stimulated O O
B O O
cells O O
. O O

Furthermore B-conn Conjunction
, O O
the O O
expression O O
of O O
BMP O O
receptors O O
and O O
BMP-6 O O
induced O O
activation O O
of O O
the O O
Smad O O
signalling O O
pathway O O
with O O
subsequent O O
regulation O O
of O O
the O O
target O O
genes O O
Id1–Id4 O O
, O O
were O O
resolved O O
. O O

Finally B-conn Temporal.Precedence
, O O
we O O
investigated O O
whether O O
B O O
cells O O
also O O
were O O
capable O O
of O O
producing O O
BMP-6 O O
. O O

Results O O

The O O
effects O O
of O O
BMP-6 O O
on O O
normal O O
and O O
neoplastic O O
hematopoietic O O
cells O O
prompted O O
us O O
to O O
investigate O O
the O O
effects O O
of O O
BMP-6 O O
on O O
normal O O
human O O
B O O
cells O O
. O O

All O O
experiments O O
in O O
this O O
study O O
were O O
performed O O
under O O
serum-free O O
conditions O O
as O O
FCS O O
has O O
been O O
shown O O
to O O
interfere O O
with O O
BMP-signalling O O
-LSB-14 O O
-RSB- O O
-LRB- O O
own O O
observations O O
-RRB- O O
. O O

To B-conn Purpose.Goal
study O O
the O O
effect O O
of O O
BMP-6 O O
on O O
proliferation O O
, O O
B-cells O O
from O O
healthy O O
volunteers O O
were O O
stimulated O O
with O O
anti-IgM O O
and/or O O
CD40L O O
in O O
the O O
presence O O
or O O
absence O O
of O O
BMP-6 O O
for O O
three O O
days O O
. O O

We O O
found O O
that O O
BMP-6 O O
led O O
to O O
a O O
35 O O
% O O
mean O O
reduction O O
of O O
anti-IgM- O O
induced O O
DNA O O
synthesis O O
-LRB- O O
n O O
= O O
8 O O
; O O
p O O
≤ O O
0.0002 O O
, O O
Figure O O
1A O O
-RRB- O O
. O O

Similar O O
results O O
were O O
obtained O O
for O O
B O O
cells O O
treated O O
with O O
anti-IgM O O
and O O
CD40L O O
-LRB- O O
26 O O
% O O
mean O O
reduction O O
, O O
n O O
= O O
6 O O
; O O
p O O
≤ O O
0.023 O O
-RRB- O O
. O O

The O O
BMP-6-induced O O
inhibition O O
of O O
proliferation O O
was O O
dose-dependent O O
in O O
both O O
peripheral O O
B O O
cells O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
and O O
the O O
Burkitt O O
lymphoma O O
cell O O
line O O
Ramos O O
-LRB- O O
40 O O
% O O
reduction O O
of O O
DNA O O
synthesis O O
, O O
Figure O O
1C O O
-RRB- O O
. O O

The O O
BMP-6 O O
effects O O
could O O
be O O
reversed O O
by B-conn Purpose.Enablement
addition O O
of O O
the O O
extracellular O O
inhibitor O O
Noggin O O
-LRB- O O
Figure O O
1D O O
-RRB- O O
. O O

Similarly B-conn Similarity
, O O
a O O
combination O O
of O O
the O O
soluble O O
BMP O O
receptors O O
BMP-RIB-Fc O O
and O O
BMP-RII-Fc O O
also O O
neutralized O O
the O O
effects O O
of O O
BMP-6 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Next B-conn Temporal.Precedence
, O O
we O O
wanted O O
to O O
test O O
whether O O
BMP-6 O O
had O O
different O O
effect O O
on O O
naïve O O
and O O
memory O O
B O O
cells O O
. O O

Naïve O O
-LRB- O O
CD19+CD27- O O
-RRB- O O
and O O
memory O O
-LRB- O O
CD19+CD27+ O O
-RRB- O O
B O O
cells O O
were O O
isolated O O
from O O
peripheral O O
blood O O
by B-conn Purpose.Enablement
cell O O
sorting O O
of O O
immunobead-isolated O O
CD19+ O O
B O O
cells O O
-LSB-15 O O
-RSB- O O
, O O
and O O
tested O O
for O O
their O O
capacity O O
to O O
proliferate O O
in O O
the O O
presence O O
of O O
BMP-6 O O
. O O

However B-conn Concession.Contra-expectation
, O O
BMP-6 O O
inhibited O O
anti-IgM O O
induced O O
DNA O O
synthesis O O
in O O
the O O
two O O
subpopulations O O
to O O
a O O
similar O O
extent O O
, O O
with O O
a O O
mean O O
reduction O O
of O O
DNA-synthesis O O
of O O
45 O O
% O O
-LRB- O O
n O O
= O O
5 O O
; O O
p O O
≤ O O
0,004 O O
-RRB- O O
for O O
naïve O O
B O O
cells O O
and O O
48 O O
% O O
-LRB- O O
n O O
= O O
5 O O
; O O
p O O
≤ O O
0,001 O O
-RRB- O O
for O O
memory O O
B O O
cells O O
-LRB- O O
Figure O O
1E O O
-RRB- O O
. O O

Next B-conn Temporal.Precedence
, O O
we O O
wanted O O
to O O
establish O O
whether O O
BMP-6 O O
also O O
could O O
affect O O
the O O
viability O O
of O O
normal O O
B O O
cells O O
. O O

Cell O O
viability O O
was O O
determined O O
by B-conn Purpose.Enablement
propidium O O
iodide O O
-LRB- O O
PI O O
-RRB- O O
staining O O
after B-conn Temporal.Succession
culture O O
with O O
or O O
without O O
BMP-6 O O
for O O
48 O O
hours O O
. O O

Interestingly O O
, O O
BMP-6 O O
showed O O
a O O
small O O
, O O
but O O
reproducible O O
mean O O
increase O O
of O O
cell O O
death O O
from O O
17 O O
to O O
23 O O
% O O
-LRB- O O
n O O
= O O
5 O O
; O O
p O O
≤ O O
0,003 O O
-RRB- O O
in O O
anti-IgM O O
stimulated O O
CD27+ O O
memory O O
B O O
cells O O
. O O

Furthermore B-conn Conjunction
, O O
Ramos O O
cells O O
showed O O
a O O
mean O O
increase O O
in O O
cell O O
death O O
from O O
20 O O
to O O
50 O O
% O O
-LRB- O O
n O O
= O O
3 O O
, O O
p O O
< O O
0,001 O O
, O O
figure O O
3 O O
-RRB- O O
after B-conn Temporal.Succession
BMP-6 O O
treatment O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
cell O O
death O O
of O O
total O O
CD19+ O O
cells O O
-LRB- O O
n O O
= O O
6 O O
; O O
p O O
≤ O O
0,32 O O
; O O
data O O
not O O
shown O O
-RRB- O O
or O O
CD27-IgG- O O
naïve O O
B O O
cells O O
was O O
not O O
significantly O O
affected O O
-LRB- O O
n O O
= O O
5 O O
; O O
p O O
≤ O O
0,65 O O
, O O
figure O O
2 O O
-RRB- O O
. O O

Detailed O O
knowledge O O
regarding O O
expression O O
of O O
different O O
BMP O O
receptors O O
in O O
B O O
cells O O
is O O
currently O O
not O O
available O O
. O O

To B-conn Purpose.Goal
further O O
elucidate O O
the O O
role O O
of O O
BMPs O O
in O O
human O O
B O O
cells O O
, O O
we O O
performed O O
western O O
blot O O
analysis O O
for O O
type O O
I O O
and O O
type O O
II O O
BMP O O
receptors O O
. O O

This O O
analysis O O
revealed O O
that O O
the O O
type O O
I O O
receptors O O
Act-RIA O O
, O O
BMP-RIB O O
and O O
the O O
type O O
II O O
receptors O O
BMP-RII O O
and O O
Act-RIIb O O
are O O
expressed O O
on O O
resting O O
human O O
B-cells O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

Ramos O O
cells O O
expressed O O
the O O
type O O
I O O
receptors O O
Act-RIA O O
, O O
weakly O O
BMP-RIB O O
and O O
the O O
type O O
II O O
receptor O O
BMP-RII O O
, O O
but O O
more O O
weakly O O
than O O
normal O O
B O O
cells O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

HL60 O O
cells O O
were O O
used O O
for O O
comparison O O
and O O
weakly O O
expressed O O
Act-RIA O O
and O O
BMP-RII O O
. O O

Taken O O
together O O
, O O
these O O
data O O
show O O
that O O
normal O O
human O O
B O O
cells O O
and O O
Ramos O O
cells O O
express O O
a O O
set O O
of O O
BMP O O
receptors O O
, O O
previously O O
shown O O
to O O
bind O O
BMP-6 O O
-LSB-16 O O
-RSB- O O
. O O

Upon B-conn Temporal.Synchronous
ligand O O
binding O O
, O O
the O O
type O O
II O O
receptor O O
transphosphorylates O O
and O O
activates O O
the O O
type O O
I O O
receptor O O
. O O

Type O O
I O O
receptors O O
can O O
signal O O
via O O
several O O
pathways O O
. O O

We O O
examined O O
the O O
effect O O
of O O
BMP-6 O O
on O O
Smad O O
phosphorylation O O
, O O
as B-conn Cause.Reason
the O O
activation O O
of O O
Smad O O
is O O
considered O O
to O O
be O O
a O O
major O O
signalling O O
pathway O O
for O O
BMPs O O
-LSB-17 O O
-RSB- O O
. O O

B O O
cells O O
were O O
cultured O O
in O O
serum-free O O
media O O
over O O
night O O
and O O
then B-conn Temporal.Precedence
treated O O
with O O
BMP-6 O O
for O O
various O O
time O O
points O O
. O O

Total O O
protein O O
lysates O O
were O O
prepared O O
, O O
and B-conn Conjunction
the O O
amounts O O
of O O
the O O
phosphorylated O O
forms O O
of O O
Smad1/5/8 O O
were O O
determined O O
by O O
western O O
blot O O
analysis O O
. O O

Interestingly O O
, O O
treatment O O
with O O
500 O O
ng/ml O O
BMP-6 O O
induced O O
phosphorylation O O
of O O
Smad O O
. O O

The O O
BMP-6 O O
induced O O
phosphorylation O O
was O O
high O O
at O O
the O O
earliest O O
time O O
point O O
tested O O
-LRB- O O
15 O O
minutes O O
-RRB- O O
, O O
and O O
remained O O
high O O
for O O
at O O
least O O
48 O O
hours O O
-LRB- O O
Figure O O
5 O O
-RRB- O O
. O O

A O O
similar O O
phosphorylation O O
was O O
observed O O
in O O
Ramos O O
cells O O
, O O
but O O
not O O
in O O
HL60 O O
cells O O
-LRB- O O
Figure O O
6 O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
we O O
also O O
tested O O
whether O O
other O O
known O O
downstream O O
signalling O O
pathways O O
of O O
BMP-6 O O
could O O
be O O
triggered O O
by O O
BMP-6 O O
in O O
human O O
B O O
cells O O
. O O

However B-conn Concession.Contra-expectation
, O O
we O O
did O O
not O O
observe O O
any O O
significant O O
changes O O
in O O
the O O
level O O
of O O
phospho-STAT3 O O
or O O
phospho-p38 O O
upon B-conn Temporal.Synchronous
BMP-6 O O
treatment O O
of O O
B O O
cells O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Next B-conn Temporal.Precedence
, O O
we O O
wanted O O
to O O
explore O O
whether O O
the O O
BMP-6 O O
induced O O
phosphorylation O O
of O O
Smad O O
1/5/8 O O
also O O
could O O
induce O O
transcriptional O O
changes O O
of O O
target O O
genes O O
. O O

In O O
this O O
regard O O
, O O
the O O
inhibitors O O
of O O
DNA O O
binding O O
proteins O O
-LRB- O O
Ids O O
-RRB- O O
are O O
considered O O
to O O
be O O
some O O
of O O
the O O
major O O
target O O
genes O O
for O O
Smad-signalling O O
-LSB-17 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
, O O
B O O
cells O O
were O O
pre-incubated O O
over O O
night O O
in O O
X-VIVO O O
15 O O
, O O
and O O
then B-conn Temporal.Precedence
cultured O O
in O O
medium O O
alone O O
or O O
in O O
the O O
presence O O
of O O
BMP-6 O O
for O O
various O O
time O O
points O O
before B-conn Temporal.Precedence
preparation O O
of O O
total O O
RNA O O
. O O

The O O
amount O O
of O O
Id1–Id4 O O
mRNA O O
was O O
quantified O O
by O O
real-time O O
RT-PCR O O
. O O

Interestingly O O
, O O
we O O
observed O O
a O O
specific O O
four-fold O O
upregulation O O
of O O
Id1 O O
mRNA O O
in O O
BMP-6-treated O O
B O O
cells O O
-LRB- O O
Figure O O
7 O O
-RRB- O O
. O O

The O O
up-regulation O O
of O O
Id1 O O
mRNA O O
was O O
characteristic O O
of O O
an O O
early O O
inducible O O
gene O O
, O O
with O O
maximal O O
upregulation O O
two B-conn Temporal.Succession
hours I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
addition O O
of O O
BMP-6 O O
and O O
returned O O
to O O
baseline O O
after O O
24 O O
hours O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
no O O
significant O O
changes O O
were O O
observed O O
for O O
Id2 O O
and O O
Id3 O O
mRNA O O
, O O
whereas B-conn Contrast
Id4-transcripts O O
were O O
not O O
detectable O O
-LRB- O O
Figure O O
7 O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

Western O O
blot O O
analysis O O
revealed O O
that O O
the O O
BMP-6-induced O O
upregulation O O
of O O
Id1 O O
mRNA O O
also B-conn Conjunction
was O O
correlated O O
with O O
upregulation O O
of O O
Id1 O O
protein O O
as O O
well O O
. O O

The O O
increase O O
in O O
Id1 O O
protein O O
level O O
was O O
detectable O O
after O O
one O O
hour O O
and O O
increased O O
until O O
24 O O
hours O O
after O O
BMP-6 O O
addition O O
, O O
showing O O
a O O
16-fold O O
upregulation O O
compared O O
with O O
t0 O O
-LRB- O O
p O O
≤ O O
0.020 O O
, O O
n O O
= O O
4 O O
-RRB- O O
-LRB- O O
Figure O O
8 O O
and O O
9 O O
-RRB- O O
. O O

In O O
line O O
with O O
the O O
mRNA O O
data O O
, O O
no O O
consistent O O
change O O
in O O
the O O
amounts O O
of O O
Id2 O O
and O O
Id3 O O
protein O O
could O O
be O O
observed O O
-LRB- O O
Figure O O
8 O O
and O O
9 O O
-RRB- O O
. O O

We O O
were O O
able O O
to O O
block O O
the O O
Id1 O O
specific O O
band O O
with O O
a O O
blocking O O
peptide O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Taken O O
together O O
, O O
these O O
data O O
suggest O O
that O O
Id1 O O
could O O
be O O
a O O
possible O O
target O O
gene O O
for O O
mediating O O
the O O
effects O O
of O O
BMP-6 O O
in O O
human O O
B O O
cells O O
, O O
whereas B-conn Contrast
Id2 O O
and O O
Id3 O O
not O O
seem O O
to O O
be O O
involved O O
. O O

The O O
fact O O
that O O
BMP-6 O O
has O O
been O O
reported O O
to O O
act O O
as O O
an O O
autocrine O O
stimulator O O
in O O
chondrocytes O O
-LSB-18 O O
-RSB- O O
and O O
ovarium O O
-LSB-19 O O
-RSB- O O
, O O
prompted O O
us O O
to O O
investigate O O
whether O O
normal O O
human O O
B O O
cells O O
could O O
produce O O
BMP-6 O O
upon B-conn Temporal.Synchronous
stimulation O O
. O O

Ramos O O
cells O O
, O O
which O O
have O O
been O O
described O O
to O O
express O O
BMP-6 O O
mRNA O O
endogenously O O
-LSB-20 O O
-RSB- O O
, O O
and O O
the O O
T O O
cell O O
line O O
Jurkat O O
, O O
served O O
as O O
positive O O
and O O
negative O O
controls O O
, O O
respectively O O
. O O

Endogenous O O
BMP-6 O O
mRNA O O
levels O O
in O O
normal O O
B O O
cells O O
were O O
quantified O O
by O O
real-time O O
RT-PCR O O
after B-conn Temporal.Succession
stimulation O O
with O O
anti-IgM O O
for O O
different O O
time O O
points O O
. O O

Interestingly O O
, O O
the O O
up-regulation O O
of O O
BMP-6 O O
mRNA O O
was O O
characteristic O O
of O O
an O O
early-to O O
intermediate O O
inducible O O
gene O O
with O O
maximal O O
upregulation O O
four B-conn Temporal.Succession
hours I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
addition O O
of O O
anti-IgM O O
. O O

The O O
level O O
of O O
BMP-6 O O
mRNA O O
was O O
back O O
to O O
baseline O O
after O O
24 O O
hours O O
upon O O
stimulation O O
-LRB- O O
Figure O O
10 O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
both O O
FCS O O
and O O
human O O
AB-serum O O
induced O O
significant O O
upregulation O O
of O O
BMP-6 O O
mRNA O O
-LRB- O O
Figure O O
11 O O
-RRB- O O
. O O

Interestingly O O
, O O
in O O
a O O
separate O O
study O O
we O O
have O O
found O O
that O O
normal O O
human O O
T O O
cells O O
do O O
not O O
express O O
BMP-6 O O
mRNA O O
after B-conn Temporal.Succession
activation O O
-LRB- O O
Sivertsen O O
et O O
al O O
, O O
manuscript O O
in O O
preparation O O
-RRB- O O
. O O

Next B-conn Temporal.Precedence
, O O
we O O
wanted O O
to O O
detect O O
BMP-6 O O
protein O O
in O O
normal O O
B-cells O O
and O O
tested O O
various O O
commercially O O
available O O
antibodies O O
. O O

However B-conn Concession.Contra-expectation
, O O
in O O
our O O
hands O O
these O O
anti-BMP-6 O O
antibodies O O
did O O
only O O
recognize O O
the O O
recombinant O O
BMP-6 O O
protein O O
and O O
not O O
the O O
native O O
protein O O
. O O

Discussion O O

Recent O O
studies O O
have O O
demonstrated O O
an O O
important O O
role O O
for O O
BMP O O
superfamily O O
members O O
in O O
hematopoietic O O
stem O O
cells O O
, O O
early O O
thymocytes O O
-LSB-6,7 O O
-RSB- O O
and O O
B-cell O O
malignancies O O
-LSB-8,11,12 O O
-RSB- O O
, O O
but B-conn Contrast
a O O
role O O
for O O
BMPs O O
in O O
normal O O
human O O
B O O
cells O O
has O O
previously O O
not O O
been O O
reported O O
. O O

The O O
present O O
study O O
demonstrated O O
a O O
significant O O
antiproliferative O O
effect O O
of O O
BMP-6 O O
in O O
peripheral O O
blood O O
CD19+ O O
B O O
cells O O
. O O

Additionally B-conn Conjunction
, O O
BMP-6 O O
induced O O
cell O O
death O O
in O O
CD27+ O O
memory O O
B O O
cells O O
as O O
well O O
as O O
in O O
a O O
Burkitt O O
lymphoma O O
cell O O
line O O
-LRB- O O
Ramos O O
-RRB- O O
. O O

Importantly O O
, O O
BMP-6 O O
induced O O
a O O
rapid O O
and O O
marked O O
increase O O
in O O
Smad-1/5/8 O O
phosphorylation O O
. O O

Furthermore B-conn Conjunction
, O O
the O O
BMP-6 O O
induced O O
Smad O O
phosphorylation O O
was O O
followed O O
by O O
a O O
selective O O
upregulation O O
of O O
Id1 O O
mRNA O O
and O O
subsequent O O
Id1 O O
protein O O
. O O

In O O
the O O
present O O
study O O
, O O
the O O
demonstrated O O
antiproliferative O O
effect O O
of O O
BMP-6 O O
in O O
anti-IgM O O
treated O O
B O O
cells O O
was O O
significant O O
and O O
dose-dependent O O
. O O

Importantly O O
, O O
the O O
anti-proliferative O O
effect O O
of O O
BMP-6 O O
could O O
be O O
completely O O
neutralized O O
by B-conn Purpose.Enablement
the O O
use O O
of O O
a O O
natural O O
inhibitor O O
, O O
Noggin O O
. O O

This O O
is O O
in O O
line O O
with O O
others O O
, O O
showing O O
that O O
Noggin O O
can O O
function O O
as O O
a O O
BMP-6 O O
antagonist O O
-LSB-21,22 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
combination O O
of O O
soluble O O
BMP-RIB-Fc O O
and O O
BMP-RII-Fc O O
fusion O O
proteins O O
also O O
neutralized O O
the O O
anti-proliferative O O
effect O O
of O O
BMP-6 O O
in O O
human O O
B O O
cells O O
. O O

Interestingly O O
, O O
as O O
for O O
other O O
TGF O O
family O O
members O O
, O O
bifunctional O O
effects O O
have O O
also O O
been O O
demonstrated O O
for O O
BMPs O O
. O O

Whereas B-conn Contrast
several O O
of O O
the O O
BMPs O O
have O O
been O O
shown O O
to O O
promote O O
proliferation O O
in O O
various O O
cell O O
types O O
including O O
condrocytes O O
-LSB-23 O O
-RSB- O O
, O O
liver O O
-LSB-24 O O
-RSB- O O
and O O
granulosa O O
cells O O
-LSB-25 O O
-RSB- O O
, O O
antiproliferative O O
effects O O
and O O
induction O O
of O O
apoptosis O O
has O O
been O O
reported O O
for O O
B O O
and O O
T O O
lineage O O
cells O O
. O O

Similar O O
effects O O
as O O
demonstrated O O
for O O
BMP-6 O O
on O O
human O O
B O O
cells O O
in O O
the O O
present O O
study O O
, O O
were O O
demonstrated O O
for O O
BMP-2 O O
, O O
4 O O
, O O
6 O O
and O O
-7 O O
in O O
human O O
myeloma O O
cells O O
-LSB-9-11 O O
-RSB- O O
. O O

Other O O
members O O
of O O
the O O
BMP-family O O
have O O
also B-conn Conjunction
been O O
reported O O
to O O
induce O O
apoptosis O O
, O O
including O O
in O O
mouse O O
B O O
lineage O O
cells O O
-LSB-26 O O
-RSB- O O
. O O

Additionally B-conn Conjunction
, O O
BMP-4 O O
inhibits O O
thymocyte O O
proliferation O O
-LSB-6 O O
-RSB- O O
. O O

Taken O O
together O O
, O O
these O O
data O O
suggest O O
that O O
the O O
role O O
of O O
BMPs O O
in O O
the O O
regulation O O
of O O
proliferation O O
and O O
apoptosis O O
is O O
highly O O
cell O O
type O O
dependent O O
. O O

To B-conn Purpose.Goal
examine O O
how O O
BMP-6 O O
exerts O O
its O O
functional O O
effects O O
in O O
B O O
cells O O
, O O
we O O
analysed O O
BMP O O
receptor O O
expression O O
by O O
western O O
blot O O
analysis O O
. O O

Human O O
peripheral O O
B O O
cells O O
were O O
found O O
to O O
express O O
the O O
BMP O O
type O O
I O O
receptors O O
Act-RIA O O
and O O
BMP-RIB O O
, O O
and O O
the O O
type O O
II-receptors O O
BMP-RII O O
and O O
Act-RIIb O O
, O O
which O O
signal O O
after B-conn Temporal.Succession
binding O O
of O O
several O O
BMPs O O
, O O
including O O
BMP-6 O O
-LSB-16,13 O O
-RSB- O O
. O O

To O O
further O O
explore O O
BMP-6 O O
induced O O
signalling O O
, O O
activation O O
of O O
several O O
pathways O O
is O O
possible O O
. O O

The O O
major O O
signalling O O
pathway O O
known O O
to O O
date O O
, O O
is O O
activation O O
of O O
R-Smads O O
-LSB-13,27 O O
-RSB- O O
. O O

In O O
that O O
respect O O
, O O
BMPs O O
have O O
been O O
shown O O
to O O
exert O O
antiproliferative O O
effects O O
in O O
B O O
lineage O O
cells O O
via O O
phosphorylation O O
of O O
R-Smad O O
-LSB-11,28 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
BMP-2 O O
has O O
been O O
shown O O
to O O
induce O O
activation O O
of O O
STAT3 O O
in O O
myeloma O O
cells O O
-LSB-9 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
phosphorylation O O
of O O
R-Smad O O
was O O
not O O
investigated O O
in O O
that O O
study O O
. O O

BMP-2 O O
has O O
also B-conn Conjunction
been O O
shown O O
to O O
induce O O
phosphorylation O O
of O O
p38 O O
-LSB-29 O O
-RSB- O O
. O O

Thus B-conn Cause.Claim
, O O
phosphorylation O O
of O O
p38 O O
, O O
STAT3 O O
and O O
Smad1/5/8 O O
represent O O
important O O
BMP-signalling O O
pathways O O
that O O
mediated O O
the O O
effects O O
of O O
BMPs O O
and B-conn Conjunction
even O O
cross-talk O O
between O O
these O O
pathways O O
has O O
been O O
reported O O
-LSB-29,30 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
were O O
not O O
able O O
to O O
detect O O
BMP-6-induced O O
changes O O
in O O
the O O
phosphorylation O O
status O O
of O O
STAT3 O O
or O O
p38 O O
in O O
human O O
peripheral O O
B O O
cells O O
. O O

Instead B-conn Alternative.Chosen alternative
, O O
a O O
rapid O O
and O O
marked O O
phosphorylation O O
of O O
Smad1/5/8 O O
was O O
revealed O O
. O O

In O O
a O O
parallel O O
study O O
, O O
we O O
have O O
found O O
that O O
other O O
BMPs O O
also O O
induced O O
phosphorylation O O
of O O
Smad1/5/8 O O
in O O
peripheral O O
B O O
cells O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

We O O
are O O
currently O O
pursuing O O
microarray O O
studies O O
to B-conn Purpose.Goal
identify O O
the O O
signalling O O
pathways O O
and O O
target O O
genes O O
that O O
are O O
differently O O
regulated O O
by O O
the O O
various O O
BMPs O O
in O O
human O O
B O O
cells O O
. O O

Upregulation O O
of O O
Id1 O O
via O O
Smad1/5/8 O O
phosphorylation O O
is O O
a O O
known O O
mechanism O O
for O O
BMP-6 O O
signalling O O
in O O
other O O
cell O O
systems O O
-LSB-31,32 O O
-RSB- O O
and B-conn Conjunction
regulation O O
of O O
Id-proteins O O
is O O
thought O O
to O O
be O O
an O O
important O O
mechanism O O
for O O
Smad-signalling O O
-LSB-17 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
, O O
real-time O O
RT-PCR O O
experiments O O
revealed O O
a O O
specific O O
four-fold O O
upregulation O O
for O O
Id1 O O
in O O
BMP-6-treated O O
B O O
cells O O
, O O
while B-conn Contrast
the O O
amount O O
of O O
Id2–Id4 O O
remained O O
unchanged O O
. O O

In O O
agreement O O
with O O
this O O
, O O
western O O
blot O O
analysis O O
demonstrated O O
an O O
upregulation O O
of O O
Id1 O O
protein O O
, O O
while B-conn Contrast
the O O
amount O O
of O O
Id2 O O
and O O
Id3 O O
protein O O
levels O O
remained O O
unchanged O O
. O O

Previously O O
, O O
Id1 O O
has O O
been O O
considered O O
not O O
to O O
be O O
expressed O O
in O O
later O O
developmental O O
stages O O
than O O
pro-B O O
cells O O
-LSB-33,34 O O
-RSB- O O
, O O
and B-conn Conjunction
its O O
constitutive O O
expression O O
has O O
been O O
reported O O
to O O
impair O O
mouse O O
B O O
cell O O
development O O
-LSB-35 O O
-RSB- O O
. O O

Therefore B-conn Cause.Claim
, O O
our O O
demonstration O O
of O O
the O O
time-dependent O O
upregulation O O
of O O
Id1 O O
mRNA O O
and O O
protein O O
in O O
mature O O
normal O O
human O O
B O O
cells O O
is O O
of O O
particular O O
interest O O
. O O

In O O
that O O
respect O O
, O O
it O O
is O O
noteworthy O O
that O O
TGF-β O O
signalling O O
in O O
early O O
and O O
mature O O
B O O
cells O O
induces O O
both O O
Id2 O O
and O O
Id3 O O
expression O O
-LSB-36,37 O O
-RSB- O O
, O O
but O O
not O O
Id1 O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Interestingly O O
, O O
these O O
results O O
show O O
that O O
various O O
members O O
of O O
the O O
TGF-β O O
family O O
regulate O O
Id O O
proteins O O
differently O O
. O O

Id2 O O
and O O
Id3 O O
are O O
considered O O
to O O
be O O
the O O
Id O O
proteins O O
mainly O O
expressed O O
in O O
mature O O
B O O
cells O O
-LSB-38 O O
-RSB- O O
. O O

The O O
present O O
study O O
also O O
found O O
Id2 O O
and O O
Id3 O O
protein O O
in O O
B O O
cells O O
to O O
be O O
more O O
highly O O
expressed O O
than O O
Id1 O O
in O O
resting O O
B O O
cells O O
. O O

However B-conn Concession.Contra-expectation
, O O
BMP-6 O O
did O O
not O O
induce O O
significant O O
changes O O
in O O
the O O
protein O O
expression O O
of O O
Id2 O O
and O O
Id3 O O
. O O

It O O
is O O
believed O O
that O O
Id O O
proteins O O
block O O
differentiation O O
and O O
promote O O
proliferation O O
in O O
various O O
cell O O
types O O
-LSB-39,33 O O
-RSB- O O
. O O

Id O O
proteins O O
act O O
as O O
dominant-negative O O
inhibitors O O
of O O
E-proteins O O
and O O
Pax5 O O
function O O
by B-conn Purpose.Enablement
forming O O
dimers O O
with O O
these O O
proteins O O
, O O
making O O
them O O
unable O O
to O O
bind O O
DNA O O
. O O

It O O
has O O
been O O
proposed O O
that O O
the O O
balance O O
among O O
E-proteins O O
, O O
Pax5 O O
and O O
Id O O
proteins O O
might O O
have O O
an O O
important O O
role O O
in O O
activated O O
B O O
cells O O
-LSB-38 O O
-RSB- O O
. O O

In O O
that O O
respect O O
, O O
E-proteins O O
have O O
been O O
implicated O O
in O O
both O O
the O O
promotion O O
and O O
inhibition O O
of O O
cell O O
survival O O
and O O
growth O O
at O O
different O O
points O O
in O O
lymphocyte O O
development O O
-LSB-40 O O
-RSB- O O
. O O

The O O
antiproliferative O O
and O O
death O O
inducing O O
effect O O
of O O
BMP-6 O O
in O O
B O O
cells O O
with O O
concomitant O O
upregulation O O
of O O
Id1 O O
protein O O
is O O
therefore B-conn Cause.Claim
in O O
line O O
with O O
the O O
view O O
that O O
Id O O
proteins O O
are O O
required O O
for O O
the O O
induction O O
of O O
growth O O
arrest O O
and O O
apoptosis O O
in O O
B-lymphocyte O O
progenitors O O
by O O
TGF-β O O
-LSB-40 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
Id O O
proteins O O
are O O
known O O
as O O
important O O
parts O O
of O O
signalling O O
pathways O O
involved O O
in O O
development O O
, O O
cell O O
cycle O O
and O O
tumorigenesis O O
-LSB-32 O O
-RSB- O O
. O O

It O O
is O O
well O O
established O O
that O O
various O O
members O O
of O O
the O O
Id O O
family O O
are O O
overexpressed O O
in O O
a O O
range O O
of O O
human O O
tumours O O
and B-conn Conjunction
generally O O
, O O
Id1 O O
appears O O
to O O
be O O
the O O
family O O
member O O
most O O
widely O O
overexpressed O O
in O O
a O O
variety O O
of O O
human O O
malignancies O O
-LSB-41 O O
-RSB- O O
, O O
including O O
multiple O O
myeloma O O
-LSB-42,32 O O
-RSB- O O
. O O

Additionally B-conn Conjunction
, O O
our O O
findings O O
that O O
BMP-6 O O
activates O O
intracellular O O
signalling O O
pathways O O
in O O
human O O
B O O
cells O O
might O O
be O O
of O O
potential O O
pathophysiological O O
significance O O
in O O
lymphoma O O
and O O
inflammation O O
. O O

High O O
BMP-6 O O
mRNA O O
expression O O
in O O
DLBCL O O
has O O
been O O
shown O O
to O O
correlate O O
to O O
unfavourable O O
outcome O O
-LSB-12 O O
-RSB- O O
. O O

In O O
this O O
respect O O
, O O
it O O
is O O
of O O
interest O O
that O O
targeted O O
expression O O
of O O
Id1 O O
to O O
B-lymphocytes O O
resulted O O
in O O
aberrant O O
B O O
cell O O
development O O
, O O
massive O O
apoptosis O O
, O O
and O O
subsequent O O
development O O
of O O
B O O
cell O O
lymphomas O O
-LSB-35 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
BMP-6 O O
has O O
been O O
suggested O O
to O O
play O O
a O O
role O O
in O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
-LSB-43,44 O O
-RSB- O O
and B-conn Conjunction
elevated O O
levels O O
of O O
Id1 O O
and O O
Id3 O O
have O O
been O O
found O O
in O O
the O O
synovia O O
of O O
RA-patients O O
-LSB-45 O O
-RSB- O O
. O O

Altogether O O
, O O
these O O
results O O
point O O
to O O
an O O
important O O
role O O
for O O
Id O O
proteins O O
in O O
the O O
regulation O O
of O O
normal O O
B O O
cell O O
homeostasis O O
and O O
in O O
diseases O O
, O O
where O O
B O O
cells O O
are O O
involved O O
. O O

It O O
will O O
therefore B-conn Cause.Result
be O O
important O O
to O O
further O O
elucidate O O
the O O
role O O
of O O
Id-1 O O
in O O
human O O
B O O
cells O O
by O O
selective O O
over O O
expression O O
or O O
inhibition O O
of O O
Id-1 O O
gene O O
expression O O
. O O

Given B-conn Cause.Justification
the O O
role O O
of O O
BMP-6 O O
in O O
mature O O
human O O
B O O
cells O O
demonstrated O O
here O O
, O O
identification O O
of O O
BMP-6 O O
producing O O
cells O O
in O O
vivo O O
with O O
possibility O O
of O O
interaction O O
with O O
naïve O O
and O O
memory O O
B O O
cells O O
might O O
contribute O O
to O O
the O O
understanding O O
of O O
mature O O
B O O
cell O O
biology O O
. O O

High O O
BMP-6 O O
mRNA O O
expression O O
in O O
DLBCL O O
has O O
been O O
detected O O
by O O
gene O O
expression O O
profiling O O
-LSB-12 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
production O O
of O O
BMP-6 O O
transcripts O O
in O O
normal O O
activated O O
B O O
cells O O
was O O
detected O O
in O O
the O O
same O O
study O O
. O O

Of O O
note O O
, O O
an O O
autocrine O O
BMP-6 O O
loop O O
has O O
been O O
reported O O
by O O
others O O
in O O
chondrocytes O O
and O O
in O O
the O O
ovarium O O
-LSB-46,19,18 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
we O O
wanted O O
to O O
explore O O
the O O
possibility O O
for O O
an O O
autocrine O O
BMP-6 O O
loop O O
in O O
human O O
B O O
cells O O
. O O

We O O
analysed O O
the O O
expression O O
BMP-6 O O
mRNA O O
in O O
peripheral O O
blood O O
B O O
cells O O
by B-conn Purpose.Enablement
real-time O O
PCR O O
, O O
and O O
report O O
here O O
the O O
upregulation O O
of O O
endogenous O O
BMP-6 O O
transcripts O O
after B-conn Temporal.Succession
stimulation O O
with O O
FCS O O
, O O
human O O
AB-serum O O
and O O
, O O
most O O
importantly O O
, O O
anti-IgM O O
. O O

However B-conn Concession.Contra-expectation
, O O
our O O
attempts O O
to O O
study O O
BMP-6 O O
protein O O
levels O O
were O O
unsuccessful O O
due B-conn Cause.Reason
to I-conn Cause.Reason
problems O O
with O O
unspecific O O
binding O O
of O O
the O O
anti-BMP-6 O O
antibodies O O
tested O O
, O O
and O O
lack O O
of O O
specific O O
staining O O
in O O
control O O
cells O O
known O O
to O O
express O O
BMP-6 O O
mRNA O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
recombinant O O
protein O O
was O O
readily O O
detected O O
. O O

In O O
that O O
respect O O
, O O
few O O
investigators O O
have O O
detected O O
BMP-6 O O
protein O O
in O O
humans O O
, O O
especially O O
in O O
non-pathogenic O O
tissue O O
. O O

The O O
possibility O O
of O O
BMP-6 O O
production O O
in O O
human O O
B-cells O O
is O O
in O O
line O O
with O O
a O O
recent O O
work O O
that O O
reported O O
the O O
production O O
of O O
BMP-6 O O
in O O
mouse O O
B O O
cells O O
, O O
infiltrating O O
the O O
bone O O
marrow O O
of O O
mice O O
with O O
inflammatory O O
arthritis O O
-LSB-43 O O
-RSB- O O
. O O

In O O
this O O
study O O
, O O
a O O
role O O
for O O
BMPs O O
in O O
the O O
inflammatoric O O
process O O
of O O
arthritis O O
was O O
suggested O O
. O O

The O O
upregulation O O
of O O
the O O
BMP-6-transcripts O O
after O O
IgM-crosslinking O O
is O O
of O O
pathophysiologic O O
interest O O
-LSB-12 O O
-RSB- O O
. O O

A O O
loss O O
of O O
TGF-β-responsiveness O O
has O O
been O O
suggested O O
to O O
be O O
a O O
critical O O
contribution O O
to O O
malignant O O
transformation O O
-LSB-47,48 O O
-RSB- O O
and B-conn Conjunction
similar O O
oncogenic O O
mechanisms O O
have O O
been O O
postulated O O
for O O
BMPs O O
. O O

Lines O O
of O O
evidence O O
suggest O O
-LSB-49 O O
-RSB- O O
that O O
at O O
early O O
stages O O
of O O
carcinogenesis O O
, O O
BMP-6 O O
is O O
not O O
a O O
tumour O O
promoter O O
, O O
but O O
suppresses O O
benign O O
and O O
malignant O O
tumour O O
outgrowth O O
. O O

These O O
findings O O
are O O
in O O
good O O
agreement O O
with O O
previous O O
findings O O
for O O
other O O
TGF-β O O
family O O
members O O
, O O
including O O
TGF-β1 O O
and O O
BMP-4 O O
-LSB-50 O O
-RSB- O O
, O O
indicating O O
that O O
cellular O O
context O O
of O O
the O O
BMP O O
target O O
cell O O
might O O
define O O
the O O
various O O
observed O O
effects O O
. O O

In B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
the O O
upregulation O O
of O O
BMP-6 O O
transcript O O
in O O
B O O
cells O O
, O O
we O O
were O O
not O O
able O O
to O O
detect O O
BMP-6 O O
transcripts O O
in O O
human O O
peripheral O O
blood O O
CD4+ O O
or O O
CD8+ O O
T O O
cells O O
-LRB- O O
resting O O
or O O
stimulated O O
with O O
anti-CD3 O O
and O O
anti-CD28 O O
; O O
data O O
not O O
shown O O
-RRB- O O
, O O
consistent O O
with O O
the O O
findings O O
in O O
T O O
cell O O
lines O O
-LSB-20 O O
-RSB- O O
and O O
T O O
cells O O
in O O
mice O O
-LSB-43 O O
-RSB- O O
. O O

Other O O
potential O O
BMP-6 O O
sources O O
for O O
mature O O
B O O
cells O O
in O O
vivo O O
might O O
be O O
other O O
cells O O
of O O
the O O
immune O O
system O O
or O O
tissue O O
with O O
contact O O
to O O
the O O
hematopoietic O O
system O O
. O O

One O O
well O O
recognized O O
source O O
for O O
BMP-6 O O
production O O
is O O
the O O
human O O
bone O O
and O O
bone O O
marrow O O
stroma O O
-LSB-51,8 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
it O O
is O O
noteworthy O O
that O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
-LRB- O O
HUVEC O O
-RRB- O O
highly O O
express O O
BMP-6 O O
mRNA O O
-LSB-52 O O
-RSB- O O
, O O
and B-conn Conjunction
vascular O O
endothelium O O
has O O
been O O
reported O O
to O O
produce O O
BMP-6 O O
-LSB-53 O O
-RSB- O O
. O O

These O O
studies O O
might O O
imply O O
a O O
role O O
for O O
BMP-6 O O
in O O
transendothelial O O
migration O O
of O O
B O O
cells O O
. O O

BMP-6 O O
mRNA O O
has O O
been O O
demonstrated O O
in O O
murine O O
macrophage O O
cell O O
lines O O
, O O
but O O
not O O
in O O
humans O O
-LSB-54 O O
-RSB- O O
. O O

In O O
accordance O O
with O O
these O O
findings O O
, O O
other O O
human O O
cell O O
lines O O
of O O
neutrophil O O
and O O
monocytic O O
origin O O
have O O
been O O
described O O
to O O
be O O
negative O O
for O O
the O O
BMP-6 O O
transcript O O
-LSB-20 O O
-RSB- O O
. O O

To O O
our O O
knowledge O O
, O O
there O O
is O O
currently O O
no O O
report O O
about O O
BMP-6 O O
production O O
of O O
human O O
dendritic O O
cells O O
. O O

Conclusion O O

In O O
conclusion O O
, O O
our O O
results O O
show O O
that O O
BMP-6 O O
induces O O
activation O O
of O O
intracellular O O
Smad O O
signalling O O
in O O
mature O O
human O O
B-cells O O
with O O
consecutive O O
production O O
of O O
Id1 O O
protein O O
. O O

Furthermore B-conn Conjunction
, O O
we O O
report O O
that O O
BMP-6 O O
has O O
an O O
antiproliferative O O
effect O O
in O O
B O O
cells O O
stimulated O O
with O O
anti-IgM O O
alone O O
or O O
the O O
combined O O
action O O
of O O
anti-IgM O O
and O O
CD40L O O
. O O

Additionally B-conn Conjunction
, O O
BMP-6 O O
induces O O
cell O O
death O O
in O O
activated O O
memory O O
B O O
cells O O
and O O
Ramos O O
cells O O
. O O

Taken O O
together O O
, O O
these O O
results O O
provide O O
a O O
rationale O O
to O O
further O O
examine O O
the O O
role O O
of O O
BMP-6 O O
signalling O O
in O O
normal O O
B O O
cell O O
biology O O
as O O
well O O
as O O
in O O
pathologic O O
conditions O O
like O O
B O O
cell O O
malignancies O O
and O O
autoimmune O O
disorders O O
. O O

Methods O O

If O O
not O O
specified O O
, O O
all O O
cells O O
were O O
cultured O O
in O O
X-VIVO O O
15™ O O
-LRB- O O
BioWhittaker O O
, O O
Verviers O O
, O O
Belgium O O
-RRB- O O
serum-free O O
medium O O
at O O
37°C O O
and O O
5 O O
% O O
CO2 O O
in O O
air O O
. O O

Peripheral O O
blood O O
was O O
provided O O
by O O
the O O
Blood O O
Bank O O
at O O
Buskerud O O
Regional O O
Hospital O O
with O O
formal O O
agreement O O
by O O
the O O
patients O O
, O O
and O O
approval O O
by O O
the O O
regional O O
ethics O O
committee O O
. O O

Highly O O
purified O O
resting O O
human O O
B-lymphocytes O O
-LRB- O O
CD19+ O O
cells O O
-RRB- O O
were O O
isolated O O
from O O
the O O
peripheral O O
blood O O
by B-conn Purpose.Enablement
rosetting O O
with O O
immunomagnetic O O
beads O O
-LRB- O O
Dynabeads O O
M450 O O
; O O
Dynal O O
, O O
Oslo O O
, O O
Norway O O
-RRB- O O
as O O
described O O
-LSB-55 O O
-RSB- O O
. O O

This O O
procedure O O
yields O O
less O O
than O O
0.5 O O
% O O
T O O
cells O O
, O O
0.1 O O
% O O
NK O O
cells O O
, O O
and O O
0.5 O O
% O O
monocytes O O
as O O
judged O O
by O O
indirect O O
immunofluorescence O O
staining O O
. O O

The O O
following O O
cell O O
lines O O
from O O
human O O
lymphoid O O
malignancies O O
were O O
maintained O O
in O O
RPMI O O
1640 O O
-LRB- O O
PAA O O
Laboratories O O
GmbH O O
, O O
Pasching O O
, O O
Austria O O
-RRB- O O
supplemented O O
with O O
10 O O
% O O
foetal O O
bovine O O
serum O O
-LRB- O O
FCS O O
-RRB- O O
, O O
100 O O
units/ml O O
penicillin O O
G O O
, O O
and O O
100 O O
units/ml O O
of O O
streptomycin O O
sulphate O O
, O O
but O O
serum-starved O O
for O O
at O O
least O O
four O O
hours O O
and O O
cultured O O
in O O
X-VIVO O O
15™ O O
when O O
included O O
in O O
experiments O O
: O O
EBV-negative O O
BL O O
cell O O
lines O O
Ramos O O
-LRB- O O
ECACC O O
85030802 O O
-RRB- O O
, O O
HL60 O O
-LRB- O O
JCRB0085 O O
-RRB- O O
. O O

The O O
following O O
reagents O O
were O O
used O O
at O O
indicated O O
concentrations O O
: O O
recombinant O O
human O O
-LRB- O O
rhu O O
-RRB- O O
BMP-6 O O
-LRB- O O
1 O O
μg/ml O O
, O O
if O O
not O O
specified O O
otherwise O O
-RRB- O O
, O O
rhu O O
BMP-RIB/ALK-6/Fc O O
Chimera O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
, O O
rhu O O
BMPR-II/Fc O O
Chimera O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
, O O
and O O
recombinant O O
mouse O O
Noggin O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
were O O
purchased O O
from O O
R&D O O
Systems O O
-LRB- O O
Abingdon O O
, O O
UK O O
-RRB- O O
; O O
Anti-IgM O O
F O O
-LRB- O O
ab O O
-RRB- O O
2 O O
fragments O O
of O O
rabbit O O
polyclonal O O
antibodies O O
to O O
human O O
IgM O O
heavy O O
chain O O
-LRB- O O
37.5 O O
μg/ml O O
-RRB- O O
was O O
obtained O O
from O O
Dako O O
, O O
Copenhagen O O
, O O
Denmark O O
and O O
rhu O O
CD40 O O
ligand O O
-LRB- O O
CD40L O O
, O O
10 O O
ng/ml O O
-RRB- O O
was O O
a O O
gift O O
from O O
Immunex O O
Corp. O O
-LRB- O O
Seattle O O
, O O
WA O O
-RRB- O O
. O O

Antibodies O O
against O O
the O O
human O O
BMP-receptors O O
Act-RIA O O
, O O
BMP-RIB O O
, O O
BMPR-II O O
, O O
Act-RIIA O O
and O O
Act-RIIb O O
were O O
purchased O O
from O O
R O O
& O O
D O O
Systems O O
-LRB- O O
Abingdon O O
, O O
UK O O
-RRB- O O
. O O

Detection O O
of O O
the O O
BMP-6-protein O O
has O O
been O O
tried O O
with O O
the O O
following O O
antibodies O O
: O O
goat O O
polyclonal O O
anti-BMP-6 O O
-LRB- O O
Santa O O
Cruz O O
, O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
, O O
monoclonal O O
mouse O O
anti-BMP-6 O O
and O O
polyclonal O O
goat O O
anti-BMP-6 O O
from O O
R O O
& O O
D O O
Systems O O
-LRB- O O
Abingdon O O
, O O
UK O O
-RRB- O O
, O O
and O O
mouse O O
monoclonal O O
anti-BMP-6 O O
-LRB- O O
Chemicon O O
International O O
Inc O O
, O O
Temecula O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Characterisation O O
of O O
BMP-signalling O O
pathways O O
was O O
done O O
by B-conn Purpose.Enablement
use O O
of O O
anti-phospho-Smad1 O O
, O O
-5 O O
, O O
-and O O
8 O O
polyclonal O O
antibody O O
-LRB- O O
Chemicon O O
, O O
Temecula O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Expression O O
levels O O
of O O
Id1–3 O O
proteins O O
were O O
detected O O
with O O
polyclonal O O
rabbit O O
antibody O O
and B-conn Continuation
detection O O
was O O
blocked O O
with O O
blocking O O
peptide O O
from O O
Santa O O
Cruz O O
Biotechnology O O
-LRB- O O
Santa O O
Cruz O O
, O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

As O O
secondary O O
antibodies O O
served O O
anti-mouse O O
, O O
anti-goat O O
or O O
anti-rabbit O O
IgG- O O
horseradish O O
peroxidase O O
-LRB- O O
HRP O O
-RRB- O O
from O O
Dakocytomation O O
AS O O
-LRB- O O
Copenhagen O O
, O O
Denmark O O
-RRB- O O
for O O
immunoblot O O
analysis O O
. O O

Anti-β-actin O O
was O O
from O O
Santa-Cruz O O
. O O

From O O
Becton O O
Dickinson O O
-LRB- O O
San O O
Jose O O
, O O
CA O O
-RRB- O O
, O O
we O O
purchased O O
anti-CD19-PE O O
, O O
anti-CD19-FITC O O
. O O

The O O
antibodies O O
used O O
for O O
cell O O
sorting O O
were O O
anti-CD19 O O
PC5 O O
from O O
Immunotech O O
SA O O
-LRB- O O
Marseille O O
, O O
France O O
-RRB- O O
and O O
anti-CD27 O O
PE O O
from O O
Becton O O
Dickinson O O
, O O
Biosciences O O
Pharmingen O O
-LRB- O O
San O O
Diego O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Highly O O
purified O O
CD19+CD27- O O
or O O
CD19+CD27+ O O
cells O O
were O O
obtained O O
by B-conn Purpose.Enablement
staining O O
CD19+ O O
cells O O
with O O
anti-CD27 O O
PE O O
and O O
CD19 O O
PC5 O O
mAbs O O
for O O
30 O O
minutes O O
at O O
4°C O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
washing O O
with O O
PBS O O
and O O
sorting O O
on O O
FACS O O
DiVa O O
from O O
Becton O O
Dickinson O O
. O O

B O O
cells O O
from O O
peripheral O O
blood O O
or O O
cultured O O
cell-lines O O
were O O
lysed O O
in O O
lysis O O
buffer O O
-LRB- O O
glycerol O O
10 O O
% O O
, O O
β-mercaptoethanol O O
5 O O
% O O
, O O
0.0625 O O
M O O
Tris-HCL O O
-LSB-pH O O
6.8 O O
-RSB- O O
, O O
sodium O O
dodecyl O O
sulphate O O
-LSB-SDS O O
-RSB- O O
2.5 O O
% O O
w/vol O O
-RRB- O O
. O O

Total O O
protein O O
-LRB- O O
30–100 O O
μg O O
-RRB- O O
from O O
each O O
sample O O
was O O
run O O
on O O
10 O O
% O O
or O O
12 O O
% O O
SDS/polyacrylamide O O
-LRB- O O
SDS/PAGE O O
-RRB- O O
gels O O
and O O
blotted O O
onto O O
nitrocellulose O O
filters O O
-LRB- O O
Protran O O
; O O
Schleicher O O
&Schuell O O
GmbH O O
, O O
Dassel O O
, O O
Germany O O
-RRB- O O
. O O

Blocking O O
, O O
washing O O
and O O
incubation O O
of O O
the O O
filters O O
with O O
primary O O
antibodies O O
were O O
done O O
according O O
to O O
the O O
manufacturer O O
's O O
protocols O O
at O O
room O O
temperature O O
-LRB- O O
RT O O
-RRB- O O
. O O

After B-conn Temporal.Succession
washing O O
with O O
TBS/0.1 O O
% O O
Tween-20 O O
-LRB- O O
TBS-T O O
-RRB- O O
, O O
the O O
filters O O
were O O
incubated O O
with O O
horseradish O O
peroxidase O O
-LRB- O O
HRP O O
-RRB- O O
coupled O O
to O O
relevant O O
secondary O O
antibodies O O
-LRB- O O
see O O
above O O
-RRB- O O
for O O
60 O O
minutes O O
at O O
RT. O O
Enzyme O O
activity O O
was O O
visualised O O
by O O
the O O
enhanced O O
chemiluminescence O O
system O O
, O O
ECL+PLUS O O
-LRB- O O
Amersham O O
, O O
Buckinghamshire O O
, O O
UK O O
-RRB- O O
. O O

Densitometric O O
analysis O O
was O O
performed O O
by B-conn Purpose.Enablement
scanning O O
hyperfilms O O
on O O
a O O
Personal O O
Densitometer O O
SI O O
-LRB- O O
Molecular O O
Dynamics O O
, O O
Sunnyvale O O
, O O
CA O O
-RRB- O O
. O O

Quantification O O
of O O
Id1 O O
, O O
Id2 O O
and O O
Id3 O O
protein O O
was O O
calculated O O
by B-conn Purpose.Enablement
normalizing O O
the O O
specific O O
protein O O
bands O O
to O O
β-actin O O
using O O
Image O O
Quant O O
5.5 O O
software O O
-LRB- O O
Molecular O O
Dynamics O O
-RRB- O O
. O O

Endogenous O O
expression O O
of O O
the O O
BMP-6 O O
gene O O
was O O
examined O O
by O O
reverse O O
transcription-polymerase O O
chain O O
reaction O O
. O O

Total O O
RNA O O
was O O
isolated O O
using O O
Absolutely O O
RNA™ O O
RT-PCR O O
Miniprep O O
Kit O O
-LRB- O O
Stratagene O O
Europe O O
, O O
Amsterdam O O
, O O
Netherland O O
-RRB- O O
according O O
to O O
the O O
manufacturers O O
instructions O O
. O O

Quantification O O
of O O
the O O
isolated O O
total O O
RNA O O
was O O
achieved O O
by B-conn Purpose.Enablement
using O O
spectrophotometric O O
OD260 O O
measurements O O
. O O

Equal O O
amounts O O
of O O
RNA O O
were O O
then B-conn Temporal.Precedence
reverse O O
transcribed O O
to O O
cDNA O O
with O O
TaqMan® O O
Reverse O O
Transcription O O
Reagents O O
-LRB- O O
Applied O O
Biosystems O O
, O O
Foster O O
City O O
, O O
CA O O
, O O
U.S.A O O
-RRB- O O
. O O

To B-conn Purpose.Goal
measure O O
mRNA O O
expression O O
of O O
BMP6 O O
, O O
Id1–Id4 O O
and O O
PGK1 O O
PCR O O
were O O
carried O O
out O O
with O O
TaqMan® O O
universal O O
master O O
mix O O
. O O

Primers O O
and O O
probes O O
were O O
provided O O
by O O
Assay-on-Demand O O
-LRB- O O
Applied O O
Biosystems O O
-RRB- O O
. O O

PCR O O
reactions O O
were O O
carried O O
out O O
in O O
a O O
final O O
volume O O
of O O
25 O O
μl O O
-LRB- O O
BMP-6 O O
-RRB- O O
or O O
20 O O
μl O O
-LRB- O O
ID1 O O
-RRB- O O
. O O

The O O
cDNA O O
added O O
to O O
each O O
reaction O O
was O O
equivalent O O
to O O
the O O
input O O
of O O
20 O O
ng O O
of O O
total O O
RNA O O
. O O

The O O
gene O O
expression O O
was O O
quantified O O
using O O
the O O
standard O O
curve O O
method O O
-LRB- O O
BMP6 O O
-RRB- O O
, O O
or O O
the O O
comparative O O
CT O O
method O O
-LRB- O O
Id1 O O
-RRB- O O
as O O
described O O
in O O
ABI7700 O O
User O O
Bulletin O O
2 O O
-LRB- O O
Applied O O
Biosystems O O
-RRB- O O
. O O

The O O
expression O O
was O O
then B-conn Temporal.Precedence
normalized O O
to O O
the O O
expression O O
level O O
of O O
PGK1 O O
. O O

PGK1 O O
was O O
chosen O O
, O O
because B-conn Cause.Reason
it O O
has O O
been O O
shown O O
to O O
have O O
low O O
expression O O
variability O O
among O O
lymphocyte O O
specimens O O
-LSB-56 O O
-RSB- O O
. O O

Expression O O
levels O O
in O O
B O O
cells O O
were O O
then B-conn Temporal.Precedence
related O O
to O O
the O O
expression O O
levels O O
in O O
Ramos O O
cells O O
. O O

For B-conn Purpose.Goal
estimation O O
of O O
DNA O O
synthesis O O
, O O
CD19+ O O
cells O O
-LRB- O O
7.5 O O
× O O
104 O O
cells/0.2 O O

ml O O
-RRB- O O
or O O
Ramos O O
cells O O
-LRB- O O
1 O O
× O O
104 O O
cells/0.2 O O

ml O O
-RRB- O O
were O O
cultured O O
in O O
triplicate O O
in O O
microtiter O O
wells O O
. O O

The O O
cells O O
were O O
pulsed O O
with O O
3.7 O O
× O O
104Bq O O
-LSB-3H O O
-RSB- O O
thymidine O O
-LRB- O O
Amersham O O
, O O
Buckinghamshire O O
, O O
UK O O
-RRB- O O
for O O
the O O
last O O
16 O O
h O O
of O O
a O O
72-h O O
incubation O O
. O O

The O O
cells O O
were O O
harvested O O
using O O
an O O
automated O O
cell O O
harvester O O
-LRB- O O
Packard O O
Instrument O O
Company O O
, O O
Meriden O O
, O O
CT O O
, O O
USA O O
-RRB- O O
and B-conn Conjunction
-LSB-3H O O
-RSB- O O
thymidine O O
incorporation O O
was O O
determined O O
in O O
a O O
scintillation O O
counter O O
-LRB- O O
TopCount O O
, O O
Packard O O
Instrument O O
Company O O
Inc. O O
, O O
Meriden O O
, O O
CT O O
-RRB- O O
. O O

Cell O O
death O O
was O O
measured O O
by O O
vital O O
dye O O
exclusion O O
test O O
by B-conn Purpose.Enablement
staining O O
cells O O
with O O
5 O O
μg/ml O O
propidium O O
iodide O O
-LRB- O O
-LSB-PI O O
-RSB- O O
; O O
Calbiochem O O
Corp. O O
; O O
La O O
Jolla O O
, O O
CA O O
; O O
5 O O
mg/ml O O
-RRB- O O
for O O
one O O
minute O O
on O O
ice O O
. O O

At O O
least O O
1,000 O O
cells O O
per O O
sample O O
were O O
run O O
on O O
a O O
BD O O
FACSCalibur O O
flow O O
cytometer O O
. O O

The O O
statistical O O
significance O O
of O O
differences O O
between O O
groups O O
was O O
determined O O
using O O
the O O
paired O O
two-tailed O O
Wilcoxon O O
nonparametric O O
test O O
, O O
by B-conn Purpose.Enablement
applying O O
SPSS10.1 O O
software O O
-LRB- O O
SPSS O O
Inc. O O
, O O
Chicago O O
, O O
IL O O
, O O
USA O O
-RRB- O O
. O O

P O O
values O O
less O O
than O O
0.05 O O
were O O
considered O O
significant O O
. O O

List O O
of O O
abbreviations O O

BMP O O
, O O
Bone O O
morphogenetic O O
protein O O

DLBCL O O
, O O
diffuse O O
large O O
B O O
cell O O
lymphoma O O

Id O O
, O O
inhibitor O O
of O O
dna O O
binding O O

Smad O O
, O O
the O O
name O O
Smad O O
originates O O
from O O
the O O
Drosophila O O
protein O O
, O O
MAD O O
and O O
the O O
Caenorhabditis O O
elegans O O
proteins O O
, O O
sma-2 O O
, O O
3 O O
and O O
4 O O

STAT O O
, O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O

Authors O O
' O O
contributions O O

CK O O
designed O O
and O O
conducted O O
experiments O O
, O O
oversaw O O
research O O
, O O
and O O
wrote O O
paper O O
. O O

EAS O O
designed O O
and O O
conducted O O
experiments O O
, O O
oversaw O O
research O O
. O O

MEH O O
designed O O
and O O
conducted O O
experiments O O
, O O
oversaw O O
research O O
. O O

LF O O
designed O O
and O O
conducted O O
experiments O O
. O O

EBS O O
designed O O
experiments O O
, O O
oversaw O O
research O O
, O O
and O O
wrote O O
paper O O
. O O

JHM O O
designed O O
and O O
conducted O O
experiments O O
, O O
oversaw O O
research O O
, O O
and O O
wrote O O
paper O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
BMP-6 O O
inhibits O O
proliferation O O
of O O
human O O
B O O
cells O O
. O O

A O O
-RRB- O O
CD19+ O O
B O O
cells O O
were O O
isolated O O
from O O
peripheral O O
blood O O
and O O
stimulated O O
in O O
triplicates O O
with O O
anti-IgM O O
-LRB- O O
37.5 O O
μg/ml O O
-RRB- O O
or O O
anti-IgM O O
and O O
CD40 O O
ligand O O
-LRB- O O
CD40L O O
; O O
10 O O
ng/ml O O
-RRB- O O
in O O
the O O
presence O O
or O O
absence O O
of O O
BMP-6 O O
for O O
72 O O
hours O O
. O O

DNA O O
synthesis O O
was O O
measured O O
by O O
-LSB-3H O O
-RSB- O O
-thymidine O O
incorporation O O
for O O
the O O
last O O
18 O O
hours O O
. O O

Data O O
are O O
given O O
as O O
relative O O
proliferation O O
obtained O O
by B-conn Purpose.Enablement
normalizing O O
the O O
mean O O
counts O O
per O O
minute O O
-LRB- O O
cpm O O
-RRB- O O
for O O
each O O
stimulation O O
to O O
the O O
mean O O
cpm O O
obtained O O
for O O
anti-IgM O O
stimulated O O
cells O O
± O O
SEM O O
. O O
-LRB- O O
mean O O
cpm O O
= O O
25 O O
352 O O
for O O
anti-IgM O O
stimulated O O
cells O O
, O O
* O O
p O O
≤ O O
0.0002 O O
-LRB- O O
n O O
= O O
8 O O
-RRB- O O
, O O
** O O
p O O
≤ O O
0.023 O O
-LRB- O O
n O O
= O O
6 O O
-RRB- O O
. O O

B O O
-RRB- O O
Dose O O
dependent O O
inhibition O O
of O O
BMP-6 O O
of O O
anti-IgM O O
induced O O
DNA-synthesis O O
of O O
CD19+ O O
B O O
cells O O
-LRB- O O
relative O O
proliferation O O
± O O
SEM O O
, O O
n O O
= O O
3 O O
-RRB- O O
and B-conn Conjunction
C O O
-RRB- O O
the O O
Burkitt O O
lymphoma O O
cell O O
line O O
Ramos O O
-LRB- O O
relative O O
proliferation O O
± O O
SEM O O
, O O
n O O
= O O
3 O O
-RRB- O O
. O O

Ramos O O
cells O O
were O O
cultured O O
for O O
72 O O
hours O O
and B-conn Conjunction
-LSB-3H O O
-RSB- O O
-thymidine O O
were O O
added O O
for O O
the O O
last O O
4 O O
hours O O
. O O

D O O
-RRB- O O
Noggin O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
and O O
BMP-6 O O
-LRB- O O
0,25 O O
or O O
1 O O
μg/ml O O
-RRB- O O
were O O
preincubated O O
for O O
1 O O
h O O
at O O
37°C O O
and B-conn Conjunction
then B-conn Temporal.Precedence
added O O
to O O
the O O
CD19+ O O
B O O
cells O O
in O O
the O O
presence O O
of O O
anti-IgM O O
-LRB- O O
37.5 O O
μg/ml O O
-RRB- O O
. O O

Cells O O
were O O
cultured O O
for O O
72 O O
h O O
and B-conn Conjunction
DNA O O
synthesis O O
was O O
measured O O
by O O
3H-thymidine O O
incorporation O O
. O O

One O O
representative O O
of O O
three O O
separate O O
experiments O O
is O O
shown O O
-LRB- O O
mean O O
cpm O O
± O O
SD O O
of O O
triplicates O O
-RRB- O O
. O O

E O O
-RRB- O O
Highly O O
purified O O
CD19+CD27- O O
or O O
CD19+CD27+ O O
cells O O
were O O
obtained O O
by B-conn Purpose.Enablement
cell O O
sorting O O
of O O
CD19+ O O
cells O O
and O O
stimulated O O
with O O
anti-IgM O O
in O O
the O O
presence O O
or O O
absence O O
of O O
BMP-6 O O
, O O
as O O
indicated O O
for O O
72 O O
hours O O
. O O

DNA O O
synthesis O O
was O O
measuredby O O
-LSB-3H O O
-RSB- O O
-thymidine O O
incorporation O O
. O O

Data O O
are O O
given O O
as O O
relative O O
proliferation O O
obtained O O
by B-conn Purpose.Enablement
normalizing O O
the O O
mean O O
cpm O O
for O O
each O O
stimulation O O
to O O
the O O
mean O O
cpm O O
obtained O O
for O O
anti-IgM O O
stimulated O O
cells O O
-LRB- O O
mean O O
cpm O O
= O O
18 O O
221 O O
for O O
CD19+CD27- O O
naïve O O
B O O
cells O O
, O O
mean O O
cpm O O
= O O
8 O O
930 O O
for O O
CD19+CD27+ O O
memory O O
B O O
cells O O
, O O
n O O
= O O
5 O O
; O O
* O O
p O O
≤ O O
0,004 O O
, O O
** O O
p O O
≤ O O
0.001 O O
-RRB- O O
. O O

Figure O O
2 O O
: O O
BMP-6 O O
induces O O
cell O O
death O O
in O O
B O O
cells O O
. O O

CD19+CD27- O O
naïve O O
B O O
cells O O
or O O
CD19+CD27+ O O
memory O O
B O O
cells O O
were O O
cultured O O
for O O
48 O O
h O O
with O O
BMP-6 O O
-LRB- O O
1 O O
μg/ml O O
-RRB- O O
with O O
or O O
without O O
anti-IgM O O
-LRB- O O
37.5 O O
μg/ml O O
-RRB- O O
. O O

Cell O O
death O O
-LRB- O O
PI+ O O
cells O O
-RRB- O O
was O O
then B-conn Temporal.Precedence
measured O O
by O O
flow O O
cytometry O O
analysis O O
. O O

Data O O
are O O
shown O O
as O O
mean O O
percentage O O
PI+ O O
cells O O
from O O
five O O
independent O O
donors O O
-LRB- O O
± O O
SEM O O
; O O
p O O
≤ O O
0,003 O O
-RRB- O O
. O O

Figure O O
3 O O
: O O
Ramos O O
cells O O
were O O
cultured O O
in O O
the O O
presence O O
or O O
absense O O
of O O
BMP-6 O O
-LRB- O O
1 O O
μg/ml O O
-RRB- O O
for O O
48 O O
h O O
before B-conn Temporal.Precedence
analysis O O
of O O
cell O O
death O O
by O O
PI O O
staining O O
. O O

Data O O
are O O
shown O O
as O O
mean O O
percentage O O
PI+ O O
cells O O
-LRB- O O
± O O
SEM O O
, O O
n O O
= O O
3 O O
, O O
p O O
≤ O O
0,001 O O
-RRB- O O
. O O

Figure O O
4 O O
: O O
CD19+ O O
B O O
cells O O
express O O
BMP O O
type O O
I O O
and O O
type O O
II O O
receptors O O
. O O

Total O O
cell O O
lysates O O
were O O
prepared O O
from O O
the O O
myeloid O O
cell O O
line O O
HL60 O O
, O O
the O O
cell O O
line O O
Ramos O O
or O O
CD19+ O O
B O O
cells O O
isolated O O
from O O
peripheral O O
blood O O
and O O
analyzed O O
by O O
western O O
blot O O
for O O
expression O O
of O O
BMP O O
type O O
I O O
and O O
type O O
II O O
receptors O O
. O O

One O O
representative O O
experiment O O
of O O
four O O
is O O
shown O O
. O O

Figure O O
5 O O
: O O
BMP-6-induced O O
phosphorylation O O
of O O
Smad1/5/8 O O
in O O
CD19+ O O
B O O
cells O O
and O O
Ramos O O
, O O
but O O
not O O
in O O
HL60 O O
cells O O
. O O

CD19+ O O
B O O
cells O O
, O O
or O O
the O O
cell O O
lines O O
Ramos O O
or O O
HL60 O O

Figure O O
6 O O
: O O
were O O
cultured O O
in O O
X-vivo O O
15 O O
over O O
night O O
before B-conn Temporal.Precedence
treatment O O
with O O
BMP-6 O O
for O O
30 O O
minutes O O
, O O
or O O
for O O
the O O
indicated O O
time O O
points O O
before B-conn Temporal.Precedence
total O O
cell O O
lysates O O
were O O
prepared O O
. O O

The O O
amount O O
of O O
phosphorylated O O
Smad O O
1/5/8 O O
was O O
determined O O
by O O
western-blot O O
analysis O O
. O O

The O O
membranes O O
were O O
reprobed O O
for O O
Smad1 O O
. O O

One O O
representative O O
experiment O O
of O O
three O O
is O O
shown O O
. O O

Figure O O
7 O O
: O O
BMP-6 O O
induced O O
upregulation O O
of O O
Id1 O O
at O O
the O O
mRNA O O
and O O
protein O O
level O O
. O O

CD19+ O O
B O O
cells O O
were O O
cultured O O
in O O
X-vivo O O
15 O O
over O O
night O O
before B-conn Temporal.Precedence
treatment O O
with O O
BMP-6 O O
for O O
the O O
indicated O O
time O O
points O O
. O O

Total O O
RNA O O
was O O
extracted O O
and B-conn Conjunction
Id1 O O
, O O
Id2 O O
or O O
Id3-expression O O
was O O
analysed O O
by O O
real-time O O
RT-PCR O O
; O O
values O O
are O O
normalised O O
to O O
the O O
expression O O
level O O
of O O
PGK1 O O
mRNA O O
and O O
expressed O O
as O O
relative O O
quantification O O
-LRB- O O
2-average O O
ΔΔCT O O
– O O
relative O O
to O O
Id1 O O
, O O
Id2 O O
or O O
Id3 O O
expression O O
in O O
the O O
cell-line O O
Ramos O O
-RRB- O O
. O O

One O O
representative O O
of O O
three O O
independent O O
experiments O O
is O O
shown O O
. O O

Figure O O
8 O O
: O O
Id O O
protein O O
expression O O
was O O
determined O O
by O O
western-blot O O
analysis O O
. O O

CD19+ O O
B O O
cells O O
were O O
cultured O O
in O O
X-vivo O O
15 O O
over O O
night O O
before B-conn Temporal.Precedence
treatment O O
with O O
BMP-6 O O
for O O
the O O
indicated O O
time O O
points O O
and B-conn Conjunction
cell O O
lysates O O
were O O
prepared O O
. O O

One O O
representative O O
experiment O O
of O O
three O O
is O O
shown O O
. O O

HeLa O O
cells O O
were O O
used O O
as O O
a O O
positive O O
control O O
for O O
Id1 O O
protein O O
detection O O
. O O

Figure O O
9 O O
: O O
Relative O O
protein O O
expression O O
of O O
Id1 O O
, O O
Id2 O O
and O O
Id3 O O
. O O

Quantifications O O
of O O
Id1 O O
, O O
Id2 O O
and O O
Id3 O O
protein O O
levels O O
were O O
performed O O
using O O
β-actin O O
as O O
normalization O O
and O O
expressed O O
as O O
mean O O
± O O
SEM O O
-LRB- O O
Id1 O O
: O O
n O O
= O O
4 O O
, O O
* O O
p O O
≤ O O
0.020 O O
; O O
Id2 O O
and O O
Id3 O O
: O O
n O O
= O O
3 O O
-RRB- O O
. O O

Figure O O
10 O O
: O O
Anti-IgM O O
rapidly O O
upregulates O O
BMP-6 O O
mRNA O O
expression O O
in O O
human O O
B-cells O O
. O O

CD19-positive O O
B O O
cells O O
were O O
cultured O O
in O O
X-vivo O O
15 O O
over O O
night O O
and O O
stimulated O O
with O O
anti-IgM O O
for O O
the O O
indicated O O
time O O
periods O O
, O O
before B-conn Temporal.Precedence
total O O
RNA O O
was O O
extracted O O
. O O

The O O
expression O O
of O O
BMP-6 O O
mRNA O O
by O O
realtime O O
RT-PCR O O
; O O
values O O
are O O
normalised O O
to O O
the O O
expression O O
level O O
of O O
PGK1 O O
mRNA O O
and O O
expressed O O
as O O
relative O O
quantification O O
-LRB- O O
2-average O O
ΔΔCT O O
– O O
relative O O
to O O
BMP-6 O O
expression O O
in O O
the O O
cell-line O O
Ramos O O
. O O

One O O
representative O O
of O O
five O O
independent O O
experiments O O
is O O
shown O O
. O O

Figure O O
11 O O
: O O
Fetal O O
calf O O
serum O O
and O O
human O O
AB O O
serum O O
upregulates O O
BMP-6 O O
mRNA O O
expression O O
in O O
human O O
B-cells O O
. O O

CD19-positive O O
B O O
cells O O
were O O
cultured O O
in O O
X-vivo O O
15 O O
over O O
night O O
and O O
with O O
fetal O O
calf O O
serum O O
or O O
human O O
AB O O
serum O O
at O O
the O O
indicated O O
dilutions O O
for O O
four O O
hours O O
, O O
before B-conn Temporal.Precedence
total O O
RNA O O
was O O
extracted O O
. O O

The O O
expression O O
of O O
BMP-6 O O
mRNA O O
by O O
realtime O O
RT-PCR O O
; O O
values O O
are O O
normalised O O
to O O
the O O
expression O O
level O O
of O O
PGK1 O O
mRNA O O
and O O
expressed O O
as O O
relative O O
quantification O O
-LRB- O O
2-average O O
ΔΔCT O O
– O O
relative O O
to O O
BMP-6 O O
expression O O
in O O
the O O
cell-line O O
Ramos O O
. O O

One O O
representative O O
of O O
three O O
independent O O
experiments O O
is O O
shown O O
. O O

Control O O
of O O
gene O O
expression O O
during O O
T O O
cell O O
activation O O
: O O
alternate O O
regulation O O
of O O
mRNA O O
transcription O O
and O O
mRNA O O
stability O O

Abstract O O

Background O O
: O O
Microarray O O
technology O O
has O O
become O O
highly O O
valuable O O
for O O
identifying O O
complex O O
global O O
changes O O
in O O
gene O O
expression O O
patterns O O
. O O

The O O
effective O O
correlation O O
of O O
observed O O
changes O O
in O O
gene O O
expression O O
with O O
shared O O
transcription O O
regulatory O O
elements O O
remains O O
difficult O O
to O O
demonstrate O O
convincingly O O
. O O

One O O
reason O O
for O O
this O O
difficulty O O
may O O
result O O
from O O
the O O
intricate O O
convergence O O
of O O
both O O
transcriptional O O
and O O
mRNA O O
turnover O O
events O O
which O O
, O O
together O O
, O O
directly O O
influence O O
steady-state O O
mRNA O O
levels O O
. O O

Results O O
: O O
In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
investigate O O
the O O
relative O O
contribution O O
of O O
gene O O
transcription O O
and O O
changes O O
in O O
mRNA O O
stability O O
regulation O O
to O O
standard O O
analyses O O
of O O
gene O O
expression O O
, O O
we O O
used O O
two O O
distinct O O
microarray O O
methods O O
which O O
individually O O
measure O O
nuclear O O
gene O O
transcription O O
and O O
changes O O
in O O
polyA O O
mRNA O O
gene O O
expression O O
. O O

Gene O O
expression O O
profiles O O
were O O
obtained O O
from O O
both O O
polyA O O
mRNA O O
-LRB- O O
whole-cell O O
-RRB- O O
and O O
nuclear O O
run-on O O
-LRB- O O
newly O O
transcribed O O
-RRB- O O
RNA O O
across O O
a O O
time O O
course O O
of O O
one O O
hour O O
following B-conn Temporal.Succession
the O O
activation O O
of O O
human O O
Jurkat O O
T O O
cells O O
with O O
PMA O O
plus O O
ionomycin O O
. O O

Comparative O O
analysis O O
revealed O O
that O O
regulation O O
of O O
mRNA O O
stability O O
may O O
account O O
for O O
as O O
much O O
as O O
50 O O
% O O
of O O
all O O
measurements O O
of O O
changes O O
in O O
polyA O O
mRNA O O
in O O
this O O
system O O
, O O
as B-conn Cause.Justification
inferred I-conn Cause.Justification
by I-conn Cause.Justification
the O O
absence O O
of O O
any O O
corresponding O O
regulation O O
of O O
nuclear O O
gene O O
transcription O O
activity O O
for O O
these O O
groups O O
of O O
genes O O
. O O

Genes O O
which O O
displayed O O
dramatic O O
elevations O O
in O O
both O O
mRNA O O
and O O
nuclear O O
run-on O O
RNA O O
were O O
shown O O
to O O
be O O
inhibited O O
by B-conn Cause.Reason
Actinomycin O O
D O O
-LRB- O O
ActD O O
-RRB- O O
pre-treatment O O
of O O
cells O O
while B-conn Contrast
large O O
numbers O O
of O O
genes O O
regulated O O
only O O
through O O
altered O O
mRNA O O
turnover O O
-LRB- O O
both O O
up O O
and O O
down O O
-RRB- O O
were O O
ActD-resistant O O
. O O

Consistent O O
patterns O O
across O O
the O O
time O O
course O O
were O O
observed O O
for O O
both O O
transcribed O O
and O O
stability-regulated O O
genes O O
. O O

Conclusion O O
: O O
We O O
propose O O
that O O
regulation O O
of O O
mRNA O O
stability O O
contributes O O
significantly O O
to O O
the O O
observed O O
changes O O
in O O
gene O O
expression O O
in O O
response O O
to O O
external O O
stimuli O O
, O O
as O O
measured O O
by O O
high O O
throughput O O
systems O O
. O O

Background O O

Virtually O O
all O O
microarray O O
studies O O
to-date O O
have O O
measured O O
changes O O
in O O
steady-state O O
mRNA O O
levels O O
by B-conn Purpose.Enablement
harvesting O O
total O O
cellular O O
RNA O O
and O O
using O O
it O O
to O O
generate O O
probes O O
through O O
a O O
variety O O
of O O
strategies O O
including O O
end-labeling O O
of O O
purified O O
mRNA O O
-LSB-1 O O
-RSB- O O
, O O
incorporating O O
a O O
label O O
into O O
the O O
first O O
strand O O
cDNA O O
made O O
from O O
mRNA O O
-LSB-2 O O
-RSB- O O
, O O
or O O
attaching O O
a O O
T7 O O
RNA O O
polymerase O O
promoter O O
during O O
cDNA O O
synthesis O O
, O O
then O O
labeling O O
of O O
the O O
resulting O O
RNA O O
-LSB-3 O O
-RSB- O O
. O O

More O O
recently O O
, O O
several O O
groups O O
have O O
demonstrated O O
the O O
feasibility O O
of O O
hybridizing O O
metabolically O O
labeled O O
mRNAs O O
directly O O
from O O
nuclear O O
run-on O O
-LRB- O O
NRO O O
-RRB- O O
reactions O O
to O O
nylon O O
filter O O
microarrays O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
investigate O O
nascent O O
transcripts O O
-LSB-1,4-6 O O
-RSB- O O
. O O

Schuhmacher O O
et O O
al. O O
-LSB-5 O O
-RSB- O O
, O O
in B-conn Instantiation
particular I-conn Instantiation
, O O
used O O
a O O
B O O
cell O O
line O O
carrying O O
a O O
conditional O O
, O O
tetracycline-regulated O O
myc O O
gene O O
, O O
and B-conn Conjunction
found O O
that O O
myc O O
induction O O
resulted O O
in O O
only O O
a O O
small O O
overlap O O
in O O
regulated O O
mRNAs O O
at O O
4 O O
hours O O
post-induction O O
when B-conn Temporal.Synchronous
comparing O O
polyA O O
mRNA O O
and O O
NRO O O
RNA O O
on O O
microarrays O O
. O O

This O O
early O O
work O O
provided O O
evidence O O
that O O
transcriptional O O
activation O O
of O O
genes O O
does O O
not O O
necessarily O O
lead O O
to O O
a O O
corresponding O O
increase O O
of O O
their O O
steady-state O O
mRNA O O
levels O O
. O O

More O O
recently O O
, O O
our O O
laboratory O O
has O O
examined O O
the O O
relationship O O
between O O
newly O O
transcribed O O
-LRB- O O
NRO O O
-RRB- O O
RNA O O
and O O
polyA O O
mRNA O O
in O O
a O O
stress O O
model O O
using O O
human O O
non-small O O
lung O O
carcinoma O O
H1299 O O
cells O O
. O O

In B-conn Temporal.Synchronous
response I-conn Temporal.Synchronous
to I-conn Temporal.Synchronous
a O O
variety O O
of O O
stresses O O
-LRB- O O
ultraviolet O O
light O O
, O O
heat O O
shock O O
, O O
or O O
prostaglandin O O
-RRB- O O
, O O
we O O
found O O
that O O
approximately O O
half O O
of O O
the O O
observed O O
changes O O
in O O
mRNA O O
levels O O
of O O
stress-regulated O O
genes O O
were O O
accompanied O O
by O O
a O O
corresponding O O
increase O O
or O O
decrease O O
in O O
gene O O
transcription O O
as O O
measured O O
by O O
NRO O O
. O O

The O O
remaining O O
half O O
of O O
stress-altered O O
changes O O
in O O
gene O O
expression O O
was O O
largely O O
attributable O O
to O O
changes O O
in O O
mRNA O O
turnover O O
, O O
thus B-conn Cause.Claim
suggesting O O
that O O
, O O
on O O
a O O
global O O
level O O
, O O
changes O O
in O O
mRNA O O
turnover O O
profoundly O O
influence O O
gene O O
expression O O
patterns O O
-LSB-6 O O
-RSB- O O
. O O

Several O O
questions O O
, O O
however B-conn Concession.Contra-expectation
, O O
remained O O
to O O
be O O
answered O O
from O O
these O O
earlier O O
studies O O
. O O

Since B-conn Cause.Reason
in O O
both O O
the O O
myc O O
induction O O
and O O
stress O O
experiments O O
, O O
as O O
mentioned O O
above O O
, O O
measurements O O
of O O
both O O
newly O O
transcribed O O
and O O
polyA O O
mRNAs O O
were O O
made O O
at O O
a O O
single O O
time O O
point O O
, O O
there O O
existed O O
a O O
reasonable O O
possibility O O
of O O
temporal O O
disjunctions O O
between O O
the O O
timing O O
of O O
mRNA O O
new O O
gene O O
synthesis O O
and O O
the O O
rates O O
of O O
accumulation O O
of O O
mRNA O O
in O O
the O O
cell O O
. O O

The O O
second O O
question O O
remaining O O
unanswered O O
is O O
whether O O
or O O
not O O
highly O O
significant O O
levels O O
of O O
mRNA O O
stability O O
regulation O O
-LRB- O O
> O O
50 O O
% O O
of O O
all O O
measured O O
gene O O
expression O O
in O O
the O O
stress O O
example O O
-RRB- O O
is O O
common O O
to O O
different O O
biological O O
model O O
systems O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
begin O O
to O O
address O O
these O O
questions O O
we O O
investigated O O
changes O O
at O O
the O O
levels O O
of O O
transcription O O
and O O
total O O
cellular O O
mRNA O O
abundance O O
simultaneously O O
across O O
a O O
time O O
course O O
of O O
activation O O
using O O
Jurkat O O
T O O
cells O O
. O O

T-cell O O
activation O O
is O O
one O O
of O O
the O O
most O O
widely O O
studied O O
models O O
of O O
cellular O O
response O O
to O O
exogenous O O
stimulation O O
. O O

The O O
initial O O
events O O
include O O
rapid O O
signaling O O
via O O
protein-protein O O
interactions O O
, O O
phosphorylation/dephosphorylation O O
of O O
target O O
signaling O O
molecules O O
, O O
and O O
release O O
of O O
Ca2+ O O
from O O
intracellular O O
stores O O
. O O

Subsequent O O
activation O O
of O O
signal O O
transduction O O
cascades O O
culminates O O
in O O
the O O
implementation O O
of O O
gene O O
expression O O
patterns O O
characteristic O O
of O O
the O O
immune O O
response O O
. O O

Initial O O
microarray O O
studies O O
using O O
T O O
cells O O
have O O
focused O O
on O O
gene O O
expression O O
changes O O
occurring O O
several O O
hours O O
after B-conn Temporal.Succession
activation O O
-LSB-7-13 O O
-RSB- O O
, O O
even B-conn Concession.Expectation
though I-conn Concession.Expectation
earlier O O
work O O
using O O
more O O
traditional O O
methods O O
had O O
defined O O
the O O
commitment O O
period O O
for O O
T-cell O O
activation O O
, O O
including O O
alteration O O
in O O
gene O O
expression O O
patterns O O
, O O
as O O
occurring O O
between B-conn Temporal.Succession
1–2 I-conn Temporal.Succession
h I-conn Temporal.Succession
after I-conn Temporal.Succession
exposure O O
to O O
the O O
activating O O
agent O O
-LSB-14 O O
-RSB- O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
investigate O O
these O O
earlier O O
gene O O
expression O O
changes O O
we O O
chose O O
to O O
examine O O
a O O
time O O
course O O
of O O
activation O O
spanning O O
the O O
first O O
hour O O
after O O
stimulation O O
. O O

While B-conn Contrast
a O O
recent O O
study O O
by O O
Garcia-Martinez O O
et O O
al. O O
-LSB-15 O O
-RSB- O O
in O O
yeast O O
using O O
a O O
similar O O
approach O O
demonstrated O O
large O O
shifts O O
in O O
mRNA O O
stability O O
following O O
a O O
glucose-to-galactose O O
shift O O
, O O
the O O
work O O
presented O O
here O O
is O O
the O O
first O O
systematic O O
accounting O O
of O O
the O O
changes O O
in O O
both O O
gene O O
transcription O O
and O O
mRNA O O
stability O O
in B-conn Temporal.Succession
response I-conn Temporal.Succession
to I-conn Temporal.Succession
a O O
major O O
cellular O O
activation O O
event O O
over O O
a O O
defined O O
time O O
period O O
in O O
higher O O
eukaryotes O O
. O O

Results O O

T-cell O O
commitment O O
is O O
believed O O
to O O
occur O O
early O O
during O O
activation O O
and B-conn Conjunction
therefore B-conn Cause.Result
changes O O
in O O
gene O O
expression O O
during O O
the O O
earliest O O
stages O O
of O O
induction O O
are O O
of O O
particular O O
interest O O
. O O

An O O
experimental O O
model O O
using O O
human O O
Jurkat O O
T O O
cells O O
activated O O
with O O
PMA O O
and O O
ionomycin O O
was O O
used O O
to B-conn Purpose.Goal
investigate O O
early O O
changes O O
in O O
gene O O
expression O O
-LRB- O O
up O O
to O O
one O O
hour O O
of O O
stimulation O O
-RRB- O O
, O O
focusing O O
on O O
both O O
changes O O
in O O
mRNA O O
transcription O O
rates O O
as O O
well O O
as O O
polyA O O
mRNA O O
levels O O
. O O

One O O
hour O O
was O O
chosen O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
examine O O
gene O O
regulatory O O
events O O
occurring O O
immediately B-conn Temporal.Succession
after I-conn Temporal.Succession
activation O O
and O O
to O O
avoid O O
, O O
for O O
the O O
most O O
part O O
, O O
the O O
influence O O
of O O
secondary O O
gene O O
regulatory O O
mechanisms O O
taking O O
place O O
at O O
later O O
time O O
points O O
-LRB- O O
e.g. O O
, O O
increased O O
synthesis O O
of O O
transcription O O
factors O O
-RRB- O O
. O O

NRO O O
RNA O O
was O O
prepared O O
from O O
isolated O O
cell O O
nuclei O O
-LRB- O O
Methods O O
-RRB- O O
and O O
polyA O O
mRNA O O
from O O
intact O O
cells O O
. O O

Figure O O
1 O O
shows O O
an O O
example O O
of O O
filter O O
images O O
obtained O O
after O O
hybridization O O
of O O
arrays O O
using O O
either O O
NRO O O
RNA O O
or O O
polyA O O
mRNA O O
. O O

Cells O O
stimulated O O
for O O
30 O O
minutes O O
exhibited O O
moderate O O
changes O O
in O O
gene O O
expression O O
in O O
the O O
mRNA O O
arrays O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
NRO O O
RNA O O
arrays O O
revealed O O
rapid O O
and O O
robust O O
changes O O
in O O
transcription O O
that O O
were O O
evident O O
as O O
early O O
as O O
5 O O
minutes O O
following O O
induction O O
. O O

Unexpectedly O O
, O O
a O O
careful O O
analysis O O
of O O
all O O
significant O O
changes O O
in O O
gene O O
expression O O
across O O
the O O
time O O
course O O
revealed O O
that O O
these O O
early-response O O
genes O O
-LRB- O O
as O O
identified O O
by O O
NRO O O
-RRB- O O
were O O
a O O
relatively O O
small O O
subset O O
of O O
all O O
of O O
the O O
genes O O
shown O O
to O O
be O O
regulated O O
-LRB- O O
see O O
below O O
-RRB- O O
. O O

In O O
all O O
, O O
a O O
total O O
of O O
4608 O O
genes O O
, O O
including O O
sets O O
of O O
genes O O
enriched O O
for O O
immune O O
response O O
and O O
signal O O
transduction O O
function O O
, O O
were O O
polled O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

Of O O
these O O
genes O O
, O O
2386 O O
showed O O
significant O O
regulation O O
-LRB- O O
p O O
< O O
0.001 O O
, O O
or O O
Z O O
ratio O O
> O O
± O O
1.5 O O
-RRB- O O
during O O
the O O
time O O
course O O
of O O
one O O
hour O O
post O O
activation O O
by B-conn Cause.Reason
either O O
changing O O
gene O O
transcription O O
or O O
polyA O O
mRNA O O
levels O O
. O O

These O O
significantly O O
regulated O O
genes O O
were O O
chosen O O
for O O
further O O
analysis O O
. O O

The O O
distribution O O
and O O
direction O O
-LRB- O O
increase O O
, O O
decrease O O
, O O
or O O
no O O
change O O
-RRB- O O
of O O
significant O O
changes O O
in O O
gene O O
expression O O
either O O
at O O
the O O
transcriptional O O
level O O
-LRB- O O
NRO O O
-RRB- O O
or O O
at O O
the O O
level O O
of O O
polyA O O
mRNA O O
-LRB- O O
whole-cell O O
-RRB- O O
are O O
displayed O O
in O O
the O O
table O O
in O O
Figure O O
2. O O
The O O
single O O
most O O
common O O
expression O O
event O O
-LRB- O O
55.2 O O
% O O
-RRB- O O
was O O
an O O
up O O
or O O
down O O
regulation O O
at O O
one O O
or O O
more O O
time O O
points O O
as O O
measured O O
in O O
mRNA O O
without O O
a O O
corresponding O O
-LRB- O O
either O O
up O O
or O O
down O O
-RRB- O O
regulation O O
as O O
measured O O
by O O
transcription O O
at O O
any O O
time O O
point O O
. O O

The O O
second O O
largest O O
group O O
of O O
regulated O O
genes O O
-LRB- O O
27.4 O O
% O O
-RRB- O O
showed O O
changes O O
in O O
transcription O O
with O O
no O O
corresponding O O
change O O
in O O
polyA O O
mRNA O O
. O O

Examples O O
of O O
genes O O
dramatically O O
up-regulated O O
in O O
this O O
second O O
class O O
included O O
CD69 O O
, O O
a O O
type O O
II O O
transmembrane O O
receptor O O
involved O O
in O O
lymphocyte O O
proliferation O O
and O O
a O O
classic O O
marker O O
of O O
early O O
T O O
cell O O
activation O O
; O O
PPP3C O O
, O O
the O O
catalytic O O
subunit O O
of O O
the O O
calmodulin-activated O O
phosphatase O O
, O O
calcineurin O O
, O O
which O O
plays O O
a O O
central O O
role O O
in O O
signal O O
transduction O O
from O O
the O O
T O O
cell O O
receptor O O
to O O
the O O
nucleus O O
; O O
as O O
well O O
as O O
several O O
members O O
of O O
the O O
JUN O O
family O O
of O O
transcription O O
factor O O
immediate O O
early O O
response O O
genes O O
-LRB- O O
Fig. O O
3A O O
-RRB- O O
. O O

The O O
final O O
, O O
relatively O O
minor O O
groups O O
of O O
regulated O O
genes O O
included O O
genes O O
which O O
were O O
regulated O O
at O O
both O O
the O O
transcriptional O O
and O O
the O O
polyA O O
mRNA O O
levels O O
in O O
either O O
the O O
same O O
-LRB- O O
8.4 O O
% O O
-RRB- O O
or O O
opposite O O
directions O O
-LRB- O O
9 O O
% O O
-RRB- O O
. O O

The O O
relatively O O
low O O
concordance O O
between O O
transcriptional O O
production O O
of O O
mRNA O O
and O O
its O O
measured O O
appearance O O
in O O
polyA O O
mRNA O O
levels O O
was O O
somewhat O O
surprising O O
, O O
although B-conn Concession.Contra-expectation
clear O O
examples O O
of O O
coordinated O O
step-wise O O
production O O
were O O
noted O O
for O O
some O O
key O O
genes O O
, O O
as O O
for O O
example O O
, O O
the O O
early O O
response O O
genes O O
EGR1 O O
and O O
ETR101 O O
-LRB- O O
previously O O
shown O O
to O O
be O O
induced O O
at O O
30 O O
minutes O O
by O O
phorbol O O
ester O O
treatment O O
of O O
a O O
human O O
promyelocytic O O
leukemia O O
cell O O
line O O
-LSB-16 O O
-RSB- O O
and O O
, O O
the O O
apoptosis-related O O
genes O O
DAP O O
-LRB- O O
death-associated O O
protein O O
, O O
mediator O O
of O O
interferon-gamma-induced O O
apoptosis O O
-RRB- O O
and O O
CASP3 O O
, O O
as O O
well O O
as O O
the O O
immune O O
response O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
-LRB- O O
STAT O O
-RRB- O O
6 O O
-LRB- O O
Fig. O O
3A O O
-RRB- O O
. O O

Dramatic O O
activation O O
of O O
immune O O
response O O
, O O
immediate-early O O
response O O
genes O O
, O O
and O O
apoptosis-related O O
genes O O
was O O
observed O O
in O O
the O O
nuclear O O
run-on O O
RNA O O
as O O
early O O
as O O
5 O O
minutes O O
following O O
activation O O
-LRB- O O
Fig. O O
3A O O
-RRB- O O
. O O

This O O
group O O
of O O
genes O O
included O O
immediate-early O O
response O O
genes O O
commonly O O
up-regulated O O
during O O
cellular O O
activation O O
-LRB- O O
ETR101 O O
, O O
Myb O O
, O O
Myc O O
, O O
and O O
genes O O
of O O
the O O
JUN O O
and O O
EGR O O
families O O
-RRB- O O
, O O
genes O O
specifically O O
associated O O
with O O
an O O
early O O
response O O
in O O
immune O O
cells O O
-LRB- O O
IL6 O O
, O O
IL8 O O
, O O
STAT4 O O
, O O
STAT6 O O
, O O
PPP3C O O
, O O
NFKBIA O O
, O O
IRF5 O O
, O O
and O O
CD69 O O
-RRB- O O
, O O
as O O
well O O
as O O
genes O O
involved O O
in O O
regulating O O
apoptosis O O
-LRB- O O
BCL2A1 O O
, O O
CASP3 O O
, O O
CASP9 O O
, O O
CASP10 O O
, O O
and O O
DAP O O
-RRB- O O
. O O

Many O O
of O O
these O O
same O O
genes O O
were O O
eventually O O
up-regulated O O
in O O
polyA O O
mRNA O O
later O O
in O O
the O O
time O O
course O O
and B-conn Conjunction
their O O
increase O O
in O O
expression O O
after O O
one O O
hour O O
was O O
independently O O
validated O O
by O O
single O O
end-point O O
PCR O O
validation O O
using O O
GS320 O O
technology O O
-LRB- O O
Fig. O O
3B O O
-RRB- O O
. O O

A O O
particularly O O
interesting O O
example O O
of O O
the O O
dichotomy O O
between O O
transcription O O
and O O
changes O O
in O O
polyA O O
mRNA O O
levels O O
was O O
seen O O
in O O
the O O
production O O
of O O
the O O
mRNAs O O
encoding O O
NFKB1 O O
-LRB- O O
NF-kappa O O
B O O
-RRB- O O
, O O
a O O
key O O
mediator O O
of O O
the O O
transcriptional O O
control O O
of O O
genes O O
involved O O
in O O
the O O
immune O O
response O O
and O O
acute O O
phase O O
reactions O O
, O O
and O O
its O O
inhibitor O O
, O O
NFKBIA O O
-LRB- O O
NF-kappa O O
B O O
inhibitor O O
A O O
-RRB- O O
. O O

Both O O
NFKB1 O O
and O O
NFKBIA O O
have O O
previously O O
been O O
shown O O
by O O
microarray O O
analysis O O
to O O
be O O
significantly O O
induced O O
in O O
polyA O O
mRNA O O
between O O
3–4 O O
hrs O O
following O O
phorbol O O
or O O
lectin O O
activation O O
of O O
either O O
Jurkat O O
or O O
human O O
peripheral O O
blood O O
lymphocytes O O
-LSB-7,8,11,17 O O
-RSB- O O
. O O

As O O
demonstrated O O
here O O
-LRB- O O
Fig. O O
3C O O
-RRB- O O
, O O
the O O
production O O
of O O
NFKB1 O O
mRNA O O
clearly O O
increases O O
between O O
30 O O
minutes O O
and O O
one O O
hour O O
at O O
the O O
transcriptional O O
level O O
without O O
a O O
detectable O O
corresponding O O
increase O O
in O O
polyA O O
mRNA O O
during O O
that O O
time O O
-LRB- O O
subsequent O O
PCR O O
analysis O O
did O O
show O O
some O O
increase O O
at O O
the O O
steady-state O O
level O O
between O O
0 O O
and O O
60 O O
minutes O O
for O O
the O O
NFKB1 O O
gene O O
but B-conn Concession.Contra-expectation
this O O
increase O O
failed O O
to O O
meet O O
the O O
significance O O
thresholds O O
set O O
for O O
the O O
microarray O O
analysis O O
-RRB- O O
. O O

NFKBIA O O
, O O
on B-conn Contrast
the I-conn Contrast
other I-conn Contrast
hand I-conn Contrast
, O O
is O O
rapidly O O
induced O O
transcriptionally O O
to O O
a O O
maximum O O
level O O
by O O
30 O O
minutes O O
, O O
returning O O
essentially O O
to O O
baseline O O
within O O
one O O
hour O O
. O O

Meanwhile B-conn Conjunction
, O O
NFKBIA O O
steady-state O O
levels O O
can O O
be O O
seen O O
to O O
gradually O O
rise O O
across O O
the O O
first O O
hour O O
of O O
the O O
time O O
course O O
. O O

Analysis O O
of O O
the O O
dynamics O O
of O O
gene O O
expression O O
for O O
NFKB1 O O
and O O
its O O
inhibitor O O
as O O
deduced O O
from O O
conventional O O
microarrays O O
might O O
suggest O O
that O O
by O O
one O O
hour O O
NFKB1 O O
production O O
had O O
not O O
yet O O
begun O O
-LRB- O O
contradicted O O
by O O
the O O
NRO O O
data O O
here O O
-RRB- O O
, O O
and B-conn Conjunction
also O O
that O O
the O O
mRNA O O
for O O
the O O
inhibitor O O
of O O
NKFKB1 O O
is O O
steadily O O
increasing O O
-LRB- O O
when O O
, O O
in O O
fact O O
, O O
it O O
is O O
clear O O
from O O
NRO O O
data O O
that O O
virtually O O
all O O
increases O O
in O O
the O O
production O O
of O O
NFKBIA O O
have O O
concluded O O
by O O
one O O
hour O O
-RRB- O O
. O O

These O O
data O O
provide O O
a O O
clear O O
example O O
of O O
how O O
information O O
from O O
nuclear O O
run-on O O
microarrays O O
can O O
enhance O O
studies O O
of O O
gene O O
activation O O
and O O
feedback O O
mechanisms O O
. O O

Consistency O O
at O O
each O O
time O O
point O O
for O O
genes O O
regulated O O
by O O
activation-induced O O
changes O O
in O O
mRNA O O
stability O O
can O O
be O O
seen O O
in O O
a O O
graph O O
of O O
the O O
Z O O
ratio O O
differences O O
-LRB- O O
Methods O O
-RRB- O O
between O O
NRO O O
and O O
polyA O O
mRNA O O
calculated O O
for O O
all O O
genes O O
at O O
all O O
time O O
points O O
-LRB- O O
Fig. O O
4A O O
-RRB- O O
. O O

These O O
putative O O
stability-regulated O O
genes O O
exhibited O O
a O O
very O O
high O O
degree O O
of O O
consistency O O
at O O
all O O
the O O
time O O
points O O
measured O O
. O O

This O O
replicability O O
is O O
further O O
illustrated O O
in O O
the O O
heat O O
map O O
of O O
clustered O O
gene O O
expression O O
in O O
Figure O O
4B O O
in O O
which O O
the O O
data O O
for O O
each O O
gene O O
has O O
been O O
independently O O
normalized O O
to O O
its O O
baseline O O
-LRB- O O
0 O O
time O O
-RRB- O O
level O O
. O O

Large O O
numbers O O
of O O
genes O O
as O O
measured O O
in O O
the O O
polyA O O
mRNA O O
are O O
consistently O O
and O O
strongly O O
regulated O O
following B-conn Temporal.Succession
activation O O
. O O

Some O O
of O O
these O O
changes O O
are O O
mirrored O O
by O O
changes O O
in O O
gene O O
transcription O O
-LRB- O O
NRO O O
-RRB- O O
but B-conn Concession.Contra-expectation
most O O
are O O
not O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
compare O O
changes O O
in O O
gene O O
expression O O
patterns O O
at O O
the O O
transcriptional O O
and O O
polyA O O
mRNA O O
levels O O
in O O
a O O
systematic O O
fashion O O
, O O
a O O
simple O O
barcode O O
of O O
1 O O
, O O
-1 O O
, O O
or O O
0 O O
was O O
applied O O
to O O
all O O
significant O O
changes O O
in O O
gene O O
expression O O
indicating O O
up O O
, O O
down O O
, O O
or O O
no O O
change O O
, O O
respectively O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
a O O
value O O
of O O
-1 O O
, O O
0 O O
, O O
or O O
1 O O
-LRB- O O
low O O
, O O
moderate O O
, O O
or O O
high O O
-RRB- O O
was O O
assigned O O
to O O
each O O
gene O O
according O O
to O O
its O O
relative O O
intensity O O
at O O
baseline O O
-LRB- O O
0 O O
time O O
-RRB- O O
. O O

An O O
analysis O O
of O O
the O O
distribution O O
of O O
these O O
gene O O
expression O O
patterns O O
-LRB- O O
Fig. O O
5 O O
-RRB- O O
revealed O O
that O O
both O O
at O O
the O O
transcriptional O O
and O O
the O O
steady-state O O
levels O O
two O O
thirds O O
of O O
all O O
genes O O
were O O
restricted O O
to O O
just O O
one O O
of O O
20 O O
patterns O O
-LRB- O O
out O O
of O O
a O O
possible O O
number O O
of O O
729 O O
-RRB- O O
and B-conn Conjunction
that O O
half O O
of O O
these O O
patterns O O
were O O
shared O O
between O O
the O O
two O O
groups O O
. O O

An O O
interesting O O
distinction O O
between O O
the O O
two O O
groups O O
was O O
that O O
whereas B-conn Contrast
up-regulation O O
from O O
a O O
moderately O O
high O O
level O O
of O O
baseline O O
expression O O
was O O
highly O O
favored O O
for O O
new O O
gene O O
synthesis O O
, O O
down-regulation O O
from O O
a O O
moderately O O
high O O
level O O
of O O
baseline O O
expression O O
was O O
very O O
highly O O
favored O O
during O O
polyA O O
mRNA O O
regulation O O
-LRB- O O
Fig. O O
6 O O
-RRB- O O
. O O

In B-conn Reinforcement
fact I-conn Reinforcement
, O O
down-regulation O O
, O O
as O O
a O O
consistent O O
trend O O
, O O
was O O
much O O
less O O
common O O
among O O
transcriptional-regulated O O
than O O
steady-state-regulated O O
genes O O
, O O
with O O
implications O O
-LRB- O O
see O O
below O O
-RRB- O O
as O O
to O O
the O O
roles O O
these O O
modes O O
of O O
regulation O O
play O O
in O O
concert O O
for O O
the O O
control O O
of O O
gene O O
expression O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
confirm O O
that O O
stability O O
regulation O O
was O O
in O O
fact O O
a O O
reasonable O O
explanation O O
for O O
the O O
observation O O
that O O
the O O
expression O O
levels O O
of O O
large O O
numbers O O
of O O
genes O O
were O O
changing O O
at O O
the O O
whole O O
cell O O
but O O
not O O
the O O
transcriptional O O
level O O
, O O
a O O
series O O
of O O
experiments O O
were O O
carried O O
out O O
in O O
which O O
activation O O
of O O
Jurkat O O
cells O O
was O O
carried O O
out O O
in O O
the O O
presence O O
or O O
absence O O
of O O
the O O
transcription O O
inhibitor O O
Actinomycin O O
D. O O
Analysis O O
of O O
polyA O O
mRNA O O
demonstrated O O
the O O
strong O O
inhibition O O
of O O
mRNA O O
levels O O
for O O
genes O O
previously O O
shown O O
to O O
be O O
transcriptionally O O
up-regulated O O
-LRB- O O
Fig. O O
7A O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
large O O
numbers O O
of O O
genes O O
which O O
were O O
significantly O O
regulated O O
in O O
polyA O O
mRNA O O
but O O
not O O
in O O
NRO O O
RNA O O
were O O
not O O
affected O O
by O O
Actinomycin O O
D O O
treatment O O
-LRB- O O
Fig. O O
7B O O
&7C O O
-RRB- O O
. O O

Among O O
these O O
unaffected O O
genes O O
there O O
was O O
a O O
bias O O
towards O O
presumptively O O
de-stablized O O
genes O O
-LRB- O O
Fig. O O
7C O O
-RRB- O O
consistent O O
with O O
the O O
earlier O O
conclusion O O
-LRB- O O
Fig. O O
6B O O
-RRB- O O
that O O
down-regulation O O
is O O
the O O
predominant O O
motif O O
in O O
overall O O
polyA O O
mRNA O O
levels O O
. O O

Although B-conn Concession.Expectation
an O O
examination O O
of O O
the O O
functional O O
classifications O O
of O O
stability O O
regulated O O
versus O O
transcriptionally O O
regulated O O
genes O O
yielded O O
no O O
obvious O O
trends O O
, O O
some O O
biological O O
pathways O O
appear O O
to O O
be O O
differentially O O
, O O
and O O
sometimes O O
, O O
exhaustively O O
regulated O O
by O O
each O O
type O O
of O O
expression O O
event O O
. O O

One O O
example O O
of O O
this O O
can O O
be O O
seen O O
in O O
the O O
apoptotic O O
pathways O O
, O O
which O O
are O O
comprehensively O O
regulated O O
during O O
the O O
Jurkat O O
activation O O
scenario O O
-LSB-16,18,19 O O
-RSB- O O
. O O

As O O
can O O
be O O
seen O O
from O O
the O O
pathway O O
schematic O O
illustrated O O
in O O
Figure O O
8 O O
, O O
some O O
major O O
effectors O O
of O O
apoptosis O O
such O O
as O O
CASP O O
3 O O
, O O
4 O O
, O O
8 O O
, O O
9 O O
, O O
&10 O O
-LRB- O O
up-regulated O O
-RRB- O O
and O O
BCL2 O O
-LRB- O O
down-regulated O O
-RRB- O O
, O O
are O O
controlled O O
by O O
new O O
gene O O
synthesis O O
while B-conn Contrast
other O O
factors O O
such O O
as O O
CASP O O
1 O O
, O O
6 O O
, O O
&7 O O
-LRB- O O
up-regulated O O
-RRB- O O
and O O
BCL2L2 O O
-LRB- O O
down-regulated O O
-RRB- O O
appear O O
to O O
be O O
regulated O O
by O O
stability O O
processes O O
alone O O
. O O

Regardless B-conn Concession.Expectation
of I-conn Concession.Expectation
the O O
cellular O O
rationale O O
for O O
regulating O O
at O O
the O O
level O O
of O O
new O O
gene O O
synthesis O O
or O O
mRNA O O
stability O O
, O O
it O O
is O O
clear O O
from O O
these O O
data O O
that O O
there O O
is O O
a O O
strong O O
internal O O
coherence O O
: O O
genes O O
regulated O O
by O O
one O O
mechanism O O
do O O
not O O
crossover O O
to O O
the O O
other O O
within O O
the O O
time O O
frame O O
investigated O O
. O O

Common O O
patterns O O
of O O
transcription O O
factor O O
binding O O
sites O O
in O O
the O O
upstream O O
promoter O O
regions O O
of O O
groups O O
of O O
genes O O
whose O O
transcription O O
was O O
significantly O O
up-regulated O O
were O O
detected O O
. O O

An O O
enrichment O O
of O O
transcription O O
factor-binding O O
sites O O
for O O
both O O
NFAT O O
and O O
NFκB O O
was O O
found O O
in O O
the O O
promoter O O
regions O O
of O O
genes O O
most O O
significantly O O
up-regulated O O
at O O
1 O O
hour O O
as O O
shown O O
in O O
Figure O O
9 O O
. O O

The O O
frequency O O
with O O
which O O
both O O
NFAT- O O
and O O
NFκB-binding O O
sites O O
were O O
found O O
in O O
the O O
promoters O O
of O O
this O O
group O O
of O O
genes O O
was O O
significantly O O
greater O O
than O O
that O O
seen O O
for O O
other O O
genes O O
in O O
the O O
array O O
-LSB-e.g. O O
, O O
genes O O
down-regulated O O
at O O
this O O
time O O
point O O
or O O
genes O O
selected O O
at O O
random O O
-LSB-supplemental O O
data O O
-RSB- O O
. O O

The O O
discovery O O
that O O
NFAT- O O
and O O
NFκB-binding O O
sites O O
were O O
enriched O O
in O O
the O O
promoters O O
of O O
these O O
genes O O
was O O
not O O
unexpected O O
, O O
since B-conn Cause.Justification
these O O
transcription O O
factors O O
, O O
along O O
with O O
AP-1 O O
components O O
Fos O O
and O O
Jun O O
, O O
constitute O O
the O O
major O O
transcription O O
factors O O
involved O O
in O O
the O O
early O O
stages O O
of O O
T-cell O O
activation O O
. O O

Indeed B-conn Reinforcement
, O O
the O O
frequency O O
of O O
genes O O
significantly O O
up-regulated O O
in O O
NRO O O
RNA O O
and O O
enriched O O
for O O
AP-1 O O
binding O O
sites O O
peaks O O
during O O
the O O
time O O
course O O
-LRB- O O
supplemental O O
data O O
-RRB- O O
. O O

Many O O
of O O
the O O
genes O O
that O O
are O O
transcriptionally O O
upregulated O O
at O O
1 O O
hour O O
, O O
such O O
as O O
CD69 O O
, O O
are O O
elevated O O
throughout O O
the O O
time O O
examined O O
, O O
although B-conn Concession.Contra-expectation
a O O
few O O
genes O O
including O O
PTEN O O
, O O
DUSP5 O O
, O O
and O O
NFκB1 O O
itself O O
, O O
show O O
elevated O O
transcription O O
only O O
after O O
60 O O
minutes O O
. O O

The O O
simultaneous O O
increase O O
of O O
NFκB1 O O
gene O O
transcription O O
-LRB- O O
between O O
30 O O
minutes O O
and O O
1 O O
hour O O
-RRB- O O
combined O O
with O O
a O O
noticeable O O
increase O O
in O O
the O O
transcription O O
of O O
genes O O
containing O O
NFκB-binding O O
sites O O
-LRB- O O
at O O
one O O
hour O O
-RRB- O O
demonstrates O O
the O O
synchronous O O
relationship O O
between O O
the O O
appearance O O
of O O
this O O
transcription O O
factor O O
and O O
its O O
downstream O O
targets O O
at O O
the O O
indicated O O
time O O
points O O
. O O

Discussion O O

The O O
absence O O
of O O
significant O O
regulation O O
at O O
the O O
transcriptional O O
level O O
during O O
a O O
time O O
in O O
which O O
gene O O
expression O O
is O O
strongly O O
perturbed O O
at O O
the O O
polyA O O
mRNA O O
level O O
during O O
T O O
cell O O
activation O O
reveals O O
that O O
many O O
genes O O
are O O
being O O
regulated O O
through O O
changes O O
in O O
stability O O
. O O

The O O
lack O O
of O O
detectable O O
transcriptional O O
regulation O O
of O O
large O O
numbers O O
of O O
steady-state O O
mRNA O O
gene O O
changes O O
is O O
particularly O O
striking O O
insofar B-conn Cause.Reason
as I-conn Cause.Reason
the O O
NRO O O
measurements O O
are O O
likely O O
to O O
be O O
even O O
more O O
sensitive O O
to O O
changes O O
in O O
gene O O
expression O O
than O O
polyA O O
mRNA O O
measurements O O
since B-conn Cause.Reason
they O O
are O O
a O O
direct O O
measure O O
of O O
newly O O
synthesized O O
mRNA O O
. O O

This O O
finding O O
is O O
consistent O O
with O O
the O O
work O O
of O O
Raghavan O O
et O O
. O O

al. O O
-LSB-12,20 O O
-RSB- O O
who O O
also O O
noted O O
the O O
presence O O
of O O
numerous O O
transcripts O O
exhibiting O O
stimulus-dependent O O
changes O O
in O O
mRNA O O
decay O O
in O O
human O O
T O O
lymphocytes O O
treated O O
for O O
3 O O
hours O O
with O O
anti-CD3 O O
and/or O O
anti-CD28 O O
antibodies O O
. O O

These O O
experiments O O
were O O
carried O O
out O O
by B-conn Purpose.Enablement
arresting O O
transcription O O
with O O
Actinomycin O O
D O O
-LRB- O O
in O O
the O O
presence O O
or O O
absence O O
of O O
activation O O
-RRB- O O
, O O
and B-conn Conjunction
mRNA O O
turnover O O
rates O O
were O O
globally O O
measured O O
by B-conn Purpose.Enablement
applying O O
polyA O O
mRNA O O
to O O
microarrays O O
. O O

Similarly B-conn Similarity
, O O
in O O
this O O
current O O
work O O
, O O
patterns O O
of O O
Actinomycin O O
D O O
resistant O O
changes O O
in O O
gene O O
expression O O
among O O
groups O O
of O O
genes O O
significantly O O
regulated O O
only O O
at O O
the O O
polyA O O
mRNA O O
level O O
supports O O
the O O
observation O O
that O O
large O O
numbers O O
of O O
genes O O
are O O
regulated O O
primarily O O
by B-conn Cause.Reason
stability O O
during O O
T O O
cell O O
activation O O
. O O

The O O
smaller O O
, O O
but O O
still O O
substantial O O
, O O
group O O
of O O
genes O O
which O O
displayed O O
significant O O
transcriptional O O
regulation O O
without O O
any O O
corresponding O O
changes O O
in O O
polyA O O
mRNA O O
, O O
may O O
either O O
be O O
a O O
reflection O O
of O O
the O O
enhanced O O
sensitivity O O
of O O
transcriptional O O
detection O O
or O O
, O O
perhaps O O
, O O
result O O
from O O
a O O
persistent O O
lag O O
between O O
changes O O
in O O
transcriptional O O
output O O
and O O
their O O
reflection O O
in O O
steady-state O O
mRNA O O
levels O O
. O O

Such O O
a O O
lag O O
might O O
arise O O
from O O
differences O O
in O O
scale O O
of O O
the O O
absolute O O
size O O
of O O
mRNA O O
pools O O
between O O
newly O O
transcribed O O
and O O
polyA O O
mRNA O O
. O O

In O O
this O O
scenario O O
, O O
changes O O
in O O
the O O
amounts O O
of O O
mRNA O O
that O O
are O O
readily O O
detectable O O
by O O
nuclear O O
run-on O O
may O O
be O O
too O O
small O O
to O O
have O O
an O O
immediate O O
detectable O O
impact O O
on O O
the O O
steady-state O O
RNA O O
pools O O
, O O
possibly O O
for O O
long O O
periods O O
of O O
time O O
. O O

Another O O
possibility O O
is O O
that O O
the O O
nascent O O
mRNAs O O
of O O
some O O
of O O
these O O
genes O O
are O O
so O O
rapidly O O
degraded O O
that O O
they O O
never O O
significantly O O
impact O O
on O O
polyA O O
mRNA O O
levels O O
at O O
all O O
. O O

As O O
previously O O
noted O O
-LRB- O O
Fig. O O
6 O O
-RRB- O O
, O O
up-regulation O O
of O O
gene O O
expression O O
was O O
a O O
dominant O O
trend O O
for O O
transcriptionally O O
regulated O O
genes O O
while B-conn Contrast
down-regulation O O
was O O
dramatically O O
favored O O
for O O
genes O O
regulated O O
at O O
the O O
polyA O O
mRNA O O
level O O
. O O

From O O
the O O
standpoint O O
of O O
an O O
overall O O
cellular O O
economy O O
of O O
gene O O
expression O O
, O O
effective O O
control O O
at O O
the O O
level O O
of O O
transcription O O
can O O
be O O
achieved O O
primarily B-conn Purpose.Enablement
by I-conn Purpose.Enablement
turning O O
on O O
new O O
gene O O
transcription O O
, O O
while B-conn Contrast
at O O
the O O
whole-cell O O
level O O
, O O
rapid O O
and O O
effective O O
regulation O O
can O O
be O O
achieved O O
by B-conn Purpose.Enablement
massive O O
shifts O O
in O O
the O O
stability O O
of O O
existing O O
mRNA O O
pools O O
. O O

In B-conn Reinforcement
fact I-conn Reinforcement
, O O
the O O
single O O
most O O
dramatic O O
regulatory O O
event O O
experimentally O O
observed O O
was O O
the O O
rapid O O
clearance O O
of O O
large O O
pools O O
of O O
steady-state O O
mRNA O O
, O O
presumably B-conn Cause.Reason
as I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
a O O
sudden O O
and O O
demanding O O
change O O
in O O
cellular O O
conditions O O
. O O

Questions O O
remain O O
as O O
to O O
the O O
extent O O
that O O
this O O
type O O
of O O
regulation O O
may O O
occur O O
under O O
differing O O
biological O O
scenarios O O
. O O

Global O O
regulation O O
of O O
mRNA O O
stability O O
has O O
thus O O
far O O
been O O
systematically O O
studied O O
under O O
conditions O O
of O O
stress O O
and O O
cellular O O
activation O O
. O O

It O O
remains O O
to O O
be O O
determined O O
whether O O
or O O
not O O
changes O O
in O O
mRNA O O
stability O O
are O O
responsible O O
for O O
altering O O
gene O O
expression O O
programs O O
in O O
response O O
to O O
other O O
biological O O
conditions O O
. O O

The O O
existence O O
of O O
these O O
regulatory O O
paradigms O O
may O O
require O O
a O O
reevaluation O O
of O O
the O O
common O O
model O O
of O O
the O O
control O O
of O O
gene O O
expression O O
which O O
essentially O O
invokes O O
the O O
turning O O
on O O
and O O
off O O
of O O
gene O O
transcription O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
explain O O
changes O O
in O O
polyA O O
mRNA O O
levels O O
. O O

Conclusion O O

Although B-conn Concession.Expectation
stability O O
regulation O O
might O O
reasonably O O
be O O
considered O O
as O O
a O O
cellular O O
measure O O
to B-conn Purpose.Goal
bridge O O
the O O
gap O O
between O O
the O O
very O O
rapid O O
events O O
of O O
signal O O
transduction O O
and O O
the O O
longer O O
term O O
induction O O
of O O
cellular O O
programs O O
involving O O
the O O
coordinated O O
transcription O O
of O O
batteries O O
of O O
new O O
gene O O
synthesis O O
, O O
the O O
current O O
data O O
actually O O
suggests O O
otherwise O O
. O O

One O O
of O O
the O O
goals O O
in O O
this O O
work O O
was O O
to O O
examine O O
changes O O
in O O
gene O O
expression O O
due B-conn Cause.Reason
to I-conn Cause.Reason
altered O O
transcription O O
and O O
those O O
due B-conn Cause.Reason
to I-conn Cause.Reason
altered O O
turnover O O
across O O
a O O
time O O
course O O
allowing O O
sufficient O O
time O O
for O O
the O O
resolution O O
of O O
time O O
disparities O O
between O O
new O O
mRNA O O
synthesis O O
and O O
their O O
appearance O O
as O O
measurable O O
cellular O O
pools O O
. O O

Sufficient O O
time O O
for O O
effective O O
transcription O O
and O O
even O O
translation O O
was O O
clearly O O
demonstrated O O
by O O
the O O
example O O
of O O
NFKB1 O O
mRNA O O
induction O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
the O O
transcription O O
of O O
its O O
downstream O O
targets O O
. O O

Patterns O O
of O O
stability O O
regulated O O
genes O O
were O O
, O O
in O O
this O O
model O O
system O O
, O O
non-random O O
and O O
surprisingly O O
persistent O O
throughout O O
the O O
entire O O
time O O
course O O
suggesting O O
that O O
stability O O
regulation O O
was O O
a O O
major O O
component O O
in O O
the O O
control O O
of O O
gene O O
expression O O
for O O
significant O O
periods O O
of O O
time O O
. O O

The O O
presence O O
of O O
highly O O
active O O
and O O
global O O
regulation O O
of O O
polyA O O
mRNA O O
levels O O
by O O
stability-altering O O
mechanisms O O
suggests O O
a O O
new O O
significant O O
level O O
of O O
regulation O O
in O O
the O O
control O O
of O O
gene O O
expression O O
which O O
spans O O
wide O O
phylogenetic O O
distances O O
from O O
yeast O O
-LSB-15 O O
-RSB- O O
to O O
humans O O
, O O
emphasizes O O
a O O
possible O O
parsimonious O O
role O O
for O O
new O O
gene O O
synthesis O O
in O O
response O O
to O O
changing O O
cellular O O
environments O O
, O O
and O O
may O O
help O O
to O O
explain O O
some O O
of O O
the O O
difficulties O O
encountered O O
in O O
attempts O O
to O O
comprehensively O O
correlate O O
clustered O O
changes O O
in O O
polyA O O
mRNA O O
with O O
common O O
promoter O O
regulatory O O
elements O O
. O O

Methods O O

The O O
human O O
Jurkat O O
E6-1 O O
T O O
cell O O
line O O
was O O
cultured O O
in O O
RPMI-1640 O O
medium O O
-LRB- O O
GIBCO-BRL O O
, O O
Gaithersburg O O
, O O
MD O O
-RRB- O O
supplemented O O
with O O
10 O O
% O O
FCS O O
-LRB- O O
Hyclone O O
, O O
Logan O O
, O O
UT O O
-RRB- O O
and O O
antibiotics O O
, O O
and O O
incubated O O
at O O
37°C O O
, O O
5 O O
% O O
CO2 O O
. O O

Cells O O
were O O
stimulated O O
with O O
40 O O
ng/ml O O
phorbol O O
12-myristate O O
13-acetate O O
-LRB- O O
PMA O O
-RRB- O O
and O O
1 O O
μM O O
ionomycin O O
-LRB- O O
Sigma O O
, O O
St. O O
Louis O O
, O O
MO O O
-RRB- O O
-LRB- O O
P+I O O
-RRB- O O
. O O

Actinomycin O O
D O O
-LRB- O O
A.G. O O

Scientific O O
, O O
San O O
Diego O O
, O O
CA O O
-RRB- O O
was O O
added O O
at O O
10 O O
ug/ml O O
30 B-conn Temporal.Precedence
minutes I-conn Temporal.Precedence
prior I-conn Temporal.Precedence
to I-conn Temporal.Precedence
activation O O
with O O
PMA O O
+ O O
I O O
. O O

Isolation O O
of O O
nuclei O O
and O O
preparation O O
of O O
nuclear O O
run-on O O
-LRB- O O
NRO O O
-RRB- O O
RNA O O
were O O
as O O
described O O
-LSB-6,21 O O
-RSB- O O
with O O
some O O
modifications O O
. O O

Briefly B-conn Restatement.Specification
, O O
~108 O O
cells O O
per O O
sample O O
were O O
pelleted O O
, O O
washed O O
with O O
PBS O O
, O O
resuspended O O
in O O
ice-cold O O
lysis O O
buffer O O
-LRB- O O
20 O O
mM O O
Tris-HCl O O
-LSB-pH O O
7.4 O O
-RSB- O O
, O O
20 O O
mM O O
NaCl O O
, O O
5 O O
mM O O
MgCl2 O O
, O O
0.25 O O
% O O
-LSB-v/v O O
-RSB- O O
NP-40 O O
-RRB- O O
, O O
and O O
incubated O O
on O O
ice O O
for O O
5 O O
min O O
. O O

Nuclei O O
were O O
spun O O
down O O
, O O
resuspended O O
in O O
storage O O
buffer O O
-LRB- O O
50 O O
mM O O
Tris-HCl O O
-LSB-pH O O
8.3 O O
-RSB- O O
, O O
5 O O
mM O O
MgCl2 O O
, O O
0.1 O O
mM O O
EDTA-NaOH O O
-LSB-pH O O
8.0 O O
-RSB- O O
, O O
40 O O
% O O
-LSB-v/v O O
-RSB- O O
glycerol O O
-RRB- O O
and B-conn Conjunction
stored O O
at O O
-80°C O O
until B-conn Temporal.Precedence
use O O
. O O

Thawed O O
nuclei O O
-LRB- O O
200-μl O O
aliquots O O
-RRB- O O
were O O
mixed O O
with O O
200 O O
μl O O
of O O
reaction O O
buffer O O
-LRB- O O
5 O O
mM O O
Tris-HCl O O
-LSB-pH O O
8.0 O O
-RSB- O O
, O O
0.15 O O
mM O O
KCl O O
, O O
2.5 O O
mM O O
MgCl2 O O
, O O
2.5 O O
mM O O
DTT O O
, O O
0.5 O O
mM O O
of O O
each O O
ATP O O
, O O
UTP O O
, O O
GTP O O
-RRB- O O
plus O O
500 O O
μCi O O
of O O
-LSB-α-33P O O
-RSB- O O
UTP O O
-LRB- O O
3,000 O O
Ci/mmol O O
, O O
10 O O
mCi/ml O O
; O O
ICN O O
-RRB- O O
, O O
and O O
incubated O O
for O O
30 O O
min O O
at O O
30°C O O
with O O
shaking O O
. O O

Samples O O
were O O
then B-conn Temporal.Precedence
incubated O O
with O O
DNase O O
I O O
-LRB- O O
100U O O
, O O
RNase-free O O
; O O
Roche O O
Diagnostics O O
-RRB- O O
for O O
20 O O
min O O
at O O
37°C O O
, O O
and O O
with O O
proteinase O O
K O O
-LRB- O O
1 O O
μg/μl O O
-RRB- O O
for O O
1 O O
h O O
at O O
37°C O O
. O O

Finally B-conn Temporal.Precedence
, O O
nascent O O
RNA O O
was O O
purified O O
by O O
Sephadex O O
G-50 O O
column O O
filtration O O
. O O

For B-conn Purpose.Goal
the O O
preparation O O
of O O
polyA O O
mRNA O O
cellular O O
RNA O O
, O O
resting O O
or O O
stimulated O O
Jurkat O O
cells O O
were O O
lysed O O
in O O
STAT60™ O O
-LRB- O O
TEL-TEST O O
, O O
INC. O O
, O O
Friendswood O O
, O O
TX O O
-RRB- O O
as O O
described O O
-LSB-6 O O
-RSB- O O
. O O

RNA O O
concentration O O
and O O
quality O O
were O O
assessed O O
spectrophotometrically O O
and O O
by O O
agarose O O
gel O O
electrophoresis O O
. O O

NRO O O
RNA O O
was O O
stored O O
at O O
-80°C O O
until B-conn Temporal.Precedence
use O O
. O O

PolyA O O
mRNA O O
samples O O
were O O
radiolabeled O O
and O O
hybridized O O
as O O
previously O O
described O O
-LSB-22 O O
-RSB- O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
5 O O
μg O O
of O O
total O O
mRNA O O
for O O
each O O
sample O O
was O O
annealed O O
, O O
in O O
16 O O
μl O O
H2O O O
, O O
with O O
1 O O
μg O O
of O O
24-mer O O
poly O O
-LRB- O O
dT O O
-RRB- O O
primer O O
-LRB- O O
Research O O
Genetics O O
, O O
Alabama O O
-RRB- O O
, O O
by B-conn Purpose.Enablement
heating O O
at O O
65°C O O
for O O
10 O O
min O O
and O O
cooling O O
on O O
ice O O
for O O
2 O O
min O O
. O O

The O O
RT O O
reaction O O
was O O
performed O O
by B-conn Purpose.Enablement
adding O O
8 O O
μl O O
of O O
5X O O
first O O
strand O O
RT O O
buffer O O
-LRB- O O
Life O O
Technologies O O
, O O
Rockville O O
, O O
MD O O
-RRB- O O
, O O
4 O O
μl O O
of O O
20 O O
mM O O
dNTPs O O
minus O O
dCTP O O
-RRB- O O
-LRB- O O
Pharmacia O O
, O O
Piscataway O O
, O O
NJ O O
-RRB- O O
, O O
4 O O
μl O O
of O O
0.1 O O
M O O
DTT O O
, O O
40 O O
U O O
of O O
RNAseOUT O O
-LRB- O O
Life O O
Technologies O O
-RRB- O O
, O O
6 O O
μl O O
of O O
3000 O O
Ci/mmol O O
α-33P O O
dCTP O O
-LRB- O O
ICN O O
Biomedicals O O
, O O
Costa O O
Mesa O O
, O O
CA O O
-RRB- O O
to O O
the O O
RNA/primer O O
mixture O O
to O O
a O O
final O O
volume O O
of O O
40 O O
μl O O
. O O

Two O O
μl O O
-LRB- O O
400 O O
U O O
-RRB- O O
of O O
Superscript O O
II O O
reverse O O
transcriptase O O
-LRB- O O
Life O O
Technologies O O
-RRB- O O
was O O
then B-conn Temporal.Precedence
added O O
, O O
and B-conn Conjunction
the O O
sample O O
was O O
incubated O O
for O O
60 O O
min O O
at O O
42°C O O
. O O

The O O
reaction O O
was O O
stopped O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
five O O
μl O O
of O O
0.5 O O
M O O
EDTA O O
. O O

The O O
samples O O
were O O
incubated O O
at O O
65°C O O
for O O
30 O O
min O O
after B-conn Temporal.Succession
addition O O
of O O
10 O O
μl O O
of O O
0.1 O O
M O O
NaOH O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
hydrolyze O O
and O O
remove O O
RNA O O
. O O

The O O
samples O O
were O O
pH O O
neutralized O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
25 O O
μl O O
of O O
0.5 O O
M O O
Tris O O
, O O
pH O O
8.0 O O
, O O
and O O
purified O O
using O O
Bio-Rad O O
6 O O
purification O O
columns O O
-LRB- O O
Hercules O O
, O O
CA O O
-RRB- O O
. O O

An O O
aliquout O O
of O O
each O O
labled O O
sample O O
was O O
quantitated O O
by B-conn Purpose.Enablement
liquid O O
scintillation O O
counting O O
using O O
a O O
Beckman O O
LS O O
6500 O O
. O O

The O O
entire O O
remaining O O
sample O O
was O O
stored O O
at O O
-20°C O O
until B-conn Temporal.Precedence
use O O
. O O

Microarray O O
construction O O
and O O
hybridization O O
were O O
previously O O
described O O
-LSB-23 O O
-RSB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
NIA O O
Human O O
Focused O O
Arrays O O
consisting O O
of O O
a O O
set O O
of O O
4600 O O
spotted O O
cDNAs O O
, O O
arrayed O O
in O O
duplicate O O
, O O
representing O O
a O O
set O O
of O O
2742 O O
non-redundant O O
genes O O
-LRB- O O
enriched O O
in O O
genes O O
involved O O
in O O
immune O O
function O O
and O O
signal O O
transduction O O
-RRB- O O
, O O
were O O
printed O O
on O O
Nytran O O
+ O O
Supercharge O O
nylon O O
membranes O O
-LRB- O O
Schleicher O O
& O O
Schuell O O
, O O
Keene O O
, O O
NH O O
-RRB- O O
, O O
and O O
hybridized O O
with O O
-LSB-α-33P O O
-RSB- O O
dCTP-labeled O O
cDNA O O
or O O
-LSB-α-33P O O
-RSB- O O
UTP O O
RNA O O
probes O O
overnight O O
at O O
50°C O O
as O O
previously O O
described O O
-LSB-22 O O
-RSB- O O
, O O
protocols O O
available O O
at O O
. O O

Hybridized O O
arrays O O
were O O
rinsed O O
in O O
2 O O
X O O
SSC O O
and O O
0.1 O O
% O O
SDS O O
twice O O
at O O
55°C O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
washes O O
in O O
2 O O
X O O
SSC O O
and O O
0.1 O O
% O O
SDS O O
at O O
55°C O O
. O O

Microarrays O O
were O O
exposed O O
for O O
1–3 O O
d O O
and O O
scanned O O
using O O
a O O
PhosphorImager O O
-LRB- O O
Molecular O O
Dynamics O O
, O O
Sunnyvale O O
, O O
CA O O
-RRB- O O
at O O
a O O
50-μm O O
pixel O O
resolution O O
. O O

ArrayPro O O
software O O
-LRB- O O
MediaCybernetics O O
, O O
Silver O O
Spring O O
, O O
MD O O
-RRB- O O
was O O
used O O
to O O
convert O O
the O O
hybridization O O
signals O O
into O O
raw O O
intensity O O
values O O
; O O
data O O
generated O O
were O O
transferred O O
into O O
Microsoft O O
Excel O O
for O O
further O O
analysis O O
. O O

Single O O
endpoint O O
PCR O O
was O O
carried O O
out O O
on O O
polyA O O
mRNA O O
for B-conn Purpose.Goal
gene O O
detection O O
and O O
relative O O
quantitative O O
comparison O O
between O O
baseline O O
-LRB- O O
0 O O
time O O
-RRB- O O
and O O
I O O
hour O O
activation O O
-LRB- O O
with O O
PMA O O
+I O O
-RRB- O O
. O O

In B-conn Restatement.Specification
brief I-conn Restatement.Specification
, O O
GS320 O O
libraries O O
for O O
both O O
control O O
and O O
activated O O
polyA O O
mRNA O O
were O O
prepared O O
as O O
described O O
-LSB-24 O O
-RSB- O O
, O O
normalized O O
using O O
a O O
panel O O
of O O
ribosomal O O
protein O O
genes O O
, O O
and B-conn Conjunction
specific O O
genes O O
were O O
amplified O O
in O O
duplicate O O
using O O
predefined O O
GS320 O O
primers O O
. O O

RNA O O
samples O O
-LRB- O O
typically O O
n O O
= O O
3 O O
to O O
n O O
= O O
5 O O
-RRB- O O
were O O
prepared O O
from O O
multiple O O
experiments O O
, O O
each O O
of O O
which O O
consisted O O
of O O
a O O
consecutive O O
series O O
of O O
time O O
points O O
. O O

Equal O O
amounts O O
of O O
total O O
RNA O O
-LRB- O O
5 O O
μg O O
-RRB- O O
or O O
NRO O O
RNA O O
-LRB- O O
108 O O
cell-equivalents O O
-RRB- O O
were O O
used O O
in O O
each O O
hybridization O O
. O O

Raw O O
intensity O O
data O O
for O O
each O O
experiment O O
was O O
transformed O O
to O O
log10 O O
, O O
then B-conn Temporal.Precedence
used O O
for O O
the O O
calculation O O
of O O
Z O O
scores O O
as O O
described O O
-LSB-22 O O
-RSB- O O
-LSB-see O O
Additional O O
file O O
1 O O
-RSB- O O
. O O

Significant O O
changes O O
in O O
gene O O
expression O O
were O O
calculated O O
in O O
the O O
form O O
of O O
Z O O
ratios O O
and/or O O
Z O O
test O O
values O O
-LRB- O O
-LSB-25 O O
-RSB- O O
-RRB- O O
, O O
using O O
Z O O
score O O
values O O
in O O
all O O
calculations O O
. O O

Z O O
ratios O O
constitute O O
a O O
measure O O
of O O
the O O
change O O
in O O
gene O O
expression O O
of O O
a O O
given O O
gene O O
from O O
its O O
baseline O O
value O O
-LRB- O O
in O O
this O O
case O O
– O O
time O O
0 O O
-RRB- O O
, O O
expressed O O
in O O
units O O
of O O
standard O O
deviation O O
from O O
the O O
average O O
change O O
of O O
all O O
genes O O
for O O
that O O
comparison O O
. O O

Z O O
ratios O O
are O O
a O O
direct O O
measure O O
of O O
the O O
likelihood O O
that O O
an O O
observed O O
change O O
is O O
an O O
outlier O O
in O O
an O O
otherwise O O
normal O O
distribution O O
and O O
, O O
as O O
such O O
, O O
are O O
independent O O
from O O
underlying O O
intensity O O
values O O
. O O

Since B-conn Cause.Reason
the O O
contents O O
of O O
the O O
population O O
of O O
nuclear O O
run-on O O
and O O
polyA O O
mRNA O O
are O O
different O O
in O O
both O O
complexity O O
and O O
number O O
, O O
care O O
was O O
taken O O
not O O
to O O
compare O O
Z O O
score O O
normalized O O
intensities O O
directly O O
. O O

Comparisons O O
between O O
Z O O
ratios O O
, O O
however B-conn Concession.Contra-expectation
, O O
test O O
for O O
equivalence O O
of O O
significant O O
changes O O
between O O
the O O
transcriptional O O
and O O
steady-state O O
changes O O
in O O
gene O O
expression O O
each O O
relative O O
to O O
its O O
own O O
population O O
. O O

All O O
gene O O
expression O O
changes O O
were O O
assessed O O
through B-conn Purpose.Enablement
comparison O O
with O O
untreated O O
cells O O
-LRB- O O
time O O
0 O O
-RRB- O O
. O O

A O O
Z O O
ratio O O
value O O
of O O
± O O
1.50 O O
and/or O O
a O O
Z O O
test O O
value O O
p O O
< O O
0.0001 O O
were O O
the O O
significance O O
thresholds O O
used O O
in O O
this O O
study O O
. O O

Hierarchical O O
clustering O O
was O O
performed O O
using O O
the O O
Cluster O O
and O O
TreeView O O
software O O
programs O O
, O O
developed O O
at O O
Stanford O O
University O O
-LSB-26 O O
-RSB- O O
. O O

The O O
clustering O O
algorithm O O
was O O
set O O
to O O
complete O O
linkage O O
clustering O O
using O O
the O O
uncentered O O
Pearson O O
correlation O O
. O O

Mapping O O
of O O
transcription O O
factor O O
binding O O
sites O O
in O O
selected O O
genes O O
was O O
performed O O
using O O
software O O
from O O
Genomatix O O
Software O O
Gmbh O O
, O O
Munich O O
, O O
Germany O O
. O O

See O O
Additional O O
file O O
2 O O
for O O
a O O
complete O O
description O O
of O O
the O O
analysis O O
. O O

Abbreviations O O

NRO O O
, O O
nuclear O O
run-on O O
; O O
P+I O O
, O O
PMA O O
plus O O
Ionomycin O O
; O O
ActD O O
, O O
Actinomycin O O
D O O

Authors O O
' O O
contributions O O

CC O O
and O O
JF O O
performed O O
the O O
microarray O O
assays O O
-LRB- O O
JF-NRO O O
RNA O O
, O O
CC-polyA O O
mRNA O O
-RRB- O O
. O O

CC O O
carried O O
out O O
statistical O O
analysis O O
, O O
and O O
drafted O O
the O O
manuscript O O
-LRB- O O
with O O
MG O O
& O O
KGB O O
-RRB- O O
. O O

JR O O
and O O
LD O O
performed O O
the O O
PCR O O
validation O O
assays O O
. O O

TW O O
assisted O O
with O O
promoter O O
analysis O O
and O O
YSC-C O O
participated O O
in O O
the O O
design O O
of O O
the O O
study O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Hybridization O O
images O O
of O O
polyA O O
mRNA O O
and O O
nuclear O O
run-on O O
-LRB- O O
NRO O O
-RRB- O O
RNA O O
. O O

Depicted O O
are O O
signals O O
in O O
fields O O
of O O
arrays O O
corresponding O O
to O O
untreated O O
-LRB- O O
time O O
0 O O
-RRB- O O
, O O
as O O
well O O
as O O
5 O O
, O O
and O O
30 O O
min O O
after O O
induction O O
of O O
Jurkat O O
cells O O
using O O
40 O O
ng/ml O O
PMA O O
and O O
1 O O
μM O O
Ionomycin O O
-LRB- O O
P+I O O
-RRB- O O
. O O

Two-color O O
overlays O O
contrast O O
either O O
5 O O
min O O
or O O
30 O O
min O O
-LRB- O O
red O O
-RRB- O O
versus O O
0 O O
-LRB- O O
green O O
-RRB- O O
for O O
polyA O O
mRNA O O
and O O
NRO O O
RNAs O O
. O O

Figure O O
2 O O
: O O
Distributions O O
of O O
significantly O O
regulated O O
genes O O
in O O
both O O
polyA O O
mRNA O O
and O O
nuclear O O
run-on O O
-LRB- O O
NRO O O
-RRB- O O
RNA O O
. O O

For B-conn Purpose.Goal
this O O
analysis O O
, O O
a O O
gene O O
was O O
considered O O
to O O
be O O
up- O O
or O O
down-regulated O O
in O O
either O O
polyA O O
mRNA O O
RNA O O
or O O
NRO O O
RNA O O
-LRB- O O
Altered O O
Gene O O
Expression O O
-RRB- O O
if B-conn Condition.Hypothetical
it O O
was O O
significantly O O
different O O
from O O
the O O
baseline O O
at O O
any O O
point O O
during O O
the O O
time O O
course O O
of O O
activation O O
; O O
all O O
other O O
genes O O
are O O
in O O
the O O
' O O
Unaltered O O
Gene O O
Expression O O
' O O
category O O
. O O

The O O
number O O
and O O
per O O
cent O O
of O O
genes O O
in O O
each O O
of O O
8 O O
possible O O
regulatory O O
categories O O
are O O
displayed O O
. O O

Figure O O
3 O O
: O O
Comparison O O
between O O
polyA O O
mRNA O O
and O O
nuclear O O
run-on O O
RNA O O
of O O
immediate O O
early O O
gene O O
activation O O
in O O
Jurkat O O
T O O
cells O O
. O O

A.1 O O
Heatmap O O
of O O
relative O O
gene O O
expression O O
intensities O O
-LRB- O O
Z O O
scores O O
-RRB- O O
. O O

A.2 O O
Graphical O O
representation O O
of O O
the O O
same O O
data O O
illustrating O O
an O O
immediately O O
apparent O O
up-regulation O O
of O O
gene O O
expression O O
in O O
NRO O O
but O O
not O O
polyA O O
mRNA O O
. O O

B. O O
Single O O
end-point O O
PCR O O
validation O O
of O O
up-regulation O O
in O O
polyA O O
mRNA O O
by O O
1 O O
hour O O
of O O
a O O
subset O O
of O O
genes O O
shown O O
to O O
be O O
activated O O
within O O
5 O O
minutes O O
by O O
nuclear O O
run-on O O
RNA O O
. O O

C. O O
Patterns O O
of O O
polyA O O
mRNA O O
and O O
nuclear O O
run-on O O
RNA O O
levels O O
for O O
NFKB1 O O
and O O
its O O
inhibitor O O
-LRB- O O
NFKBIA O O
-RRB- O O
. O O

Figure O O
4 O O
: O O
Global O O
comparison O O
of O O
gene O O
expression O O
changes O O
in O O
polyA O O
mRNA O O
and O O
NRO O O
RNA. O O
A. O O
At O O
each O O
time O O
period O O
indicated O O
columns O O
correspond O O
to O O
the O O
values O O
derived O O
by B-conn Purpose.Enablement
subtracting O O
the O O
Z O O
ratio O O
of O O
NRO O O
RNA O O
from O O
the O O
Z O O
ratio O O
of O O
polyA O O
mRNA O O
for O O
every O O
gene O O
. O O

Equivalency O O
between O O
calculations O O
varies O O
around O O
0 O O
, O O
data O O
is O O
aligned O O
using O O
a O O
combined O O
average O O
index O O
, O O
and O O
is O O
displayed O O
from O O
left O O
to O O
right O O
to B-conn Purpose.Goal
represent O O
the O O
highest O O
average O O
positive O O
Z O O
ratio O O
difference O O
to O O
the O O
lowest O O
average O O
negative O O
Z O O
ratio O O
difference O O
. O O

Columns O O
in O O
red O O
correspond O O
to O O
genes O O
exhibiting O O
significant O O
differences O O
-LRB- O O
Z O O
ratio O O
difference O O
values O O
greater O O
or O O
less O O
than O O
± O O
1.5 O O
-RRB- O O
in O O
gene O O
expression O O
changes O O
when B-conn Temporal.Synchronous
comparing O O
polyA O O
mRNA O O
and O O
NRO O O
RNA O O
for O O
each O O
gene O O
at O O
each O O
time O O
point O O
. O O

B. O O
Hierarchical O O
clustering O O
of O O
all O O
significant O O
changes O O
in O O
gene O O
expression O O
in O O
either O O
NRO O O
or O O
polyA O O
mRNA O O
across O O
the O O
time O O
course O O
of O O
activation O O
. O O

The O O
median O O
Z O O
score O O
data O O
for O O
each O O
gene O O
is O O
individually O O
normalized O O
to O O
its O O
baseline O O
value O O
in O O
for O O
the O O
sake O O
of O O
this O O
comparison O O
. O O

Figure O O
5 O O
: O O
Frequency O O
distribution O O
of O O
gene O O
expression O O
patterns O O
generated O O
from O O
polyA O O
mRNA O O
or O O
NRO O O
RNA O O
. O O

The O O
top O O
20 O O
patterns O O
for O O
each O O
method O O
is O O
shown O O
. O O

Significant O O
changes O O
in O O
gene O O
expression O O
were O O
assigned O O
a O O
1 O O
, O O
-1 O O
, O O
or O O
0 O O
for O O
up O O
, O O
down O O
, O O
or O O
no O O
change O O
, O O
respectively O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
a O O
value O O
of O O
-1 O O
, O O
0 O O
, O O
or O O
1 O O
-LRB- O O
low O O
, O O
moderate O O
, O O
or O O
high O O
-RRB- O O
was O O
assigned O O
to O O
each O O
gene O O
according O O
to O O
its O O
relative O O
intensity O O
at O O
baseline O O
-LRB- O O
0 O O
time O O
-RRB- O O
. O O

The O O
absolute O O
numbers O O
of O O
genes O O
in O O
each O O
pattern O O
are O O
reported O O
in O O
the O O
column O O
labeled O O
Top O O
20 O O
and B-conn Conjunction
the O O
percentage O O
of O O
those O O
genes O O
relative O O
to O O
all O O
significantly O O
regulated O O
genes O O
can O O
be O O
found O O
in O O
the O O
column O O
labeled O O
% O O
Sig O O
. O O

Totals O O
are O O
as O O
indicated O O
at O O
the O O
bottom O O
of O O
each O O
column O O
. O O

Filled-in O O
boxes O O
denote O O
patterns O O
equally O O
shared O O
in O O
the O O
top O O
20 O O
between O O
both O O
methods O O

Figure O O
6 O O
: O O
Differential O O
distribution O O
of O O
transcriptional O O
and O O
polyA O O
mRNA O O
up- O O
-LRB- O O
A O O
-RRB- O O
or O O
down- O O
-LRB- O O
B O O
-RRB- O O
regulated O O
gene O O
expression O O
patterns O O
during O O
Jurkat O O
T O O
cell O O
activation O O
. O O

The O O
number O O
of O O
genes O O
consistently O O
regulated O O
-LRB- O O
up O O
or O O
down O O
at O O
every O O
time O O
point O O
-RRB- O O
are O O
correlated O O
with O O
their O O
relative O O
expression O O
baselines O O
-LRB- O O
Z O O
score O O
: O O
high>1 O O
, O O
1>medium>-1 O O
, O O
low<-1 O O
-RRB- O O
. O O

Figure O O
7 O O
: O O
Persistence O O
of O O
stability-regulated O O
changes O O
in O O
gene O O
expression O O
in O O
the O O
presence O O
of O O
Actinomycin O O
D. O O
A. O O
Effect O O
of O O
Actinomycin O O
D O O
on O O
the O O
-LRB- O O
P+I O O
-RRB- O O
-induced O O
changes O O
in O O
the O O
expression O O
patterns O O
of O O
gene O O
deemed O O
to O O
be O O
transcriptionally O O
regulated O O
. O O

Z O O
ratio O O
comparisons O O
are O O
made O O
to O O
the O O
baseline O O
or O O
unactivated O O
state O O
. O O

B. O O
Lack O O
of O O
an O O
effect O O
of O O
Actinomycin O O
D O O
on O O
the O O
-LRB- O O
P+I O O
-RRB- O O
-induced O O
changes O O
in O O
the O O
expression O O
patterns O O
of O O
genes O O
deemed O O
to O O
be O O
stability O O
regulated O O
. O O

The O O
absolute O O
differences O O
-LRB- O O
Z O O
diff O O
-RRB- O O
between O O
the O O
activated O O
and O O
un-activated O O
state O O
for O O
both O O
polyA O O
mRNA O O
and O O
NRO O O
RNA O O
for O O
a O O
subset O O
of O O
these O O
genes O O
is O O
shown O O
. O O

C. O O
Comparison O O
of O O
the O O
Z O O
ratios O O
for O O
all O O
significantly O O
regulated O O
genes O O
in O O
the O O
presence O O
or O O
absence O O
of O O
Actinomycin O O
D O O
showing O O
no O O
corresponding O O
regulation O O
in O O
NRO O O
RNA O O
. O O

Data O O
is O O
sorted O O
by O O
polyA O O
mRNA O O
-LRB- O O
without O O
ActD O O
-RRB- O O
values O O
and O O
a O O
significance O O
threshold O O
of O O
Z O O
ratios O O
> O O
± O O
1.5 O O
was O O
used O O
for O O
these O O
calculations O O
. O O

Figure O O
8 O O
: O O
Regulation O O
of O O
apoptotic O O
pathways O O
during O O
T O O
cell O O
activation O O
involves O O
changes O O
in O O
gene O O
expression O O
by B-conn Purpose.Enablement
both O O
mRNA O O
transcriptional O O
and O O
mRNA O O
stability O O
mechanisms O O
. O O

Genes O O
colored O O
in O O
red O O
and O O
blue O O
were O O
up- O O
or O O
down-regulated O O
in O O
polyA O O
mRNA O O
only O O
. O O

Genes O O
colored O O
in O O
yellow O O
and O O
purple O O
were O O
up- O O
or O O
down-regulated O O
in O O
NRO O O
RNA O O
. O O

Pathway O O
is O O
from O O
a O O
Kegg O O
map O O
modified O O
in O O
Genmapp2.0 O O

-LSB-27 O O
-RSB- O O
. O O

Figure O O
9 O O
: O O
Enrichment O O
of O O
NFAT O O
and O O
NFκB O O
transcription O O
factor-binding O O
sites O O
in O O
the O O
promoter O O
regions O O
of O O
genes O O
upregulated O O
after O O
60 O O
min O O
of O O
treatment O O
of O O
human O O
Jurkat O O
T O O
cells O O
with O O
PMA O O
+ O O
Ionomycin O O
. O O

Color O O
gradient O O
from O O
bright O O
red O O
to O O
bright O O
green O O
is O O
directly O O
proportional O O
to O O
Z O O
ratios O O
and O O
indicates O O
the O O
increase O O
-LRB- O O
red O O
-RRB- O O
or O O
decrease O O
-LRB- O O
green O O
-RRB- O O
of O O
gene O O
expression O O
relative O O
to O O
baseline O O
at O O
each O O
of O O
the O O
indicated O O
time O O
points O O
. O O

Optimisation O O
of O O
the O O
RT-PCR O O
detection O O
of O O
immunomagnetically O O
enriched O O
carcinoma O O
cells O O

Abstract O O

Background O O
: O O
Immunomagnetic O O
enrichment O O
followed O O
by O O
RT-PCR O O
-LRB- O O
immunobead O O
RT-PCR O O
-RRB- O O
is O O
an O O
efficient O O
methodology O O
to O O
identify O O
disseminated O O
carcinoma O O
cells O O
in O O
the O O
blood O O
and O O
bone O O
marrow O O
. O O

The O O
RT-PCR O O
assays O O
must O O
be O O
both O O
specific O O
for O O
the O O
tumor O O
cells O O
and O O
sufficiently O O
sensitive O O
to B-conn Purpose.Goal
enable O O
detection O O
of O O
single O O
tumor O O
cells O O
. O O

We O O
have O O
developed O O
a O O
method O O
to O O
test O O
RT-PCR O O
assays O O
for O O
any O O
cancer O O
. O O

This O O
has O O
been O O
investigated O O
using O O
a O O
panel O O
of O O
RT-PCR O O
markers O O
suitable O O
for O O
the O O
detection O O
of O O
breast O O
cancer O O
cells O O
. O O

Methods O O
: O O
In O O
the O O
assay O O
, O O
a O O
single O O
cell O O
line-derived O O
tumor O O
cell O O
is O O
added O O
to O O
100 O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMNCs O O
-RRB- O O
after B-conn Temporal.Precedence
which I-conn Temporal.Precedence
mRNA O O
is O O
isolated O O
and O O
reverse O O
transcribed O O
for O O
RT-PCR O O
analysis O O
. O O

PBMNCs O O
without O O
added O O
tumor O O
cells O O
are O O
used O O
as O O
specificity O O
controls O O
. O O

The O O
previously O O
studied O O
markers O O
epidermal O O
growth O O
factor O O
receptor O O
-LRB- O O
EGFR O O
-RRB- O O
, O O
mammaglobin O O
1 O O
-LRB- O O
MGB1 O O
-RRB- O O
, O O
epithelial O O
cell O O
adhesion O O
molecule O O
-LRB- O O
EpCAM/TACSTD1 O O
-RRB- O O
, O O
mucin O O
1 O O
-LRB- O O
MUC1 O O
-RRB- O O
, O O
carcinoembryonic O O
antigen O O
-LRB- O O
CEA O O
-RRB- O O
were O O
tested O O
. O O

Two O O
new O O
epithelial-specific O O
markers O O
ELF3 O O
and O O
EphB4 O O
were O O
also B-conn Conjunction
tested O O
. O O

Results O O
: O O
MUC1 O O
was O O
unsuitable O O
as B-conn Cause.Justification
strong O O
amplification O O
was O O
detected O O
in O O
100 O O
cell O O
PBMNC O O
controls O O
. O O

Expression O O
of O O
ELF3 O O
, O O
EphB4 O O
, O O
EpCAM O O
, O O
EGFR O O
, O O
CEA O O
and O O
MGB1 O O
was O O
found O O
to O O
be O O
both O O
specific O O
for O O
the O O
tumor O O
cell O O
, O O
as B-conn Cause.Justification
demonstrated I-conn Cause.Justification
by I-conn Cause.Justification
the O O
absence O O
of O O
a O O
signal O O
in O O
most O O
100 O O
cell O O
PBMNC O O
controls O O
, O O
and O O
sensitive O O
enough O O
to B-conn Purpose.Goal
detect O O
a O O
single O O
tumor O O
cell O O
in O O
100 O O
PBMNCs O O
using O O
a O O
single O O
round O O
of O O
RT-PCR O O
. O O

Conclusions O O
: O O
ELF3 O O
, O O
EphB4 O O
, O O
EpCAM O O
, O O
EGFR O O
, O O
CEA O O
and O O
MGB1 O O
are O O
appropriate O O
RT-PCR O O
markers O O
for O O
use O O
in O O
a O O
marker O O
panel O O
to B-conn Purpose.Goal
detect O O
disseminated O O
breast O O
cancer O O
cells O O
after B-conn Temporal.Succession
immunomagnetic O O
enrichment O O
. O O

Background O O

Reverse O O
transcriptase-polymerase O O
chain O O
reaction O O
-LRB- O O
RT-PCR O O
-RRB- O O
assays O O
have O O
been O O
developed O O
for B-conn Purpose.Goal
the O O
detection O O
of O O
disseminated O O
carcinoma O O
cells O O
by B-conn Purpose.Enablement
targeting O O
epithelial O O
or O O
tumor O O
specific O O
mRNA O O
in O O
bone O O
marrow O O
, O O
peripheral O O
blood O O
, O O
or O O
lymph O O
nodes O O
-LRB- O O
reviewed O O
in O O
-LSB-1 O O
-RSB- O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
limitations O O
may O O
arise O O
from O O
deficient O O
expression O O
in O O
circulating O O
tumor O O
cells O O
or O O
low O O
level O O
illegitimate O O
expression O O
in O O
haematopoietic O O
cells O O
, O O
particularly B-conn Condition.Hypothetical
if I-conn Condition.Hypothetical
a O O
nested O O
PCR O O
approach O O
is O O
used O O
-LSB-2-5 O O
-RSB- O O
. O O

We O O
developed O O
an O O
immunobead-based O O
technique O O
for O O
the O O
enrichment O O
of O O
epithelial O O
cells O O
to O O
increase O O
the O O
signal O O
to O O
noise O O
ratio O O
for O O
PCR O O
based O O
protocols O O
-LSB-6 O O
-RSB- O O
. O O

This O O
was O O
subsequently B-conn Temporal.Precedence
adapted O O
to O O
RT-PCR O O
methodology O O
-LSB-7 O O
-RSB- O O
. O O

We O O
have O O
shown O O
immunobead O O
RT-PCR O O
is O O
of O O
sufficient O O
sensitivity O O
to B-conn Purpose.Goal
identify O O
1 O O
tumor O O
epithelial O O
cell O O
in O O
a O O
background O O
of O O
106 O O
blood O O
cells O O
-LSB-7,8 O O
-RSB- O O
. O O

A O O
recent O O
study O O
compared O O
immunobead O O
RT-PCR O O
with O O
regular O O
RT-PCR O O
using O O
CEA O O
as O O
the O O
marker O O
for O O
colon O O
cancer O O
cells O O
spiked O O
into O O
normal O O
blood O O
samples O O
and O O
confirmed O O
that O O
the O O
immunobead O O
RT-PCR O O
method O O
is O O
more O O
sensitive O O
and O O
specific O O
than O O
the O O
regular O O
RT-PCR O O
method O O
-LSB-9 O O
-RSB- O O
. O O

Up O O
to O O
100 O O
peripheral O O
blood O O
leukocytes O O
-LRB- O O
PBLs O O
-RRB- O O
may O O
be O O
concurrently O O
isolated O O
with O O
the O O
tumor O O
cells O O
during O O
the O O
immunobead O O
method O O
-LSB-10 O O
-RSB- O O
. O O

We O O
previously O O
had O O
similar O O
levels O O
of O O
PBL O O
contamination O O
. O O

Now B-conn Cause.Reason
that I-conn Cause.Reason
we O O
carry O O
out O O
incubations O O
at O O
4°C O O
and O O
take O O
off O O
the O O
cell O O
pellets O O
from O O
the O O
magnets O O
for O O
washing O O
, O O
considerably O O
fewer O O
than O O
10 O O
cells O O
are O O
isolated O O
-LRB- O O
unpublished O O
observations O O
-RRB- O O
. O O

It O O
is O O
nevertheless B-conn Concession.Contra-expectation
important O O
to O O
assess O O
whether O O
this O O
small O O
number O O
of O O
cells O O
can O O
lead O O
to O O
false O O
positives O O
due B-conn Cause.Reason
to I-conn Cause.Reason
illegitimate O O
expression O O
. O O

In O O
this O O
paper O O
, O O
we O O
introduce O O
a O O
new O O
strategy O O
for O O
the O O
testing O O
of O O
RT-PCR O O
assays O O
using O O
a O O
method O O
in O O
which O O
a O O
single O O
tumor O O
cell O O
is O O
mixed O O
with O O
100 O O
PBMNCs O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
RT-PCR O O
analysis O O
. O O

100 O O
PBMNCs O O
without O O
added O O
tumor O O
cells O O
are O O
used O O
as O O
specificity O O
controls O O
. O O

This O O
method O O
has O O
allowed O O
the O O
identification O O
of O O
a O O
panel O O
of O O
RT-PCR O O
markers O O
of O O
sufficient O O
sensitivity O O
and O O
specificity O O
for O O
immunobead O O
RT-PCR O O
. O O

This O O
study O O
includes O O
an O O
assessment O O
of O O
2 O O
previously O O
untested O O
markers O O
ELF3 O O
-LRB- O O
also O O
known O O
as O O
ESX O O
-RRB- O O
-LSB-11 O O
-RSB- O O
and O O
EphB4 -LSB-12 O O
-RSB- O O
, O O
as O O
well O O
as O O
the O O
previously O O
studied O O
markers O O
mucin O O
1 O O
-LRB- O O
MUC1 O O
-RRB- O O
, O O
carcinoembryonic O O
antigen O O
-LRB- O O
CEA O O
-RRB- O O
, O O
epidermal O O
growth O O
factor O O
receptor O O
-LRB- O O
EGFR O O
-RRB- O O
, O O
epithelial O O
cell O O
adhesion O O
molecule O O
-LRB- O O
EpCAM O O
-RRB- O O
and O O
mammaglobin O O
1 O O
-LRB- O O
MGB1 O O
-RRB- O O
markers O O
. O O

Whether O O
a O O
RT-PCR O O
is O O
useful O O
depends O O
not B-conn Conjunction
only I-conn Conjunction
on O O
the O O
marker O O
used O O
but B-conn Conjunction
also I-conn Conjunction
on O O
the O O
assay O O
conditions O O
for O O
that O O
marker O O
. O O

A O O
useful O O
marker O O
will O O
be O O
both O O
sensitive O O
enough O O
to B-conn Purpose.Goal
enable O O
detection O O
of O O
a O O
single O O
tumor O O
cell O O
and O O
specific O O
enough O O
to B-conn Purpose.Goal
not O O
be O O
amplified O O
from O O
PBLs O O
. O O

However B-conn Concession.Contra-expectation
, O O
as B-conn Cause.Justification
immunomagnetic O O
cell O O
isolates O O
have O O
very O O
low O O
contamination O O
by O O
PBLs O O
, O O
it O O
is O O
desirable O O
to O O
check O O
the O O
possibility O O
of O O
illegitimate O O
expression O O
in O O
the O O
very O O
low O O
number O O
of O O
PBLs O O
that O O
are O O
retained O O
after B-conn Temporal.Succession
an O O
immunobead O O
harvest O O
. O O

To B-conn Purpose.Goal
test O O
both O O
specificity O O
and O O
sensitivity O O
of O O
our O O
chosen O O
markers O O
, O O
we O O
developed O O
an O O
assay O O
in O O
which O O
a O O
single O O
tumor O O
cell O O
is O O
deposited O O
into O O
a O O
microcentrifuge O O
tube O O
containing O O
100 O O
normal O O
PBMNCs O O
. O O

100 O O
PBMNCs O O
were O O
chosen O O
as B-conn Cause.Reason
we O O
believe O O
that O O
this O O
number O O
covers O O
the O O
maximum O O
amount O O
of O O
PBMNC O O
contamination O O
that O O
we O O
or O O
others O O
are O O
likely O O
to O O
encounter O O
. O O

Methods O O

Peripheral O O
blood O O
was O O
collected O O
from O O
patients O O
with O O
polycythemia O O
vera O O
who O O
presented O O
for O O
treatment O O
at O O
The O O
Queen O O
Elizabeth O O
Hospital O O
, O O
Adelaide O O
, O O
Australia O O
. O O

Informed O O
consent O O
was O O
obtained O O
in O O
all O O
cases O O
and B-conn Conjunction
ethics O O
approval O O
was O O
obtained O O
from O O
The O O
Queen O O
Elizabeth O O
Hospital O O
Ethics O O
of O O
Human O O
Research O O
Committee O O
. O O

Mononuclear O O
cells O O
were O O
collected O O
by O O
centrifugation O O
through O O
a O O
Ficoll O O
gradient O O
, O O
washed O O
with O O
phosphate-buffered O O
saline O O
-LRB- O O
PBS O O
-RRB- O O
and O O
counted O O
using O O
a O O
haemocytometer O O
. O O

In O O
the O O
course O O
of O O
this O O
investigation O O
, O O
PBMNCs O O
from O O
eight O O
different O O
patients O O
were O O
used O O
. O O

The O O
breast O O
cancer O O
cell O O
lines O O
MDA-MB-453 O O
, O O
T47-D O O
, O O
MDA-MB-468 O O
, O O
MCF-7 O O
, O O
were O O
cultured O O
in O O
DMEM O O
, O O
pH O O
7.4 O O
-LRB- O O
Invitrogen O O
, O O
Carlsbad O O
, O O
CA O O
-RRB- O O
supplemented O O
with O O
100 O O
U/ml O O
penicillin O O
, O O
100 O O
μg/ml O O
streptomycin O O
, O O
160 O O
μg/ml O O
L-glutamine O O
and O O
10 O O
% O O
heat-inactivated O O
fetal O O
bovine O O
serum O O
-LRB- O O
JRH O O
Biosciences O O
, O O
Lenexa O O
, O O
KS O O
-RRB- O O
in O O
75 O O
cm2 O O
vented O O
tissue O O
culture O O
flasks O O
at O O
37°C O O
in O O
a O O
5 O O
% O O
CO2 O O
environment O O
. O O

Log O O
phase O O
cells O O
were O O
collected O O
at O O
less O O
than O O
90 O O
% O O
confluency O O
by O O
trypsin O O
digestion O O
and O O
centrifugation O O
for O O
5 O O
min O O
at O O
1000 O O
rpm O O
, O O
resuspended O O
in O O
phosphate O O
buffered O O
saline O O
-LRB- O O
PBS O O
-RRB- O O
and O O
counted O O
using O O
a O O
haemocytometer O O
. O O

The O O
cell O O
lines O O
were O O
purchased O O
from O O
the O O
American O O
Type O O
Culture O O
Collection O O
-LRB- O O
ATCC O O
, O O
Rockville O O
, O O
MD O O
-RRB- O O
. O O

A O O
dilute O O
suspension O O
of O O
a O O
cell O O
line O O
was O O
prepared O O
in O O
calcium O O
and O O
magnesium O O
free O O
Dulbecco O O
's O O
PBS O O
. O O

Single O O
cells O O
were O O
visualised O O
using O O
an O O
inverted O O
phase O O
microscope O O
and O O
selected O O
by B-conn Purpose.Enablement
using O O
a O O
micropipette O O
to B-conn Purpose.Goal
draw O O
up O O
the O O
cell O O
in O O
a O O
1 O O
μl O O
volume O O
. O O

The O O
cell O O
was O O
deposited O O
into O O
a O O
0.5 O O
ml O O
microcentrifuge O O
tube O O
containing O O
100 O O
peripheral O O
blood O O
mononuclear O O
cells O O
in O O
1 O O
μl O O
of O O
calcium O O
and O O
magnesium O O
free O O
Dulbecco O O
's O O
PBS O O
. O O

Aliquots O O
that O O
contained O O
100 O O
mononuclear O O
cells O O
only O O
were O O
included O O
as O O
controls O O
for O O
the O O
specificity O O
of O O
the O O
RT-PCR O O
. O O

The O O
cell O O
mixture O O
was O O
lysed O O
in O O
a O O
15 O O
μl O O
volume O O
of O O
solution O O
containing O O
0.3 O O
% O O
v/v O O
Nonidet O O
P-40 O O
detergent O O
-LRB- O O
Sigma O O
-RRB- O O
, O O
500 O O
ng O O
random O O
hexamers O O
-LRB- O O
Pharmacia O O
, O O
Uppsala O O
, O O
Sweden O O
-RRB- O O
, O O
20 O O
U O O
of O O
RNasin O O
-LRB- O O
Promega O O
, O O
Madison O O
, O O
WI O O
-RRB- O O
and O O
10 O O
mM O O
DTT O O
. O O

Following B-conn Temporal.Succession
70°C O O
denaturation O O
for O O
3 O O
minutes O O
, O O
reverse O O
transcription O O
was O O
initiated O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
5× O O
First O O
Strand O O
Buffer O O
, O O
200 O O
U O O
of O O
Superscript O O
II O O
-LRB- O O
Invitrogen O O
-RRB- O O
, O O
0.5 O O
mM O O
of O O
each O O
deoxynucleotide O O
triphosphate O O
-LRB- O O
Roche O O
, O O
Mannheim O O
, O O
Germany O O
-RRB- O O
, O O
with O O
Ultra-pure O O
water O O
-LRB- O O
Fisher O O
Biotech O O
, O O
Perth O O
, O O
Australia O O
-RRB- O O
to O O
a O O
final O O
volume O O
of O O
30 O O
μl O O
. O O

The O O
reaction O O
was O O
incubated O O
at O O
42°C O O
for O O
50 O O
minutes O O
, O O
and B-conn Conjunction
then B-conn Temporal.Precedence
the O O
reverse O O
transcriptase O O
was O O
inactivated O O
at O O
70°C O O
for O O
10 O O
minutes O O
. O O

After B-conn Temporal.Succession
reverse O O
transcription O O
, O O
4 O O
μl O O
of O O
cDNA O O
was O O
used O O
as O O
the O O
template O O
in O O
a O O
single O O
round O O
of O O
PCR O O
amplification O O
with O O
200 O O
nM O O
of O O
each O O
gene O O
specific O O
primer O O
pair O O
-LRB- O O
Table O O
1 O O
-RRB- O O
, O O
1 O O
U O O
of O O
Hot O O
Star O O
Taq O O
-LRB- O O
Qiagen O O
, O O
Valencia O O
, O O
CA O O
-RRB- O O
, O O
2.5 O O
mM O O
MgCl2 O O
, O O
and O O
200 O O
μM O O
of O O
each O O
deoxynucleotide O O
triphosphate O O
, O O
in O O
the O O
supplied O O
PCR O O
buffer O O
. O O

Cycling O O
conditions O O
included O O
an O O
initial O O
denaturation O O
step O O
at O O
95°C O O
for O O
15 O O
minutes O O
, O O
then O O
1 O O
minute O O
at O O
each O O
of O O
94°C O O
, O O
66–68°C O O
and O O
72°C O O
for O O
45–55 O O
cycles O O
and O O
a O O
final O O
extension O O
of O O
7 O O
minutes O O
at O O
72°C O O
. O O

Amplification O O
products O O
were O O
visualised O O
by B-conn Purpose.Enablement
ethidium O O
bromide O O
staining O O
following B-conn Temporal.Succession
separation O O
by O O
electrophoresis O O
through O O
agarose O O
gels O O
. O O

In O O
each O O
case O O
an O O
RT O O
negative O O
control O O
, O O
made O O
up O O
of O O
the O O
components O O
of O O
the O O
RT O O
reaction O O
mixture O O
with O O
or O O
without O O
lysis O O
mix O O
, O O
and O O
without O O
the O O
addition O O
of O O
RNA O O
, O O
was O O
used O O
as O O
the O O
template O O
in O O
the O O
PCR O O
reaction O O
-LRB- O O
no O O
cDNA O O
made O O
and O O
therefore B-conn Cause.Result
no O O
amplification O O
expected O O
-RRB- O O
. O O

The O O
PCR O O
negative O O
control O O
contains O O
the O O
reagents O O
of O O
the O O
PCR O O
reaction O O
but O O
lacks O O
template O O
. O O

Cell O O
line O O
cDNA O O
was O O
included O O
as O O
a O O
positive O O
control O O
for O O
the O O
PCR O O
reaction O O
. O O

Genomic O O
DNA O O
-LRB- O O
100 O O
ng O O
-RRB- O O
was O O
used O O
to B-conn Purpose.Goal
confirm O O
that O O
a O O
product O O
of O O
equal O O
size O O
to O O
the O O
cDNA O O
product O O
would O O
not O O
be O O
amplified O O
from O O
the O O
DNA O O
in O O
the O O
cell O O
lysate O O
. O O

Results O O

The O O
expression O O
of O O
each O O
of O O
the O O
RT-PCR O O
markers O O
was O O
assessed O O
for O O
its O O
suitability O O
as O O
a O O
breast O O
cancer O O
marker O O
. O O

RNA O O
was O O
extracted O O
from O O
seven O O
breast O O
cancer O O
cell O O
lines O O
, O O
reverse O O
transcribed O O
into O O
cDNA O O
then B-conn Temporal.Precedence
amplified O O
using O O
primers O O
specific O O
for O O
the O O
different O O
markers O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

Transcripts O O
corresponding O O
to O O
EpCAM O O
were O O
amplified O O
from O O
all O O
of O O
the O O
cell O O
lines O O
tested O O
-LRB- O O
Fig. O O
1. O O
, O O
panel O O
1 O O
-RRB- O O
. O O

This O O
validates O O
the O O
use O O
of O O
antibodies O O
that O O
recognise O O
epitopes O O
of O O
this O O
protein O O
as O O
the O O
immunobead O O
label O O
for O O
magnetic O O
isolation O O
of O O
the O O
breast O O
carcinoma O O
cells O O
-LSB-6 O O
-RSB- O O
and O O
confirms O O
earlier O O
results O O
which O O
showed O O
uniform O O
bright O O
fluorescence O O
in O O
breast O O
cancer O O
cell O O
lines O O
and O O
biopsies O O
stained O O
with O O
one O O
of O O
these O O
antibodies O O
, O O
Ber-Ep4 O O
-LSB-7 O O
-RSB- O O
. O O

ELF3 O O
, O O
EphB4 O O
and O O
MUC1 O O
were O O
amplified O O
in O O
all O O
cell O O
lines O O
at O O
consistently O O
high O O
levels O O
-LRB- O O
Fig. O O
1 O O
, O O
panels O O
2 O O
, O O
3 O O
and O O
4 O O
-RRB- O O
. O O

EGFR O O
expression O O
was O O
also B-conn Conjunction
easily O O
detectable O O
-LRB- O O
Fig. O O
1 O O
, O O
panel O O
5 O O
-RRB- O O
even B-conn Concession.Expectation
though I-conn Concession.Expectation
several O O
reports O O
have O O
suggested O O
it O O
is O O
expressed O O
at O O
low O O
levels O O
in O O
MCF-7 O O
and O O
T47-D O O
and O O
is O O
not O O
expressed O O
in O O
MDA-MB-453 O O
-LSB-13,14 O O
-RSB- O O
. O O

MGB1 O O
transcripts O O
were O O
amplified O O
from O O
all O O
cell O O
lines O O
except O O
for O O
MCF-7 O O
-LRB- O O
Fig. O O
1 O O
, O O
panel O O
2 O O
-RRB- O O
and B-conn Conjunction
CEA O O
was O O
amplified O O
from O O
all O O
cell O O
lines O O
except O O
PMC42 O O
-LRB- O O
Fig. O O
1 O O
panel O O
6 O O
-RRB- O O
. O O

Tubes O O
that O O
contained O O
100 O O
PBMNCs O O
and O O
one O O
tumor O O
cell O O
were O O
used O O
to B-conn Purpose.Goal
determine O O
the O O
sensitivity O O
of O O
each O O
RT-PCR O O
marker O O
. O O

Most O O
of O O
the O O
sensitivity O O
tests O O
were O O
performed O O
using O O
MDA-MB-453 O O
cells O O
but B-conn Concession.Contra-expectation
four O O
different O O
breast O O
cancer O O
cell O O
lines O O
have O O
been O O
included O O
in O O
this O O
part O O
of O O
the O O
study O O
, O O
two O O
that O O
are O O
ER O O
negative O O
-LRB- O O
MDA-MB-453 O O
, O O
and O O
MDA-MB-468 O O
-RRB- O O
and O O
two O O
that O O
are O O
ER O O
positive O O
-LRB- O O
MCF-7 O O
and O O
T47-D O O
-RRB- O O
. O O

Analysing O O
the O O
samples O O
to O O
which O O
a O O
single O O
breast O O
cancer O O
cell O O
had O O
been O O
added O O
to O O
100 O O
PBMNC O O
showed O O
that O O
we O O
can O O
detect O O
the O O
tumor O O
cell O O
most O O
often O O
with O O
ELF3 O O
-LRB- O O
40/43 O O
– O O
93 O O
% O O
-RRB- O O
and O O
EpCAM O O
-LRB- O O
36/40 O O
– O O
89 O O
% O O
-RRB- O O
-LRB- O O
Figures O O
2 O O
and O O
3 O O
, O O
tables O O
2 O O
and O O
3 O O
-RRB- O O
. O O

EphB4 O O
specific O O
amplification O O
detected O O
31/40 O O
-LRB- O O
77.5 O O
% O O
-RRB- O O
, O O

MUC1 O O
10/20 O O
-LRB- O O
67 O O
% O O
-RRB- O O
, O O
CEA O O
9/20 O O
-LRB- O O
45 O O
% O O
-RRB- O O
, O O
EGFR O O
19/43 O O
-LRB- O O
44 O O
% O O
-RRB- O O
and O O
MGB1 O O
9/35 O O
-LRB- O O
26 O O
% O O
-RRB- O O
. O O

Tubes O O
that O O
contained O O
100 O O
PBMNCs O O
only O O
were O O
included O O
to B-conn Purpose.Goal
determine O O
specificity O O
-LRB- O O
Table O O
2 O O
-RRB- O O
. O O

After B-conn Temporal.Succession
combining O O
the O O
data O O
obtained O O
from O O
several O O
different O O
experiments O O
and O O
several O O
different O O
normal O O
individuals O O
in O O
reactions O O
using O O
the O O
appropriate O O
number O O
of O O
amplification O O
cycles O O
, O O
we O O
found O O
no O O
expression O O
of O O
EGFR O O
-LRB- O O
0/27 O O
-RRB- O O
, O O
MGB1 O O
-LRB- O O
0/24 O O
-RRB- O O
, O O
EphB4 O O
-LRB- O O
0/21 O O
-RRB- O O
, O O
EpCAM O O
-LRB- O O
0/21 O O
-RRB- O O
or O O
CEA O O
-LRB- O O
0/18 O O
-RRB- O O
, O O
-LRB- O O
Figures O O
2 O O
and O O
3 O O
, O O
Table O O
2 O O
-RRB- O O
. O O

Only O O
ELF3 O O
and O O
MUC1 O O
gave O O
positive O O
bands O O
. O O

These O O
results O O
were O O
for O O
45 O O
cycles O O
of O O
amplification O O
except O O
for O O
CEA O O
which O O
was O O
run O O
for O O
55 O O
cycles O O
. O O

We O O
also B-conn Conjunction
examined O O
ELF3 O O
, O O
EphB4 O O
and O O
MUC1 O O
at O O
55 O O
cycles O O
in O O
a O O
small O O
number O O
of O O
experiments O O
. O O

We O O
amplified O O
transcripts O O
that O O
corresponded O O
to O O
ELF3 O O
-LRB- O O
1/6 O O
-RRB- O O
, O O
EphB4 O O
-LRB- O O
3/12 O O
-RRB- O O
and O O
MUC1 O O
-LRB- O O
3/12 O O
-RRB- O O
in O O
some O O
of O O
the O O
PBMNC O O
control O O
tubes O O
. O O

The O O
ELF3 O O
and O O
EphB4 O O
bands O O
were O O
visible O O
following B-conn Temporal.Succession
ethidium O O
bromide O O
staining O O
but O O
were O O
less O O
intense O O
than O O
the O O
band O O
amplified O O
after B-conn Temporal.Succession
the O O
addition O O
of O O
a O O
single O O
tumor O O
cell O O
and B-conn Conjunction
in O O
no O O
cases O O
were O O
all O O
three O O
of O O
the O O
PBMNC O O
controls O O
positive O O
in O O
the O O
same O O
experiment O O
. O O

We O O
assume O O
that O O
the O O
ELF3 O O
band O O
is O O
a O O
result O O
of O O
amplification O O
of O O
illegitimate O O
transcripts O O
. O O

This O O
band O O
was O O
eliminated O O
when B-conn Temporal.Synchronous
only O O
35 O O
cycles O O
of O O
amplification O O
-LRB- O O
0/15 O O
-RRB- O O
were O O
performed O O
but B-conn Concession.Contra-expectation
because B-conn Cause.Reason
only O O
a O O
small O O
amount O O
of O O
product O O
was O O
amplified O O
after O O
45 O O
or O O
55 O O
cycles O O
in O O
these O O
controls O O
we O O
could O O
distinguish O O
samples O O
that O O
contained O O
tumor O O
cells O O
and O O
those O O
that O O
did O O
not O O
through B-conn Purpose.Enablement
comparison O O
of O O
the O O
intensity O O
of O O
bands O O
. O O

Analysing O O
the O O
samples O O
to O O
which O O
a O O
single O O
breast O O
cancer O O
cell O O
had O O
been O O
added O O
to O O
100 O O
PBMNC O O
showed O O
that O O
we O O
could O O
still B-conn Concession.Contra-expectation
detect O O
the O O
tumor O O
cell O O
most O O
often O O
with O O
ELF3 O O
-LRB- O O
15/16 O O
– O O
94 O O
% O O
-RRB- O O
. O O

Tests O O
using O O
single O O
tumour O O
cells O O
in O O
a O O
100 O O
PBMNC O O
background O O
detected O O
15/16 O O
-LRB- O O
94 O O
% O O
-RRB- O O
of O O
tumour O O
cells O O
after O O
35 O O
cycles O O
. O O

Unlike O O
ELF3 O O
, O O
the O O
MUC1 O O
PBMNC O O
band O O
was O O
of O O
comparable O O
intensity O O
to O O
those O O
achieved O O
after B-conn Temporal.Succession
tumor O O
cell O O
addition O O
making O O
it O O
impossible O O
to O O
distinguish O O
samples O O
that O O
contain O O
tumor O O
cells O O
from O O
those O O
that O O
do O O
n't O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

Discussion O O

The O O
development O O
of O O
optimized O O
methods O O
for O O
detecting O O
tumor O O
cells O O
in O O
the O O
peripheral O O
blood O O
and O O
bone O O
marrow O O
of O O
cancer O O
patients O O
may O O
enhance O O
our O O
ability O O
to O O
identify O O
those O O
patients O O
in O O
need O O
of O O
further O O
therapy O O
. O O

Nested O O
RT-PCR O O
of O O
PBMNCs O O
has O O
been O O
the O O
most O O
common O O
method O O
to O O
detect O O
epithelial O O
– O O
specific O O
markers O O
. O O

Due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
high O O
level O O
of O O
sensitivity O O
of O O
nested O O
RT-PCR O O
, O O
even O O
low O O
levels O O
of O O
illegitimate O O
transcription O O
in O O
PBMNCs O O
can O O
cause O O
false-positive O O
results O O
-LSB-2-5 O O
-RSB- O O
. O O

Nested O O
RT-PCR O O
is O O
also B-conn Conjunction
more O O
time O O
consuming O O
and B-conn Conjunction
stringent O O
procedures O O
need O O
to O O
be O O
observed O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
minimise O O
the O O
risk O O
of O O
false O O
positives O O
due B-conn Cause.Reason
to I-conn Cause.Reason
PCR O O
product O O
cross O O
contamination O O
. O O

It O O
is O O
thus B-conn Cause.Result
desirable O O
that O O
the O O
RT-PCR O O
is O O
performed O O
in O O
a O O
single O O
round O O
to B-conn Purpose.Goal
avoid O O
potential O O
contamination O O
problems O O
. O O

The O O
use O O
of O O
immunobead O O
enrichment O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
reverse O O
transcription O O
has O O
allowed O O
the O O
use O O
of O O
a O O
single O O
round O O
of O O
PCR O O
amplification O O
to B-conn Purpose.Goal
screen O O
a O O
whole O O
blood O O
sample O O
. O O

Our O O
original O O
methodology O O
used O O
blotting O O
and O O
detection O O
with O O
an O O
oligonucleotide O O
to B-conn Purpose.Goal
increase O O
sensitivity O O
-LSB-7 O O
-RSB- O O
but B-conn Contrast
this O O
is O O
no O O
longer O O
necessary O O
with O O
the O O
more O O
efficient O O
RT-PCR O O
assays O O
presented O O
here O O
, O O
in B-conn Cause.Reason
particular I-conn Cause.Reason
because I-conn Cause.Reason
of I-conn Cause.Reason
the O O
use O O
of O O
a O O
hot O O
start O O
Taq O O
polymerase O O
. O O

To B-conn Purpose.Goal
improve O O
RT-PCR O O
detection O O
further O O
, O O
the O O
identification O O
of O O
epithelial O O
or O O
carcinoma O O
cell O O
specific O O
markers O O
that O O
are O O
expressed O O
at O O
a O O
sufficient O O
level O O
to B-conn Purpose.Goal
enable O O
detection O O
of O O
a O O
single O O
cell O O
after B-conn Temporal.Succession
only O O
one O O
round O O
of O O
non-nested O O
PCR O O
are O O
needed O O
. O O

For O O
this O O
reason O O
, O O
we O O
have O O
used O O
single O O
tumor O O
cells O O
in O O
a O O
background O O
of O O
100 O O
PBMNCs O O
to B-conn Purpose.Goal
screen O O
seven O O
different O O
RT-PCR O O
assays O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
identify O O
the O O
best O O
ones O O
for O O
inclusion O O
in O O
a O O
panel O O
for B-conn Purpose.Goal
the O O
immunobead O O
RT-PCR O O
based O O
detection O O
of O O
circulating O O
tumor O O
cells O O
. O O

We O O
used O O
breast O O
cancer O O
cell O O
lines O O
as O O
the O O
source O O
of O O
tumor O O
cells O O
. O O

Whereas B-conn Contrast
breast O O
cancer O O
cell O O
lines O O
may O O
have O O
different O O
levels O O
of O O
expression O O
of O O
markers O O
compared O O
to O O
disseminated O O
breast O O
cancer O O
cells O O
, O O
cells O O
from O O
different O O
individuals O O
, O O
and O O
even O O
within O O
an O O
individual O O
, O O
are O O
likely O O
to O O
display O O
considerable O O
heterogeneity O O
. O O

We O O
sought O O
to O O
overcome O O
this O O
difficulty O O
by O O
using O O
a O O
number O O
of O O
cell O O
lines O O
. O O

The O O
use O O
of O O
cell O O
lines O O
has O O
the O O
great O O
advantage O O
of O O
providing O O
reproducible O O
controls O O
to B-conn Purpose.Goal
test O O
the O O
sensitivity O O
of O O
the O O
RT-PCR O O
assays O O
during O O
studies O O
of O O
patient O O
material O O
. O O

The O O
immunobead O O
enrichment O O
step O O
relies O O
on O O
the O O
expression O O
of O O
an O O
epithelial O O
cell O O
adhesion O O
molecule O O
-LRB- O O
EpCAM O O
-RRB- O O
-LRB- O O
current O O
gene O O
symbol O O
, O O
TACTSD1 O O
, O O
tumor-associated O O
calcium O O
signal O O
transducer O O
1 O O
-RRB- O O
, O O
which O O
is O O
recognized O O
by O O
an O O
antibody O O
on O O
immunobeads O O
. O O

We O O
considered O O
this O O
to O O
be O O
an O O
appropriate O O
positive O O
control O O
, O O
as B-conn Cause.Justification
any O O
cell O O
that O O
is O O
detected O O
using O O
the O O
immunobeads O O
should O O
express O O
the O O
EpCAM O O
gene O O
. O O

All O O
of O O
the O O
breast O O
cancer O O
cell O O
lines O O
expressed O O
the O O
EpCAM O O
gene O O
and B-conn Conjunction
no O O
message O O
was O O
detected O O
in O O
any O O
of O O
24 O O
aliquots O O
that O O
contained O O
100 O O
PBMNC O O
. O O

Tests O O
of O O
the O O
single O O
tumor O O
cell O O
and O O
100 O O
PBMNC O O
aliquots O O
with O O
EpCAM O O
showed O O
that O O
it O O
was O O
also B-conn Conjunction
expressed O O
to O O
a O O
sufficient O O
level O O
to B-conn Purpose.Goal
enable O O
detection O O
of O O
the O O
tumor O O
cell O O
in O O
31/35 O O
-LRB- O O
89 O O
% O O
-RRB- O O
cases O O
after B-conn Temporal.Succession
45 O O
cycles O O
of O O
PCR O O
amplification O O
. O O

We O O
therefore B-conn Cause.Claim
consider O O
EpCAM O O
a O O
useful O O
addition O O
to O O
a O O
marker O O
panel O O
for B-conn Purpose.Goal
the O O
detection O O
of O O
breast O O
tumor O O
cells O O
. O O

It O O
is O O
possible O O
that O O
the O O
sensitivity O O
with O O
this O O
marker O O
can O O
be O O
improved O O
if B-conn Condition.Hypothetical
more O O
PCR O O
cycles O O
are O O
performed O O
. O O

Mucin O O
1 O O
-LRB- O O
MUC1 O O
-RRB- O O
is O O
another O O
epithelial O O
glycoprotein O O
expressed O O
in O O
breast O O
epithelial O O
cells O O
. O O

It O O
is O O
a O O
commonly O O
used O O
if O O
controversial O O
marker O O
for O O
detection O O
of O O
circulating O O
tumor O O
cells O O
-LSB-5 O O
-RSB- O O
. O O

Recently O O
, O O
it O O
was O O
reported O O
that O O
that O O
immunomagnetic O O
separation O O
followed O O
by O O
MUC1-specific O O
real O O
time O O
RT-PCR O O
allowed O O
the O O
semi-quantitative O O
detection O O
of O O
circulating O O
mammary O O
cells O O
if B-conn Condition.Hypothetical
amplification O O
above O O
a O O
cycle O O
threshold O O
value O O
of O O
38 O O
was O O
obtained O O
-LSB-15 O O
-RSB- O O
. O O

Using O O
our O O
assay O O
, O O
MUC1 O O
transcripts O O
were O O
detected O O
in O O
1/6 O O
100 O O
PBMNC O O
only O O
samples O O
and O O
10/15 O O
tumor O O
cell O O
samples O O
. O O

Although B-conn Concession.Expectation
we O O
did O O
not O O
use O O
real-time O O
PCR O O
for O O
our O O
assay O O
, O O
the O O
intensity O O
of O O
the O O
positive O O
bands O O
in O O
the O O
PBMNC O O
only O O
samples O O
was O O
comparable O O
to O O
that O O
obtained O O
with O O
the O O
tumor O O
cell O O
samples O O
and B-conn Conjunction
it O O
was O O
concluded O O
that O O
detection O O
of O O
MUC1 O O
transcripts O O
would O O
result O O
in O O
too O O
many O O
false O O
positive O O
results O O
to O O
warrant O O
its O O
inclusion O O
in O O
our O O
panel O O
. O O

Interestingly O O
, O O
during O O
the O O
course O O
of O O
this O O
study O O
it O O
was O O
reported O O
that O O
a O O
majority O O
of O O
CK O O
-LRB- O O
+ O O
-RRB- O O
/MUC1 O O
-LRB- O O
+ O O
-RRB- O O
tumor O O
cells O O
circulating O O
in O O
the O O
blood O O
of O O
patients O O
with O O
advanced O O
breast O O
cancer O O
also O O
displayed O O
apoptotic O O
features O O
such O O
as O O
an O O
`` O O
inclusion O O
type O O
'' O O
cytokeratin O O
staining O O
pattern O O
and O O
nuclear O O
condensation O O
with O O
apoptosis-related O O
DNA O O
strand O O
breaks O O
-LSB-16 O O
-RSB- O O
. O O

It O O
was O O
concluded O O
that O O
the O O
predictive O O
value O O
of O O
such O O
CK O O
-LRB- O O
+ O O
-RRB- O O
/MUC1 O O
-LRB- O O
+ O O
-RRB- O O
positive O O
cells O O
should O O
be O O
considered O O
separately O O
when B-conn Temporal.Synchronous
analysing O O
tumor O O
cell O O
dissemination O O
, O O
further O O
supporting O O
our O O
decision O O
not O O
to O O
include O O
MUC1 O O
. O O

Elevated O O
levels O O
of O O
serum O O
carcinoembryonic O O
antigenCEA O O
are O O
commonly O O
used O O
as O O
a O O
clinical O O
tool O O
in B-conn Purpose.Goal
the O O
diagnosis O O
and O O
monitoring O O
of O O
metastasis O O
but B-conn Contrast
the O O
use O O
of O O
CEA O O
as O O
an O O
immunobead O O
RT-PCR O O
marker O O
-LSB-17 O O
-RSB- O O
has O O
given O O
varying O O
results O O
. O O

CEA O O
has O O
been O O
considered O O
to O O
show O O
no O O
diagnostic O O
value O O
as O O
a O O
RT-PCR O O
marker O O
for B-conn Purpose.Goal
the O O
detection O O
of O O
micrometastases O O
because B-conn Cause.Reason
it O O
is O O
expressed O O
in O O
the O O
blood O O
and O O
lymph O O
nodes O O
of O O
patients O O
without O O
cancer O O
-LSB-5 O O
-RSB- O O
. O O

However B-conn Contrast
, O O
in O O
a O O
comparison O O
of O O
immunobead O O
RT-PCR O O
and O O
regular O O
RT-PCR O O
amplification O O
, O O
it O O
was O O
shown O O
that O O
immunobead O O
isolation O O
increases O O
the O O
specificity O O
of O O
CEA -LSB-8 O O
-RSB- O O
. O O

Using O O
55 O O
PCR O O
cycles O O
for O O
CEA O O
, O O
we O O
found O O
amplification O O
in O O
none O O
of O O
the O O
PBMNC O O
only O O
samples O O
and O O
gained O O
a O O
positive O O
result O O
for O O
45 O O
% O O
of O O
the O O
single O O
tumor O O
cell O O
samples O O
we O O
tested O O
. O O

Thus B-conn Cause.Claim
, O O
CEA O O
appears O O
to O O
be O O
a O O
very O O
useful O O
marker O O
when B-conn Temporal.Synchronous
immunobead O O
enrichment O O
is O O
performed O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
RT-PCR O O
. O O

Epidermal O O
growth O O
factor O O
receptor O O
-LRB- O O
EGFR O O
, O O
HER1 O O
, O O
ErbB1 O O
-RRB- O O
is O O
a O O
tyrosine O O
kinase O O
whose O O
activation O O
plays O O
an O O
important O O
role O O
in O O
the O O
regulation O O
of O O
cell O O
proliferation O O
, O O
differentiation O O
and O O
survival O O
with O O
a O O
pivotal O O
role O O
in O O
maintenance O O
and O O
repair O O
of O O
epithelial O O
tissues O O
. O O

EGFR O O
is O O
overexpressed O O
in O O
50–70 O O
% O O
of O O
human O O
primary O O
breast O O
, O O
lung O O
, O O
and O O
colon O O
carcinomas O O
-LSB-18 O O
-RSB- O O
. O O

A O O
study O O
using O O
nested O O
RT-PCR O O
and O O
Southern O O
blotting O O
to B-conn Purpose.Goal
detect O O
EGFR O O
transcripts O O
in O O
blood O O
samples O O
from O O
patients O O
with O O
metastatic O O
colon O O
cancer O O
found O O
that O O
10.5 O O
% O O
of O O
healthy O O
donors O O
were O O
positive O O
which O O
suggests O O
that O O
their O O
assay O O
detected O O
illegitimate O O
transcription O O
. O O

However B-conn Contrast
, O O
none O O
of O O
the O O
27 O O
PBMNC O O
only O O
aliquots O O
tested O O
in O O
our O O
assay O O
yielded O O
EGFR O O
amplification O O
products O O
and B-conn Conjunction
19/43 O O
-LRB- O O
44 O O
% O O
-RRB- O O
single O O
tumor O O
cells O O
were O O
detected O O
. O O

A O O
comparison O O
of O O
the O O
results O O
obtained O O
for O O
the O O
two O O
ER O O
positive O O
cell O O
lines O O
-LRB- O O
6/20 O O
-RRB- O O
with O O
those O O
obtained O O
for O O
the O O
two O O
ER O O
negative O O
cell O O
lines O O
-LRB- O O
13/23 O O
-RRB- O O
suggests O O
that O O
ER O O
status O O
will O O
affect O O
the O O
efficacy O O
of O O
this O O
marker O O
but B-conn Concession.Contra-expectation
it O O
remains O O
a O O
useful O O
marker O O
. O O

Mammaglobin O O
1 O O
-LRB- O O
MGB1 O O
-RRB- O O
expression O O
is O O
limited O O
to O O
mammary O O
epithelium O O
and O O
is O O
often O O
up-regulated O O
in O O
human O O
breast O O
cancer O O
-LSB-20 O O
-RSB- O O
. O O

The O O
gene O O
has O O
been O O
localised O O
to O O
chromosome O O
11q13 O O
in O O
a O O
region O O
frequently O O
amplified O O
in O O
breast O O
cancer O O
. O O

Using O O
nested O O
RT-PCR O O
, O O
it O O
was O O
shown O O
that O O
MGB1 O O
transcripts O O
are O O
detectable O O
in O O
blood O O
from O O
breast O O
cancer O O
patients O O
-LSB-21 O O
-RSB- O O
. O O

Marchetti O O
et O O
al O O
. O O
, O O
-LRB- O O
2001 O O
-RRB- O O
analysed O O
lymph O O
nodes O O
from O O
breast O O
cancer O O
and O O
normal O O
patients O O
and O O
suggest O O
that O O
MGB1 O O
is O O
a O O
more O O
sensitive O O
and O O
more O O
specific O O
RT-PCR O O
marker O O
than O O
a O O
panel O O
of O O
six O O
other O O
markers O O
that O O
included O O
CEA O O
, O O
CK19 O O
and O O
MUC1-LSB-22 O O
-RSB- O O
. O O

MGB1 O O
transcripts O O
were O O
not O O
detected O O
by O O
us O O
in O O
any O O
of O O
the O O
PBMNC O O
only O O
aliquots O O
. O O

In O O
our O O
hands O O
, O O
MGB1 O O
transcripts O O
were O O
only O O
detected O O
in O O
9/35 O O
-LRB- O O
26 O O
% O O
-RRB- O O
of O O
the O O
single O O
tumor O O
cells O O
tested O O
but B-conn Concession.Contra-expectation
because B-conn Cause.Reason
this O O
marker O O
is O O
mammary-specific O O
, O O
its O O
inclusion O O
in O O
a O O
panel O O
of O O
RT-PCR O O
markers O O
is O O
warranted O O
. O O

It O O
is O O
possible O O
that O O
the O O
sensitivity O O
with O O
this O O
marker O O
can O O
be O O
improved O O
if B-conn Condition.Hypothetical
more O O
PCR O O
cycles O O
are O O
performed O O
. O O

ELF3 O O
, O O
also O O
known O O
as O O
Epithelial-Specific O O
with O O
serine O O
bo O O
X O O
-LRB- O O
ESX O O
-RRB- O O
, O O
is O O
a O O
member O O
of O O
the O O
Ets O O
multigene O O
family O O
of O O
transcriptional O O
regulators O O
and O O
is O O
localised O O
to O O
chromosome O O
1q32 O O
in O O
a O O
region O O
known O O
to O O
be O O
amplified O O
in O O
50 O O
% O O
of O O
early O O
breast O O
cancers O O
-LSB-11,23 O O
-RSB- O O
.ELF3 O O
mRNA O O
expression O O
is O O
restricted O O
to O O
tissues O O
of O O
epithelial O O
origin O O
, O O
including O O
normal O O
and O O
malignant O O
human O O
mammary O O
ductal O O
epithelium O O
with O O
no O O
expression O O
reported O O
in O O
lympho-haematopoietic O O
tissues O O
. O O

In O O
our O O
assay O O
, O O
faint O O
bands O O
were O O
visible O O
at O O
188 O O
bp O O
both O O
after O O
45 O O
cycles O O
-LRB- O O
1/6 O O
-RRB- O O
and O O
after O O
55 O O
cycles O O
-LRB- O O
5/30 O O
-RRB- O O
in O O
the O O
PBMNC O O
only O O
aliquots O O
. O O

However B-conn Concession.Contra-expectation
the O O
strong O O
intensity O O
of O O
the O O
bands O O
for O O
the O O
40/43 O O
-LRB- O O
93 O O
% O O
-RRB- O O
samples O O
with O O
a O O
single O O
tumor O O
cell O O
was O O
considered O O
indicative O O
of O O
a O O
positive O O
result O O
in O O
these O O
cases O O
. O O

Decreasing O O
the O O
cycle O O
number O O
to O O
35 O O
eliminated O O
the O O
weak O O
band O O
in O O
the O O
PBMNC O O
only O O
aliquots O O
-LRB- O O
0/15 O O
-RRB- O O
, O O
yet O O
still B-conn Concession.Contra-expectation
allowed O O
consistent O O
detection O O
of O O
the O O
tumor O O
cells O O
in O O
our O O
assay O O
-LRB- O O
15/16 O O
– O O
94 O O
% O O
-RRB- O O
and B-conn Continuation
therefore B-conn Cause.Claim
ELF3 O O
is O O
a O O
useful O O
marker O O
for O O
inclusion O O
in O O
our O O
panel O O
. O O

EphB4 O O
is O O
a O O
member O O
of O O
the O O
Eph O O
family O O
of O O
receptor O O
protein O O
tyrosine O O
kinases O O
and O O
has O O
recently O O
been O O
reported O O
to O O
be O O
up-regulated O O
in O O
cancers O O
from O O
prostate O O
, O O
breast O O
, O O
endometrium O O
, O O
lung O O
and O O
colon O O
-LSB-12,24-27 O O
-RSB- O O
. O O

It O O
is O O
thought O O
to O O
play O O
an O O
important O O
role O O
in O O
the O O
development O O
and O O
oncogenesis O O
of O O
various O O
tissues O O
through B-conn Purpose.Enablement
modifications O O
to O O
cell-cell O O
communication O O
and O O
adhesion O O
. O O

Although B-conn Concession.Expectation
EphB4 O O
was O O
detected O O
in O O
some O O
PBMNC O O
cell O O
only O O
controls O O
at O O
55 O O
cycles O O
the O O
level O O
of O O
intensity O O
of O O
the O O
corresponding O O
bands O O
on O O
agarose O O
gels O O
was O O
low O O
and B-conn Conjunction
decreasing O O
the O O
cycle O O
number O O
to O O
45 O O
resulted O O
in O O
no O O
positive O O
samples O O
out O O
of O O
21 O O
tests O O
. O O

Using O O
EphB4 O O
specific O O
primers O O
with O O
45 O O
cycles O O
we O O
could O O
detect O O
77.5 O O
% O O
of O O
single O O
tumor O O
cells O O
-LRB- O O
31/40 O O
-RRB- O O
proving O O
this O O
to O O
be O O
an O O
useful O O
marker O O
in O O
this O O
assay O O
. O O

The O O
various O O
markers O O
used O O
here O O
show O O
different O O
degrees O O
of O O
heterogeneity O O
i.e O O
the O O
numbers O O
of O O
single O O
tumor O O
cells O O
that O O
they O O
are O O
detected O O
in O O
. O O

Interestingly O O
, O O
the O O
more O O
heterogeneous O O
markers O O
also B-conn Conjunction
gave O O
the O O
least O O
false O O
positives O O
in O O
the O O
controls O O
. O O

It O O
is O O
unclear O O
whether O O
this O O
is O O
due O O
to O O
the O O
sensitivity O O
of O O
the O O
test O O
or O O
due O O
to O O
stochastic O O
differences O O
in O O
whether O O
a O O
cell O O
expresses O O
a O O
transcript O O
or O O
not O O
. O O

Heterogeneity O O
at O O
the O O
single O O
cell O O
level O O
must O O
be O O
taken O O
into O O
account O O
when B-conn Temporal.Synchronous
designing O O
an O O
RT-PCR O O
assay O O
and B-conn Continuation
this O O
study O O
is O O
the O O
first O O
one O O
to O O
address O O
this O O
. O O

Using O O
a O O
panel O O
of O O
several O O
markers O O
will O O
reduce O O
this O O
source O O
of O O
error O O
. O O

This O O
can O O
be O O
seen O O
in O O
table O O
3 O O
where O O
nearly O O
every O O
tumour O O
cell O O
is O O
positive O O
for O O
more O O
than O O
one O O
marker O O
. O O

One O O
T-47D O O
cell O O
is O O
negative O O
for O O
all O O
5 O O
markers O O
tested O O
and B-conn Concession.Contra-expectation
it O O
is O O
possible O O
that O O
this O O
cell O O
was O O
not O O
viable O O
at O O
the O O
time O O
of O O
selection O O
. O O

The O O
need O O
to O O
be O O
both O O
specific O O
and O O
sensitive O O
may O O
entail O O
finding O O
a O O
balance O O
between O O
the O O
specificity O O
and O O
sensitivity O O
. O O

Our O O
findings O O
in O O
the O O
PBMNC O O
suggest O O
that O O
illegitimate O O
transcription O O
occurs O O
in O O
all O O
cells O O
rather O O
than O O
a O O
subset O O
. O O

When B-conn Condition.Hypothetical
large O O
numbers O O
of O O
cells O O
are O O
present O O
or B-conn Alternative.Disjunctive
the O O
assay O O
is O O
very O O
sensitive O O
, O O
false O O
positives O O
will O O
be O O
common O O
. O O

ELF3 O O
had O O
a O O
fairly O O
high O O
false O O
positive O O
rate O O
of O O
amplification O O
in O O
PBMNC O O
at O O
45 O O
cycles O O
presumably B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
detecting O O
illegitimate O O
transcription O O
in O O
a O O
very O O
small O O
number O O
of O O
these O O
cells O O
. O O

However B-conn Concession.Contra-expectation
, O O
ELF3 O O
was O O
one O O
of O O
the O O
more O O
robust O O
markers O O
giving O O
very O O
strong O O
amplification O O
of O O
single O O
tumour O O
cells O O
at O O
45 O O
cycles O O
. O O

Amplification O O
from O O
the O O
controls O O
was O O
eliminated O O
when B-conn Temporal.Succession
only O O
35 O O
cycles O O
of O O
amplification O O
were O O
performed O O
. O O

Because B-conn Cause.Reason
only O O
a O O
small O O
amount O O
of O O
product O O
was O O
amplified O O
after O O
45 O O
cycles O O
in O O
these O O
controls O O
we O O
could O O
distinguish O O
samples O O
that O O
contained O O
tumor O O
cells O O
and O O
those O O
that O O
did O O
not O O
through B-conn Purpose.Enablement
comparison O O
of O O
the O O
intensity O O
of O O
bands O O
. O O

This O O
suggests O O
that O O
this O O
and O O
similar O O
markers O O
will O O
be O O
useful O O
in O O
a O O
real-time O O
PCR O O
methodology O O
where O O
positive O O
signals O O
can O O
be O O
more O O
readily O O
differentiated O O
from O O
background O O
signals O O
-LSB-15 O O
-RSB- O O
. O O

As O O
mentioned O O
, O O
one O O
question O O
is O O
whether O O
cell O O
lines O O
are O O
truly O O
representative O O
of O O
circulating O O
tumor O O
cells O O
. O O

A O O
large O O
number O O
of O O
circulating O O
tumor O O
cells O O
are O O
believed O O
to O O
be O O
in O O
G0 O O
-LSB-1 O O
-RSB- O O
, O O
whereas B-conn Contrast
the O O
cell O O
line O O
controls O O
used O O
are O O
from O O
log O O
phase O O
cells O O
. O O

We O O
compared O O
the O O
expression O O
of O O
ELF3 O O
, O O
EphB4 O O
and O O
EGFR O O
in O O
cells O O
grown O O
under O O
conditions O O
of O O
serum O O
starvation O O
, O O
during O O
log O O
phase O O
and O O
at O O
full O O
confluence O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

We O O
saw O O
no O O
appreciable O O
difference O O
in O O
the O O
expression O O
levels O O
of O O
any O O
of O O
these O O
3 O O
genes O O
under O O
any O O
of O O
the O O
conditions O O
tested O O
. O O

Whereas B-conn Contrast
it O O
is O O
difficult O O
to O O
model O O
the O O
clinical O O
situation O O
, O O
where O O
patterns O O
of O O
gene O O
expression O O
are O O
likely O O
to O O
be O O
heterogeneous O O
, O O
the O O
assay O O
presented O O
in O O
this O O
communication O O
is O O
useful O O
for O O
testing O O
potential O O
RT-PCR O O
markers O O
and O O
as O O
a O O
meaningful O O
control O O
in O O
the O O
determination O O
of O O
the O O
presence O O
of O O
disseminated O O
tumor O O
cells O O
in O O
clinical O O
samples O O
. O O

To B-conn Purpose.Goal
fully O O
validate O O
these O O
markers O O
, O O
a O O
clinical O O
study O O
using O O
immunomagnetically O O
enriched O O
cells O O
from O O
patients O O
is O O
needed O O
. O O

Such O O
a O O
study O O
is O O
currently O O
in O O
progress O O
. O O

Conclusions O O

Immunobead O O
RT-PCR O O
is O O
a O O
powerful O O
methodology O O
for O O
the O O
detection O O
of O O
disseminated O O
carcinoma O O
cells O O
. O O

We O O
need O O
RT-PCR O O
assays O O
that O O
are O O
sensitive O O
enough O O
to B-conn Purpose.Goal
detect O O
very O O
low O O
numbers O O
of O O
captured O O
carcinoma O O
cells O O
As B-conn Cause.Reason
haematopoietic O O
cells O O
may O O
be O O
non-specifically O O
retained O O
during O O
immunomagnetic O O
enrichment O O
of O O
epithelial O O
cells O O
, O O
these O O
RT-PCR O O
markers O O
also B-conn Conjunction
need O O
to O O
be O O
tested O O
for O O
their O O
specificity O O
. O O

A O O
set O O
of O O
RT-PCR O O
markers O O
has O O
been O O
tested O O
for O O
their O O
ability O O
to O O
detect O O
a O O
single O O
carcinoma O O
cell O O
using O O
a O O
single O O
round O O
of O O
PCR O O
and O O
ethidium O O
bromide O O
visualization O O
. O O

We O O
have O O
identified O O
six O O
useful O O
markers O O
that O O
include O O
the O O
previously O O
described O O
markers O O
EpCAM O O
, O O
EGFR O O
, O O
CEA O O
and O O
MGB1 O O
as O O
well O O
as O O
two O O
novel O O
markers O O
EphB4 O O
, O O
and O O
ELF3 O O
. O O

This O O
panel O O
of O O
markers O O
should O O
allow O O
the O O
detection O O
of O O
virtually O O
every O O
tumor O O
cell O O
and B-conn Conjunction
this O O
means O O
that O O
a O O
positive O O
result O O
will O O
be O O
obtained O O
each O O
time O O
an O O
immunobead O O
harvest O O
has O O
captured O O
at O O
least O O
one O O
breast O O
cancer O O
cell O O
. O O

Most O O
of O O
these O O
markers O O
will O O
also B-conn Conjunction
be O O
useful O O
in O O
the O O
analysis O O
of O O
other O O
carcinomas O O
such O O
as O O
colon O O
, O O
lung O O
and O O
prostate O O
. O O

Competing O O
interests O O

None O O
declared O O
. O O

Pre-publication O O
history O O

The O O
pre-publication O O
history O O
for O O
this O O
paper O O
can O O
be O O
accessed O O
here O O
: O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Expression O O
of O O
seven O O
RT-PCR O O
markers O O
in O O
a O O
panel O O
of O O
seven O O
breast O O
cancer O O
cell O O
lines O O
. O O

Each O O
marker O O
is O O
shown O O
in O O
a O O
separate O O
panel O O
and B-conn Continuation
the O O
size O O
of O O
the O O
amplified O O
product O O
is O O
indicated O O
in O O
base O O
pairs O O
-LRB- O O
bp O O
-RRB- O O
M O O
indicates O O
the O O
pUC19/HpaII O O
marker O O
, O O
-ve O O
indicates O O
the O O
RT-PCR O O
negative O O
control O O
. O O

Weak O O
genomic O O
or O O
primer O O
dimer O O
bands O O
are O O
seen O O
for O O
some O O
RT-PCRs O O
. O O

Figure O O
2 O O
: O O
Expression O O
of O O
seven O O
RT-PCR O O
markers O O
in O O
5 O O
separate O O
single O O
MDA-MB-453 O O
cells O O
lysed O O
with O O
100 O O
normal O O
PBMNC O O
. O O

Lane O O
M O O
– O O
pUC19/HpaII O O
molecular O O
weight O O
marker O O
. O O

The O O
following O O
3 O O
lanes O O
are O O
amplifications O O
from O O
100 O O
PBMNC O O
only O O
. O O

The O O
following O O
5 O O
lanes O O
are O O
amplifications O O
from O O
one O O
MDA-MB-453 O O
cell O O
in O O
100 O O
PBMNC O O
, O O
Lane O O
C O O
is O O
the O O
cDNA O O
positive O O
control O O
, O O
Lane O O
G O O
is O O
the O O
genomic O O
DNA O O
control O O
-LRB- O O
G O O
-RRB- O O
, O O
Lane O O
R O O
is O O
the O O
RT O O
– O O
negative O O
control O O
; O O
Lanes O O
labelled O O
N O O
are O O
the O O
PCR O O
negative O O
controls O O
. O O

Genomic O O
bands O O
can O O
be O O
seen O O
for O O
many O O
ELF3 O O
amplifications O O
. O O

Figure O O
3 O O
: O O
Expression O O
of O O
seven O O
RT-PCR O O
markers O O
in O O
5 O O
separate O O
single O O
MCF-7 O O
cells O O
lysed O O
with O O
100 O O
normal O O
MNC O O
. O O

Lane O O
M O O
– O O
pUC19/HpaII O O
molecular O O
weight O O
marker O O
. O O

The O O
following O O
3 O O
lanes O O
are O O
amplifications O O
from O O
100 O O
PBMNC O O
only O O
. O O

The O O
following O O
5 O O
lanes O O
are O O
amplifications O O
from O O
one O O
MCF-7 O O
cell O O
in O O
100 O O
PBMNC O O
, O O
Lane O O
C O O
is O O
the O O
cDNA O O
positive O O
control O O
, O O
Lane O O
G O O
is O O
the O O
genomic O O
DNA O O
control O O
-LRB- O O
G O O
-RRB- O O
, O O
Lane O O
R O O
is O O
the O O
RT O O
– O O
negative O O
control O O
; O O
Lanes O O
labelled O O
N O O
are O O
the O O
PCR O O
negative O O
controls O O
. O O

Genomic O O
bands O O
can O O
be O O
seen O O
for O O
many O O
ELF3 O O
amplifications O O
, O O

Table O O
1 O O
: O O
Primer O O
sequences O O
-LRB- O O
sense O O
-LRB- O O
s O O
-RRB- O O
and O O
anti-sense O O
-LRB- O O
as O O
-RRB- O O
-RRB- O O
, O O
melting O O
temperatures O O
-LRB- O O
Tm O O
-RRB- O O
, O O
annealing O O
temperature O O
and O O
expected O O
product O O
size O O
in O O
nucleotides O O
-LRB- O O
nt O O
-RRB- O O
for O O
each O O
of O O
the O O
seven O O
selected O O
marker O O
genes O O
. O O

Table O O
2 O O
: O O
Comparison O O
of O O
the O O
expression O O
of O O
the O O
seven O O
selected O O
markers O O
in O O
either O O
100 O O
PBMNCs O O
only O O
, O O
or O O
after O O
the O O
addition O O
of O O
a O O
single O O
tumor O O
cell O O
from O O
one O O
of O O
four O O
different O O
cell O O
lines O O
. O O

Table O O
3 O O
: O O
Profile O O
of O O
gene O O
expression O O
from O O
10 O O
different O O
experiments O O
each O O
using O O
5 O O
single O O
tumour O O
cell/100 O O
PBMNC O O
aliquots O O
from O O
four O O
different O O
cell O O
lines O O
. O O

The O O
Ews-ERG O O
Fusion O O
Protein O O
Can O O
Initiate O O
Neoplasia O O
from O O
Lineage-Committed O O
Haematopoietic O O
Cells O O

Abstract O O

The O O
EWS-ERG O O
fusion O O
protein O O
is O O
found O O
in O O
human O O
sarcomas O O
with O O
the O O
chromosomal O O
translocation O O
t O O
-LRB- O O
21 O O
; O O
22 O O
-RRB- O O
-LRB- O O
q22 O O
; O O
q12 O O
-RRB- O O
, O O
where O O
the O O
translocation O O
is O O
considered O O
to O O
be O O
an O O
initiating O O
event O O
in O O
sarcoma O O
formation O O
within O O
uncommitted O O
mesenchymal O O
cells O O
, O O
probably O O
long-lived O O
progenitors O O
capable O O
of O O
self O O
renewal O O
. O O

The O O
fusion O O
protein O O
may O O
not O O
therefore B-conn Cause.Result
have O O
an O O
oncogenic O O
capability O O
beyond O O
these O O
progenitors O O
. O O

To B-conn Purpose.Goal
assess O O
whether O O
EWS-ERG O O
can O O
be O O
a O O
tumour O O
initiator O O
in O O
cells O O
other O O
than O O
mesenchymal O O
cells O O
, O O
we O O
have O O
analysed O O
Ews-ERG O O
fusion O O
protein O O
function O O
in O O
a O O
cellular O O
environment O O
not O O
typical O O
of O O
that O O
found O O
in O O
human O O
cancers O O
, O O
namely B-conn Restatement.Specification
, O O
committed O O
lymphoid O O
cells O O
. O O

We O O
have O O
used O O
Ews-ERG O O
invertor O O
mice O O
having O O
an O O
inverted O O
ERG O O
cDNA O O
cassette O O
flanked O O
by O O
loxP O O
sites O O
knocked O O
in O O
the O O
Ews O O
intron O O
8 O O
, O O
crossed O O
with O O
mice O O
expressing O O
Cre O O
recombinase O O
under O O
the O O
control O O
of O O
the O O
Rag1 O O
gene O O
to B-conn Purpose.Goal
give O O
conditional O O
, O O
lymphoid-specific O O
expression O O
of O O
the O O
fusion O O
protein O O
. O O

Clonal O O
T O O
cell O O
neoplasias O O
arose O O
in O O
these O O
mice O O
. O O

This O O
conditional O O
Ews O O
gene O O
fusion O O
model O O
of O O
tumourigenesis O O
shows O O
that O O
Ews-ERG O O
can O O
cause O O
haematopoietic O O
tumours O O
and B-conn Conjunction
the O O
precursor O O
cells O O
are O O
committed O O
cells O O
. O O

Thus B-conn Cause.Claim
, O O
Ews-ERG O O
can O O
function O O
in O O
cells O O
that O O
do O O
not O O
have O O
to O O
be O O
pluripotent O O
progenitors O O
or O O
mesenchymal O O
cells O O
. O O

Introduction O O

Chromosomal O O
translocations O O
are O O
characteristic O O
of O O
many O O
human O O
cancers O O
, O O
and O O
are O O
especially O O
well O O
studied O O
in O O
leukaemias O O
, O O
lymphomas O O
, O O
and O O
sarcomas O O
-LSB-1,2 O O
-RSB- O O
. O O

Epithelial O O
tumours O O
also B-conn Conjunction
carry O O
chromosomal O O
translocations O O
, O O
but B-conn Concession.Contra-expectation
while B-conn Contrast
those O O
in O O
leukaemias O O
, O O
lymphomas O O
, O O
and O O
sarcomas O O
tend O O
to O O
be O O
reciprocal O O
translocations O O
, O O
those O O
in O O
carcinomas O O
are O O
often O O
non-reciprocal O O
translocations O O
-LSB-3 O O
-RSB- O O
. O O

The O O
main O O
outcomes O O
of O O
the O O
reciprocal O O
translocations O O
are O O
either O O
forced O O
oncogene O O
expression O O
, O O
as O O
found O O
in O O
lymphoid O O
malignancies O O
, O O
or O O
gene O O
fusion O O
, O O
found O O
in O O
both O O
leukaemias O O
and O O
sarcomas O O
-LSB-1,2 O O
-RSB- O O
. O O

Gene O O
fusion O O
occurs O O
when B-conn Temporal.Synchronous
the O O
translocation O O
breakpoints O O
are O O
within O O
the O O
introns O O
of O O
genes O O
, O O
such B-conn Cause.Result
that I-conn Cause.Result
the O O
two O O
translocated O O
chromosomes O O
have O O
new O O
exon O O
organisation O O
, O O
leading O O
to O O
the O O
formation O O
of O O
chimaeric O O
mRNA O O
species O O
and O O
, O O
in O O
turn O O
, O O
chimaeric O O
proteins O O
. O O

Some O O
translocations O O
must O O
function O O
within O O
stem O O
cells O O
to B-conn Purpose.Goal
initiate O O
disease O O
while B-conn Contrast
others O O
function O O
in O O
both O O
stem O O
cells O O
and O O
more O O
committed O O
cells O O
to B-conn Purpose.Goal
provide O O
related O O
or O O
distinct O O
functions O O
-LRB- O O
reviewed O O
in O O
-LSB-4 O O
-RSB- O O
-RRB- O O
. O O

Different O O
tumour O O
phenotypes O O
can O O
result O O
from O O
specific O O
versions O O
of O O
related O O
fusion O O
proteins O O
, O O
for B-conn Instantiation
instance I-conn Instantiation
, O O
the O O
Philadelphia O O
t O O
-LRB- O O
9 O O
; O O
22 O O
-RRB- O O
translocation O O
-LRB- O O
which O O
yields O O
the O O
BCR-ABL O O
-LSB-breakpoint O O
cluster O O
region O O
gene–Abelson O O
leukaemia O O
oncogene O O
-RSB- O O
fusion O O
-RRB- O O
occurs O O
in O O
both O O
myeloid- O O
and O O
lymphoid-lineage O O
tumours O O
, O O
dictated O O
by B-conn Purpose.Enablement
the O O
position O O
of O O
the O O
translocation O O
junction O O
within O O
the O O
BCR O O
gene O O
-LSB-5 O O
-RSB- O O
. O O

The O O
biological O O
consequences O O
of O O
the O O
BCR-ABL O O
fusion O O
have O O
been O O
studied O O
in O O
relation O O
to O O
stem O O
cell O O
properties O O
-LSB-6–8 O O
-RSB- O O
. O O

These O O
studies O O
show O O
that O O
the O O
BCR-ABL O O
fusion O O
protein O O
does O O
not O O
confer O O
self-renewal O O
potential O O
on O O
committed O O
myeloid O O
progenitors O O
, O O
whereas B-conn Contrast
other O O
translocation O O
fusion O O
proteins O O
-LRB- O O
e.g. O O
, O O
MOZ-TIF2 O O
-RRB- O O
do O O
-LSB-7 O O
-RSB- O O
. O O

The O O
MLL O O
-LRB- O O
mixed O O
lineage O O
leukaemia O O
-RRB- O O
gene O O
has O O
more O O
than O O
30 O O
known O O
fusion O O
partners O O
-LSB-9,10 O O
-RSB- O O
, O O
and B-conn Conjunction
retroviral O O
transduction O O
experiments O O
with O O
MLL-ENL O O
fusion O O
showed O O
that O O
the O O
multipotent O O
myeloid O O
progenitors O O
and O O
committed O O
myeloid O O
progenitors O O
could O O
respond O O
to O O
an O O
MLL O O
fusion O O
protein O O
to B-conn Purpose.Goal
become O O
leukaemic O O
, O O
suggesting O O
the O O
existence O O
of O O
cancer O O
stem O O
cells O O
distinct O O
from O O
multipotent O O
stem O O
cells O O
of O O
the O O
tissue O O
of O O
origin O O
-LSB-11 O O
-RSB- O O
. O O

While B-conn Contrast
some O O
translocations O O
have O O
these O O
dual O O
properties O O
, O O
others O O
only O O
function O O
in O O
committed O O
cells O O
such O O
as O O
those O O
translocations O O
mediated O O
by B-conn Purpose.Enablement
the O O
RAG-VDJ O O
-LRB- O O
recombinase O O
activating O O
gene O O
and O O
variable O O
, O O
joining O O
, O O
diversity O O
regions O O
-RRB- O O
recombinase O O
of O O
the O O
lymphoid O O
lineage O O
-LSB-1 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
, O O
naturally O O
occurring O O
translocations O O
, O O
such O O
as O O
that O O
of O O
LMO2 O O
-LRB- O O
LIM O O
domain O O
only O O
2 O O
-RRB- O O
in O O
T O O
cell O O
acute O O
leukaemia O O
, O O
only O O
function O O
in O O
committed O O
cells O O
. O O

Such O O
issues O O
are O O
not O O
confined O O
to O O
haematopoietic O O
malignancies O O
. O O

The O O
EWS-FUS O O
family O O
, O O
typically O O
involved O O
in O O
sarcoma O O
aetiology O O
, O O
exhibits O O
characteristics O O
of O O
tumour O O
initiators O O
-LSB-12–15 O O
-RSB- O O
. O O

The O O
EWS O O
gene O O
, O O
at O O
Chromosome O O
22 O O
band O O
q12 O O
, O O
was O O
first O O
identified O O
in O O
Ewing O O
's O O
sarcoma O O
by B-conn Purpose.Enablement
its O O
association O O
with O O
FLI1 O O
and O O
ATF1 O O
-LSB-16,17 O O
-RSB- O O
and O O
subsequently B-conn Temporal.Precedence
found O O
in O O
subsets O O
of O O
Ewing O O
's O O
sarcoma O O
with O O
either O O
ERG O O
or O O
ETV1 O O
, O O
and O O
E1AF O O
and O O
FEV O O
-LSB-17–21 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
EWS O O
gene O O
is O O
involved O O
in O O
other O O
sarcomas O O
and O O
with O O
yet O O
different O O
partners O O
, O O
such O O
as O O
WT1 O O
-LRB- O O
Wilms O O
tumour O O
1 O O
gene O O
-RRB- O O
in O O
desmoplastic O O
small O O
round O O
cell O O
sarcoma O O
-LSB-22 O O
-RSB- O O
or O O
CHN O O
in O O
myxoid O O
chondrosarcoma O O
-LSB-23 O O
-RSB- O O
. O O

A O O
further O O
ramification O O
of O O
this O O
infidelity O O
is O O
that O O
the O O
FUS O O
gene O O
, O O
first O O
identified O O
by B-conn Purpose.Enablement
its O O
fusion O O
with O O
the O O
CHOP O O
gene O O
in O O
t O O
-LRB- O O
12 O O
; O O
16 O O
-RRB- O O
of O O
malignant O O
myxoid O O
liposarcoma O O
and O O
related O O
to O O
the O O
EWS O O
gene O O
-LSB-24,25 O O
-RSB- O O
, O O
has O O
also B-conn Conjunction
been O O
found O O
in O O
Ewing O O
's O O
sarcoma O O
fused O O
with O O
the O O
ERG O O
gene O O
, O O
but B-conn Concession.Contra-expectation
also O O
a O O
similar O O
FUS-ERG O O
fusion O O
has O O
been O O
described O O
in O O
some O O
acute O O
myeloid O O
leukaemias O O
-LSB-26–28 O O
-RSB- O O
. O O

Finally B-conn Conjunction
, O O
the O O
EWS O O
gene O O
can O O
also O O
be O O
involved O O
with O O
the O O
CHOP O O
gene O O
by B-conn Purpose.Enablement
chromosomal O O
translocation O O
in O O
malignant O O
myxoid O O
liposarcoma O O
-LSB-29 O O
-RSB- O O
, O O
analogous O O
to O O
FUS-CHOP O O
. O O

The O O
chromosomal O O
translocations O O
in O O
Ewing O O
's O O
and O O
other O O
sarcomas O O
are O O
considered O O
as O O
primary O O
initiating O O
events O O
. O O

Thus B-conn Cause.Result
the O O
EWS O O
fusions O O
function O O
in O O
the O O
cancer O O
precursor O O
cell O O
and O O
are O O
required O O
throughout O O
tumour O O
formation O O
until O O
the O O
emergence O O
of O O
the O O
overt O O
cancer O O
, O O
because B-conn Cause.Reason
the O O
chromosomal O O
translocation O O
is O O
present O O
in O O
the O O
cancer O O
at O O
the O O
time O O
of O O
presentation O O
. O O

The O O
fusion O O
protein O O
may O O
therefore B-conn Cause.Result
be O O
instructive O O
by B-conn Purpose.Enablement
imparting O O
a O O
phenotype O O
on O O
the O O
cell O O
by B-conn Purpose.Enablement
affecting O O
a O O
specific O O
differentiation O O
programme O O
, O O
which O O
must O O
be O O
part O O
of O O
the O O
genetic O O
make-up O O
of O O
the O O
cancer O O
stem O O
cell O O
, O O
since B-conn Cause.Justification
the O O
chromosomal O O
translocation O O
is O O
an O O
initiating O O
and O O
persistent O O
feature O O
. O O

The O O
pre-existing O O
chromosomal O O
translocation O O
creates O O
a O O
cellular O O
environment O O
allowing O O
secondary O O
mutations O O
to O O
arise O O
in O O
progeny O O
cells O O
, O O
resulting O O
in O O
overt O O
cancer O O
. O O

Conditional O O
mouse O O
models O O
of O O
the O O
EWS- O O
and O O
FUS-associated O O
chromosomal O O
translocations O O
should O O
give O O
insights O O
into O O
how O O
these O O
fusions O O
influence O O
the O O
malignant O O
phenotype O O
. O O

We O O
have O O
analysed O O
whether O O
EWS O O
fusions O O
function O O
only O O
in O O
the O O
domain O O
of O O
mesenchymal O O
progenitors O O
and O O
whether O O
they O O
function O O
in O O
other O O
cell O O
lineages O O
, O O
specifically B-conn Restatement.Specification
within O O
committed O O
cells O O
, O O
as O O
has O O
been O O
demonstrated O O
for O O
MLL O O
fusions O O
-LSB-11 O O
-RSB- O O
. O O

We O O
have O O
developed O O
mouse O O
models O O
mimicking O O
chromosomal O O
translocations O O
by B-conn Purpose.Enablement
employing O O
homologous O O
recombination O O
in O O
embryonic O O
stem O O
-LRB- O O
ES O O
-RRB- O O
cells O O
to B-conn Purpose.Goal
create O O
mutant O O
alleles O O
in O O
mice O O
. O O

These O O
methods O O
were O O
either O O
the O O
knock-in O O
model O O
, O O
which O O
involved O O
fusing O O
the O O
MLL O O
gene O O
partner O O
AF9 O O
into O O
the O O
mouse O O
Mll O O
gene O O
, O O
resulting O O
in O O
acute O O
myeloid O O
leukaemias O O
in O O
mice O O
-LSB-30,31 O O
-RSB- O O
, O O
or O O
the O O
translocator O O
model O O
-LSB-32,33 O O
-RSB- O O
to O O
give O O
de O O
novo O O
chromosomal O O
translocations O O
, O O
resulting O O
in O O
cell-specific O O
leukaemias O O
-LSB-34 O O
-RSB- O O
. O O

We O O
have O O
applied O O
a O O
new O O
conditional O O
chromosomal O O
translocation O O
model O O
-LRB- O O
designated O O
the O O
invertor O O
model O O
-RRB- O O
-LSB-35 O O
-RSB- O O
to O O
the O O
EWS-ERG O O
gene O O
fusion O O
to B-conn Purpose.Goal
gain O O
insights O O
into O O
the O O
functional O O
significance O O
of O O
the O O
fusion O O
protein O O
in O O
tumourigenesis O O
. O O

Invertor O O
mice O O
are O O
made O O
by B-conn Purpose.Enablement
knocking O O
a O O
floxed O O
cDNA O O
cassette O O
into O O
the O O
intron O O
of O O
a O O
target O O
gene O O
downstream O O
of O O
the O O
mouse O O
exon O O
equivalent O O
to O O
that O O
usually O O
involved O O
in O O
human O O
chromosomal O O
translocations O O
-LSB-35 O O
-RSB- O O
. O O

The O O
floxed O O
cassette O O
is O O
introduced O O
into O O
the O O
intron O O
in O O
a O O
reverse O O
transcriptional O O
orientation O O
and O O
can O O
be O O
inverted O O
by B-conn Purpose.Enablement
Cre O O
recombinase O O
to B-conn Purpose.Goal
create O O
a O O
transcription O O
unit O O
capable O O
of O O
generating O O
an O O
appropriate O O
fusion O O
mRNA O O
-LRB- O O
see O O
below O O
and O O
Figure O O
1A O O
-RRB- O O
. O O

We O O
have O O
sought O O
to O O
determine O O
whether O O
an O O
Ews-ERG O O
fusion O O
can O O
be O O
oncogenic O O
in O O
a O O
cell O O
type O O
not O O
generally O O
associated O O
with O O
human O O
tumours O O
-LRB- O O
specifically B-conn Restatement.Specification
in O O
lymphoid O O
cells O O
-RRB- O O
and O O
also B-conn Conjunction
to O O
determine O O
whether O O
Ews-ERG O O
fusion O O
can O O
initiate O O
leukaemia O O
from O O
committed O O
cells O O
. O O

We O O
found O O
that O O
clonal O O
T O O
cell O O
lymphoma O O
arose O O
in O O
the O O
invertor O O
model O O
when B-conn Temporal.Synchronous
Cre O O
expression O O
was O O
controlled O O
by B-conn Purpose.Enablement
the O O
lymphocyte-specific O O
Rag1 O O
gene O O
, O O
showing O O
that O O
Ews-ERG O O
is O O
leukaemogenic O O
in O O
lymphoid O O
cells O O
. O O

Our O O
results O O
show O O
that O O
Ews-ERG O O
can O O
function O O
as O O
an O O
oncogene O O
in O O
committed O O
cells O O
of O O
mice O O
and O O
suggest O O
that O O
EWS-ERG O O
is O O
able O O
to O O
contribute O O
to O O
neoplasia O O
in O O
a O O
variety O O
of O O
cellular O O
contexts O O
in O O
vivo O O
. O O

Results O O

The O O
use O O
of O O
homologous O O
recombination O O
to B-conn Purpose.Goal
generate O O
oncogene O O
fusions O O
was O O
established O O
with O O
the O O
creation O O
of O O
the O O
Mll-AF9 O O
mouse O O
model O O
-LSB-30 O O
-RSB- O O
. O O

We O O
attempted O O
a O O
similar O O
approach O O
to B-conn Purpose.Goal
make O O
Ews O O
fusions O O
of O O
the O O
type O O
found O O
in O O
specific O O
human O O
sarcomas O O
and O O
leukaemias O O
-LRB- O O
Figure O O
S1 O O
shows O O
sequences O O
of O O
Chop O O
, O O
ATF1 O O
, O O
and O O
Fli1 O O
together O O
with O O
AF9 O O
sequences O O
used O O
for O O
the O O
knock-in O O
targeting O O
clones O O
-RRB- O O
. O O

While B-conn Concession.Expectation
we O O
were O O
able O O
to O O
obtain O O
homologous O O
recombination O O
knock-in O O
clones O O
either O O
with O O
a O O
vector O O
carrying O O
only O O
a O O
transfer O O
cassette O O
or O O
with O O
the O O
Ews-AF9 O O
control O O
fusion O O
, O O
no O O
clones O O
were O O
obtained O O
with O O
any O O
of O O
the O O
Ews O O
fusions O O
equivalent O O
to O O
those O O
naturally O O
found O O
in O O
human O O
cancers O O
-LRB- O O
Table O O
S1 O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
chimaeras O O
could O O
be O O
made O O
with O O
the O O
Ews O O
cassette O O
and O O
the O O
Ews-AF9 O O
knock-in O O
-LRB- O O
Table O O
S1 O O
-RRB- O O
. O O

We O O
concluded O O
that O O
Ews O O
fusions O O
of O O
the O O
type O O
naturally O O
associated O O
with O O
human O O
cancers O O
could O O
be O O
lethal O O
in O O
ES O O
cells O O
, O O
obviating O O
the O O
generation O O
of O O
targeted O O
cells O O
. O O

We O O
have O O
recently O O
developed O O
a O O
new O O
conditional O O
knock-in O O
method O O
based O O
on O O
inversion O O
of O O
a O O
loxP-flanked O O
cDNA O O
cassette O O
by O O
Cre O O
recombinase O O
-LSB-35 O O
-RSB- O O
. O O

This O O
Ews-ERG O O
invertor O O
model O O
is O O
diagrammatically O O
shown O O
in O O
Figure O O
1A O O
. O O

In B-conn Restatement.Specification
outline I-conn Restatement.Specification
, O O
homologous O O
recombination O O
in O O
mouse O O
ES O O
cells O O
was O O
used O O
to B-conn Purpose.Goal
introduce O O
a O O
floxed O O
ERG O O
cDNA O O
cassette O O
downstream O O
of O O
Ews O O
exon O O
7. O O
The O O
cassette O O
comprised O O
a O O
short O O
intronic O O
sequence O O
, O O
an O O
acceptor O O
splice O O
site O O
, O O
ERG O O
cDNA O O
, O O
a O O
polyA O O
site O O
, O O
and O O
a O O
neomycin O O
gene O O
-LRB- O O
to O O
select O O
homologous O O
recombinant O O
ES O O
cells O O
-RRB- O O
, O O
placed O O
in O O
the O O
opposite O O
transcription O O
orientation O O
to O O
the O O
Ews O O
gene O O
. O O

Expression O O
of O O
Cre O O
recombinase O O
inverts O O
the O O
cassette O O
, O O
bringing O O
the O O
acceptor O O
splice O O
site O O
into O O
the O O
correct O O
orientation O O
with O O
the O O
Ews O O
exon O O
7 O O
donor O O
splice O O
site O O
, O O
to B-conn Purpose.Goal
allow O O
post-transcriptional O O
production O O
of O O
Ews-ERG O O
fusion O O
mRNA O O
-LRB- O O
Figure O O
1B O O
shows O O
the O O
post-inversion O O
genomic O O
sequence O O
at O O
the O O
junction O O
of O O
Ews O O
and O O
ERG O O
-RRB- O O
. O O

Targeted O O
ES O O
cells O O
were O O
injected O O
into O O
blastocysts O O
, O O
and O O
these O O
yielded O O
normal O O
numbers O O
of O O
chimaeras O O
, O O
which O O
gave O O
rise O O
to O O
heterozygous O O
carriers O O
of O O
the O O
Ews-ERG O O
invertor O O
allele O O
-LRB- O O
invertor O O
mice O O
-RRB- O O
. O O

In O O
these O O
invertor O O
mice O O
, O O
Ews-ERG O O
protein O O
can O O
only O O
be O O
made O O
after O O
Cre-mediated O O
inversion O O
and O O
thus B-conn Cause.Result
can O O
be O O
cell-specifically O O
dependent O O
on O O
Cre O O
expression O O
. O O

We O O
investigated O O
the O O
ability O O
of O O
Ews-ERG O O
fusion O O
protein O O
to O O
contribute O O
to O O
leukaemogenesis O O
by B-conn Purpose.Enablement
causing O O
the O O
inversion O O
of O O
the O O
ERG-containing O O
cassette O O
in O O
lymphoid O O
cells O O
using O O
Rag1-Cre O O
knock-in O O
mice O O
-LSB-36 O O
-RSB- O O
. O O

Out O O
of O O
the O O
cohort O O
of O O
29 O O
mice O O
carrying O O
both O O
Ews-ERG O O
and O O
Rag1-Cre O O
genes O O
, O O
25 O O
mice O O
-LRB- O O
86 O O
% O O
-RRB- O O
developed O O
leukaemia O O
associated O O
with O O
thymoma O O
within O O
500 O O
d O O
, O O
whereas B-conn Contrast
the O O
Ews-ERG-only O O
cohort O O
-LRB- O O
20 O O
mice O O
-RRB- O O
did O O
not O O
display O O
neoplasia O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

Blood O O
smears O O
at O O
the O O
time O O
of O O
sacrifice O O
of O O
Ews-ERG O O
; O O
Rag1-Cre O O
mice O O
typically O O
showed O O
elevated O O
numbers O O
of O O
large O O
leukocytes O O
, O O
with O O
lymphoid O O
morphology O O
of O O
different O O
maturities O O
, O O
including O O
lymphoblasts O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
bone O O
marrow O O
sections O O
showed O O
high O O
levels O O
of O O
infiltrating O O
lymphoblasts O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

The O O
diseased O O
mice O O
all O O
had O O
large O O
thymomas O O
, O O
usually O O
associated O O
with O O
splenomegaly O O
-LRB- O O
Table O O
1 O O
-RRB- O O
and O O
lymphadenopathy O O
, O O
and B-conn Conjunction
the O O
histology O O
of O O
spleens O O
showed O O
either O O
complete O O
loss O O
of O O
normal O O
architecture O O
-LRB- O O
loss O O
of O O
demarcated O O
white O O
and O O
red O O
pulp O O
-RRB- O O
, O O
partial O O
loss O O
, O O
or O O
normal O O
architecture O O
-LRB- O O
Figure O O
S2 O O
-RRB- O O
. O O

Similarly B-conn Similarity
, O O
the O O
level O O
of O O
infiltration O O
of O O
leukaemic O O
lymphocytes O O
into O O
liver O O
and O O
kidney O O
varied O O
, O O
with O O
some O O
having O O
large O O
amounts O O
of O O
perivascular O O
deposits O O
and O O
others O O
marginal O O
levels O O
. O O

All O O
mice O O
had O O
thymomas O O
with O O
homogeneous O O
presence O O
of O O
large O O
leukaemic O O
cells O O
. O O

These O O
characteristics O O
, O O
together O O
with O O
evidence O O
of O O
clonal O O
Tcrb O O
gene O O
rearrangements O O
and O O
expression O O
of O O
TCR-associated O O
CD8 O O
and O O
CD4 O O
-LRB- O O
see O O
below O O
-RRB- O O
, O O
permit O O
diagnosis O O
of O O
large O O
cell O O
anaplastic O O
T O O
cell O O
lymphoma O O
according O O
to O O
the O O
Bethesda O O
proposals O O
for O O
lymphoid O O
tumours O O
in O O
mice O O
-LSB-37 O O
-RSB- O O
. O O

The O O
Ews-ERG O O
fusion O O
appears O O
crucial O O
for O O
malignancies O O
in O O
the O O
invertor O O
mice O O
, O O
as B-conn Cause.Justification
disease O O
only O O
arose O O
in O O
mice O O
with O O
both O O
the O O
Ews-ERG O O
and O O
Rag1-Cre O O
genes O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
and O O
comprised O O
clonal O O
tumours O O
-LRB- O O
Figure O O
3 O O
-RRB- O O
. O O

The O O
presence O O
of O O
Ews-ERG O O
mRNA O O
was O O
confirmed O O
in O O
spleens O O
of O O
these O O
mice O O
, O O
identical O O
with O O
that O O
in O O
Ews-ERG O O
ES O O
cells O O
transfected O O
with O O
Cre O O
expression O O
plasmids O O
-LRB- O O
see O O
Figure O O
S1 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
steady O O
state O O
orientation O O
of O O
the O O
loxP-flanked O O
ERG O O
cassette O O
was O O
studied O O
using O O
filter O O
hybridisation O O
and B-conn Conjunction
we O O
found O O
that O O
the O O
ERG O O
sequence O O
had O O
become O O
inverted O O
into O O
the O O
5′ O O
to O O
3′ O O
orientation O O
with O O
respect O O
to O O
the O O
Ews O O
gene O O
in O O
each O O
case O O
of O O
thymoma O O
-LRB- O O
Figure O O
3A O O
; O O
Table O O
1 O O
-RRB- O O
. O O

The O O
other O O
tissues O O
examined O O
have O O
little O O
evidence O O
of O O
an O O
inverted O O
band O O
. O O

Finally B-conn Temporal.Precedence
, O O
the O O
presence O O
of O O
the O O
Ews-ERG O O
fusion O O
protein O O
was O O
shown O O
by B-conn Purpose.Enablement
Western O O
blotting O O
of O O
thymoma O O
proteins O O
using O O
antibodies O O
binding O O
to O O
either O O
Ews O O
or O O
ERG O O
, O O
which O O
detected O O
respectively O O
the O O
normal O O
mouse O O
Ews O O
or O O
Erg O O
proteins O O
and O O
the O O
Ews-ERG O O
fusion O O
molecule O O
in O O
thymoma O O
T O O
cells O O
of O O
an O O
Ews-ERG O O
; O O
Rag1-Cre O O
mouse O O
-LRB- O O
Figure O O
3D O O
-RRB- O O
. O O

Studies O O
of O O
progenitor O O
gene O O
expression O O
have O O
indicated O O
the O O
promiscuous O O
expression O O
of O O
lymphoid O O
markers O O
precedes O O
lineage O O
commitment O O
-LSB-38 O O
-RSB- O O
and B-conn Conjunction
thus B-conn Cause.Result
, O O
the O O
Rag1-Cre O O
allele O O
might O O
be O O
expressing O O
in O O
cells O O
destined O O
to O O
become O O
non-lymphoid O O
. O O

The O O
Rag1-Cre O O
knock-in O O
allele O O
was O O
previously O O
shown O O
to O O
be O O
specific O O
for O O
lymphoid O O
cells O O
using O O
a O O
reporter O O
assay O O
dependent O O
on O O
Cre-mediated O O
deletion O O
of O O
a O O
loxP-flanked O O
-LRB- O O
floxed O O
-RRB- O O
segment O O
of O O
the O O
Lmo2 O O
gene O O
-LSB-36 O O
-RSB- O O
. O O

We O O
have O O
sustained O O
these O O
observations O O
using O O
an O O
additional O O
reporter O O
assay O O
, O O
namely B-conn Restatement.Specification
the O O
ROSA-loxSTOP-lacZ O O
-LRB- O O
ROSA26-R O O
-RRB- O O
allele O O
-LSB-39 O O
-RSB- O O
where O O
β-galactosidase O O
-LRB- O O
βgal O O
-RRB- O O
expression O O
is O O
activated O O
by B-conn Purpose.Enablement
deletion O O
of O O
a O O
loxP-pA O O
site O O
. O O

Haematopoietic O O
populations O O
from O O
mice O O
carrying O O
both O O
Rag1-Cre O O
and O O
ROSA26-R O O
alleles O O
were O O
stained O O
with O O
fluorescent O O
antibodies O O
binding O O
to O O
various O O
surface O O
markers O O
, O O
and B-conn Conjunction
flow O O
cytometry O O
was O O
carried O O
out O O
for O O
co-detection O O
of O O
antibody- O O
and O O
βgal-derived O O
fluorescence O O
-LRB- O O
Figure O O
S3 O O
-RRB- O O
. O O

βgal O O
signal O O
was O O
found O O
in O O
thymus O O
and O O
spleen O O
-LRB- O O
almost O O
all O O
cells O O
-RRB- O O
, O O
and B-conn Conjunction
in O O
bone O O
marrow O O
, O O
a O O
population O O
of O O
βgal+ O O
cells O O
exist O O
but O O
did O O
not O O
co-express O O
with O O
CD34 O O
, O O
Sca1 O O
, O O
Ckit O O
, O O
or O O
Ter119 O O
-LRB- O O
or O O
Mac1 O O
, O O
not O O
shown O O
-RRB- O O
. O O

This O O
means O O
that O O
the O O
Rag1-Cre O O
is O O
restricted O O
to O O
lymphoid O O
cells O O
, O O
as O O
previously O O
shown O O
-LSB-36 O O
-RSB- O O
. O O

The O O
Rag1-Cre O O
gene O O
is O O
expressed O O
in O O
both O O
B O O
and O O
T O O
cells O O
, O O
but B-conn Concession.Contra-expectation
only O O
T O O
cell O O
tumours O O
have O O
arisen O O
in O O
the O O
Ews-ERG O O
; O O
Rag1-Cre O O
invertor O O
line O O
. O O

The O O
possible O O
inversion O O
of O O
the O O
Ews-ERG O O
gene O O
in O O
B O O
cells O O
was O O
investigated O O
using O O
RT-PCR O O
analysis O O
of O O
expressed O O
Ews-ERG O O
fusion O O
mRNA O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

RNA O O
was O O
prepared O O
from O O
whole O O
spleen O O
or O O
thymus O O
or O O
from O O
flow-sorted O O
B220+ O O
spleen O O
cells O O
-LRB- O O
3,400 O O
cells O O
-RRB- O O
or O O
Thy1.2+ O O
spleen O O
cells O O
-LRB- O O
6,400 O O
cells O O
-RRB- O O
and O O
RT-PCR O O
performed O O
. O O

Pax5 O O
and O O
CD3 O O
primers O O
-LSB-38 O O
-RSB- O O
were O O
used O O
for O O
specific O O
detection O O
of O O
B O O
cell O O
and O O
T O O
cell O O
transcripts O O
, O O
respectively O O
. O O

Pax5 O O
transcripts O O
were O O
detected O O
in O O
cDNA O O
made O O
from O O
spleen O O
and O O
B220+ O O
sorted O O
cells O O
, O O
and O O
CD3 O O
in O O
the O O
spleen O O
, O O
thymus O O
and O O
thy1.2+ O O

sorted O O
cells O O
-LRB- O O
Figure O O
4A O O
and O O
4B O O
-RRB- O O
. O O

No O O
evidence O O
of O O
CD3 O O
expression O O
was O O
found O O
in O O
the O O
sorted O O
B220+ O O
cells O O
, O O
or O O
of O O
Pax5 O O
in O O
the O O
sorted O O
Thy1.2+ O O
cells O O
, O O
showing O O
that O O
the O O
sorted O O
cells O O
were O O
practically O O
free O O
of O O
contaminating O O
T O O
or O O
B O O
cells O O
, O O
respectively O O
. O O

The O O
presence O O
of O O
Ews-ERG O O
fusion O O
RNA O O
was O O
analysed O O
with O O
RT-PCR O O
primers O O
, O O
yielding O O
a O O
product O O
spanning O O
the O O
fusion O O
junction O O
that O O
was O O
detected O O
with O O
an O O
internal O O
junction O O
probe O O
. O O

Ews-ERG O O
RT-PCR O O
product O O
was O O
detected O O
in O O
the O O
unfractionated O O
spleen O O
and O O
thymus O O
sources O O
, O O
as O O
well O O
as O O
in O O
the O O
purified O O
, O O
sorted O O
B220+ O O
and O O
Thy1.2+ O O
cells O O
. O O

Therefore B-conn Cause.Claim
, O O
Cre-mediated O O
inversion O O
of O O
the O O
Ews-ERG O O
gene O O
occurs O O
in O O
both O O
T O O
and O O
B O O
cells O O
. O O

The O O
presence O O
of O O
thymomas O O
in O O
all O O
afflicted O O
Ews-ERG O O
; O O
Rag1-Cre O O
mice O O
suggested O O
that O O
the O O
haematological O O
malignancy O O
in O O
these O O
mice O O
comprised O O
T O O
cells O O
. O O

This O O
was O O
confirmed O O
by B-conn Purpose.Enablement
FACS O O
analysis O O
of O O
T O O
cell O O
surface O O
markers O O
and B-conn Conjunction
by O O
determination O O
of O O
T O O
cell O O
or O O
B O O
cell O O
receptor O O
gene O O
rearrangement O O
status O O
. O O

The O O
majority O O
of O O
normal O O
mouse O O
thymic O O
T O O
cells O O
express O O
both O O
the O O
CD4 O O
and O O
CD8 O O
surface O O
markers O O
-LRB- O O
double O O
positive O O
-LSB-DP O O
-RSB- O O
cells O O
-RRB- O O
, O O
as O O
well O O
as O O
the O O
pan-T O O
cell O O
marker O O
Thy1 O O
-LRB- O O
CD90 O O
-RRB- O O
-LRB- O O
wt O O
in O O
Figure O O
5 O O
-RRB- O O
. O O

The O O
situation O O
with O O
the O O
thymomas O O
of O O
invertor O O
mice O O
varied O O
from O O
mainly O O
CD4+CD8+ O O
DP O O
cells O O
-LRB- O O
e.g. O O
, O O
M2 O O
in O O
Figure O O
5 O O
-RRB- O O
to O O
mainly O O
CD8+ O O
single O O
positive O O
-LRB- O O
SP O O
-RRB- O O
cells O O
-LRB- O O
e.g. O O
, O O
M3 O O
in O O
Figure O O
5 O O
-RRB- O O
to O O
mainly O O
double O O
negative O O
cells O O
-LRB- O O
e.g. O O
, O O
M4 O O
in O O
Figure O O
5 O O
-RRB- O O
. O O

Thirteen O O
of O O
the O O
cohort O O
of O O
25 O O
leukaemic O O
invertor O O
mice O O
were O O
analysed O O
for O O
their O O
thymic O O
T O O
cell O O
profile O O
by O O
FACS O O
-LRB- O O
summarized O O
in O O
Table O O
1 O O
-RRB- O O
. O O

While B-conn Concession.Expectation
we O O
found O O
either O O
CD8+ O O
SP O O
or O O
CD4+CD8+ O O
DP O O
thymomas O O
, O O
none O O
showed O O
a O O
CD4+ O O
SP O O
phenotype O O
. O O

Two O O
of O O
the O O
thymomas O O
had O O
a O O
mixed O O
phenotype O O
comprising O O
mainly O O
CD8+ O O
SP O O
cells O O
, O O
with O O
a O O
sub-population O O
of O O
DP O O
cells O O
-LRB- O O
M3 O O
and O O
M6 O O
in O O
Table O O
1 O O
-RRB- O O
. O O

The O O
clonality O O
of O O
these O O
T O O
cell O O
tumours O O
was O O
assessed O O
by B-conn Purpose.Enablement
filter O O
hybridisation O O
of O O
genomic O O
thymoma O O
DNA O O
with O O
a O O
T O O
cell O O
receptor O O
β O O
probe O O
-LRB- O O
Tcrb O O
-RRB- O O
from O O
the O O
Jβ2 O O
region O O
-LSB-40 O O
-RSB- O O
-LRB- O O
diagrammatically O O
shown O O
in O O
Figure O O
3B O O
-RRB- O O
. O O

The O O
probe O O
detects O O
a O O
5-kb O O
band O O
in O O
non-lymphoid O O
DNA O O
corresponding O O
to O O
the O O
intact O O
Tcrb O O
gene O O
; O O
if O O
V-D-J O O
or O O
D-J O O
joins O O
have O O
occurred O O
, O O
new O O
restriction O O
fragments O O
are O O
created O O
, O O
giving O O
rise O O
to O O
“rearranged O O
'' O O
bands O O
on O O
the O O
hybridisation O O
autoradiograph O O
. O O

Figure O O
3B O O
shows O O
the O O
rearrangement O O
status O O
of O O
12 O O
of O O
the O O
Ews-ERG O O
thymomas O O
. O O

All O O
except O O
one O O
-LRB- O O
M9 O O
-RRB- O O
showed O O
at O O
least O O
one O O
rearranged O O
Jβ2 O O
allele O O
and O O
several O O
have O O
two O O
rearranged O O
alleles O O
-LRB- O O
e.g. O O
, O O
M18 O O
-RRB- O O
. O O

Variable O O
amounts O O
of O O
residual O O
germ O O
line O O
allele O O
were O O
present O O
. O O

The O O
Tcrb O O
rearrangement O O
status O O
of O O
the O O
cohort O O
of O O
Ews-ERG O O
leukaemic O O
mice O O
is O O
summarized O O
in O O
Table O O
1 O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
status O O
of O O
the O O
immunoglobulin O O
locus O O
was O O
examined O O
with O O
a O O
probe O O
from O O
the O O
region O O
between O O
JH O O
and O O
Cμ O O
segments O O
-LSB-41 O O
-RSB- O O
-LRB- O O
see O O
Figure O O
3C O O
-RRB- O O
. O O

Single O O
Igh O O
allele O O
rearrangements O O
were O O
observed O O
in O O
about O O
half O O
of O O
the O O
cohort O O
-LRB- O O
Table O O
1 O O
-RRB- O O
, O O
including O O
ones O O
in O O
which O O
FACS O O
analysis O O
and O O
Tcrb O O
clonality O O
hybridisations O O
showed O O
the O O
tumours O O
to O O
be O O
clonal O O
T O O
cell O O
malignancies O O
. O O

The O O
Igh O O
rearrangements O O
are O O
therefore B-conn Cause.Claim
likely O O
to O O
be O O
abortive O O
rearrangements O O
. O O

Confirmation O O
that O O
the O O
Tcrb O O
rearrangements O O
observed O O
by O O
hybridisations O O
were O O
due B-conn Cause.Reason
to I-conn Cause.Reason
productive O O
V-D-J O O
joins O O
was O O
made O O
by B-conn Purpose.Enablement
sequence O O
analysis O O
of O O
the O O
Tcrb O O
genes O O
in O O
four O O
of O O
the O O
cases O O
. O O

PCR O O
amplification O O
from O O
thymoma O O
DNA O O
was O O
carried O O
out O O
with O O
pools O O
of O O
Vβ O O
primers O O
and O O
a O O
Jβ2 O O
reverse O O
primer O O
-LRB- O O
primer O O
sequences O O
from O O
-LSB-42,43 O O
-RSB- O O
-RRB- O O
and B-conn Conjunction
sequences O O
identified O O
with O O
the O O
ImMunoGeneTics O O
database O O
-LSB-44,45 O O
-RSB- O O
. O O

Table O O
2 O O
shows O O
the O O
V-D-J O O
junctional O O
sequences O O
indicating O O
the O O
presence O O
of O O
productive O O
T O O
cell O O
receptor O O
β O O
genes O O
. O O

In O O
all O O
cases O O
, O O
N-region O O
diversity O O
is O O
present O O
between O O
the O O
V-D O O
and O O
D-J O O
junctions O O
. O O

In O O
the O O
thymoma O O
DNA O O
from O O
M2 O O
, O O
a O O
non-productive O O
join O O
has O O
also B-conn Conjunction
occurred O O
, O O
in B-conn Conjunction
addition I-conn Conjunction
to I-conn Conjunction
the O O
productive O O
one O O
, O O
resulting O O
in O O
an O O
out-of-frame O O
joint O O
. O O

Discussion O O

Human O O
cancers O O
of O O
mesenchymal O O
origin O O
involve O O
the O O
EWS O O
gene O O
with O O
various O O
partner O O
genes O O
, O O
such O O
as O O
in O O
the O O
chromosomal O O
translocation O O
t O O
-LRB- O O
21 O O
; O O
22 O O
-RRB- O O
-LRB- O O
q22 O O
; O O
q12 O O
-RRB- O O
where O O
EWS O O
fuses O O
with O O
ERG O O
to B-conn Purpose.Goal
encode O O
a O O
novel O O
EWS-ERG O O
fusion O O
protein O O
-LSB-18 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
EWS O O
gene O O
fusions O O
with O O
various O O
partners O O
are O O
described O O
in O O
clear O O
cell O O
sarcoma O O
, O O
desmoplastic O O
small O O
round O O
cell O O
tumours O O
, O O
chondrosarcoma O O
, O O
and O O
myxoid O O
liposarcoma O O
, O O
suggesting O O
that O O
EWS O O
fusion O O
proteins O O
are O O
functional O O
for O O
various O O
cell O O
types O O
of O O
mesenchymal O O
origin O O
and O O
that O O
restrictions O O
in O O
humans O O
are O O
dictated O O
largely O O
by O O
the O O
cells O O
in O O
which O O
the O O
chromosomal O O
translocations O O
occur O O
. O O

We O O
tested O O
the O O
hypothesis O O
of O O
cell O O
type O O
specificity O O
by B-conn Purpose.Enablement
assessing O O
the O O
possible O O
universality O O
of O O
EWS-ERG O O
as O O
an O O
oncogene O O
. O O

Our O O
experimental O O
system O O
was O O
designed O O
to O O
invoke O O
conditional O O
, O O
cell-specific O O
expression O O
of O O
the O O
Ews-ERG O O
fusion O O
to B-conn Purpose.Goal
analyse O O
the O O
target O O
cell O O
in O O
which O O
it O O
can O O
function O O
. O O

Consistent O O
EWS-ERG O O
occurrence O O
in O O
human O O
sarcomas O O
suggests O O
that O O
it O O
may O O
only O O
function O O
in O O
mesenchymal O O
cells O O
, O O
where O O
it O O
may O O
function O O
in O O
initiation O O
of O O
the O O
cancer O O
as O O
well O O
as O O
in O O
maintenance O O
of O O
the O O
cancer O O
stem O O
cell O O
-LRB- O O
i.e. O O
, O O
cells O O
within O O
the O O
tumour O O
that O O
have O O
self-renewing O O
capacity O O
and O O
maintain O O
the O O
tumour O O
-RRB- O O
. O O

Our O O
results O O
show O O
that O O
lymphomas O O
arise O O
when B-conn Temporal.Synchronous
Ews-ERG O O
is O O
aberrantly O O
expressed O O
in O O
the O O
committed O O
cells O O
of O O
the O O
lymphoid O O
lineage O O
. O O

The O O
Ews-ERG O O
invertor O O
allele O O
was O O
activated O O
in O O
lymphocytes O O
, O O
using O O
the O O
Rag1-Cre O O
knock-in O O
mice O O
-LSB-36 O O
-RSB- O O
, O O
to B-conn Purpose.Goal
determine O O
if O O
lymphoid O O
malignancies O O
would O O
arise O O
. O O

We O O
found O O
that O O
invertor O O
Ews-ERG O O
mice O O
develop O O
clonal O O
T O O
cell O O
malignancies O O
. O O

The O O
T O O
cells O O
were O O
of O O
varying O O
phenotypes O O
but B-conn Concession.Contra-expectation
the O O
majority O O
of O O
cases O O
expressed O O
CD8 O O
on O O
the O O
cell O O
surface O O
and O O
had O O
productive O O
V-D-Jβ O O
rearrangements O O
, O O
indicative O O
of O O
mature O O
T O O
cells O O
. O O

Since B-conn Cause.Reason
Cre-mediated O O
inversion O O
through O O
loxP O O
sites O O
recreates O O
the O O
loxP O O
sequence O O
, O O
there O O
is O O
potential O O
for O O
the O O
cassette O O
to O O
flip O O
back O O
and O O
forth O O
with O O
continued O O
Cre O O
expression O O
. O O

This O O
had O O
no O O
obvious O O
deleterious O O
effect O O
on O O
tumourigenesis O O
in O O
the O O
Ews-ERG O O
invertors O O
as O O
judged O O
by O O
various O O
criteria O O
-LRB- O O
tumour O O
penetrance O O
, O O
consistent O O
T O O
cell O O
phenotype O O
, O O
and O O
pathology O O
-RRB- O O
. O O

Thus B-conn Cause.Result
, O O
the O O
invertor O O
allele O O
of O O
transformed O O
cells O O
may O O
be O O
fixed O O
in O O
the O O
correct O O
orientation O O
for O O
synthesis O O
of O O
Ews-ERG O O
mRNA O O
when O O
Rag1-Cre O O
is O O
no O O
longer O O
effective O O
. O O

On B-conn Concession.Contra-expectation
the I-conn Concession.Contra-expectation
other I-conn Concession.Contra-expectation
hand I-conn Concession.Contra-expectation
, O O
the O O
lack O O
of O O
CD4+ O O
SP O O
thymomas O O
is O O
difficult O O
to O O
encompass O O
with O O
this O O
explanation O O
, O O
suggesting O O
that O O
other O O
biological O O
mechanisms O O
may O O
be O O
involved O O
in O O
this O O
bias O O
. O O

The O O
Rag1-Cre O O
mouse O O
line O O
used O O
constitutively O O
expresses O O
Cre O O
in O O
lymphoid O O
cells O O
-LSB-36 O O
-RSB- O O
, O O
and O O
the O O
resulting O O
Ews-ERG O O
fusion O O
causes O O
T O O
lymphocyte O O
tumours O O
in O O
mice O O
, O O
which O O
is O O
not O O
known O O
in O O
the O O
spectrum O O
of O O
EWS-associated O O
human O O
cancers O O
. O O

On B-conn Concession.Contra-expectation
the I-conn Concession.Contra-expectation
other I-conn Concession.Contra-expectation
hand I-conn Concession.Contra-expectation
, O O
FUS-ERG O O
has O O
been O O
found O O
in O O
leukaemias O O
, O O
albeit O O
myeloid O O
type O O
-LSB-26,46 O O
-RSB- O O
. O O

This O O
implies O O
that O O
the O O
EWS-FUS O O
fusion O O
proteins O O
could O O
be O O
effective O O
in O O
a O O
spectrum O O
of O O
cell O O
types O O
, O O
broader O O
than O O
normally O O
seen O O
in O O
human O O
malignancies O O
-LRB- O O
i.e. O O
, O O
sarcomas O O
and O O
myeloid O O
leukaemias O O
-RRB- O O
. O O

In O O
some O O
cells O O
, O O
it O O
may O O
be O O
that O O
EWS-FUS O O
fusions O O
are O O
lethal O O
and B-conn Conjunction
thus B-conn Cause.Result
those O O
cells O O
acquiring O O
a O O
translocation O O
would O O
die O O
; O O
in O O
others O O
, O O
the O O
fusion O O
protein O O
may O O
be O O
tolerated O O
and O O
thus B-conn Cause.Result
may O O
become O O
tumours O O
. O O

In O O
this O O
respect O O
, O O
the O O
absence O O
of O O
B O O
cell O O
tumours O O
in O O
the O O
Ews-ERG O O
invertors O O
is O O
of O O
interest O O
as O O
both O O
B O O
and O O
T O O
cells O O
undergo O O
inversion O O
of O O
the O O
Ews-ERG O O
cassette O O
-LRB- O O
see O O
Figure O O
4 O O
-RRB- O O
because B-conn Cause.Reason
Rag1-Cre O O
is O O
expressed O O
in O O
both O O
cell O O
types O O
-LSB-36 O O
-RSB- O O
-LRB- O O
see O O
Figure O O
S3 O O
-RRB- O O
. O O

The O O
absence O O
of O O
B O O
cell O O
tumours O O
may O O
reflect O O
toxicity O O
of O O
the O O
fusion O O
protein O O
for O O
B O O
cells O O
although B-conn Concession.Contra-expectation
this O O
seems O O
unlikely O O
given O O
that O O
we O O
can O O
detect O O
the O O
fusion O O
mRNA O O
in O O
selected O O
B220+ O O
B O O
lymphocytes O O
-LRB- O O
see O O
Figure O O
4 O O
-RRB- O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
it O O
may O O
mean O O
that O O
Ews-ERG O O
does O O
not O O
function O O
in O O
B O O
cells O O
or B-conn Alternative.Disjunctive
that O O
the O O
development O O
of O O
B O O
cell O O
tumours O O
is O O
inhibited O O
by B-conn Purpose.Enablement
the O O
T O O
cell O O
malignancies O O
, O O
which O O
may O O
arise O O
earlier O O
and O O
then O O
dominate O O
the O O
lymphoid O O
compartment O O
. O O

The O O
ability O O
of O O
Ews-ERG O O
to O O
specifically O O
cause O O
B O O
cell O O
tumours O O
could O O
be O O
evaluated O O
by B-conn Purpose.Enablement
using O O
B-cell-specific O O
Cre-expressing O O
mouse O O
lines O O
such O O
as O O
CD19-Cre O O
. O O

Our O O
results O O
show O O
that O O
the O O
Ews-ERG O O
fusion O O
, O O
normally O O
restricted O O
to O O
sarcomas O O
in O O
humans O O
, O O
can O O
initiate O O
T O O
lymphocyte O O
tumours O O
, O O
if B-conn Condition.Hypothetical
conditionally O O
expressed O O
in O O
committed O O
lymphoid O O
cells O O
. O O

Leukaemogenesis O O
in O O
Ews-ERG O O
invertor O O
mice O O
thus B-conn Cause.Result
concurs O O
with O O
the O O
hypothesis O O
that O O
EWS O O
fusions O O
can O O
cause O O
neoplasia O O
arising O O
in O O
various O O
cell O O
types O O
. O O

Further B-conn Conjunction
, O O
our O O
data O O
imply O O
that O O
the O O
cellular O O
context O O
of O O
EWS-associated O O
chromosomal O O
translocations O O
in O O
humans O O
does O O
not O O
have O O
to O O
be O O
a O O
stem O O
cell O O
or O O
even O O
a O O
multi-potent O O
progenitor O O
, O O
as B-conn Cause.Reason
committed O O
lymphocyte O O
precursors O O
expressing O O
Rag O O
recombinase O O
genes O O
are O O
the O O
leukaemic O O
precursors O O
in O O
our O O
invertor O O
model O O
. O O

The O O
same O O
conclusions O O
can O O
be O O
applied O O
to O O
FUS-associated O O
chromosomal O O
translocations O O
that O O
seem O O
to O O
be O O
largely O O
interchangeable O O
with O O
EWS O O
, O O
given O O
the O O
spectrum O O
of O O
cancers O O
in O O
which O O
these O O
are O O
found O O
and O O
the O O
relatedness O O
of O O
FUS- O O
and O O
EWS-coded O O
proteins O O
-LSB-24,25 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
, O O
EWS O O
or O O
FUS O O
chromosomal O O
translocations O O
probably O O
arise O O
more O O
by O O
virtue O O
of O O
accessibility O O
of O O
the O O
genes O O
to O O
chromosomal O O
translocations O O
than O O
by O O
the O O
precise O O
cellular O O
specificity O O
of O O
the O O
resultant O O
fusion O O
proteins O O
. O O

Materials O O
and O O
Methods O O

The O O
Ews O O
genomic O O
targeting O O
clone O O
was O O
constructed O O
from O O
γ O O
phage O O
DNA O O
isolated O O
from O O
mouse O O
129 O O
DNA O O
-LSB-47 O O
-RSB- O O
. O O

The O O
knock-in O O
clones O O
for O O
potential O O
Ews O O
fusions O O
with O O
AF9 O O
, O O
Fli1 O O
, O O
Chop O O
, O O
and O O
ATF1 O O
were O O
made O O
using O O
a O O
transfer O O
vector O O
pC2A-neo O O
-LSB-35 O O
-RSB- O O
, O O
and B-conn Conjunction
the O O
sequences O O
of O O
these O O
cDNA O O
cassettes O O
are O O
given O O
in O O
Figure O O
S1 O O
. O O

Knock-in O O
was O O
achieved O O
by B-conn Purpose.Enablement
homologous O O
recombination O O
as O O
described O O
-LSB-47 O O
-RSB- O O
. O O

The O O
ERG O O
inversion O O
knock-in O O
cassette O O
-LSB-35 O O
-RSB- O O
was O O
prepared O O
using O O
cDNA O O
made O O
from O O
human O O
colon O O
carcinoma O O
COLO320 O O
mRNA O O
-LRB- O O
the O O
sequence O O
of O O
the O O
ERG O O
segment O O
, O O
corresponding O O
to O O
the O O
part O O
of O O
ERG O O
found O O
in O O
EWS-ERG O O
fusion O O
-LSB-19 O O
-RSB- O O
is O O
shown O O
Figure O O
S1 O O
-RRB- O O
. O O

A O O
diagram O O
of O O
overall O O
structure O O
of O O
the O O
ERG O O
inversion O O
cassette O O
is O O
shown O O
in O O
Figure O O
1A O O
, O O
indicating O O
the O O
initial O O
orientation O O
of O O
the O O
ERG O O
inversion O O
cassette O O
-LRB- O O
3′ O O
to O O
5′ O O
with O O
respect O O
to O O
Ews O O
-RRB- O O
and O O
this O O
was O O
determined O O
by O O
restriction O O
site O O
mapping O O
and O O
genomic O O
DNA O O
sequencing O O
. O O

After B-conn Temporal.Succession
identification O O
of O O
targeted O O
ES O O
cells O O
, O O
these O O
were O O
injected O O
into O O
C57BL/6 O O
blastocysts O O
, O O
chimaeric O O
mice O O
were O O
produced O O
, O O
and O O
germ O O
line O O
transmission O O
of O O
the O O
inversion O O
knock-in O O
allele O O
was O O
obtained O O
. O O

These O O
mice O O
were O O
bred O O
with O O
mice O O
expressing O O
Cre O O
from O O
a O O
Rag1 O O
knock-in O O
-LSB-36 O O
-RSB- O O
. O O

Specificity O O
of O O
expression O O
of O O
the O O
Rag1-Cre O O
allele O O
has O O
previously O O
been O O
described O O
-LSB-36 O O
-RSB- O O
and O O
was O O
sustained O O
using O O
the O O
ROSA26-R O O
reporter O O
mice O O
-LSB-39 O O
-RSB- O O
-LRB- O O
see O O
Figure O O
S3 O O
-RRB- O O
. O O

Genomic O O
DNA O O
was O O
prepared O O
from O O
tissues O O
using O O
proteinase O O
K O O
digestion O O
and O O
phenol-chloroform O O
extraction O O
, O O
and B-conn Conjunction
filter O O
hybridisations O O
were O O
carried O O
out O O
with O O
radiolabelled O O
probes O O
as O O
described O O
-LSB-48,49 O O
-RSB- O O
. O O

The O O
probes O O
used O O
to B-conn Purpose.Goal
detect O O
antigen O O
receptor O O
gene O O
rearrangements O O
were O O
a O O
heavy-chain O O
Ig O O
μ O O
intron O O
enhancer O O
probe O O
-LSB-41 O O
-RSB- O O
and O O
a O O
T O O
cell O O
receptor O O
Jβ2 O O
probe O O
-LSB-40 O O
-RSB- O O
. O O

T O O
cell O O
receptor O O
V-D-Jβ O O
junction O O
sequences O O
were O O
obtained O O
by B-conn Purpose.Enablement
PCR O O
amplification O O
from O O
thymoma O O
DNA O O
with O O
pools O O
of O O
Vβ O O
primers O O
and O O
a O O
Jβ2 O O
reverse O O
primer O O
-LRB- O O
primer O O
sequences O O
from O O
-LSB-42,43 O O
-RSB- O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
product O O
was O O
fractionated O O
on O O
agarose O O
to B-conn Purpose.Goal
determine O O
the O O
presence O O
of O O
a O O
single O O
amplified O O
band O O
. O O

In B-conn Temporal.Precedence
turn I-conn Temporal.Precedence
, O O
each O O
band O O
was O O
eluted O O
and O O
the O O
sequence O O
obtained O O
using O O
the O O
Jβ2N O O
primer O O
-LSB-43 O O
-RSB- O O
and O O
identified O O
by B-conn Purpose.Enablement
comparison O O
with O O
the O O
ImMunoGeneTics O O
database O O
-LSB-44,45 O O
-RSB- O O
. O O

RT-PCR O O
was O O
carried O O
out O O
on O O
cDNA O O
as O O
described O O
-LSB-34 O O
-RSB- O O
. O O

RNA O O
was O O
prepared O O
using O O
RNeasy O O
-LRB- O O
Quiagen O O
, O O
Valencia O O
, O O
California O O
, O O
United O O
States O O
-RRB- O O
from O O
cells O O
that O O
were O O
labelled O O
with O O
FITC-conjugated O O
antibodies O O
and O O
isolated O O
by B-conn Purpose.Enablement
flow O O
cytometry O O
. O O

Sequences O O
have O O
been O O
described O O
for O O
Pax5 O O
and O O
CD3 O O
RT-PCR O O
primers O O
-LSB-38 O O
-RSB- O O
, O O
and B-conn Conjunction
the O O
sequences O O
of O O
the O O
Ews-ERG O O
primers O O
were O O
5′- O O
CCACAGGATGGTAACAAGCCTGC-3′ O O
-LRB- O O
Ews O O
-RRB- O O
and O O
5′- O O
CGAACTTGTAGGCGTAGC-3′ O O
-LRB- O O
ERG O O
-RRB- O O
. O O

The O O
hybridisation O O
probe O O
was O O
a O O
303-bp O O
fragment O O
of O O
Ews-ERG O O
residing O O
within O O
the O O
RT-PCR O O
product O O
. O O

A O O
cohort O O
of O O
mice O O
was O O
established O O
by B-conn Purpose.Enablement
inter-breeding O O
the O O
Ews-ERG O O
invertor O O
line O O
with O O
a O O
Rag1-Cre O O
line O O
-LSB-36 O O
-RSB- O O
to B-conn Purpose.Goal
generate O O
littermates O O
with O O
Ews-ERG O O
+ O O
Rag1-Cre O O
or O O
Ews-ERG O O
genotypes O O
. O O

Genotypes O O
were O O
determined O O
using O O
filter O O
hybridisation O O
of O O
genomic O O
DNA O O
from O O
a O O
small O O
tail O O
biopsy O O
. O O

The O O
health O O
status O O
of O O
these O O
mice O O
was O O
monitored O O
, O O
and O O
if B-conn Condition.Hypothetical
signs O O
of O O
ill O O
health O O
appeared O O
, O O
mice O O
were O O
sacrificed O O
and O O
a O O
post-mortem O O
was O O
carried O O
out O O
. O O

Tissue O O
samples O O
were O O
removed O O
for O O
single O O
cell O O
preparation O O
for O O
determination O O
of O O
surface O O
protein O O
expression O O
phenotype O O
, O O
for O O
nucleic O O
acid O O
preparation O O
, O O
or O O
for O O
fixation O O
in O O
10 O O
% O O
formalin O O
for O O
histology O O
. O O

Blood O O
smears O O
were O O
prepared O O
and O O
stained O O
with O O
May-Grünwald-Giemsa O O
. O O

For O O
histology O O
, O O
fixed O O
tissues O O
were O O
embedded O O
in O O
wax O O
and O O
0.4-μ O O
sections O O
made O O
, O O
stained O O
with O O
haematoxylin O O
and O O
eosin O O
after O O
mounting O O
on O O
slides O O
. O O

FACS O O
analysis O O
was O O
conducted O O
using O O
a O O
FACSCalibur O O
with O O
fluorescent O O
antibodies O O
purchased O O
from O O
BD O O
Biosciences O O
-LRB- O O
San O O
Jose O O
, O O
California O O
, O O
United O O
States O O
-RRB- O O
. O O

Data O O
were O O
analysed O O
with O O
CellQuest O O
software O O
-LRB- O O
BD O O
Biosciences O O
-RRB- O O
. O O

Western O O
protein O O
detection O O
was O O
carried O O
out O O
as O O
described O O
-LSB-36 O O
-RSB- O O
using O O
18 O O
μg O O
of O O
protein O O
per O O
lane O O
and O O
proteins O O
fractionated O O
on O O
4 O O
% O O
–20 O O
% O O
SDS-PAGE O O
. O O

The O O
separated O O
proteins O O
were O O
electro-transferred O O
to O O
PVDF O O
nylon O O
membranes O O
-LRB- O O
Millipore O O
, O O
Billerica O O
, O O
Massachusetts O O
, O O
United O O
States O O
-RRB- O O
and O O
specific O O
proteins O O
detected O O
using O O
anti-Ews O O
antibody O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
, O O
Santa O O
Cruz O O
, O O
California O O
, O O
United O O
States O O
; O O
raised O O
against O O
the O O
amino O O
terminus O O
of O O
Ews O O
-RRB- O O
or O O
anti-ERG O O
antibody O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
; O O
raised O O
against O O
the O O
carboxy O O
terminus O O
of O O
ERG O O
-RRB- O O
. O O

Antibody O O
bound O O
to O O
filter O O
was O O
detected O O
using O O
secondary O O
antibodies O O
and O O
ECL O O
as O O
described O O
by O O
the O O
manufacturer O O
-LRB- O O
Amersham O O
Biosciences O O
, O O
Amersham O O
, O O
United O O
Kingdom O O
-RRB- O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Strategy O O
for B-conn Purpose.Goal
Generating O O
Ews-ERG O O
Invertor O O
Gene O O
by B-conn Purpose.Enablement
Homologous O O
Recombination O O
-LRB- O O
A O O
-RRB- O O
The O O
method O O
for O O
making O O
invertor O O
mice O O
is O O
described O O
in O O
detail O O
elsewhere O O
-LSB-35 O O
-RSB- O O
. O O

In B-conn Restatement.Generalization
summary I-conn Restatement.Generalization
, O O
an O O
invertor O O
cassette O O
comprising O O
a O O
short O O
intronic O O
region O O
with O O
an O O
acceptor O O
splice O O
site O O
, O O
human O O
ERG O O
cDNA O O
sequence O O
-LRB- O O
shown O O
in O O
Figure O O
S1 O O
-RRB- O O
, O O
a O O
polyA O O
site O O
, O O
and O O
the O O
MC1neopA O O
gene O O
all O O
flanked O O
by O O
loxP O O
sites O O
-LRB- O O
depicted O O
by B-conn Purpose.Enablement
black O O
triangles O O
-RRB- O O
was O O
knocked O O
in O O
, O O
using O O
homologous O O
recombination O O
, O O
into O O
Ews O O
intron O O
8 O O
. O O

The O O
transcription O O
orientation O O
of O O
the O O
targeted O O
ERG O O
cDNA O O
invertor O O
cassette O O
was O O
opposite O O
from O O
that O O
of O O
the O O
endogenous O O
Ews O O
gene O O
after B-conn Temporal.Succession
initial O O
homologous O O
recombination O O
. O O

Germ O O
line O O
carrier O O
mice O O
of O O
this O O
targeted O O
allele O O
were O O
crossed O O
with O O
Cre-expressing O O
mouse O O
strains O O
-LSB-36 O O
-RSB- O O
, O O
and B-conn Conjunction
, O O
as O O
indicated O O
in O O
the O O
right O O
hand O O
side O O
of O O
the O O
diagram O O
, O O
the O O
invertor O O
cassette O O
is O O
turned O O
around O O
to B-conn Purpose.Goal
create O O
a O O
transcription O O
orientation O O
identical O O
with O O
that O O
of O O
Ews O O
. O O

Thus B-conn Cause.Result
, O O
after B-conn Temporal.Succession
transcription O O
, O O
a O O
pre-mRNA O O
is O O
made O O
with O O
the O O
donor O O
splice O O
site O O
of O O
Ews O O
exon O O
7 O O
adjacent O O
to O O
the O O
acceptor O O
site O O
of O O
the O O
invertor O O
cassette O O
, O O
allowing O O
post-transcriptional O O
fusion O O
of O O
Ews O O
with O O
ERG O O
in O O
an O O
analogous O O
format O O
to O O
that O O
found O O
in O O
human O O
sarcomas O O
with O O
t O O
-LRB- O O
21 O O
; O O
22 O O
-RRB- O O
. O O
-LRB- O O
B O O
-RRB- O O

Genomic O O
sequence O O
adjacent O O
to O O
the O O
Ews O O
exon O O
7 O O
and O O
the O O
ERG O O
invertor O O
cassette O O
-LRB- O O
the O O
derived O O
amino O O
acid O O
sequence O O
is O O
shown O O
in O O
the O O
single O O
letter O O
code O O
-RRB- O O
obtained O O
from O O
DNA O O
of O O
ES O O
cells O O
and O O
of O O
thymus O O
after B-conn Temporal.Succession
Cre-mediated O O
inversion O O
. O O

The O O
Ews O O
intron O O
7/8 O O
donor O O
splice O O
site O O
is O O
indicated O O
by O O
an O O
arrow O O
. O O

The O O
boxed O O
sequence O O
-LRB- O O

TCTAG/ O O

CGAT O O
-RRB- O O
corresponds O O
to O O
the O O
ligation O O
of O O
filled-in O O
XbaI O O
-LRB- O O
Ews O O
genomic O O
-RRB- O O
and O O
ClaI O O
-LRB- O O
ERG O O
invertor O O
cassette O O
-RRB- O O
sites O O
-LRB- O O
for O O
detailed O O
description O O
see O O
-LSB-35 O O
-RSB- O O
-RRB- O O
. O O

The O O
boxed O O
XbaI O O
site O O
-LRB- O O

TCTAGA O O
-RRB- O O
corresponds O O
to O O
the O O
position O O
of O O
cloning O O
of O O
the O O
mouse O O
Af4 O O
intronic O O
sequence O O
-LRB- O O
shaded O O
-RRB- O O
in O O
the O O
ERG O O
invertor O O
cassette O O
. O O

On O O
the O O
3′ O O
side O O
of O O
the O O
fused O O
XbaI-ClaI O O
sites O O
, O O
there O O
is O O
a O O
loxP O O
site O O
originating O O
from O O
the O O
ERG O O
invertor O O
cassette O O
-LRB- O O
see O O
Figure O O
S1 O O
-RRB- O O
followed O O
by O O
the O O
Af4 O O
intron O O
4 O O
-LRB- O O
shaded O O
-RRB- O O
upstream O O
of O O
the O O
ERG O O
cDNA O O
sequence O O
. O O

The O O
Af4 O O
acceptor O O
splice O O
site O O
is O O
indicated O O
by O O
an O O
arrow O O
, O O
and O O
is O O
followed O O
by O O
the O O
ERG O O
cDNA O O
sequence O O
. O O

A O O
NotI O O
site O O
used O O
for O O
cloning O O
the O O
amplified O O
ERG O O
sequence O O
is O O
boxed O O
-LRB- O O
see O O
also O O
Figure O O
S1 O O
-RRB- O O
-LRB- O O
note O O
this O O
sequence O O
is O O
non-contiguous O O
and O O
the O O
dots O O
represent O O
a O O
gap O O
; O O
the O O
full O O
sequence O O
appears O O
in O O
-LSB-35 O O
-RSB- O O
-RRB- O O
. O O

Figure O O
2 O O
: O O
Incidence O O
of O O
Haematological O O
Malignancy O O
and O O
Characteristics O O
of O O
Ews-ERG O O
Invertor O O
MiceCohorts O O
of O O
29 O O
Ews-ERG O O
; O O
Rag1-Cre O O
mice O O
and O O
20 O O
Ews-ERG O O
control O O
mice O O
were O O
monitored O O
over O O
a O O
period O O
of O O
approximately O O
17 O O
mo O O
. O O

Mice O O
were O O
culled O O
and O O
a O O
post-mortem O O
conducted O O
when O O
signs O O
of O O
ill O O
health O O
were O O
observed O O
. O O

Leukaemia/lymphoma O O
was O O
established O O
by B-conn Purpose.Enablement
various O O
criteria O O
-LRB- O O
see O O
Materials O O
and O O
Methods O O
-RRB- O O
. O O

Top O O
panel O O
shows O O
the O O
survival O O
curve O O
of O O
Ews-ERG O O
; O O
Rag1-Cre O O
-LRB- O O
+Cre O O
-RRB- O O
or O O
Ews-ERG O O
-LRB- O O
−Cre O O
-RRB- O O
mice O O
as O O
a O O
function O O
of O O
time O O
-LRB- O O
days O O
-RRB- O O
. O O

Bottom O O
panel O O
shows O O
the O O
histology O O
of O O
blood O O
and O O
bone O O
marrow O O
from O O
leukaemic O O
mice O O
-LRB- O O
M21 O O
and O O
M20 O O
, O O
respectively O O
-RRB- O O
. O O

Blood O O
smears O O
were O O
stained O O
with O O
May-Grünwald-Giemsa O O
stain O O
and O O
photographed O O
at O O
400× O O
magnification O O
, O O
whilst B-conn Contrast
bone O O
marrow O O
was O O
photographed O O
at O O
1,000× O O
. O O

Figure O O
3 O O
: O O
Clonality O O
of O O
T O O
Cell O O
Neoplasias O O
inEws-ERG O O
Invertor O O
MiceGenomic O O
DNA O O
was O O
prepared O O
from O O
various O O
tissues O O
of O O
invertor O O
mice O O
with O O
thymomas O O
. O O

Genomic O O
analysis O O
was O O
carried O O
out O O
using O O
filter O O
hybridisation O O
to B-conn Purpose.Goal
assess O O
the O O
presence O O
of O O
the O O
inverted O O
ERG O O
cassette O O
in O O
the O O
tumour O O
cells O O
-LRB- O O
A O O
-RRB- O O
, O O
and B-conn Purpose.Goal
to O O
assess O O
whether O O
the O O
lymphocytes O O
involved O O
in O O
the O O
tumours O O
were O O
clonal O O
T O O
-LRB- O O
B O O
-RRB- O O
or O O
B O O
cells O O
-LRB- O O
C O O
-RRB- O O
. O O
-LRB- O O
A O O
-RRB- O O
Inversion O O
hybridisation O O
autoradiograph O O
. O O

DNA O O
was O O
prepared O O
from O O
the O O
thymoma O O
and O O
other O O
tissues O O
of O O
M18 O O
, O O
cleaved O O
with O O
EcoRI O O
and O O
hybridised O O
to O O
the O O
5′ O O
Ews O O
probe O O
-LRB- O O
which O O
detects O O
a O O
5-kb O O
targeted O O
ERG O O
cassette O O
fragment O O
or O O
a O O
6.5-kb O O
Cre-inverted O O
fragment O O
-RRB- O O
. O O

If B-conn Condition.Hypothetical
the O O
ERG O O
cassette O O
is O O
inverted O O
by B-conn Purpose.Enablement
Cre O O
activity O O
, O O
the O O
size O O
of O O
the O O
EcoRI O O
fragment O O
increases O O
from O O
the O O
initial O O
targeted O O
gene O O
size O O
, O O
as O O
indicated O O
in O O
the O O
maps O O
below O O
the O O
figure O O
. O O

The O O
data O O
shown O O
are O O
for O O
DNA O O
extracted O O
from O O
spleen O O
-LRB- O O
spl O O
-RRB- O O
, O O
thymus O O
-LRB- O O
thy O O
-RRB- O O
, O O
liver O O
-LRB- O O
liv O O
-RRB- O O
, O O
kidney O O
-LRB- O O
kid O O
-RRB- O O
or O O
tail O O
-LRB- O O
ES O O
cell O O
DNA O O
is O O
used O O
as O O
a O O
control O O
-RRB- O O
. O O

The O O
Cre-mediated O O
inverted O O
band O O
-LRB- O O
∼6.5 O O
kb O O
-RRB- O O
is O O
evident O O
in O O
thymus O O
DNA O O
-LRB- O O
thymoma O O
-RRB- O O
. O O

The O O
summary O O
of O O
the O O
data O O
from O O
the O O
cohort O O
of O O
invertor O O
mice O O
is O O
in O O
Table O O
2 O O
. O O

Note O O
that O O
despite O O
extensive O O
infiltration O O
of O O
spleen O O
detected O O
by B-conn Purpose.Enablement
histology O O
, O O
we O O
cannot O O
see O O
the O O
inverted O O
band O O
by O O
Southern O O
blot O O
; O O
this O O
presumably O O
reflects O O
regional O O
clustering O O
of O O
neoplastic O O
cells O O
in O O
spleen O O
. O O

Restriction O O
fragment O O
sizes O O
are O O
represented O O
as O O
germ O O
line O O
-LRB- O O
GL O O
-RRB- O O
, O O
inverted O O
allele O O
of O O
ERG O O
cassette O O
-LRB- O O
inv O O
-RRB- O O
and O O
initial O O
targeted O O
Ews O O
allele O O
-LRB- O O
Tgt O O
-RRB- O O
. O O

The O O
organisation O O
of O O
the O O
targeted O O
Ews O O
allele O O
is O O
indicated O O
underneath O O
. O O

The O O
hybridisation O O
autoradiograph O O
shows O O
the O O
location O O
of O O
Ews O O
exon O O
7 O O
and O O
the O O
initial O O
targeted O O
orientation O O
-LRB- O O
bottom O O
-RRB- O O
or O O
inverted O O
orientation O O
of O O
ERG O O
invertor O O
cassette O O
after B-conn Temporal.Succession
Cre-mediated O O
recombination O O
-LRB- O O
top O O
-RRB- O O
. O O

a O O
, O O
acceptor O O
splice O O
site. O O
-LRB- O O
B O O
-RRB- O O

Autoradiograph O O
showing O O
rearrangement O O
of O O
T O O
cell O O
receptor O O
β O O
locus O O
. O O

A O O
T O O
cell O O
receptor O O
Jβ2 O O
probe O O
-LSB-40 O O
-RSB- O O
-LRB- O O
diagrammatically O O
shown O O
below O O
the O O
autoradiograph O O
-RRB- O O
detects O O
a O O
5-kb O O
germ O O
line O O
HindIII O O
Jβ2 O O
band O O
whilst O O
V-D-Jβ2 O O
joins O O
in O O
T O O
cells O O
result O O
in O O
new O O
HindIII-sized O O
bands O O
depending O O
on O O
the O O
nature O O
of O O
the O O
rearrangement O O
. O O

Each O O
of O O
12 O O
thymoma O O
DNAs O O
that O O
were O O
compared O O
showed O O
one O O
or O O
two O O
Jβ2 O O
alleles O O
rearranged O O
, O O
signifying O O
that O O
these O O
tumours O O
were O O
clonal O O
T O O
cells O O
. O O

In O O
some O O
thymoma O O
samples O O
, O O
there O O
is O O
almost O O
complete O O
absence O O
of O O
the O O
germ O O
line O O
band O O
, O O
indicating O O
that O O
the O O
thymuses O O
of O O
these O O
mice O O
are O O
solely O O
comprised O O
of O O
malignant O O
clonal O O
T O O
cells O O
. O O

DNA O O
sequence O O
analysis O O
of O O
the O O
V-D-J O O
junctions O O
of O O
mice O O
M2 O O
, O O
M5 O O
, O O
M13 O O
, O O
and O O
M18 O O
showed O O
functional O O
V-D-J O O
joins O O
-LRB- O O
see O O
Table O O
2 O O
-RRB- O O
. O O
-LRB- O O
C O O
-RRB- O O

Autoradiograph O O
showing O O
rearrangement O O
status O O
of O O
immunoglobulin O O
heavy-chain O O
genes O O
. O O

A O O
Cμ O O
intron O O
probe O O
-LSB-41 O O
-RSB- O O
-LRB- O O
diagrammatically O O
shown O O
below O O
the O O
autoradiograph O O
-RRB- O O
was O O
used O O
to B-conn Purpose.Goal
hybridise O O
a O O
set O O
of O O
thymoma O O
DNAs O O
for B-conn Purpose.Goal
the O O
presence O O
of O O
Igh O O
rearranged O O
bands O O
. O O

Only O O
two O O
samples O O
showed O O
rearrangements. O O
-LRB- O O
D O O
-RRB- O O

Detection O O
of O O
Ews-Erg O O
fusion O O
protein O O
in O O
thymoma O O
cells O O
. O O

Single O O
cell O O
suspensions O O
were O O
made O O
of O O
T O O
cells O O
from O O
a O O
normal O O
thymus O O
-LRB- O O
wt O O
-RRB- O O
or O O
from O O
the O O
thymoma O O
of O O
M6 O O
, O O
protein O O
fractionated O O
on O O
4 O O
% O O
–20 O O
% O O
acrylamide O O
gel O O
, O O
and O O
transferred O O
to O O
nylon O O
membranes O O
. O O

Specific O O
proteins O O
were O O
detected O O
with O O
anti-Ews O O
or O O
anti-ERG O O
antibody O O
. O O

Figure O O
4 O O
: O O
B O O
and O O
T O O
Cells O O
Express O O
the O O
Ews-ERG O O
Fusion O O
RNAA O O
96-d-old O O
mouse O O
with O O
both O O
Ews-ERG O O
and O O
Rag1-Cre O O
alleles O O
was O O
used O O
as O O
a O O
source O O
of O O
spleen O O
and O O
thymus O O
cells O O
. O O

Single O O
cell O O
suspensions O O
of O O
spleen O O
cells O O
were O O
labelled O O
with O O
anti-B220 O O
or O O
with O O
anti-Thy1.2 O O

and O O
were O O
purified O O
using O O
a O O
MoFlo O O
preparative O O
flow O O
cytometer O O
. O O

Estimated O O
purities O O
were O O
achieved O O
of O O
greater O O
than O O
95 O O
% O O
. O O

cDNA O O
was O O
prepared O O
from O O
RNA O O
extracted O O
from O O
sorted O O
cells O O
or O O
from O O
aliquots O O
of O O
unsorted O O
populations O O
and O O
RT-PCR O O
-LRB- O O
approximately O O
3,400 O O
B220+ O O
or O O
6,400 O O
Thy1.2+ O O
cell O O
equivalents O O
per O O
PCR O O
reaction O O
-RRB- O O
carried O O
out O O
with O O
specific O O
Pax5 O O
-LRB- O O
A O O
-RRB- O O
, O O
CD3 O O
-LRB- O O
B O O
-RRB- O O
or O O
Ews-ERG O O
-LRB- O O
C O O
-RRB- O O
primers O O
. O O

PCR O O
reaction O O
products O O
were O O
fractionated O O
on O O
1 O O
% O O
agarose O O
gels O O
and O O
either O O
stained O O
with O O
ethidium O O
bromide O O
and O O
photographed O O
-LRB- O O
A O O
and O O
B O O
-RRB- O O
or O O
gel O O
blotted O O
and O O
hybridised O O
with O O
an O O
Ews-ERG O O
probe O O
-LRB- O O
C O O
-RRB- O O

Figure O O
5 O O
: O O
Analysis O O
of O O
Cell O O
Surface O O
Antigens O O
of O O
Thymomas O O
from O O
Ews-ERG O O
Invertor O O
Mice O O
Using O O
Flow O O
CytometryThymus O O
tissue O O
was O O
resected O O
from O O
mice O O
with O O
thymoma O O
and O O
FACS O O
analysis O O
performed O O
to B-conn Purpose.Goal
determine O O
T O O
cell O O
phenotype O O
-LRB- O O
summarised O O
in O O
Table O O
1 O O
-RRB- O O
. O O

The O O
data O O
in O O
the O O
figure O O
show O O
representative O O
flow O O
diagrams O O
of O O
three O O
tumour-bearing O O
mice O O
-LRB- O O
M2 O O
, O O
M3 O O
, O O
and O O
M4 O O
-RRB- O O
compared O O
with O O
a O O
wild-type O O
C57BL/6 O O
control O O
-LRB- O O
wt O O
-RRB- O O
, O O
using O O
anti-Thy1 O O
-LRB- O O
y-axis O O
-RRB- O O
plus O O
anti-B220 O O
-LRB- O O
x-axis O O
-RRB- O O
antibodies O O
or O O
using O O
anti-CD8 O O
-LRB- O O
y-axis O O
-RRB- O O
plus O O
anti-CD4 O O
-LRB- O O
x-axis O O
-RRB- O O
antibodies O O
. O O

The O O
three O O
thymomas O O
show O O
a O O
range O O
of O O
CD4 O O
and O O
CD8 O O
co-expression O O
phenotypes O O
characterizing O O
the O O
thymomas O O
generated O O
in O O
the O O
Ews-ERG O O
; O O
Rag1-Cre O O
invertor O O
mice O O
. O O
. O O

Table O O
1 O O
: O O
Tumour O O
Characteristics O O
of O O
Ews-ERG O O
Invertor O O
Mice O O
Expressing O O
Cre O O
Recombinase O O
from O O
the O O
Rag1 O O
Gene O O

Table O O
2 O O
: O O
Sequences O O
of O O
Rearranged O O
TCR O O
Jβ O O
Loci O O
in O O
Ews-ERG O O
Thymoma O O
DNA O O

A O O
role O O
for O O
the O O
Tec O O
family O O
kinase O O
ITK O O
in O O
regulating O O
SEB O O
induced O O
Interleukin-2 O O
production O O
in O O
vivo O O
via O O
c-jun O O
phosphorylation O O

Abstract O O

Background O O
: O O
Exposure O O
to O O
Staphylococcal O O
Enterotoxin O O
B O O
-LRB- O O
SEB O O
-RRB- O O
, O O
a O O
bacterial O O
superantigen O O
secreted O O
by O O
the O O
Gram-positive O O
bacteria O O
Staphyloccocus O O
aureus O O
, O O
results O O
in O O
the O O
expansion O O
and O O
eventual O O
clonal O O
deletion O O
and O O
anergy O O
of O O
Vβ8+ O O
T O O
cells O O
, O O
as O O
well O O
as O O
massive O O
cytokine O O
release O O
, O O
including O O
Interleukin-2 O O
-LRB- O O
IL-2 O O
-RRB- O O
. O O

This O O
IL-2 O O
is O O
rapidly O O
secreted O O
following B-conn Temporal.Succession
exposure O O
to O O
SEB O O
and O O
may O O
contribute O O
to O O
the O O
symptoms O O
seen O O
following B-conn Temporal.Succession
exposure O O
to O O
this O O
bacterial O O
toxin O O
. O O

The O O
Tec O O
family O O
kinase O O
ITK O O
has O O
been O O
shown O O
to O O
be O O
important O O
for O O
the O O
production O O
of O O
IL-2 O O
by O O
T O O
cells O O
stimulated O O
in O O
vitro O O
and O O
may O O
represent O O
a O O
good O O
target O O
for O O
blocking O O
the O O
production O O
of O O
this O O
cytokine O O
in O O
vivo O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
determine O O
if O O
ITK O O
represents O O
such O O
a O O
target O O
, O O
mice O O
lacking O O
ITK O O
were O O
analyzed O O
for O O
their O O
response O O
to O O
SEB O O
exposure O O
. O O

Results O O
: O O
It O O
was O O
found O O
that O O
T O O
cells O O
from O O
mice O O
lacking O O
ITK O O
exhibited O O
significantly O O
reduced O O
proliferative O O
responses O O
to O O
SEB O O
exposure O O
in O O
vitro O O
, O O
as O O
well O O
as O O
in O O
vivo O O
. O O

Examination O O
of O O
IL-2 O O
production O O
revealed O O
that O O
ITK O O
null O O
mice O O
produced O O
reduced O O
levels O O
of O O
this O O
cytokine O O
in O O
vitro O O
, O O
and O O
more O O
dramatically O O
, O O
in O O
vivo O O
. O O

In O O
vivo O O
analysis O O
of O O
c-jun O O
phosphorylation O O
, O O
previously O O
shown O O
to O O
be O O
critical O O
for O O
regulating O O
IL-2 O O
production O O
, O O
revealed O O
that O O
this O O
pathway O O
was O O
specifically O O
activated O O
in O O
SEB O O
reactive O O
Vβ8+ O O
-LRB- O O
but O O
not O O
non-reactive O O
Vβ6+ O O
-RRB- O O
T O O
cells O O
from O O
WT O O
mice O O
, O O
but O O
not O O
in O O
Vβ8+ O O
T O O
cells O O
from O O
ITK O O
null O O
mice O O
. O O

However B-conn Contrast
, O O
toxicity O O
analysis O O
indicated O O
that O O
both O O
WT O O
and O O
ITK O O
null O O
animals O O
were O O
similarly O O
affected O O
by O O
SEB O O
exposure O O
. O O

Conclusion O O
: O O
These O O
data O O
show O O
that O O
ITK O O
is O O
required O O
for O O
IL-2 O O
production O O
induced O O
by O O
SEB O O
in O O
vivo O O
, O O
and O O
may O O
regulate O O
signals O O
leading O O
IL-2 O O
production O O
, O O
in B-conn Purpose.Enablement
part I-conn Purpose.Enablement
by I-conn Purpose.Enablement
regulating O O
phosphorylation O O
of O O
c-jun O O
. O O

The O O
data O O
also B-conn Conjunction
suggest O O
that O O
perturbing O O
T O O
cell O O
activation O O
pathways O O
leading O O
to O O
IL-2 O O
does O O
not O O
necessarily O O
lead O O
to O O
improved O O
responses O O
to O O
SEB O O
toxicity O O
. O O

Background O O

Superantigens O O
-LRB- O O
SAGs O O
-RRB- O O
are O O
microbial O O
toxins O O
of O O
bacterial O O
and O O
viral O O
origin O O
with O O
the O O
ability O O
to O O
activate O O
5–20 O O
% O O
of O O
the O O
T O O
cell O O
population O O
, O O
causing O O
T O O
cell O O
activation O O
, O O
cytokine O O
release O O
and O O
systemic O O
shock O O
-LSB-1,2 O O
-RSB- O O
. O O

Most O O
SAGs O O
share O O
the O O
ability O O
to O O
simultaneously O O
bind O O
the O O
class O O
II O O
major O O
histocompatibility O O
complex O O
molecules O O
and O O
the O O
variable O O
region O O
of O O
the O O
T O O
cell O O
receptor O O
β-chain O O
, O O
without O O
the O O
need O O
to O O
be O O
processed O O
by O O
antigen O O
presenting O O
cells O O
-LSB-1,2 O O
-RSB- O O
. O O

Thus B-conn Restatement.Equivalence
SEB O O
can O O
interact O O
directly O O
with O O
MHC O O
class O O
II O O
molecules O O
on O O
APCs O O
and O O
activate O O
T O O
cells O O
bearing O O
the O O
proper O O
TcR O O
Vβ O O
chains O O
. O O

The O O
result O O
of O O
this O O
interaction O O
is O O
large-scale O O
stimulation O O
of O O
any O O
T O O
cell O O
that O O
expresses O O
the O O
proper O O
TCR O O
Vβ O O
chain O O
. O O

A O O
number O O
of O O
studies O O
have O O
shown O O
that O O
when B-conn Temporal.Synchronous
mice O O
are O O
challenged O O
with O O
a O O
SAG O O
such O O
as O O
Staphylococcal O O
Enterotoxin O O
B O O
-LRB- O O
SEB O O
-RRB- O O
, O O
toxicity O O
results O O
from O O
massive O O
induction O O
of O O
cytokines O O
derived O O
from O O
T-helper-type-1 O O
-LRB- O O
TH1 O O
-RRB- O O
type O O
cells O O
such O O
as O O
IL-2 O O
, O O
IFN-γ O O
, O O
TNF-α O O
and O O
TNF-β O O
-LSB-1,3 O O
-RSB- O O
. O O

This O O
cytokine O O
production O O
is O O
accompanied O O
by O O
expansion O O
of O O
the O O
numbers O O
of O O
SEB O O
reactive O O
T O O
cells O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
cell O O
death O O
and O O
the O O
induction O O
of O O
functional O O
`` O O
anergy O O
'' O O
-LSB-4-6 O O
-RSB- O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
for I-conn Purpose.Goal
a O O
T O O
cell O O
to O O
be O O
activated O O
antigen O O
presenting O O
cells O O
-LRB- O O
APC O O
-RRB- O O
must O O
present O O
antigen O O
, O O
either O O
an O O
antigenic O O
peptide O O
or O O
SAG O O
. O O

In O O
vitro O O
, O O
this O O
interaction O O
with O O
the O O
TcR O O
has O O
been O O
shown O O
to O O
lead O O
to O O
the O O
activation O O
of O O
a O O
number O O
of O O
tyrosine O O
kinases O O
, O O
including O O
the O O
Src O O
family O O
kinase O O
Lck O O
, O O
the O O
Syk O O
family O O
kinase O O
Zap-70 O O
and O O
the O O
Tec O O
family O O
kinase O O
ITK O O
-LRB- O O
for O O
review O O
see O O
-LSB-7-10 O O
-RSB- O O
-RRB- O O
. O O

This O O
then B-conn Temporal.Precedence
results O O
in O O
the O O
activation O O
of O O
a O O
number O O
of O O
signaling O O
pathways O O
including O O
members O O
of O O
the O O
MAPK O O
family O O
of O O
kinases O O
, O O
ERK O O
, O O
JNK O O
and O O
p38 O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
transcription O O
factor O O
activation O O
-LSB-10 O O
-RSB- O O
. O O

In O O
vivo O O
, O O
activation O O
of O O
these O O
T O O
cells O O
lead O O
to O O
the O O
induction O O
of O O
cytokine O O
secretion O O
within O O
hours O O
of O O
SEB O O
exposure O O
-LSB-1,3 O O
-RSB- O O
. O O

ITK O O
is O O
expressed O O
primarily O O
in O O
T O O
cells O O
, O O
NK O O
cells O O
and O O
mast O O
cells O O
-LSB-11-13 O O
-RSB- O O
. O O

In O O
T O O
cells O O
, O O
it O O
is O O
rapidly O O
activated O O
following B-conn Temporal.Succession
TcR O O
crosslinking O O
in O O
vitro O O
-LSB-14,15 O O
-RSB- O O
. O O

Mice O O
lacking O O
ITK O O
exhibit O O
reduced O O
proliferation O O
and O O
IL-2 O O
production O O
in O O
vitro O O
, O O
and O O
reduced O O
T O O
cell O O
differentiation O O
in O O
vitro O O
and O O
in O O
vivo O O
, O O
with O O
TH2 O O
cell O O
differentiation O O
preferentially O O
affected O O
-LSB-15-19 O O
-RSB- O O
. O O

The O O
observed O O
reduced O O
proliferation O O
of O O
ITK O O
null O O
T O O
cells O O
in O O
vitro O O
is O O
IL-2 O O
dependent O O
as B-conn Cause.Justification
it O O
could O O
be O O
rescued O O
by B-conn Purpose.Enablement
the O O
addition O O
of O O
exogenous O O
IL-2 O O
-LSB-20 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
these O O
animals O O
are O O
not O O
entirely O O
immunocompromised O O
, O O
with O O
residual O O
responses O O
against O O
LCM O O
, O O
Vaccinia O O
and O O
VS O O
viruses O O
-LSB-21 O O
-RSB- O O
. O O

We O O
have O O
tested O O
whether O O
ITK O O
null O O
mice O O
are O O
susceptible O O
to O O
SEB O O
induced O O
IL-2 O O
secretion O O
. O O

We O O
show O O
here O O
that O O
mice O O
lacking O O
ITK O O
have O O
much O O
reduced O O
IL-2 O O
production O O
and O O
T O O
cell O O
expansion O O
in O O
response O O
to O O
SEB O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

We O O
also B-conn Conjunction
show O O
that O O
SEB O O
induced O O
the O O
activation O O
of O O
the O O
JNK O O
MAPK O O
pathway O O
in O O
responding O O
T O O
cells O O
in O O
vivo O O
, O O
and B-conn Conjunction
that O O
ITK O O
null O O
T O O
cells O O
were O O
defective O O
in O O
the O O
activation O O
of O O
this O O
pathway O O
in O O
vivo O O
. O O

However B-conn Concession.Contra-expectation
, O O
toxicity O O
analysis O O
indicated O O
that O O
both O O
WT O O
and O O
ITK O O
null O O
animals O O
were O O
similarly O O
affected O O
by O O
SEB O O
exposure O O
. O O

Our O O
data O O
suggest O O
that O O
ITK O O
is O O
required O O
for O O
full O O
IL-2 O O
secretion O O
following B-conn Temporal.Succession
SEB O O
exposure O O
, O O
and B-conn Conjunction
that O O
this O O
may O O
be O O
due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
regulation O O
of O O
the O O
JNK O O
pathway O O
by O O
ITK O O
in O O
vivo O O
. O O

However B-conn Concession.Contra-expectation
, O O
reducing O O
T O O
cell O O
signals O O
does O O
not O O
necessarily O O
lead O O
to O O
better O O
physiological O O
responses O O
to O O
SEB O O
exposure O O
. O O

Results O O

It O O
has O O
previously O O
been O O
reported O O
that O O
T O O
cells O O
from O O
mice O O
lacking O O
ITK O O
exhibit O O
much O O
reduced O O
proliferation O O
in O O
response O O
to O O
anti-CD3 O O
or O O
TcR O O
antibodies O O
in O O
vitro O O
-LSB-15,16,18 O O
-RSB- O O
. O O

By B-conn Contrast
contrast I-conn Contrast
, O O
these O O
T O O
cells O O
did O O
not O O
have O O
any O O
defects O O
and O O
actually O O
had O O
higher O O
proliferative O O
responses O O
following B-conn Temporal.Succession
anti-CD28/PMA O O
stimulation O O
-LSB-20 O O
-RSB- O O
. O O

These O O
data O O
do O O
not O O
provide O O
clear O O
answers O O
as O O
to O O
whether O O
ITK O O
would O O
present O O
a O O
good O O
target O O
for O O
inhibition O O
of O O
SEB O O
induced O O
T O O
cell O O
activation O O
in O O
vivo O O
, O O
and O O
in O O
particular O O
, O O
in O O
the O O
cytokine O O
response O O
observed O O
following B-conn Temporal.Succession
SAG O O
exposure O O
. O O

We O O
therefore B-conn Cause.Result
first O O
tested O O
whether O O
ITK O O
null O O
T O O
cells O O
could O O
respond O O
to O O
SEB O O
stimulation O O
by B-conn Purpose.Enablement
proliferation O O
in O O
vitro O O
. O O

Pooled O O
splenocytes O O
and O O
lymph O O
node O O
cells O O
from O O
WT O O
or O O
ITK O O
null O O
animals O O
were O O
cultured O O
in O O
vitro O O
in O O
the O O
presence O O
of O O
varying O O
concentrations O O
of O O
SEB O O
-LRB- O O
5 O O
μg/ml O O
, O O
0.5 O O
μg/ml O O
, O O
0.05 O O
μg/ml O O
, O O
0.005 O O
μg/ml O O
, O O
and O O
0.0005 O O
μg/ml O O
-RRB- O O
, O O
and B-conn Conjunction
proliferation O O
analyzed O O
over O O
a O O
5-day O O
period O O
. O O

We O O
found O O
that O O
WT O O
cells O O
responded O O
normally O O
by B-conn Purpose.Enablement
proliferating O O
between O O
days O O
2 O O
and O O
3 O O
, O O
with O O
maximum O O
proliferation O O
observed O O
at O O
day O O
5 O O
and O O
the O O
5 O O
μg/ml O O
dose O O
of O O
SEB O O
-LRB- O O
Fig. O O
1a O O
-RRB- O O
. O O

Analysis O O
of O O
the O O
dose O O
response O O
at O O
5 O O
days O O
indicated O O
that O O
the O O
WT O O
cells O O
responded O O
in O O
a O O
dose O O
dependent O O
fashion O O
-LRB- O O
Fig. O O
1b O O
-RRB- O O
. O O

By B-conn Contrast
contrast I-conn Contrast
, O O
cells O O
from O O
ITK O O
mice O O
showed O O
very O O
little O O
response O O
, O O
regardless B-conn Concession.Expectation
of I-conn Concession.Expectation
the O O
dose O O
of O O
SEB O O
used O O
for O O
stimulation O O
-LRB- O O
Fig. O O
1a O O
, O O
b O O
-RRB- O O
. O O

We O O
next B-conn Temporal.Precedence
determined O O
if O O
the O O
same O O
results O O
would O O
be O O
obtained O O
in O O
purified O O
T O O
cell O O
populations O O
from O O
these O O
mice O O
. O O

T O O
cells O O
were O O
purified O O
from O O
WT O O
and O O
ITK O O
null O O
mice O O
, O O
and O O
stimulated O O
with O O
varying O O
dose O O
of O O
SEB O O
, O O
in O O
the O O
presence O O
of O O
APCs O O
. O O

Analysis O O
of O O
the O O
data O O
over O O
the O O
5 O O
days O O
indicated O O
that O O
in O O
the O O
presence O O
of O O
the O O
highest O O
concentration O O
of O O
SEB O O
tested O O
-LRB- O O
10 O O
μg/ml O O
-RRB- O O
, O O
WT O O
T O O
cells O O
responded O O
more O O
robustly O O
than O O
ITK O O
null O O
T O O
cells O O
-LRB- O O
see O O
Fig. O O
1c O O
-RRB- O O
. O O

Indeed B-conn Reinforcement
, O O
at O O
all O O
the O O
doses O O
tested O O
, O O
our O O
analysis O O
indicated O O
that O O
ITK O O
null O O
T O O
cells O O
responded O O
less O O
than O O
WT O O
T O O
cells O O
on O O
day O O
3 O O
, O O
4 O O
and O O
5 O O
-LRB- O O
Fig. O O
1d–f O O
-RRB- O O
, O O
while B-conn Contrast
proliferation O O
was O O
equivalent O O
when B-conn Temporal.Synchronous
PMA O O
and O O
Ionomycin O O
was O O
used O O
to B-conn Purpose.Goal
bypass O O
TcR O O
signals O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

These O O
data O O
indicate O O
that O O
ITK O O
null O O
T O O
cells O O
have O O
significantly O O
reduced O O
proliferative O O
responses O O
to O O
SEB O O
in O O
vitro O O
. O O

Interleukin-2 O O
is O O
one O O
of O O
the O O
cytokines O O
induced O O
by B-conn Purpose.Enablement
exposure O O
to O O
SEB O O
-LSB-22 O O
-RSB- O O
. O O

ITK O O
has O O
been O O
shown O O
to O O
regulate O O
IL-2 O O
secretion O O
in O O
vitro O O
by O O
T O O
cells O O
stimulated O O
anti-CD3/TcR O O
antibodies O O
or O O
in O O
response O O
to O O
peptide O O
antigen O O
-LSB-15,18,23,24 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
determined O O
the O O
levels O O
of O O
IL-2 O O
in O O
supernatants O O
from O O
cells O O
similarly O O
stimulated O O
with O O
SEB O O
in O O
vitro O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

While B-conn Contrast
WT O O
T O O
cells O O
responded O O
to O O
SEB O O
by B-conn Purpose.Enablement
secretion O O
of O O
IL-2 O O
within O O
24 O O
hrs. O O
of O O
stimulation O O
in O O
a O O
dose O O
dependent O O
manner O O
-LRB- O O
see O O
Fig. O O
2a O O
for O O
5 O O
μg/ml O O
dose O O
-RRB- O O
, O O
starting O O
at O O
the O O
0.5 O O
μg/ml O O
SEB O O
concentration O O
-LRB- O O
Fig. O O
2bi O O
-RRB- O O
, O O
ITK O O
null O O
T O O
cells O O
made O O
very O O
little O O
IL-2 O O
, O O
and B-conn Conjunction
the O O
small O O
amount O O
of O O
IL-2 O O
that O O
was O O
made O O
was O O
only O O
at O O
the O O
highest O O
concentration O O
of O O
SEB O O
tested O O
-LRB- O O
5 O O
μg/ml O O
-RRB- O O
. O O

ITK O O
null O O
T O O
cells O O
consistently O O
secreted O O
less O O
IL-2 O O
over O O
the O O
5-day O O
period O O
and O O
dose O O
range O O
-LRB- O O
Fig. O O
2b O O
-RRB- O O
. O O

These O O
data O O
indicate O O
that O O
as O O
previously O O
reported O O
for O O
TcR O O
or O O
antigenic O O
stimulation O O
, O O
ITK O O
regulates O O
the O O
production O O
of O O
IL-2 O O
in O O
vitro O O
in O O
response O O
to O O
SEB O O
stimulation O O
-LSB-15,18,23,24 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
these O O
data O O
indicate O O
that O O
ITK O O
regulates O O
T O O
cell O O
proliferation O O
in O O
response O O
to O O
SEB O O
in O O
vitro O O
, O O
it O O
is O O
possible O O
that O O
within O O
the O O
context O O
of O O
antigen O O
presentation O O
and O O
optimal O O
co-stimulatory O O
signals O O
in O O
vivo O O
, O O
ITK O O
null O O
T O O
cells O O
may O O
exhibit O O
a O O
better O O
response O O
. O O

Exposure O O
of O O
animals O O
to O O
SEB O O
results O O
in O O
an O O
expansion O O
of O O
the O O
SEB O O
reactive O O
T O O
cell O O
population O O
with O O
a O O
peak O O
of O O
around O O
2 O O
days O O
post O O
exposure O O
-LSB-2,4 O O
-RSB- O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
determine O O
if O O
the O O
reduced O O
proliferative O O
responses O O
seen O O
with O O
the O O
ITK O O
null O O
T O O
cells O O
in O O
vitro O O
was O O
also O O
seen O O
in O O
vivo O O
, O O
we O O
exposed O O
WT O O
and O O
ITK O O
null O O
animals O O
to O O
SEB O O
and O O
determined O O
the O O
percentages O O
of O O
Vβ8 O O
and O O
Vβ6 O O
positive O O
cells O O
in O O
the O O
CD4+ O O
population O O
by O O
flow O O
cytometry O O
after O O
2 O O
, O O
4 O O
and O O
5 O O
days O O
as O O
a O O
measure O O
of O O
T O O
cell O O
expansion O O
. O O

T O O
cells O O
bearing O O
Vβ8 O O
TcR O O
chains O O
are O O
responsive O O
to O O
SEB O O
stimulation O O
while B-conn Contrast
those O O
that O O
bear O O
Vβ6 O O
TcR O O
chains O O
are O O
not O O
, O O
so B-conn Cause.Result
we O O
analyzed O O
these O O
two O O
populations O O
of O O
T O O
cells O O
. O O

As O O
previously O O
reported O O
, O O
in O O
WT O O
animals O O
, O O
we O O
observed O O
an O O
approximately O O
4 O O
fold O O
expansion O O
in O O
Vβ8 O O
CD4+ O O
T O O
cells O O
in O O
spleen O O
and O O
lymph O O
nodes O O
following B-conn Temporal.Succession
SEB O O
exposure O O
-LRB- O O
as O O
compared O O
to O O
exposure O O
to O O
PBS O O
, O O
fig O O
3a O O
, O O
b O O
-RRB- O O
, O O
while B-conn Contrast
Vβ6 O O
CD4+ O O
T O O
cell O O
populations O O
were O O
largely O O
unchanged O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

By B-conn Contrast
contrast I-conn Contrast
, O O
there O O
was O O
statistically O O
significantly O O
less O O
expansion O O
of O O
ITK O O
null O O
Vβ8+CD4+ O O
T O O
cells O O
following B-conn Temporal.Succession
SEB O O
exposure O O
, O O
although B-conn Concession.Contra-expectation
these O O
cells O O
still B-conn Concession.Contra-expectation
expanded O O
-LRB- O O
Fig. O O
3a O O
, O O
b O O
-RRB- O O
As O O
previously O O
reported O O
, O O
the O O
percentages O O
of O O
T O O
cells O O
bearing O O
Vβ6 O O
did O O
not O O
change O O
over O O
this O O
period O O
in O O
either O O
the O O
WT O O
or O O
ITK O O
null O O
mice O O
-LRB- O O
data O O
not O O
shown O O
and O O
-LSB-4 O O
-RSB- O O
-RRB- O O
. O O

Thus B-conn Cause.Claim
the O O
absence O O
of O O
ITK O O
results O O
in O O
reduced O O
T O O
cell O O
expansion O O
in O O
vivo O O
in O O
response O O
to O O
SEB O O
. O O

T O O
cells O O
from O O
ITK O O
null O O
mice O O
proliferate O O
less O O
in O O
vitro O O
and O O
in O O
vivo O O
, O O
and O O
secrete O O
significantly O O
less O O
IL-2 O O
in O O
vitro O O
in O O
response O O
to O O
SEB O O
. O O

We O O
therefore B-conn Cause.Result
determined O O
if O O
they O O
would O O
also O O
secrete O O
less O O
IL-2 O O
following B-conn Temporal.Succession
SEB O O
stimulation O O
in O O
vivo O O
. O O

Groups O O
of O O
mice O O
were O O
exposed O O
to O O
SEB O O
i.v. O O
and B-conn Conjunction
at O O
various O O
time O O
points O O
their O O
serum O O
was O O
taken O O
and O O
analyzed O O
for O O
IL-2 O O
production O O
. O O

We O O
found O O
that O O
in B-conn Contrast
comparison I-conn Contrast
to I-conn Contrast
in O O
vitro O O
IL-2 O O
production O O
, O O
when B-conn Temporal.Synchronous
WT O O
mice O O
were O O
exposed O O
to O O
SEB O O
in O O
vivo O O
they O O
produced O O
IL-2 O O
within O O
1 O O
hr. O O
, O O
which O O
peaked O O
at O O
around O O
2 O O
hrs O O
. O O

-LRB- O O
Fig. O O
4 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
consistent O O
with O O
the O O
in O O
vitro O O
stimulation O O
, O O
ITK O O
deficient O O
mice O O
secrete O O
significantly O O
less O O
IL-2 O O
in O O
response O O
to O O
SEB O O
in O O
vivo O O
-LRB- O O
Fig. O O
4 O O
-RRB- O O
. O O

Based O O
on O O
these O O
data O O
we O O
conclude O O
that O O
in O O
vivo O O
IL-2 O O
production O O
occurs O O
earlier O O
than O O
observed O O
in O O
vitro O O
, O O
and B-conn Conjunction
that O O
ITK O O
null O O
T O O
cells O O
continue O O
to O O
exhibit O O
defects O O
in O O
IL-2 O O
production O O
in O O
response O O
to O O
SEB O O
in O O
vivo O O
, O O
even O O
in O O
the O O
presumed O O
presence O O
of O O
adequate O O
costimulatory O O
signals O O
in O O
vivo O O
. O O

The O O
JNK O O
MAPK O O
pathway O O
has O O
been O O
shown O O
to O O
be O O
essential O O
for O O
IL-2 O O
production O O
upon B-conn Temporal.Synchronous
stimulation O O
of O O
T O O
cells O O
by O O
the O O
TcR O O
and O O
CD28 O O
in O O
vitro O O
-LSB-25-28 O O
-RSB- O O
. O O

This O O
pathway O O
leads O O
to O O
phosphorylation O O
of O O
c-jun O O
and O O
activation O O
of O O
an O O
AP-1 O O
transcription O O
factor O O
complex O O
that O O
is O O
required O O
for O O
IL-2 O O
transcription O O
-LSB-28 O O
-RSB- O O
. O O

While B-conn Concession.Expectation
activation O O
of O O
the O O
JNK O O
pathway O O
leading O O
to O O
phosphorylation O O
and O O
activation O O
of O O
c-jun O O
has O O
been O O
demonstrated O O
in O O
T O O
cells O O
following B-conn Temporal.Succession
TcR O O
and O O
CD28 O O
crosslinking O O
in O O
vitro O O
, O O
as O O
well O O
as O O
by O O
peptide O O
antigen O O
stimulation O O
in O O
vivo O O
, O O
it O O
is O O
not O O
clear O O
whether O O
the O O
SAG O O
SEB O O
activates O O
this O O
pathway O O
in O O
vivo O O
-LSB-29,30 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
tested O O
whether O O
SEB O O
could O O
induce O O
phosphorylation O O
of O O
c-jun O O
in O O
WT O O
T O O
cells O O
stimulated O O
with O O
SEB O O
in O O
vivo O O
. O O

To B-conn Purpose.Goal
do O O
this O O
, O O
we O O
adapted O O
a O O
method O O
initially O O
used O O
by O O
Jenkins O O
and O O
colleagues O O
to O O
analyze O O
phosphorylation O O
of O O
c-jun O O
following B-conn Temporal.Succession
in O O
vivo O O
exposure O O
of O O
antigen O O
. O O

In O O
this O O
protocol O O
, O O
mice O O
were O O
exposed O O
to O O
SEB O O
, O O
then B-conn Temporal.Precedence
cells O O
from O O
lymph O O
nodes O O
, O O
spleen O O
and O O
blood O O
rapidly O O
isolated O O
and O O
fixed O O
, O O
and B-conn Conjunction
antibodies O O
specific O O
for O O
phosphorylated O O
c-jun O O
used O O
to O O
analyze O O
its O O
phosphorylation O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
cells O O
were O O
stained O O
with O O
antibodies O O
specific O O
to O O
Vβ8 O O
or O O
Vβ6 O O
to O O
detect O O
SEB O O
responsive O O
and O O
non-responsive O O
T O O
cells O O
respectively O O
. O O

Flow O O
cytometry O O
was O O
employed O O
to O O
detect O O
phosphorylation O O
of O O
c-jun O O
-LSB-30 O O
-RSB- O O
. O O

Figure I-conn Temporal.Succession
5 O O
demonstrates O O
that O O
1 B-conn Temporal.Succession
hr I-conn Temporal.Succession
. O O

after O O
intravenous O O
exposure O O
to O O
SEB O O
, O O
Vβ8+ O O
SEB O O
reactive O O
T O O
cells O O
in O O
spleen O O
and O O
lymph O O
nodes O O
contain O O
higher O O
levels O O
of O O
phosphorylated O O
c-jun O O
-LRB- O O
cf O O
. O O

Figs O O
. O O

5a O O
, O O
b O O
iii O O
& O O
iv O O
-RRB- O O
. O O

Similar O O
results O O
were O O
found O O
in O O
animals O O
exposed O O
to O O
SEB O O
i.p. O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

By B-conn Contrast
contrast I-conn Contrast
, O O
T O O
cells O O
non-reactive O O
to O O
SEB O O
in O O
the O O
same O O
animals O O
, O O
those O O
bearing O O
Vβ6+ O O
TcRs O O
, O O
did O O
not O O
have O O
any O O
increase O O
in O O
phosphorylated O O
c-jun O O
-LRB- O O
cf O O
. O O

Figs O O
. O O

5a O O
, O O
b O O
, O O
i O O
& O O
ii O O
-RRB- O O
. O O

This O O
demonstrates O O
that O O
in O O
the O O
same O O
animal O O
, O O
only O O
those O O
T O O
cells O O
that O O
interact O O
with O O
and O O
can O O
be O O
activated O O
by O O
SEB O O
respond O O
by B-conn Purpose.Enablement
phosphorylation O O
of O O
c-jun O O
, O O
while B-conn Contrast
at O O
the O O
same O O
time O O
, O O
those O O
T O O
cells O O
that O O
are O O
not O O
reactive O O
are O O
not O O
activated O O
, O O
demonstrating O O
specificity O O
. O O

Similarly O O
, O O
animals O O
injected O O
with O O
PBS O O
showed O O
no O O
such O O
change O O
in O O
phosphorylated O O
c-jun O O
in O O
either O O
the O O
SEB O O
reactive O O
or O O
non-reactive O O
T O O
cell O O
populations O O
, O O
indicating O O
that O O
this O O
was O O
an O O
SEB O O
mediated O O
event O O
-LRB- O O
Fig. O O
5a–b O O
-RRB- O O
. O O

Other O O
controls O O
including O O
secondary O O
reagents O O
alone O O
demonstrate O O
the O O
specificity O O
of O O
antibody O O
staining O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

We O O
next O O
determined O O
whether O O
T O O
cells O O
lacking O O
ITK O O
could O O
induce O O
c-jun O O
phosphorylation O O
in B-conn Temporal.Synchronous
response I-conn Temporal.Synchronous
to I-conn Temporal.Synchronous
SEB O O
activation O O
in O O
vivo O O
. O O

ITK O O
null O O
mice O O
were O O
exposed O O
to O O
SEB O O
as O O
described O O
above O O
, O O
and B-conn Conjunction
phosphorylation O O
of O O
c-jun O O
determined O O
in O O
Vβ8+ O O
T O O
cell O O
population O O
-LRB- O O
SEB O O
reactive O O
-RRB- O O
or O O
Vβ6+ O O
T O O
cell O O
population O O
-LRB- O O
non-reactive O O
-RRB- O O
in O O
the O O
same O O
animals O O
. O O

These O O
experiments O O
show O O
that O O
in O O
the O O
absence O O
of O O
ITK O O
, O O
SEB O O
does O O
not O O
lead O O
to O O
phosphorylation O O
of O O
c-jun O O
in O O
either O O
T O O
cell O O
population O O
-LRB- O O
Fig. O O
6a–d O O
-RRB- O O
. O O

Thus B-conn Cause.Claim
, O O
the O O
absence O O
of O O
ITK O O
results O O
in O O
the O O
lack O O
of O O
SEB O O
phosphorylation O O
of O O
c-jun O O
, O O
which O O
could O O
affect O O
the O O
ability O O
of O O
these O O
T O O
cells O O
to O O
produce O O
IL-2 O O
. O O

To B-conn Purpose.Goal
determine O O
if O O
this O O
lack O O
of O O
c-jun O O
phosphorylation O O
in O O
ITK O O
null O O
T O O
cells O O
in O O
response O O
to O O
SEB O O
reflected O O
global O O
nonresponsiveness O O
in O O
these O O
cells O O
, O O
we O O
determined O O
whether O O
these O O
cells O O
were O O
indeed O O
activated O O
by O O
SEB O O
exposure O O
. O O

To B-conn Purpose.Goal
do O O
this O O
, O O
we O O
measured O O
increases O O
in O O
CD69 O O
expression O O
, O O
a O O
cell O O
surface O O
protein O O
that O O
is O O
rapidly O O
expressed O O
by O O
activated O O
T O O
cells O O
in O O
a O O
Ras/MAPK O O
dependent O O
manner O O
-LSB-31-33 O O
-RSB- O O
. O O

Similar O O
experiments O O
were O O
performed O O
as O O
those O O
examining O O
c-jun O O
phosphorylation O O
, O O
except B-conn Exception
that I-conn Exception
we O O
used O O
specific O O
antibodies O O
against O O
CD69 O O
to B-conn Purpose.Goal
determine O O
if O O
the O O
SEB O O
reactive O O
cells O O
had O O
been O O
activated O O
. O O

Figure O O
7 O O
demonstrates O O
that O O
Vβ8+CD4+ O O
T O O
cells O O
but O O
not O O
Vβ6+CD4+ O O
T O O
cells O O
from O O
both O O
WT O O
and O O
ITK O O
null O O
mice O O
exhibited O O
increases O O
in O O
CD69 O O
expression O O
2 B-conn Temporal.Succession
hours I-conn Temporal.Succession
following I-conn Temporal.Succession
SEB O O
exposure O O
, O O
indicating O O
that O O
in O O
both O O
cases O O
, O O
the O O
T O O
cells O O
were O O
responding O O
to O O
SEB O O
activation O O
-LRB- O O
Fig. O O
7 O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
SEB O O
induced O O
CD69 O O
expression O O
on O O
a O O
higher O O
percentage O O
of O O
Vβ8+CD4+ O O
SEB O O
responding O O
T O O
cells O O
in O O
WT O O
mice O O
than O O
in O O
ITK O O
null O O
mice O O
-LRB- O O
73.5 O O
+/- O O
12 O O
% O O
in O O
WT O O
vs. O O
43.6 O O
+/- O O
0.5 O O
% O O
in O O
ITK O O
null O O
-RRB- O O
. O O

However B-conn Contrast
, O O
there O O
was O O
no O O
difference O O
in O O
the O O
MFI O O
of O O
CD69 O O
expression O O
WT O O
responding O O
T O O
cells O O
vs. O O
ITK O O
null O O
responding O O
T O O
cells O O
-LRB- O O
362.5 O O
_+/- O O
6.3 O O
in O O
WT O O
vs. O O
375 O O
+/- O O
11.3 O O
in O O
ITK O O
null O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
there O O
was O O
no O O
difference O O
in O O
the O O
expression O O
of O O
CD25 O O
on O O
WT O O
or O O
ITK O O
null O O
T O O
cells O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Thus B-conn Cause.Claim
the O O
lack O O
of O O
SEB O O
induced O O
c-jun O O
phosphorylation O O
in O O
ITK O O
null O O
T O O
cells O O
seems O O
to O O
reflect O O
the O O
specific O O
role O O
of O O
ITK O O
in O O
regulating O O
this O O
event O O
in B-conn Temporal.Synchronous
response I-conn Temporal.Synchronous
to I-conn Temporal.Synchronous
SEB O O
exposure O O
in O O
vivo O O
. O O

Exposure O O
of O O
mice O O
to O O
SEB O O
and O O
LPS O O
results O O
in O O
toxicity O O
culminating O O
in O O
death O O
-LSB-1 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
analyzed O O
the O O
effect O O
of O O
exposure O O
to O O
SEB/LPS O O
on O O
ITK O O
null O O
mice O O
. O O

However B-conn Concession.Contra-expectation
, O O
in O O
contrast O O
to O O
the O O
results O O
with O O
IL-2 O O
secretion O O
and O O
T O O
cell O O
expansion O O
, O O
both O O
mice O O
were O O
affected O O
similarly O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

Thus B-conn Restatement.Specification
the O O
same O O
proportion O O
of O O
mice O O
became O O
sick O O
following B-conn Temporal.Succession
exposure O O
to O O
SEB O O
and O O
LPS O O
, O O
suggesting O O
that O O
although B-conn Concession.Expectation
the O O
absence O O
of O O
ITK O O
affects O O
IL-2 O O
secretion O O
following B-conn Temporal.Succession
SEB O O
exposure O O
, O O
its O O
absence O O
does O O
not O O
affect O O
the O O
ability O O
of O O
SEB O O
to O O
induce O O
sickness O O
in O O
these O O
mice O O
. O O

Discussion O O

It O O
is O O
well O O
established O O
that O O
exposure O O
to O O
SEB O O
results O O
in O O
large O O
scale O O
cytokine O O
production O O
, O O
which O O
in O O
part O O
is O O
responsible O O
for O O
symptoms O O
of O O
exposure O O
to O O
this O O
toxin O O
-LSB-1,2,35 O O
-RSB- O O
. O O

T O O
cells O O
have O O
been O O
shown O O
to O O
be O O
largely O O
responsible O O
for O O
this O O
excessive O O
cytokine O O
production O O
-LSB-35,36 O O
-RSB- O O
. O O

Current O O
suggestions O O
for O O
pharmacologically O O
blocking O O
the O O
symptoms O O
of O O
SEB O O
exposure O O
include O O
T O O
cell O O
signal O O
transduction O O
inhibitors O O
such O O
as O O
CsA O O
and O O
Perfenidone O O
, O O
however B-conn Concession.Contra-expectation
, O O
these O O
agents O O
have O O
significant O O
side O O
effects O O
-LSB-37,38 O O
-RSB- O O
. O O

Here O O
we O O
present O O
a O O
promising O O
target O O
for O O
inhibition O O
IL-2 O O
production O O
induced O O
by O O
SEB O O
exposure O O
, O O
the O O
tyrosine O O
kinase O O
ITK O O
. O O

We O O
show O O
that O O
mice O O
lacking O O
ITK O O
have O O
significantly O O
reduced O O
T O O
cell O O
expansion O O
and O O
IL-2 O O
secretion O O
upon B-conn Temporal.Synchronous
exposure O O
to O O
SEB O O
in O O
vivo O O
. O O

Furthermore B-conn Conjunction
, O O
we O O
show O O
that O O
the O O
SEB O O
induced O O
signaling O O
pathway O O
leading O O
to O O
c-jun O O
phosphorylation O O
, O O
an O O
indication O O
of O O
JNK O O
pathway O O
activation O O
, O O
is O O
significantly O O
reduced O O
in O O
ITK O O
null O O
T O O
cells O O
, O O
although B-conn Concession.Contra-expectation
these O O
T O O
cells O O
could O O
respond O O
to O O
SEB O O
activation O O
by B-conn Purpose.Enablement
upregulating O O
CD69 O O
, O O
and B-conn Conjunction
there O O
was O O
no O O
difference O O
in O O
the O O
overall O O
toxicity O O
of O O
SEB/LPS O O
in O O
these O O
mice O O
compared O O
to O O
WT O O
mice O O
. O O

Previous O O
work O O
performed O O
in O O
vitro O O
suggests O O
that O O
ITK O O
is O O
required O O
for O O
the O O
anti-TcR/CD3 O O
antibody O O
mediated O O
activation O O
of O O
the O O
transcription O O
factor O O
NFAT O O
, O O
via B-conn Purpose.Enablement
regulation O O
of O O
calcium O O
influx O O
into O O
TcR O O
stimulated O O
T O O
cells O O
-LSB-19,39 O O
-RSB- O O
. O O

ITK O O
null O O
T O O
cells O O
also B-conn Conjunction
exhibit O O
reduced O O
AP-1 O O
DNA O O
binding O O
activity O O
when B-conn Temporal.Synchronous
stimulated O O
in O O
vitro O O
with O O
anti-CD3 O O
antibodies O O
-LSB-19 O O
-RSB- O O
. O O

It O O
has O O
also B-conn Conjunction
been O O
shown O O
that O O
JNK O O
activation O O
lies O O
in O O
part O O
downstream O O
of O O
ITK O O
following O O
TcR O O
crosslinking O O
in O O
vitro O O
-LSB-23 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
these O O
experiments O O
were O O
performed O O
in O O
vitro O O
and B-conn Conjunction
it O O
is O O
not O O
clear O O
that O O
effects O O
seen O O
in O O
vitro O O
would O O
reflect O O
what O O
happens O O
in O O
vivo O O
, O O
since B-conn Cause.Justification
other O O
cell-cell O O
interactions O O
may O O
allow O O
for O O
activation O O
of O O
pathways O O
that O O
are O O
not O O
seen O O
using O O
in O O
vitro O O
activation O O
with O O
antibodies O O
. O O

Our O O
data O O
however B-conn Contrast
, O O
suggest O O
that O O
indeed O O
, O O
ITK O O
lies O O
downstream O O
of O O
the O O
TcR O O
and O O
is O O
required O O
for O O
IL-2 O O
secretion O O
and O O
c-jun O O
phosphorylation O O
in O O
vivo O O
. O O

Corroborating O O
a O O
role O O
for O O
c-jun O O
activation O O
in O O
IL-2 O O
production O O
, O O
mice O O
carrying O O
a O O
dominant O O
negative O O
c-jun O O
have O O
much O O
reduced O O
IL-2 O O
secretion O O
in O O
vitro O O
-LSB-28 O O
-RSB- O O
-LRB- O O
mice O O
lacking O O
c-jun O O
die O O
during O O
embryogenesis O O
-LSB-40 O O
-RSB- O O
-RRB- O O
. O O

Similarly O O
, O O
JNK O O
has O O
been O O
implicated O O
in O O
IL-2 O O
secretion O O
by O O
T O O
cells O O
in O O
vitro O O
-LSB-25-27 O O
-RSB- O O
. O O

Our O O
data O O
lend O O
support O O
to O O
this O O
idea O O
that O O
the O O
JNK-c-jun O O
pathway O O
is O O
involved O O
in O O
the O O
production O O
of O O
IL-2 O O
by O O
T O O
cells O O
in O O
vivo O O
. O O

Curiously O O
, O O
the O O
immunosuppresant O O
CsA O O
has O O
been O O
shown O O
to O O
inhibit O O
the O O
effects O O
of O O
SEB O O
exposure O O
in O O
mice O O
if B-conn Condition.Hypothetical
delivered O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
SEB O O
exposure O O
-LSB-36 O O
-RSB- O O
, O O
however B-conn Concession.Contra-expectation
it O O
does O O
not O O
inhibit O O
SEB O O
induced O O
effects O O
in O O
monkeys O O
if B-conn Condition.Hypothetical
delivered O O
at O O
the O O
same O O
time O O
as O O
SEB O O
-LSB-38 O O
-RSB- O O
. O O

The O O
effects O O
of O O
CsA O O
on O O
SEB O O
induced O O
symptoms O O
has O O
been O O
suggested O O
to O O
be O O
due B-conn Cause.Reason
to I-conn Cause.Reason
its O O
effects O O
on O O
inhibiting O O
IL-2 O O
and O O
other O O
cytokine O O
production O O
due B-conn Cause.Reason
to I-conn Cause.Reason
inhibition O O
of O O
activation O O
of O O
the O O
transcription O O
factor O O
NFAT O O
-LSB-36,41 O O
-RSB- O O
, O O
however B-conn Concession.Contra-expectation
, O O
CsA O O
also O O
inhibits O O
activation O O
of O O
the O O
JNK O O
pathway O O
following B-conn Temporal.Succession
TcR/CD3 O O
and O O
CD28 O O
stimulation O O
-LSB-29,30 O O
-RSB- O O
, O O
and B-conn Continuation
so B-conn Cause.Result
CsA O O
pretreatment O O
may O O
act O O
to O O
prevent O O
early O O
T O O
cell O O
activation O O
of O O
these O O
pathways O O
, O O
thus B-conn Cause.Result
blocking O O
cytokine O O
production O O
and O O
protecting O O
mice O O
from O O
the O O
effects O O
of O O
subsequent O O
SEB O O
exposure O O
. O O

Mice O O
lacking O O
ITK O O
exhibit O O
reduced O O
T O O
cell O O
responses O O
in O O
vitro O O
, O O
but O O
also B-conn Conjunction
have O O
reduced O O
percentages O O
of O O
CD4+ O O
T O O
cells O O
-LRB- O O
approximately O O
60–70 O O
% O O
of O O
WT O O
, O O
-LSB-16 O O
-RSB- O O
-RRB- O O
. O O

While B-conn Concession.Expectation
this O O
would O O
be O O
expected O O
to O O
reduced O O
the O O
overall O O
T O O
cell O O
response O O
in O O
vivo O O
to O O
SEB O O
exposure O O
, O O
if B-conn Condition.Hypothetical
these O O
cells O O
were O O
able O O
to O O
respond O O
to O O
SEB O O
, O O
we O O
would O O
expect O O
an O O
equivalent O O
reduction O O
in O O
the O O
amount O O
of O O
IL-2 O O
secreted O O
in O O
vivo O O
in O O
response O O
to O O
SEB O O
. O O

We O O
would O O
also B-conn Conjunction
expect O O
to O O
see O O
an O O
equivalent O O
reduction O O
in O O
proliferation O O
in O O
vitro O O
. O O

However B-conn Concession.Contra-expectation
, O O
in O O
vivo O O
, O O
we O O
observed O O
much O O
reduced O O
IL-2 O O
secretion O O
, O O
and O O
reduced O O
expansion O O
of O O
Vβ8+CD4+ O O
T O O
cells O O
, O O
although B-conn Concession.Contra-expectation
this O O
was O O
not O O
as O O
dramatic O O
as O O
the O O
reduction O O
in O O
IL-2 O O
secretion O O
. O O

Indeed B-conn Reinforcement
, O O
it O O
has O O
been O O
observed O O
that O O
SEB O O
induced O O
T O O
cell O O
expansion O O
in O O
IL-2 O O
null O O
mice O O
, O O
indicating O O
that O O
IL-2 O O
is O O
not O O
necessary O O
for O O
expansion O O
of O O
T O O
cells O O
in O O
vivo O O
following O O
SEB O O
exposure O O
. O O

However B-conn Concession.Contra-expectation
, O O
even O O
with O O
the O O
reduced O O
T O O
cell O O
responses O O
observed O O
in O O
ITK O O
null O O
mice O O
, O O
they O O
still O O
suffer O O
from O O
SEB/LPS O O
induced O O
toxicity O O
similar O O
to O O
that O O
seen O O
in O O
the O O
WT O O
mice O O
. O O

It O O
should O O
be O O
noted O O
however B-conn Concession.Contra-expectation
, O O
that O O
C57BL/6 O O
mice O O
are O O
much O O
less O O
sensitive O O
to O O
SEB O O
induce O O
lethal O O
shock O O
than O O
Balb/c O O
mice O O
-LSB-34 O O
-RSB- O O
. O O

Thus B-conn Cause.Result
we O O
observed O O
very O O
few O O
deaths O O
in O O
our O O
experiments O O
, O O
and B-conn Cause.Claim
ITK O O
may O O
protect O O
Balb/c O O
mice O O
from O O
actual O O
death O O
. O O

We O O
are O O
currently O O
crossing O O
these O O
mice O O
onto O O
the O O
Balb/c O O
background O O
to B-conn Purpose.Goal
determine O O
if O O
this O O
is O O
the O O
case O O
. O O

Conclusion O O

In O O
conclusion O O
, O O
we O O
have O O
show O O
that O O
ITK O O
is O O
required O O
for O O
IL-2 O O
production O O
induced O O
by O O
SEB O O
in O O
vivo O O
and O O
in O O
vitro O O
. O O

We O O
have O O
also B-conn Conjunction
shown O O
that O O
ITK O O
may O O
regulate O O
signals O O
leading O O
IL-2 O O
production O O
in B-conn Purpose.Enablement
part I-conn Purpose.Enablement
by I-conn Purpose.Enablement
regulating O O
phosphorylation O O
of O O
c-jun O O
. O O

However B-conn Concession.Contra-expectation
, O O
mice O O
lacking O O
ITK O O
exhibit O O
similar O O
responses O O
to O O
SEB O O
toxicity O O
. O O

The O O
data O O
suggest O O
that O O
the O O
inability O O
of O O
T O O
cell O O
lacking O O
ITK O O
to O O
produce O O
IL-2 O O
cannot O O
be O O
overcome O O
by B-conn Purpose.Enablement
SAG O O
stimulation O O
, O O
and B-conn Conjunction
that O O
perturbing O O
T O O
cell O O
activation O O
pathways O O
leading O O
to O O
IL-2 O O
production O O
does O O
not O O
necessarily O O
lead O O
to O O
improved O O
responses O O
to O O
SEB O O
toxicity O O
. O O

Methods O O

Wild O O
type O O
mice O O
and O O
ITK-deficient O O
mice O O
-LRB- O O
C57BL/6 O O
background O O
, O O
-LSB-16 O O
-RSB- O O
-RRB- O O
between O O
8 O O
and O O
10 O O
weeks O O
were O O
used O O
in O O
all O O
experiments O O
. O O

RAG1-/- O O
mice O O
were O O
a O O
kind O O
gift O O
of O O
Dr. O O
Eric O O
Harvill O O
-LRB- O O
Penn O O
State O O
University O O
-RRB- O O
and O O
were O O
similarly O O
used O O
between O O
6–10 O O
weeks O O
of O O
age O O
. O O

The O O
Institutional O O
Animal O O
Care O O
and O O
Use O O
Committee O O
of O O
The O O
Pennsylvania O O
State O O
University O O
approved O O
all O O
experiments O O
. O O

WT O O
and O O
ITK O O
deficient O O
mice O O
were O O
injected O O
intraperitoneally O O
-LRB- O O
i.p. O O
-RRB- O O
with O O
50 O O
μg O O
SEB O O
in O O
PBS O O
-LRB- O O
Sigma-Aldrich O O
, O O
St. O O
Louis O O
, O O
MO O O
-RRB- O O
and O O
after O O
2 O O
days O O
, O O
were O O
sacrificed O O
and B-conn Conjunction
splenocytes O O
stained O O
with O O
antibodies O O
specific O O
for O O
Vβ8 O O
-LRB- O O
SEB O O
reactive O O
T O O
cells O O
-RRB- O O
or O O
Vβ6 O O
-LRB- O O
non-reactive O O
T O O
cells O O
-RRB- O O
and B-conn Conjunction
CD4 O O
directly O O
conjugated O O
to O O
FITC O O
and O O
PE O O
respectively O O
-LRB- O O
BDPharmingen O O
, O O
San O O
Diego O O
, O O
CA O O
-RRB- O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
mice O O
were O O
injected O O
i.p. O O
with O O
50 O O
μg O O
SEB O O
and O O
eye-bled O O
every O O
2 O O
days O O
for O O
5 O O
days O O
. O O

Following B-conn Temporal.Succession
lysis O O
of O O
red O O
blood O O
cells O O
, O O
the O O
remaining O O
cells O O
were O O
stained O O
as O O
described O O
above O O
for O O
the O O
splenocytes O O
. O O

Lymphocytes O O
were O O
identified O O
by O O
flow O O
cytometry O O
by O O
their O O
forward O O
and O O
side O O
scatter O O
characteristics O O
. O O

We O O
used O O
a O O
protocol O O
reported O O
by O O
Zell O O
et O O
al O O
to O O
determine O O
the O O
phosphorylation O O
status O O
of O O
c-jun O O
, O O
as O O
a O O
measure O O
of O O
activation O O
of O O
the O O
JNK-c-jun O O
pathway O O
in O O
SEB O O
responding O O
T O O
cells O O
. O O

WT O O
and O O
ITK O O
deficient O O
mice O O
were O O
injected O O
i.p. O O
or O O
intravenously O O
-LRB- O O
i.v. O O
-RRB- O O
with O O
50 O O
μg O O
SEB O O
and O O
allowed O O
to O O
survive O O
for O O
an O O
1 O O
hr O O
. O O

Similar O O
results O O
were O O
found O O
with O O
both O O
routes O O
of O O
administration O O
. O O

Animals O O
were O O
sacrificed O O
and B-conn Conjunction
spleens O O
, O O
lymph O O
nodes O O
, O O
and O O
blood O O
rapidly O O
isolated O O
, O O
and O O
dounced O O
in O O
2 O O
% O O
paraformaldehyde O O
to B-conn Purpose.Goal
rapidly O O
fix O O
the O O
cells O O
as O O
previously O O
described O O
-LSB-30 O O
-RSB- O O
. O O

Cells O O
were O O
stained O O
with O O
antibodies O O
to O O
Vβ8 O O
or O O
Vβ6 O O
directly O O
conjugated O O
to O O
PE O O
-LRB- O O
BDPharmingen O O
, O O
San O O
Diego O O
, O O
CA O O
-RRB- O O
, O O
then B-conn Temporal.Precedence
permeabilized O O
with O O
saponin O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
stained O O
for O O
intracellular O O
phosphorylated-c-jun O O
with O O
a O O
monoclonal O O
antibody O O
against O O
phosphorylated O O
c-jun O O
-LRB- O O
IgG1 O O
, O O
Cell O O
Signaling O O
, O O
Beverly O O
, O O
MA O O
-RRB- O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
biotinylated O O
rabbit O O
anti-mouse O O
IgG1 O O
and O O
streptavidin O O
conjugated O O
to O O
FITC O O
. O O

Controls O O
included O O
secondary O O
reagents O O
alone O O
. O O

Upregulation O O
of O O
CD69 O O
by O O
SEB O O
in O O
vivo O O
was O O
performed O O
using O O
similar O O
approaches O O
, O O
except B-conn Exception
that I-conn Exception
T O O
cells O O
were O O
not O O
fixed O O
or O O
permeabilized O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
staining O O
with O O
PE-conjugated O O
anti-CD69 O O
monoclonal O O
antibody O O
-LRB- O O
BDPharmingen O O
, O O
San O O
Diego O O
, O O
CA O O
-RRB- O O
. O O

This O O
was O O
followed O O
by O O
analysis O O
by O O
flow O O
cytometry O O
, O O
with O O
post O O
analysis O O
performed O O
using O O
the O O
WinMDI O O
program O O
2.8 O O
-LRB- O O
The O O
Scripps O O
Research O O
Institute O O
, O O
La O O
Jolla O O
, O O
CA O O
-RRB- O O
. O O

Lymph O O
nodes O O
and O O
spleens O O
were O O
isolated O O
from O O
WT O O
and O O
ITK O O
deficient O O
mice O O
and O O
pooled O O
. O O

Red O O
blood O O
cells O O
were O O
removed O O
using O O
ACK O O
lysis O O
buffer O O
, O O
and B-conn Conjunction
cells O O
resuspended O O
in O O
complete O O
RPMI O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
left O O
unstimulated O O
or O O
stimulated O O
with O O
varying O O
concentrations O O
of O O
SEB O O
-LRB- O O
5 O O
μg/ml O O
, O O
0.5 O O
μg/ml O O
, O O
0.05 O O
μg/ml O O
, O O
0.005 O O
μg/ml O O
, O O
and O O
0.0005 O O
μg/ml O O
-RRB- O O
at O O
a O O
concentration O O
of O O
2 O O
× O O
106 O O
cells/ml O O
. O O

These O O
cells O O
were O O
incubated O O
at O O
37°C O O
for O O
5 O O
days O O
and O O
pulsed O O
once O O
a O O
day O O
for O O
5 O O
days O O
with O O
0.5 O O
μCi O O
tritiated O O
thymidine O O
per O O
well O O
for O O
12 O O
hrs O O
. O O

before O O
harvest O O
. O O

T O O
cells O O
were O O
purified O O
from O O
WT O O
and O O
ITK O O
null O O
mice O O
using O O
MiniMACS O O
separation O O
columns O O
-LRB- O O
Miltenyi O O
Biotec O O
Inc O O
, O O
Auburn O O
, O O
CA O O
-RRB- O O
, O O
and O O
plated O O
at O O
2 O O
× O O
106 O O
cells/ml O O
and O O
stimulated O O
as O O
above O O
, O O
in O O
the O O
presence O O
of O O
splenocytes O O
from O O
RAG O O
null O O
mice O O
pre-treated O O
with O O
mitomycin O O
C. O O
All O O
experiments O O
were O O
done O O
in O O
triplicate O O
. O O

Pooled O O
lymphocytes O O
and O O
splenocytes O O
from O O
WT O O
and O O
ITK O O
deficient O O
mice O O
were O O
incubated O O
with O O
varying O O
concentrations O O
of O O
SEB O O
-LRB- O O
5 O O
μg/ml O O
, O O
0.5 O O
μg/ml O O
, O O
0.05 O O
μg/ml O O
, O O
0.005 O O
μg/ml O O
, O O
and O O
0.0005 O O
μg/ml O O
-RRB- O O
for O O
5 O O
days O O
as O O
described O O
above O O
for O O
in O O
vitro O O
proliferation O O
. O O

Supernatants O O
were O O
sampled O O
once O O
a O O
day O O
over O O
this O O
period O O
and O O
analyzed O O
for O O
IL-2 O O
using O O
ELISAs O O
according O O
to O O
the O O
manufacturer O O
's O O
recommendations O O
-LRB- O O
BDPharmingen O O
, O O
San O O
Diego O O
, O O
CA O O
-RRB- O O
. O O

WT O O
and O O
ITK O O
deficient O O
mice O O
were O O
injected O O
with O O
50 O O
μg O O
SEB O O
i.v. O O
, O O
and O O
serum O O
isolated O O
from O O
cardiac O O
blood O O
from O O
mice O O
1 O O
, O O
2 O O
, O O
4 O O
, O O
8 O O
, O O
12 O O
, O O
and O O
24 O O
hrs O O
. O O

post O O
SEB O O
exposure O O
and O O
used O O
to O O
perform O O
an O O
ELISA O O
to O O
determine O O
IL-2 O O
levels O O
. O O

PBS O O
injected O O
mice O O
served O O
as O O
controls O O
, O O
and B-conn Continuation
there O O
was O O
no O O
change O O
in O O
IL-2 O O
secretion O O
in O O
these O O
animals O O
. O O

Values O O
were O O
compared O O
using O O
student O O
's O O
t O O
test O O
and O O
considered O O
significant O O
if B-conn Condition.Hypothetical
p O O
< O O
0.05 O O
. O O

List O O
of O O
abbreviations O O
used O O

ITK O O
Interleukin-2 O O
inducible O O
T O O
cell O O
Kinase O O

IL-2 O O
Interleukin-2 O O

SEB O O
Staphylococcal O O
Enterotoxin O O
B O O

SAG O O
Superantigen O O

Th1 O O
T-helper O O
1 O O
cells O O

Th2 O O
T-helper O O
2 O O
cells O O

Syk O O
Spleen O O
tyrosine O O
kinase O O

Zap-70 O O
Zeta O O
chain O O
Associated O O
protein-70 O O

Lck O O
Lstra O O
cell O O
kinase O O

MAPK O O
Mitogen O O
Activated O O
Protein O O
Kinase O O

ERK O O
Extracellular O O
signal O O
Regulated O O
Kinase O O

JNK O O
c-jun O O
N-terminal O O
kinase O O

NK O O
Natural O O
Killer O O
cells O O

LCM O O
Lymphocytic O O
Choriomeningitis O O

VS O O
Vesicular O O
Stomatitis O O

PMA O O
Phorbol O O
Myristic O O
Acid O O

PBS O O
Phosphate O O
Buffered O O
Saline O O

NFAT O O
Nuclear O O
Factor O O
of O O
Activated O O
T O O
cells O O

AP-1 O O
Activator O O
protein O O
1 O O

CsA O O
Cyclosporin O O
A O O

Authors O O
' O O
contributions O O

AA O O
designed O O
the O O
experiments O O
. O O

MJR O O
and O O
JH O O
performed O O
experiments O O
leading O O
to O O
figure O O
1. O O
MJR O O
performed O O
experiments O O
leading O O
to O O
figures O O
2 O O
, O O
3 O O
, O O
4 O O
, O O
5 O O
, O O
6 O O
, O O
7. O O
AA O O
and O O
AJH O O
provided O O
financial O O
support O O
and O O
supervision O O
. O O

MJR O O
, O O
AJH O O
and O O
AA O O
wrote O O
the O O
manuscript O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
ITK O O
regulates O O
proliferation O O
in O O
vitro O O
in O O
response O O
to O O
SEB O O
. O O

Splenocytes O O
and O O
lymph O O
node O O
cells O O
from O O
WT O O
-LRB- O O
filled O O
circles O O
-RRB- O O
and O O
ITK O O
deficient O O
-LRB- O O
open O O
circles O O
-RRB- O O
mice O O
were O O
stimulated O O
in O O
vitro O O
with O O
the O O
indicated O O
concentrations O O
of O O
SEB O O
, O O
and B-conn Conjunction
proliferative O O
response O O
determined O O
. O O

Time O O
course O O
of O O
proliferation O O
over O O
the O O
indicated O O
doses O O
of O O
SEB O O
a O O
-RRB- O O
5 O O
μg/ml O O
SEB O O
, O O
b O O
-RRB- O O
dose O O
curve O O
of O O
0.0005 O O
, O O
0.005 O O
, O O
0.05 O O
, O O
0.5 O O
, O O
& O O
5 O O
μg/ml O O
SEB O O
analyzed O O
at O O
5 O O
days O O
post O O
stimulation O O
. O O

Purified O O
WT O O
-LRB- O O
filled O O
circles O O
-RRB- O O
and O O
ITK O O
deficient O O
-LRB- O O
open O O
circles O O
-RRB- O O
T O O
cells O O
were O O
stimulated O O
in O O
vitro O O
over O O
the O O
indicated O O
time O O
with O O
c O O
-RRB- O O
10 O O
μg/ml O O
SEB O O
, O O
or O O
a O O
dose O O
curve O O
of O O
0.01 O O
, O O
0.1 O O
, O O
1 O O
, O O
and O O
10 O O
μg/ml O O
SEB O O
and O O
analyzed O O
at O O
d O O
-RRB- O O
3 O O
days O O
, O O
e O O
-RRB- O O
4 O O
days O O
or O O
f O O
-RRB- O O
5 O O
days O O
post O O
stimulation O O
. O O

* O O
indicates O O
statistically O O
significant O O
difference O O
with O O
a O O
p O O
< O O
0.05 O O
. O O

Figure O O
2 O O
: O O
ITK O O
regulates O O
IL-2 O O
secretion O O
in O O
vitro O O
in O O
response O O
to O O
SEB O O
. O O

Splenocytes O O
and O O
lymph O O
node O O
cells O O
from O O
WT O O
-LRB- O O
filled O O
circles O O
-RRB- O O
or O O
ITK O O
deficient O O
-LRB- O O
open O O
circles O O
-RRB- O O
mice O O
were O O
stimulated O O
in O O
vitro O O
with O O
the O O
indicated O O
concentrations O O
of O O
SEB O O
and O O
IL-2 O O
levels O O
secreted O O
in O O
supernatants O O
determined O O
. O O

a O O
-RRB- O O
Time O O
course O O
of O O
IL-2 O O
secretion O O
at O O
5 O O
μg/ml O O
SEB O O
dose O O
. O O

b O O
-RRB- O O
IL-2 O O
secretion O O
over O O
the O O
indicated O O
times O O
and O O
doses O O
. O O

-LRB- O O
i O O
-RRB- O O
Day O O
1 O O
; O O
-LRB- O O
ii O O
-RRB- O O
Day O O
2 O O
; O O
-LRB- O O
iii O O
-RRB- O O
Day O O
3 O O
; O O
-LRB- O O
iv O O
-RRB- O O
Day O O
4 O O
and O O
-LRB- O O
v O O
-RRB- O O
Day O O
5. O O
* O O
indicates O O
statistically O O
significant O O
difference O O
with O O
a O O
p O O
< O O
0.05 O O
. O O

Figure O O
3 O O
: O O
Reduced O O
T O O
cell O O
expansion O O
in O O
response O O
to O O
SEB O O
exposure O O
in O O
vivo O O
. O O

a O O
-RRB- O O
WT O O
-LRB- O O
filled O O
circles O O
-RRB- O O
or O O
ITK O O
deficient O O
mice O O
-LRB- O O
open O O
circles O O
-RRB- O O
were O O
injected O O
with O O
50 O O
μg O O
SEB O O
i.p. O O
and O O
peripheral O O
blood O O
lymphocytes O O
analyzed O O
after O O
2 O O
, O O
4 O O
and O O
5 O O
days O O
as O O
in O O
the O O
materials O O
and O O
methods O O
for O O
the O O
percentage O O
of O O
Vβ8+CD4+ O O
T O O
cells O O
as O O
indicated O O
-LRB- O O
Vβ6+CD4+ O O
T O O
cells O O
showed O O
no O O
change O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

b O O
-RRB- O O
The O O
same O O
data O O
plotted O O
as O O
fold O O
increase O O
in O O
percentage O O
of O O
Vβ8+CD4+ O O
T O O
cells O O
in O O
peripheral O O
blood O O
. O O

* O O
indicates O O
a O O
statistically O O
significant O O
difference O O
with O O
a O O
p O O
< O O
0.05 O O
. O O

Figure O O
4 O O
: O O
ITK O O
null O O
mice O O
secrete O O
less O O
IL-2 O O
in B-conn Temporal.Synchronous
response I-conn Temporal.Synchronous
to I-conn Temporal.Synchronous
SEB O O
exposure O O
in O O
vivo O O
. O O

WT O O
-LRB- O O
filled O O
circles O O
-RRB- O O
and O O
ITK O O
deficient O O
-LRB- O O
open O O
circles O O
-RRB- O O
mice O O
were O O
injected O O
i.v. O O
with O O
50 O O
μg O O
SEB O O
and B-conn Conjunction
blood O O
sampled O O
after O O
1 O O
, O O
2 O O
, O O
4 O O
, O O
8 O O
, O O
12 O O
and O O
24 O O
hrs O O
. O O

post O O
injection O O
. O O

IL-2 O O
in O O
serum O O
was O O
determined O O
by O O
ELISA O O
. O O

Figure O O
5 O O
: O O
SEB O O
induces O O
activation O O
of O O
the O O
JNK O O
pathway O O
specifically O O
in O O
responding O O
T O O
cells O O
in O O
vivo O O
. O O

WT O O
mice O O
were O O
injected O O
with O O
50 O O
μg O O
SEB O O
or O O
PBS O O
i.v. O O
and O O
sacrificed O O
after O O
1 O O
hr O O
. O O

Spleen O O
and O O
lymph O O
nodes O O
were O O
harvested O O
and O O
analyzed O O
for O O
the O O
presence O O
of O O
phosphorylated O O
c-jun O O
in O O
the O O
Vβ8+ O O
and O O
Vβ6+ O O
T O O
cell O O
populations O O
. O O

a O O
-RRB- O O
Spleen O O
: O O
-LRB- O O
i O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ6+ O O
T O O
cells O O
from O O
PBS O O
injected O O
mice O O
. O O

-LRB- O O
ii O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ6+ O O
T O O
cells O O
from O O
SEB O O
injected O O
mice O O
. O O

-LRB- O O
iii O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ8+ O O
T O O
cells O O
from O O
the O O
same O O
PBS O O
injected O O
mice O O
in O O
-LRB- O O
i O O
-RRB- O O
. O O

-LRB- O O
iv O O
-RRB- O O
phosphorylation O O
c-jun O O
in O O
Vβ8+ O O
T O O
cells O O
from O O
the O O
same O O
SEB O O
injected O O
mice O O
in O O
-LRB- O O
ii O O
-RRB- O O
. O O

b O O
-RRB- O O
Lymph O O
Node O O
: O O
-LRB- O O
i O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ6+ O O
T O O
cells O O
from O O
PBS O O
injected O O
mice O O
. O O

-LRB- O O
ii O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ6+ O O
T O O
cells O O
from O O
SEB O O
injected O O
mice O O
. O O

-LRB- O O
iii O O
-RRB- O O
phosphorylation O O
of O O
c-jun O O
in O O
Vβ8+ O O
T O O
cells O O
from O O
the O O
same O O
PBS O O
injected O O
mice O O
in O O
-LRB- O O
i O O
-RRB- O O
. O O

-LRB- O O
iv O O
-RRB- O O
phosphorylation O O
c-jun O O
in O O
Vβ8+ O O
T O O
cells O O
from O O
the O O
same O O
SEB O O
injected O O
mice O O
in O O
-LRB- O O
ii O O
-RRB- O O
. O O

Arrow O O
points O O
to O O
the O O
population O O
of O O
cells O O
responding O O
to O O
SEB O O
stimulation O O
by B-conn Purpose.Enablement
activation O O
of O O
the O O
JNK O O
pathway O O
by B-conn Purpose.Enablement
inducing O O
c-jun O O
phosphorylation O O
. O O

Figure O O
6 O O
: O O
ITK O O
is O O
required O O
for O O
SEB O O
mediated O O
induction O O
of O O
c-jun O O
phosphorylation O O
in O O
responding O O
T O O
cells O O
in O O
vivo O O
. O O

WT O O
-LRB- O O
top O O
panels O O
-RRB- O O
or O O
ITK O O
null O O
-LRB- O O
bottom O O
panels O O
-RRB- O O
mice O O
were O O
injected O O
with O O
50 O O
μg O O
SEB O O
or O O
PBS O O
i.v. O O
and O O
sacrificed O O
after O O
1 O O
hr O O
. O O

Splenocytes O O
were O O
then B-conn Temporal.Precedence
analyzed O O
for O O
the O O
presence O O
of O O
phosphorylated O O
c-jun O O
in O O
the O O
Vβ8+ O O
and O O
Vβ6+ O O
T O O
cell O O
populations O O
. O O

a O O
-RRB- O O
Vβ6+ O O
T O O
cells O O
from O O
WT O O
mice O O
; O O
b O O
-RRB- O O
Vβ8+ O O
T O O
cells O O
from O O
WT O O
mice O O
; O O
c O O
-RRB- O O
Vβ6+ O O
T O O
cells O O
from O O
ITK O O
null O O
mice O O
; O O
d O O
-RRB- O O
Vβ8+ O O
T O O
cells O O
from O O
ITK O O
null O O
mice O O
. O O

Figure O O
7 O O
: O O
ITK O O
is O O
not O O
necessary O O
for O O
SEB O O
induced O O
upregulation O O
of O O
CD69 O O
inresponding O O
T O O
cells O O
in O O
vivo O O
. O O

WT O O
-LRB- O O
top O O
panels O O
-RRB- O O
or O O
ITK O O
null O O
-LRB- O O
bottom O O
panels O O
-RRB- O O
mice O O
were O O
injected O O
with O O
50 O O
μg O O
SEB O O
or O O
PBS O O
i.v. O O
and O O
sacrificed O O
after O O
2 O O
hrs O O
. O O

Splenocytes O O
were O O
then B-conn Temporal.Precedence
analyzed O O
for O O
the O O
presence O O
of O O
CD69 O O
on O O
the O O
Vβ8+ O O
and O O
Vβ6+ O O
T O O
cell O O
populations O O
. O O

a O O
-RRB- O O
Vβ6+ O O
T O O
cells O O
from O O
WT O O
mice O O
; O O
b O O
-RRB- O O
Vβ8+ O O
T O O
cells O O
from O O
WT O O
mice O O
; O O
c O O
-RRB- O O
Vβ6+ O O
T O O
cells O O
from O O
ITK O O
null O O
mice O O
; O O
d O O
-RRB- O O
Vβ8+ O O
T O O
cells O O
from O O
ITK O O
null O O
mice O O
. O O

Table O O
1 O O
: O O
Effect O O
of O O
SEB O O
on O O
health O O
and O O
survival O O
of O O
WT O O
and O O
ITK O O
null O O
mice O O
. O O

Mice O O
-LRB- O O
WT O O
or O O
ITK O O
null O O
-RRB- O O
were O O
injected O O
with O O
the O O
indicated O O
amount O O
of O O
LPS O O
, O O
followed B-conn Temporal.Precedence
4 I-conn Temporal.Precedence
hours I-conn Temporal.Precedence
later I-conn Temporal.Precedence
by I-conn Temporal.Precedence
50 O O
μg O O
SEB O O
, O O
both O O
delivered O O
Ip O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
mice O O
were O O
injected O O
with O O
20 O O
mg O O
. O O

D-Gal O O
and O O
50 O O
μg O O
SEB O O
at O O
the O O
same O O
time O O
. O O

All O O
injections O O
were O O
delivered O O
intraperitoneally O O
. O O

Mice O O
were O O
then B-conn Temporal.Precedence
monitored O O
for O O
the O O
presence O O
of O O
ruffled O O
fur O O
, O O
mucous O O
in O O
feces O O
and O O
lethargy O O
. O O

* O O
mice O O
had O O
ruffled O O
fur O O
, O O
mucous O O
in O O
feces O O
and O O
were O O
lethargic O O
. O O

** O O
mouse O O
died O O
over O O
the O O
course O O
of O O
the O O
experiment O O
. O O

*** O O
mouse O O
had O O
to O O
be O O
euthanized O O
due B-conn Cause.Reason
to I-conn Cause.Reason
severity O O
of O O
sickness O O
. O O

Haploinsufficiency O O
for O O
BRCA1 O O
is O O
associated O O
with O O
normal O O
levels O O
of O O
DNA O O
nucleotide O O
excision O O
repair O O
in O O
breast O O
tissue O O
and O O
blood O O
lymphocytes O O

Abstract O O

Background O O
: O O
Screening O O
mammography O O
has O O
had O O
a O O
positive O O
impact O O
on O O
breast O O
cancer O O
mortality O O
but O O
cannot O O
detect O O
all O O
breast O O
tumors O O
. O O

In O O
a O O
small O O
study O O
, O O
we O O
confirmed O O
that O O
low O O
power O O
magnetic O O
resonance O O
imaging O O
-LRB- O O
MRI O O
-RRB- O O
could O O
identify O O
mammographically O O
undetectable O O
tumors O O
by B-conn Purpose.Enablement
applying O O
it O O
to O O
a O O
high O O
risk O O
population O O
. O O

Tumors O O
detected O O
by O O
this O O
new O O
technology O O
could O O
have O O
unique O O
etiologies O O
and/or O O
presentations O O
, O O
and O O
may O O
represent O O
an O O
increasing O O
proportion O O
of O O
clinical O O
practice O O
as B-conn Temporal.Synchronous
new O O
screening O O
methods O O
are O O
validated O O
and O O
applied O O
. O O

A O O
very O O
important O O
aspect O O
of O O
this O O
etiology O O
is O O
genomic O O
instability O O
, O O
which O O
is O O
associated O O
with O O
the O O
loss O O
of O O
activity O O
of O O
the O O
breast O O
cancer-predisposing O O
genes O O
BRCA1 O O
and O O
BRCA2 O O
. O O

In O O
sporadic O O
breast O O
cancer O O
, O O
however B-conn Concession.Contra-expectation
, O O
there O O
is O O
evidence O O
for O O
the O O
involvement O O
of O O
a O O
different O O
pathway O O
of O O
DNA O O
repair O O
, O O
nucleotide O O
excision O O
repair O O
-LRB- O O
NER O O
-RRB- O O
, O O
which O O
remediates O O
lesions O O
that O O
cause O O
a O O
distortion O O
of O O
the O O
DNA O O
helix O O
, O O
including O O
DNA O O
cross-links O O
. O O

Case O O
presentation O O
: O O
We O O
describe O O
a O O
breast O O
cancer O O
patient O O
with O O
a O O
mammographically O O
undetectable O O
stage O O
I O O
tumor O O
identified O O
in O O
our O O
MRI O O
screening O O
study O O
. O O

She O O
was O O
originally O O
considered O O
to O O
be O O
at O O
high O O
risk O O
due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
familial O O
occurrence O O
of O O
breast O O
and O O
other O O
types O O
of O O
cancer O O
, O O
and O O
after B-conn Temporal.Succession
diagnosis O O
was O O
confirmed O O
as O O
a O O
carrier O O
of O O
a O O
Q1200X O O
mutation O O
in O O
the O O
BRCA1 O O
gene O O
. O O

In O O
vitro O O
analysis O O
of O O
her O O
normal O O
breast O O
tissue O O
showed O O
no O O
differences O O
in O O
growth O O
rate O O
or O O
differentiation O O
potential O O
from O O
disease-free O O
controls O O
. O O

Analysis O O
of O O
cultured O O
blood O O
lymphocyte O O
and O O
breast O O
epithelial O O
cell O O
samples O O
with O O
the O O
unscheduled O O
DNA O O
synthesis O O
-LRB- O O
UDS O O
-RRB- O O
assay O O
revealed O O
no O O
deficiency O O
in O O
NER O O
. O O

Conclusion O O
: O O
As B-conn Temporal.Synchronous
new O O
breast O O
cancer O O
screening O O
methods O O
become O O
available O O
and O O
cost O O
effective O O
, O O
patients O O
such O O
as O O
this O O
one O O
will O O
constitute O O
an O O
increasing O O
proportion O O
of O O
the O O
incident O O
population O O
, O O
so B-conn Cause.Claim
it O O
is O O
important O O
to O O
determine O O
whether O O
they O O
differ O O
from O O
current O O
patients O O
in O O
any O O
clinically O O
important O O
ways O O
. O O

Despite B-conn Concession.Expectation
her O O
status O O
as O O
a O O
BRCA1 O O
mutation O O
carrier O O
, O O
and O O
her O O
mammographically O O
dense O O
breast O O
tissue O O
, O O
we O O
did O O
not O O
find O O
increased O O
cell O O
proliferation O O
or O O
deficient O O
differentiation O O
potential O O
in O O
breast O O
epithelial O O
cells O O
from O O
this O O
patient O O
which O O
might O O
have O O
contributed O O
to O O
her O O
cancer O O
susceptibility O O
. O O

Although B-conn Concession.Expectation
NER O O
deficiency O O
has O O
been O O
demonstrated O O
repeatedly O O
in O O
blood O O
samples O O
from O O
sporadic O O
breast O O
cancer O O
patients O O
, O O
analysis O O
of O O
blood O O
cultured O O
lymphocytes O O
and O O
breast O O
epithelial O O
cells O O
for O O
this O O
patient O O
proves O O
definitively O O
that O O
heterozygosity O O
for O O
inactivation O O
of O O
BRCA1 O O
does O O
not O O
intrinsically O O
confer O O
this O O
type O O
of O O
genetic O O
instability O O
. O O

These O O
data O O
suggest O O
that O O
the O O
mechanism O O
of O O
genomic O O
instability O O
driving O O
the O O
carcinogenic O O
process O O
may O O
be O O
fundamentally O O
different O O
in O O
hereditary O O
and O O
sporadic O O
breast O O
cancer O O
, O O
resulting O O
in O O
different O O
genotoxic O O
susceptibilities O O
, O O
oncogene O O
mutations O O
, O O
and O O
a O O
different O O
molecular O O
pathogenesis O O
. O O

Background O O

A O O
reduction O O
in O O
breast O O
cancer O O
mortality O O
has O O
been O O
observed O O
in O O
recent O O
years O O
that O O
has O O
been O O
partially O O
attributed O O
to O O
the O O
widespread O O
adoption O O
of O O
screening O O
mammography O O
-LSB-1 O O
-RSB- O O
. O O

Traditional O O
screening O O
mammography O O
, O O
however B-conn Concession.Contra-expectation
, O O
fails O O
to O O
detect O O
15 O O
% O O
of O O
incident O O
cancers O O
-LSB-2 O O
-RSB- O O
. O O

New O O
, O O
complementary O O
imaging O O
techniques O O
are O O
therefore B-conn Cause.Result
under O O
development O O
that O O
may O O
increase O O
the O O
accuracy O O
of O O
primary O O
screening O O
. O O

We O O
performed O O
a O O
small O O
study O O
to O O
validate O O
the O O
use O O
of O O
low O O
power O O
magnetic O O
resonance O O
imaging O O
-LRB- O O
MRI O O
-RRB- O O
to O O
prospectively O O
detect O O
breast O O
alterations O O
and O O
malignancy O O
and O O
to O O
determine O O
the O O
feasibility O O
of O O
applying O O
this O O
technique O O
to O O
a O O
high-risk O O
population O O
-LSB-3 O O
-RSB- O O
. O O

We O O
present O O
here O O
a O O
subject O O
from O O
that O O
study O O
whose O O
early O O
stage O O
tumor O O
was O O
not O O
detectable O O
by O O
mammography O O
. O O

This O O
patient O O
was O O
enrolled O O
in O O
the O O
screening O O
study O O
due B-conn Cause.Reason
to I-conn Cause.Reason
her O O
family O O
history O O
of O O
breast O O
and O O
other O O
neoplasias O O
. O O

After B-conn Temporal.Succession
tumor O O
diagnosis O O
, O O
she O O
was O O
determined O O
to O O
be O O
heterozygous O O
for O O
a O O
putative O O
inactivating O O
mutation O O
in O O
the O O
BRCA1 O O
gene O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
she O O
had O O
dense O O
breast O O
tissue O O
, O O
an O O
impediment O O
to O O
mammography O O
that O O
is O O
in O O
itself O O
a O O
risk O O
factor O O
for O O
breast O O
cancer O O
-LSB-4 O O
-RSB- O O
. O O

Breast O O
development O O
and O O
lactational O O
differentiation O O
also O O
appear O O
to O O
individually O O
modify O O
breast O O
cancer O O
risk O O
, O O
with O O
early O O
term O O
pregnancy O O
conferring O O
a O O
persistent O O
protective O O
effect O O
-LSB-5 O O
-RSB- O O
. O O

Exposure O O
to O O
ionizing O O
radiation O O
, O O
while B-conn Concession.Expectation
a O O
lifetime O O
risk O O
factor O O
for O O
breast O O
cancer O O
, O O
appears O O
to O O
be O O
more O O
dangerous O O
when B-conn Temporal.Synchronous
it O O
occurs O O
during O O
alveolar O O
differentiation O O
of O O
the O O
breast O O
at O O
adolescence O O
-LSB-6 O O
-RSB- O O
. O O

Using O O
a O O
novel O O
tissue O O
engineering O O
system O O
-LSB-7 O O
-RSB- O O
, O O
we O O
therefore B-conn Cause.Result
examined O O
the O O
growth O O
and O O
differentiation O O
of O O
normal O O
breast O O
epithelial O O
samples O O
from O O
this O O
patient O O
via O O
live-cell O O
imaging O O
. O O

The O O
BRCA1 O O
hereditary O O
breast O O
cancer O O
gene O O
has O O
been O O
shown O O
to O O
be O O
involved O O
in O O
DNA O O
double O O
strand O O
break O O
repair O O
-LSB-8,9 O O
-RSB- O O
. O O

DNA O O
repair O O
defects O O
have O O
also B-conn Conjunction
been O O
identified O O
in O O
the O O
peripheral O O
blood O O
cells O O
of O O
sporadic O O
breast O O
cancer O O
patients O O
-LSB-10-13 O O
-RSB- O O
, O O
but B-conn Concession.Contra-expectation
, O O
in O O
this O O
case O O
, O O
it O O
seems O O
to O O
involve O O
a O O
different O O
pathway O O
of O O
DNA O O
repair O O
, O O
nucleotide O O
excision O O
repair O O
-LRB- O O
NER O O
-RRB- O O
-LSB-14-16 O O
-RSB- O O
. O O

We O O
have O O
extended O O
this O O
observation O O
of O O
NER O O
deficiency O O
to O O
the O O
tumor O O
itself O O
, O O
as O O
well O O
as O O
the O O
adjoining O O
non-diseased O O
normal O O
breast O O
tissue O O
-LSB-17 O O
-RSB- O O
. O O

NER O O
is O O
a O O
complex O O
pathway O O
of O O
DNA O O
repair O O
-LSB-18 O O
-RSB- O O
normally O O
associated O O
with O O
removal O O
of O O
pyrimidine-pyrimidine O O
intrastrand O O
crosslinks O O
-LRB- O O
“dimers O O
'' O O
-RRB- O O
caused O O
by O O
exposure O O
to O O
UV O O
light O O
. O O

NER O O
deficiency O O
is O O
the O O
basis O O
of O O
hereditary O O
xeroderma O O
pigmentosum O O
-LRB- O O
XP O O
-RRB- O O
-LSB-19 O O
-RSB- O O
, O O
a O O
disease O O
with O O
a O O
1200-fold O O
increase O O
in O O
incidence O O
of O O
skin O O
cancer O O
-LSB-20 O O
-RSB- O O
. O O

The O O
signal O O
for O O
activation O O
of O O
the O O
NER O O
pathway O O
is O O
actually O O
very O O
general O O
; O O
any O O
lesion O O
causing O O
a O O
distortion O O
in O O
the O O
DNA O O
helix O O
, O O
including O O
crosslinks O O
caused O O
by O O
oxidative O O
radicals O O
, O O
certain O O
types O O
of O O
mismatches O O
-LRB- O O
purine-purine O O
or O O
pyrimidine-pyrimidine O O
-RRB- O O
and O O
so O O
called O O
“bulky O O
'' O O
adducts O O
caused O O
by O O
phase O O
I O O
metabolism O O
of O O
polyaromatic O O
hydrocarbons O O
-LSB-21 O O
-RSB- O O
. O O

It O O
has O O
recently O O
been O O
shown O O
that O O
BRCA1 O O
expression O O
can O O
enhance O O
NER O O
activity O O
, O O
although B-conn Concession.Contra-expectation
this O O
analysis O O
was O O
not O O
performed O O
in O O
breast O O
cells O O
-LSB-22,23 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
applied O O
the O O
functional O O
unscheduled O O
DNA O O
synthesis O O
-LRB- O O
UDS O O
-RRB- O O
assay O O
for O O
NER O O
capacity O O
to O O
multiple O O
samples O O
of O O
normal O O
tissue O O
from O O
this O O
patient O O
, O O
to B-conn Purpose.Goal
determine O O
whether O O
haploinsufficiency O O
for O O
BRCA1 O O
was O O
a O O
mechanism O O
of O O
NER O O
deficiency O O
. O O

We O O
have O O
developed O O
a O O
method O O
to O O
reliably O O
culture O O
non-diseased O O
breast O O
tissue O O
-LRB- O O
with O O
a O O
success O O
rate O O
of O O
100 O O
% O O
-RRB- O O
and O O
breast O O
tumors O O
-LRB- O O
with O O
a O O
success O O
rate O O
of O O
85 O O
% O O
-RRB- O O
-LSB-7,17 O O
-RSB- O O
. O O

Case O O
presentation O O

We O O
describe O O
a O O
breast O O
cancer O O
patient O O
whose O O
tumor O O
was O O
detected O O
by O O
MRI O O
. O O

She O O
was O O
enrolled O O
into O O
a O O
pilot O O
screening O O
study O O
of O O
low O O
power O O
MRI O O
due B-conn Cause.Reason
to I-conn Cause.Reason
her O O
familial O O
risk O O
. O O

She O O
had O O
mammographically O O
dense O O
breasts O O
and B-conn Conjunction
her O O
tumor O O
was O O
undetectable O O
mammographically O O
. O O

The O O
patient O O
was O O
a O O
35.7 O O
year O O
old O O
woman O O
who O O
presented O O
with O O
a O O
very O O
strong O O
family O O
history O O
of O O
breast O O
cancer O O
as O O
depicted O O
in O O
Figure O O
1 O O
, O O
and O O
negative O O
physical O O
and O O
mammographic O O
examination O O
. O O

She O O
had O O
extremely O O
dense O O
breast O O
tissue O O
bilaterally O O
by O O
mammography O O
as O O
well O O
as O O
fibrocystic O O
breast O O
tissue O O
by O O
physical O O
examination O O
. O O

She O O
had O O
no O O
previous O O
personal O O
history O O
of O O
breast O O
biopsy O O
or O O
abnormal O O
mammograms O O
. O O

The O O
5 O O
year O O
breast O O
cancer O O
risk O O
for O O
this O O
patient O O
as O O
calculated O O
by O O
the O O
BRCAPRO O O
model O O
was O O
5.7 O O
% O O
, O O
and B-conn Conjunction
her O O
probability O O
of O O
being O O
a O O
BRCA1 O O
or O O
BRCA2 O O
carrier O O
was O O
0.47 O O
. O O

The O O
Gail O O
model O O
risk O O
assessment O O
was O O
calculated O O
using O O
the O O
following O O
information O O
: O O
Race-Caucasian O O
; O O
Age-35 O O
; O O
Age O O
at O O
first O O
menses-12 O O
; O O
Age O O
at O O
first O O
live O O
birth-nulliparous O O
; O O
Number O O
of O O
first-degree O O
relatives O O
with O O
breast O O
cancer-2 O O
; O O
Number O O
of O O
previous O O
breast O O
biopsies-0 O O
. O O

The O O
calculated O O
5 O O
year O O
Gail O O
risk O O
was O O
1.0 O O
% O O
and B-conn Conjunction
her O O
lifetime O O
risk O O
was O O
31.3 O O
% O O
. O O

Following B-conn Temporal.Succession
genetic O O
counseling O O
, O O
the O O
patient O O
elected O O
to O O
undergo O O
DNA O O
sequencing O O
of O O
the O O
BRCA1 O O
and O O
BRCA2 O O
genes O O
, O O
which O O
revealed O O
a O O
Q1200X O O
truncation O O
mutation O O
in O O
one O O
of O O
her O O
BRCA1 O O
alleles O O
. O O

The O O
C O O
to O O
T O O
mutation O O
at O O
codon O O
1200 O O
in O O
exon O O
11 O O
results O O
in O O
the O O
change O O
of O O
the O O
amino O O
acid O O
glutamine O O
to O O
a O O
stop O O
codon O O
with O O
resulting O O
protein O O
truncation O O
and O O
loss O O
of O O
function O O
. O O

Exon O O
11 O O
is O O
the O O
largest O O
exon O O
in O O
BRCA1 O O
and O O
has O O
the O O
highest O O
frequency O O
of O O
reported O O
mutations O O
. O O

The O O
Q1200X O O
mutation O O
has O O
been O O
independently O O
observed O O
several O O
times O O
-LSB-24 O O
-RSB- O O
. O O

The O O
bilateral O O
screening O O
mammogram O O
was O O
compared O O
to O O
previous O O
films O O
from O O
another O O
hospital O O
. O O

The O O
breast O O
tissue O O
was O O
described O O
as O O
heterogeneously O O
dense O O
, O O
thus B-conn Cause.Result
lowering O O
the O O
sensitivity O O
. O O

There O O
were O O
no O O
masses O O
, O O
significant O O
calcifications O O
or O O
other O O
findings O O
and B-conn Conjunction
the O O
mammogram O O
was O O
interpreted O O
as O O
negative O O
bilaterally O O
. O O

A O O
one-year O O
follow-up O O
was O O
recommended O O
. O O

The O O
patient O O
was O O
then B-conn Temporal.Precedence
MRI O O
scanned O O
as O O
previously O O
described O O
-LSB-3 O O
-RSB- O O
, O O
with O O
pre- O O
and O O
post-gadolinium O O
enhancement O O
images O O
evaluating O O
both O O
breasts O O
simultaneously O O
in O O
the O O
axial O O
plane O O
. O O

In O O
the O O
upper-outer O O
left O O
breast O O
there O O
was O O
a O O
small O O
-LRB- O O
approximately O O
1 O O
cm O O
-RRB- O O
, O O
round O O
, O O
well-demarcated O O
enhancing O O
lesion O O
. O O

This O O
lesion O O
was O O
seen O O
on O O
both O O
the O O
initial O O
delay O O
after B-conn Temporal.Succession
contrast O O
injection O O
and B-conn Conjunction
the O O
delayed O O
contrast O O
enhanced O O
subtraction O O
images O O
. O O

The O O
lesion O O
appeared O O
to O O
accumulate O O
contrast O O
to O O
a O O
greater O O
extent O O
on O O
the O O
delayed O O
subtraction O O
images O O
with O O
an O O
additional O O
lesion O O
adjacent O O
to O O
the O O
first O O
. O O

In O O
the O O
medial O O
aspect O O
of O O
the O O
mid O O
right O O
breast O O
, O O
there O O
were O O
several O O
small O O
punctate O O
areas O O
of O O
enhancement O O
on O O
both O O
the O O
immediate O O
and O O
delayed O O
subtraction O O
views O O
. O O

Also B-conn Conjunction
in O O
the O O
right O O
breast O O
just O O
above O O
the O O
nipple O O
level O O
medial O O
and O O
close O O
to O O
the O O
chest O O
wall O O
an O O
additional O O
enhancing O O
lesion O O
was O O
seen O O
. O O

This O O
lesion O O
was O O
approximately O O
1.5 O O
cm O O
, O O
round O O
, O O
well-demarcated O O
and O O
continued O O
to O O
accumulate O O
contrast O O
on O O
the O O
delayed O O
subtraction O O
images O O
. O O

This O O
lesion O O
appeared O O
to O O
have O O
a O O
small O O
non-enhancing O O
septation O O
. O O

Under O O
ultrasound O O
, O O
the O O
lesion O O
of O O
concern O O
in O O
the O O
left O O
breast O O
was O O
identified O O
and O O
biopsied O O
, O O
as O O
well O O
as O O
one O O
lesion O O
in O O
the O O
right O O
breast O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

The O O
core O O
biopsy O O
of O O
the O O
left O O
breast O O
revealed O O
infiltrating O O
ductal O O
carcinoma O O
in O O
2 O O
of O O
5 O O
core O O
fragments O O
; O O
high O O
nuclear O O
grade O O
, O O
with O O
no O O
lymphatic O O
invasion O O
seen O O
. O O

The O O
core O O
biopsy O O
of O O
the O O
right O O
breast O O
demonstrated O O
benign O O
pathology O O
, O O
specifically B-conn Restatement.Specification
, O O
fibrosis O O
with O O
focal O O
ductal O O
epithelial O O
hyperplasia O O
. O O

Although B-conn Concession.Expectation
a O O
surgical O O
candidate O O
for O O
lumpectomy O O
and O O
radiation O O
, O O
the O O
patient O O
chose O O
to O O
undergo O O
left O O
modified O O
radical O O
mastectomy O O
with O O
left O O
axillary O O
lymph O O
node O O
dissection O O
and O O
contralateral O O
prophylactic O O
total O O
mastectomy O O
because B-conn Cause.Reason
of I-conn Cause.Reason
her O O
genetic O O
risk O O
status O O
. O O

The O O
pathology O O
in O O
the O O
left O O
breast O O
was O O
consistent O O
with O O
the O O
imaging O O
and O O
core O O
biopsy O O
in O O
size O O
and O O
description O O
. O O

Tumor O O
size O O
was O O
8 O O
mm O O
in O O
greatest O O
dimension O O
, O O
nuclear O O
grade O O
III O O
, O O
ER/PR O O
and O O
Her2/neu O O
negative O O
, O O
and O O
the O O
nodal O O
status O O
-LRB- O O
0/4 O O
-RRB- O O
was O O
negative O O
-LRB- O O
stage O O
TIaN0M0 O O
-RRB- O O
. O O

The O O
patient O O
underwent O O
4 O O
cycles O O
of O O
chemotherapy O O
and O O
has O O
been O O
reportedly O O
healthy O O
since B-conn Temporal.Succession
. O O

Because B-conn Cause.Reason
of I-conn Cause.Reason
the O O
positive O O
BRCA1 O O
mutation O O
results O O
, O O
she O O
subsequently B-conn Temporal.Precedence
underwent O O
prophylactic O O
bilateral O O
salpingo-oophorectomy O O
. O O

A O O
number O O
of O O
life O O
history O O
factors O O
have O O
been O O
associated O O
with O O
breast O O
cancer O O
incidence O O
that O O
are O O
widely O O
interpreted O O
as O O
representing O O
lifetime O O
exposure O O
of O O
the O O
breast O O
tissue O O
to O O
estrogen-induced O O
mitogenesis O O
-LSB-25 O O
-RSB- O O
. O O

An O O
alternative O O
interpretation O O
, O O
based O O
on O O
epithelial O O
cell O O
differentiation O O
, O O
suggests O O
that O O
lactational O O
differentiation O O
, O O
such O O
as O O
occurs O O
during O O
term O O
pregnancy O O
, O O
confers O O
resistance O O
to O O
carcinogenesis O O
-LSB-26,27 O O
-RSB- O O
. O O

We O O
have O O
developed O O
a O O
novel O O
human O O
mammary O O
epithelial O O
-LRB- O O
HME O O
-RRB- O O
tissue O O
engineering O O
system O O
wherein O O
many O O
aspects O O
of O O
organotypic O O
differentiation O O
are O O
reiterated O O
in O O
vitro O O
-LSB-28 O O
-RSB- O O
. O O

In O O
this O O
system O O
, O O
breast O O
epithelial O O
cells O O
initially O O
retain O O
cell-to-cell O O
contact O O
while B-conn Temporal.Synchronous
they O O
proliferate O O
, O O
then B-conn Temporal.Precedence
undergo O O
an O O
architectural O O
reorganization O O
, O O
first O O
to O O
form O O
three-dimensional O O
mammospheres O O
, O O
and O O
later O O
vast O O
networks O O
of O O
branching O O
ductal O O
and O O
lobular O O
structures O O
. O O

Tumor O O
and O O
some O O
pre-neoplastic O O
samples O O
fail O O
to O O
form O O
such O O
architecture O O
. O O

Normal O O
tissue O O
from O O
this O O
patient O O
, O O
who O O
is O O
both O O
a O O
BRCA1 O O
mutation O O
carrier O O
and O O
has O O
dense O O
breasts O O
, O O
was O O
evaluated O O
to B-conn Purpose.Goal
determine O O
whether O O
either O O
of O O
these O O
factors O O
affected O O
de O O
novo O O
differentiation O O
in O O
this O O
system O O
. O O

Four O O
discrete O O
pieces O O
of O O
fresh O O
tissue O O
were O O
provided O O
for O O
live-cell O O
analysis O O
from O O
each O O
of O O
the O O
patient O O
's O O
ipsilateral O O
and O O
contralateral O O
breasts O O
. O O

In O O
the O O
case O O
of O O
the O O
ipsilateral O O
breast O O
, O O
this O O
tissue O O
was O O
provided O O
at O O
increasing O O
distance O O
from O O
the O O
tumor O O
margin O O
in O O
1 O O
cm O O
increments O O
. O O

All O O
of O O
these O O
normal O O
samples O O
attached O O
and O O
grew O O
in O O
our O O
culture O O
system O O
and O O
were O O
examined O O
for O O
cell-to-cell O O
interactions O O
and O O
morphology O O
over O O
a O O
period O O
of O O
one O O
month O O
. O O

In O O
the O O
context O O
of O O
breast O O
reduction O O
explant O O
cultures O O
from O O
22 O O
patients O O
with O O
no O O
breast O O
disease O O
, O O
these O O
patient O O
samples O O
manifested O O
typical O O
mixtures O O
of O O
fibroblastic O O
and O O
epithelial O O
cells O O
. O O

After O O
several O O
days O O
in O O
culture O O
without O O
passaging O O
, O O
the O O
epithelial O O
cells O O
began O O
to O O
self-organize O O
, O O
initially O O
forming O O
three-dimensional O O
mammospheres O O
-LRB- O O
Figure O O
3A O O
-RRB- O O
, O O
and O O
, O O
after O O
2 O O
weeks O O
in O O
culture O O
, O O
more O O
complex O O
pre-ductal O O
linear O O
columns O O
of O O
epithelial O O
cells O O
-LRB- O O
Figure O O
3B O O
-RRB- O O
. O O

The O O
tissue O O
explants O O
from O O
both O O
breasts O O
showed O O
similar O O
patterns O O
of O O
behavior O O
-LRB- O O
Figure O O
3 O O
-RRB- O O
. O O

Tissue O O
cultured O O
from O O
a O O
contemporaneous O O
disease-free O O
control O O
and O O
the O O
contralateral O O
breast O O
of O O
a O O
sporadic O O
breast O O
cancer O O
patient O O
showed O O
similar O O
morphology O O
and O O
architecture O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

It O O
has O O
been O O
suggested O O
that O O
the O O
association O O
between O O
breast O O
density O O
and O O
risk O O
of O O
breast O O
cancer O O
is O O
due B-conn Cause.Reason
to I-conn Cause.Reason
increased O O
cell O O
proliferation O O
-LSB-29 O O
-RSB- O O
. O O

One O O
measure O O
of O O
cell O O
growth O O
and O O
viability O O
is O O
the O O
S-phase O O
index O O
-LRB- O O
SPI O O
-RRB- O O
or O O
the O O
percentage O O
of O O
cells O O
incorporating O O
radiolabeled O O
thymidine O O
over O O
a O O
specific O O
incubation O O
period O O
-LRB- O O
in O O
our O O
case O O
, O O
2 O O
hours O O
-RRB- O O
. O O

In O O
a O O
previous O O
study O O
with O O
22 O O
normal O O
breast O O
reduction O O
epithelium O O
-LSB-BRE O O
-RSB- O O
cultures O O
we O O
observed O O
a O O
wide O O
range O O
of O O
proliferation O O
rates O O
, O O
with O O
SPI O O
ranging O O
from O O
a O O
low O O
of O O
0.2 O O
% O O
to O O
a O O
high O O
of O O
46.0 O O
% O O
-LRB- O O
mean O O
of O O
18.3 O O
± O O
2.6 O O
% O O
-RRB- O O
-LSB-30 O O
-RSB- O O
. O O

The O O
contemporaneous O O
control O O
sample O O
from O O
a O O
disease-free O O
breast O O
reduction O O
patient O O
had O O
an O O
SPI O O
of O O
30.9 O O
% O O
, O O
at O O
the O O
higher O O
end O O
of O O
this O O
normal O O
range O O
. O O

The O O
ipsilateral O O
and O O
contralateral O O
tissue O O
samples O O
from O O
the O O
hereditary O O
breast O O
cancer O O
patient O O
exhibited O O
SPI O O
of O O
26.6 O O
% O O
and O O
26.2 O O
% O O
, O O
respectively O O
, O O
placing O O
them O O
at O O
slightly O O
over O O
the O O
70th O O
percentile O O
for O O
growth O O
rate O O
. O O

The O O
contralateral O O
sample O O
from O O
the O O
sporadic O O
breast O O
cancer O O
patient O O
had O O
an O O
SPI O O
of O O
17.0 O O
% O O
, O O
placing O O
it O O
slightly O O
under O O
the O O
50th O O
percentile O O
. O O

Thus B-conn Cause.Claim
, O O
all O O
of O O
these O O
breast O O
cancer O O
patient O O
samples O O
appeared O O
to O O
grow O O
well O O
in O O
our O O
system O O
, O O
with O O
SPI O O
well O O
within O O
the O O
range O O
of O O
our O O
normal O O
samples O O
. O O

The O O
similarity O O
of O O
the O O
SPI O O
values O O
from O O
the O O
two O O
samples O O
from O O
the O O
BRCA1 O O
mutation O O
carrier O O
does O O
not O O
appear O O
to O O
be O O
accidental O O
; O O
the O O
chances O O
of O O
selecting O O
two O O
samples O O
from O O
the O O
normal O O
population O O
with O O
values O O
as O O
close O O
or O O
closer O O
is O O
very O O
small O O
-LRB- O O
P O O
= O O
0.026 O O
-RRB- O O
. O O

Peripheral O O
blood O O
lymphocytes O O
and O O
normal O O
breast O O
epithelial O O
tissue O O
from O O
the O O
hereditary O O
cancer O O
patient O O
were O O
then B-conn Temporal.Precedence
cultured O O
for B-conn Purpose.Goal
performance O O
of O O
the O O
functional O O
UDS O O
assay O O
, O O
which O O
requires O O
living O O
cells O O
for O O
radiolabel O O
incorporation O O
during O O
DNA O O
repair O O
synthesis O O
following B-conn Temporal.Succession
UV O O
exposure O O
. O O

This O O
assay O O
is O O
diagnostic O O
for O O
the O O
inherited O O
cancer-prone O O
disease O O
XP O O
, O O
where O O
it O O
is O O
usually O O
performed O O
in O O
lymphocytes O O
or O O
skin O O
fibroblasts O O
. O O

Our O O
novel O O
HME O O
tissue O O
engineering O O
system O O
allows O O
us O O
to O O
apply O O
the O O
assay O O
to O O
breast O O
epithelial O O
cells O O
, O O
and B-conn Continuation
we O O
have O O
previously O O
demonstrated O O
tissue-specificity O O
in O O
the O O
NER O O
capacity O O
of O O
these O O
cells O O
in O O
normal O O
samples O O
from O O
patients O O
undergoing O O
breast O O
reduction O O
mammoplasty O O
-LSB-30 O O
-RSB- O O
. O O

Patient O O
data O O
is O O
therefore B-conn Cause.Result
expressed O O
relative O O
to O O
the O O
average O O
of O O
our O O
breast O O
reduction O O
controls O O
. O O

Analysis O O
of O O
cultured O O
blood O O
lymphocytes O O
from O O
the O O
patient O O
established O O
that O O
they O O
had O O
normal O O
NER O O
capacity O O
-LRB- O O
99.6 O O
% O O
of O O
the O O
average O O
of O O
our O O
33 O O
normal O O
samples O O
-RRB- O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

This O O
is O O
well O O
above O O
the O O
cut-off O O
established O O
in O O
our O O
sporadic O O
breast O O
cancer O O
population O O
, O O
< O O
70 O O
% O O
average O O
normal O O
activity O O
, O O
which O O
when B-conn Temporal.Synchronous
applied O O
to O O
our O O
cases O O
and O O
controls O O
yielded O O
a O O
significant O O
odds O O
ratio O O
of O O
37.4 O O
-LSB-31 O O
-RSB- O O
. O O

A O O
trend O O
towards O O
age O O
dependence O O
had O O
been O O
noted O O
in O O
the O O
analysis O O
of O O
the O O
UDS O O
data O O
of O O
the O O
normal O O
controls O O
-LRB- O O
P O O
= O O
0.059 O O
-RRB- O O
-LSB-30 O O
-RSB- O O
; O O
addition O O
of O O
the O O
patient O O
sample O O
supports O O
this O O
trend O O
, O O
but B-conn Concession.Contra-expectation
it O O
still O O
fails O O
to O O
reach O O
significance O O
-LRB- O O
P O O
= O O
0.056 O O
-RRB- O O
. O O

The O O
functional O O
NER O O
assay O O
was O O
then B-conn Temporal.Precedence
applied O O
to O O
the O O
contemporaneous O O
disease-free O O
breast O O
reduction O O
control O O
sample O O
, O O
one O O
sample O O
each O O
from O O
the O O
ipsilateral O O
and O O
contralateral O O
breasts O O
of O O
the O O
patient O O
, O O
and O O
to O O
a O O
sample O O
from O O
the O O
contralateral O O
breast O O
of O O
an O O
apparently O O
sporadic O O
breast O O
cancer O O
patient O O
. O O

The O O
NER O O
of O O
the O O
BRE O O
non-diseased O O
control O O
was O O
1.82 O O
times O O
the O O
average O O
of O O
our O O
normal O O
data O O
set O O
for O O
this O O
tissue O O
and O O
within O O
the O O
range O O
of O O
normal O O
. O O

The O O
NER O O
capacity O O
of O O
the O O
ipsilateral O O
breast O O
epithelial O O
sample O O
was O O
1.05 O O
times O O
the O O
average O O
of O O
our O O
population O O
of O O
BRE O O
controls O O
, O O
clearly O O
exhibiting O O
no O O
overt O O
DNA O O
repair O O
deficiency O O
-LRB- O O
Figure O O
5 O O
-RRB- O O
. O O

The O O
contralateral O O
sample O O
was O O
very O O
similar O O
, O O
with O O
an O O
NER O O
capacity O O
of O O
1.17 O O
times O O
BRE O O
normal O O
. O O

Although B-conn Concession.Expectation
the O O
NER O O
values O O
of O O
these O O
two O O
samples O O
from O O
the O O
same O O
patient O O
are O O
similar O O
, O O
they O O
are O O
not O O
close O O
enough O O
to O O
distinguish O O
themselves O O
as O O
coming O O
from O O
the O O
same O O
individual O O
-LRB- O O
P O O
= O O
0.16 O O
-RRB- O O
. O O

The O O
NER O O
capacity O O
of O O
the O O
contralateral O O
sample O O
from O O
the O O
sporadic O O
breast O O
cancer O O
patient O O
was O O
1.62 O O
times O O
the O O
average O O
of O O
the O O
BRE O O
controls O O
, O O
also O O
in O O
the O O
normal O O
range O O
. O O

Our O O
earlier O O
analysis O O
of O O
NER O O
in O O
our O O
normal O O
population O O
revealed O O
no O O
effects O O
of O O
age O O
or O O
cell O O
proliferation O O
-LRB- O O
as O O
represented O O
by O O
the O O
SPI O O
-RRB- O O
. O O

All O O
of O O
these O O
additional O O
patient O O
samples O O
are O O
consistent O O
with O O
those O O
results O O
. O O

Discussion O O

At O O
least O O
two O O
types O O
of O O
breast O O
tumors O O
are O O
not O O
accurately O O
detected O O
by O O
traditional O O
screening O O
mammography O O
: O O
`` O O
interval O O
'' O O
tumors O O
that O O
arise O O
quickly O O
between O O
screenings O O
, O O
and O O
tumors O O
whose O O
density O O
is O O
not O O
sufficient O O
to O O
distinguish O O
them O O
from O O
the O O
surrounding O O
normal O O
tissue O O
. O O

The O O
latter O O
situation O O
is O O
more O O
likely O O
to O O
occur O O
in O O
women O O
with O O
dense O O
normal O O
breast O O
tissue O O
, O O
which O O
, O O
in O O
turn O O
, O O
is O O
more O O
typical O O
of O O
younger O O
women O O
. O O

Thus B-conn Restatement.Equivalence
, O O
mammographically O O
undetectable O O
tumors O O
may O O
have O O
a O O
number O O
of O O
characteristics O O
, O O
such O O
as O O
fast O O
growth O O
, O O
low O O
density O O
, O O
early O O
onset O O
and/or O O
occurrence O O
in O O
dense O O
breasts O O
that O O
might O O
distinguish O O
them O O
from O O
mammographically O O
detectable O O
tumors O O
in O O
terms O O
of O O
molecular O O
etiology O O
and O O
clinical O O
parameters O O
of O O
prognosis O O
and O O
response O O
. O O

The O O
present O O
patient O O
had O O
an O O
early O O
onset O O
breast O O
tumor O O
, O O
but O O
had O O
both O O
hereditary O O
susceptibility O O
due B-conn Cause.Reason
to I-conn Cause.Reason
her O O
BRCA1 O O
mutation O O
and O O
dense O O
breasts O O
, O O
so B-conn Cause.Result
her O O
presentation O O
is O O
not O O
unusual O O
in O O
this O O
context O O
. O O

It O O
is O O
possible O O
that O O
breast O O
tumors O O
detected O O
by O O
complementary O O
screening O O
methods O O
in O O
the O O
future O O
will O O
demonstrate O O
unique O O
clinical O O
and O O
molecular O O
features O O
, O O
when B-conn Temporal.Synchronous
it O O
becomes O O
feasible O O
to O O
perform O O
such O O
screening O O
in O O
the O O
general O O
population O O
. O O

Since B-conn Cause.Reason
the O O
BRCA1 O O
gene O O
product O O
is O O
known O O
to O O
play O O
a O O
role O O
in O O
DNA O O
double O O
strand O O
break O O
repair O O
-LSB-8,9 O O
-RSB- O O
, O O
it O O
has O O
been O O
suggested O O
that O O
decreased O O
repair O O
capacity O O
is O O
the O O
basis O O
of O O
the O O
breast O O
cancer O O
predisposition O O
observed O O
in O O
mutation O O
carriers O O
-LSB-32-35 O O
-RSB- O O
. O O

Such O O
a O O
cellular O O
phenotype O O
has O O
been O O
difficult O O
to O O
demonstrate O O
, O O
however B-conn Concession.Contra-expectation
-LSB-36-39 O O
-RSB- O O
. O O

An O O
alternate O O
possibility O O
is O O
that O O
the O O
mutation O O
affects O O
the O O
growth O O
or O O
differentiation O O
of O O
breast O O
epithelial O O
cells O O
in O O
a O O
manner O O
consistent O O
with O O
cancer O O
susceptibility O O
. O O

It O O
has O O
been O O
suggested O O
that O O
dense O O
breast O O
tissue O O
is O O
indicative O O
of O O
generalized O O
hyperproliferation O O
that O O
might O O
promote O O
oncogenesis O O
-LSB-29 O O
-RSB- O O
. O O

Our O O
findings O O
show O O
that O O
all O O
8 O O
samples O O
, O O
derived O O
from O O
both O O
the O O
involved O O
and O O
the O O
uninvolved O O
breasts O O
of O O
a O O
hereditary O O
breast O O
cancer O O
patient O O
develop O O
normal O O
epithelial O O
architecture O O
in O O
vitro O O
, O O
implying O O
that O O
the O O
epithelial/stromal O O
-LRB- O O
paracrine O O
-RRB- O O
interactions O O
necessary O O
for O O
the O O
development O O
of O O
this O O
complex O O
architecture O O
are O O
intact O O
and O O
normal O O
in O O
BRCA1 O O
heterozygotes O O
despite B-conn Concession.Expectation
their O O
greater O O
risk O O
of O O
breast O O
cancer O O
. O O

The O O
SPI O O
results O O
also B-conn Conjunction
indicate O O
that O O
this O O
non-diseased O O
epithelial O O
tissue O O
falls O O
into O O
the O O
typical O O
range O O
of O O
normal O O
for O O
BRE O O
control O O
cultures O O
and O O
is O O
demonstrating O O
typical O O
growth O O
in O O
our O O
HME O O
tissue O O
engineering O O
system O O
. O O

NER O O
deficiency O O
is O O
most O O
often O O
associated O O
with O O
XP O O
, O O
sensitivity O O
to O O
UV-induced O O
DNA O O
damage O O
and O O
skin O O
cancer O O
-LSB-18-21 O O
-RSB- O O
. O O

The O O
NER O O
deficiency O O
of O O
XP O O
patients O O
is O O
manifested O O
in O O
other O O
tissues O O
, O O
however B-conn Concession.Contra-expectation
, O O
as O O
shown O O
by O O
their O O
high O O
spontaneous O O
frequency O O
of O O
mutation O O
in O O
blood O O
lymphocytes O O
-LSB-40 O O
-RSB- O O
and O O
the O O
occurrence O O
of O O
other O O
types O O
of O O
tumors O O
-LSB-41 O O
-RSB- O O
. O O

The O O
observation O O
that O O
sporadic O O
breast O O
cancer O O
patients O O
have O O
low O O
levels O O
of O O
NER O O
in O O
peripheral O O
lymphocytes O O
suggests O O
that O O
sporadic O O
breast O O
cancer O O
is O O
associated O O
with O O
constitutively O O
low O O
levels O O
of O O
NER O O
-LSB-14-16 O O
-RSB- O O
. O O

Our O O
results O O
from O O
a O O
single O O
patient O O
demonstrate O O
, O O
however B-conn Concession.Contra-expectation
, O O
that O O
while B-conn Concession.Expectation
overexpression O O
of O O
BRCA1 O O
may O O
enhance O O
NER O O
-LSB-22 O O
-RSB- O O
, O O
haploinsufficiency O O
for O O
this O O
gene O O
does O O
not O O
necessarily O O
result O O
in O O
detectable O O
NER O O
deficiency O O
. O O

Since B-conn Cause.Justification
it O O
is O O
clear O O
that O O
genomic O O
instability O O
is O O
a O O
necessary O O
prerequisite O O
for O O
the O O
completion O O
of O O
the O O
complex O O
multi-step O O
carcinogenic O O
pathway O O
-LRB- O O
s O O
-RRB- O O
involved O O
in O O
breast O O
cancer O O
, O O
a O O
fundamental O O
difference O O
in O O
the O O
mechanisms O O
of O O
genomic O O
instability O O
arising O O
in O O
hereditary O O
and O O
sporadic O O
breast O O
tumors O O
would O O
be O O
likely O O
to O O
translate O O
into O O
fundamentally O O
different O O
patterns O O
of O O
molecular O O
pathogenesis O O
that O O
could O O
impact O O
on O O
clinical O O
management O O
. O O

The O O
relative O O
NER O O
capacities O O
of O O
tumor O O
and O O
normal O O
tissue O O
may O O
have O O
important O O
practical O O
implications O O
. O O

If B-conn Condition.Hypothetical
breast O O
tumors O O
from O O
hereditary O O
patients O O
exhibit O O
NER O O
deficiency O O
similar O O
to O O
that O O
observed O O
in O O
sporadic O O
patients O O
, O O
while B-conn Contrast
their O O
normal O O
tissues O O
exhibit O O
normal O O
levels O O
of O O
this O O
type O O
of O O
DNA O O
repair O O
, O O
then B-conn Condition.Hypothetical
the O O
tumors O O
would O O
be O O
hypersensitive O O
to O O
a O O
range O O
of O O
chemotherapeutic O O
drugs O O
, O O
including O O
alkylating O O
agents O O
-LRB- O O
cyclosphosphamide O O
-RRB- O O
, O O
cross-linking O O
agents O O
-LRB- O O
cis-platinum O O
-RRB- O O
and O O
bulky O O
DNA O O
adducting O O
agents O O
-LRB- O O
melphalan O O
-RRB- O O
. O O

Individualization O O
of O O
chemotherapy O O
based O O
on O O
some O O
aspect O O
of O O
NER O O
expression O O
is O O
being O O
pursued O O
in O O
colon O O
-LSB-42 O O
-RSB- O O
, O O
testicular O O
-LSB-43,44 O O
-RSB- O O
and O O
ovarian O O
cancer O O
-LSB-45 O O
-RSB- O O
. O O

Conclusion O O

This O O
patient O O
and O O
her O O
tumor O O
represent O O
the O O
vanguard O O
of O O
a O O
new O O
population O O
of O O
early O O
stage O O
breast O O
cancer O O
patients O O
that O O
will O O
be O O
increasingly O O
diagnosed O O
as B-conn Temporal.Synchronous
new O O
screening O O
technologies O O
complementary O O
to O O
mammography O O
are O O
validated O O
and O O
become O O
practicable O O
. O O

We O O
have O O
shown O O
that O O
low O O
power O O
MRI O O
can O O
detect O O
a O O
stage O O
I O O
tumor O O
in O O
dense O O
breast O O
tissue O O
; O O
the O O
same O O
technology O O
can O O
also O O
impact O O
upon O O
interval O O
tumors O O
by B-conn Purpose.Enablement
staggering O O
the O O
procedure O O
with O O
mammography O O
rather O O
than O O
applying O O
them O O
coincidently O O
. O O

Although B-conn Concession.Expectation
we O O
did O O
not O O
observe O O
obvious O O
differences O O
in O O
the O O
growth O O
rate O O
or O O
differentiation O O
potential O O
of O O
the O O
dense O O
breast O O
tissue O O
from O O
this O O
patient O O
, O O
we O O
cannot O O
rule O O
out O O
the O O
possibility O O
that O O
some O O
or O O
all O O
of O O
the O O
tumors O O
detectable O O
only O O
by O O
complementary O O
screening O O
procedures O O
will O O
differ O O
from O O
the O O
present O O
clinical O O
experience O O
in O O
important O O
ways O O
. O O

Our O O
live-cell O O
analysis O O
takes O O
a O O
step O O
toward O O
defining O O
cellular O O
characteristics O O
that O O
may O O
be O O
useful O O
for O O
cancer O O
risk O O
assessment O O
, O O
but B-conn Concession.Contra-expectation
we O O
are O O
only O O
beginning O O
to O O
investigate O O
the O O
possibilities O O
of O O
the O O
system O O
. O O

It O O
may O O
be O O
that O O
different O O
growth O O
conditions O O
, O O
or O O
induction O O
with O O
genotoxic O O
or O O
estrogenic O O
agents O O
, O O
will O O
allow O O
for O O
the O O
greater O O
differentiation O O
of O O
breast O O
tissue O O
and O O
tumor O O
behaviours O O
. O O

This O O
technique O O
also B-conn Conjunction
allows O O
for O O
the O O
application O O
of O O
functional O O
assays O O
to O O
patient O O
samples O O
, O O
as O O
exemplified O O
in O O
this O O
report O O
by O O
the O O
UDS O O
assay O O
for O O
NER O O
capacity O O
. O O

Those O O
UDS O O
results O O
, O O
although B-conn Concession.Expectation
from O O
a O O
single O O
patient O O
, O O
demonstrate O O
definitively O O
that O O
the O O
constitutively O O
low O O
NER O O
capacities O O
reported O O
in O O
several O O
sporadic O O
breast O O
populations O O
do O O
not O O
arise O O
as O O
a O O
pleiomorphic O O
effect O O
of O O
BRCA1 O O
haploinsufficency O O
. O O

Thus B-conn Cause.Claim
, O O
the O O
basis O O
of O O
genetic O O
instability O O
, O O
a O O
fundamental O O
element O O
in O O
breast O O
carcinogenesis O O
, O O
may O O
differ O O
between O O
sporadic O O
and O O
hereditary O O
breast O O
tumors O O
. O O

This O O
results O O
in O O
different O O
susceptibilities O O
to O O
inducing O O
agents O O
, O O
mutations O O
in O O
different O O
sets O O
of O O
oncogenes O O
and O O
tumor O O
suppressor O O
genes O O
, O O
and O O
, O O
ultimately O O
, O O
tumors O O
of O O
different O O
molecular O O
etiology O O
that O O
express O O
different O O
clinically O O
relevant O O
phenotypes O O
. O O

Methods O O

The O O
patient O O
was O O
a O O
35.7 O O
year O O
old O O
woman O O
with O O
strong O O
family O O
history O O
of O O
breast O O
cancer O O
recruited O O
into O O
a O O
clinical O O
trial O O
of O O
MRI O O
screening O O
for O O
young O O
woman O O
at O O
high O O
risk O O
for O O
breast O O
cancer O O
with O O
dense O O
breast O O
tissue O O
-LSB-3 O O
-RSB- O O
. O O

Gadolinium O O
enhancement O O
images O O
revealed O O
a O O
small O O
1 O O
cm O O
lesion O O
in O O
the O O
upper-outer O O
quadrant O O
of O O
the O O
left O O
breast O O
, O O
identified O O
pathologically O O
as O O
an O O
infiltrating O O
ductal O O
carcinoma O O
. O O

The O O
patient O O
underwent O O
a O O
modified O O
radical O O
mastectomy O O
of O O
the O O
left O O
breast O O
and O O
chose O O
to O O
also B-conn Conjunction
undergo O O
a O O
contralateral O O
prophylactic O O
total O O
mastectomy O O
. O O

Blood O O
and O O
tissue O O
were O O
obtained O O
for O O
analysis O O
with O O
consent O O
under O O
Magee-Womens O O
Hospital O O
-LRB- O O
of O O
the O O
University O O
of O O
Pittsburgh O O
Medical O O
Center O O
-RRB- O O
IRB O O
# O O
MWH-94-108 O O
. O O

Data O O
from O O
this O O
hereditary O O
breast O O
cancer O O
patient O O
were O O
compared O O
to O O
that O O
from O O
two O O
additional O O
patients O O
as O O
well O O
as O O
previously O O
published O O
controls O O
. O O

The O O
first O O
new O O
control O O
patient O O
was O O
a O O
20 O O
year O O
old O O
women O O
undergoing O O
breast O O
reduction O O
mammoplasty O O
. O O

The O O
second O O
contemporaneous O O
control O O
patient O O
was O O
a O O
36 O O
year O O
old O O
woman O O
undergoing O O
cosmetic O O
surgery O O
on O O
her O O
contralateral O O
breast O O
two B-conn Temporal.Succession
years I-conn Temporal.Succession
after I-conn Temporal.Succession
successful O O
lumpectomy O O
to O O
remove O O
an O O
apparently O O
sporadic O O
stage O O
IIA O O
breast O O
tumor O O
-LRB- O O
2.5 O O
cm O O
, O O
negative O O
for O O
estrogen O O
and O O
progesterone O O
receptors O O
, O O
13 O O
lymph O O
nodes O O
negative O O
-RRB- O O
. O O

She O O
had O O
undergone O O
standard O O
radiotherapy O O
and O O
chemotherapy O O
with O O
adriamycin O O
and O O
cyclophosphamide O O
. O O

Histopathological O O
analysis O O
confirmed O O
that O O
the O O
breast O O
tissue O O
from O O
both O O
of O O
these O O
control O O
patients O O
was O O
free O O
of O O
cancer O O
and O O
within O O
the O O
acceptable O O
histological O O
range O O
of O O
normal O O
. O O

Fresh O O
tissues O O
from O O
the O O
patient O O
were O O
obtained O O
within O O
5 O O
hours O O
of O O
surgery O O
. O O

After B-conn Temporal.Succession
pathological O O
evaluation O O
, O O
excess O O
tissue O O
not O O
needed O O
for O O
diagnosis O O
was O O
placed O O
into O O
DMEM O O
containing O O
10 O O
% O O
fetal O O
calf O O
serum O O
and O O
3x O O
antibiotic O O
antimycotic O O
-LRB- O O
Sigma O O
, O O
St. O O
Louis O O
, O O
MO O O
-RRB- O O
at O O
4°C O O
. O O

This O O
tissue O O
was O O
then B-conn Temporal.Precedence
processed O O
as O O
described O O
in O O
Latimer O O
et O O
al. O O
-LSB-30 O O
-RSB- O O
and O O
placed O O
into O O
culture O O
on O O
a O O
diluted O O
form O O
of O O
matrigel O O
-LRB- O O
1:1 O O
with O O
DMEM O O
-RRB- O O
in O O
the O O
novel O O
MWRIα O O
medium O O
-LSB-7 O O
-RSB- O O
. O O

Eight O O
samples O O
of O O
the O O
principal O O
patient O O
's O O
tissue O O
were O O
obtained O O
for O O
culture O O
after O O
bilateral O O
mastectomy O O
surgery O O
. O O

We O O
were O O
not O O
able O O
to O O
obtain O O
a O O
sample O O
of O O
her O O
tumor O O
, O O
because B-conn Cause.Reason
it O O
was O O
utilized O O
entirely O O
for O O
clinical O O
diagnosis O O
. O O

We O O
were O O
able O O
to O O
obtain O O
4 O O
pieces O O
of O O
histologically O O
normal O O
non-tumor O O
adjacent O O
tissue O O
at O O
increasing O O
1 O O
cm O O
intervals O O
from O O
the O O
tumor O O
margin O O
from O O
her O O
left O O
-LRB- O O
ipsilateral O O
-RRB- O O
breast O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
we O O
obtained O O
4 O O
similar O O
pieces O O
of O O
fresh O O
tissue O O
from O O
her O O
contralateral O O
breast O O
. O O

All O O
were O O
placed O O
into O O
primary O O
explant O O
-LRB- O O
HME O O
-RRB- O O
culture O O
. O O

For B-conn Purpose.Goal
analysis O O
of O O
cell O O
growth O O
and O O
in O O
vitro O O
differentiation O O
, O O
explants O O
were O O
cultured O O
and O O
imaged O O
every O O
second O O
day O O
using O O
a O O
digital O O
Hamamatsu O O
Orca O O
camera O O
for O O
30–60 O O
days O O
. O O

Images O O
were O O
analyzed O O
on O O
a O O
Macintosh O O
G4 O O
computer O O
using O O
QED O O
imaging O O
software O O
-LRB- O O
Media O O
Cybernetics O O
, O O
Inc. O O
, O O
Silver O O
Spring O O
, O O
MD O O
-RRB- O O
. O O

Breast O O
reduction O O
mammoplasty O O
tissues O O
were O O
obtained O O
from O O
patients O O
ages O O
20–70 O O
at O O
Magee-Womens O O
Hospital O O
under O O
the O O
above O O
IRB O O
. O O

A O O
neighboring O O
piece O O
of O O
mammoplasty O O
tissue O O
-LRB- O O
from O O
the O O
same O O
0.25 O O
cm2 O O
sample O O
-RRB- O O
to O O
that O O
placed O O
into O O
primary O O
culture O O
was O O
fixed O O
and O O
processed O O
in O O
paraffin O O
. O O

These O O
sections O O
were O O
examined O O
by O O
a O O
pathologist O O
to B-conn Purpose.Goal
verify O O
the O O
histological O O
features O O
and O O
normality O O
of O O
the O O
tissue O O
. O O

Breast O O
tissue O O
was O O
processed O O
as O O
previously O O
described O O
-LSB-30 O O
-RSB- O O
. O O

Tissue O O
was O O
rinsed O O
three O O
times O O
in O O
PBS O O
containing O O
antibiotics O O
, O O
disaggregated O O
and O O
placed O O
into O O
MWRIα O O
medium O O
-LSB-7 O O
-RSB- O O
on O O
a O O
thin O O
coat O O
of O O
matrigel O O
. O O

Peripheral O O
blood O O
lymphocytes O O
-LRB- O O
PBLs O O
-RRB- O O
were O O
obtained O O
with O O
consent O O
from O O
normal O O
healthy O O
control O O
subjects O O
ages O O
20–50 O O
working O O
at O O
Magee-Womens O O
Hospital O O
or O O
students O O
at O O
the O O
University O O
of O O
Pittsburgh O O
. O O

Foreskin O O
fibroblast O O
-LRB- O O
FF O O
-RRB- O O
tissue O O
was O O
obtained O O
as O O
discarded O O
tissue O O
from O O
newborn O O
infants O O
after B-conn Temporal.Succession
circumcision O O
and O O
utilized O O
between O O
passages O O
7 O O
and O O
10 O O
. O O

These O O
control O O
populations O O
have O O
been O O
previously O O
described O O
in O O
greater O O
detail O O
-LSB-30,46 O O
-RSB- O O
. O O

Breast O O
tissue O O
samples O O
from O O
the O O
two O O
new O O
control O O
patients O O
were O O
processed O O
in O O
the O O
same O O
manner O O
. O O

Primary O O
cultures O O
of O O
mammary O O
tissue O O
, O O
established O O
10–14 O O
days O O
, O O
were O O
labeled O O
with O O
3H-thymidine O O
for O O
a O O
period O O
of O O
2 O O
hours O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
a O O
chase O O
with O O
cold O O
thymidine O O
for O O
2 O O
hours O O
and O O
then B-conn Temporal.Precedence
processed O O
for O O
autoradiography O O
. O O

After B-conn Temporal.Succession
a O O
10–12 O O
day O O
exposure O O
, O O
slides O O
were O O
processed O O
and O O
analyzed O O
by O O
two O O
independent O O
, O O
blinded O O
scorers O O
who O O
evaluated O O
the O O
tissue O O
samples O O
for O O
the O O
percentage O O
of O O
cells O O
in O O
S O O
phase O O
-LRB- O O
characterized O O
by O O
complete O O
coverage O O
of O O
the O O
nucleus O O
with O O
silver O O
grains O O
-RRB- O O
. O O

NER O O
was O O
measured O O
by O O
autoradiography O O
of O O
unscheduled O O
DNA O O
synthesis O O
after B-conn Temporal.Succession
UV O O
damage O O
-LRB- O O
UDS O O
-RRB- O O
-LSB-47,48 O O
-RSB- O O
. O O

After B-conn Temporal.Succession
a O O
total O O
of O O
10–14 O O
days O O
in O O
culture O O
, O O
without O O
passaging O O
, O O
cultures O O
were O O
irradiated O O
with O O
UV O O
light O O
at O O
254 O O
nm O O
at O O
a O O
mean O O
fluence O O
of O O
1.2 O O
Joules/m2 O O
for O O
12 O O
seconds O O
in O O
the O O
absence O O
of O O
culture O O
medium O O
, O O
for O O
a O O
total O O
dose O O
of O O
14 O O
J/m2 O O
. O O

Each O O
sample O O
was O O
represented O O
by O O
at O O
least O O
two O O
chamber O O
slides O O
. O O

One O O
chamber O O
of O O
each O O
2-chamber O O
slide O O
was O O
shielded O O
from O O
the O O
UV O O
dose O O
to O O
be O O
used O O
as O O
an O O
unirradiated O O
control O O
sample O O
. O O

Primary O O
cultures O O
had O O
not O O
reached O O
confluence O O
and O O
were O O
still O O
actively O O
growing O O
at O O
the O O
time O O
the O O
UDS O O
assay O O
was O O
performed O O
. O O

Control O O
FF O O
were O O
plated O O
subconfluently O O
2 O O
days O O
before O O
the O O
UDS O O
assay O O
to B-conn Purpose.Goal
insure O O
that O O
they O O
also O O
were O O
not O O
in O O
a O O
quiescent O O
state O O
brought O O
on O O
by O O
confluence O O
. O O

After B-conn Temporal.Succession
UV O O
exposure O O
, O O
all O O
cultures O O
were O O
incubated O O
in O O
medium O O
supplemented O O
with O O
10 O O
μCi O O
ml O O
-LSB-3H O O
-RSB- O O
methyl-thymidine O O
-LRB- O O
~80 O O
Ci O O
mmol-1 O O
-RRB- O O
-LRB- O O
PerkinElmer O O
Life O O
Sciences O O
, O O
Boston O O
, O O
MA O O
-RRB- O O
for O O
2 O O
hours O O
at O O
37°C O O
. O O

Labeling O O
medium O O
was O O
then B-conn Temporal.Precedence
replaced O O
with O O
unlabeled O O
chasing O O
medium O O
containing O O
10-3 O O
M O O
non-radioactive O O
thymidine O O
-LRB- O O
Sigma O O
-RRB- O O
and O O
incubated O O
for O O
a O O
further O O
2 O O
hours O O
to B-conn Purpose.Goal
clear O O
radioactive O O
label O O
from O O
the O O
intracellular O O
nucleotide O O
pools O O
. O O

After O O
incubation O O
in O O
the O O
post-labeling O O
medium O O
, O O
cells O O
were O O
fixed O O
in O O
1X O O
SSC O O
, O O
33 O O
% O O
acetic O O
acid O O
in O O
ethanol O O
, O O
followed O O
by O O
70 O O
% O O
ethanol O O
and O O
finally B-conn Temporal.Precedence
rinsed O O
in O O
4 O O
% O O
perchloric O O
acid O O
over O O
night O O
at O O
4°C O O
. O O

All O O
slides O O
were O O
dried O O
and O O
subsequently B-conn Temporal.Precedence
dipped O O
in O O
photographic O O
emulsion O O
-LRB- O O
Kodak O O
type O O
NTB2 O O
-RRB- O O
and O O
exposed O O
for O O
10 O O
to O O
14 O O
days O O
in O O
complete O O
darkness O O
at O O
4°C O O
. O O

The O O
length O O
of O O
exposure O O
of O O
emulsion O O
was O O
determined O O
in O O
each O O
experiment O O
by B-conn Purpose.Enablement
preparing O O
FF O O
`` O O
tester O O
'' O O
slides O O
. O O

After O O
10–12 O O
days O O
these O O
tester O O
slides O O
were O O
developed O O
and O O
grain O O
counting O O
was O O
performed O O
. O O

If B-conn Condition.Hypothetical
the O O
nuclei O O
over O O
the O O
foreskin O O
fibroblasts O O
averaged O O
50 O O
or O O
more O O
grains O O
per O O
nucleus O O
, O O
then B-conn Condition.Hypothetical
the O O
rest O O
of O O
the O O
experimental O O
slides O O
were O O
developed O O
. O O

If B-conn Condition.Hypothetical
the O O
grain O O
count O O
was O O
below O O
this O O
level O O
, O O
the O O
remaining O O
slides O O
were O O
left O O
to O O
expose O O
1–3 O O
days O O
longer O O
before B-conn Temporal.Precedence
being O O
developed O O
. O O

After B-conn Temporal.Succession
photographic O O
development O O
of O O
emulsion O O
, O O
all O O
slides O O
were O O
stained O O
with O O
Giemsa O O
, O O
then B-conn Temporal.Precedence
examined O O
at O O
a O O
total O O
magnification O O
of O O
1000X O O
on O O
a O O
Zeiss O O
Axioskop O O
under O O
oil O O
emersion O O
for O O
grains O O
located O O
immediately O O
over O O
the O O
nuclei O O
of O O
non-S O O
phase O O
cells O O
-LSB-48 O O
-RSB- O O
. O O

Local O O
background O O
grain O O
counts O O
were O O
evaluated O O
in O O
each O O
microscopic O O
field O O
over O O
an O O
area O O
the O O
same O O
size O O
as O O
a O O
representative O O
nucleus O O
, O O
and B-conn Conjunction
this O O
total O O
was O O
subtracted O O
from O O
the O O
grain O O
count O O
of O O
each O O
nucleus O O
in O O
that O O
field O O
. O O

The O O
average O O
number O O
of O O
grains O O
per O O
nucleus O O
was O O
quantified O O
for O O
each O O
side O O
of O O
the O O
chamber O O
slide O O
, O O
both O O
unirradiated O O
and O O
irradiated O O
. O O

The O O
final O O
NER O O
value O O
for O O
each O O
slide O O
was O O
calculated O O
by B-conn Purpose.Enablement
subtracting O O
the O O
unirradiated O O
mean O O
-LRB- O O
grains O O
per O O
nucleus O O
-RRB- O O
from O O
the O O
irradiated O O
mean O O
-LRB- O O
grains O O
per O O
nucleus O O
-RRB- O O
, O O
after B-conn Temporal.Succession
the O O
initial O O
subtraction O O
of O O
local O O
background O O
in O O
each O O
field O O
. O O

NER O O
was O O
initially O O
expressed O O
as O O
a O O
percentage O O
of O O
the O O
activity O O
of O O
concurrently O O
analyzed O O
FF O O
. O O

Four O O
FF O O
slides O O
were O O
scored O O
per O O
experiment O O
, O O
by O O
an O O
average O O
of O O
three O O
counters O O
. O O

200 O O
nuclei O O
were O O
counted O O
per O O
slide O O
, O O
for O O
a O O
total O O
of O O
800 O O
, O O
with O O
an O O
average O O
of O O
61.6 O O
grains/nucleus O O
. O O

Six O O
slides O O
were O O
evaluated O O
for O O
the O O
patient O O
's O O
PBL O O
sample O O
, O O
two O O
by O O
each O O
of O O
three O O
counters O O
. O O

An O O
average O O
of O O
195 O O
nuclei O O
were O O
scored O O
per O O
slide O O
-LRB- O O
for O O
a O O
total O O
of O O
almost O O
1200 O O
-RRB- O O
, O O
with O O
an O O
average O O
of O O
7.5 O O
grains/nucleus O O
. O O

Four O O
slides O O
were O O
counted O O
for O O
the O O
contemporaneous O O
breast O O
reduction O O
control O O
, O O
two O O
each O O
by O O
two O O
counters O O
. O O

There O O
were O O
an O O
average O O
of O O
200 O O
nuclei O O
per O O
slide O O
and O O
14.1 O O
grains/nucleus O O
. O O

Six O O
slides O O
were O O
scored O O
from O O
the O O
patient O O
's O O
ipsilateral O O
breast O O
tissue O O
sample O O
, O O
two O O
by O O
each O O
of O O
three O O
independent O O
counters O O
, O O
and B-conn Conjunction
five O O
slides O O
were O O
counted O O
from O O
the O O
contralateral O O
sample O O
, O O
again O O
by O O
three O O
independent O O
counters O O
. O O

An O O
average O O
of O O
just O O
over O O
100 O O
nuclei O O
were O O
evaluated O O
per O O
slide O O
for O O
each O O
sample O O
, O O
for O O
a O O
total O O
of O O
almost O O
600 O O
nuclei O O
for O O
the O O
ipsilateral O O
sample O O
and O O
over O O
500 O O
for O O
the O O
contralateral O O
sample O O
. O O

As O O
the O O
NER O O
capacities O O
indicate O O
, O O
these O O
samples O O
had O O
very O O
similar O O
counts O O
; O O
about O O
35 O O
grains/nucleus O O
for O O
the O O
ipsilateral O O
sample O O
and O O
28 O O
grains/nucleus O O
for O O
the O O
contralateral O O
sample O O
. O O

Finally B-conn Conjunction
, O O
four O O
slides O O
were O O
counted O O
from O O
the O O
contralateral O O
sample O O
of O O
a O O
sporadic O O
breast O O
cancer O O
patient O O
, O O
by O O
three O O
counters O O
. O O

There O O
were O O
an O O
average O O
of O O
200 O O
nuclei O O
per O O
slide O O
and O O
29.4 O O
grains O O
per O O
nucleus O O
. O O

To B-conn Purpose.Goal
ensure O O
accuracy O O
and O O
guard O O
against O O
transcription O O
errors O O
, O O
raw O O
grain O O
counts O O
from O O
the O O
UDS O O
assay O O
were O O
processed O O
independently O O
in O O
duplicate O O
, O O
once O O
using O O
StatView O O
-LRB- O O
version O O
5.0.1 O O
, O O

SAS O O
Institute O O
, O O
Inc. O O
, O O
Cary O O
, O O
NC O O
-RRB- O O
, O O
and O O
once O O
using O O
the O O
Data O O
Analysis O O
Toolpack O O
of O O
the O O
Excel O O
2001 O O
spreadsheet O O
program O O
-LRB- O O
Microsoft O O
Corp. O O
, O O
Redmond O O
, O O
WA O O
-RRB- O O
. O O

The O O
final O O
count O O
from O O
slides O O
of O O
the O O
same O O
cell O O
type O O
within O O
the O O
same O O
experiment O O
and O O
developed O O
the O O
same O O
day O O
were O O
averaged O O
together O O
and O O
expressed O O
as O O
a O O
percentage O O
of O O
concurrently O O
analyzed O O
FF O O
. O O

These O O
results O O
were O O
then B-conn Temporal.Precedence
normalized O O
by B-conn Purpose.Enablement
comparison O O
to O O
the O O
average O O
for O O
the O O
tissue O O
type O O
control O O
population O O
-LSB-48 O O
-RSB- O O
. O O

Competing O O
interests O O

The O O
authors O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Authors O O
' O O
contributions O O

JJL O O
conceived O O
of O O
the O O
study O O
, O O
executed O O
it O O
, O O
and O O
drafted O O
the O O
manuscript O O
. O O

WSR O O
recruited O O
and O O
consented O O
the O O
patient O O
, O O
provided O O
clinical O O
samples O O
and O O
information O O
. O O

JMJ O O
evaluated O O
the O O
UDS O O
assay O O
and O O
analyzed O O
the O O
data O O
. O O

AKS O O
performed O O
the O O
histopathological O O
analysis O O
of O O
the O O
tissue O O
. O O

VGV O O
participated O O
in O O
the O O
study O O
design O O
and O O
data O O
interpretation O O
. O O

SGG O O
participated O O
in O O
the O O
design O O
and O O
coordination O O
of O O
the O O
study O O
and O O
helped O O
to O O
draft O O
the O O
manuscript O O
. O O

Pre-publication O O
history O O

The O O
pre-publication O O
history O O
for O O
this O O
paper O O
can O O
be O O
accessed O O
here O O
: O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Pedigree O O
of O O
the O O
patient O O
-LRB- O O
indicated O O
by O O
arrow O O
-RRB- O O
. O O

She O O
, O O
one O O
maternal O O
aunt O O
and O O
one O O
maternal O O
cousin O O
had O O
breast O O
cancer O O
diagnosed O O
at O O
36 O O
, O O
44 O O
and O O
41 O O
years O O
old O O
, O O
respectively O O
, O O
as O O
indicated O O
by O O
the O O
half-filled O O
symbols O O
, O O
and B-conn Conjunction
her O O
aunt O O
died O O
of O O
the O O
disease O O
. O O

Her O O
cousin O O
underwent O O
lumpectomy O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
chemotherapy O O
, O O
radiotherapy O O
and O O
is O O
presently O O
on O O
tamoxifen O O
. O O

Her O O
mother O O
had O O
breast O O
cancer O O
in O O
both O O
breasts O O
, O O
diagnosed O O
at O O
ages O O
41 O O
and O O
42 O O
, O O
as O O
indicated O O
by O O
the O O
completely O O
filled O O
symbol O O
. O O

She O O
underwent O O
bilateral O O
mastectomy O O
and O O
hysterectomy O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
chemotherapy O O
and O O
radiotherapy O O
and O O
died O O
of O O
the O O
disease O O
at O O
age O O
44 O O
. O O

A O O
second O O
maternal O O
aunt O O
was O O
diagnosed O O
with O O
colon O O
cancer O O
at O O
age O O
52 O O
-LRB- O O
light O O
half-filled O O
symbol O O
-RRB- O O
and O O
breast O O
cancer O O
at O O
age O O
55 O O
-LRB- O O
dark O O
half-filled O O
symbol O O
-RRB- O O
. O O

Based O O
on O O
this O O
pattern O O
of O O
familial O O
cancer O O
the O O
patient O O
was O O
considered O O
to O O
be O O
at O O
high O O
risk O O
of O O
developing O O
breast O O
cancer O O
and O O
was O O
entered O O
into O O
the O O
low O O
power O O
MRI O O
screening O O
validation O O
and O O
feasibility O O
study O O
. O O

Following B-conn Temporal.Succession
her O O
diagnosis O O
, O O
she O O
was O O
confirmed O O
as O O
carrying O O
a O O
Q1200X O O
mutation O O
in O O
the O O
BRCA1 O O
gene O O
. O O

Figure O O
2 O O
: O O
Ultrasound O O
of O O
the O O
MRI-detected O O
lesion O O
. O O

Following B-conn Temporal.Succession
MRI O O
, O O
the O O
patient O O
was O O
scheduled O O
for O O
ultrasound O O
to B-conn Purpose.Goal
identify O O
the O O
questionable O O
lesions O O
seen O O
on O O
MRI O O
for O O
possible O O
core O O
biopsy O O
. O O

Under O O
ultrasound O O
the O O
lesion O O
of O O
concern O O
was O O
identified O O
and O O
biopsied O O
at O O
the O O
1:00 O O
location O O
in O O
the O O
left O O
breast O O
. O O

Additionally B-conn Conjunction
, O O
one O O
lesion O O
seen O O
by O O
MRI O O
in O O
the O O
right O O
breast O O
at O O
the O O
4:00 O O
location O O
was O O
identified O O
and O O
biopsied O O
. O O

Figure O O
3 O O
: O O
Micrographs O O
of O O
the O O
non-diseased O O
primary O O
human O O
mammary O O
epithelial O O
cultures O O
-LRB- O O
HMEC O O
-RRB- O O
from O O
the O O
BRCA1 O O
mutation O O
carrier O O
. O O

A O O
-RRB- O O
Contralateral O O
breast O O
– O O
A O O
cluster O O
of O O
epithelial O O
cells O O
called O O
a O O
mammosphere O O
is O O
shown O O
on O O
the O O
left O O
center O O
of O O
the O O
image O O
sitting O O
on O O
a O O
field O O
of O O
fibroblasts O O
. O O

B O O
-RRB- O O
Ipsilateral O O
breast O O
– O O
The O O
original O O
fresh O O
tissue O O
block O O
from O O
which O O
this O O
culture O O
was O O
derived O O
was O O
located O O
4 O O
cm O O
from O O
the O O
infiltrating O O
ductal O O
carcinoma O O
. O O

The O O
structure O O
shown O O
is O O
a O O
cluster O O
of O O
rounded O O
epithelial O O
cells O O
manifesting O O
a O O
column O O
configuration O O
called O O
`` O O
pre-ductal O O
linearization O O
'' O O
. O O

Both O O
images O O
were O O
captured O O
under O O
Differential O O
Interference O O
Contrast O O
-LRB- O O
DIC O O
-RRB- O O
optics O O
on O O
a O O
Zeiss O O
Axiovert O O
100 O O
microscope O O
at O O
a O O
total O O
of O O
140x O O
magnification O O
. O O

Figure O O
4 O O
: O O
Comparison O O
of O O
the O O
NER O O
capacity O O
of O O
a O O
PBL O O
sample O O
from O O
our O O
BRCA1 O O
mutation O O
carrier O O
patient O O
with O O
those O O
of O O
a O O
population O O
of O O
disease-free O O
controls O O
. O O

The O O
dark O O
horizontal O O
line O O
indicates O O
the O O
average O O
for O O
the O O
normal O O
population O O
, O O
while B-conn Conjunction
the O O
dotted O O
lines O O
indicate O O
upper O O
limits O O
for O O
residual O O
NER O O
activity O O
in O O
patients O O
with O O
the O O
hereditary O O
NER O O
deficiency O O
disease O O
XP O O
-LRB- O O
0.50 O O
-RRB- O O
and O O
the O O
cut-off O O
established O O
in O O
our O O
breast O O
tissue O O
study O O
that O O
identified O O
tumors O O
with O O
high O O
sensitivity O O
and O O
specificity O O
-LRB- O O
0.70 O O
-RRB- O O
. O O

Figure O O
5 O O
: O O
Comparison O O
of O O
the O O
NER O O
capacities O O
of O O
two O O
samples O O
of O O
normal O O
breast O O
epithelium O O
from O O
our O O
BRCA1 O O
mutation O O
carrier O O
patient O O
with O O
those O O
of O O
a O O
population O O
of O O
disease-free O O
controls O O
who O O
underwent O O
breast O O
reduction O O
mammoplasty O O
. O O

The O O
dark O O
horizontal O O
line O O
indicates O O
the O O
average O O
for O O
the O O
normal O O
population O O
of O O
breast O O
reduction O O
epithelium O O
-LRB- O O
BRE O O
-RRB- O O
, O O
while B-conn Conjunction
the O O
dotted O O
lines O O
indicate O O
upper O O
limits O O
for O O
residual O O
NER O O
activity O O
in O O
patients O O
with O O
the O O
hereditary O O
NER O O
deficiency O O
disease O O
XP O O
-LRB- O O
0.50 O O
-RRB- O O
and O O
the O O
cut-off O O
established O O
in O O
our O O
breast O O
tissue O O
study O O
that O O
identified O O
tumors O O
with O O
high O O
sensitivity O O
and O O
specificity O O
-LRB- O O
0.70 O O
-RRB- O O
. O O

The O O
patient O O
sample O O
on O O
the O O
left O O
was O O
derived O O
from O O
the O O
ipsilateral O O
-LRB- O O
left O O
-RRB- O O
breast O O
, O O
while B-conn Conjunction
the O O
sample O O
on O O
the O O
right O O
was O O
from O O
the O O
contralateral O O
-LRB- O O
right O O
-RRB- O O
breast O O
. O O

Sex O O
hormone O O
modulation O O
of O O
cell O O
growth O O
and O O
apoptosis O O
of O O
the O O
human O O
monocytic/macrophage O O
cell O O
line O O

Abstract O O

Sex O O
hormones O O
seem O O
to O O
modulate O O
the O O
immune/inflammatory O O
responses O O
by O O
different O O
mechanisms O O
in O O
female O O
and O O
male O O
rheumatoid O O
arthritis O O
patients O O
. O O

The O O
effects O O
of O O
17β-oestradiol O O
and O O
of O O
testosterone O O
were O O
tested O O
on O O
the O O
cultured O O
human O O
monocytic/macrophage O O
cell O O
line O O
-LRB- O O
THP-1 O O
-RRB- O O
activated O O
with O O
IFN-γ O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
investigate O O
their O O
role O O
in O O
cell O O
proliferation O O
and O O
apoptosis O O
. O O

Activated O O
human O O
THP-1 O O
cells O O
were O O
cultured O O
in O O
the O O
presence O O
of O O
17β-oestradiol O O
and O O
testosterone O O
-LRB- O O
final O O
concentration O O
, O O
10 O O
nM O O
-RRB- O O
. O O

The O O
evaluation O O
of O O
markers O O
of O O
cell O O
proliferation O O
included O O
the O O
NF-κB O O
DNA-binding O O
assay O O
, O O
the O O
NF-κB O O
inhibition O O
complex O O
, O O
the O O
proliferating O O
cell O O
nuclear O O
antigen O O
expression O O
and O O
the O O
methyl-tetrazolium O O
salt O O
test O O
. O O

Apoptosis O O
was O O
detected O O
by O O
the O O
annexin O O
V-propidium O O
assay O O
and O O
by O O
the O O
cleaved O O
poly-ADP O O
ribose O O
polymerase O O
expression O O
. O O

Specific O O
methods O O
included O O
flow O O
analysis O O
cytometry O O
scatter O O
analysis O O
, O O
immunocytochemistry O O
and O O
western O O
blot O O
analysis O O
. O O

Cell O O
growth O O
inhibition O O
and O O
increased O O
apoptosis O O
were O O
observed O O
in O O
testosterone-treated O O
THP-1 O O
cells O O
. O O

Increased O O
poly-ADP O O
ribose O O
polymerase-cleaved O O
expression O O
and O O
decreased O O
proliferating O O
cell O O
nuclear O O
antigen O O
expression O O
, O O
as O O
well O O
as O O
an O O
increase O O
of O O
IκB-α O O
and O O
a O O
decrease O O
of O O
the O O
IκB-α O O
phosphorylated O O
form O O
-LRB- O O
ser O O
32 O O
-RRB- O O
, O O
were O O
found O O
in O O
testosterone-treated O O
THP-1 O O
cells O O
. O O

However B-conn Contrast
, O O
the O O
NF-κB O O
DNA O O
binding O O
was O O
found O O
increased O O
in O O
17β-oestradiol-treated O O
THP-1 O O
cells O O
. O O

The O O
treatment O O
with O O
staurosporine O O
-LRB- O O
enhancer O O
of O O
apoptosis O O
-RRB- O O
induced O O
decreased O O
NF-κB O O
DNA O O
binding O O
in O O
all O O
conditions O O
, O O
but O O
particularly O O
in O O
testosterone-treated O O
THP-1 O O
cells O O
. O O

Treatment O O
of O O
THP-1 O O
by O O
sex O O
hormones O O
was O O
found O O
to O O
influence O O
cell O O
proliferation O O
and O O
apoptosis O O
. O O

Androgens O O
were O O
found O O
to O O
increase O O
the O O
apoptosis O O
, O O
and B-conn Conjunction
oestrogens O O
showed O O
a O O
protective O O
trend O O
on O O
cell O O
death O O
– O O
both O O
acting O O
as O O
modulators O O
of O O
the O O
NF-κB O O
complex O O
. O O

Introduction O O

Experimental O O
and O O
clinical O O
evidence O O
indicates O O
that O O
immune O O
reactivity O O
is O O
greater O O
in O O
females O O
than O O
in O O
males O O
and O O
suggests O O
that O O
gonadal O O
steroids O O
may O O
play O O
an O O
important O O
role O O
in O O
the O O
regulation O O
of O O
the O O
immune O O
response O O
-LSB-1-4 O O
-RSB- O O
. O O

Indeed B-conn Reinforcement
, O O
many O O
cells O O
of O O
the O O
immune O O
system O O
have O O
been O O
found O O
to O O
possess O O
functional O O
sex O O
hormone O O
receptors O O
, O O
such O O
as O O
CD8-positive O O
T O O
cells O O
, O O
B O O
cells O O
and O O
, O O
notably O O
, O O
monocytes/macrophages O O
-LSB-5,6 O O
-RSB- O O
. O O

Therefore B-conn Restatement.Specification
, O O
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
was O O
found O O
to O O
inhibit O O
cellular O O
apoptosis O O
, O O
to O O
increase O O
antibody O O
production O O
by O O
B O O
cells O O
and O O
to O O
exert O O
dose-related O O
effects O O
on O O
T-cell O O
functions O O
-LSB-7 O O
-RSB- O O
. O O

Androgens O O
seem O O
to O O
exert O O
effects O O
opposite O O
to O O
those O O
of O O
E2 O O
on O O
immune O O
response O O
-LSB-8 O O
-RSB- O O
. O O

Clinical O O
epidemiology O O
clearly O O
confirms O O
a O O
higher O O
prevalence O O
of O O
autoimmune O O
diseases O O
in O O
female O O
subjects O O
when O O
compared O O
with O O
male O O
subjects O O
-LSB-9 O O
-RSB- O O
. O O

The O O
studies O O
concerning O O
the O O
functional O O
interaction O O
between O O
the O O
NF-κB O O
pathway O O
and O O
members O O
of O O
the O O
steroid O O
hormone O O
receptor O O
family O O
, O O
and O O
their O O
role O O
in O O
synovial O O
inflammation O O
, O O
have O O
advanced O O
significantly O O
, O O
although B-conn Concession.Contra-expectation
with O O
controversial O O
results O O
-LSB-10,11 O O
-RSB- O O
. O O

In B-conn Restatement.Specification
particular I-conn Restatement.Specification
, O O
after B-conn Temporal.Succession
binding O O
with O O
E2 O O
, O O
oestrogen O O
receptors O O
have O O
been O O
shown O O
to O O
interact O O
with O O
NF-κB O O
factors O O
, O O
via O O
transcriptional O O
co-factors O O
, O O
resulting O O
in O O
mutual O O
or O O
non-mutual O O
antagonism O O
. O O

Other O O
studies O O
hypothesize O O
that O O
, O O
since B-conn Cause.Reason
oestrogen O O
receptors O O
may O O
repress O O
both O O
constitutive O O
and O O
inducible O O
NF-κB O O
activity O O
, O O
the O O
overexpression O O
of O O
NF-κB-inducible O O
genes O O
in O O
oestrogen O O
receptor-negative O O
cells O O
might O O
contribute O O
to O O
malignant O O
cell O O
growth O O
and O O
chemotherapeutic O O
resistance O O
-LSB-12,13 O O
-RSB- O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
further O O
studies O O
report O O
that O O
E2 O O
blocks O O
the O O
transcriptional O O
activity O O
of O O
p65 O O
in O O
macrophages O O
-LSB-14 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
these O O
opposite O O
observations O O
arise O O
using O O
different O O
cell O O
lines O O
-LRB- O O
human/animals O O
-RRB- O O
and O O
culture O O
conditions O O
as O O
well O O
as O O
different O O
hormone O O
concentrations O O
-LSB-15 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
multiple O O
mechanisms O O
concerning O O
the O O
interaction O O
between O O
oestrogen O O
receptors O O
and O O
NF-κB O O
have O O
been O O
proposed O O
, O O
such O O
as O O
repression O O
of O O
NF-κB O O
DNA O O
binding O O
by O O
physical O O
association O O
with O O
oestrogen O O
receptors O O
and O O
the O O
regulation O O
of O O
IκB-α O O
expression O O
by O O
oestrogens O O
-LSB-16,17 O O
-RSB- O O
. O O

The O O
androgen O O
receptor O O
seems O O
to O O
be O O
closely O O
related O O
to O O
the O O
glucocorticoid O O
receptor O O
in O O
terms O O
of O O
both O O
structure O O
and O O
sequence O O
homology O O
. O O

The O O
androgen O O
receptor O O
and O O
the O O
glucocorticoid O O
receptor O O
have O O
been O O
shown O O
to O O
interact O O
and O O
repress O O
activator O O
protein O O
1 O O
via O O
a O O
similar O O
mechanism O O
; O O
consequently B-conn Cause.Claim
, O O
it O O
would O O
not O O
be O O
surprising O O
that O O
the O O
androgen O O
receptor O O
might O O
also O O
interact O O
with O O
NF-κB O O
in O O
a O O
manner O O
very O O
similar O O
to O O
that O O
observed O O
for O O
the O O
glucocorticoid O O
receptor O O
-LSB-18 O O
-RSB- O O
. O O

Both O O
the O O
androgen O O
receptor O O
and O O
NF-κB O O
are O O
inducible O O
transcription O O
factors O O
with O O
some O O
opposing O O
functions O O
in O O
the O O
regulation O O
of O O
immune O O
and O O
inflammatory O O
responses O O
-LSB-19 O O
-RSB- O O
. O O

It O O
is O O
possible O O
that O O
inflammatory O O
agents O O
that O O
activate O O
NF-κB O O
in O O
vivo O O
may O O
interfere O O
with O O
normal O O
androgen O O
signalling O O
, O O
and B-conn Continuation
recent O O
studies O O
indicate O O
that O O
the O O
androgen O O
receptor O O
and O O
NF-κB O O
-LRB- O O
subunit O O
p65 O O
-RRB- O O
are O O
mutual O O
transcriptional O O
antagonists O O
-LSB-20 O O
-RSB- O O
. O O

The O O
present O O
study O O
was O O
therefore B-conn Cause.Result
undertaken O O
to B-conn Purpose.Goal
examine O O
the O O
long-term O O
-LRB- O O
time O O
course O O
of O O
7 O O
days O O
-RRB- O O
effects O O
of O O
sex O O
hormones O O
on O O
activated O O
cultured O O
human O O
monocytic/macrophage O O
cell O O
line O O
-LRB- O O
THP-1 O O
-RRB- O O
cells O O
by B-conn Purpose.Enablement
investigating O O
their O O
effects O O
on O O
cell O O
proliferation O O
and O O
apoptosis O O
. O O

These O O
cells O O
are O O
equipped O O
with O O
functional O O
sex O O
hormone O O
receptors O O
and O O
are O O
an O O
important O O
target O O
of O O
sex O O
steroid O O
hormones O O
, O O
particularly O O
in O O
inflammatory O O
diseases O O
such O O
as O O
rheumatoid O O
arthritis O O
-LRB- O O
RA O O
-RRB- O O
-LSB-21 O O
-RSB- O O
. O O

In B-conn Restatement.Specification
particular I-conn Restatement.Specification
, O O
in O O
the O O
present O O
study O O
we O O
used O O
pharmacological O O
concentrations O O
of O O
E2 O O
-LRB- O O
final O O
concentration O O
, O O
10 O O
nM O O
; O O
Sigma-Aldrich O O
, O O
Milan O O
, O O
Italy O O
-RRB- O O
that O O
have O O
been O O
already O O
described O O
as O O
the O O
most O O
efficient O O
in O O
stimulating O O
macrophages O O
in O O
vitro O O
-LSB-22 O O
-RSB- O O
. O O

Accordingly B-conn Cause.Result
, O O
the O O
same O O
concentration O O
has O O
been O O
used O O
for O O
testosterone O O
-LSB-23 O O
-RSB- O O
. O O

We O O
therefore B-conn Restatement.Generalization
investigated O O
sex O O
hormone O O
effects O O
on O O
the O O
NF-κB O O
pathway O O
, O O
as O O
a O O
complex O O
of O O
molecules O O
modulating O O
cellular O O
responses O O
in O O
activated O O
cells O O
. O O

Materials O O
and O O
methods O O

THP-1 O O
cells O O
-LRB- O O
Interlab O O
cell O O
line O O
collection O O
HTL097014 O O
; O O
IST O O
c/o O O
CBA O O
, O O
Genoa O O
, O O
Italy O O
-RRB- O O
were O O
cultured O O
in O O
RPMI-1640 O O
medium O O
supplemented O O
with O O
2 O O
% O O
foetal O O
bovine O O
serum O O
-LRB- O O
Sigma-Aldrich O O
-RRB- O O
-LRB- O O
5 O O
% O O
CO2 O O
humidified O O
atmosphere O O
at O O
37°C O O
-RRB- O O
. O O

Moreover B-conn Conjunction
, O O
the O O
absence O O
of O O
binding O O
of O O
the O O
hormones O O
with O O
other O O
foetal O O
bovine O O
serum O O
components O O
related O O
to O O
growth O O
rate O O
and O O
the O O
survival O O
of O O
cultured O O
THP-1 O O
cells O O
over O O
the O O
course O O
of O O
7 O O
days O O
were O O
investigated O O
. O O

The O O
cells O O
were O O
maintained O O
in O O
logarithmic O O
growth O O
by O O
passage O O
every O O
3–4 O O
days O O
. O O

The O O
viability O O
of O O
the O O
cells O O
-LRB- O O
97–98 O O
% O O
-RRB- O O
was O O
tested O O
by O O
the O O
Trypan O O
blue O O
exclusion O O
procedure O O
. O O

Briefly B-conn Restatement.Specification
, O O
the O O
cells O O
were O O
seeded O O
into O O
six-well O O
flat-bottom O O
plates O O
-LRB- O O
106 O O
cells/well O O
-RRB- O O
and O O
were O O
treated O O
with O O
500 O O
U/ml O O
IFN-γ O O
-LRB- O O
Sigma-Aldrich O O
-RRB- O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
differentiate O O
THP-1 O O
into O O
macrophage O O
cells O O
-LSB-24 O O
-RSB- O O
. O O

The O O
activation O O
and O O
transformation O O
of O O
the O O
cells O O
was O O
evaluated O O
by O O
the O O
expression O O
of O O
different O O
macrophage O O
antigens O O
: O O
CD68 O O
, O O
CD14 O O
, O O
HAM O O
56 O O
, O O
Mac O O
387 O O
. O O

The O O
THP-1 O O
activated O O
cells O O
were O O
then B-conn Temporal.Precedence
incubated O O
for O O
24 O O
, O O
48 O O
, O O
72 O O
, O O
96 O O
and O O
168 O O
hours O O
with O O
E2 O O
and O O
testosterone O O
-LRB- O O
10 O O
nM O O
-RRB- O O
. O O

After O O
that O O
time O O
samples O O
of O O
THP-1 O O
cells O O
were O O
also O O
treated O O
with O O
an O O
apoptosis O O
inducer O O
-LSB-25 O O
-RSB- O O
, O O
staurosporine O O
-LRB- O O
17 O O
nM O O
; O O
Sigma O O
Aldrich O O
-RRB- O O
, O O
for O O
24 O O
hours O O
. O O

At O O
the O O
end O O
of O O
the O O
different O O
incubation O O
times O O
, O O
the O O
cells O O
were O O
harvested O O
, O O
washed O O
in O O
Dulbecco O O
's O O
phosphate-buffered O O
saline O O
-LRB- O O
DPBS O O
-RRB- O O
and O O
treated O O
with O O
different O O
lysis O O
buffers O O
for O O
the O O
nuclear O O
and O O
total O O
protein O O
extraction O O
. O O

Part O O
of O O
the O O
cell O O
was O O
then B-conn Temporal.Precedence
collected O O
for O O
DNA O O
content O O
-LRB- O O
normal O O
and O O
apoptotic O O
-RRB- O O
evaluation O O
by O O
flow O O
analysis O O
cytometry O O
scatter O O
analysis O O
and O O
for O O
immunocytochemistry O O
analysis O O
. O O

The O O
immunocytochemistry O O
analysis O O
to O O
evaluate O O
the O O
expression O O
of O O
CD68 O O
, O O
CD14 O O
, O O
HAM56 O O
and O O
Mac387 O O
in O O
the O O
treated O O
cells O O
showed O O
positive O O
results O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
confirming O O
the O O
activation O O
of O O
monocytes O O
by O O
IFN-γ O O
. O O

The O O
cell O O
growth O O
was O O
evaluated O O
at O O
different O O
times O O
by O O
the O O
methyl-tetrazolium O O
salt O O
test O O
, O O
which O O
represents O O
a O O
quantitative O O
colorimetric O O
assay O O
to O O
detect O O
cell O O
survival O O
and O O
proliferation O O
. O O

The O O
test O O
is O O
based O O
on O O
the O O
ability O O
of O O
living O O
cells O O
to O O
cleave O O
the O O
tetrazolium O O
ring O O
at O O
the O O
level O O
of O O
active O O
mitochondria O O
. O O

Briefly B-conn Restatement.Specification
, O O
the O O
cells O O
were O O
seeded O O
into O O
96-well O O
microtitre O O
plates O O
and O O
were O O
treated O O
according O O
to O O
the O O
experimental O O
design O O
. O O

At O O
the O O
established O O
time O O
, O O
50 O O
μl O O
methyl-tetrazolium O O
salt O O
labelling O O
reagent O O
-LSB-3- O O
-LRB- O O
4,5-dimethylthiazol-2-yl O O
-RRB- O O
-2,5-diphenyltetrazolium O O
bromide O O
, O O
5 O O
mg/ml O O
in O O
PBS O O
-RSB- O O
was O O
added O O
to O O
each O O
well O O
and O O
incubated O O
in O O
humidified O O
atmosphere O O
at O O
37°C O O
. O O

Four B-conn Temporal.Precedence
hours I-conn Temporal.Precedence
later I-conn Temporal.Precedence
, O O
100 O O
μl O O
dimethylsulfoxide O O
were O O
introduced O O
into O O
each O O
well O O
and O O
mixed O O
thoroughly O O
. O O

The O O
absorbance O O
was O O
calculated O O
at O O
540 O O
nm O O
, O O
using O O
a O O
scanning O O
multiwell O O
spectrophotometer O O
. O O

Standard O O
curves O O
were O O
constructed O O
for O O
THP-1 O O
cells O O
using O O
known O O
plating O O
densities O O
, O O
allowing O O
the O O
cell O O
number O O
to O O
be O O
calculated O O
from O O
this O O
optical O O
density O O
reading O O
. O O

Each O O
experiment O O
was O O
performed O O
in O O
triplicate O O
. O O

The O O
apoptotic O O
events O O
were O O
evaluated O O
after O O
168 O O
hours O O
from O O
both O O
sex O O
hormone O O
stimulation O O
and O O
staurosporine O O
treatment O O
-LRB- O O
17 O O
nM O O
for O O
24 O O
hours O O
-RRB- O O
by O O
annexin O O
V-propidium O O
iodide O O
analysis O O
-LRB- O O
MBL O O
Co. O O
, O O
Ltd O O
, O O
Nagoya O O
, O O
Japan O O
-RRB- O O
, O O
in B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
detect O O
the O O
early-stage O O
apoptosis O O
-LRB- O O
cells O O
only O O
annexin-positive O O
-RRB- O O
and O O
the O O
late-stage O O
apoptosis O O
-LRB- O O
cells O O
annexin-positive O O
and O O
propidium-positive O O
-RRB- O O
. O O

After B-conn Temporal.Succession
resuspending O O
the O O
cells O O
-LRB- O O
1 O O
× O O
105 O O
-RRB- O O
into O O
200 O O
μl O O
of O O
1 O O
x O O
binding O O
buffer O O
, O O
1 O O
μl O O
fluorescein-labelled O O
annexin O O
V O O
and O O
1 O O
μl O O
propidium O O
iodide O O
were O O
added O O
. O O

Then B-conn Temporal.Precedence
the O O
cells O O
were O O
incubated O O
for O O
5 O O
min O O
at O O
room O O
temperature O O
-LRB- O O
dark O O
light O O
-RRB- O O
. O O

Finally B-conn Temporal.Precedence
, O O
the O O
cells O O
were O O
plated O O
on O O
glass O O
slides O O
and O O
analysed O O
by O O
fluorescence O O
microscopy O O
-LRB- O O
550 O O
nm O O
-RRB- O O
for O O
a O O
total O O
of O O
500 O O
cells O O
per O O
sample O O
, O O
which O O
allows O O
detection O O
even O O
of O O
a O O
single O O
apoptotic O O
cell O O
. O O

To B-conn Purpose.Goal
confirm O O
the O O
reduced O O
DNA O O
content O O
-LRB- O O
oligonucleosomal-size O O
fragments O O
-RRB- O O
the O O
cells O O
stimulated O O
with O O
hormones O O
, O O
without O O
and O O
with O O
staurosporine O O
, O O
after B-conn Temporal.Succession
fixation O O
were O O
stained O O
with O O
intercalating O O
dyes O O
-LRB- O O
propidium O O
iodide O O
-RRB- O O
and O O
were O O
analysed O O
by O O
flow O O
analysis O O
cytometry O O
scatter O O
-LRB- O O
Becton-Dickinson-Immunocytometry O O
Systems O O
, O O
Erembodegem O O
, O O
Belgium O O
-RRB- O O
. O O

THP-1 O O
cells O O
were O O
harvested O O
at O O
a O O
concentration O O
of O O
5 O O
× O O
103 O O
, O O
being O O
sedimented O O
on O O
poly-L-lysine-coated O O
glass O O
slides O O
for O O
40 O O
min O O
at O O
4°C O O
. O O

The O O
spots O O
were O O
then B-conn Temporal.Precedence
air-dried O O
and O O
fixed O O
in O O
cold O O
acetone O O
for O O
30 O O
s O O
, O O
and O O
stored O O
at O O
-20°C O O
until B-conn Temporal.Precedence
the O O
immunodetermination O O
of O O
poly-ADP O O
ribose O O
polymerase O O
-LRB- O O
PARP O O
-RRB- O O
-cleaved O O
expression O O
, O O
proliferating O O
cell O O
nuclear O O
antigen O O
-LRB- O O
PCNA O O
-RRB- O O
expression O O
, O O
NF-κB O O
, O O
IκB-α O O
and O O
IκB-α-ser O O
32 O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
, O O
Santa O O
Cruz O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

After B-conn Temporal.Succession
rehydration O O
in O O
PBS O O
, O O
spots O O
were O O
incubated O O
with O O
the O O
anti-human O O
antibody O O
at O O
different O O
dilutions O O
at O O
room O O
temperature O O
. O O

The O O
second O O
and O O
third O O
steps O O
were O O
performed O O
using O O
the O O
improved O O
biotin-streptavidin-amplified O O
detection O O
system O O
-LRB- O O
Vector O O
Laboratories O O
Inc. O O
, O O
Burlingame O O
, O O
CA O O
, O O
USA O O
-RRB- O O
. O O

Briefly B-conn Restatement.Specification
, O O
according O O
to O O
this O O
method O O
, O O
cells O O
were O O
incubated O O
with O O
the O O
secondary O O
antibody O O
-LRB- O O
biotinylated O O
IgG O O
, O O
1:20 O O
dilution O O
-RRB- O O
for O O
20 O O
min O O
at O O
room O O
temperature O O
and O O
then B-conn Temporal.Precedence
, O O
after B-conn Temporal.Succession
several O O
washes O O
in O O
PBS O O
, O O
cells O O
were O O
treated O O
with O O
the O O
concentrated O O
enzyme O O
label O O
-LRB- O O
biotin-streptavidin-peroxidase O O
-RRB- O O
for O O
20 O O
min O O
and O O
, O O
finally B-conn Temporal.Precedence
, O O
incubated O O
at O O
room O O
temperature O O
with O O
the O O
peroxidase-substrate O O
solution O O
-LRB- O O
0.04 O O
% O O
3,3-diaminobenzidine O O
-LSB-Sigma-Aldrich O O
-RSB- O O
in O O
50 O O
mM O O
Tris-HCl O O
buffer O O
containing O O
0.3 O O
% O O
hydrogen O O
peroxide O O
-RRB- O O
for O O
15 O O
min O O
. O O

After B-conn Temporal.Succession
rinsing O O
with O O
PBS O O
, O O
slides O O
were O O
counterstained O O
with O O
haematoxylin O O
, O O
were O O
dried O O
and O O
cover O O
slipped O O
with O O
Eukitt O O
, O O
and O O
were O O
examined O O
by O O
light O O
microscopy O O
and O O
computerized O O
image O O
analysis O O
. O O

Controls O O
were O O
treated O O
identically O O
, O O
except B-conn Exception
for I-conn Exception
omitting O O
the O O
primary O O
or O O
secondary O O
antibodies O O
. O O

Image O O
analysis O O
was O O
performed O O
with O O
the O O
Leica O O
Q500 O O
MC O O
Image O O
Analysis O O
System O O
-LRB- O O
Leica O O
, O O
Cambridge O O
, O O
UK O O
-RRB- O O
. O O

For O O
each O O
sample O O
, O O
100 O O
cells O O
were O O
randomly O O
analysed O O
and B-conn Continuation
the O O
pixels O O
per O O
micron O O
square O O
-LRB- O O
positive O O
area O O
-RRB- O O
were O O
quantified O O
by O O
the O O
Leica O O
Q500 O O
software O O
. O O

The O O
single O O
cells O O
were O O
randomly O O
selected O O
by O O
the O O
operators O O
using O O
the O O
cursor O O
and O O
then B-conn Temporal.Precedence
automatically O O
measured O O
as O O
the O O
positive O O
area O O
. O O

A O O
constant O O
optical O O
threshold O O
and O O
filter O O
combination O O
was O O
set O O
to B-conn Purpose.Goal
select O O
only O O
the O O
positive O O
cells O O
. O O

The O O
results O O
were O O
analysed O O
by O O
the O O
analysis O O
of O O
variance O O
non-parametric O O
test O O
-LRB- O O
Bonferroni O O
test O O
-RRB- O O
, O O
and B-conn Continuation
the O O
values O O
are O O
presented O O
as O O
means O O
± O O
standard O O
deviations O O
. O O

Cells O O
were O O
lysed O O
in O O
buffer O O
containing O O
20 O O
mM O O
Tris-HCl O O
, O O
150 O O
mM O O
NaCl O O
, O O
1 O O
mM O O
phenylmethylsulfonylfluoride O O
, O O
5 O O
mg/ml O O
aprotinin O O
, O O
0.5 O O
% O O
Nonidet O O
P-40 O O
-LRB- O O
Sigma-Aldrich O O
-RRB- O O
for O O
1 O O
hour O O
at O O
4°C O O
. O O

The O O
lysates O O
were O O
centrifuged O O
for O O
10 O O
min O O
at O O
13,000 O O
rpm O O
. O O

The O O
surnatants O O
were O O
collected O O
and O O
stored O O
at O O
-80°C O O
. O O

The O O
samples O O
of O O
surnatants O O
were O O
thereafter B-conn Temporal.Precedence
diluted O O
with O O
reducing O O
sample O O
buffer O O
and O O
were O O
separated O O
by O O
electrophoresis O O
on O O
a O O
10 O O
% O O
SDS-PAGE O O
gel O O
-LRB- O O
20 O O
μg O O
protein O O
per O O
lane O O
loaded O O
-RRB- O O
. O O

The O O
proteins O O
were O O
transferred O O
onto O O
Hybond-C-nitrocellulose O O
membrane O O
-LRB- O O
Amersham O O
Italia O O
, O O
Milan O O
, O O
Italy O O
-RRB- O O
. O O

The O O
reaction O O
was O O
blocked O O
by O O
DPBS O O
with O O
5 O O
% O O
non-fat O O
powdered O O
milk O O
at O O
4°C O O
overnight O O
. O O

For O O
immunoblot O O
analysis O O
, O O
the O O
membranes O O
were O O
incubated O O
with O O
the O O
different O O
antibodies O O
for O O
1 O O
hour O O
-LRB- O O
NF-κB O O
, O O
IκB-α O O
, O O
IκB-α-ser O O
32 O O
, O O
respectively O O
; O O
Santa O O
Cruz O O
Biotechnology O O
-RRB- O O
-LRB- O O
dilution O O
1:200 O O
-RRB- O O
in O O
DPBS O O
at O O
room O O
temperature O O
with O O
constant O O
shaking O O
, O O
and O O
were O O
washed O O
extensively O O
in O O
0.05 O O
% O O
DPBS/Tween O O
20 O O
, O O
pH O O
7.4 O O
. O O

Finally B-conn Temporal.Precedence
, O O
the O O
membranes O O
were O O
incubated O O
with O O
secondary O O
horseradish O O
peroxidase-labelled O O
polyclonal O O
anti-goat O O
IgG O O
antibody O O
-LRB- O O
SC-2020 O O
; O O
Santa O O
Cruz O O
Biotechnology O O
-RRB- O O
-LRB- O O
dilution O O
1:5000 O O
-RRB- O O
in O O
DPBS O O
for O O
1 O O
hour O O
at O O
room O O
temperature O O
. O O

After B-conn Temporal.Succession
washing O O
three O O
times O O
in O O
DPBS O O
, O O
the O O
bands O O
were O O
detected O O
using O O
the O O
enhanced O O
chemiluminescence O O
system O O
-LRB- O O
Amersham O O
Italia O O
-RRB- O O
. O O

Double-stranded O O
oligonucleotides O O
corresponding O O
to O O
the O O
wild-type O O
and O O
mutated O O
NF-κB O O
consensus O O
element O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
-RRB- O O
were O O
used O O
as O O
32P-labelled O O
probes O O
or O O
as O O
unlabelled O O
competitors O O
-LRB- O O
100 O O
times O O
-RRB- O O
. O O

The O O
assays O O
were O O
performed O O
in O O
a O O
final O O
volume O O
of O O
20 O O
μl O O
containing O O
10 O O
mM O O
Tris-HCl O O
-LRB- O O
pH O O
7.5 O O
-RRB- O O
, O O
50 O O
mM O O
NaCl O O
, O O
1 O O
mM O O
dithiothreitol O O
, O O
1 O O
mM O O
ethylenediamine O O
tetraacetic O O
acid O O
and O O
10 O O
% O O
glycerol O O
. O O

Briefly B-conn Restatement.Specification
, O O
7 O O
μg O O
cell O O
nuclear O O
extracts O O
, O O
unstimulated O O
or O O
stimulated O O
with O O
testosterone O O
and O O
E2 O O
as O O
previously O O
described O O
, O O
were O O
pre-incubated O O
with O O
4 O O
μg O O
poly O O
-LRB- O O
dI-dC O O
-RRB- O O
-LRB- O O
Pharmacia O O
, O O
Milan O O
, O O
Italy O O
-RRB- O O
as O O
a O O
non-specific O O
competitor O O
, O O
for O O
10 O O
min O O
at O O
room O O
temperature O O
. O O

End-labelled O O
oligonucleotides O O
-LRB- O O
10 O O
fmol O O
, O O
about O O
30,000 O O
cpm O O
-RRB- O O
were O O
then B-conn Temporal.Precedence
added O O
to O O
each O O
mixture O O
to O O
a O O
final O O
volume O O
of O O
20 O O
μl O O
and O O
were O O
incubated O O
for O O
an O O
additional O O
20 O O
min O O
. O O

The O O
bound/retarded O O
complexes O O
were O O
separated O O
from O O
the O O
free O O
probe O O
by O O
electrophoresis O O
on O O
5 O O
% O O
polyacrylamide O O
gels O O
and O O
were O O
visualized O O
by O O
autoradiography O O
of O O
the O O
dried O O
gels O O
. O O

A O O
lane O O
without O O
nuclear O O
extract O O
was O O
also B-conn Conjunction
included O O
as O O
the O O
negative O O
control O O
. O O

Competition O O
experiments O O
were O O
performed O O
in O O
the O O
presence O O
of O O
a O O
100-fold O O
molar O O
excess O O
of O O
unlabelled O O
wall-type O O
or O O
mutated O O
NF-κB O O
oligonucleotide O O
, O O
added O O
to O O
the O O
pre-incubation O O
step O O
. O O

For O O
the O O
super O O
shift O O
assay O O
, O O
2 O O
μl O O
anti-p65 O O
, O O
c-rel O O
and O O
p50 O O
NF-κB O O
subunit O O
antibodies O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
-RRB- O O
were O O
included O O
in O O
the O O
pre-incubation O O
mixture O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
the O O
addition O O
of O O
the O O
probe O O
. O O

A O O
lane O O
containing O O
pre-immune O O
serum O O
was O O
always O O
included O O
as O O
the O O
control O O
. O O

Results O O

As O O
already O O
stated O O
, O O
hormonal O O
signals O O
regulate O O
the O O
amount O O
of O O
the O O
cell-cycle O O
control O O
proteins O O
and O O
of O O
the O O
transcription O O
factors O O
-LSB-26 O O
-RSB- O O
. O O

In O O
the O O
present O O
study O O
, O O
after O O
168 O O
hours O O
we O O
observed O O
a O O
significant O O
growth O O
inhibition O O
of O O
the O O
human O O
monocytic O O
cell O O
line O O
activated O O
with O O
IFN-γ O O
and O O
treated O O
with O O
testosterone O O
, O O
when B-conn Temporal.Synchronous
compared O O
with O O
the O O
other O O
conditions O O
studied O O
. O O

At O O
168 O O
hours O O
the O O
cell O O
growth O O
was O O
reduced O O
by O O
14.8 O O
% O O
versus O O
untreated O O
controls O O
and O O
by O O
12.7 O O
% O O
versus O O
E2-treated O O
cells O O
. O O

These O O
data O O
were O O
obtained O O
with O O
the O O
methyl-tetrazolium O O
salt O O
test O O
and O O
confirmed O O
with O O
the O O
trypan O O
blue O O
exclusion O O
assay O O
-LRB- O O
Fig. O O
1 O O
-RRB- O O
. O O

The O O
bromodeoxyuridine/propidium O O
iodide O O
incorporation O O
test O O
showed O O
similar O O
results O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Further O O
interesting O O
data O O
were O O
related O O
to O O
the O O
modulation O O
of O O
the O O
PCNA O O
expression O O
, O O
as O O
a O O
marker O O
for O O
proliferating O O
cells O O
. O O

This O O
marker O O
was O O
analysed O O
by O O
immunocytochemistry O O
and B-conn Conjunction
the O O
data O O
were O O
confirmed O O
by O O
western O O
blot O O
analysis O O
. O O

In O O
the O O
testosterone-treated O O
cells O O
, O O
the O O
expression O O
of O O
the O O
PCNA O O
at O O
the O O
immunocytochemistry O O
analysis O O
was O O
found O O
decreased O O
by O O
24 O O
% O O
when B-conn Temporal.Synchronous
compared O O
with O O
untreated O O
cells O O
, O O
and O O
was O O
decreased O O
by O O
40 O O
% O O
when B-conn Temporal.Synchronous
compared O O
with O O
E2-treated O O
cells O O
-LRB- O O
Fig. O O
2a–d O O
-RRB- O O
. O O

Interestingly O O
, O O
the O O
testosterone-treated O O
cells O O
showed O O
staining O O
positivity O O
localized O O
in O O
the O O
cell O O
cytoplasm O O
, O O
whereas B-conn Contrast
in O O
the O O
untreated O O
and O O
E2-treated O O
cells O O
the O O
PCNA O O
expression O O
was O O
found O O
predominantly O O
in O O
the O O
nucleus O O
. O O

In O O
the O O
present O O
study O O
the O O
inhibitory O O
role O O
of O O
E2 O O
on O O
apoptosis O O
, O O
as O O
well O O
as O O
the O O
pro-apoptotic O O
effects O O
exerted O O
by O O
testosterone O O
in O O
long-term O O
treatment O O
of O O
THP-1 O O
cells O O
, O O
were O O
investigated O O
. O O

The O O
annexin O O
V-propidium O O
iodide O O
analysis O O
showed O O
a O O
significant O O
increase O O
of O O
early O O
and O O
late O O
apoptosis O O
in O O
testosterone-treated O O
cells O O
when B-conn Temporal.Synchronous
compared O O
with O O
other O O
conditions O O
. O O

In O O
the O O
absence O O
of O O
staurosporine O O
, O O
the O O
apoptosis O O
was O O
found O O
increased O O
in O O
testosterone-treated O O
cells O O
-LRB- O O
9.9 O O
% O O
-RRB- O O
when B-conn Temporal.Synchronous
compared O O
with O O
control O O
untreated O O
cells O O
-LRB- O O
2.7 O O
% O O
-RRB- O O
and O O
with O O
E2-treated O O
cells O O
-LRB- O O
3.8 O O
% O O
-RRB- O O
. O O

In O O
the O O
presence O O
of O O
staurosporine O O
, O O
the O O
apoptotic O O
cells O O
were O O
increased O O
in O O
all O O
conditions O O
. O O

In O O
testosterone-treated O O
cells O O
-LRB- O O
24.8 O O
% O O
-RRB- O O
the O O
apoptosis O O
was O O
found O O
increased O O
when B-conn Temporal.Synchronous
compared O O
with O O
untreated O O
cells O O
-LRB- O O
19.4 O O
% O O
-RRB- O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
in O O
the O O
E2-treated O O
-LRB- O O
15 O O
% O O
-RRB- O O
cells O O
the O O
apoptosis O O
was O O
decreased O O
versus O O
controls O O
-LRB- O O
19.4 O O
% O O
-RRB- O O
-LRB- O O
Fig. O O
3a O O
-RRB- O O
. O O

These O O
data O O
were O O
confirmed O O
by O O
flow O O
analysis O O
cytometry O O
scatter O O
analysis O O
-LRB- O O
Fig. O O
3b O O
, O O
c O O
-RRB- O O
. O O

The O O
immunocytochemistry O O
analysis O O
showed O O
a O O
significant O O
increase O O
of O O
the O O
PARP-cleaved O O
form O O
in O O
testosterone-treated O O
cells O O
compared O O
with O O
other O O
conditions O O
, O O
suggesting O O
an O O
increase O O
of O O
pro-apoptotic O O
events O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
the O O
PARP-cleaved O O
staining O O
showed O O
a O O
decrease O O
-LRB- O O
19 O O
% O O
versus O O
untreated O O
controls O O
-RRB- O O
in O O
E2-treated O O
cells O O
, O O
suggesting O O
a O O
trend O O
of O O
oestrogens O O
in O O
protecting O O
cells O O
from O O
the O O
apoptotic O O
stimuli O O
-LRB- O O
Fig. O O
4a–e O O
-RRB- O O
. O O

These O O
data O O
were O O
confirmed O O
with O O
western O O
blot O O
analysis O O
. O O

The O O
defined O O
mechanism O O
of O O
NF-κB O O
activation O O
includes O O
the O O
site-specific O O
phosphorylation O O
and O O
subsequent O O
degradation O O
of O O
the O O
inhibitory O O
IκB-α O O
factor O O
, O O
which O O
usually O O
retains O O
the O O
NF-κB O O
factors O O
inactivated O O
in O O
cytosol O O
-LSB-27 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
performed O O
western O O
blot O O
analysis O O
to B-conn Purpose.Goal
detect O O
the O O
expression O O
of O O
NF-κB O O
-LRB- O O
p65 O O
-RRB- O O
, O O
IκB-α O O
and O O
the O O
IκB-α O O
phosphorylated O O
form O O
-LRB- O O
IκB-α-ser O O
32 O O
-RRB- O O
in O O
THP-1 O O
cells O O
treated O O
with O O
the O O
different O O
hormone O O
combinations O O
. O O

As O O
shown O O
in O O
western O O
blot O O
analysis O O
-LRB- O O
Fig. O O
5 O O
-RRB- O O
a O O
decreased O O
expression O O
of O O
NF-κB O O
-LRB- O O
p65 O O
-RRB- O O
and O O
an O O
increased O O
content O O
of O O
IκB-α O O
with O O
a O O
concomitant O O
decrease O O
of O O
the O O
IκB-α O O
phosphorylated O O
form O O
was O O
observed O O
in O O
testosterone-treated O O
cells O O
when B-conn Temporal.Synchronous
compared O O
with O O
untreated O O
controls O O
and O O
with O O
E2-treated O O
THP-1 O O
cells O O
; O O
the O O
differences O O
between O O
conditions O O
observed O O
with O O
staurosporine O O
treatment O O
were O O
similar O O
but B-conn Concession.Contra-expectation
the O O
expression O O
was O O
lower O O
. O O

The O O
observed O O
differences O O
between O O
E2-treated O O
and O O
testosterone-treated O O
THP-1 O O
cells O O
were O O
confirmed O O
by O O
immunocytochemistry O O
staining O O
and O O
image O O
analysis O O
; O O
similar O O
data O O
were O O
observed O O
with O O
staurosporine O O
treatment O O
-LRB- O O
Table O O
1 O O
-RRB- O O
. O O

The O O
concomitant O O
electrophoretic O O
mobility O O
shift O O
assay O O
analysis O O
for O O
the O O
evaluation O O
of O O
the O O
NF-κB O O
DNA O O
binding O O
confirmed O O
an O O
increased O O
binding O O
in O O
E2-treated O O
cells O O
, O O
when B-conn Temporal.Synchronous
compared O O
with O O
other O O
conditions O O
with O O
or O O
without O O
staurosporine O O
, O O
as O O
shown O O
in O O
Fig. O O
6a O O
. O O

Finally B-conn Temporal.Precedence
, O O
the O O
gel O O
shift O O
assay O O
of O O
nuclear O O
protein O O
extracts O O
from O O
E2-treated O O
cells O O
again O O
showed O O
an O O
increase O O
of O O
the O O
p65 O O
subunit O O
DNA O O
binding O O
-LRB- O O
Fig. O O
6b O O
-RRB- O O
when B-conn Temporal.Synchronous
compared O O
with O O
other O O
conditions O O
. O O

Similar O O
results O O
were O O
obtained O O
during O O
staurosporine O O
treatment O O
. O O

Discussion O O

Monocytes/macrophages O O
contribute O O
to O O
the O O
autoimmune O O
process O O
, O O
mainly O O
acting O O
as O O
antigen-processing/presenting O O
cells O O
and O O
sources O O
of O O
inflammatory O O
cytokines O O
, O O
particularly O O
at O O
the O O
level O O
of O O
the O O
synovial O O
tissue O O
in O O
RA O O
-LSB-28 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
sex O O
hormones O O
can O O
exert O O
local O O
actions O O
-LRB- O O
paracrine O O
-RRB- O O
in O O
the O O
tissues O O
in O O
which O O
they O O
are O O
formed O O
, O O
including O O
the O O
synovial O O
tissue O O
-LSB-29,30 O O
-RSB- O O
. O O

Activated O O
THP-1 O O
cells O O
differentiate O O
into O O
macrophages O O
for O O
long-term O O
cultures O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
synovial O O
macrophages O O
are O O
characterized O O
by O O
a O O
short O O
life O O
during O O
in O O
vitro O O
culture O O
. O O

The O O
present O O
study O O
shows O O
opposite O O
effects O O
by O O
sex O O
hormones O O
on O O
cultures O O
of O O
activated O O
monocytic/macrophage O O
cells O O
-LRB- O O
THP-1 O O
cells O O
-RRB- O O
concerning O O
their O O
modulatory O O
effects O O
on O O
cell O O
proliferation O O
and/or O O
apoptosis O O
. O O

The O O
signalling O O
pathways O O
modulating O O
the O O
pro-inflammatory O O
and O O
anti-inflammatory O O
mechanisms O O
seem O O
to O O
involve O O
steroidal O O
hormone O O
receptor O O
activation O O
and O O
the O O
NF-κB O O
complex O O
factors O O
, O O
In B-conn Conjunction
addition I-conn Conjunction
, O O
oestrogens O O
may O O
differently O O
regulate O O
NF-κB O O
activation O O
depending O O
on O O
the O O
cell O O
type O O
tested O O
-LSB-14,31 O O
-RSB- O O
. O O

E2 O O
therefore B-conn Restatement.Specification
increased O O
the O O
expression O O
of O O
markers O O
of O O
cell O O
growth O O
and O O
proliferation O O
, O O
whereas B-conn Contrast
testosterone O O
induced O O
an O O
increase O O
of O O
the O O
PARP-cleaved O O
expression O O
, O O
indicating O O
DNA O O
damage O O
and O O
apoptosis O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
to B-conn Purpose.Goal
support O O
the O O
proliferative O O
role O O
exerted O O
by O O
E2 O O
, O O
the O O
THP-1 O O
cells O O
pre-treated O O
with O O
the O O
oestrogens O O
showed O O
a O O
decrease O O
of O O
staurosporine-induced O O
apoptosis O O
when B-conn Temporal.Synchronous
compared O O
with O O
testosterone-treated O O
and O O
untreated O O
cells O O
. O O

Furthermore B-conn Conjunction
, O O
the O O
increased O O
NF-κB O O
p65 O O
expression O O
and O O
the O O
evident O O
NF-κB O O
binding O O
to O O
DNA O O
in O O
E2-treated O O
cells O O
, O O
when B-conn Temporal.Synchronous
compared O O
with O O
untreated O O
cells O O
or O O
with O O
testosterone-treated O O
cells O O
, O O
as O O
well O O
as O O
the O O
increased O O
levels O O
of O O
the O O
IκB-α O O
phosphorylated O O
form O O
, O O
seems O O
to O O
support O O
the O O
major O O
enhancing O O
role O O
exerted O O
by O O
oestrogens O O
on O O
the O O
immune/inflammatory O O
response O O
by B-conn Purpose.Enablement
activating O O
the O O
NF-κB O O
complex O O
. O O

On B-conn Contrast
the I-conn Contrast
contrary I-conn Contrast
, O O
the O O
observed O O
positive O O
upregulation O O
of O O
IκB-α O O
exerted O O
by O O
testosterone O O
treatment O O
presumably O O
dampens O O
the O O
pro-inflammatory O O
effects O O
mediated O O
by O O
the O O
NF-κB O O
activation O O
, O O
and O O
therefore B-conn Cause.Claim
might O O
represent O O
a O O
further O O
mechanism O O
by O O
which O O
androgens O O
exert O O
anti-inflammatory O O
effects O O
. O O

Recent O O
studies O O
support O O
these O O
results O O
, O O
showing O O
that O O
E2 O O
inhibits O O
apoptosis O O
in O O
different O O
cell O O
types O O
-LRB- O O
cardiac O O
myocytes O O
and O O
others O O
-RRB- O O
whereas B-conn Contrast
androgens O O
have O O
been O O
found O O
to O O
induce O O
apoptosis O O
-LSB-32,33 O O
-RSB- O O
. O O

The O O
increased O O
concentrations O O
of O O
oestrogens O O
-LRB- O O
and O O
low O O
androgens O O
-RRB- O O
recently O O
described O O
at O O
the O O
level O O
of O O
the O O
synovial O O
fluid O O
of O O
RA O O
patients O O
of O O
both O O
sexes O O
-LSB-29 O O
-RSB- O O
seem O O
to O O
support O O
their O O
possible O O
modulator O O
roles O O
on O O
synovial O O
tissue O O
hyperplasia O O
and O O
chronic O O
synovial O O
cell O O
activation O O
, O O
by B-conn Purpose.Enablement
considering O O
the O O
oestrogenic O O
effects O O
on O O
cell O O
proliferation O O
and O O
apoptosis O O
. O O

These O O
observations O O
have O O
been O O
recently O O
obtained O O
also B-conn Conjunction
in O O
human O O
breast O O
cancer O O
cells O O
-LSB-34 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
explain O O
increased O O
oestrogen O O
concentrations O O
in O O
RA O O
synovial O O
fluids O O
, O O
the O O
pro-inflammatory O O
cytokines O O
-LRB- O O
tumour O O
necrosis O O
factor O O
alpha O O
, O O
IL-1β O O
, O O
IL-6 O O
-RRB- O O
have O O
been O O
found O O
to O O
accelerate O O
the O O
metabolic O O
conversion O O
of O O
oestrogens O O
from O O
androgens O O
by B-conn Purpose.Enablement
inducing O O
the O O
synovial O O
tissue O O
aromatases O O
-LSB-35-37 O O
-RSB- O O
. O O

As B-conn Cause.Result
a I-conn Cause.Result
consequence I-conn Cause.Result
, O O
locally O O
increased O O
oestrogen O O
levels O O
might O O
exert O O
activating O O
effects O O
on O O
synovial O O
cell O O
proliferation O O
, O O
including O O
macrophages O O
and O O
fibroblasts O O
-LSB-38 O O
-RSB- O O
. O O

Conclusion O O

In O O
the O O
present O O
study O O
the O O
concentrations O O
for O O
E2 O O
and O O
testosterone O O
tested O O
seem O O
to O O
modulate O O
the O O
activity O O
of O O
NF-κB O O
molecules O O
in O O
the O O
human O O
monocytic/macrophage O O
cell O O
line O O
-LRB- O O
THP-1 O O
-RRB- O O
with O O
opposite O O
effects O O
, O O
interfering O O
with O O
cell O O
growth O O
and O O
apoptosis O O
. O O

These O O
observations O O
might O O
provide O O
a O O
further O O
biological O O
link O O
between O O
gender O O
effects O O
and O O
the O O
complex O O
inflammatory O O
process O O
involved O O
in O O
rheumatoid O O
synovitis O O
. O O

Further O O
studies O O
, O O
using O O
peripheral O O
metabolites O O
of O O
oestrogens O O
and O O
synovial O O
macrophages O O
from O O
RA O O
patients O O
, O O
might O O
extend O O
the O O
value O O
of O O
these O O
observations O O
. O O

Abbreviations O O

DPBS O O
= O O
Dulbecco O O
's O O
phosphate-buffered O O
saline O O
; O O
E2 O O
= O O
17β-oestradiol O O
; O O
IFN O O
= O O
interferon O O
; O O
IL O O
= O O
interleukin O O
; O O
NF O O
= O O
nuclear O O
factor O O
; O O
PARP O O
= O O
poly-ADP O O
ribose O O
polymerase O O
; O O
PBS O O
= O O
phosphate-buffered O O
saline O O
; O O
PCNA O O
= O O
proliferating O O
cell O O
nuclear O O
antigen O O
; O O
RA O O
= O O
rheumatoid O O
arthritis O O
; O O
THP-1 O O
= O O
cultured O O
human O O
monocytic/macrophage O O
cell O O
line O O
. O O

Competing O O
interests O O

The O O
author O O
-LRB- O O
s O O
-RRB- O O
declare O O
that O O
they O O
have O O
no O O
competing O O
interests O O
. O O

Authors O O
' O O
contributions O O

MC O O
conceived O O
the O O
study O O
and O O
drafted O O
the O O
manuscript O O
. O O

SC O O
participated O O
in O O
conducting O O
THP-1 O O
cell O O
growth O O
and O O
the O O
functional O O
assay O O
. O O

PM O O
conducted O O
the O O
immunocytochemistry O O
assay O O
and O O
the O O
western O O
blot O O
assay O O
. O O

PG O O
conducted O O
the O O
electrophoretic O O
mobility O O
shift O O
assay O O
and O O
the O O
super O O
shift O O
assay O O
. O O

AS O O
helped O O
to O O
perform O O
statistical O O
analysis O O
. O O

BV O O
participated O O
in O O
the O O
study O O
design O O
, O O
coordination O O
and O O
data O O
analysis O O
, O O
and O O
drafted O O
the O O
manuscript O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Growth O O
rate O O
of O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
without O O
or O O
with O O
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
and O O
testosterone O O
-LRB- O O
T O O
-RRB- O O
, O O
and O O
with O O
staurosporine O O
after O O
168 O O
hours O O
. O O

The O O
number O O
of O O
recovered O O
live O O
cells O O
at O O
different O O
times O O
was O O
evaluated O O
using O O
the O O
methyl O O
tetrazolium O O
salt O O
reduction O O
test O O
. O O

Results O O
are O O
expressed O O
as O O
the O O
mean O O
± O O
standard O O
deviation O O
of O O
five O O
different O O
experiments O O
. O O

Figure O O
2 O O
: O O
Proliferating O O
cell O O
nuclear O O
antigen O O
-LRB- O O
PCNA O O
-RRB- O O
expression O O
in O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
. O O

-LRB- O O
a O O
-RRB- O O
Proliferating O O
cell O O
nuclear O O
antigen O O
-LRB- O O
PCNA O O
-RRB- O O
expression O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
after B-conn Temporal.Succession
hormonal O O
treatment O O
. O O

Results O O
are O O
expressed O O
as O O
the O O
mean O O
± O O
standard O O
deviation O O
of O O
the O O
percentage O O
of O O
staining O O
area O O
-LRB- O O
positive O O
area O O
defined O O
as O O
the O O
number O O
of O O
pixels O O
detectable O O
per O O
micron O O
square O O
-RRB- O O
for O O
100 O O
cells O O
in O O
five O O
different O O
experiments O O
. O O

Bottom O O
: O O
western O O
blot O O
analysis O O
. O O

-LRB- O O
b O O
-RRB- O O
PCNA O O
expression O O
in O O
untreated O O
THP-1 O O
cells O O
-LRB- O O
control O O
-LSB-cnt O O
-RSB- O O
-RRB- O O
. O O

-LRB- O O
c O O
-RRB- O O
PCNA O O
expression O O
in O O
THP-1 O O
cells O O
treated O O
with O O
testosterone O O
-LRB- O O
T O O
-RRB- O O
after O O
168 O O
hours O O
. O O

-LRB- O O
d O O
-RRB- O O
PCNA O O
expression O O
in O O
THP-1 O O
cells O O
treated O O
with O O
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
after O O
168 O O
hours O O
-LRB- O O
magnification O O
, O O
× O O
500 O O
-RRB- O O
. O O

Figure O O
3 O O
: O O
Apoptosis O O
evaluation O O
in O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
. O O

-LRB- O O
a O O
-RRB- O O
Apoptosis O O
evaluation O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
without O O
and O O
with O O
staurosporine O O
. O O

Results O O
are O O
expressed O O
as O O
the O O
mean O O
± O O
standard O O
deviation O O
of O O
the O O
percentage O O
number O O
of O O
annexin-positive O O
cells O O
in O O
five O O
different O O
experiments O O
. O O

-LRB- O O
b O O
-RRB- O O
Apoptotic O O
DNA O O
evaluation O O
in O O
THP-1 O O
cells O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
without O O
staurosporine O O
as O O
detected O O
by O O
flow O O
analysis O O
cytometry O O
scatter O O
analysis O O
. O O

Region O O
G O O
, O O
control O O
-LRB- O O
cnt O O
-RRB- O O
, O O
3.96 O O
% O O
; O O
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
, O O
5.54 O O
% O O
; O O
testosterone O O
-LRB- O O
T O O
-RRB- O O
, O O
15.9 O O
% O O
. O O

-LRB- O O
c O O
-RRB- O O
Apoptotic O O
DNA O O
evaluation O O
in O O
THP-1 O O
cells O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
and O O
staurosporine O O
-LRB- O O
stau O O
-RRB- O O
for O O
24 O O
hours O O
, O O
as O O
detected O O
by O O
flow O O
analysis O O
cytometry O O
scatter O O
analysis O O
. O O

Region O O
G O O
: O O
control/S O O
, O O
18.9 O O
% O O
; O O
E2/S O O
, O O
16.5 O O
% O O
; O O
T/S O O
, O O
24.5 O O
% O O
. O O

PI O O
, O O
propidium O O
iodide O O
. O O

Figure O O
4 O O
: O O
Poly-ADP-ribose O O
polymerase O O
-LRB- O O
PARP O O
-RRB- O O
-cleaved O O
expression O O
in O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
. O O

-LRB- O O
a O O
-RRB- O O
Poly-ADP-ribose O O
polymerase O O
-LRB- O O
PARP O O
-RRB- O O
-cleaved O O
expression O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
in O O
basal O O
conditions O O
and O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
and O O
staurosporine O O
-LRB- O O
stau O O
-RRB- O O
. O O

Results O O
are O O
expressed O O
as O O
the O O
mean O O
± O O
standard O O
deviation O O
of O O
the O O
percentage O O
of O O
the O O
positive O O
area O O
for O O
100 O O
cells O O
in O O
five O O
different O O
experiments O O
. O O

Bottom O O
: O O
western O O
blot O O
analysis O O
related O O
to O O
PARP-cleaved O O
expression O O
in O O
untreated O O
cells O O
-LRB- O O
basal O O
condition O O
-RRB- O O
and O O
cells O O
treated O O
with O O
hormones O O
and O O
staurosporine O O
. O O

-LRB- O O
b O O
-RRB- O O
PARP-cleaved O O
expression O O
in O O
THP-1 O O
cells O O
-LRB- O O
basal O O
condition O O
-RRB- O O
. O O

-LRB- O O
c O O
-RRB- O O
PARP-cleaved O O
expression O O
in O O
THP-1 O O
cells O O
after O O
normal O O
medium O O
. O O

-LRB- O O
d O O
-RRB- O O
PARP-cleaved O O
expression O O
in O O
THP-1 O O
cells O O
after B-conn Temporal.Succession
testosterone O O
-LRB- O O
T O O
-RRB- O O
treatment O O
. O O

-LRB- O O
e O O
-RRB- O O
PARP-cleaved O O
expression O O
in O O
THP-1 O O
cells O O
after B-conn Temporal.Succession
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
treatment O O
. O O

cnt O O
, O O
control O O
. O O

Figure O O
5 O O
: O O
NF-κB O O
p65 O O
, O O
IκB-α O O
and O O
phosphorylated O O
IκB-α O O
-LRB- O O
ser O O
32 O O
-RRB- O O
protein O O
expression O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
without O O
or O O
with O O
staurosporine O O
. O O

The O O
results O O
are O O
representative O O
of O O
four O O
separate O O
experiments O O
. O O

CNT O O
, O O
control O O
; O O
T O O
, O O
testosterone O O
; O O
E2 O O
, O O
17β-oestradiol O O
. O O

Figure O O
6 O O
: O O
Electrophoretic O O
mobility O O
shift O O
assay O O
for O O
NF-κB O O
-LRB- O O
arrow O O
-RRB- O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
. O O

-LRB- O O
a O O
-RRB- O O
Electrophoretic O O
mobility O O
shift O O
assay O O
for O O
NF-κB O O
-LRB- O O
arrow O O
-RRB- O O
in O O
the O O
cultured O O
human O O
THP-1 O O
cell O O
line O O
after O O
168 O O
hours O O
of O O
hormonal O O
treatment O O
and O O
without O O
or O O
with O O
staurosporine O O
-LRB- O O
17 O O
nM O O
-RRB- O O
reveals O O
an O O
increased O O
DNA O O
binding O O
in O O
17β-oestradiol O O
-LRB- O O
E2 O O
-RRB- O O
-treated O O
cells O O
. O O

-LRB- O O
b O O
-RRB- O O
Super O O
shift O O
assay O O
for O O
p65 O O
-LRB- O O
arrow O O
-RRB- O O
in O O
the O O
cells O O
under O O
the O O
same O O
conditions O O
confirms O O
the O O
increased O O
binding O O
of O O
p65 O O
in O O
E2-treated O O
cells O O
. O O

The O O
results O O
are O O
representative O O
of O O
four O O
separate O O
experiments O O
. O O

cnt O O
, O O
control O O
; O O
T O O
, O O
testosterone O O
. O O

Table O O
1 O O
: O O
NF-κB O O
complex O O
, O O
IκB-α O O
and O O
IκB-α-ser O O
32 O O
evaluated O O
by O O
immunocytochemistry O O

Development O O
of O O
real-time O O
NASBA O O
assays O O
with O O
molecular O O
beacon O O
detection O O
to O O
quantify O O
mRNA O O
coding O O
for O O
HHV-8 O O
lytic O O
and O O
latent O O
genes O O

Abstract O O

Background O O
: O O
Human O O
herpesvirus-8 O O
-LRB- O O
HHV-8 O O
-RRB- O O
is O O
linked O O
to O O
the O O
pathogenesis O O
of O O
Kaposi O O
's O O
sarcoma O O
-LRB- O O
KS O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
HHV-8 O O
DNA O O
load O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
-LRB- O O
PBMC O O
-RRB- O O
is O O
associated O O
with O O
the O O
clinical O O
stage O O
of O O
KS O O
. O O

To B-conn Purpose.Goal
examine O O
the O O
expression O O
of O O
HHV-8 O O
in O O
PBMC O O
, O O
four O O
HHV-8 O O
mRNA O O
specific O O
NASBA O O
assays O O
were O O
developedMethodsWe O O
have O O
developed O O
four O O
quantitative O O
nucleic O O
acid O O
sequence-based O O
amplification O O
assays O O
-LRB- O O
NASBA-QT O O
-RRB- O O
specifically B-conn Purpose.Goal
to I-conn Purpose.Goal
detect O O
mRNA O O
coding O O
for O O
ORF O O
73 O O
-LRB- O O
latency-associated O O
nuclear O O
antigen O O
, O O
LANA O O
-RRB- O O
, O O
vGCR O O
-LRB- O O
a O O
membrane O O
receptor O O
-RRB- O O
, O O
vBcl-2 O O
-LRB- O O
a O O
viral O O
inhibitor O O
of O O
apoptosis O O
-RRB- O O
and O O
vIL-6 O O
-LRB- O O
a O O
viral O O
growth O O
factor O O
-RRB- O O
. O O

The O O
NASBA O O
technique O O
amplifies O O
nucleic O O
acids O O
without O O
thermocycling O O
and B-conn Conjunction
mRNA O O
can O O
be O O
amplified O O
in O O
a O O
dsDNA O O
background O O
. O O

A O O
molecular O O
beacon O O
is O O
used O O
during O O
amplification O O
to B-conn Purpose.Goal
enable O O
real-time O O
detection O O
of O O
the O O
product O O
. O O

The O O
assays O O
were O O
tested O O
on O O
PBMC O O
samples O O
of O O
two O O
AIDS-KS O O
patients O O
from O O
the O O
Amsterdam O O
Cohort O O
. O O

Results O O
: O O
For O O
all O O
four O O
assays O O
, O O
the O O
limit O O
of O O
detection O O
-LRB- O O
LOD O O
-RRB- O O
of O O
50 O O
molecules O O
and O O
the O O
limit O O
of O O
quantification O O
-LRB- O O
LOQ O O
-RRB- O O
of O O
100 O O
molecules O O
were O O
determined O O
using O O
in O O
vitro O O
transcribed O O
RNA O O
. O O

The O O
linear O O
dynamic O O
range O O
was O O
50 O O
to O O
107 O O
molecules O O
of O O
HHV-8 O O
mRNA O O
. O O

We O O
found O O
HHV-8 O O
mRNA O O
expression O O
in O O
9 O O
out O O
of O O
the O O
10 O O
tested O O
samples O O
. O O

Conclusion O O
: O O
These O O
real-time O O
NASBA O O
assays O O
with O O
beacon O O
detection O O
provide O O
tools O O
for O O
further O O
study O O
of O O
HHV-8 O O
expression O O
in O O
patient O O
material O O
. O O

Background O O

Homosexual O O
men O O
infected O O
with O O
HIV-1 O O
are O O
at O O
increased O O
risk O O
for O O
developing O O
AIDS-related O O
Kaposi O O
's O O
sarcoma O O
-LRB- O O
AIDS-KS O O
-RRB- O O
due B-conn Cause.Reason
to I-conn Cause.Reason
co-infection O O
with O O
HHV-8 O O
, O O
a O O
gamma O O
herpes O O
virus O O
. O O

Also O O
known O O
as O O
Kaposi O O
's O O
sarcoma O O
associated O O
herpes O O
virus O O
, O O
HHV-8 O O
was O O
first O O
discovered O O
in O O
1994 O O
in O O
KS-affected O O
tissue O O
-LSB-1 O O
-RSB- O O
. O O

Since B-conn Temporal.Precedence
then I-conn Temporal.Precedence
it O O
also B-conn Conjunction
has O O
been O O
associated O O
with O O
the O O
development O O
of O O
multicentric O O
Castleman O O
's O O
disease O O
and O O
primary O O
effusion O O
lymphoma O O
-LRB- O O
PEL O O
-RRB- O O
-LSB-2-5 O O
-RSB- O O
. O O

HHV-8 O O
DNA O O
has O O
been O O
detected O O
in O O
both O O
tissues O O
and O O
bodily O O
fluids O O
-LSB-6,7 O O
-RSB- O O
. O O

Studies O O
initially O O
focused O O
on O O
HHV-8 O O
and O O
its O O
association O O
with O O
KS O O
, O O
transmission O O
of O O
HHV-8 O O
, O O
and O O
the O O
natural O O
history O O
of O O
HHV-8 O O
infection O O
. O O

As O O
shown O O
by O O
Renwick O O
et O O
al. O O
and O O
Jacobsen O O
et O O
al. O O
-LSB-8,9 O O
-RSB- O O
seroconversion O O
for O O
HHV-8 O O
during O O
HIV O O
infection O O
increases O O
the O O
risk O O
of O O
developing O O
KS O O
, O O
implying O O
that O O
HIV-1 O O
has O O
an O O
impact O O
on O O
HHV-8 O O
. O O

Laboratory O O
assays O O
developed O O
for O O
the O O
detection O O
of O O
HHV-8 O O
include O O
serologic O O
assays O O
such O O
as O O
immunofluorescence O O
antibody O O
assays O O
-LSB-10-13 O O
-RSB- O O
, O O
immunoblot O O
assays O O
-LSB-10 O O
-RSB- O O
, O O
and O O
various O O
enzyme O O
immunoassays O O
-LSB-14-16 O O
-RSB- O O
. O O

PCR-based O O
assays O O
have O O
also B-conn Conjunction
been O O
used O O
to O O
detect O O
HHV-8 O O
DNA O O
-LSB-1 O O
-RSB- O O
. O O

With O O
the O O
serologic O O
assays O O
, O O
sensitivity O O
and O O
specificity O O
are O O
always O O
problematic O O
. O O

No O O
single O O
assay O O
is O O
completely O O
sensitive O O
and O O
specific O O
-LSB-17 O O
-RSB- O O
. O O

We O O
would O O
prefer O O
a O O
method O O
using O O
viral O O
RNA O O
or O O
DNA O O
as O O
a O O
marker O O
for O O
the O O
presence O O
of O O
HHV-8 O O
. O O

Though B-conn Concession.Expectation
DNA O O
is O O
an O O
obvious O O
choice O O
because B-conn Cause.Reason
HHV-8 O O
is O O
a O O
DNA O O
virus O O
, O O
we O O
have O O
chosen O O
RNA O O
, O O
because B-conn Cause.Reason
it O O
indicates O O
activity O O
of O O
the O O
virus O O
and O O
may O O
thus B-conn Cause.Claim
be O O
a O O
better O O
prognostic O O
marker O O
. O O

Active O O
infected O O
cells O O
produce O O
more O O
RNA O O
than O O
DNA O O
. O O

In O O
situ O O
hybridisation O O
has O O
shown O O
that O O
most O O
HHV-8 O O
infected O O
cells O O
in O O
KS O O
lesions O O
are O O
latently O O
infected O O
-LSB-18,19 O O
-RSB- O O
. O O

but B-conn Contrast
lytic O O
HHV-8 O O
infection O O
is O O
clearly O O
present O O
in O O
a O O
small O O
proportion O O
of O O
cells O O
-LSB-20-22 O O
-RSB- O O
. O O

A O O
method O O
for O O
the O O
detection O O
of O O
RNA O O
is O O
RT-PCR O O
. O O

To B-conn Purpose.Goal
increase O O
sensitivity O O
an O O
additional O O
amplification O O
step O O
can O O
follow O O
the O O
RT-PCR O O
. O O

This O O
method O O
is O O
time O O
consuming O O
and O O
also B-conn Conjunction
increases O O
the O O
likelihood O O
of O O
false O O
positive O O
reactions O O
due B-conn Cause.Reason
to I-conn Cause.Reason
cross-contamination. O O
Nucleic O O
acid O O
sequence-based O O
amplification O O
-LRB- O O
NASBA O O
-RRB- O O
is O O
a O O
single-step O O
isothermal O O
RNA-specific O O
amplification O O
process O O
-LSB-23 O O
-RSB- O O
that O O
amplifies O O
mRNA O O
in O O
a O O
dsDNA O O
background O O
-LSB-24 O O
-RSB- O O
. O O

NASBA O O
has O O
proved O O
successful O O
in O O
the O O
detection O O
of O O
various O O
mRNAs O O
-LSB-24-26 O O
-RSB- O O
and O O
in O O
the O O
detection O O
of O O
both O O
viral O O
-LSB-23 O O
-RSB- O O
and O O
bacterial O O
-LSB-27 O O
-RSB- O O
RNA O O
in O O
clinical O O
samples O O
. O O

By B-conn Purpose.Enablement
combining O O
the O O
standard O O
NASBA O O
technology O O
-LSB-28 O O
-RSB- O O
with O O
a O O
molecular O O
beacon O O
that O O
anneals O O
during O O
amplification O O
to O O
the O O
target O O
sequence O O
, O O
a O O
real-time O O
detection O O
system O O
is O O
generated O O
-LSB-29 O O
-RSB- O O
. O O

This O O
paper O O
describes O O
our O O
development O O
of O O
real-time O O
NASBA O O
assays O O
to O O
quantify O O
four O O
functionally O O
different O O
genes O O
of O O
HHV-8 O O
: O O
ORF O O
73 O O
, O O
a O O
latent O O
gene O O
, O O
vGCR O O
, O O
a O O
constitutively O O
active O O
gene O O
, O O
and O O
the O O
lytic O O
genes O O
vBcl-2 O O
and O O
vIL-6 O O
. O O

To B-conn Purpose.Goal
normalise O O
the O O
input O O
mRNA O O
we O O
developed O O
a O O
fifth O O
NASBA O O
for O O
a O O
constitutively O O
expressed O O
mRNA O O
, O O
U1A O O
mRNA O O
, O O
and O O
standardised O O
the O O
specific O O
HHV8 O O
mRNAs O O
to O O
the O O
expression O O
of O O
U1A O O
mRNA O O
. O O

Methods O O

Our O O
first O O
assay O O
was O O
developed O O
for O O
ORF O O
73 O O
and O O
is O O
based O O
on O O
the O O
amplification O O
of O O
a O O
192 O O
bp O O
fragment O O
situated O O
within O O
the O O
gene O O
. O O

ORF O O
73 O O
encodes O O
the O O
major O O
immunogenic O O
latency-associated O O
nuclear O O
antigen O O
-LRB- O O
LANA O O
-RRB- O O
of O O
HHV-8 O O
. O O

LANA O O
is O O
essential O O
for O O
maintenance O O
of O O
this O O
virus O O
in O O
latently O O
infected O O
cells O O
-LSB-30,31 O O
-RSB- O O
. O O

It O O
is O O
expressed O O
only O O
in O O
such O O
cells O O
and O O
thus B-conn Cause.Result
gives O O
a O O
good O O
indication O O
of O O
latent O O
HHV-8 O O
infection O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
LANA O O
interacts O O
with O O
the O O
tumour O O
suppressor O O
protein O O
p53 O O
and O O
represses O O
its O O
transcriptional O O
activity O O
-LSB-32 O O
-RSB- O O
. O O

Our O O
second O O
assay O O
was O O
developed O O
for O O
vGCR O O
, O O
G-protein O O
coupled O O
receptor O O
, O O
and O O
amplifies O O
a O O
168 O O
bp O O
fragment O O
. O O

A O O
receptor O O
that O O
binds O O
several O O
CXC O O
and O O
CC O O
chemokines O O
, O O
vGCR O O
appears O O
to O O
be O O
constitutively O O
active O O
-LSB-33 O O
-RSB- O O
, O O
although B-conn Contrast
some O O
studies O O
indicate O O
that O O
it O O
is O O
expressed O O
only O O
during O O
lytic O O
replication O O
-LSB-34 O O
-RSB- O O
. O O

It O O
may O O
contribute O O
to O O
the O O
pathogenesis O O
of O O
KS O O
by B-conn Purpose.Enablement
increasing O O
the O O
release O O
of O O
cellular O O
growth O O
factors O O
such O O
as O O
VEGF O O
-LSB-33 O O
-RSB- O O
. O O

It O O
transforms O O
rodent O O
fibroblasts O O
and O O
induces O O
expression O O
of O O
angiogenic O O
factors O O
-LSB-35 O O
-RSB- O O
. O O

The O O
final O O
two O O
assays O O
were O O
developed O O
for O O
the O O
genes O O
vBcl-2 O O
and O O
vIL-6 O O
. O O

The O O
assay O O
for O O
vBcl-2 O O
amplifies O O
a O O
216-bp O O
fragment O O
, O O
and B-conn Conjunction
for O O
vIL-6 O O
the O O
fragment O O
is O O
186 O O
bp O O
. O O

vBcl-2 O O
and O O
vIL-6 O O
are O O
both O O
early O O
lytic O O
genes O O
, O O
as B-conn Cause.Justification
their O O
expression O O
increases O O
within O O
10 O O
hours O O
after B-conn Temporal.Succession
induction O O
-LSB-9 O O
-RSB- O O
. O O

vBcl-2 O O
is O O
a O O
member O O
of O O
the O O
Bcl-2 O O
family O O
, O O
and B-conn Continuation
functional O O
studies O O
indicate O O
that O O
vBcl-2 O O
prevents O O
Bax-mediated O O
apoptosis O O
and O O
thus B-conn Cause.Claim
is O O
an O O
anti-apoptotic O O
protein O O
-LSB-36,37 O O
-RSB- O O
. O O

It O O
is O O
primarily O O
active O O
during O O
lytic O O
replication O O
and B-conn Conjunction
its O O
expression O O
pattern O O
suggests O O
that O O
it O O
may O O
function O O
to O O
prolong O O
the O O
survival O O
of O O
cells O O
in O O
which O O
lytic O O
infection O O
is O O
present O O
. O O

vIL-6 O O
is O O
a O O
secreted O O
cytokine O O
that O O
maintains O O
proliferation O O
of O O
IL-6-dependent O O
mouse O O
and O O
human O O
mycelia O O
cell O O
lines O O
-LSB-21,38,39 O O
-RSB- O O
and O O
prevents O O
apoptosis O O
-LSB-21,38,40 O O
-RSB- O O
. O O

A O O
NASBA O O
reaction O O
is O O
based O O
on O O
the O O
simultaneous O O
activity O O
of O O
avian O O
myeloblastosis O O
virus O O
-LRB- O O
AMV O O
-RRB- O O
reverse O O
transcriptase O O
-LRB- O O
RT O O
-RRB- O O
, O O
RNase O O
H O O
and O O
T7 O O
RNA O O
polymerase O O
with O O
two O O
oligonucleotide O O
primers O O
to B-conn Purpose.Goal
produce O O
amplification O O
of O O
the O O
desired O O
fragment O O
more O O
than O O
1012 O O
fold O O
in O O
90 O O
to O O
120 O O
minutes O O
-LSB-23,41 O O
-RSB- O O
. O O

In O O
a O O
NASBA O O
reaction O O
, O O
nucleic O O
acids O O
are O O
a O O
template O O
for O O
the O O
amplification O O
reaction O O
only B-conn Condition.Hypothetical
if I-conn Condition.Hypothetical
they O O
are O O
single O O
stranded O O
and O O
located O O
in O O
the O O
primer-binding O O
region O O
. O O

Because B-conn Cause.Reason
the O O
NASBA O O
reaction O O
is O O
isothermal O O
-LRB- O O
41°C O O
-RRB- O O
, O O
specific O O
amplification O O
of O O
ssRNA O O
is O O
possible O O
if B-conn Condition.Hypothetical
denaturation O O
of O O
dsDNA O O
is O O
prevented O O
in O O
the O O
sample O O
preparation O O
procedure O O
. O O

It O O
is O O
thus B-conn Cause.Claim
possible O O
to O O
pickup O O
mRNA O O
in O O
a O O
dsDNA O O
background O O
without O O
getting O O
false O O
positive O O
results O O
caused O O
by O O
genomic O O
dsDNA O O
, O O
in O O
contrast O O
with O O
RT-PCR O O
. O O

In O O
figure O O
1 O O
a O O
schematic O O
presentation O O
of O O
the O O
NASBA O O
amplification O O
is O O
given O O
. O O

NASBA O O
is O O
achieved O O
with O O
the O O
P1 O O
-LRB- O O
antisense O O
-RRB- O O
– O O
P2 O O
-LRB- O O
sense O O
-RRB- O O
oligonucleotide O O
set O O
. O O

The O O
overhang O O
on O O
P1 O O
encodes O O
the O O
promoter O O
sequence O O
for O O
the O O
T7 O O
RNA O O
polymerase O O
. O O

By B-conn Purpose.Enablement
using O O
molecular O O
beacons O O
with O O
the O O
NASBA O O
amplification O O
a O O
real-time O O
detection O O
system O O
can O O
be O O
generated O O
. O O

Molecular O O
beacons O O
are O O
stem-and-loop-structured O O
oligonucleotides O O
with O O
a O O
fluorescent O O
label O O
at O O
the O O
5 O O
' O O
end O O
and O O
a O O
universal O O
quencher O O
at O O
the O O
3 O O
' O O
end O O
. O O

They O O
are O O
highly O O
specific O O
for O O
their O O
target O O
and O O
hybridise O O
with O O
their O O
amplified O O
target O O
RNA O O
when B-conn Temporal.Synchronous
present O O
in O O
a O O
NASBA O O
amplification O O
reaction O O
to O O
form O O
a O O
stable O O
hybrid O O
-LSB-42 O O
-RSB- O O
at O O
a O O
relative O O
low O O
temperature O O
-LRB- O O
41°C O O
-RRB- O O
. O O

The O O
NASBA O O
quantification O O
method O O
is O O
based O O
on O O
a O O
standard O O
curve O O
with O O
a O O
known O O
input O O
of O O
RNA O O
. O O

For O O
this O O
input O O
we O O
used O O
in O O
vitro O O
RNA O O
that O O
was O O
transcribed O O
from O O
four O O
different O O
plasmids O O
. O O

These O O
plasmids O O
were O O
generated O O
by B-conn Purpose.Enablement
cloning O O
a O O
specific O O
PCR O O
product O O
for O O
each O O
of O O
the O O
four O O
target O O
genes O O
, O O
using O O
primer O O
sets O O
located O O
on O O
the O O
borders O O
of O O
the O O
different O O
genes O O
. O O

Primer O O
sequences O O
are O O
shown O O
in O O
table O O
1. O O
Input O O
for O O
the O O
PCR O O
was O O
the O O
nucleic O O
acids O O
of O O
the O O
BCP-1 O O
cell O O
line O O
-LRB- O O
a O O
cell O O
line O O
containing O O
HHV-8 O O
-RRB- O O
. O O

The O O
sizes O O
of O O
the O O
four O O
different O O
PCR O O
fragments O O
were O O
595 O O
bp O O
, O O
926 O O
bp O O
, O O
473 O O
bp O O
, O O
and O O
589 O O
bp O O
for O O
ORF O O
73 O O
, O O
vGCR O O
, O O
vBcl-2 O O
and O O
vIL-6 O O
, O O
respectively O O
-LRB- O O
table O O
1 O O
-RRB- O O
. O O

Each O O
PCR O O
fragment O O
was O O
cloned O O
into O O
the O O
TOPO-TA O O
plasmid O O
-LRB- O O
Invitrogen/ O O
Lifetechnologies O O
, O O
Carlsbad O O
, O O
USA O O
-RRB- O O
, O O
and B-conn Conjunction
after B-conn Temporal.Succession
all O O
inserts O O
were O O
verified O O
by B-conn Purpose.Enablement
sequencing O O
, O O
the O O
fragments O O
were O O
cloned O O
in O O
a O O
plasmide O O
, O O
pBluescript O O
SK O O
-LRB- O O
Stratagene O O
, O O
La O O
Jolla O O
, O O
USA O O
-RRB- O O
. O O

In O O
vitro O O
RNA O O
was O O
generated O O
from O O
these O O
plasmids O O
using O O
T7 O O
or O O
T3 O O
RNA O O
polymerase O O
, O O
depending O O
on O O
the O O
orientation O O
of O O
the O O
fragment O O
, O O
and O O
was O O
treated O O
with O O
DNase O O
to B-conn Purpose.Goal
remove O O
the O O
plasmid O O
. O O

The O O
Q-RNA O O
was O O
purified O O
by O O
RNeasy O O
-LRB- O O
Qiagen O O
, O O
Hilden O O
, O O
Germany O O
-RRB- O O
, O O
quantified O O
spectrophotometrically O O
, O O
and O O
checked O O
by O O
eye O O
on O O
agarose O O
gel O O
. O O

The O O
resulting O O
in O O
vitro O O
RNA O O
was O O
used O O
for O O
the O O
four O O
different O O
standard O O
curves O O
. O O

NASBA O O
amplification O O
requires O O
a O O
sense O O
and O O
an O O
anti-sense O O
primer O O
, O O
and B-conn Conjunction
for O O
real-time O O
detection O O
a O O
unique O O
beacon O O
is O O
added O O
to O O
the O O
reaction O O
. O O

We O O
developed O O
molecular O O
beacons O O
that O O
could O O
hybridise O O
with O O
the O O
known O O
sequences O O
of O O
the O O
four O O
HHV-8 O O
genes O O
, O O
as O O
shown O O
in O O
table O O
2. O O
All O O
the O O
beacons O O
have O O
6-fluorescine O O
-LRB- O O
6-FAM O O
-RRB- O O
as O O
the O O
fluorescent O O
label O O
at O O
the O O
5 O O
' O O
end O O
and O O
a O O
-LRB- O O
4- O O
-LRB- O O
dimethylamino O O
-RRB- O O
phenyl O O
-RRB- O O
azo O O
-RRB- O O
benzoic O O
acid O O
-LRB- O O
Dabcyl O O
-RRB- O O
as O O
universal O O
quencher O O
at O O
the O O
3 O O
' O O
end O O
. O O

A O O
BLAST O O
analysis O O
revealed O O
that O O
in O O
each O O
case O O
, O O
neither O O
the O O
primers O O
nor O O
the O O
beacon O O
shared O O
significant O O
homology O O
with O O
any O O
known O O
nucleotide O O
sequences O O
other O O
than O O
the O O
target O O
gene O O
. O O

The O O
quality O O
of O O
the O O
different O O
beacons O O
was O O
tested O O
with O O
a O O
melting O O
curve O O
-LRB- O O
from O O
80°C O O
to O O
20°C O O
-RRB- O O
and O O
acryl O O
amide O O
gel O O
electrophoresis O O
. O O

Each O O
reaction O O
consisted O O
of O O
5 O O
μl O O
of O O
the O O
sample O O
RNA O O
and O O
10 O O
μl O O
of O O
NASBA O O
reaction O O
mix O O
. O O

This O O
mix O O
consisted O O
of O O
80 O O
mM O O
Tris-HCl O O
-LSB-pH O O
8.5 O O
-RSB- O O
, O O
24 O O
mM O O
MgCl2 O O
, O O
140 O O
mM O O
KCl O O
, O O
1.0 O O
mM O O
DTT O O
, O O
2.0 O O
mM O O
of O O
each O O
dNTP O O
, O O
4.0 O O
mM O O
each O O
of O O
ATP O O
, O O
UTP O O
and O O
CTP O O
, O O
3.0 O O
mM O O
GTP O O
, O O
and O O
1.0 O O
mM O O
ITP O O
in O O
30 O O
% O O
DMSO O O
. O O

This O O
solution O O
also B-conn Conjunction
contained O O
the O O
anti-sense O O
and O O
sense O O
primers O O
for O O
amplification O O
and O O
the O O
molecular O O
beacons O O
used O O
for O O
detection O O
. O O

The O O
final O O
concentration O O
for O O
the O O
primes O O
was O O
0.1 O O
μM O O
and O O
for O O
the O O
beacons O O
40 O O
nM O O
. O O

The O O
reaction O O
mixtures O O
were O O
incubated O O
at O O
65°C O O
for O O
5 O O
min O O
, O O
and B-conn Conjunction
after B-conn Temporal.Succession
cooling O O
to O O
41°C O O
for O O
5 O O
min O O
to B-conn Purpose.Goal
allow O O
for O O
primer O O
annealing O O
, O O
5 O O
μl O O
of O O
enzyme O O
mix O O
was O O
added O O
by B-conn Purpose.Enablement
pipetting O O
into O O
the O O
lids O O
of O O
the O O
microtubes O O
and O O
subsequently B-conn Temporal.Precedence
spinning O O
down O O
. O O

This O O
mix O O
contained O O
, O O
per O O
reaction O O
, O O
375 O O
mM O O
sorbitol O O
, O O
2.1 O O
μg O O
BSA O O
, O O
0.08 O O
U O O
RNase O O
H O O
, O O
32 O O
U O O
T7 O O
RNA O O
polymerase O O
and O O
6.4 O O
U O O
AMV O O
reverse O O
transcriptase O O
. O O

Reactions O O
were O O
incubated O O
at O O
41°C O O
for O O
120 O O
min O O
in O O
a O O
fluorometer O O
-LRB- O O
Cytofluor O O
4000 O O
; O O
Perkin-Elmer O O
, O O
Wellesley O O
, O O
Mass. O O
-RRB- O O
. O O

The O O
RNA O O
amplicons O O
generated O O
in O O
the O O
NASBA O O
process O O
are O O
detected O O
by O O
molecular O O
beacons O O
-LSB-29 O O
-RSB- O O
. O O

These O O
beacons O O
generate O O
a O O
fluorescent O O
signal O O
during O O
amplification O O
when B-conn Temporal.Synchronous
hybridising O O
with O O
their O O
target O O
. O O

The O O
fluorescence O O
is O O
measured O O
continuously O O
during O O
amplification O O
for B-conn Purpose.Goal
real-time O O
monitoring O O
-LRB- O O
i.e. O O
, O O
as O O
the O O
reaction O O
proceeds O O
-RRB- O O
. O O

A O O
threshold O O
is O O
determined O O
by B-conn Purpose.Enablement
setting O O
the O O
fluorescence O O
emitted O O
in O O
the O O
first O O
5 O O
measure O O
points O O
as O O
a O O
background O O
. O O

The O O
time-point O O
at O O
which O O
a O O
reaction O O
rises O O
above O O
this O O
threshold O O
of O O
detection O O
and O O
becomes O O
positive O O
is O O
determined O O
. O O

This O O
time-to-positivity O O
-LRB- O O
TTP O O
-RRB- O O
principle O O
is O O
similar O O
to O O
real-time O O
PCR O O
-LSB-43 O O
-RSB- O O
. O O

A O O
calibration O O
curve O O
with O O
50 O O
, O O
102 O O
, O O
103 O O
, O O
104 O O
, O O
105 O O
, O O
106 O O
and O O
107 O O
molecules O O
HHV-8 O O
mRNA O O
was O O
included O O
in O O
each O O
experiment O O
. O O

The O O
number O O
of O O
mRNA O O
copies O O
per O O
sample O O
input O O
can O O
be O O
extrapolated O O
from O O
the O O
standard O O
curve O O
. O O

De O O
Baar O O
et O O
al O O
showed O O
that O O
it O O
is O O
possible O O
to O O
use O O
ttp O O
values O O
for O O
quantification O O
without O O
the O O
use O O
of O O
an O O
internal O O
calibrator O O
-LSB-44 O O
-RSB- O O
. O O

For B-conn Purpose.Goal
standardisation O O
of O O
the O O
amount O O
of O O
RNA O O
input O O
the O O
U1A O O
assay O O
was O O
used O O
in O O
each O O
experiment O O
. O O

U1A O O
mRNA O O
encodes O O
for O O
one O O
of O O
the O O
proteins O O
of O O
the O O
U1 O O
snRNP O O
-LSB-45,46 O O
-RSB- O O
. O O

Because B-conn Cause.Reason
U1A O O
is O O
constitutively O O
expressed O O
, O O
the O O
amount O O
of O O
U1A O O
mRNA O O
measured O O
in O O
the O O
samples O O
is O O
an O O
indication O O
of O O
total O O
RNA O O
input O O
. O O

The O O
mean O O
of O O
6 O O
assays O O
-LRB- O O
variation O O
0.6 O O
log O O
-RRB- O O
was O O
taken O O
as O O
the O O
input O O
RNA O O
amount O O
of O O
the O O
sample O O
, O O
and B-conn Conjunction
sample O O
input O O
RNA O O
was O O
normalised O O
accordingly O O
. O O

The O O
NASBA O O
conditions O O
for O O
the O O
U1A O O
assay O O
were O O
the O O
same O O
as O O
those O O
for O O
the O O
HHV-8 O O
assay O O
, O O
with O O
the O O
exception O O
of O O
the O O
final O O
concentration O O
of O O
the O O
primer O O
-LRB- O O
0.2 O O
μM O O
-RRB- O O
and O O
the O O
beacon O O
-LRB- O O
50 O O
nM O O
-RRB- O O
. O O

The O O
DNA O O
fractions O O
of O O
the O O
PBMC O O
samples O O
were O O
tested O O
for O O
the O O
presence O O
of O O
HHV-8 O O
DNA O O
using O O
a O O
nested O O
PCR O O
for O O
ORF O O
73 O O
described O O
by O O
Goudsmit O O
et O O
al. O O
-LSB-47 O O
-RSB- O O
. O O

As O O
a O O
quantification O O
of O O
the O O
amount O O
of O O
DNA O O
input O O
, O O
a O O
limited O O
dilution O O
PCR O O
for O O
the O O
cellular O O
CCR5 O O
gene O O
was O O
used O O
. O O

With O O
limited O O
dilution O O
, O O
an O O
estimation O O
of O O
copies O O
of O O
HHV-8 O O
DNA O O
was O O
made O O
in O O
relation O O
to O O
the O O
amount O O
of O O
cells O O
. O O

For O O
both O O
the O O
ORF O O
73 O O
and O O
the O O
CCR5 O O
nested O O
PCR O O
, O O
the O O
detection O O
level O O
was O O
5 O O
molecules O O
input O O
per O O
reaction O O
. O O

To B-conn Purpose.Goal
test O O
our O O
assays O O
in O O
vivo O O
, O O
we O O
selected O O
PBMC O O
samples O O
from O O
two O O
participants O O
of O O
the O O
Amsterdam O O
Cohort O O
Studies O O
. O O

Described O O
elsewhere O O
in O O
detail O O
-LSB-48,49 O O
-RSB- O O
, O O
they O O
were O O
both O O
HIV-1-infected O O
men O O
with O O
Kaposi O O
's O O
sarcoma O O
but O O
had O O
very O O
different O O
disease O O
development O O
. O O

Patient O O
1 O O
was O O
a O O
30-year-old O O
man O O
who O O
was O O
demonstrated O O
to O O
be O O
HIV-1-seropositive O O
in O O
1995 O O
. O O

In O O
July O O
1996 O O
he O O
was O O
diagnosed O O
with O O
KS O O
. O O

He O O
did O O
not O O
respond O O
to O O
anti-retroviral O O
or O O
chemotherapy O O
and O O
died O O
in O O
January O O
of O O
1997 O O
as B-conn Cause.Reason
a I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
severe O O
infiltration O O
of O O
KS O O
in O O
both O O
lungs O O
. O O

Patient O O
2 O O
is O O
a O O
36-year-old O O
man O O
who O O
visited O O
our O O
outpatient O O
clinic O O
in O O
1992 O O
with O O
an O O
increasing O O
number O O
of O O
KS-related O O
skin O O
lesions O O
. O O

After B-conn Temporal.Succession
he O O
started O O
anti-retroviral O O
therapy O O
several O O
lesions O O
disappeared O O
and B-conn Conjunction
complete O O
remission O O
was O O
gradually O O
reached O O
over O O
the O O
course O O
of O O
two O O
years O O
. O O

These O O
two O O
patients O O
were O O
chosen O O
in B-conn Cause.Reason
large I-conn Cause.Reason
part I-conn Cause.Reason
for I-conn Cause.Reason
the O O
diversity O O
in O O
their O O
course O O
of O O
Kaposi O O
's O O
sarcoma O O
. O O

We O O
tested O O
three O O
samples O O
for O O
patient O O
1 O O
and O O
seven O O
samples O O
for O O
patient O O
2 O O
collected O O
over O O
time O O
, O O
all O O
taken O O
after O O
diagnosis O O
of O O
KS O O
. O O

After B-conn Temporal.Succession
the O O
frozen O O
PBMC O O
samples O O
were O O
thawed O O
the O O
cells O O
were O O
collected O O
and O O
resuspended O O
in O O
Trizol™ O O
buffer O O
to B-conn Purpose.Goal
isolate O O
RNA O O
and O O
DNA O O
simultaneously O O
, O O
according O O
to O O
the O O
manufacturer O O
's O O
recommendations O O
. O O

Precipitated O O
RNA O O
was O O
redissolved O O
in O O
50 O O
μl O O
H2O O O
. O O

For O O
each O O
time-point O O
, O O
a O O
known O O
amount O O
of O O
cells O O
-LRB- O O
7.6–11.1 O O
* O O
106 O O
cells O O
-RRB- O O
were O O
isolated O O
. O O

With O O
high O O
input O O
of O O
total O O
RNA O O
we O O
found O O
that O O
background O O
RNA O O
can O O
disturb O O
the O O
amplification O O
if B-conn Condition.Hypothetical
present O O
in O O
large O O
amounts O O
and B-conn Cause.Result
it O O
was O O
necessary O O
to O O
dilute O O
the O O
samples O O
. O O

To B-conn Purpose.Goal
have O O
a O O
broad O O
range O O
in O O
the O O
dilution O O
for O O
the O O
RNA O O
quantification O O
in O O
the O O
NASBA O O
experiments O O
, O O
the O O
samples O O
were O O
diluted O O
10,100 O O
, O O
and O O
1000 O O
times O O
. O O

Of O O
these O O
diluted O O
samples O O
5 O O
μl O O
was O O
used O O
per O O
reaction O O
, O O
and B-conn Conjunction
10 O O
μl O O
of O O
reaction O O
mix O O
was O O
added O O
. O O

U1A O O
mRNA O O
was O O
used O O
as O O
an O O
external O O
standard O O
to B-conn Purpose.Goal
compare O O
quantification O O
signals O O
among O O
the O O
different O O
samples O O
. O O

Results O O

These O O
newly O O
developed O O
assays O O
can O O
be O O
used O O
quantitatively O O
by B-conn Purpose.Enablement
testing O O
a O O
standard O O
curve O O
of O O
samples O O
with O O
a O O
known O O
amount O O
of O O
mRNA O O
molecules O O
within O O
the O O
same O O
experiment O O
as O O
the O O
unknown O O
samples O O
, O O
then B-conn Temporal.Precedence
extrapolating O O
the O O
results O O
to O O
the O O
standard O O
curve O O
. O O

Typical O O
amplification O O
curves O O
could O O
be O O
plotted O O
in O O
which O O
an O O
increase O O
of O O
fluorescence O O
was O O
observed O O
until B-conn Temporal.Precedence
most O O
of O O
the O O
molecular O O
beacon O O
had O O
hybridised O O
with O O
the O O
synthesised O O
amplicons O O
and B-conn Conjunction
the O O
fluorescence O O
reached O O
a O O
maximum O O
level O O
. O O

Such O O
an O O
amplification O O
of O O
in O O
vitro O O
synthesised O O
ORF O O
73 O O
RNA O O
is O O
shown O O
in O O
the O O
insert O O
in O O
figure O O
2a O O
. O O

The O O
time-point O O
at O O
which O O
the O O
fluorescence O O
signal O O
became O O
detectable O O
over O O
the O O
background O O
i.e. O O
, O O
time-to-positivity O O
-LRB- O O
ttp O O
-RRB- O O
, O O
was O O
linear O O
over O O
a O O
range O O
of O O
at O O
least O O
six O O
orders O O
of O O
magnitude O O
of O O
input O O
RNA O O
molecules O O
, O O
as O O
shown O O
by O O
the O O
dilution O O
series O O
of O O
in O O
vitro O O
synthesised O O
RNA O O
. O O

In O O
figure O O
2a O O
the O O
relationship O O
between O O
ttp O O
values O O
of O O
the O O
standard O O
curve O O
for O O
ORF O O
73 O O
and O O
the O O
log O O
input O O
of O O
in O O
vitro O O
RNA O O
is O O
shown O O
. O O

This O O
relationship O O
extended O O
from O O
107 O O
to O O
50 O O
molecules O O
input O O
. O O

The O O
dilution O O
series O O
of O O
in O O
vitro O O
RNA O O
showed O O
a O O
detection O O
level O O
of O O
50 O O
molecules O O
input O O
. O O

For B-conn Purpose.Goal
accurate O O
quantification O O
the O O
required O O
level O O
is O O
102 O O
molecules O O
input O O
per O O
assay O O
. O O

The O O
line O O
is O O
calculated O O
with O O
linear O O
regression O O
analysis O O
. O O

Besides B-conn Alternative.Conjunctive
the O O
limit O O
of O O
detection O O
-LRB- O O
LOD O O
-RRB- O O
, O O
the O O
limit O O
of O O
quantification O O
-LRB- O O
LOQ O O
-RRB- O O
can O O
be O O
determined O O
. O O

For O O
ORF O O
73 O O
, O O
the O O
LOD O O
is O O
50 O O
molecules O O
input O O
-LRB- O O
84 O O
% O O
pos. O O
-RRB- O O
while B-conn Conjunction
the O O
LOQ O O
is O O
102 O O
molecules O O
per O O
reaction O O
. O O

The O O
linear O O
quantification O O
of O O
the O O
ORF O O
73 O O
assay O O
was O O
determined O O
to O O
be O O
between O O
102 O O
to O O
107 O O
copies O O
RNA O O
per O O
reaction O O
-LRB- O O
R O O
2 O O
= O O
0.96 O O
, O O
p O O
< O O
0.001 O O
, O O
fig O O
. O O

2a O O
-RRB- O O
. O O

The O O
sensitivity O O
of O O
all O O
four O O
assays O O
was O O
studied O O
using O O
five O O
serial O O
dilutions O O
. O O

The O O
linear O O
regression O O
analyses O O
for O O
the O O
other O O
assays O O
are O O
shown O O
in O O
figure O O
2b,2c,2d,2e O O
. O O

The O O
assay O O
for O O
vGCR O O
has O O
a O O
very O O
small O O
standard O O
deviation O O
, O O
and B-conn Conjunction
the O O
amplification O O
is O O
linear O O
from O O
107 O O
to O O
50 O O
molecules O O
input O O
per O O
reaction O O
-LRB- O O
R O O
2 O O
> O O
0.99 O O
, O O
p O O
< O O
0.001 O O
, O O
fig O O
. O O

2b O O
-RRB- O O
. O O

The O O
LOD O O
is O O
50 O O
molecules O O
-LRB- O O
55 O O
% O O
pos. O O
-RRB- O O
and B-conn Conjunction
the O O
LOQ O O
is O O
102 O O
molecules O O
per O O
reaction O O
. O O

The O O
assays O O
for O O
both O O
vBcl-2 O O
and O O
vIL-6 O O
are O O
weaker O O
but B-conn Concession.Contra-expectation
still O O
within O O
a O O
workable O O
range O O
. O O

As O O
above O O
, O O
the O O
linear O O
quantification O O
was O O
between O O
102 O O
to O O
107 O O
copies O O
RNA O O
per O O
reaction O O
-LRB- O O
R O O
2 O O
= O O
0.94 O O
and O O
R O O
2 O O
= O O
0.95 O O
respectively O O
, O O
p O O
< O O
0.001 O O
, O O
fig O O
. O O

2c,2d O O
-RRB- O O
. O O

For O O
both O O
assays O O
, O O
the O O
LOD O O
is O O
50 O O
molecules O O
-LRB- O O
72 O O
% O O
and O O
50 O O
% O O
pos O O
. O O

respectively O O
-RRB- O O
and O O
the O O
LOQ O O
is O O
102 O O
molecules O O
per O O
reaction O O
. O O

U1A O O
has O O
a O O
linear O O
quantification O O
range O O
of O O
103 O O
to O O
108 O O
molecules O O
-LRB- O O
R2 O O
= O O
0.99 O O
, O O
p O O
< O O
0.001 O O
, O O
fig O O
2e O O
-RRB- O O
. O O

The O O
assay O O
for O O
U1A O O
had O O
a O O
sensitivity O O
of O O
only O O
103 O O
copies O O
input/reaction O O
, O O
which O O
is O O
feasible O O
due B-conn Cause.Reason
to I-conn Cause.Reason
the O O
high O O
expression O O
level O O
of O O
U1A O O
. O O

The O O
specificity O O
of O O
the O O
five O O
assays O O
was O O
tested O O
by B-conn Purpose.Enablement
spiking O O
each O O
reaction O O
with O O
106 O O
molecules O O
of O O
in O O
vitro O O
RNA O O
that O O
the O O
primers O O
and O O
beacon O O
were O O
not O O
designed O O
for O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
ORF O O
73 O O
in O O
vitro O O
RNA O O
did O O
not O O
give O O
a O O
signal O O
with O O
the O O
vGCR O O
assay O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
replicate O O
independent O O
experiments O O
, O O
the O O
time-to-positivity O O
-LRB- O O
TTP O O
-RRB- O O
value O O
had O O
a O O
linear O O
relationship O O
with O O
the O O
logarithm O O
of O O
the O O
amount O O
of O O
in O O
vitro O O
RNA O O
added O O
in O O
the O O
reaction O O
. O O

Subsequent O O
experiments O O
used O O
serial O O
10-fold O O
dilutions O O
of O O
in O O
vitro O O
RNA O O
-LRB- O O
from O O
107 O O
to O O
102 O O
and O O
50 O O
molecules O O
per O O
reaction O O
-RRB- O O
as O O
a O O
standard O O
curve O O
to O O
determine O O
the O O
amount O O
of O O
HHV-8 O O
RNA O O
in O O
samples O O
. O O

The O O
experiments O O
were O O
done O O
on O O
different O O
days O O
and O O
by O O
different O O
people O O
with O O
no O O
significant O O
variation O O
in O O
results O O
, O O
which O O
confirmed O O
the O O
robustness O O
of O O
the O O
assays O O
and O O
also O O
their O O
ease O O
of O O
performance O O
. O O

To B-conn Purpose.Goal
address O O
the O O
functionality O O
and O O
quality O O
of O O
the O O
HHV-8 O O
assays O O
in O O
vivo O O
, O O
they O O
were O O
tested O O
on O O
PBMC O O
samples O O
collected O O
after O O
KS O O
diagnosis O O
from O O
two O O
participants O O
in O O
the O O
Amsterdam O O
Cohort O O
Studies O O
. O O

In O O
total O O
, O O
10 O O
frozen O O
samples O O
were O O
analysed O O
. O O

As O O
a O O
positive O O
control O O
, O O
all O O
samples O O
were O O
tested O O
for O O
the O O
presence O O
of O O
HHV-8 O O
DNA O O
with O O
a O O
nested O O
PCR O O
and O O
were O O
found O O
to O O
be O O
positive O O
-LRB- O O
see O O
Materials O O
and O O
Methods O O
-RRB- O O
. O O

The O O
copies O O
of O O
HHV-8 O O
DNA O O
varied O O
between O O
2 O O
and O O
2 O O
* O O
102 O O
per O O
103 O O
cells O O
-LRB- O O
table O O
3 O O
-RRB- O O
. O O

A O O
relation O O
has O O
been O O
shown O O
between O O
the O O
HHV-8 O O
DNA O O
levels O O
in O O
PBMC O O
and O O
the O O
extent O O
of O O
Kaposi O O
's O O
sarcoma O O
-LSB-50 O O
-RSB- O O
. O O

A O O
possible O O
correlation O O
between O O
DNA O O
levels O O
and O O
mRNA O O
expression O O
should O O
be O O
investigated O O
. O O

The O O
results O O
of O O
the O O
HHV-8 O O
assays O O
are O O
shown O O
in O O
table O O
3. O O
Of O O
the O O
10 O O
samples O O
, O O
9 O O
were O O
positive O O
for O O
ORF O O
73 O O
, O O
whereas B-conn Contrast
only O O
half O O
were O O
positive O O
for O O
vGCR O O
. O O

While B-conn Contrast
vBcl-2 O O
was O O
measured O O
in O O
9 O O
out O O
of O O
10 O O
samples O O
, O O
vIL-6 O O
was O O
detected O O
in O O
approximately O O
half O O
of O O
the O O
samples O O
. O O

All O O
the O O
samples O O
that O O
were O O
positive O O
for O O
ORF O O
73 O O
were O O
also O O
positive O O
for O O
vBcl-2 O O
. O O

Surprisingly O O
the O O
samples O O
were O O
positive O O
for O O
a O O
latent O O
and O O
a O O
lytic O O
gene O O
at O O
the O O
same O O
time O O
. O O

The O O
variation O O
in O O
expression O O
levels O O
is O O
large O O
both O O
among O O
the O O
different O O
assays O O
and O O
among O O
the O O
samples O O
. O O

No O O
clear O O
trend O O
in O O
the O O
expression O O
of O O
HHV-8-specific O O
mRNA O O
can O O
be O O
distinguished O O
, O O
based O O
on O O
HHV-8 O O
DNA O O
levels O O
, O O
patient O O
, O O
or O O
disease O O
status O O
. O O

Discussion O O

In O O
general O O
the O O
NASBA O O
assay O O
has O O
several O O
advantages O O
over O O
the O O
PCR O O
technique O O
-LSB-51 O O
-RSB- O O
. O O

The O O
amplification O O
procedure O O
of O O
the O O
NASBA O O
assay O O
is O O
entirely O O
isothermal O O
and O O
is O O
conducted O O
at O O
41°C O O
; O O
it O O
does O O
not O O
require O O
thermal O O
cycling O O
instrumentation O O
. O O

The O O
NASBA O O
product O O
is O O
single-stranded O O
and O O
can O O
therefore B-conn Cause.Result
be O O
readily O O
detected O O
by O O
hybridisation O O
analysis O O
. O O

Our O O
four O O
real-time O O
NASBA O O
assays O O
offer O O
these O O
benefits O O
and O O
also O O
the O O
five O O
features O O
that O O
define O O
validation O O
of O O
any O O
assay O O
: O O
accuracy O O
, O O
sensitivity O O
, O O
precision O O
, O O
robustness O O
, O O
and O O
specificity O O
. O O

With O O
the O O
use O O
of O O
standard O O
curves O O
in O O
each O O
experiment O O
, O O
accuracy O O
is O O
achieved O O
. O O

The O O
sensitivity O O
is O O
determined O O
with O O
a O O
linear O O
standard O O
curve O O
. O O

The O O
limit O O
of O O
detection O O
-LRB- O O
LOD O O
-RRB- O O
and O O
the O O
limit O O
of O O
quantification O O
-LRB- O O
LOQ O O
-RRB- O O
are O O
determined O O
. O O

For O O
all O O
the O O
HHV-8 O O
assays O O
, O O
the O O
LOD O O
is O O
50 O O
molecules O O
per O O
reaction O O
and B-conn Conjunction
LOQ O O
was O O
100 O O
molecules O O
per O O
reaction O O
. O O

To O O
achieve O O
linear O O
amplification O O
requires O O
at O O
least O O
5 O O
concentrations O O
on O O
the O O
linear O O
portion O O
of O O
the O O
curve O O
. O O

For O O
the O O
HHV-8 O O
assays O O
, O O
the O O
linear O O
range O O
spans O O
7 O O
concentrations O O
and B-conn Conjunction
for O O
U1A O O
it O O
spans O O
6 O O
concentrations O O
. O O

Quantification O O
was O O
achieved O O
within O O
this O O
linear O O
range O O
of O O
at O O
least O O
six O O
orders O O
of O O
magnitude O O
-LRB- O O
102 O O
to O O
107 O O
molecules O O
per O O
reaction O O
-RRB- O O
. O O

Within O O
this O O
linear O O
range O O
quantification O O
of O O
at O O
least O O
six O O
orders O O
of O O
magnitude O O
-LRB- O O
102 O O
to O O
107 O O
molecules O O
per O O
reaction O O
-RRB- O O
was O O
achieved O O
. O O

The O O
precision O O
of O O
the O O
assays O O
was O O
measured O O
as O O
the O O
standard O O
deviation O O
and O O
the O O
confidence O O
interval O O
-LRB- O O
fig O O
. O O

2 O O
-RRB- O O
. O O

We O O
used O O
5 O O
replicates O O
of O O
7 O O
different O O
concentrations O O
of O O
the O O
standard O O
curve O O
. O O

Robustness O O
was O O
determined O O
by B-conn Purpose.Enablement
having O O
different O O
people O O
perform O O
the O O
experiments O O
on O O
different O O
days O O
. O O

Specificity O O
was O O
shown O O
with O O
spiking O O
experiments O O
. O O

The O O
lower O O
detection O O
level O O
of O O
the O O
assays O O
was O O
approximately O O
50 O O
copies O O
per O O
reaction O O
. O O

The O O
assays O O
work O O
equally O O
well O O
in O O
vivo O O
as O O
in O O
vitro O O
e.g. O O
, O O
for O O
quantification O O
of O O
HHV-8 O O
RNA O O
in O O
PBMCs O O
. O O

The O O
onset O O
of O O
KS O O
is O O
associated O O
with O O
a O O
high O O
HHV-8 O O
load O O
in O O
PBMC O O
-LSB-19 O O
-RSB- O O
and B-conn Continuation
this O O
indicates O O
that O O
HHV-8 O O
infected O O
circulating O O
cells O O
play O O
an O O
important O O
role O O
in O O
KS O O
development O O
-LSB-20,52,53 O O
-RSB- O O
. O O

HHV-8 O O
can O O
infect O O
circulating O O
B O O
cells O O
, O O
monocytes/macrophages O O
, O O
T O O
cells O O
and O O
KS-like O O
spindle O O
cell O O
progenitors O O
-LSB-54-56 O O
-RSB- O O
. O O

In O O
KS O O
lesions O O
B O O
cells O O
are O O
rare O O
or O O
absent O O
, O O
but B-conn Contrast
monocytes O O
macrophages O O
are O O
abundantly O O
present O O
-LSB-52 O O
-RSB- O O
, O O
this O O
suggest O O
that O O
circulating O O
monocytes O O
may O O
recruit O O
the O O
virus O O
into O O
tissues O O
or O O
transmit O O
the O O
virus O O
to O O
other O O
cells O O
. O O

Since B-conn Cause.Reason
lymphocytes O O
and O O
monocytes O O
infiltrating O O
KS O O
lesions O O
can O O
be O O
productively O O
infected O O
by O O
HHV-8 O O
-LSB-20,22 O O
-RSB- O O
, O O
it O O
is O O
important O O
to O O
look O O
at O O
active O O
infection O O
in O O
the O O
PBMC O O
. O O

PBMCs O O
of O O
two O O
AIDS-KS O O
patients O O
were O O
selected O O
and O O
analysed O O
for O O
the O O
presence O O
of O O
HHV-8 O O
mRNA O O
. O O

In O O
90 O O
% O O
of O O
our O O
samples O O
, O O
ORF O O
73 O O
mRNA O O
and O O
vBcl-2 O O
mRNA O O
were O O
detected O O
, O O
whereas B-conn Contrast
for O O
vIL-6 O O
mRNA O O
and O O
vGCR O O
mRNA O O
were O O
present O O
in O O
60 O O
% O O
and O O
50 O O
% O O
, O O
respectively O O
. O O

The O O
expression O O
levels O O
of O O
all O O
four O O
genes O O
varied O O
widely O O
. O O

Comparing O O
the O O
different O O
expression O O
levels O O
of O O
the O O
four O O
HHV-8 O O
genes O O
within O O
one O O
sample O O
or O O
comparing O O
expression O O
levels O O
of O O
one O O
gene O O
in O O
one O O
patient O O
did O O
not O O
show O O
an O O
apparent O O
tendency O O
. O O

No O O
clear O O
trend O O
can O O
be O O
distinguished O O
based O O
on O O
the O O
HHV-8 O O
DNA O O
levels O O
, O O
patient O O
or O O
disease O O
status O O
. O O

Nevertheless B-conn Concession.Contra-expectation
the O O
finding O O
of O O
expression O O
of O O
different O O
HHV8 O O
specific O O
genes O O
in O O
PBMCs O O
is O O
notable O O
in O O
itself O O
, O O
as B-conn Cause.Reason
it O O
has O O
not O O
been O O
described O O
before O O
. O O

HHV-8 O O
RNA O O
has O O
been O O
found O O
in O O
tissues O O
, O O
endothelial O O
cells O O
and O O
spindle O O
cells O O
-LSB-18,57,58 O O
-RSB- O O
. O O

In O O
90 O O
% O O
of O O
fresh O O
KS-affected O O
tissues O O
, O O
HHV-8 O O
RNA O O
has O O
been O O
detected O O
with O O
RT-PCR O O
-LSB-59 O O
-RSB- O O
. O O

In O O
situ O O
hybridisation O O
and O O
LANA O O
immunohistochemistry O O
have O O
confirmed O O
HHV-8 O O
gene O O
expression O O
in O O
KS O O
spindle O O
cells O O
within O O
KS O O
lesions O O
-LSB-18,58,60-62 O O
-RSB- O O
. O O

Expression O O
of O O
lytic O O
HHV-8 O O
genes O O
has O O
also B-conn Conjunction
been O O
documented O O
in O O
monocytes O O
and O O
macrophages O O
in O O
KS O O
lesions O O
-LSB-20 O O
-RSB- O O
. O O

Conclusion O O

The O O
assays O O
that O O
were O O
developed O O
work O O
well O O
for O O
the O O
detection O O
and O O
quantification O O
of O O
HHV-8 O O
specific O O
mRNA O O
. O O

Although B-conn Concession.Expectation
no O O
clear O O
trend O O
in O O
the O O
expression O O
pattern O O
could O O
be O O
distinguished O O
the O O
finding O O
of O O
expression O O
of O O
different O O
HHV8 O O
specific O O
genes O O
in O O
PBMCs O O
is O O
important O O
in O O
itself O O
. O O

As B-conn Cause.Reason
this O O
suggests O O
that O O
HHV-8 O O
replication O O
takes O O
place O O
in O O
the O O
PBMC O O
. O O

The O O
PBMCs O O
we O O
used O O
were O O
obtained O O
from O O
two O O
patients O O
. O O

To B-conn Purpose.Goal
draw O O
conclusions O O
about O O
the O O
clinical O O
and O O
prognostic O O
utility O O
of O O
these O O
assays O O
more O O
patients O O
and O O
patient O O
samples O O
need O O
to O O
be O O
analysed O O
. O O

However B-conn Concession.Contra-expectation
, O O
as B-conn Cause.Reason
the O O
assays O O
are O O
able O O
to O O
quantify O O
HHV-8 O O
mRNA O O
in O O
PBMC O O
samples O O
we O O
feel O O
that O O
these O O
real-time O O
NASBA O O
assays O O
with O O
beacon O O
detection O O
provide O O
tools O O
for O O
further O O
study O O
of O O
HHV-8 O O
expression O O
in O O
patient O O
material O O
. O O

Competing O O
interests O O

None O O
declared O O
. O O

Authors O O
' O O
contributions O O

AP O O
carried O O
out O O
the O O
assay O O
development O O
and O O
validation O O
, O O
preformed O O
the O O
NASBA O O
experiments O O
and O O
drafted O O
the O O
manuscript O O
. O O

JG O O
participated O O
in O O
the O O
study O O
design O O
. O O

MC O O
participated O O
in O O
the O O
study O O
design O O
and O O
carried O O
out O O
its O O
supervision O O
. O O

Pre-publication O O
history O O

The O O
pre-publication O O
history O O
for O O
this O O
paper O O
can O O
be O O
accessed O O
here O O
: O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
NASBA O O
amplification O O
reaction O O
NASBA O O
amplification O O
reaction O O
with O O
the O O
P1 O O
-LRB- O O
anti-sense O O
-RRB- O O
– O O
P2 O O
-LRB- O O
sense O O
-RRB- O O
oligonucleotide O O
primer O O
set O O
. O O

The O O
overhang O O
on O O
the O O
P1 O O
encodes O O
the O O
promoter O O
sequence O O
for O O
the O O
T7 O O
RNA O O
polymerase O O
. O O

A O O
molecular O O
beacon O O
with O O
a O O
fluorophore O O
and O O
a O O
quencer O O
with O O
the O O
NASBA O O
amplification O O
reaction O O
generates O O
a O O
real-time O O
detection O O
system O O
. O O

Figure O O
2 O O
: O O
Standard O O
curves O O
in O O
vitro O O
RNA O O
Figure O O
2 O O
a-d O O
. O O

Relationship O O
of O O
time-to-positivity O O
-LRB- O O
TTP O O
-RRB- O O
to O O
HHV-8 O O
mRNA O O
copy O O
number O O
. O O

The O O
number O O
of O O
mRNA O O
molecules O O
present O O
in O O
the O O
reaction O O
is O O
indicated O O
on O O
the O O
x O O
axis O O
and B-conn Conjunction
the O O
ttp O O
value O O
in O O
indicated O O
on O O
the O O
y O O
axis O O
. O O

For O O
the O O
data O O
obtained O O
with O O
50 O O
, O O
102 O O
to O O
107 O O
molecules O O
, O O
the O O
values O O
of O O
TTP O O
are O O
the O O
mean O O
of O O
five O O
replicates O O
of O O
independent O O
experiments O O
. O O

For O O
the O O
U1A O O
the O O
range O O
of O O
RNA O O
input O O
was O O
103 O O
to O O
108 O O
. O O

Error O O
bars O O
indicate O O
the O O
standard O O
deviation O O
for O O
the O O
values O O
of O O
ttp O O
. O O

The O O
solid O O
line O O
was O O
obtained O O
by O O
linear O O
regression O O
analysis O O
of O O
the O O
data O O
from O O
50 O O
to O O
107 O O
molecules O O
, O O
and B-conn Conjunction
the O O
dotted O O
lines O O
indicate O O
the O O
95 O O
% O O
confidence O O
intervals O O
for O O
the O O
regression O O
. O O

Inserts O O
a-d O O
: O O
Amplification O O
plot O O
of O O
a O O
10-fold O O
dilution O O
serial O O
dilution O O
of O O
in O O
vitro O O
RNA O O
for O O
ORF O O
73 O O
, O O
vGCR O O
, O O
vBcl-2 O O
and O O
vIL-6 O O
. O O

The O O
amount O O
of O O
input O O
RNA O O
1 O O
* O O
107 O O
, O O
1 O O
* O O
106 O O
, O O
1 O O
* O O
105 O O
, O O
1 O O
* O O
104 O O
, O O
1 O O
* O O
103 O O
, O O
1 O O
* O O
102 O O
, O O
50 O O
and O O
0 O O
molecules O O
. O O

Insert O O
e O O
: O O
Amplification O O
plot O O
of O O
a O O
10-fold O O
dilution O O
serial O O
dilution O O
of O O
U1A O O
in O O
vitro O O
RNA O O
, O O
the O O
amount O O
of O O
input O O
RNA O O
1 O O
* O O
108 O O
, O O
1 O O
* O O
107 O O
, O O
1 O O
* O O
106 O O
, O O
1 O O
* O O
105 O O
, O O
1 O O
* O O
104 O O
, O O
1 O O
* O O
103 O O
and O O
0 O O
molecules O O
. O O

Table O O
1 O O
: O O
Primers O O
for O O
PCR O O
fragment O O
in O O
plasmids O O

Table O O
2 O O
: O O
Sequences O O
of O O
the O O
primers O O
and O O
beacons O O
for O O
each O O
of O O
the O O
assays O O

Table O O
3 O O
: O O
The O O
ratio O O
mRNA O O
of O O
-LRB- O O
HHV-8 O O
/ O O
U1A O O
-RRB- O O
× O O
107 O O

Stage-specific O O
changes O O
in O O
fetal O O
thymocyte O O
proliferation O O
during O O
the O O
CD4-8- O O
to O O
CD4+8+ O O
transition O O
in O O
wild O O
type O O
, O O
Rag1-/- O O
, O O
and O O
Hoxa3 O O
, O O
Pax1 O O
mutant O O
mice O O

Abstract O O

Background O O
: O O
The O O
function O O
of O O
the O O
thymic O O
microenvironment O O
is O O
to O O
promote O O
thymocyte O O
maturation O O
, O O
in B-conn Purpose.Enablement
part I-conn Purpose.Enablement
via I-conn Purpose.Enablement
regulation O O
of O O
thymocyte O O
proliferation O O
and O O
cell O O
death O O
. O O

Defects O O
in O O
fetal O O
thymic O O
epithelial O O
cell O O
-LRB- O O
TEC O O
-RRB- O O
development O O
and O O
function O O
, O O
and O O
therefore B-conn Cause.Result
in O O
the O O
formation O O
of O O
a O O
functional O O
microenvironment O O
, O O
can O O
be O O
caused O O
either O O
directly O O
by O O
TEC O O
differentiation O O
defects O O
or O O
indirectly O O
by O O
defective O O
thymocyte O O
maturation O O
. O O

In O O
this O O
paper O O
we O O
studied O O
fetal O O
thymocyte O O
proliferation O O
during O O
the O O
early O O
transition O O
from O O
the O O
CD3-4-8- O O
-LRB- O O
triple O O
negative O O
, O O
TN O O
-RRB- O O
to O O
CD4+8+ O O
-LRB- O O
double O O
positive O O
, O O
DP O O
-RRB- O O
stages O O
. O O

We O O
compared O O
wild O O
type O O
mice O O
with O O
Rag1-/- O O
mice O O
and O O
with O O
Hoxa3+/-Pax1-/- O O
compound O O
mutant O O
mice O O
, O O
which O O
have O O
blocks O O
at O O
different O O
stages O O
of O O
thymocyte O O
development O O
. O O

Results O O
: O O
Wild O O
type O O
fetal O O
and O O
adult O O
thymus O O
showed O O
stage-specific O O
differences O O
in O O
the O O
proliferation O O
profiles O O
of O O
developing O O
thymocytes O O
, O O
with B-conn Restatement.Specification
fetal O O
stages O O
showing O O
generally O O
higher O O
levels O O
of O O
proliferation O O
. O O

The O O
proliferation O O
profile O O
of O O
fetal O O
thymocytes O O
from O O
Rag1-/- O O
mutants O O
also B-conn Conjunction
had O O
stage-specific O O
increases O O
in O O
proliferation O O
compared O O
to O O
wild O O
type O O
fetal O O
thymocytes O O
, O O
in B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
the O O
lower O O
proliferation O O
previously O O
reported O O
for O O
thymocytes O O
from O O
adult O O
Rag1-/- O O
mutants O O
. O O

We O O
have O O
previously O O
shown O O
that O O
Hoxa3+/-Pax1-/- O O
mice O O
have O O
abnormal O O
fetal O O
TEC O O
development O O
, O O
resulting O O
in O O
increased O O
apoptosis O O
at O O
the O O
TN O O
to O O
DP O O
transition O O
and O O
decreased O O
DP O O
cell O O
numbers O O
. O O

Fetal O O
thymocytes O O
from O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
had O O
increased O O
proliferation O O
, O O
but O O
fewer O O
proliferating O O
cells O O
, O O
at O O
the O O
DP O O
stage O O
. O O

We O O
also B-conn Conjunction
observed O O
a O O
decrease O O
in O O
the O O
level O O
of O O
the O O
cytokines O O
IL-7 O O
and O O
SCF O O
produced O O
by O O
Hoxa3+/-Pax1-/-TECs. O O
Conclusion O O
: O O
Our O O
results O O
indicate O O
complex O O
and O O
stage-specific O O
effects O O
of O O
abnormal O O
TEC O O
development O O
on O O
thymocyte O O
proliferation O O
. O O

Background O O

Thymocyte O O
development O O
occurs O O
within O O
a O O
complex O O
network O O
of O O
cells O O
, O O
extracellular O O
matrix O O
, O O
and O O
secreted O O
factors O O
referred O O
to O O
as O O
the O O
thymic O O
microenvironment O O
-LSB-1 O O
-RSB- O O
. O O

Current O O
evidence O O
suggests O O
that O O
this O O
microenvironment O O
is O O
created O O
during O O
fetal O O
thymus O O
organogenesis O O
through B-conn Purpose.Enablement
stage-dependent O O
interactions O O
between O O
differentiating O O
thymic O O
epithelial O O
cells O O
-LRB- O O
TECs O O
-RRB- O O
and O O
developing O O
thymocytes O O
-LSB-2-6 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
blocks O O
at O O
different O O
stages O O
of O O
thymocyte O O
development O O
result O O
in O O
differential O O
effects O O
on O O
TEC O O
differentiation O O
and O O
function O O
. O O

Because B-conn Cause.Reason
of I-conn Cause.Reason
the O O
complex O O
interdependence O O
of O O
TEC O O
and O O
thymocyte O O
differentiation O O
, O O
defects O O
in O O
fetal O O
TEC O O
development O O
can O O
be O O
caused O O
either O O
directly O O
by O O
cell-autonomous O O
TEC O O
differentiation O O
defects O O
, O O
or O O
indirectly O O
by O O
defective O O
thymocyte O O
maturation O O
. O O

Once B-conn Temporal.Succession
a O O
mature O O
thymic O O
environment O O
is O O
formed O O
, O O
many O O
, O O
if O O
not O O
all O O
stages O O
of O O
thymocyte O O
maturation O O
require O O
interactions O O
with O O
thymic O O
epithelial O O
cells O O
. O O

Therefore B-conn Cause.Result
, O O
defects O O
in O O
TECs O O
can O O
in O O
turn O O
cause O O
defects O O
in O O
thymocyte O O
differentiation O O
, O O
proliferation O O
, O O
or O O
cell O O
death O O
. O O

Thymocyte O O
differentiation O O
undergoes O O
two O O
main O O
transitions O O
. O O

The O O
first O O
is O O
from O O
the O O
CD3-4-8- O O
-LRB- O O
triple O O
negative O O
, O O
TN O O
-RRB- O O
to O O
the O O
CD4+8+ O O
-LRB- O O
double O O
positive O O
, O O
DP O O
-RRB- O O
stages O O
. O O

During O O
this O O
transition O O
, O O
T O O
cell O O
precursors O O
sequentially O O
gain O O
and O O
lose O O
cell O O
surface O O
expression O O
of O O
CD44 O O
and O O
CD25 O O
markers O O
, O O
express O O
the O O
pre-T O O
cell O O
receptor O O
-LRB- O O
pTCR O O
-RRB- O O
, O O
and O O
undergo O O
β-selection O O
-LSB-2,7-9 O O
-RSB- O O
. O O

The O O
other O O
transition O O
is O O
from O O
CD4+8+ O O
DP O O
to O O
CD4+ O O
or O O
CD8+ O O
single O O
positive O O
-LRB- O O
SP O O
-RRB- O O
thymocytes O O
, O O
in O O
which O O
DP O O
cells O O
express O O
CD3 O O
, O O
rearrange O O
their O O
α-TCR O O
, O O
undergo O O
positive O O
and O O
negative O O
selection O O
, O O
and O O
down O O
regulate O O
CD4 O O
or O O
CD8 O O
to O O
become O O
functional O O
CD8+ O O
or O O
CD4+ O O
SP O O
T O O
cells O O
-LSB-10,11 O O
-RSB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
to I-conn Conjunction
functional O O
and O O
cell O O
surface O O
marker O O
changes O O
, O O
each O O
thymocyte O O
differentiation O O
stage O O
is O O
marked O O
by O O
characteristic O O
changes O O
in O O
proliferation O O
and O O
apoptosis O O
-LSB-12-18 O O
-RSB- O O
. O O

The O O
most O O
well O O
defined O O
role O O
for O O
TECs O O
in O O
directly O O
affecting O O
thymocyte O O
differentiation O O
is O O
to O O
mediate O O
positive O O
selection O O
via B-conn Purpose.Enablement
expression O O
of O O
MHC O O
molecules O O
-LSB-11,19-22 O O
-RSB- O O
. O O

However B-conn Contrast
, O O
it O O
is O O
still O O
unclear O O
whether O O
TECs O O
directly O O
promote O O
specific O O
stages O O
of O O
thymocyte O O
differentiation O O
during O O
stages O O
that O O
do O O
not O O
involve O O
MHC-TCR O O
interactions O O
, O O
or B-conn Alternative.Disjunctive
whether O O
their O O
role O O
at O O
other O O
stages O O
is O O
primarily O O
to O O
promote O O
cell O O
growth O O
and O O
/or O O
survival O O
. O O

Cytokines O O
produced O O
by O O
TECs O O
have O O
been O O
shown O O
to O O
promote O O
proliferation O O
in O O
early O O
stages O O
of O O
thymocyte O O
development O O
, O O
and O O
have O O
been O O
proposed O O
to O O
regulate O O
apoptosis O O
and O O
differentiation O O
, O O
although B-conn Concession.Contra-expectation
their O O
precise O O
roles O O
remain O O
controversial O O
-LSB-23,24 O O
-RSB- O O
. O O

TECs O O
have O O
also B-conn Conjunction
been O O
shown O O
to O O
promote O O
thymocyte O O
proliferation O O
in O O
SP O O
cells O O
after B-conn Temporal.Succession
selection O O
has O O
occurred O O
-LSB-15 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
a O O
defined O O
role O O
for O O
TECs O O
at O O
the O O
TN-DP O O
transition O O
remains O O
elusive O O
. O O

Much O O
of O O
the O O
research O O
on O O
this O O
transition O O
has O O
focused O O
on O O
the O O
role O O
of O O
the O O
pre-TCR O O
. O O

Mounting O O
evidence O O
suggests O O
that O O
the O O
pre-TCR O O
does O O
not O O
require O O
interaction O O
with O O
a O O
ligand O O
to B-conn Purpose.Goal
perform O O
its O O
function O O
, O O
and B-conn Conjunction
the O O
subsequent O O
CD44-25- O O
-LRB- O O
TN4 O O
or O O
pre-DP O O
-RRB- O O
to O O
DP O O
transition O O
has O O
been O O
termed O O
`` O O
programmed O O
differentiation O O
'' O O
to O O
indicate O O
that O O
this O O
step O O
can O O
occur O O
in O O
isolated O O
thymocytes O O
, O O
presumably O O
without O O
input O O
from O O
extrinsic O O
signals O O
-LSB-25-27 O O
-RSB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
there O O
is O O
also O O
evidence O O
that O O
the O O
thymic O O
microenvironment O O
does O O
contribute O O
signals O O
required O O
for O O
the O O
TN-DP O O
transition O O
, O O
particularly B-conn Purpose.Goal
to I-conn Purpose.Goal
promote O O
thymocyte O O
proliferation O O
and O O
apoptosis O O
-LSB-13,28-30 O O
-RSB- O O
. O O

The O O
specific O O
nature O O
and O O
purpose O O
of O O
the O O
TEC O O
contribution O O
during O O
this O O
important O O
transition O O
therefore B-conn Cause.Claim
remains O O
to O O
be O O
determined O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
investigate O O
the O O
regulation O O
of O O
thymocyte O O
development O O
by O O
TECs O O
, O O
we O O
are O O
studying O O
Hoxa3+/-Pax1-/- O O
compound O O
mutant O O
mice O O
. O O

Hoxa3 O O
and O O
Pax1 O O
are O O
transcription O O
factors O O
that O O
act O O
in O O
a O O
common O O
pathway O O
regulating O O
thymus O O
organogenesis O O
and O O
thymic O O
epithelial O O
cell O O
development O O
-LSB-29,31-34 O O
-RSB- O O
. O O

Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
have O O
defects O O
in O O
TEC O O
development O O
including O O
reduced O O
numbers O O
of O O
TECs O O
, O O
fewer O O
MHC O O
Class O O
II+ O O
TECs O O
, O O
and O O
changes O O
in O O
TEC O O
proliferation O O
and O O
apoptosis O O
. O O

These O O
TEC O O
defects O O
result O O
in O O
thymocyte O O
maturation O O
defects O O
that O O
include O O
a O O
decrease O O
in O O
total O O
thymocyte O O
number O O
and O O
a O O
10-fold O O
reduction O O
in O O
the O O
number O O
of O O
DP O O
thymocytes O O
, O O
but O O
an O O
apparently O O
normal O O
transition O O
from O O
the O O
TN3 O O
to O O
the O O
pre-DP O O
stage O O
. O O

The O O
decrease O O
in O O
DP O O
cells O O
is O O
associated O O
with O O
increased O O
apoptosis O O
in O O
both O O
pre-DP O O
and O O
DP O O
cells O O
-LSB-29 O O
-RSB- O O
. O O

As B-conn Cause.Justification
the O O
defects O O
at O O
the O O
TN O O
to O O
DP O O
transition O O
in O O
these O O
mutants O O
are O O
caused O O
by O O
defective O O
TEC O O
function O O
rather O O
than O O
thymocyte-intrinsic O O
defects O O
, O O
these O O
mice O O
represent O O
an O O
opportunity O O
to O O
study O O
the O O
role O O
of O O
TECs O O
in O O
promoting O O
this O O
transition O O
. O O

To B-conn Purpose.Goal
further O O
investigate O O
the O O
role O O
of O O
TECs O O
in O O
promoting O O
thymocyte O O
death O O
and O O
growth O O
during O O
the O O
TN O O
to O O
DP O O
transition O O
, O O
we O O
assayed O O
the O O
proliferation O O
of O O
specific O O
thymocyte O O
subsets O O
using O O
BrdU O O
incorporation O O
, O O
which O O
detects O O
cycling O O
cells O O
in O O
S-phase O O
. O O

We O O
compared O O
fetal O O
and O O
adult O O
wild O O
type O O
mice O O
with O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
-LSB-29,34 O O
-RSB- O O
. O O

We O O
also B-conn Conjunction
assayed O O
Rag1-/- O O
mice O O
, O O
which O O
have O O
defects O O
in O O
TEC O O
development O O
due B-conn Cause.Reason
to I-conn Cause.Reason
arrested O O
thymocyte O O
maturation O O
at O O
the O O
TN3 O O
stage O O
-LSB-35 O O
-RSB- O O
. O O

We O O
found O O
stage-specific O O
differences O O
in O O
proliferation O O
levels O O
between O O
fetal O O
and O O
adult O O
wild O O
type O O
thymocytes O O
. O O

We O O
also B-conn Conjunction
found O O
distinct O O
patterns O O
of O O
thymocyte O O
proliferation O O
in O O
the O O
Rag1-/- O O
and O O
Hoxa3 O O
, O O
Pax1 O O
mutants O O
. O O

The O O
abnormal O O
cell O O
death O O
and O O
proliferation O O
patterns O O
in O O
the O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutant O O
fetal O O
thymocytes O O
might O O
be O O
caused O O
in B-conn Cause.Reason
part I-conn Cause.Reason
by I-conn Cause.Reason
observed O O
reductions O O
in O O
the O O
transcription O O
levels O O
of O O
the O O
cytokines O O
IL-7 O O
and O O
SCF O O
produced O O
by O O
TECs O O
. O O

Our O O
results O O
support O O
a O O
critical O O
role O O
for O O
microenvironment O O
created O O
by O O
TECs O O
in O O
regulating O O
thymocyte O O
proliferation O O
during O O
the O O
TN O O
to O O
DP O O
transition O O
, O O
and O O
show O O
that O O
this O O
function O O
is O O
disrupted O O
in O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
. O O

Results O O

As O O
an O O
initial O O
analysis O O
, O O
we O O
compared O O
thymocyte O O
proliferation O O
between O O
thymocytes O O
from O O
late O O
fetal O O
-LRB- O O
E17.5 O O
-RRB- O O
and O O
adult O O
-LRB- O O
6–8 O O
week O O
-RRB- O O
wild O O
type O O
C57BL6/J O O
mice O O
. O O

Although B-conn Contrast
differences O O
in O O
the O O
proliferation O O
of O O
fetal O O
vs. O O
adult O O
TCR-expressing O O
thymocytes O O
and O O
have O O
been O O
reported O O
-LSB-36 O O
-RSB- O O
, O O
we O O
were O O
interested O O
in O O
investigating O O
the O O
more O O
immature O O
thymocyte O O
subsets O O
. O O

BrdU O O
labeled O O
fetal O O
and O O
adult O O
thymi O O
were O O
analyzed O O
for O O
the O O
percent O O
of O O
proliferating O O
cells O O
in O O
different O O
CD3-4-8- O O
TN O O
thymocyte O O
subsets O O
defined O O
by O O
CD44 O O
and O O
CD25 O O
expression O O
-LSB-8 O O
-RSB- O O
. O O

The O O
CD3+4+8+ O O
population O O
was O O
defined O O
by O O
co-staining O O
of O O
all O O
three O O
markers O O
-LRB- O O
Fig. O O
1A O O
-RRB- O O
. O O

A O O
typical O O
analysis O O
of O O
the O O
BrdU+ O O
cells O O
in O O
DP O O
cells O O
and O O
the O O
four O O
CD44 O O
vs. O O
CD25 O O
subsets O O
within O O
the O O
TN O O
cell O O
population O O
is O O
shown O O
in O O
Figure O O
1 O O
. O O

Compiled O O
data O O
for O O
each O O
subset O O
from O O
all O O
experiments O O
is O O
shown O O
in O O
Table O O
1 O O
. O O

The O O
wild O O
type O O
adult O O
-LRB- O O
Fig. O O
1C O O
, O O
1F O O
-RRB- O O
and O O
fetal O O
-LRB- O O
Fig. O O
1D O O
, O O
1F O O
-RRB- O O
thymocyte O O
proliferation O O
profile O O
patterns O O
differed O O
significantly O O
at O O
specific O O
stages O O
. O O

The O O
overall O O
proliferation O O
level O O
in O O
TN O O
cells O O
was O O
increased O O
by O O
50 O O
% O O
in O O
fetal O O
thymocytes O O
-LRB- O O
p O O
< O O
0.01 O O
-RRB- O O
. O O

Most O O
dramatically O O
, O O
the O O
percentages O O
of O O
BrdU+ O O
cells O O
in O O
fetal O O
thymocytes O O
were O O
10-fold O O
higher O O
than O O
in O O
the O O
adult O O
at O O
the O O
earliest O O
, O O
TN1 O O
-LRB- O O
CD44+25- O O
-RRB- O O
thymocyte O O
differentiation O O
stage O O
-LRB- O O
P O O
< O O
0.001 O O
-RRB- O O
. O O

A O O
much O O
lower O O
, O O
but O O
still O O
significant O O
increase O O
was O O
seen O O
in O O
fetal O O
TN2 O O
cells O O
-LRB- O O
25 O O
% O O
increase O O
, O O
p O O
< O O
0.01 O O
-RRB- O O
. O O

Proliferation O O
was O O
also B-conn Conjunction
significantly O O
higher O O
at O O
the O O
fetal O O
TN3 O O
stage O O
compared O O
to O O
adult O O
-LRB- O O
50 O O
% O O
increase O O
, O O
p O O
< O O
0.01 O O
-RRB- O O
. O O

Proliferation O O
at O O
the O O
TN4/pre-DP O O
-LRB- O O
CD44-25- O O
-RRB- O O
stage O O
was O O
similar O O
between O O
fetal O O
and O O
adult O O
thymocytes O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
DP O O
cells O O
showed O O
a O O
3-fold O O
increase O O
in O O
proliferation O O
in O O
the O O
fetal O O
thymus O O
relative O O
to O O
adult O O
-LRB- O O
p O O
< O O
0.01 O O
-RRB- O O
. O O

Therefore B-conn Restatement.Generalization
, O O
nearly O O
every O O
stage O O
from O O
the O O
earliest O O
TN O O
to O O
the O O
DP O O
stages O O
showed O O
significantly O O
increased O O
proliferation O O
in O O
fetal O O
thymocytes O O
relative O O
to O O
adults O O
. O O

It O O
was O O
possible O O
that O O
the O O
lower O O
percentage O O
of O O
proliferating O O
cells O O
seen O O
in O O
the O O
TN1 O O
population O O
in O O
adults O O
was O O
due B-conn Cause.Reason
to I-conn Cause.Reason
an O O
increased O O
number O O
of O O
B O O
cells O O
and O O
NK O O
cells O O
in O O
the O O
adult O O
thymus O O
, O O
which O O
would O O
not O O
have O O
been O O
excluded O O
in O O
our O O
initial O O
analysis O O
. O O

As B-conn Cause.Reason
this O O
was O O
one O O
of O O
the O O
most O O
striking O O
differences O O
seen O O
between O O
fetal O O
and O O
adult O O
stages O O
, O O
we O O
repeated O O
this O O
analysis O O
adding O O
antibodies O O
against O O
B220 O O
and O O
NK1.1 O O
to O O
CD3 O O
, O O
4 O O
and O O
8 O O
in O O
the O O
excluded O O
gate O O
-LRB- O O
Fig. O O
1G O O
, O O
1H O O
-RRB- O O
. O O

Even O O
excluding O O
these O O
cell O O
populations O O
, O O
there O O
is O O
still O O
a O O
significantly O O
lower O O
percentage O O
of O O
proliferating O O
cells O O
in O O
the O O
TN1 O O
population O O
in O O
the O O
adult O O
thymus O O
than O O
in O O
the O O
fetal O O
thymus O O
-LRB- O O
Fig. O O
1I O O
-RRB- O O
. O O

Therefore B-conn Cause.Claim
, O O
this O O
difference O O
is O O
not B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
different O O
numbers O O
of O O
B O O
and O O
NK O O
cells O O
in O O
the O O
adult O O
vs. O O
fetal O O
thymus O O
. O O

We O O
also B-conn Conjunction
compared O O
proliferation O O
of O O
fetal O O
thymocytes O O
from O O
Rag1-/- O O
mice O O
to O O
the O O
results O O
obtained O O
from O O
wild O O
type O O
mice O O
. O O

Thymocytes O O
in O O
the O O
adult O O
Rag1-/- O O
thymus O O
have O O
been O O
previously O O
shown O O
to O O
have O O
overall O O
lower O O
levels O O
of O O
proliferation O O
than O O
adult O O
wild O O
type O O
TN O O
thymocytes O O
-LSB-13 O O
-RSB- O O
, O O
particularly O O
at O O
the O O
TN3 O O
stage O O
-LSB-37-40 O O
-RSB- O O
. O O

At O O
fetal O O
stages O O
, O O
our O O
results O O
showed O O
that O O
proliferation O O
also O O
varied O O
between O O
thymocytes O O
in O O
the O O
wild O O
type O O
and O O
Rag1-/- O O
thymus O O
at O O
discrete O O
stages O O
of O O
thymocyte O O
differentiation O O
. O O

At O O
the O O
earliest O O
TN1 O O
stage O O
, O O
thymocyte O O
proliferation O O
levels O O
in O O
Rag1-/- O O
thymi O O
were O O
similar O O
to O O
fetal O O
wild O O
type O O
cells O O
-LRB- O O
Fig. O O
1E O O
, O O
1F O O
; O O
Table O O
1 O O
-RRB- O O
. O O

At O O
the O O
TN2 O O
stage O O
, O O
fetal O O
thymocytes O O
from O O
Rag1-/- O O
mice O O
had O O
a O O
proliferation O O
level O O
nearly O O
twice O O
that O O
of O O
wild O O
type O O
fetal O O
thymocytes O O
-LRB- O O
p O O
< O O
0.001 O O
-RRB- O O
. O O

By O O
the O O
TN3 O O
stage O O
, O O
the O O
percentage O O
of O O
proliferating O O
Rag1-/- O O
thymocytes O O
had O O
dropped O O
slightly O O
below O O
that O O
of O O
wild O O
type O O
fetal O O
thymocytes O O
-LRB- O O
~30 O O
% O O
decrease O O
, O O
p O O
< O O
0.01 O O
-RRB- O O
, O O
equal O O
to O O
wild O O
type O O
adult O O
TN3 O O
proliferation O O
levels O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
percentages O O
of O O
BrdU+ O O
cells O O
in O O
TN1 O O
and O O
TN2 O O
subsets O O
in O O
the O O
Rag1-/- O O
fetal O O
thymus O O
were O O
significantly O O
higher O O
than O O
those O O
of O O
the O O
wild O O
type O O
adults O O
-LRB- O O
P O O
< O O
0.001 O O
-RRB- O O
. O O

These O O
results O O
with O O
Rag1-/- O O
fetal O O
thymocytes O O
contrast O O
with O O
thymocytes O O
in O O
the O O
Rag-/- O O
adult O O
, O O
which O O
have O O
much O O
lower O O
proliferation O O
than O O
wild O O
type O O
adult O O
thymocytes O O
at O O
all O O
stages O O
of O O
thymocyte O O
differentiation O O
-LSB-13 O O
-RSB- O O
. O O

Our O O
previous O O
analysis O O
of O O
the O O
Hoxa3+/-Pax1-/- O O
compound O O
mutant O O
thymocyte O O
phenotype O O
showed O O
a O O
specific O O
partial O O
block O O
at O O
the O O
TN O O
to O O
DP O O
transition O O
, O O
associated O O
with O O
increased O O
apoptosis O O
at O O
both O O
the O O
TN4/pre-DP O O
and O O
DP O O
subsets O O
, O O
and O O
a O O
10-fold O O
decrease O O
in O O
DP O O
cell O O
numbers O O
-LSB-29 O O
-RSB- O O
. O O

Using O O
BrdU O O
analysis O O
, O O
we O O
compared O O
the O O
proliferation O O
of O O
Hoxa3+/-Pax1-/- O O
fetal O O
thymocytes O O
during O O
the O O
TN O O
to O O
DP O O
transition O O
compared O O
to O O
littermate O O
controls O O
. O O

Thymocyte O O
proliferation O O
levels O O
for O O
all O O
genotypes O O
-LRB- O O
Hoxa3+/- O O
, O O
Pax1+/- O O
, O O
Pax1-/- O O
, O O
and O O
Hoxa3+/-Pax1-/- O O
-RRB- O O
were O O
similar O O
to O O
wild O O
type O O
in O O
all O O
of O O
the O O
canonical O O
TN1-TN4 O O
stages O O
-LRB- O O
Fig. O O
2A,2B,2C O O
; O O
Table O O
1 O O
-RRB- O O
, O O
consistent O O
with O O
the O O
normal O O
percentages O O
and O O
cell O O
numbers O O
for O O
these O O
subpopulations O O
previously O O
reported O O
-LSB-29 O O
-RSB- O O
. O O

Recent O O
papers O O
by O O
Penit O O
, O O
et O O
al. O O
have O O
provided O O
data O O
from O O
cell O O
cycle O O
analysis O O
suggesting O O
that O O
a O O
discrete O O
CD44-25lo O O
population O O
with O O
a O O
specific O O
proliferation O O
profile O O
can O O
be O O
identified O O
, O O
such B-conn Cause.Result
that I-conn Cause.Result
the O O
transition O O
from O O
TN3 O O
to O O
DP O O
can O O
be O O
further O O
subdivided O O
into O O
CD25hi O O
, O O
CD25lo O O
, O O
and O O
CD25- O O
subsets O O
-LSB-12,13 O O
-RSB- O O
. O O

Analysis O O
of O O
proliferation O O
using O O
these O O
more O O
narrowly O O
defined O O
subsets O O
still O O
showed O O
values O O
similar O O
to O O
wild O O
type O O
in O O
the O O
CD44-25lo O O
subset O O
-LRB- O O
Fig. O O
2D,2E,2F O O
; O O
Table O O
2 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
proliferation O O
level O O
of O O
DP O O
cells O O
increased O O
nearly O O
2-fold O O
in O O
compound O O
mutants O O
compared O O
to O O
wild O O
type O O
-LRB- O O
Fig. O O
2C O O
, O O
2F O O
; O O
Table O O
1 O O
-RRB- O O
. O O

In O O
spite O O
of O O
this O O
increase O O
in O O
the O O
percentage O O
of O O
proliferating O O
cells O O
, O O
the O O
actual O O
number O O
of O O
BrdU+ O O
DP O O
cells O O
was O O
reduced O O
4-fold O O
compared O O
to O O
wild O O
type O O
in O O
the O O
compound O O
mutants O O
-LRB- O O
15.03 O O
± O O
8.73 O O
× O O
104 O O
vs. O O
61.94 O O

± O O
32.12 O O
× O O
104 O O
in O O
wild O O
type O O
; O O
p O O
< O O
0.01 O O
-RRB- O O
. O O

The O O
numbers O O
of O O
proliferating O O
cells O O
at O O
the O O
pre-DP O O
stage O O
were O O
unchanged O O
-LRB- O O
not O O
shown O O
-RRB- O O
. O O

Combined O O
with O O
our O O
previous O O
results O O
, O O
this O O
result O O
shows O O
that O O
both O O
increased O O
apoptosis O O
and O O
reduced O O
proliferation O O
contribute O O
to O O
the O O
decrease O O
in O O
DP O O
cells O O
in O O
the O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
. O O

Unfortunately O O
, O O
Hoxa3+/-Pax1-/- O O
mice O O
die O O
at O O
birth O O
, O O
preventing O O
analysis O O
of O O
thymocyte O O
proliferation O O
in O O
adult O O
compound O O
mutants O O
. O O

Cytokines O O
produced O O
by O O
TECs O O
are O O
good O O
candidates O O
for O O
mediating O O
at O O
least O O
some O O
of O O
these O O
changes O O
in O O
thymocyte O O
proliferation O O
and O O
apoptosis O O
in O O
the O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
. O O

Using O O
semi-quantitative O O
RT-PCR O O
, O O
we O O
analyzed O O
the O O
expression O O
of O O
two O O
cytokines O O
that O O
are O O
produced O O
by O O
TECs O O
, O O
IL-7 O O
and O O
SCF O O
, O O
in O O
pooled O O
, O O
genotype-matched O O
E14.5 O O
thymi O O
-LRB- O O
Fig. O O
3 O O
-RRB- O O
. O O

Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
had O O
decreased O O
transcription O O
of O O
both O O
cytokines O O
relative O O
to O O
all O O
other O O
genotypes O O
, O O
including O O
Pax1-/- O O
single O O
mutants O O
. O O

However B-conn Concession.Contra-expectation
, O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
were O O
not O O
completely O O
missing O O
either O O
cytokine O O
analyzed O O
, O O
and B-conn Conjunction
the O O
magnitude O O
of O O
the O O
decrease O O
was O O
variable O O
between O O
pools O O
. O O

To B-conn Purpose.Goal
test O O
whether O O
the O O
changes O O
in O O
cytokine O O
levels O O
were O O
responsible O O
for O O
the O O
observed O O
thymocyte O O
development O O
phenotypes O O
, O O
we O O
attempted O O
to O O
rescue O O
these O O
phenotypes O O
by B-conn Purpose.Enablement
supplementation O O
in O O
fetal O O
thymic O O
organ O O
culture O O
-LRB- O O
FTOC O O
-RRB- O O
. O O

E15.5 O O
embryonic O O
thymic O O
lobes O O
from O O
individual O O
embryos O O
were O O
cultured O O
separately O O
in O O
FTOC O O
, O O
with O O
or O O
without O O
added O O
IL-7 O O
or O O
SCF O O
. O O

Cultures O O
from O O
control O O
genotypes O O
-LRB- O O
wild O O
type O O
, O O
Pax1+/- O O
, O O
Hoxa3+/- O O
, O O
Pax1-/- O O
-RRB- O O
behaved O O
as O O
expected O O
-LSB-41-46 O O
-RSB- O O
, O O
with O O
addition O O
of O O
IL-7 O O
causing O O
an O O
increase O O
in O O
the O O
percentage O O
of O O
DN O O
cells O O
and O O
a O O
corresponding O O
decrease O O
in O O
DP O O
cells O O
, O O
while B-conn Contrast
adding O O
SCF O O
had O O
no O O
significant O O
effect O O
on O O
thymocyte O O
development O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
to O O
our O O
surprise O O
the O O
two O O
separated O O
lobes O O
from O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
did O O
not O O
always O O
develop O O
in O O
predictable O O
ways O O
. O O

In B-conn Reinforcement
fact I-conn Reinforcement
, O O
separated O O
lobes O O
cultured O O
under O O
identical O O
conditions O O
in O O
the O O
absence O O
of O O
any O O
added O O
cytokines O O
had O O
widely O O
differing O O
results O O
. O O

Changes O O
in O O
thymocyte O O
cell O O
number O O
and O O
differentiation O O
after B-conn Temporal.Succession
culture O O
were O O
highly O O
variable O O
; O O
for B-conn Instantiation
example I-conn Instantiation
, O O
cell O O
numbers O O
could O O
differ O O
stochastically O O
after B-conn Temporal.Succession
culture O O
by O O
as O O
much O O
as O O
10-fold O O
between O O
two O O
lobes O O
from O O
the O O
same O O
compound O O
mutant O O
embryo O O
. O O

This O O
result O O
was O O
never O O
obtained O O
with O O
separately O O
cultured O O
thymic O O
lobes O O
from O O
any O O
other O O
genotype O O
, O O
which O O
always O O
developed O O
identically O O
when B-conn Circumstance.Forward Circumstance
cultured O O
without O O
cytokines O O
. O O

This O O
property O O
of O O
the O O
compound O O
mutant O O
thymic O O
lobes O O
probably O O
reflects O O
phenotypic O O
variability O O
previously O O
seen O O
in O O
our O O
histological O O
and O O
gross O O
morphological O O
analysis O O
of O O
these O O
mutants O O
-LSB-29,34 O O
-RSB- O O
. O O

Discussion O O

In O O
this O O
study O O
, O O
we O O
have O O
examined O O
thymocyte O O
proliferation O O
in O O
the O O
fetal O O
and O O
adult O O
wild O O
type O O
thymus O O
. O O

Our O O
results O O
showed O O
clear O O
stage-specific O O
differences O O
in O O
wild O O
type O O
thymocyte O O
proliferation O O
depending O O
on O O
the O O
developmental O O
age O O
of O O
the O O
microenvironment O O
-LRB- O O
i.e. O O

fetal O O
vs. O O
adult O O
-RRB- O O
. O O

We O O
also B-conn Conjunction
analyzed O O
two O O
mutant O O
strains O O
that O O
have O O
either O O
cell-autonomous O O
-LRB- O O
Hoxa3+/-Pax1-/- O O
-RRB- O O
or O O
non-cell-autonomous O O
-LRB- O O
Rag1-/- O O
-RRB- O O
TEC O O
defects O O
, O O
with O O
blocks O O
at O O
different O O
stages O O
of O O
thymocyte O O
differentiation O O
. O O

Abnormal O O
TEC O O
development O O
in O O
both O O
of O O
these O O
mutant O O
strains O O
resulted O O
in O O
both O O
increases O O
and O O
decreases O O
in O O
thymocyte O O
proliferation O O
in O O
a O O
stage-specific O O
manner O O
, O O
rather O O
than O O
simply O O
an O O
overall O O
reduced O O
ability O O
to O O
promote O O
proliferation O O
. O O

There O O
is O O
considerable O O
evidence O O
that O O
thymopoiesis O O
differs O O
in O O
the O O
fetal O O
thymus O O
during O O
the O O
initial O O
creation O O
of O O
the O O
microenvironment O O
, O O
as O O
opposed O O
to O O
adult O O
thymus O O
function O O
-LRB- O O
reviewed O O
in O O
-LSB-47 O O
-RSB- O O
-RRB- O O
. O O

Differences O O
have O O
been O O
reported O O
in O O
responses O O
to O O
some O O
cytokines O O
, O O
in O O
signaling O O
at O O
the O O
TN-DP O O
transition O O
in O O
fetal O O
compared O O
to O O
adult O O
thymus O O
, O O
and O O
in O O
proliferation O O
of O O
CD4+ O O
SP O O
thymocytes O O
-LSB-36,48-50 O O
-RSB- O O
. O O

The O O
proliferation O O
profiles O O
of O O
both O O
wild O O
type O O
and O O
Rag-/- O O
fetal O O
thymocytes O O
support O O
the O O
hypothesis O O
that O O
fetal O O
thymocyte O O
maturation O O
is O O
fundamentally O O
different O O
from O O
thymocyte O O
development O O
in O O
the O O
adult O O
thymus O O
. O O

The O O
TN1 O O
and O O
DP O O
stages O O
both O O
show O O
increased O O
proliferation O O
in O O
wild-type O O
fetal O O
thymocytes O O
compared O O
to O O
adults O O
. O O

This O O
difference O O
at O O
the O O
TN1 O O
stage O O
is O O
not B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
the O O
presence O O
of O O
more O O
B O O
or O O
NK O O
cells O O
in O O
the O O
adult O O
thymus O O
. O O

Although B-conn Concession.Expectation
it O O
is O O
formally O O
possible O O
that O O
some O O
other O O
cell O O
type O O
may O O
still O O
be O O
included O O
in O O
our O O
TN1 O O
population O O
, O O
this O O
analysis O O
strongly O O
suggests O O
that O O
TN1 O O
cells O O
have O O
different O O
proliferation O O
profiles O O
in O O
fetal O O
and O O
adult O O
thymus O O
. O O

It O O
has O O
been O O
well O O
documented O O
that O O
thymocytes O O
in O O
adult O O
Rag1 O O
or O O
Rag2 O O
mutants O O
have O O
dramatically O O
reduced O O
proliferation O O
compared O O
to O O
wild O O
type O O
, O O
particularly O O
at O O
the O O
TN3 O O
stage O O
-LSB-37-40 O O
-RSB- O O
, O O
and B-conn Conjunction
Penit O O
et O O
al. O O
reported O O
2–10 O O
fold O O
reductions O O
at O O
every O O
stage O O
of O O
thymocyte O O
development O O
in O O
Rag-/- O O
adults O O
-LSB-13 O O
-RSB- O O
. O O

Recent O O
work O O
by O O
Petrie O O
, O O
et O O
al. O O
has O O
shown O O
that O O
this O O
reduced O O
proliferation O O
is O O
not O O
intrinsic O O
to O O
Rag O O
mutant O O
thymocytes O O
, O O
but O O
rather B-conn Alternative.Chosen alternative
is O O
secondary O O
to O O
thymic O O
microenvironment O O
defects O O
in O O
Rag O O
mutants O O
-LSB-37 O O
-RSB- O O
. O O

Our O O
results O O
show O O
that O O
at O O
fetal O O
stages O O
, O O
Rag O O
mutant O O
thymocytes O O
have O O
a O O
proliferation O O
profile O O
that O O
is O O
much O O
more O O
similar O O
to O O
wild O O
type O O
thymocytes O O
at O O
the O O
same O O
stage O O
, O O
with O O
less O O
than O O
a O O
2-fold O O
difference O O
in O O
the O O
percentage O O
of O O
proliferating O O
cells O O
at O O
any O O
stage O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
TN3 O O
stage O O
thymocytes O O
in O O
the O O
Rag-/- O O
adult O O
thymus O O
have O O
proliferation O O
levels O O
3-fold O O
below O O
wild O O
type O O
thymus O O
-LSB-13,37 O O
-RSB- O O
, O O
while B-conn Contrast
in O O
the O O
Rag-/- O O
fetal O O
thymus O O
TN3 O O
cells O O
are O O
only O O
25–30 O O
% O O
lower O O
than O O
in O O
wild O O
type O O
fetal O O
thymus O O
. O O

Proliferation O O
is O O
not O O
changed O O
at O O
all O O
stages O O
, O O
and O O
is O O
actually O O
increased O O
relative O O
to O O
wild O O
type O O
at O O
the O O
TN2 O O
stage O O
. O O

This O O
increase O O
at O O
the O O
TN2 O O
stage O O
may O O
be O O
due O O
to O O
the O O
failure O O
of O O
TN2 O O
cells O O
to O O
initiate O O
TCRβ O O
gene O O
rearrangement O O
at O O
this O O
stage O O
, O O
which O O
is O O
normally O O
associated O O
with O O
decreased O O
proliferation.Rag-/- O O
mutants O O
have O O
a O O
profound O O
thymocyte O O
development O O
block O O
at O O
the O O
TN3 O O
to O O
TN4/preDP O O
transition O O
-LSB-51 O O
-RSB- O O
. O O

During B-conn Temporal.Synchronous
normal O O
wild O O
type O O
fetal O O
thymus O O
development O O
, O O
significant O O
DP O O
cell O O
development O O
does O O
not O O
occur O O
until O O
E16.5 O O
in O O
most O O
genetic O O
backgrounds O O
. O O

As B-conn Cause.Result
a I-conn Cause.Result
result I-conn Cause.Result
, O O
at O O
E17.5 O O
the O O
thymic O O
microenvironment O O
in O O
Rag O O
mutants O O
has O O
not O O
been O O
exposed O O
to O O
abnormal O O
thymocyte O O
development O O
for O O
very O O
long O O
, O O
and O O
has O O
not O O
yet O O
developed O O
the O O
full O O
phenotype O O
seen O O
in O O
the O O
steady O O
state O O
adult O O
Rag O O
mutant O O
thymus O O
-LSB-35 O O
-RSB- O O
. O O

In O O
the O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
, O O
cell-autonomous O O
TEC O O
defects O O
cause O O
a O O
partial O O
block O O
at O O
the O O
DN-DP O O
transition O O
, O O
so B-conn Cause.Result
thymocytes O O
do O O
progress O O
to O O
DP O O
and O O
SP O O
stages O O
, O O
albeit B-conn Concession.Contra-expectation
at O O
reduced O O
frequencies O O
-LSB-29 O O
-RSB- O O
. O O

TEC O O
defects O O
are O O
seen O O
as O O
early O O
as O O
E12.5 O O
in O O
these O O
mutants O O
, O O
from O O
the O O
earliest O O
stages O O
of O O
organogenesis O O
-LSB-34 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
the O O
TEC O O
defects O O
in O O
these O O
mice O O
would O O
be O O
expected O O
to O O
have O O
different O O
effects O O
on O O
thymocyte O O
proliferation O O
than O O
in O O
Rag O O
mutants O O
. O O

In O O
this O O
study O O
, O O
we O O
found O O
stage-specific O O
changes O O
in O O
thymocyte O O
proliferation O O
at O O
the O O
DP O O
stage O O
. O O

Our O O
previous O O
analysis O O
reported O O
decreased O O
DP O O
cell O O
number O O
and O O
increased O O
apoptosis O O
in O O
both O O
the O O
pre-DP O O
and O O
DP O O
stages O O
in O O
these O O
mutants O O
-LSB-29 O O
-RSB- O O
. O O

DP O O
cell O O
numbers O O
in O O
both O O
this O O
and O O
our O O
previous O O
study O O
were O O
decreased O O
10-fold O O
in O O
the O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
. O O

At O O
first O O
glance O O
, O O
the O O
increase O O
in O O
the O O
percentage O O
of O O
proliferating O O
cells O O
at O O
the O O
DP O O
stage O O
appears O O
contradictory O O
to O O
this O O
phenotype O O
. O O

However B-conn Concession.Contra-expectation
, O O
this O O
increase O O
actually O O
corresponds O O
to O O
decreased O O
numbers O O
of O O
proliferating O O
DP O O
cells O O
compared O O
to O O
wild O O
type O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
pre-DP O O
cells O O
did O O
not O O
have O O
a O O
change O O
in O O
the O O
number O O
or O O
percentage O O
of O O
proliferating O O
cells O O
, O O
suggesting O O
that O O
the O O
signals O O
promoting O O
proliferation O O
of O O
these O O
cells O O
is O O
still O O
present O O
, O O
and B-conn Conjunction
that O O
proliferation O O
of O O
DP O O
and O O
pre-DP O O
cells O O
may O O
be O O
regulated O O
independently O O
. O O

Pre-DP O O
cells O O
do O O
have O O
a O O
three-fold O O
increase O O
in O O
apoptosis O O
-LSB-29 O O
-RSB- O O
, O O
suggesting O O
that O O
separate O O
signals O O
regulate O O
proliferation O O
and O O
survival O O
of O O
these O O
cells O O
. O O

Combined O O
with O O
our O O
previous O O
data O O
, O O
this O O
result O O
suggests O O
that O O
the O O
decrease O O
in O O
DP O O
cell O O
numbers O O
seen O O
in O O
the O O
Hoxa3-Pax1 O O
compound O O
mutants O O
is O O
both O O
due O O
to O O
an O O
increase O O
in O O
the O O
number O O
of O O
pre-DP O O
and O O
DP O O
cells O O
undergoing O O
apoptosis O O
as O O
well O O
as O O
a O O
decrease O O
in O O
the O O
number O O
of O O
proliferating O O
DP O O
. O O

Insufficiencies O O
of O O
multiple O O
cytokines O O
might O O
be O O
involved O O
in O O
the O O
changes O O
in O O
proliferation O O
and O O
cell O O
death O O
at O O
the O O
CD44-25- O O
and O O
DP O O
stages O O
in O O
Hoxa3-Pax1 O O
compound O O
mutants O O
. O O

SCF O O
and O O
IL-7 O O
are O O
first O O
expressed O O
as O O
early O O
as O O
E12.5 O O
in O O
the O O
developing O O
thymus O O
, O O
well B-conn Temporal.Precedence
before I-conn Temporal.Precedence
significant O O
thymocyte O O
maturation O O
takes O O
place O O
-LSB-52,53 O O
-RSB- O O
. O O

Although B-conn Contrast
the O O
number O O
of O O
TECs O O
is O O
reduced O O
by O O
about O O
2-fold O O
in O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
, O O
the O O
number O O
of O O
thymocytes O O
is O O
reduced O O
by O O
a O O
slightly O O
greater O O
amount O O
, O O
around O O
3-fold O O
-LSB-29 O O
-RSB- O O
. O O

Therefore B-conn Cause.Claim
, O O
the O O
reductions O O
seen O O
in O O
cytokine O O
message O O
levels O O
in O O
the O O
Hoxa3+/-Pax1-/-compound O O
mutants O O
are O O
not O O
secondary O O
to O O
decreased O O
TEC O O
numbers O O
. O O

In B-conn Reinforcement
fact I-conn Reinforcement
, O O
these O O
mutants O O
should O O
have O O
a O O
relative O O
increase O O
in O O
the O O
proportion O O
of O O
TECs O O
, O O
making O O
the O O
reductions O O
seen O O
in O O
cytokine O O
levels O O
in O O
the O O
mutant O O
thymi O O
even O O
more O O
striking O O
. O O

The O O
reduced O O
expression O O
of O O
these O O
cytokines O O
in O O
Hoxa3+/-Pax1-/- O O
compound O O
mutants O O
could O O
be O O
an O O
indirect O O
effect O O
of O O
defective O O
TEC O O
differentiation O O
, O O
or O O
could O O
be O O
direct O O
downstream O O
targets O O
since B-conn Cause.Justification
both O O
Hoxa3 O O
and O O
Pax1 O O
are O O
expressed O O
in O O
fetal O O
thymus O O
-LSB-54,55 O O
-RSB- O O
. O O

Comparison O O
of O O
the O O
Hoxa3+/-Pax1-/- O O
phenotype O O
with O O
those O O
of O O
cytokine O O
mutants O O
do O O
not O O
reveal O O
many O O
similarities O O
-LSB-30,46,56-61 O O
-RSB- O O
, O O
probably B-conn Cause.Reason
because I-conn Cause.Reason
of I-conn Cause.Reason
the O O
simultaneous O O
reductions O O
in O O
multiple O O
cytokines O O
in O O
the O O
Hoxa3+/-Pax1-/- O O
mutants O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
SCF O O
and O O
IL-7 O O
have O O
been O O
shown O O
to O O
have O O
synergistic O O
functions O O
-LSB-62,63 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
changes O O
in O O
multiple O O
cytokines O O
in O O
Hoxa3+/-Pax1-/- O O
mutants O O
would O O
be O O
expected O O
to O O
have O O
complex O O
effects O O
on O O
thymocyte O O
development O O
that O O
could O O
be O O
difficult O O
to O O
predict O O
. O O

Interpretation O O
of O O
the O O
observed O O
phenotype O O
is O O
further O O
complicated O O
by B-conn Cause.Reason
the I-conn Cause.Reason
fact I-conn Cause.Reason
that I-conn Cause.Reason
none O O
of O O
the O O
cytokines O O
tested O O
are O O
completely O O
absent O O
. O O

A O O
striking O O
example O O
is O O
the O O
complete O O
absence O O
of O O
γδTCR+ O O
thymocyte O O
development O O
in O O
IL-7 O O
mutants O O
, O O
in B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
normal O O
γδTCR+ O O
cell O O
development O O
in O O
Hoxa3+/-Pax1-/- O O
mutants O O
-LSB-29 O O
-RSB- O O
, O O
which O O
have O O
dramatically O O
reduced O O
IL-7 O O
levels O O
. O O

This O O
result O O
suggests O O
that O O
although B-conn Concession.Expectation
γδTCR+ O O
cell O O
development O O
requires O O
IL-7 O O
, O O
low O O
levels O O
are O O
sufficient O O
for O O
this O O
function O O
. O O

Therefore B-conn Cause.Claim
, O O
analysis O O
of O O
mutants O O
with O O
low O O
levels O O
of O O
cytokines O O
may O O
provide O O
a O O
system O O
for O O
uncovering O O
both O O
dosage-dependent O O
requirements O O
and O O
later O O
functions O O
for O O
these O O
factors O O
in O O
promoting O O
thymocyte O O
development O O
. O O

It O O
is O O
also O O
possible O O
that O O
some O O
of O O
the O O
differences O O
seen O O
between O O
Hoxa3+/-Pax1-/- O O
and O O
cytokine O O
mutant O O
phenotypes O O
reflect O O
different O O
effects O O
of O O
cytokines O O
at O O
fetal O O
and O O
adult O O
stages O O
. O O

Studies O O
of O O
IL-7R O O
mutants O O
showed O O
relatively O O
normal O O
thymocyte O O
maturation O O
at O O
fetal O O
stages O O
, O O
albeit B-conn Concession.Contra-expectation
with O O
reduced O O
thymocyte O O
numbers O O
, O O
in B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
a O O
severe O O
block O O
in O O
thymocyte O O
differentiation O O
in O O
adult O O
thymus O O
-LSB-49 O O
-RSB- O O
. O O

Analysis O O
of O O
cytokine O O
mutants O O
during O O
fetal O O
stages O O
could O O
therefore B-conn Cause.Result
reveal O O
a O O
more O O
complete O O
picture O O
of O O
the O O
role O O
of O O
these O O
cytokines O O
during O O
fetal O O
thymus O O
development O O
. O O

Conclusions O O

Our O O
results O O
show O O
that O O
fetal O O
and O O
adult O O
wild O O
type O O
thymocytes O O
have O O
stage-specific O O
differences O O
in O O
proliferation O O
, O O
with B-conn Restatement.Specification
both O O
TN1 O O
and O O
DP O O
cells O O
exhibiting O O
higher O O
levels O O
of O O
proliferation O O
in O O
fetal O O
thymus O O
. O O

This O O
fetal O O
wild-type O O
profile O O
was O O
very O O
similar O O
to O O
that O O
seen O O
for O O
fetal O O
Rag O O
mutant O O
thymocytes O O
, O O
in B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
adult O O
Rag-/- O O
thymus O O
. O O

Therefore B-conn Cause.Claim
, O O
the O O
changes O O
in O O
proliferation O O
seen O O
in O O
the O O
fetal O O
Rag O O
mutant O O
thymocytes O O
reflect O O
the O O
earliest O O
microenvironment O O
changes O O
occurring O O
as B-conn Cause.Reason
a I-conn Cause.Reason
result I-conn Cause.Reason
of I-conn Cause.Reason
defective O O
TEC-thymocyte O O
interactions O O
in O O
the O O
Rag-/- O O
thymus O O
. O O

The O O
current O O
study O O
further B-conn Conjunction
supports O O
a O O
role O O
for O O
TECs O O
in O O
regulating O O
both O O
thymocyte O O
proliferation O O
and O O
survival O O
during O O
the O O
DN-DP O O
transition O O
, O O
and O O
suggests O O
that O O
proliferation O O
and O O
apoptosis O O
of O O
TN4 O O
and O O
DP O O
cells O O
are O O
regulated O O
independently O O
. O O

Our O O
results O O
provide O O
direct O O
genetic O O
evidence O O
for O O
these O O
functions O O
of O O
TECs O O
, O O
by B-conn Purpose.Enablement
showing O O
that O O
these O O
processes O O
are O O
defective O O
in O O
mutants O O
with O O
a O O
primary O O
TEC O O
differentiation O O
defect O O
-LRB- O O
the O O
Hoxa3 O O
, O O
Pax1 O O
compound O O
mutants O O
-RRB- O O
. O O

Taken O O
together O O
, O O
our O O
results O O
further O O
define O O
the O O
role O O
TECs O O
play O O
at O O
this O O
complex O O
stage O O
of O O
thymocyte O O
development O O
. O O

Methods O O

Hoxa3+/-Pax1+/- O O
mice O O
were O O
mated O O
to O O
Pax1+/- O O
or O O
Pax1-/- O O
mice O O
and O O
genotyped O O
for O O
both O O
Hoxa3 O O
and O O
Pax1 O O
by O O
PCR O O
as O O
described O O
previously O O
-LSB-29 O O
-RSB- O O
. O O

Comparisons O O
were O O
made O O
between O O
littermates O O
from O O
the O O
same O O
colony O O
. O O

Rag1-/- O O
mice O O
-LRB- O O
Jackson O O
Labs O O
-RRB- O O
were O O
maintained O O
as O O
a O O
homozygous O O
mutant O O
colony O O
. O O

All O O
mice O O
were O O
maintained O O
as O O
congenic O O
on O O
a O O
C57BL/6 O O
genetic O O
background O O
. O O

Noon O O
of O O
the O O
day O O
of O O
vaginal O O
plug O O
was O O
considered O O
E0.5 O O
. O O

All O O
animal O O
use O O
procedures O O
were O O
approved O O
by O O
the O O
Medical O O
College O O
of O O
Georgia O O
Committee O O
on O O
Animal O O
Use O O
for O O
Research O O
and O O
Education O O
-LRB- O O
CAURE O O
-RRB- O O
. O O

Fetal O O
thymocyte O O
in O O
vivo O O
BrdU O O
incorporation O O
was O O
done O O
by B-conn Purpose.Enablement
intraperitoneal O O
injection O O
of O O
BrdU O O
-LRB- O O
5-Bromo-2'-Deoxyuridine O O
; O O
Sigma O O
-RRB- O O
on O O
the O O
morning O O
of O O
E17.5 O O
, O O
two O O
doses O O
per O O
mouse O O
and O O
1 O O
mg O O
per O O
dose O O
with O O
a O O
0.5 O O
hour O O
pause O O
, O O
as O O
previously O O
described O O
-LSB-13 O O
-RSB- O O
. O O

Two B-conn Temporal.Succession
hours I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
first O O
injection O O
, O O
fetal O O
thymi O O
were O O
isolated O O
by B-conn Purpose.Enablement
dissection O O
and O O
single-cell O O
suspensions O O
prepared O O
by B-conn Purpose.Enablement
passing O O
the O O
thymocytes O O
through O O
cell O O
strainers O O
. O O

Adult O O
thymocyte O O
in O O
vivo O O
BrdU O O
incorporation O O
was O O
done O O
by B-conn Purpose.Enablement
the O O
same O O
injection O O
protocol O O
using O O
6–8 O O
week O O
old O O
C57BL/6 O O
adult O O
mice O O
. O O

Four-color O O
flow O O
cytometry O O
was O O
performed O O
using O O
the O O
following O O
monoclonal O O
antibodies O O
-LRB- O O
Pharmingen O O
-RRB- O O
: O O
biotin O O
anti-mouse O O
CD25 O O
-LRB- O O
clone O O
: O O
7D4 O O
-RRB- O O
visualized O O
with O O
Per-CP O O
conjugated O O
streptavidin O O
; O O
APC O O
anti-mouse O O
CD44 O O
-LRB- O O
clone O O
: O O
IM7 O O
-RRB- O O
; O O
and O O
three O O
phycoerythrin O O
-LRB- O O
PE O O
-RRB- O O
conjugated O O
antibodies O O
: O O
anti-mouse O O
CD4 O O
-LRB- O O
clone O O
: O O
RM4-5 O O
-RRB- O O
, O O
anti-mouse O O
CD8a O O
-LRB- O O
clone O O
: O O
53–6.7 O O
-RRB- O O
, O O
and O O
anti-mouse O O
CD3ε O O
-LRB- O O
clone O O
: O O
145-2C11 O O
-RRB- O O
. O O

In O O
some O O
experiments O O
, O O
PE O O
conjugated O O
antibodies O O
against O O
B220 O O
-LRB- O O
clone O O
: O O
RA3-6B2 O O
-RRB- O O
and O O
NK1.1 O O
-LRB- O O
clone O O
: O O
PK136 O O
-RRB- O O
were O O
also O O
included O O
. O O

After B-conn Temporal.Succession
cell O O
surface O O
staining O O
, O O
the O O
cells O O
were O O
fixed O O
with O O
2 O O
% O O
paraformaldehyde O O
-LRB- O O
PFA O O
-RRB- O O
/PBS O O
at O O
4°C O O
overnight O O
. O O

The O O
cells O O
were O O
then B-conn Temporal.Precedence
washed O O
, O O
permeabilized O O
with O O
0.1 O O
% O O
Triton O O
X-100/ O O
0.1 O O
% O O
Na-Citrate O O
-LRB- O O
pH7.2 O O
-RRB- O O
on O O
ice O O
for O O
2 O O
min O O
, O O
and O O
then B-conn Temporal.Precedence
treated O O
with O O
50 O O
units O O
of O O
DNaseI O O
at O O
37°C O O
for O O
10 O O
min O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
stained O O
with O O
FITC O O
anti-BrdU O O
antibody O O
-LRB- O O
Pharmingen O O
-RRB- O O
. O O

Data O O
were O O
collected O O
by B-conn Purpose.Enablement
selectively O O
gating O O
either O O
CD3-4-8- O O
or O O
CD3+4+8+ O O
populations O O
-LRB- O O
Becton O O
Dickinson O O
dual O O
laser O O
FACSCalibur O O
-RRB- O O
, O O
and B-conn Conjunction
analyses O O
were O O
performed O O
with O O
Cellquest O O
software O O
. O O

Significant O O
differences O O
were O O
determined O O
by O O
the O O
unpaired O O
Student O O
's O O
t-test O O
or O O
ANOVA O O
analysis O O
. O O

E14.5 O O
fetal O O
thymic O O
lobes O O
were O O
collected O O
and O O
stored O O
in O O
the O O
TRIzol O O
-LRB- O O
GIBCO O O
BRL O O
-RRB- O O
at O O
-70°C O O
until B-conn Temporal.Precedence
RNA O O
isolation O O
. O O

Pools O O
of O O
5-to10 O O
thymi O O
from O O
embryos O O
of O O
the O O
same O O
genotype O O
were O O
homogenized O O
using O O
Micro O O
Pellet O O
Pestles O O
-LRB- O O
Nalge O O
Nunc O O
International O O
-RRB- O O
in O O
1.5 O O
ml-eppendorf O O
tubes O O
. O O

RNA O O
was O O
isolated O O
and B-conn Conjunction
the O O
genomic O O
DNA O O
was O O
depleted O O
by B-conn Purpose.Enablement
using O O
DNaseI O O
-LRB- O O
Amplification O O
Grade O O
, O O
GIBCO O O
BRL O O
-RRB- O O
following O O
the O O
manufacturer O O
's O O
protocols O O
. O O

Reverse O O
transcription O O
of O O
1 O O
μg O O
of O O
total O O
RNA O O
to O O
cDNA O O
was O O
done O O
using O O
SuperScript O O
II O O
following O O
the O O
manufacturer O O
's O O
protocol O O
-LRB- O O
GIBCO O O
BRL O O
-RRB- O O
. O O

Equal O O
amounts O O
of O O
cDNA O O
from O O
different O O
genotypes O O
were O O
added O O
to O O
a O O
final O O
20 O O
μl O O
PCR O O
reaction O O
mixture O O
using O O
the O O
QIAGEN O O
Taq O O
PCR O O
kits O O
. O O

PCR O O
conditions O O
were O O
: O O
94°C O O
30 O O
sec O O
, O O
50°C O O
1 O O
min O O
, O O
72°C O O
1 O O
min O O
for O O
IL-7 O O
, O O
SCF O O
and O O
their O O
internal O O
control O O
β-actin O O
; O O
or O O
94°C O O
30 O O
sec O O
, O O
60°C O O
1 O O
min O O
, O O
72°C O O
1 O O
min O O
for O O
TGFβ1 O O
and O O
its O O
internal O O
control O O
β-actin O O
. O O

PCR O O
products O O
were O O
visualized O O
by O O
5 O O
% O O
acrylamide O O
gel O O
electrophoresis O O
and O O
ethidium O O
bromide O O
staining O O
. O O

Band O O
densities O O
were O O
measured O O
and O O
analyzed O O
using O O
the O O
Molecular O O
Analyst O O
software O O
package O O
-LRB- O O
Bio-Rad O O
Laboratories O O
, O O
Version O O
1.4.1 O O
-RRB- O O
. O O

Primer O O
sequences O O
were O O
: O O
IL-7 O O
-LSB-65 O O
-RSB- O O
: O O
IL-7 O O
-LRB- O O
5 O O
' O O
-RRB- O O
5 O O
' O O
ACT O O
ACA O O
CCC O O
ACC O O
TCC O O
CGC O O
A3 O O
' O O
; O O
IL-7 O O
-LRB- O O
3 O O
' O O
-RRB- O O
5 O O
' O O
TCT O O
CAG O O
TAG O O
TCT O O
CTT O O
TAG O O
G3 O O
' O O
; O O
SCF O O
-LSB-65 O O
-RSB- O O
: O O
SCF O O
-LRB- O O
5 O O
' O O
-RRB- O O
5 O O
' O O
TCT O O
TCA O O
ACT O O
GCT O O
CCT O O
ATT O O
T3 O O
' O O
; O O
SCF O O
-LRB- O O
3 O O
' O O
-RRB- O O
5 O O
' O O
ACT O O
GCT O O
ACT O O
GCT O O
GTC O O
ATT O O
C3 O O
' O O
; O O
TGFβ1 O O
-LSB-66 O O
-RSB- O O
: O O
TGFβ1 O O
-LRB- O O
5 O O
' O O
-RRB- O O
5 O O
' O O
GCG O O
GAC O O
TAC O O
TAT O O
GCT O O
AAA O O
GAG O O
G3 O O
' O O
; O O
TGFβ1 O O
-LRB- O O
3 O O
' O O
-RRB- O O
5 O O
' O O
GTT O O
GTG O O
TTG O O
GTT O O
GTA O O
GAG O O
GGC O O
A3 O O
' O O
; O O
β-actin O O
-LSB-67 O O
-RSB- O O
: O O
β-actin O O
-LRB- O O
5 O O
' O O
-RRB- O O
5 O O
' O O
GGG O O
TCA O O
GAA O O
GGA O O
CTC O O
CTA O O
TG3 O O
' O O
; O O
β-actin O O
-LRB- O O
3 O O
' O O
-RRB- O O
5 O O
' O O
GTA O O
ACA O O
ATG O O
CCA O O
TGT O O
TCA O O
AT3 O O
' O O
. O O

Thymic O O
lobes O O
were O O
dissected O O
from O O
E15.5 O O
embryos O O
. O O

The O O
two O O
lobes O O
from O O
each O O
embryo O O
cultured O O
separately O O
in O O
high O O
oxygen O O
submersion O O
culture O O
as O O
previously O O
described O O
-LSB-41 O O
-RSB- O O
. O O

Fetal O O
thymic O O
organ O O
cultures O O
were O O
supplemented O O
with O O
100 O O
u/ml O O
of O O
IL-7 O O
or O O
20 O O
ng/ml O O
of O O
SCF O O
-LRB- O O
Pepro O O
Tech O O
Inc. O O
-RRB- O O
as O O
previously O O
described O O
-LSB-41 O O
-RSB- O O
. O O

For O O
each O O
embryo O O
, O O
one O O
lobe O O
was O O
treated O O
while B-conn Temporal.Synchronous
the O O
other O O
was O O
cultured O O
in O O
parallel O O
without O O
supplemental O O
cytokine O O
as O O
an O O
internal O O
control O O
. O O

In O O
control O O
experiments O O
, O O
lobes O O
were O O
cultured O O
separately O O
under O O
identical O O
conditions O O
without O O
cytokine O O
. O O

After O O
five O O
days O O
in O O
culture O O
, O O
the O O
cells O O
were O O
stained O O
by O O
PE-anti-mouse O O
CD4 O O
and O O
FITC-anti-mouse O O
CD8 O O
and O O
analyzed O O
by O O
flow O O
cytometry O O
as O O
above O O
. O O

Authors O O
' O O
contributions O O

DMS O O
conceived O O
of O O
the O O
study O O
and O O
performed O O
all O O
of O O
the O O
experiments O O
described O O
. O O

NRM O O
contributed O O
to O O
the O O
design O O
of O O
the O O
study O O
and O O
data O O
analysis O O
, O O
and O O
drafted O O
the O O
manuscript O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
DNA O O
synthesis O O
patterns O O
of O O
fetal O O
vs. O O
adult O O
thymocyte O O
subsets O O
as O O
measured O O
by O O
incorporation O O
of O O
BrdU O O
A. O O
Thymocytes O O
were O O
gated O O
as O O
either O O
CD3-4-8- O O
TN O O
or O O
CD3+4+8+ O O
DP O O
by O O
cell O O
surface O O
marker O O
expression O O
and O O
forward O O
scatter O O
-LRB- O O
SP O O
cells O O
should O O
be O O
located O O
between O O
these O O
two O O
gates O O
, O O
and O O
therefore O O
excluded O O
from O O
analysis O O
-RRB- O O
. O O

B. O O
Gate O O
used O O
for O O
analysis O O
of O O
BrdU O O
incorporation O O
on O O
gated O O
subpopulations O O
. O O

Panels O O
C-E O O
show O O
CD44 O O
vs. O O
CD25 O O
dot O O
plots O O
of O O
the O O
gated O O
CD3-4-8- O O
population O O
from O O
5–6 O O
week O O
old O O
adult O O
C57BL/6 O O
-LRB- O O
C O O
-RRB- O O
, O O
E17.5 O O
fetal O O
C57BL/6 O O
-LRB- O O
D O O
-RRB- O O
, O O
and O O
E17.5 O O
fetal O O
RAG-/- O O
-LRB- O O
E O O
-RRB- O O
. O O

Percentages O O
are O O
shown O O
in O O
each O O
quadrant O O
. O O

F. O O
Percentages O O
of O O
BrdU+ O O
cells O O
-LRB- O O
Mean O O
± O O
SEM O O
-RRB- O O
in O O
each O O
subset O O
of O O
TN O O
cells O O
defined O O
by O O
CD44 O O
and O O
CD25 O O
, O O
and O O
in O O
DP O O
cells O O
. O O

G. O O
Adult O O
wild-type O O
thymocytes O O
were O O
gated O O
as O O
CD3-4-8-B220-NK1.1- O O
. O O

H. O O
CD44 O O
vs. O O
CD25 O O
dot O O
plots O O
of O O
the O O
gated O O
population O O
from O O
-LRB- O O
G O O
-RRB- O O
. O O

I. O O
Percentage O O
of O O
BrdU+ O O
cells O O
-LRB- O O
mean O O
± O O
SEM O O
-RRB- O O
in O O
adult O O
and O O
fetal O O
TN1 O O
thymocytes O O
excluding O O
B O O
and O O
NK O O
cells O O
-LRB- O O
H O O
, O O
G O O
-RRB- O O
. O O

Figure O O
2 O O
: O O
Proliferation O O
of O O
E17.5 O O
Hoxa3-Pax1 O O
compound O O
mutant O O
thymocytes O O
compared O O
to O O
wild O O
type O O
. O O

Panels O O
A-B O O
show O O
CD44 O O
vs. O O
CD25 O O
dot O O
plots O O
of O O
the O O
gated O O
CD3-4-8- O O
population O O
from O O
E17.5 O O
wild O O
type O O
-LRB- O O
A O O
-RRB- O O
and O O
Hoxa3+/-Pax1-/- O O
-LRB- O O
B O O
-RRB- O O
thymus O O
. O O

Percentages O O
are O O
shown O O
in O O
each O O
quadrant O O
. O O

C. O O
Percentages O O
of O O
BrdU+ O O
cells O O
-LRB- O O
Mean O O
± O O
SEM O O
-RRB- O O
in O O
each O O
of O O
4 O O
subsets O O
of O O
TN O O
cells O O
defined O O
by O O
CD44 O O
and O O
CD25 O O
, O O
and O O
in O O
DP O O
cells O O
. O O

D O O
, O O
E. O O
CD44 O O
vs. O O
CD25 O O
dot O O
plots O O
of O O
the O O
gated O O
CD3-4-8- O O
population O O
divided O O
into O O
five O O
subsets O O
as O O
defined O O
by O O
-LSB-12 O O
-RSB- O O
. O O

F. O O
Percentages O O
of O O
BrdU+ O O
cells O O
-LRB- O O
Mean O O
± O O
SEM O O
-RRB- O O
in O O
each O O
of O O
3 O O
CD44- O O
TN O O
subsets O O
defined O O
in O O
panels O O
D O O
and O O
E. O O
DP O O
values O O
shown O O
for O O
comparison O O
are O O
the O O
same O O
as O O
in O O
C O O
. O O

Figure O O
3 O O
: O O
Expression O O
of O O
cytokines O O
in O O
fetal O O
thymi O O
of O O
Hoxa3+/-Pax1-/- O O
mice O O
and O O
controls O O
measured O O
by O O
semi-quantitative O O
RT-PCR O O
Each O O
lane O O
contains O O
pooled O O
cDNA O O
from O O
5–10 O O
E14.5 O O
embryonic O O
thymi O O
of O O
the O O
same O O
genotype O O
. O O

Representative O O
results O O
from O O
one O O
of O O
three O O
experiments O O
for O O
each O O
cytokine O O
are O O
shown O O
. O O

β-actin O O
was O O
used O O
as O O
a O O
control O O
. O O

Panel O O
A O O
, O O
expression O O
of O O
IL-7 O O
; O O
Panel O O
B O O
, O O
expression O O
of O O
SCF O O
. O O

Table O O
1 O O
: O O
Percentage O O
-LRB- O O
Mean O O
± O O
SD O O
-RRB- O O
of O O
BrdU+ O O
cells O O
in O O
each O O
subset O O
of O O
fetal O O
thymocytes O O

Table O O
2 O O
: O O
Percentages O O
-LRB- O O
Mean O O
± O O
SD O O
-RRB- O O
of O O
BrdU+ O O
cells O O
in O O
selected O O
subsets O O
of O O
wild-type O O
and O O
compound O O
mutant O O
fetal O O
thymocytes O O

Down-regulation O O
of O O
interferon O O
regulatory O O
factor O O
4 O O
gene O O
expression O O
in O O
leukemic O O
cells O O
due O O
to O O
hypermethylation O O
of O O
CpG O O
motifs O O
in O O
the O O
promoter O O
region O O

Abstract O O

Although B-conn Concession.Expectation
the O O
bcr-abl O O
translocation O O
has O O
been O O
shown O O
to O O
be O O
the O O
causative O O
genetic O O
aberration O O
in O O
chronic O O
myeloid O O
leukemia O O
-LRB- O O
CML O O
-RRB- O O
, O O
there O O
is O O
mounting O O
evidence O O
that O O
the O O
deregulation O O
of O O
other O O
genes O O
, O O
such O O
as O O
the O O
transcription O O
factor O O
interferon O O
regulatory O O
factor O O
4 O O
-LRB- O O
IRF-4 O O
-RRB- O O
, O O
is O O
also O O
implicated O O
in O O
the O O
pathogenesis O O
of O O
CML O O
. O O

Promoter O O
methylation O O
of O O
CpG O O
target O O
sites O O
or O O
direct O O
deletions/insertions O O
of O O
genes O O
are O O
mechanisms O O
of O O
a O O
reversible O O
or O O
permanent O O
silencing O O
of O O
gene O O
expression O O
, O O
respectively O O
. O O

Therefore B-conn Cause.Result
, O O
we O O
investigated O O
whether O O
IRF-4 O O
promoter O O
methylation O O
or O O
mutation O O
may O O
be O O
involved O O
in O O
the O O
regulation O O
of O O
IRF-4 O O
expression O O
in O O
leukemia O O
cells O O
. O O

Whereas B-conn Contrast
promoter O O
mutations O O
or O O
structural O O
rearrangements O O
could O O
be O O
excluded O O
as O O
a O O
cause O O
of O O
altered O O
IRF-4 O O
expression O O
in O O
hematopoietic O O
cells O O
, O O
the O O
IRF-4 O O
promoter O O
methylation O O
status O O
was O O
found O O
to O O
significantly O O
influence O O
IRF-4 O O
transcription O O
. O O

First O O
, O O
treatment O O
of O O
IRF-4-negative O O
lymphoid O O
, O O
myeloid O O
and O O
monocytic O O
cell O O
lines O O
with O O
the O O
methylation-inhibitor O O
5-aza-2-deoxycytidine O O
resulted O O
in O O
a O O
time- O O
and O O
concentration-dependent O O
increase O O
of O O
IRF-4 O O
mRNA O O
and O O
protein O O
levels O O
. O O

Second B-conn Temporal.Precedence
, O O
using O O
a O O
restriction-PCR-assay O O
and O O
bisulfite-sequencing O O
we O O
identified O O
specifically O O
methylated O O
CpG O O
sites O O
in O O
IRF-4-negative O O
but O O
not O O
in O O
IRF-4-positive O O
cells O O
. O O

Third B-conn Temporal.Precedence
, O O
we O O
clearly O O
determined O O
promoter O O
methylation O O
as O O
a O O
mechanism O O
for O O
IRF-4 O O
down-regulation O O
via B-conn Purpose.Enablement
reporter O O
gene O O
assays O O
, O O
but O O
did O O
not O O
detect O O
an O O
association O O
of O O
methylational O O
status O O
and O O
mRNA O O
expression O O
of O O
DNA O O
methyltransferases O O
or O O
methyl-CpG-binding O O
proteins O O
. O O

Together O O
, O O
these O O
data O O
suggest O O
CpG O O
site-specific O O
IRF-4 O O
promoter O O
methylation O O
as O O
a O O
putative O O
mechanism O O
of O O
down-regulated O O
IRF-4 O O
expression O O
in O O
leukemia O O
. O O

INTRODUCTION O O

Chronic O O
myeloid O O
leukemia O O
-LRB- O O
CML O O
-RRB- O O
is O O
a O O
clonal O O
myeloproliferative O O
disorder O O
with O O
a O O
typical O O
three O O
phased O O
course O O
-LRB- O O
chronic O O
, O O
accelerated O O
and O O
blastic O O
phase O O
-RRB- O O
reflecting O O
the O O
loss O O
of O O
differentiation O O
and O O
malignant O O
progress O O
which O O
inevitably O O
leads O O
to O O
death O O
after B-conn Temporal.Succession
the O O
blastic O O
phase O O
-LRB- O O
1,2 O O
-RRB- O O
. O O

The O O
hallmark O O
genetic O O
aberration O O
of O O
CML O O
is O O
a O O
reciprocal O O
chromosomal O O
translocation O O
t O O
-LRB- O O
9 O O
; O O
22 O O
-RRB- O O
leading O O
to O O
expression O O
of O O
a O O
bcr-abl O O
fusion O O
gene O O
, O O
an O O
aberrant O O
activated O O
tyrosine O O
kinase O O
-LRB- O O
2 O O
-RRB- O O
. O O

Treatment O O
with O O
interferon O O
α O O
-LRB- O O
IFN-α O O
-RRB- O O
prolongs O O
survival O O
of O O
CML O O
patients O O
and O O
is O O
associated O O
with O O
a O O
complete O O
cytogenetic O O
response O O
in O O
5–33 O O
% O O
of O O
CML O O
patients O O
-LRB- O O
1,2 O O
-RRB- O O
. O O

Recently O O
, O O
we O O
described O O
an O O
impaired O O
expression O O
of O O
the O O
interferon O O
regulatory O O
factor O O
4 O O
-LRB- O O
IRF-4 O O
-RRB- O O
in O O
CML O O
, O O
correlating O O
with O O
poor O O
response O O
to O O
IFN-α O O
treatment O O
-LRB- O O
3 O O
-RRB- O O
. O O

The O O
cause O O
of O O
the O O
silencing O O
of O O
IRF-4 O O
level O O
remained O O
unclear O O
. O O

Interferon O O
regulatory O O
factors O O
-LRB- O O
IRFs O O
-RRB- O O
are O O
a O O
family O O
of O O
transcriptional O O
regulators O O
defined O O
by B-conn Purpose.Enablement
a O O
characteristic O O
homology O O
in O O
their O O
DNA-binding O O
domain O O
. O O

They O O
play O O
an O O
important O O
role O O
in O O
the O O
regulation O O
of O O
various O O
genes O O
-LRB- O O
such O O
as O O
IFNs O O
, O O
interleukins O O
, O O
MHC O O
class O O
I/II O O
-RRB- O O
, O O
apoptosis O O
and O O
differentiation/maturation O O
-LRB- O O
4–6 O O
-RRB- O O
. O O

IRF-4 O O
-LRB- O O
ICSAT/Pip/MUM1/LSIRF O O
-RRB- O O
is O O
one O O
member O O
with O O
very O O
restricted O O
expression O O
pattern O O
: O O
Predominately O O
B- O O
and O O
activated O O
T-lymphocytes O O
are O O
IRF-4 O O
positive O O
-LRB- O O
7–11 O O
-RRB- O O
. O O

In O O
contrast O O
to O O
other O O
IRFs O O
, O O
expression O O
of O O
IRF-4 O O
cannot O O
be O O
induced O O
by B-conn Purpose.Enablement
IFNs O O
, O O
but O O
by O O
antigen O O
stimulation O O
, O O
crosslinking O O
of O O
T- O O
or O O
B-cell O O
receptors O O
or O O
phorbol-myristate-acetate O O
-LRB- O O
10,11 O O
-RRB- O O
. O O

Consistent O O
with O O
the O O
restriction O O
of O O
expression O O
to O O
immunocompetent O O
cells O O
, O O
mice O O
with O O
deletion O O
of O O
IRF-4 O O
failed O O
to B-conn Purpose.Goal
develop O O
mature O O
and O O
functionally O O
active O O
B- O O
and O O
T-lymphocytes O O
-LRB- O O
12 O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
impaired O O
expression O O
of O O
IRF-4 O O
in O O
CML O O
was O O
predominately O O
found O O
in O O
T-cells O O
-LRB- O O
3 O O
-RRB- O O
. O O

These O O
data O O
suggest O O
a O O
crucial O O
role O O
for B-conn Purpose.Goal
IRF-4 O O
in O O
the O O
function O O
of O O
immune O O
cells O O
. O O

Methylation O O
of O O
dinucleotide O O
cytosine-guanosine O O
motifs O O
-LRB- O O
CpG O O
-RRB- O O
, O O
especially O O
in O O
CpG O O
islands O O
located O O
in O O
promoter O O
regions O O
, O O
is O O
one O O
of O O
the O O
mechanisms O O
of O O
gene O O
regulation O O
in O O
mammals O O
and O O
a O O
common O O
event O O
of O O
gene O O
silencing O O
in O O
human O O
neoplasias O O
-LRB- O O
13,14 O O
-RRB- O O
. O O

As O O
opposed O O
to O O
normal O O
cells O O
, O O
hypermethylation O O
of O O
CpG O O
islands O O
is O O
a O O
frequently O O
observed O O
phenomenon O O
in O O
every O O
cancer O O
type O O
. O O

De O O
novo O O
DNA O O
methylation O O
of O O
genes O O
such O O
as O O
cell O O
cycle O O
, O O
DNA O O
repair O O
, O O
apoptosis O O
and O O
tumor O O
suppressor O O
genes O O
is O O
therefore B-conn Cause.Result
thought O O
to O O
be O O
involved O O
in O O
tumorigenesis O O
-LRB- O O
15–17 O O
-RRB- O O
. O O

Examples O O
for O O
such O O
aberrated O O
genes O O
are O O
MGMT O O
, O O
DAPK O O
, O O
p14ARF O O
, O O
p15INK4b O O
, O O
p16INK4a O O
, O O
BRCA1 O O
, O O
CDH13 O O
and O O
APAF-1 O O
-LRB- O O
17–19 O O
-RRB- O O
. O O

In O O
CML O O
, O O
methylation O O
is O O
known O O
to O O
regulate O O
expression O O
of O O
the O O
c-abl O O
, O O
the O O
bcr O O
gene O O
and O O
others O O
-LRB- O O
20–23 O O
-RRB- O O
, O O
and B-conn Conjunction
the O O
extent O O
of O O
methylation O O
in O O
the O O
c-abl O O
promoter O O
has O O
been O O
shown O O
to O O
be O O
associated O O
with O O
advanced O O
disease O O
-LRB- O O
24 O O
-RRB- O O
. O O

Hypermethylation O O
due B-conn Cause.Reason
to I-conn Cause.Reason
overexpression O O
of O O
DNA O O
methyltransferases O O
-LRB- O O
DNMTs O O
-RRB- O O
remains O O
one O O
possible O O
explanation O O
for B-conn Purpose.Goal
de O O
novo O O
methylation O O
in O O
tumorigenesis O O
. O O

Recently O O
, O O
DNMTs O O
have O O
been O O
shown O O
to O O
be O O
up-regulated O O
in O O
hematopoietic O O
malignancies O O
-LRB- O O
25 O O
-RRB- O O
. O O

Methyl-CpG-binding O O
proteins O O
-LRB- O O
MBPs O O
-RRB- O O
are O O
thought O O
to O O
inhibit O O
the O O
binding O O
of O O
transcriptional O O
factors O O
to O O
the O O
promoter O O
and O O
are O O
therefore B-conn Cause.Result
discussed O O
as O O
one O O
mechanism O O
of O O
transcription O O
inhibition O O
by B-conn Purpose.Enablement
hypermethylation O O
-LRB- O O
26 O O
-RRB- O O
. O O

In O O
this O O
work O O
, O O
we O O
studied O O
mechanisms O O
of O O
IRF-4 O O
gene O O
expression O O
silencing O O
in O O
leukemic O O
cells O O
. O O

We O O
analyzed O O
the O O
IRF-4 O O
promoter O O
region O O
for B-conn Purpose.Goal
genetic O O
aberrations O O
and O O
methylational O O
status O O
in O O
IRF-4-positive O O
and O O
-negative O O
hematopoietic O O
cells O O
. O O

MATERIALS O O
AND O O
METHODS O O

K-562 O O
, O O
Jurkat O O
and O O
U-937 O O
were O O
obtained O O
from O O
the O O
ATCC O O
-LRB- O O
American O O
Type O O
Culture O O
Collection O O
, O O
Rockville O O
, O O
USA O O
-RRB- O O
and O O
EM-2 O O
, O O
LAMA-84 O O
, O O
CML-T1 O O
, O O
BV-173 O O
, O O
SD-1 O O
and O O
RPMI-8226 O O
from O O
the O O
DSMZ O O
-LRB- O O
Deutsche O O
Sammlung O O
von O O
Mikroorganismen O O
und O O
Zellkulturen O O
GmbH O O
, O O
Braunschweig O O
, O O
Germany O O
-RRB- O O
. O O

All O O
cell O O
lines O O
, O O
except B-conn Exception
BV-173 O O
, O O
SD-1 O O
and O O
RPMI-8226 O O
, O O
were O O
IRF-4-negative O O
. O O

All O O
cell O O
lines O O
were O O
maintained O O
at O O
5 O O
% O O
CO2 O O
in O O
RPMI O O
1640 O O
medium O O
with O O
1 O O
% O O
glutamine O O
-LRB- O O
Gibco/BRL O O
Eggenstein O O
, O O
Germany O O
-RRB- O O
supplemented O O
with O O
10 O O
% O O
fetal O O
calf O O
serum O O
-LRB- O O
Gibco/BRL O O
-RRB- O O
, O O
1 O O
% O O
penicillin/streptomycin O O
-LRB- O O
Biochrom O O
, O O
Berlin O O
, O O
Germany O O
-RRB- O O
. O O

When B-conn Condition.Hypothetical
indicated O O
, O O
cells O O
were O O
treated O O
with O O
5-aza-2-deoxycytidine O O
-LRB- O O
AzadC O O
-RRB- O O
or O O
5-azacytidine O O
-LRB- O O
AzaC O O
-RRB- O O
-LRB- O O
Sigma O O
, O O
Taufkirchen O O
, O O
Germany O O
-RRB- O O
for O O
different O O
time O O
periods O O
. O O

Owing O O
to O O
their O O
chemical O O
instability O O
fresh O O
substances O O
were O O
re-added O O
every O O
24 O O
h O O
. O O

For B-conn Purpose.Goal
analysis O O
of O O
the O O
IRF-4 O O
promoter O O
region O O
for O O
permanent O O
aberrations O O
such O O
as O O
insertions/deletions O O
or O O
mutation O O
, O O
we O O
PCR-amplified O O
two O O
fragments O O
from O O
genomic O O
DNA O O
, O O
which O O
was O O
extracted O O
from O O
depicted O O
cell O O
lines O O
with O O
a O O
commercial O O
kit O O
-LRB- O O
Qiagen O O
, O O
Hilde O O
, O O
Germany O O
-RRB- O O
as O O
recommended O O
. O O

The O O
primers O O
were O O
1-forward O O
: O O
5′-TTGAGATGGAGTCTTGCTCTGT-3′ O O
, O O
1-reverse O O
: O O
5′-CCAGGACCTCAGGAGGCCAGTCA-3′ O O
; O O
2-forward O O
: O O
5′-AGCGGTGAAACTGAGAGTGCGAGGT-3′ O O
, O O
2-reverse O O
: O O
5′-GCCACATCGCTGCAGTTTAG-3′ O O
. O O

The O O
products O O
were O O
cloned O O
with O O
the O O
‘TOPO O O
TA O O
cloning O O
kit’ O O
-LRB- O O
Invitrogen O O
, O O
Groningen O O
, O O
The O O
Netherlands O O
-RRB- O O
. O O

After B-conn Temporal.Succession
bacterial O O
amplification O O
of O O
the O O
cloned O O
PCR O O
fragments O O
by B-conn Purpose.Enablement
standard O O
procedures O O
, O O
at O O
least O O
three O O
clones O O
from O O
each O O
sample O O
were O O
sequenced O O
with O O
an O O
automated O O
sequencer O O
-LRB- O O
ABI O O
Prism O O
377 O O
, O O
Applied O O
Bio-systems O O
, O O
Foster O O
City O O
, O O
USA O O
-RRB- O O
as O O
recommended O O
by O O
the O O
manufacturer O O
. O O

To B-conn Purpose.Goal
analyze O O
the O O
IRF-4 O O
transcriptional O O
level O O
, O O
RNA O O
was O O
extracted O O
from O O
cells O O
using O O
the O O
commercial O O
RNAzol-kit O O
-LRB- O O
Paesel O O
, O O
Frankfurt O O
, O O
Germany O O
-RRB- O O
. O O

An O O
aliquot O O
of O O
1 O O
μg O O
total O O
RNA O O
was O O
used O O
for O O
cDNA O O
synthesis O O
as O O
described O O
previously O O
-LRB- O O
27 O O
-RRB- O O
. O O

RNA O O
expression O O
analysis O O
for O O
IRF-4 O O
and O O
the O O
reference O O
gene O O
β-actin O O
was O O
carried O O
out O O
by B-conn Purpose.Enablement
semi-quantitative O O
PCR O O
as O O
described O O
previously O O
-LRB- O O
3,27 O O
-RRB- O O
. O O

PCR O O
products O O
were O O
verified O O
by B-conn Purpose.Enablement
automated O O
sequencing O O
. O O

PCR O O
primers O O
and O O
conditions O O
for O O
expression O O
analysis O O
of O O
DNMT O O
or O O
MBP O O
-LRB- O O
DNMT1 O O
DNMT3A O O
, O O
DNMT3B O O
, O O
MeCP O O
, O O
MBD1 O O
, O O
MBD2 O O
and O O
MBD4 O O
-RRB- O O
were O O
published O O
elsewhere O O
-LRB- O O
28 O O
-RRB- O O
. O O

For B-conn Purpose.Goal
analysis O O
of O O
IRF-4 O O
protein O O
expression O O
, O O
a O O
standard O O
immunoblotting O O
assay O O
was O O
performed O O
as O O
described O O
previously O O
-LRB- O O
29 O O
-RRB- O O
. O O

Briefly O O
, O O
protein O O
lysates O O
were O O
generated O O
by B-conn Purpose.Enablement
incubating O O
1 O O
× O O
106 O O
cells O O
in O O
100 O O
µl O O
RIPA O O
buffer O O
-LRB- O O
1 O O
% O O
NP-40 O O
, O O
0.5 O O
% O O
sodiumdesoxycholate O O
, O O
0.1 O O
% O O
SDS O O
, O O
100 O O
µg/ml O O
phenylmethylsulfonyl O O
fluoride O O
, O O
10 O O
µl/ml O O
protease-inhibitory-mix O O
, O O
1 O O
µmol/ml O O
sodiumorthovanadate O O
in O O
phosphate-buffered O O
saline O O
-RRB- O O
for O O
30 O O
min O O
on O O
ice O O
. O O

After B-conn Temporal.Succession
centrifugation O O
, O O
protein O O
concentration O O
of O O
the O O
supernatant O O
was O O
determined O O
by B-conn Purpose.Enablement
BCA-method O O
-LRB- O O
Pierce O O
, O O
Rockford O O
, O O
IL O O
-RRB- O O
as O O
recommended O O
. O O

Protein O O
lysates O O
-LRB- O O
70–100 O O
µg O O
-RRB- O O
were O O
electrophoresed O O
on O O
polyacrylamide O O
gels O O
and O O
transferred O O
to O O
a O O
PVDF-membrane O O
-LRB- O O
Immobilon O O
P O O
, O O
0.45 O O
µm O O
; O O
Millipore O O
, O O
Eschborn O O
, O O
Germany O O
-RRB- O O
. O O

Membranes O O
were O O
blocked O O
with O O
2.5 O O
% O O
blocking O O
reagent O O
-LRB- O O
Boehringer O O
Mannheim O O
, O O
Germany O O
-RRB- O O
in O O
TBST O O
buffer O O
-LRB- O O
4.44 O O
g/l O O
Tris–HCL O O
, O O
2.65 O O
g/l O O
TrisOH O O
, O O
8.07 O O
g/l O O
NaCl O O
, O O
0.2 O O
g/l O O
KCl O O
and O O
500 O O
µl/l O O
Tween-20 O O
in O O
H2O O O
-RRB- O O
and O O
subsequently O O
incubated O O
with O O
primary O O
antibody O O
as O O
indicated O O
and O O
horseradish O O
peroxidase-conjugated O O
secondary O O
antibody O O
, O O
anti-mouse O O
or O O
anti-goat O O
IgG O O
-LRB- O O
DAKO O O
, O O
Hamburg O O
, O O
Germany O O
-RRB- O O
, O O
respectively O O
. O O

The O O
membranes O O
were O O
then B-conn Temporal.Precedence
developed O O
with O O
an O O
ECL O O
detection O O
kit O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
, O O
Freiburg O O
, O O
Germany O O
-RRB- O O
. O O

The O O
primary O O
antibodies O O
were O O
goat O O
anti-IRF-4/ICSAT O O
-LRB- O O
M-17 O O
-RRB- O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
, O O
Santa O O
Cruz O O
, O O
CA O O
-RRB- O O
and O O
mouse O O
anti-β-actin O O
-LRB- O O
AC-74 O O
-RRB- O O
-LRB- O O
Sigma O O
-RRB- O O
. O O

DNA O O
was O O
extracted O O
with O O
a O O
commercial O O
kit O O
-LRB- O O
Qiagen O O
-RRB- O O
as O O
recommended O O
. O O

Since B-conn Cause.Reason
the O O
restriction O O
ability O O
of O O
several O O
endonucleases O O
is O O
inhibited O O
by B-conn Purpose.Enablement
methylation O O
of O O
their O O
target O O
sequence O O
, O O
we O O
used O O
methylation-sensitive O O
enzymes O O
HpaII O O
and O O
HaeII-isochizomer O O
Bsp143II O O
and O O
Bsh1236I O O
-LRB- O O
MBI O O
Fermentas O O
, O O
St O O
Leon-Rot O O
, O O
Germany O O
-RRB- O O
-LRB- O O
20,24 O O
-RRB- O O
. O O

As O O
control O O
the O O
methylation-resistant O O
enzyme O O
MspI O O
and O O
an O O
enzyme O O
with O O
no O O
recognition O O
site O O
in O O
the O O
target O O
promoter O O
, O O
EcoRI O O
, O O
were O O
used O O
. O O

DNA O O
-LRB- O O
0.8 O O
µg O O
-RRB- O O
was O O
digested O O
by B-conn Purpose.Enablement
40 O O
U O O
the O O
respective O O
enzyme O O
for O O
6 O O
h O O
and O O
, O O
to B-conn Purpose.Goal
ensure O O
complete O O
cleavage O O
, O O
additional O O
20 O O
U O O
for O O
16 O O
h O O
. O O

Thereafter B-conn Temporal.Precedence
100 O O
ng O O
of O O
digested O O
DNA O O
was O O
used O O
to O O
a O O
PCR O O
amplification O O
of O O
two O O
fragments O O
-LRB- O O
F1 O O
and O O
F2 O O
-RRB- O O
spanning O O
part O O
of O O
the O O
IRF-4 O O
promoter O O
-LRB- O O
30 O O
-RRB- O O
-LRB- O O
GenBank O O
U52683 O O
; O O
see O O
Figure O O
3A O O
-RRB- O O
. O O

The O O
sequences O O
of O O
the O O
primers O O
were O O
F1-forward O O
: O O
5′-TTGAGATGGAGTCTTGCTCTGT-3′ O O
, O O
F1-reverse O O
: O O
ATCACTTCCAGACTTCAGTTCACCT-3′ O O
-LRB- O O
341 O O
bp O O
-RRB- O O
; O O
F2-forward O O
: O O
5′-AAGGTGAACTGAAGTCTGGAAGTGA-3′ O O
, O O
F2-reverse O O
: O O
5′-CCAGGACCTCAGGAGGCCAGTCA-3′ O O
-LRB- O O
474 O O
bp O O
-RRB- O O
. O O

The O O
PCR O O
conditions O O
were O O
described O O
elsewhere O O
-LRB- O O
3 O O
-RRB- O O
. O O

PCR O O
was O O
performed O O
with O O
an O O
annealing O O
temperature O O
of O O
62°C O O
and O O
35 O O
cycles O O
. O O

When B-conn Temporal.Succession
DNA O O
was O O
methylated O O
at O O
specific O O
sites O O
, O O
the O O
sensitive O O
enzymes O O
were O O
not O O
able O O
to O O
digest O O
the O O
DNA O O
and O O
amplification O O
took O O
place O O
; O O
in O O
case O O
of O O
no O O
methylation O O
, O O
DNA O O
was O O
digested O O
and O O
no O O
product O O
was O O
generated O O
. O O

The O O
PCR O O
products O O
were O O
electrophoresed O O
on O O
a O O
3 O O
% O O
agarose O O
gel O O
, O O
were O O
stained O O
with O O
ethidium O O
bromide O O
and O O
photographed O O
. O O

PCR O O
products O O
were O O
verified O O
by B-conn Purpose.Enablement
automated O O
sequencing O O
. O O

DNA O O
was O O
extracted O O
as O O
described O O
above O O
. O O

Bisulfite O O
treatment O O
of O O
DNA O O
, O O
leading O O
to O O
conversion O O
of O O
unmethylated O O
cytosine O O
to O O
uracil O O
residues O O
and O O
no O O
change O O
of O O
methylated O O
cytosine O O
residues O O
, O O
was O O
performed O O
as O O
described O O
as O O
follows O O
. O O

Briefly O O
, O O
1 O O
µg O O
of O O
DNA O O
and O O
2 O O
µg O O
of O O
poly O O
-LRB- O O
dA–dT O O
-RRB- O O
-LRB- O O
poly O O
-LRB- O O
dA–dT O O
-RRB- O O
copolymers O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
-RRB- O O
were O O
denaturated O O
for O O
20 O O
min O O
at O O
42°C O O
in O O
0.3 O O
M O O
NaOH O O
in O O
a O O
volume O O
of O O
50 O O
µl O O
. O O

Fresh O O
solutions O O
of O O
30 O O
µl O O
of O O
10 O O
mM O O
hydrochinon O O
-LRB- O O
Sigma O O
-RRB- O O
and O O
530 O O
µl O O
of O O
3 O O
M O O
sodium O O
bisulfite O O
-LRB- O O
pH O O
5.0 O O
; O O
Sigma O O
-RRB- O O
were O O
added O O
, O O
the O O
solution O O
was O O
gently O O
mixed O O
, O O
overlayed O O
with O O
mineral O O
oil O O
and O O
incubated O O
in O O
the O O
dark O O
for O O
12–13 O O
h O O
at O O
50°C O O
. O O

The O O
aqueous O O
phase O O
was O O
recovered O O
using O O
the O O
‘Wizard O O
DNA O O
clean-up O O
system’ O O
-LRB- O O
Promega O O
, O O
Mannheim O O
, O O
Germany O O
-RRB- O O
. O O

The O O
purified O O
DNA O O
was O O
subsequently O O
mixed O O
with O O
1 O O
M O O
NaOH O O
to O O
a O O
final O O
concentration O O
of O O
0.3 O O
M O O
and O O
incubated O O
for O O
20 O O
min O O
at O O
37°C O O
to B-conn Purpose.Goal
ensure O O
complete O O
desulfonisation O O
. O O

DNA O O
was O O
ethanol O O
precipitated O O
in O O
the O O
presence O O
of O O
1/10 O O
vol O O
of O O
3 O O
M O O
sodium O O
acetate O O
, O O
washed O O
with O O
70 O O
% O O
ethanol O O
and O O
resuspended O O
in O O
50 O O
µl O O
H2O O O
. O O

Subsequent O O
PCR O O
amplification O O
of O O
4 O O
µl O O
bisulfite-treated O O
DNA O O
was O O
used O O
for B-conn Purpose.Goal
cloning O O
of O O
two O O
fragments O O
of O O
the O O
IRF-4 O O
promoter O O
-LRB- O O
BS-I O O
and O O
BS-II O O
-RRB- O O
into O O
pCR2.1 O O
vector O O
with O O
the O O
‘TOPO O O
TA O O
cloning O O
kit’ O O
-LRB- O O
Invitrogen O O
-RRB- O O
-LRB- O O
see O O
Figure O O
3A O O
-RRB- O O
. O O

The O O
primers O O
used O O
for O O
PCR O O
amplification O O
of O O
the O O
BS-I O O
and O O
BS-II O O
fragments O O
contain O O
the O O
putative O O
altered O O
sequence O O
of O O
the O O
sense O O
strand O O
due B-conn Cause.Reason
to I-conn Cause.Reason
bisulfite O O
treatment O O
-LRB- O O
converted O O
cytosine O O
residues O O
are O O
written O O
in O O
bold O O
letters O O
-RRB- O O
: O O
BS-I-forward O O
5′-TATTTGGATTTTTAGGGAGTTTTTTTT-3′ O O
, O O
BS-I-reverse O O
5′-ACCCAACTCCCTTAAACTATTAAACT-3′ O O
-LRB- O O
187 O O
bp O O
-RRB- O O
; O O
BS-II-forward O O
5′-AGTTTAATAGTTTAAGGGAGTTGGGT-3′ O O
, O O
BS-II-reverse O O
5′-CTCACCCTAAACTCAAAACTAAAAAC-3′ O O
-LRB- O O
674 O O
bp O O
-RRB- O O
. O O

After B-conn Temporal.Succession
bacterial O O
amplification O O
of O O
the O O
cloned O O
PCR O O
fragments O O
by B-conn Purpose.Enablement
standard O O
procedures O O
, O O
eight O O
clones O O
from O O
each O O
sample O O
were O O
sequenced O O
with O O
an O O
automated O O
sequencer O O
-LRB- O O
ABI O O
Prism O O
377 O O
, O O
Applied O O
Biosystems O O
-RRB- O O
. O O

The O O
IRF-4 O O
promoter-reporter O O
gene O O
construct O O
was O O
generously O O
provided O O
by O O
J. O O
Hiscott O O
-LRB- O O
31 O O
-RRB- O O
. O O

Constructs O O
were O O
methylated O O
in O O
vitro O O
with O O
CpG O O
Methylase O O
-LRB- O O
M.Sss O O
I O O
-RRB- O O
as O O
recommended O O
by O O
the O O
manufacturer O O
-LRB- O O
NE O O
Biolabs O O
-RRB- O O
and B-conn Conjunction
complete O O
methylation O O
was O O
checked O O
via B-conn Purpose.Enablement
restriction O O
analysis O O
-LRB- O O
Figure O O
5A O O
-RRB- O O
. O O

Reporter O O
gene O O
assays O O
using O O
the O O
dual O O
luciferase O O
assay O O
-LRB- O O
Promega O O
-RRB- O O
were O O
performed O O
similar O O
to O O
previous O O
reports O O
-LRB- O O
29 O O
-RRB- O O
. O O

Briefly O O
, O O
5 O O
nM O O
of O O
the O O
reporter O O
construct O O
and O O
the O O
transfection O O
control O O
construct O O
expressing O O
the O O
renilla O O
luciferase O O
gene O O
were O O
transientlyco-expressed O O
via B-conn Purpose.Enablement
electroporation O O
. O O

The O O
control O O
construct O O
served O O
as O O
an O O
internal O O
reference O O
for B-conn Purpose.Goal
transfection O O
efficiency O O
. O O

Forty-eight B-conn Temporal.Succession
hours I-conn Temporal.Succession
after I-conn Temporal.Succession
transfection O O
, O O
luciferase O O
activity O O
was O O
measured O O
with O O
a O O
LB O O
96 O O
P O O
microlumat O O
-LRB- O O
EG&G O O
Berthold O O
, O O
Bad O O
Wildbad O O
, O O
Germany O O
-RRB- O O
. O O

IRF-4 O O
promoter O O
activation O O
was O O
quantified O O
as O O
a O O
ratio O O
of O O
measured O O
firefly O O
light O O
units O O
-LRB- O O
flu O O
-RRB- O O
relative O O
to O O
renilla O O
-LRB- O O
rlu O O
-RRB- O O
. O O

Each O O
experiment O O
was O O
carried O O
out O O
at O O
least O O
three O O
times O O
. O O

RESULTS O O

We O O
have O O
previously O O
demonstrated O O
a O O
lack O O
of O O
IRF-4 O O
expression O O
in O O
leukemia O O
patients O O
and O O
specifically O O
in O O
CML O O
T-cells O O
-LRB- O O
3 O O
-RRB- O O
. O O

Here O O
, O O
we O O
demonstrate O O
the O O
absence O O
of O O
IRF-4 O O
expression O O
in O O
various O O
hematopoietic O O
cell O O
lines O O
, O O
such O O
as O O
Jurkat O O
, O O
a O O
T-cell O O
leukemia O O
, O O
CML-T1 O O
, O O
a O O
bcr-abl-positive O O
T-cell O O
line O O
, O O
K-562 O O
, O O
a O O
bcr-abl-positve O O
erythroleukemia O O
, O O
U-937 O O
, O O
a O O
monocytic O O
leukemia O O
, O O
EM-2 O O
and O O
LAMA-84 O O
, O O
bcr-abl-positve O O
myeloid O O
leukemia O O
, O O
but O O
not O O
in O O
SD-1 O O
, O O
a O O
bcr-abl-positive O O
acute O O
lymphoblastic O O
leukemia O O
-LRB- O O
pre O O
B-ALL O O
-RRB- O O
, O O
RPMI-8226 O O
, O O
a O O
multiple O O
myeloma O O
and O O
BV-173 O O
, O O
a O O
bcr-abl-positive O O
B-cell O O
line O O
-LRB- O O
Figures O O
1A O O
and O O
5D O O
-RRB- O O
. O O

After B-conn Temporal.Succession
sequencing O O
of O O
the O O
IRF-4 O O
promoter O O
, O O
it O O
could O O
be O O
excluded O O
that O O
absence O O
of O O
IRF-4 O O
expression O O
in O O
any O O
of O O
the O O
above O O
cell O O
lines O O
was O O
due O O
to O O
genetic O O
aberrations O O
. O O

However B-conn Contrast
, O O
2 O O
bp O O
changes O O
-LRB- O O
nucleotide O O
−1081 O O
, O O
T→C O O
and O O
−1068 O O
, O O
A→C O O
-RRB- O O
could O O
be O O
detected O O
in O O
both O O
the O O
IRF-4-positive O O
BV-173 O O
and O O
the O O
IRF-4-negative O O
LAMA-84 O O
, O O
EM-2 O O
and O O
K-562 O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
. O O

At O O
position O O
−116 O O
an O O
A→C O O
substitution O O
was O O
found O O
in O O
EM-2 O O
, O O
K-562 O O
and O O
CML-T1 O O
, O O
whereas B-conn Contrast
Jurkat O O
, O O
BV-173 O O
and O O
SD-1 O O
exhibited O O
a O O
mixed O O
A/C O O
sequence O O
and O O
U-937 O O
, O O
LAMA-84 O O
and O O
RPMI-8226 O O
no O O
substitution O O
at O O
all O O
-LRB- O O
Figure O O
1B O O
-RRB- O O
. O O

Consequently B-conn Cause.Result
, O O
these O O
alterations O O
are O O
unlikely O O
to O O
affect O O
IRF-4 O O
expression O O
. O O

We O O
next O O
analyzed O O
whether O O
promoter O O
methylation O O
could O O
be O O
responsible O O
for B-conn Purpose.Goal
down-regulation O O
of O O
IRF-4 O O
expression O O
. O O

A O O
region O O
including O O
exon1 O O
in O O
the O O
IRF-4 O O
promoter O O
exhibited O O
a O O
large O O
number O O
of O O
CpG-rich O O
sequences O O
-LRB- O O
Figure O O
3A O O
-RRB- O O
. O O

Several O O
chemical O O
substances O O
such O O
as O O
5-aza-2-deoxycytidine O O
-LRB- O O
AzadC O O
-RRB- O O
or O O
5-azacytidine O O
-LRB- O O
AzaC O O
-RRB- O O
inhibit O O
de O O
novo O O
and O O
maintenance O O
methylation O O
, O O
and O O
thus B-conn Cause.Result
can O O
be O O
used O O
to B-conn Purpose.Goal
discern O O
promoter O O
methylation O O
-LRB- O O
32,33 O O
-RRB- O O
. O O

We O O
used O O
AzadC O O
to B-conn Purpose.Goal
generate O O
unmethylated O O
DNA O O
. O O

A O O
72 O O
h O O
AzadC-treatment O O
resulted O O
in O O
a O O
concentration-dependent O O
activation O O
of O O
IRF-4 O O
transcription O O
in O O
Jurkat O O
and O O
CML-T1 O O
T-cells O O
as O O
well O O
as O O
in O O
U-937 O O
, O O
K-562 O O
and O O
EM-2 O O
cell O O
lines O O
-LRB- O O
Figure O O
2A O O
-RRB- O O
. O O

IRF-4 O O
transcription O O
was O O
induced O O
in O O
a O O
time-dependent O O
manner O O
and O O
was O O
observed O O
as B-conn Temporal.Succession
early I-conn Temporal.Succession
as I-conn Temporal.Succession
24 I-conn Temporal.Succession
h I-conn Temporal.Succession
after I-conn Temporal.Succession
treatment O O
with O O
AzadC O O
and O O
increased O O
over O O
time O O
until O O
72 O O
h O O
-LRB- O O
Figure O O
2B O O
-RRB- O O
. O O

Time O O
and O O
strength O O
of O O
the O O
appearance O O
of O O
IRF-4 O O
transcripts O O
varied O O
among O O
cell O O
lines O O
, O O
i.e. O O
. O O

CML-T1 O O
responded O O
strongest O O
to O O
AzadC-treatment O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
line O O
with O O
this O O
, O O
AzadC-treatment O O
of O O
CML-T1 O O
and O O
LAMA-84 O O
cells O O
also B-conn Conjunction
translated O O
in O O
an O O
induction O O
of O O
IRF-4 O O
protein O O
expression O O
-LRB- O O
Figure O O
2C O O
-RRB- O O
. O O

Accordingly B-conn Conjunction
, O O
treatment O O
of O O
the O O
IRF-4-positive O O
cell O O
line O O
BV-173 O O
, O O
SD-1 O O
and O O
RPMI-8226 O O
with O O
AzadC O O
had O O
no O O
effect O O
on O O
IRF-4 O O
expression O O
-LRB- O O
Figure O O
2D O O
-RRB- O O
. O O

There O O
was O O
no O O
difference O O
in O O
the O O
effects O O
of O O
AzaC O O
versus O O
AzadC O O
, O O
as O O
both O O
increased O O
the O O
IRF-4 O O
mRNA O O
level O O
in O O
CML-T1 O O
cells O O
as O O
well O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

This O O
implied O O
that O O
promoter O O
methylation O O
may O O
control O O
IRF-4 O O
expression O O
, O O
but O O
an O O
alternative O O
explanation O O
may O O
be O O
activation O O
of O O
positive O O
transcriptional O O
regulators O O
of O O
IRF-4 O O
by O O
AzadC O O
-LRB- O O
or O O
AzaC O O
-RRB- O O
. O O

To B-conn Purpose.Goal
further O O
investigate O O
promoter O O
methylation O O
as O O
a O O
regulatory O O
mechanism O O
of O O
IRF-4 O O
gene O O
expression O O
, O O
restriction-PCR-assays O O
were O O
performed O O
-LRB- O O
20,24 O O
-RRB- O O
, O O
where O O
only O O
methylated O O
DNA O O
would O O
not O O
be O O
cut O O
enabling O O
subsequent O O
PCR O O
amplification O O
and O O
vice O O
versa O O
. O O

Genomic O O
DNA O O
from O O
leukemic O O
cells O O
Jurkat O O
, O O
CML-T1 O O
, O O
U-937 O O
, O O
K-562 O O
, O O
EM-2 O O
and O O
BV-173 O O
was O O
digested O O
with O O
the O O
methylation-sensitive O O
enzymes O O
HpaII O O
, O O
Bsh1236I O O
and O O
HaeII-isochizomer O O
Bsp143II O O
. O O

EcoRI O O
, O O
which O O
has O O
no O O
recognition O O
site O O
within O O
the O O
IRF-4 O O
promoter O O
, O O
and O O
the O O
methylation-resistant O O
enzyme O O
MspI O O
served O O
as O O
controls O O
. O O

Two O O
separate O O
amplification O O
reactions O O
were O O
performed O O
, O O
generating O O
two O O
fragments O O
, O O
F1 O O
and O O
F2 O O
-LRB- O O
Figure O O
3A O O
-RRB- O O
. O O

After B-conn Temporal.Succession
digestion O O
with O O
HpaII O O
and O O
Bsp143II O O
a O O
sufficient O O
PCR O O
amplification O O
of O O
F1 O O
and O O
F2 O O
was O O
detected O O
in O O
DNA O O
from O O
IRF-4-negative O O
Jurkat O O
, O O
CML-T1 O O
, O O
U-937 O O
, O O
K-562 O O
and O O
EM-2 O O
cells O O
, O O
suggesting O O
a O O
promoter O O
methylation O O
-LRB- O O
and O O
restriction O O
protection O O
-RRB- O O
at O O
the O O
respective O O
recognition O O
sites O O
-LRB- O O
Figure O O
3B O O
and O O
C O O
-RRB- O O
. O O

Notably O O
, O O
in O O
IRF-4-positive O O
SD-1 O O
cells O O
digestion O O
with O O
the O O
methylation-sensitive O O
enzymes O O
completely O O
inhibited O O
amplification O O
of O O
F1 O O
and O O
F2 O O
. O O

In O O
IRF-4-positive O O
BV-173 O O
cells O O
a O O
HpaII O O
, O O
but O O
not O O
a O O
Bsh1236I O O
digestion O O
, O O
significantly O O
reduced O O
the O O
amplifiable O O
DNA O O
message O O
of O O
F2 O O
-LRB- O O
Figure O O
3C O O
-RRB- O O
, O O
whereas B-conn Contrast
amplification O O
of O O
F1 O O
was O O
not O O
affected O O
-LRB- O O
Figure O O
3B O O
-RRB- O O
. O O

This O O
implied O O
that O O
IRF-4 O O
transcription O O
in O O
SD-1 O O
and O O
BV-173 O O
cells O O
is O O
associated O O
with O O
less O O
promoter O O
methylation O O
-LRB- O O
in O O
BV-173 O O
especially O O
at O O
HpaII O O
sites O O
-RRB- O O
as O O
compared O O
with O O
the O O
tested O O
IRF-4-negative O O
cells O O
. O O

In B-conn Purpose.Goal
order I-conn Purpose.Goal
to I-conn Purpose.Goal
exactly O O
map O O
the O O
methylation O O
sites O O
within O O
the O O
IRF-4 O O
promoter O O
, O O
we O O
treated O O
DNA O O
of O O
Jurkat O O
, O O
CML-T1 O O
, O O
U-937 O O
, O O
K-562 O O
and O O
EM-2 O O
cells O O
as O O
well O O
as O O
of O O
SD-1 O O
, O O
RPMI-8226 O O
and O O
BV-173 O O
control O O
cells O O
with O O
bisulfite O O
, O O
which O O
chemically O O
converts O O
unmethylated O O
cytosine O O
to O O
uracil O O
, O O
whereas B-conn Contrast
it O O
has O O
no O O
effect O O
on O O
methylated O O
cytosine O O
, O O
i.e. O O
in O O
CpG O O
-LRB- O O
34 O O
-RRB- O O
. O O

This O O
technique O O
is O O
especially O O
useful O O
for B-conn Purpose.Goal
detection O O
of O O
unknown O O
methylation O O
patterns O O
. O O

PCR O O
amplification O O
, O O
cloning O O
and O O
sequencing O O
of O O
the O O
bisulfite-treated O O
DNA O O
showed O O
a O O
specific O O
methylation O O
pattern O O
of O O
the O O
analyzed O O
62 O O
CpG O O
sites O O
in O O
all O O
cell O O
lines O O
-LRB- O O
Figure O O
4 O O
and O O
Table O O
1 O O
-RRB- O O
. O O

In B-conn Restatement.Generalization
general I-conn Restatement.Generalization
, O O
the O O
methylational O O
status O O
ranged O O
from O O
one O O
cell O O
line O O
with O O
a O O
nearly O O
non-methylated O O
IRF-4 O O
promoter O O
-LRB- O O
SD-1 O O
, O O
IRF-4-positive O O
-RRB- O O
to O O
a O O
completely O O
methylated O O
IRF-4 O O
promoter O O
in O O
CML-T1 O O
-LRB- O O
IRF-4-negative O O
-RRB- O O
. O O

Interestingly O O
, O O
the O O
percentage O O
of O O
CpG O O
methylation O O
in O O
the O O
IRF-4 O O
promoter O O
from O O
IRF-4-positive O O
cells O O
was O O
very O O
low O O
-LRB- O O
mean O O
24 O O
% O O
-RRB- O O
as O O
compared O O
with O O
IRF-4-negative O O
cells O O
-LRB- O O
mean O O
94 O O
% O O
-RRB- O O
-LRB- O O
Figure O O
4A O O
and O O
Table O O
1 O O
-RRB- O O
. O O

A O O
5′-region O O
-LRB- O O
R1 O O
-RRB- O O
with O O
13 O O
hypermethylated O O
CpG O O
sites O O
-LRB- O O
mean O O
number O O
of O O
methylated O O
clones O O
5.5 O O
of O O
8 O O
with O O
77 O O
% O O
methylated O O
CpGs O O
-RRB- O O
was O O
found O O
in O O
most O O
cells O O
-LRB- O O
except O O
SD-1 O O
and O O
RPMI-8226 O O
-RRB- O O
and O O
a O O
3′-region O O
-LRB- O O
R3 O O
-RRB- O O
of O O
6 O O
hypomethylated O O
CpG O O
sites O O
-LRB- O O
mean O O
number O O
of O O
methylated O O
clones O O
1.7 O O
of O O
8 O O
with O O
33 O O
% O O
methylated O O
CpGs O O
-RRB- O O
was O O
found O O
in O O
most O O
cells O O
-LRB- O O
except O O
CML-T1 O O
and O O
U-937 O O
-RRB- O O
-LRB- O O
Figure O O
4A O O
and O O
Table O O
1 O O
-RRB- O O
. O O

Intriguingly O O
, O O
a O O
stretch O O
of O O
13 O O
CpG O O
sites O O
-LRB- O O
# O O
10–22 O O
; O O
R2 O O
-RRB- O O
was O O
detected O O
in O O
between O O
these O O
regions O O
, O O
which O O
were O O
highly O O
methylated O O
in O O
IRF-4-negative O O
-LRB- O O
mean O O
number O O
of O O
methylated O O
clones O O
7.1 O O
of O O
8 O O
with O O
89 O O
% O O
methylated O O
CpGs O O
-RRB- O O
but O O
totally O O
non-methylated O O
in O O
IRF-4-positive O O
cells O O
-LRB- O O
Figure O O
4A O O
and O O
B O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
three O O
CpG O O
sites O O
at O O
the O O
5′ O O
end O O
-LRB- O O
# O O
54 O O
, O O
56 O O
, O O
58 O O
-RRB- O O
and O O
two O O
CpG O O
motifs O O
at O O
the O O
3′ O O
end O O
-LRB- O O
# O O
1 O O
, O O
2 O O
-RRB- O O
showed O O
this O O
direct O O
correlation O O
between O O
high O O
methylation O O
status O O
and O O
absence O O
of O O
IRF-4 O O
expression O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
two O O
CpG O O
sites O O
located O O
in O O
a O O
NFκB O O
-LRB- O O
# O O
48 O O
-RRB- O O
and O O
a O O
SP1 O O
element O O
-LRB- O O
# O O
45 O O
-RRB- O O
are O O
less O O
methylated O O
in O O
IRF-4-positive O O
than O O
in O O
IRF-4-negative O O
cells O O
-LRB- O O
mean O O
number O O
of O O
methylated O O
clones O O
: O O
1/8 O O
versus O O
8/8 O O
-RRB- O O
. O O

These O O
results O O
indicate O O
the O O
involvement O O
of O O
CpG O O
methylation O O
in O O
the O O
regulation O O
of O O
IRF-4 O O
expression O O
in O O
leukemic O O
cells O O
. O O

To B-conn Purpose.Goal
provide O O
evidence O O
for O O
a O O
direct O O
effect O O
of O O
methylational O O
status O O
on O O
IRF-4 O O
promoter O O
activity O O
we O O
performed O O
reporter O O
gene O O
assays O O
with O O
IRF-4 O O
promoter O O
constructs O O
before O O
and O O
after O O
their O O
in O O
vitro O O
methylation O O
. O O

A O O
complete O O
methylation O O
of O O
these O O
constructs O O
was O O
checked O O
via B-conn Purpose.Enablement
restriction O O
assays O O
with O O
methylation-sensitive O O
endonucleases O O
-LRB- O O
Figure O O
5A O O
-RRB- O O
. O O

Intriguingly O O
, O O
methylation O O
of O O
the O O
IRF-4 O O
promoter O O
significantly O O
decreased O O
promoter O O
activity O O
in O O
IRF-4-positive O O
SD-1 O O
cells O O
by O O
85.0 O O
% O O
-LRB- O O
Figure O O
5B O O
-RRB- O O
. O O

The O O
silencing O O
effect O O
of O O
CpG O O
methylation O O
was O O
not O O
restricted O O
to O O
IRF-4-positive O O
cells O O
, O O
since B-conn Cause.Justification
in O O
vitro O O
methylation O O
led O O
to O O
a O O
92.9 O O
% O O
abrogation O O
of O O
promoter O O
activity O O
in O O
IRF-4-negative O O
Jurkat O O
cells O O
-LRB- O O
Figure O O
5C O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
control O O
methylation O O
of O O
a O O
reporter O O
construct O O
with O O
a O O
different O O
promoter O O
-LRB- O O
FasL O O
-RRB- O O
as O O
well O O
as O O
an O O
empty O O
vector O O
had O O
no O O
effect O O
on O O
the O O
reporter O O
activity O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

These O O
data O O
proved O O
a O O
direct O O
association O O
between O O
methylation O O
and O O
activity O O
of O O
the O O
IRF-4 O O
promoter O O
. O O

Since B-conn Cause.Reason
abundance O O
of O O
DNMT O O
and O O
MBP O O
contribute O O
to O O
promoter O O
regulation O O
via B-conn Purpose.Enablement
methylation O O
-LRB- O O
25,26,28 O O
-RRB- O O
, O O
we O O
studied O O
their O O
mRNA O O
expression O O
to B-conn Purpose.Goal
investigate O O
a O O
possible O O
mechanism O O
for O O
the O O
observed O O
methylation O O
differences O O
in O O
the O O
IRF-4 O O
promoter O O
. O O

To O O
this O O
end O O
, O O
we O O
did O O
not O O
detect O O
a O O
significant O O
difference O O
in O O
DNMT O O
-LRB- O O
DNMT1 O O
, O O
DNMT3A O O
and O O
DNMT3B O O
-RRB- O O
or O O
MBP O O
-LRB- O O
MBD1 O O
, O O
MBD2 O O
, O O
MBD4 O O
and O O
MeCP O O
-RRB- O O
mRNA O O
expression O O
between O O
IRF-4-positive O O
and O O
-negative O O
cells O O
-LRB- O O
Figure O O
5D O O
-RRB- O O
. O O

In O O
fact O O
, O O
all O O
analyzed O O
cells O O
had O O
moderate O O
to O O
high O O
mRNA O O
levels O O
of O O
these O O
tested O O
DNMT/MBPs O O
and O O
differences O O
in O O
expression O O
were O O
not O O
correlated O O
with O O
IRF-4 O O
status O O
. O O

These O O
results O O
indicate O O
a O O
distinct O O
cause O O
of O O
the O O
methylation O O
differences O O
in O O
IRF-4-positive O O
and O O
-negative O O
cells O O
rather O O
than O O
changes O O
in O O
the O O
DNMT O O
and O O
MBP O O
mRNA O O
transcription O O
. O O

DISCUSSION O O

Many O O
genetic O O
lesions O O
are O O
known O O
to O O
influence O O
gene O O
expression O O
of O O
tumor O O
suppressor O O
genes O O
. O O

Whereas B-conn Contrast
mutations O O
and O O
deletions O O
or O O
insertions O O
have O O
permanent O O
effects O O
, O O
reversible O O
mechanisms O O
are O O
gene O O
methylation O O
, O O
or O O
expression O O
and O O
activation O O
of O O
transcription O O
factors O O
, O O
respectively O O
. O O

We O O
studied O O
a O O
putative O O
cause O O
for B-conn Purpose.Goal
absent O O
IRF-4 O O
expression O O
in O O
leukemia O O
cells O O
and O O
first O O
focused O O
on O O
genetic O O
aberrations O O
of O O
the O O
promoter O O
. O O

We O O
observed O O
no O O
genetic O O
alterations O O
in O O
the O O
IRF-4 O O
promoter O O
, O O
which O O
can O O
account O O
for O O
the O O
lack O O
of O O
IRF-4 O O
expression O O
: O O
The O O
detected O O
base O O
pair O O
changes O O
at O O
position O O
−1081 O O
-LRB- O O
T→C O O
substitution O O
-RRB- O O
, O O
at O O
position O O
−1068 O O
-LRB- O O
A→C O O
substitution O O
-RRB- O O
and O O
at O O
position O O
−116 O O
-LRB- O O
A→C O O
substitution O O
-RRB- O O
are O O
unlikely O O
responsible O O
for O O
absent O O
IRF-4-expression O O
since B-conn Cause.Justification
the O O
first O O
two O O
mutations O O
were O O
found O O
both O O
in O O
IRF-4-positive O O
and O O
-negative O O
cells O O
whereas B-conn Contrast
the O O
latter O O
change O O
was O O
not O O
detected O O
consistently O O
in O O
all O O
IRF-4-negative O O
or O O
-positive O O
cells O O
and O O
may O O
thus B-conn Cause.Result
be O O
a O O
polymorphism O O
. O O

All O O
three O O
substitutions O O
did O O
not O O
change O O
any O O
known O O
putative O O
transcription O O
factor O O
binding O O
sites O O
-LRB- O O
30,31 O O
-RRB- O O
and O O
also O O
do O O
not O O
affect O O
any O O
restriction O O
sites O O
or O O
primer O O
binding O O
sites O O
of O O
the O O
used O O
assays O O
. O O

However B-conn Concession.Contra-expectation
, O O
permanent O O
genetic O O
variations O O
in O O
the O O
IRF-4 O O
coding O O
sequence O O
, O O
such O O
as O O
deletions O O
or O O
mutations O O
resulting O O
in O O
stop-codons O O
have O O
not O O
been O O
excluded O O
by B-conn Purpose.Enablement
sequence O O
analysis O O
. O O

Since B-conn Cause.Justification
IRF-4 O O
expression O O
in O O
cell O O
lines O O
and O O
CML O O
can O O
be O O
induced O O
by B-conn Purpose.Enablement
demethylation O O
and O O
successful O O
IFN-α O O
therapy O O
-LRB- O O
3 O O
-RRB- O O
, O O
respectively O O
, O O
the O O
existence O O
of O O
such O O
genetic O O
aberrations O O
seems O O
unlikely O O
. O O

We O O
then O O
investigated O O
whether O O
the O O
previously O O
described O O
down-regulation O O
of O O
IRF-4 O O
expression O O
in O O
human O O
myeloid O O
leukemias O O
was O O
due O O
to O O
a O O
differential O O
hypermethylation O O
of O O
the O O
promoter O O
, O O
since B-conn Cause.Reason
the O O
presented O O
re-expression O O
due O O
to O O
AzadC-treatment O O
might O O
also O O
be O O
a O O
result O O
of O O
activation O O
of O O
positive O O
transcriptional O O
regulators O O
of O O
IRF-4 O O
. O O

Methylation O O
of O O
CpG O O
sites O O
is O O
a O O
common O O
mechanism O O
of O O
silencing O O
genes O O
in O O
leukemia O O
and O O
has O O
also O O
been O O
shown O O
for O O
another O O
IRF O O
, O O
IRF-7 O O
-LRB- O O
35 O O
-RRB- O O
and O O
for O O
PU.1 O O
-LRB- O O
36 O O
-RRB- O O
, O O
an O O
interacting O O
partner O O
of O O
IRF-4 O O
. O O

To B-conn Purpose.Goal
elucidate O O
the O O
relevance O O
of O O
this O O
mechanism O O
for O O
the O O
regulation O O
of O O
IRF-4 O O
expression O O
, O O
various O O
leukemic O O
cells O O
were O O
treated O O
with O O
demethylating O O
agents O O
and O O
promoters O O
were O O
sequenced O O
after B-conn Temporal.Succession
bisulfite O O
treatment O O
. O O

We O O
found O O
that O O
IRF-4 O O
expression O O
could O O
indeed O O
be O O
connected O O
to O O
the O O
methylation O O
status O O
of O O
distinct O O
CpG O O
motifs O O
in O O
the O O
IRF-4 O O
promoter O O
. O O

In O O
Figure O O
4A O O
, O O
those O O
CpG O O
sites O O
are O O
shown O O
-LRB- O O
bottom O O
line O O
-RRB- O O
, O O
whose O O
hypermethylation O O
may O O
account O O
for O O
the O O
absence O O
of O O
IRF-4 O O
expression O O
in O O
the O O
respective O O
cells O O
. O O

One O O
of O O
them O O
-LRB- O O
# O O
54 O O
-RRB- O O
is O O
adjacent O O
to O O
an O O
identified O O
regulatory O O
element O O
-LRB- O O
NFκB-site O O
-RRB- O O
, O O
indicating O O
a O O
possible O O
involvement O O
of O O
this O O
site O O
. O O

At O O
two O O
further O O
CpG O O
sites O O
-LRB- O O
# O O
48 O O
, O O
45 O O
-RRB- O O
the O O
methylation O O
status O O
in O O
IRF-4-positive O O
was O O
lower O O
than O O
that O O
of O O
IRF-4-negative O O
cells O O
. O O

These O O
CpG O O
sites O O
are O O
located O O
in O O
an O O
NFκB O O
and O O
an O O
SP1 O O
element O O
-LRB- O O
31 O O
-RRB- O O
and O O
thus B-conn Cause.Result
may O O
also O O
play O O
a O O
role O O
in O O
regulation O O
of O O
IRF-4 O O
expression O O
. O O

It O O
has O O
been O O
shown O O
that O O
NFκB O O
elements O O
play O O
an O O
important O O
role O O
in O O
IRF-4 O O
induction O O
as O O
IRF-4 O O
expression O O
depends O O
on O O
binding O O
of O O
the O O
transactivator O O
c-Rel O O
to O O
these O O
elements O O
in O O
the O O
IRF-4 O O
promoter O O
-LRB- O O
31,37 O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
methylation O O
of O O
the O O
central O O
CpG O O
in O O
the O O
NFκB O O
element O O
inhibits O O
binding O O
of O O
the O O
NFκB O O
protein O O
complexes O O
-LRB- O O
38 O O
-RRB- O O
, O O
promoting O O
the O O
significance O O
of O O
the O O
observed O O
methylation O O
differences O O
in O O
IRF-4-positive O O
and O O
-negative O O
cells O O
. O O

Via B-conn Purpose.Enablement
in O O
vitro O O
methylation O O
and O O
reporter O O
gene O O
assays O O
we O O
could O O
clearly O O
appoint O O
the O O
silencing O O
of O O
the O O
IRF-4 O O
promoter O O
to O O
a O O
methylation O O
effect O O
, O O
which O O
may O O
thus B-conn Cause.Claim
be O O
the O O
mechanism O O
of O O
IRF-4 O O
deregulation O O
in O O
vivo O O
. O O

One O O
possible O O
cause O O
for O O
the O O
aberrant O O
methylation O O
in O O
tumorigenesis O O
is O O
an O O
increased O O
level O O
of O O
DNMTs O O
during B-conn Temporal.Synchronous
the O O
pathogenetic O O
process O O
. O O

In O O
colon O O
, O O
lung O O
and O O
hematologic O O
malignancies O O
, O O
overexpression O O
of O O
DNMT1 O O
, O O
a O O
maintenance O O
DNMT O O
, O O
has O O
been O O
detected O O
-LRB- O O
39–41 O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
it O O
has O O
been O O
shown O O
that O O
CML O O
cells O O
in O O
the O O
acute O O
phase O O
exhibited O O
elevated O O
levels O O
of O O
the O O
three O O
known O O
DNMTs O O
, O O
while B-conn Contrast
CML O O
cells O O
in O O
chronic O O
phase O O
expressed O O
normal O O
levels O O
of O O
DNMTs O O
if B-conn Condition.Hypothetical
compared O O
with O O
normal O O
bone O O
marrow O O
cells O O
-LRB- O O
25 O O
-RRB- O O
. O O

Interestingly O O
, O O
a O O
positive O O
correlation O O
between O O
DNMT1 O O
expression O O
levels O O
and O O
hypermethylation O O
of O O
p15INK4b O O
has O O
been O O
detected O O
in O O
AML O O
-LRB- O O
25 O O
-RRB- O O
. O O

In O O
this O O
work O O
, O O
we O O
did O O
not O O
detect O O
significant O O
mRNA O O
expression O O
differences O O
of O O
selected O O
DNMT O O
or O O
MBP O O
, O O
making O O
it O O
an O O
unlikely O O
cause O O
for O O
the O O
observed O O
methylation O O
and O O
thus B-conn Cause.Result
IRF-4 O O
expression O O
differences O O
in O O
leukemia O O
cells O O
. O O

The O O
finding O O
that O O
IRF-4 O O
expression O O
is O O
silenced O O
by B-conn Purpose.Enablement
promoter O O
hypermethylation O O
might O O
represent O O
a O O
mechanism O O
that O O
accounts O O
for O O
the O O
previously O O
observed O O
loss O O
of O O
IRF-4 O O
expression O O
in O O
CML O O
. O O

Indeed B-conn Reinforcement
, O O
several O O
clinical O O
trials O O
with O O
leukemia O O
patients O O
and O O
patients O O
with O O
myelodysplastic O O
syndromes O O
demonstrated O O
the O O
potential O O
clinical O O
benefit O O
of O O
a O O
treatment O O
with O O
demethylating O O
agents O O
-LRB- O O
42–45 O O
-RRB- O O
. O O

The O O
expression O O
of O O
another O O
IRF O O
, O O
IFN O O
consensus O O
sequence O O
binding O O
protein O O
-LRB- O O
ICSBP/IRF-8 O O
-RRB- O O
, O O
is O O
impaired O O
in O O
myeloid O O
leukemias O O
especially O O
CML O O
-LRB- O O
27,46,47 O O
-RRB- O O
. O O

But B-conn Concession.Contra-expectation
in B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
IRF-4 O O
, O O
the O O
loss O O
of O O
this O O
IRF O O
could O O
not O O
be O O
reverted O O
in O O
ICSBP-negative O O
cell O O
lines O O
-LRB- O O
EM-2 O O
, O O
CML-T1 O O
, O O
K-562 O O
and O O
LAMA-84 O O
-RRB- O O
by O O
treatment O O
with O O
AzadC O O
-LRB- O O
Figure O O
6 O O
-RRB- O O
and B-conn Conjunction
AzadC O O
has O O
no O O
effect O O
on O O
ICSBP O O
levels O O
in O O
ICSBP-positive O O
U-937 O O
cells O O
-LRB- O O
Figure O O
6 O O
-RRB- O O
. O O

These O O
data O O
suggest O O
a O O
distinct O O
regulatory O O
mechanism O O
for O O
these O O
two O O
IRFs O O
. O O

IRF-4 O O
, O O
similar O O
to O O
many O O
other O O
classical O O
tumor O O
suppressor O O
genes O O
p15INK4b O O
, O O
p16INK4a O O
or O O
p53 O O
, O O
may O O
thus O O
be O O
a O O
subject O O
of O O
alterations O O
in O O
the O O
promoter O O
methylation O O
status O O
leading O O
to O O
expression O O
changes O O
, O O
which O O
might O O
contribute O O
to O O
the O O
initiation O O
and/or O O
progression O O
of O O
cancer O O
. O O

Still B-conn Concession.Contra-expectation
, O O
the O O
obvious O O
functional O O
diversity O O
of O O
IRF-4 O O
remains O O
remarkable O O
and O O
cannot O O
be O O
fully O O
explained O O
by B-conn Purpose.Enablement
the O O
IRF-4 O O
promoter O O
methylation O O
status O O
. O O

For B-conn Instantiation
example I-conn Instantiation
, O O
IRF-4 O O
is O O
primarily O O
known O O
for O O
its O O
oncogenic O O
features O O
. O O

In O O
multiple O O
myeloma O O
-LRB- O O
MM O O
-RRB- O O
a O O
translocation O O
on O O
chromosome O O
14q O O
was O O
reported O O
to O O
lead O O
to O O
a O O
fusion O O
gene O O
of O O
immunoglobulin O O
heavy-chain O O
-LRB- O O
IgH O O
-RRB- O O
and O O
IRF-4 O O
resulting O O
in O O
a O O
subsequent O O
overexpression O O
of O O
IRF-4 O O
-LRB- O O
48,49 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
abundant O O
IRF-4 O O
expression O O
was O O
found O O
to O O
be O O
a O O
marker O O
for B-conn Purpose.Goal
various O O
subsets O O
of O O
lymphomas O O
, O O
such O O
as O O
diffuse O O
large O O
B-cell O O
lymphomas O O
, O O
primary O O
effusion O O
lymphoma O O
, O O
and O O
marginal O O
zone O O
lymphoma O O
, O O
and O O
adult O O
T-cell O O
leukemia O O
-LRB- O O
11,31,50–52 O O
-RRB- O O
. O O

This O O
draws O O
a O O
more O O
complex O O
picture O O
of O O
the O O
role O O
of O O
IRF-4 O O
. O O

Down-regulation O O
of O O
IRF-4 O O
may O O
promote O O
leukemogenesis O O
in O O
myeloid O O
cell O O
context O O
-LRB- O O
3 O O
-RRB- O O
, O O
which O O
was O O
recently O O
confirmed O O
in O O
IRF-4−/− O O
ICSBP−/− O O
double O O
knock-out O O
mice O O
-LRB- O O
53 O O
-RRB- O O
, O O
while B-conn Contrast
IRF-4 O O
up-regulation O O
may O O
induce O O
a O O
growth O O
advantage O O
in O O
lymphomas O O
or O O
MM O O
-LRB- O O
48 O O
-RRB- O O
. O O

Taken O O
together O O
, O O
our O O
data O O
suggest O O
that O O
IRF-4 O O
promoter O O
methylation O O
regulates O O
IRF-4 O O
expression O O
, O O
and O O
that O O
aberrant O O
expression O O
of O O
IRF-4 O O
in O O
certain O O
types O O
of O O
leukemia O O
may O O
be O O
a O O
consequence O O
of O O
IRF-4 O O
promoter O O
hypermethylation O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Correlation O O
of O O
IRF-4 O O
mRNA O O
expression O O
and O O
nucleotide O O
changes O O
in O O
the O O
IRF-4 O O
promoter O O
. O O

-LRB- O O
A O O
-RRB- O O
RT–PCR O O
of O O
different O O
hematopoietic O O
cell O O
lines O O
. O O

-LRB- O O
B O O
-RRB- O O
nucleotide O O
changes O O
in O O
the O O
promoter O O
of O O
IRF-4-positive O O
or O O
-negative O O
cells O O
in O O
comparison O O
to O O
the O O
germline O O
sequence O O
at O O
positions O O
98 O O
, O O
111 O O
and O O
1063 O O
-LRB- O O
GenBank O O
accession O O
no O O
. O O

U52683 O O
-RRB- O O
, O O
representing O O
nucleotide O O
−1081 O O
, O O
−1068 O O
and O O
−116 O O
-LRB- O O
30 O O
-RRB- O O
or O O
−1094 O O
, O O
−1081 O O
and O O
−129 O O
-LRB- O O
31 O O
-RRB- O O
, O O
respectively O O
. O O

Figure O O
2 O O
: O O
Expression O O
of O O
IRF-4 O O
in O O
hematopoietic O O
cells O O
after O O
treatment O O
with O O
AzadC O O
. O O

Representative O O
cells O O
and O O
experiments O O
are O O
shown O O
. O O

-LRB- O O
A O O
-RRB- O O
RT–PCR O O
after B-conn Temporal.Succession
incubation O O
of O O
CML-T1 O O
and O O
EM-2 O O
with O O
0.5 O O
, O O
1 O O
and O O
3 O O
µM O O
AzadC O O
for O O
72 O O
h O O
; O O
-LRB- O O
B O O
-RRB- O O
RT–PCR O O
after B-conn Temporal.Succession
treatment O O
of O O
CML-T1 O O
and O O
EM-2 O O
with O O
3 O O
µM O O
AzadC O O
for O O
24 O O
, O O
48 O O
and O O
72 O O
h O O
; O O
-LRB- O O
C O O
-RRB- O O
immunoblotting O O
after B-conn Temporal.Succession
treatment O O
of O O
CML-T1 O O
and O O
LAMA-84 O O
with O O
1 O O
and O O
3 O O
µM O O
AzadC O O
for O O
72 O O
h O O
; O O
-LRB- O O
D O O
-RRB- O O
RT–PCR O O
after B-conn Temporal.Succession
treatment O O
of O O
BV-173 O O
for O O
24 O O
, O O
48 O O
and O O
72 O O
h O O
and O O
RPMI-8226 O O
for O O
72 O O
h O O
with O O
3 O O
µM O O
AzadC O O
. O O

Figure O O
3 O O
: O O
Restriction-PCR-assay O O
of O O
the O O
IRF-4 O O
promoter O O
in O O
hematopoietic O O
cells O O
. O O

-LRB- O O
A O O
-RRB- O O
Simplified O O
structure O O
of O O
the O O
CpG O O
sites O O
in O O
the O O
human O O
IRF-4 O O
promoter O O
region O O
including O O
exon O O
1 O O
. O O

Each O O
CpG O O
motif O O
is O O
shown O O
as O O
circle O O
and O O
numbered O O
-LRB- O O
above O O
, O O
labeling O O
beginning O O
from O O
the O O
3′ O O
end O O
moving O O
upstream O O
-RRB- O O
. O O

Restriction O O
sites O O
, O O
fragments O O
-LRB- O O
F1 O O
, O O
F2 O O
-RRB- O O
of O O
the O O
restriction-PCR-assay O O
and O O
regions O O
amplified O O
after B-conn Temporal.Succession
bisulfite O O
treatment O O
for O O
sequencing O O
are O O
shown O O
below O O
. O O

The O O
numbers O O
in O O
italics O O
refer O O
to O O
the O O
sequence O O
data O O
by O O
Grossman O O
et O O
al O O
. O O
-LRB- O O
30 O O
-RRB- O O
. O O

-LRB- O O
B O O
and O O
C O O
-RRB- O O
Restriction-PCR-assay O O
. O O

Restriction O O
of O O
DNA O O
with O O
EcoRI O O
-LRB- O O
E O O
, O O
no O O
recognition O O
site O O
-RRB- O O
, O O
HpaII O O
-LRB- O O
H O O
, O O
sensitive O O
-RRB- O O
, O O
Bsp143II O O
-LRB- O O
BII O O
, O O
sensitive O O
-RRB- O O
, O O
Bsh1236I O O
-LRB- O O
BI O O
, O O
sensitive O O
-RRB- O O
and O O
MspI O O
-LRB- O O
M O O
, O O
resistant O O
-RRB- O O
and O O
subsequent O O
PCR O O
amplification O O
. O O

Three O O
representative O O
IRF-4-negative O O
-LRB- O O
K-562 O O
, O O
CML-T1 O O
, O O
EM-2 O O
-RRB- O O
and O O
two O O
IRF-4-positive O O
cell O O
lines O O
-LRB- O O
SD-1 O O
, O O
BV-173 O O
-RRB- O O
are O O
shown O O
. O O

IRF-4 O O
expression O O
is O O
denoted O O
on O O
the O O
right O O
. O O

-LRB- O O
B O O
-RRB- O O
PCR-fragment O O
1 O O
-LRB- O O
F1 O O
-RRB- O O
; O O
-LRB- O O
C O O
-RRB- O O
PCR-fragment O O
2 O O
-LRB- O O
F2 O O
-RRB- O O
. O O

Figure O O
4 O O
: O O
Methylation O O
pattern O O
of O O
CpG O O
sites O O
in O O
the O O
IRF-4 O O
promoter O O
region O O
. O O

Methylation O O
is O O
detected O O
via B-conn Purpose.Enablement
sequencing O O
of O O
bisulfite-treated O O
DNA O O
from O O
hematopoietic O O
cells O O
. O O

-LRB- O O
A O O
-RRB- O O
Schematic O O
figure O O
of O O
the O O
IRF-4 O O
promoter O O
region O O
-LRB- O O
see O O
Figure O O
3A O O
-RRB- O O
for O O
each O O
cell O O
line O O
. O O

Each O O
CpG O O
motif O O
is O O
shown O O
as O O
circle O O
and O O
numbered O O
-LRB- O O
above O O
, O O
labeling O O
beginning O O
from O O
the O O
3′ O O
end O O
moving O O
upstream O O
-RRB- O O
, O O
white O O
circles O O
mean O O
no O O
methylated O O
clone O O
-LRB- O O
from O O
eight O O
-RRB- O O
, O O
gray O O
circles O O
mean O O
one O O
to O O
four O O
methylated O O
clones O O
and O O
black O O
circles O O
mean O O
five O O
to O O
eight O O
methylated O O
clones O O
. O O

IRF-4 O O
expression O O
is O O
denoted O O
on O O
the O O
right O O
. O O

Below O O
, O O
CpG O O
sites O O
maybe O O
responsible O O
for B-conn Purpose.Goal
methylation-dependent O O
IRF-4 O O
silencing O O
-LRB- O O
arrows O O
-RRB- O O
; O O
R1 O O
, O O
region O O
with O O
generally O O
high O O
methylation O O
; O O
R2 O O
, O O
region O O
with O O
correlation O O
between O O
methylation O O
and O O
IRF-4 O O
expression O O
; O O
R3 O O
, O O
region O O
with O O
generally O O
low O O
methylation O O
. O O

Putative O O
binding O O
sites O O
for O O
transcription O O
factors O O
are O O
shown O O
above O O
-LRB- O O
5× O O
AP1 O O
, O O
3× O O
Sp1 O O
, O O
2× O O
Ets-1 O O
, O O
2× O O
κB O O
, O O
1× O O
NF-3 O O
, O O
1× O O
CD28RE O O
, O O
1× O O
PU.1 O O
-RRB- O O
. O O

-LRB- O O
B O O
-RRB- O O
Schematic O O
figure O O
of O O
specific O O
region O O
2 O O
-LRB- O O
R2 O O
-RRB- O O
: O O
CpG O O
sites O O
from O O
# O O
10 O O
to O O
# O O
22 O O
are O O
shown O O
above O O
. O O

Number O O
of O O
methylated O O
clones O O
-LRB- O O
from O O
eight O O
-RRB- O O
is O O
shown O O
for O O
each O O
cell O O
line O O
. O O

Figure O O
5 O O
: O O
Investigation O O
of O O
putative O O
mechanisms O O
for O O
IRF-4 O O
deregulation O O
. O O

-LRB- O O
A–C O O
-RRB- O O
Influence O O
of O O
in O O
vitro O O
methylation O O
on O O
the O O
activity O O
of O O
an O O
IRF-4 O O
promoter-reporter O O
gene O O
construct O O
. O O

-LRB- O O
A O O
-RRB- O O
Control O O
of O O
complete O O
methylation O O
via B-conn Purpose.Enablement
restriction O O
. O O

Digestion O O
of O O
the O O
construct O O
before O O
-LRB- O O
lanes O O
2 O O
, O O
4 O O
and O O
6 O O
-RRB- O O
and O O
after O O
methylation O O
-LRB- O O
lanes O O
1 O O
, O O
3 O O
and O O
5 O O
-RRB- O O
with O O
respective O O
methylation-sensitive O O
-LRB- O O
HpaII O O
, O O
lanes O O
1 O O
and O O
2 O O
-RRB- O O
and O O
-resistant O O
endonucleases O O
-LRB- O O
MspI O O
, O O
lanes O O
3 O O
and O O
4 O O
-RRB- O O
. O O

-LRB- O O
B O O
and O O
C O O
-RRB- O O
Reporter O O
gene O O
assays O O
with O O
non-methylated O O
control O O
-LRB- O O
co O O
-RRB- O O
and O O
in O O
vitro O O
methylated O O
-LRB- O O
met O O
-RRB- O O
IRF-4 O O
promoter O O
constructs O O
and O O
SD-1 O O
-LRB- O O
B O O
-RRB- O O
or O O
Jurkat O O
cells O O
-LRB- O O
C O O
-RRB- O O
. O O

The O O
promoter O O
activity O O
is O O
displayed O O
as O O
fold O O
increase O O
to O O
non-methylated O O
construct O O
-LRB- O O
via O O
ratio O O
of O O
firefly O O
to O O
renilla O O
luciferase O O
-RRB- O O
. O O

-LRB- O O
D O O
-RRB- O O
Expression O O
of O O
DNMT O O
and O O
MBP O O
mRNA O O
in O O
various O O
hematopoietic O O
cells O O
. O O

RT–PCR O O
of O O
various O O
hematopoietic O O
cells O O
: O O
SD-1 O O
-LRB- O O
lane O O
1 O O
-RRB- O O
, O O
RPMI-8226 O O
-LRB- O O
lane O O
2 O O
-RRB- O O
, O O
BV-173 O O
-LRB- O O
lane O O
3 O O
-RRB- O O
, O O
U-937 O O
-LRB- O O
lane O O
4 O O
-RRB- O O
, O O
CML-T1 O O
-LRB- O O
lane O O
5 O O
-RRB- O O
, O O
LAMA-84 O O
-LRB- O O
lane O O
6 O O
-RRB- O O
, O O
Jurkat O O
-LRB- O O
lane O O
7 O O
-RRB- O O
, O O
EM-2 O O
-LRB- O O
lane O O
8 O O
-RRB- O O
and O O
K-562 O O
-LRB- O O
lane O O
9 O O
-RRB- O O
. O O

β-Actin O O
is O O
used O O
as O O
reference O O
. O O

Figure O O
6 O O
: O O
Expression O O
of O O
ICSBP O O
in O O
hematopoietic O O
cells O O
after B-conn Temporal.Succession
treatment O O
with O O
AzadC O O
. O O

Representative O O
experiments O O
are O O
shown O O
. O O

-LRB- O O
A O O
-RRB- O O
RT–PCR O O
after B-conn Temporal.Succession
treatment O O
of O O
CML-T1 O O
and O O
EM-2 O O
with O O
3 O O
µM O O
AzadC O O
for O O
24 O O
, O O
48 O O
and O O
72 O O
h O O
; O O
-LRB- O O
B O O
-RRB- O O
RT–PCR O O
after B-conn Temporal.Succession
treatment O O
of O O
LAMA-84 O O
and O O
U-937 O O
with O O
3 O O
µM O O
AzadC O O
for O O
24 O O
, O O
48 O O
and O O
72 O O
h O O
. O O

Table O O
1 O O
: O O
Sequencing O O
of O O
bisulfite-treated O O
DNA O O
from O O
hematopoietic O O
cells O O

BRCA1 O O
function O O
in O O
T O O
lymphocytes O O
: O O
a O O
cellular O O
specificity O O
of O O
a O O
different O O
kind O O

Abstract O O

Recent O O
work O O
by O O
Mak O O
et O O
al O O
demonstrates O O
that O O
mice O O
carrying O O
a O O
T-cell-specific O O
disruption O O
of O O
the O O
brca1 O O
gene O O
display O O
markedly O O
impaired O O
T-lymphocyte O O
development O O
and O O
proliferation O O
in O O
the O O
absence O O
of O O
any O O
increased O O
tendency O O
for O O
the O O
formation O O
of O O
tumors O O
. O O

Interestingly O O
, O O
the O O
extent O O
of O O
these O O
defects O O
was O O
found O O
to O O
be O O
highly O O
dependent O O
on O O
cellular O O
context O O
. O O

Contrasting O O
the O O
rather O O
broad O O
tissue O O
expression O O
pattern O O
of O O
brca1 O O
against O O
its O O
exquisitely O O
selective O O
etiologic O O
role O O
in O O
cancers O O
of O O
the O O
breast O O
and O O
ovary O O
, O O
many O O
of O O
us O O
are O O
left O O
to O O
ponder O O
- O O
where O O
is O O
the O O
specificity O O
? O O

Full O O
text O O

Mutation O O
in O O
the O O
human O O
BRCA1 O O
gene O O
is O O
thought O O
to O O
account O O
for O O
45 O O
% O O
of O O
familial O O
cancers O O
and O O
for O O
more O O
than O O
80 O O
% O O
of O O
inherited O O
ovarian O O
cancers O O
. O O

Its O O
identification O O
and O O
mapping O O
to O O
chromosome O O
arm O O
17q O O
, O O
in O O
1990 O O
, O O
was O O
followed O O
by O O
intense O O
efforts O O
to O O
isolate O O
the O O
gene O O
. O O

It O O
therefore B-conn Cause.Claim
came O O
as O O
something O O
of O O
a O O
surprise O O
in O O
1994 O O
when B-conn Temporal.Synchronous
the O O
gene O O
was O O
isolated O O
and O O
found O O
to O O
encode O O
a O O
1863-amino-acid O O
protein O O
that O O
was O O
expressed O O
in O O
a O O
wide O O
variety O O
of O O
tissues O O
, O O
with O O
highest O O
expression O O
in O O
the O O
thymus O O
and O O
testes O O
. O O

The O O
flurry O O
of O O
publications O O
that O O
followed O O
the O O
isolation O O
of O O
the O O
BRCA1 O O
gene O O
has O O
slowly O O
begun O O
to O O
put O O
these O O
initial O O
findings O O
into O O
perspective O O
. O O

One O O
of O O
the O O
most O O
important O O
of O O
these O O
has O O
been O O
the O O
observation O O
that O O
BRCA1 O O
plays O O
a O O
major O O
role O O
in O O
DNA O O
damage O O
repair O O
. O O

DNA O O
repair O O
proteins O O
play O O
a O O
central O O
role O O
in O O
T-cell O O
lineage O O
development O O
because B-conn Cause.Reason
they O O
act O O
to O O
ligate O O
or O O
repair O O
DNA O O
double-stranded O O
breaks O O
-LRB- O O
DSBs O O
-RRB- O O
that O O
occur O O
during O O
the O O
initiation O O
of O O
V O O
-LRB- O O
D O O
-RRB- O O
J O O
recombination O O
of O O
the O O
T-cell O O
receptor O O
-LRB- O O
TCR O O
-RRB- O O
. O O

For O O
this O O
reason O O
, O O
Mak O O
et O O
al O O
-LSB-1 O O
-RSB- O O
sought O O
to O O
determine O O
the O O
role O O
of O O
BRCA1 O O
in O O
T-cell O O
maturation O O
and O O
function O O
. O O

By B-conn Purpose.Enablement
using O O
the O O
Cre/lox/P O O
system O O
to O O
generate O O
mice O O
with O O
a O O
homozygous O O
deletion O O
of O O
brca1 O O
exons O O
5 O O
and O O
6 O O
restricted O O
to O O
the O O
T-cell O O
compartment O O
-LRB- O O
mice O O
homozygous O O
for O O
the O O
' O O
floxed O O
' O O
brca1 O O
exons O O
were O O
crossed O O
with O O
transgenic O O
mice O O
expressing O O
the O O
Cre O O
recombinase O O
under O O
the O O
control O O
of O O
the O O
T-cell O O
specific O O
lck O O
promoter O O
-RRB- O O
, O O
those O O
investigators O O
were O O
able O O
to O O
study O O
T-cell O O
brca1 O O
function O O
while B-conn Temporal.Synchronous
also B-conn Conjunction
circumventing O O
the O O
early O O
embryonic O O
lethality O O
associated O O
with O O
the O O
brca1 O O
mutation O O
. O O

To O O
their O O
surprise O O
, O O
Mak O O
et O O
al O O
found O O
that O O
T O O
cells O O
from O O
mice O O
that O O
lacked O O
brca1 O O
showed O O
no O O
abnormality O O
in O O
rearrangement O O
of O O
the O O
TCR O O
loci O O
. O O

What O O
they O O
observed O O
instead B-conn Alternative.Chosen alternative
was O O
a O O
significant O O
-LRB- O O
90 O O
% O O
-RRB- O O
depletion O O
of O O
the O O
thymocytes O O
, O O
with O O
a O O
developmental O O
defect O O
occurring O O
at B-conn Temporal.Succession
some I-conn Temporal.Succession
point I-conn Temporal.Succession
after I-conn Temporal.Succession
the O O
very O O
' O O
immature O O
' O O
double-negative O O
stage O O
of O O
T-lymphocyte O O
maturation O O
. O O

The O O
most O O
interesting O O
part O O
of O O
this O O
work O O
is O O
what O O
they O O
found O O
on O O
application O O
of O O
the O O
brca1 O O
mutant O O
to O O
different O O
genetic O O
backgrounds O O
. O O

Prior O O
transgenic O O
studies O O
with O O
the O O
brca1 O O
gene O O
-LSB-2,3 O O
-RSB- O O
revealed O O
that O O
loss O O
of O O
brca1 O O
function O O
is O O
associated O O
with O O
an O O
increase O O
in O O
the O O
expression O O
and O O
activity O O
of O O
the O O
p53 O O
tumor O O
suppressor O O
gene O O
. O O

The O O
increased O O
levels O O
of O O
p53 O O
is O O
thought O O
to O O
occur O O
in B-conn Cause.Reason
response I-conn Cause.Reason
to I-conn Cause.Reason
the O O
marked O O
accumulation O O
of O O
chromosomal O O
abnormalities O O
in O O
cells O O
that O O
carry O O
the O O
brca1 O O
mutation O O
, O O
an O O
observation O O
that O O
is O O
consistent O O
with O O
a O O
role O O
for O O
brca1 O O
in O O
DNA O O
repair O O
. O O

The O O
high O O
levels O O
of O O
p53 O O
increase O O
the O O
transcription O O
of O O
genes O O
that O O
are O O
involved O O
in O O
growth O O
inhibition O O
and O O
apoptosis O O
- O O
including O O
p21 O O
and O O
Bax O O
- O O
and O O
is O O
a O O
major O O
contributor O O
to O O
the O O
early O O
embryonic O O
lethality O O
associated O O
with O O
the O O
brca1 O O
mutation O O
. O O

Increases O O
in O O
p53 O O
, O O
p21 O O
and O O
Bax O O
, O O
as O O
well O O
as O O
increased O O
apoptosis O O
and O O
sensitivity O O
to O O
ionizing O O
radiation O O
, O O
were O O
demonstrated O O
in O O
the O O
thymocytes O O
carrying O O
the O O
targeted O O
brca1 O O
mutation O O
. O O

Moreover B-conn Conjunction
, O O
application O O
of O O
the O O
brca1 O O
mutation O O
in O O
a O O
p53-null O O
genetic O O
background O O
led O O
to O O
significant O O
thymocyte O O
rescue O O
with O O
full O O
recovery O O
of O O
cells O O
in O O
the O O
thymus O O
and O O
70 O O
% O O
recovery O O
of O O
cells O O
in O O
the O O
lymph O O
node O O
. O O

Not O O
surprisingly O O
, O O
these O O
' O O
rescued O O
' O O
double-mutant O O
cells O O
showed O O
multiple O O
cytogenetic O O
changes O O
, O O
an O O
observation O O
that O O
affirms O O
the O O
' O O
caretaker O O
' O O
role O O
of O O
brca1 O O
as O O
a O O
guardian O O
of O O
the O O
genome O O
. O O

Notably O O
, O O
the O O
effects O O
of O O
genetic O O
background O O
were O O
dependent O O
on O O
the O O
T-cell O O
context O O
. O O

Expression O O
of O O
the O O
brca1 O O
mutant O O
in O O
a O O
p21-null O O
background O O
caused O O
little O O
rescue O O
of O O
the O O
cells O O
in O O
the O O
thymus O O
, O O
but O O
provided O O
a O O
recovery O O
in O O
the O O
lymph O O
nodes O O
that O O
was O O
equivalent O O
to O O
that O O
produced O O
in O O
the O O
p53-null O O
background O O
. O O

Introduction O O
of O O
the O O
brca1 O O
gene O O
in O O
cells O O
carrying O O
an O O
antiapoptotic O O
Bcl2 O O
transgene O O
induced O O
significant O O
rescue O O
of O O
cells O O
in O O
the O O
thymus O O
, O O
but O O
produced O O
little O O
recovery O O
of O O
cells O O
in O O
peripheral O O
-LRB- O O
lymph O O
node O O
-RRB- O O
compartments O O
. O O

A O O
possible O O
explanation O O
for O O
this O O
observation O O
is O O
that O O
cells O O
of O O
the O O
thymus O O
-LRB- O O
a O O
mainly O O
nonprofilerating O O
compartment O O
-RRB- O O
are O O
much O O
more O O
sensitive O O
to O O
apoptosis O O
, O O
whereas B-conn Contrast
those O O
in O O
the O O
peripheral O O
lymph O O
nodes O O
-LRB- O O
a O O
rapidly O O
proliferating O O
compartment O O
-RRB- O O
are O O
much O O
more O O
influenced O O
by O O
components O O
that O O
induce O O
cell O O
cycle O O
arrest O O
. O O

Indeed B-conn Reinforcement
, O O
the O O
relative O O
sensitivity O O
to O O
apoptosis O O
versus O O
cell O O
cycle O O
arrest O O
varies O O
between O O
cellular O O
compartments O O
and/or O O
cell O O
types O O
. O O

Such O O
differences O O
probably O O
occur O O
through O O
a O O
hierarchy O O
of O O
cell-specific O O
and O O
pathway-specific O O
programs O O
of O O
cellular O O
behavior O O
. O O

So O O
how O O
might O O
the O O
lack O O
of O O
a O O
single O O
gene O O
effect O O
cells O O
of O O
different O O
origins O O
so O O
divergently O O
? O O

The O O
answer O O
may O O
lie O O
in O O
two O O
biochemically O O
distinct O O
consequences O O
of O O
the O O
loss O O
of O O
brca1 O O
function O O
. O O

The O O
first O O
is O O
the O O
resultant O O
increase O O
in O O
chromosome O O
abnormalities O O
, O O
namely O O
DNA O O
DSBs O O
, O O
which O O
are O O
observed O O
in O O
the O O
brca1 O O
mutants O O
. O O

A O O
key O O
feature O O
that O O
may O O
differentiate O O
a O O
cell O O
's O O
response O O
to O O
brca1 O O
deficiency O O
is O O
how O O
robustly O O
it O O
may O O
react O O
to O O
increased O O
DSB O O
levels O O
. O O

Tissue O O
types O O
that O O
are O O
actively O O
engaged O O
in O O
DNA O O
repair/recombination O O
activities O O
-LRB- O O
such O O
as O O
thymus O O
, O O
spleen O O
, O O
and O O
testes O O
-RRB- O O
may O O
have O O
a O O
greater O O
surveillance O O
for O O
loss O O
of O O
integrity O O
of O O
the O O
genome O O
that O O
results O O
from O O
brca1 O O
deficiency O O
. O O

Affected O O
cells O O
would O O
be O O
more O O
rapidly O O
removed O O
from O O
the O O
population O O
through B-conn Purpose.Enablement
the O O
action O O
of O O
' O O
gatekeeper O O
' O O
genes O O
such O O
as O O
p53 O O
. O O

Support O O
for O O
this O O
notion O O
comes O O
from O O
what O O
we O O
have O O
learned O O
from O O
model O O
systems O O
in O O
which O O
other O O
DNA O O
repair O O
genes O O
have O O
been O O
deleted O O
. O O

This O O
includes O O
the O O
class O O
of O O
nonhomologous O O
end-joining O O
proteins O O
-LRB- O O
NHEJs O O
-RRB- O O
, O O
which O O
are O O
important O O
components O O
of O O
DNA O O
repair O O
-LSB-4 O O
-RSB- O O
. O O

These O O
proteins O O
include O O
XRCC4 O O
, O O
DNA-PK O O
, O O
the O O
Ku O O
80/86 O O
proteins O O
and O O
DNA O O
ligase O O
IV O O
, O O
and B-conn Continuation
they O O
function O O
to O O
repair O O
random O O
DNA O O
breaks O O
that O O
are O O
produced O O
by O O
genotoxic O O
agents O O
-LRB- O O
eg O O
ionizing O O
radiation O O
-RRB- O O
and O O
specific O O
breaks O O
that O O
occur O O
during O O
programmed O O
gene O O
rearrangement O O
-LRB- O O
eg O O
V-LSB-D O O
-RSB- O O
J O O
joining O O
of O O
the O O
TCR O O
-RRB- O O
. O O

Loss O O
of O O
function O O
of O O
these O O
genes O O
leads O O
to O O
decreased O O
and/or O O
error-prone O O
DSB O O
repair O O
. O O

In O O
many O O
cases O O
the O O
NHEJ O O
deficiency O O
led O O
to O O
increased O O
apoptosis O O
in O O
the O O
selected O O
tissues O O
, O O
and B-conn Conjunction
in O O
several O O
the O O
application O O
of O O
the O O
deficiency O O
to O O
a O O
p53-null O O
background O O
increased O O
survival O O
and O O
the O O
incidence O O
of O O
lymphoid O O
tumors O O
-LSB-5,6 O O
-RSB- O O
. O O

Using O O
a O O
similar O O
approach O O
, O O
a O O
conditional O O
mutation O O
of O O
brca1 O O
in O O
mammary O O
epithelia O O
was O O
found O O
to O O
lead O O
to O O
rapid O O
tumor O O
formation O O
when B-conn Temporal.Synchronous
introduced O O
into O O
a O O
p53-null O O
background O O
-LSB-7 O O
-RSB- O O
. O O

Interestingly O O
, O O
mammary O O
tumor O O
formation O O
in O O
the O O
presence O O
of O O
p53 O O
occurred O O
after B-conn Temporal.Succession
a O O
long O O
latency O O
, O O
and B-conn Conjunction
many O O
of O O
the O O
tumors O O
were O O
associated O O
with O O
genetic O O
instability O O
and O O
alteration O O
of O O
p53 O O
transcription O O
. O O

In O O
this O O
example O O
, O O
the O O
loss O O
of O O
p53 O O
function O O
may O O
have O O
been O O
a O O
direct O O
consequence O O
of O O
genetic O O
instability O O
. O O

In O O
this O O
regard O O
, O O
it O O
would O O
be O O
interesting O O
to O O
determine O O
whether O O
NHEJ-deficient O O
mice O O
that O O
survive O O
their O O
lymphoid O O
tumors O O
go O O
on O O
to O O
develop O O
tumors O O
of O O
any O O
other O O
organ O O
. O O

So B-conn Restatement.Generalization
is O O
it O O
just O O
that O O
simple O O
? O O

Could O O
the O O
tissue O O
specificity O O
of O O
BRCA1-linked O O
tumors O O
reflect O O
a O O
careful O O
balance O O
between O O
the O O
' O O
caretakers O O
' O O
and O O
' O O
gatekeepers O O
' O O
of O O
the O O
cell O O
and O O
the O O
programmed O O
requirements O O
of O O
the O O
cell O O
for O O
DNA O O
damage O O
surveillance O O
? O O

Could O O
the O O
organ O O
susceptibility O O
of O O
the O O
BRCA1 O O
mutation O O
simply O O
reflect O O
the O O
fact O O
that O O
the O O
mammary O O
gland O O
gatekeepers O O
have O O
a O O
greater O O
tendency O O
to O O
' O O
be O O
asleep O O
at O O
the O O
wheel O O
' O O
in O O
the O O
face O O
of O O
BRCA1 O O
deficiency O O
? O O

Indeed B-conn Reinforcement
, O O
aspects O O
of O O
these O O
concepts O O
are O O
important O O
in O O
T-cell O O
development O O
because B-conn Cause.Justification
immature O O
T-cells O O
are O O
much O O
more O O
resistant O O
to O O
p53-independent O O
cell O O
death O O
pathways O O
that O O
are O O
induced O O
by O O
the O O
presence O O
of O O
DSBs O O
-LSB-8 O O
-RSB- O O
. O O

Thus B-conn Cause.Claim
, O O
surveillance O O
of O O
gatekeeper O O
pathways O O
can O O
be O O
influenced O O
by O O
both O O
tissue O O
type O O
and O O
ontogeny O O
. O O

The O O
key O O
to O O
this O O
solution O O
will O O
ultimately O O
come O O
from O O
developing O O
a O O
better O O
understanding O O
of O O
the O O
second O O
major O O
biochemical O O
consequence O O
of O O
BRCA1 O O
deficiency O O
: O O
the O O
loss O O
of O O
functional O O
complexes O O
between O O
BRCA1- O O
and O O
BRCA1-interacting O O
proteins O O
-LRB- O O
BIPs O O
-RRB- O O
. O O

BRCA1 O O
contains O O
several O O
functional O O
domains O O
that O O
interact O O
with O O
a O O
cavalcade O O
of O O
proteins O O
, O O
including O O
ATM O O
, O O
p53 O O
, O O
RB O O
, O O
c-Myc O O
, O O
BRCA2 O O
, O O
DNA O O
repair O O
factors O O
, O O
E2F O O
, O O
and O O
others O O
. O O

Many O O
of O O
the O O
BIPs O O
are O O
proto-oncogenes O O
or O O
tumor O O
suppressors O O
that O O
can O O
regulate O O
transcription O O
through O O
both O O
direct O O
and O O
indirect O O
mechanisms O O
. O O

What O O
has O O
become O O
clear O O
from O O
the O O
growing O O
list O O
of O O
BIPs O O
is O O
that O O
BRCA1 O O
is O O
probably O O
involved O O
in O O
multiple O O
biologic O O
programs O O
of O O
cellular O O
behavior O O
, O O
including O O
transcription O O
, O O
cell-cycle O O
regulation O O
, O O
DNA O O
damage O O
repair O O
, O O
centrosome O O
duplication O O
, O O
and O O
cell O O
growth O O
and O O
apoptosis O O
. O O

However B-conn Concession.Contra-expectation
, O O
none O O
of O O
the O O
BIPs O O
identified O O
thus O O
far O O
show O O
a O O
tissue O O
restricted O O
pattern O O
of O O
expression O O
that O O
could O O
explain O O
the O O
tissue O O
tropism O O
of O O
brca1-related O O
cancers O O
. O O

Still B-conn Concession.Contra-expectation
the O O
concept O O
that O O
the O O
cellular O O
outcome O O
of O O
BRCA1 O O
expression O O
can O O
be O O
dictated O O
by O O
specific O O
BIP O O
expression O O
has O O
been O O
verified O O
by O O
the O O
finding O O
that O O
a O O
cell O O
's O O
susceptibility O O
to O O
brca1-induced O O
cell O O
cycle O O
arrest O O
is O O
dependent O O
on O O
the O O
presence O O
of O O
RB O O
-LSB-9 O O
-RSB- O O
. O O

Future O O
emphasis O O
will O O
have O O
to O O
be O O
placed O O
on O O
identifying O O
those O O
cellular O O
genes O O
and O O
gene O O
products O O
that O O
become O O
altered O O
-via O O
transcriptional O O
, O O
post-transcriptional O O
or O O
post-translational O O
mechanisms O O
- O O
when B-conn Temporal.Synchronous
there O O
is O O
a O O
disruption O O
in O O
brca1 O O
expression O O
. O O

Combined O O
genomic O O
and O O
proteomic O O
approaches O O
will O O
be O O
needed O O
to O O
unravel O O
the O O
mysteries O O
of O O
BRCA1 O O
as O O
both O O
a O O
caretaker O O
of O O
the O O
genome O O
and O O
as O O
an O O
essential O O
component O O
of O O
cellular O O
homeostasis O O
and O O
development O O
. O O

Figure O O
and O O
Table O O
captions O O

Tumour-stromal O O
interactions O O
: O O
Role O O
of O O
the O O
stroma O O
in O O
mammary O O
development O O

Abstract O O

Mammary O O
development O O
depends O O
on O O
branching O O
morphogenesis O O
, O O
namely B-conn Restatement.Specification
the O O
bifurcation O O
and O O
extension O O
of O O
ductal O O
growth O O
points O O
-LRB- O O
end O O
buds O O
-RRB- O O
and O O
secretory O O
lobules O O
into O O
a O O
more O O
or O O
less O O
fatty O O
stroma O O
. O O

Because B-conn Cause.Reason
breast O O
carcinomas O O
are O O
overwhelmingly O O
ductal O O
in O O
origin O O
, O O
this O O
review O O
focuses O O
on O O
stromal O O
influences O O
guiding O O
postnatal O O
ductal O O
development O O
and B-conn Conjunction
there O O
is O O
only O O
the O O
briefest O O
account O O
of O O
the O O
role O O
of O O
embryonic O O
stroma O O
-LRB- O O
mesenchyme O O
-RRB- O O
. O O

The O O
stroma O O
as O O
the O O
necessary O O
target O O
for O O
endocrine O O
mammogens O O
and O O
the O O
source O O
of O O
stimulatory O O
growth O O
factors O O
is O O
described O O
and B-conn Conjunction
the O O
importance O O
of O O
mammary O O
epithelium-induced O O
modifications O O
of O O
the O O
periductal O O
stroma O O
is O O
emphasized O O
. O O

Evidence O O
is O O
presented O O
that O O
if B-conn Condition.Hypothetical
they O O
are O O
to O O
grow O O
, O O
end O O
buds O O
must O O
condition O O
proximal O O
fatty O O
stroma O O
by B-conn Purpose.Enablement
recruiting O O
white O O
blood O O
cells O O
as O O
well O O
as O O
inducing O O
stromal O O
cell O O
division O O
and O O
, O O
possibly O O
, O O
estrogen O O
receptors O O
. O O

The O O
induction O O
of O O
a O O
fibrous O O
stromal O O
tunic O O
around O O
the O O
end O O
bud O O
is O O
described O O
and B-conn Conjunction
its O O
likely O O
role O O
as O O
a O O
complex O O
ductal O O
morphogen O O
is O O
discussed O O
; O O
a O O
possible O O
role O O
in O O
growth O O
inhibition O O
is O O
also B-conn Conjunction
considered O O
. O O

Although B-conn Concession.Expectation
the O O
signals O O
governing O O
fibrotic O O
induction O O
, O O
ductal O O
morphogenesis O O
, O O
and O O
growth O O
inhibition O O
are O O
unknown O O
, O O
a O O
role O O
for O O
transforming O O
growth O O
factor-β O O
is O O
highly O O
likely O O
and O O
is O O
discussed O O
. O O

Finally B-conn Conjunction
, O O
a O O
need O O
for O O
new O O
conceptual O O
and O O
experimental O O
approaches O O
to O O
understanding O O
stromal-epithelial O O
signaling O O
is O O
discussed O O
. O O

Introduction O O

Mammary O O
gland O O
development O O
occurs O O
in O O
two O O
morphogenetically O O
distinct O O
phases O O
. O O

The O O
first O O
begins O O
with O O
the O O
differentiation O O
of O O
a O O
mammary O O
ductal O O
rudiment O O
from O O
the O O
embryonic O O
epidermis O O
and O O
ends O O
after B-conn Temporal.Succession
puberty O O
with O O
an O O
elegant O O
arborated O O
system O O
of O O
ducts O O
-LRB- O O
Fig. O O
1a O O
-RRB- O O
. O O

In O O
the O O
second O O
phase O O
, O O
beginning O O
with O O
pregnancy O O
, O O
acinar O O
milk-secretory O O
lobules O O
develop O O
on O O
this O O
primary O O
framework O O
. O O

This O O
review O O
focuses O O
on O O
organotypic O O
branching O O
morphogenesis O O
as O O
it O O
occurs O O
during O O
the O O
ductal O O
, O O
as O O
opposed O O
to O O
the O O
lobular O O
, O O
phase O O
, O O
because B-conn Cause.Reason
it O O
is O O
during O O
ductal O O
development O O
that O O
stromal O O
influences O O
are O O
demonstrably O O
the O O
most O O
crucial O O
to O O
organogenesis O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
more O O
than O O
90 O O
% O O
of O O
human O O
mammary O O
carcinomas O O
are O O
ductal O O
in O O
origin O O
and B-conn Conjunction
it O O
is O O
becoming O O
increasingly O O
clear O O
that O O
the O O
subversion O O
of O O
reciprocal O O
signals O O
between O O
parenchyma O O
and O O
stroma O O
are O O
an O O
important O O
aspect O O
of O O
tumor O O
progression O O
. O O

Finally B-conn Conjunction
, O O
although B-conn Concession.Expectation
reference O O
will O O
be O O
made O O
to O O
the O O
influence O O
of O O
the O O
embryonic O O
stroma O O
, O O
called O O
the O O
mesenchyme O O
, O O
on O O
mammary O O
development O O
, O O
the O O
emphasis O O
will O O
be O O
on O O
postnatal O O
events O O
because B-conn Cause.Reason
these O O
arguably O O
have O O
a O O
more O O
direct O O
bearing O O
on O O
breast O O
cancer O O
. O O

Mammary O O
ducts O O
grow O O
through O O
a O O
complex O O
stroma O O

By B-conn Purpose.Enablement
parturition O O
, O O
the O O
mammary O O
stroma O O
comprises O O
multiple O O
cellular O O
and O O
acellular O O
elements O O
. O O

In O O
the O O
mouse O O
, O O
which O O
is O O
the O O
most O O
thoroughly O O
studied O O
model O O
and O O
the O O
focus O O
of O O
this O O
review O O
, O O
adipocytes O O
are O O
the O O
most O O
abundant O O
cell O O
type O O
, O O
followed O O
by O O
fibroblasts O O
, O O
various O O
migratory O O
blood O O
cells O O
, O O
endothelial O O
cells O O
-LRB- O O
blood O O
vessels O O
-RRB- O O
, O O
and O O
nerve O O
cells O O
. O O

Acellular O O
elements O O
include O O
fibrous O O
and O O
non-fibrous O O
collagens O O
, O O
proteoglycans O O
, O O
and O O
glycoproteins O O
, O O
all O O
of O O
which O O
provide O O
mechanical O O
support O O
to O O
the O O
tissue O O
as O O
well O O
as O O
forming O O
a O O
dynamic O O
, O O
developmentally O O
active O O
extracellular O O
matrix/basal O O
lamina O O
complex O O
at O O
the O O
epithelial-stromal O O
boundary O O
-LRB- O O
Fig. O O
1b O O
-RRB- O O
-LSB-1 O O
-RSB- O O
. O O

This O O
complex O O
connective O O
tissue O O
is O O
found O O
in O O
the O O
mammary O O
glands O O
of O O
different O O
species O O
with O O
various O O
ratios O O
of O O
fibrous O O
to O O
fatty O O
elements O O
-LSB-2 O O
-RSB- O O
, O O
and B-conn Continuation
it O O
is O O
within O O
this O O
matrix O O
that O O
mammary O O
ducts O O
elongate O O
, O O
arborate O O
, O O
and O O
, O O
finally B-conn Temporal.Precedence
, O O
terminate O O
growth O O
-LRB- O O
Fig. O O
1a O O
-RRB- O O
. O O

The O O
mammary O O
gland O O
pictured O O
-LRB- O O
Fig. O O
1 O O
-RRB- O O
is O O
a O O
snapshot O O
of O O
the O O
situation O O
in O O
adolescence O O
, O O
roughly O O
midway O O
in O O
the O O
ductal O O
phase O O
of O O
organogenesis O O
. O O

End O O
buds O O
, O O
the O O
highly O O
mitotic O O
ductal O O
growth O O
points O O
-LRB- O O
Fig. O O
2a O O
-RRB- O O
, O O
are O O
in O O
the O O
process O O
of O O
elongating O O
by B-conn Purpose.Enablement
penetrating O O
the O O
fatty O O
stroma O O
; O O
some O O
can O O
be O O
seen O O
bifurcating O O
. O O

Others O O
that O O
are O O
approaching O O
the O O
edge O O
of O O
the O O
fat O O
pad O O
-LRB- O O
at O O
the O O
right O O
of O O
the O O
image O O
-RRB- O O
are O O
in O O
various O O
stages O O
of O O
terminating O O
-LRB- O O
getting O O
smaller O O
-RRB- O O
or O O
have O O
ceased O O
to O O
grow O O
altogether O O
-LRB- O O
blunt-tipped O O
structures O O
-RRB- O O
. O O

During B-conn Temporal.Synchronous
this O O
period O O
of O O
maximum O O
ductal O O
elongation O O
, O O
more O O
than O O
95 O O
% O O
of O O
the O O
gland O O
is O O
growth-quiescent O O
, O O
maintaining O O
the O O
open O O
spaces O O
between O O
ducts O O
-LRB- O O
Fig. O O
1a O O
-RRB- O O
. O O

A O O
prominent O O
, O O
epithelium-induced O O
modification O O
of O O
the O O
periductal O O
stroma O O
is O O
also B-conn Conjunction
noteworthy O O
. O O

Type O O
I O O
collagen-rich O O
fibrous O O
connective O O
tissue O O
begins O O
to O O
ensheath O O
the O O
end O O
bud O O
on O O
its O O
flank O O
, O O
roughly O O
at O O
the O O
point O O
in O O
which O O
it O O
begins O O
to O O
constrict O O
to O O
ductal O O
dimensions O O
-LRB- O O
Figs O O
1b O O
and O O
2a O O
-RRB- O O
. O O

This O O
sheath O O
, O O
which O O
also B-conn Conjunction
comprises O O
the O O
basal-lamina/extracellular O O
matrix O O
complex O O
, O O
is O O
retained O O
and O O
forms O O
a O O
fibrous O O
sleeve O O
around O O
the O O
subtending O O
duct O O
. O O

At O O
this O O
point O O
in O O
its O O
development O O
, O O
then B-conn Restatement.Generalization
, O O
the O O
signature O O
features O O
of O O
the O O
gland O O
are O O
the O O
following O O
: O O
-LRB- O O
1 O O
-RRB- O O
ductal O O
as O O
opposed O O
to O O
lobular O O
morphology O O
; O O
-LRB- O O
2 O O
-RRB- O O
large O O
, O O
open O O
spaces O O
between O O
ducts O O
; O O
-LRB- O O
3 O O
-RRB- O O
most O O
active O O
growth O O
focused O O
in O O
end O O
buds O O
; O O
-LRB- O O
4 O O
-RRB- O O
regressed O O
end O O
buds O O
at O O
the O O
edge O O
of O O
the O O
fat O O
pad O O
. O O

A O O
role O O
for O O
the O O
stroma O O
in O O
defining O O
each O O
of O O
these O O
glandular O O
features O O
is O O
supported O O
by O O
experimental O O
evidence O O
that O O
is O O
discussed O O
below O O
. O O

In O O
seminal O O
experiments O O
by O O
Kratochwil O O
and O O
Sakakura O O
, O O
mammary O O
parenchyma O O
was O O
shown O O
to O O
possess O O
a O O
developmental O O
plasticity O O
that O O
is O O
constrained O O
and O O
directed O O
by O O
the O O
stroma O O
-LSB-3 O O
-RSB- O O
. O O

When B-conn Temporal.Synchronous
Kratochwil O O
cultured O O
a O O
composite O O
of O O
embryonic O O
mammary O O
epithelium O O
and O O
embryonic O O
sub-mandibular O O
-LRB- O O
salivary O O
-RRB- O O
mesenchyme O O
, O O
the O O
mammary O O
tissue O O
developed O O
salivary O O
gland-like O O
lobules O O
. O O

Extending O O
these O O
experiments O O
in O O
vivo O O
, O O
Sakakura O O
demonstrated O O
that O O
not O O
only O O
embryonic O O
but O O
also O O
adult O O
mammary O O
tissue O O
could O O
respond O O
in O O
this O O
way O O
to O O
salivary O O
mesenchymal O O
signals O O
. O O

Importantly O O
, O O
the O O
instructive O O
properties O O
of O O
the O O
stroma O O
did O O
not O O
extend O O
to O O
cytodifferentiation O O
: O O
in O O
a O O
pregnant O O
host O O
animal O O
, O O
salivary-like O O
mammary O O
transplants O O
synthesized O O
the O O
milk O O
protein O O
α-lactal-bumin O O
. O O

Interestingly O O
, O O
fetal O O
mammary O O
mesenchyme O O
grafted O O
into O O
the O O
adult O O
gland O O
accelerated O O
tumorigenesis O O
, O O
providing O O
an O O
early O O
indication O O
that O O
modifications O O
of O O
stromal O O
signaling O O
could O O
influence O O
the O O
progress O O
of O O
neoplasia O O
. O O

The O O
absence O O
of O O
extensive O O
ductal O O
side O O
branching O O
and O O
infilling O O
of O O
interductal O O
spaces O O
is O O
not B-conn Cause.Reason
due I-conn Cause.Reason
to I-conn Cause.Reason
the O O
terminal O O
differentiation O O
of O O
ductal O O
cells O O
. O O

Even O O
the O O
smallest O O
fragment O O
of O O
a O O
duct O O
, O O
when B-conn Temporal.Synchronous
transplanted O O
to O O
stroma O O
devoid O O
of O O
parenchyma O O
, O O
undergoes O O
aggressive O O
growth O O
and O O
can O O
fill O O
a O O
fat O O
pad O O
with O O
a O O
morphologically O O
and O O
functionally O O
complete O O
ductal O O
system O O
. O O

This O O
capacity O O
is O O
attributed O O
to O O
up O O
to O O
three O O
populations O O
of O O
mammary O O
stem O O
or O O
progenitor O O
cells O O
-LSB-4 O O
-RSB- O O
and O O
is O O
subject O O
to O O
stromal O O
inhibition O O
. O O

When O O
similar O O
fragments O O
are O O
transplanted O O
into O O
a O O
space O O
between O O
existing O O
ducts O O
the O O
graft O O
is O O
maintained O O
but O O
does O O
not O O
grow O O
-LRB- O O
Daniel O O
, O O
unpublished O O
data O O
-RRB- O O
. O O

Normal O O
inhibition O O
of O O
ductal O O
branching O O
must O O
therefore B-conn Cause.Claim
overcome O O
a O O
stromal O O
background O O
that O O
is O O
strongly O O
stimulatory O O
; O O
there O O
is O O
now O O
excellent O O
evidence O O
that O O
transforming O O
growth O O
factor-βs O O
-LRB- O O
TGF-βs O O
-RRB- O O
, O O
acting O O
in O O
part O O
on O O
stromal O O
targets O O
, O O
are O O
responsible O O
. O O

The O O
rapid O O
and O O
reversible O O
inhibition O O
of O O
end O O
bud O O
growth O O
by O O
experimentally O O
implanted O O
TGF-β1 O O
demonstrates O O
the O O
mammotrophic O O
activity O O
of O O
this O O
growth O O
factor O O
, O O
whereas B-conn Contrast
its O O
normally O O
high O O
concentration O O
in O O
the O O
periductal O O
extracellular O O
matrix O O
and O O
its O O
localized O O
loss O O
over O O
lateral O O
buds O O
strongly O O
implies O O
an O O
action O O
that O O
modulates O O
secondary O O
ductal O O
growth O O
-LSB-5 O O
-RSB- O O
. O O

Studies O O
with O O
transgenic O O
mice O O
overexpressing O O
a O O
constitutively O O
activated O O
form O O
of O O
TGF-β1 O O
-LSB-6 O O
-RSB- O O
, O O
as O O
well O O
as O O
function-ablating O O
mutant O O
TGF-β O O
signaling O O
receptors O O
, O O
were O O
confirmatory O O
. O O

The O O
ectopic O O
expression O O
of O O
TGF-β1 O O
resulted O O
in O O
a O O
significant O O
decrease O O
in O O
lateral O O
branching O O
, O O
and B-conn Conjunction
mutant O O
TGF-β O O
receptors O O
expressed O O
in O O
the O O
stroma O O
increased O O
lateral O O
branch O O
infilling O O
-LSB-7 O O
-RSB- O O
. O O

Because B-conn Cause.Justification
the O O
latter O O
are O O
an O O
important O O
site O O
of O O
TGF-β O O
action O O
, O O
normal O O
chronic O O
inhibition O O
of O O
branching O O
must O O
depend O O
, O O
in O O
part O O
, O O
on O O
TGF-β-regulated O O
secondary O O
signals O O
. O O

Recently O O
, O O
hepatocyte O O
growth O O
factor O O
-LRB- O O
HGF O O
-RRB- O O
, O O
which O O
can O O
stimulate O O
the O O
branching O O
of O O
mammary O O
epithelial O O
tubes O O
in O O
vitro O O
and O O
is O O
negatively O O
modulated O O
by O O
TGF-β O O
, O O
has O O
emerged O O
as O O
a O O
candidate O O
secondary O O
signal O O
-LSB-8 O O
-RSB- O O
. O O

In O O
this O O
model O O
, O O
TGF-β O O
inhibits O O
branching O O
through B-conn Purpose.Enablement
the O O
inhibition O O
of O O
HGF O O
expression O O
in O O
the O O
periductal O O
stroma O O
-LRB- O O
reviewed O O
in O O
this O O
issue O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
protean O O
effects O O
of O O
TGF-βs O O
on O O
mitogenesis O O
and O O
extracellular O O
matrix O O
dynamics O O
in O O
mammary O O
tissue O O
make O O
the O O
assignment O O
of O O
any O O
single O O
, O O
TGF-β-mediated O O
mechanism O O
premature O O
-LSB-5 O O
-RSB- O O
. O O

Ductal O O
elongation O O
and O O
branching O O
depend O O
on O O
parenchyma-induced O O
modifications O O
of O O
the O O
periductal O O
stroma O O

It O O
is O O
striking O O
that O O
ductal O O
growth O O
is O O
so O O
exquisitely O O
focused O O
in O O
the O O
end O O
buds O O
. O O

The O O
impression O O
that O O
precisely O O
localized O O
, O O
as O O
opposed O O
to O O
general O O
, O O
signals O O
guide O O
this O O
development O O
is O O
unavoidable O O
. O O

In B-conn Reinforcement
fact I-conn Reinforcement
, O O
this O O
impression O O
is O O
correct O O
and B-conn Cause.Justification
epithelium-induced O O
changes O O
develop O O
the O O
growth-promoting O O
potential O O
of O O
the O O
stroma O O
immediately O O
in O O
front O O
of O O
end O O
buds O O
. O O

Exciting O O
new O O
evidence O O
demonstrates O O
that O O
migratory O O
white O O
blood O O
cells O O
, O O
macrophages O O
and O O
eosinophils O O
, O O
are O O
drawn O O
to O O
the O O
vicinity O O
of O O
the O O
end O O
bud O O
by O O
chemoattractants O O
and O O
, O O
surprisingly O O
, O O
prove O O
to O O
be O O
essential O O
for O O
the O O
normal O O
development O O
of O O
end O O
buds O O
-LSB-9 O O
-RSB- O O
. O O

Interestingly O O
, O O
extensive O O
DNA O O
synthesis O O
in O O
the O O
stroma O O
around O O
end O O
buds O O
accompanies O O
this O O
activity O O
, O O
indicating O O
that O O
new O O
stromal O O
cells O O
are O O
not O O
only O O
recruited O O
to O O
the O O
vicinity O O
of O O
the O O
end O O
bud O O
but O O
are O O
also O O
induced O O
by O O
it O O
to O O
proliferate O O
-LSB-10 O O
-RSB- O O
. O O

The O O
absence O O
of O O
stromal O O
DNA O O
synthesis O O
around O O
growth-terminated O O
ducts O O
emphasizes O O
that O O
these O O
inductive O O
signals O O
are O O
growth-related O O
and O O
are O O
not B-conn Cause.Reason
due I-conn Cause.Reason
merely I-conn Cause.Reason
to I-conn Cause.Reason
the O O
presence O O
of O O
epithelium O O
. O O

Steroid O O
autoradiographic O O
experiments O O
have O O
demonstrated O O
that O O
estrogen O O
receptors O O
are O O
concentrated O O
in O O
the O O
nuclei O O
of O O
stromal O O
cells O O
around O O
end O O
buds O O
but O O
not O O
in O O
rapidly O O
dividing O O
cap O O
cells O O
-LRB- O O
a O O
stem O O
cell O O
layer O O
covering O O
the O O
tip O O
of O O
the O O
end O O
bud O O
-RRB- O O
, O O
indicating O O
a O O
paracrine O O
mechanism O O
-LSB-11 O O
-RSB- O O
. O O

This O O
was O O
confirmed O O
when B-conn Temporal.Synchronous
estrogen O O
receptor O O
knockout O O
-LRB- O O
ERKO O O
-RRB- O O
mice O O
were O O
used O O
to O O
investigate O O
whether O O
the O O
steroid O O
acts O O
on O O
epithelial O O
or O O
stromal O O
targets O O
. O O

Cunha O O
et O O
al O O
-LSB-12 O O
-RSB- O O
surgically O O
transplanted O O
ERKO O O
epithelium O O
in O O
combination O O
with O O
either O O
ERKO O O
or O O
wild-type O O
stroma O O
under O O
renal O O
capsules O O
in O O
athymic O O
mice O O
and O O
demonstrated O O
that O O
, O O
whereas B-conn Contrast
wild-type O O
stroma O O
supported O O
organotypic O O
growth O O
of O O
the O O
ERKO O O
epithelium O O
, O O
no O O
ductal O O
growth O O
was O O
seen O O
with O O
wild-type O O
epithelium O O
in O O
ERKO O O
stroma O O
. O O

It O O
has O O
been O O
suggested O O
that O O
estrogen O O
receptors O O
are O O
uniquely O O
concentrated O O
around O O
end O O
buds O O
, O O
but B-conn Concession.Contra-expectation
this O O
has O O
not O O
been O O
proved O O
-LSB-11 O O
-RSB- O O
, O O
leaving O O
open O O
the O O
possibilities O O
that O O
elongating O O
ducts O O
stimulate O O
the O O
induction O O
of O O
estrogen O O
receptors O O
in O O
nearby O O
stromal O O
cells O O
, O O
attract O O
estrogen O O
receptor-positive O O
stromal O O
cells O O
, O O
or O O
stimulate O O
their O O
proliferation O O
. O O

In O O
addition O O
to O O
estrogen O O
, O O
other O O
ductal O O
mammogens O O
act O O
through B-conn Purpose.Enablement
intermediaries O O
generated O O
in O O
the O O
stroma O O
-LRB- O O
reviewed O O
in O O
this O O
issue O O
and O O
in O O
-LSB-13 O O
-RSB- O O
-RRB- O O
. O O

These O O
include O O
epidermal O O
growth O O
factor O O
, O O
activins/inhibins O O
, O O
and O O
growth O O
hormone O O
, O O
which O O
stimulates O O
the O O
synthesis O O
of O O
insulin-like O O
growth O O
factor O O
. O O

Growth O O
stimulatory O O
stromal-epithelial O O
interactions O O
are O O
shown O O
diagrammatically O O
in O O
Fig. O O
3 O O
. O O

Organotypic O O
development O O
depends O O
on O O
two O O
obvious O O
structural O O
modifications O O
of O O
the O O
end O O
bud O O
, O O
its O O
constriction O O
into O O
a O O
tube O O
and O O
its O O
bifurcation O O
. O O

Preceding O O
either O O
, O O
there O O
is O O
focal O O
induction O O
by O O
the O O
end O O
bud O O
of O O
type O O
I O O
collagen-rich O O
connective O O
tissue O O
and O O
extracellular O O
matrix O O
on O O
its O O
flank O O
-LRB- O O
Fig. O O
1b O O
-RRB- O O
and O O
in O O
the O O
clefts O O
that O O
indent O O
the O O
tip O O
when B-conn Temporal.Synchronous
two O O
new O O
end O O
buds O O
form O O
-LRB- O O
not O O
shown O O
-RRB- O O
. O O

An O O
active O O
role O O
for O O
collagen O O
in O O
shaping O O
the O O
duct O O
is O O
indicated O O
. O O

In O O
vitro O O
, O O
mammary O O
epithelial O O
cells O O
embedded O O
in O O
collagen O O
gels O O
form O O
narrow O O
tubules O O
that O O
are O O
also B-conn Conjunction
seen O O
in O O
vivo O O
when B-conn Temporal.Synchronous
fragments O O
of O O
duct O O
form O O
similar O O
tubules O O
in O O
a O O
bolus O O
of O O
injected O O
type O O
1 O O
collagen O O
-LRB- O O
reviewed O O
in O O
-LSB-13 O O
-RSB- O O
-RRB- O O
. O O

Mechanistically O O
, O O
by B-conn Purpose.Enablement
binding O O
to O O
members O O
of O O
the O O
integrin O O
family O O
of O O
extracellular O O
matrix O O
receptors O O
, O O
collagen O O
can O O
stimulate O O
the O O
formation O O
of O O
actin-cytoskeletal O O
foci O O
that O O
are O O
capable O O
of O O
changing O O
mammary O O
cell O O
shape O O
-LSB-14 O O
-RSB- O O
. O O

Indeed B-conn Reinforcement
, O O
β1-integrin O O
was O O
localized O O
at O O
the O O
basal O O
surfaces O O
of O O
the O O
end O O
bud O O
epithelium O O
, O O
and B-conn Conjunction
function-blocking O O
antibodies O O
against O O
β-integrin O O
, O O
as O O
well O O
as O O
antibodies O O
against O O
laminin O O
, O O
reversibly O O
inhibited O O
end O O
bud O O
development O O
in O O
vivo O O
, O O
while B-conn Temporal.Synchronous
blocking O O
tubulogenesis O O
in O O
vitro O O
-LSB-15 O O
-RSB- O O
. O O

The O O
molecular O O
signals O O
governing O O
the O O
sites O O
of O O
fibrous O O
induction O O
are O O
largely O O
unknown O O
; O O
however B-conn Concession.Contra-expectation
, O O
TGF-βs O O
seem O O
likely O O
to O O
have O O
a O O
role O O
. O O

The O O
experimental O O
release O O
of O O
TGF-β1 O O
in O O
the O O
vicinity O O
of O O
an O O
end O O
bud O O
by O O
plastic O O
implants O O
caused O O
epithelium-dependent O O
induction O O
of O O
a O O
fibrous O O
connective O O
tissue O O
cap O O
over O O
the O O
end O O
bud O O
tip O O
. O O

The O O
molecular O O
composition O O
of O O
this O O
cap O O
reflected O O
that O O
of O O
the O O
fibrous O O
connective O O
tissue O O
on O O
the O O
flank O O
of O O
the O O
end O O
bud O O
and O O
in O O
developing O O
clefts O O
before B-conn Temporal.Precedence
bifurcation O O
, O O
suggesting O O
that O O
TGF-β1 O O
might O O
be O O
the O O
normal O O
inducer O O
-LSB-16 O O
-RSB- O O
. O O

More O O
recently O O
, O O
parathyroid-hormone-related O O
protein O O
-LRB- O O
PTHrP O O
-RRB- O O
has O O
been O O
shown O O
to O O
be O O
crucial O O
for O O
normal O O
ductal O O
development O O
. O O

Transgenic O O
animals O O
overexpressing O O
the O O
peptide O O
show O O
severe O O
impairment O O
of O O
ductal O O
extension O O
and O O
branching O O
-LSB-17 O O
-RSB- O O
. O O

Pertinent O O
to O O
this O O
discussion O O
, O O
PTHrP O O
synthesis O O
is O O
concentrated O O
in O O
the O O
cap O O
cells O O
of O O
end O O
buds O O
and O O
their O O
myoepithelial O O
descendents O O
on O O
the O O
flank O O
, O O
whereas B-conn Contrast
cognate O O
receptors O O
seem O O
to O O
be O O
concentrated O O
in O O
the O O
immediately O O
adjacent O O
fibrous O O
tissue O O
. O O

This O O
indicates O O
a O O
potential O O
role O O
in O O
stromal O O
induction O O
. O O

With O O
this O O
in O O
mind O O
, O O
the O O
fact O O
that O O
TGF-β O O
can O O
positively O O
regulate O O
PTHrP O O
is O O
interesting O O
-LSB-17 O O
-RSB- O O
because B-conn Cause.Reason
TGF-β O O
is O O
present O O
, O O
often O O
at O O
high O O
levels O O
, O O
in O O
the O O
end O O
bud O O
-LSB-18 O O
-RSB- O O
-LRB- O O
Fig. O O
3b O O
-RRB- O O
. O O

These O O
observations O O
suggest O O
that O O
TGF-βs O O
might O O
indirectly O O
cause O O
the O O
induction O O
of O O
the O O
fibrous O O
sheath O O
of O O
end O O
buds O O
and B-conn Conjunction
that O O
experiments O O
to O O
investigate O O
whether O O
PTHrP O O
induces O O
fibrosis O O
and B-conn Conjunction
whether O O
TGF-β1 O O
normally O O
regulates O O
PTHrP O O
during O O
ductal O O
development O O
would O O
be O O
fruitful O O
. O O

A O O
combined O O
role O O
for O O
TGF-β-induced O O
fibrous O O
stroma O O
in O O
inhibiting O O
end O O
bud O O
growth O O
while B-conn Temporal.Synchronous
guiding O O
morphogenesis O O
has O O
been O O
suggested O O
-LSB-5 O O
-RSB- O O
. O O

Consistent O O
with O O
this O O
hypothesis O O
is O O
the O O
observation O O
that O O
fibrous O O
connective O O
tissue O O
on O O
the O O
flank O O
progressively O O
advances O O
to O O
envelop O O
the O O
tips O O
of O O
end O O
buds O O
that O O
are O O
in O O
the O O
process O O
of O O
stopping O O
growth O O
-LSB-19 O O
-RSB- O O
. O O

Arguing O O
against O O
the O O
matrix O O
as O O
a O O
primary O O
growth O O
inhibitor O O
, O O
however B-conn Concession.Contra-expectation
, O O
implanted O O
TGF-β O O
inhibits O O
DNA O O
synthesis O O
up O O
to O O
12 O O
h O O
before B-conn Temporal.Precedence
the O O
appearance O O
of O O
the O O
fibrous O O
cap O O
. O O

Furthermore B-conn Conjunction
, O O
surprisingly O O
high O O
levels O O
of O O
DNA O O
synthesis O O
can O O
be O O
detected O O
in O O
matrix-ensheathed O O
, O O
growth-quiescent O O
ducts O O
, O O
some O O
quite O O
distant O O
from O O
the O O
end O O
bud O O
-LRB- O O
Fig. O O
2 O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
this O O
DNA O O
synthesis O O
might O O
or O O
might O O
not O O
be O O
related O O
to O O
mitosis O O
-LSB-20 O O
-RSB- O O
, O O
it O O
nevertheless B-conn Concession.Contra-expectation
demonstrates O O
that O O
growth-stimulatory O O
signals O O
can O O
be O O
quite O O
active O O
in O O
ducts O O
beneath O O
an O O
intact O O
fibrous O O
stromal O O
sheath O O
. O O

Even B-conn Concession.Expectation
though I-conn Concession.Expectation
it O O
is O O
clear O O
that O O
stromal O O
signals O O
must O O
ultimately O O
inhibit O O
end O O
bud O O
growth O O
-LSB-how O O
else O O
can O O
their O O
regression O O
before B-conn Temporal.Precedence
reaching O O
the O O
limits O O
of O O
the O O
fat O O
pad O O
be O O
explained O O
-LRB- O O
Fig. O O
1a O O
-RRB- O O
? O O
-RSB- O O
, O O
their O O
identity O O
remains O O
unknown O O
-LRB- O O
Fig. O O
3b O O
-RRB- O O
. O O

Resolving O O
signaling O O
between O O
epithelium O O
and O O
stroma O O

During O O
the O O
past O O
decade O O
, O O
classic O O
mammary O O
tissue O O
recombination O O
experiments O O
have O O
been O O
recalled O O
to O O
duty O O
, O O
this O O
time O O
using O O
tissue O O
from O O
genetically O O
engineered O O
mice O O
, O O
and O O
have O O
led O O
to O O
important O O
insights O O
into O O
the O O
stromal O O
origins O O
of O O
ductal O O
mammogenic O O
signals O O
. O O

Much O O
less O O
is O O
known O O
about O O
the O O
epithelial O O
signals O O
that O O
reorganize O O
the O O
periductal O O
stroma O O
and B-conn Continuation
, O O
as O O
I O O
have O O
discussed O O
briefly O O
above O O
, O O
these O O
retrograde O O
signals O O
are O O
crucial O O
to O O
the O O
realization O O
of O O
the O O
morphogenetic O O
and O O
growth-promoting O O
potential O O
of O O
the O O
stroma O O
. O O

Identifying O O
the O O
relevant O O
epithelial O O
signals O O
and O O
placing O O
them O O
in O O
a O O
proper O O
temporal O O
order O O
with O O
regard O O
to O O
the O O
elicitation O O
of O O
stromal O O
signals O O
and O O
the O O
ensuing O O
morphogenetic O O
events O O
is O O
now O O
a O O
major O O
challenge O O
that O O
will O O
require O O
new O O
conceptual O O
as O O
well O O
as O O
experimental O O
tools O O
. O O

The O O
strong O O
evolutionary O O
conservation O O
of O O
reciprocal O O
, O O
epithelial-stromal O O
signaling O O
in O O
branching O O
morphogenesis O O
, O O
which O O
encompasses O O
the O O
development O O
of O O
branched O O
airways O O
from O O
insects O O
to O O
mammals O O
, O O
for B-conn Instantiation
example I-conn Instantiation
, O O
suggests O O
that O O
careful O O
study O O
of O O
these O O
systems O O
could O O
provide O O
new O O
ideas O O
pertinent O O
to O O
mammary O O
growth O O
and O O
morphogenesis O O
-LSB-21 O O
-RSB- O O
. O O

Conclusion O O

In O O
an O O
earlier O O
review O O
-LSB-13 O O
-RSB- O O
I O O
suggested O O
that O O
bringing O O
modern O O
molecular O O
methods O O
to O O
bear O O
to B-conn Purpose.Goal
investigate O O
the O O
dynamics O O
of O O
gene O O
expression O O
in O O
the O O
stroma O O
and O O
epithelium O O
at O O
obvious O O
growth O O
and O O
morphogenetic O O
inflection O O
points O O
-LRB- O O
eg O O
in O O
front O O
of O O
end O O
buds O O
-RRB- O O
would O O
be O O
useful O O
. O O

However B-conn Concession.Contra-expectation
, O O
this O O
approach O O
does O O
not O O
address O O
the O O
vital O O
issue O O
of O O
the O O
temporal O O
order O O
of O O
signaling O O
, O O
the O O
resolution O O
of O O
which O O
would O O
benefit O O
from O O
a O O
' O O
time-zero O O
' O O
experimental O O
condition O O
, O O
in O O
which O O
growth-static O O
mammary O O
ducts O O
could O O
be O O
induced O O
to O O
grow O O
in O O
a O O
controlled O O
manner O O
. O O

Although B-conn Concession.Expectation
there O O
should O O
be O O
several O O
ways O O
of O O
accomplishing O O
this O O
, O O
simple O O
ductal O O
transplants O O
come O O
first O O
to O O
mind O O
. O O

Through B-conn Purpose.Enablement
an O O
analysis O O
of O O
the O O
initiation O O
and O O
earliest O O
phases O O
of O O
transplant O O
outgrowth O O
over O O
a O O
finely O O
spaced O O
time-course O O
, O O
it O O
might O O
be O O
possible O O
to O O
obtain O O
an O O
orderly O O
reading O O
of O O
reciprocal O O
epithelial O O
and O O
stromal O O
signals O O
that O O
underlie O O
stromal O O
reorganization O O
and O O
ductal O O
extension O O
. O O

Abbreviations O O

ERKO O O
= O O
estrogen O O
receptor O O
knockout O O
; O O
HGF O O
= O O
hepatocyte O O
growth O O
factor O O
; O O
PTHrP O O
= O O
parathyroid-hormone-related O O
protein O O
; O O
TGF-β O O
= O O
transforming O O
growth O O
factor-β O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Ducts O O
and O O
end O O
buds O O
in O O
the O O
juvenile O O
mouse O O
mammary O O
gland O O
. O O

-LRB- O O
a O O
-RRB- O O
Photomicrograph O O
illustrating O O
the O O
mammary O O
ductal O O
system O O
in O O
a O O
5-week-old O O
nulliparous O O
mouse O O
. O O

Note O O
the O O
' O O
open O O
' O O
ductal O O
architecture O O
, O O
which O O
leaves O O
80 O O
% O O
or O O
more O O
of O O
the O O
gland O O
parenchyma-free O O
. O O

End O O
buds O O
-LRB- O O
large O O
arrows O O
-RRB- O O
identify O O
growing O O
ducts O O
. O O

Those O O
end O O
buds O O
that O O
are O O
arrayed O O
along O O
the O O
right-hand O O
side O O
of O O
the O O
gland O O
are O O
in O O
various O O
stages O O
of O O
regression O O
. O O

Blunt-tipped O O
branches O O
-LRB- O O
small O O
arrows O O
-RRB- O O
mark O O
growth-quiescent O O
ducts O O
. O O

The O O
nipple O O
-LRB- O O
asterisk O O
-RRB- O O
is O O
at O O
base O O
of O O
the O O
gland O O
. O O

Magnification O O
approximately O O
×15 O O
. O O

-LRB- O O
b O O
-RRB- O O
Photomicrograph O O
of O O
a O O
longitudinal O O
section O O
through O O
an O O
end O O
bud O O
and O O
subtending O O
duct O O
. O O

The O O
induction O O
of O O
a O O
fibrous O O
connective O O
tissue O O
sheath O O
-LRB- O O
large O O
arrows O O
-RRB- O O
coincides O O
with O O
the O O
constriction O O
of O O
the O O
end O O
bud O O
to O O
ductal O O
dimensions O O
. O O

The O O
alcian O O
blue O O
stain O O
used O O
in O O
this O O
preparation O O
detects O O
glycosaminoglycans O O
and O O
highlights O O
the O O
extracellular O O
matrix/basal O O
lamina O O
complex O O
at O O
the O O
epithelial-stromal O O
interface O O
-LRB- O O
small O O
arrows O O
-RRB- O O
-LSB-19 O O
-RSB- O O
. O O

Magnification O O
×250 O O
. O O

Figure O O
2 O O
: O O
Photomicrographs O O
illustrating O O
patterns O O
of O O
DNA O O
synthesis O O
in O O
an O O
end O O
bud O O
, O O
its O O
immediately O O
subtending O O
duct O O
, O O
and O O
a O O
lateral O O
branch O O
-LRB- O O
a O O
-RRB- O O
, O O
as O O
well O O
as O O
in O O
a O O
duct O O
distant O O
from O O
the O O
growth O O
front O O
-LRB- O O
b O O
-RRB- O O
. O O

-LSB-3H O O
-RSB- O O
Thymidine O O
autoradiographs O O
were O O
stained O O
with O O
alcian O O
blue O O
. O O

Large O O
arrows O O
, O O
fibrous O O
sheath O O
around O O
end O O
bud O O
; O O
small O O
arrows O O
, O O
DNA O O
synthetic O O
cells O O
. O O

Magnification O O
×250 O O
. O O

Figure O O
3 O O
: O O
Diagrams O O
depicting O O
stromal-epithelial O O
signaling O O
affecting O O
mammary O O
ductal O O
growth O O
and O O
its O O
inhibition O O
. O O

-LRB- O O
a O O
-RRB- O O
Growth O O
stimulatory O O
signals O O
. O O

Endocrine O O
mammogens O O
-LSB-estrogen O O
-LRB- O O
E O O
-RRB- O O
, O O
growth O O
hormone O O
-LRB- O O
GH O O
-RRB- O O
-RSB- O O
, O O
acting O O
on O O
stromal O O
targets O O
in O O
front O O
of O O
the O O
end O O
bud O O
, O O
stimulate O O
the O O
synthesis O O
of O O
the O O
local O O
mammogens O O
epidermal O O
growth O O
factor O O
-LRB- O O
EGF O O
-RRB- O O
, O O
insulin-like O O
growth O O
factor-1 O O
-LRB- O O
IGF-1 O O
-RRB- O O
, O O
and O O
members O O
of O O
the O O
activin/inhibin O O
family O O
. O O

From O O
the O O
end O O
bud O O
, O O
unknown O O
retrograde O O
signals O O
-LRB- O O
broken O O
lines O O
-RRB- O O
stimulate O O
vicinal O O
DNA O O
synthesis O O
and O O
attract O O
macrophages O O
and O O
eosinophils O O
. O O

The O O
stimulation O O
of O O
lateral O O
branches O O
along O O
mature O O
ducts O O
involves O O
the O O
focal O O
loss O O
or O O
inactivation O O
of O O
transforming O O
growth O O
factor-β1 O O
-LRB- O O
TGF-β1 O O
-RRB- O O
, O O
relieving O O
the O O
inhibition O O
of O O
hepatocyte O O
growth O O
factor O O
-LRB- O O
HGF O O
-RRB- O O
synthesis O O
and O O
permitting O O
lateral O O
branch O O
development O O
. O O

Outer O O
shaded O O
zone O O
, O O
fibrous O O
sheath O O
; O O
L O O
, O O
lumen O O
. O O

-LRB- O O
b O O
-RRB- O O
TGF-β O O
in O O
growth O O
inhibition O O
and O O
induction O O
of O O
the O O
periductal O O
fibrous O O
sheath O O
. O O

Although B-conn Concession.Expectation
end O O
buds O O
are O O
inhibited O O
by O O
exogenous O O
TGF-β O O
, O O
it O O
remains O O
unproven O O
as O O
the O O
natural O O
mechanism O O
for O O
end O O
bud O O
growth O O
termination O O
. O O

In O O
a O O
purely O O
speculative O O
model O O
for O O
fibrous O O
induction O O
, O O
TGF-β O O
, O O
acting O O
in O O
a O O
paracrine O O
mode O O
on O O
cap/myoepithelial O O
cells O O
-LRB- O O
black O O
layer O O
-RRB- O O
, O O
induces O O
parathyroid-hormone-related O O
protein O O
-LRB- O O
P O O
-RRB- O O
. O O

Secreted O O
parathyroid-hormone-related O O
protein O O
then B-conn Temporal.Precedence
acts O O
on O O
stromal O O
targets O O
, O O
inducing O O
highly O O
localized O O
fibrosis O O
. O O

Finally B-conn Temporal.Precedence
, O O
along O O
the O O
duct O O
, O O
TGF-β1 O O
inhibits O O
lateral O O
branching O O
by B-conn Purpose.Enablement
blocking O O
HGF O O
action O O
. O O

Cellular O O
Notch O O
responsiveness O O
is O O
defined O O
by O O
phosphoinositide O O
3-kinase-dependent O O
signals O O

Abstract O O

Background O O
: O O
Notch O O
plays O O
a O O
wide-ranging O O
role O O
in O O
controlling O O
cell O O
fate O O
, O O
differentiation O O
and O O
development O O
. O O

The O O
PI3K-Akt O O
pathway O O
is O O
a O O
similarly O O
conserved O O
signalling O O
pathway O O
which O O
regulates O O
processes O O
such O O
as O O
differentiation O O
, O O
proliferation O O
and O O
survival O O
. O O

Mice O O
with O O
disrupted O O
Notch O O
and O O
PI3K O O
signalling O O
show O O
phenotypic O O
similarities O O
during B-conn Temporal.Synchronous
haematopoietic O O
cell O O
development O O
, O O
suggesting O O
functional O O
interaction O O
between O O
these O O
pathways O O
. O O

Results O O
: O O
We O O
show O O
that O O
cellular O O
responsiveness O O
to O O
Notch O O
signals O O
depends O O
on O O
the O O
activity O O
of O O
the O O
PI3K-Akt O O
pathway O O
in O O
cells O O
as O O
diverse O O
as O O
CHO O O
cells O O
, O O
primary O O
T-cells O O
and O O
hippocampal O O
neurons O O
. O O

Induction O O
of O O
the O O
endogenous O O
PI3K-Akt O O
pathway O O
in O O
CHO O O
cells O O
-LRB- O O
by B-conn Purpose.Enablement
the O O
insulin O O
pathway O O
-RRB- O O
, O O
in O O
T-cells O O
-LRB- O O
via B-conn Purpose.Enablement
TCR O O
activation O O
-RRB- O O
or O O
in O O
neurons O O
-LRB- O O
via B-conn Purpose.Enablement
TrKB O O
activation O O
-RRB- O O
potentiates O O
Notch-dependent O O
responses O O
. O O

We O O
propose O O
that O O
the O O
PI3K-Akt O O
pathway O O
exerts O O
its O O
influence O O
on O O
Notch O O
primarily O O
via B-conn Purpose.Enablement
inhibition O O
of O O
GSK3-beta O O
, O O
a O O
kinase O O
known O O
to O O
phosphorylate O O
and O O
regulate O O
Notch O O
signals O O
. O O

Conclusion O O
: O O
The O O
PI3K-Akt O O
pathway O O
acts O O
as O O
a O O
`` O O
gain O O
control O O
'' O O
for O O
Notch O O
signal O O
responses O O
. O O

Since B-conn Cause.Justification
physiological O O
levels O O
of O O
intracellular O O
Notch O O
are O O
often O O
low O O
, O O
coincidence O O
with O O
PI3K-activation O O
may O O
be O O
crucial O O
for B-conn Purpose.Goal
induction O O
of O O
Notch-dependent O O
responses O O
. O O

Background O O

The O O
phosphoinositide-3-kinases O O
-LRB- O O
PI3Ks O O
-RRB- O O
constitute O O
an O O
enzyme O O
family O O
of O O
p85/p110 O O
heterodimers O O
responsible O O
for B-conn Purpose.Goal
regulating O O
numerous O O
biological O O
processes O O
in O O
diverse O O
cell O O
types O O
-LSB-1 O O
-RSB- O O
such O O
as O O
cellular O O
proliferation O O
, O O
differentiation O O
and O O
survival O O
. O O

Of O O
particular O O
interest O O
is O O
the O O
role O O
of O O
this O O
pathway O O
in O O
lymphocyte O O
activation O O
, O O
where O O
antigen O O
and O O
cytokine O O
receptor O O
ligation O O
result O O
in O O
activation O O
of O O
PI3K-driven O O
signals O O
-LSB-2 O O
-RSB- O O
. O O

A O O
key O O
target O O
of O O
PI3K O O
activity O O
is O O
Akt/PKB O O
, O O
which O O
mediates O O
many O O
of O O
the O O
effects O O
of O O
PI3K O O
activation O O
-LSB-3 O O
-RSB- O O
. O O

PI3K O O
is O O
activated O O
in O O
T-cells O O
both B-conn Purpose.Enablement
in I-conn Purpose.Enablement
response I-conn Purpose.Enablement
to I-conn Purpose.Enablement
T-cell O O
receptor O O
-LRB- O O
TCR O O
-RRB- O O
stimulation O O
, O O
and B-conn Conjunction
by O O
engagement O O
of O O
the O O
co-stimulatory O O
receptor O O
CD28 O O
. O O

Gene O O
targeting O O
studies O O
have O O
emphasised O O
the O O
essential O O
role O O
PI3K O O
plays O O
in O O
these O O
responses O O
: O O
whereas B-conn Contrast
PI3K-deficient O O
mice O O
are O O
immunodeficient O O
-LSB-4,5 O O
-RSB- O O
, O O
constitutive O O
activity O O
is O O
associated O O
with O O
hyperproliferative O O
T-cell O O
responses O O
and O O
autoimmunity O O
-LSB-6 O O
-RSB- O O
. O O

Equally O O
, O O
preventing O O
the O O
termination O O
of O O
PI3K O O
activity O O
by B-conn Purpose.Enablement
conditional O O
gene O O
targeting O O
of O O
the O O
lipid O O
phosphatase O O
Pten O O
in O O
T-cells O O
leads O O
to O O
autoimmunity O O
and O O
development O O
of O O
lymphoma O O
-LSB-7 O O
-RSB- O O
. O O

These O O
studies O O
demonstrate O O
that O O
PI3K O O
activity O O
is O O
tightly O O
regulated O O
and O O
plays O O
an O O
integral O O
role O O
in O O
the O O
maintenance O O
of O O
lymphocyte O O
homeostasis O O
. O O

The O O
Notch O O
signalling O O
pathway O O
plays O O
a O O
critical O O
role O O
in O O
a O O
wide O O
range O O
of O O
developmental O O
processes O O
in O O
the O O
embryo O O
, O O
including O O
binary O O
lineage O O
decisions O O
and O O
boundary O O
formation O O
-LSB-8 O O
-RSB- O O
. O O

Binding O O
of O O
the O O
Notch O O
ligands O O
Delta O O
or O O
Jagged O O
to O O
the O O
Notch O O
receptor O O
instigates O O
proteolytic O O
cleavage O O
which O O
releases O O
the O O
Notch O O
intracellular O O
domain O O
-LRB- O O
N-IC O O
-RRB- O O
-LSB-8 O O
-RSB- O O
which O O
activates O O
the O O
transcription O O
factor O O
CBF-1 O O
which O O
, O O
in B-conn Temporal.Precedence
turn I-conn Temporal.Precedence
, O O
controls O O
target O O
genes O O
such O O
as O O
Hes-1 O O
-LSB-9 O O
-RSB- O O
. O O

Central O O
to O O
Notch O O
's O O
role O O
is O O
its O O
ability O O
to O O
modulate O O
the O O
differentiative O O
potential O O
of O O
pluripotent O O
cells O O
, O O
for B-conn Instantiation
instance I-conn Instantiation
in O O
the O O
neural O O
stem O O
cell O O
compartment O O
. O O

The O O
effects O O
of O O
Notch O O
also B-conn Conjunction
extend O O
to O O
the O O
developing O O
immune O O
system O O
, O O
where O O
it O O
directs O O
the O O
differentiation O O
of O O
lymphoid O O
precursors O O
-LSB-10 O O
-RSB- O O
. O O

Recent O O
data O O
have O O
highlighted O O
unexpected O O
functions O O
for O O
the O O
Notch O O
pathway O O
in O O
regulating O O
cells O O
of O O
the O O
peripheral O O
immune O O
system O O
. O O

Co-incident O O
delivery O O
of O O
Notch O O
signals O O
to O O
T-cells O O
exerts O O
a O O
profound O O
effect O O
upon O O
the O O
outcome O O
of O O
antigen-stimulation O O
in O O
vitro O O
-LSB-11-13 O O
-RSB- O O
suggesting O O
that O O
interplay O O
between O O
the O O
antigen O O
receptor O O
and O O
Notch O O
pathways O O
regulate O O
the O O
outcome O O
of O O
peripheral O O
T-cell O O
responses O O
. O O

Mice O O
expressing O O
catalytically O O
inactive O O
PI3K O O
subunit O O
p110δ O O
-LSB-5 O O
-RSB- O O
or O O
a O O
deletion O O
of O O
p110δ O O
-LSB-4 O O
-RSB- O O
exhibit O O
defective O O
B-cell O O
and O O
T-cell O O
receptor O O
signalling O O
: O O
antigen-mediated O O
activation O O
of O O
BCR O O
or O O
TCR O O
fails O O
to B-conn Purpose.Goal
activate O O
Akt O O
and O O
cells O O
exhibit O O
defective O O
proliferation O O
and O O
cytokine O O
responses O O
. O O

Recent O O
publications O O
have O O
demonstrated O O
that O O
Notch O O
signals O O
modulate O O
cytokine O O
production O O
by O O
T-cells O O
-LSB-12,13 O O
-RSB- O O
, O O
suggesting O O
that O O
the O O
Notch O O
pathway O O
integrates O O
with O O
TCR-mediated O O
signals O O
to B-conn Purpose.Goal
modulate O O
cytokine O O
production O O
. O O

Furthermore B-conn Conjunction
, O O
marginal O O
zone O O
B O O
-LRB- O O
MZB O O
-RRB- O O
cell O O
development O O
is O O
severely O O
impaired O O
in O O
both O O
p110δ- O O
and O O
Notch2-deficient O O
mice O O
-LSB-4,14 O O
-RSB- O O
. O O

Taken O O
together O O
with O O
Notch O O
's O O
ability O O
to O O
modulate O O
TCR O O
signals O O
, O O
this O O
phenotypic O O
similarity O O
suggested O O
to O O
us O O
the O O
possibility O O
of O O
Notch/PI3K O O
signalling O O
integration O O
. O O

Our O O
studies O O
reveal O O
that O O
the O O
PI3K-Akt O O
pathway O O
is O O
a O O
potent O O
inducer O O
of O O
Notch-dependent O O
responses O O
in O O
cell O O
types O O
as O O
diverse O O
T-cells O O
and O O
neurons O O
, O O
demonstrating O O
that O O
this O O
is O O
a O O
cell O O
signalling O O
paradigm O O
with O O
broad O O
applicability O O
. O O

Results O O

To B-conn Purpose.Goal
address O O
whether O O
the O O
PI3K O O
pathway O O
is O O
a O O
regulator O O
of O O
Notch-responsiveness O O
, O O
we O O
generated O O
a O O
Jurkat O O
E6.1 O O
T-cell O O
line O O
which O O
stably O O
expresses O O
full-length O O
human O O
Notch2 O O
cDNA O O
-LRB- O O
J-N2 O O
cells O O
-RRB- O O
. O O

J-N2 O O
cells O O
were O O
treated O O
with O O
plate-bound O O
recombinant O O
human O O
Delta1 O O
protein O O
-LRB- O O
hereafter O O
referred O O
to O O
as O O
Delta1-Fc O O
-RRB- O O
fusion O O
protein O O
, O O
and B-conn Conjunction
Notch O O
signalling O O
was O O
measured O O
using O O
a O O
transiently-transfected O O
CBF1-driven O O
luciferase O O
reporter O O
construct O O
-LRB- O O
p10xCBF1-luc O O
-RRB- O O
. O O

Plate-bound O O
recombinant O O
Delta1-Fc O O
efficiently O O
transactivated O O
CBF1-luc O O
, O O
driving O O
around O O
a O O
10-fold O O
increase O O
in O O
activity O O
-LRB- O O
Fig. O O
1A O O
-RRB- O O
. O O

A O O
similar O O
result O O
was O O
obtained O O
using O O
the O O
murine O O
Hes-1 O O
promoter O O
cloned O O
upstream O O
of O O
the O O
luciferase O O
reporter O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Strikingly O O
, O O
treatment O O
of O O
these O O
cells O O
with O O
the O O
PI3K O O
inhibitor O O
LY294002 O O
led O O
to O O
a O O
dose-dependent O O
decrease O O
in O O
Delta1-Fc-induced O O
Notch O O
signalling O O
-LRB- O O
Fig. O O
1A O O
-RRB- O O
. O O

A O O
similar O O
result O O
was O O
observed O O
with O O
the O O
mechanistically-distinct O O
PI3K O O
inhibitor O O
Wortmannin O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

The O O
integrity O O
of O O
this O O
reporter O O
assay O O
as O O
an O O
accurate O O
reflection O O
of O O
Notch O O
signalling O O
was O O
confirmed O O
by B-conn Purpose.Enablement
assessing O O
mRNA O O
levels O O
of O O
the O O
Notch O O
target O O
gene O O
Hes-1 O O
by O O
Q-PCR O O
in O O
Delta1-Fc-treated O O
J-N2 O O
cells O O
-LRB- O O
Fig. O O
1B O O
-RRB- O O
. O O

As O O
with O O
the O O
CBF1-dependent O O
reporter O O
, O O
treatment O O
with O O
LY294002 O O
inhibited O O
the O O
up-regulation O O
of O O
Hes-1 O O
by O O
Delta1-Fc O O
. O O

The O O
lipid O O
phosphatase O O
Pten O O
dephosphorylates O O
the O O
3 O O
' O O
phosphoinositide O O
products O O
of O O
PI3K O O
catalysis O O
and O O
prevents O O
downstream O O
PI3K O O
signaling O O
-LSB-1 O O
-RSB- O O
. O O

Jurkat O O
E6.1 O O
cells O O
are O O
deficient O O
in O O
expression O O
of O O
Pten O O
, O O
and O O
therefore B-conn Cause.Result
have O O
a O O
highly O O
active O O
PI3K-Akt O O
pathway O O
-LSB-15 O O
-RSB- O O
. O O

We O O
therefore B-conn Cause.Result
hypothesised O O
that O O
reconstituting O O
this O O
enzyme O O
would O O
reduce O O
Notch O O
signalling O O
. O O

Transient O O
expression O O
of O O
Pten O O
in O O
J-N2 O O
cells O O
led O O
to O O
a O O
decrease O O
in O O
both O O
basal O O
and O O
Notch O O
ligand-induced O O
activation O O
of O O
CBF1-dependent O O
gene O O
expression O O
-LRB- O O
Fig. O O
1C O O
-RRB- O O
. O O

Pten-transfected O O
and O O
control O O
cells O O
showed O O
equivalent O O
CBF1-reporter O O
activity O O
in O O
the O O
presence O O
of O O
LY294002 O O
, O O
demonstrating O O
that O O
once O O
PI3K O O
activity O O
is O O
abolished O O
pharmacologically O O
, O O
Pten O O
over-expression O O
becomes O O
redundant O O
. O O

The O O
PI3K O O
pathway O O
activates O O
several O O
enzymes O O
, O O
including O O
the O O
central O O
signalling O O
molecule O O
Akt/PKB O O
. O O

To B-conn Purpose.Goal
further O O
define O O
the O O
mechanism O O
by O O
which O O
PI3K O O
activity O O
regulates O O
Notch O O
signals O O
, O O
we O O
asked O O
whether O O
the O O
inhibitory O O
effect O O
of O O
LY294002 O O
could O O
be O O
recapitulated O O
with O O
an O O
inhibitor O O
of O O
Akt O O
. O O

Blocking O O
Akt O O
activity O O
in O O
J-N2 O O
cells O O
with O O
the O O
selective O O
inhibitor O O
SH-6 O O
-LSB-16 O O
-RSB- O O
inhibited O O
Delta1-Fc-mediated O O
upregulation O O
of O O
Notch O O
signalling O O
-LRB- O O
Fig. O O
1D O O
-RRB- O O
. O O

Taken O O
together O O
, O O
these O O
data O O
identify O O
the O O
PI3K-Akt O O
pathway O O
as O O
being O O
responsible O O
for O O
the O O
high O O
level O O
of O O
ligand-induced O O
Notch O O
activation O O
in O O
J-N2 O O
cells O O
. O O

We O O
next O O
investigated O O
whether O O
PI3K O O
activity O O
also O O
regulates O O
Notch-responsiveness O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
. O O

We O O
asked O O
whether O O
PI3K O O
induction O O
, O O
triggered O O
by B-conn Purpose.Enablement
TCR O O
activation O O
, O O
could O O
influence O O
Hes-1 O O
levels O O
-LRB- O O
Fig. O O
2A O O
-RRB- O O
. O O

In O O
the O O
absence O O
of O O
any O O
exogenously O O
added O O
Delta O O
1 O O
-LRB- O O
open O O
bars-IgG O O
control O O
-RRB- O O
, O O
TCR O O
activation O O
-LRB- O O
with O O
anti-CD3/anti-CD28 O O
antibodies O O
-RRB- O O
up-regulated O O
Hes-1 O O
levels O O
in O O
a O O
LY294002-sensitive O O
manner O O
. O O

Significantly O O
, O O
this O O
induction O O
was O O
also B-conn Conjunction
blocked O O
by O O
the O O
gamma O O
secretase O O
inhibitor O O
DAPT O O
, O O
consistent O O
with O O
an O O
absolute O O
requirement O O
for O O
N-IC O O
. O O

We O O
also B-conn Conjunction
studied O O
the O O
induction O O
of O O
Hes-1 O O
by B-conn Purpose.Enablement
Delta O O
1-Fc O O
treatment O O
-LRB- O O
closed O O
bars O O
-RRB- O O
. O O

In O O
the O O
absence O O
of O O
TCR O O
activation O O
, O O
Delta O O
1-Fc O O
induced O O
a O O
small O O
, O O
but O O
consistent O O
induction O O
of O O
Hes-1 O O
. O O

However B-conn Contrast
, O O
coincidence O O
of O O
Delta O O
1-Fc O O
with O O
TCR O O
activation O O
-LRB- O O
anti-CD3/anti-CD28 O O
antibodies O O
-RRB- O O
dramatically O O
up-regulated O O
Hes-1 O O
levels O O
in O O
a O O
LY294002-sensitive O O
manner O O
. O O

Again O O
, O O
this O O
induction O O
was O O
also O O
blocked O O
by O O
the O O
gamma O O
secretase O O
inhibitor O O
DAPT O O
. O O

LY294002 O O
also B-conn Conjunction
inhibited O O
Notch O O
signalling O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
transfected O O
with O O
p10xCBF1-luc O O
and O O
a O O
Notch1 O O
intracellular O O
domain O O
expression O O
plasmid O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
, O O
demonstrating O O
that O O
the O O
effect O O
of O O
PI3K O O
on O O
Notch O O
is O O
exerted O O
downstream O O
of O O
Notch O O
cleavage O O
. O O

Thus B-conn Cause.Claim
, O O
TCR O O
activation O O
dramatically O O
increases O O
the O O
cellular O O
response O O
to O O
Notch O O
signals O O
in O O
primary O O
human O O
T O O
cells O O
via B-conn Purpose.Enablement
a O O
mechanism O O
requiring O O
the O O
PI3K-Akt O O
pathway O O
. O O

We O O
then B-conn Temporal.Precedence
tested O O
whether O O
Akt O O
activation O O
is O O
sufficient O O
to B-conn Purpose.Goal
boost O O
Notch-responsiveness O O
in O O
human O O
T O O
cells O O
. O O

Over-expression O O
of O O
a O O
constitutively-active O O
Akt O O
construct O O
-LRB- O O
gagAkt O O
-LSB-17 O O
-RSB- O O
-RRB- O O
was O O
sufficient O O
to B-conn Purpose.Goal
potentiate O O
the O O
ability O O
of O O
pN1-IC O O
to O O
drive O O
CBF1-dependent O O
reporter O O
activity O O
-LRB- O O
Fig. O O
2B O O
-RRB- O O
. O O

Previous O O
data O O
has O O
suggested O O
that O O
inactivation O O
of O O
GSK3β O O
by O O
the O O
Wingless O O
pathway O O
enhanced O O
Notch O O
signals O O
by B-conn Purpose.Enablement
preventing O O
inhibitory O O
phosphorylation O O
of O O
N-IC O O
by O O
GSK3β O O
-LSB-18 O O
-RSB- O O
. O O

Therefore B-conn Cause.Result
, O O
given O O
that O O
Akt O O
phoshorylates O O
and O O
inactivates O O
GSK3β O O
-LSB-19 O O
-RSB- O O
, O O
we O O
hypothesised O O
that O O
Akt-dependent O O
inactivation O O
of O O
GSK3β O O
might O O
be O O
responsible O O
for O O
Notch O O
potentiation O O
. O O

To B-conn Purpose.Goal
address O O
this O O
question O O
, O O
we O O
looked O O
at O O
the O O
N1-IC-induced O O
Notch O O
response O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
treated O O
with O O
the O O
GSK3β O O
inhibitor O O
lithium O O
chloride O O
. O O

Increasing O O
concentrations O O
of O O
LiCl O O
induced O O
a O O
dramatic O O
increase O O
in O O
Notch O O
signalling O O
-LRB- O O
Fig. O O
3A O O
-RRB- O O
. O O

In O O
contrast O O
to O O
N1-IC O O
overexpression O O
, O O
triggering O O
Notch O O
signalling O O
using O O
recombinant O O
ligand O O
to B-conn Purpose.Goal
ligate O O
endogenous O O
full O O
length O O
Notch O O
generates O O
far O O
weaker O O
signalling O O
. O O

This O O
fact O O
, O O
coupled O O
with O O
limited O O
transfection O O
efficiency O O
of O O
primary O O
T O O
cells O O
, O O
makes O O
it O O
technically O O
difficult O O
to B-conn Purpose.Goal
achieve O O
robust O O
induction O O
of O O
a O O
transfected O O
CBF1 O O
reporter O O
construct O O
by O O
Delta1-Fc O O
. O O

However B-conn Concession.Contra-expectation
, O O
given O O
the O O
large O O
potentiation O O
of O O
Notch-responsiveness O O
by O O
LiCl O O
-LRB- O O
Fig. O O
3A O O
-RRB- O O
, O O
we O O
hypothesised O O
that O O
, O O
in O O
the O O
presence O O
of O O
LiCl O O
, O O
robust O O
Delta1-Fc O O
dependent O O
induction O O
of O O
a O O
CBF1 O O
reporter O O
could O O
be O O
observed O O
. O O

We O O
found O O
that O O
, O O
consistent O O
with O O
the O O
technical O O
issues O O
outline O O
above O O
, O O
plate-bound O O
Delta1-Fc O O
activates O O
the O O
CBF1 O O
reporter O O
weakly O O
and O O
unreliably O O
in O O
the O O
absence O O
of O O
LiCl O O
-LRB- O O
Fig. O O
3B O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
LiCl O O
greatly O O
potentiates O O
activation O O
of O O
the O O
reporter O O
by O O
plate-bound O O
Delta1-Fc O O
-LRB- O O
Fig. O O
3B O O
-RRB- O O
. O O

Thus B-conn Cause.Result
, O O
the O O
GSK3β O O
inhibitor O O
LiCl O O
is O O
sufficient O O
to O O
potentiate O O
primary O O
Notch-responsiveness O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
, O O
triggered O O
either B-conn Alternative.Disjunctive
by O O
N1-IC O O
expression O O
, O O
or B-conn Alternative.Disjunctive
by O O
ligation O O
of O O
endogenous O O
full O O
length O O
Notch O O
by O O
plate-bound O O
ligand O O
. O O

In O O
Jurkat O O
T-cells O O
, O O
deficient O O
in O O
Pten O O
expression O O
, O O
basal O O
Akt O O
activity O O
is O O
high O O
-LSB-15 O O
-RSB- O O
, O O
so B-conn Cause.Result
we O O
expected O O
GSK3β O O
to O O
be O O
maximally O O
inhibited O O
. O O

Consistent O O
with O O
this O O
, O O
LiCl O O
treatment O O
did O O
not O O
exert O O
any O O
further O O
effect O O
on O O
Delta1-induced O O
signalling O O
in O O
Jurkat-N2 O O
cells O O
-LRB- O O
Fig. O O
3C O O
-RRB- O O
. O O

To B-conn Purpose.Goal
investigate O O
whether O O
PI3K-dependent O O
regulation O O
of O O
Notch O O
responsiveness O O
may O O
be O O
a O O
general O O
phenomenon O O
extending O O
beyond O O
T-cell O O
biology O O
, O O
we O O
took O O
advantage O O
of O O
a O O
Notch-dependent O O
CHO O O
cell O O
reporter O O
assay O O
which O O
we O O
have O O
previously O O
described O O
-LSB-20 O O
-RSB- O O
. O O

In O O
this O O
assay O O
, O O
CHO O O
cells O O
which O O
stably O O
express O O
a O O
human O O
Notch2 O O
receptor O O
cDNA O O
and O O
a O O
CBF1-dependent O O
luciferase O O
reporter O O
construct O O
-LRB- O O
termed O O
CHO-N2 O O
-RRB- O O
are O O
co-cultured O O
with O O
a O O
second O O
CHO O O
cell O O
line O O
which O O
stably O O
expresses O O
the O O
full-length O O
human O O
Delta1 O O
cDNA O O
-LRB- O O
termed O O
CHO-hDelta1 O O
-RRB- O O
. O O

CHO-hDelta1 O O
cells O O
trigger O O
a O O
dose-dependent O O
luciferase O O
response O O
to O O
the O O
CHO-N2 O O
cells O O
, O O
whilst B-conn Contrast
control O O
CHO O O
parental O O
cells O O
fail O O
to O O
activate O O
the O O
Notch O O
pathway O O
-LRB- O O
Fig. O O
4A O O
-RRB- O O
. O O

We O O
next B-conn Temporal.Precedence
asked O O
if O O
activation O O
of O O
the O O
PI3K O O
pathway O O
influenced O O
Notch O O
signals O O
in O O
this O O
assay O O
system O O
. O O

As O O
predicted O O
from O O
our O O
T-cell O O
studies O O
, O O
including O O
insulin O O
in O O
the O O
culture O O
medium O O
potentiated O O
Notch O O
signalling O O
, O O
and O O
this O O
effect O O
was O O
blocked O O
almost O O
completely O O
by B-conn Purpose.Enablement
inclusion O O
of O O
LY294002 O O
-LRB- O O
Fig. O O
4B O O
-RRB- O O
. O O

From O O
our O O
observations O O
with O O
T-cells O O
, O O
we O O
hypothesisesd O O
that O O
GSK3β O O
inhibition O O
with O O
LiCl O O
could O O
substitute O O
for O O
insulin O O
in O O
potentiating O O
Notch O O
signalling O O
induced O O
by O O
CHO-hDelta1 O O
cells O O
. O O

LiCl O O
does O O
indeed B-conn Reinforcement
potentiate O O
Notch O O
signalling O O
in O O
the O O
CHO O O
co-culture O O
system O O
, O O
leading O O
to O O
a O O
substantial O O
enhancement O O
of O O
ligand-dependent O O
reporter O O
activity O O
-LRB- O O
Fig. O O
4C O O
-RRB- O O
. O O

We O O
then O O
extended O O
our O O
study O O
further O O
, O O
this O O
time O O
into O O
primary O O
neurons O O
, O O
cell O O
types O O
where O O
Notch O O
plays O O
an O O
emerging O O
role O O
in O O
processes O O
such O O
as O O
dendritic O O
patterning O O
and O O
synaptic O O
plasticity O O
-LSB-21,22 O O
-RSB- O O
. O O

As O O
observed O O
with O O
T-cells O O
, O O
inhibition O O
of O O
GSK3β O O
with O O
lithium O O
chloride O O
strongly O O
enhanced O O
the O O
level O O
of O O
Notch O O
signalling O O
in O O
rat O O
primary O O
hippocampal O O
neurons O O
in O O
a O O
dose-dependent O O
manner O O
-LRB- O O
Fig. O O
4D O O
-RRB- O O
. O O

PI3K-activating O O
neurotrophins O O
such O O
as O O
BDNF O O
regulate O O
cell O O
survival O O
, O O
proliferation O O
and O O
differentiation O O
of O O
both O O
peripheral O O
and O O
central O O
neurons O O
-LSB-23 O O
-RSB- O O
. O O

Strikingly O O
, O O
BDNF O O
treatment O O
potentiated O O
pN1-IC-driven O O
reporter O O
activity O O
, O O
and B-conn Conjunction
this O O
was O O
abrogated O O
by B-conn Purpose.Enablement
treatment O O
with O O
LY294002 O O
-LRB- O O
Fig. O O
4D O O
-RRB- O O
. O O

Pten O O
transfection O O
ablated O O
both O O
basal O O
and O O
BDNF-stimulated O O
reporter O O
signalling O O
, O O
further O O
underlining O O
the O O
role O O
of O O
the O O
PI3K O O
pathway O O
in O O
promoting O O
Notch-responsiveness O O
in O O
neurons O O
. O O

Moreover B-conn Conjunction
, O O
over-expression O O
of O O
constitutively O O
active O O
gagAkt O O
was O O
sufficient O O
to B-conn Purpose.Goal
potentiate O O
pN1-IC-driven O O
reporter O O
activity O O
-LRB- O O
Fig. O O
4E O O
-RRB- O O
. O O

To B-conn Purpose.Goal
further O O
reinforce O O
this O O
finding O O
, O O
expression O O
of O O
a O O
constitutively-active O O
GSK3β O O
construct O O
-LRB- O O
S9A O O
-RRB- O O
, O O
which O O
is O O
resistant O O
to O O
inactivation O O
by O O
Akt O O
, O O
prevented O O
BDNF O O
induction O O
of O O
Notch O O
responsiveness O O
-LRB- O O
Fig. O O
4E O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
expression O O
of O O
wild-type O O
GSK3β O O
, O O
which O O
is O O
inhibited O O
by O O
Akt O O
activity O O
, O O
failed O O
to O O
significantly O O
reduce O O
reporter O O
activity O O
. O O

As O O
observed O O
with O O
T-cells O O
, O O
inhibition O O
of O O
GSK3β O O
with O O
lithium O O
chloride O O
strongly O O
enhanced O O
the O O
level O O
of O O
Notch O O
signalling O O
in O O
a O O
dose-dependent O O
manner O O
-LRB- O O
Fig. O O
4D O O
-RRB- O O
. O O

Thus B-conn Cause.Claim
the O O
PI3K-Akt O O
pathway O O
positively O O
regulates O O
Notch O O
signals O O
via O O
GSK3β O O
in O O
neurons O O
as O O
well O O
as O O
T-cells O O
, O O
as O O
summarised O O
in O O
Fig. O O
5 O O
. O O

Discussion O O

The O O
dynamic O O
and O O
interactive O O
nature O O
of O O
intracellular O O
communication O O
dictates O O
that O O
cells O O
are O O
in O O
receipt O O
of O O
multiple O O
environmental O O
signals O O
at O O
any O O
given O O
time O O
. O O

The O O
cellular O O
output O O
must O O
represent O O
a O O
net O O
response O O
to O O
a O O
diverse O O
set O O
of O O
cues O O
, O O
and B-conn Conjunction
therefore B-conn Cause.Result
the O O
pathways O O
mediating O O
these O O
responses O O
are O O
frequently O O
integrated O O
. O O

Our O O
studies O O
demonstrate O O
for O O
the O O
first O O
time O O
that O O
PI3K O O
activity O O
strongly O O
potentiates O O
Notch O O
responsiveness O O
in O O
diverse O O
cell O O
types O O
. O O

Given O O
the O O
vital O O
nature O O
of O O
PI3K O O
and O O
Notch O O
in O O
controlling O O
cellular O O
survival O O
and O O
differentiation O O
, O O
the O O
implications O O
of O O
this O O
finding O O
are O O
far-reaching O O
. O O

Ligation O O
of O O
lymphocyte O O
antigen O O
receptors O O
leads O O
to O O
activation O O
of O O
PI3K O O
, O O
initiating O O
a O O
diverse O O
and O O
wide-ranging O O
set O O
of O O
signalling O O
pathways O O
-LSB-2 O O
-RSB- O O
. O O

Our O O
findings O O
that O O
PI3K O O
activation O O
enhances O O
Notch O O
signalling O O
leads O O
us O O
to O O
suggest O O
that O O
Notch O O
pathway O O
activation O O
might O O
be O O
an O O
inherent O O
consequence O O
of O O
lymphocyte O O
activation O O
. O O

This O O
positions O O
the O O
Notch O O
pathway O O
as O O
a O O
central O O
mediator O O
of O O
antigen-dependent O O
stimulation O O
of O O
immune O O
cells O O
. O O

T-cells O O
are O O
entirely O O
quiescent O O
in O O
the O O
absence O O
of O O
antigen O O
signals O O
, O O
but O O
are O O
shifted O O
rapidly O O
into O O
a O O
state O O
of O O
activation O O
following B-conn Temporal.Succession
TCR O O
ligation O O
. O O

Inappropriate O O
control O O
of O O
this O O
activation O O
can O O
lead O O
to O O
autoimmune O O
disease O O
, O O
and B-conn Conjunction
therefore B-conn Cause.Result
negative O O
feedback O O
loops O O
are O O
an O O
inherent O O
feature O O
of O O
T-cell O O
biology O O
. O O

Recent O O
data O O
show O O
that O O
Notch O O
signals O O
block O O
Akt O O
activation O O
in O O
peripheral O O
CD4+ O O
T-cells O O
-LSB-13 O O
-RSB- O O
. O O

Indeed B-conn Reinforcement
we O O
also O O
observe O O
that O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
recombinant O O
Delta1-IgG4 O O
fusion O O
protein O O
, O O
or O O
Notch-IC O O
expression O O
, O O
blocks O O
TCR-mediated O O
phosphorylation O O
of O O
Akt O O
and O O
GSK3β O O
-LRB- O O
GM O O
, O O
BC O O
, O O
unpublished O O
data O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
Akt O O
activation O O
is O O
essential O O
for B-conn Purpose.Goal
production O O
of O O
cytokines O O
such O O
as O O
IL2 O O
and O O
IFNγ O O
by O O
T-cells O O
-LSB-24 O O
-RSB- O O
, O O
constitutive O O
activity O O
is O O
associated O O
with O O
cellular O O
transformation O O
-LSB-25 O O
-RSB- O O
, O O
and B-conn Conjunction
therefore B-conn Cause.Result
the O O
existence O O
of O O
a O O
negative O O
feedback O O
loop O O
to O O
limit O O
antigen-dependent O O
Akt O O
activation O O
would O O
appear O O
rational O O
. O O

We O O
have O O
shown O O
that O O
co-incident O O
Notch O O
signals O O
are O O
enhanced O O
upon B-conn Temporal.Synchronous
TCR O O
activation O O
, O O
and B-conn Conjunction
we O O
hypothesise O O
that O O
by B-conn Purpose.Enablement
inhibiting O O
Akt O O
activity O O
, O O
enhanced O O
Notch O O
signalling O O
may O O
constitute O O
a O O
negative O O
feedback O O
control O O
impacting O O
upon O O
peripheral O O
T-cell O O
activation O O
. O O

It O O
is O O
interesting O O
to O O
note O O
that O O
whilst B-conn Concession.Expectation
the O O
model O O
we O O
propose O O
is O O
consistent O O
with O O
the O O
data O O
generated O O
in O O
peripheral O O
T-cells O O
, O O
a O O
number O O
of O O
studies O O
suggest O O
that O O
the O O
opposite O O
is O O
true O O
-LSB-26-28 O O
-RSB- O O
. O O

Ciofani O O
et O O
al O O
demonstrate O O
that O O
during B-conn Temporal.Synchronous
the O O
earliest O O
stages O O
of O O
T-cell O O
development O O
in O O
the O O
thymus O O
Notch O O
signals O O
co-operate O O
with O O
pre-TCR O O
signalling O O
to B-conn Purpose.Goal
activate O O
Akt-dependent O O
metabolism O O
, O O
thereby B-conn Cause.Result
promoting O O
expansion O O
of O O
those O O
T-cells O O
which O O
have O O
undergone O O
favourable O O
TCR O O
rearrangement O O
. O O

The O O
functional O O
outcome O O
of O O
PI3K/Notch O O
pathway O O
interaction O O
thus B-conn Cause.Result
appears O O
to O O
reverse O O
from O O
developing O O
to O O
mature O O
T-cells O O
, O O
an O O
observation O O
which O O
further O O
underlines O O
the O O
ability O O
of O O
the O O
Notch O O
pathway O O
to B-conn Purpose.Goal
perform O O
multiple O O
, O O
context-dependent O O
, O O
tasks O O
during B-conn Temporal.Synchronous
development O O
. O O

We O O
suggest O O
that O O
a O O
molecular O O
understanding O O
of O O
how O O
Notch O O
can O O
function O O
as O O
a O O
bi-directional O O
regulator O O
of O O
Akt O O
activity O O
is O O
a O O
research O O
priority O O
. O O

Our O O
data O O
strongly O O
suggests O O
that O O
PI3K O O
activity O O
links O O
to O O
the O O
Notch O O
signalling O O
pathway O O
through B-conn Purpose.Enablement
Akt-mediated O O
inactivation O O
of O O
GSK3β O O
, O O
a O O
known O O
downstream O O
effector O O
of O O
Akt O O
. O O

In O O
support O O
of O O
this O O
data O O
, O O
PI3K O O
and O O
GSK3β O O
-LSB-18,28,29 O O
-RSB- O O
have O O
both O O
been O O
identified O O
as O O
binding O O
partners O O
for O O
N-IC O O
in O O
immunoprecipitation O O
studies O O
. O O

GSK3β O O
has O O
also B-conn Conjunction
previously O O
been O O
positioned O O
as O O
a O O
component O O
of O O
the O O
downstream O O
Notch O O
signalling O O
pathway O O
in O O
lateral O O
inhibition O O
in O O
Drosophila O O
-LSB-30 O O
-RSB- O O
. O O

Furthermore B-conn Conjunction
, O O
GSK3β O O
activity O O
is O O
inhibited O O
downstream O O
of O O
both O O
the O O
wingless O O
and O O
PI3K O O
pathways O O
, O O
and O O
thus B-conn Cause.Claim
represents O O
a O O
convergent O O
site O O
for B-conn Purpose.Goal
integration O O
of O O
extracellular O O
signals O O
with O O
the O O
Notch O O
pathway O O
. O O

Indeed B-conn Reinforcement
, O O
inhibiting O O
GSK3β O O
activity O O
by B-conn Purpose.Enablement
activating O O
the O O
wingless O O
pathway O O
with O O
Wnt-1 O O
has O O
been O O
shown O O
to O O
enhance O O
Notch-dependent O O
reporter O O
activity O O
in O O
NIH-3T3 O O
cells O O
-LSB-18 O O
-RSB- O O
. O O

We O O
note O O
, O O
however B-conn Concession.Contra-expectation
, O O
that O O
although B-conn Concession.Expectation
an O O
interaction O O
between O O
GSK3β O O
and O O
Notch O O
seems O O
conclusively O O
proven O O
, O O
the O O
functional O O
consequences O O
of O O
this O O
interaction O O
are O O
not O O
consistent O O
between O O
different O O
studies O O
. O O

Whilst B-conn Contrast
our O O
data O O
agrees O O
with O O
that O O
of O O
Espinosa O O
et O O
al. O O
-LSB-18 O O
-RSB- O O
, O O
that O O
is O O
that O O
GSK3β O O
activity O O
inhibits O O
Notch O O
signalling O O
, O O
data O O
from O O
the O O
Nye O O
laboratory O O
in O O
GSK3β-deficient O O
murine O O
embryonic O O
fibroblasts O O
demonstrates O O
that O O
GSK3β O O
phosphorylates O O
and O O
stabilises O O
Notch-IC O O
, O O
leading O O
to O O
enhanced O O
signalling O O
-LSB-29 O O
-RSB- O O
. O O

Although B-conn Concession.Expectation
we O O
have O O
no O O
definitive O O
explanation O O
for O O
these O O
experimental O O
differences O O
, O O
it O O
is O O
possible O O
that O O
, O O
as O O
discussed O O
above O O
for O O
thymocytes O O
and O O
T-cells O O
, O O
the O O
effect O O
of O O
GSK3b O O
on O O
Notch O O
changes O O
between O O
embryonic O O
and O O
mature O O
tissues O O
. O O

Notch O O
's O O
role O O
during B-conn Temporal.Synchronous
embryonic O O
development O O
is O O
not O O
to B-conn Purpose.Goal
directly O O
program O O
neuronal O O
differentiation O O
itself O O
, O O
but O O
to B-conn Purpose.Goal
inhibit O O
this O O
cell O O
fate O O
choice O O
in O O
neighbouring O O
cells O O
during O O
the O O
lateral O O
inhibition O O
process O O
-LSB-8 O O
-RSB- O O
. O O

During B-conn Temporal.Synchronous
neurogenesis O O
, O O
this O O
is O O
achieved O O
by B-conn Purpose.Enablement
Notch O O
target O O
genes O O
blocking O O
transcription O O
of O O
pro-neural O O
transcription O O
factors O O
such O O
as O O
MASH-1 O O
. O O

Interestingly O O
, O O
conditional O O
deletion O O
of O O
Pten O O
in O O
neural O O
progenitors O O
leads O O
to O O
dramatic O O
alterations O O
in O O
brain O O
architecture O O
, O O
an O O
observation O O
which O O
the O O
authors O O
attribute O O
to O O
increased O O
proliferation O O
and O O
self-renewal O O
of O O
neural O O
stem O O
cell O O
populations O O
-LSB-31 O O
-RSB- O O
. O O

Given O O
that O O
the O O
data O O
presented O O
here O O
establishes O O
the O O
Notch-suppressing O O
capability O O
of O O
Pten O O
, O O
deregulated O O
renewal O O
of O O
progenitors O O
in O O
these O O
mice O O
may O O
be O O
in O O
part O O
due B-conn Cause.Reason
to I-conn Cause.Reason
enhanced O O
Notch O O
signalling O O
. O O

This O O
hypothesis O O
awaits O O
testing O O
. O O

Notch O O
also O O
plays O O
an O O
emerging O O
role O O
in O O
differentiating O O
neurons O O
by B-conn Purpose.Enablement
inhibiting O O
dendritic O O
outgrowth O O
-LSB-21 O O
-RSB- O O
. O O

It O O
is O O
tempting O O
to O O
speculate O O
that O O
Notch-dependent O O
dendritic O O
retraction O O
, O O
reliant O O
on O O
neuron-neuron O O
interactions O O
, O O
is O O
augmented O O
by B-conn Purpose.Enablement
target-derived O O
neurotrophic O O
factors O O
promoting O O
PI3K O O
signalling O O
. O O

In O O
differentiated O O
neurons O O
, O O
Notch O O
contributes O O
to O O
synaptic O O
plasticity O O
, O O
learning O O
and O O
memory O O
-LSB-22,32 O O
-RSB- O O
. O O

The O O
long-standing O O
involvement O O
of O O
BDNF O O
and O O
other O O
neurotrophins O O
in O O
synaptic O O
plasticity O O
raise O O
the O O
possibility O O
that O O
PI3K-Notch O O
interplay O O
is O O
at O O
work O O
in O O
this O O
scenario O O
as O O
well O O
. O O

Conclusion O O

Our O O
data O O
demonstrates O O
that O O
the O O
potentiation O O
of O O
Notch O O
signalling O O
by O O
PI3K O O
is O O
conserved O O
in O O
ontologically-distinct O O
cell O O
types O O
, O O
leading O O
us O O
to O O
suggest O O
that O O
it O O
represents O O
a O O
general O O
mechanism O O
of O O
signal O O
integration O O
linking O O
two O O
evolutionarily-conserved O O
pathways O O
together O O
. O O

This O O
apparently O O
simple O O
observation O O
has O O
far-reaching O O
implications O O
regarding O O
the O O
mechanisms O O
by O O
which O O
stem O O
cell O O
self-renewal O O
and O O
differentiation O O
proceeds O O
. O O

It O O
will O O
be O O
interesting O O
to O O
assess O O
the O O
relevance O O
of O O
this O O
finding O O
in O O
other O O
signalling O O
contexts O O
, O O
such O O
as O O
tumour O O
formation O O
, O O
where O O
Notch O O
and O O
PI3K O O
have O O
important O O
roles O O
. O O

Methods O O

SH-6 O O
, O O
lithium O O
chloride O O
, O O
LY294002 O O
, O O
Wortmannin O O
and O O
BDNF O O
were O O
from O O
Calbiochem O O
. O O

Human O O
IgG4 O O
was O O
from O O
Sigma O O
. O O

Dual-Glo O O
Luciferase O O
assay O O
system O O
was O O
from O O
Promega O O
. O O

pN1-IC O O
was O O
constructed O O
by B-conn Purpose.Enablement
inserting O O
nucleotides O O
coding O O
for O O
the O O
intracellular O O
domain O O
of O O
human O O
Notch1 O O
-LRB- O O
amino O O
acids O O
1758 O O
to O O
2557 O O
-RRB- O O
preceded O O
by O O
an O O
initiator O O
ATG O O
codon O O
into O O
the O O
BamHI O O
and O O
EcoRI O O
sites O O
of O O
pcDNA3.1 O O
-LRB- O O
Invitrogen O O
-RRB- O O
. O O

pAdTATA-luc O O
was O O
constructed O O
by B-conn Purpose.Enablement
inserting O O
the O O
Adenoviral O O
major O O
late O O
promoter O O
TATA O O
sequence O O
immediately O O
5 O O
' O O
of O O
the O O
luciferase O O
gene O O
in O O
plasmid O O
pGL3Basic O O
-LRB- O O
Promega O O
-RRB- O O
. O O

p10xCBF1-luc O O
was O O
constructed O O
by B-conn Purpose.Enablement
inserting O O
10 O O
copies O O
of O O
the O O
CBF1 O O
binding O O
site O O
5 O O
' O O
of O O
the O O
AdTATA O O
box O O
in O O
pAdTATA-luc O O
. O O

pTK-Renilla O O
was O O
from O O
Promega O O
. O O

Human O O
Pten O O
expression O O
construct O O
was O O
generated O O
by B-conn Purpose.Enablement
PCR O O
amplification O O
of O O
full-length O O
human O O
Pten O O
from O O
CD4+ O O
T-cell O O
cDNA O O
, O O
and O O
then B-conn Temporal.Precedence
cloned O O
into O O
the O O
HindIII O O
and O O
EcoRI O O
sites O O
of O O
pcDNA3.1 O O
. O O

Constitutively-active O O
-LRB- O O
gagAkt O O
-RRB- O O
and O O
kinase O O
dead O O
-LRB- O O
Akt-KD O O
-RRB- O O
Akt O O
expression O O
constructs O O
were O O
a O O
kind O O
gift O O
from O O
Dr. O O
Julian O O
Downward O O
-LSB-17 O O
-RSB- O O
. O O

Wild-type O O
-LRB- O O
WT O O
-RRB- O O
and O O
constitutively-active O O
-LRB- O O
S9A O O
-RRB- O O
GSK3β O O
constructs O O
were O O
a O O
kind O O
gift O O
from O O
Dr. O O
J. O O
Sadoshima O O
-LSB-33 O O
-RSB- O O
. O O

All O O
plasmids O O
were O O
prepared O O
using O O
the O O
EndoFree O O
maxiprep O O
system O O
-LRB- O O
Qiagen O O
-RRB- O O
. O O

Jurkat O O
E6.1 O O
cells O O
and O O
Jurkat-N2 O O
cells O O
were O O
grown O O
in O O
RPMI1640 O O
-LRB- O O
+10 O O
% O O
v/v O O
FBS O O
, O O
2 O O
mM O O
L-glutamine O O
-RRB- O O
. O O

Primary O O
CD4+ O O
T O O
cells O O
were O O
isolated O O
from O O
freshly-collected O O
donor O O
blood O O
as O O
follows O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
were O O
prepared O O
by B-conn Purpose.Enablement
centrifugation O O
over O O
Ficoll-Paque O O
, O O
incubated O O
with O O
anti-CD4-coated O O
magnetic O O
beads O O
-LRB- O O
Miltenyi O O
Biotec O O
-RRB- O O
and O O
selected O O
on O O
LS O O
positive O O
selection O O
columns O O
-LRB- O O
Miltenyi O O
Biotec O O
-RRB- O O
. O O

After B-conn Temporal.Succession
purification O O
, O O
primary O O
CD4+ O O
T-cells O O
were O O
cultured O O
in O O
RPMI1640 O O
-LRB- O O
supplemented O O
with O O
10 O O
% O O
v/v O O
FBS O O
, O O
2 O O
mM O O
L-glutamine O O
and O O
5 O O
× O O
10-6M O O
β-mercaptoethanol O O
-RRB- O O
. O O

CHO-N2 O O
and O O
CHO-Delta1 O O
cells O O
have O O
been O O
described O O
previously O O
-LSB-20 O O
-RSB- O O
and O O
were O O
routinely O O
cultured O O
in O O
DMEM O O
-LRB- O O
+10 O O
% O O
v/v/FBS O O
, O O
2 O O
mM O O
L-glutamine O O
-RRB- O O
. O O

Rat O O
primary O O
hippocampal O O
neurons O O
were O O
isolated O O
and O O
cultured O O
as O O
described O O
-LSB-34 O O
-RSB- O O
, O O
except B-conn Exception
growth O O
media O O
was O O
supplemented O O
with O O
B27 O O
-LRB- O O
Gibco/BRL O O
-RRB- O O
. O O

Jurkat O O
E6.1 O O
cells O O
and O O
Jurkat-N2 O O
cells O O
were O O
transfected O O
using O O
Lipofectamine O O
2000 O O
-LRB- O O
Invitrogen O O
-RRB- O O
. O O

Cells O O
were O O
left O O
24 O O
h O O
post-transfection O O
, O O
washed O O
, O O
counted O O
and O O
re-plated O O
in O O
triplicate O O
at O O
2 O O
× O O
105 O O
cells/well O O
into O O
flat-bottomed O O
96-well O O
plates O O
which O O
had O O
been O O
-LRB- O O
where O O
relevant O O
-RRB- O O
pre-coated O O
o/n O O
at O O
4°C O O
with O O
hDelta1-Fc O O
. O O

Cells O O
were O O
stimulated O O
, O O
incubated O O
o/n O O
and O O
luciferase O O
activity O O
measured O O
using O O
the O O
Dual-Glo O O
system O O
-LRB- O O
Promega O O
-RRB- O O
. O O

Firefly O O
luciferase O O
signal O O
from O O
the O O
Notch-dependent O O
p10xCBF1-luc O O
was O O
normalised O O
using O O
the O O
Renilla O O
luciferase O O
signal O O
driven O O
by O O
the O O
pTK-Renilla O O
. O O

Primary O O
CD4+ O O
T O O
cells O O
were O O
transfected O O
using O O
the O O
Amaxa O O
' O O
nucleofection O O
' O O
system O O
according O O
to O O
the O O
manufacturer O O
's O O
instructions O O
. O O

Briefly O O
, O O
5 O O
× O O
106 O O
purified O O
CD4+ O O
T-cells O O
were O O
resuspended O O
in O O
100 O O
μl O O
of O O
the O O
appropriate O O
Amaxa O O
solution O O
and O O
transfected O O
with O O
5 O O
μg O O
plasmid O O
DNA O O
using O O
Protocol O O
U-14 O O
. O O

Cells O O
were O O
immediately O O
transferred O O
to O O
1 O O
ml O O
of O O
pre-warmed O O
media O O
, O O
counted O O
and O O
plated O O
as O O
required O O
. O O

After B-conn Temporal.Succession
stimulation O O
luciferase O O
activity O O
was O O
detected O O
using O O
the O O
Dual-glo O O
assay O O
system O O
-LRB- O O
Promega O O
-RRB- O O
. O O

For O O
neuronal O O
experiments O O
, O O
rat O O
primary O O
hippocampal O O
neurons O O
were O O
transfected O O
after B-conn Temporal.Succession
9 O O
days O O
in O O
culture O O
using O O
Lipofectamine O O
2000 O O
and O O
stimulated O O
36-48 O O
hours O O
later O O
. O O

Dual-Glo O O
Luciferase O O
assays O O
were O O
performed O O
following B-conn Temporal.Succession
o/n O O
stimulation O O
. O O

A O O
fusion O O
protein O O
comprising O O
the O O
extracellular O O
domain O O
of O O
human O O
Delta1 O O
fused O O
to O O
the O O
Fc O O
domain O O
of O O
human O O
IgG4 O O
was O O
prepared O O
by B-conn Purpose.Enablement
inserting O O
a O O
nucleotide O O
sequence O O
coding O O
for O O
the O O
extracellular O O
domain O O
of O O
human O O
Delta1 O O
-LRB- O O
amino O O
acids O O
1 O O
to O O
537 O O
-RRB- O O
into O O
the O O
expression O O
vector O O
pCON© O O
-LRB- O O
Lonza O O
Biologics O O
-RRB- O O
. O O

This O O
plasmid O O
was O O
expressed O O
in O O
CHO O O
cells O O
, O O
purified O O
by B-conn Purpose.Enablement
affinity O O
chromatography O O
on O O
ProteinA-Sepharose O O
-LRB- O O
Amersham O O
Biosciences O O
-RRB- O O
before B-conn Temporal.Precedence
concentration O O
and O O
buffer O O
exchange O O
into O O
PBS O O
. O O

Batch O O
activity O O
of O O
this O O
protein O O
was O O
confirmed O O
as O O
previously O O
described O O
-LSB-35 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
assess O O
the O O
effect O O
of O O
isolated O O
Delta1-Fc O O
signalling O O
on O O
Jurkat-N2 O O
and O O
CD4+ O O
T-cells O O
, O O
96- O O
or O O
24-well O O
plates O O
were O O
coated O O
overnight O O
at O O
4°C O O
with O O
anti-hIgG4 O O
-LRB- O O
1 O O
μg/ml O O
, O O
BD O O
Biosciences O O
-RRB- O O
. O O

Plates O O
were O O
washed O O
with O O
PBS O O
and O O
incubated O O
for O O
2 O O
hours O O
at O O
37°C O O
with O O
20 O O
μg/ml O O
Delta1-Fc O O
or O O
hIgG4 O O
control O O
, O O
washed O O
once O O
again O O
with O O
PBS O O
, O O
before B-conn Temporal.Precedence
cells O O
were O O
plated O O
for B-conn Purpose.Goal
stimulation O O
. O O

To B-conn Purpose.Goal
examine O O
the O O
effect O O
of O O
coincident O O
Delta1-Fc O O
and O O
T-cell O O
receptor O O
signalling O O
on O O
primary O O
CD4+ O O
T-cells O O
, O O
96- O O
or O O
24-well O O
plates O O
were O O
first O O
coated O O
overnight O O
at O O
4°C O O
with O O
a O O
mixture O O
of O O
capture O O
antibodies O O
consisting O O
of O O
anti-mouse O O
IgG2a O O
-LRB- O O
1 O O
μg/ml O O
, O O
BD O O
Biosciences O O
-RRB- O O
and O O
anti-hIgG4 O O
-LRB- O O
1 O O
μg/ml O O
, O O
BD O O
Biosciences O O
-RRB- O O
. O O

Plates O O
were O O
washed O O
with O O
PBS O O
and O O
incubated O O
2 O O
hours O O
at O O
37°C O O
with O O
a O O
mixture O O
of O O
anti-CD3 O O
-LRB- O O
3 O O
μg/ml O O
, O O
clone O O
Hit3a O O
, O O
BD O O
Biosciences O O
-RRB- O O
and O O
20 O O
μg/ml O O
Delta1-Fc O O
or O O
hIgG4 O O
control O O
-LRB- O O
Sigma O O
-RRB- O O
. O O

Plates O O
were O O
again O O
washed O O
with O O
PBS O O
and B-conn Conjunction
purified O O
CD4+ O O
T O O
cells O O
were O O
seeded O O
at O O
2 O O
× O O
105/well O O
in O O
the O O
presence O O
of O O
soluble O O
anti-CD28 O O
-LRB- O O
2 O O
μg/ml O O
, O O
clone O O
CD28.2 O O
, O O
BD O O
Bioscience O O
-RRB- O O
. O O

This O O
assay O O
has O O
been O O
described O O
previously O O
-LSB-20 O O
-RSB- O O
. O O

Briefly O O
, O O
a O O
CHO O O
cell O O
line O O
-LRB- O O
CHO-N2 O O
-RRB- O O
was O O
established O O
which O O
expressed O O
both O O
a O O
full-length O O
human O O
Notch2 O O
cDNA O O
, O O
and B-conn Conjunction
p10xCBF1-luc O O
. O O

2 O O
× O O
104 O O
CHO-N2 O O
cells O O
were O O
plated O O
per O O
well O O
into O O
96-well O O
plates O O
, O O
and O O
left O O
to B-conn Purpose.Goal
adhere O O
for O O
2 O O
hours O O
. O O

Notch O O
signalling O O
was O O
activated O O
by B-conn Purpose.Enablement
plating O O
an O O
additional O O
CHO O O
line O O
which O O
stably O O
expresses O O
full-length O O
human O O
Delta1 O O
-LRB- O O
CHO-hDelta1 O O
-RRB- O O
onto O O
the O O
CHO-N2 O O
cells O O
. O O

Cells O O
were O O
co-cultured O O
in O O
this O O
manner O O
overnight O O
, O O
and B-conn Conjunction
luciferase O O
activity O O
determined O O
as O O
described O O
. O O

RNA O O
was O O
isolated O O
from O O
cell O O
samples O O
using O O
Rneasy O O
kits O O
-LRB- O O
Qiagen O O
-RRB- O O
. O O

First O O
strand O O
cDNA O O
was O O
synthesised O O
with O O
SuperScriptII O O
-LRB- O O
Invitrogen O O
-RRB- O O
oligo-d O O
-LRB- O O
T O O
-RRB- O O
and O O
random O O
decamers O O
-LRB- O O
Invitrogen O O
-RRB- O O
. O O

Q-PCR O O
was O O
performed O O
using O O
SYBR O O
green O O
detection O O
chemistry O O
on O O
the O O
Roche O O
Lightcycler O O
system O O
. O O

Gene-specific O O
quantification O O
was O O
achieved O O
by B-conn Purpose.Enablement
comparing O O
each O O
cDNA O O
to O O
a O O
serially-diluted O O
standard O O
plasmid O O
containing O O
the O O
relevant O O
amplicon O O
. O O

Relative O O
Hes-1 O O
expression O O
levels O O
were O O
normalised O O
to O O
18S O O
rRNA O O
housekeeping O O
gene O O
. O O

Primer O O
sequences O O
used O O
were O O
as O O
follows O O
-LRB- O O
5 O O
' O O
to O O
3 O O
' O O
-RRB- O O
: O O
18S O O
rRNA O O
, O O
GTAACCCGTTGAACCCCATT O O
and O O
CCATCCAATCGGTAGTAGCG O O
; O O
Hes-1 O O
, O O
CTCTCTTCCCTCCGGACTCT O O
and O O
GGCGCAATCCAATATGAAC O O
. O O

Authors O O
' O O
contributions O O

GM O O
and O O
GH O O
conceived O O
this O O
study O O
and O O
wrote O O
the O O
manuscript O O
. O O

GM O O
was O O
experimentally O O
involved O O
in O O
CHO O O
, O O
Jurkat O O
and O O
primary O O
T-cell O O
assays O O
. O O

GH O O
was O O
experimentally O O
involved O O
in O O
the O O
neuronal O O
studies O O
. O O

GW O O
carried O O
out O O
all O O
the O O
CHO O O
and O O
Jurkat O O
assays O O
and O O
the O O
primary O O
T-cell O O
experiments O O
involving O O
N1-IC O O
transfection O O
. O O

YS O O
and O O
EB O O
carried O O
out O O
the O O
primary O O
T-cell O O
experiments O O
involving O O
Delta1-Fc O O
stimulation O O
. O O

SP O O
was O O
experimentally O O
involved O O
in O O
the O O
neuronal O O
studies O O
. O O

AL O O
, O O
BC O O
and O O
MT O O
provided O O
susbstantial O O
intellectual O O
input O O
into O O
all O O
aspects O O
of O O
this O O
study O O
. O O

All O O
authors O O
read O O
and O O
approved O O
the O O
final O O
manuscript O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Inhibition O O
of O O
the O O
PI3K-Akt O O
pathway O O
impairs O O
Notch O O
signalling O O
in O O
Jurkat O O
T-cells O O
. O O

-LRB- O O
A O O
-RRB- O O
J-N2 O O
cells O O
were O O
transfected O O
with O O
14 O O
μg O O
of O O
p10xCBF1-luc O O
and O O
1 O O
μg O O
pTK-RL O O
, O O
incubated O O
overnight O O
, O O
then B-conn Temporal.Precedence
plated O O
onto O O
96-well O O
plates O O
coated O O
with O O
either O O
20 O O
μg/ml O O
hIgG4 O O
or O O
20 O O
μg/ml O O
hDelta1-Fc O O
along O O
with O O
LY294002 O O
for O O
6 O O
hours O O
. O O

CBF1-reporter O O
gene O O
activity O O
is O O
normalised O O
to O O
Renilla O O
control O O
in O O
this O O
and O O
all O O
luciferase O O
assays O O
. O O

-LRB- O O
B O O
-RRB- O O
J-N2 O O
cells O O
were O O
plated O O
onto O O
either O O
hIgG4 O O
or O O
Delta1-Fc O O
± O O
10 O O
μM O O
LY294002 O O
, O O
and O O
incubated O O
for O O
8 O O
hours O O
before B-conn Temporal.Precedence
being O O
processed O O
for B-conn Purpose.Goal
Hes1 O O
mRNA O O
levels O O
by B-conn Purpose.Enablement
Q-PCR O O
-LRB- O O
Hes1/18 O O
rRNA O O
-RRB- O O
. O O

-LRB- O O
C O O
-RRB- O O
J-N2 O O
cells O O
were O O
transfected O O
with O O
10 O O
μg O O
of O O
pCBF1x10-luc O O
, O O
4 O O
μg O O
of O O
Pten O O
expression O O
construct O O
or O O
empty O O
pcDNA3.1 O O
vector,1 O O
μg O O
of O O
pTK-RL O O
, O O
and O O
treated O O
with O O
either O O
20 O O
μg/ml O O
hIgG4 O O
or O O
20 O O
μg/ml O O
hDelta1-Fc O O
± O O
10 O O
μM O O
LY294002 O O
. O O

CBF1-reporter O O
activity O O
was O O
measured O O
after B-conn Temporal.Succession
6 O O
hr O O
. O O

All O O
data O O
is O O
presented O O
as O O
mean O O
± O O
s.d. O O
, O O
and O O
is O O
representative O O
of O O
three O O
repeat O O
experiments O O
. O O

-LRB- O O
D O O
-RRB- O O
J-N2 O O
cells O O
were O O
transfected O O
with O O
p10xCBF1-luc O O
and O O
pTK-RL O O
and O O
stimulated O O
as O O
described O O
in O O
Fig. O O
1A O O
, O O
except O O
that O O
cells O O
were O O
treated O O
with O O
Akt O O
inhibitor O O
SH-6 O O
-LRB- O O
50 O O
μM O O
-RRB- O O
or O O
DMSO O O
vehicle O O
for O O
6 O O
hours O O
. O O

Figure O O
2 O O
: O O
The O O
PI3K-Akt O O
pathway O O
regulates O O
Notch-responsiveness O O
in O O
primary O O
human O O
CD4+ O O
T-cells O O
. O O

-LRB- O O
A O O
-RRB- O O
24-well O O
tissue O O
culture O O
plates O O
were O O
coated O O
with O O
anti-human O O
IgG4 O O
and O O
anti-mouse O O
IgG2a O O
capture O O
antibodies O O
at O O
1 O O
μg/ml O O
in O O
PBS O O
, O O
and O O
incubated O O
at O O
4°C O O
, O O
overnight O O
. O O

Appropriate O O
stimuli O O
added O O
: O O
Delta1-Fc O O
or O O
hIgG4 O O
as O O
control O O
, O O
both O O
at O O
20 O O
μg/ml O O
in O O
PBS O O
and O O
anti-CD3 O O
-LRB- O O
Hit3a O O
, O O
IgG2a O O
-RRB- O O
or O O
mIgG O O
as O O
control O O
, O O
both O O
at O O
1 O O
μg/ml O O
in O O
PBS O O
, O O
and O O
incubated O O
at O O
37°C O O
, O O
3 O O
h O O
. O O

Plates O O
were O O
washed O O
with O O
PBS O O
and O O
positively O O
selected O O
hCD4+ O O
T-cells O O
were O O
seeded O O
at O O
2 O O
× O O
106 O O
cells/well O O
, O O
in O O
1 O O
ml O O
of O O
media O O
to O O
a O O
total O O
of O O
1 O O
× O O
107 O O
cells/stimulation O O
. O O

Cells O O
were O O
stimulated O O
overnight O O
± O O
10 O O
μM O O
DAPT O O
or O O
10 O O
μM O O
LY294002 O O
and O O
2 O O
μg/ml O O
anti-CD28 O O
where O O
applicable O O
. O O

Cells O O
were O O
pooled O O
, O O
RNA O O
prepared O O
and O O
cDNA O O
synthesised O O
as O O
described O O
in O O
Methods O O
. O O

Relative O O
Hes1 O O
expression O O
was O O
determined O O
by B-conn Purpose.Enablement
Q-PCR O O
. O O

Data O O
shown O O
represents O O
triplicate O O
assays O O
of O O
cDNA O O
prepared O O
from O O
pooled O O
cells O O
, O O
and O O
is O O
representative O O
of O O
two O O
individual O O
experiments O O
performed O O
using O O
CD4+ O O
T-cells O O
prepared O O
from O O
different O O
donors. O O
-LRB- O O
B O O
-RRB- O O

Human O O
primary O O
CD4+ O O
T-cells O O
were O O
nucleofected O O
with O O
4 O O
μg O O
p10xCBF-luc O O
, O O
0.5 O O
μg O O
pTK-RL O O
and O O
1 O O
μg O O
of O O
either O O
pN1-IC O O
or O O
empty O O
pcDNA3.1 O O
, O O
and O O
2 O O
μg O O
of O O
either O O
gagAkt O O
or O O
kinase-dead O O
-LRB- O O
KD O O
-RRB- O O
Akt O O
construct O O
. O O

CBF1-reporter O O
activity O O
is O O
presented O O
as O O
mean O O
normalised O O
luminescence O O
± O O
s.d. O O
. O O

Data O O
representative O O
of O O
two O O
repeat O O
experiments O O
from O O
different O O
blood O O
donors O O
. O O

Figure O O
3 O O
: O O
Inhibiting O O
GSK3β O O
with O O
lithium O O
chloride O O
enhances O O
Notch O O
signals O O
in O O
primary O O
human O O
CD4+ O O
, O O
but O O
not O O
Jurkat O O
, O O
T-cells O O
. O O

-LRB- O O
A O O
-RRB- O O
Primary O O
human O O
CD4+ O O
T-cells O O
were O O
nucleofected O O
with O O
4 O O
μg O O
p10xCBF-luc O O
, O O
0.5 O O
μg O O
pTK-RL O O
and O O
1 O O
μg O O
of O O
either O O
pN1-IC O O
or O O
pcDNA3.1 O O
and O O
plated O O
o/n O O
in O O
triplicate O O
with O O
increasing O O
concentrations O O
of O O
LiCl O O
. O O

Data O O
is O O
presented O O
as O O
the O O
fold O O
induction O O
in O O
normalised O O
luminescence O O
compared O O
to O O
the O O
untreated O O
vector O O
only O O
control O O
. O O

-LRB- O O
B O O
-RRB- O O
Primary O O
human O O
CD4+ O O
T-cells O O
were O O
nucleofected O O
with O O
4 O O
μg O O
p10xCBF-luc O O
and O O
exposed O O
to O O
different O O
levels O O
of O O
plate-bound O O
Delta1-Fc O O
in O O
the O O
presence O O
or O O
absence O O
of O O
LiCl O O
-LRB- O O
10 O O
mM O O
-RRB- O O
. O O

-LRB- O O
C O O
-RRB- O O
J-N2 O O
cells O O
were O O
transfected O O
with O O
p10xCBF1-luc O O
and O O
pTK-RL O O
and O O
stimulated O O
overnight O O
in O O
increasing O O
concentrations O O
of O O
LiCl O O
. O O

Data O O
is O O
presented O O
as O O
the O O
fold O O
induction O O
in O O
normalised O O
luminescence O O
compared O O
to O O
the O O
untreated O O
IgG4 O O
control O O
. O O

Figure O O
4 O O
: O O
The O O
PI3k/GSK3β O O
pathway O O
also O O
regulates O O
Notch O O
signalling O O
in O O
CHO O O
cells O O
and O O
in O O
primary O O
neurons O O
. O O

-LRB- O O
A O O
-RRB- O O
CHO-N2 O O
cells O O
were O O
co-cultured O O
with O O
increasing O O
numbers O O
of O O
either O O
CHO-hDelta1 O O
or O O
control O O
CHO O O
cells O O
and O O
luciferase O O
reporter O O
activity O O
assayed O O
for O O
after B-conn Temporal.Succession
24 O O
hours O O
. O O

CBF1-dependent O O
reporter O O
activity O O
is O O
presented O O
as O O
the O O
fold O O
induction O O
in O O
luminescence O O
versus O O
CHO-N2 O O
cell O O
only O O
value O O
. O O

Mean O O
± O O
sem O O
given O O
. O O

-LRB- O O
B O O
-RRB- O O
CHO-N2 O O
cells O O
were O O
co-cultured O O
with O O
104 O O
CHO-hDelta1 O O
cells O O
per O O
well O O
± O O
insulin O O
± O O
LY294002 O O
as O O
indicated O O
. O O

CBF1-reporter O O
activity O O
is O O
presented O O
as O O
fold O O
induction O O
of O O
non-insulin O O
stimulated O O
cells O O
. O O

-LRB- O O
C O O
-RRB- O O
CHO-N2 O O
cells O O
were O O
co-cultured O O
with O O
increasing O O
numbers O O
of O O
CHO-hDelta1 O O
in O O
the O O
presence O O
or O O
absence O O
of O O
LiCl O O
-LRB- O O
10 O O
mM O O
-RRB- O O
. O O

-LRB- O O
D O O
-RRB- O O
Rat O O
primary O O
hippocampal O O
neurons O O
were O O
transfected O O
with O O
0.5 O O
μg O O
of O O
p10xCBF1-luc O O
and O O
0.05 O O
μg O O
pTK-RL O O
, O O
then B-conn Temporal.Precedence
stimulated O O
overnight O O
with O O
either O O
LiCl O O
or O O
25 O O
ng/ml O O
BDNF O O
± O O
10 O O
μM O O
LY294002 O O
. O O

-LRB- O O
E O O
-RRB- O O
Neurons O O
were O O
transfected O O
with O O
0.2 O O
μg O O
of O O
p10xCBF1-luc O O
, O O
0.05 O O
μg O O
pTK-RL O O
, O O
0.05 O O
μg O O
of O O
pN1-IC O O
and O O
0.4 O O
μg O O
of O O
the O O
relevant O O
expression O O
plasmid O O
. O O

CBF1-reporter O O
activity O O
is O O
presented O O
as O O
normalised O O
luminescence O O
± O O
s.e.m O O
-LRB- O O
n O O
= O O
3 O O
-RRB- O O
. O O
-LRB- O O
* O O
p O O

< O O
0.05 O O
, O O
Mann O O
Whitney O O
U O O
test O O
-RRB- O O
. O O

Figure O O
5 O O
: O O
A O O
schematic O O
depicting O O
a O O
proposed O O
mechanism O O
for O O
the O O
influence O O
of O O
the O O
PI3K O O
pathway O O
on O O
Notch-responsiveness. O O
See O O
text O O
for O O
discussion O O
of O O
this O O
model O O
. O O

Btk O O
expression O O
is O O
controlled O O
by O O
Oct O O
and O O
BOB.1/OBF.1 O O

Abstract O O

BOB.1/OBF.1 O O
is O O
a O O
lymphocyte-restricted O O
transcriptional O O
coactivator O O
. O O

It O O
binds O O
together O O
with O O
the O O
Oct1 O O
and O O
Oct2 O O
transcription O O
factors O O
to O O
DNA O O
and O O
enhances O O
their O O
transactivation O O
potential O O
. O O

Mice O O
deficient O O
for O O
the O O
transcriptional O O
coactivator O O
BOB.1/OBF.1 O O
show O O
several O O
defects O O
in O O
differentiation O O
, O O
function O O
and O O
signaling O O
of O O
B O O
cells O O
. O O

In B-conn Circumstance.Forward Circumstance
search O O
of O O
BOB.1/OBF.1 O O
regulated O O
genes O O
we O O
identified O O
Btk—a O O
cytoplasmic O O
tyrosine O O
kinase—as O O
a O O
direct O O
target O O
of O O
BOB.1/OBF.1 O O
. O O

Analyses O O
of O O
the O O
human O O
as O O
well O O
as O O
murine O O
Btk O O
promoters O O
revealed O O
a O O
non-consensus O O
octamer O O
site O O
close O O
to O O
the O O
start O O
site O O
of O O
transcription O O
. O O

Here O O
we O O
show O O
that O O
Oct O O
proteins O O
together O O
with O O
BOB.1/OBF.1 O O
are O O
able O O
to O O
form O O
ternary O O
complexes O O
on O O
these O O
sites O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

This O O
in B-conn Temporal.Precedence
turn I-conn Temporal.Precedence
leads O O
to O O
the O O
induction O O
of O O
Btk O O
promoter O O
activity O O
in O O
synergism O O
with O O
the O O
transcription O O
factor O O
PU.1 O O
. O O

Btk O O
, O O
like O O
BOB.1/OBF.1 O O
, O O

plays O O
a O O
critical O O
role O O
in O O
B O O
cell O O
development O O
and O O
B O O
cell O O
receptor O O
signalling O O
. O O

Therefore B-conn Cause.Claim
the O O
down-regulation O O
of O O
Btk O O
expression O O
in O O
BOB.1/OBF.1-deficient O O

B O O
cells O O
could O O
be O O
related O O
to O O
the O O
functional O O
and O O
developmental O O
defects O O
observed O O
in O O
BOB.1/OBF.1-deficient O O

mice O O
. O O

INTRODUCTION O O

The O O
octamer O O
motif O O
ATGCAAAT O O
is O O
important O O
for O O
B O O
cell-specific O O
gene O O
regulation O O
. O O

Although B-conn Concession.Expectation
it O O
is O O
also O O
found O O
in O O
promoters O O
of O O
ubiquitously O O
expressed O O
genes O O
-LRB- O O
1–3 O O
-RRB- O O
, O O
it O O
is O O
a O O
critical O O
element O O
in O O
the O O
regulatory O O
regions O O
of O O
several O O
B O O
cell-specific O O
expressed O O
genes O O
, O O
like O O
immunoglobulin O O
genes O O
-LRB- O O
4,5 O O
-RRB- O O
, O O
B29 O O
-LRB- O O
Igβ O O
-RRB- O O
, O O
CD20 O O
and O O
CD21 O O
-LRB- O O
6–8 O O
-RRB- O O
. O O

Detailed O O
analyses O O
of O O
the O O
octamer O O
sequence O O
revealed O O
that O O
mutations O O
in O O
most O O
positions O O
of O O
the O O
conserved O O
motif O O
interfere O O
with O O
its O O
function O O
-LRB- O O
9 O O
-RRB- O O
. O O

In O O
B O O
cells O O
, O O
two O O
octamer O O
transcription O O
factors O O
bind O O
to O O
the O O
octamer O O
element O O
, O O
the O O
ubiquitously O O
expressed O O
Oct1 O O
and O O
the O O
lymphocyte-specific O O
expressed O O
Oct2 O O
-LRB- O O
10 O O
-RRB- O O
. O O

For B-conn Purpose.Goal
B-cell-specific O O
activity O O
these O O
transcription O O
factors O O
need O O
to O O
interact O O
with O O
an O O
additional O O
lymphocyte-restricted O O
coactivator O O
named O O
BOB.1/OBF.1 O O
-LRB- O O
alternative O O
names O O
are O O
Bob.1 O O
, O O

OBF-1 O O
, O O
OCA-B O O
-RRB- O O
-LRB- O O
11,12 O O
-RRB- O O
. O O

BOB.1/OBF.1 O O
displays O O
only O O
weak O O
DNA O O
binding O O
and O O
is O O
recruited O O
to O O
the O O
octamer O O
sequence O O
predominantly B-conn Purpose.Enablement
via I-conn Purpose.Enablement
interaction O O
of O O
its O O
N-terminal O O
domain O O
with O O
the O O
POU-domains O O
of O O
Oct O O
factors O O
-LRB- O O
11–19 O O
-RRB- O O
. O O

The O O
transactivation O O
domains O O
of O O
both O O
type O O
of O O
proteins—Oct O O
and O O
BOB.1/OBF.1—act O O
in O O
synergy O O
to O O
mediate O O
octamer-dependent O O
transcription O O
. O O

A O O
BOB.1/OBF.1 O O
protein O O
isoform O O
bearing O O
an O O
N-terminal O O
myristoylated O O
extension O O
was O O
found O O
to O O
be O O
localized O O
in O O
the O O
membrane O O
fraction O O
-LRB- O O
20 O O
-RRB- O O
. O O

The O O
function O O
of O O
this O O
isoform O O
is O O
not O O
understood O O
yet O O
. O O

Gene O O
targeting O O
experiments O O
revealed O O
that O O
BOB.1/OBF.1 O O
is O O
important O O
at O O
several O O
stages O O
of O O
B O O
cell O O
development O O
in O O
the O O
bone O O
marrow O O
as O O
well O O
as O O
in O O
peripheral O O
secondary O O
lymphoid O O
tissues O O
. O O

In O O
the O O
bone O O
marrow O O
the O O
number O O
of O O
immature O O
as O O
well O O
transitional O O
B O O
cells O O
is O O
reduced O O
and B-conn Cause.Result
fewer O O
cells O O
reach O O
the O O
periphery O O
-LRB- O O
21 O O
-RRB- O O
. O O

BOB.1/OBF.1 O O
is O O
expressed O O
throughout O O
B O O
cell O O
ontogeny O O
, O O
albeit B-conn Concession.Contra-expectation
at O O
different O O
levels O O
. O O

The O O
highest O O
expression O O
is O O
found O O
in O O
germinal O O
center O O
B O O
cells O O
-LRB- O O
22,23 O O
-RRB- O O
. O O

The O O
most O O
striking O O
characteristic O O
of O O
BOB.1/OBF.1−/− O O

mice O O
is O O
the O O
complete O O
failure O O
to O O
form O O
germinal O O
centers O O
in O O
spleen O O
and O O
lymph O O
nodes O O
-LRB- O O
24–26 O O
-RRB- O O
. O O

Therefore B-conn Cause.Result
, O O
the O O
production O O
of O O
switched O O
immunoglobulin O O
isotypes O O
is O O
strongly O O
reduced O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
development O O
of O O
the O O
marginal O O
zone O O
B O O
cell O O
compartment O O
in O O
BOB.1/OBF.1−/− O O

mice O O
is O O
severely O O
affected O O
-LRB- O O
27 O O
-RRB- O O
. O O

The O O
B-cell-specific O O
expression O O
of O O
a O O
bcl2-transgene O O
can O O
rescue O O
several O O
aspects O O
of O O
early O O
lymphopoiesis O O
in O O
BOB.1/OBF.1−/− O O

mice O O
. O O

However B-conn Concession.Contra-expectation
, O O
terminal O O
differentiation O O
and O O
specific O O
B O O
cell O O
responses O O
are O O
still O O
defective O O
-LRB- O O
28 O O
-RRB- O O
. O O

BOB.1/OBF.1 O O
is O O
also B-conn Conjunction
inducible O O
expressed O O
in O O
T O O
cells O O
-LRB- O O
29,30 O O
-RRB- O O
. O O

A O O
critical O O
function O O
in O O
T O O
cells O O
has O O
however B-conn Concession.Contra-expectation
not O O
been O O
identified O O
yet O O
. O O

Some O O
of O O
the O O
defects O O
in O O
early O O
and O O
late O O
B O O
cell O O
development O O
as O O
well O O
as O O
in O O
B O O
cell O O
function O O
were O O
reminiscent O O
of O O
defects O O
in O O
mice O O
deficient O O
of O O
functional O O
Bruton O O
's O O
tyrosine O O
kinase O O
-LRB- O O
Btk O O
-RRB- O O
. O O

Mutations O O
in O O
the O O
gene O O
coding O O
for O O
Btk O O
cause O O
X-linked O O
agammaglobulinemia O O
-LRB- O O
XLA O O
-RRB- O O
in O O
humans O O
-LRB- O O
31 O O
-RRB- O O
and O O
X-linked O O
immunodeficiency O O
-LRB- O O
Xid O O
-RRB- O O
in O O
mice O O
-LSB-reviewed O O
in O O
Ref O O
. O O
-LRB- O O
32 O O
-RRB- O O
-RSB- O O
. O O

The O O
Xid O O
phenotype O O
is O O
characterized O O
by O O
a O O
defect O O
in O O
the O O
transition O O
from O O
the O O
pre-B O O
to O O
immature O O
B O O
cells O O
in O O
the O O
bone O O
marrow O O
as O O
well O O
as O O
by O O
a O O
reduced O O
number O O
of O O
peripheral O O
B O O
cells O O
that O O
exhibit O O
an O O
immature O O
phenotype O O
-LRB- O O
33–35 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
B-1 O O
cell O O
compartment O O
is O O
absent O O
in O O
Xid-mice O O
. O O

Consequently B-conn Cause.Result
, O O
the O O
levels O O
of O O
serum O O
IgM O O
and O O
IgG3 O O
are O O
low O O
. O O

Similar O O
to O O
BOB.1/OBF.1−/− O O

animals O O
-LRB- O O
25,27 O O
-RRB- O O
, O O
mice O O
deficient O O
for O O
an O O
functional O O
Btk O O
show O O
severe O O
defects O O
in O O
B O O
cell O O
receptor O O
signaling O O
, O O
expressed O O
by O O
reduced O O
tyrosine O O
phosphorylation O O
-LSB-reviewed O O
in O O
-LRB- O O
32 O O
-RRB- O O
-RSB- O O
, O O
reduced O O
elevation O O
of O O
intracellular O O
Ca2+ O O
levels O O
-LRB- O O
36 O O
-RRB- O O
, O O
reduced O O
activation O O
of O O
NF-κB O O
-LRB- O O
37,38 O O
-RRB- O O
as O O
well O O
as O O
impaired O O
proliferation O O
upon O O
IgM O O
crosslinking O O
-LRB- O O
33,34 O O
-RRB- O O
. O O

Based O O
on O O
these O O
findings O O
one O O
may O O
suggest O O
that O O
BOB.1/OBF.1 O O
and O O
Btk O O
have O O
overlapping O O
functions O O
. O O

However B-conn Concession.Contra-expectation
, O O
mice O O
mutant O O
for O O
both O O
proteins O O
almost O O
completely O O
lack O O
peripheral O O
B O O
cells O O
and O O
show O O
a O O
severe O O
agammaglobulinemia O O
-LRB- O O
39 O O
-RRB- O O
, O O
a O O
phenotype O O
resembling O O
human O O
XLA O O
-LRB- O O
31 O O
-RRB- O O
. O O

Thus B-conn Restatement.Generalization
, O O
although B-conn Concession.Expectation
BOB.1/OBF.1 O O
and O O
Btk O O
share O O
some O O
overlapping O O
functions O O
, O O
they O O
are O O
also O O
involved O O
in O O
distinct O O
signaling O O
pathways O O
, O O
which O O
are O O
important O O
for O O
B O O
cell O O
development O O
and O O
function O O
. O O

To B-conn Purpose.Goal
get O O
insights O O
into O O
the O O
regulation O O
of O O
Btk O O
expression O O
the O O
human O O
-LRB- O O
40,41 O O
-RRB- O O
and O O
murine O O
-LRB- O O
42,43 O O
-RRB- O O
promoter O O
regions O O
were O O
analyzed O O
for O O
conserved O O
regulatory O O
elements O O
-LRB- O O
44–49 O O
-RRB- O O
. O O

Recently O O
, O O
regulatory O O
elements O O
necessary O O
for O O
Btk O O
gene O O
activation O O
were O O
also O O
identified O O
in O O
intron1 O O
. O O

The O O
btk O O
promoter O O
does O O
not O O
contain O O
an O O
obvious O O
TATA O O
box O O
. O O

Transcription O O
is O O
initiated O O
at O O
a O O
putative O O
initiator O O
element O O
. O O

Deletion O O
analyses O O
revealed O O
that O O
a O O
sequence O O
of O O
280 O O
bp O O
upstream O O
of O O
the O O
start O O
site O O
of O O
transcription O O
is O O
sufficient O O
for O O
the O O
cell-type-specific O O
regulation O O
of O O
Btk O O
expression O O
. O O

The O O
transcription O O
factors O O
Sp1 O O
, O O
Sp3 O O
, O O
Spi-B O O
and O O
PU.1 O O
are O O
able O O
to O O
synergistically O O
activate O O
the O O
Btk O O
promoter O O
. O O

However B-conn Concession.Contra-expectation
, O O
in O O
PU.1-deficient O O
fetal O O
liver O O
cells O O
-LRB- O O
48 O O
-RRB- O O
as O O
well O O
as O O
SP1−/− O O
embryonic O O
stem O O
cells O O
-LRB- O O
49 O O
-RRB- O O
, O O
Btk O O
expression O O
was O O
either O O
reduced O O
or O O
not O O
affected O O
but O O
not O O
abolished O O
. O O

This O O
indicates O O
that O O
additional O O
, O O
yet O O
not O O
identified O O
factors O O
also O O
contribute O O
to O O
Btk O O
promoter O O
activity O O
. O O

Here O O
we O O
show O O
that O O
the O O
transcription O O
factors O O
Oct1 O O
and O O
Oct2 O O
are O O
able O O
to O O
bind O O
in O O
concert O O
with O O
the O O
coactivator O O
BOB.1/OBF.1 O O
to O O
a O O
non-perfect O O
octamer O O
site O O
within O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
leading O O
to O O
their O O
activation O O
. O O

Moreover B-conn Conjunction
, O O
Oct O O
and O O
BOB.1/OBF.1 O O
proteins O O
activate O O
the O O
murine O O
Btk O O
promoter O O
synergistically O O
with O O
PU.1 O O
. O O

The O O
importance O O
of O O
the O O
Oct/BOB.1/OBF.1-mediated O O

btk O O
gene O O
activation O O
is O O
underlined O O
by O O
the O O
fact O O
that O O
in O O
BOB.1/OBF.1-deficient O O

B O O
cells O O
expression O O
of O O
Btk O O
is O O
impaired O O
. O O

Thus B-conn Cause.Result
, O O
we O O
identified O O
the O O
non-perfect O O
octamer O O
site O O
present O O
in O O
human O O
as O O
well O O
in O O
the O O
murine O O
Btk O O
promoter O O
as O O
a O O
conserved O O
regulatory O O
site O O
important O O
for O O
B O O
cell-specific O O
btk O O
gene O O
regulation O O
. O O

MATERIALS O O
AND O O
METHODS O O

C57BL/6 O O
wild O O
type O O
and O O
BOB.1/OBF.1−/− O O

mice O O
on O O
the O O
same O O
genetic O O
background O O
as O O
well O O
as O O
the O O
1.5/B.1−/− O O

mice O O
were O O
obtained O O
from O O
our O O
breeding O O
facility O O
. O O

Mice O O
were O O
analyzed O O
8–12 B-conn Temporal.Succession
weeks I-conn Temporal.Succession
after I-conn Temporal.Succession
birth O O
. O O

The O O
generation O O
of O O
mice O O
1.5/B.1−/− O O
, O O

transgenic O O
for O O
µE-tTa O O
and O O
tetO-BOB.1/OBF.1 O O
has O O
been O O
described O O
-LRB- O O
21 O O
-RRB- O O
. O O

Cells O O
were O O
labeled O O
with O O
an O O
anti-B220-biotin-antibody O O
and O O
revealed O O
by O O
Streptavidin-Cy-Chrom O O
and O O
subsequently B-conn Temporal.Precedence
sorted O O
with O O
a O O
FACSORT O O
plus O O
cytometer O O
-LRB- O O
Becton O O
Dickinson O O
-RRB- O O
. O O

Stainings O O
were O O
performed O O
in O O
PBS O O
containing O O
0.1 O O
% O O
BSA O O
-LRB- O O
Roche O O
Diagnostics O O
, O O
Mannheim O O
, O O
GER O O
-RRB- O O
, O O
0.1 O O
% O O
Na-azid O O
and O O
saturating O O
concentrations O O
of O O
anti-CD16/CD32 O O
to O O
block O O
FcγIII/II O O
receptors O O
. O O

All O O
antibodies O O
were O O
purchased O O
from O O
Becton O O
Dickinson O O
. O O

Single O O
cell O O
suspensions O O
from O O
mouse O O
splenocytes O O
were O O
incubated O O
with O O
antibodies O O
against O O
CD4 O O
, O O
CD8 O O
-LRB- O O
derived O O
from O O
an O O
antibody-producing O O
hybridoma O O
cell O O
line O O
-RRB- O O
and B-conn Temporal.Precedence
positive O O
cells O O
were O O
eliminated O O
by O O
complement O O
lysis O O
using O O
baby O O
rabbit O O
complement O O
-LRB- O O
Cedarlane O O
-RRB- O O
. O O

This O O
treatment O O
was O O
followed O O
by O O
a O O
lympholyte O O
M O O
gradient O O
-LRB- O O
Cedarlane O O
-RRB- O O
to B-conn Purpose.Goal
eliminate O O
red O O
blood O O
as O O
well O O
as O O
dead O O
cells O O
. O O

The O O
purity O O
of O O
the O O
B220+ O O
B O O
cell O O
population O O
was O O
>95 O O
% O O
. O O

NIH/3T3 O O
and O O
HeLa O O
cells O O
were O O
cultured O O
in O O
DMEM O O
-LRB- O O
Life O O
Technologies O O
, O O
Inc. O O
-RRB- O O
, O O
BJAB O O
and O O
S194 O O
cells O O
in O O
RPMI O O
-LRB- O O
Life O O
Technologies O O
, O O
Inc. O O
-RRB- O O
supplemented O O
both O O
with O O
10 O O
% O O
FCS O O
, O O
antibiotics O O
and O O
50 O O
µM O O
β-ME O O
, O O
and O O
grown O O
at O O
37°C O O
and O O
5 O O
% O O
CO2 O O
. O O

Transfections O O
of O O
NIH/3T3 O O
cells O O
were O O
performed O O
by O O
electroporation O O
-LRB- O O
Bio-Rad O O
-RRB- O O
with O O
450 O O
V O O
and O O
250 O O
µF O O
in O O
phosphate O O
buffered O O
saline O O
. O O

Pre-B O O
cell O O
lines O O
were O O
established O O
by B-conn Purpose.Enablement
culturing O O
bone O O
marrow O O
cells O O
from O O
mice O O
of O O
the O O
indicated O O
genotype O O
under O O
the O O
stimulatory O O
influence O O
of O O
irradiated O O
adherent O O
stromal O O
cells O O
ST2 O O
and O O
the O O
cytokine O O
IL-7 O O
. O O

As O O
culture O O
medium O O
was O O
used O O
IMDM O O
-LRB- O O
Life O O
Technologies O O
, O O
Inc. O O
-RRB- O O
supplemented O O
with O O
5 O O
% O O
FCS O O
, O O
antibiotics O O
, O O
50 O O
µM O O
β-ME O O
, O O
2 O O
% O O
supernatant O O
from O O
IL-7 O O
producing O O
cells O O
J558 O O
-LRB- O O
A O O
. O O

Rolink O O
, O O
Basel O O
-RRB- O O
and O O
5 O O
% O O
Primatone O O
-LRB- O O
PAN O O
Systems O O
GmbH O O
-RRB- O O
. O O

Cells O O
were O O
grown O O
at O O
37°C O O
and O O
10 O O
% O O
CO2 O O
. O O

The O O
murine O O
Btk O O
promotor O O
-LRB- O O
−436 O O
to O O
+79 O O
-RRB- O O
was O O
cloned O O
into O O
the O O
pTKL/2 O O
vector O O
containing O O
the O O
HSV-thymidine O O
kinase O O
promoter O O
-LRB- O O
−105 O O
to O O
+52 O O
-RRB- O O
from O O
the O O
pBLCAT2 O O
in O O
front O O
of O O
the O O
firefly O O
luciferase O O
coding O O
region O O
. O O

The O O
HSV-thymidine O O
kinase O O
promoter O O
was O O
excised O O
by O O
a O O
restriction O O
endonuclease O O
digest O O
using O O
HindIII O O
and O O
BglII O O
and O O
replaced O O
by O O
the O O
Btk O O
promoter O O
cloned O O
via O O
genomic O O
PCR O O
using O O
the O O
following O O
primers O O
: O O
mBtkpr-HindIII O O
: O O
GAG O O
TAA O O
GCT O O
TTC O O
TTT O O
GTC O O
TGT O O
CCT O O
CC O O
; O O
mBtkprom-BglII O O
: O O
TGA O O
GAT O O
GCC O O
AGA O O
TCT O O
TGG O O
AAG O O
GTG O O
. O O

The O O
mutant O O
Btk O O
promoter O O
was O O
created O O
by O O
site-directed O O
in O O
vitro O O
mutagenesis O O
-LRB- O O
Stratagene O O
-RRB- O O
using O O
the O O
following O O
primers O O
: O O
mBTKprom O O
3M O O
5 O O
' O O
: O O
GTA O O
AAG O O
AGG O O
TCC O O
CAG O O
TAC O O
AAT O O
GTC O O
GGG O O
GGG O O
TGG O O
; O O
mBTKprom O O
3M O O
3 O O
' O O
: O O
CCA O O
CCC O O
CCC O O
GAC O O
ATT O O
GTA O O
CTG O O
GGA O O
CCT O O
CTT O O
TAC O O
. O O

The O O
wild-type O O
BOB.1/OBF.1 O O
cDNA O O
was O O
cloned O O
into O O
the O O
expression O O
vector O O
pcDNA3 O O
. O O

The O O
cloning O O
of O O
the O O
Oct2 O O
and O O
PU.1 O O
expression O O
vectors O O
has O O
been O O
described O O
-LRB- O O
50,51 O O
-RRB- O O
. O O

For O O
in O O
vitro O O
translation O O
of O O
BOB.1/OBF.1 O O
the O O
pMT/PKA-Bob O O
expression O O
vector O O
was O O
used O O
-LRB- O O
15 O O
-RRB- O O
. O O

Proteins O O
were O O
prepared O O
using O O
lysis O O
buffer O O
containing O O
20 O O
mM O O
Tris O O
pH O O
7.5 O O
, O O
1 O O
mM O O
EDTA O O
, O O
100 O O
mM O O
NaCl O O
, O O
1 O O
% O O
Triton O O
X-100 O O
, O O
0.5 O O
% O O
sodiumdeoxycholat O O
and O O
0.1 O O
% O O
SDS O O
. O O

Proteins O O
were O O
resolved O O
on O O
a O O
12.5 O O
% O O
SDS–PAGE O O
and O O
transferred O O
to O O
PVDF O O
membrane O O
-LRB- O O
Millipore O O
-RRB- O O
. O O

For O O
immunodetection O O
of O O
Btk O O
a O O
polyclonal O O
anti-Btk O O
antibody O O
was O O
used O O
-LRB- O O
BD O O
-RRB- O O
. O O

For O O
detection O O
of O O
Rel-A O O
a O O
Rel-A-specific O O
polyclonal O O
antibody O O
-LRB- O O
Santa O O
Cruz O O
Biotechnology O O
-RRB- O O
was O O
purchased O O
. O O

Proteins O O
were O O
visualized O O
using O O
anti-mouse O O
or O O
anti-rabbit O O
horseradish O O
peroxidase O O
conjugated O O
antibodies O O
, O O
respectively O O
-LRB- O O
Pierce O O
-RRB- O O
and O O
the O O
ECL O O
detection O O
system O O
-LRB- O O
Amersham O O
-RRB- O O
. O O

Total O O
RNA O O
was O O
prepared O O
using O O
the O O
Trizol®-reagent O O
-LRB- O O
Life O O
Technologies O O
, O O
Inc. O O
-RRB- O O
according O O
to O O
the O O
protocol O O
of O O
the O O
manufacturer O O
. O O

After B-conn Temporal.Succession
separation O O
of O O
RNAs O O
on O O
a O O
1 O O
% O O
formaldehyde O O
agarose O O
gel O O
, O O
northern O O
blot O O
analyses O O
were O O
performed O O
as O O
described O O
in O O
Ref O O
. O O
-LRB- O O
52 O O
-RRB- O O

Preparation O O
of O O
whole O O
cell O O
extracts O O
for O O
electrophoretic O O
mobility O O
shift O O
assay O O
-LRB- O O
EMSA O O
-RRB- O O
and O O
the O O
protocol O O
of O O
the O O
EMSA O O
procedure O O
have O O
been O O
described O O
earlier O O
-LRB- O O
53,54 O O
-RRB- O O
. O O

For O O
EMSA O O
, O O
the O O
following O O
oligonucleotides O O
were O O
annealed O O
and O O
subsequently B-conn Temporal.Precedence
labeled O O
using O O
P32 O O
αdCTP O O
in O O
a O O
fill-in O O
reaction O O
: O O
mBtkprom O O
5′-gcgg O O
AGA O O
GGT O O
CCC O O
AGG O O
CAA O O
ATG O O
TCG O O
GGG O O
GG O O
, O O
mBtk O O
prom O O
3′-gcgg O O
CCC O O
CCC O O
GAC O O
ATT O O
TGC O O
CTG O O
GGA O O
CCT O O
CT O O
; O O
hBtkprom O O
5′ O O
gcgg O O
AGA O O
GGT O O
CCC O O
AAG O O
CAA O O
ATG O O
AAG O O
GGC O O
GG O O
, O O
hBtkprom O O
3′-ggcg O O
CCG O O
CCC O O
TTC O O
ATT O O
TGC O O
TTG O O
GGA O O
CCT O O
CT O O
; O O
mBtkprom-Mut O O
5′-gcgg O O
AGA O O
GGT O O
CCC O O
AGT O O
ACA O O
ATG O O
TCG O O
GGG O O
GG O O
, O O
mBtkprom-Mut O O
3′-gcgg O O
CCC O O
CCC O O
GAC O O
ATT O O
GTA O O
CTG O O
GGA O O
CCT O O
CT O O
; O O
hBtkprom-Mut O O
5′-gcgg O O
AGA O O
GGT O O
CCC O O
AGT O O
ACA O O
ATG O O
AAG O O
GGC O O
GG O O
, O O
hBtkprom-Mut O O
3′-ggcg O O
CCG O O
CCC O O
TTC O O
ATT O O
GTA O O
CTG O O
GGA O O
CCT O O
CT O O
; O O
Oct O O
consensus O O
5′-gcgg O O
ACC O O
TGG O O
GTA O O
ATT O O
TGC O O
ATT O O
TCT O O
AAA O O
AT O O
, O O
Oct O O
consensus O O
3′-gcgg O O
ATT O O
TTA O O
GAA O O
ATG O O
CAA O O
ATT O O
ACC O O
CAG O O
GT O O
. O O

For O O
competition O O
experiments O O
, O O
the O O
unlabeled O O
annealed O O
oligonucleotides O O
were O O
used O O
. O O

The O O
indicated O O
amount O O
of O O
oligonucleotides O O
was O O
added O O
to O O
the O O
EMSA O O
reaction O O
mixture O O
. O O

For O O
supershift O O
experiments O O
an O O
anti-Oct1-antibody O O
-LRB- O O
serum O O
-RRB- O O
, O O
anti-Oct2-antibody O O
-LRB- O O
C-20 O O
; O O
Santa O O
Cruz O O
Biotechnology O O
; O O
no O O
. O O

sc-233 O O
-RRB- O O
or O O
anti-BOB.1/OBF.1-antibody O O

-LRB- O O
serum O O
-RRB- O O
were O O
used O O
. O O

Modified O O
EMSA O O
conditions O O
for O O
the O O
detection O O
of O O
specific O O
Oct/BOB.1/OBF.1 O O
complexes O O
were O O
previously O O
described O O
-LRB- O O
55 O O
-RRB- O O
. O O

In O O
these O O
experiments O O
2 O O
µg O O
HeLa-extracts O O
and O O
2.5 O O
µl O O
in O O
vitro O O
translated O O
BOB.1/OBF.1 O O
protein O O
or O O
the O O
same O O
amount O O
of O O
unprogrammed O O
TNT-lysates O O
-LRB- O O
Promega O O
-RRB- O O
were O O
added O O
where O O
indicated O O
. O O

The O O
chromatin O O
immunoprecipitation O O
-LRB- O O
ChIP O O
-RRB- O O
Assay O O
kit O O
-LRB- O O
Biomol O O
GmbH O O
, O O
Hamburg O O
, O O
Germany O O
, O O
# O O
17-295 O O
-RRB- O O
was O O
used O O
according O O
to O O
the O O
manufacturers O O
instructions O O
with O O
minor O O
modifications O O
described O O
elsewhere O O
-LRB- O O
56 O O
-RRB- O O
. O O

The O O
samples O O
were O O
amplified O O
using O O
Taq O O
DNA O O
polymerase O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
-RRB- O O
using O O
the O O
following O O
primers O O
: O O
mBtkprom-ChIP O O
5′-GGT O O
TAT O O
GAC O O
CTG O O
TTG O O
TTT O O
GTT O O
CAG O O
C O O
, O O
mBtkprom-ChIP O O
3′-CAC O O
CCT O O
TTC O O
GCA O O
GCC O O
ACT O O
C. O O
The O O
primers O O
for O O
the O O
analyses O O
of O O
the O O
H2B O O
or O O
Pax5 O O
promoters O O
are O O
described O O
in O O
Ref O O
. O O
-LRB- O O
56 O O
-RRB- O O
. O O

RESULTS O O

In B-conn Purpose.Goal
search O O
for O O
BOB.1/OBF.1 O O
target O O
genes O O
we O O
analyzed O O
the O O
promoter O O
regions O O
of O O
genes O O
implicated O O
in O O
B O O
cell O O
development O O
and O O
function O O
for O O
the O O
presence O O
of O O
the O O
octamer O O
motif O O
. O O

Analyses O O
of O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
revealed O O
a O O
conserved O O
non-perfect O O
octamer O O
motif O O
within O O
the O O
first O O
200 O O
bp O O
upstream O O
of O O
the O O
start O O
site O O
of O O
transcription O O
-LRB- O O
Figure O O
1 O O
-RRB- O O
. O O

Both O O
octamer O O
motifs O O
differ O O
from O O
the O O
consensus O O
sequence O O
ATGCAAAT O O
at O O
the O O
second O O
position O O
. O O

The O O
human O O
Btk O O
promoter O O
motif O O
bears O O
a O O
T→A O O
transversion O O
, O O
whereas B-conn Contrast
the O O
murine O O
variant O O
shows O O
a O O
T→G O O
transversion O O
. O O

Since B-conn Cause.Reason
it O O
was O O
shown O O
that O O
a O O
mutation O O
in O O
this O O
position O O
of O O
the O O
octamer O O
motif O O
interferes O O
with O O
Oct O O
binding O O
-LRB- O O
9 O O
-RRB- O O
we O O
wondered O O
whether O O
these O O
sites O O
might O O
nevertheless B-conn Concession.Contra-expectation
play O O
a O O
role O O
for O O
Btk O O
promoter O O
activity O O
. O O

Initially O O
, O O
nuclear O O
extracts O O
from O O
BJAB O O
cells O O
were O O
incubated O O
with O O
labeled O O
probes O O
bearing O O
either O O
the O O
consensus O O
octamer O O
motif O O
or O O
the O O
putative O O
octamer O O
binding O O
sites O O
identified O O
in O O
the O O
murine O O
or O O
human O O
Btk O O
promoters O O
-LRB- O O
Figure O O
2A O O
and O O
B O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
complex O O
formation O O
was O O
much O O
weaker O O
in O O
the O O
case O O
of O O
the O O
Btk O O
promoter O O
sites O O
compared O O
with O O
the O O
consensus O O
octamer O O
motif O O
, O O
similar O O
complexes O O
could O O
be O O
detected O O
upon B-conn Temporal.Synchronous
extended O O
exposure O O
. O O

When B-conn Temporal.Synchronous
the O O
octamer O O
motifs O O
in O O
the O O
murine O O
and O O
human O O
Btk O O
promoters O O
were O O
further O O
mutated O O
and O O
then B-conn Temporal.Precedence
used O O
as O O
probes O O
, O O
no O O
specific O O
binding O O
could O O
be O O
detected O O
-LRB- O O
Figure O O
2C O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
complex O O
formation O O
could O O
be O O
efficiently O O
inhibited O O
by B-conn Purpose.Enablement
competition O O
with O O
unlabeled O O
oligonucleotides O O
bearing O O
the O O
wild-type O O
murine O O
or O O
human O O
Btk O O
promoter O O
octamer O O
motifs O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
mutated O O
octamer O O
motifs O O
failed O O
to O O
compete O O
for O O
Oct1 O O
and O O
Oct2 O O
binding O O
-LRB- O O
Figure O O
2A O O
and O O
B O O
-RRB- O O
. O O

Competition O O
was O O
much O O
more O O
efficient O O
when B-conn Temporal.Synchronous
a O O
consensus O O
octamer O O
motif O O
was O O
used O O
-LRB- O O
Figure O O
2A O O
and O O
B O O
-RRB- O O
. O O

In O O
supershift O O
experiments O O
we O O
could O O
demonstrate O O
that O O
the O O
shifted O O
complexes O O
contain O O
Oct1 O O
and O O
Oct2 O O
proteins O O
-LRB- O O
Figure O O
2D O O
-RRB- O O
. O O

Oct2-specific O O
antibodies O O
revealed O O
several O O
supershifted O O
complexes O O
consistent O O
with O O
the O O
existence O O
of O O
several O O
Oct2 O O
isoforms O O
-LRB- O O
57 O O
-RRB- O O
. O O

Together O O
these O O
findings O O
indicate O O
that O O
the O O
identified O O
octamer O O
motifs O O
within O O
the O O
murine O O
and O O
human O O
Btk O O
promoters O O
serve O O
as O O
binding O O
sites O O
for O O
Oct1 O O
and O O
Oct2 O O
, O O
although B-conn Concession.Contra-expectation
showing O O
reduced O O
affinities O O
for O O
Oct1 O O
and O O
Oct2 O O
compared O O
with O O
a O O
consensus O O
site O O
. O O

Next O O
we O O
asked O O
, O O
whether O O
BOB.1/OBF.1 O O
is O O
able O O
to O O
form O O
ternary O O
complexes O O
together O O
with O O
Oct1 O O
and O O
Oct2 O O
on O O
the O O
murine O O
and O O
human O O
Btk O O
promoters O O
. O O

It O O
is O O
extremely O O
difficult O O
to O O
obtain O O
ternary O O
complexes O O
even O O
on O O
consensus O O
octamer O O
motives O O
by O O
EMSA O O
with O O
endogenous O O
proteins O O
in O O
B O O
cell O O
extracts O O
-LRB- O O
55,58 O O
-RRB- O O
. O O

Therefore B-conn Cause.Result
, O O
we O O
used O O
an O O
in O O
vitro O O
complementation O O
system O O
. O O

HeLa O O
nuclear O O
extracts O O
were O O
complemented O O
with O O
in O O
vitro O O
translated O O
BOB.1/OBF.1 O O
and O O
incubated O O
with O O
either O O
the O O
labeled O O
the O O
consensus O O
octamer O O
motif O O
or O O
the O O
motifs O O
found O O
in O O
the O O
human O O
or O O
murine O O
Btk O O
promoters O O
-LRB- O O
Figure O O
3 O O
-RRB- O O
. O O

Indeed B-conn Circumstance.Backward Circumstance
, O O
ternary O O
complex O O
formation O O
could O O
be O O
detected O O
at O O
these O O
non-conserved O O
octamer O O
sequences O O
-LRB- O O
Figure O O
3B O O
and O O
C O O
, O O
lane O O
3 O O
-RRB- O O
. O O

Supershift O O
experiments O O
revealed O O
that O O
these O O
complexes O O
were O O
composed O O
of O O
Oct1 O O
and O O
BOB.1/OBF.1 O O
-LRB- O O
Figure O O
3 O O
, O O
lanes O O
4 O O
and O O
5 O O
-RRB- O O
. O O

BOB.1/OBF.1-specific O O

antibodies O O
prevented O O
ternary O O
complex O O
formation O O
. O O

However B-conn Concession.Contra-expectation
, O O
an O O
Oct1 O O
binding O O
was O O
still O O
possible O O
under O O
these O O
conditions O O
using O O
the O O
consensus O O
octamer O O
site O O
as O O
labeled O O
probe O O
-LRB- O O
compare O O
lanes O O
2 O O
, O O
4 O O
and O O
8 O O
in O O
Figure O O
3A O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
only O O
very O O
weak O O
Oct1 O O
binding O O
could O O
be O O
detected O O
with O O
the O O
non-consensus O O
Btk-octamer O O
motifs O O
-LRB- O O
lanes O O
2 O O
, O O
4 O O
and O O
8 O O
in O O
Figures O O
3B O O
and O O
C O O
-RRB- O O
. O O

Moreover B-conn Conjunction
, O O
the O O
addition O O
of O O
anti-Oct1 O O
antibodies O O
leads O O
to O O
a O O
clear O O
Oct1 O O
supershift O O
when B-conn Temporal.Synchronous
the O O
consensus O O
octamer O O
site O O
was O O
used O O
as O O
probe O O
-LRB- O O
Figure O O
3A O O
, O O
lane O O
5 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
no O O
clear O O
Oct1 O O
supershift O O
could O O
be O O
detected O O
with O O
the O O
Btk O O
octamer O O
sites O O
-LRB- O O
Figures O O
3B O O
and O O
C O O
, O O
lane O O
5 O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
the O O
ternary O O
complex O O
formation O O
was O O
prevented O O
, O O
indicating O O
that O O
this O O
complex O O
is O O
composed O O
of O O
BOB.1/OBF.1 O O
and O O
Oct1 O O
. O O

The O O
addition O O
of O O
an O O
anti-Oct2 O O
antibody O O
did O O
not O O
interfere O O
with O O
complex O O
formation O O
-LRB- O O
Figure O O
3 O O
, O O
lane O O
6 O O
-RRB- O O
, O O
since B-conn Cause.Reason
HeLa O O
cells O O
do O O
not O O
express O O
Oct2 O O
. O O

These O O
data O O
indicate O O
that O O
in O O
case O O
of O O
the O O
non-consensus O O
octamer O O
sites O O
BOB.1/OBF.1 O O
supports O O
the O O
binding O O
of O O
Oct1 O O
. O O

To B-conn Purpose.Goal
investigate O O
whether O O
BOB.1/OBF.1 O O
binds O O
to O O
the O O
Btk O O
promoter O O
in O O
vivo O O
, O O
ChIP O O
experiments O O
were O O
performed O O
using O O
primary O O
B O O
cells O O
isolated O O
from O O
spleens O O
of O O
wild-type O O
mice O O
. O O

Oct1 O O
, O O
Oct2 O O
and O O
BOB.1/OBF.1 O O
are O O
all O O
bound O O
to O O
the O O
murine O O
Btk O O
promoter O O
in O O
B O O
cells O O
in O O
vivo O O
albeit B-conn Concession.Contra-expectation
with O O
reduced O O
affinity O O
in O O
comparison O O
to O O
the O O
H2B O O
promoter O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

To B-conn Purpose.Goal
control O O
for O O
the O O
specificity O O
of O O
the O O
ChIP O O
experiments O O
, O O
antibodies O O
recognizing O O
unrelated O O
proteins O O
-LRB- O O
PLCγ1 O O
and O O
Lyn O O
-RRB- O O
were O O
used O O
for O O
precipitation O O
. O O

No O O
signals O O
were O O
observed O O
in O O
these O O
controls O O
-LRB- O O
Figure O O
4 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
no O O
binding O O
of O O
any O O
of O O
these O O
proteins O O
to O O
the O O
murine O O
Pax5 O O
promoter O O
that O O
does O O
not O O
contain O O
an O O
octamer O O
motif O O
could O O
be O O
observed O O
. O O

Since B-conn Cause.Reason
we O O
observed O O
binding O O
of O O
BOB.1/OBF.1 O O
together O O
with O O
Oct O O
to O O
the O O
Btk O O
promoter O O
, O O
we O O
asked O O
whether O O
this O O
binding O O
results O O
in O O
the O O
activation O O
of O O
Btk O O
promoter O O
activity O O
. O O

Therefore B-conn Cause.Result
, O O
the O O
murine O O
Btk O O
promoter O O
was O O
cloned O O
in O O
front O O
of O O
a O O
luciferase O O
reporter O O
gene O O
and O O
transfected O O
into O O
NIH/3T3 O O
cells O O
along O O
with O O
Oct2 O O
, O O
BOB.1/OBF1 O O
or O O
with O O
combinations O O
of O O
these O O
expression O O
vectors O O
. O O

Consistent O O
with O O
our O O
binding O O
studies O O
, O O
we O O
observed O O
that O O
BOB.1/OBF.1 O O
together O O
with O O
Oct2 O O
was O O
able O O
to O O
activate O O
the O O
murine O O
Btk O O
promoter O O
∼150-fold O O
in O O
a O O
dose-dependent O O
manner O O
-LRB- O O
Figure O O
5A O O
, O O
B O O
and O O
data O O
not O O
shown O O
-RRB- O O
. O O

Notably B-conn Restatement.Specification
, O O
Oct2 O O
together O O
with O O
BOB.1/OBF.1 O O
was O O
a O O
potent O O
inducer O O
of O O
Btk O O
promoter O O
activity O O
, O O
whereas B-conn Contrast
Oct1 O O
had O O
no O O
effect O O
at O O
all O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Since B-conn Cause.Reason
the O O
transcription O O
factor O O
PU.1 O O
was O O
shown O O
to O O
be O O
important O O
for O O
the O O
Btk O O
promoter O O
activity O O
and B-conn Conjunction
the O O
PU.1 O O
sites O O
are O O
conserved O O
between O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
-LRB- O O
Figure O O
1 O O
-RRB- O O
, O O
we O O
wondered O O
whether O O
Oct2 O O
and O O
BOB.1/OBF.1 O O
can O O
enhance O O
PU.1-mediated O O
transactivation O O
of O O
the O O
Btk O O
promoter O O
. O O

Transfection O O
experiments O O
using O O
NIH/3T3 O O
cells O O
revealed O O
that O O
BOB.1/OBF.1 O O
together O O
with O O
PU.1 O O
only O O
marginally O O
enhanced O O
PU.1-mediated O O
Btk O O
promoter O O
activity O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
co-transfection O O
of O O
Oct2 O O
together O O
with O O
PU.1 O O
stimulated O O
PU.1-mediated O O
Btk O O
promoter O O
activity O O
significantly O O
-LRB- O O
from O O
6- O O
to O O
75-fold O O
-RRB- O O
. O O

Moreover B-conn Conjunction
, O O
co-transfection O O
of O O
PU.1 O O
together O O
with O O
Oct2 O O
and O O
BOB.1/OBF.1 O O
led O O
to O O
an O O
even O O
stronger O O
and O O
synergistic O O
activation O O
-LRB- O O
325-fold O O
-RRB- O O
of O O
the O O
murine O O
Btk O O
promoter O O
-LRB- O O
Figure O O
5C O O
-RRB- O O
. O O

In B-conn Restatement.Generalization
conclusion I-conn Restatement.Generalization
these O O
findings O O
indicate O O
that O O
the O O
transcriptional O O
coactivator O O
BOB.1/OBF.1 O O
regulates O O
the O O
Btk O O
promoter O O
activity O O
in O O
B O O
cells O O
in O O
vitro O O
as O O
well O O
as O O
in O O
vivo O O
, O O
in O O
concert O O
with O O
Oct O O
and O O
PU.1 O O
proteins O O
. O O

To B-conn Purpose.Goal
further O O
analyze O O
the O O
in O O
vivo O O
relevance O O
of O O
the O O
Btk O O
promoter O O
octamer O O
motif O O
we O O
mutated O O
the O O
octamer O O
sequence O O
from O O
AGGCAAAT O O
to O O
AGtacAAT O O
. O O

This O O
mutation O O
prevented O O
binding O O
of O O
Oct O O
transcription O O
factors O O
-LRB- O O
Figure O O
2C O O
-RRB- O O
. O O

When B-conn Temporal.Synchronous
this O O
mutated O O
construct O O
was O O
transfected O O
into O O
the O O
murine O O
B O O
cell O O
line O O
S194 O O
the O O
activity O O
was O O
reduced O O
to O O
60 O O
% O O
compared O O
with O O
the O O
wild-type O O
Btk O O
promoter O O
-LRB- O O
Figure O O
6A O O
-RRB- O O
. O O

This O O
demonstrates O O
that O O
the O O
octamer O O
motif O O
significantly O O
contributes O O
to O O
overall O O
promoter O O
activity O O
in O O
addition O O
to O O
the O O
PU.1 O O
and O O
Sp1/Sp3 O O
binding O O
sites O O
. O O

A O O
prediction O O
based O O
on O O
this O O
result O O
would O O
be O O
that O O
Btk O O
expression O O
should O O
be O O
attenuated O O
in O O
B O O
cells O O
lacking O O
BOB.1/OBF.1 O O
expression O O
. O O

We O O
therefore B-conn Cause.Result
examined O O
IL-7-dependent O O
and O O
stroma O O
cell-dependent O O
pre O O
B O O
cell O O
lines O O
established O O
from O O
the O O
bone O O
marrow O O
of O O
wild O O
type O O
and O O
BOB.1/OBF.1−/− O O

mice O O
for O O
expression O O
of O O
Btk O O
-LRB- O O
Figure O O
6B O O
-RRB- O O
. O O

Indeed B-conn Reinforcement
, O O
Btk O O
protein O O
expression O O
is O O
reduced O O
in O O
BOB.1/OBF.1−/− O O

pre O O
B O O
cells O O
. O O

The O O
requirement O O
of O O
BOB.1/OBF.1 O O
for O O
Btk O O
expression O O
in O O
pre-B O O
cell O O
lines O O
was O O
further B-conn Conjunction
analysed O O
in O O
IL-7-dependent O O
cell O O
lines O O
expressing O O
a O O
conditional O O
BOB.1/OBF.1 O O
transgene O O
on O O
a O O
BOB.1/OBF.1−/− O O

mutant O O
background O O
. O O

To B-conn Purpose.Goal
achieve O O
conditional O O
expression O O
of O O
BOB.1.OBF.1 O O
the O O
tet-off O O
system O O
was O O
used O O
-LRB- O O
27,56,59 O O
-RRB- O O
. O O

In O O
the O O
absence O O
of O O
Doxycyclin O O
-LRB- O O
Dox O O
-RRB- O O
the O O
co-activator O O
BOB.1/OBF.1 O O
is O O
expressed O O
, O O
whereas B-conn Contrast
in O O
the O O
presence O O
of O O
Dox O O
its O O
expression O O
is O O
repressed O O
. O O

RNA O O
was O O
prepared O O
from O O
either O O
untreated O O
or O O
Dox O O
treated O O
pre-B O O
cells O O
and O O
analysed O O
in O O
northern O O
blot O O
experiments O O
. O O

When B-conn Temporal.Synchronous
BOB.1/OBF.1 O O
expression O O
was O O
shut-off O O
by B-conn Purpose.Enablement
doxycyclin O O
addition O O
, O O
the O O
expression O O
of O O
Btk O O
was O O
reduced O O
further O O
supporting O O
the O O
clear O O
dependence O O
of O O
Btk O O
expression O O
in O O
pre-B O O
cells O O
on O O
BOB.1/OBF.1 O O
-LRB- O O
Figure O O
6C O O
-RRB- O O
. O O

To B-conn Purpose.Goal
investigate O O
, O O
whether O O
the O O
down-regulation O O
of O O
Btk O O
expression O O
in O O
the O O
absence O O
of O O
BOB.1/OBF.1 O O
is O O
also O O
seen O O
in O O
mature O O
B220+ O O
cells O O
, O O
these O O
cells O O
were O O
sorted O O
by O O
FACS O O
from O O
spleens O O
of O O
wild O O
type O O
and O O
BOB.1/OBF.1−/− O O

mice O O
and O O
analyzed O O
by O O
protein O O
immunoblot O O
. O O

Again O O
, O O
Btk O O
expression O O
was O O
strongly O O
reduced O O
in O O
B220+ O O
BOB.1/OBF.1−/− O O

cells O O
in O O
comparison O O
with O O
wild-type O O
cells O O
-LRB- O O
Figure O O
6D O O
-RRB- O O
. O O

Furthermore B-conn Conjunction
, O O
in O O
northern O O
blot O O
analyses O O
of O O
RNA O O
prepared O O
from O O
splenocytes O O
of O O
wild O O
type O O
or O O
BOB.1/OBF.1−/− O O

mice O O
a O O
reduced O O
Btk–mRNA O O
expression O O
was O O
detected O O
when B-conn Temporal.Synchronous
BOB.1/OBF.1 O O
is O O
not O O
expressed O O
-LRB- O O
Figure O O
6E O O
-RRB- O O
. O O

Together O O
, O O
these O O
experiments O O
clearly O O
indicate O O
the O O
physiological O O
importance O O
of O O
BOB.1/OBF.1 O O
for O O
the O O
B-cell-specific O O
expression O O
of O O
Btk O O
. O O

DISCUSSION O O

The O O
regulation O O
of O O
B O O
cell O O
type-specific O O
gene O O
expression O O
plays O O
an O O
essential O O
role O O
for O O
B O O
cell O O
generation O O
, O O
maturation O O
, O O
development O O
and O O
function O O
. O O

A O O
large O O
number O O
of O O
transcription O O
factors O O
have O O
been O O
shown O O
to O O
be O O
involved O O
in O O
the O O
regulation O O
of O O
B O O
cell O O
fate O O
-LRB- O O
60 O O
-RRB- O O
. O O

One O O
of O O
those O O
factors O O
is O O
the O O
transcriptional O O
coactivator O O
BOB.1/OBF.1 O O
, O O
which O O
enhances O O
the O O
transcriptional O O
activity O O
of O O
the O O
Oct1 O O
and O O
Oct2 O O
transcription O O
factors O O
. O O

To B-conn Purpose.Goal
get O O
more O O
insights O O
into O O
the O O
physiological O O
role O O
of O O
BOB.1/OBF.1 O O
the O O
transcriptional O O
network O O
controlled O O
by O O
BOB.1/OBF.1 O O
needs O O
to O O
be O O
elucidated O O
. O O

Here O O
we O O
show O O
that O O
BOB.1/OBF.1 O O
regulates O O
Btk O O
gene O O
expression O O
. O O

Although B-conn Concession.Expectation
the O O
Btk O O
promoter O O
had O O
been O O
analyzed O O
quite O O
extensively O O
for O O
binding O O
of O O
transcription O O
factors O O
-LRB- O O
44–49 O O
-RRB- O O
, O O
the O O
presence O O
of O O
a O O
functional O O
octamer O O
site O O
within O O
the O O
first O O
200 O O
bp O O
upstream O O
of O O
the O O
start O O
site O O
of O O
transcription O O
had O O
not O O
been O O
reported O O
. O O

Although B-conn Concession.Expectation
footprint O O
experiments O O
identified O O
a O O
protected O O
region O O
in O O
the O O
human O O
Btk O O
promoter O O
region O O
extending O O
from O O
−130 O O
to O O
−152 O O
bp O O
-LRB- O O
the O O
human O O
Btk O O
promoter O O
octamer O O
motif O O
is O O
located O O
at O O
−145 O O
to O O
−152 O O
bp O O
; O O
see O O
Figure O O
1 O O
-RRB- O O
, O O
this O O
area O O
was O O
only O O
analyzed O O
for O O
the O O
binding O O
of O O
Sp1/3 O O
factors O O
to O O
the O O
GC O O
rich O O
box O O
-LRB- O O
48 O O
-RRB- O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
DNA O O
probe O O
used O O
in O O
gel O O
shift O O
experiments O O
to O O
detect O O
Sp1/3 O O
binding O O
did O O
not O O
encompass O O
the O O
octamer O O
motif O O
. O O

Therefore B-conn Cause.Result
, O O
protein–DNA O O
complexes O O
reflecting O O
Oct O O
binding O O
to O O
the O O
Btk O O
promoter O O
could O O
not O O
be O O
observed O O
in O O
these O O
experiments O O
. O O

Furthermore B-conn Conjunction
, O O
in O O
search O O
for O O
factors O O
involved O O
in O O
cell-type-specific O O
Btk O O
expression O O
, O O
those O O
protein O O
complexes O O
observed O O
in O O
gel O O
shift O O
experiments O O
were O O
excluded O O
from O O
detailed O O
analyses O O
that O O
were O O
found O O
to O O
bind O O
to O O
the O O
Btk O O
promoter O O
also O O
in O O
cells O O
were O O
Btk O O
is O O
not O O
expressed O O
such O O
as O O
T O O
cells O O
and O O
fibroblasts O O
-LRB- O O
46 O O
-RRB- O O
. O O

However B-conn Concession.Contra-expectation
, O O
Oct O O
proteins O O
are O O
not O O
exclusively O O
expressed O O
in O O
B O O
cells O O
and B-conn Conjunction
Oct1 O O
is O O
also O O
found O O
in O O
T O O
cells O O
and O O
fibroblasts O O
. O O

We O O
could O O
show O O
that O O
Oct1 O O
as O O
well O O
Oct2 O O
are O O
able O O
to O O
bind O O
to O O
the O O
murine O O
as O O
well O O
to O O
the O O
human O O
Btk O O
promoter O O
, O O
albeit B-conn Concession.Contra-expectation
this O O
binding O O
activity O O
was O O
much O O
weaker O O
than O O
that O O
observed O O
using O O
a O O
consensus O O
octamer O O
site O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
ternary O O
complexes O O
composed O O
of O O
Oct1 O O
and O O
BOB.1/OBF.1 O O
could O O
be O O
detected O O
on O O
the O O
murine O O
and O O
human O O
Btk O O
Oct O O
sites O O
in O O
a O O
reconstituted O O
system O O
. O O

This O O
clearly O O
demonstrates O O
that O O
Oct O O
proteins O O
together O O
with O O
BOB.1/OBF.1 O O
are O O
able O O
to O O
bind O O
to O O
the O O
non-perfect O O
Oct O O
motifs O O
found O O
in O O
the O O
Btk O O
promoter O O
in O O
vitro O O
. O O

Interestingly O O
, O O
whereas B-conn Contrast
in O O
the O O
absence O O
of O O
BOB.1/OBF.1 O O
only O O
a O O
weak O O
binding O O
of O O
Oct O O
factors O O
was O O
observed O O
, O O
the O O
ternary O O
complex O O
formation O O
was O O
found O O
similar O O
to O O
that O O
formed O O
on O O
the O O
consensus O O
octamer O O
motif O O
. O O

Similar O O
results O O
were O O
observed O O
when B-conn Temporal.Synchronous
the O O
Oct-dependent O O
and O O
BOB.1/OBF.1-dependent O O

osteopontin O O
promoter O O
had O O
been O O
analyzed O O
-LRB- O O
61,62 O O
-RRB- O O
. O O

This O O
promoter O O
contains O O
a O O
PORE O O
-LRB- O O
Palindromic O O
Oct O O
factor O O
Recognition O O
Element O O
; O O
ATTTG O O
-LRB- O O
N5 O O
-RRB- O O
CAAAT O O
-RRB- O O
that O O
enables O O
Oct O O
factors O O
to O O
assemble O O
homo- O O
or O O
hetero-dimers O O
at O O
this O O
site O O
in O O
vitro O O
. O O

The O O
PORE-mediated O O
Oct O O
dimerization O O
was O O
suggested O O
to O O
be O O
an O O
essential O O
prerequisite O O
for O O
binding O O
of O O
BOB.1/OBF.1 O O
to O O
such O O
an O O
octamer O O
site O O
-LRB- O O
63 O O
-RRB- O O
. O O

These O O
studies O O
also B-conn Conjunction
demonstrated O O
that O O
the O O
transversion O O
T→G O O
at O O
the O O
second O O
position O O
of O O
the O O
consensus O O
octamer O O
site O O
-LRB- O O
identified O O
in O O
the O O
murine O O
Btk O O
promoter O O
-RRB- O O
impairs O O
Oct O O
binding O O
. O O

However B-conn Contrast
, O O
luciferase O O
reporter O O
assays O O
revealed O O
that O O
the O O
T→G O O
transversion O O
results O O
in O O
increased O O
promoter O O
activity O O
in O O
comparison O O
to O O
the O O
wild-type O O
PORE O O
promoter O O
-LRB- O O
62 O O
-RRB- O O
. O O

In O O
line O O
with O O
this O O
observation O O
it O O
was O O
shown O O
that O O
the O O
presence O O
of O O
BOB.1/OBF.1 O O
enables O O
Oct O O
factors O O
to O O
bind O O
to O O
this O O
unfavorable O O
non-consensus O O
octamer O O
motifs O O
-LRB- O O
62 O O
-RRB- O O
. O O

Although B-conn Concession.Expectation
the O O
octamer O O
motifs O O
identified O O
in O O
Btk O O
promoter O O
do O O
not O O
represent O O
classical O O
PORE O O
motifs O O
, O O
we O O
show O O
here O O
that O O
Oct O O
proteins O O
and O O
BOB.1/OBF.1 O O
bind O O
to O O
this O O
site O O
in O O
vitro O O
. O O

Thus B-conn Cause.Result
the O O
presence O O
of O O
BOB.1/OBF.1 O O
facilitates O O
binding O O
of O O
Oct O O
proteins O O
to O O
at O O
least O O
a O O
subset O O
of O O
non-consensus O O
octamer O O
motifs O O
. O O

ChiP O O
experiments O O
revealed O O
that O O
ternary O O
complex O O
formation O O
also B-conn Conjunction
occurs O O
in O O
vivo O O
. O O

Furthermore B-conn Conjunction
, O O
Oct O O
and O O
BOB.1/OBF.1 O O
proteins O O
act O O
in O O
synergy O O
with O O
PU.1—a O O
previously O O
identified O O
factor O O
important O O
for O O
Btk O O
promoter O O
regulation O O
-LRB- O O
46,48,49 O O
-RRB- O O
—to O O
induce O O
Btk O O
promoter O O
activity O O
. O O

Since B-conn Cause.Reason
the O O
PU.1 O O
binding O O
site O O
identified O O
in O O
the O O
human O O
Btk O O
promoter O O
is O O
conserved O O
and O O
present O O
in O O
the O O
murine O O
Btk O O
promoter O O
-LRB- O O
Figure O O
1 O O
-RRB- O O
we O O
suggest O O
that O O
the O O
mechanism O O
of O O
Btk O O
gene O O
regulation O O
by O O
Oct/BOB.1/OBF.1 O O
and O O
PU.1 O O
is O O
conserved O O
between O O
mouse O O
and O O
humans O O
. O O

The O O
importance O O
of O O
PU.1 O O
for O O
Btk O O
gene O O
regulation O O
is O O
underlined O O
by O O
the O O
fact O O
that O O
the O O
absence O O
of O O
PU.1 O O
leads O O
to O O
a O O
two- O O
to O O
3-fold O O
reduction O O
of O O
Btk O O
expression O O
-LRB- O O
48 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
deficiency O O
of O O
Sp1 O O
that O O
also O O
stimulates O O
Btk O O
promoter O O
activity O O
together O O
with O O
PU.1 O O
-LRB- O O
49 O O
-RRB- O O
had O O
no O O
influence O O
on O O
Btk O O
expression O O
-LRB- O O
49 O O
-RRB- O O
. O O

Here O O
we O O
showed O O
that O O
BOB.1/OBF.1-deficiency O O

results O O
in O O
a O O
severe O O
reduction O O
of O O
Btk O O
expression O O
in O O
immature O O
bone O O
marrow O O
derived O O
pre-B O O
cells O O
as O O
well O O
as O O
in O O
peripheral O O
B220+ O O
splenocytes O O
. O O

These O O
data O O
indicate O O
the O O
physiological O O
importance O O
of O O
Oct/BOB.1/OBF.1 O O
together O O
with O O
PU.1 O O
in O O
B O O
cell-specific O O
Btk O O
gene O O
regulation O O
at O O
early O O
and O O
late O O
stages O O
of O O
B O O
cell O O
development O O
. O O

If B-conn Condition.Factual
Btk O O
is O O
a O O
direct O O
target O O
of O O
BOB.1/OBF.1 O O
the O O
phenotype O O
of O O
mice O O
deficient O O
in O O
either O O
BOB.1/OBF.1 O O
or O O
Btk O O
should O O
be O O
related O O
. O O

Indeed B-conn Reinforcement
, O O
both O O
knock-out O O
mice O O
share O O
similar O O
characteristics O O
, O O
like O O
defects O O
in O O
B O O
cell O O
development O O
in O O
bone O O
marrow O O
and O O
spleen O O
, O O
resulting O O
in O O
a O O
2- O O
to O O
4-fold O O
reduction O O
of O O
peripheral O O
B O O
cell O O
number O O
and O O
defects O O
in O O
B O O
cell O O
receptor O O
signaling O O
. O O

However B-conn Concession.Contra-expectation
, O O
both O O
knock-out O O
mice O O
have O O
also O O
unique O O
features O O
: O O
whereas B-conn Contrast
the O O
marginal O O
zone O O
B O O
cell O O
compartment O O
is O O
almost O O
missing O O
in O O
BOB.1/OBF.1−/− O O

mice O O
-LRB- O O
27 O O
-RRB- O O
this O O
B O O
cell O O
subset O O
was O O
found O O
normal O O
in O O
Xid O O
mice O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
B-1 O O
population O O
is O O
depleted O O
in O O
Xid O O
mice O O
-LRB- O O
33,34,64 O O
-RRB- O O
and O O
normal O O
in O O
BOB.1/OBF.1−/− O O

mice O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
mice O O
mutant O O
for O O
both O O
proteins O O
show O O
a O O
more O O
severe O O
defect O O
than O O
each O O
mouse O O
itself O O
. O O

This O O
phenotype O O
resembles O O
that O O
of O O
severe O O
agammaglobulinemia O O
in O O
human O O
XLA O O
-LRB- O O
31,39 O O
-RRB- O O
. O O

Therefore B-conn Cause.Claim
, O O
Btk O O
and O O
BOB.1/OBF.1 O O
seem O O
to O O
be O O
involved O O
in O O
overlapping O O
as O O
well O O
as O O
distinct O O
signaling O O
pathways O O
. O O

Taken O O
together O O
, O O
the O O
analyses O O
of O O
the O O
murine O O
and O O
human O O
Btk O O
promoter O O
revealed O O
the O O
presence O O
of O O
a O O
functional O O
octamer O O
motif O O
. O O

The O O
transcription O O
factors O O
Oct1/2 O O
as O O
well O O
as O O
the O O
coactivator O O
BOB.1/OBF.1 O O
bind O O
to O O
these O O
sites O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

The O O
physiological O O
relevance O O
of O O
the O O
octamer O O
was O O
shown O O
in O O
BOB.1/OBF.1−/− O O

B O O
cells O O
were O O
the O O
expression O O
of O O
Btk O O
is O O
strongly O O
reduced O O
. O O

The O O
finding O O
that O O
the O O
presence O O
of O O
BOB.1/OBF.1 O O
facilitates O O
the O O
binding O O
of O O
Oct O O
factors O O
to O O
the O O
non-consensus O O
octamer O O
sequence O O
identified O O
in O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
could O O
reflect O O
a O O
mechanism O O
of O O
fine-tuned O O
regulation O O
of O O
promoter O O
activity O O
depending O O
on O O
Oct O O
and O O
BOB.1/OBF.1 O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Comparative O O
analysis O O
of O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
. O O

Nucleotide O O
sequences O O
of O O
the O O
human O O
-LRB- O O
+33 O O
to O O
−232 O O
bp O O
-RRB- O O
and O O
murine O O
-LRB- O O
+33 O O
to O O
−243 O O
bp O O
-RRB- O O
Btk O O
promoters O O
are O O
presented O O
. O O

The O O
positions O O
of O O
the O O
octamer O O
motif O O
, O O
the O O
GT- O O
, O O
GC- O O
and O O
Pu-boxes O O
as O O
well O O
as O O
the O O
initiator O O
site O O
and O O
the O O
start O O
site O O
of O O
transcription O O
-LRB- O O
+1 O O
-RRB- O O
are O O
indicated O O
. O O

Figure O O
2 O O
: O O
Octamer O O
factors O O
Oct1 O O
and O O
Oct2 O O
bind O O
to O O
the O O
non-consensus O O
octamer O O
site O O
of O O
the O O
murine O O
and O O
human O O
Btk O O
promoters O O
. O O

-LRB- O O
A O O
and O O
B O O
-RRB- O O
EMSA O O
with O O
nuclear O O
extracts O O
from O O
the O O
B O O
cell O O
line O O
BJAB O O
and O O
labeled O O
probes O O
presenting O O
either O O
a O O
consensus O O
octamer O O
site O O
-LRB- O O
Oct O O
cons O O
-RRB- O O
or O O
the O O
non-conserved O O
octamer O O
site O O
identified O O
in O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
-LRB- O O
murBtkprom O O
, O O
humBtkprom O O
-RRB- O O
. O O

Competitor O O
binding O O
sites O O
with O O
the O O
wild-type O O
-LRB- O O
murBtkprom O O
, O O
humBtkprom O O
-RRB- O O
or O O
mutated O O
octamer O O
mortif O O
from O O
the O O
Btk O O
promoter O O
-LSB-mBtkprom O O
Mut O O
, O O
humBtkprom O O
Mut O O
; O O
the O O
octamer O O
motifs O O
A O O
-LRB- O O
A/G O O
-RRB- O O
GCAAAT O O
were O O
mutated O O
to O O
AgtacAAT O O
-RSB- O O
or O O
with O O
the O O
consensus O O
octamer O O
-LRB- O O
Oct O O
cons O O
-RRB- O O
site O O
were O O
added O O
in O O
different O O
molar O O
excess O O
-LRB- O O
10× O O
, O O
30× O O
, O O
100× O O
-RRB- O O
. O O

-LRB- O O
C O O
-RRB- O O
The O O
mutated O O
sites O O
were O O
also O O
unable O O
to O O
bind O O
Oct1 O O
or O O
Oct2 O O
proteins O O
when O O
tested O O
as O O
labeled O O
probes O O
. O O

-LRB- O O
D O O
-RRB- O O
EMSA O O
supershift O O
with O O
the O O
indicated O O
probes O O
and O O
antibodies O O
specific O O
for O O
Oct1 O O
and O O
Oct2 O O
. O O

EMSA O O
experiments O O
using O O
the O O
non-conserved O O
octamer O O
site O O
identified O O
in O O
the O O
human O O
and O O
murine O O
Btk O O
promoters O O
-LRB- O O
murBtkprom O O
, O O
humBtkprom O O
-RRB- O O
were O O
exposed O O
three-times O O
longer O O
than O O
experiments O O
where O O
the O O
wild-type O O
octamer O O
was O O
used O O
. O O

Figure O O
3 O O
: O O
Ternary O O
complex O O
formation O O
on O O
Btk O O
promoter O O
octamer O O
motifs O O
. O O

EMSA O O
experiments O O
with O O
HeLa O O
nuclear O O
extracts O O
were O O
performed O O
using O O
labeled O O
probes O O
bearing O O
either O O
a O O
consensus O O
octamer O O
motif O O
-LRB- O O
cons O O
Oct O O
site O O
-RRB- O O
or O O
the O O
octamer O O
sequences O O
identified O O
within O O
the O O
murine O O
or O O
human O O
Btk O O
promoter O O
-LRB- O O
Oct-hum O O
Btk O O
prom O O
, O O
Oct-mur O O
Btk O O
prom O O
-RRB- O O
. O O

Unprogrammed O O
reticulocyte O O
lysate O O
or O O
in O O
vitro O O
translated O O
BOB.1/OBF.1 O O
protein O O
were O O
included O O
. O O

Complexes O O
were O O
analyzed O O
by B-conn Purpose.Enablement
adding O O
specific O O
antibodies O O
for O O
Oct1 O O
, O O
Oct2 O O
or O O
BOB.1/OBF.1 O O
as O O
indicated O O
. O O

Figure O O
4 O O
: O O
ChIP O O
assay O O
. O O

BOB.1/OBF.1 O O
binds O O
together O O
with O O
Oct1 O O
and O O
Oct2 O O
to O O
the O O
murine O O
Btk O O
promoter O O
. O O

The O O
chromatin O O
of O O
primary O O
wild-type O O
B O O
cells O O
was O O
cross-linked O O
, O O
sheared O O
and O O
immunoprecipitated O O
with O O
the O O
indicated O O
antibodies O O
. O O

Immunoprecipitated O O
DNA O O
was O O
purified O O
and O O
used O O
as O O
template O O
in O O
PCR O O
with O O
primers O O
specific O O
for O O
the O O
murine O O
Btk O O
promoter O O
-LRB- O O
−280 O O
to O O
−10 O O
-RRB- O O
, O O
or O O
for O O
the O O
H2B O O
and O O
Pax5 O O
promoters O O
as O O
internal O O
controls O O
. O O

Chromatin O O
immunoprecipitated O O
with O O
anti-PLCγ1 O O
and O O
anti-Lyn O O
antibodies O O
was O O
included O O
as O O
negative O O
controls O O
. O O

Amplified O O
products O O
were O O
detected O O
on O O
ethidium O O
bromide O O
stained O O
agarose O O
gels O O
. O O

Figure O O
5 O O
: O O
Analysis O O
of O O
the O O
dependence O O
of O O
the O O
murine O O
Btk O O
promoter O O
activity O O
on O O
Oct O O
and O O
BOB.1/OBF.1 O O
proteins O O
in O O
transient O O
transfection O O
experiments O O
using O O
NIH/3T3 O O
fibroblasts O O
. O O

Activity O O
of O O
the O O
murine O O
Btk O O
promoter O O
without O O
co-transfection O O
was O O
set O O
to O O
one O O
. O O

The O O
fold O O
induction O O
upon B-conn Temporal.Synchronous
co-transfection O O
of O O
Oct2 O O
, O O
BOB.1/OBF.1 O O
or O O
PU.1 O O
or O O
combinations O O
of O O
these O O
expression O O
vectors O O
was O O
determined O O
. O O

The O O
experiments O O
were O O
repeated O O
five O O
times O O
and O O
mean O O
values O O
as O O
well O O
as O O
SD O O
were O O
determined O O
. O O

-LRB- O O
A O O
-RRB- O O
The O O
murine O O
Btk O O
promoter O O
is O O
induced O O
when O O
Oct2 O O
and O O
BOB.1/OBF.1 O O
are O O
coexpressed O O
. O O

-LRB- O O
B O O
-RRB- O O
The O O
activation O O
of O O
the O O
murine O O
Btk O O
promoter O O
by O O
Oct2 O O
and O O
BOB.1/OBF.1 O O
is O O
dose-dependent O O
. O O

-LRB- O O
C O O
-RRB- O O
Synergistic O O
activation O O
of O O
the O O
murine O O
Btk O O
promoter O O
by O O
Oct2 O O
, O O
BOB.1/OBF.1 O O
, O O
and O O
PU.1 O O
. O O

Figure O O
6 O O
: O O
The O O
transcriptional O O
coactivator O O
BOB.1/OBF.1 O O
is O O
critical O O
for O O
Btk O O
expression O O
in O O
vivo O O
. O O

-LRB- O O
A O O
-RRB- O O
Mutations O O
within O O
the O O
octamer O O
motif O O
of O O
the O O
murine O O
btk O O
promoter O O
lead O O
to O O
a O O
reduction O O
of O O
promoter O O
activity O O
. O O

The O O
murine O O
S194 O O
B O O
cell O O
line O O
was O O
transfected O O
with O O
either O O
the O O
wild O O
type O O
-LRB- O O
murBtk O O
pr O O
-RRB- O O
or O O
the O O
mutant O O
Btk O O
promoter O O
-LRB- O O
mBtk O O
pr O O
Mut O O
-RRB- O O
. O O

The O O
activity O O
of O O
the O O
wild-type O O
promoter O O
was O O
set O O
to O O
100 O O
% O O
. O O

The O O
activity O O
of O O
the O O
mutant O O
Btk O O
promoter O O
was O O
determined O O
relative O O
to O O
the O O
wild-type O O
promoter O O
activity O O
. O O

The O O
experiments O O
were O O
repeated O O
five O O
times O O
and O O
mean O O
values O O
as O O
well O O
as O O
SD O O
were O O
determined O O
. O O

-LRB- O O
B O O
-RRB- O O
Protein O O
extracts O O
from O O
pre O O
B O O
cell O O
lines O O
established O O
from O O
the O O
bone O O
marrow O O
of O O
wild O O
type O O
or O O
BOB.1/OBF.1−/−mice O O

were O O
analyzed O O
for O O
Btk O O
expression O O
by O O
western O O
blot O O
. O O

-LRB- O O
C O O
-RRB- O O
RNA O O
prepared O O
from O O
bone O O
marrow O O
derived O O
pre O O
B O O
cell O O
lines O O
, O O
established O O
from O O
mice O O
expressing O O
a O O
conditional O O
BOB.1/OBF.1 O O
transgene O O
on O O
a O O
BOB.1/OBF.1-mutant O O

background O O
, O O
was O O
analyzed O O
for O O
Btk O O
mRNA O O
expression O O
by O O
northern O O
blot O O
. O O

In O O
the O O
absence O O
of O O
Doxycyclin O O
-LRB- O O
Dox O O
-RRB- O O
the O O
co-activator O O
BOB.1/OBF.1 O O
is O O
expressed O O
, O O
whereas B-conn Contrast
in O O
the O O
presence O O
of O O
Dox O O
its O O
expression O O
is O O
repressed O O
. O O

-LRB- O O
D O O
-RRB- O O
Protein O O
extracts O O
were O O
prepared O O
from O O
sorted O O
B220+mice O O
were O O
analyzed O O
for O O
Btk O O
expression O O
by O O
western O O
blot O O
. O O

-LRB- O O
C O O
-RRB- O O
RNA O O
prepared O O
from O O
bone O O
marrow O O
derived O O
pre O O
B O O
cell O O
lines O O
, O O
established O O
from O O
mice O O
expressing O O
a O O
conditional O O
BOB.1/OBF.1 O O
transgene O O
on O O
a O O
BOB.1/OBF.1-mutant O O

background O O
, O O
was O O
analyzed O O
for O O
Btk O O
mRNA O O
expression O O
by O O
northern O O
blot O O
. O O

In O O
the O O
absence O O
of O O
Doxycyclin O O
-LRB- O O
Dox O O
-RRB- O O
the O O
co-activator O O
BOB.1/OBF.1 O O
is O O
expressed O O
, O O
whereas O O
in O O
the O O
presence O O
of O O
Dox O O
its O O
expression O O
is O O
repressed O O
. O O

-LRB- O O
D O O
-RRB- O O
Protein O O
extracts O O
were O O
prepared O O
from O O
sorted O O
B220+ O O
splenocytes O O
from O O
either O O
wild O O
type O O
or O O
BOB.1/OBF.1−/− O O

mice O O
and O O
analyzed O O
for O O
Btk O O
expression O O
. O O

-LRB- O O
E O O
-RRB- O O
RNA O O
was O O
prepared O O
from O O
splenocytes O O
from O O
wild O O
type O O
or O O
BOB.1/OBF.1−/− O O

mice O O
and B-conn Conjunction
the O O
Btk–mRNA O O
expression O O
was O O
analyzed O O
by O O
northern O O
blot O O
. O O

RelA O O
-LRB- O O
p65 O O
-RRB- O O
or O O
GAPDH O O
were O O
used O O
as O O
loading O O
controls O O
. O O

WB O O
= O O
western O O
blot O O
; O O
NB O O
= O O
northern O O
blot O O
. O O

Mechanisms O O
Mediating O O
the O O
Biologic O O
Activity O O
of O O

Synthetic O O
Proline O O
, O O
Glycine O O
, O O
and O O
Hydroxyproline O O

Polypeptides O O
in O O
Human O O
Neutrophils O O

Abstract O O

The O O
accumulation O O
of O O
neutrophils O O
at O O
sites O O
of O O
tissue O O
injury O O
or O O

infection O O
is O O
mediated O O
by O O
chemotactic O O
factors O O
released O O
as O O
part O O
of O O

the O O
inflammatory O O
process O O
. O O

Some I-conn Cause.Reason
of O O
these O O
factors O O
are O O
generated O O
as B-conn Cause.Reason

a O O
direct O O
consequence O O
of O O
tissue O O
injury O O
or O O
infection O O
, O O
including O O

degradation O O
fragments O O
of O O
connective O O
tissue O O
collagen O O
and O O

bacterial- O O
or O O
viral-derived O O
peptides O O
containing O O
collagen-related O O

structural O O
motifs O O
. O O

In O O
these O O
studies O O
, O O
we O O
examined O O
biochemical O O

mechanisms O O
mediating O O
the O O
biologic O O
activity O O
of O O
synthetic O O

polypeptides O O
consisting O O
of O O
repeated O O
units O O
of O O
proline O O
-LRB- O O
Pro O O
-RRB- O O
, O O

glycine O O
-LRB- O O
Gly O O
-RRB- O O
, O O
and O O
hydroxyproline O O
-LRB- O O
Hyp O O
-RRB- O O
, O O
major O O
amino O O
acids O O
found O O

within O O
mammalian O O
and O O
bacterial O O
collagens O O
. O O

We O O
found O O
that O O
the O O

peptides O O
were O O
chemoattractants O O
for O O
neutrophils O O
. O O

Moreover B-conn Conjunction
, O O
their O O

chemotactic O O
potency O O
was O O
directly O O
related O O
to O O
their O O
size O O
and O O

composition O O
. O O

Thus B-conn Restatement.Specification
, O O
the O O
pentameric O O
peptides O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O

-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
were O O
more O O
active O O
in O O
inducing O O
chemotaxis O O
than O O

the O O
corresponding O O
decameric O O
peptides O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
and O O

-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
. O O

In B-conn Conjunction
addition I-conn Conjunction
, O O
the O O
presence O O
of O O
Hyp O O
in O O

peptides O O
reduced O O
chemotactic O O
activity O O
. O O

The O O
synthetic O O
peptides O O

were O O
also B-conn Conjunction
found O O
to O O
reduce O O
neutrophil O O
apoptosis O O
. O O

In O O
contrast O O
to O O

chemotaxis O O
, O O
this O O
activity O O
was O O
independent O O
of O O
peptide O O
size O O
or O O

composition O O
. O O

The O O
effects O O
of O O
the O O
peptides O O
on O O
both O O
chemotaxis O O
and O O

apoptosis O O
were O O
blocked O O
by O O
inhibitors O O
of O O
phosphatidylinositol O O

3-kinase O O
-LRB- O O
PI3-K O O
-RRB- O O
and O O
p38 O O
mitogen-activated O O
protein O O
-LRB- O O
MAP O O
-RRB- O O
kinase O O
. O O

However B-conn Concession.Contra-expectation
, O O
only O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
induced O O

expression O O
of O O
PI3-K O O
and O O
phosphorylation O O
of O O
p38 O O
MAP O O
kinase O O
, O O

suggesting O O
a O O
potential O O
mechanism O O
underlying O O
reduced O O
chemotactic O O

activity O O
of O O
Hyp-containing O O
peptides O O
. O O

Although B-conn Concession.Expectation
none O O
of O O
the O O

synthetic O O
peptides O O
tested O O
had O O
any O O
effect O O
on O O
intracellular O O
calcium O O

mobilization O O
, O O
each O O
induced O O
nuclear O O
binding O O
activity O O
of O O
the O O

transcription O O
factor O O
NF-κB O O
. O O

These O O
findings O O
indicate O O
that O O

polymeric O O
polypeptides O O
containing O O
Gly-X-Y O O
collagen-related O O

structural O O
motifs O O
promote O O
inflammation O O
by B-conn Purpose.Enablement
inducing O O
chemotaxis O O
and O O

blocking O O
apoptosis O O
. O O

However B-conn Concession.Contra-expectation
, O O
distinct O O
calcium-independent O O

signaling O O
pathways O O
appear O O
to O O
be O O
involved O O
in O O
these O O
activities O O
. O O

BACKGROUND O O

The O O
inflammatory O O
response O O
is O O
characterized O O
by O O
an O O
accumulation O O
of O O
neutrophils O O
at O O
sites O O
of O O
tissue O O
injury O O
and O O
infection O O
. O O

Neutrophils O O
respond O O
to O O
chemotactic O O
factors O O
including O O
connective O O
tissue O O
degradation O O
products O O
, O O
leukotriene O O
B4 O O
, O O
and O O
bacterially-derived O O
formylmethionine-leucine-phenylalanine O O
-LRB- O O
fMLP O O
-RRB- O O
, O O
released O O
from O O
damaged O O
tissue O O
or O O
by O O
invading O O
pathogens O O
. O O

In O O
previous O O
studies O O
we O O
demonstrated O O
that O O
collagenase O O
or O O
cyanogen O O
bromide O O
digests O O
of O O
native O O
collagen O O
, O O
as O O
well O O
as O O
synthetic O O
collagen-like O O
polypeptides O O
containing O O
glycine O O
-LRB- O O
Gly O O
-RRB- O O
, O O
proline O O
-LRB- O O
Pro O O
-RRB- O O
, O O
and O O
hydroxyproline O O
-LRB- O O
Hyp O O
-RRB- O O
are O O
potent O O
chemoattractants O O
for O O
human O O
neutrophils O O
-LSB-1 O O
, O O
2 O O
, O O
3 O O
-RSB- O O
. O O

These O O
polypeptides O O
also B-conn Conjunction
activated O O
macrophages O O
to O O
release O O
neutrophil O O
chemokines O O
-LSB-4 O O
-RSB- O O
. O O

The O O
present O O
studies O O
were O O
aimed O O
at O O
analyzing O O
mechanisms O O
mediating O O
the O O
biological O O
activity O O
of O O
collagen O O
degradation O O
products O O
using O O
synthetic O O
polypeptides O O
as O O
a O O
model O O
. O O

Synthetic O O
polypeptides O O
are O O
similar O O
to O O
degradation O O
products O O
generated O O
from O O
mammalian O O
collagen O O
and/or O O
to O O
collagen-related O O
structural O O
motifs O O
produced O O
by O O
bacteria O O
and O O
viruses O O
-LSB-5 O O
-RSB- O O
. O O

The O O
use O O
of O O
synthetic O O
model O O
peptides O O
of O O
varying O O
length O O
and O O
composition O O
allowed O O
us O O
to O O
perform O O
structure-activity O O
studies O O
. O O

Chemoattractants O O
such O O
as O O
fMLP O O
and O O
interleukin-8 O O
-LRB- O O
IL-8 O O
-RRB- O O
initiate O O
their O O
biological O O
activity O O
by B-conn Purpose.Enablement
binding O O
to O O
specific O O
cell O O
surface O O
receptors O O
. O O

For O O
most O O
chemoattractants O O
, O O
this O O
is O O
followed O O
by O O
mobilization O O
of O O
intracellular O O
calcium O O
, O O
activation O O
of O O
protein O O
kinases O O
, O O
and O O
translocation O O
and O O
binding O O
of O O
transcription O O
factors O O
to O O
consensus O O
sequences O O
in O O
promoter O O
regions O O
of O O
genes O O
regulating O O
the O O
inflammatory O O
response O O
-LSB-6 O O
, O O
7 O O
, O O
8 O O
-RSB- O O
. O O

We O O
speculated O O
that O O
variations O O
in O O
the O O
activity O O
of O O
the O O
synthetic O O
peptides O O
may O O
be O O
related O O
to O O
their O O
distinct O O
ability O O
to O O
activate O O
these O O
signaling O O
pathways O O
. O O

METHODS O O

The O O
synthetic O O
polypeptides O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
were O O
purchased O O
from O O
Peptides O O
International O O
-LRB- O O
Louisville O O
, O O
Ky O O
-RRB- O O
. O O

Hanks O O
' O O
balanced O O
salt O O
solution O O
-LRB- O O
HBSS O O
-RRB- O O
and O O
fMLP O O
were O O
obtained O O
from O O
Sigma O O
-LRB- O O
St O O
Louis O O
, O O
Mo O O
-RRB- O O
. O O

LY O O
294002 O O
was O O
from O O
Calbiochem O O
-LRB- O O
La O O
Jolla O O
, O O
Calif O O
-RRB- O O
and O O
SB O O
203580 O O
from O O
Biomol O O
-LRB- O O
Plymouth O O
Meeting O O
, O O
Pa O O
-RRB- O O
. O O

Indo-1 O O
acetoxymethyl O O
ester O O
-LRB- O O
Indo-1 O O
AM O O
-RRB- O O
was O O
purchased O O
from O O
Molecular O O
Probes O O
-LRB- O O
Eugene O O
, O O
Ore O O
-RRB- O O
and O O
stored O O
as O O
a O O
1 mM O O
stock O O
solution O O
in O O
dimethylsufoxide O O
at O O
−20°C O O
. O O

Rabbit O O
polyclonal O O
antibodies O O
against O O
NF-κB-p50 O O
, O O
NF-κB-p65 O O
, O O
and O O
p38 O O
MAP O O
kinase O O
, O O
as O O
well O O
as O O
horseradish O O
peroxidase- O O
-LRB- O O
HRP- O O
-RRB- O O
linked O O
secondary O O
antibodies O O
, O O
were O O
from O O
Santa O O
Cruz O O
Biotechnology O O
-LRB- O O
Santa O O
Cruz O O
, O O
Calif O O
-RRB- O O
. O O

Mouse O O
monoclonal O O
anti-phospho-p38 O O
MAP O O
kinase O O
-LRB- O O
Thr180/Tyr182 O O
-RRB- O O
antibody O O
-LRB- O O
IgG1 O O
-RRB- O O
was O O
purchased O O
from O O
Cell O O
Signaling O O
Technology O O
-LRB- O O
Beverly O O
, O O
Mass O O
-RRB- O O
, O O
and B-conn Conjunction
mouse O O
monoclonal O O
anti-phosphatidylinositol O O
3-kinase O O
-LRB- O O
PI3-K O O
-RRB- O O
-LRB- O O
p85-subunit-reactive O O
-RRB- O O
antibody O O
from O O
BD O O
Biosciences O O
PharMingen O O
-LRB- O O
San O O
Diego O O
, O O
Calif O O
-RRB- O O
. O O

Double-stranded O O
DNA O O
probes O O
used O O
for O O
electrophoretic O O
mobility O O
shift O O
assays O O
-LRB- O O
EMSAs O O
-RRB- O O
were O O
obtained O O
from O O
IDT O O
Technologies O O
-LRB- O O
Coralville O O
, O O
Iowa O O
-RRB- O O
. O O

FITC-linked O O
Annexin O O
V O O
was O O
from O O
R O O
& O O
D O O
Systems O O
-LRB- O O
Minneapolis O O
, O O
Minn O O
-RRB- O O
, O O
and B-conn Conjunction
propidium O O
iodide O O
from O O
Calbiochem O O
-LRB- O O
San O O
Diego O O
, O O
Calif O O
-RRB- O O
. O O

Human O O
neutrophils O O
were O O
isolated O O
from O O
heparinized O O
peripheral O O
venous O O
blood O O
by O O
dextran O O
sedimentation O O
and O O
Ficoll O O
density O O
gradient O O
centrifugation O O
as O O
previously O O
described O O
-LSB-9 O O
-RSB- O O
. O O

These O O
studies O O
were O O
approved O O
by O O
the O O
Institutional O O
Review O O
Board O O
of O O
UMDNJ O O
Robert O O
Wood O O
Johnson O O
Medical O O
School O O
. O O

Migration O O
of O O
neutrophils O O
through O O
nucleopore O O
polycarbonate O O
filters O O
was O O
assayed O O
using O O
the O O
modified O O
Boyden O O
chamber O O
technique O O
-LSB-10 O O
-RSB- O O
. O O

For O O
our O O
studies O O
we O O
used O O
a O O
48-well O O
microchemotaxis O O
chamber O O
-LRB- O O
Neuro O O
Probe O O
, O O
Inc O O
, O O
Pleasanton O O
, O O
Calif O O
-RRB- O O
. O O

Thirty O O
microliters O O
of O O
synthetic O O
peptides O O
, O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
, O O
or O O
medium O O
control O O
were O O
placed O O
in O O
each O O
well O O
of O O
the O O
lower O O
chamber O O
. O O

A O O
5-μm O O
pore-size O O
filter O O
was O O
then B-conn Temporal.Precedence
placed O O
over O O
the O O
wells O O
and B-conn Conjunction
the O O
upper O O
chamber O O
set O O
into O O
place O O
. O O

Fifty O O
microliters O O
of O O
a O O
neutrophil O O
suspension O O
-LRB- O O
1 O O
× O O
105cells O O
-RRB- O O
in O O
HBSS O O
containing O O
0.5 O O
% O O
bovine O O
serum O O
albumin O O
-LRB- O O
BSA O O
-RRB- O O
and O O
2.4 mg/ml O O
HEPES O O
, O O
pH O O
7.2 O O
, O O
was O O
added O O
to O O
each O O
well O O
. O O

After B-conn Temporal.Succession
incubation O O
for O O
45 minutes O O
at O O
37°C O O
, O O
the O O
filter O O
containing O O
adhered O O
, O O
migrated O O
neutrophils O O
was O O
removed O O
and O O
stained O O
with O O
Wright-Giemsa O O
. O O

Chemotaxis O O
was O O
quantified O O
as O O
the O O
number O O
of O O
cells O O
that O O
migrated O O
through O O
the O O
filter O O
in O O
10 O O
oil O O
immersion O O
fields O O
. O O

In O O
some O O
experiments O O
, O O
cells O O
were O O
incubated O O
at O O
room O O
temperature O O
with O O
LY O O
294002 O O
-LRB- O O
50 μM O O
, O O
5 minutes O O
-RRB- O O
or O O
SB O O
203580 O O
-LRB- O O
30 μM O O
, O O
1 hour O O
-RRB- O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
the O O
analysis O O
of O O
chemotactic O O
responsiveness O O
. O O

Indo-1 O O
AM O O
was O O
used O O
to O O
measure O O
intracellular O O
calcium O O
mobilization O O
-LSB-11 O O
-RSB- O O
. O O

Neutrophils O O
were O O
inoculated O O
into O O
Nunc O O
coverglass O O
chambers O O
-LRB- O O
2 O O
× O O
106 cells/chamber O O
-RRB- O O
and O O
allowed O O
to O O
adhere O O
overnight O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
washed O O
with O O
HBSS O O
containing O O
0.3 O O
% O O
BSA O O
and O O
incubated O O
in O O
1 μM O O
Indo-1 O O
AM O O
at O O
37°C O O
. O O

After O O
30 minutes O O
, O O
the O O
cells O O
were O O
washed O O
three O O
times O O
and B-conn Conjunction
1 mL O O
of O O
HBSS O O
containing O O
0.3 O O
% O O
BSA O O
was O O
added O O
to O O
each O O
well O O
. O O

Intracellular O O
calcium O O
was O O
quantified O O
on O O
a O O
Meridian O O
ACAS O O
570 O O
Anchored O O
Cell O O
Analysis O O
System O O
-LRB- O O
Okemos O O
, O O
Mich O O
-RRB- O O
equipped O O
with O O
an O O
Innova O O
90 O O
5-W O O
laser O O
adjusted O O
to O O
an O O
output O O
of O O
100 mW O O
. O O

For B-conn Purpose.Goal
measurement O O
of O O
cellular O O
fluorescence O O
, O O
Indo-1 O O
was O O
excited O O
using O O
the O O
ultraviolet O O
lines O O
-LRB- O O
351–364 nm O O
-RRB- O O
of O O
the O O
argon O O
laser O O
. O O

Calcium O O
mobilization O O
was O O
quantified O O
by B-conn Purpose.Enablement
scanning O O
single O O
130 O O
× O O
130 μm O O
fields O O
containing O O
≥ O O
15 O O
cells O O
every O O
8 seconds O O
for O O
a O O
total O O
of O O
5 O O
minutes O O
and O O
collecting O O
the O O
emissions O O
at O O
485 nm O O
-LRB- O O
calcium-free O O
Indo-1 O O
-RRB- O O
and O O
405 nm O O
-LRB- O O
calcium-saturated O O
Indo-1 O O
-RRB- O O
. O O

Data O O
are O O
presented O O
as O O
the O O
ratio O O
of O O
emission O O
at O O
405 nm O O
relative O O
to O O
485 nm O O
. O O

Synthetic O O
peptides O O
-LRB- O O
10 nM O O
-RRB- O O
or O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
were O O
added O O
to O O
the O O
cells O O
180 B-conn Temporal.Succession
seconds I-conn Temporal.Succession
after I-conn Temporal.Succession
stable O O
baselines O O
were O O
established O O
. O O

Neutrophils O O
were O O
incubated O O
-LRB- O O
37°C O O
-RRB- O O
with O O
medium O O
control O O
, O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
, O O
or O O
10 nM O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
or O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
for O O
2 O O
hours O O
-LRB- O O
PI3-K O O
-RRB- O O
or O O
5 minutes O O
-LRB- O O
p38 O O
, O O
phospho-p38 O O
-RRB- O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
solubilized O O
in O O
buffer O O
containing O O
50 O O
mM O O
HEPES O O
, O O
pH O O
7.4 O O
, O O
10 mM O O
KCl O O
, O O
1 mM O O
EDTA O O
, O O
1 mM O O
DTT O O
, O O
1 μg/mL O O
pepstatin O O
A O O
, O O
1 μg/mL O O
leupeptin O O
, O O
10 μg/mL O O
soybean O O
trypsin O O
inhibitor O O
, O O
10 μg/mL O O
aprotinin O O
, O O
and O O
1 O O
% O O
Triton O O
X-100 O O
. O O

After O O
10 minutes O O
in O O
ice O O
, O O
lysates O O
were O O
centrifuged O O
-LRB- O O
4000 O O
xg O O
, O O
5 minutes O O
-RRB- O O
and B-conn Conjunction
protein O O
concentrations O O
in O O
the O O
supernatants O O
were O O
quantified O O
using O O
a O O
BCA O O
Protein O O
Assay O O
Kit O O
-LRB- O O
Pierce O O
, O O
Rockford O O
, O O
Ill O O
-RRB- O O
with O O
BSA O O
as O O
the O O
standard O O
. O O

Aliquots O O
of O O
supernatants O O
containing O O
10 μg O O
of O O
protein O O
were O O
fractionated O O
on O O
7.5 O O
% O O
SDS O O
polyacrylamide O O
gels O O
and O O
electroblotted O O
onto O O
0.45 μm O O
nitrocellulose O O
paper O O
-LRB- O O
Bio-Rad O O
, O O
Hercules O O
, O O
Calif O O
-RRB- O O
at O O
250 mA O O
for O O
4 hours O O
in O O
a O O
Mini O O
Trans-Blot O O
Electrophoretic O O
Transfer O O
Cell O O
-LRB- O O
Bio-Rad O O
-RRB- O O
in O O
25 mM O O
Tris O O
, O O
pH O O
8.3 O O
, O O
192 mM O O
Gly O O
, O O
20 O O
% O O
-LRB- O O
v/v O O
-RRB- O O
methanol O O
. O O

Blots O O
were O O
then B-conn Temporal.Precedence
incubated O O
in O O
a O O
1 O O
: O O
250 O O
dilution O O
of O O
anti-phospho-p38 O O
MAP O O
kinase O O
antibody O O
, O O
anti-p38 O O
MAP O O
kinase O O
, O O
or O O
anti-PI3-K O O
antibody O O
. O O

After B-conn Temporal.Succession
washing O O
, O O
the O O
blots O O
were O O
incubated O O
with O O
goat O O
antimouse O O
IgG O O
-LRB- O O
1 O O
: O O
2000 O O
-RRB- O O
or O O
sheep O O
antirabbit O O
IgG O O
-LRB- O O
1 O O
: O O
1000 O O
-RRB- O O
HRP-conjugated O O
antibodies O O
for O O
1 hour O O
at O O
room O O
temperature O O
. O O

Proteins O O
were O O
detected O O
using O O
a O O
Renaissance O O
Western O O
Blot O O
Chemiluminescence O O
Reagent O O
Plus O O
kit O O
-LRB- O O
NEN O O
Life O O
Sciences O O
, O O
Boston O O
, O O
Mass O O
-RRB- O O
. O O

Neutrophils O O
were O O
washed O O
in O O
PBS O O
, O O
resuspended O O
in O O
Dulbecco O O
's O O
Modified O O
Eagle O O
's O O
Medium O O
-LRB- O O
DMEM O O
-RRB- O O
containing O O
10 O O
% O O
fetal O O
bovine O O
serum O O
, O O
and O O
incubated O O
in O O
a O O
shaking O O
water O O
bath O O
at O O
37°C O O
for O O
24 O O
hours O O
in O O
the O O
presence O O
or O O
absence O O
of O O
peptides O O
-LRB- O O
10 nM O O
-RRB- O O
. O O

Cells O O
were O O
then B-conn Temporal.Precedence
centrifuged O O
, O O
resuspended O O
-LRB- O O
2 O O
× O O
106 cells/mL O O
-RRB- O O
in O O
binding O O
buffer O O
-LRB- O O
10 mM O O
HEPES/NaOH O O
, O O
pH O O
7.4 O O
, O O
140 mM O O
NaCl O O
, O O
2.5 mM O O
CaCl2 O O
-RRB- O O
, O O
and O O
incubated O O
-LRB- O O
15 minutes O O
, O O
room O O
temperature O O
-RRB- O O
with O O
Annexin O O
V O O
and O O
propidium O O
iodide O O
. O O

Samples O O
were O O
analyzed O O
by O O
flow O O
cytometry O O
on O O
a O O
Coulter O O
EPICS O O
Profile O O
II O O
-LRB- O O
Hialeah O O
, O O
Fla O O
-RRB- O O
. O O

Viable O O
, O O
apoptotic O O
, O O
and O O
necrotic O O
neutrophil O O
populations O O
were O O
gated O O
electronically O O
and B-conn Conjunction
data O O
analyzed O O
using O O
quadrant O O
statistics O O
based O O
on O O
relative O O
Annexin O O
V O O
and O O
propidium O O
iodide O O
fluorescence O O
-LSB-12 O O
-RSB- O O
. O O

To B-conn Purpose.Goal
prepare O O
nuclear O O
extracts O O
, O O
neutrophils O O
-LRB- O O
2 O O
× O O
106 O O
-RRB- O O
were O O
microcentrifuged O O
for O O
15 seconds O O
and O O
then B-conn Temporal.Precedence
resuspended O O
in O O
400 μL O O
of O O
cold O O
buffer O O
-LRB- O O
10 mM O O
HEPES O O
, O O
pH O O
7.9 O O
, O O
10 mM O O
KCl O O
, O O
0.1 mM O O
EDTA O O
, O O
0.1 mM O O
EGTA O O
, O O
1 mM O O
DTT O O
, O O
0.5 mM O O
PMSF O O
-RRB- O O
. O O

After O O
15 minutes O O
in O O
ice O O
, O O
25 μL O O
of O O
a O O
10 O O
% O O
solution O O
of O O
NP-40 O O
was O O
added O O
, O O
and B-conn Conjunction
the O O
sample O O
mixed O O
on O O
a O O
vortex O O
for O O
10 seconds O O
. O O

The O O
lysates O O
were O O
then B-conn Temporal.Precedence
centrifuged O O
for O O
30 seconds O O
in O O
a O O
microfuge O O
, O O
the O O
nuclear O O
pellets O O
resuspended O O
in O O
50 μL O O
of O O
ice-cold O O
buffer O O
-LRB- O O
20 O O
mM O O
HEPES O O
, O O
pH O O
7.9 O O
, O O
0.4 M O O
NaCl O O
, O O
1 mM O O
EDTA O O
, O O
1 mM O O
EGTA O O
, O O
1 mM O O
DTT O O
, O O
1 mM O O
PMSF O O
-RRB- O O
and O O
placed O O
on O O
a O O
rocker O O
platform O O
at O O
4°C O O
for O O
15 minutes O O
. O O

The O O
sample O O
was O O
then B-conn Temporal.Precedence
microcentrifuged O O
for O O
5 minutes O O
at O O
4°C O O
and B-conn Conjunction
the O O
resulting O O
soluble O O
nuclear O O
extracts O O
were O O
collected O O
. O O

Double-stranded O O
probes O O
containing O O
an O O
NF-κB O O
-LRB- O O
AGTTGAGGGGACCGCCCGCGGCCCGT O O
-RRB- O O
consensus O O
sequence O O
were O O
labeled O O
with O O
-LRB- O O
γ-32P O O
-RRB- O O
-dCTP O O
. O O

For B-conn Purpose.Goal
binding O O
reactions O O
, O O
nuclear O O
extracts O O
-LRB- O O
50 μg O O
of O O
protein O O
-RRB- O O
were O O
incubated O O
for O O
15 minutes O O
at O O
room O O
temperature O O
with O O
labeled O O
probe O O
in O O
buffer O O
containing O O
10 mM O O
Tris-HCl O O
, O O
pH O O
7.4 O O
, O O
40 mM O O
NaCl O O
, O O
10 mM O O
EDTA O O
, O O
1 mM O O
2-mercaptoethanol O O
, O O
0.1 O O
% O O
NP-40 O O
, O O
4 O O
% O O
glycerol O O
, O O
and O O
0.1 μg/μL O O
poly O O
. O O

-LRB- O O
dI-dC O O
-RRB- O O
poly O O
. O O

-LRB- O O
dI-dC O O
-RRB- O O
-LRB- O O
Amersham O O
Pharmacia O O
Biotech O O
, O O
Piscataway O O
, O O
NJ O O
-RRB- O O
. O O

For B-conn Purpose.Goal
competitive O O
binding O O
assays O O
, O O
nuclear O O
extracts O O
were O O
incubated O O
with O O
a O O
100-fold O O
excess O O
unlabeled O O
probe O O
. O O

Supershift O O
assays O O
were O O
performed O O
by B-conn Purpose.Enablement
incubation O O
of O O
the O O
samples O O
with O O
polyclonal O O
antibodies O O
to O O
p50 O O
or O O
p65 O O
-LRB- O O
1 μg/60 μL O O
reaction O O
volume O O
-RRB- O O
for O O
1 hour O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
the O O
addition O O
of O O
the O O
labeled O O
probe O O
. O O

Samples O O
were O O
electrophoresed O O
on O O
4 O O
% O O
nondenaturing O O
polyacrylamide O O
gels O O
in O O
buffer O O
-LRB- O O
0.04 M O O
Tris-acetate O O
, O O
0.001 M O O
EDTA O O
, O O
pH O O
8.0 O O
-RRB- O O
at O O
15 V/cm O O
. O O

Gels O O
were O O
then B-conn Temporal.Precedence
dried O O
and O O
autoradiographed O O
. O O

RESULTS O O

We O O
have O O
previously O O
demonstrated O O
that O O
synthetic O O
pentameric O O
peptides O O
consisting O O
of O O
Pro O O
and O O
Gly O O
, O O
or O O
Pro O O
, O O
Hyp O O
, O O
and O O
Gly O O
are O O
chemoattractants O O
for O O
neutrophils O O
-LSB-1 O O
, O O
2 O O
, O O
3 O O
-RSB- O O
. O O
Figure O O
1 O O
shows O O
that O O
the O O
chemotactic O O
activity O O
of O O
these O O
peptides O O
is O O
dose O O
related O O
, O O
reaching O O
a O O
maximum O O
at O O
10 nM O O
. O O

Increasing O O
the O O
length O O
of O O
the O O
peptides O O
from O O
five O O
to O O
ten O O
repeated O O
units O O
reduced O O
their O O
chemotactic O O
activity O O
. O O

At O O
concentrations O O
of O O
1 O O
and O O
10 nM O O
, O O
peptides O O
consisting O O
of O O
Pro O O
, O O
Gly O O
, O O
and O O
Hyp O O
were O O
less O O
chemotactic O O
than O O
peptides O O
consisting O O
of O O
only O O
Pro O O
and O O
Gly O O
. O O

At O O
optimal O O
concentrations O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
the O O
most O O
potent O O
of O O
the O O
synthetic O O
peptides O O
, O O
was O O
approximately O O
60 O O
% O O
less O O
active O O
than O O
fMLP O O
in O O
inducing O O
chemotaxis O O
-LRB- O O
data O O
not O O
shown O O
-RRB- O O
. O O

Activated O O
neutrophils O O
are O O
cleared O O
from O O
inflamed O O
sites O O
by B-conn Purpose.Enablement
the O O
process O O
of O O
apoptosis O O
, O O
followed B-conn Temporal.Precedence
by I-conn Temporal.Precedence
macrophage O O
phagocytosis O O
. O O

This O O
leads O O
to O O
resolution O O
rather O O
than O O
persistence O O
of O O
tissue O O
injury O O
. O O

Chemoattractants O O
such O O
as O O
fMLP O O
promote O O
inflammation O O
by B-conn Purpose.Enablement
activating O O
neutrophils O O
and O O
prolonging O O
the O O
survival O O
of O O
these O O
cells O O
in O O
tissues O O
by B-conn Purpose.Enablement
blocking O O
apoptosis O O
-LSB-13 O O
-RSB- O O
. O O

In O O
further O O
studies O O
, O O
we O O
analyzed O O
the O O
effects O O
of O O
synthetic O O
polymeric O O
peptides O O
on O O
neutrophil O O
apoptosis O O
. O O

One O O
of O O
the O O
earliest O O
signs O O
of O O
apoptosis O O
is O O
translocation O O
of O O
phosphatidylserine O O
-LRB- O O
PS O O
-RRB- O O
from O O
the O O
inner O O
to O O
the O O
outer O O
surface O O
of O O
the O O
plasma O O
membrane O O
, O O
which O O
can O O
be O O
detected O O
by O O
Annexin O O
V O O
binding O O
-LSB-14 O O
-RSB- O O
. O O

Approximately O O
30 O O
% O O
of O O
neutrophils O O
was O O
found O O
to O O
undergo O O
spontaneous O O
apoptosis O O
after B-conn Temporal.Succession
24 hours O O
in O O
culture O O
-LRB- O O
Figure O O
2 O O
-RRB- O O
. O O

This O O
activity O O
was O O
significantly O O
reduced O O
in O O
the O O
presence O O
of O O
the O O
polypeptides O O
. O O

The O O
effects O O
of O O
the O O
synthetic O O
peptides O O
were O O
similar O O
to O O
fMLP O O
. O O

In B-conn Contrast
contrast I-conn Contrast
to I-conn Contrast
chemotaxis O O
, O O
no O O
differences O O
were O O
noted O O
in O O
the O O
antiapoptotic O O
activity O O
of O O
collagen-like O O
peptides O O
in O O
terms O O
of O O
their O O
size O O
or O O
composition O O
. O O

We O O
next B-conn Temporal.Precedence
investigated O O
potential O O
biochemical O O
signaling O O
pathways O O
mediating O O
the O O
biologic O O
activity O O
of O O
these O O
peptides O O
in O O
neutrophils O O
. O O

For B-conn Purpose.Goal
comparative O O
purposes O O
, O O
we O O
also B-conn Conjunction
evaluated O O
the O O
response O O
of O O
the O O
cells O O
to O O
fMLP O O
. O O

Treatment O O
of O O
neutrophils O O
with O O
fMLP O O
caused O O
a O O
rapid O O
and O O
transient O O
increase O O
in O O
intracellular O O
calcium O O
, O O
which O O
was O O
evident O O
within O O
30 seconds O O
-LRB- O O
Figure O O
3 O O
-RRB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
none O O
of O O
the O O
synthetic O O
polypeptides O O
induced O O
calcium O O
mobilization O O
in O O
neutrophils O O
. O O

PI3-K O O
catalyzes O O
the O O
formation O O
of O O
phosphatidylinositol O O
3,4,5-triphosphate O O
and O O
plays O O
a O O
key O O
role O O
in O O
neutrophil O O
activation O O
and O O
chemotaxis O O
-LSB-15 O O
, O O
16 O O
-RSB- O O
. O O

Low O O
levels O O
of O O
PI3-K O O
protein O O
were O O
detectable O O
in O O
unstimulated O O
neutrophils O O
-LRB- O O
Figure O O
4a O O
-RRB- O O
. O O

Treatment O O
of O O
the O O
cells O O
with O O
pentameric O O
peptides O O
consisting O O
of O O
Pro O O
and O O
Gly O O
resulted O O
in O O
a O O
twofold O O
increase O O
in O O
PI3-K O O
. O O

This O O
was O O
evident O O
after O O
2 hours O O
and O O
was O O
similar O O
to O O
the O O
response O O
observed O O
with O O
fMLP O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
the O O
pentameric O O
peptide O O
containing O O
Hyp O O
had O O
no O O
effect O O
on O O
PI3-K O O
, O O
and B-conn Conjunction
increasing O O
the O O
length O O
of O O
the O O
peptides O O
from O O
5 O O
to O O
10 O O
repeated O O
units O O
did O O
not O O
alter O O
the O O
quantity O O
of O O
PI3-K O O
detected O O
. O O

To B-conn Purpose.Goal
analyze O O
the O O
role O O
of O O
PI3-K O O
in O O
collagen O O
peptide-induced O O
chemotaxis O O
and O O
apoptosis O O
, O O
cells O O
were O O
treated O O
with O O
LY O O
294002 O O
-LSB-17 O O
-RSB- O O
. O O

This O O
PI3-K O O
inhibitor O O
was O O
found O O
to O O
reduce O O
chemotaxis O O
induced O O
by O O
fMLP O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
as O O
well O O
as O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
by O O
50 O O
% O O
-LRB- O O
Figure O O
1b O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

No O O
major O O
differences O O
were O O
noted O O
in O O
the O O
sensitivity O O
of O O
the O O
peptides O O
to O O
the O O
PI3-K O O
inhibitor O O
. O O

Similarly O O
, O O
LY O O
294002 O O
was O O
found O O
to O O
block O O
the O O
inhibitory O O
effects O O
of O O
both O O
fMLP O O
and O O
synthetic O O
peptides O O
on O O
apoptosis O O
. O O

As O O
observed O O
with O O
chemotaxis O O
, O O
no O O
differences O O
were O O
observed O O
in O O
the O O
sensitivity O O
of O O
the O O
antiapoptotic O O
effects O O
of O O
the O O
peptides O O
to O O
PI3-K O O
inhibition O O
-LRB- O O
Figure O O
2 O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

In O O
the O O
absence O O
of O O
these O O
peptides O O
, O O
LY O O
294002 O O
had O O
no O O
effect O O
on O O
chemotaxis O O
or O O
apoptosis O O
. O O

Recent O O
studies O O
have O O
implicated O O
MAP O O
kinases O O
in O O
chemoattractant-induced O O
signaling O O
and O O
in O O
PI3-K O O
activation O O
in O O
neutrophils O O
-LSB-18 O O
, O O
19 O O
, O O
20 O O
-RSB- O O
. O O

We O O
found O O
that O O
untreated O O
neutrophils O O
expressed O O
relatively O O
large O O
quantities O O
of O O
total O O
p38 O O
MAP O O
kinase O O
protein O O
-LRB- O O
Figure O O
4b O O
-RRB- O O
. O O

Expression O O
of O O
this O O
protein O O
was O O
unaltered O O
by O O
fMLP O O
or O O
by O O
synthetic O O
polypeptides O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
only O O
low O O
levels O O
of O O
phospho-p38 O O
MAP O O
kinase O O
were O O
detected O O
in O O
unstimulated O O
neutrophils O O
, O O
and B-conn Conjunction
this O O
was O O
markedly O O
increased O O
in O O
response O O
to O O
fMLP O O
, O O
as O O
well O O
as O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
-LRB- O O
Figure O O
4c O O
-RRB- O O
. O O

The O O
effects O O
of O O
these O O
peptides O O
on O O
phospho-p38 O O
expression O O
were O O
rapid O O
, O O
peaking O O
5 O O
minutes O O
after O O
treatment O O
and O O
persisting O O
for O O
at O O
least O O
20 minutes O O
-LRB- O O
Figure O O
4d O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

Treatment O O
of O O
neutrophils O O
with O O
peptides O O
containing O O
Hyp O O
had O O
no O O
significant O O
effect O O
on O O
phospho-p38 O O
protein O O
expression O O
-LRB- O O
Figure O O
4c O O
-RRB- O O
. O O

Pretreatment O O
of O O
the O O
cells O O
with O O
SB O O
203580 O O
, O O
a O O
p38 O O
MAP O O
kinase O O
inhibitor O O
-LSB-21 O O
-RSB- O O
, O O
was O O
found O O
to O O
significantly O O
reduce O O
chemotaxis O O
induced O O
by O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
as O O
well O O
as O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
-LRB- O O
Figure O O
1b O O
-RRB- O O
. O O

Similarly O O
, O O
SB O O
203580 O O
blocked O O
the O O
effects O O
of O O
fMLP O O
and O O
synthetic O O
peptides O O
on O O
apoptosis O O
, O O
indicating O O
that O O
this O O
response O O
is O O
also O O
p38 O O
MAP O O
kinase-dependent O O
-LRB- O O
Figure O O
2 O O
, O O
data O O
not O O
shown O O
-RRB- O O
. O O

The O O
transcription O O
factor O O
NF-κB O O
is O O
known O O
to O O
be O O
activated O O
by O O
chemoattractants O O
through O O
MAP O O
kinases O O
-LSB-22 O O
-RSB- O O
. O O

We O O
found O O
that O O
each O O
of O O
the O O
synthetic O O
peptides O O
, O O
like O O
fMLP O O
, O O
induced O O
nuclear O O
binding O O
of O O
NF-κB O O
-LRB- O O
Figure O O
5 O O
-RRB- O O
. O O

This O O
response O O
was O O
independent O O
of O O
peptide O O
length O O
or O O
composition O O
. O O

Supershift O O
assays O O
revealed O O
that O O
the O O
NF-κB O O
complex O O
contained O O
both O O
p50 O O
and O O
p65 O O
-LRB- O O
not O O
shown O O
-RRB- O O
. O O

Preincubation O O
of O O
nuclear O O
extracts O O
with O O
excess O O
unlabeled O O
probe O O
competitively O O
reduced O O
binding O O
of O O
the O O
labeled O O
probe O O
, O O
demonstrating O O
its O O
specificity O O
. O O

DISCUSSION O O

Neutrophil O O
chemotaxis O O
and O O
survival O O
are O O
regulated O O
by O O
inflammatory O O
mediators O O
that O O
are O O
present O O
at O O
sites O O
of O O
infection O O
or O O
injury O O
. O O

Whereas B-conn Contrast
proinflammatory O O
mediators O O
promote O O
chemotaxis O O
and O O
block O O
apoptosis O O
, O O
antiinflammatory O O
cytokines O O
are O O
proapoptotic O O
and O O
abrogate O O
the O O
chemotactic O O
response O O
. O O

Coordinate O O
regulation O O
of O O
chemotaxis O O
and O O
survival O O
allows O O
for O O
the O O
persistence O O
of O O
neutrophils O O
at O O
sites O O
of O O
injury O O
, O O
as O O
well O O
as O O
effective O O
termination O O
of O O
the O O
inflammatory O O
response O O
-LSB-23 O O
-RSB- O O
. O O

The O O
present O O
studies O O
demonstrate O O
that O O
synthetic O O
peptides O O
containing O O
collagen-like O O
structural O O
motifs O O
induce O O
chemotaxis O O
and O O
reduce O O
apoptosis O O
in O O
neutrophils O O
. O O

These O O
results O O
are O O
consistent O O
with O O
a O O
proinflammatory O O
role O O
of O O
these O O
peptides O O
. O O

This O O
is O O
supported O O
by O O
reports O O
that O O
synthetic O O
collagen-like O O
peptides O O
also O O
stimulate O O
oxidative O O
metabolism O O
and O O
macrophage O O
release O O
of O O
neutrophil O O
chemokines O O
-LSB-4 O O
, O O
24 O O
-RSB- O O
. O O

Tissue O O
injury O O
is O O
associated O O
with O O
breakdown O O
of O O
interstitial O O
connective O O
tissue O O
. O O

Our O O
findings O O
that O O
peptides O O
containing O O
collagen-like O O
structural O O
motifs O O
exhibit O O
proinflammatory O O
activity O O
suggests O O
that O O
they O O
may O O
play O O
a O O
role O O
in O O
amplifying O O
acute O O
immunological O O
responses O O
to O O
infection O O
or O O
injury O O
. O O

Consistent O O
with O O
previous O O
studies O O
-LSB-2 O O
, O O
3 O O
-RSB- O O
, O O
we O O
found O O
that O O
the O O
chemotactic O O
activity O O
of O O
the O O
synthetic O O
polypeptides O O
was O O
directly O O
related O O
to O O
their O O
size O O
and O O
composition O O
. O O

Thus B-conn Restatement.Specification
, O O
larger O O
peptides O O
containing O O
ten O O
repeated O O
subunits O O
were O O
less O O
active O O
than O O
those O O
containing O O
five O O
subunits O O
. O O

Moreover B-conn Conjunction
, O O
peptides O O
consisting O O
of O O
Pro O O
, O O
Gly O O
, O O
and O O
Hyp O O
were O O
less O O
chemotactic O O
than O O
peptides O O
consisting O O
of O O
only O O
Pro O O
and O O
Gly O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
although B-conn Concession.Expectation
each O O
of O O
the O O
peptides O O
markedly O O
reduced O O
neutrophil O O
apoptosis O O
, O O
these O O
effects O O
were O O
independent O O
of O O
peptide O O
size O O
or O O
structure O O
. O O

These O O
data O O
suggest O O
that O O
collagen O O
peptide-induced O O
chemotaxis O O
and O O
apoptosis O O
involve O O
distinct O O
receptors O O
and/or O O
signaling O O
mechanisms O O
. O O

One O O
early O O
step O O
in O O
the O O
signaling O O
pathway O O
induced O O
by O O
chemoattractants O O
is O O
mobilization O O
of O O
intracellular O O
Ca++ O O
-LSB-25 O O
, O O
26 O O
-RSB- O O
. O O

In O O
contrast O O
to O O
fMLP O O
, O O
the O O
synthetic O O
peptides O O
had O O
no O O
effect O O
on O O
calcium O O
mobilization O O
in O O
human O O
neutrophils O O
. O O

These O O
findings O O
suggest O O
that O O
the O O
chemotactic O O
and O O
antiapoptotic O O
actions O O
of O O
these O O
peptides O O
do O O
not O O
require O O
changes O O
in O O
intracellular O O
calcium O O
. O O

This O O
is O O
consistent O O
with O O
reports O O
of O O
other O O
proinflammatory O O
mediators O O
that O O
alter O O
neutrophil O O
chemotaxis O O
and O O
apoptosis O O
by O O
mechanisms O O
independent O O
of O O
intracellular O O
calcium O O
shifts O O
, O O
including O O
transforming O O
growth O O
factor-β1 O O
, O O
soluble O O
Fas O O
ligand O O
, O O
immune O O
complexes O O
, O O
and O O
the O O
antineutrophil O O
antibody O O
, O O
DL1.2 O O
-LSB-27 O O
, O O
28 O O
, O O
29 O O
, O O
30 O O
-RSB- O O
. O O

Our O O
findings O O
suggest O O
that O O
the O O
requirement O O
for O O
increases O O
in O O
intracellular O O
calcium O O
for B-conn Purpose.Goal
induction O O
of O O
biological O O
activity O O
depends O O
on O O
the O O
chemoattractant O O
. O O

Activation O O
of O O
protein O O
kinases O O
including O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
is O O
thought O O
to O O
play O O
a O O
critical O O
role O O
in O O
chemoattractant-induced O O
signaling O O
leading O O
to O O
biologic O O
responses O O
-LSB-19 O O
, O O
20 O O
, O O
31 O O
, O O
32 O O
, O O
33 O O
, O O
34 O O
, O O
35 O O
, O O
36 O O
-RSB- O O
. O O

Consistent O O
with O O
this O O
idea O O
, O O
we O O
found O O
that O O
the O O
effects O O
of O O
the O O
synthetic O O
peptides O O
on O O
chemotaxis O O
and O O
apoptosis O O
were O O
dependent O O
on O O
both O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
activity O O
. O O

Thus B-conn Restatement.Specification
, O O
LY O O
294002 O O
and O O
SB O O
203580 O O
, O O
inhibitors O O
of O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
, O O
respectively O O
, O O
blocked O O
both O O
the O O
chemotactic O O
and O O
antiapoptotic O O
activity O O
of O O
each O O
of O O
the O O
peptides O O
. O O

However B-conn Concession.Contra-expectation
, O O
whereas B-conn Contrast
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
induced O O
PI3-K O O
and O O
phospho-p38 O O
expression O O
in O O
neutrophils O O
, O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
had O O
no O O
effect O O
on O O
these O O
proteins O O
. O O

Peptides O O
containing O O
Hyp O O
were O O
also O O
less O O
potent O O
chemoattractants O O
than O O
peptides O O
containing O O
only O O
Pro O O
and O O
Gly O O
. O O

These O O
findings O O
suggest O O
that O O
the O O
relative O O
chemotactic O O
potency O O
of O O
these O O
peptides O O
may O O
be O O
related O O
to O O
their O O
efficacy O O
in O O
upregulating O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
. O O

Alternatively B-conn Alternative.Disjunctive
, O O
fMLP O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
and O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
may O O
induce O O
rapid O O
alterations O O
in O O
the O O
subcellular O O
localization O O
of O O
PI3-K O O
protein O O
in O O
neutrophils O O
, O O
leading O O
to O O
increased O O
accessibility O O
and O O
detection O O
by O O
immunoblotting O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
this O O
does O O
not O O
appear O O
to O O
be O O
the O O
case O O
for O O
apoptosis O O
. O O

Thus B-conn Restatement.Specification
, O O
an O O
inability O O
to O O
induce O O
PI3-K O O
or O O
phospho-p38 O O
MAP O O
kinase O O
had O O
no O O
effect O O
on O O
the O O
antiapoptotic O O
activity O O
of O O
Hyp-containing O O
peptides O O
. O O

The O O
observation O O
that O O
the O O
antiapoptotic O O
effects O O
of O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
were O O
blocked O O
by O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
inhibitors O O
indicates O O
that O O
these O O
signaling O O
pathways O O
are O O
nevertheless O O
essential O O
for O O
this O O
response O O
. O O

However B-conn Concession.Contra-expectation
, O O
they O O
appear O O
to O O
be O O
activated O O
distinctly O O
by O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
n O O
and O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
n O O
peptides O O
. O O

Previous O O
studies O O
have O O
suggested O O
that O O
PI3-K-mediated O O
responses O O
induced O O
by O O
chemoattractants O O
involve O O
mobilization O O
of O O
intracellular O O
calcium O O
through B-conn Purpose.Enablement
activation O O
of O O
phospholipase O O
C O O
-LSB-37 O O
-RSB- O O
. O O

Alterations O O
in O O
cytosolic O O
Ca2+ O O
are O O
also B-conn Conjunction
important O O
in O O
inducing O O
p38 O O
MAP O O
kinase O O
activity O O
in O O
neutrophils O O
-LSB-38 O O
-RSB- O O
. O O

In B-conn Contrast
contrast I-conn Contrast
, O O
our O O
findings O O
indicate O O
that O O
synthetic O O
peptide-induced O O
activation O O
of O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
, O O
leading O O
to O O
chemotaxis O O
and O O
reduced O O
apoptosis O O
, O O
occurs O O
though O O
calcium-independent O O
pathways O O
. O O

It O O
is O O
possible O O
that O O
phosphoinositides O O
, O O
or O O
phosphorylated O O
protein O O
products O O
of O O
PI3-K O O
or O O
p38 O O
MAP O O
kinase O O
, O O
interact O O
directly O O
with O O
actin-binding O O
proteins O O
, O O
resulting O O
in O O
directed O O
migration O O
of O O
the O O
cells O O
-LSB-39 O O
-RSB- O O
. O O

p38 O O
MAP O O
kinase O O
is O O
also O O
known O O
to O O
phosphorylate O O
proteins O O
that O O
may O O
regulate O O
chemotaxis O O
and O O
apoptosis O O
by O O
calcium-independent O O
mechanisms O O
, O O
including O O
MAP O O
kinase-activated O O
proteins O O
2 O O
, O O
3 O O
, O O
and O O
5 O O
, O O
as O O
well O O
as O O
the O O
transcription O O
factors O O
ATF-2 O O
and O O
CHOP-1 O O
-LSB-40 O O
-RSB- O O
. O O

Signaling O O
via O O
PI3-K O O
and O O
p38 O O
MAP O O
kinase O O
leads O O
to O O
the O O
activation O O
of O O
the O O
transcription O O
factor O O
NF-κB O O
, O O
which O O
is O O
known O O
to O O
regulate O O
genes O O
involved O O
in O O
inflammatory O O
responses O O
to O O
tissue O O
injury O O
-LSB-41 O O
-RSB- O O
. O O

NF-κB O O
has O O
been O O
reported O O
to O O
be O O
involved O O
in O O
chemoattractant-induced O O
neutrophil O O
activation O O
as O O
well O O
as O O
the O O
suppression O O
of O O
apoptosis O O
-LSB-22 O O
, O O
42 O O
-RSB- O O
. O O

Moreover B-conn Conjunction
, O O
mice O O
lacking O O
the O O
NF-κB O O
subunit O O
c-Rel O O
are O O
resistant O O
to O O
collagen-induced O O
arthritis O O
, O O
and B-conn Conjunction
inhibition O O
of O O
NF-κB O O
blocks O O
neutrophil O O
migration O O
into O O
damaged O O
lungs O O
in O O
vivo O O
-LSB-43 O O
, O O
44 O O
, O O
45 O O
-RSB- O O
. O O

We O O
found O O
that O O
peptides O O
containing O O
collagen-related O O
structural O O
motifs O O
induced O O
NF-κB O O
nuclear O O
binding O O
activity O O
in O O
neutrophils O O
. O O

However B-conn Concession.Contra-expectation
, O O
no O O
significant O O
differences O O
in O O
activity O O
were O O
observed O O
based O O
on O O
the O O
size O O
or O O
composition O O
of O O
the O O
peptides O O
. O O

These O O
findings O O
are O O
consistent O O
with O O
the O O
antiapoptotic O O
effects O O
of O O
these O O
synthetic O O
peptides O O
and O O
suggest O O
that O O
the O O
chemotactic O O
and O O
antiapoptotic O O
effects O O
of O O
the O O
peptides O O
involve O O
distinct O O
signaling O O
pathways O O
leading O O
to O O
NF-κB O O
activation O O
. O O

CONCLUSIONS O O

Polymeric O O
polypeptides O O
containing O O
collagen-related O O
structural O O
motifs O O
promote O O
inflammation O O
by B-conn Purpose.Enablement
inducing O O
chemotaxis O O
and O O
blocking O O
apoptosis O O
. O O

However B-conn Concession.Contra-expectation
, O O
distinct O O
calcium-independent O O
signaling O O
pathways O O
appear O O
to O O
be O O
involved O O
in O O
these O O
activities O O
. O O

Neutrophil O O
chemotaxis O O
and O O
apoptosis O O
are O O
a O O
key O O
to O O
initiating O O
and O O
controlling O O
inflammation O O
. O O

The O O
accumulation O O
and O O
persistence O O
of O O
these O O
cells O O
in O O
tissues O O
in B-conn Temporal.Succession
response I-conn Temporal.Succession
to I-conn Temporal.Succession
protein O O
fragments O O
generated O O
by O O
invasive O O
pathogens O O
or O O
by O O
the O O
degradation O O
of O O
connective O O
tissue O O
collagen O O
may O O
exacerbate O O
injury O O
. O O

An O O
understanding O O
of O O
the O O
mechanisms O O
mediating O O
these O O
processes O O
is O O
essential O O
in O O
developing O O
strategies O O
for B-conn Purpose.Goal
limiting O O
maladaptive O O
inflammatory O O
responses O O
. O O

Figure O O
and O O
Table O O
captions O O

Figure O O
1 O O
: O O
Induction O O
of O O
chemotaxis O O
by O O
synthetic O O

polypeptides O O
. O O

Neutrophil O O
chemotaxis O O
was O O
assayed O O
using O O
microwell O O

chambers O O
. O O

Each O O
bar O O
represents O O
the O O
mean O O
± O O
SEM O O
of O O
3–4 O O

experiments O O
. O O

Background O O
levels O O
of O O
migration O O
were O O
subtracted O O
from O O

each O O
value O O
. O O

-LRB- O O
a O O
-RRB- O O
Dose-dependent O O
effects O O
of O O
peptides O O
on O O
neutrophil O O

chemotaxis O O
. O O

-LRB- O O
b O O
-RRB- O O
Cells O O
were O O
incubated O O
with O O
medium O O
control O O
, O O
the O O
p38 O O

MAP O O
kinase O O
inhibitor O O
SB O O
203580 O O
-LRB- O O
30 μM O O
, O O
1 hour O O
-RRB- O O
or O O
the O O

PI3-K O O
inhibitor O O
LY O O
294002 O O
-LRB- O O
50 μM O O
, O O
5 minutes O O
-RRB- O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence

the O O
analysis O O
of O O
chemotactic O O
responsiveness O O
to O O
polypeptides O O

-LRB- O O
10 nM O O
-RRB- O O
. O O

-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
n O O
, O O
-LRB- O O
PPG O O
-RRB- O O
n O O
; O O

-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
n O O
, O O
-LRB- O O
POG O O
-RRB- O O
n O O
. O O

Figure O O
2 O O
: O O
Measurement O O
of O O
neutrophil O O
apoptosis O O
. O O

Cells O O
were O O

incubated O O
in O O
a O O
shaking O O
water O O
bath O O
-LRB- O O
37°C O O
-RRB- O O
in O O
the O O
presence O O
or O O

absence O O
of O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
, O O
synthetic O O

polypeptides O O
, O O
SB O O
203580 O O
, O O
or O O
LY O O
294002 O O
for O O
24 hours O O
and O O
then B-conn Temporal.Precedence

labeled O O
with O O
Annexin O O
V O O
and O O
propidium O O
iodide O O
and O O
analyzed O O
by O O
flow O O

cytometry O O
. O O

Data O O
were O O
analyzed O O
using O O
Coulter O O
quadrant O O
statistics O O

based O O
on O O
relative O O
fluorescence O O
binding O O
of O O
Annexin O O
V O O
and O O
propidium O O

iodide O O
. O O

Each O O
bar O O
represents O O
the O O
mean O O
± O O
SEM O O
of O O
3–4 O O

experiments O O
. O O

Significantly O O
different O O
-LRB- O O
P O O
< O O
.05 O O
-RRB- O O

from O O

control O O
. O O

Figure O O
3 O O
: O O
Effects O O
of O O
synthetic O O
polypeptides O O
on O O
calcium O O

mobilization O O
. O O

Neutrophils O O
were O O
incubated O O
with O O
Indo-1 O O

-LRB- O O
1 μM O O
-RRB- O O
. O O

After B-conn Temporal.Succession
establishing O O
a O O
stable O O
baseline O O
, O O
10 nM O O

-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
or O O

fMLP O O
was O O
added O O
-LRB- O O
arrow O O
-RRB- O O
to O O
the O O
cells O O
. O O

Calcium O O
mobilization O O
is O O

indicated O O
by O O
an O O
increase O O
in O O
the O O
Indo-1 O O
fluorescence O O
ratio O O
. O O

Each O O

graph O O
represents O O
the O O
average O O
change O O
in O O
ratio O O
in O O
a O O
field O O
containing O O

not O O
less O O
than O O
15 O O
cells O O
. O O

Figure O O
4 O O
: O O
Effects O O
of O O
synthetic O O
polypeptides O O
on O O
PI3-K O O
and O O
p38 O O
MAP O O

kinase O O
expression O O
. O O

Neutrophils O O
were O O
incubated O O
-LRB- O O
37°C O O
-RRB- O O
with O O

medium O O
control O O
, O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
, O O
or O O
10 nM O O

-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
, O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
10 O O
, O O
-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
5 O O
, O O
or O O

-LRB- O O
Pro-Hyp-Gly O O
-RRB- O O
10 O O
for O O
2 hours O O
-LRB- O O
PI3-K O O
-RRB- O O
or O O
5 minutes O O

-LRB- O O
p38 O O
, O O
phospho-p38 O O
-RRB- O O
. O O

-LRB- O O
a O O
-RRB- O O
PI3-K O O
, O O
-LRB- O O
b O O
-RRB- O O
p38 O O
, O O
-LRB- O O
c O O
-RRB- O O
phospho-p38 O O
, O O
-LRB- O O
d O O
-RRB- O O

protein O O
expressions O O
were O O
measured O O
using O O
western O O
blotting O O

and O O
quantified O O
by O O
densitometry O O
. O O

Time O O
course O O
of O O
phospho-p38 O O
protein O O

expression O O
in O O
response O O
to O O
-LRB- O O
Pro-Pro-Gly O O
-RRB- O O
5 O O
. O O

Western O O
blots O O
were O O

scanned O O
by O O
densitometry O O
and B-conn Conjunction
data O O
presented O O
as O O
relative O O
intensity O O

units O O
. O O

One O O
representative O O
experiment O O
of O O
3 O O
is O O
shown O O
for O O
each O O

analysis O O
. O O

Figure O O
5 O O
: O O
Effects O O
of O O
synthetic O O
polypeptides O O
on O O
NF-κB O O

nuclear O O
binding O O
activity O O
. O O

Neutrophils O O
-LRB- O O
1 O O
× O O
106/mL O O
-RRB- O O
were O O

treated O O
with O O
medium O O
control O O
-LRB- O O
Med O O
-RRB- O O
, O O
synthetic O O
peptides O O

-LRB- O O
10 nM O O
-RRB- O O
, O O
or O O
fMLP O O
-LRB- O O
5 O O
× O O
10−8 M O O
-RRB- O O
for O O

30 minutes O O
. O O

Nuclear O O
extracts O O
-LRB- O O
50 μg O O
of O O
protein O O
-RRB- O O
were O O

analyzed O O
for O O
NF-κB O O
binding O O
activity O O
using O O
a O O
gel O O
retardation O O

assay O O
. O O

Extracts O O
, O O
prepared O O
from O O
fMLP-treated O O
cells O O
were O O
incubated O O

in O O
ice O O
for O O
1 hour O O
with O O
antibodies O O
to O O
the O O
p50 O O
or O O
p65 O O

subunits O O
of O O
NF-κB O O
-LRB- O O
1 μg O O
-RRB- O O
, O O
or O O
100-fold O O
excess O O

unlabeled O O
cold O O
competitor O O
-LRB- O O
Comp O O
-RRB- O O
prior B-conn Temporal.Precedence
to I-conn Temporal.Precedence
the O O
labeled O O

probe O O
. O O

